<SEC-DOCUMENT>0001739940-23-000016.txt : 20230505
<SEC-HEADER>0001739940-23-000016.hdr.sgml : 20230505
<ACCEPTANCE-DATETIME>20230505105025
ACCESSION NUMBER:		0001739940-23-000016
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		111
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230505
DATE AS OF CHANGE:		20230505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cigna Group
		CENTRAL INDEX KEY:			0001739940
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				824991898
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38769
		FILM NUMBER:		23891932

	BUSINESS ADDRESS:	
		STREET 1:		900 COTTAGE GROVE ROAD
		CITY:			BLOOMFIELD
		STATE:			CT
		ZIP:			06002
		BUSINESS PHONE:		8602266000

	MAIL ADDRESS:	
		STREET 1:		900 COTTAGE GROVE ROAD
		CITY:			BLOOMFIELD
		STATE:			CT
		ZIP:			06002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cigna Corp
		DATE OF NAME CHANGE:	20181221

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Halfmoon Parent, Inc.
		DATE OF NAME CHANGE:	20180508
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ci-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:aba5d1e1-3c5d-49dc-8b95-aefd0f7f3078,g:b4e2c703-69a2-450e-a66f-edc6453c1c81,d:d1800413722c4e30b53ad5d464cab4e8--><html xmlns:srt="http://fasb.org/srt/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ci="http://www.thecignagroup.com/20230331" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ci-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xL2ZyYWc6MmJjZmM1ZWVlMGU3NDgxZmFmN2Q3ZjczZjhlNjcxOTkvdGFibGU6YTIyNTNiYTRlNjNlNDM4Y2E2MmVkNzI2YjY0NGUzYTAvdGFibGVyYW5nZTphMjI1M2JhNGU2M2U0MzhjYTYyZWQ3MjZiNjQ0ZTNhMF8zLTItMS0xLTU0NzA5OA_c55f8419-2789-43c1-ae2b-9329352bb7c0">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xL2ZyYWc6MmJjZmM1ZWVlMGU3NDgxZmFmN2Q3ZjczZjhlNjcxOTkvdGFibGU6YTIyNTNiYTRlNjNlNDM4Y2E2MmVkNzI2YjY0NGUzYTAvdGFibGVyYW5nZTphMjI1M2JhNGU2M2U0MzhjYTYyZWQ3MjZiNjQ0ZTNhMF80LTItMS0xLTU0NzA5OA_3be8c4ed-a9c3-4a7d-b8ca-f9b1982870bf">2023</ix:nonNumeric><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xL2ZyYWc6MmJjZmM1ZWVlMGU3NDgxZmFmN2Q3ZjczZjhlNjcxOTkvdGFibGU6YTIyNTNiYTRlNjNlNDM4Y2E2MmVkNzI2YjY0NGUzYTAvdGFibGVyYW5nZTphMjI1M2JhNGU2M2U0MzhjYTYyZWQ3MjZiNjQ0ZTNhMF81LTItMS0xLTU0NzA5OA_9325a0e8-92ab-4efa-a45a-a43de0cb53ef">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xL2ZyYWc6MmJjZmM1ZWVlMGU3NDgxZmFmN2Q3ZjczZjhlNjcxOTkvdGFibGU6YTIyNTNiYTRlNjNlNDM4Y2E2MmVkNzI2YjY0NGUzYTAvdGFibGVyYW5nZTphMjI1M2JhNGU2M2U0MzhjYTYyZWQ3MjZiNjQ0ZTNhMF82LTItMS0xLTU0NzA5OA_c987e69b-171e-4370-970f-9485c0dee199">false</ix:nonNumeric><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xL2ZyYWc6MmJjZmM1ZWVlMGU3NDgxZmFmN2Q3ZjczZjhlNjcxOTkvdGFibGU6YTIyNTNiYTRlNjNlNDM4Y2E2MmVkNzI2YjY0NGUzYTAvdGFibGVyYW5nZTphMjI1M2JhNGU2M2U0MzhjYTYyZWQ3MjZiNjQ0ZTNhMF83LTItMS0xLTU0NzA5OA_74959c11-1477-4342-963c-7ebfdf4dcabe">0001739940</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="i41bcd1ff54304762b1285aa37c402aca_D20230101-20230331" xsi:nil="true" name="ci:FairValueMeasurementNonPerformanceRiskAdjustment" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MDcvZnJhZzpjYWUwOTVmYmVmM2I0NThlYTA1MTlkNDBlNmE0NTZjZC90YWJsZTowN2I1ZTg0ZThkMzI0ZGE0YjQ2NWQ0ODg0OGUzNzhhZS90YWJsZXJhbmdlOjA3YjVlODRlOGQzMjRkYTRiNDY1ZDQ4ODQ4ZTM3OGFlXzItNC0xLTEtNTQ3MDk4_81f12584-882b-44a3-a343-0c1442b82cce"></ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i3bcfd173fa8c4857abc112fc0044dc2d_D20220101-20220331" xsi:nil="true" name="ci:FairValueMeasurementNonPerformanceRiskAdjustment" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MDcvZnJhZzpjYWUwOTVmYmVmM2I0NThlYTA1MTlkNDBlNmE0NTZjZC90YWJsZTowN2I1ZTg0ZThkMzI0ZGE0YjQ2NWQ0ODg0OGUzNzhhZS90YWJsZXJhbmdlOjA3YjVlODRlOGQzMjRkYTRiNDY1ZDQ4ODQ4ZTM3OGFlXzItNS0xLTEtNTQ3MDk4_b3d5e9d4-5d0d-4c6b-9d33-516c7e17b3b7"></ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i51f0ae43a8284805b5e99637347441a3_D20230101-20230331" xsi:nil="true" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTAvZnJhZzplYTM0YzRjYTY3Nzk0MTExOTA2MWJjNGY4ZWMzOWUwOC90YWJsZToyMmE2Yzg4N2I3MGM0MTNkOGRkMGU2YmRhODdhNzY5YS90YWJsZXJhbmdlOjIyYTZjODg3YjcwYzQxM2Q4ZGQwZTZiZGE4N2E3NjlhXzQtNC0xLTEtNTQ3MDk4_507cef23-fa02-4ce5-9aaa-99955a3aeebf"></ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i3d8b2a4b61444ca69c5e9a155af379a2_D20220101-20220331" xsi:nil="true" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTAvZnJhZzplYTM0YzRjYTY3Nzk0MTExOTA2MWJjNGY4ZWMzOWUwOC90YWJsZToyMmE2Yzg4N2I3MGM0MTNkOGRkMGU2YmRhODdhNzY5YS90YWJsZXJhbmdlOjIyYTZjODg3YjcwYzQxM2Q4ZGQwZTZiZGE4N2E3NjlhXzQtNS0xLTEtNTQ3MDk4_7fdc730a-0b22-4eda-8650-b87fc12831a2"></ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" xsi:nil="true" name="ci:RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTAvZnJhZzplYTM0YzRjYTY3Nzk0MTExOTA2MWJjNGY4ZWMzOWUwOC90YWJsZToyMmE2Yzg4N2I3MGM0MTNkOGRkMGU2YmRhODdhNzY5YS90YWJsZXJhbmdlOjIyYTZjODg3YjcwYzQxM2Q4ZGQwZTZiZGE4N2E3NjlhXzYtNC0xLTEtNTQ3MDk4_87c9b64b-6167-4ee9-ae3d-9b3e966b7feb"></ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" xsi:nil="true" name="ci:RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTAvZnJhZzplYTM0YzRjYTY3Nzk0MTExOTA2MWJjNGY4ZWMzOWUwOC90YWJsZToyMmE2Yzg4N2I3MGM0MTNkOGRkMGU2YmRhODdhNzY5YS90YWJsZXJhbmdlOjIyYTZjODg3YjcwYzQxM2Q4ZGQwZTZiZGE4N2E3NjlhXzYtNS0xLTEtNTQ3MDk4_c99fe177-e013-44fe-a8fb-5379a6f16f74"></ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" xsi:nil="true" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTAvZnJhZzplYTM0YzRjYTY3Nzk0MTExOTA2MWJjNGY4ZWMzOWUwOC90YWJsZToyMmE2Yzg4N2I3MGM0MTNkOGRkMGU2YmRhODdhNzY5YS90YWJsZXJhbmdlOjIyYTZjODg3YjcwYzQxM2Q4ZGQwZTZiZGE4N2E3NjlhXzctNC0xLTEtNTQ3MDk4_cd3fda68-9b4f-4a26-9f06-d6ffc8371988"></ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" xsi:nil="true" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTAvZnJhZzplYTM0YzRjYTY3Nzk0MTExOTA2MWJjNGY4ZWMzOWUwOC90YWJsZToyMmE2Yzg4N2I3MGM0MTNkOGRkMGU2YmRhODdhNzY5YS90YWJsZXJhbmdlOjIyYTZjODg3YjcwYzQxM2Q4ZGQwZTZiZGE4N2E3NjlhXzctNS0xLTEtNTQ3MDk4_d83ec1ba-2e13-4d37-9d94-9b56587a3ad1"></ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ci-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdeb9c39ab4c4ab3bc182291feaa44c7_I20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i933d49a7caa5445f9359253b5b0b5023_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i2699cfc415ab4727a3246be3ce9a03fb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cf64ff3b0a2466f81f78f097b7c8d5d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i530643094c274242bf05d8df55f63659_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="icfbd026f02e243f087fcef41ca300348_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id32446380c2041c8b63ae668e812de11_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia07eeeff84fa4f25a2dd79fdc9bc15dd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2b7588439a24468b996c973b3308b0f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7d813880f744d49943f15dd7e540ba0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90dec54128bd417fa982da7f2d7685f2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d2cebed8b184349b833533515099744_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0206ebaad6534ebe9f01b32c7c8377aa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7909946bc91943678368051fb2668b17_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf856e4d292f45ee82a219747b70690d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c0abb6b8064491c945d2af1005f4e61_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22ee4c2e55934757aa575a02b3920fb4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05dd3918d78c4bf1a755567f7c64ddb8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia464d53888f74e16b5ba9e62ba445568_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34d79544d8cb4787abb0f63293d81023_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ca2b0796c79476594136b360600f553_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99423769f3dd4edb99594b8b2aee677e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e2dbc865d7444349a0f2776dabcbca6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20a54758336f4568bce7df2f2f0da706_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b841b999bc847b2a7d961377de9d3de_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70ad8103265e4886a5533cccf894688b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i617514263e2a477ba7f3b8a9a6a9674a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2c898b920ca42a186661453324aadcd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30c711c00bcf422fafd828ded50e4f64_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85fc8a53e3214c7c985953d9b3dc5a78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia71485e3f57d4b1e87922c63f04789e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie21827b448914783ad89a1e60a05565f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb159500cff1416584b25f65dcff1e94_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd620fc2833e42f18e79f1190828960c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9c54d8a0b0d4d1f9f08d455276b0990_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29e9fa809dec40e4a4434d5f6b246b71_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75919ae416364991a9685e11cb5779d9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11d2197648684bb191b9dfd2c8308df3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i417f3083e801423e81a8d2f395260442_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia44468c92367407098fcf49709295d14_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46e8477b53954f2eb5c8d27ecfddb379_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7677f2aaed8c4a29a27ff12fecd40d9e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7fe65d9692f4e978e3eeb7d6c41aef0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1487aaff9d704b1b9f53a37e55ac7eea_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i677503e86b4241c6889f0c64707d9e13_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic71911f816574fdb881509b52a744fc9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04417f56eeb14234a4bf022e54781719_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0168835d0324407988eb74d7d61484da_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c7aed585f9d4d058090d2ff63838ee3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51b230fe17da43ddb1e4f787e7e5b489_I20220701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ci:InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6534aa5174f46daae1011252bc79cfa_D20220701-20220701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ci:InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b459f141c6c4b0da2923bbbd4e8c935_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9856273e9b994b9094b394811fc62689_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia476822164994b318ba1a7d0dfc61cc8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202383InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i5453dc8934554e9faf7e6b1ef64dbf8b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202383InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9fd170cd0b544f4947eb9267c3105ae_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2023765InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75f10178c4e44f02b6fd42a4130fb189_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2023765InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b1750dc39384c35b545131f314c0819_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2023FloatingRateInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d639de145c64f1fb64c4f7629a3f64e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2023FloatingRateInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic135eb18221a4aa39a034dad9dff9585_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20233InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i414bed4bfa4b4862a19a234bbdaf714d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20233InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9658fcabcb764ce5972950cced53289b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2023375InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6aac5c43478c4cf5872ab0d87fb7cab3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2023375InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacf9c0f395864206b0df7660a5342177_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2024613InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f6de552f34d46ddaeb308e06fae469b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2024613InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7f9f54a14524ef2ac66996f0eca9b9c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202435InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44063dd30ab24985935f4de84ca1db87_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202435InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8a730c53413415aaeb8a8df0ed50e7c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2025325InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i980904614f6544cc9a3e363b158e13cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2025325InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id66a58d38b054171873c7dc463a8d253_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20254125InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd0a8f836e6446e7a62ab400a6266eb2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20254125InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i738c83b591a342bcb031de2dbdb544f9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202645InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bd4adeaf8a34f6e935f49888c83341b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202645InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e91d995dc4d4716a67317f53051bfdd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2026125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ceafda26d1e4338a268d433a918d78a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2026125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i895d782074b54523b13b795cfbfb9154_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20265685Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b061b9ba35943ad9b01618d52b31bc0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20265685Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ddccf40663440f6a73b0908b9484769_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202734InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72bd03d2619c44c29af788238edb9b7a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202734InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93ed3d337efa49aeacbaf2137357b0ff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:DebenturesDue20277875InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3751913bfc0a45b7896c5c9cf5f54426_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:DebenturesDue20277875InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43e32ecefdb440f3860ab5c831273423_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2027305Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b5927dc1e2f4399b084401a0572efa8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2027305Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07cc745a98c84df4bf6dc07b30708361_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20284375InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15576a81e11a4a38ae45657dbce148c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20284375InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a285f2991c9444c9755852b3eabda27_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue203024InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2689f890bb1c42d68cefbbeb43a87908_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue203024InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66e2ace24fe24d90b02d99ff1be0dd09_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20312375InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i482114586ed84365b9534d71073eda66_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20312375InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d96d999b8824e5484e9bc064061c29a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:StepDownNotesDueJanuary2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cdc895b7a2741f2ba68c6eb57fcd620_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:StepDownNotesDueJanuary2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64c8340c95104f9da98216f9c6c92918_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20335400InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86cfeb71e3864eeca439c4353bb752e1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20335400InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3197f7cdd54b4088ae3c71e0ad16d93f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2036615InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7642ca01b359422c83d2c36109bbe311_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2036615InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bd52da1beae4ef3b43d1878bb83c53f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue203848InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46c86b75d1b641a38501f46eab131bf7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue203848InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc0d48e2aeb3466da82305ee7c4b7be0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue204032InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia12dcb2f4a5544df8a2c619e6c94a70b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue204032InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id71094b2f34d4d978a441ba8995647fa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20415875InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5223523086642cba0dcbb8ed2b11004_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20415875InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e5d78ed27a4483e8828d091e08d011d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20416125InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48fdb56eaaaa4b408d38131d70e82896_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20416125InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib12f851059264a8d8a5b7886c8931917_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20425375InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8300dd98b4ec4864a2dcf4b8241cfdfb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20425375InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib290912817514769b3acd20a811fc92b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue204648InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3b44eaa966347caa1dcffe029cf7ae9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue204648InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9bfe6abbbb94e408b73c2c728c561ae_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20473875Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1438a2bf41684eb7a1a30324f2a19a84_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20473875Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a19a44748f045febddded935137ce5c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue204849InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i365a75f6100e40feb386d3c9e27ceb30_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue204849InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd2e63c77f194ff6bc9c2d7d25ffca38_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue205034InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e2dc1d6708c4916be653839738f0143_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue205034InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdcc30e5c6a242ed85b05fc34479449c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue205134InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87d06b6f0c7d4557ad2660d8e87b98f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue205134InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49ecf3f26ca94fe88ab72567822a17c1_I20230115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:StepDownNotesDueJanuary2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if31115610c334a439c3f11aa884c91ce_I20230307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5019884ac20741cf8a16eed471340bcf_I20230307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20265685Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93b7c27710884424a2eec7dcef7b23f9_D20230307-20230307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20265685Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-07</xbrli:startDate><xbrli:endDate>2023-03-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffbc2955b58a40d8b0178672d5fb531f_I20230307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20335400InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i809f71ecb14a46c19821cd0c10cf40d1_D20230307-20230307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20335400InterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-07</xbrli:startDate><xbrli:endDate>2023-03-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd4fe3f6c8b04276b496fb8ac4ef9399_D20230307-20230307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20265685Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-07</xbrli:startDate><xbrli:endDate>2023-03-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b7488d47bd4be38856523de2a8e659_D20230307-20230307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20335400InterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-07</xbrli:startDate><xbrli:endDate>2023-03-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if507247b2d15417b965fab339f79fe0a_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37d8822645414b32a762b437086b9814_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i968eab3e6c6a464b8621cc1f22f13849_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditFacilityMaturingApril2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e9aa8daf53f4df3bad80c887b287e24_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditFacilityMaturingApril2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be2fccd54774ea28094ccdeb4da1bf1_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:A364DayRevolvingCreditAgreementMaturingApril2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i402359fab32e4e2e81a9d588165d9963_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:A364DayRevolvingCreditAgreementMaturingApril2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab20c9aeb2d14f4aaac0f23ac89dd20e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i542bd1f117ca43d18940ed6fff533658_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37973f57d1cd47349579d1c948a6c36c_D20230401-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e7b2848129a456d9e6bd7711efd7860_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbd12673dfe8421ca4a56e0ea3593be9_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:A364DayRevolvingCreditAgreementMaturingApril2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83622a269b3f44fba77ec17337d55e2d_D20230401-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:A364DayRevolvingCreditAgreementMaturingApril2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad29666a07fc46d68f52e52e2f6aaab4_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAgreementsApril2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc00f288660a48daae4fccef391cd358_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAgreementsApril2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="revolvingcreditfacility"><xbrli:measure>ci:revolvingCreditFacility</xbrli:measure></xbrli:unit><xbrli:unit id="position"><xbrli:measure>ci:position</xbrli:measure></xbrli:unit><xbrli:context id="ia05553ebdf9b4a5b971cdfd702e8a711_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa7f8f9afed94f2c8a4d8a3fadcba829_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75204ef5bacc45e484f57be2c4af5158_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67f0445844a9443db40d9291472caedc_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9c3e4e75f4d46b58ea05c03cbcb7a51_D20230323-20230323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-23</xbrli:startDate><xbrli:endDate>2023-03-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i194fae94da834e3e8279dc01c624343d_D20220324-20220324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-24</xbrli:startDate><xbrli:endDate>2022-03-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9df7da12ac1d49b3b2f3b1ad8b0cc70f_D20230426-20230426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-26</xbrli:startDate><xbrli:endDate>2023-04-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ccb9215d3f94df49e58cec62ca66848_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12abbe9e13194148aca94163b7fb2f0a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie62ccc5f564845298d35afec66862cec_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5db337d577d24323b93b59b505c32718_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i316a5e098c694bcebb1694c166dcab76_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3314d3839844dbab40e20dd517db732_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i582bfa8cb42448fb904b42f8fd26b53c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NoncatastrophicEventAxis">ci:CompletionFactorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cde04d0ebee47b58537b475418eccf3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NoncatastrophicEventAxis">ci:CompletionFactorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8f7bc9e3c3445a6980b765bf65b3c78_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NoncatastrophicEventAxis">ci:MedicalCostTrendMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a56d790203f47048913b46660f4d92c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NoncatastrophicEventAxis">ci:MedicalCostTrendMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie07ab2d445d1463d93902530db5e0775_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i473b5ac171fe47d1b52a690302b8557d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0a2caf1b06d407cb66dd5cc1db191bc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5e56cac561c4deaa30c887f1b7ca3b8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id78aeb82d8af4ed7bfd1cfe99bf87fa7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06c863b5932f4981934aca0c04125d8c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c0f09cba3a64073b1bafdd99ecce319_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbf37f4fce204b8e884d185c87969b4b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5e93c29f2c5415ea367dd5375f9e1f7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7558e0f62de4d41b5896e38c58e6285_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis">us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i738906a5eed64e83ba37b8588bebd0dd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis">us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb0a38d6988945d98411fa2cfb859c04_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis">ci:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifef5e98d887a4bb79bae5426330ad2b3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis">ci:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib570f0c807bc458bb372ecd4c53d8d16_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e6d884b55ec4e72892c2a763b882366_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc70e358d2cd4b0ea0945ae4e8b52dff_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica8c06a177734445979e540fbc4f756d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28d661611097476d8854fab93897521d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7177e4ee9a5c4f679379c6951ad9f6f7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a1939888a3f4aeba81ff8cbc1ac2f55_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i780ea719429c4f5cb4d6a43778d44e51_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia10fa22d1a0e4292823f2466bb3ac18a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04eae3ae08ff4a07bf7a9b55fc3507d2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9388bcc230334c26b5f9322df9d8591c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24318b9a944f4a469e7a3f8caa0b899c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6be26d0bc42043479ce8c2aef240151d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8b0de1554c74c03ad99462fed6a95b3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89103ff921074d9f97701ff931699e77_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63373aa6dda746ada1c737d9b67a0111_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b5560c0ea484a0f968eb97de6b00cf7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfa79a53adb54371bdf95c80bb23094d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8581a4b7b794c4faf53cae6809eec3d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7018a961b27d4b63814f4c220228acd0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if29f75017f4f4bb0a8b89780edfbb7d9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1fb483551e4be28ea7d121f976ed2f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b1a96c7936742f1ba643f3f3ec01c9a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97b1549db8444e2797ebd89df1ce900e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a5f607d270f47999ff876f8ac44a118_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:EmpowerAnnuityInsuranceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if34b462c128a4ea8b60fe20ba370c163_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:EmpowerAnnuityInsuranceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e4431aa2e584220a1f57a7dccc10533_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:EmpowerAnnuityInsuranceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedcac50b09424b1aa432ff4b96017412_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:EmpowerAnnuityInsuranceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fd2fee2cdaf404fa42202dda7b39b0d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:PrudentialInsuranceCompanyOfAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4941e338d0b4e0b8e6d69cfd7dde626_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:PrudentialInsuranceCompanyOfAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c41111216894d92a04d6b36cddf134f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:PrudentialInsuranceCompanyOfAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12710504ce2d46fcb5c81a1e9c69a306_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:PrudentialInsuranceCompanyOfAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11dc2245009f49c584be01347c7fdde9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LifeInsuranceCompanyOfNorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7de558709bb64232bfbbe65efd501378_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LifeInsuranceCompanyOfNorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3083d42461248ae9fa7521f47d83dcf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LifeInsuranceCompanyOfNorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c45fc7e2545455c909e8f4c5d88874b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LifeInsuranceCompanyOfNorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i454476c483c445ca9cee416255427da7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">us-gaap:OtherReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf1c5ed75d824327908e9fac5f4b684c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">us-gaap:OtherReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c13b36393fe4c24a2b794f5f3cd158e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">us-gaap:OtherReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14769193c2c44d64b974d678e97f5a09_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">us-gaap:OtherReinsurerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id01894bb31a3496e95680d18ead03b0a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ee2dd01b1f0498e93bcd1ddbe776129_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i524a1762651448f19786403decb53347_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81f3744507dd4c6dbd6080857f121446_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7992aeade34b40958cdbbd41e22d97c6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife4968b18fb541b9a5883c174de67fc1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b71494c09c24a38b31d30590816b909_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f9ecf64e8fc403ea59b7253fb207588_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i412908e744344c22a44e310a933e677e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5eb4d443a88b4c8a801ccccb711a03ea_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5fc53d0faf24ca488cf6251cc8e3cd9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide82cffd58fc4bd9a6a046a625886af2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f712834ae454cc19bd99506f5b35f37_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteedInsuranceContractTypeOfBenefitAxis">us-gaap:GuaranteedMinimumDeathBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffb569d2047445a09609c8caab034843_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia933eb83cc3d4717aa4b14ae0603c0cc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41bcd1ff54304762b1285aa37c402aca_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteedInsuranceContractTypeOfBenefitAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bcfd173fa8c4857abc112fc0044dc2d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteedInsuranceContractTypeOfBenefitAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e7f3a48f7c442e2a74854517e46d848_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ab9b6688ad640f6bddb9c9f39e1b287_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ci:CededCreditCollateralizationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskSecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib58c428a8e7841c4b87ec82e8a298b2c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:SunLifeAssuranceCompanyOfCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e422e0176b14d37a373faa93a5ef72e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:SunLifeAssuranceCompanyOfCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c53eb427a65420e90086c325382b3c6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LibertyMutualInsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4a0c523a4d649ed9576b306aa61bf9d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LibertyMutualInsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d00cd3a880946819131992a6001d101_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ci:CededCreditCollateralizationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskSecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LibertyMutualInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ea827e8736f47cdac2e72202d163b29_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:SCORSEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e712fcd6b0f49c58dd469be40702369_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:SCORSEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d949019d7c44dcea3311dc5c763edbb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ci:CededCreditCollateralizationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskSecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:SCORSEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i112f3631ecd842d7934b73fe1e30c901_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6833d4eac60499bac8b8e40d102c734_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd51b7e314aa426795bbfa7b1914c75a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d4227ad42c24dc39f4e62e2b85e81a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56553614bb1d4575a81f8b42e1e9b673_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie585d9251acf4ffaa79b1ef027535117_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ddaaa564876446e911564680d7ad205_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PolicyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c539efc04b24f10bb5bd030d79f630c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PolicyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1141eeb8e3f34513b86f0ce1f1a4c72c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a7d37bc4c9a46d6a3949bc3551de6de_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5a5174826024b3b8526bf7dcd6066e5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie234bd06bf9543618cd63eb8ff57535e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1269c3f703d94ed6840f2e30642de9bc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c306daec09546e08812586ae9f36ee0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic820b1328eff4b35a3d9cd660b0c2801_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7918ae8d451f4168bead8514e67d96dc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3942feca4c1d4b8b9e0695b4afd3cfd1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic28ad1e10f5a40aab28b4519e660c08a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i014e7b52c0f34c96a0a52bc15cdbbb2b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab84ae88cd084601b0a81a723bc6f470_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib356a619fa9e420489d64c64c7002bfe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d7923da0ee04654b571d67b56b68fcc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ec5355a990d4c00b92ee9f78c5841da_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:InvestmentsCreditRatingAxis">ci:InvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05eea674d36b42b9b7fd99b97319f904_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ci:InvestmentsCreditRatingAxis">ci:InvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffb70a8f680e4c8290525b7e1fef6da3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ci:InvestmentsCreditRatingAxis">ci:BelowInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30b568ddad034fb38476af6dff0d5b42_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ci:InvestmentsCreditRatingAxis">ci:BelowInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52a0532147074a69a79d2bde730cc6b4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ci:EquitySecuritiesFVNIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:HealthcareSectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia91b63f759a34db984a3518b4db4eae5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:LtvLessThan60PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53e6849ed22a418fbb6188f47afafa8f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:LtvLessThan60PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i227e56a283374d43b53193cb2ae5296a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:LtvLessThan60PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb8ba53337fd497ab5e68995d0c88cd2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:LtvLessThan60PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc795fae04a24e6bbfae9210f9e9def8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:Ltv60To79PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id71bd449e9c6454cacf21e30ce2c498b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:Ltv60To79PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia74150594d8b46d49cdade2e93655870_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:Ltv60To79PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide32893117054ad98838d727032c109e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:Ltv60To79PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0150b47337d4406b098b239d61060d8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">us-gaap:Ltv80To100PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37f1db0b0e904b5291a5862d25f76c60_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">us-gaap:Ltv80To100PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57d71fb7be6245038f50e90a278d63e9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">us-gaap:Ltv80To100PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9d56cac03234e309389948e70c6ec5b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">us-gaap:Ltv80To100PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e013bc327d64747b0fccc969e1f0449_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4810804d0794cab810a5c6d840e43f8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a727657552e4bba86a90d288d5a606b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib51509dfe7384c87a20dfce010e9054b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibddf171f855d455eb0339d11c5a8b669_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87598f99e83e4f8fad5b7954451b7bf8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94d91ccb4d8945f2b31211b7f940aa8c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">srt:PartnershipInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6214eeb319f84edc87092fa100092fae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">srt:PartnershipInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd9435629cbc409e80fce5ba86b95ec5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1c8862dc33f41798f458e182a06dc81_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c40a4ac7f2a434f87a71b9ba541fbed_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic52a72b46e934d71b88725042436b309_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4088ab619834175a08deb5b39beb15b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f13ab64129a4c8fb094e735383237e5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9f8a274704049218d1ef098ed77fc12_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a01ce3605c34a9aa36f20dfda34e4fb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77341c9a2ae245cc8c56080a14bfe2ae_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0cce95292e14776a7278f0e33003cdf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia07ed9d3c52b404e94ba85d570434570_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73b62bf7014e45babcc9a18ea1226d9e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i032a4c4c66d44f95966d06b499946c31_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i989ef71163ae4e9c8eaafced6a9b1a25_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i930d264a52e74abd92fd6023e6324ee9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i950a2d2b127a4b9581697e8ffc5a5f06_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cf66280f27c4cdab8de0ed3b972cd3f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d4d88313bd744c9b9bfe00dc4beadb1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6458608672034857ab59db70911f8c1c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie93c0af573094af9b33586116b3a5681_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7c3e6ee73bb44aaaf1dc02c1f8d9b9e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i126d653bef214cb5a2293e321a3c6a1f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c23114e19414957ab7bf2b512b8032d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i911bced2d64f49388c06235bcf671712_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i210b492f12ea4598b3c1eaa7fe5053a9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b60856ce8d24fbba0e9bdc9e6c8e8c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9589c2b720554541a51b62fcbedfa89c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98bf5cf8552e4f3f93ab9849ef07ea23_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f40ed4344194d4fa94fd6bc5ff74a0f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ade3d59c3b74f71a757f3ce93ec3fe0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1d1efad88f74a06b2f78f6f4a608383_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b20e60e442842d383d58e1005c97d30_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe9c93b5d23348ed9f2d2524fee1a2f6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibabd51e3f7364ae0a5c3a97072265a04_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id300a0f63845475da13c0c4f8959c18c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedcadbdbe30c4f6e8eb2478149ef29e7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i496ceb12f2c94b9b995de6a325274988_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e6aa69b6ac14548852cbc0cb1dd129c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b18e9f370634eaca75f7ac03fc42ec6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i122d51c6af904c34830a2d18ee8b3883_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ea52ae05bad4666b5128b751245b170_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87b7744b55da48babac0660b53c793fc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407a2545ce8c476abfbe4489ad433944_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i635a05614dc44dfaa59bf4c4b0677a6c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8480eea330a24711916d476ea14fc9ff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i362c06fa9cc443e7bd73051dc42cbaca_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife2fcb28e086422c8dc4e953d482abc9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2522a8f54759495caa0225401ceef646_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i346d7b1c76574be19f46677e85e8c5b1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1008fa627a0f446c963b0e67d8dfd067_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d801185130948b6b2dfb025cf2c9afe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2172b84fcfbb48169b1cf9a8c8d71a74_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9534d4bd0db4a8cb06ac21b74224b43_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i173890bd1b474d3198c5dfb300324f59_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic61449fd99784439939f74a26e23b495_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65136b8ff46f4dcdace35ad210e68997_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf1f04ddb0f54df990cf80a00f7696af_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if04209b927ad49a5ba1f009ea469bf3a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b42664d2d054b1cb8a6a20eb860282a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic382cb79965348f7b830702205a70233_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia299f05a1244456c8e2a637925cd98ee_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d3981d68ffb4ab1bb2f4ebea953bca7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i220f8c95ac454213bbf6528472654e1f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i777f12cc915c480f8486fbf1ff5fb6c4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe8a9caf5fe04d33a35af66b6ea9dad3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24dc2bb53ce4ae88734117cb7dae442_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i545e52d4ab804995a43a6de0a3f9451d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id68863ce55b24c80abd273a20e11d928_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id54e9025aabe47faba625607f255ae82_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i522b8ff4b68a4b3b83655840fe0d0999_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i603fe8aa57f54159aa3dd133fca86c4d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4564af3a4a1e4f07bd83540908642eeb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc819642d63d44d7812cdbbde998e471_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac58c114e37e4838bf9723da6c4ec12f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie20fd12fb4e5463baaf5a977f3780fb8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i233fdf4af61947d7882a46454c266f5e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2a7a90ae1f548208c8ec8f1cbcbb9c3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94d1343670dd4e47affa7005b7f60ff6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6207da178a44fb3864bb680dfb0bea3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:DebtAndEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64364361359847419628a63147bdad2e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:DebtAndEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:DebtAndEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:DebtAndEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22c741b1ef01438c9bc0c95b9bc802d8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:DebtAndEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b4e0a32ed2947fcac341851c89b111c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:DebtAndEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib60c510aad1f4274b05705d4451bb34a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58dc13e2e83f45fd86f4fa7e2de05b1f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b20b8ea802488fb1423cffdd53e8f6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica72812ec3684d749901011e62b0851b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f62a525c9374ed5aa1cf92ab9b8c5e1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99d6d20ebb17402f979ebdb5a3daba9c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14917100852d4b948ca51e874a6b0212_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34c7bd2940204fe29e4f3ff5202d63eb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e61a85231a745cf8f18edb83018a703_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i495afe57b9e945e19224d443146762a4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if62bb74d9f924edb9286be35b3c7f345_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">srt:PartnershipInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i364eea148f374c20a2f0c593046922d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">srt:PartnershipInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94fa67011b4847c1abf1f21028ae49ec_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">srt:PartnershipInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icff956d5fbf6434c977eea973ab12ba8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i032c221bd5464f3fb6549e1bb245453c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36aa4fc292e346ff9124e93f204c8bef_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1e80cb53c7b4030ad4a2f2374f1b4a4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54d622066b6642138a4374276ced4e96_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cac1c831b434f6aa1415442992376c4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cde07c70a8d4809a5d5efd16dd587e7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c58cb565aea4436b757679a195e2465_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic830eb3995b34b459ed632cf6d7d18c9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40c865978ae54de8924e8ce3f15cd96f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77f80db721434c238adc7b810844e85e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7922415e72f84dc0925918d4db42294a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05431ad3c0184457a9136c2f15684621_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib508898f275f4a768acf67c63c4a4668_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">srt:PartnershipInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5800d762bbc4479e8c8005dfaec6b354_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia35e6eb5dace45a085e40ef481f10932_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if429d97f6f9945029dfcdc1fc970e03f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5868b67b67224406aa46fb0e8471fa5e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30053fba320b4d05beed1c1e1964b4b6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49c2e14e07b54fc488c910392b015f3e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51f0ae43a8284805b5e99637347441a3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d8b2a4b61444ca69c5e9a155af379a2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18bbba0896f543cb9afd321606482dda_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="entity"><xbrli:measure>ci:entity</xbrli:measure></xbrli:unit><xbrli:context id="i699bc3f219a0454d9541076c3ff72173_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74213a55ce4840b39cb8ba80e171a3c6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1e2a8ecd49b468db83c7246a6233f79_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27a2c2fd471047389035115e103c4803_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ec41b20522442a78d304f69275d1f6f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib47e378add8046febeed46402863f4f0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eedce94285e450ea3c9ec311118b0dc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf6aec08fb614f1f9373704db9a45990_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3574069d949f4ff58e5ed013efd6e44e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie315d35584a941c298193aa052832950_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9da4771b623549e5a758939e8718e0c6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociLiabilityForFuturePolicyBenefitParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f0e583ccd0840039ba45ea866313d48_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociLiabilityForFuturePolicyBenefitParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b0fa25db54c4cd5b97bf60ce65ce025_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bc43d6d65d948eabf0c43a48194633f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f5efb187a364a69a0332046f8b9dc86_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dfb7b298e8348bebbdbb2ffbb195fc5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id43a85e5eb1645de94bf7c939c4071e2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f42f5791c2144cbba874ff9a5058d6e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic32d3eff65f84a3d9776350854ae8231_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id05c2da7d3ae4ceeb35fccff9cd109a3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12523f50e770418e8cf76bec13c9b6f9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57486b0895474a619153155e196783bb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70d4659b2e374fa3b6fa858f21168b54_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f152f9fd42e4e7bb1d7e7e7177095a5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0fe44d65b564dfb91c260cbd59420f9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32dd55f2fefd4ac7af712ac3651d80a0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae231709f2154539b08738af3e5159cc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5730b56e2aba4bf0b30069589628b932_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49e8b987a931474faf2d5c0788c6dd63_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i947635db683b4b3daa054f199155a2d0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i382b1889e4f048a797548743cf8e44d8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i500856a7a2f34b819a1cf711b4cbedd5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0deee6eee2ee46eeafe6188d0a931786_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9329656f7a714f9e906a28f984a13e6d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7bdac56a5c747909f091b44b4679bf5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida787829236f4e5b915c9415a14edb54_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i854c62090cb94df2a90a243d3b2a0448_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:RetirementAndLifeInsuranceContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:FinancialGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i003bcebd887e4bdcb34dc4edd5766fda_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:RetirementAndLifeInsuranceContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:FinancialGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ffe330f5d2e42feb4023beb365c915f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie05d40387e70450eb97782a7626bd016_D20160301-20160331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">ci:PricingConcessionsThroughRemainingContractTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsLitigationWithAnthemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-01</xbrli:startDate><xbrli:endDate>2016-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2602421334c748649e7b6a705dad545e_D20160301-20160331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsLitigationWithAnthemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">ci:PricingConcessionsAfterRemainingTermOfAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-01</xbrli:startDate><xbrli:endDate>2016-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e3b74c468ff4912bbea80db07b86240_D20160301-20160331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsLitigationWithAnthemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">ci:DamagesForServiceIssuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-01</xbrli:startDate><xbrli:endDate>2016-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41708a20f5d543b49694e126b9d63ab6_D20160419-20160419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsCounterclaimsAgainstElevanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-04-19</xbrli:startDate><xbrli:endDate>2016-04-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>ci:claim</xbrli:measure></xbrli:unit><xbrli:context id="i4776d8e52c934378b5373425506ecca3_I20160419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsCounterclaimsAgainstElevanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-04-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bd9f07d9d3a43dab2134f8b473b3aa9_D20220331-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsLitigationWithAnthemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">ci:PricingConcessionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife782ca69c664ec9a42a195307da9dad_I20230308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsLitigationWithAnthemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="expert"><xbrli:measure>ci:expert</xbrli:measure></xbrli:unit><xbrli:context id="i3ea40c1add1f432fa8308f993c435e87_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69df325bba59494fa467077df69372c4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i477f7b8fc897444eb3eebca010f1c1a0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0aa4b4d327cd427280e23f867e7643d7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i070491a32c554309b0445a4d7d37f76a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b088ac82fa046b686f50cf0918542f7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06b3a5cafe1847468ebadf3df7edea80_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cfd792e023147cea75b506ff355c317_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ci:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21521b1995554ec8b02652d45c45d285_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95c34c40cb7248e783ae13fc742a640d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic95354c853bf4761a405bfd3190f1ed6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4127249d3cc243de9f905eb276897d65_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i569d8e14804541b9a5e8a0e5a286a5bc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i724c42af69b6448fb2e4a5b6e6c155f7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i098db1bf768848acb5c35d20817215a9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ci:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d60420098854826bb75b05e15a8dd62_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:NetworkPharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeb14631940d478e80234443fdde93c4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:NetworkPharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b73e14198fb493797caa14157f4db48_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:HomeDeliveryAndSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1d9f3a8c7e244afaeef48f7c0e28797_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:HomeDeliveryAndSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dc2e436d3a3436ca9bb0c3657718683_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OtherPharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib360b82d50b24f408baf926cbd36d43a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OtherPharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie39a13614111404c93bbc50726bc2979_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46b371195fbd4772a749aa7a8dd2fd45_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08e34d7cd37940d9be3d86d7521f5686_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:MedicalRiskProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1dd8e92561043ffbfbeda8cee9c928f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:MedicalRiskProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3e9e00387384de780ea3b39d4254134_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:StopLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33cfaac4439f45c89db679459cae7478_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:StopLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i834a123ddeb74d1eaa0c05c2490b66b9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OtherCommercialMedicalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3733229295b04395a86ff23f3d3e14d6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OtherCommercialMedicalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd3caeb6fdf54d798d5192a6b8874b10_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:MedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5f66cd5ef874b81984fce532b63f71b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:MedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic24d316520f741b8aeeb8ece569a197f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:MedicarePartDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i300f527e494a4843be09f505c8e493ff_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:MedicarePartDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i700e68e0f51a4716a2d3851471d18417_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:IndividualAndFamilyPlansShortDurationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8ae8fc97f3b4994bbaf95a5fe2b78d5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:IndividualAndFamilyPlansShortDurationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36971d451ade4af1a50bd70e7bb2a491_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2336928c4ea49a6bc4d4b5d15ee8bb8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaf7a109b0e34a0b924d846bbfe77c7a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:GroupMedicalInsuranceShortDurationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19b8b552cfe8495aa3582c0783a57614_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:GroupMedicalInsuranceShortDurationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c721be6f0264a54b1ef23c9b0206b6e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:IndividualPrivateMedicalInsuranceLongDurationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9dbc603d392490aa593c0ee390a23ae_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:IndividualPrivateMedicalInsuranceLongDurationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2847aa537584cefa3f2f5652bedb86f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:USMedicalProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib92eee19a6c741c3adc4a9c5ace7b113_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:USMedicalProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia11f9b58557a432b96d0a2ff40cf82c3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">ci:OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idccd94a3f926401c88f9bd7436ab16f5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">ci:OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bccbb16e5d84306923a81662d3ea9ab_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">ci:OtherOperationsSegmentOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79d10ac7a0e94fe7b6f88281dfc04939_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">ci:OtherOperationsSegmentOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d6a700163d4c319d21beade0fbcc04_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:ServiceFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1627e82149974da486e8f3cc3f75d2ab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:ServiceFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a92f9eb139e45b58b6841d00343544b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:ServiceFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idffd5dd03d124226bb773704874daf86_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:ServiceFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b6cacd9b87c4887ab34f6e65fe9d106_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:ServiceFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3577cdfec471463b8b1da0e53a0c050c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:ServiceFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22cd581f72e445d8916b2124487b2977_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e8cce4152f1403bace3946d48f2b9f5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10032a6591314de5846c1184b289a4b8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9e80ce4c0d14006b2d6a845fa506e93_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9556a32ddbb54ebeb4e7256d387ed702_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:GuaranteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:PharmacyBenefitsManagementServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63fb1e4d8af94facb895426daf4d4db1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:GuaranteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:PharmacyBenefitsManagementServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTMtMS0xLTU0NzA5OA_20560a86-6865-406c-95e4-b3ce23b74169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTMtMS0xLTU0NzA5OA_20560a86-6865-406c-95e4-b3ce23b74169" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzE4Mg_c38bd102-2a43-40c9-954e-9ee16d667456" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTQtMS0xLTU0NzA5OA_5e85d59a-d8a5-45a7-8a41-a74c2856ca74" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTQtMS0xLTU0NzA5OA_5e85d59a-d8a5-45a7-8a41-a74c2856ca74" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzI1Mg_621034ee-a185-4141-b59a-278aa5be2095" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTQtMS0xLTU0NzA5OA_79aa366d-893d-4698-8351-155de9b73318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTQtMS0xLTU0NzA5OA_79aa366d-893d-4698-8351-155de9b73318" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzU0OTc1NTgxNDQ3OQ_1dc42f8b-c807-4376-a384-691001e0ef4e" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIyLTctMS0xLTU0NzA5OA_12493226-c472-47e5-99ea-a9c4706db302 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE2LTctMS0xLTU0NzA5OA_01ad8e17-2c25-4100-9031-1579a895ff34 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzMwLTctMS0xLTU0NzA5OA_fbc1a597-6d69-4d17-8314-e2aeec6dfd6f id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzctNy0xLTEtNTQ3MDk4_b608a220-43b4-414e-bb6d-c0d3e771d842 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI0LTctMS0xLTU0NzA5OA_8c91905f-ebae-4e12-89d6-f1a4630a6fc5 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEwLTctMS0xLTU0NzA5OA_36cf6d52-c0ac-4ef6-9830-7348e5cae671 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzgtNy0xLTEtNTQ3MDk4_82bd1d0d-3d97-4d39-b707-03d5f4ea8e2f id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE5LTctMS0xLTU0NzA5OA_3dea0a2f-db00-4c45-bc82-390112e51307 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI2LTctMS0xLTU0NzA5OA_e5fba830-b7e9-4d2a-9d4e-e9ecb3440398 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE3LTctMS0xLTU0NzA5OA_2c887ebd-2fb1-4159-b27e-a29d03ae639e id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI3LTctMS0xLTU0NzA5OA_b71d309d-9ca3-4c0b-aa5c-2b67275d02db id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE1LTctMS0xLTU0NzA5OA_aa2ba26f-2635-4ed1-9fe2-749bf50cc82a id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzktNy0xLTEtNTQ3MDk4_924c3d8b-87cf-4a58-aeee-db86200494dc id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzExLTctMS0xLTU0NzA5OA_b9e95365-24e8-46b2-a0f0-ac7626b5a698 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIzLTctMS0xLTU0NzA5OA_1556d15b-48f1-4191-86f8-73377cfb6937 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI5LTctMS0xLTU0NzA5OA_7e94545c-5dd5-40ad-8402-14ded75dd02b id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI1LTctMS0xLTU0NzA5OA_102a37c5-08ac-4a1e-9332-52a57043267b id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEzLTctMS0xLTU0NzA5OA_2fc001d2-249f-4ef4-b606-4b3956446652 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE4LTctMS0xLTU0NzA5OA_56970ec1-46d1-42da-a19c-a4deb639cfd2 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE0LTctMS0xLTU0NzA5OA_3fd58480-6fc6-4346-a85f-569666fd106e" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTItMS0xLTU0NzA5OA_40db761f-a266-4f65-b6bb-86c4a203c722" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzU0OTc1NTgxNDQ3OQ_1dc42f8b-c807-4376-a384-691001e0ef4e" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE1LTQtMS0xLTU0NzA5OA_08201fda-a8c1-48b1-a456-652c75763d3d id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM0LTQtMS0xLTU0NzA5OA_c8b5a649-4307-44a0-8705-f02d8e5553a0 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM4LTQtMS0xLTU0NzA5OA_0a46c049-4e5a-4a2c-9b85-91fe5e21e7b5 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU5LTQtMS0xLTU0NzA5OA_124c1341-e99b-4b0c-900b-2319a9a1cc23 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ2LTQtMS0xLTU0NzA5OA_734b41b3-f6ac-4705-bf15-debe8f54f256 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ3LTQtMS0xLTU0NzA5OA_61721542-f2fa-4d6d-9c5c-be545c576895 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE3LTQtMS0xLTU0NzA5OA_c98a3aef-75fc-4145-9646-9dc96c93bd53 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE5LTQtMS0xLTU0NzA5OA_819649f3-b4f0-463e-a6e6-f6842fedb49a id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUwLTQtMS0xLTU0NzA5OA_1affbf90-4413-432e-a4d7-521bcd13abd1 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzgtNC0xLTEtNTQ3MDk4_8e1d38cf-145b-41b9-934d-9ce973338066 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUtNC0xLTEtNTQ3MDk4_75d0f478-a637-4d65-9d55-db1b304a5c7d id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzktNC0xLTEtNTQ3MDk4_7d5e6dba-3610-4bc5-b89a-22e31afef865 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE2LTQtMS0xLTU0NzA5OA_ee545fb6-5653-452f-a623-cf1d3704df43 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI1LTQtMS0xLTU0NzA5OA_d181c0e4-9505-4b4c-9ded-757953e6fa5e id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMyLTQtMS0xLTU0NzA5OA_2aa57fe0-3a8a-43b1-bcd4-775311586a6c id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ4LTQtMS0xLTU0NzA5OA_2f7b09c1-467e-4f4f-8d6b-ccfcaf6d6078 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzEzLTQtMS0xLTU0NzA5OA_e4485689-2c24-432d-a1a5-de5296efaf00 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI3LTQtMS0xLTU0NzA5OA_8f14592e-f58f-4106-a62a-d3eae03b38bb id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ1LTQtMS0xLTU0NzA5OA_f74a5de7-af04-4de7-8e81-e0c1c1b37162 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ0LTQtMS0xLTU0NzA5OA_63c16f86-df27-450f-8108-101e7edd1461 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU0LTQtMS0xLTU0NzA5OA_68007cd1-77bc-4f06-9fe8-d027ebcdfddb id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMxLTQtMS0xLTU0NzA5OA_5cc64e46-1759-4e32-825a-339e5c70c6a9 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ5LTQtMS0xLTU0NzA5OA_5fa23537-0afa-4035-be93-f7dd6e860b28 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIwLTQtMS0xLTU0NzA5OA_5d85ce0f-1d51-41c7-9500-4a00e6cd94eb id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMwLTQtMS0xLTU0NzA5OA_4b1b73d9-48a8-4977-9879-b16785f9f348 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUyLTQtMS0xLTU0NzA5OA_56327850-ce35-456e-8228-496dbf146b1f id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU4LTQtMS0xLTU0NzA5OA_d3399559-aa7f-4d23-8b23-b043ad991fd6 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU1LTQtMS0xLTU0NzA5OA_320766a2-bc6b-4671-b705-848e1fb2e4c4 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUxLTQtMS0xLTU0NzA5OA_203e5dfe-669d-43c4-b19d-ee961dcd4bb6 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE0LTQtMS0xLTU0NzA5OA_dc5978fe-0471-42d8-a6b8-729286e3dc3c id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM1LTQtMS0xLTU0NzA5OA_47e7f790-a8a5-4142-8bc4-161a595b03e0 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM2LTQtMS0xLTU0NzA5OA_de053d13-eae1-4d0c-914d-d26c4f8b03ef id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE4LTQtMS0xLTU0NzA5OA_5be68d15-7aaf-4b97-9dc1-2546e2482032 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQwLTQtMS0xLTU0NzA5OA_5b3debd5-a815-40c2-a5f3-15cb4eb1276e id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM5LTQtMS0xLTU0NzA5OA_b2a52d56-ac5d-462c-9f34-5d79bdbc9058 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIzLTQtMS0xLTU0NzA5OA_eb3b95b7-35b8-4ef7-b06f-c37bf28c7a72 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI5LTQtMS0xLTU0NzA5OA_63be975e-a5ef-47ac-b600-86d8cda714e6 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzctNC0xLTEtNTQ3MDk4_07359145-9265-4897-becc-719305fd869b id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI2LTQtMS0xLTU0NzA5OA_d5873846-d3a3-41c1-86e3-23f911b4d30b" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzktMy0xLTEtNTQ3MDk4_46f8e2ec-fd55-44cd-a088-ab4007ad34df id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzgtMy0xLTEtNTQ3MDk4_51d694db-a877-47da-b5f9-5123c07b3070 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQxLTMtMS0xLTU0NzA5OA_731c83fa-4eea-409a-86d1-8ef2c67b0e56 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMyLTMtMS0xLTU0NzA5OA_4809f36f-6a2f-4048-8673-5a1061b6d99c id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzctMy0xLTEtNTQ3MDk4_b136721f-f061-4fe3-af15-6ae5cb0c5c55 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEzLTMtMS0xLTU0NzA5OA_e72c918c-a597-474e-a170-f2142e110cde id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQwLTMtMS0xLTU0NzA5OA_99927523-d0b4-4bf2-bbf5-8db7be5836c2 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE3LTMtMS0xLTU0NzA5OA_0579eb36-c167-4f6e-ac4f-8d839aa63d39 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ1LTMtMS0xLTU0NzA5OA_ccc13179-2a66-4ae0-a061-19c1ea7c9991 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI2LTMtMS0xLTU0NzA5OA_b0aeb6ff-21f1-4e80-b147-de6a735a696d id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIwLTMtMS0xLTU0NzA5OA_6c111ea2-82cb-4b26-a946-7f22aaa08789 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMzLTMtMS0xLTU0NzA5OA_031c2ccf-4ee1-437f-9758-c51d899420bd id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMwLTMtMS0xLTU0NzA5OA_a44adfa6-6eae-4b0f-b1d1-3eed36def226 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMxLTMtMS0xLTU0NzA5OA_01113199-5d06-4601-8809-daf773980ca9 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ3LTMtMS0xLTU0NzA5OA_97090691-b4c3-43b5-b77b-061701c2fa9e id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE4LTMtMS0xLTU0NzA5OA_606c6e00-9244-4d69-aba4-00e335e87c0c id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE5LTMtMS0xLTU0NzA5OA_57070670-5068-4a3b-9b4b-84eb01a3e79c id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM3LTMtMS0xLTU0NzA5OA_a4ce84c7-19ab-464f-b99d-4d830b9eedf0 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ2LTMtMS0xLTU0NzA5OA_3652dd29-c6f7-4939-a019-d0a25976ad42 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ0LTMtMS0xLTU0NzA5OA_864afb31-0910-42a1-b5b6-717fed9ea74f id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI5LTMtMS0xLTU0NzA5OA_7ffe16a4-d89f-49d6-9763-76e5f24f322c id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIxLTMtMS0xLTU0NzA5OA_f7fff571-48ef-4940-a349-e127170daa6d id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM1LTMtMS0xLTU0NzA5OA_1910bc6f-591d-4929-a6ae-39b31a5bd6fd id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQzLTMtMS0xLTU0NzA5OA_f720eea4-20f9-40aa-9c2e-55cf9814c9cf id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEwLTMtMS0xLTU0NzA5OA_e184b990-0d77-4d55-ad49-e7ed65c4679c id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE0LTMtMS0xLTU0NzA5OA_e8dbe745-b137-4a8a-83e0-1f7061ec6fcc id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQyLTMtMS0xLTU0NzA5OA_36c37ec6-ca45-43f2-999c-6357a46584de id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE2LTMtMS0xLTU0NzA5OA_0c15b4f5-83d2-4988-a69a-4a901dd62c36 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM0LTMtMS0xLTU0NzA5OA_917de155-e4db-434c-8967-b1ec380a671b id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI0LTMtMS0xLTU0NzA5OA_acf1354a-c049-49fb-8776-a986bbb3b160 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzYtMy0xLTEtNTQ3MDk4_e483f4e2-0134-4faf-8374-b9e8c431fc37 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI3LTMtMS0xLTU0NzA5OA_de2112bc-0175-4727-adc0-cb5da30eceb7 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM2LTMtMS0xLTU0NzA5OA_8eeedf58-d0e2-40f8-8b86-077a5ed635f8 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI1LTMtMS0xLTU0NzA5OA_18ac489a-f37c-4ec1-a714-d74297b28e87 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIzLTMtMS0xLTU0NzA5OA_20ec4532-c297-4eb0-9e39-01131f073d2c id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEyLTMtMS0xLTU0NzA5OA_5bbe8a6d-2253-45d5-8f58-a6331a9768ea" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTEtMS0xLTU4NTgyMA_a5c7dd7b-fc0d-48e3-86ba-a2f614e48cef id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTMtMS0xLTU4NTgyMA_a7849b11-b004-4f86-8107-ca09bbf49e09 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMy0xLTEtNTQ3MDk4_c47cdd19-3043-4ddc-8472-3fb8251772c5 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTMtMS0xLTU0NzA5OA_2557cd11-338d-4aa3-86ba-661f15475ab4 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTktMS0xLTU4NTgyMA_353edb31-5e7d-4833-baa6-84be8085eb18 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTExLTEtMS01ODU4MjA_98bb3c29-d795-4c01-b373-aa494ce0b2d1 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTEzLTEtMS01ODU4MjA_c2bc670e-180e-4a86-b5f3-3963b956f308 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTEtMS0xLTU0NzA5OA_9356d6da-3934-4e59-b329-f57e0dfa69e3 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE1LTEtMS01ODU4MjA_32e6079e-6d8c-452a-9487-2b21fb789b79 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTUtMS0xLTU0NzA5OA_e205003c-80c6-4204-b42d-5e25a7ea436c id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE3LTEtMS01ODU4MjA_edaf8827-9b73-4399-bc97-527cd8e302e2 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTUtMS0xLTU4NTgyMA_9e956362-a4b5-4535-a069-df21dc860b72 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMS0xLTEtNTQ3MDk4_b11e4b39-97be-4030-992e-f4b750eaa8de id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtNy0xLTEtNTQ3MDk4_2d1ad352-3fd3-4c93-8d68-6014b98ef8cb id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTctMS0xLTU0NzA5OA_90433d9f-2558-4927-afa9-7a1032a8b39a id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtNS0xLTEtNTQ3MDk4_7268058b-daf3-4f83-b55f-ca21c3179757 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtOS0xLTEtNTQ3MDk4_80c452f7-d6bd-4b5b-a0ba-20e188f66261 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTctMS0xLTU4NTgyMA_024f2260-cfee-444f-bac6-dcb6062dcf0c" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzIwLTctMS0xLTU0NzA5OA_c602d313-2305-4b2e-ac6d-814d71a51d5d id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzQtNy0xLTEtNTQ3MDk4_8ab5a675-2a99-441f-a3fb-56dc1264a26a id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzYtNy0xLTEtNTQ3MDk4_35c93aec-9e7e-4334-bc7f-e8ec9b9a4686 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNy0xLTEtNTQ3MDk4_35bee086-c8e3-40db-b944-6b19988ccfe7 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNy0xLTEtNTk3NDcx_1c048248-06d6-4527-9699-9259b5dbd011 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEyLTctMS0xLTU0NzA5OA_e5bd59b8-acff-40a9-84f0-57e953521a33 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzExLTctMS0xLTU0NzA5OA_3dfd2d59-cc65-4740-803c-0b1b5451cba2 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE2LTctMS0xLTU0NzA5OA_659b721e-341f-4097-bf9b-a992c9a31cc2 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE5LTctMS0xLTU0NzA5OA_3a6c2d42-a5ed-4b47-8f76-2d52bf842af8 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE3LTctMS0xLTU0NzA5OA_bdb6324f-b7ae-484d-a5d1-a9cbaf53feaa id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE4LTctMS0xLTU0NzA5OA_8ead8ea9-7460-4be6-aa76-7648b71546a0 id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEzLTctMS0xLTU0NzA5OA_4c603a81-46c3-4370-942a-6aff72d75ecd" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTItMS0xLTU0NzA5OA_8eee97e6-4411-4def-985b-4e731dff18d0" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzI1Mg_621034ee-a185-4141-b59a-278aa5be2095" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTEtMS0xLTU0NzA5OA_8d2482df-cd75-47ae-976b-bacf4ba05ab7" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzE4Mg_c38bd102-2a43-40c9-954e-9ee16d667456" order="1"></ix:relationship></ix:resources></ix:header></div><div id="id1800413722c4e30b53ad5d464cab4e8_1015"></div><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;text-align:center"><img src="ci-20230331_g1.jpg" alt="cignagroup_logo_color_pos_rgb_600ppi.jpg" style="height:48px;margin-bottom:5pt;vertical-align:text-bottom;width:112px"/></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FORM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTkx_d9cf79b6-2490-441b-8176-72c7b5822219">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl84OQ_d2e074b8-b3ca-47a4-a046-8fc30c4e8dc5">&#9746;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the quarterly period ended <ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTE_536396f0-42a7-4530-a9b9-9d788e8a68cd">March&#160;31, 2023</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTc_6fbb033d-da2b-4a95-be64-b6c86f8ba39a">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the transition period from _____ to _____</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commission File Number </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTky_9fa3a692-6231-419f-abd8-d4f8b4220e37">001-38769</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8zODk_c3521966-0528-4b00-b910-c6f36222c01f">The Cigna Group</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Exact name of registrant as specified in its charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6YjFmNDdjZWE1ODQ1NGExYjg4YTMwYTJlYzgwOWZjNWIvdGFibGVyYW5nZTpiMWY0N2NlYTU4NDU0YTFiODhhMzBhMmVjODA5ZmM1Yl8wLTAtMS0xLTU0NzA5OA_548ad97c-92b9-498d-b00b-62fa90c318e2">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6YjFmNDdjZWE1ODQ1NGExYjg4YTMwYTJlYzgwOWZjNWIvdGFibGVyYW5nZTpiMWY0N2NlYTU4NDU0YTFiODhhMzBhMmVjODA5ZmM1Yl8wLTEtMS0xLTU0NzA5OA_c5e0c5fc-a1d6-4bd3-8382-1da0f33bd57d">82-4991898</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl80NDk_c806883d-9c02-4f92-a44e-dfc929979b73">900 Cottage Grove Road</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl80NTM_bcb914f3-d892-4e4e-9e53-c0119dfbf585">Bloomfield</ix:nonNumeric>,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTkz_57564d37-0ec5-477c-87a1-d4d6b2ef86eb">Connecticut</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl80Njk_e5fe5642-5982-4bc0-bbce-2a556b36259d">06002</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">(<ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl81MjY_41a393b6-9963-4089-b3f1-8a5d17bb187e">860</ix:nonNumeric>)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl81MzA_90d78b84-0a6e-4d4c-bf2e-5920be8a33f8">226-6000</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Registrant's telephone number, including area code)</span></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Not Applicable</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6Y2I4ODg0NjU1MDAxNGZjYTlmYTgzZDFiYjU4YmZmOGIvdGFibGVyYW5nZTpjYjg4ODQ2NTUwMDE0ZmNhOWZhODNkMWJiNThiZmY4Yl8xLTAtMS0xLTU0NzA5OA_1ad8176a-bfd7-41f8-b118-ec5c50f251a6">Common Stock, Par Value $0.01</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6Y2I4ODg0NjU1MDAxNGZjYTlmYTgzZDFiYjU4YmZmOGIvdGFibGVyYW5nZTpjYjg4ODQ2NTUwMDE0ZmNhOWZhODNkMWJiNThiZmY4Yl8xLTEtMS0xLTU0NzA5OA_3602fcec-f473-401e-a3e6-549cbdd97534">CI</ix:nonNumeric></span></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6Y2I4ODg0NjU1MDAxNGZjYTlmYTgzZDFiYjU4YmZmOGIvdGFibGVyYW5nZTpjYjg4ODQ2NTUwMDE0ZmNhOWZhODNkMWJiNThiZmY4Yl8xLTItMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjE1ZTBiMmY5NDQ1NDQxYzBhMTRkMTRjNzg2NjQzYjkzXzQ_7c3034a0-6cbf-4406-b2e3-1f4640c9b329">New York Stock Exchange</ix:nonNumeric>, Inc.</span></div></td></tr></table></div><div style="margin-bottom:10pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> <ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8xMDk0_d0e18b38-b942-4668-9a06-b3b98204fa8b">Yes</ix:nonNumeric>  &#9744; No</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> <ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8xMzg4_0cb88475-81eb-4f23-a245-317ab519cd40">Yes</ix:nonNumeric>  &#9744; No</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.951%"><tr><td style="width:1.0%"></td><td style="width:37.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6OTJhNzRkNWQ1OGMwNDYxOWI4NjM5YzRmYTMzNGEyN2YvdGFibGVyYW5nZTo5MmE3NGQ1ZDU4YzA0NjE5Yjg2MzljNGZhMzM0YTI3Zl8wLTAtMS0xLTU0NzA5OA_c7411039-b502-42b5-86dc-8bc4281b6f3a">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6OTJhNzRkNWQ1OGMwNDYxOWI4NjM5YzRmYTMzNGEyN2YvdGFibGVyYW5nZTo5MmE3NGQ1ZDU4YzA0NjE5Yjg2MzljNGZhMzM0YTI3Zl8xLTMtMS0xLTU0NzA5OA_96211037-197b-45ef-b168-bb8e87983b3a">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6OTJhNzRkNWQ1OGMwNDYxOWI4NjM5YzRmYTMzNGEyN2YvdGFibGVyYW5nZTo5MmE3NGQ1ZDU4YzA0NjE5Yjg2MzljNGZhMzM0YTI3Zl8yLTMtMS0xLTU0NzA5OA_5b1be86d-9c70-4a90-9abd-00be0c769b3d">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  &#9744; </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  &#9744; Yes  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTkw_01af121c-5cca-4799-8ec2-d6025b66fedb">&#9746;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of April&#160;28, 2023, <ix:nonFraction unitRef="shares" contextRef="ifdeb9c39ab4c4ab3bc182291feaa44c7_I20230428" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTM1_e76ae1c1-4518-4d6a-bebd-c8fab9a66aff">295,872,231</ix:nonFraction> shares of the issuer's common stock were outstanding.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_1018"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CIGNA GROUP</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.506%"><tr><td style="width:1.0%"></td><td style="width:14.136%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1021">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1021">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_286">Item 1. Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_286">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_292">Consolidated Statements of Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_292">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_298">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_298">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_301">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_301">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_307">Consolidated Statements of Changes in Total Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_307">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_313">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_313">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_325">Notes to the Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_325">8</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_97">Item 2. Management</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_97">'</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_97">s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_97">35</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1024">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1024">50</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_925">Item 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_925">51</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1027">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1027">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1030">Item 1. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1030">52</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1033">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1033">52</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_82">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_82">52</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1036">Item 5. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1036">52</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1039">Item 6. Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1039">53</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1042">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_1042">54</a></span></div></td></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As used herein, the "Company" refers to one or more of The Cigna Group and its consolidated subsidiaries.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_1021"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FINANCIAL INFORMATION</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_286"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">FINANCIAL STATEMENTS</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_292"></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.955%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The Cigna Group</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Income</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmacy revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i933d49a7caa5445f9359253b5b0b5023_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzctNS0xLTEtNTQ3MDk4_6e356be0-72f3-46bb-b2ec-d6cdaced9880">32,144</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2699cfc415ab4727a3246be3ce9a03fb_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzctNy0xLTEtNTQ3MDk4_b608a220-43b4-414e-bb6d-c0d3e771d842">30,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzgtNS0xLTEtNTQ3MDk4_0426fc01-519a-4958-adfe-82c54a97504d">11,025</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzgtNy0xLTEtNTQ3MDk4_82bd1d0d-3d97-4d39-b707-03d5f4ea8e2f">10,356</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fees and other revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf64ff3b0a2466f81f78f097b7c8d5d_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzktNS0xLTEtNTQ3MDk4_83b59999-c3a8-4739-8c25-4ba6307c28eb">3,071</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530643094c274242bf05d8df55f63659_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzktNy0xLTEtNTQ3MDk4_924c3d8b-87cf-4a58-aeee-db86200494dc">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEwLTUtMS0xLTU0NzA5OA_0bd806e6-8bc2-45cd-9d98-d8fa5ef6363e">277</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEwLTctMS0xLTU0NzA5OA_36cf6d52-c0ac-4ef6-9830-7348e5cae671">414</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TOTAL REVENUES</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzExLTUtMS0xLTU0NzA5OA_0ac468c7-3646-477e-b021-17aca69f01c6">46,517</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzExLTctMS0xLTU0NzA5OA_b9e95365-24e8-46b2-a0f0-ac7626b5a698">44,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefits and expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmacy and other service costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEzLTUtMS0xLTU0NzA5OA_c3c745e0-faab-4ee8-8cde-d370e47072c2">31,459</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEzLTctMS0xLTU0NzA5OA_2fc001d2-249f-4ef4-b606-4b3956446652">29,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical costs and other benefit expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE0LTUtMS0xLTU0NzA5OA_7debbd55-0a05-499d-85f8-24e2c1dc9b25">9,046</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE0LTctMS0xLTU0NzA5OA_3fd58480-6fc6-4346-a85f-569666fd106e">8,272</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE1LTUtMS0xLTU0NzA5OA_8ef06699-9103-4116-a1ac-5f12a5850f10">3,538</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE1LTctMS0xLTU0NzA5OA_aa2ba26f-2635-4ed1-9fe2-749bf50cc82a">3,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE2LTUtMS0xLTU0NzA5OA_b75edf90-41d6-4615-be11-f855076cc6ea">459</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE2LTctMS0xLTU0NzA5OA_01ad8e17-2c25-4100-9031-1579a895ff34">458</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TOTAL BENEFITS AND EXPENSES</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE3LTUtMS0xLTU0NzA5OA_a4296909-1b07-4580-a873-be3c6ca28ba8">44,502</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE3LTctMS0xLTU0NzA5OA_2c887ebd-2fb1-4159-b27e-a29d03ae639e">41,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE4LTUtMS0xLTU0NzA5OA_bddbf9b0-ac12-4b2d-99c8-52a4c706dcae">2,015</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE4LTctMS0xLTU0NzA5OA_56970ec1-46d1-42da-a19c-a4deb639cfd2">2,188</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE5LTUtMS0xLTU0NzA5OA_0417fc0c-d9d1-4020-8536-9fb60abef367">358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE5LTctMS0xLTU0NzA5OA_3dea0a2f-db00-4c45-bc82-390112e51307">299</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment losses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIyLTUtMS0xLTU0NzA5OA_dea2bf33-feea-4208-9d1c-304c2192f354">56</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIyLTctMS0xLTU0NzA5OA_12493226-c472-47e5-99ea-a9c4706db302">322</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIzLTUtMS0xLTU0NzA5OA_0118b9fd-629d-466b-8f3f-c42b8544fc63">1,601</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIzLTctMS0xLTU0NzA5OA_1556d15b-48f1-4191-86f8-73377cfb6937">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TOTAL INCOME TAXES</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI0LTUtMS0xLTU0NzA5OA_acdde8f0-b78f-47ac-ab80-838071023113">295</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI0LTctMS0xLTU0NzA5OA_8c91905f-ebae-4e12-89d6-f1a4630a6fc5">355</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI1LTUtMS0xLTU0NzA5OA_57915525-1cff-455e-b188-41e347a02700">1,306</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI1LTctMS0xLTU0NzA5OA_102a37c5-08ac-4a1e-9332-52a57043267b">1,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI2LTUtMS0xLTU0NzA5OA_91475474-3f2d-48b5-bf8e-b8c29b92e368">39</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI2LTctMS0xLTU0NzA5OA_e5fba830-b7e9-4d2a-9d4e-e9ecb3440398">15</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SHAREHOLDERS' NET INCOME</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI3LTUtMS0xLTU0NzA5OA_f9fafe56-8ed2-4d6f-85bd-a235e72de841">1,267</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI3LTctMS0xLTU0NzA5OA_b71d309d-9ca3-4c0b-aa5c-2b67275d02db">1,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholders' net income per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI5LTUtMS0xLTU0NzA5OA_f4aca24b-ae68-440a-b82e-8c23a078cd0f">4.28</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI5LTctMS0xLTU0NzA5OA_7e94545c-5dd5-40ad-8402-14ded75dd02b">3.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzMwLTUtMS0xLTU0NzA5OA_43717eef-eeda-4033-8829-51818dafe390">4.24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzMwLTctMS0xLTU0NzA5OA_fbc1a597-6d69-4d17-8314-e2aeec6dfd6f">3.73</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"> <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef" footnoteRole="http://www.xbrl.org/2003/role/footnote">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</ix:footnote></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">The accompanying Notes to the Consolidated Financial Statements (unaudited) are an integral part of these statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_298"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.788%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.680%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The Cigna Group<br/>Consolidated Statements of Comprehensive Income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzQtNS0xLTEtNTQ3MDk4_90abbf5c-7b6f-4d51-a697-b841700bba8e">1,306</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzQtNy0xLTEtNTQ3MDk4_8ab5a675-2a99-441f-a3fb-56dc1264a26a">1,212</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net unrealized appreciation (depreciation) on securities and derivatives</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzYtNS0xLTEtNTQ3MDk4_f276bbbb-bd88-440b-a0ac-8eef469af0a7">194</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzYtNy0xLTEtNTQ3MDk4_35c93aec-9e7e-4334-bc7f-e8ec9b9a4686">843</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net long-duration insurance and contractholder liabilities measurement adjustments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNS0xLTEtNTk3NDcx_0bd12898-7e42-4129-9e81-236baab51a8d">331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNy0xLTEtNTk3NDcx_1c048248-06d6-4527-9699-9259b5dbd011">459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net translation gains (losses) on foreign currencies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNS0xLTEtNTQ3MDk4_ead6c906-7a6c-4fb7-9789-df781e279724">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNy0xLTEtNTQ3MDk4_35bee086-c8e3-40db-b944-6b19988ccfe7">63</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Postretirement benefits liability adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzExLTUtMS0xLTU0NzA5OA_124e425c-a9a7-4f6c-8bc2-6e1caf5929b8">10</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzExLTctMS0xLTU0NzA5OA_3dfd2d59-cc65-4740-803c-0b1b5451cba2">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEyLTUtMS0xLTU0NzA5OA_fd5acbb8-bf0b-474e-bfb9-b76bf7f9dabd">111</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEyLTctMS0xLTU0NzA5OA_e5bd59b8-acff-40a9-84f0-57e953521a33">434</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEzLTUtMS0xLTU0NzA5OA_6452969d-1612-49e0-bccf-da70eb8edb52">1,195</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEzLTctMS0xLTU0NzA5OA_4c603a81-46c3-4370-942a-6aff72d75ecd">778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Comprehensive income (loss) attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE2LTUtMS0xLTU0NzA5OA_ff61b6b8-d30d-4d80-b1db-ff4e37fe7953">34</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE2LTctMS0xLTU0NzA5OA_659b721e-341f-4097-bf9b-a992c9a31cc2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to other noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE3LTUtMS0xLTU0NzA5OA_219d76bb-1cfd-4a30-81fa-4f24f0619c8e">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE3LTctMS0xLTU0NzA5OA_bdb6324f-b7ae-484d-a5d1-a9cbaf53feaa">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss attributable to redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:TemporaryEquityOtherComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE4LTUtMS0xLTU0NzA5OA_63d67157-cbdb-4538-b2fe-eafb5c25c089">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:TemporaryEquityOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE4LTctMS0xLTU0NzA5OA_8ead8ea9-7460-4be6-aa76-7648b71546a0">2</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE5LTUtMS0xLTU0NzA5OA_96cc84e3-5f58-47a6-a5c4-3a404b9cade2">39</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE5LTctMS0xLTU0NzA5OA_3a6c2d42-a5ed-4b47-8f76-2d52bf842af8">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SHAREHOLDERS' COMPREHENSIVE INCOME</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzIwLTUtMS0xLTU0NzA5OA_4741fbbc-64f4-4c52-9dbb-a934e1607170">1,156</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzIwLTctMS0xLTU0NzA5OA_c602d313-2305-4b2e-ac6d-814d71a51d5d">765</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"> <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30" footnoteRole="http://www.xbrl.org/2003/role/footnote">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</ix:footnote></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">The accompanying Notes to the Consolidated Financial Statements (unaudited) are an integral part of these statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_301"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The Cigna Group<br/>Consolidated Balance Sheets</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>March 31,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>December 31,</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzYtMS0xLTEtNTQ3MDk4_c621c55d-67d7-47e3-b168-0052f146dfd0">7,935</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzYtMy0xLTEtNTQ3MDk4_e483f4e2-0134-4faf-8374-b9e8c431fc37">5,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzctMS0xLTEtNTQ3MDk4_6e58cd50-6ceb-4b37-8d1e-c2cfab519842">914</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzctMy0xLTEtNTQ3MDk4_b136721f-f061-4fe3-af15-6ae5cb0c5c55">905</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzgtMS0xLTEtNTQ3MDk4_b4d406ff-5343-4643-ac40-11099267e6c1">17,704</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzgtMy0xLTEtNTQ3MDk4_51d694db-a877-47da-b5f9-5123c07b3070">17,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzktMS0xLTEtNTQ3MDk4_d59cf30e-f796-4b3a-bb6b-273cef19a621">4,211</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzktMy0xLTEtNTQ3MDk4_46f8e2ec-fd55-44cd-a088-ab4007ad34df">4,777</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEwLTEtMS0xLTU0NzA5OA_c986094d-b6d4-47ba-9f14-f6b999e97223">1,263</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEwLTMtMS0xLTU0NzA5OA_e184b990-0d77-4d55-ad49-e7ed65c4679c">1,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEyLTEtMS0xLTU0NzA5OA_9aa0ecb2-439c-4277-89fe-46bea7f792cd">32,027</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEyLTMtMS0xLTU0NzA5OA_5bbe8a6d-2253-45d5-8f58-a6331a9768ea">30,122</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEzLTEtMS0xLTU0NzA5OA_ea1db71c-8e69-41b8-a9ba-5d0040b2e4eb">19,010</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEzLTMtMS0xLTU0NzA5OA_e72c918c-a597-474e-a170-f2142e110cde">16,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reinsurance recoverables</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:ReinsuranceRecoverablesNonCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE0LTEtMS0xLTU0NzA5OA_5aa64ebd-3245-41fa-b2f9-6098ad15f8b8">5,286</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:ReinsuranceRecoverablesNonCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE0LTMtMS0xLTU0NzA5OA_e8dbe745-b137-4a8a-83e0-1f7061ec6fcc">5,416</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE2LTEtMS0xLTU0NzA5OA_3488d113-25f8-4aa1-89ac-45d540354775">3,837</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE2LTMtMS0xLTU0NzA5OA_0c15b4f5-83d2-4988-a69a-4a901dd62c36">3,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE3LTEtMS0xLTU0NzA5OA_22f3dc03-b2bf-49bc-8bb6-b280ed1a5cc1">45,811</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE3LTMtMS0xLTU0NzA5OA_0579eb36-c167-4f6e-ac4f-8d839aa63d39">45,811</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE4LTEtMS0xLTU0NzA5OA_7569facc-91d2-4d21-92bd-8be7564fc737">32,102</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE4LTMtMS0xLTU0NzA5OA_606c6e00-9244-4d69-aba4-00e335e87c0c">32,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE5LTEtMS0xLTU0NzA5OA_2c2493a2-3ce3-4378-99ae-832990eaaeec">2,563</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE5LTMtMS0xLTU0NzA5OA_57070670-5068-4a3b-9b4b-84eb01a3e79c">2,704</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Separate account assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIwLTEtMS0xLTU0NzA5OA_73bd6393-42e4-4c26-bd35-1e8639ec8172">7,340</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIwLTMtMS0xLTU0NzA5OA_6c111ea2-82cb-4b26-a946-7f22aaa08789">7,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIxLTEtMS0xLTU0NzA5OA_f02ed902-0ce0-4c35-9002-03d3b852b2fe">147,976</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIxLTMtMS0xLTU0NzA5OA_f7fff571-48ef-4940-a349-e127170daa6d">143,885</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current insurance and contractholder liabilities</span></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:InsuranceAndContractholderLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIzLTEtMS0xLTU0NzA5OA_16b33893-917f-4017-91d2-5ed04b0af8be">7,166</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:InsuranceAndContractholderLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIzLTMtMS0xLTU0NzA5OA_20ec4532-c297-4eb0-9e39-01131f073d2c">5,409</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmacy and other service costs payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:PharmacyAndServiceCostsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI0LTEtMS0xLTU0NzA5OA_fe804b71-1e9a-4c19-a1b6-4401dfc4cd2c">17,609</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:PharmacyAndServiceCostsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI0LTMtMS0xLTU0NzA5OA_acf1354a-c049-49fb-8776-a986bbb3b160">17,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI1LTEtMS0xLTU0NzA5OA_41022e96-79cf-4ae2-b967-2c90bf775832">7,360</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI1LTMtMS0xLTU0NzA5OA_18ac489a-f37c-4ec1-a714-d74297b28e87">7,775</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:AccruedExpensesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI2LTEtMS0xLTU0NzA5OA_36e0b0c3-6a81-41fd-947c-c799fd45fc5e">9,174</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:AccruedExpensesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI2LTMtMS0xLTU0NzA5OA_b0aeb6ff-21f1-4e80-b147-de6a735a696d">7,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI3LTEtMS0xLTU0NzA5OA_af932630-72d2-4203-875c-3422bc72559b">3,418</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI3LTMtMS0xLTU0NzA5OA_de2112bc-0175-4727-adc0-cb5da30eceb7">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI5LTEtMS0xLTU0NzA5OA_4bd306e6-839c-4c2c-b81f-894b16d96e37">44,727</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI5LTMtMS0xLTU0NzA5OA_7ffe16a4-d89f-49d6-9763-76e5f24f322c">41,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current insurance and contractholder liabilities</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:InsuranceAndContractholderLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMwLTEtMS0xLTU0NzA5OA_9338ff28-17c3-49d4-936e-a69df5160a76">11,790</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:InsuranceAndContractholderLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMwLTMtMS0xLTU0NzA5OA_a44adfa6-6eae-4b0f-b1d1-3eed36def226">11,976</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMxLTEtMS0xLTU0NzA5OA_a72ff1c4-b417-405a-9c9b-515020a6cbaa">7,707</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMxLTMtMS0xLTU0NzA5OA_01113199-5d06-4601-8809-daf773980ca9">7,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMyLTEtMS0xLTU0NzA5OA_c0f8cb04-d992-459f-9791-c1cfd7642a3d">2,692</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMyLTMtMS0xLTU0NzA5OA_4809f36f-6a2f-4048-8673-5a1061b6d99c">2,766</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMzLTEtMS0xLTU0NzA5OA_a441e383-0c72-4d47-8ae9-41916e7dff83">29,124</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMzLTMtMS0xLTU0NzA5OA_031c2ccf-4ee1-437f-9758-c51d899420bd">28,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Separate account liabilities</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM0LTEtMS0xLTU0NzA5OA_5e011b86-a445-4574-a876-e058c3178a9e">7,340</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM0LTMtMS0xLTU0NzA5OA_917de155-e4db-434c-8967-b1ec380a671b">7,278</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TOTAL LIABILITIES</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM1LTEtMS0xLTU0NzA5OA_82f48fc6-4b1e-4072-9c12-7f8af979830f">103,380</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM1LTMtMS0xLTU0NzA5OA_1910bc6f-591d-4929-a6ae-39b31a5bd6fd">99,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingencies &#8212; Note 16</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM2LTEtMS0xLTU0NzA5OA_410c945c-c96b-491a-aab5-2707b7dffd8e"></ix:nonFraction></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM2LTMtMS0xLTU0NzA5OA_8eeedf58-d0e2-40f8-8b86-077a5ed635f8"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM3LTEtMS0xLTU0NzA5OA_139a7533-451c-41dc-8ff0-569767ca17ec">78</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM3LTMtMS0xLTU0NzA5OA_a4ce84c7-19ab-464f-b99d-4d830b9eedf0">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholders' equity</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTEtMS0xLTU0NzA5OA_8d2482df-cd75-47ae-976b-bacf4ba05ab7">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTMtMS0xLTU0NzA5OA_20560a86-6865-406c-95e4-b3ce23b74169">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQwLTEtMS0xLTU0NzA5OA_749f47b6-7e8a-4561-9acb-d82b9dd137b2">30,332</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQwLTMtMS0xLTU0NzA5OA_99927523-d0b4-4bf2-bbf5-8db7be5836c2">30,233</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQxLTEtMS0xLTU0NzA5OA_31dd39bd-e7bc-411b-a63d-52b3f6de38c4">1,769</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQxLTMtMS0xLTU0NzA5OA_731c83fa-4eea-409a-86d1-8ef2c67b0e56">1,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQyLTEtMS0xLTU0NzA5OA_197c57a2-bd47-44dd-ab83-2284e16d8de2">38,841</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQyLTMtMS0xLTU0NzA5OA_36c37ec6-ca45-43f2-999c-6357a46584de">37,940</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Treasury stock, at cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQzLTEtMS0xLTU0NzA5OA_b9475012-22a7-4ae9-892e-77643aa0f42f">22,906</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQzLTMtMS0xLTU0NzA5OA_f720eea4-20f9-40aa-9c2e-55cf9814c9cf">21,844</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TOTAL SHAREHOLDERS' EQUITY</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ0LTEtMS0xLTU0NzA5OA_1d1f7e3a-db3d-4cac-83ed-611def49fc83">44,502</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ0LTMtMS0xLTU0NzA5OA_864afb31-0910-42a1-b5b6-717fed9ea74f">44,675</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ1LTEtMS0xLTU0NzA5OA_27b904c3-684c-4f48-9492-f5d20d449ec0">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ1LTMtMS0xLTU0NzA5OA_ccc13179-2a66-4ae0-a061-19c1ea7c9991">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ2LTEtMS0xLTU0NzA5OA_5b43daf5-7f14-40c1-9f9e-61a4a640ca5f">44,518</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ2LTMtMS0xLTU0NzA5OA_3652dd29-c6f7-4939-a019-d0a25976ad42">44,688</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ3LTEtMS0xLTU0NzA5OA_ccd73141-40ba-4156-bf25-d59af259b96b">147,976</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ3LTMtMS0xLTU0NzA5OA_97090691-b4c3-43b5-b77b-061701c2fa9e">143,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6" footnoteRole="http://www.xbrl.org/2003/role/footnote">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</ix:footnote></span></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzE4Mg_c38bd102-2a43-40c9-954e-9ee16d667456" footnoteRole="http://www.xbrl.org/2003/role/footnote">Par value per share, $<ix:nonFraction unitRef="usdPerShare" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzM2_9d52a65c-ab4b-4b2c-9f9f-46cb2ad62472"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzM2_ed619e9c-b002-40d3-a381-4d57cd3798be">0.01</ix:nonFraction></ix:nonFraction>; shares issued, <ix:nonFraction unitRef="shares" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzU1_4aae0c51-0138-475b-b5bf-de6d9a74ac64">399</ix:nonFraction> million as of March&#160;31, 2023 and <ix:nonFraction unitRef="shares" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzcx_7e34226c-205b-48d0-af19-97bea63e04f5">398</ix:nonFraction> million as of December&#160;31, 2022; authorized shares, <ix:nonFraction unitRef="shares" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzEwMw_a5cea792-bbb4-494e-8ce0-566675b6131a"><ix:nonFraction unitRef="shares" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzEwMw_a685b8f1-7c80-4df2-b418-9462b66f3001">600</ix:nonFraction></ix:nonFraction> million.</ix:footnote></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">The accompanying Notes to the Consolidated Financial Statements (unaudited) are an integral part of these statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_307"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="54" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The Cigna Group</span></td></tr><tr><td colspan="54" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Changes in Total Equity</span></td></tr><tr><td colspan="54" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unaudited</span></td></tr><tr><td colspan="54" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shareholders' Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other Non- controlling Interests</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance at December 31, 2022, as retrospectively restated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id32446380c2041c8b63ae668e812de11_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMS0xLTEtNTQ3MDk4_b11e4b39-97be-4030-992e-f4b750eaa8de">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07eeeff84fa4f25a2dd79fdc9bc15dd_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMy0xLTEtNTQ3MDk4_c47cdd19-3043-4ddc-8472-3fb8251772c5">30,233</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b7588439a24468b996c973b3308b0f_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtNS0xLTEtNTQ3MDk4_7268058b-daf3-4f83-b55f-ca21c3179757">1,658</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7d813880f744d49943f15dd7e540ba0_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtNy0xLTEtNTQ3MDk4_2d1ad352-3fd3-4c93-8d68-6014b98ef8cb">37,940</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90dec54128bd417fa982da7f2d7685f2_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtOS0xLTEtNTQ3MDk4_80c452f7-d6bd-4b5b-a0ba-20e188f66261">21,844</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d2cebed8b184349b833533515099744_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTEtMS0xLTU0NzA5OA_9356d6da-3934-4e59-b329-f57e0dfa69e3">44,675</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0206ebaad6534ebe9f01b32c7c8377aa_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTMtMS0xLTU0NzA5OA_2557cd11-338d-4aa3-86ba-661f15475ab4">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTUtMS0xLTU0NzA5OA_e205003c-80c6-4204-b42d-5e25a7ea436c">44,688</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTctMS0xLTU0NzA5OA_90433d9f-2558-4927-afa9-7a1032a8b39a">66</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Effect of issuing stock for employee benefit plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7909946bc91943678368051fb2668b17_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzctMy0xLTEtNTQ3MDk4_6d00cfc8-0223-4448-80f7-4fbcadf65647">99</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf856e4d292f45ee82a219747b70690d_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzctOS0xLTEtNTQ3MDk4_4d856e91-c15f-4906-920e-caed86139078">104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzctMTEtMS0xLTU0NzA5OA_4a05ae94-38c4-4422-bd33-018f22bb3a0f">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzctMTUtMS0xLTU0NzA5OA_45b0779e-7fc8-4215-b26d-149f25866e19">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c0abb6b8064491c945d2af1005f4e61_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzgtNS0xLTEtNTQ3MDk4_9f7f0761-168a-4143-8751-1b6e70602d3e">111</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzgtMTEtMS0xLTU0NzA5OA_ada1d0a2-27d5-41bd-8a61-a81867fb1fc0">111</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzgtMTUtMS0xLTU0NzA5OA_1a3a396b-f4f2-49eb-9b27-c5887fc98e80">111</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ee4c2e55934757aa575a02b3920fb4_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzktNy0xLTEtNTQ3MDk4_9322eacc-4ac3-4f72-b023-ab9b97e1c447">1,267</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzktMTEtMS0xLTU0NzA5OA_ed450034-cb02-4600-85b0-6be0b24371ec">1,267</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05dd3918d78c4bf1a755567f7c64ddb8_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzktMTMtMS0xLTU0NzA5OA_ffaa1eeb-3c56-4a8c-9797-638020385245">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzktMTUtMS0xLTU0NzA5OA_751bce05-f144-4c38-b496-13c786334bd4">1,272</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzktMTctMS0xLTU0NzA5OA_67a91ea2-19d3-409a-acb2-c0ee2d14b8d3">34</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common dividends declared (per share: $<ix:nonFraction unitRef="usdPerShare" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjg4YjViZjdkNDM0MDQxNjJiMDYwZGEwM2JmNWUxOTIyXzU0OTc1NTgxMzk0MQ_46f2df2d-c6cc-4fac-86d3-47034aa0fc58">1.23</ix:nonFraction>)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22ee4c2e55934757aa575a02b3920fb4_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEwLTctMS0xLTU0NzA5OA_9a813110-264d-4d1f-abe7-329797f92bfa">366</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEwLTExLTEtMS01NDcwOTg_0cd1c19d-bbad-4ac2-981c-89caf1d96a67">366</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEwLTE1LTEtMS01NDcwOTg_ed6444c1-3031-4f8d-8fcf-609bda5ba755">366</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf856e4d292f45ee82a219747b70690d_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzExLTktMS0xLTU0NzA5OA_2326caaf-c9ab-4e1c-abdf-b838c848c5f8">958</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzExLTExLTEtMS01NDcwOTg_86b34cca-cac0-47a9-85de-d617bb80ebff">958</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzExLTE1LTEtMS01NDcwOTg_cc26bb71-1de2-4683-9cfc-58aa1d667808">958</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other transactions impacting noncontrolling interests</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331" decimals="-6" name="ci:NoncontrollingInterestOtherChanges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEyLTExLTEtMS01NDcwOTg_6187d803-3e26-4edf-b90b-75910aa3a2a9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05dd3918d78c4bf1a755567f7c64ddb8_D20230101-20230331" decimals="-6" sign="-" name="ci:NoncontrollingInterestOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEyLTEzLTEtMS01NDcwOTg_8a6ed664-dc95-4bbf-926b-fc35b33dfb4e">2</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:NoncontrollingInterestOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEyLTE1LTEtMS01NDcwOTg_8797416f-afe7-4852-83e0-f46671a9b04f">2</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:TemporaryEquityOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEyLTE3LTEtMS01NDcwOTg_dfaa5478-3447-4800-8522-b48ad7c74bf9">22</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia464d53888f74e16b5ba9e62ba445568_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTEtMS0xLTU0NzA5OA_0177b6de-4b7a-4eaa-b504-3f34767c35f0">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34d79544d8cb4787abb0f63293d81023_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTMtMS0xLTU0NzA5OA_03db70c1-def6-43ad-84aa-af3e229b4525">30,332</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ca2b0796c79476594136b360600f553_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTUtMS0xLTU0NzA5OA_2d4c9807-3947-433b-af43-6f26299eefff">1,769</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99423769f3dd4edb99594b8b2aee677e_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTctMS0xLTU0NzA5OA_ae1c0d33-979f-4468-ad09-a30911f5ddb2">38,841</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e2dbc865d7444349a0f2776dabcbca6_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTktMS0xLTU0NzA5OA_ccff80b3-017d-49ef-b312-38d4238603f0">22,906</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20a54758336f4568bce7df2f2f0da706_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTExLTEtMS01NDcwOTg_16da37cf-5f2f-4582-aade-bfe11dcbaccf">44,502</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b841b999bc847b2a7d961377de9d3de_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTEzLTEtMS01NDcwOTg_550fa676-19a0-4547-aef2-ed987230c5cf">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTE1LTEtMS01NDcwOTg_56ffa54d-dba1-4758-be51-9502a99a6e99">44,518</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTE3LTEtMS01NDcwOTg_5f1c233a-6d93-40fe-b23d-d5b7991d3dbb">78</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="54" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shareholders' Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other Non- controlling Interests</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance at December 31, 2021, as retrospectively restated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70ad8103265e4886a5533cccf894688b_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTEtMS0xLTU4NTgyMA_a5c7dd7b-fc0d-48e3-86ba-a2f614e48cef">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i617514263e2a477ba7f3b8a9a6a9674a_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTMtMS0xLTU4NTgyMA_a7849b11-b004-4f86-8107-ca09bbf49e09">29,574</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c898b920ca42a186661453324aadcd_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTUtMS0xLTU4NTgyMA_9e956362-a4b5-4535-a069-df21dc860b72">1,068</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c711c00bcf422fafd828ded50e4f64_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTctMS0xLTU4NTgyMA_024f2260-cfee-444f-bac6-dcb6062dcf0c">32,623</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85fc8a53e3214c7c985953d9b3dc5a78_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTktMS0xLTU4NTgyMA_353edb31-5e7d-4833-baa6-84be8085eb18">14,175</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71485e3f57d4b1e87922c63f04789e4_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTExLTEtMS01ODU4MjA_98bb3c29-d795-4c01-b373-aa494ce0b2d1">46,958</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21827b448914783ad89a1e60a05565f_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTEzLTEtMS01ODU4MjA_c2bc670e-180e-4a86-b5f3-3963b956f308">18</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb159500cff1416584b25f65dcff1e94_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE1LTEtMS01ODU4MjA_32e6079e-6d8c-452a-9487-2b21fb789b79">46,976</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb159500cff1416584b25f65dcff1e94_I20211231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE3LTEtMS01ODU4MjA_edaf8827-9b73-4399-bc97-527cd8e302e2">54</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Effect of issuing stock for employee benefit plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd620fc2833e42f18e79f1190828960c_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTMtMS0xLTU0NzA5OA_e66eb9e9-b5ff-4bea-9267-9691b5528320">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9c54d8a0b0d4d1f9f08d455276b0990_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTktMS0xLTU0NzA5OA_f2e52c45-7c4c-4cd1-b5fc-d70ba4132bcb">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTExLTEtMS01NDcwOTg_de3fbf9f-6c73-4f79-b986-ea91e2ae4d0e">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE1LTEtMS01NDcwOTg_ce501d47-0f65-4c33-b6e4-4922ea8a529f">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e9fa809dec40e4a4434d5f6b246b71_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIwLTUtMS0xLTU0NzA5OA_8c4362bd-d6c5-4b38-a16a-0b22e8e25e98">432</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIwLTExLTEtMS01NDcwOTg_3892c3db-305a-43d9-9dd1-9fdd436e567d">432</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIwLTE1LTEtMS01NDcwOTg_e2f7e909-98e7-467c-a1a1-a1189b362298">432</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:TemporaryEquityOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIwLTE3LTEtMS01NDcwOTg_b955c582-e45d-4b4a-8a3f-80e139d5d626">2</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75919ae416364991a9685e11cb5779d9_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIxLTctMS0xLTU0NzA5OA_29a9ea18-123f-4e60-8ede-afc93f3e61b7">1,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIxLTExLTEtMS01NDcwOTg_ce207828-e761-4822-a1e3-87f5760126fa">1,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d2197648684bb191b9dfd2c8308df3_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIxLTEzLTEtMS01NDcwOTg_198fc92d-dc43-4bfa-8550-621b6199c137">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIxLTE1LTEtMS01NDcwOTg_1fdb090f-2262-4ef9-9148-c79d3b5513ed">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIxLTE3LTEtMS01NDcwOTg_f3b9566a-0e7f-45c7-b5c1-9078e2b64e5c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common dividends declared (per share: $<ix:nonFraction unitRef="usdPerShare" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIyLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmEwOTVhNTg4MWM2ZTRlOTFiNDhlYjJjYzY1ZDFlYTBhXzQy_43e2c3cb-4403-4fd4-b583-7604908d607e">1.12</ix:nonFraction>)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75919ae416364991a9685e11cb5779d9_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIyLTctMS0xLTU0NzA5OA_749be484-9632-4a66-93e8-1d9e71fdaed6">356</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIyLTExLTEtMS01NDcwOTg_b8b8e2b2-3ba3-447e-bdc6-ba13280e45ce">356</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIyLTE1LTEtMS01NDcwOTg_90726f2b-ca8e-4f69-933a-bf6720e36968">356</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd620fc2833e42f18e79f1190828960c_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIzLTMtMS0xLTU0NzA5OA_7d9c8e01-4e33-4460-b979-fa4e117b8496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9c54d8a0b0d4d1f9f08d455276b0990_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIzLTktMS0xLTU0NzA5OA_5bad0200-7e49-44cd-9be9-ea9d56240585">1,334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIzLTExLTEtMS01NDcwOTg_f60477f2-976f-4715-b028-eda73b45b2a6">1,334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIzLTE1LTEtMS01NDcwOTg_671f01ec-9701-46c0-bdc9-c52fd55a36a2">1,334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other transactions impacting noncontrolling interests</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd620fc2833e42f18e79f1190828960c_D20220101-20220331" decimals="-6" name="ci:NoncontrollingInterestOtherChanges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI0LTMtMS0xLTU0NzA5OA_4fe56696-7ea2-4fc3-8479-09b8f1fc097d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331" decimals="-6" name="ci:NoncontrollingInterestOtherChanges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI0LTExLTEtMS01NDcwOTg_9d4e9c33-349e-4334-8c04-1eab000c25ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11d2197648684bb191b9dfd2c8308df3_D20220101-20220331" decimals="-6" sign="-" name="ci:NoncontrollingInterestOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI0LTEzLTEtMS01NDcwOTg_64fc28a9-ff2f-4de7-9af7-6ace3944866a">8</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:NoncontrollingInterestOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI0LTE1LTEtMS01NDcwOTg_81413a06-329a-4923-b321-4953765ba090">8</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:TemporaryEquityOtherChanges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI0LTE3LTEtMS01NDcwOTg_b0e3440c-76d8-43eb-be3f-3f4af4187c76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i417f3083e801423e81a8d2f395260442_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTEtMS0xLTU0NzA5OA_ecdff555-0469-47c4-84a1-c5b20f4723ff">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia44468c92367407098fcf49709295d14_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTMtMS0xLTU0NzA5OA_c602da25-7ce7-4963-bf5d-aeaea461d450">29,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e8477b53954f2eb5c8d27ecfddb379_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTUtMS0xLTU0NzA5OA_c6f01889-f311-4569-9d8b-17b549a10a04">1,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7677f2aaed8c4a29a27ff12fecd40d9e_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTctMS0xLTU0NzA5OA_cbfdf355-c992-49a1-ad55-af2e0bdd8e6f">33,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7fe65d9692f4e978e3eeb7d6c41aef0_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTktMS0xLTU0NzA5OA_d149c7ed-455f-47e2-96b5-619ca8a0a49a">15,581</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1487aaff9d704b1b9f53a37e55ac7eea_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTExLTEtMS01NDcwOTg_2dd97d86-31f8-4224-bd5f-37b90ae84672">46,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i677503e86b4241c6889f0c64707d9e13_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTEzLTEtMS01NDcwOTg_51686e55-76db-4f21-a077-29b43cc1a1f1">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTE1LTEtMS01NDcwOTg_90a25ab5-2ea0-4c13-b677-547f35e2e1ed">46,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTE3LTEtMS01NDcwOTg_efb68e77-e9cc-41d9-83dd-f6de8f9edf4f">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b" footnoteRole="http://www.xbrl.org/2003/role/footnote">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements to the Consolidated Financial Statements for further information.</ix:footnote></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">The accompanying Notes to the Consolidated Financial Statements (unaudited) are an integral part of these statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_313"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">The Cigna Group</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Consolidated Statements of Cash Flows</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.430%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unaudited</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUtMi0xLTEtNTQ3MDk4_2ea5f69c-d416-448e-bb36-09910a2b4819">1,306</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUtNC0xLTEtNTQ3MDk4_75d0f478-a637-4d65-9d55-db1b304a5c7d">1,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzctMi0xLTEtNTQ3MDk4_432b92bc-159e-475e-be2a-44a4e68a74a0">749</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzctNC0xLTEtNTQ3MDk4_07359145-9265-4897-becc-719305fd869b">717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Realized investment losses, net</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzgtMi0xLTEtNTQ3MDk4_66fb6307-ef47-4615-ba70-e0f1bcf066e9">56</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzgtNC0xLTEtNTQ3MDk4_8e1d38cf-145b-41b9-934d-9ce973338066">322</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzktMi0xLTEtNTQ3MDk4_f8e3061f-66d6-40a5-95a3-74ce0a42482d">108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzktNC0xLTEtNTQ3MDk4_7d5e6dba-3610-4bc5-b89a-22e31afef865">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net changes in assets and liabilities, net of non-operating effects:</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzEzLTItMS0xLTU0NzA5OA_59400853-b280-48e5-b6b6-d25c3e63b991">479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzEzLTQtMS0xLTU0NzA5OA_e4485689-2c24-432d-a1a5-de5296efaf00">983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE0LTItMS0xLTU0NzA5OA_afccda8d-f738-43d6-83e3-a62dd4b053a1">566</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE0LTQtMS0xLTU0NzA5OA_dc5978fe-0471-42d8-a6b8-729286e3dc3c">222</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reinsurance recoverable and Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReinsuranceRecoverable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE1LTItMS0xLTU0NzA5OA_ac1f642b-424b-4750-8cf8-a0ad4836e55d">72</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReinsuranceRecoverable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE1LTQtMS0xLTU0NzA5OA_08201fda-a8c1-48b1-a456-652c75763d3d">584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Insurance liabilities</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE2LTItMS0xLTU0NzA5OA_adeea012-5ec7-4275-b45b-751fc16cfb7c">1,533</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE2LTQtMS0xLTU0NzA5OA_ee545fb6-5653-452f-a623-cf1d3704df43">142</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pharmacy and other service costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:IncreaseDecreaseInPharmacyAndServiceCostsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE3LTItMS0xLTU0NzA5OA_c83f5d69-b6ba-440e-b609-5dc7f75655e1">539</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:IncreaseDecreaseInPharmacyAndServiceCostsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE3LTQtMS0xLTU0NzA5OA_c98a3aef-75fc-4145-9646-9dc96c93bd53">74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts payable and Accrued expenses and other liabilities</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE4LTItMS0xLTU0NzA5OA_64fcb767-ea9b-4cd6-bd78-28b6cdf701ab">690</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE4LTQtMS0xLTU0NzA5OA_5be68d15-7aaf-4b97-9dc1-2546e2482032">85</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE5LTItMS0xLTU0NzA5OA_6957f021-fd3a-4027-85b0-e8e5c3cbd997">104</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE5LTQtMS0xLTU0NzA5OA_819649f3-b4f0-463e-a6e6-f6842fedb49a">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">NET CASH PROVIDED BY OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIwLTItMS0xLTU0NzA5OA_c9f6e341-8fd6-4de6-8745-3e39e7e9e4eb">5,028</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIwLTQtMS0xLTU0NzA5OA_5d85ce0f-1d51-41c7-9500-4a00e6cd94eb">2,030</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Proceeds from investments sold:</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities and equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:ProceedsFromSaleOfDebtAndEquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIzLTItMS0xLTU0NzA5OA_bd7dc2bb-115d-4dc5-9051-23f6caab80d8">196</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:ProceedsFromSaleOfDebtAndEquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIzLTQtMS0xLTU0NzA5OA_eb3b95b7-35b8-4ef7-b06f-c37bf28c7a72">757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Investment maturities and repayments:</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities and equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI1LTItMS0xLTU0NzA5OA_b982d66d-0bf7-4283-aa1e-173848a0f44a">257</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI1LTQtMS0xLTU0NzA5OA_d181c0e4-9505-4b4c-9ded-757953e6fa5e">456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLoansReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI2LTItMS0xLTU0NzA5OA_c67a0cae-4032-4def-8beb-2e4e31d07de6">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLoansReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI2LTQtMS0xLTU0NzA5OA_d5873846-d3a3-41c1-86e3-23f911b4d30b">65</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other sales, maturities and repayments (primarily short-term and other long-term investments)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI3LTItMS0xLTU0NzA5OA_91707dc4-a1fa-4db4-b860-3490747dd97e">160</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI3LTQtMS0xLTU0NzA5OA_8f14592e-f58f-4106-a62a-d3eae03b38bb">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Investments purchased or originated:</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities and equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:PaymentsToAcquireDebtAndEquitySecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI5LTItMS0xLTU0NzA5OA_d5dcfe2f-537d-4dbe-a509-b71a27e5649c">2,794</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:PaymentsToAcquireDebtAndEquitySecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI5LTQtMS0xLTU0NzA5OA_63be975e-a5ef-47ac-b600-86d8cda714e6">1,246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireMortgageNotesReceivable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMwLTItMS0xLTU0NzA5OA_7af09f4f-d640-4683-8418-e3242c2967d0">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireMortgageNotesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMwLTQtMS0xLTU0NzA5OA_4b1b73d9-48a8-4977-9879-b16785f9f348">59</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (primarily short-term and other long-term investments)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMxLTItMS0xLTU0NzA5OA_97918b9c-1038-481e-aa39-eecba17269e2">377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMxLTQtMS0xLTU0NzA5OA_5cc64e46-1759-4e32-825a-339e5c70c6a9">425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Property and equipment purchases, net</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:PaymentsForProceedsFromPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMyLTItMS0xLTU0NzA5OA_a11165fc-1df2-42f3-8090-95e1fdf71aa4">408</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:PaymentsForProceedsFromPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMyLTQtMS0xLTU0NzA5OA_2aa57fe0-3a8a-43b1-bcd4-775311586a6c">288</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Divestitures, net of cash sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM0LTItMS0xLTU0NzA5OA_e63647ad-9477-44e1-9699-8d92326ee87e">22</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM0LTQtMS0xLTU0NzA5OA_c8b5a649-4307-44a0-8705-f02d8e5553a0">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM1LTItMS0xLTU0NzA5OA_27ed17fc-4b0b-4198-aa7f-08c4fbc656f9">43</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM1LTQtMS0xLTU0NzA5OA_47e7f790-a8a5-4142-8bc4-161a595b03e0">6</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">NET CASH USED IN INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM2LTItMS0xLTU0NzA5OA_70345755-cf0c-4988-a295-e637114d5c5f">2,983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM2LTQtMS0xLTU0NzA5OA_de053d13-eae1-4d0c-914d-d26c4f8b03ef">324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deposits and interest credited to contractholder deposit funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:AdditionsToContractHoldersFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM4LTItMS0xLTU0NzA5OA_5a829602-6405-4026-a01b-8f74f0fa2203">45</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:AdditionsToContractHoldersFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM4LTQtMS0xLTU0NzA5OA_0a46c049-4e5a-4a2c-9b85-91fe5e21e7b5">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Withdrawals and benefit payments from contractholder deposit funds</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:WithdrawalFromContractHoldersFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM5LTItMS0xLTU0NzA5OA_8f71d9ae-eb58-44d9-8a4b-3d4a46ffee5e">48</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:WithdrawalFromContractHoldersFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM5LTQtMS0xLTU0NzA5OA_b2a52d56-ac5d-462c-9f34-5d79bdbc9058">49</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net change in short-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:ProceedsFromRepaymentsOfOtherShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQwLTItMS0xLTU0NzA5OA_f51533f3-ef10-41aa-a536-35710f37d854">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:ProceedsFromRepaymentsOfOtherShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQwLTQtMS0xLTU0NzA5OA_5b3debd5-a815-40c2-a5f3-15cb4eb1276e">463</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ0LTItMS0xLTU0NzA5OA_d9983382-31cc-4f97-bac8-232ec3e3ea79">80</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ0LTQtMS0xLTU0NzA5OA_63c16f86-df27-450f-8108-101e7edd1461">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net proceeds on issuance of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ1LTItMS0xLTU0NzA5OA_378dd899-4718-48c8-b1e1-3b05400db02d">1,491</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ1LTQtMS0xLTU0NzA5OA_f74a5de7-af04-4de7-8e81-e0c1c1b37162">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ2LTItMS0xLTU0NzA5OA_aee5ff7d-85ff-44f7-9d66-420ec660f3a8">962</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ2LTQtMS0xLTU0NzA5OA_734b41b3-f6ac-4705-bf15-debe8f54f256">1,368</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ3LTItMS0xLTU0NzA5OA_cdb7a7b7-2f27-4e7c-b256-98b5f44bcf16">30</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ3LTQtMS0xLTU0NzA5OA_61721542-f2fa-4d6d-9c5c-be545c576895">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock dividend paid</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ4LTItMS0xLTU0NzA5OA_d847ff3c-0b5e-4914-830c-24f8c7743237">368</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ4LTQtMS0xLTU0NzA5OA_2f7b09c1-467e-4f4f-8d6b-ccfcaf6d6078">357</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ5LTItMS0xLTU0NzA5OA_43209fba-e332-4bec-9f42-e031fa1f1196">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ5LTQtMS0xLTU0NzA5OA_5fa23537-0afa-4035-be93-f7dd6e860b28">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">NET CASH USED IN FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUwLTItMS0xLTU0NzA5OA_159fac32-9301-4dd8-a831-931f6808a70a">37</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUwLTQtMS0xLTU0NzA5OA_1affbf90-4413-432e-a4d7-521bcd13abd1">2,171</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of foreign currency rate changes on cash, cash equivalents and restricted cash </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUxLTItMS0xLTU0NzA5OA_0f510e80-73b4-43de-ae6d-32f4b8ca0136">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUxLTQtMS0xLTU0NzA5OA_203e5dfe-669d-43c4-b19d-ee961dcd4bb6">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUyLTItMS0xLTU0NzA5OA_cd9bbdef-bbbe-40e2-925e-1a8b95601eed">2,013</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUyLTQtMS0xLTU0NzA5OA_56327850-ce35-456e-8228-496dbf146b1f">488</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash January 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTItMS0xLTU0NzA5OA_40db761f-a266-4f65-b6bb-86c4a203c722">5,976</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb159500cff1416584b25f65dcff1e94_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTQtMS0xLTU0NzA5OA_79aa366d-893d-4698-8351-155de9b73318">5,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, March 31,</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU0LTItMS0xLTU0NzA5OA_cab9c01b-bba2-4a36-a9fe-361fe56e5dd6">7,989</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU0LTQtMS0xLTU0NzA5OA_68007cd1-77bc-4f06-9fe8-d027ebcdfddb">5,060</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents reclassified to Assets of businesses held for sale</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU1LTItMS0xLTU0NzA5OA_115e8e3b-10ab-4648-a8b2-a80b2bcb8c21">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU1LTQtMS0xLTU0NzA5OA_320766a2-bc6b-4671-b705-848e1fb2e4c4">591</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash March 31, per Consolidated Balance Sheets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTItMS0xLTU0NzA5OA_8eee97e6-4411-4def-985b-4e731dff18d0">7,989</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTQtMS0xLTU0NzA5OA_5e85d59a-d8a5-45a7-8a41-a74c2856ca74">4,469</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Supplemental Disclosure of Cash Information:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes paid, net of refunds</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU4LTItMS0xLTU0NzA5OA_ab0c4445-b790-47d0-92cb-6e4eb3c7f7ce">77</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU4LTQtMS0xLTU0NzA5OA_d3399559-aa7f-4d23-8b23-b043ad991fd6">43</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU5LTItMS0xLTU0NzA5OA_720fb73b-5148-4904-b702-04500e9623df">322</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU5LTQtMS0xLTU0NzA5OA_124c1341-e99b-4b0c-900b-2319a9a1cc23">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc" footnoteRole="http://www.xbrl.org/2003/role/footnote">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</ix:footnote></span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzU0OTc1NTgxNDQ3OQ_1dc42f8b-c807-4376-a384-691001e0ef4e" footnoteRole="http://www.xbrl.org/2003/role/footnote">Includes $<ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzI1ODM4NTIzMjUzMTA2_4df9f1d4-3d6c-46bf-9b9c-e4feff6e7297">425</ix:nonFraction> million reported in Assets of businesses held for sale as of January 1, 2022.</ix:footnote></span></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzI1Mg_621034ee-a185-4141-b59a-278aa5be2095" footnoteRole="http://www.xbrl.org/2003/role/footnote">Restricted cash and cash equivalents were reported in other long-term investments.</ix:footnote></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">The accompanying Notes to the Consolidated Financial Statements (unaudited) are an integral part of these statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_325"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CIGNA GROUP</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) </span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.830%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Note Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Footnote</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">USINESS AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">APITAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">TRUCTURE</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_331">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_331">Description of Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_331">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_334">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_334">Summary of Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_334">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_364">3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_364">Accounts Receivable, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_364">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_220">4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_220">Supplier Finance Program</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_220">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_385">5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_385">Mergers, Acquisitions and Divestitures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_385">11</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_430">6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_430">Earnings Per Share</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_430">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_451">7</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_451">Debt</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_451">13</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_472">8</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_472">Common and Preferred Stock</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_472">14</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">NSURANCE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">NFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_490">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_490">Insurance and Contractholder Liabilities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_490">15</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_562">10</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_562">Reinsurance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_562">20</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">NVESTMENTS</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_622">11</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_622">Investments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_622">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_736">12</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_736">Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_736">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_793">13</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_793">Variable Interest Entities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_793">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_811">14</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_811">Accumulated Other Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_811">29</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">OMPLIANCE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">, R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">EGULATION AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ONTINGENCIES</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_859">15</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_859">Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_859">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_871">16</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:20pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_871">Contingencies and Other Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_871">30</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ESULTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ETAILS</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_889">17</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:20pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_889">Segment Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_889">32</a></span></div></td></tr></table></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_331"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMzEvZnJhZzpiYjUzZDdmNTBjOTU0MmQ3YjMwOTE1YjRkMDQwZDBmYy90ZXh0cmVnaW9uOmJiNTNkN2Y1MGM5NTQyZDdiMzA5MTViNGQwNDBkMGZjXzQxNDY_87e6250d-e64a-4d48-a001-84a70e2da569" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8211; Description of Business</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Cigna Group, together with its subsidiaries (either individually or collectively referred to as the "Company", "we," "us" or "our"), is a global health company with a mission of helping those we serve improve their health and vitality. Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental and related products and services. </span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The majority of these products are offered through employers and other groups such as governmental and non-governmental organizations, unions and associations. Cigna Healthcare also offers commercial health and dental insurance and Medicare products to individuals in the United States and selected international markets. In addition to these ongoing operations, The Cigna Group also has certain run-off operations.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A full description of our segments follows:</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Evernorth Health Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> includes a broad range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in Pharmacy Benefits, Home Delivery Pharmacy, Specialty Pharmacy, Distribution and Care Delivery and Management Solutions, which are provided to health plans, employers, government organizations and health care providers.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cigna Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> includes the U.S. Commercial, U.S. Government and International Health operating segments which provide comprehensive medical and coordinated solutions to clients and customers. U.S. Commercial products and services include medical, pharmacy, behavioral health, dental and other products and services for insured and self-insured clients. U.S. Government solutions include Medicare Advantage, Medicare Supplement and Medicare Part D plans for seniors and individual health insurance plans. International Health solutions include health care coverage in our international markets, as well as health care benefits for globally mobile individuals and employees of multinational organizations. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> comprises the remainder of our business operations, which includes ongoing businesses and exited businesses. Our ongoing businesses include continuing business (corporate-owned life insurance ("COLI")) and our run-off businesses. Our run-off businesses include (i) variable annuity reinsurance business (also referred to as "guaranteed minimum death benefit ("GMDB") and guaranteed minimum income benefit ("GMIB") business) that was effectively exited through reinsurance with Berkshire Hathaway Life Insurance Company of Nebraska ("Berkshire") in 2013, (ii) settlement annuity business, and (iii) individual life insurance and annuity and retirement benefits businesses comprised of deferred gains from the sales of these businesses. Our exited businesses include our interest in a joint venture in T&#252;rkiye, which was sold in December 2022 and the international life, accident and supplemental benefits businesses sold in July 2022 (the "Chubb transaction").</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">reflects amounts not allocated to operating segments, including net interest expense (defined as interest on corporate debt less net investment income on investments not supporting segment and other operations), certain litigation matters, expense associated with our frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs and intersegment eliminations for products and services sold between segments.</span></div></ix:nonNumeric><div id="id1800413722c4e30b53ad5d464cab4e8_334"></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMzQvZnJhZzo3YjM0NjI3ZDcxYjQ0MjhkOTBkMTY0Nzk3ODIwNjFhMS90ZXh0cmVnaW9uOjdiMzQ2MjdkNzFiNDQyOGQ5MGQxNjQ3OTc4MjA2MWExXzkwOA_9647b300-85a2-49d0-95d0-2d0ed780e7bb" continuedAt="ie3bbf1c3352f46e4bd395631941d4607" escape="true"><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8211; Summary of Significant Accounting Policies&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMzQvZnJhZzo3YjM0NjI3ZDcxYjQ0MjhkOTBkMTY0Nzk3ODIwNjFhMS90ZXh0cmVnaW9uOjdiMzQ2MjdkNzFiNDQyOGQ5MGQxNjQ3OTc4MjA2MWExXzkxMQ_6eddb992-a01d-42a4-a465-ef652cab63f2" continuedAt="i107dc638a2214a0da1f6424f1ce31e6f" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Basis of Presentation</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Consolidated Financial Statements include the accounts of The Cigna Group and its consolidated subsidiaries. Intercompany transactions and accounts have been eliminated in consolidation. These Consolidated Financial Statements were prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP"). Certain amounts in prior years have been reclassified to conform to the current year presentation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amounts recorded in the Consolidated Financial Statements necessarily reflect management's estimates and assumptions about medical costs, investment and receivable valuations, interest rates and other factors. Significant estimates are discussed throughout these Notes; however, actual results could differ from those estimates. The impact of a change in estimate is generally included in earnings in the period of adjustment.</span></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_337"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ie3bbf1c3352f46e4bd395631941d4607" continuedAt="i4f44ba8c79ba4e1882924dcbc5d3b803"><ix:continuation id="i107dc638a2214a0da1f6424f1ce31e6f">These interim Consolidated Financial Statements are unaudited but include all adjustments (including normal recurring adjustments) necessary, in the opinion of management, for a fair statement of financial position and results of operations for the periods reported. The interim Consolidated Financial Statements and Notes should be read in conjunction with the Consolidated Financial Statements and Notes included in the 2022 Annual Report on Form 10-K ("2022 Form 10-K"). The preparation of interim Consolidated Financial Statements necessarily relies heavily on estimates. This and other factors, including the seasonal nature of portions of the health care and related benefits business, as well as competitive and other market conditions, call for caution in estimating full-year results based on interim results of operations.</ix:continuation></ix:continuation></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_343"></div><ix:continuation id="i4f44ba8c79ba4e1882924dcbc5d3b803" continuedAt="i8c49872f58194635a2922cc98fb5d3be"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNDMvZnJhZzplNzdkNTIyYWY0Nzk0MmJmYWE1ZDY1MmU1ZWRmYmU1Zi90ZXh0cmVnaW9uOmU3N2Q1MjJhZjQ3OTQyYmZhYTVkNjUyZTVlZGZiZTVmXzUwNjY_e454230b-e920-4641-a7da-2d29bd2011c3" continuedAt="ic0577d86b79d4766a00d6f30842b8354" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Recent Accounting Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's 2022 Form 10-K includes discussion of significant recent accounting pronouncements that either have impacted or may impact our financial statements in the future. The following information provides updates on recently adopted accounting pronouncements that have occurred since the Company filed its 2022 Form 10-K. There are no accounting pronouncements not yet adopted as of March&#160;31, 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Targeted Improvements to the Accounting for Long-Duration Contracts ("LDTI"), Accounting Standards Update ("ASU") 2018-12 and related amendments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Cigna Group adopted LDTI January 1, 2023, which includes the following key provisions:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Changes to the measurement of the future policy benefits liability for traditional and limited-pay insurance contracts:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Assumptions used to measure cash flows (such as mortality, morbidity and lapse assumptions) are updated at least annually with the effect of changes in those assumptions remeasured retrospectively and reflected in current period net income. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Discount rate assumptions are updated quarterly based on market-level yields for low credit risk fixed income instruments ("upper-medium grade fixed-income instrument"), with any changes reflected in other comprehensive income. The upper-medium grade fixed-income instrument yield is interpreted to mean A-rated.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Deferred policy acquisition costs ("DAC") related to long-duration insurance contracts are amortized on a constant-level basis over the expected term of the related contracts. Other related deferred or capitalized balances (such as unearned revenue liability and value of business acquired) may use this simplified amortization method. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Market risk benefits ("MRB"), defined as protecting the contractholder from other-than-nominal capital market risk and exposing the insurer to that risk, are measured at fair value, with changes in fair value recognized in net income each period, except for the effect of the Company's change in nonperformance risk (own credit risk), which is recognized in other comprehensive income. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Additional disclosures, including disaggregated roll forwards for the liability for future policy benefits, market risk benefits, separate account liabilities and DAC, as well as information about significant inputs, judgments, assumptions and methods used in measurement.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The transition methods applied at adoption were:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The liability for future policy benefits was remeasured using a modified retrospective approach applied to all outstanding contracts as of the beginning of the earliest period presented and was recognized in the opening balance of retained earnings. The impact of remeasuring the future policy benefits liability for the discount rate was recorded through accumulated other comprehensive income. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">DAC followed the transition method used for future policyholder benefits.</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Market risk benefits were remeasured at fair value at the beginning of the earliest period presented. The difference between this fair value and carrying value was recognized in the opening balance of retained earnings, excluding the effect of the Company's change in nonperformance risk (own credit risk), which is recognized in accumulated other comprehensive income. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effects of adoption:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The new guidance applies to our long-duration insurance products predominantly within the Cigna Healthcare segment and Other Operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The cumulative effects of adopting the new standard were immaterial. The impacts were a decrease to January 1, 2021 Shareholders' equity of $<ix:nonFraction unitRef="usd" contextRef="i04417f56eeb14234a4bf022e54781719_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNDMvZnJhZzplNzdkNTIyYWY0Nzk0MmJmYWE1ZDY1MmU1ZWRmYmU1Zi90ZXh0cmVnaW9uOmU3N2Q1MjJhZjQ3OTQyYmZhYTVkNjUyZTVlZGZiZTVmXzU0OTc1NTgxNTAxNTg_8e592cd3-14d9-49bc-b122-702440c3ca10">139</ix:nonFraction> million and an increase to Shareholders' net income for the year ended December 31, 2022 and December 31, 2021 of $<ix:nonFraction unitRef="usd" contextRef="i0168835d0324407988eb74d7d61484da_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNDMvZnJhZzplNzdkNTIyYWY0Nzk0MmJmYWE1ZDY1MmU1ZWRmYmU1Zi90ZXh0cmVnaW9uOmU3N2Q1MjJhZjQ3OTQyYmZhYTVkNjUyZTVlZGZiZTVmXzU0OTc1NTgxNTAxOTg_3e478653-f5d2-459c-924f-87ac8f613430">36</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3c7aed585f9d4d058090d2ff63838ee3_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNDMvZnJhZzplNzdkNTIyYWY0Nzk0MmJmYWE1ZDY1MmU1ZWRmYmU1Zi90ZXh0cmVnaW9uOmU3N2Q1MjJhZjQ3OTQyYmZhYTVkNjUyZTVlZGZiZTVmXzU0OTc1NTgxNTAxODQ_c31d1402-edbf-4b0e-bfcd-c5bed269632e">5</ix:nonFraction> million, respectively. The corresponding impact to diluted earnings per share was an increase of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0168835d0324407988eb74d7d61484da_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNDMvZnJhZzplNzdkNTIyYWY0Nzk0MmJmYWE1ZDY1MmU1ZWRmYmU1Zi90ZXh0cmVnaW9uOmU3N2Q1MjJhZjQ3OTQyYmZhYTVkNjUyZTVlZGZiZTVmXzU0OTc1NTgxNTAyMTI_22a9a366-8fdc-4316-b699-3de6d1b3d7a9">0.11</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i3c7aed585f9d4d058090d2ff63838ee3_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNDMvZnJhZzplNzdkNTIyYWY0Nzk0MmJmYWE1ZDY1MmU1ZWRmYmU1Zi90ZXh0cmVnaW9uOmU3N2Q1MjJhZjQ3OTQyYmZhYTVkNjUyZTVlZGZiZTVmXzU0OTc1NTgxNTAyMjE_74afdefe-5447-4944-9c21-a6b573d3881c">0.02</ix:nonFraction> for the year ended December 31, 2022 and December 31, 2021, respectively. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The prior periods within our Consolidated Statements of Income, Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets, Consolidated Statements of Changes in Total Equity and Consolidated Statements of Cash Flows were restated to conform to the current presentation. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Prior period balances in the Company's footnote disclosures have been updated to reflect adjustments resulting from the adoption of this standard. Refer to Note 9 to the Consolidated Financial Statements for the Company's updated accounting policies. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">It is possible that our income recognition pattern could change on a prospective basis for several reasons: </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Applying periodic assumption updates, versus the locked-in model, may change our timing of profit or loss recognition. </span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8c49872f58194635a2922cc98fb5d3be"><ix:continuation id="ic0577d86b79d4766a00d6f30842b8354"><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">DAC amortization is on a constant level basis over the expected term of the related contracts and no longer tied to the emergence of profit on such contracts. </span></div><div style="text-indent:45pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, in December 2022, the Financial Accounting Standards Board ("FASB") published ASU 2022-05, which simplified the retrospective adoption of LDTI by permitting companies to make an accounting policy election to exclude contracts that are sold and removed from the balance sheet prior to the effective date of the standard from the retrospective adoption of LDTI. The Cigna Group made this policy election for the contracts sold in the Chubb transaction and our divested interest in a joint venture in T&#252;rkiye.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_364"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNjQvZnJhZzozZTEyZjczNTljZGM0NzdmOGQxMmQ4ZWZhMGVlYTU0ZS90ZXh0cmVnaW9uOjNlMTJmNzM1OWNkYzQ3N2Y4ZDEyZDhlZmEwZWVhNTRlXzEy_afb972f0-1dd4-48b5-8b8c-e7c0120b4690" continuedAt="i9157b2348f8540aa846549639f97d998" escape="true">Note 3 &#8211; Accounts Receivable, Net</ix:nonNumeric></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_370"></div><ix:continuation id="i9157b2348f8540aa846549639f97d998" continuedAt="icaccee1e320a4869a9eb8a445dced0b3"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90ZXh0cmVnaW9uOjRmYzQ3OTRiNWM2OTQ3Mjg4NjExODljZmRmZmU4NDAzXzU0_418d5290-1ba7-4b36-9984-d249fc9e3f03" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts were included within Accounts receivable, net:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noninsurance customer receivables</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:PharmaceuticalManufacturerReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzEtMS0xLTEtNTQ3MDk4_3789cfb3-6536-4b13-8385-ec38881c735b">7,845</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:PharmaceuticalManufacturerReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzEtMy0xLTEtNTQ3MDk4_6f57fd82-c8db-43ba-9698-826c801e7b86">6,899</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical manufacturers receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzItMS0xLTEtNTQ3MDk4_ca1ec2b8-3c9a-4cc5-b00e-4806011e978b">7,128</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzItMy0xLTEtNTQ3MDk4_160cb97b-c22f-49c5-b0a9-deec01f4ad61">7,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insurance customer receivables</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:InsuranceCustomerReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzMtMS0xLTEtNTQ3MDk4_02dc2513-6a50-4c5f-a5e2-98a7adbd08cb">2,467</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:InsuranceCustomerReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzMtMy0xLTEtNTQ3MDk4_d92d5c33-5ec5-4f61-91ac-3a541bb4eaa7">2,963</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzQtMS0xLTEtNTQ3MDk4_c4e18d79-850a-428f-9ae9-d53923867bf8">264</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzQtMy0xLTEtNTQ3MDk4_93af2b82-7262-47f3-9fa4-8eec6e149764">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzctMS0xLTEtNTQ3MDk4_f7641ff5-910b-4341-8d5d-5e43a78f303c">17,704</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzctMy0xLTEtNTQ3MDk4_c968669a-f9a8-4a0a-9509-31030e69f737">17,218</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_373"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icaccee1e320a4869a9eb8a445dced0b3" continuedAt="i669a012c543b48ed9e7f00673251eec7">These receivables are reported net of our allowances of $<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-8" name="ci:AllowanceForReceivablesCurrent" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzMvZnJhZzo1MjZjNTQwNzAzNTc0M2JlODA0NDY5NGJkODg2ZTk1ZS90ZXh0cmVnaW9uOjUyNmM1NDA3MDM1NzQzYmU4MDQ0Njk0YmQ4ODZlOTVlXzYx_d41bf9cc-2a34-4dea-bb24-319cf32433c0">2.1</ix:nonFraction> billion as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-8" name="ci:AllowanceForReceivablesCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzMvZnJhZzo1MjZjNTQwNzAzNTc0M2JlODA0NDY5NGJkODg2ZTk1ZS90ZXh0cmVnaW9uOjUyNmM1NDA3MDM1NzQzYmU4MDQ0Njk0YmQ4ODZlOTVlXzc3_0b697ce0-dbfa-44c0-8445-7d3a43acad4b">1.9</ix:nonFraction> billion as of December&#160;31, 2022. These allowances include contractual allowances for certain rebates receivable with pharmaceutical manufacturers and certain receivables from third-party payors, discounts and claims adjustments issued to customers in the form of client credits, an allowance for current expected credit losses and other non-credit adjustments.</ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_379"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i669a012c543b48ed9e7f00673251eec7">The Company's allowance for current expected credit losses was $<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzkvZnJhZzpjYThhMDE1ZDcyYzA0OWQ3YmRhNjI3NmNmYWRmNzQ3Mi90ZXh0cmVnaW9uOmNhOGEwMTVkNzJjMDQ5ZDdiZGE2Mjc2Y2ZhZGY3NDcyXzY4_c3ff9742-a8d0-4cab-8db7-47179fd40c77">87</ix:nonFraction> million as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzkvZnJhZzpjYThhMDE1ZDcyYzA0OWQ3YmRhNjI3NmNmYWRmNzQ3Mi90ZXh0cmVnaW9uOmNhOGEwMTVkNzJjMDQ5ZDdiZGE2Mjc2Y2ZhZGY3NDcyXzg0_60fbcb27-6cf8-44e9-b68c-8e98c04a9b8b">86</ix:nonFraction> million as of December&#160;31, 2022.</ix:continuation></span></div><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_220"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:SupplierFinanceProgramTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yMjAvZnJhZzo3YmVhN2QxZjg2MTA0NzkwYTQ5ZjRjZTU5OGE4ZmViYy90ZXh0cmVnaW9uOjdiZWE3ZDFmODYxMDQ3OTBhNDlmNGNlNTk4YThmZWJjXzQxNzgxNDQxODU4Mzk5_13abbc0f-1209-49ef-9bb7-427a8d27b679" continuedAt="idfdd89b920104cebbfa93bbc1abe17d9" escape="true">Note 4 &#8211; Supplier Finance Program</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="idfdd89b920104cebbfa93bbc1abe17d9" continuedAt="ia6a82628662141999fdad13aa542c690">The Company facilitates a voluntary supplier finance program (the "program") that provides suppliers the opportunity to sell their receivables due from us (i.e., our payment obligations to the suppliers) to a financial institution, on a non-recourse basis, in order to be paid earlier than our payment terms require. The Cigna Group is not a party to the program and agrees to commercial terms with its suppliers independently of their participation in the program. Amounts due to suppliers that participate in the program are generally paid within <ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:SupplierFinanceProgramPaymentTimingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yMjAvZnJhZzo3YmVhN2QxZjg2MTA0NzkwYTQ5ZjRjZTU5OGE4ZmViYy90ZXh0cmVnaW9uOjdiZWE3ZDFmODYxMDQ3OTBhNDlmNGNlNTk4YThmZWJjXzQxNzgxNDQxODU4NDEy_b234839a-7c66-49ac-a93e-84386a6206e1">one month</ix:nonNumeric> following the invoice date. A supplier's participation in the program has no impact on the Company's payment terms and the Company has no economic interest in a supplier's decision to participate in the program. The suppliers, at their sole discretion, determine which invoices, if any, to sell to the financial institution. No guarantees or pledged assets are provided by the Company or any of our subsidiaries under the program. </ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ia6a82628662141999fdad13aa542c690">As of March&#160;31, 2023 and December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-8" name="ci:SupplierFinanceProgramObligationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yMjAvZnJhZzo3YmVhN2QxZjg2MTA0NzkwYTQ5ZjRjZTU5OGE4ZmViYy90ZXh0cmVnaW9uOjdiZWE3ZDFmODYxMDQ3OTBhNDlmNGNlNTk4YThmZWJjXzE4MTQxOTQxODYwODA4_5f45b071-6339-4b27-b070-7c7e54cd66f7">1.5</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-8" name="ci:SupplierFinanceProgramObligationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yMjAvZnJhZzo3YmVhN2QxZjg2MTA0NzkwYTQ5ZjRjZTU5OGE4ZmViYy90ZXh0cmVnaW9uOjdiZWE3ZDFmODYxMDQ3OTBhNDlmNGNlNTk4YThmZWJjXzE4MTQxOTQxODYwNzg1_f30b59da-87f9-4642-bb07-310f727cc534">1.3</ix:nonFraction>&#160;billion, respectively, of the Company's outstanding payment obligations were confirmed as valid within the program by the financial institution and reflected in Accounts payable in the Consolidated Balance Sheets. The amounts confirmed as valid for both periods are predominately associated with one supplier. We have been informed by the financial institution that $<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yMjAvZnJhZzo3YmVhN2QxZjg2MTA0NzkwYTQ5ZjRjZTU5OGE4ZmViYy90ZXh0cmVnaW9uOjdiZWE3ZDFmODYxMDQ3OTBhNDlmNGNlNTk4YThmZWJjXzE2NDkyNjc0NDMwMjA_9a3a1f23-fd02-40e9-8bca-9c811f865849">324</ix:nonFraction>&#160;million as of March&#160;31, 2023 of the Company's outstanding payment obligations were voluntarily elected by suppliers to be sold to the financial institution under the program.</ix:continuation> </span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_385"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zODUvZnJhZzpiNWY3MmYyOGM1YWY0ZDk0YmZmNzU5NGQ0OTU3MTcwMS90ZXh0cmVnaW9uOmI1ZjcyZjI4YzVhZjRkOTRiZmY3NTk0ZDQ5NTcxNzAxXzEz_44dac6b4-f27e-4075-a758-769180b94157" continuedAt="i2b6dcb90a8fd4aca86e536c90951d1c4" escape="true">Note 5 &#8211; Mergers, Acquisitions and Divestitures </ix:nonNumeric></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_388"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt;text-decoration:underline"><ix:continuation id="i2b6dcb90a8fd4aca86e536c90951d1c4" continuedAt="i4d9f0be2f7d84ecbaac90b45c5dbcdcc">Divestiture of International Businesses</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i4d9f0be2f7d84ecbaac90b45c5dbcdcc" continuedAt="ibef3eb071dfc402293661699d8ec7236">In July 2022, the Company completed the sale of its life, accident and supplemental benefits businesses in six countries (Hong Kong, Indonesia, New Zealand, South Korea, Taiwan and Thailand) (the "Chubb transaction") for approximately $<ix:nonFraction unitRef="usd" contextRef="i51b230fe17da43ddb1e4f787e7e5b489_I20220701" decimals="-8" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zODgvZnJhZzo3YmU0MTVlZjg2Mzg0NGM5OGM3YjI0ZjI1ZjhmNzRiMi90ZXh0cmVnaW9uOjdiZTQxNWVmODYzODQ0Yzk4YzdiMjRmMjVmOGY3NGIyXzI2Nw_9855449e-3fbe-4b8e-8de8-e2ae60d00953">5.4</ix:nonFraction> billion in cash. The Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="ia6534aa5174f46daae1011252bc79cfa_D20220701-20220701" decimals="-8" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zODgvZnJhZzo3YmU0MTVlZjg2Mzg0NGM5OGM3YjI0ZjI1ZjhmNzRiMi90ZXh0cmVnaW9uOjdiZTQxNWVmODYzODQ0Yzk4YzdiMjRmMjVmOGY3NGIyXzMwNQ_38f4370f-3aac-48aa-8c28-51171b314cc1">1.7</ix:nonFraction>&#160;billion pre-tax ($<ix:nonFraction unitRef="usd" contextRef="ia6534aa5174f46daae1011252bc79cfa_D20220701-20220701" decimals="-8" name="ci:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zODgvZnJhZzo3YmU0MTVlZjg2Mzg0NGM5OGM3YjI0ZjI1ZjhmNzRiMi90ZXh0cmVnaW9uOjdiZTQxNWVmODYzODQ0Yzk4YzdiMjRmMjVmOGY3NGIyXzMxNw_f584a412-728e-4c02-a305-c21a8640e0fb">1.4</ix:nonFraction>&#160;billion after-tax), which includes recognition of previously unrealized capital losses on investments sold and translation loss on foreign currencies. In December 2022, the Company also divested its ownership interest in a joint venture in T&#252;rkiye.</ix:continuation></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_406"></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.84pt;text-decoration:underline"><ix:continuation id="ibef3eb071dfc402293661699d8ec7236" continuedAt="ie3d5220ce45f4ef49247811746c38d0a">Integration and Transaction-related Costs</ix:continuation></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ie3d5220ce45f4ef49247811746c38d0a" continuedAt="i5b0184b8bf76492e83b4af0c28e5f49b">In 2023 and 2022, the Company incurred net costs mainly related to the Chubb transaction. In the first three months of 2022, the Company also incurred net costs related to the sale of the Group Disability and Life business and acquisition of MDLIVE. These net </ix:continuation></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i5b0184b8bf76492e83b4af0c28e5f49b">costs were $<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:TransactionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80MDYvZnJhZzo5ZWEwNjdkNzZiMmQ0ZWY3YjNlZjRjZGFjYmQyM2Y1MC90ZXh0cmVnaW9uOjllYTA2N2Q3NmIyZDRlZjdiM2VmNGNkYWNiZDIzZjUwXzQ2MQ_d0015958-f379-4ca0-94cf-542ec2cfb56a">1</ix:nonFraction> million pre-tax ($<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:TransactionRelatedCostsAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80MDYvZnJhZzo5ZWEwNjdkNzZiMmQ0ZWY3YjNlZjRjZGFjYmQyM2Y1MC90ZXh0cmVnaW9uOjllYTA2N2Q3NmIyZDRlZjdiM2VmNGNkYWNiZDIzZjUwXzQ3Mw_5fb79ec6-3849-4b41-9aca-3f1fbb848af9">1</ix:nonFraction> million after-tax) for the three months ended March 31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:TransactionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80MDYvZnJhZzo5ZWEwNjdkNzZiMmQ0ZWY3YjNlZjRjZGFjYmQyM2Y1MC90ZXh0cmVnaW9uOjllYTA2N2Q3NmIyZDRlZjdiM2VmNGNkYWNiZDIzZjUwXzQ5OA_5928028c-b476-41fc-be8b-3ff0457ebabc">52</ix:nonFraction> million pre-tax ($<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:TransactionRelatedCostsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80MDYvZnJhZzo5ZWEwNjdkNzZiMmQ0ZWY3YjNlZjRjZGFjYmQyM2Y1MC90ZXh0cmVnaW9uOjllYTA2N2Q3NmIyZDRlZjdiM2VmNGNkYWNiZDIzZjUwXzUxOA_4b2eb7af-0439-4c98-8e76-f981753d2d66">37</ix:nonFraction> million after-tax) for the three months ended March&#160;31, 2022. These costs consisted primarily of certain projects to separate or integrate the Company's systems, products and services, fees for legal, advisory and other professional services and certain employment-related costs.</ix:continuation></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_430"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80MzAvZnJhZzoxMzVhOTA4MjcxZmQ0MWUzOTdkZDcwOWJhNjljNWM1NC90ZXh0cmVnaW9uOjEzNWE5MDgyNzFmZDQxZTM5N2RkNzA5YmE2OWM1YzU0XzEy_0dd57210-0ff2-4c28-b8df-4ae1336dec7e" continuedAt="id2e451e6f0194b39b49bce1033ffb58f" escape="true">Note 6 &#8211; Earnings Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_436"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="id2e451e6f0194b39b49bce1033ffb58f" continuedAt="i43ae8f3b0721483294c8a4e71d4c54e3"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80MzYvZnJhZzozNGU2N2NiZDkyOTc0YjgwYjBmMGNmZGZhZDIwNTNiYS90ZXh0cmVnaW9uOjM0ZTY3Y2JkOTI5NzRiODBiMGYwY2ZkZmFkMjA1M2JhXzY4_356e26ce-2f86-4b21-a20f-de31d0255aee" continuedAt="i8cf1b9aa6abb425ea9319ee3606deb1d" escape="true">Basic and diluted earnings per share were computed as follows:</ix:nonNumeric></ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_442"></div><ix:continuation id="i43ae8f3b0721483294c8a4e71d4c54e3" continuedAt="iefeb7bd3648c4272afe2ea517780e61e"><ix:continuation id="i8cf1b9aa6abb425ea9319ee3606deb1d"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.238%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Shares in thousands, dollars in millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of<br/>Dilution</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of<br/>Dilution</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shareholders' net income</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzUtMS0xLTEtNTQ3MDk4_26798cb3-528a-4633-94be-0789f44a397f">1,267</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzUtNS0xLTEtNTQ3MDk4_ea2c9391-cd50-499a-8df1-06f1872bc683">1,267</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzUtNy0xLTEtNTQ3MDk4_825c1c1a-68d3-4aa6-97b1-1226133cfbcd">1,197</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzUtMTEtMS0xLTU0NzA5OA_b6a031ca-0ff8-4005-b37f-9df64ffe2b31">1,197</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzctMS0xLTEtNTQ3MDk4_55ecce30-3580-4edd-a891-be08a57255a2">295,706</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzctNS0xLTEtNTQ3MDk4_ecb68f28-048c-4f42-89f8-a7f550e22658">295,706</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzctNy0xLTEtNTQ3MDk4_6be72884-cf54-4d3d-9c9d-ec0f7f44da16">318,487</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzctMTEtMS0xLTU0NzA5OA_97cfcc6f-1b09-4908-816c-cf65020f969c">318,487</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzgtMy0xLTEtNTQ3MDk4_043d66a2-9b65-4c8d-bba7-4f56be02b504">3,293</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzgtNS0xLTEtNTQ3MDk4_40d55dfe-e1f1-4fac-accb-75e7f44d8bda">3,293</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzgtOS0xLTEtNTQ3MDk4_455c5a46-6351-4d84-9c3c-71ae4f356e8e">2,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzgtMTEtMS0xLTU0NzA5OA_10bc6f3e-cf1a-4278-bf37-d7ba6d3622b6">2,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total shares</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzktMS0xLTEtNTQ3MDk4_de6ba747-de34-4165-9820-a68b1c9157de">295,706</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzktMy0xLTEtNTQ3MDk4_c407aa71-99a5-4b2c-a67a-87cc8b0fa8c5">3,293</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzktNS0xLTEtNTQ3MDk4_d88f874f-b103-4789-a623-4adc4164fc0a">298,999</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzktNy0xLTEtNTQ3MDk4_c6683929-73b3-4009-b747-14a65085a0de">318,487</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzktOS0xLTEtNTQ3MDk4_3526c446-bacd-4aca-a325-30c33447b89d">2,795</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzktMTEtMS0xLTU0NzA5OA_85c7d57a-a10d-4fbb-821b-4018e02aba58">321,282</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings per share</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzEwLTEtMS0xLTU0NzA5OA_7adbeb62-6194-42ad-a82b-8aa25eea5abf">4.28</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="2" sign="-" name="ci:EarningsPerShareEffectOfDilution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzEwLTMtMS0xLTU0NzA5OA_9f834017-d3e1-455c-a9a9-b860a5a38ddc">0.04</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzEwLTUtMS0xLTU0NzA5OA_d93553ec-c83a-4933-9686-2879d491cd7f">4.24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzEwLTctMS0xLTU0NzA5OA_06f31ab4-74fa-4596-9b89-8ffcdea853c8">3.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="2" sign="-" name="ci:EarningsPerShareEffectOfDilution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzEwLTktMS0xLTU0NzA5OA_bd55a729-ff6f-4722-8ab8-9025972f3536">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzEwLTExLTEtMS01NDcwOTg_3ac78294-948c-4e15-af9e-5a431bda66a7">3.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amounts reflected above for the three months ended March 31, 2022 have been restated to reflect the impact of adopting amended accounting guidance for long-duration insurance contracts (discussed in Note 2 to the Consolidated Financial Statements).</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_445"></div><ix:continuation id="iefeb7bd3648c4272afe2ea517780e61e" continuedAt="i2c16b5f2dfba4109bd396065773b23f9"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDUvZnJhZzo2NjA5MmZhZjZjYjM0NmQ5OGU2NjI3OGY5YzE3MDNiZS90ZXh0cmVnaW9uOjY2MDkyZmFmNmNiMzQ2ZDk4ZTY2Mjc4ZjljMTcwM2JlXzE2Mg_baf142df-e646-4be9-94a1-bb75779c6080" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect was anti-dilutive:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.955%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.152%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Anti-dilutive options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b459f141c6c4b0da2923bbbd4e8c935_D20230101-20230331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDUvZnJhZzo2NjA5MmZhZjZjYjM0NmQ5OGU2NjI3OGY5YzE3MDNiZS90YWJsZToyMTZkMzk2ZmZlM2Y0MTAwYjY3MDU5ODAzYTU3NjJiMi90YWJsZXJhbmdlOjIxNmQzOTZmZmUzZjQxMDBiNjcwNTk4MDNhNTc2MmIyXzMtNS0xLTEtNTQ3MDk4_7608c3e0-dcc1-4b98-a2e1-5c132ddff20a">0.9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9856273e9b994b9094b394811fc62689_D20220101-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDUvZnJhZzo2NjA5MmZhZjZjYjM0NmQ5OGU2NjI3OGY5YzE3MDNiZS90YWJsZToyMTZkMzk2ZmZlM2Y0MTAwYjY3MDU5ODAzYTU3NjJiMi90YWJsZXJhbmdlOjIxNmQzOTZmZmUzZjQxMDBiNjcwNTk4MDNhNTc2MmIyXzMtNy0xLTEtNTQ3MDk4_600b3afb-a962-43e7-aa06-0c84c7e865aa">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_448"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i2c16b5f2dfba4109bd396065773b23f9">The Company held approximately <ix:nonFraction unitRef="shares" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDgvZnJhZzpmOWI1NDU1NWZjNzc0ZTkwYmY5NTExNTQ3YzYwNGUxMC90ZXh0cmVnaW9uOmY5YjU0NTU1ZmM3NzRlOTBiZjk1MTE1NDdjNjA0ZTEwXzM2_cff52d07-47a6-4109-a404-2a9734798741">102.7</ix:nonFraction> million shares of common stock in treasury at March&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDgvZnJhZzpmOWI1NDU1NWZjNzc0ZTkwYmY5NTExNTQ3YzYwNGUxMC90ZXh0cmVnaW9uOmY5YjU0NTU1ZmM3NzRlOTBiZjk1MTE1NDdjNjA0ZTEwXzgx_65f98705-dc94-4d70-a9c7-867d189249f9">99.1</ix:nonFraction> million shares as of December&#160;31, 2022 and <ix:nonFraction unitRef="shares" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDgvZnJhZzpmOWI1NDU1NWZjNzc0ZTkwYmY5NTExNTQ3YzYwNGUxMC90ZXh0cmVnaW9uOmY5YjU0NTU1ZmM3NzRlOTBiZjk1MTE1NDdjNjA0ZTEwXzEwNA_5f82f94f-09f0-49c0-b527-c0c6693f2375">77.3</ix:nonFraction> million shares as of March&#160;31, 2022.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_451"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90ZXh0cmVnaW9uOmI0ZDg5Y2M4OWRmMzQ5OWJhOGY3NDdmZDUxNGIxZDZjXzQyNA_fc62fadf-63a4-4625-a302-f01ec121a8e4" continuedAt="id60b50f3c6d640b1838fcffd9d198702" escape="true"><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8211; Debt</span></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:ScheduleOfShortTermDebtLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90ZXh0cmVnaW9uOmI0ZDg5Y2M4OWRmMzQ5OWJhOGY3NDdmZDUxNGIxZDZjXzQyNw_80147c39-2c7b-477d-846b-00f7bfe5610f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The outstanding amounts of debt, net of issuance costs, discounts or premiums, and finance leases were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term debt</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia476822164994b318ba1a7d0dfc61cc8_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZDc2NzkwZTU2ZDc4NDI3NTk5ODM4YjBmNzI4NmRjMDNfNA_f6cbf7d9-f6e8-4a1d-9976-17f1362aa461">17</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ia476822164994b318ba1a7d0dfc61cc8_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZDc2NzkwZTU2ZDc4NDI3NTk5ODM4YjBmNzI4NmRjMDNfOA_2782fbfd-3486-4c13-ad33-b3278b18cd59">8.300</ix:nonFraction>% Notes due January 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia476822164994b318ba1a7d0dfc61cc8_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQtMi0xLTEtNTQ3MDk4_1897c4b2-77af-432b-920b-abcefcc7a93d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5453dc8934554e9faf7e6b1ef64dbf8b_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQtNC0xLTEtNTQ3MDk4_060447dc-88d9-41c3-9435-c588e4c8a241">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic9fd170cd0b544f4947eb9267c3105ae_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzUtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246NWQ2ZTUzYjE4Yjk5NDI3N2JlODI5NDJmZjM2M2I3ZGJfNA_80a8bc88-2cd6-4c45-ba12-691a002f27ee">63</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ic9fd170cd0b544f4947eb9267c3105ae_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzUtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246NWQ2ZTUzYjE4Yjk5NDI3N2JlODI5NDJmZjM2M2I3ZGJfOA_87740afd-8f61-4b36-908e-aebf6e033498">7.650</ix:nonFraction>% Notes due March 2023</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9fd170cd0b544f4947eb9267c3105ae_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzUtMi0xLTEtNTQ3MDk4_a5bec557-194f-4d61-a10b-db4e1ec99d60">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f10178c4e44f02b6fd42a4130fb189_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzUtNC0xLTEtNTQ3MDk4_72df14db-631d-4c65-b013-9bbdb524560b">63</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i3b1750dc39384c35b545131f314c0819_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzYtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZWE4NGIwOGY5M2I1NDM3YTkwYWM5MGM4NjE5YzBiNWVfNA_f5835481-a2a6-4811-b735-6336e52321e4">700</ix:nonFraction> million, Floating Rate Notes due July 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b1750dc39384c35b545131f314c0819_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzYtMi0xLTEtNTQ3MDk4_694ce160-0f0f-49a4-a4dd-8368ab538795">700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d639de145c64f1fb64c4f7629a3f64e_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzYtNC0xLTEtNTQ3MDk4_43181fdf-c775-4ae9-a479-a4161fe5e327">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic135eb18221a4aa39a034dad9dff9585_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzctMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZDEzZDRkNmY3Y2ViNDczNWI5NzZmZTljY2M4OWMyMDBfNA_39977f94-f9da-4f3e-b718-7cb2115fe8d2">1,000</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="ic135eb18221a4aa39a034dad9dff9585_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzctMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZDEzZDRkNmY3Y2ViNDczNWI5NzZmZTljY2M4OWMyMDBfOA_161dd9ac-109c-4af5-8c7a-85b956b3831d">3.000</ix:nonFraction>% Notes due July 2023</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic135eb18221a4aa39a034dad9dff9585_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzctMi0xLTEtNTQ3MDk4_43de2ccb-2839-4c17-bf43-2843357662a3">996</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414bed4bfa4b4862a19a234bbdaf714d_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzctNC0xLTEtNTQ3MDk4_7059dba2-7a39-42e8-a2ad-4ec91eaa6d52">994</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i9658fcabcb764ce5972950cced53289b_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzgtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZDUyNTNjYmE4YjY5NGNjODljMDQ2NjJjNjA2ZmNiZDFfNA_35a1db67-ce59-4d03-b58b-9e96aed0424c">1,187</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="i9658fcabcb764ce5972950cced53289b_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzgtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZDUyNTNjYmE4YjY5NGNjODljMDQ2NjJjNjA2ZmNiZDFfOA_2131f811-92a3-4dd8-9c06-d8515e637c8e">3.750</ix:nonFraction>% Notes due July 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9658fcabcb764ce5972950cced53289b_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzgtMi0xLTEtNTQ3MDk4_a13450e8-bea3-4dfd-830a-64678a03a877">1,187</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aac5c43478c4cf5872ab0d87fb7cab3_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzgtNC0xLTEtNTQ3MDk4_c911e2f6-4bb4-4e4f-bc68-135aab33c3e9">1,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iacf9c0f395864206b0df7660a5342177_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzktMC0xLTEtNTgwMDkxL3RleHRyZWdpb246MTA5ZGMyYzM3MmQxNGI3Mjg1ZDYxZWIwMGVmY2ZiMzZfNA_aea1f4c8-c9b7-4f08-a77f-e61d4f8516b9">500</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="iacf9c0f395864206b0df7660a5342177_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzktMC0xLTEtNTgwMDkxL3RleHRyZWdpb246MTA5ZGMyYzM3MmQxNGI3Mjg1ZDYxZWIwMGVmY2ZiMzZfOA_f9082ba0-fd5a-42f8-ba9f-b4c7a616e687">0.613</ix:nonFraction>% Notes due March 2024</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacf9c0f395864206b0df7660a5342177_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzktMi0xLTEtNjEwMjIw_6b09fa3b-823b-4722-a59b-8a0329e0a52f">499</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f6de552f34d46ddaeb308e06fae469b_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzktNC0xLTEtNTg1Mzg3_29183070-be5a-4a92-bfb1-29a41ede1cdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, including finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzktMi0xLTEtNTQ3MDk4_67175fb5-e76d-498d-939b-d65ddecea006">36</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzktNC0xLTEtNTQ3MDk4_3388a1b0-ce87-496a-b643-3f6b7a7d8c3b">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total short-term debt</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzEwLTItMS0xLTU0NzA5OA_3c92c3d2-8d79-4e94-a7ea-145ae30fc406">3,418</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzEwLTQtMS0xLTU0NzA5OA_50c8f6ac-7895-4a7a-8831-a78e6f5a6d52">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iacf9c0f395864206b0df7660a5342177_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE3LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmVlNDE3N2ZkMTY4YzQ5M2E4OGFmMzIyOGU2ZjFiNGZiXzQ_aea1f4c8-c9b7-4f08-a77f-e61d4f8516b9">500</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="iacf9c0f395864206b0df7660a5342177_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE3LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmVlNDE3N2ZkMTY4YzQ5M2E4OGFmMzIyOGU2ZjFiNGZiXzg_f9082ba0-fd5a-42f8-ba9f-b4c7a616e687">0.613</ix:nonFraction>% Notes due March 2024</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacf9c0f395864206b0df7660a5342177_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE3LTItMS0xLTU0NzA5OA_610a1965-361a-42c7-bef1-441da615bf58">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f6de552f34d46ddaeb308e06fae469b_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE3LTQtMS0xLTU0NzA5OA_7f788b15-db12-46a7-a3f7-fe9160054708">499</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib7f9f54a14524ef2ac66996f0eca9b9c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE4LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjM4NWMxODdmODBiZjQ1MjliOGQ1NGZkNTQ1MDA3ZmIwXzQ_ce9a7ed0-01ed-45fe-b62a-1509405128b1">1,000</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ib7f9f54a14524ef2ac66996f0eca9b9c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE4LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjM4NWMxODdmODBiZjQ1MjliOGQ1NGZkNTQ1MDA3ZmIwXzg_fe9da043-cf08-436b-868f-a4badc089486">3.500</ix:nonFraction>% Notes due June 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7f9f54a14524ef2ac66996f0eca9b9c_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE4LTItMS0xLTU0NzA5OA_4e5a1276-d97a-41f4-bc53-34a84af12804">992</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44063dd30ab24985935f4de84ca1db87_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE4LTQtMS0xLTU0NzA5OA_2af9c558-4a56-4677-ba91-5422a7fc1600">990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic8a730c53413415aaeb8a8df0ed50e7c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE5LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmNiYmI3MmM1OTFjYjRmNDU5ZDdjNTM5NmQ0MTllN2ZiXzQ_8d734c44-88f5-44af-8c7d-e02b174eb7d8">900</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ic8a730c53413415aaeb8a8df0ed50e7c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE5LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmNiYmI3MmM1OTFjYjRmNDU5ZDdjNTM5NmQ0MTllN2ZiXzg_ba53e804-be01-482b-b73a-bb0e436f31a1">3.250</ix:nonFraction>% Notes due April 2025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a730c53413415aaeb8a8df0ed50e7c_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE5LTItMS0xLTU0NzA5OA_718b5596-847c-43ed-a796-ebc15d97cb9f">878</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i980904614f6544cc9a3e363b158e13cc_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE5LTQtMS0xLTU0NzA5OA_c6ab676d-e586-4388-9b7b-88e2caf31c4d">872</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id66a58d38b054171873c7dc463a8d253_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmZmNDIxYTAyZGZjNjRiNzdiZTBhYTA1YmNhNmQ1ZDI1XzQ_4d2593bb-660b-438e-8b96-cc125326256b">2,200</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="id66a58d38b054171873c7dc463a8d253_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmZmNDIxYTAyZGZjNjRiNzdiZTBhYTA1YmNhNmQ1ZDI1Xzg_eb1c0c44-c4a6-4999-80ef-26987e0b0d6f">4.125</ix:nonFraction>% Notes due November 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id66a58d38b054171873c7dc463a8d253_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIwLTItMS0xLTU0NzA5OA_e2d5e8bd-8974-46c7-9e2c-53a74ccf599f">2,195</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0a8f836e6446e7a62ab400a6266eb2_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIwLTQtMS0xLTU0NzA5OA_877bf60f-b365-4f44-a033-878ee4d56b96">2,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i738c83b591a342bcb031de2dbdb544f9_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIxLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjk0NzkyMDE0Y2FhNTQ4YzBiN2JkYzAwYjkyYjAwMmM5XzQ_b3031e99-93e1-48e8-9cb4-2ccca7aca68d">1,500</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i738c83b591a342bcb031de2dbdb544f9_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIxLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjk0NzkyMDE0Y2FhNTQ4YzBiN2JkYzAwYjkyYjAwMmM5Xzg_cd9abd22-8d16-462c-933e-11ee9662bbf5">4.500</ix:nonFraction>% Notes due February 2026</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c83b591a342bcb031de2dbdb544f9_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIxLTItMS0xLTU0NzA5OA_34afe7e5-7c12-46ad-b14c-bac51d7c0299">1,503</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bd4adeaf8a34f6e935f49888c83341b_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIxLTQtMS0xLTU0NzA5OA_d3bec110-3610-41cc-bb70-bc3c9220cb57">1,503</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i9e91d995dc4d4716a67317f53051bfdd_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIyLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjY4YjFkMmZiOWQ4NDQ4ODQ5ZTM4ZTdiMGU2Y2JlZDljXzQ_1f6d99be-e2f9-4706-b3d0-ec928f33d33b">800</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="i9e91d995dc4d4716a67317f53051bfdd_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIyLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjY4YjFkMmZiOWQ4NDQ4ODQ5ZTM4ZTdiMGU2Y2JlZDljXzg_808eb465-fcff-4ebd-90f6-b8cc701c536f">1.250</ix:nonFraction>% Notes due March 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e91d995dc4d4716a67317f53051bfdd_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIyLTItMS0xLTU0NzA5OA_e1c01252-dfaf-4d1a-989f-6fd0927b3d4e">797</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ceafda26d1e4338a268d433a918d78a_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIyLTQtMS0xLTU0NzA5OA_a6e2c488-074e-476f-84f3-ee5eeaf49998">797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i895d782074b54523b13b795cfbfb9154_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTAtMS0xLTU2NTcyMi90ZXh0cmVnaW9uOjMxNWY1YmFhZDIwYTQ1OWRhMTY4ZWI3MjJkYjE2MzE1XzE2NDkyNjc0NDE2OTY_e67eeea2-296a-4e6a-9689-ccad5724bab4">700</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="i895d782074b54523b13b795cfbfb9154_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTAtMS0xLTU2NTcyMi90ZXh0cmVnaW9uOjMxNWY1YmFhZDIwYTQ1OWRhMTY4ZWI3MjJkYjE2MzE1XzE2NDkyNjc0NDE3MDQ_475b6eba-cc1f-4031-a21a-0aa9fe8b7cde">5.685</ix:nonFraction>% Notes due March 2026</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895d782074b54523b13b795cfbfb9154_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTItMS0xLTU2NTg5Mg_a8bf47a9-3ef8-41bb-86da-ff11e4492eb8">697</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b061b9ba35943ad9b01618d52b31bc0_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTQtMS0xLTU2NjI5NQ_5d68a223-ced9-40a9-8788-2b6f8310eb47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i2ddccf40663440f6a73b0908b9484769_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmQwMWU1MDYxMGExNDQ5NzNhNTBmYTQ0Y2E2NWFiNzcxXzQ_15b7b4df-3e20-4cc8-a0d4-60e39dcd52cc">1,500</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i2ddccf40663440f6a73b0908b9484769_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmQwMWU1MDYxMGExNDQ5NzNhNTBmYTQ0Y2E2NWFiNzcxXzg_24754482-0878-4113-9f81-3c5b65cff137">3.400</ix:nonFraction>% Notes due March 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddccf40663440f6a73b0908b9484769_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTItMS0xLTU0NzA5OA_4b740c91-5667-48c9-a815-a2fdf2b24fb1">1,440</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72bd03d2619c44c29af788238edb9b7a_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTQtMS0xLTU0NzA5OA_21d370da-7480-43ca-9b9c-4cf4d90e3950">1,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i93ed3d337efa49aeacbaf2137357b0ff_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI0LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjZhZmU2N2E2ZDlmZDRmZWNhZTUzMGEwOTc2MzBhYmQ5XzQ_7e80fd10-d32c-4ee0-bb75-d49a6a6849d1">259</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i93ed3d337efa49aeacbaf2137357b0ff_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI0LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjZhZmU2N2E2ZDlmZDRmZWNhZTUzMGEwOTc2MzBhYmQ5Xzg_e1449750-c611-40bb-a96a-f6d3e27b0514">7.875</ix:nonFraction>% Debentures due May 2027</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ed3d337efa49aeacbaf2137357b0ff_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI0LTItMS0xLTU0NzA5OA_66e64fca-7763-4e2c-8dd8-f321ec653e7b">259</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3751913bfc0a45b7896c5c9cf5f54426_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI0LTQtMS0xLTU0NzA5OA_d6cd2f83-32b2-4a37-b819-322fb56eea49">259</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i43e32ecefdb440f3860ab5c831273423_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI1LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjc5ODBkOTk5NTYxZDRkNTU4NTRiNmNiMTU3MDBkNDY2XzQ_a1392108-f2f1-4a45-8d7b-3b5fdceb5a2c">600</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i43e32ecefdb440f3860ab5c831273423_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI1LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjc5ODBkOTk5NTYxZDRkNTU4NTRiNmNiMTU3MDBkNDY2Xzg_e2e00902-27b6-4c9d-aaa1-1c011b686689">3.050</ix:nonFraction>% Notes due October 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43e32ecefdb440f3860ab5c831273423_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI1LTItMS0xLTU0NzA5OA_c405c44b-a786-48a1-9b84-ad439e4d46ae">597</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5927dc1e2f4399b084401a0572efa8_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI1LTQtMS0xLTU0NzA5OA_d61be6f3-cd6c-4d92-8a47-3fc2e20525fb">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i07cc745a98c84df4bf6dc07b30708361_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI2LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmU5ZjRjZGFmZDAxODQ3YTVhNDZhYzI1NjcwNjBlZDMwXzQ_c1eafcbe-317e-40fe-92e6-d81e352117b2">3,800</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i07cc745a98c84df4bf6dc07b30708361_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI2LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmU5ZjRjZGFmZDAxODQ3YTVhNDZhYzI1NjcwNjBlZDMwXzg_03ab16ac-c8a3-4f62-af88-018df67cda5e">4.375</ix:nonFraction>% Notes due October 2028</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07cc745a98c84df4bf6dc07b30708361_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI2LTItMS0xLTU0NzA5OA_3df2e2a8-bfe2-48ef-acde-21d091377780">3,785</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15576a81e11a4a38ae45657dbce148c1_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI2LTQtMS0xLTU0NzA5OA_08f176c5-0442-471d-9b30-53945c5110e4">3,785</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i7a285f2991c9444c9755852b3eabda27_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI3LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdjYTMzMzFiMTAyOTQxY2ZiZDEwOTk3ZmU4M2E2ZTVlXzQ_4696891d-4f30-438a-a4f2-76d0fa7cebad">1,500</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i7a285f2991c9444c9755852b3eabda27_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI3LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdjYTMzMzFiMTAyOTQxY2ZiZDEwOTk3ZmU4M2E2ZTVlXzg_231f0c04-87b1-4c5f-9bcb-087d5a22f300">2.400</ix:nonFraction>% Notes due March 2030</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a285f2991c9444c9755852b3eabda27_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI3LTItMS0xLTU0NzA5OA_cc5cff24-4c16-4ab7-b884-4fe0782c35dd">1,492</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2689f890bb1c42d68cefbbeb43a87908_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI3LTQtMS0xLTU0NzA5OA_e9a1a211-73f4-42dd-993c-2a24dcdac2c3">1,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i66e2ace24fe24d90b02d99ff1be0dd09_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI4LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmIwNzgyMzM0MjAwOTQzMzE5NTUwMzAxNmY4NGQ2YjJhXzQ_835c2234-d9cd-4a69-9b47-c76f8e8f7efe">1,500</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="i66e2ace24fe24d90b02d99ff1be0dd09_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI4LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmIwNzgyMzM0MjAwOTQzMzE5NTUwMzAxNmY4NGQ2YjJhXzg_83f25c93-3520-4b72-8e60-46815ff79652">2.375</ix:nonFraction>% Notes due March 2031 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e2ace24fe24d90b02d99ff1be0dd09_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI4LTItMS0xLTU0NzA5OA_390f6cdf-d9dc-4491-b73f-b019ae662f59">1,398</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482114586ed84365b9534d71073eda66_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI4LTQtMS0xLTU0NzA5OA_c8b39b97-d540-49b5-a819-d87df2897396">1,380</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i9d96d999b8824e5484e9bc064061c29a_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI5LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjUxOWQ1NmExNGE1MTQ3ODk5MzlmNmVlZTZlYThkNWMzXzQ_7bb118bc-92e1-4c77-aad8-901522f4db03">45</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i9d96d999b8824e5484e9bc064061c29a_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI5LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjUxOWQ1NmExNGE1MTQ3ODk5MzlmNmVlZTZlYThkNWMzXzg_f278f887-9622-4317-b5d2-6e7d217151ba">8.080</ix:nonFraction>% Step Down Notes due January 2033 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d96d999b8824e5484e9bc064061c29a_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI5LTItMS0xLTU0NzA5OA_e24e6123-217b-48a6-8589-4b1449c71d80">45</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cdc895b7a2741f2ba68c6eb57fcd620_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI5LTQtMS0xLTU0NzA5OA_99927a45-1653-4156-94eb-cc133cf5ba38">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i64c8340c95104f9da98216f9c6c92918_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTAtMS0xLTU2NTgzOC90ZXh0cmVnaW9uOjFiOTk3Y2JlNjk1NzQ3NzJiNzliNDBkNTBhNjc1YTFlXzE2NDkyNjc0NDE2OTk_da3dbbf2-38a1-4663-b0f8-1a4aa5b903f2">800</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="i64c8340c95104f9da98216f9c6c92918_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTAtMS0xLTU2NTgzOC90ZXh0cmVnaW9uOjFiOTk3Y2JlNjk1NzQ3NzJiNzliNDBkNTBhNjc1YTFlXzE2NDkyNjc0NDE3MDU_8263f4ce-e389-4ebb-b0a7-b692507a2ec6">5.400</ix:nonFraction>% Notes due March 2033</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64c8340c95104f9da98216f9c6c92918_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTItMS0xLTU2NTg4Mg_e7a14495-6aa4-443d-902a-13fb4b17fed5">794</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86cfeb71e3864eeca439c4353bb752e1_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTQtMS0xLTU2NjMwNA_3be35600-7386-4e14-9792-2ff8ca331df4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i3197f7cdd54b4088ae3c71e0ad16d93f_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjhjMTdmNjMyMDc5NzRjNzJiYzkzYzA0M2M1MjVjZTc5XzQ_e928520f-b918-4cba-b9c1-e4ae8bfc114d">190</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i3197f7cdd54b4088ae3c71e0ad16d93f_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjhjMTdmNjMyMDc5NzRjNzJiYzkzYzA0M2M1MjVjZTc5Xzg_8d618112-cd14-4bb9-b228-864b6d016b6b">6.150</ix:nonFraction>% Notes due November 2036</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3197f7cdd54b4088ae3c71e0ad16d93f_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMwLTItMS0xLTU0NzA5OA_75b3885d-4fdf-4e75-87a5-e698ace60262">190</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7642ca01b359422c83d2c36109bbe311_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMwLTQtMS0xLTU0NzA5OA_d0481fc3-bee8-4266-9029-26c532dde6c5">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4bd52da1beae4ef3b43d1878bb83c53f_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjZjMGZmNjQwZjYxMzRiY2U4MDJlNmIxYjJkNzIyMDEyXzQ_4d3c76dd-3a59-4d62-84f8-f90d5ec15461">2,200</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i4bd52da1beae4ef3b43d1878bb83c53f_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjZjMGZmNjQwZjYxMzRiY2U4MDJlNmIxYjJkNzIyMDEyXzg_58f2c0bc-44af-49ce-9e33-387287570436">4.800</ix:nonFraction>% Notes due August 2038 </span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bd52da1beae4ef3b43d1878bb83c53f_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTItMS0xLTU0NzA5OA_76157e22-f8c3-406a-9d0f-3a8ddbc500aa">2,192</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46c86b75d1b641a38501f46eab131bf7_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTQtMS0xLTU0NzA5OA_508ef3a1-eedc-4517-b654-921bf1ae57c7">2,192</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ifc0d48e2aeb3466da82305ee7c4b7be0_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMyLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmNmZjE1ZDE3MWJmNTRjMTJhMjMzNTllYmNlZWIyYzI5XzQ_a370499b-063a-4491-bb7e-e6e71fa88fe4">750</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ifc0d48e2aeb3466da82305ee7c4b7be0_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMyLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmNmZjE1ZDE3MWJmNTRjMTJhMjMzNTllYmNlZWIyYzI5Xzg_4bea3736-e44e-45cb-a762-a4dd0b9d0f3d">3.200</ix:nonFraction>% Notes due March 2040</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc0d48e2aeb3466da82305ee7c4b7be0_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMyLTItMS0xLTU0NzA5OA_54e7b365-9a33-4c08-98f9-2eb4b5c4d172">743</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia12dcb2f4a5544df8a2c619e6c94a70b_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMyLTQtMS0xLTU0NzA5OA_7b90b627-65ef-4caa-821b-dcf720094c8e">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id71094b2f34d4d978a441ba8995647fa_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMzLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmViMWIxMTFmOTE0YTRiYTBiNTI4ZTIwMDgwNjliYmVhXzQ_c2131434-faf4-4bd2-91a4-ff179f5b8c24">121</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="id71094b2f34d4d978a441ba8995647fa_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMzLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmViMWIxMTFmOTE0YTRiYTBiNTI4ZTIwMDgwNjliYmVhXzg_0b531cba-19f7-453f-aeb8-8cdfcdeeb566">5.875</ix:nonFraction>% Notes due March 2041</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id71094b2f34d4d978a441ba8995647fa_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMzLTItMS0xLTU0NzA5OA_5315c6e2-66ae-4beb-a83a-9948380391be">119</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5223523086642cba0dcbb8ed2b11004_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMzLTQtMS0xLTU0NzA5OA_50cf4e5f-872d-4119-a1c8-df41a6f933a2">119</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4e5d78ed27a4483e8828d091e08d011d_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM0LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjJiZDY0Y2FkOTM2OTQwYTViOGVmYzc5ZjBlOThiYTJhXzQ_bab427d1-960a-4ee8-84d5-616d873ec097">448</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i4e5d78ed27a4483e8828d091e08d011d_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM0LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjJiZDY0Y2FkOTM2OTQwYTViOGVmYzc5ZjBlOThiYTJhXzg_477cce6b-b561-41ad-90ec-de079f17bc50">6.125</ix:nonFraction>% Notes due November 2041</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e5d78ed27a4483e8828d091e08d011d_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM0LTItMS0xLTU0NzA5OA_833c0524-0d10-4cdf-9592-53a7d983164b">488</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48fdb56eaaaa4b408d38131d70e82896_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM0LTQtMS0xLTU0NzA5OA_7c56b647-9665-473e-a339-f7c6da92b289">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib12f851059264a8d8a5b7886c8931917_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM1LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmFkZWQ5ODk2NWYwMDQ4ZjFhOTZjODM5ODQ5MmMyNTFjXzQ_ed370d3e-ab08-4ba4-a042-357d56c37284">317</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ib12f851059264a8d8a5b7886c8931917_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM1LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmFkZWQ5ODk2NWYwMDQ4ZjFhOTZjODM5ODQ5MmMyNTFjXzg_3939e5bc-25bc-44f2-af5a-3bdc1c97333d">5.375</ix:nonFraction>% Notes due February 2042</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib12f851059264a8d8a5b7886c8931917_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM1LTItMS0xLTU0NzA5OA_4c58c30f-c42a-4509-8cae-eaa4d9faad4d">315</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8300dd98b4ec4864a2dcf4b8241cfdfb_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM1LTQtMS0xLTU0NzA5OA_ed0c3215-6422-431c-b7c0-8698d10fd936">315</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib290912817514769b3acd20a811fc92b_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM2LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjkxOTdlYjkyMTVmYzQ0ZDY4NWQzY2ExMjAwMDE4OTdlXzQ_217d02fb-b800-468a-804a-af81ccda474a">1,500</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ib290912817514769b3acd20a811fc92b_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM2LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjkxOTdlYjkyMTVmYzQ0ZDY4NWQzY2ExMjAwMDE4OTdlXzg_8f16737e-1aab-4937-90ca-49de0712756c">4.800</ix:nonFraction>% Notes due July 2046</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib290912817514769b3acd20a811fc92b_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM2LTItMS0xLTU0NzA5OA_bc400bd3-1641-4de8-b776-b8bab438b756">1,466</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3b44eaa966347caa1dcffe029cf7ae9_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM2LTQtMS0xLTU0NzA5OA_6271d714-5ce4-4b89-a68c-b8af07b553f8">1,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib9bfe6abbbb94e408b73c2c728c561ae_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM3LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjZmN2Y2OWE0OWIyODRiMDJhOGM2MjkwM2NjMzdiMzBmXzQ_d88de763-7c7a-4219-bba9-29f41994ce44">1,000</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ib9bfe6abbbb94e408b73c2c728c561ae_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM3LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjZmN2Y2OWE0OWIyODRiMDJhOGM2MjkwM2NjMzdiMzBmXzg_4f902388-2825-4429-b872-ac4e6f7ad605">3.875</ix:nonFraction>% Notes due October 2047</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9bfe6abbbb94e408b73c2c728c561ae_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM3LTItMS0xLTU0NzA5OA_a8e3375b-24b7-473d-9b6e-b9a9707da51d">989</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1438a2bf41684eb7a1a30324f2a19a84_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM3LTQtMS0xLTU0NzA5OA_cd2a2c26-6389-4a1f-97ac-343bfcadfddd">989</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i0a19a44748f045febddded935137ce5c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM4LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmZmMmE5MTU0ZGIzNzRmZDI5YmNhYTJiNDRiZDU2YmJhXzQ_2b344549-6edc-4a28-8ea2-00d8af0978bf">3,000</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i0a19a44748f045febddded935137ce5c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM4LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmZmMmE5MTU0ZGIzNzRmZDI5YmNhYTJiNDRiZDU2YmJhXzg_7ddd843b-c31e-44c3-9731-79e14cb84e5a">4.900</ix:nonFraction>% Notes due December 2048</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a19a44748f045febddded935137ce5c_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM4LTItMS0xLTU0NzA5OA_574bd9e9-0e51-43d9-8a40-dd93a31f55cc">2,969</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i365a75f6100e40feb386d3c9e27ceb30_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM4LTQtMS0xLTU0NzA5OA_f2fb098f-37cf-455f-ace2-3be711392a7e">2,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="icd2e63c77f194ff6bc9c2d7d25ffca38_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM5LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjA3Zjg0NzE3N2MzMTQ0NWJhNTE0NGVhNTgwMThlZGYwXzQ_f2204554-1ac7-4fee-aa99-764851f4f294">1,250</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="icd2e63c77f194ff6bc9c2d7d25ffca38_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM5LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjA3Zjg0NzE3N2MzMTQ0NWJhNTE0NGVhNTgwMThlZGYwXzg_96452555-e071-4471-be1b-aa33d3b54993">3.400</ix:nonFraction>% Notes due March 2050</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd2e63c77f194ff6bc9c2d7d25ffca38_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM5LTItMS0xLTU0NzA5OA_66b2c3bf-eb3f-438d-9612-241965f5ee59">1,236</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2dc1d6708c4916be653839738f0143_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM5LTQtMS0xLTU0NzA5OA_a32a097f-1b74-4d31-aef8-13b39a9e7664">1,236</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ibdcc30e5c6a242ed85b05fc34479449c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjI1YmRhNjU4NTk5MjRmM2Q4MGNmNDM2ZGE3NjkwNWE4XzQ_33cc3112-5d56-4cbe-bc30-e736e9448d03">1,500</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="ibdcc30e5c6a242ed85b05fc34479449c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjI1YmRhNjU4NTk5MjRmM2Q4MGNmNDM2ZGE3NjkwNWE4Xzg_5084396a-197c-48f1-a158-bcaaf5c29fdd">3.400</ix:nonFraction>% Notes due March 2051</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdcc30e5c6a242ed85b05fc34479449c_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQwLTItMS0xLTU0NzA5OA_5bd49c5c-ca76-4ae3-b39b-5c321a67209b">1,478</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d06b6f0c7d4557ad2660d8e87b98f5_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQwLTQtMS0xLTU0NzA5OA_42b7b4db-bbdc-4fd3-bc46-5466d20d03df">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, including finance leases</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:OtherLongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQxLTItMS0xLTU0NzA5OA_4cbf4426-54d6-400c-9f37-9ff0e95c367b">67</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:OtherLongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQxLTQtMS0xLTU0NzA5OA_2628dcb5-e743-4290-94d2-a5e4ecda300d">66</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQyLTItMS0xLTU0NzA5OA_f3c87ec4-abb7-46ad-b9c1-b46a88d28da7">29,124</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQyLTQtMS0xLTU0NzA5OA_7a09aa32-0159-4090-a281-09f84ed13df8">28,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">The Company has entered into interest rate swap contracts hedging a portion of these fixed-rate debt instruments. See Note 11 in the Company's 2022 Form 10-K for further information about the Company's interest rate risk management and these derivative instruments.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Interest rate step down to <ix:nonFraction unitRef="number" contextRef="i49ecf3f26ca94fe88ab72567822a17c1_I20230115" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90ZXh0cmVnaW9uOmI0ZDg5Y2M4OWRmMzQ5OWJhOGY3NDdmZDUxNGIxZDZjXzM5NA_517ef796-7a5f-47ea-baca-b9c933344193">8.080</ix:nonFraction>% effective January 15, 2023.</span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_460"></div><ix:continuation id="id60b50f3c6d640b1838fcffd9d198702" continuedAt="icde16c58750b47718ff264d9b5e9b8a0"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Long-term debt</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Debt Issuance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:ScheduleOfIssuancesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90ZXh0cmVnaW9uOjFlYmNmMWZmZmVmNjQ4ZGRiMzlkYjdmZWU0NTIyMGE3XzEzMDg_86ec3d75-a0bc-4db0-8466-047631f38b01" continuedAt="i5d09f3b380374751888677315ad32c5e" escape="true">On March 7, 2023, the Company issued $<ix:nonFraction unitRef="usd" contextRef="if31115610c334a439c3f11aa884c91ce_I20230307" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90ZXh0cmVnaW9uOjFlYmNmMWZmZmVmNjQ4ZGRiMzlkYjdmZWU0NTIyMGE3XzI4MA_4ca2ae9b-5a1f-48ed-b8ab-464d380109ec">1.5</ix:nonFraction>&#160;billion of new senior notes. The proceeds of this issuance will be used for general corporate purposes, and may include repayment of outstanding debt securities. Interest on this debt is paid semi-annually.</ix:nonNumeric></span></div><ix:continuation id="i5d09f3b380374751888677315ad32c5e" continuedAt="ibdbda7c9e2fa4af99e6ef13438b16143"><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.777%"><tr><td style="width:1.0%"></td><td style="width:23.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5019884ac20741cf8a16eed471340bcf_I20230307" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90YWJsZTphMDU5MDc1MmYxM2Y0MjU0YWExYzQ1MjQ5MGEwNDc4ZS90YWJsZXJhbmdlOmEwNTkwNzUyZjEzZjQyNTRhYTFjNDUyNDkwYTA0NzhlXzEtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246MGE3NGNjMDMyNzE3NDc5ZDg1ZmQwYTg0YTlkMTU5MzVfNA_52860a62-756a-4099-9ee2-184b88cbcdd6">700</ix:nonFraction> million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5019884ac20741cf8a16eed471340bcf_I20230307" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90YWJsZTphMDU5MDc1MmYxM2Y0MjU0YWExYzQ1MjQ5MGEwNDc4ZS90YWJsZXJhbmdlOmEwNTkwNzUyZjEzZjQyNTRhYTFjNDUyNDkwYTA0NzhlXzEtNC0xLTEtNTQ3MDk4_a61a1b1a-b036-4c67-a2d1-319be244f5f6">5.685</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i93b7c27710884424a2eec7dcef7b23f9_D20230307-20230307" decimals="-6" name="ci:ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90YWJsZTphMDU5MDc1MmYxM2Y0MjU0YWExYzQ1MjQ5MGEwNDc4ZS90YWJsZXJhbmdlOmEwNTkwNzUyZjEzZjQyNTRhYTFjNDUyNDkwYTA0NzhlXzEtNi0xLTEtNTQ3MDk4_e96c7294-5982-4afe-bc7a-e09fdf4ca2cb">698</ix:nonFraction> million</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iffbc2955b58a40d8b0178672d5fb531f_I20230307" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90YWJsZTphMDU5MDc1MmYxM2Y0MjU0YWExYzQ1MjQ5MGEwNDc4ZS90YWJsZXJhbmdlOmEwNTkwNzUyZjEzZjQyNTRhYTFjNDUyNDkwYTA0NzhlXzItMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZmFkNGNhOTBlNTZiNDIzZGJhYzYyZWExYzcwZTI0ZDBfNA_a2b44b1c-37b1-44b4-834f-30105f0f76e9">800</ix:nonFraction> million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 15, 2033</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iffbc2955b58a40d8b0178672d5fb531f_I20230307" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90YWJsZTphMDU5MDc1MmYxM2Y0MjU0YWExYzQ1MjQ5MGEwNDc4ZS90YWJsZXJhbmdlOmEwNTkwNzUyZjEzZjQyNTRhYTFjNDUyNDkwYTA0NzhlXzItNC0xLTEtNTQ3MDk4_fc44350a-da80-4f1d-ae87-81d84f6a0fef">5.400</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i809f71ecb14a46c19821cd0c10cf40d1_D20230307-20230307" decimals="-6" name="ci:ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90YWJsZTphMDU5MDc1MmYxM2Y0MjU0YWExYzQ1MjQ5MGEwNDc4ZS90YWJsZXJhbmdlOmEwNTkwNzUyZjEzZjQyNTRhYTFjNDUyNDkwYTA0NzhlXzItNi0xLTEtNTQ3MDk4_61cb7457-fa12-43c6-8fcc-31eb333a8955">796</ix:nonFraction> million</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"> Redeemable at any time discounted at the U.S. Treasury rate plus <ix:nonFraction unitRef="number" contextRef="ifd4fe3f6c8b04276b496fb8ac4ef9399_D20230307-20230307" decimals="4" name="ci:DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90ZXh0cmVnaW9uOjFlYmNmMWZmZmVmNjQ4ZGRiMzlkYjdmZWU0NTIyMGE3XzU3NQ_7b78f33e-2674-4ce5-921b-84c31e6e45ea">20</ix:nonFraction> basis points. Redeemable at par on or after March 15, 2024.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"><ix:continuation id="ibdbda7c9e2fa4af99e6ef13438b16143" continuedAt="ieb62e83c85e048f192ef5c758c993411">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"><ix:continuation id="ieb62e83c85e048f192ef5c758c993411"> Redeemable at any time discounted at the U.S. Treasury rate plus <ix:nonFraction unitRef="number" contextRef="i11b7488d47bd4be38856523de2a8e659_D20230307-20230307" decimals="4" name="ci:DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90ZXh0cmVnaW9uOjFlYmNmMWZmZmVmNjQ4ZGRiMzlkYjdmZWU0NTIyMGE3XzcwOA_3668e3c7-dc4e-4689-8763-33d51c143e9b">25</ix:nonFraction> basis points. Redeemable at par on or after December 15, 2032.</ix:continuation> </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_454"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="icde16c58750b47718ff264d9b5e9b8a0" continuedAt="idc8ebbfe49894c42b2b1edb0c69a786e"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Short-term and Credit Facilities Debt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revolving Credit Agreements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Our revolving credit agreements provide us with the ability to borrow amounts for general corporate purposes, including providing liquidity support if necessary under our commercial paper program discussed below.</span></div></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_5898"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="idc8ebbfe49894c42b2b1edb0c69a786e" continuedAt="i89870a032e4e4f86992179176b13251d">As of March&#160;31, 2023, The Cigna Group had a $<ix:nonFraction unitRef="usd" contextRef="if507247b2d15417b965fab339f79fe0a_I20220430" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8zNw_e9a76249-49fe-4fe0-9b4e-12299702e5c2">3.0</ix:nonFraction> billion <ix:nonNumeric contextRef="i37d8822645414b32a762b437086b9814_D20220401-20220430" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8xODYw_30145194-a9df-41a0-bf59-4d071142c4a3">five-year</ix:nonNumeric> revolving credit and letter of credit agreement maturing in April 2027; a $<ix:nonFraction unitRef="usd" contextRef="i968eab3e6c6a464b8621cc1f22f13849_I20220430" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8xMTU_6f1ffec4-9331-481c-ba40-c624cb9113f3">1.0</ix:nonFraction> billion <ix:nonNumeric contextRef="i2e9aa8daf53f4df3bad80c887b287e24_D20220401-20220430" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8xODU5_97d6d05f-0c35-4bcd-b3b5-794234820196">three-year</ix:nonNumeric> revolving credit agreement maturing in April 2025; and a $<ix:nonFraction unitRef="usd" contextRef="i2be2fccd54774ea28094ccdeb4da1bf1_I20220430" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8xNzM_fd0083cd-44e4-4d8a-a10c-c82308c0e374">1.0</ix:nonFraction> billion <ix:nonNumeric contextRef="i402359fab32e4e2e81a9d588165d9963_D20220401-20220430" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8xODY0_c5c3a924-0db7-4032-b98c-c3a506c5a855">364-day</ix:nonNumeric> revolving credit agreement maturing in April 2023. There were <ix:nonFraction unitRef="usd" contextRef="iab20c9aeb2d14f4aaac0f23ac89dd20e_I20230331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8yMzc_fc27790f-7b37-40b2-a5e4-b6d17e256136">no</ix:nonFraction> outstanding balances under these revolving credit agreements as of March&#160;31, 2023.</ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_5929"></div><ix:continuation id="i89870a032e4e4f86992179176b13251d" continuedAt="i2248469175a94b758eaa9af254c495ad"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In April 2023, The Cigna Group entered into the following revolving credit agreements (the "Credit Agreements"), which replaced the agreements discussed above:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">a $<ix:nonFraction unitRef="usd" contextRef="i542bd1f117ca43d18940ed6fff533658_I20230430" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xNTk_a84ef919-62bc-4936-9c83-ef860cae259a">4.0</ix:nonFraction> billion <ix:nonNumeric contextRef="i37973f57d1cd47349579d1c948a6c36c_D20230401-20230430" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xNTUy_b26252ed-c34c-431d-85b9-a8e5f4ee396e">five-year</ix:nonNumeric> revolving credit and letter of credit agreement that will mature in April 2028 with an option to extend the maturity date for additional <ix:nonNumeric contextRef="i37973f57d1cd47349579d1c948a6c36c_D20230401-20230430" name="ci:DebtInstrumentExtensionTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xNTU0_8c2e9253-9785-4712-b802-45be394ac738">one-year</ix:nonNumeric> periods, subject to consent of the banks. The Company can borrow up to $<ix:nonFraction unitRef="usd" contextRef="i542bd1f117ca43d18940ed6fff533658_I20230430" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8zNzg_a84ef919-62bc-4936-9c83-ef860cae259a">4.0</ix:nonFraction> billion under the credit agreement for general corporate purposes, with up to $<ix:nonFraction unitRef="usd" contextRef="i6e7b2848129a456d9e6bd7711efd7860_I20230430" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV80NTE_6764b0dc-b915-4803-8591-a175092b6355">500</ix:nonFraction> million available for issuance of letters of credit. </span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">a $<ix:nonFraction unitRef="usd" contextRef="idbd12673dfe8421ca4a56e0ea3593be9_I20230430" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV81MDI_63360fe6-3a4f-460c-82f7-5e78a05d7c33">1.0</ix:nonFraction> billion <ix:nonNumeric contextRef="i83622a269b3f44fba77ec17337d55e2d_D20230401-20230430" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV81NDk3NTU4MTU0NjQ_ec238a25-b530-454f-96c8-894fa3ea727f">364-day</ix:nonNumeric> revolving credit agreement that will mature in April 2024. The Company can borrow up to $<ix:nonFraction unitRef="usd" contextRef="idbd12673dfe8421ca4a56e0ea3593be9_I20230430" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV81OTI_63360fe6-3a4f-460c-82f7-5e78a05d7c33">1.0</ix:nonFraction> billion under the credit agreement for general corporate purposes. This agreement includes the option to "term out" any revolving loans that are outstanding at maturity by converting them into a term loan maturing on the <ix:nonNumeric contextRef="i83622a269b3f44fba77ec17337d55e2d_D20230401-20230430" name="ci:LineOfCreditFacilityConversionToTermLoanTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xNTUz_2a3fe312-6ee6-4190-9216-17e05d6ec4a5">one-year</ix:nonNumeric> anniversary of conversion.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Each of the Credit Agreements include an option to increase commitments in an aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="iad29666a07fc46d68f52e52e2f6aaab4_I20230430" decimals="INF" name="ci:LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV85NDc_e38fdf3b-54fc-4254-a92e-22b031e792cc">1.5</ix:nonFraction> billion across both facilities for a maximum total commitment of $<ix:nonFraction unitRef="usd" contextRef="iad29666a07fc46d68f52e52e2f6aaab4_I20230430" decimals="INF" name="ci:LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xMDEw_02443b8e-edd8-4691-9953-ecc086df691e">6.5</ix:nonFraction> billion. The Credit Agreements allow for borrowings at either a base rate or an adjusted term Secured Overnight Funding Rate ("SOFR") plus, in each case, an applicable margin based on the Company's senior unsecured credit ratings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Each of the <ix:nonFraction unitRef="revolvingcreditfacility" contextRef="ibc00f288660a48daae4fccef391cd358_I20230430" decimals="INF" name="ci:NumberOfRevolvingCreditFacility" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xMjQ5_16d66da8-6b7d-4f9d-a32c-156206233a1c">two</ix:nonFraction> facilities is diversified among <ix:nonFraction unitRef="position" contextRef="iad29666a07fc46d68f52e52e2f6aaab4_I20230430" decimals="INF" name="ci:NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xMjg0_fc38cb34-642c-462c-8b17-d3401b6a8e27">21</ix:nonFraction> large commercial banks, all of which had an A- equivalent or higher rating by at least one Nationally Recognized Statistical Rating Organization as of March 31, 2023. Each facility also contains customary covenants and restrictions, including a financial covenant that the Company's leverage ratio, as defined in the Credit Agreements, may not exceed <ix:nonFraction unitRef="number" contextRef="iad29666a07fc46d68f52e52e2f6aaab4_I20230430" decimals="INF" name="ci:LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xNDc4_beb0e07c-78ce-4717-99b5-dd9ea8ee3f2c">60</ix:nonFraction>% subject to certain exceptions upon the consummation of an acquisition. </span></div></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_5865"></div><div><ix:continuation id="i2248469175a94b758eaa9af254c495ad" continuedAt="i88dc30ae91aa4d72950c606d54ed6ab1"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Commercial Paper. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under our commercial paper program, we may issue short-term, unsecured commercial paper notes privately placed on a discounted basis through certain broker-dealers at any time not to exceed an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="ia05553ebdf9b4a5b971cdfd702e8a711_I20230331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODY1L2ZyYWc6YWRiMGY3NGU1NDg4NGFjNTkzZTUyMjhjMWJiMjE4MWQvdGV4dHJlZ2lvbjphZGIwZjc0ZTU0ODg0YWM1OTNlNTIyOGMxYmIyMTgxZF8yMzY_2e557b81-d977-42f8-a558-a6d89e721ff6">5.0</ix:nonFraction> billion. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The net proceeds of issuances have been and are expected to be used for general corporate purposes. There was <ix:nonFraction unitRef="usd" contextRef="ia05553ebdf9b4a5b971cdfd702e8a711_I20230331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODY1L2ZyYWc6YWRiMGY3NGU1NDg4NGFjNTkzZTUyMjhjMWJiMjE4MWQvdGV4dHJlZ2lvbjphZGIwZjc0ZTU0ODg0YWM1OTNlNTIyOGMxYmIyMTgxZF80NDU_51b0aa4f-be92-4231-bd72-ca5523ceaf88">no</ix:nonFraction> commercial paper outstanding balance as of March&#160;31, 2023.</span></ix:continuation></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_463"></div><div><ix:continuation id="i88dc30ae91aa4d72950c606d54ed6ab1" continuedAt="ic988ca0148fd41fe92224269924496a8"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Debt Covenants. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company was in compliance with its debt covenants as of March&#160;31, 2023.</span></ix:continuation></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_469"></div><ix:continuation id="ic988ca0148fd41fe92224269924496a8"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Interest Expense</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest expense on long-term and short-term debt was $<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjkvZnJhZzo1ZjQzODQ2YWJlNzE0MDVhYmUwNDZhODY1NzU0ZTJjYS90ZXh0cmVnaW9uOjVmNDM4NDZhYmU3MTQwNWFiZTA0NmE4NjU3NTRlMmNhXzExMQ_9acef062-60f5-4e7f-ab48-e3d5de60a079">345</ix:nonFraction> million for the three months ended March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjkvZnJhZzo1ZjQzODQ2YWJlNzE0MDVhYmUwNDZhODY1NzU0ZTJjYS90ZXh0cmVnaW9uOjVmNDM4NDZhYmU3MTQwNWFiZTA0NmE4NjU3NTRlMmNhXzE3Nw_a0de348a-45fe-41f0-af90-23b2ca54b7fb">314</ix:nonFraction> million for the three months ended March&#160;31, 2022.</span></div></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_472"></div><div><span id="ieafdbf35cbd14b18b106efbc6851b607_13"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzIvZnJhZzplYWZkYmYzNWNiZDE0YjE4YjEwNmVmYmM2ODUxYjYwNy90ZXh0cmVnaW9uOmVhZmRiZjM1Y2JkMTRiMThiMTA2ZWZiYzY4NTFiNjA3XzEy_9d02c753-1293-4cbe-84fa-e771720010ed" continuedAt="i1f216c336bbd45548684d04ee6124af8" escape="true">Note 8 &#8211; Common and Preferred Stock</ix:nonNumeric></span></div><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_478"></div><ix:continuation id="i1f216c336bbd45548684d04ee6124af8" continuedAt="ieb0d7837530041e49743940268be292d"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Dividends</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the first quarter of 2023, The Cigna Group declared quarterly cash dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzc3_d569d0e5-36ac-420e-bbcc-2164f968a01a">1.23</ix:nonFraction> per share of the Company's common stock. In the first quarter of 2022, The Cigna Group declared quarterly cash dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="iaa7f8f9afed94f2c8a4d8a3fadcba829_D20220701-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzE5Nw_6fe552b2-6b0c-49d8-8ae3-3c471b9ee6b8"><ix:nonFraction unitRef="usdPerShare" contextRef="i75204ef5bacc45e484f57be2c4af5158_D20221001-20221231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzE5Nw_9361f3f4-f93f-4209-98b5-7a00e29671a2"><ix:nonFraction unitRef="usdPerShare" contextRef="i67f0445844a9443db40d9291472caedc_D20220401-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzE5Nw_a969759e-0c5c-4bfe-b5c5-0a501e3916ba"><ix:nonFraction unitRef="usdPerShare" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzE5Nw_d9900ec1-8b3e-4e97-99d3-c997a74f22dd">1.12</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per share of the Company's common stock.</span></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:DividendsDeclaredTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzEwMzM_98595cc5-46c9-4521-87b7-47aeec8e29ac" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table provides details of the Company's dividend payments:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount per Share</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount Paid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"> (in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 8, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 23, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ib9c3e4e75f4d46b58ea05c03cbcb7a51_D20230323-20230323" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90YWJsZToyNDEyNTFmYjk2ZjU0ZjE5ODFiOGY3Yjc2Y2MzNjkxYi90YWJsZXJhbmdlOjI0MTI1MWZiOTZmNTRmMTk4MWI4ZjdiNzZjYzM2OTFiXzItMi0xLTEtNTQ3MDk4_1b458679-c41c-4b8c-8247-87b0d881e380">1.23</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib9c3e4e75f4d46b58ea05c03cbcb7a51_D20230323-20230323" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90YWJsZToyNDEyNTFmYjk2ZjU0ZjE5ODFiOGY3Yjc2Y2MzNjkxYi90YWJsZXJhbmdlOjI0MTI1MWZiOTZmNTRmMTk4MWI4ZjdiNzZjYzM2OTFiXzItMy0xLTEtNTQ3MDk4_88c81aa6-5077-40e3-bc1b-4aa830718841">368</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 9, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 24, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i194fae94da834e3e8279dc01c624343d_D20220324-20220324" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90YWJsZToyNDEyNTFmYjk2ZjU0ZjE5ODFiOGY3Yjc2Y2MzNjkxYi90YWJsZXJhbmdlOjI0MTI1MWZiOTZmNTRmMTk4MWI4ZjdiNzZjYzM2OTFiXzctMi0xLTEtNTQ3MDk4_0bf12113-505f-4a37-b5e2-0053a4a89eb9">1.12</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i194fae94da834e3e8279dc01c624343d_D20220324-20220324" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90YWJsZToyNDEyNTFmYjk2ZjU0ZjE5ODFiOGY3Yjc2Y2MzNjkxYi90YWJsZXJhbmdlOjI0MTI1MWZiOTZmNTRmMTk4MWI4ZjdiNzZjYzM2OTFiXzctMy0xLTEtNTQ3MDk4_8749013a-b42d-4a36-bb30-a8f6141aa086">357</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April&#160;26, 2023, the Board of Directors declared the second quarter cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9df7da12ac1d49b3b2f3b1ad8b0cc70f_D20230426-20230426" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzM4Nw_7b37fbf9-5878-4d56-a6c8-f4af5d1d3b55">1.23</ix:nonFraction> per share of The Cigna Group common stock to be paid on June&#160;22, 2023 to shareholders of record on June&#160;7, 2023. The Company currently intends to pay regular quarterly </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ieb0d7837530041e49743940268be292d">dividends, with future declarations subject to approval by its Board of Directors and the Board's determination that the declaration of dividends remains in the best interests of The Cigna Group and its shareholders. The decision of whether to pay future dividends and the amount of any such dividends will be based on the Company's financial position, results of operations, cash flows, capital requirements, the requirements of applicable law and any other factors the Board may deem relevant.</ix:continuation></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_490"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8211; <ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90ZXh0cmVnaW9uOjIwZjgzYjA5Mjk3NDQ5MDQ4YWFkOGUxMWVhODc3YTAwXzk1MTA3NzU1ODAzNDYx_8c781003-ed5b-464f-a045-58afacbbcccc" continuedAt="ibeee9b7ce09246cf9b12b699c2f6b8ae" escape="true">Insurance and Contractholder Liabilities</ix:nonNumeric></span></div><ix:continuation id="ibeee9b7ce09246cf9b12b699c2f6b8ae" continuedAt="i6ea1d1a54a6d4e19bcdc30728a5f1981"><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt;text-decoration:underline">Account Balances &#8211; Insurance and Contractholder Liabilities</span></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90ZXh0cmVnaW9uOjIwZjgzYjA5Mjk3NDQ5MDQ4YWFkOGUxMWVhODc3YTAwXzU0OTc1NTgxNTgzNg_25e61b7a-db46-4bcb-a789-93509735493b" continuedAt="id951857da41e46a8bc09d12b7cb05b35" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's insurance and contractholder liabilities were comprised of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unpaid claims and claim expenses</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtMS0xLTEtNjIzNTMy_5bb9bd06-0531-43e0-bae0-bb492ef64ba2">4,880</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtMy0xLTEtNjIzNTMy_d039058b-cb36-45a5-8684-e7987ba2973b">79</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtNS0xLTEtNjIzNTMy_8c694165-b0d1-4726-b0e5-cf8941a95da1">4,959</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtNy0xLTEtNjIzNTMy_4c44fbbb-e5a4-4fa8-98b7-4a4dde711823">4,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtOS0xLTEtNjIzNTMy_6089e291-d1a0-4987-b8a9-7329dc4c68eb">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtMTEtMS0xLTYyMzUzMg_7544aebc-5d38-4135-a50e-c79b2ce0b3a9">4,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtMTMtMS0xLTYyMzUzMg_e98654a2-5a55-48f2-8561-4f6d4d5f38ce">4,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-6" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtMS0xLTEtNjIzNTMy_b48791db-8674-439b-b1bd-184808c3b26b">97</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-6" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtMy0xLTEtNjIzNTMy_b5ce1245-4d80-418d-801a-fb9822f8152f">175</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtNS0xLTEtNjIzNTMy_d89f447e-62f7-4f41-8742-378647c8ea7f">272</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db337d577d24323b93b59b505c32718_I20221231" decimals="-6" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtNy0xLTEtNjIzNTMy_34456350-60df-4907-a577-79cfe3f8c5f8">107</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db337d577d24323b93b59b505c32718_I20221231" decimals="-6" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtOS0xLTEtNjIzNTMy_e13cf29d-f43e-4d12-ae9b-ebedf265eeea">177</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db337d577d24323b93b59b505c32718_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtMTEtMS0xLTYyMzUzMg_254f5c12-7546-41b2-bc77-422ebd9c9d5b">284</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" decimals="-6" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtMTMtMS0xLTYyMzUzMg_9f8286bb-2c77-480e-82e6-e9870100533c">744</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Future policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtMS0xLTEtNTQ3MDk4_035e9247-46f0-40dd-bc7a-c6f0cc6c41ea">59</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtMy0xLTEtNTQ3MDk4_7b3d3e84-e8c6-40ed-83fa-270e11548141">542</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtNS0xLTEtNTQ3MDk4_9d43d7e6-9085-4a0b-b951-af88c8d5edb2">601</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtNy0xLTEtNTQ3MDk4_babea748-b5e5-4f7e-b68e-cabbfa4ac365">43</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtOS0xLTEtNTQ3MDk4_be064ed0-fee4-4ea4-9a98-c6da6f08f3bc">544</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtMTEtMS0xLTU0NzA5OA_7a32d953-673a-40bc-a91b-812bc54c83a5">587</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitsIncludingDisposalGroups" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtMTMtMS0xLTU0NzA5OA_d5c670d2-918d-4aa4-9c9b-8d0345646b6a">681</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctMS0xLTEtNTQ3MDk4_b411b74b-3aa8-4bbc-b190-91ed4aafcfd0">290</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctMy0xLTEtNTQ3MDk4_3fd7fedc-fd04-49d2-be84-5190f105d6de">3,341</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctNS0xLTEtNTQ3MDk4_f119c422-c7b2-4ad5-86c4-12975c59aa9c">3,631</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db337d577d24323b93b59b505c32718_I20221231" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctNy0xLTEtNTQ3MDk4_8db5654a-c548-41c1-8ece-19b166c7caff">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db337d577d24323b93b59b505c32718_I20221231" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctOS0xLTEtNTQ3MDk4_d5ba6cf8-a2f8-4c1a-b38d-87b3f4d82970">3,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db337d577d24323b93b59b505c32718_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctMTEtMS0xLTU0NzA5OA_7725153c-3d8b-49b9-99f2-44b586137289">3,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitsIncludingDisposalGroups" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctMTMtMS0xLTU0NzA5OA_504416fa-0564-44d2-a16b-861c194487bd">7,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractholder deposit funds</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="ci:PolicyholderContractDepositCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTEtMS0xLTYyMzU1Mg_95be5efb-149f-4fa5-8faa-db3a584d0be8">12</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="ci:PolicyholderContractDepositNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTMtMS0xLTYyMzU1Mg_99bb151d-857b-4e1c-a5a9-c3af33ba81c5">151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:PolicyholderContractDeposits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTUtMS0xLTYyMzU1Mg_d9950d5d-7a30-44bf-b7ac-f6e3e4506683">163</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="ci:PolicyholderContractDepositCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTctMS0xLTYyMzU1Mg_11d3dbe2-ea69-4d06-9210-1ce22fa21e6e">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="ci:PolicyholderContractDepositNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTktMS0xLTYyMzU1Mg_6b2bab4b-f6b7-4396-8383-b293b9cd80ba">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="us-gaap:PolicyholderContractDeposits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTExLTEtMS02MjM1NTI_f1c7dd2e-a304-4793-91c9-ea501c557b75">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="us-gaap:PolicyholderContractDeposits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTEzLTEtMS02MjM1NTI_f5feb7c6-7780-4d6a-ba0e-3dbf68114105">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-6" name="ci:PolicyholderContractDepositCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTEtMS0xLTYyMzU1Mg_3219af24-84a2-4b6b-815e-cd44d819d021">361</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-6" name="ci:PolicyholderContractDepositNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTMtMS0xLTYyMzU1Mg_660f50bf-6b79-4adc-9a84-a6407518e18b">6,309</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-6" name="us-gaap:PolicyholderContractDeposits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTUtMS0xLTYyMzU1Mg_a3378675-db62-4e7b-b8d0-f98ed2416fe9">6,670</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db337d577d24323b93b59b505c32718_I20221231" decimals="-6" name="ci:PolicyholderContractDepositCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTctMS0xLTYyMzU1Mg_20f264d2-3cb3-4268-a167-a36d13bb43ae">351</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db337d577d24323b93b59b505c32718_I20221231" decimals="-6" name="ci:PolicyholderContractDepositNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTktMS0xLTYyMzU1Mg_14408c21-7081-4e52-a302-c01e8c56d292">6,358</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db337d577d24323b93b59b505c32718_I20221231" decimals="-6" name="us-gaap:PolicyholderContractDeposits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTExLTEtMS02MjM1NTI_04afc309-9d6b-41b3-bd1f-ad498916883d">6,709</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" decimals="-6" name="us-gaap:PolicyholderContractDeposits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTEzLTEtMS02MjM1NTI_7ed97f41-c95c-46e2-800b-bcf44eb9b2f1">6,843</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market risk benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:MarketRiskBenefitLiabilityAmountCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtMS0xLTEtNTQ3MDk4_04a8d8f3-b922-426f-9ba1-cd12f5abeb98">48</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:MarketRiskBenefitLiabilityAmountNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtMy0xLTEtNTQ3MDk4_40b06e5b-69c1-4615-a9d9-044d928942f0">1,172</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:MarketRiskBenefitLiabilityAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtNS0xLTEtNTQ3MDk4_c02862dd-8be9-442c-882b-9ab64955402a">1,220</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:MarketRiskBenefitLiabilityAmountCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtNy0xLTEtNTQ3MDk4_bc61b84a-8295-4d22-986f-9c9e5909fbeb">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:MarketRiskBenefitLiabilityAmountNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtOS0xLTEtNTQ3MDk4_f6f5ed5e-0f7e-40fe-aa9a-e21015488d80">1,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:MarketRiskBenefitLiabilityAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtMTEtMS0xLTU0NzA5OA_19b911eb-d7fa-43db-83e5-268c6cf1a09f">1,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="us-gaap:MarketRiskBenefitLiabilityAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtMTMtMS0xLTU0NzA5OA_352e30a0-e941-4515-8167-5413f32df080">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:UnearnedPremiumsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktMS0xLTEtNTQ3MDk4_d98b4b2d-fffe-4330-88e5-4c919e9a563a">1,419</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:UnearnedPremiumsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktMy0xLTEtNTQ3MDk4_2fc03291-267b-4bee-ade1-e31d94b8d8d4">21</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:UnearnedPremiums" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktNS0xLTEtNTQ3MDk4_45dc1738-89b0-4759-b1c3-45ae960172e8">1,440</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:UnearnedPremiumsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktNy0xLTEtNTQ3MDk4_23ce4b85-c174-4cbe-9223-585021cf7b11">576</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:UnearnedPremiumsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktOS0xLTEtNTQ3MDk4_3e6dd27d-70c4-4840-9f76-5ee1c59047af">22</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:UnearnedPremiums" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktMTEtMS0xLTU0NzA5OA_49f3e92f-560e-414e-bbc1-a00f2f905be3">598</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="ci:UnearnedPremiumsIncludingDisposalGroups" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktMTMtMS0xLTU0NzA5OA_c0cb0070-6ab9-45df-a6cb-db36e8dfcca2">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="ci:InsuranceAndContractholderLiabilitiesIncludingDisposalGroups" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTEzLTEtMS01NjczNDk_770f401d-4348-41b9-9aab-6aa92adefae2">23,509</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insurance and contractholder liabilities classified as Liabilities of businesses held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="ci:DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE0LTEzLTEtMS01NjczNTY_df938b7c-5b34-4839-b218-dab8222ffaa6">4,562</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total insurance and contractholder liabilities</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:InsuranceAndContractholderLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTEtMS0xLTU0NzA5OA_0d683982-5b12-45ba-b851-5595eae77c35">7,166</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:InsuranceAndContractholderLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTMtMS0xLTU0NzA5OA_ab522b81-b527-400f-aa77-a9f2dac5bbb2">11,790</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:InsuranceAndContractholderLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTUtMS0xLTU0NzA5OA_94f2633e-1aec-401a-b8a8-68831c039d1b">18,956</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:InsuranceAndContractholderLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTctMS0xLTU0NzA5OA_e15d746b-4598-452c-9627-e90e59194624">5,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:InsuranceAndContractholderLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTktMS0xLTU0NzA5OA_2444524a-50e0-41ca-92e4-b864d2ff3cbc">11,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:InsuranceAndContractholderLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTExLTEtMS01NDcwOTg_cb1666c9-e127-45d2-b6f0-1bcddded3484">17,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="ci:InsuranceAndContractholderLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTEzLTEtMS01NDcwOTg_a932c0d6-0003-4d8f-ad4b-18aa628e80b1">18,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.94pt">Amounts classified as Liabilities of businesses held for sale primarily include $<ix:nonFraction unitRef="usd" contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" decimals="-8" name="ci:LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90ZXh0cmVnaW9uOjIwZjgzYjA5Mjk3NDQ5MDQ4YWFkOGUxMWVhODc3YTAwXzIxMA_83bd8e0f-1ce1-422e-a4a4-48fd3e509b64">3.7</ix:nonFraction>&#160;billion of Future policy benefits, $<ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-8" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90ZXh0cmVnaW9uOjIwZjgzYjA5Mjk3NDQ5MDQ4YWFkOGUxMWVhODc3YTAwXzI0MA_35cf57da-e861-4523-acd9-b15aaa2d20fe">0.4</ix:nonFraction>&#160;billion of Unpaid claims and $<ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-8" name="ci:PolicyholderContractDepositsAttributableToDisposalGroups" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90ZXh0cmVnaW9uOjIwZjgzYjA5Mjk3NDQ5MDQ4YWFkOGUxMWVhODc3YTAwXzI2NA_8c890b92-a141-4625-ba46-af45e554e13e">0.4</ix:nonFraction>&#160;billion of Unearned premiums as of March&#160;31, 2022.</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Insurance and contractholder liabilities expected to be paid within one year are classified as current. The Company adopted amended accounting guidance for long-duration insurance contracts on January 1, 2023, discussed further in Note 2 to the Consolidated Financial Statements, which resulted in restatement of prior period amounts. Additionally, see below updated accounting policies and incremental disclosures associated with future policy benefits (Note 9C), contractholder deposit funds (Note 9D), and market risk benefits (Note 9E).</span></div></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_502"></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.84pt;text-decoration:underline"><ix:continuation id="i6ea1d1a54a6d4e19bcdc30728a5f1981" continuedAt="i882e07f37fae445ead39bee922a9ebaa">Unpaid Claims and Claim Expenses &#8211; Cigna Healthcare</ix:continuation></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i882e07f37fae445ead39bee922a9ebaa" continuedAt="i493c01cf51754f3ea5aca1605e9a0710"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDIvZnJhZzozZDNhNWZiNTM4MzI0MWU5OTA5N2JlNTViOTIxYTkwOS90ZXh0cmVnaW9uOjNkM2E1ZmI1MzgzMjQxZTk5MDk3YmU1NWI5MjFhOTA5XzQ1OA_2da03472-dd86-4ac5-9995-45507a2caa38" escape="true">This liability reflects estimates of the ultimate cost of claims that have been incurred but not reported, including expected development on reported claims, those that have been reported but not yet paid (reported claims in process) and other medical care expenses and services payable that are primarily comprised of accruals for incentives and other amounts payable to health care professionals and facilities.</ix:nonNumeric> </ix:continuation></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_508"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i493c01cf51754f3ea5aca1605e9a0710" continuedAt="i8196fee429ac4e5f9496d0dbbdf32768">The total of incurred but not reported liabilities plus expected development on reported claims, including reported claims in process, was $<ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-8" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90ZXh0cmVnaW9uOmE5MjIwYTE0NzM5ODQ3M2ZhYmI2ZmMxNzBkNWNjOGRiXzE0NA_770c4739-98d6-4ae4-acb3-a3d206e3492d">4.6</ix:nonFraction> billion at March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-8" name="ci:LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90ZXh0cmVnaW9uOmE5MjIwYTE0NzM5ODQ3M2ZhYmI2ZmMxNzBkNWNjOGRiXzE1Nw_885d0b59-78b0-4b9d-be92-016d0c3c4fbc">4.2</ix:nonFraction> billion at March&#160;31, 2022. </ix:continuation></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8196fee429ac4e5f9496d0dbbdf32768" continuedAt="ie519410b52584384b8ded547e4c34e00"><ix:continuation id="id951857da41e46a8bc09d12b7cb05b35"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Activity, net of intercompany transactions, in the unpaid claims liability for the Cigna Healthcare segment was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.041%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzQtMS0xLTEtNTQ3MDk4_79c6af41-5e6f-4b3b-93ce-7829475a10a0">4,176</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3314d3839844dbab40e20dd517db732_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzQtMy0xLTEtNTQ3MDk4_cab736f5-5323-4dc3-8248-3b3b1ce1795b">4,261</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Reinsurance and other amounts recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzUtMS0xLTEtNTQ3MDk4_81176d85-60f3-468a-9ee6-fc23886cb95a">221</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3314d3839844dbab40e20dd517db732_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzUtMy0xLTEtNTQ3MDk4_c1f7e22c-1e5d-496a-b374-0e7b8b793ebf">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance, net</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzYtMS0xLTEtNTQ3MDk4_c4be79fc-e967-4269-b62e-de25dbfc346d">3,955</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3314d3839844dbab40e20dd517db732_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzYtMy0xLTEtNTQ3MDk4_5f2301e6-39c0-472e-b8bf-64f5863df2b1">4,000</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred costs related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzktMS0xLTEtNTQ3MDk4_0749bb2d-d90a-426e-aae3-8594bb50ed73">9,041</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzktMy0xLTEtNTQ3MDk4_77f3497f-f4f8-4e94-8732-63bcab42db4c">8,024</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzEwLTEtMS0xLTU0NzA5OA_ee0da9f3-ba2e-4a01-9a5a-ca604a889fe2">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzEwLTMtMS0xLTU0NzA5OA_6f019744-36a3-4720-8175-15740e0b92f8">276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzExLTEtMS0xLTU0NzA5OA_e921668e-2990-4119-888a-6a5885ccc4ed">8,897</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzExLTMtMS0xLTU0NzA5OA_9900d7e6-905f-4c7e-927e-d5794339d26e">7,748</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid costs related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzEzLTEtMS0xLTU0NzA5OA_817f7a56-cd6c-4150-9d55-d88ee2f79dc3">5,316</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzEzLTMtMS0xLTU0NzA5OA_febcc9ed-7f20-4192-84e1-65719ac350c1">4,634</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE0LTEtMS0xLTU0NzA5OA_793d074b-876a-4848-9c76-22cd058da01d">2,795</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE0LTMtMS0xLTU0NzA5OA_07005c17-4cb0-4514-bf57-afd0b64d9226">2,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE1LTEtMS0xLTU0NzA5OA_16dc2b7d-0e17-4ffb-8fc8-2ce1e2c18584">8,111</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE1LTMtMS0xLTU0NzA5OA_4115c93f-640f-47d3-999a-c282a7cf5062">7,456</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE3LTEtMS0xLTU0NzA5OA_637365fe-d988-43b8-83b2-4d72d78a0a74">4,741</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE3LTMtMS0xLTU0NzA5OA_ec4a5693-f658-4663-ad34-3f6b10014458">4,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Reinsurance and other amounts recoverable</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE4LTEtMS0xLTU0NzA5OA_0d723937-c916-4228-a994-fd895e674fa4">218</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE4LTMtMS0xLTU0NzA5OA_70df34c1-d1d5-45cd-bd83-eaf64d427558">199</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE5LTEtMS0xLTU0NzA5OA_f9a1807d-2155-41f3-ae94-ef26810bb621">4,959</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE5LTMtMS0xLTU0NzA5OA_20861f38-def8-4fbd-af26-7488d4de1769">4,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:ReinsuranceAccountingPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90ZXh0cmVnaW9uOmE5MjIwYTE0NzM5ODQ3M2ZhYmI2ZmMxNzBkNWNjOGRiXzEwODQ_dce0273b-93b5-45b4-8395-c1b450030ff3" continuedAt="i57f1ab2321104b06a53e42521f48d5e7" escape="true">Reinsurance and other amounts recoverable reflect amounts due from reinsurers and policyholders to cover incurred but not reported and pending claims of certain business for which the Company administers the plan benefits without any right of offset. See Note 10 to the Consolidated Financial Statements for additional information on reinsurance</ix:nonNumeric>.</span></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90ZXh0cmVnaW9uOmE5MjIwYTE0NzM5ODQ3M2ZhYmI2ZmMxNzBkNWNjOGRiXzEwODM_68fac909-f80d-433e-83fd-6a6bbfea0408" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Variances in incurred costs related to prior years' unpaid claims and claim expenses that resulted from the differences between actual experience and the Company's key assumptions were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Actual completion factors</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582bfa8cb42448fb904b42f8fd26b53c_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzUtMS0xLTEtNTQ3MDk4_80a9a333-b095-499e-8110-00b6a8451fe9">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i582bfa8cb42448fb904b42f8fd26b53c_D20230101-20230331" decimals="3" name="ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzUtMy0xLTEtNTQ3MDk4_1cd41644-bbcb-4368-a13b-40307748018c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cde04d0ebee47b58537b475418eccf3_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzUtNS0xLTEtNTQ3MDk4_29438b3b-dee6-4fce-b27f-66f0af7d918c">99</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2cde04d0ebee47b58537b475418eccf3_D20220101-20220331" decimals="3" name="ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzUtNy0xLTEtNTQ3MDk4_050d358b-6ad8-4478-9c3f-975ca01094ba">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical cost trend</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8f7bc9e3c3445a6980b765bf65b3c78_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzYtMS0xLTEtNTQ3MDk4_83a3d29d-6f6c-4971-ae92-c9eede9165e4">143</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie8f7bc9e3c3445a6980b765bf65b3c78_D20230101-20230331" decimals="3" name="ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzYtMy0xLTEtNTQ3MDk4_b2415a94-c74b-4b24-8558-24677e5c3ad7">0.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a56d790203f47048913b46660f4d92c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzYtNS0xLTEtNTQ3MDk4_6ee848f7-78eb-46ff-9255-e192073bbe67">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a56d790203f47048913b46660f4d92c_D20220101-20220331" decimals="3" name="ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzYtNy0xLTEtNTQ3MDk4_eac720bf-1319-4a92-b748-5e2c73db1941">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total favorable variance</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzgtMS0xLTEtNTQ3MDk4_95592f1b-8229-4e8b-8cb2-7c48c91b37b6">144</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="3" name="ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzgtMy0xLTEtNTQ3MDk4_38a1df85-d0a4-4c78-8f10-49b68a8b9491">0.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzgtNS0xLTEtNTQ3MDk4_6709686a-2322-4ed3-988e-d85946510484">276</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="3" name="ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzgtNy0xLTEtNTQ3MDk4_6fa08a57-4da4-4da1-81cf-c25687434074">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Percentage of current year incurred costs as reported for the year ended December&#160;31, 2022.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Percentage of current year incurred costs as reported for the year ended December&#160;31, 2021.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Favorable prior year development in both years reflects lower than expected utilization of medical services as compared to our assumptions.</span></div></ix:continuation><div id="id1800413722c4e30b53ad5d464cab4e8_526"></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">C.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline"><ix:continuation id="ie519410b52584384b8ded547e4c34e00" continuedAt="i276735f0a2e44a1bba8ebb844faf22e6">Future Policy Benefits</ix:continuation></span></div><ix:continuation id="i276735f0a2e44a1bba8ebb844faf22e6" continuedAt="i31fc7785a4264d02a4d1db28cc334184"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:FuturePolicyBenefitsLiabilityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzU0OTc1NTgzMTQxOA_4bf3fab3-235d-4b30-9756-a339ba61010a" continuedAt="ib7479f753d4e4c5cbf87dfecc7e388ba" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting Policy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Future policy benefits represent the present value of estimated future obligations, estimated using actuarial methods, for long-term insurance policies and annuity products currently in force, consisting primarily of reserves for annuity contracts, life insurance benefits, and certain supplemental health products that are guaranteed renewable beyond one year.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contracts are grouped at a level no higher than issue year, based on the original contract issue date, and at lower levels of disaggregation within each issue year for certain businesses to reflect factors including product type, plan type and currency. Management estimates these obligations based on assumptions for premiums, interest rates, mortality or morbidity, future claim adjudication expenses and surrenders. Mortality, morbidity and surrender assumptions are based on the Company's own experience and published actuarial tables, and are updated at least annually, to the extent changes in circumstances require. Interest rate assumptions are based on</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">market-level yields for low credit risk fixed income instruments ("upper-medium grade fixed-income instrument"). For interest accretion purposes, interest rates are fixed at the year of the cohort's inception, however for purposes of liability measurement, are updated to the current rate quarterly, with all changes in the interest rate from inception to current period reported through Accumulated other comprehensive loss. For contracts issued domestically, we use observable inputs from a published spot rate curve for terms up to <ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzQxNzgxNDQxODczMDAw_78425758-2fd4-43cb-ad7d-b1e12e771cd3">30</ix:nonNumeric> years and extrapolate for longer terms using a constant forward rate approach. For contracts issued by foreign operating entities with functional currencies other than the U.S. dollar, we use observable inputs to approximate a risk free rate and add a credit spread adjustment to align with a low credit risk fixed income instrument. For terms beyond the last observable risk free rates, which vary by international market, we extrapolate to the ultimate forward rate assuming a constant credit spread.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i31fc7785a4264d02a4d1db28cc334184" continuedAt="i3c72485d9bd04871b40e2da23ef2d2be"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ib7479f753d4e4c5cbf87dfecc7e388ba">For the annuity business, the premium paying period is shorter than the benefit coverage period, and a deferred profit liability ("DPL") is reported in future policy benefits representing gross premium received in excess of net premiums. DPL is amortized based on expected future benefit payments.</ix:continuation></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cigna Healthcare</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3Xzk1MTA3NzU1ODIwMTUy_6a03a391-4b57-4a64-b822-45ac6a740690" continuedAt="i6881fc5403ba4d49a513b185443d777c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average interest rates applied and duration for future policy benefits in the Cigna Healthcare segment, consisting primarily of supplemental health products including individual Medicare supplement, limited benefit health products and individual private medical insurance, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest accretion rate </span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTowNDBkMGJjYTAwNWY0YjE2YWUyYzcwMmRlNmE5OTc5Yy90YWJsZXJhbmdlOjA0MGQwYmNhMDA1ZjRiMTZhZTJjNzAyZGU2YTk5NzljXzItMS0xLTEtNTQ3MDk4_89f7c3de-e649-4a29-bdf9-85806c5ffa1b">2.59</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTowNDBkMGJjYTAwNWY0YjE2YWUyYzcwMmRlNmE5OTc5Yy90YWJsZXJhbmdlOjA0MGQwYmNhMDA1ZjRiMTZhZTJjNzAyZGU2YTk5NzljXzItMy0xLTEtNTQ3MDk4_9669dcb9-af07-46db-a156-31d6bf306a3f">2.64</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current discount rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTowNDBkMGJjYTAwNWY0YjE2YWUyYzcwMmRlNmE5OTc5Yy90YWJsZXJhbmdlOjA0MGQwYmNhMDA1ZjRiMTZhZTJjNzAyZGU2YTk5NzljXzMtMS0xLTEtNTQ3MDk4_a1d2a83e-3ea4-4240-9f1d-256f45dd8a9f">5.29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTowNDBkMGJjYTAwNWY0YjE2YWUyYzcwMmRlNmE5OTc5Yy90YWJsZXJhbmdlOjA0MGQwYmNhMDA1ZjRiMTZhZTJjNzAyZGU2YTk5NzljXzMtMy0xLTEtNTQ3MDk4_a10a12b7-f50d-48b6-bb19-37674b2265d5">4.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average duration </span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTowNDBkMGJjYTAwNWY0YjE2YWUyYzcwMmRlNmE5OTc5Yy90YWJsZXJhbmdlOjA0MGQwYmNhMDA1ZjRiMTZhZTJjNzAyZGU2YTk5NzljXzQtMS0xLTEtNTQ3MDk4_ecfc70f3-fd69-4d61-afe8-e44965f6a498">8.05</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTowNDBkMGJjYTAwNWY0YjE2YWUyYzcwMmRlNmE5OTc5Yy90YWJsZXJhbmdlOjA0MGQwYmNhMDA1ZjRiMTZhZTJjNzAyZGU2YTk5NzljXzQtMy0xLTEtNTQ3MDk4_fa30ad4b-7f1c-4ea9-903b-939547fb915f">7.45</ix:nonNumeric> years</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The net liability for future policy benefits for the segment's supplemental health products represents the present value of benefits expected to be paid to policyholders, net of the present value of expected net premiums, which is the portion of expected future gross premium expected to be collected from policyholders that is required to provide for all expected future benefits and expenses. <ix:continuation id="i6881fc5403ba4d49a513b185443d777c" continuedAt="i3e750a3ec8e249ef8df5843a3e4303aa">The present values of expected net premiums and expected future policy benefits for the Cigna Healthcare segment are as follows: </ix:continuation></span></div><ix:continuation id="i3e750a3ec8e249ef8df5843a3e4303aa" continuedAt="i6732a9ad64fe497f908e8d22573326d9"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:73.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.525%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Present value of expected net premiums</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzQtMS0xLTEtNTQ3MDk4_b8e58a1a-8817-41c6-a5ff-e7ba727288b8">8,557</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3314d3839844dbab40e20dd517db732_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzQtMy0xLTEtNTQ3MDk4_b75ec6ca-d92c-4903-8827-5a47066e9aa7">9,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reversal of effect of beginning of period discount rate assumptions</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzUtMS0xLTEtNTQ3MDk4_326dc799-9416-40ce-b39f-9088be41635b">1,537</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3314d3839844dbab40e20dd517db732_I20211231" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzUtMy0xLTEtNTQ3MDk4_10e5e7c0-4829-456d-800a-d090b8887d60">367</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of assumption changes and actual variances from expected experience</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzYtMS0xLTEtNTQ3MDk4_66801276-6a4d-40e0-ab19-25a44f4b9787">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3314d3839844dbab40e20dd517db732_I20211231" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzYtMy0xLTEtNTQ3MDk4_b5dd06dc-9d21-404e-827d-9de1f65dd98e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances and lapses </span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzctMS0xLTEtNTQ3MDk4_7229fe62-667b-4713-801e-f6cfa500b654">306</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzctMy0xLTEtNTQ3MDk4_7ccb69e5-3904-4800-b0b0-26b47f2e619b">143</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net premiums collected</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzgtMS0xLTEtNTQ3MDk4_b08999bf-3c5c-4901-b665-34146445a260">326</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzgtMy0xLTEtNTQ3MDk4_cf04cb45-6c4f-4ccf-8ea5-258509f01f2e">310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzktMS0xLTEtNTQ3MDk4_d8a185fb-24bd-4769-813b-ccf327a742db">56</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzktMy0xLTEtNTQ3MDk4_1b36d62f-d0f3-4e83-bc1d-90ce397ede0a">46</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance at original discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzEwLTEtMS0xLTU0NzA5OA_4e14fb6a-f69a-41f4-b085-3d97c4beee07">10,130</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzEwLTMtMS0xLTU0NzA5OA_00fa4e77-4c8e-4d49-9f1a-8f674264e396">8,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of end of period discount rate assumptions</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzExLTEtMS0xLTU0NzA5OA_a8f81ec5-c301-4a92-9b86-4049b8e888ed">1,312</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzExLTMtMS0xLTU0NzA5OA_4d98ae9f-d133-4cdc-917a-9ee0bbffb387">376</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzEyLTEtMS0xLTU0NzA5OA_b3df9be4-f9ce-4a3b-aeeb-208d7bcf56bf">8,818</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzEyLTMtMS0xLTU0NzA5OA_cb59a5d2-821f-4e78-af11-48fdea90d25c">8,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Present value of expected policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE1LTEtMS0xLTU0NzA5OA_d1d26687-a97f-4fcc-a7d6-fd93ca51fdf6">8,945</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3314d3839844dbab40e20dd517db732_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE1LTMtMS0xLTU0NzA5OA_ddfabffc-b877-40f9-8ab2-8eb482791635">9,794</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reversal of effect of discount rate assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE2LTEtMS0xLTU0NzA5OA_2fe112d5-a8f3-4edc-9aa8-56ad17b73aef">1,611</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3314d3839844dbab40e20dd517db732_I20211231" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE2LTMtMS0xLTU0NzA5OA_73bda4f9-3c97-4b40-bd7a-56df83f4ee88">379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of assumption changes and actual variances from expected experience</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE3LTEtMS0xLTU0NzA5OA_8ac22905-3420-4870-9d3f-fb2ae56bb80b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3314d3839844dbab40e20dd517db732_I20211231" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE3LTMtMS0xLTU0NzA5OA_47ec7a3e-8dc5-4fa7-b739-9a02a2889427">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances and lapses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE4LTEtMS0xLTU0NzA5OA_2256e121-255b-4fef-b238-833f68ac9c35">307</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE4LTMtMS0xLTU0NzA5OA_e6ef9865-3db4-41ee-8918-fd1c32c94855">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE5LTEtMS0xLTU0NzA5OA_764fafbd-5f00-4b31-a584-48f75fe2926f">326</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE5LTMtMS0xLTU0NzA5OA_bdb2b8d2-f416-4bbd-aa32-7bf85c7b401f">385</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIwLTEtMS0xLTU0NzA5OA_feab1ae2-f98e-414b-8b6d-1c2c1adc91c9">58</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIwLTMtMS0xLTU0NzA5OA_e0415c52-d9cc-45b7-9849-bfb3758adf0b">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance at original discount rate</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIxLTEtMS0xLTU0NzA5OA_76da9bc7-de18-48a6-991e-825791dfc2ee">10,595</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIxLTMtMS0xLTU0NzA5OA_d7bc6ab2-1574-49b5-81a8-661551497228">9,297</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of discount rate assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIyLTEtMS0xLTU0NzA5OA_ceb533c7-96d6-4abb-83f8-9d3819e62406">1,378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIyLTMtMS0xLTU0NzA5OA_b4c4bd7a-5dd4-4d9a-9357-8696321d9563">392</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIzLTEtMS0xLTU0NzA5OA_8aba3050-d1ad-4ba6-a470-8291e539fe68">9,217</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIzLTMtMS0xLTU0NzA5OA_85020a96-5194-4406-812f-0cb07193b471">8,905</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability for future policy benefits </span></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzI1LTEtMS0xLTU0NzA5OA_e30c23d1-a808-420e-843a-877a849d1ef5">399</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzI1LTMtMS0xLTU0NzA5OA_3b658f49-7cf7-4084-a229-4d00445f39cd">455</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzI2LTEtMS0xLTU0NzA5OA_277455a7-bb87-43d1-8614-5bf8327c1d43">202</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzI2LTMtMS0xLTU0NzA5OA_6a239376-84d5-4237-bb2a-c87e66b3b52c">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liability for future policy benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzI3LTEtMS0xLTU0NzA5OA_89500049-82cc-48e2-afe2-28585d5eeb3d">601</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzI3LTMtMS0xLTU0NzA5OA_c9c4047c-3257-4d63-a9ec-12bab4fb29dc">681</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes the foreign exchange rate impact of translating from transactional and functional currency to United States dollar and the impact of flooring the liability at zero. The flooring impact is calculated at the cohort level after discounting the reserves at the current discount rate.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">As of March&#160;31, 2023 and March&#160;31, 2022, respectively, undiscounted expected future gross premiums were $<ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzI3NDg3NzkwNzUzODg_fd09624f-afe6-4a7a-afce-d255cf321ab4">17.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzI3NDg3NzkwNzUzOTY_ad61f0e6-c19a-4e72-98f4-e282fad76772">13.5</ix:nonFraction> billion. As of March&#160;31, 2023 and March&#160;31, 2022, respectively, discounted expected future gross premiums were $<ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzI3NDg3NzkwNzU0ODE_559c16d5-ba3d-4ad8-afdc-6cbe70fd7ffc">12.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzI3NDg3NzkwNzU0ODk_b539c711-fd43-42bc-8d92-9a59b9d03b8e">10.7</ix:nonFraction> billion.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">As of March&#160;31, 2023 and March&#160;31, 2022, respectively, undiscounted expected future policy benefits were $<ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzI3NDg3NzkwNzU2NzQ_76985a8c-30e0-463c-bc3a-1cb32cc3ac50">12.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzI3NDg3NzkwNzU2ODI_58aacbbb-3eea-4869-86ab-a3d1eca0d547">11.2</ix:nonFraction> billion.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">The liability for future policyholder benefits includes immaterial businesses shown as reconciling items above, most of which are in run-off. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">$<ix:nonFraction unitRef="usd" contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzM5MDc_ef59845c-3a88-498d-ae0c-6a38c8c809b4">154</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzM5MTQ_5e6e3557-41da-4043-b16b-7dbdf4b30639">171</ix:nonFraction> million of reinsurance recoverable asset reported in the Consolidated Balance Sheets as of March&#160;31, 2023 and March&#160;31, 2022, respectively, relate to the liability for future policy benefits.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_529"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3c72485d9bd04871b40e2da23ef2d2be" continuedAt="iff4d7aa9d98b42e38298dc582d9d100f"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Operations</span></div><ix:continuation id="i6732a9ad64fe497f908e8d22573326d9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average interest rates applied and duration for future policy benefits in Other Operations, consisting of annuity and life insurance products, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest accretion rate </span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjkvZnJhZzphYmI3ZmI1Y2JmYmU0MDFmOTYxNTcyMDFiZjNmNjJhOC90YWJsZToyMzZhZTBjMTAyMTk0ZTZmOWJlYTA5ZWQyODE5ZDQyNS90YWJsZXJhbmdlOjIzNmFlMGMxMDIxOTRlNmY5YmVhMDllZDI4MTlkNDI1XzItMS0xLTEtNTQ3MDk4_eaaba99b-6add-43c7-9d62-96a7df12c814">5.64</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjkvZnJhZzphYmI3ZmI1Y2JmYmU0MDFmOTYxNTcyMDFiZjNmNjJhOC90YWJsZToyMzZhZTBjMTAyMTk0ZTZmOWJlYTA5ZWQyODE5ZDQyNS90YWJsZXJhbmdlOjIzNmFlMGMxMDIxOTRlNmY5YmVhMDllZDI4MTlkNDI1XzItMy0xLTEtNTQ3MDk4_e70f8788-c401-420a-b33e-2dee3062617d">5.64</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current discount rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjkvZnJhZzphYmI3ZmI1Y2JmYmU0MDFmOTYxNTcyMDFiZjNmNjJhOC90YWJsZToyMzZhZTBjMTAyMTk0ZTZmOWJlYTA5ZWQyODE5ZDQyNS90YWJsZXJhbmdlOjIzNmFlMGMxMDIxOTRlNmY5YmVhMDllZDI4MTlkNDI1XzMtMS0xLTEtNTQ3MDk4_c94dd6f4-adf9-47e0-b74e-907d69f90070">4.95</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjkvZnJhZzphYmI3ZmI1Y2JmYmU0MDFmOTYxNTcyMDFiZjNmNjJhOC90YWJsZToyMzZhZTBjMTAyMTk0ZTZmOWJlYTA5ZWQyODE5ZDQyNS90YWJsZXJhbmdlOjIzNmFlMGMxMDIxOTRlNmY5YmVhMDllZDI4MTlkNDI1XzMtMy0xLTEtNTQ3MDk4_a8e5e2f0-7964-4219-afd4-21a28eab6c64">3.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average duration </span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjkvZnJhZzphYmI3ZmI1Y2JmYmU0MDFmOTYxNTcyMDFiZjNmNjJhOC90YWJsZToyMzZhZTBjMTAyMTk0ZTZmOWJlYTA5ZWQyODE5ZDQyNS90YWJsZXJhbmdlOjIzNmFlMGMxMDIxOTRlNmY5YmVhMDllZDI4MTlkNDI1XzQtMS0xLTEtNTQ3MDk4_102f1565-eefc-44ad-8c1c-f5f75ba0645e">11.7</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjkvZnJhZzphYmI3ZmI1Y2JmYmU0MDFmOTYxNTcyMDFiZjNmNjJhOC90YWJsZToyMzZhZTBjMTAyMTk0ZTZmOWJlYTA5ZWQyODE5ZDQyNS90YWJsZXJhbmdlOjIzNmFlMGMxMDIxOTRlNmY5YmVhMDllZDI4MTlkNDI1XzQtMy0xLTEtNTQ3MDk4_dabb9b57-3484-48f7-b8e4-d76f2f543267">13.9</ix:nonNumeric> years</span></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Obligations for annuities represent discounted periodic benefits to be paid to an individual or groups of individuals over their remaining lives. Other Operations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">'</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> traditional insurance contracts, which are in run-off, have no premium remaining to be collected; therefore, future policy benefit reserves represent the present value of expected future policy benefits, discounted using the current discount rate and the remaining amortizable DPL.</span></div></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_535"></div><ix:continuation id="iff4d7aa9d98b42e38298dc582d9d100f" continuedAt="ibe682f4f60ac49b1b440b4dec7912baa"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Future policy benefits for Other Operations includes DPL of $<ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitsDeferredProfitLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUwOTk0_5277f800-aa85-43a7-98e7-73a8c276647b">392</ix:nonFraction> million as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" decimals="-6" name="ci:LiabilityForFuturePolicyBenefitsDeferredProfitLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUxMDAy_dd298733-eb55-4d9d-9ea5-bea58713287a">384</ix:nonFraction>&#160;million as of March&#160;31, 2022. Future policy benefits excluding DPL, were $<ix:nonFraction unitRef="usd" contextRef="i5db337d577d24323b93b59b505c32718_I20221231" decimals="-8" name="ci:LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUxMjA2_8765fdea-5ae3-4ac6-b5d7-527b551944d6"><ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-8" name="ci:LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUxMjA2_cb2b32a2-e143-4e4e-94cf-739d955064d5">3.2</ix:nonFraction></ix:nonFraction>&#160;billion as of both March&#160;31, 2023 and December&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" decimals="-8" name="ci:LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzM4NDgyOTA3MDA3MjE_5b1699d5-6635-4d84-836a-17eaa7b6d7b7">3.9</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="ie07ab2d445d1463d93902530db5e0775_I20211231" decimals="-8" name="ci:LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzM4NDgyOTA3MDA3Mzg_363db60a-4c86-4f6f-a123-ea45a6da5422">4.3</ix:nonFraction>&#160;billion as of March&#160;31, 2022 and December&#160;31, 2021, respectively. These balances exclude amounts classified as Liabilities of businesses held for sale of $<ix:nonFraction unitRef="usd" contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" decimals="-8" name="ci:LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUyMDI4_83bd8e0f-1ce1-422e-a4a4-48fd3e509b64">3.7</ix:nonFraction>&#160;billion as of March&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ie07ab2d445d1463d93902530db5e0775_I20211231" decimals="-8" name="ci:LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUzMzEw_37cb1063-84b7-4d85-b960-e13b33908a7e">3.8</ix:nonFraction>&#160;billion as of December&#160;31, 2021. The change in future policy benefits reserves year-to-date was primarily driven by changes in the current discount rate. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Undiscounted expected future policy benefits were $<ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUxNjc0_b8f47e94-ebf8-43f2-a0e1-1ae486d6d148">4.6</ix:nonFraction>&#160;billion as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUxNjgy_b68cf143-5062-4811-b8d6-1998e58fb15f">4.7</ix:nonFraction>&#160;billion as of March&#160;31, 2022. As of March&#160;31, 2023 and March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUyMzgz_b0a3dc69-22bb-452b-a4e8-9647267a485f">1.0</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUyMzkx_56472dbe-0bd5-4d9a-be94-3513a29efa59">1.2</ix:nonFraction>&#160;billion of the future policy benefit reserve was recoverable through treaties with external reinsurers.</span></div></ix:continuation><div id="id1800413722c4e30b53ad5d464cab4e8_538"></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt;text-decoration:underline"><ix:continuation id="ibe682f4f60ac49b1b440b4dec7912baa" continuedAt="i67bba76bbca645128d72000260100106">Contractholder Deposit Funds</ix:continuation></span></div><div><ix:continuation id="i67bba76bbca645128d72000260100106" continuedAt="i664ea13b30b941d89237ac091e8ce087"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:ContractholderDepositFundsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzgvZnJhZzowZWRhNDQyNDMzMWE0NjQxOGE2ODFmNWFmOTNkZjcxZC90ZXh0cmVnaW9uOjBlZGE0NDI0MzMxYTQ2NDE4YTY4MWY1YWY5M2RmNzFkXzU0OTc1NTgxNTI5NQ_70641201-485d-452e-9852-da4111bebd1e" continuedAt="i9c094765f15c480d95544efc5c307392" escape="true">Accounting Policy. </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i9c094765f15c480d95544efc5c307392">Liabilities for contractholder deposit funds primarily include deposits received from customers for investment-related and universal life products and investment earnings on their fund balances in Other Operations. These liabilities are adjusted to reflect administrative charges and, for universal life fund balances, mortality charges. Interest credited on these funds is accrued ratably over the contract period.</ix:continuation> </span></ix:continuation></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_544"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i664ea13b30b941d89237ac091e8ce087" continuedAt="i5c29aaba317b451c8fdb692e1713228e">Contractholder deposit fund liabilities within Other Operations were $<ix:nonFraction unitRef="usd" contextRef="i5db337d577d24323b93b59b505c32718_I20221231" decimals="-8" name="us-gaap:PolicyholderContractDeposits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDQvZnJhZzo3OTkwM2Y4NjI4MzE0NGNlODcxYTkyZGQ5OTQwNTA2My90ZXh0cmVnaW9uOjc5OTAzZjg2MjgzMTQ0Y2U4NzFhOTJkZDk5NDA1MDYzXzYw_44a221d0-8028-4ded-98e2-7e784de2dcfd"><ix:nonFraction unitRef="usd" contextRef="ie62ccc5f564845298d35afec66862cec_I20230331" decimals="-8" name="us-gaap:PolicyholderContractDeposits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDQvZnJhZzo3OTkwM2Y4NjI4MzE0NGNlODcxYTkyZGQ5OTQwNTA2My90ZXh0cmVnaW9uOjc5OTAzZjg2MjgzMTQ0Y2U4NzFhOTJkZDk5NDA1MDYzXzYw_9aa6249c-acb0-4810-bfe7-866c1f3c9dd8">6.7</ix:nonFraction></ix:nonFraction> billion as of both March&#160;31, 2023 and December&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331" decimals="-8" name="us-gaap:PolicyholderContractDeposits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDQvZnJhZzo3OTkwM2Y4NjI4MzE0NGNlODcxYTkyZGQ5OTQwNTA2My90ZXh0cmVnaW9uOjc5OTAzZjg2MjgzMTQ0Y2U4NzFhOTJkZDk5NDA1MDYzXzg3OTYwOTMwMjI5MDY_8df9100f-ba43-4459-b4d9-f9f3382b27ae">6.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ie07ab2d445d1463d93902530db5e0775_I20211231" decimals="-8" name="us-gaap:PolicyholderContractDeposits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDQvZnJhZzo3OTkwM2Y4NjI4MzE0NGNlODcxYTkyZGQ5OTQwNTA2My90ZXh0cmVnaW9uOjc5OTAzZjg2MjgzMTQ0Y2U4NzFhOTJkZDk5NDA1MDYzXzg3OTYwOTMwMjI5NDU_5d349bc8-6a4f-4fc7-bb36-c146f61f101b">6.9</ix:nonFraction> billion as of March&#160;31, 2022 and December&#160;31, 2021, respectively. Approximately <ix:nonFraction unitRef="number" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="2" name="ci:PolicyholderContractBalancePercentReinsuredExternally" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDQvZnJhZzo3OTkwM2Y4NjI4MzE0NGNlODcxYTkyZGQ5OTQwNTA2My90ZXh0cmVnaW9uOjc5OTAzZjg2MjgzMTQ0Y2U4NzFhOTJkZDk5NDA1MDYzXzU0OTc1NTgxMzk1MzQ_7ae1bf11-d1ad-48db-94b8-37f122d384a2">39</ix:nonFraction>% of the balance is reinsured externally. Activity in these liabilities is presented net of reinsurance in the Consolidated Statements of Cash Flows. The net year-to-date decrease in contractholder deposit fund liabilities generally relates to withdrawals and benefit payments from contractholder deposit funds, partially offset by deposits and interest credited to contractholder deposit funds.</ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_547"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i5c29aaba317b451c8fdb692e1713228e" continuedAt="i4a3c270395b442bdafbbeb7379d123eb">As of March&#160;31, 2023, the weighted average crediting rate, net amount at risk and cash surrender value for contractholder deposit fund liabilities not externally reinsured were <ix:nonFraction unitRef="number" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="4" name="us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzE3MA_8f9ec00b-9cdb-4d53-b199-c4043ea47e30">3.25</ix:nonFraction>%, $<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-8" name="us-gaap:PolicyholderAccountBalanceNetAmountAtRisk" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzE3NA_8da4a7a3-120d-4541-8cf1-f0d0b4dec688">3.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-8" name="us-gaap:CashSurrenderValueDuePolicyholdersAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzE4MQ_815057b2-5c64-4fd7-b9b4-0422625dc6eb">2.8</ix:nonFraction> billion, respectively. The comparative amounts as of March&#160;31, 2022 were <ix:nonFraction unitRef="number" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="4" name="us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzIzNw_119f3425-0905-402b-9147-bc65f1e285e0">3.18</ix:nonFraction>%, $<ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-8" name="us-gaap:PolicyholderAccountBalanceNetAmountAtRisk" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzI0MQ_86779f80-d528-420b-b7b1-f7714c2399a3">3.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-8" name="us-gaap:CashSurrenderValueDuePolicyholdersAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzI0OA_54ead027-6e20-4632-b426-02c5e14b65d0">2.9</ix:nonFraction> billion, respectively. As of both March 31, 2023 and March 31, 2022, more than <ix:nonFraction unitRef="number" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="2" name="ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzI3Ng_32693699-e74e-404b-98f1-e84699682b31"><ix:nonFraction unitRef="number" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="2" name="ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzI3Ng_d8743bd4-9b52-462f-b98a-b1e8cae8d844">99</ix:nonFraction></ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="i473b5ac171fe47d1b52a690302b8557d_I20220331" decimals="-8" name="us-gaap:PolicyholderFunds" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzI4Mg_ad14ef04-f1b0-4ed9-a558-8f240246b4f9"><ix:nonFraction unitRef="usd" contextRef="ia0a2caf1b06d407cb66dd5cc1db191bc_I20230331" decimals="-8" name="us-gaap:PolicyholderFunds" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzI4Mg_b1094706-b8c3-41c3-bc40-6bb2d3eef604">4.1</ix:nonFraction></ix:nonFraction> billion liability not reinsured externally is for contracts with guaranteed interest rates of <ix:nonFraction unitRef="number" contextRef="id5e56cac561c4deaa30c887f1b7ca3b8_I20230331" decimals="2" name="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditRating" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzM3OA_52a949fe-286b-4abe-a1f2-317a63cc9b79"><ix:nonFraction unitRef="number" contextRef="id78aeb82d8af4ed7bfd1cfe99bf87fa7_I20220331" decimals="2" name="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditRating" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzM3OA_97db19b1-36e9-4c95-ac84-80f25a54b0f4">3</ix:nonFraction></ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i06c863b5932f4981934aca0c04125d8c_I20230331" decimals="2" name="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditRating" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzM4Mw_35ec5978-e1e4-4daa-b4c9-415ee0b9e3fb"><ix:nonFraction unitRef="number" contextRef="i4c0f09cba3a64073b1bafdd99ecce319_I20220331" decimals="2" name="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditRating" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzM4Mw_606e8b25-fc5d-44b4-b393-4b27371c2358">4</ix:nonFraction></ix:nonFraction>%, and approximately $<ix:nonFraction unitRef="usd" contextRef="icbf37f4fce204b8e884d185c87969b4b_I20220331" decimals="-8" name="us-gaap:PolicyholderFunds" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzQwNQ_4d8c956a-ccbc-471e-b251-b555fd71ac0b"><ix:nonFraction unitRef="usd" contextRef="if5e93c29f2c5415ea367dd5375f9e1f7_I20230331" decimals="-8" name="us-gaap:PolicyholderFunds" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzQwNQ_f6a662ac-7866-4449-aec1-80d4f5cb5f9f">1.2</ix:nonFraction></ix:nonFraction> billion represented contracts with policies at the guarantee. At both of these same period ends, $<ix:nonFraction unitRef="usd" contextRef="id7558e0f62de4d41b5896e38c58e6285_I20220331" decimals="-8" name="us-gaap:PolicyholderFunds" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzQ2OA_8e52ef93-5789-4252-ae8c-a38622008dc1"><ix:nonFraction unitRef="usd" contextRef="i738906a5eed64e83ba37b8588bebd0dd_I20230331" decimals="-8" name="us-gaap:PolicyholderFunds" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzQ2OA_d520f7bf-2a4f-4cf1-94c7-9c134ba72afe">1.2</ix:nonFraction></ix:nonFraction> billion was 50-150 bps above the guarantee and the remaining $<ix:nonFraction unitRef="usd" contextRef="ieb0a38d6988945d98411fa2cfb859c04_I20220331" decimals="-8" name="us-gaap:PolicyholderFunds" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzUyNw_31c519fd-c0cc-46ff-89ac-195dd63a5499"><ix:nonFraction unitRef="usd" contextRef="ifef5e98d887a4bb79bae5426330ad2b3_I20230331" decimals="-8" name="us-gaap:PolicyholderFunds" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzUyNw_e98ab20f-911d-466f-98af-766e8cad7778">1.7</ix:nonFraction></ix:nonFraction> billion represented contracts above the guarantee that pay the policyholder based on the greater of a guaranteed minimum cash value or the actual cash value. More than <ix:nonFraction unitRef="number" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="2" name="ci:PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzY5Ng_7f96b53c-0a17-49cd-b6fb-809b2c5e7ed1"><ix:nonFraction unitRef="number" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="2" name="ci:PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzY5Ng_8c8cc0c4-2d72-4f83-a120-2b2c86855ca0">90</ix:nonFraction></ix:nonFraction>% of these contracts have actual cash values of at least 110% of the guaranteed cash value.</ix:continuation></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_550"></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.84pt;text-decoration:underline"><ix:continuation id="i4a3c270395b442bdafbbeb7379d123eb" continuedAt="ide5ee6269cb14b4697a74fdd1f6d6b84">Market Risk Benefits</ix:continuation></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ide5ee6269cb14b4697a74fdd1f6d6b84" continuedAt="i50cf28e39b23414280c8dd514b022623">Liabilities for market risk benefits consist of variable annuity reinsurance contracts (also referred to as GMDB and GMIB contracts) in Other Operations. These liabilities arise under annuities and riders to annuities written by ceding companies that guarantee the benefit received at death and, for a subset of policies, also provide contractholders the option, within <ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:AnnuitizationElectionPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTAvZnJhZzplNDk1Nzc3NGE3ZmE0MDY2OTAxZjBmZGNhMDI2NmQxNC90ZXh0cmVnaW9uOmU0OTU3Nzc0YTdmYTQwNjY5MDFmMGZkY2EwMjY2ZDE0XzQxNzgxNDQxODYyMTEz_d89424b4-100d-481c-93cd-ea143fd7a0ae">30</ix:nonNumeric> days of a policy anniversary after the appropriate waiting period, to elect minimum income payments. The Company's capital market risk exposure on variable annuity reinsurance contracts arises when the reinsured guaranteed minimum benefit exceeds the contractholder's account value in the related underlying mutual funds at the time the insurance benefit is payable under the respective contract. The Company receives and pays premium periodically based on the terms of the reinsurance agreements.</ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_5745"></div><div><ix:continuation id="i50cf28e39b23414280c8dd514b022623" continuedAt="i2165988238dd47ca9e848fcd1ac9ba30"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:MarketRiskBenefitPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzQ1L2ZyYWc6Mzk4ZTNiNTBiODk1NGM2OTg4Y2YxNDQ2NDA2OTE4OWYvdGV4dHJlZ2lvbjozOThlM2I1MGI4OTU0YzY5ODhjZjE0NDY0MDY5MTg5Zl81NDk3NTU4MTc1MjE_280083a7-b7d3-4ecb-b6fe-6c301b66d1b7" continuedAt="ic547752f9ba6479f9179f75b6196ff82" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting Policy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Variable annuity reinsurance liabilities are measured as MRBs at fair value, net of nonperformance risk, with fluctuations in value gross of reinsurer nonperformance risk reported in benefits expense while fluctuations in the Company's own </span></ix:nonNumeric></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i2165988238dd47ca9e848fcd1ac9ba30" continuedAt="i17f4c87232094809a40aba0ee71ccfa5"><ix:continuation id="ic547752f9ba6479f9179f75b6196ff82">nonperformance risk (own credit risk) are reported in Accumulated other comprehensive loss. Nonperformance risk reflects risk that a party might default and therefore not fulfill its obligations (i.e. nonpayment risk). The nonperformance risk adjustment reflects a market participant's view of nonpayment risk by adding an additional spread to the discount rate in the calculation of both (a) the variable annuity reinsurance liabilities to be paid by the Company and (b) the variable annuity reinsurance assets to be paid by the reinsurers, after considering collateral. The Company classifies variable annuity assets and liabilities in Level 3 of the fair value hierarchy described in Note 12 to the Consolidated Financial Statements because assumptions related to future annuitant behavior are largely unobservable. As discussed further in Note 10 to the Consolidated Financial Statements, due to the reinsurance agreements covering these liabilities, the liabilities do not generally impact net income except for the change in nonperformance risk on the reinsurance recoverable, which is reported in benefits expense and does not offset the nonperformance risk valuation on the liability. Variable annuity liabilities are established using capital market assumptions and assumptions related to future annuitant behavior (including mortality, lapse and annuity election rates).</ix:continuation> </ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_556"></div><div><ix:continuation id="i17f4c87232094809a40aba0ee71ccfa5" continuedAt="i9f725cc9f3424bdea3da0e489af33174"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:MarketRiskBenefitActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90ZXh0cmVnaW9uOmE0MGNhMjViNzMwOTQyMDQ4ZjY5NDAwOTgwNmFjMWM4Xzk2MjA3MjY3NDMyMzIw_0cc75045-b3a0-4b01-96fc-e249633a2723" continuedAt="i259ce37fe9844ee2a68ca2f58c8ccdef" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Market risk benefits activity was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:74.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">March 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, beginning of year</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzItMS0xLTEtNTc2NTE4_9bbd06b1-431d-4185-9da2-ec6b0b5b63ed">1,268</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="ieb159500cff1416584b25f65dcff1e94_I20211231" decimals="-6" name="us-gaap:MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzItMi0xLTEtNTc2NDcx_b7c5d17b-85b0-4b34-aea7-580ce7cb1202">1,824</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, beginning of year, before the effect of nonperformance risk (own credit risk)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzMtMS0xLTEtNTc2NTE4_edc29f1d-01c3-4cce-a8de-584d3bf05643">1,379</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="ieb159500cff1416584b25f65dcff1e94_I20211231" decimals="-6" name="us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzMtMi0xLTEtNTc2NDcx_57f117d7-a26e-45bf-bfda-5802f3b29efd">1,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Changes due to expected run-off</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzQtMS0xLTEtNTc2NTE4_0516c645-7fae-4090-af63-4c666a82a399">6</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzQtMi0xLTEtNTc2NDcx_f5f31507-3ad7-48e9-b1e6-4633d80727fa">19</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Changes due to capital markets versus expected</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzUtMS0xLTEtNTc2NTE4_000f96b2-425a-4122-9136-093b3071f328">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzUtMi0xLTEtNTc2NDcx_818b681c-b083-4d88-a262-41be0339c327">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Changes due to policyholder behavior versus expected</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzYtMS0xLTEtNTc2NTE4_8d843920-d1c7-4e4f-99a7-ee18c6360067">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzYtMi0xLTEtNTc2NDcx_2b37aad3-f4ec-449a-8ca2-b394a98adc85">9</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Assumption changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:MarketRiskBenefitIncreaseDecreaseFromOtherAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzctMS0xLTEtNTc2NTE4_17297b5a-9e93-42d3-9b34-d028a1f5592d">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:MarketRiskBenefitIncreaseDecreaseFromOtherAssumption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzctMi0xLTEtNTc2NDcx_240c8809-20dc-48b6-aa97-f12037cf42e4">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, end of year, before the effect of changes in nonperformance risk (own credit risk)</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzgtMS0xLTEtNTc2NDcx_4dcfecc9-7edc-40df-8757-96ff2f74fbcf">1,305</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzgtMi0xLTEtNTc2NDcx_edd2e794-0a2f-4a40-9413-9b2880ac2f12">1,689</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Nonperformance risk (own credit risk), end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzktMS0xLTEtNTc2NTE4_1bac2e81-139c-4afd-a394-3e1834260d50">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzktMi0xLTEtNTc2NDcx_9660f6eb-da11-452c-9e5c-2f07191e5c6c">131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, end of period</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzEwLTEtMS0xLTU3NjQ3MQ_dc9aaebf-5737-4ff9-93d7-931206cd302a">1,220</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="us-gaap:MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzEwLTItMS0xLTU3NjQ3MQ_2a65a498-c42f-4467-be66-2f8d3363cbe7">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Reinsured market risk benefit, end of period</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzExLTEtMS0xLTU3NjUxOA_055d44c9-54d9-4da1-82f7-f167d6d2da4b">1,301</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="ic71911f816574fdb881509b52a744fc9_I20220331" decimals="-6" name="us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzExLTItMS0xLTU3NjQ3MQ_3ec60296-2204-4030-8dd6-a09bdf29db68">1,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></ix:continuation></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_559"></div><ix:continuation id="i9f725cc9f3424bdea3da0e489af33174"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTkvZnJhZzoyYjM0YzE2MWM0NTc0ZGZmYjRmNDg5NWFhMTFlOWI1OS90ZXh0cmVnaW9uOjJiMzRjMTYxYzQ1NzRkZmZiNGY0ODk1YWExMWU5YjU5Xzk2MjA3MjY3NDMzNDQ2_962b08e3-0216-45d4-8ca9-d853dfc83543" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the net amount at risk and the average attained age of contractholders (weighted by exposure) for contracts assumed by the Company. The net amount at risk is the amount the Company would have to pay to contractholders if all deaths or annuitizations occurred as of the earliest possible date in accordance with the insurance contract. The Company should be reimbursed in full for these payments unless the Berkshire reinsurance limit is exceeded, as discussed further in Note 10 to the Consolidated Financial Statements.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions, excludes impact of reinsurance ceded)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net amount at risk</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib570f0c807bc458bb372ecd4c53d8d16_I20230331" decimals="-6" name="us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTkvZnJhZzoyYjM0YzE2MWM0NTc0ZGZmYjRmNDg5NWFhMTFlOWI1OS90YWJsZTpmMjQ4MTk2OGFjZmI0MTdiYTQzN2MyMzZkMDUwODM0Zi90YWJsZXJhbmdlOmYyNDgxOTY4YWNmYjQxN2JhNDM3YzIzNmQwNTA4MzRmXzItMS0xLTEtNTQ3MDk4_9bbfed7f-4f0c-4837-a975-c9b5ad209b6b">2,183</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6d884b55ec4e72892c2a763b882366_I20220331" decimals="-6" name="us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTkvZnJhZzoyYjM0YzE2MWM0NTc0ZGZmYjRmNDg5NWFhMTFlOWI1OS90YWJsZTpmMjQ4MTk2OGFjZmI0MTdiYTQzN2MyMzZkMDUwODM0Zi90YWJsZXJhbmdlOmYyNDgxOTY4YWNmYjQxN2JhNDM3YzIzNmQwNTA4MzRmXzItMy0xLTEtNTQ3MDk4_c882c238-5cf0-4ee6-a6df-119e1b5c7b91">1,892</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average attained age of contractholders (weighted by exposure)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifc70e358d2cd4b0ea0945ae4e8b52dff_D20230101-20230331" name="us-gaap:NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTkvZnJhZzoyYjM0YzE2MWM0NTc0ZGZmYjRmNDg5NWFhMTFlOWI1OS90YWJsZTpmMjQ4MTk2OGFjZmI0MTdiYTQzN2MyMzZkMDUwODM0Zi90YWJsZXJhbmdlOmYyNDgxOTY4YWNmYjQxN2JhNDM3YzIzNmQwNTA4MzRmXzMtMS0xLTEtNTQ3MDk4_48ddde58-b643-4812-8c43-6311d96cb329">75.4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ica8c06a177734445979e540fbc4f756d_D20220101-20220331" name="us-gaap:NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTkvZnJhZzoyYjM0YzE2MWM0NTc0ZGZmYjRmNDg5NWFhMTFlOWI1OS90YWJsZTpmMjQ4MTk2OGFjZmI0MTdiYTQzN2MyMzZkMDUwODM0Zi90YWJsZXJhbmdlOmYyNDgxOTY4YWNmYjQxN2JhNDM3YzIzNmQwNTA4MzRmXzMtMy0xLTEtNTQ3MDk4_6f62d4e5-6da7-4d7f-869b-8615ac93261d">76.4</ix:nonNumeric> years</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_562"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:ReinsuranceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NjIvZnJhZzo2NmZkMzg3YjZjNjk0NDhlYmNlZjM3MGNlZGM3MzNkMi90ZXh0cmVnaW9uOjY2ZmQzODdiNmM2OTQ0OGViY2VmMzcwY2VkYzczM2QyXzYyNg_6f790e66-0863-4ba3-9172-0afa9c87c910" continuedAt="i73ce06dd53be465a9c6d5bfe7257f303" escape="true"><div style="margin-bottom:10pt"><span id="i66fd387b6c69448ebcef370cedc733d2_623"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 10 &#8211; Reinsurance</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i57f1ab2321104b06a53e42521f48d5e7" continuedAt="if79dc0e8e53643dabb43f80be4984d3b">The Company's insurance subsidiaries enter into agreements with other insurance companies to limit losses from large exposures and to permit recovery of a portion of incurred losses. Reinsurance is ceded primarily in acquisition and disposition transactions when the underwriting company is not being acquired. Reinsurance does not relieve the originating insurer of liability. Therefore, reinsured liabilities must continue to be reported along with the related reinsurance recoverables. The Company regularly evaluates the financial condition of its reinsurers and monitors concentrations of its credit risk.</ix:continuation></span></div></ix:nonNumeric><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_565"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt;text-decoration:underline"><ix:continuation id="i73ce06dd53be465a9c6d5bfe7257f303" continuedAt="i79e401cb4acc42ef931398d4ddc9d5ef">Reinsurance Recoverables</ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_574"></div><ix:continuation id="i79e401cb4acc42ef931398d4ddc9d5ef" continuedAt="i79094421cc874bc3b52b1a56cfcb7894"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The majority of the Company's reinsurance recoverables resulted from acquisition and disposition transactions in which the underwriting company was not acquired. The Company bears the risk of loss if its reinsurers and retrocessionaires do not meet or are unable to meet their reinsurance obligations to the Company. <ix:continuation id="if79dc0e8e53643dabb43f80be4984d3b" continuedAt="i8428267ab3224d14ae250495b980370a">The Company reviews its reinsurance arrangements and establishes reserves against the recoverables.</ix:continuation></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></ix:continuation><div id="id1800413722c4e30b53ad5d464cab4e8_577"></div><ix:continuation id="i79094421cc874bc3b52b1a56cfcb7894" continuedAt="i53ea90e1005b425b839ed4065cc1f744"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90ZXh0cmVnaW9uOmUyYjFjMDY3NTFlODQ3ZTc5OWJjZDJhZjNlMjI2OTViXzc1MA_6a5e0dfb-37d8-4830-a8b7-7df1597ea309" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's reinsurance recoverables as of March&#160;31, 2023 are presented at amount due by range of external credit rating and collateral level in the following table, with reinsurance recoverables that are market risk benefits separately presented at fair value:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Fair value of collateral contractually required to meet or exceed carrying value of recoverable</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Collateral provisions exist that may mitigate risk of credit loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">No collateral</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ongoing Operations</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">A- equivalent and higher current ratings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d661611097476d8854fab93897521d_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzItMi0xLTEtNTQ3MDk4_504f63ae-d473-48b1-9620-0f0cefa7aad5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7177e4ee9a5c4f679379c6951ad9f6f7_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzItNC0xLTEtNTQ3MDk4_2d6a6239-2f17-479c-8482-79a13b843145">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a1939888a3f4aeba81ff8cbc1ac2f55_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzItNi0xLTEtNTQ3MDk4_449a54fe-b367-4e71-8170-e56c1eef405a">94</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i780ea719429c4f5cb4d6a43778d44e51_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzItOC0xLTEtNTQ3MDk4_ef41c16b-28a2-44ee-9899-adac5549a901">94</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">BBB- to BBB+ equivalent current credit ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia10fa22d1a0e4292823f2466bb3ac18a_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzMtMi0xLTEtNTQ3MDk4_830d7d30-d5dc-482b-bed8-25c847604514">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04eae3ae08ff4a07bf7a9b55fc3507d2_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzMtNC0xLTEtNTQ3MDk4_74f877af-b449-4ef6-8b2a-f935448f82c0">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9388bcc230334c26b5f9322df9d8591c_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzMtNi0xLTEtNTQ3MDk4_eada4234-ce26-4733-9cda-6c41808b71b7">59</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24318b9a944f4a469e7a3f8caa0b899c_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzMtOC0xLTEtNTQ3MDk4_383d396d-0a43-47c6-a52c-7665655a6839">59</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not rated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be26d0bc42043479ce8c2aef240151d_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzQtMi0xLTEtNTQ3MDk4_128d4ecf-fe7a-4f69-bfce-4cb6f3e3c8ee">142</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b0de1554c74c03ad99462fed6a95b3_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzQtNC0xLTEtNTQ3MDk4_40a9d135-43b2-4420-96a9-af73433ee74a">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89103ff921074d9f97701ff931699e77_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzQtNi0xLTEtNTQ3MDk4_1a5ccf07-9d8a-4150-baf1-e78a668d8be8">63</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63373aa6dda746ada1c737d9b67a0111_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzQtOC0xLTEtNTQ3MDk4_5e4f8221-632a-41cc-acc9-4e3b5c9d3ef4">210</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total recoverables related to ongoing operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b5560c0ea484a0f968eb97de6b00cf7_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzUtMi0xLTEtNTQ3MDk4_2e0524f5-b6e9-49ae-a660-213c548e6330">142</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa79a53adb54371bdf95c80bb23094d_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzUtNC0xLTEtNTQ3MDk4_197c518e-53c9-4c98-b52b-d83c3422f8c7">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8581a4b7b794c4faf53cae6809eec3d_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzUtNi0xLTEtNTQ3MDk4_d36b2dfd-b03a-4ae1-a2b5-232cfb6ae1a0">216</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7018a961b27d4b63814f4c220228acd0_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzUtOC0xLTEtNTQ3MDk4_22e690ba-f66b-461e-b282-99f9a40f4920">363</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquisition, disposition or run-off activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BBB+ equivalent and higher current ratings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lincoln National Life and Lincoln Life &amp; Annuity of New York</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if29f75017f4f4bb0a8b89780edfbb7d9_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzgtMi0xLTEtNTQ3MDk4_fbf094c9-0e09-490f-aeb4-abc8abbaea01">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1fb483551e4be28ea7d121f976ed2f_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzgtNC0xLTEtNTQ3MDk4_ea344f53-3835-4550-be68-11e1e219f376">2,750</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b1a96c7936742f1ba643f3f3ec01c9a_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzgtNi0xLTEtNTQ3MDk4_4b36713d-9838-4525-8483-cc8b9f64dc9f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b1549db8444e2797ebd89df1ce900e_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzgtOC0xLTEtNTQ3MDk4_7dd6b4ed-62f5-4069-bc22-76dcacd655a3">2,750</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Empower Annuity Insurance Company</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a5f607d270f47999ff876f8ac44a118_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEwLTItMS0xLTU0NzA5OA_5a098f10-b5fd-4e16-9013-2cc51dbd1412">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34b462c128a4ea8b60fe20ba370c163_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEwLTQtMS0xLTU0NzA5OA_45df7e4d-e847-4377-8478-86fd9baa6a16">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e4431aa2e584220a1f57a7dccc10533_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEwLTYtMS0xLTU0NzA5OA_be6f64a4-2df1-4e6a-bd3a-150c810ab65a">133</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedcac50b09424b1aa432ff4b96017412_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEwLTgtMS0xLTU0NzA5OA_2210cc89-c6a8-49e4-a90f-91ed5545640a">133</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prudential Insurance Company of America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fd2fee2cdaf404fa42202dda7b39b0d_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzExLTItMS0xLTU0NzA5OA_dd42c205-d5fd-4064-b825-6e68c6602e0f">380</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4941e338d0b4e0b8e6d69cfd7dde626_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzExLTQtMS0xLTU0NzA5OA_0ac99748-a8be-40df-8f26-2f6b0eec81d3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c41111216894d92a04d6b36cddf134f_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzExLTYtMS0xLTU0NzA5OA_3c8dbec0-ec62-4ace-b2b4-c98102cda92a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12710504ce2d46fcb5c81a1e9c69a306_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzExLTgtMS0xLTU0NzA5OA_1f8b7ef5-8e1b-402b-8d6c-c8bd2843086e">380</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Life Insurance Company of North America</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11dc2245009f49c584be01347c7fdde9_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEyLTItMS0xLTU0NzA5OA_190f15ad-77d1-4803-a7c5-6556478c79d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de558709bb64232bfbbe65efd501378_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEyLTQtMS0xLTU0NzA5OA_9d529333-b348-4698-be48-b6adaaa1a796">386</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3083d42461248ae9fa7521f47d83dcf_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEyLTYtMS0xLTU0NzA5OA_634ce9d4-31f9-4c86-84b1-b478ccd4ced3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c45fc7e2545455c909e8f4c5d88874b_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEyLTgtMS0xLTU0NzA5OA_e179582f-a1e0-4cd9-8aba-358260090bde">386</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i454476c483c445ca9cee416255427da7_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEzLTItMS0xLTU0NzA5OA_f1c61255-be00-4843-90e7-741ca2d5a4ea">187</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf1c5ed75d824327908e9fac5f4b684c_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEzLTQtMS0xLTU0NzA5OA_13fd995d-d107-47b4-8830-c7d8a8ae6cdc">25</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c13b36393fe4c24a2b794f5f3cd158e_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEzLTYtMS0xLTU0NzA5OA_9a326da5-3a4d-4134-9765-02fb699781cb">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14769193c2c44d64b974d678e97f5a09_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEzLTgtMS0xLTU0NzA5OA_a5448f77-f0d7-421a-8b8c-f28f634f0e28">227</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not rated</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01894bb31a3496e95680d18ead03b0a_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE1LTItMS0xLTU0NzA5OA_b18088f2-e07c-4884-934f-2075567fa845">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ee2dd01b1f0498e93bcd1ddbe776129_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE1LTQtMS0xLTU0NzA5OA_7710f68f-0e81-4d9f-a56e-92b93c423ad8">9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i524a1762651448f19786403decb53347_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE1LTYtMS0xLTU0NzA5OA_3a62b783-ebe3-4be7-89d2-17e5b4d87207">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f3744507dd4c6dbd6080857f121446_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE1LTgtMS0xLTU0NzA5OA_5af190d6-c6b5-4e29-aa18-f23b00147859">12</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total recoverables related to acquisition, disposition or run-off activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7992aeade34b40958cdbbd41e22d97c6_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE2LTItMS0xLTU0NzA5OA_73a92c9a-ec49-4974-abff-937fdbf417bc">567</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4968b18fb541b9a5883c174de67fc1_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE2LTQtMS0xLTU0NzA5OA_256d68f0-53f7-4d94-a2bd-8f71552bc4f5">3,170</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b71494c09c24a38b31d30590816b909_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE2LTYtMS0xLTU0NzA5OA_fc27d909-d667-4b06-abcd-b888ae91feaf">151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9ecf64e8fc403ea59b7253fb207588_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE2LTgtMS0xLTU0NzA5OA_ca958eab-5488-4d94-a12e-55f7434397cb">3,888</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total reinsurance recoverables before market risk benefits</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412908e744344c22a44e310a933e677e_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE3LTItMS0xLTU0NzA5OA_3a91e77f-de7f-4f56-8a51-45c3033f5548">709</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb4d443a88b4c8a801ccccb711a03ea_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE3LTQtMS0xLTU0NzA5OA_36a94361-2c2a-441d-afc3-680a0fdc319e">3,175</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5fc53d0faf24ca488cf6251cc8e3cd9_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE3LTYtMS0xLTU0NzA5OA_9602062e-6e9b-4088-a9df-c13a6596c81c">367</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE3LTgtMS0xLTU0NzA5OA_6cfefbac-8dbd-40e7-b0e5-f1c10f6916f7">4,251</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allowance for uncollectible reinsurance</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE4LTgtMS0xLTU0NzA5OA_a66aafe7-4582-4b61-b354-f9b87f30ec66">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market risk benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE5LTgtMS0xLTU4NzQyOQ_aabdb55e-ee88-4eb8-8e6c-2855e91e91aa">1,301</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total reinsurance recoverables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE5LTgtMS0xLTU0NzA5OA_038e267e-c717-4493-84dd-65b069fbfee8">5,517</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Certified by a Nationally Recognized Statistical Rating Organization ("NRSRO").</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes $<ix:nonFraction unitRef="usd" contextRef="ide82cffd58fc4bd9a6a046a625886af2_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverablesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90ZXh0cmVnaW9uOmUyYjFjMDY3NTFlODQ3ZTc5OWJjZDJhZjNlMjI2OTViXzI0Ng_9a7d2d2e-6adc-4976-8055-b80e4700d091">231</ix:nonFraction> million of current reinsurance recoverables that are reported in Other current assets.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes collateral provisions requiring the reinsurer to fully collateralize its obligation if its external credit rating is downgraded to a specified level.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Total Berkshire and certain Other recoverables reflected under acquisition, disposition or run-off activities in the Company's 2022 Form 10-K that relate to the Company&#8217;s variable annuity reinsurance products discussed in section B below are now reported at fair market value as MRBs, as further discussed in Note 9 to the Consolidated Financial Statements. At December&#160;31, 2022, we reported $<ix:nonFraction unitRef="usd" contextRef="i4f712834ae454cc19bd99506f5b35f37_I20221231" decimals="-6" name="us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90ZXh0cmVnaW9uOmUyYjFjMDY3NTFlODQ3ZTc5OWJjZDJhZjNlMjI2OTViXzU0OTc1NTgxOTM5NQ_91dc5104-9cb8-403d-a263-90fbef802bc6">711</ix:nonFraction> million related to these recoverables related to the GMDB variable annuity reinsurance product. The restated December&#160;31, 2022 variable annuity reinsurance recoverable balance is $<ix:nonFraction unitRef="usd" contextRef="iffb569d2047445a09609c8caab034843_I20221231" decimals="-8" name="us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90ZXh0cmVnaW9uOmUyYjFjMDY3NTFlODQ3ZTc5OWJjZDJhZjNlMjI2OTViXzU0OTc1NTgxOTQwMQ_e520424e-b16c-4e7d-ac44-3dcefa012972">1.4</ix:nonFraction> billion, which also includes the GMIB variable annuity reinsurance product that was classified in Other assets prior to the adoption of LDTI.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i8428267ab3224d14ae250495b980370a">Collateral levels are defined internally based on the fair value of the collateral relative to the carrying amount of the reinsurance recoverable, the frequency at which collateral is required to be replenished and the potential for volatility in the collateral's fair value.</ix:continuation></span></div></ix:continuation><div style="margin-bottom:1pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_583"></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.84pt;text-decoration:underline"><ix:continuation id="i53ea90e1005b425b839ed4065cc1f744" continuedAt="i179ff55d43b7445d86e57ef211f0fa45">Effective Exit of Variable Annuity Reinsurance Business</ix:continuation></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i179ff55d43b7445d86e57ef211f0fa45" continuedAt="i5813917aa5244f48a3d083c0506ceacb">The Company entered into an agreement with Berkshire to effectively exit the variable annuity reinsurance business via a reinsurance transaction in 2013. Variable annuity contracts are accounted for as assumed and ceded reinsurance and categorized as market risk </ix:continuation></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i5813917aa5244f48a3d083c0506ceacb" continuedAt="idfefb52772044bf2a9ea7fbdc456dfa4">benefits as discussed in Note 9 to the Consolidated Financial Statements. Berkshire reinsured <ix:nonFraction unitRef="number" contextRef="ia933eb83cc3d4717aa4b14ae0603c0cc_I20230331" decimals="INF" name="ci:CededReinsuranceAgreementReinsuredRiskPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODMvZnJhZzo2NTI4ZTdiZTU5NTI0ZmZhYjQ0MjhkZjc3MDk1ZGUwYS90ZXh0cmVnaW9uOjY1MjhlN2JlNTk1MjRmZmFiNDQyOGRmNzcwOTVkZTBhXzIwNg_6c63f176-5298-412b-8a81-001ea5032d21">100</ix:nonFraction>% of the Company's future cash flows in this business, net of other reinsurance arrangements existing at that time. The reinsurance agreement is subject to an overall limit with approximately $<ix:nonFraction unitRef="usd" contextRef="ia933eb83cc3d4717aa4b14ae0603c0cc_I20230331" decimals="-8" name="ci:CededReinsuranceAgreementCoverageLimitAmountRemaining" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODMvZnJhZzo2NTI4ZTdiZTU5NTI0ZmZhYjQ0MjhkZjc3MDk1ZGUwYS90ZXh0cmVnaW9uOjY1MjhlN2JlNTk1MjRmZmFiNDQyOGRmNzcwOTVkZTBhXzQwMw_acf7f17d-e983-4bee-bdd7-a18041e9eb5d">3.1</ix:nonFraction> billion remaining at March&#160;31, 2023. As a result of the reinsurance transaction, reserve increases are offset by a corresponding increase in the recorded reinsurance recoverable, provided the increased recoverable remains within the overall Berkshire limit.</ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_616"></div><ix:continuation id="idfefb52772044bf2a9ea7fbdc456dfa4"><ix:continuation id="i259ce37fe9844ee2a68ca2f58c8ccdef"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.432%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Collateral and Other Terms at March&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berkshire</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia933eb83cc3d4717aa4b14ae0603c0cc_I20230331" decimals="-6" name="ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzItNC0xLTEtNTQ3MDk4_67dc1566-a866-4965-b4b5-14c18b1cfb7a">1,043</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e7f3a48f7c442e2a74854517e46d848_I20221231" decimals="-6" name="ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzItNi0xLTEtNTQ3MDk4_c0776355-32bc-4d8f-a43e-9ec1cce089d8">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ab9b6688ad640f6bddb9c9f39e1b287_D20230101-20230331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzItOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246OTFiZDNhYzNiN2E2NDhjNDg4MjM3NGM5ZTUzYWIzYTVfNA_b08f653d-e628-4ac7-a723-05ff9fba48d2">90</ix:nonFraction>% were secured by assets in a trust.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sun Life Assurance Company of Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib58c428a8e7841c4b87ec82e8a298b2c_I20230331" decimals="-6" name="ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzMtNC0xLTEtNTQ3MDk4_356da99a-ae8f-4463-adbb-456f16e63774">117</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e422e0176b14d37a373faa93a5ef72e_I20221231" decimals="-6" name="ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzMtNi0xLTEtNTQ3MDk4_2672545d-aeae-44ee-896c-a3f7880b2933">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liberty Re (Bermuda) Ltd.</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c53eb427a65420e90086c325382b3c6_I20230331" decimals="-6" name="ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzQtNC0xLTEtNTQ3MDk4_4ca101c3-57f2-40f3-a8c9-3a47859005ae">128</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a0c523a4d649ed9576b306aa61bf9d_I20221231" decimals="-6" name="ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzQtNi0xLTEtNTQ3MDk4_74e7abf6-4073-425b-abe8-2ea261524bc4">128</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d00cd3a880946819131992a6001d101_D20230101-20230331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzQtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246YWVmZDI2ZTNmN2Q2NDA1MmE1YWYzYTEwMGY5NTcwM2NfNA_4598d0fe-ebf3-4f4b-a33f-c44d45e8a7bf">100</ix:nonFraction>% were secured by assets in a trust.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SCOR SE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ea827e8736f47cdac2e72202d163b29_I20230331" decimals="-6" name="ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzUtMi0xLTEtNjE0NjEz_ff9f6f98-c76a-4267-837f-63a0a51dc230">35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e712fcd6b0f49c58dd469be40702369_I20221231" decimals="-6" name="ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzUtNC0xLTEtNjE0NjEz_7c051682-c39e-417e-b2c0-a5789cf49f36">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d949019d7c44dcea3311dc5c763edbb_D20230101-20230331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzUtNi0xLTEtNjIyMzcxL3RleHRyZWdpb246MTk2MDIxODAwYjM1NGMyY2I4YTlmMzY0ZjJhY2E2M2ZfNTQ5NzU1ODEzODky_2e00e8c4-7e89-4ebf-bb8f-0217b94204c7">70</ix:nonFraction>% were secured by a letter of credit.</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market risk benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib570f0c807bc458bb372ecd4c53d8d16_I20230331" decimals="-6" name="ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzUtNC0xLTEtNTQ3MDk4_d2bc1209-a05a-48f0-b7c6-abe80121e66d">1,323</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb569d2047445a09609c8caab034843_I20221231" decimals="-6" name="ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzUtNi0xLTEtNTQ3MDk4_b3b63f95-3764-4c59-843f-f1ca6eb28017">1,398</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">All reinsurers are rated A- equivalent and higher by an NRSRO.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes IBNR and outstanding claims of $<ix:nonFraction unitRef="usd" contextRef="ib570f0c807bc458bb372ecd4c53d8d16_I20230331" decimals="-6" name="us-gaap:ReinsuranceReceivablesIncurredButNotReportedClaims" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90ZXh0cmVnaW9uOjA3ZTQ5MWJmY2Y0YTQ4YWM4YjJkM2RmYzI3ZmM3YTcyXzU0OTc1NTgxMzk4NTE_70c24c80-044c-40d6-989c-b8a5918e8557">25</ix:nonFraction> million offset by premium due of $<ix:nonFraction unitRef="usd" contextRef="ib570f0c807bc458bb372ecd4c53d8d16_I20230331" decimals="-6" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90ZXh0cmVnaW9uOjA3ZTQ5MWJmY2Y0YTQ4YWM4YjJkM2RmYzI3ZmM3YTcyXzU0OTc1NTgxMzk4Njc_66c12bcc-9c81-44fa-92e0-226b671283bd">3</ix:nonFraction> million. These amounts are excluded from market risk benefits at March&#160;31, 2023 in Note 9 and Note 10A to the Consolidated Financial Statements. At December&#160;31, 2022, IBNR and outstanding claims of $<ix:nonFraction unitRef="usd" contextRef="iffb569d2047445a09609c8caab034843_I20221231" decimals="-6" name="us-gaap:ReinsuranceReceivablesIncurredButNotReportedClaims" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90ZXh0cmVnaW9uOjA3ZTQ5MWJmY2Y0YTQ4YWM4YjJkM2RmYzI3ZmM3YTcyXzU0OTc1NTgxMzk5MTk_8a1fc47c-6b22-4915-96b6-7716995a14dd">27</ix:nonFraction> million offset by premium due of $<ix:nonFraction unitRef="usd" contextRef="iffb569d2047445a09609c8caab034843_I20221231" decimals="-6" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90ZXh0cmVnaW9uOjA3ZTQ5MWJmY2Y0YTQ4YWM4YjJkM2RmYzI3ZmM3YTcyXzU0OTc1NTgxMzk5MzY_29b5409c-6d05-4bde-8bf6-a3d4fa1bbcb5">3</ix:nonFraction> million were excluded from the market risk benefits as restated due to the adoption of LDTI.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The impact of nonperformance risk (i.e. the risk that a counterparty might default) on the variable annuity reinsurance asset was immaterial for the three months ended March&#160;31, 2023 and March&#160;31, 2022.</span></div></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_622"></div><div><span id="ie0e036408fac44b49f8f8ca726d9dbba_13"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MjIvZnJhZzplMGUwMzY0MDhmYWM0NGI0OWY4ZjhjYTcyNmQ5ZGJiYS90ZXh0cmVnaW9uOmUwZTAzNjQwOGZhYzQ0YjQ5ZjhmOGNhNzI2ZDlkYmJhXzE0_c3a01010-ff34-4856-9f4b-a32016cefb3a" continuedAt="ia34bcde63a2f43ee99143546e071c832" escape="true">Note 11 &#8211; Investments</ix:nonNumeric></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_625"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ia34bcde63a2f43ee99143546e071c832" continuedAt="i44780753d3cd4d08a102c09151901ed9">The <ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MjUvZnJhZzpjNTNhMzY2YzY4OGE0NzA5YmQ5N2RjNDNlZTZlZmU3Yi90ZXh0cmVnaW9uOmM1M2EzNjZjNjg4YTQ3MDliZDk3ZGM0M2VlNmVmZTdiXzU1Ng_92035247-adc7-4939-9994-50e98377f773" continuedAt="i09e34ac7b5de412093493d7ffb844111" escape="true">Cigna Group's investment portfolio consists of a broad range of investments including debt securities, equity securities, commercial mortgage loans, policy loans, other long-term investments, short-term investments and derivative financial instruments.</ix:nonNumeric> The sections below provide more detail regarding our investment balances and realized investment gains and losses. See Note 12 to the Consolidated Financial Statements for information about the valuation of the Company's investment portfolio. <ix:continuation id="i09e34ac7b5de412093493d7ffb844111" continuedAt="i9e44ccff88c34e53b3b1661824195d63">Further information about our accounting policies for investment assets can be found in Note 11 in the Company's 2022 Form 10-K.</ix:continuation></ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_631"></div><ix:continuation id="i44780753d3cd4d08a102c09151901ed9" continuedAt="i874fc20be224498a92a6a24ca46c6dd4"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90ZXh0cmVnaW9uOjIzOWU5NDhlNmIzOTQ3NzhiMjk3NTZmOTY5ODJjNzZiXzQwNQ_99074310-4662-4299-995d-645986798245" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the Company's investments by category and current or long-term classification:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.212%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112f3631ecd842d7934b73fe1e30c901_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzItMi0xLTEtNTQ3MDk4_0e18b5be-1baf-4349-adfd-f15107afcd1a">616</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112f3631ecd842d7934b73fe1e30c901_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzItNC0xLTEtNTQ3MDk4_70c3f1ef-7abe-47b1-9dcd-b188c0c0f1d3">9,293</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112f3631ecd842d7934b73fe1e30c901_I20230331" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzItNi0xLTEtNTQ3MDk4_bf062b8b-7526-49a1-9e07-29bd00c55077">9,909</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6833d4eac60499bac8b8e40d102c734_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzItOC0xLTEtNTQ3MDk4_eedf26cb-472c-4c95-b9ea-41627ba4fa6f">654</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6833d4eac60499bac8b8e40d102c734_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzItMTAtMS0xLTU0NzA5OA_92acb6b8-66be-4f5a-ac59-7360a2d03247">9,218</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6833d4eac60499bac8b8e40d102c734_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzItMTItMS0xLTU0NzA5OA_c0880b39-39b0-4f30-8895-7dd1ebc1322d">9,872</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd51b7e314aa426795bbfa7b1914c75a_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzMtMi0xLTEtNTQ3MDk4_7fa0a6dc-0118-45ea-9836-ea36f959c3d3">51</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd51b7e314aa426795bbfa7b1914c75a_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzMtNC0xLTEtNTQ3MDk4_44fe50fa-5f43-4296-9bed-08ef679b3046">3,069</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd51b7e314aa426795bbfa7b1914c75a_I20230331" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzMtNi0xLTEtNTQ3MDk4_2058fb4b-9519-4eb8-b508-e19065a3b2af">3,120</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4227ad42c24dc39f4e62e2b85e81a6_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzMtOC0xLTEtNTQ3MDk4_b8ee6d9a-e6ab-499f-8c1c-746f687f6d19">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4227ad42c24dc39f4e62e2b85e81a6_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzMtMTAtMS0xLTU0NzA5OA_c8d8f54b-338e-4e00-aa07-5f468d1dda34">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4227ad42c24dc39f4e62e2b85e81a6_I20221231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzMtMTItMS0xLTU0NzA5OA_ba94b3e9-d532-4ed1-bbf0-9f57f05c9705">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56553614bb1d4575a81f8b42e1e9b673_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzQtMi0xLTEtNTQ3MDk4_bcfec0e8-8693-4575-a122-49bf90095074">106</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56553614bb1d4575a81f8b42e1e9b673_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzQtNC0xLTEtNTQ3MDk4_e40f3143-def0-4c0c-9f13-88d104bdb675">1,501</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56553614bb1d4575a81f8b42e1e9b673_I20230331" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzQtNi0xLTEtNTQ3MDk4_436a6828-a095-4c74-bca1-b581c349d76a">1,607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie585d9251acf4ffaa79b1ef027535117_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzQtOC0xLTEtNTQ3MDk4_90376607-ac33-4e77-ba75-66d3c58f9b3d">67</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie585d9251acf4ffaa79b1ef027535117_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzQtMTAtMS0xLTU0NzA5OA_87f598ca-95b9-4eb9-987a-3b3e7b34748c">1,547</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie585d9251acf4ffaa79b1ef027535117_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzQtMTItMS0xLTU0NzA5OA_a9e7b0c7-65b6-465f-87ec-c7835302c618">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Policy loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ddaaa564876446e911564680d7ad205_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzUtMi0xLTEtNTQ3MDk4_d0def798-c89c-40b4-aafe-c1c393658ce5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ddaaa564876446e911564680d7ad205_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzUtNC0xLTEtNTQ3MDk4_0e41f626-3c0d-4de8-b0ab-017b0cafb801">1,211</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ddaaa564876446e911564680d7ad205_I20230331" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzUtNi0xLTEtNTQ3MDk4_074e186b-b25a-46fb-a65a-d6ae3d2e4ef9">1,211</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c539efc04b24f10bb5bd030d79f630c_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzUtOC0xLTEtNTQ3MDk4_bcc25ab6-0f3b-4db6-b36f-98a329acaaa2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c539efc04b24f10bb5bd030d79f630c_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzUtMTAtMS0xLTU0NzA5OA_ba35f1a6-7a20-4c46-aa46-989845cb089c">1,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c539efc04b24f10bb5bd030d79f630c_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzUtMTItMS0xLTU0NzA5OA_61b280f5-7553-4344-906c-d2abedbb7696">1,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term investments</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1141eeb8e3f34513b86f0ce1f1a4c72c_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzYtMi0xLTEtNTQ3MDk4_754e454a-e4ea-4dd3-9a7b-2c25c4a4ad89">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1141eeb8e3f34513b86f0ce1f1a4c72c_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzYtNC0xLTEtNTQ3MDk4_c0cde90c-0549-4485-aa7e-3f157291ee02">3,936</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1141eeb8e3f34513b86f0ce1f1a4c72c_I20230331" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzYtNi0xLTEtNTQ3MDk4_f4016007-9c30-4c52-a7e6-155c6ece4394">3,936</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7d37bc4c9a46d6a3949bc3551de6de_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzYtOC0xLTEtNTQ3MDk4_236c5ce6-7c0e-4a96-980f-55d3f562f1e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7d37bc4c9a46d6a3949bc3551de6de_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzYtMTAtMS0xLTU0NzA5OA_6b6d90a5-a005-4b7e-b98a-e77b70dea7b0">3,728</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7d37bc4c9a46d6a3949bc3551de6de_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzYtMTItMS0xLTU0NzA5OA_da8968b1-9c0f-4ed1-9e9a-28f6e7d05d53">3,728</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5a5174826024b3b8526bf7dcd6066e5_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzctMi0xLTEtNTQ3MDk4_c1e12387-33f4-47fb-a78e-e77b556ae0f0">141</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5a5174826024b3b8526bf7dcd6066e5_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzctNC0xLTEtNTQ3MDk4_2c89d064-4582-46a1-9ddb-6a99ca85bd94">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5a5174826024b3b8526bf7dcd6066e5_I20230331" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzctNi0xLTEtNTQ3MDk4_2e059c7a-4855-452e-8872-93ef7fa312a8">141</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie234bd06bf9543618cd63eb8ff57535e_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzctOC0xLTEtNTQ3MDk4_e63ea2e2-6fc6-4304-b68d-a5987657b21e">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie234bd06bf9543618cd63eb8ff57535e_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzctMTAtMS0xLTU0NzA5OA_1e653023-2e7f-4e91-957b-720145278ad8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie234bd06bf9543618cd63eb8ff57535e_I20221231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzctMTItMS0xLTU0NzA5OA_6fa37e79-c7fb-4f31-96a4-6a3cae785e8f">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzgtMi0xLTEtNTY3OTE4_75e743f7-309b-450b-a80c-13b96543a971">914</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzgtNC0xLTEtNTY3OTMw_d52e9acd-c0a5-4e5a-a4c0-00335fdb67b0">19,010</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzgtNi0xLTEtNTY3OTM1_80f464e8-e37c-4bf5-a175-3765347e496c">19,924</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzgtOC0xLTEtNTQ3MDk4_2a84f41f-1dcd-4ee6-9e67-bcf3e7a02512">905</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzgtMTAtMS0xLTU0NzA5OA_a85dbfe7-7ab3-42ac-9563-98c899590d8b">16,288</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzgtMTItMS0xLTU0NzA5OA_01f64b85-a45b-470f-806b-92ab88f4b6f5">17,193</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_634"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt;text-decoration:underline"><ix:continuation id="i874fc20be224498a92a6a24ca46c6dd4" continuedAt="i273d1776d0ec407089e6adeb49671f55">Investment Portfolio</ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_637"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i273d1776d0ec407089e6adeb49671f55" continuedAt="i88eaf32c63f74ac9ab616750ca50372b">Debt Securities</ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_10995116283798"></div><div style="margin-bottom:10pt"><ix:continuation id="i88eaf32c63f74ac9ab616750ca50372b" continuedAt="id00017fbcb554bc68567b38822f6aae6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"><ix:continuation id="i9e44ccff88c34e53b3b1661824195d63" continuedAt="i1207a69abefd4e1b8cdf04ec3346da34">Accounting policy.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i1207a69abefd4e1b8cdf04ec3346da34" continuedAt="iead2757dad3f4343926f275376b6ecb9"> Our accounting policy for debt securities (including bonds, mortgage and other asset-backed securities and preferred stocks redeemable by the investor) remains materially consistent with the policy disclosed in the Company's 2022 Form 10-K. However, with the adoption of amended accounting guidance for long-duration insurance contracts on January 1, 2023 (discussed in Note 2 to the Consolidated Financial Statements), net unrealized appreciation on debt securities supporting the Company's run-off settlement annuity business is no longer reported in Non-current insurance and contractholder liabilities but rather is reported in Accumulated other comprehensive loss.</ix:continuation> See Note 14 to the Consolidated Financial Statements for the impact to Accumulated other comprehensive loss.</span></ix:continuation></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_643"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id00017fbcb554bc68567b38822f6aae6" continuedAt="i258af1c87901463f88af03823c11d87c"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90ZXh0cmVnaW9uOjJlNDM0NjA3NzIwMzRmNzBiOTNmYmY0YWEzYzJjM2RhXzYwNg_3240bf0c-ce02-4d22-84f7-44527bf6740d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amortized cost and fair value by contractual maturity periods for debt securities were as follows as of March&#160;31, 2023:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzItMi0xLTEtNTQ3MDk4_f282aacf-f0c9-4158-970f-f25657c5c575">638</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzItNC0xLTEtNTQ3MDk4_628ef374-ec47-4e18-8c0c-fa35c5222158">630</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzMtMi0xLTEtNTQ3MDk4_3f0ad67a-4413-49c1-8d4d-38ceadff5ab0">3,972</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzMtNC0xLTEtNTQ3MDk4_0c5c3767-54d6-4825-ae41-3ca1690ccd7a">3,752</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzQtMi0xLTEtNTQ3MDk4_12988439-5173-45eb-919f-ff1b1f36a472">3,227</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzQtNC0xLTEtNTQ3MDk4_dd9de19c-08b8-496f-91b9-7d3346c9cc55">2,915</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzUtMi0xLTEtNTQ3MDk4_f5d37f72-2146-4128-9a74-dd42ab511918">2,450</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzUtNC0xLTEtNTQ3MDk4_a89adb6f-fe84-4c16-8e79-708aa2f5dac7">2,268</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed securities</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzYtMi0xLTEtNTQ3MDk4_242ce549-571b-4eee-87c8-37478d9cf22b">381</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzYtNC0xLTEtNTQ3MDk4_15adeac2-0a56-4cb8-9f64-0cbe324d1787">344</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzctMi0xLTEtNTQ3MDk4_d73c2656-867e-4182-96a7-4c8440b0c10c">10,668</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzctNC0xLTEtNTQ3MDk4_5d424130-1d61-4a44-ba5d-b8e093e2ec67">9,909</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Actual maturities of these securities could differ from their contractual maturities used in the table above because issuers may have the right to call or prepay obligations, with or without penalties.</span></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90ZXh0cmVnaW9uOjJlNDM0NjA3NzIwMzRmNzBiOTNmYmY0YWEzYzJjM2RhXzYwOQ_5cf65c3c-b98a-44f3-93fe-dfe03d42b1fd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Gross unrealized appreciation (depreciation) on debt securities by type of issuer is shown below:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.046%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Appreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal government and agency</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1269c3f703d94ed6840f2e30642de9bc_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzItMi0xLTEtNTQ3MDk4_0f5de470-ffb4-41c5-807f-7fd1110c3e8a">276</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1269c3f703d94ed6840f2e30642de9bc_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzItNC0xLTEtNTQ3MDk4_370e3b5f-d8c5-46d0-8ed6-f3755235901b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1269c3f703d94ed6840f2e30642de9bc_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzItNi0xLTEtNTQ3MDk4_d591a249-aa61-482f-9c37-17a9b3951017">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1269c3f703d94ed6840f2e30642de9bc_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzItOC0xLTEtNTQ3MDk4_b0b6ec69-0586-43c8-a26f-3cdf8c403ff5">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1269c3f703d94ed6840f2e30642de9bc_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzItMTAtMS0xLTU0NzA5OA_9140a3fb-cb84-4ec0-a923-04695084728a">297</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c306daec09546e08812586ae9f36ee0_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzMtMi0xLTEtNTQ3MDk4_261d88ad-e8db-40ab-95f8-83fcbbc19e56">42</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c306daec09546e08812586ae9f36ee0_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzMtNC0xLTEtNTQ3MDk4_19472a03-06aa-475e-abb0-e62eb80c6a68">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c306daec09546e08812586ae9f36ee0_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzMtNi0xLTEtNTQ3MDk4_0dfc2dc7-44c3-4382-b8da-25d8f49fd4a2">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c306daec09546e08812586ae9f36ee0_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzMtOC0xLTEtNTQ3MDk4_4a3df0f7-cb4d-4d46-8c20-02144707c175">1</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c306daec09546e08812586ae9f36ee0_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzMtMTAtMS0xLTU0NzA5OA_ab128420-1a76-437e-9ab1-e9ab57a329c1">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign government</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic820b1328eff4b35a3d9cd660b0c2801_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzQtMi0xLTEtNTQ3MDk4_4ac80666-0f95-4054-b3b7-78642a9d8f07">373</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic820b1328eff4b35a3d9cd660b0c2801_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzQtNC0xLTEtNTQ3MDk4_5adc6655-fe57-48a0-a4b1-e7538017d7e4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic820b1328eff4b35a3d9cd660b0c2801_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzQtNi0xLTEtNTQ3MDk4_18f1e381-9588-4ab9-bd57-82057ee2bd32">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic820b1328eff4b35a3d9cd660b0c2801_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzQtOC0xLTEtNTQ3MDk4_26e440be-447e-4bf2-90cd-a3b440a2f3e3">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic820b1328eff4b35a3d9cd660b0c2801_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzQtMTAtMS0xLTU0NzA5OA_bbb74ec0-6151-41d2-9f87-048ff9937453">371</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7918ae8d451f4168bead8514e67d96dc_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzUtMi0xLTEtNTQ3MDk4_77a86c89-d7ab-438e-9875-49dc33cae3cd">9,596</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7918ae8d451f4168bead8514e67d96dc_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzUtNC0xLTEtNTQ3MDk4_013ffda2-7407-42b9-95c7-acc18d15b56a">41</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7918ae8d451f4168bead8514e67d96dc_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzUtNi0xLTEtNTQ3MDk4_5cb3a81f-e3fd-4683-b05e-8e8291a59911">124</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7918ae8d451f4168bead8514e67d96dc_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzUtOC0xLTEtNTQ3MDk4_3bcec229-755a-42b1-b5ef-bf1cd9b23775">823</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7918ae8d451f4168bead8514e67d96dc_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzUtMTAtMS0xLTU0NzA5OA_20fb097f-4842-4296-bf84-fd65c5ee68c5">8,856</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3942feca4c1d4b8b9e0695b4afd3cfd1_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzYtMi0xLTEtNTQ3MDk4_56d90427-a19d-40b4-8f25-e2fd3ea3420b">381</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3942feca4c1d4b8b9e0695b4afd3cfd1_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzYtNC0xLTEtNTQ3MDk4_a8dd91a2-cd9e-4705-8908-622b16e38afb">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3942feca4c1d4b8b9e0695b4afd3cfd1_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzYtNi0xLTEtNTQ3MDk4_e182ea78-b7c8-4d72-80c9-7b3d9988e99c">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3942feca4c1d4b8b9e0695b4afd3cfd1_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzYtOC0xLTEtNTQ3MDk4_dcefe469-084a-4b63-8df8-1d7552b92eef">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3942feca4c1d4b8b9e0695b4afd3cfd1_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzYtMTAtMS0xLTU0NzA5OA_d1b7d709-9872-48e2-b35d-1fbfbde240d2">344</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzctMi0xLTEtNTQ3MDk4_c1d28837-7ea2-4717-b457-5fffac033612">10,668</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzctNC0xLTEtNTQ3MDk4_db0a060b-4177-4600-8dc5-33aaa629c6f3">41</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzctNi0xLTEtNTQ3MDk4_a8df212a-b13b-45a1-bc56-2ffb777e3e1f">170</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzctOC0xLTEtNTQ3MDk4_ef48f7a4-cbb9-40df-9d1e-aabc7fa04ff9">888</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzctMTAtMS0xLTU0NzA5OA_353212f8-4682-47a3-8578-e9b5ae920d37">9,909</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal government and agency</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28ad1e10f5a40aab28b4519e660c08a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzExLTItMS0xLTU0NzA5OA_ab7cbc38-454a-4615-be43-38b057446929">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28ad1e10f5a40aab28b4519e660c08a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzExLTQtMS0xLTU0NzA5OA_22370eb3-5726-422a-afdb-5f58ab3a33aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28ad1e10f5a40aab28b4519e660c08a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzExLTYtMS0xLTU0NzA5OA_b003222a-18b8-4a81-8591-8a473875d23b">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic28ad1e10f5a40aab28b4519e660c08a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzExLTgtMS0xLTU0NzA5OA_2622c498-31aa-4264-9322-ce7758e8db46">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28ad1e10f5a40aab28b4519e660c08a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzExLTEwLTEtMS01NDcwOTg_578ce64a-b359-480b-9e35-3dd0ae0155ff">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014e7b52c0f34c96a0a52bc15cdbbb2b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEyLTItMS0xLTU0NzA5OA_cd12edef-9bb3-4860-9925-7e5df2ae8bc1">43</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014e7b52c0f34c96a0a52bc15cdbbb2b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEyLTQtMS0xLTU0NzA5OA_9383a15e-3134-4ce3-8ef6-a4c894e0633d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014e7b52c0f34c96a0a52bc15cdbbb2b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEyLTYtMS0xLTU0NzA5OA_d34fb8a5-74b8-4d1b-b534-036d57d611c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i014e7b52c0f34c96a0a52bc15cdbbb2b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEyLTgtMS0xLTU0NzA5OA_f3e3b48f-cf89-4d6b-81dd-48ff4d235371">2</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014e7b52c0f34c96a0a52bc15cdbbb2b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEyLTEwLTEtMS01NDcwOTg_a6814670-0ff6-4f29-9227-4a42d470c1e3">41</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign government</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab84ae88cd084601b0a81a723bc6f470_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEzLTItMS0xLTU0NzA5OA_c4609fd1-6a2c-4ce5-b327-7e955e6cc7d1">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab84ae88cd084601b0a81a723bc6f470_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEzLTQtMS0xLTU0NzA5OA_fde6fc32-95ab-4f9c-8a1a-10f983b452fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab84ae88cd084601b0a81a723bc6f470_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEzLTYtMS0xLTU0NzA5OA_105f4dae-ab30-4e1a-9897-7a9e75fdc10b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab84ae88cd084601b0a81a723bc6f470_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEzLTgtMS0xLTU0NzA5OA_761fd036-3eae-4b2b-bf55-aa503027d2b7">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab84ae88cd084601b0a81a723bc6f470_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEzLTEwLTEtMS01NDcwOTg_e7540e84-319a-4888-9ce8-393896fbc2d1">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib356a619fa9e420489d64c64c7002bfe_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE0LTItMS0xLTU0NzA5OA_4ff3a1ce-514c-446f-b99b-72e488330160">9,742</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib356a619fa9e420489d64c64c7002bfe_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE0LTQtMS0xLTU0NzA5OA_3bb4adc2-1dc5-43b1-9976-c36a1eceab0e">44</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib356a619fa9e420489d64c64c7002bfe_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE0LTYtMS0xLTU0NzA5OA_dcff203b-f5a5-455e-af75-e28ba9f783f7">89</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib356a619fa9e420489d64c64c7002bfe_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE0LTgtMS0xLTU0NzA5OA_25880ed4-06e8-4803-a02d-6817239d8c23">981</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib356a619fa9e420489d64c64c7002bfe_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE0LTEwLTEtMS01NDcwOTg_f478d0e7-ae60-4347-ac1d-99a0ec9a38cc">8,806</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7923da0ee04654b571d67b56b68fcc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE1LTItMS0xLTU0NzA5OA_05e7dc6e-4cd1-425a-b183-86aae6a498e5">390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7923da0ee04654b571d67b56b68fcc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE1LTQtMS0xLTU0NzA5OA_e722fac9-ae82-49c2-939d-88ef31b80353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7923da0ee04654b571d67b56b68fcc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE1LTYtMS0xLTU0NzA5OA_5b90f535-e014-49eb-870d-9f6a07519e3f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d7923da0ee04654b571d67b56b68fcc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE1LTgtMS0xLTU0NzA5OA_68e49e40-f16c-4ae4-b5c0-4f0acb8c5913">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7923da0ee04654b571d67b56b68fcc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE1LTEwLTEtMS01NDcwOTg_64ad2578-0410-4803-a32a-238a2a2f3285">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE2LTItMS0xLTU0NzA5OA_d4334e99-1aa1-436d-a545-d7b01c4de098">10,842</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE2LTQtMS0xLTU0NzA5OA_8fd18c9a-9a22-4a8b-8c80-ec2d5fc530d3">44</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE2LTYtMS0xLTU0NzA5OA_fdf6ce8a-e273-4b90-94b6-4d1bcbba9e95">133</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE2LTgtMS0xLTU0NzA5OA_ba99bca8-a062-41ce-8aab-7b0c2f82e926">1,059</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE2LTEwLTEtMS01NDcwOTg_c4303e95-f935-44d6-8c3a-63f1b72e0ed9">9,872</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-right:36pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_646"></div><ix:continuation id="i258af1c87901463f88af03823c11d87c" continuedAt="ic92fe38f6967456482a76b80f3a02e89"><ix:continuation id="iead2757dad3f4343926f275376b6ecb9" continuedAt="i42d612691a7a470db7c1e981c1829433"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Review of declines in fair value. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management reviews impaired debt securities to determine whether a credit loss allowance is needed based on criteria that include:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">severity of decline;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">financial health and specific prospects of the issuer; and</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">changes in the regulatory, economic or general market environment of the issuer's industry or geographic region.</span></div></ix:continuation><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90ZXh0cmVnaW9uOjg0OGJiOGJhYmY5OTRhZTViZDJiMmIzODQ0NTkyMzZjXzc5Nw_5b755e5d-c4bc-4d6c-8044-a9eba1890453" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below summarizes debt securities with a decline in fair value from amortized cost for which an allowance for credit losses has not been recorded, by investment grade and the length of time these securities have been in an unrealized loss position. Unrealized depreciation on these debt securities is primarily due to declines in fair value resulting from increasing interest rates since these securities were purchased. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of Issues</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of Issues</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">One year or less</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment grade</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtMi0xLTEtNTQ3MDk4_fd14793b-c8ea-4a5a-b2d0-353ed36bbdef">3,176</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331" decimals="-6" name="ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtNC0xLTEtNTQ3MDk4_192acec9-4d83-4281-8529-d339c56ed333">3,362</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtNi0xLTEtNTQ3MDk4_e918aed9-e691-4872-bf06-3702f2c1251d">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="position" contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtOC0xLTEtNTQ3MDk4_6972f8c2-c9b2-4fe8-b870-e2c1d07a3224">1,019</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtMTAtMS0xLTU0NzA5OA_39fc375d-b87c-4612-9c91-3112786c17e5">5,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231" decimals="-6" name="ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtMTItMS0xLTU0NzA5OA_339a4ec6-4adc-4659-9672-23b59604eb27">6,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtMTQtMS0xLTU0NzA5OA_bd0791cd-f4e1-4439-af07-1b3a837fb04d">594</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="position" contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtMTYtMS0xLTU0NzA5OA_e694a324-3ab6-46d5-9d29-7034a149278c">1,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Below investment grade</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtMi0xLTEtNTQ3MDk4_858c4ec8-8f06-4d3e-8e30-abdb8ae6679c">353</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331" decimals="-6" name="ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtNC0xLTEtNTQ3MDk4_773254b7-3f72-4a17-a697-4e34b1c4e4da">371</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtNi0xLTEtNTQ3MDk4_dd61debd-f5df-4976-b2a4-91a49978e3b1">18</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="position" contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtOC0xLTEtNTQ3MDk4_1a22c55f-5cf4-4fd8-b943-dbcac7a45bb9">936</ix:nonFraction></span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtMTAtMS0xLTU0NzA5OA_aaeccd08-1202-45db-b389-c3e8adf617a2">887</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231" decimals="-6" name="ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtMTItMS0xLTU0NzA5OA_b3f1c971-272f-46fc-a504-1ce1d6f33c5d">964</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtMTQtMS0xLTU0NzA5OA_4837ec8c-6b43-4abd-a4cc-a8764cf7275f">77</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="position" contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtMTYtMS0xLTU0NzA5OA_a2185f6a-cce6-4d59-be8c-eeaba6a55263">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than one year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment grade</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtMi0xLTEtNTQ3MDk4_e977a85c-1716-4d7b-9915-6e355ac9a919">3,222</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331" decimals="-6" name="ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtNC0xLTEtNTQ3MDk4_e2629255-49ce-44da-ac94-9339b2003275">3,808</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtNi0xLTEtNTQ3MDk4_743a79d5-41ac-4af3-be42-6489babcb388">586</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="position" contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtOC0xLTEtNTQ3MDk4_e9ebc401-cdbe-4264-986a-1cabd1d41296">1,035</ix:nonFraction></span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtMTAtMS0xLTU0NzA5OA_415274d3-18a0-44c2-840c-39221c1773cf">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231" decimals="-6" name="ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtMTItMS0xLTU0NzA5OA_ec49ec42-6b95-4c9c-a292-8a420a941c7e">1,487</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtMTQtMS0xLTU0NzA5OA_e4cf7459-982f-4479-b3f5-41d5108a0b9c">336</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="position" contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtMTYtMS0xLTU0NzA5OA_6c877ff0-764e-4472-a008-59c90a7b2970">462</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Below investment grade</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctMi0xLTEtNTQ3MDk4_c4cb2076-971d-4b63-be86-b6de7300bc3a">682</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331" decimals="-6" name="ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctNC0xLTEtNTQ3MDk4_05f2c0cd-da57-4b5d-a2cc-239d9b8bdc3a">780</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctNi0xLTEtNTQ3MDk4_f75ca82c-abe2-4d2a-89f5-0db490d99240">98</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="position" contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctOC0xLTEtNTQ3MDk4_e8f0edbc-0034-4a31-9e0e-969ed0c8b16e">770</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctMTAtMS0xLTU0NzA5OA_d6b466eb-f094-4432-90e0-d07b01c96a79">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231" decimals="-6" name="ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctMTItMS0xLTU0NzA5OA_109af9fd-3364-44ff-bbd0-c9f87619e45d">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctMTQtMS0xLTU0NzA5OA_f69d449a-a1b8-4abc-8e75-a05436ed09f2">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="position" contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctMTYtMS0xLTU0NzA5OA_1a79021c-7aa9-4eb1-bb07-a3558ae8baad">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtMi0xLTEtNTQ3MDk4_9732935a-214f-4e24-842c-fd5646eed6e2">7,433</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtNC0xLTEtNTQ3MDk4_1fca1e92-70a1-4129-9f79-7c7b2538fc46">8,321</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtNi0xLTEtNTQ3MDk4_e057d6db-4acb-4dd7-b049-fd3967370097">888</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="position" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtOC0xLTEtNTQ3MDk4_2144f462-f929-4ad3-9220-6a3d462630d4">3,760</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtMTAtMS0xLTU0NzA5OA_76860ae3-a28c-4f1c-8557-e4001dc19666">7,901</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtMTItMS0xLTU0NzA5OA_d21c6dd2-819a-485f-b769-fc527fd15862">8,960</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtMTQtMS0xLTU0NzA5OA_a316717b-4822-4be3-98d8-ea84b3e842d7">1,059</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="position" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtMTYtMS0xLTU0NzA5OA_5bfe996a-57a8-4e4f-8ee7-3e352587929e">3,777</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_655"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic92fe38f6967456482a76b80f3a02e89" continuedAt="i0c98cfbed333455ba6f273bc721fe0f6"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Equity Securities</span></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90ZXh0cmVnaW9uOjdkNWU4NDQzZWM1MzQ0N2I4ZDRmODNhMmY4MTAzNTRiXzMzMQ_3e8bb31e-3b50-4f47-af75-d1decbaa7c15" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table provides the values of the Company's equity security investments as of March&#160;31, 2023 and December&#160;31, 2022: </span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities with readily determinable fair values</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzItMi0xLTEtNTQ3MDk4_087363fd-811a-4dea-8acf-06ade3e7f19f">680</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzItNC0xLTEtNTQ3MDk4_0c148caa-7e7d-4502-b5c5-6291b3586154">91</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzItNi0xLTEtNTQ3MDk4_0c5b66a6-30d3-4643-8842-5c948a4b78d6">673</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzItOC0xLTEtNTQ3MDk4_be0c566d-e24b-4e37-94d7-9a50f3fb6094">138</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities with no readily determinable fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzMtMi0xLTEtNTQ3MDk4_61b8c3ef-7dee-4d04-a8c2-220d8580d163">2,926</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzMtNC0xLTEtNTQ3MDk4_a1bde2c2-1afe-441f-927c-064f3e8ae4e8">3,029</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzMtNi0xLTEtNTQ3MDk4_0b3eda7f-8e80-4777-85f6-8c4730adb9ce">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzMtOC0xLTEtNTQ3MDk4_784132b0-1ccc-42cd-a999-f1e83859caf4">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzQtMi0xLTEtNTQ3MDk4_5e3b2e6b-d1fd-49e6-9e54-ab117070e5a5">3,606</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzQtNC0xLTEtNTQ3MDk4_3907894f-9506-4854-910d-278c9d826048">3,120</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzQtNi0xLTEtNTQ3MDk4_74e7ae05-378c-4b8a-ac6c-7e76f18606e7">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzQtOC0xLTEtNTQ3MDk4_ff47bfe2-d927-4958-8eb3-2da7c58c436f">622</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with our strategy to invest in targeted startup and growth-stage companies in the health care industry, approximately <ix:nonFraction unitRef="number" contextRef="i52a0532147074a69a79d2bde730cc6b4_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90ZXh0cmVnaW9uOjdkNWU4NDQzZWM1MzQ0N2I4ZDRmODNhMmY4MTAzNTRiXzE0Mg_6902c8dc-32e0-40b9-8c2b-3c0d94045ba7">95</ix:nonFraction>% of our investments in equity securities are in the health care sector.</span></div></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_664"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"><ix:continuation id="i0c98cfbed333455ba6f273bc721fe0f6" continuedAt="ia59dd3bb0fc047eeb9fe626b17762540">Commercial Mortgage Loans</ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_670"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ia59dd3bb0fc047eeb9fe626b17762540" continuedAt="i92aead41fdce4f319470412d925cf3e8"><ix:continuation id="i42d612691a7a470db7c1e981c1829433" continuedAt="i0d374937e9cb431385a692c63904bf50">Mortgage loans held by the Company are made exclusively to commercial borrowers and are diversified by property type, location and borrower. Loans are generally issued at fixed rates of interest and are secured by high quality, primarily completed and substantially leased operating properties.</ix:continuation></ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_676"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i92aead41fdce4f319470412d925cf3e8" continuedAt="i1a4490ed57614706b7cd36a76159a917"><ix:continuation id="i0d374937e9cb431385a692c63904bf50" continuedAt="iaf692a112bec4df38d6a2cdefaecd2a0">The Company regularly evaluates and monitors credit risk from the initial mortgage loan underwriting and throughout the investment holding period. For more information on the Company's accounting policies and methodologies regarding these investments, see Note 11 in the Company's 2022 Form 10-K.</ix:continuation></ix:continuation></span></div><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_679"></div><ix:continuation id="i1a4490ed57614706b7cd36a76159a917" continuedAt="i8cf50f54246f404fa6756af3c15bf928"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90ZXh0cmVnaW9uOjc4MDcxODFmMjU2OTRiOWJiNjY2YTRiMmVlNDE1OWM1XzExNQ_9a783164-6bd9-4a8b-ba6b-43577219da60" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the credit risk profile of the Company's commercial mortgage loan portfolio:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.890%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Loan-to-Value Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Debt Service Coverage Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Loan-to-Value Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Debt Service Coverage Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Loan-to-Value Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Below 60%</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia91b63f759a34db984a3518b4db4eae5_I20230331" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzItMi0xLTEtNTQ3MDk4_9637dd9f-71b0-4f46-9cc5-ceb42f32f0bf">912</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53e6849ed22a418fbb6188f47afafa8f_D20230101-20230331" decimals="2" name="ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzItNC0xLTEtNTQ3MDk4_40b166d6-56de-4f5e-99df-313834e06b41">2.11</ix:nonFraction></span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i227e56a283374d43b53193cb2ae5296a_I20221231" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzItOC0xLTEtNTQ3MDk4_d2f00ff2-c469-4c23-8d98-c34209d135f3">901</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb8ba53337fd497ab5e68995d0c88cd2_D20220101-20221231" decimals="2" name="ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzItMTAtMS0xLTU0NzA5OA_a389f378-16bb-419c-9ad5-84e54443cad6">2.12</ix:nonFraction></span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60% to 79%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc795fae04a24e6bbfae9210f9e9def8_I20230331" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzMtMi0xLTEtNTQ3MDk4_39142ab9-8d66-459b-8a05-5d1749a07dc5">504</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id71bd449e9c6454cacf21e30ce2c498b_D20230101-20230331" decimals="2" name="ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzMtNC0xLTEtNTQ3MDk4_3f9751f0-0bdb-44e7-bfc9-8e60460d2bf2">1.73</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia74150594d8b46d49cdade2e93655870_I20221231" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzMtOC0xLTEtNTQ3MDk4_88e1ce69-49c7-4769-95f3-a062ade2648b">564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide32893117054ad98838d727032c109e_D20220101-20221231" decimals="2" name="ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzMtMTAtMS0xLTU0NzA5OA_c2f6bcb1-5578-47ba-bb6f-5c4874994b79">1.73</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80% to 100%</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0150b47337d4406b098b239d61060d8_I20230331" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzQtMi0xLTEtNTQ3MDk4_0a7a3c55-cd1b-480e-a448-0eded2bb7caf">191</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37f1db0b0e904b5291a5862d25f76c60_D20230101-20230331" decimals="2" name="ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzQtNC0xLTEtNTQ3MDk4_9533a3a5-f6a5-4bc8-8fba-d9d36af5a9c1">1.32</ix:nonFraction></span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57d71fb7be6245038f50e90a278d63e9_I20221231" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzQtOC0xLTEtNTQ3MDk4_5a05a205-c3dd-43c5-bfe6-e55e1a9ade7f">149</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie9d56cac03234e309389948e70c6ec5b_D20220101-20221231" decimals="2" name="ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzQtMTAtMS0xLTU0NzA5OA_65102682-cffa-4481-a89d-a94f1ecea39e">1.17</ix:nonFraction></span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e013bc327d64747b0fccc969e1f0449_I20230331" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzgtMi0xLTEtNTQ3MDk4_a904e99c-1364-4b04-a161-e144ebef80db">1,607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4810804d0794cab810a5c6d840e43f8_D20230101-20230331" decimals="2" name="ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzgtNC0xLTEtNTQ3MDk4_58fced72-4a00-43bb-aa15-fa1e50f495d4">1.89</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4810804d0794cab810a5c6d840e43f8_D20230101-20230331" decimals="2" name="ci:FinancingReceivableCreditQualityLoanToValueRatio" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzgtNi0xLTEtNTQ3MDk4_7c89d175-2cca-4d21-ac9b-cf757ce40bfb">60</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a727657552e4bba86a90d288d5a606b_I20221231" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzgtOC0xLTEtNTQ3MDk4_c2aee398-9da2-4a8a-987e-e8fe31cfc040">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib51509dfe7384c87a20dfce010e9054b_D20220101-20221231" decimals="2" name="ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzgtMTAtMS0xLTU0NzA5OA_55f59e23-92c0-4aff-9de8-b202c4d74997">1.89</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib51509dfe7384c87a20dfce010e9054b_D20220101-20221231" decimals="2" name="ci:FinancingReceivableCreditQualityLoanToValueRatio" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzgtMTItMS0xLTU0NzA5OA_7c2293a0-1d1a-4223-8687-e405e0342b93">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_685"></div><ix:continuation id="i8cf50f54246f404fa6756af3c15bf928" continuedAt="iaac680550d9d4425aec180b7d2cf6289"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Long-Term Investments</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="iaf692a112bec4df38d6a2cdefaecd2a0" continuedAt="i0d3fd4b5f74d4e5e867df3abbcf38932">Other long-term investments include investments in unconsolidated entities, including certain limited partnerships and limited liability companies holding real estate, securities or loans. These investments are carried at cost plus the Company's ownership percentage of reporting income or loss, based on the financial statements of the underlying investments that are generally reported at fair value. Income or loss from these investments is reported on a one quarter lag due to the timing of when financial information is received from the general partner or manager of the investments. </ix:continuation></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i0d3fd4b5f74d4e5e867df3abbcf38932" continuedAt="i6c309e64874e474db26191fd2947fad7">Other long-term investments also include investment real estate carried at depreciated cost less any impairment write-downs to fair value when cash flows indicate that the carrying value may not be recoverable. Additionally, statutory and other restricted deposits and foreign currency swaps carried at fair value are reported in the table below as Other. </ix:continuation><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:ScheduleOfOtherLongTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90ZXh0cmVnaW9uOmFmMDYzNTAzZTNlZDQ0MWFiNjg3ZjI4OWI5ZDAwYWU3XzEwMTc_d55ca17f-2295-4de3-88e0-2212b15b9f3d" continuedAt="i76e2a1608bd24dbab220e4e17d745f44" escape="true">The following table provides the carrying value information for these investments:</ix:nonNumeric></span></div><div><ix:continuation id="i76e2a1608bd24dbab220e4e17d745f44"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Real estate investments</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddf171f855d455eb0339d11c5a8b669_I20230331" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzItMi0xLTEtNTQ3MDk4_88159f42-dbed-4314-bef9-cf9aca1e6267">1,434</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87598f99e83e4f8fad5b7954451b7bf8_I20221231" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzItNC0xLTEtNTQ3MDk4_b9bd40c7-3a7f-47d9-8070-3f0594531e7e">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities partnerships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d91ccb4d8945f2b31211b7f940aa8c_I20230331" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzMtMi0xLTEtNTQ3MDk4_2978ef8b-f8c3-4d67-91d3-7a7ef2703067">2,259</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6214eeb319f84edc87092fa100092fae_I20221231" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzMtNC0xLTEtNTQ3MDk4_a5893ee8-d341-47e8-b092-cad47f4a97c6">2,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9435629cbc409e80fce5ba86b95ec5_I20230331" decimals="-6" name="us-gaap:OtherLongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzQtMi0xLTEtNTQ3MDk4_ac590c81-ab19-42d3-bc02-495c0601b30a">243</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c8862dc33f41798f458e182a06dc81_I20221231" decimals="-6" name="us-gaap:OtherLongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzQtNC0xLTEtNTQ3MDk4_918438c8-2c2c-465b-af3a-3453b8cae74c">243</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzUtMi0xLTEtNTQ3MDk4_879d04b1-8647-4fb7-99c5-a08a9992a266">3,936</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzUtNC0xLTEtNTQ3MDk4_ce5c2814-30a6-4d05-8cbf-8c63b935fa7e">3,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_700"></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.84pt;text-decoration:underline"><ix:continuation id="iaac680550d9d4425aec180b7d2cf6289" continuedAt="i0e289104556e4ffcb262de8b9f1a8ca3">Derivative Financial Instruments</ix:continuation></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i0e289104556e4ffcb262de8b9f1a8ca3" continuedAt="idd0da9e01f96406190aea4acd16d2d57"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MDAvZnJhZzpiMGJiYjkxYzAwN2I0OTMxOWJjNTIxODY4MDQ1ODhkZi90ZXh0cmVnaW9uOmIwYmJiOTFjMDA3YjQ5MzE5YmM1MjE4NjgwNDU4OGRmXzg3Ng_4e314892-d55b-49ed-8848-a5bfc46f0a71" continuedAt="ieaa9fd70ef0847578d81b48a5ec45b6c" escape="true">The Company uses derivative financial instruments to manage the characteristics of investment assets (such as duration, yield, currency and liquidity) to meet the varying demands of the related insurance and contractholder liabilities. The Company also uses </ix:nonNumeric></ix:continuation></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="idd0da9e01f96406190aea4acd16d2d57" continuedAt="i282db1b5a7b443edb982d427731d1f1b"><ix:continuation id="ieaa9fd70ef0847578d81b48a5ec45b6c" continuedAt="i359ab1dc352d48ddade65979b0d23320">derivative financial instruments to hedge the risk of changes in the net assets of certain of its foreign subsidiaries due to changes in foreign currency exchange rates and to hedge the interest rate risk of certain long-term debt.</ix:continuation></ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_706"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i282db1b5a7b443edb982d427731d1f1b" continuedAt="if203d620833c4878b59ab724e28e9deb">As of March&#160;31, 2023, there have been no material changes to the Company's derivative financial instruments. The effects of derivative financial instruments used in our individual hedging strategies were not material to the Consolidated Financial Statements as of March&#160;31, 2023 and December&#160;31, 2022. The gross fair values of our derivative financial instruments are presented in Note 12 to the Consolidated Financial Statements. </ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_712"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="if203d620833c4878b59ab724e28e9deb" continuedAt="ie998d3bf511848bb8ac05d70614899d2"><ix:continuation id="i359ab1dc352d48ddade65979b0d23320">Please refer to the Company's 2022 Form 10-K for further discussion of the types of derivative financial instruments and associated accounting policies.</ix:continuation> </ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_721"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt;text-decoration:underline"><ix:continuation id="ie998d3bf511848bb8ac05d70614899d2" continuedAt="iff8844bb989e4d399150436ad9305545">Realized Investment Gains and Losses</ix:continuation></span></div><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_724"></div><div style="margin-bottom:10pt"><ix:continuation id="iff8844bb989e4d399150436ad9305545" continuedAt="i6314ee11f8cc42efb947c0316805356a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"><ix:continuation id="i6c309e64874e474db26191fd2947fad7" continuedAt="i2403fa533a41458a9c69fc81d661472b">Accounting policy. </ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i2403fa533a41458a9c69fc81d661472b">Realized investment gains and losses are based on specifically identified assets and result from sales, investment asset write-downs, change in the fair value of certain derivatives and equity securities and changes in allowances for credit losses on debt securities and commercial mortgage loan investments. With the adoption of amended accounting guidance for long-duration insurance contracts on January 1, 2023 (discussed in Note 2 to the Consolidated Financial Statements), realized investment gains and losses no longer exclude amounts that were previously required to adjust future policy benefits for the run-off settlement annuity business. Prior period net realized investment losses have been updated to reflect the impact of adopting LDTI.</ix:continuation> </span></ix:continuation></div><div id="id1800413722c4e30b53ad5d464cab4e8_727"></div><ix:continuation id="i6314ee11f8cc42efb947c0316805356a" continuedAt="i65a982dab59d4fcb869dfad15f0ab6c2"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:RealizedGainLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90ZXh0cmVnaW9uOmZmMGJhYTgxNjFhNzRkYWNhNDNjZjdjYzZhNDg0NDEwXzUxMg_e5864175-dbf1-4537-8810-4fbb930a4bd9" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following realized gains and losses on investments exclude realized gains and losses attributed to the Company's separate accounts because those gains and losses generally accrue directly to separate account policyholders:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.708%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment (losses), excluding credit loss expense and asset write-downs</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLossExcludingImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzMtNi0xLTEtNTQ3MDk4_a6dd7d19-acc3-48ff-85c0-c18087ca51d1">51</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLossExcludingImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzMtOC0xLTEtNTQ3MDk4_5ca15e5e-63e3-48e3-b6da-1ceb8c5818c0">322</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Credit loss recoveries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzQtNi0xLTEtNTQ3MDk4_a433c245-32e8-4c73-ac3d-8c84ee26175b">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzQtOC0xLTEtNTQ3MDk4_58a5f95f-c969-4a7e-afd6-dd7466e8c7cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investment asset write-downs</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:ImpairmentsOnInvestmentsTotal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzUtNi0xLTEtNTQ3MDk4_6b6cff3d-33f7-4b9d-9879-dadcf9c31589">8</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:ImpairmentsOnInvestmentsTotal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzUtOC0xLTEtNTQ3MDk4_864850e6-a81b-4f69-a50d-f19477a524fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment (losses), before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzYtNi0xLTEtNTQ3MDk4_e979d9de-a5ca-4c65-a4d0-679a16951dd2">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzYtOC0xLTEtNTQ3MDk4_49c40b0b-4470-4304-980e-17655f545dc7">322</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i65a982dab59d4fcb869dfad15f0ab6c2">Net realized investment losses for the three months ended March&#160;31, 2023 and March&#160;31, 2022 were primarily due to mark-to-market losses on a strategic health care equity securities investment.</ix:continuation> </span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_736"></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MzYvZnJhZzpjZmY5NWFlZWY4N2M0NDcxYjA0YjRjMWFiMDU2ZWNkMS90ZXh0cmVnaW9uOmNmZjk1YWVlZjg3YzQ0NzFiMDRiNGMxYWIwNTZlY2QxXzE1OTA_dd4a39e3-5a6a-47fe-a09f-938fff209499" continuedAt="i6db53cd742734922ad59cad132479472" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12 &#8211; Fair Value Measurements</span></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MzYvZnJhZzpjZmY5NWFlZWY4N2M0NDcxYjA0YjRjMWFiMDU2ZWNkMS90ZXh0cmVnaW9uOmNmZjk1YWVlZjg3YzQ0NzFiMDRiNGMxYWIwNTZlY2QxXzE1ODg_a2d201de-0f01-4a8a-9068-fbd8db44b1e5" continuedAt="i64065dcad6bb49cc8f1244fc18d5718d" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company carries certain financial instruments at fair value in the financial statements including debt securities, certain equity securities, short-term investments and derivatives. Other financial instruments are measured at fair value only under certain conditions, such as when impaired or when there are observable price changes for equity securities with no readily determinable fair value.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fair value is defined as the price at which an asset could be exchanged in an orderly transaction between market participants at the balance sheet date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a market participant, not the amount that would be paid to settle the liability with the creditor.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's financial assets and liabilities carried at fair value have been classified based upon a hierarchy defined by GAAP. The hierarchy gives the highest ranking to fair values determined using unadjusted quoted prices in active markets for identical assets and liabilities (Level 1) and the lowest ranking to fair values determined using methodologies and models with unobservable inputs (Level 3). An asset's or a liability's classification is based on the lowest level of input that is significant to its measurement. For example, a financial asset or liability carried at fair value would be classified in Level 3 if unobservable inputs were significant to the instrument's fair value, even though the measurement may be derived using inputs that are both observable (Levels 1 and 2) and unobservable (Level 3).</span></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_742"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i6db53cd742734922ad59cad132479472" continuedAt="id1587f8673634148bed582ab88dab81d"><ix:continuation id="i64065dcad6bb49cc8f1244fc18d5718d" continuedAt="i57578e26198a441ba083371908748c08">For a description of the policies, methods and assumptions that are used to estimate fair value and determine the fair value hierarchy for each class of financial instruments, see Note 12 in the Company's 2022 Form 10-K.</ix:continuation></ix:continuation></span></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_745"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline"><ix:continuation id="id1587f8673634148bed582ab88dab81d" continuedAt="i5c3ddf01e4b14d988dc3473631d6ab20">Financial Assets and Financial Liabilities Carried at Fair Value</ix:continuation></span></div><ix:continuation id="i5c3ddf01e4b14d988dc3473631d6ab20" continuedAt="i358f7d50352942acb990938f57bfd774"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90ZXh0cmVnaW9uOmJkYmUyM2JhYzU0YzQzOWRhYmE1ZmZkNDQzZjQ0NmY5XzUxMw_4e319d47-67c5-4c0c-b47b-93ef57198842" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table provides information about the Company's financial assets and liabilities carried at fair value. Further information regarding insurance assets and liabilities carried at fair value is provided in Note 9E to the Consolidated Financial Statements. Separate account assets are also recorded at fair value on the Company's Consolidated Balance Sheets and are reported separately in the Separate Accounts section below as gains and losses related to these assets generally accrue directly to contractholders:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at fair value</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal government and agency</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c40a4ac7f2a434f87a71b9ba541fbed_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtMi0xLTEtNTQ3MDk4_720567ef-8d69-433c-8e04-ce04abdf2004">151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic52a72b46e934d71b88725042436b309_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtNC0xLTEtNTQ3MDk4_e91a24ad-c6de-4802-895c-bb891c96895d">147</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4088ab619834175a08deb5b39beb15b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtNi0xLTEtNTQ3MDk4_be7e1c47-b4c0-47bf-a811-33d68128c853">146</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f13ab64129a4c8fb094e735383237e5_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtOC0xLTEtNTQ3MDk4_00111b66-cb63-4804-8d58-a40f0f5e2eb0">165</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9f8a274704049218d1ef098ed77fc12_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtMTAtMS0xLTU0NzA5OA_d292ea63-8fa0-4105-a952-cb2479b246eb">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a01ce3605c34a9aa36f20dfda34e4fb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtMTItMS0xLTU0NzA5OA_844e6820-b9d1-4509-9ac4-c34f1430ce3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77341c9a2ae245cc8c56080a14bfe2ae_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtMTQtMS0xLTU0NzA5OA_805ac004-3350-42af-bb68-af5e751ebd3b">297</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0cce95292e14776a7278f0e33003cdf_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtMTYtMS0xLTU0NzA5OA_bcf9c68e-b0b8-43f0-b2b4-6008de5f78f3">312</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local government</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07ed9d3c52b404e94ba85d570434570_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtMi0xLTEtNTQ3MDk4_eb88192d-d5df-4984-9930-149561837bc8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73b62bf7014e45babcc9a18ea1226d9e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtNC0xLTEtNTQ3MDk4_c3888377-e998-4cde-b8bd-bf5bf9f0488a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032a4c4c66d44f95966d06b499946c31_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtNi0xLTEtNTQ3MDk4_1ce80063-9513-4210-aae5-0c7c6d160bb0">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i989ef71163ae4e9c8eaafced6a9b1a25_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtOC0xLTEtNTQ3MDk4_b7e9bd09-53be-4b35-a4c0-86cf9c6ae1ae">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i930d264a52e74abd92fd6023e6324ee9_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtMTAtMS0xLTU0NzA5OA_63cc2628-73ec-45a3-bb90-ae1f32ef63e7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950a2d2b127a4b9581697e8ffc5a5f06_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtMTItMS0xLTU0NzA5OA_2ae5e9e0-10c8-4cd4-9b01-44e15a51ce8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cf66280f27c4cdab8de0ed3b972cd3f_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtMTQtMS0xLTU0NzA5OA_f7959288-a2fe-44d6-800e-60f25384982e">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d4d88313bd744c9b9bfe00dc4beadb1_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtMTYtMS0xLTU0NzA5OA_abbeed49-fc30-4543-b2c9-e69f7ac2e4d6">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6458608672034857ab59db70911f8c1c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtMi0xLTEtNTQ3MDk4_4891a336-d365-40f7-99bc-bb64077b1207">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie93c0af573094af9b33586116b3a5681_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtNC0xLTEtNTQ3MDk4_8107ee8e-e7f1-440a-a42e-f04846353516">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7c3e6ee73bb44aaaf1dc02c1f8d9b9e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtNi0xLTEtNTQ3MDk4_7fed1ac3-206e-48d2-85e8-242d62eddfa5">371</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126d653bef214cb5a2293e321a3c6a1f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtOC0xLTEtNTQ3MDk4_4076e15e-65e3-452b-85a5-2ee126bcf40e">365</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c23114e19414957ab7bf2b512b8032d_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtMTAtMS0xLTU0NzA5OA_e5c7ed87-41d0-4831-b981-2b345fa4df0d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i911bced2d64f49388c06235bcf671712_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtMTItMS0xLTU0NzA5OA_358ca9a6-6230-4051-98e9-c7955cedd96c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i210b492f12ea4598b3c1eaa7fe5053a9_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtMTQtMS0xLTU0NzA5OA_90ccbc6a-508e-47f3-a99a-75f8222e3638">371</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b60856ce8d24fbba0e9bdc9e6c8e8c3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtMTYtMS0xLTU0NzA5OA_298a1443-0436-422b-ab0f-b3ace1cec580">365</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9589c2b720554541a51b62fcbedfa89c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctMi0xLTEtNTQ3MDk4_a5f725f0-3fbe-4ce5-9394-61dd02b6cd3c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bf5cf8552e4f3f93ab9849ef07ea23_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctNC0xLTEtNTQ3MDk4_6ea4a1b0-0a56-497f-8aa5-3479edeb825a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f40ed4344194d4fa94fd6bc5ff74a0f_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctNi0xLTEtNTQ3MDk4_3cfa783e-1e4d-4cfb-9208-f0d87c4feedd">8,421</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ade3d59c3b74f71a757f3ce93ec3fe0_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctOC0xLTEtNTQ3MDk4_44e2b644-4aa9-466e-a31c-3f93ec1070ac">8,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1d1efad88f74a06b2f78f6f4a608383_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctMTAtMS0xLTU0NzA5OA_d320b76e-5cb8-48c6-b13e-82a59c7eb780">435</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b20e60e442842d383d58e1005c97d30_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctMTItMS0xLTU0NzA5OA_8f6a2645-89a3-45aa-a5a2-b66993bd384f">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe9c93b5d23348ed9f2d2524fee1a2f6_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctMTQtMS0xLTU0NzA5OA_bbefb5d1-848d-4bd6-82db-76d96dfa1c3b">8,856</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibabd51e3f7364ae0a5c3a97072265a04_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctMTYtMS0xLTU0NzA5OA_8e389d14-046c-4daa-8891-141af7994484">8,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id300a0f63845475da13c0c4f8959c18c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtMi0xLTEtNTQ3MDk4_efb3de96-368a-4c7b-8ca8-0dcf012a1a62">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedcadbdbe30c4f6e8eb2478149ef29e7_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtNC0xLTEtNTQ3MDk4_3c2b54f9-459e-412a-a844-27160d216f49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i496ceb12f2c94b9b995de6a325274988_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtNi0xLTEtNTQ3MDk4_8ad91c71-b90b-4b38-a663-e985a5df68d4">309</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e6aa69b6ac14548852cbc0cb1dd129c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtOC0xLTEtNTQ3MDk4_4b247109-ad77-48bc-b912-7b33063ec394">313</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b18e9f370634eaca75f7ac03fc42ec6_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtMTAtMS0xLTU0NzA5OA_49da9ead-e5fa-4ff3-ae58-fd571b598c98">35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i122d51c6af904c34830a2d18ee8b3883_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtMTItMS0xLTU0NzA5OA_7771a70d-b86b-4051-801b-e043de0d2190">35</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea52ae05bad4666b5128b751245b170_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtMTQtMS0xLTU0NzA5OA_6ba109b5-d9eb-4c63-9e2a-315e7a81f799">344</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b7744b55da48babac0660b53c793fc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtMTYtMS0xLTU0NzA5OA_e18fcd42-9ef9-46b4-aaa4-e5b97bd955d1">348</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407a2545ce8c476abfbe4489ad433944_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktMi0xLTEtNTQ3MDk4_fbd7089d-3dfb-41f2-a14e-bde6945ed30c">151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635a05614dc44dfaa59bf4c4b0677a6c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktNC0xLTEtNTQ3MDk4_f8053c8c-0b3b-44b0-86f7-430beb833ee9">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8480eea330a24711916d476ea14fc9ff_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktNi0xLTEtNTQ3MDk4_60cba6fb-f96d-45ba-8905-f555d1bf6023">9,288</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i362c06fa9cc443e7bd73051dc42cbaca_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktOC0xLTEtNTQ3MDk4_bd6dedba-42a9-4354-918c-1b8872be4c08">9,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife2fcb28e086422c8dc4e953d482abc9_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktMTAtMS0xLTU0NzA5OA_30daa583-cc3c-414f-8449-98cf7332b3c0">470</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522a8f54759495caa0225401ceef646_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktMTItMS0xLTU0NzA5OA_e34445b3-1e19-468c-81d7-e4c81a2d2395">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i346d7b1c76574be19f46677e85e8c5b1_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktMTQtMS0xLTU0NzA5OA_130bbc4a-3dac-4200-8e46-d9fa72d86997">9,909</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1008fa627a0f446c963b0e67d8dfd067_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktMTYtMS0xLTU0NzA5OA_1097e69d-442d-47fe-902f-95da2117de17">9,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407a2545ce8c476abfbe4489ad433944_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTItMS0xLTU0NzA5OA_c5b470b4-0fa4-4aa5-bc2f-89e5883a6cab">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635a05614dc44dfaa59bf4c4b0677a6c_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTQtMS0xLTU0NzA5OA_fc0de268-ebeb-4cb8-aa6a-fb5c40aed005">6</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8480eea330a24711916d476ea14fc9ff_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTYtMS0xLTU0NzA5OA_af465a58-cbed-4ea1-b107-40a1db0e2083">84</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i362c06fa9cc443e7bd73051dc42cbaca_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTgtMS0xLTU0NzA5OA_7b2fe36b-4751-4709-aa92-07262a47aebd">132</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife2fcb28e086422c8dc4e953d482abc9_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTEwLTEtMS01NDcwOTg_407e1720-7ea0-4b5a-bfdd-0fe45021ae7d">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522a8f54759495caa0225401ceef646_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTEyLTEtMS01NDcwOTg_88e5d2fd-2463-4e43-b8d7-2ced63323c39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i346d7b1c76574be19f46677e85e8c5b1_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTE0LTEtMS01NDcwOTg_67b7b726-3862-4913-9ab2-fd4a7de079ae">91</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1008fa627a0f446c963b0e67d8dfd067_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTE2LTEtMS01NDcwOTg_526cc767-0c3e-4fa3-ab99-48c59bc4378d">138</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407a2545ce8c476abfbe4489ad433944_I20230331" decimals="-6" name="us-gaap:OtherShortTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTItMS0xLTU0NzA5OA_a6278a64-52f7-4867-b202-895d3d7d019f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635a05614dc44dfaa59bf4c4b0677a6c_I20221231" decimals="-6" name="us-gaap:OtherShortTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTQtMS0xLTU0NzA5OA_7eea4608-61a2-4b55-a211-36a8d90c9886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8480eea330a24711916d476ea14fc9ff_I20230331" decimals="-6" name="us-gaap:OtherShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTYtMS0xLTU0NzA5OA_69c8c56c-c40c-4216-bec5-f6525ef429ee">141</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i362c06fa9cc443e7bd73051dc42cbaca_I20221231" decimals="-6" name="us-gaap:OtherShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTgtMS0xLTU0NzA5OA_1e5338c4-8a6c-44d1-8352-c2245a14a499">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife2fcb28e086422c8dc4e953d482abc9_I20230331" decimals="-6" name="us-gaap:OtherShortTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTEwLTEtMS01NDcwOTg_e3921493-53f7-47c1-a2fd-5e161b2531cc">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522a8f54759495caa0225401ceef646_I20221231" decimals="-6" name="us-gaap:OtherShortTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTEyLTEtMS01NDcwOTg_11d5af50-4b21-47f8-9915-6ba1ba9f4a2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i346d7b1c76574be19f46677e85e8c5b1_I20230331" decimals="-6" name="us-gaap:OtherShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTE0LTEtMS01NDcwOTg_1a2882b8-7740-40cf-9bce-14572cda6be0">141</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1008fa627a0f446c963b0e67d8dfd067_I20221231" decimals="-6" name="us-gaap:OtherShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTE2LTEtMS01NDcwOTg_1a1d1dbd-84db-4fd7-9fc2-8c2538849e1a">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d801185130948b6b2dfb025cf2c9afe_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTItMS0xLTU0NzA5OA_5b814c43-166d-4d81-bf7b-35dc8c9a9ee5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2172b84fcfbb48169b1cf9a8c8d71a74_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTQtMS0xLTU0NzA5OA_75d7cc04-56b9-493a-a27b-f5507a3294cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9534d4bd0db4a8cb06ac21b74224b43_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTYtMS0xLTU0NzA5OA_8d2b7f24-50cc-4347-851c-01aa36cfe34c">206</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173890bd1b474d3198c5dfb300324f59_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTgtMS0xLTU0NzA5OA_4ac88ab9-a76d-4c64-b937-d1368cc71083">230</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic61449fd99784439939f74a26e23b495_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTEwLTEtMS01NDcwOTg_cbe0412c-4931-43e0-9cbf-d97914478e94">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65136b8ff46f4dcdace35ad210e68997_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTEyLTEtMS01NDcwOTg_3465660e-e3c7-4941-9b63-92959fa69356">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf1f04ddb0f54df990cf80a00f7696af_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTE0LTEtMS01NDcwOTg_bff0cfb3-1b3a-46d5-89c8-fdc34d874d16">207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04209b927ad49a5ba1f009ea469bf3a_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTE2LTEtMS01NDcwOTg_44e9c5ef-538f-4403-b4ac-ea84a5483e35">231</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Excludes certain equity securities that have no readily determinable fair value.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:10pt;padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_751"></div><ix:continuation id="i358f7d50352942acb990938f57bfd774" continuedAt="ia83cdf8d7621469ebc5b859c9c5a6fb1"><ix:continuation id="i57578e26198a441ba083371908748c08" continuedAt="ie756d9aaeb434fa795db20b9f5c07420"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Level 3 Financial Assets and Financial Liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain inputs for instruments classified in Level 3 are unobservable (supported by little or no market activity) and significant to their resulting fair value measurement. Unobservable inputs reflect the Company's best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date. Additionally, as discussed in Note 9 to the Consolidated Financial Statements, the Company classifies variable annuity assets and liabilities in Level 3 of the fair value hierarchy.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_757"></div><ix:continuation id="ia83cdf8d7621469ebc5b859c9c5a6fb1" continuedAt="ifb5da5c8afdb42ae985a532a055e9ac9"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><ix:continuation id="ie756d9aaeb434fa795db20b9f5c07420" continuedAt="i96a6762b01764b179f4ab8187e23d39e">Quantitative Information about Unobservable Inputs</ix:continuation></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i96a6762b01764b179f4ab8187e23d39e" continuedAt="i7f4919e09ae84c2792f739f0e6a700e9">The significant unobservable input used to value our corporate and government debt securities and mortgage and other asset-backed securities is an adjustment for liquidity. This adjustment is needed to reflect current market conditions and issuer circumstances when there is limited trading activity for the security.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90ZXh0cmVnaW9uOjBjNjM1MmIzZjQxZDQ5Yzc5ZjQ3YjNhMGI4MGJmOTkwXzkyNQ_5da13032-859f-40ef-88bf-36716db071ed" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the fair value and significant unobservable inputs that were developed directly by the Company and used in pricing these debt securities. The range and weighted average basis point ("bps") amounts for liquidity reflect the Company's best estimates of the unobservable adjustments a market participant would make to calculate these fair values. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Adjustment Range (Weighted Average by Quantity) as of</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Fair value in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable input March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate and government debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b42664d2d054b1cb8a6a20eb860282a_I20230331" decimals="-6" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtMi0xLTEtNTQ3MDk4_5f7f25d4-5d10-427b-8e8e-1a8ef5dce2ca">433</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic382cb79965348f7b830702205a70233_I20221231" decimals="-6" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtNC0xLTEtNTQ3MDk4_088c1e20-dcd9-42dd-90ac-58259b59d752">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liquidity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia299f05a1244456c8e2a637925cd98ee_I20230331" decimals="3" name="us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246NDliZGI5MGY1NGZhNDgxYzlmNmMyYTZmOTgwMmEwYTdfNA_2062f6d7-7c75-47b4-a3f1-7779f775c6f9">60</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="i5d3981d68ffb4ab1bb2f4ebea953bca7_I20230331" decimals="3" name="us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246NDliZGI5MGY1NGZhNDgxYzlmNmMyYTZmOTgwMmEwYTdfOQ_54d78ebb-3001-4b99-9fc2-3cbb76224448">1060</ix:nonFraction> (<ix:nonFraction unitRef="number" contextRef="i220f8c95ac454213bbf6528472654e1f_I20230331" decimals="4" name="us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246NDliZGI5MGY1NGZhNDgxYzlmNmMyYTZmOTgwMmEwYTdfMTM_d84ff22c-76db-4b5e-9baa-0e503af650ae">300</ix:nonFraction>)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">bps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i777f12cc915c480f8486fbf1ff5fb6c4_I20221231" decimals="3" name="us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdmMzRlZjAzMjllZDRjMzRiYjI0ZDAxMGViZWRjMWJjXzQ_845a6f11-2b07-43b8-bdf5-f8b00c8f9363">60</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="ibe8a9caf5fe04d33a35af66b6ea9dad3_I20221231" decimals="3" name="us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdmMzRlZjAzMjllZDRjMzRiYjI0ZDAxMGViZWRjMWJjXzk_3cfac65f-cd88-4d0d-8250-d36bae7c112b">1060</ix:nonFraction> (<ix:nonFraction unitRef="number" contextRef="ic24dc2bb53ce4ae88734117cb7dae442_I20221231" decimals="3" name="us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdmMzRlZjAzMjllZDRjMzRiYjI0ZDAxMGViZWRjMWJjXzEz_5f8f05b9-ef3d-477d-b39a-0b2f96fdfb01">270</ix:nonFraction>)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed securities</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545e52d4ab804995a43a6de0a3f9451d_I20230331" decimals="-6" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtMi0xLTEtNTQ3MDk4_418066e8-7bf7-44fa-be18-424f8fbaa62c">35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id68863ce55b24c80abd273a20e11d928_I20221231" decimals="-6" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtNC0xLTEtNTQ3MDk4_cb9c862a-0447-4423-b887-b6d31a612144">35</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liquidity</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id54e9025aabe47faba625607f255ae82_I20230331" decimals="4" name="us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246MmVhM2E2MTk2MGZmNDAyMzhmOTRjNDM1NGQyMGZkMmRfNA_d5994148-7766-40c7-9a7e-d26dd15324aa">105</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="i522b8ff4b68a4b3b83655840fe0d0999_I20230331" decimals="3" name="us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246MmVhM2E2MTk2MGZmNDAyMzhmOTRjNDM1NGQyMGZkMmRfOQ_8796ca2e-0184-41e0-b58f-f36ef70317f2">520</ix:nonFraction> (<ix:nonFraction unitRef="number" contextRef="i603fe8aa57f54159aa3dd133fca86c4d_I20230331" decimals="3" name="us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246MmVhM2E2MTk2MGZmNDAyMzhmOTRjNDM1NGQyMGZkMmRfMTM_e28fdc1f-bd0d-41b9-a87f-8155b1240e10">310</ix:nonFraction>) </span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">bps</span></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4564af3a4a1e4f07bd83540908642eeb_I20221231" decimals="3" name="us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjU1ZTgwOGE4NTEzYTRjOWI5ZTgyMTQ0NmY3MWYyNDI3XzQ_8d170cb2-6244-4946-9a8e-26c6e29021d3">110</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="ibc819642d63d44d7812cdbbde998e471_I20221231" decimals="3" name="us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjU1ZTgwOGE4NTEzYTRjOWI5ZTgyMTQ0NmY3MWYyNDI3Xzk_8be7d993-b33f-44fa-bce1-da41c5a731bb">520</ix:nonFraction> (<ix:nonFraction unitRef="number" contextRef="iac58c114e37e4838bf9723da6c4ec12f_I20221231" decimals="3" name="us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjU1ZTgwOGE4NTEzYTRjOWI5ZTgyMTQ0NmY3MWYyNDI3XzEz_4eaa639d-2235-4b6f-9aac-12281562c878">310</ix:nonFraction>)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie20fd12fb4e5463baaf5a977f3780fb8_I20230331" decimals="-6" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzUtMi0xLTEtNTQ3MDk4_e73f209b-571c-4d23-9b3a-0b05c973f54b">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i233fdf4af61947d7882a46454c266f5e_I20221231" decimals="-6" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzUtNC0xLTEtNTQ3MDk4_614ab2f3-327d-4998-b767-9c6ba76b628a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Level 3 debt securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2a7a90ae1f548208c8ec8f1cbcbb9c3_I20230331" decimals="-6" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzYtMi0xLTEtNTQ3MDk4_981c3841-4d3a-4484-8931-b4c747ad4568">470</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d1343670dd4e47affa7005b7f60ff6_I20221231" decimals="-6" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzYtNC0xLTEtNTQ3MDk4_d342004a-cebd-4963-beee-06343bf36108">447</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A significant increase in liquidity spread adjustments would result in a lower fair value measurement, while a decrease would result in a higher fair value measurement.</span></div></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_760"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifb5da5c8afdb42ae985a532a055e9ac9" continuedAt="i37c6385413604999b792eab116b401e9"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Changes in Level 3 Financial Assets and Financial Liabilities Carried at Fair Value</span></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90ZXh0cmVnaW9uOmZmMGY1M2JmZTc3MDQyMWM5NjY0ODc1OTdiYmNmMDY5XzE1MTM_fd594dd6-74e1-4ddf-aa8b-358a46525104" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the changes in financial assets and financial liabilities classified in Level 3. Gains and losses reported in the table may include net changes in fair value that are attributable to both observable and unobservable inputs.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt and Equity Securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6207da178a44fb3864bb680dfb0bea3_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzQtNi0xLTEtNTQ3MDk4_c00062e1-eba0-4b1a-b569-a3999f8015c5">447</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64364361359847419628a63147bdad2e_I20211231" decimals="-6" name="ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzQtOC0xLTEtNTQ3MDk4_1bf0ab73-2f3c-49b9-a529-3a933a6c024c">796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains included in Shareholders' net income</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzUtNi0xLTEtNTQ3MDk4_99afbcf7-de5d-4e02-955f-fa18555c91c1">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzUtOC0xLTEtNTQ3MDk4_08f767a0-878c-46af-913e-9c13a5a706e0">12</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains (losses) included in Other comprehensive loss</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzYtNi0xLTEtNTQ3MDk4_d67aae4a-8996-4eab-b30e-13028877d2fb">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzYtOC0xLTEtNTQ3MDk4_2f08495c-129d-41cb-baaf-4b1208330c70">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Losses required to adjust future policy benefits for settlement annuities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331" decimals="-6" name="ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzctNi0xLTEtNTQ3MDk4_7268fcd5-722c-45ca-9afd-a619f013325b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331" decimals="-6" sign="-" name="ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzctOC0xLTEtNTQ3MDk4_e295daa8-df03-4036-8829-6b3d7b2a1032">12</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchases, sales and settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzktNi0xLTEtNTQ3MDk4_6d639c39-e694-4a17-97c8-781e7fb7dbca">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzktOC0xLTEtNTQ3MDk4_f105af1a-004d-41d3-b31c-28fb0b35fdc3">49</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzExLTYtMS0xLTU0NzA5OA_e9e45fa9-96a5-4831-a403-74c97477461b">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzExLTgtMS0xLTU0NzA5OA_8ba87b2d-7738-420d-ae8b-7f4afd644051">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total purchases, sales and settlements</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzEyLTYtMS0xLTU0NzA5OA_ecb8236a-6a33-4d9a-8c36-e633880b6dfd">5</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzEyLTgtMS0xLTU0NzA5OA_2b8bdc83-d1ba-4d89-863a-cb36c653e7e4">32</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transfers into/(out of) Level 3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transfers into Level 3</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE0LTYtMS0xLTU0NzA5OA_fa49dfbe-7ed2-49c8-8244-38ce4d6cc2a5">39</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE0LTgtMS0xLTU0NzA5OA_ec260379-07d4-4267-8aa6-4b9453b4639c">101</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE1LTYtMS0xLTU0NzA5OA_d0eeecac-bfd5-46e3-b1c0-2ecd1421723d">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE1LTgtMS0xLTU0NzA5OA_495bcfd8-bc46-4eb8-8ce3-4bbb92535b26">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total transfers into/(out of) Level 3</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE2LTYtMS0xLTU0NzA5OA_5ac2f7dd-1b16-4701-89ee-6cfce9f6649b">23</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE2LTgtMS0xLTU0NzA5OA_0c06bede-006e-47a6-a2e2-9045c765892a">63</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22c741b1ef01438c9bc0c95b9bc802d8_I20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE3LTYtMS0xLTU0NzA5OA_e2cb9756-2254-4d25-8e53-cf6e86eedd8a">471</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4e0a32ed2947fcac341851c89b111c_I20220331" decimals="-6" name="ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE3LTgtMS0xLTU0NzA5OA_e17cf2fb-7ad0-4559-a13a-51b2ad7e3c38">686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total gains included in Shareholders' net income attributable to instruments held at the reporting date</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331" decimals="-6" name="ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE4LTYtMS0xLTU0NzA5OA_f485e901-b808-42a0-b220-908f3822c007">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331" decimals="-6" name="ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE4LTgtMS0xLTU0NzA5OA_d32b6f71-ab55-48a4-93ec-8f78a00739a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in unrealized gain or (loss) included in Other comprehensive loss for assets held at the end of the reporting period</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE5LTYtMS0xLTU0NzA5OA_ce9b89ed-f202-4772-9c80-09669593cb84">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE5LTgtMS0xLTU0NzA5OA_07e05165-d88b-4abe-87e6-c71d2cb02a30">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Amounts do not accrue to shareholders.</span></div></ix:nonNumeric><ix:continuation id="i7f4919e09ae84c2792f739f0e6a700e9" continuedAt="i9486593697b645b1b6503e41ff764d70"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total gains and losses included in Shareholders' net income in the tables above are reflected in the Consolidated Statements of Income as Net realized investment losses and Net investment income.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Gains and losses included in Other comprehensive loss, net of tax in the tables above are reflected in Net unrealized appreciation (depreciation) on securities and derivatives in the Consolidated Statements of Comprehensive Income.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9486593697b645b1b6503e41ff764d70" continuedAt="i5ea9fff3c28d4f569909cd7a3dd25d74">Transfers into or out of the Level 3 category occur when unobservable inputs, such as the Company's best estimate of what a market participant would use to determine a current transaction price, become more or less significant to the fair value measurement. Market activity typically decreases during periods of economic uncertainty and this decrease in activity reduces the availability of market observable data. As a result, the level of unobservable judgment that must be applied to the pricing of certain instruments increases and is typically observed through the widening of liquidity spreads</ix:continuation>. Transfers between Level 2 and Level 3 during 2023 and 2022 primarily reflected changes in liquidity estimates for certain private placement issuers across several sectors. See discussion under Quantitative Information about Unobservable Inputs above for more information.</span></div></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_763"></div><ix:continuation id="i37c6385413604999b792eab116b401e9" continuedAt="iabb769c1e53f40aab93b18aa5db69506"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:PolicyholderAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjMvZnJhZzowZDAyNjI3Y2YxYzY0YzUxYmQ5MWM0ZmUyMjE0MmEwMS90ZXh0cmVnaW9uOjBkMDI2MjdjZjFjNjRjNTFiZDkxYzRmZTIyMTQyYTAxXzI2NQ_d0de532e-a47d-4fca-8948-1b0095e8857c" continuedAt="i44839f9d0ee441e69e1cef006c47a7b0" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The investment income and fair value gains and losses of Separate account assets generally accrue directly to the contractholders and, together with their deposits and withdrawals, are excluded from the Company's Consolidated Statements of Income and Cash Flows. </span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:10pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_769"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iabb769c1e53f40aab93b18aa5db69506" continuedAt="i7262da3092c847afbef2ecbe7f4636b1"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:FairValueOfSeparateAccountAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90ZXh0cmVnaW9uOjlkY2FiM2I0MDg5OTQwYWFhNGI4NjdmYmEyMzRhNDczXzM3NQ_bd9f3775-a10e-49df-bea2-a1f739144ceb" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fair values of Separate account assets were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level 3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Guaranteed separate accounts (See Note 16)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60c510aad1f4274b05705d4451bb34a_I20230331" decimals="-6" name="ci:GuaranteedSeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItMi0xLTEtNTQ3MDk4_fefd9e7e-946b-4d2a-99d1-bb6dad5a660c">213</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58dc13e2e83f45fd86f4fa7e2de05b1f_I20221231" decimals="-6" name="ci:GuaranteedSeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItNC0xLTEtNTQ3MDk4_83eb9ad3-12e6-41ae-ad35-08532755ff61">203</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b20b8ea802488fb1423cffdd53e8f6_I20230331" decimals="-6" name="ci:GuaranteedSeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItNi0xLTEtNTQ3MDk4_3e1d2466-e594-42d2-b96d-750c3f4e1977">349</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica72812ec3684d749901011e62b0851b_I20221231" decimals="-6" name="ci:GuaranteedSeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItOC0xLTEtNTQ3MDk4_d8976336-c890-456a-bf47-50040b114047">382</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f62a525c9374ed5aa1cf92ab9b8c5e1_I20230331" decimals="-6" name="ci:GuaranteedSeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItMTAtMS0xLTU0NzA5OA_497e4bee-39fb-416c-9d8f-d15a1217710e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99d6d20ebb17402f979ebdb5a3daba9c_I20221231" decimals="-6" name="ci:GuaranteedSeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItMTItMS0xLTU0NzA5OA_67bf52fe-36e5-4992-99d7-c7772dd7af4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:GuaranteedSeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItMTQtMS0xLTU0NzA5OA_e07a7ce9-a68b-4c4e-ae0c-c1c7611044fe">562</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:GuaranteedSeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItMTYtMS0xLTU0NzA5OA_1552a73b-9a75-4250-9002-7afc6a74db95">585</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-guaranteed separate accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60c510aad1f4274b05705d4451bb34a_I20230331" decimals="-6" name="ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtMi0xLTEtNTQ3MDk4_699e3d4d-f376-4264-af92-9ab9ac829b72">221</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58dc13e2e83f45fd86f4fa7e2de05b1f_I20221231" decimals="-6" name="ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtNC0xLTEtNTQ3MDk4_1b57f86f-dc7a-4f90-869b-d38db1c5301e">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b20b8ea802488fb1423cffdd53e8f6_I20230331" decimals="-6" name="ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtNi0xLTEtNTQ3MDk4_c3975889-9786-4c21-971b-f59549a5a820">5,586</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica72812ec3684d749901011e62b0851b_I20221231" decimals="-6" name="ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtOC0xLTEtNTQ3MDk4_291a6fec-1419-4fea-b585-a33987ce1beb">5,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f62a525c9374ed5aa1cf92ab9b8c5e1_I20230331" decimals="-6" name="ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtMTAtMS0xLTU0NzA5OA_ab16422f-f094-473e-9040-087cac3149d5">213</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99d6d20ebb17402f979ebdb5a3daba9c_I20221231" decimals="-6" name="ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtMTItMS0xLTU0NzA5OA_005b669d-7a64-4b7b-a0ff-9fb303d09699">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtMTQtMS0xLTU0NzA5OA_2492bbea-86ee-4f7b-84ab-1a08b4724c97">6,020</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtMTYtMS0xLTU0NzA5OA_06a6e91e-e600-476d-994f-ea73d358dc44">5,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60c510aad1f4274b05705d4451bb34a_I20230331" decimals="-6" name="ci:SeparateAccountAssetsClassifiedInFairValueHierarchy" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtMi0xLTEtNTQ3MDk4_5cbf063a-4da9-4f57-b79f-ac6c39ca31b4">434</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58dc13e2e83f45fd86f4fa7e2de05b1f_I20221231" decimals="-6" name="ci:SeparateAccountAssetsClassifiedInFairValueHierarchy" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtNC0xLTEtNTQ3MDk4_ac54e08c-9386-45a4-a45f-0da43d1236f5">414</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b20b8ea802488fb1423cffdd53e8f6_I20230331" decimals="-6" name="ci:SeparateAccountAssetsClassifiedInFairValueHierarchy" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtNi0xLTEtNTQ3MDk4_14a0b87e-5c16-42c4-b0e7-7b15a8853902">5,935</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica72812ec3684d749901011e62b0851b_I20221231" decimals="-6" name="ci:SeparateAccountAssetsClassifiedInFairValueHierarchy" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtOC0xLTEtNTQ3MDk4_9ffdf85d-ac9a-4586-acc7-6a1a56826504">5,904</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f62a525c9374ed5aa1cf92ab9b8c5e1_I20230331" decimals="-6" name="ci:SeparateAccountAssetsClassifiedInFairValueHierarchy" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtMTAtMS0xLTU0NzA5OA_00ebda4a-af61-48b5-8eb8-e2f1c8765dac">213</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99d6d20ebb17402f979ebdb5a3daba9c_I20221231" decimals="-6" name="ci:SeparateAccountAssetsClassifiedInFairValueHierarchy" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtMTItMS0xLTU0NzA5OA_102d6718-6325-4645-b2ba-dfca652a0cdc">203</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:SeparateAccountAssetsClassifiedInFairValueHierarchy" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtMTQtMS0xLTU0NzA5OA_45fbcc3e-c8c3-4862-a177-35a833ce4be7">6,582</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:SeparateAccountAssetsClassifiedInFairValueHierarchy" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtMTYtMS0xLTU0NzA5OA_300f9058-d5ac-4f44-890e-8ea16dec6382">6,521</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-guaranteed separate accounts priced at net asset value ("NAV") as a practical expedient </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzUtMTQtMS0xLTU0NzA5OA_5434c142-fb5f-444c-b9be-83ab9cff554c">758</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="ci:NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzUtMTYtMS0xLTU0NzA5OA_6dafc12d-97ef-40b4-ab44-8a40a1b3d831">757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzYtMTQtMS0xLTYxODMxNg_4ebe8533-685c-484e-9b12-30dfa74d6e7f">7,340</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzYtMTYtMS0xLTU0NzA5OA_29825374-4dbd-4494-be07-1dab449077eb">7,278</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Non-guaranteed separate accounts include $<ix:nonFraction unitRef="usd" contextRef="i14917100852d4b948ca51e874a6b0212_I20230331" decimals="-8" name="ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90ZXh0cmVnaW9uOjlkY2FiM2I0MDg5OTQwYWFhNGI4NjdmYmEyMzRhNDczXzg3_9511c22c-c5dc-42c4-a945-1b53db533586"><ix:nonFraction unitRef="usd" contextRef="i34c7bd2940204fe29e4f3ff5202d63eb_I20221231" decimals="-8" name="ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90ZXh0cmVnaW9uOjlkY2FiM2I0MDg5OTQwYWFhNGI4NjdmYmEyMzRhNDczXzg3_e2ed9c5a-d0cc-47b2-91f8-9615573413ed">4.0</ix:nonFraction></ix:nonFraction> billion as of March&#160;31, 2023 and December&#160;31, 2022 in assets supporting the Company's pension plans, including $<ix:nonFraction unitRef="usd" contextRef="i0e61a85231a745cf8f18edb83018a703_I20221231" decimals="-8" name="ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90ZXh0cmVnaW9uOjlkY2FiM2I0MDg5OTQwYWFhNGI4NjdmYmEyMzRhNDczXzE3NQ_34a2dde7-cd1c-410f-8dc0-78be9d929a7e"><ix:nonFraction unitRef="usd" contextRef="i495afe57b9e945e19224d443146762a4_I20230331" decimals="-8" name="ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90ZXh0cmVnaW9uOjlkY2FiM2I0MDg5OTQwYWFhNGI4NjdmYmEyMzRhNDczXzE3NQ_ee67379b-f07d-40c9-8199-6564d412dbc5">0.2</ix:nonFraction></ix:nonFraction> billion classified in Level 3 as of March&#160;31, 2023 and December&#160;31, 2022.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_775"></div><ix:continuation id="i7262da3092c847afbef2ecbe7f4636b1" continuedAt="i8adcf0c1c17a4c31a91220d92416583b"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i44839f9d0ee441e69e1cef006c47a7b0" continuedAt="if1dd2426aaf840f9b5aa328d8bb30d2d">Separate account assets classified in Level 3 primarily support the Company's pension plans and include certain newly-issued, privately-placed, complex or illiquid securities that are priced using methods discussed above, as well as commercial mortgage loans. </ix:continuation>Activity, including transfers into and out of Level 3, was not material for the three months ended March&#160;31, 2023 or 2022.</span></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90ZXh0cmVnaW9uOjUxMTBhNGFiODQyYzQ2YmFhY2ZmYjgxMjkwNDliM2Q1XzEwNjg_2bca64a9-d6dd-4d29-a17f-f2051d39e98d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="if1dd2426aaf840f9b5aa328d8bb30d2d">Separate account investments in securities partnerships, real estate and hedge funds are generally valued based on the separate account's ownership share of the equity of the investee (NAV as a practical expedient), including changes in the fair values of its underlying investments</ix:continuation>. Substantially all of these assets support the Company's pension plans. The following table provides additional information on these investments:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.322%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unfunded Commitment as of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redemption Frequency<br/>(if currently eligible)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redemption Notice<br/>Period</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities partnerships</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if62bb74d9f924edb9286be35b3c7f345_I20230331" decimals="-6" name="us-gaap:AlternativeInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzItMi0xLTEtNTQ3MDk4_b23848d9-78ef-474e-a893-a40754356cc1">467</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364eea148f374c20a2f0c593046922d6_I20221231" decimals="-6" name="us-gaap:AlternativeInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzItNC0xLTEtNTQ3MDk4_25a289da-dd02-4163-8b1a-79bd84682b78">451</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94fa67011b4847c1abf1f21028ae49ec_I20230331" decimals="-6" name="us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzItNi0xLTEtNTQ3MDk4_db973636-4ef5-46be-974e-530c729295fb">228</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not applicable</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not applicable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Real estate funds</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff956d5fbf6434c977eea973ab12ba8_I20230331" decimals="-6" name="us-gaap:AlternativeInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzMtMi0xLTEtNTQ3MDk4_75629eca-1f1c-4ebc-b03c-f97a61018d83">287</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032c221bd5464f3fb6549e1bb245453c_I20221231" decimals="-6" name="us-gaap:AlternativeInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzMtNC0xLTEtNTQ3MDk4_d315c56d-ad6b-46c7-a442-c71c7dade110">302</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36aa4fc292e346ff9124e93f204c8bef_I20230331" decimals="-6" name="us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzMtNi0xLTEtNTQ3MDk4_25d10118-3967-400e-98c4-42fbf16377ca">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quarterly</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie1e80cb53c7b4030ad4a2f2374f1b4a4_D20230101-20230331" name="us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzMtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdkNGQxZmY3NmNkMDQwZjQ4NWZlNTkwYjlkODk1MjJkXzQ_0a04712d-7b32-4e90-9e9a-e6a920a33bea">30</ix:nonNumeric> - <ix:nonNumeric contextRef="i54d622066b6642138a4374276ced4e96_D20230101-20230331" name="us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzMtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdkNGQxZmY3NmNkMDQwZjQ4NWZlNTkwYjlkODk1MjJkXzk_cf0dd07c-e09f-429e-8987-7a90a1406ea8">90</ix:nonNumeric> days</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedge funds</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cac1c831b434f6aa1415442992376c4_I20230331" decimals="-6" name="us-gaap:AlternativeInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzQtMi0xLTEtNTQ3MDk4_54c32a27-70ac-4f74-8de3-afb99be30d46">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cde07c70a8d4809a5d5efd16dd587e7_I20221231" decimals="-6" name="us-gaap:AlternativeInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzQtNC0xLTEtNTQ3MDk4_78b36e37-8aba-4017-8800-7dcebabbfb6b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c58cb565aea4436b757679a195e2465_I20230331" decimals="-6" name="us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzQtNi0xLTEtNTQ3MDk4_6f4c0d1c-8e0e-4e3c-a623-dbae502167a1">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Up to annually, varying by fund</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic830eb3995b34b459ed632cf6d7d18c9_D20230101-20230331" name="us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzQtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmFlYzM3Njk4ZDMwOTQyZTFiYTc2MTU2NTgyNDMwYjYwXzQ_3cae52c7-6089-42ea-ba6c-cfc9782cc064">30</ix:nonNumeric> - <ix:nonNumeric contextRef="i40c865978ae54de8924e8ce3f15cd96f_D20230101-20230331" name="us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzQtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmFlYzM3Njk4ZDMwOTQyZTFiYTc2MTU2NTgyNDMwYjYwXzk_516fdf15-d21a-46b3-898b-6cda535af266">90</ix:nonNumeric> days</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77f80db721434c238adc7b810844e85e_I20230331" decimals="-6" name="us-gaap:AlternativeInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzUtMi0xLTEtNTQ3MDk4_cb456af3-67ba-4dc7-b712-ce2d54cf01af">758</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7922415e72f84dc0925918d4db42294a_I20221231" decimals="-6" name="us-gaap:AlternativeInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzUtNC0xLTEtNTQ3MDk4_b6c63e8c-d6c9-4aa4-bc62-6b75e81dba52">757</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05431ad3c0184457a9136c2f15684621_I20230331" decimals="-6" name="us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzUtNi0xLTEtNTQ3MDk4_88934901-03f9-477f-9a35-f69994f9de8f">228</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2023, the Company does not have plans to sell any of these assets at less than fair value. These investments are structured to satisfy longer-term investment objectives. Securities partnerships are contractually non-redeemable and the underlying investment assets are expected to be liquidated by the fund managers within <ix:nonNumeric contextRef="ib508898f275f4a768acf67c63c4a4668_D20230101-20230331" name="ci:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90ZXh0cmVnaW9uOjUxMTBhNGFiODQyYzQ2YmFhY2ZmYjgxMjkwNDliM2Q1XzEwNDk_d3d81ae7-4092-4394-93c3-d7b24f5b95aa">ten years</ix:nonNumeric> after inception.</span></div></ix:continuation><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_778"></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.84pt;text-decoration:underline"><ix:continuation id="i8adcf0c1c17a4c31a91220d92416583b" continuedAt="i86c9a812986947dd8fd83edebcbfb247"><ix:continuation id="i5ea9fff3c28d4f569909cd7a3dd25d74" continuedAt="i2aaa80c2262f4787a799649675a84931">Assets and Liabilities Measured at Fair Value under Certain Conditions</ix:continuation></ix:continuation></span></div><ix:continuation id="i86c9a812986947dd8fd83edebcbfb247" continuedAt="iea432fdfcb9947fca4ececb976c5ae90"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i2aaa80c2262f4787a799649675a84931">Some financial assets and liabilities are not carried at fair value, such as commercial mortgage loans that are carried at unpaid principal, investment real estate that is carried at depreciated cost and equity securities with no readily determinable fair value when there are no observable market transactions. However, these financial assets and liabilities may be measured using fair value under certain conditions, such as when investments become impaired and are written down to their fair value, or when there are observable price changes from orderly market transactions of equity securities that otherwise had no readily determinable fair value.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three months ended March&#160;31, 2023 and 2022, impairments recognized requiring these assets to be measured at fair value were not material. Realized investment gains and losses from these observable price changes for the three months ended March&#160;31, 2023 and March&#160;31, 2022 were not material. </span></div></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">27</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_781"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">C.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline"><ix:continuation id="iea432fdfcb9947fca4ececb976c5ae90" continuedAt="ia53550cd310945a38159bda557c6faee">Fair Value Disclosures for Financial Instruments Not Carried at Fair Value</ix:continuation></span></div><ix:continuation id="ia53550cd310945a38159bda557c6faee"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90ZXh0cmVnaW9uOmU0NWMxZGVjOGQxMDRjOTQ5MTk3M2JmOWNiYTFlM2ExXzQyMA_7a715e41-4391-479b-9ac2-106473486e38" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table includes the Company's financial instruments not recorded at fair value but for which fair value disclosure is required. In addition to universal life products and finance leases, financial instruments that are carried in the Company's Consolidated Balance Sheets at amounts that approximate fair value are excluded from the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.045%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification in Fair Value Hierarchy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5800d762bbc4479e8c8005dfaec6b354_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzItNC0xLTEtNTQ3MDk4_1e4169fc-deef-47de-a037-d955c39f7e16">1,509</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia35e6eb5dace45a085e40ef481f10932_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzItNi0xLTEtNTQ3MDk4_b5130e97-1e24-4b0e-af31-c18f0a04efa3">1,607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if429d97f6f9945029dfcdc1fc970e03f_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzItOC0xLTEtNTQ3MDk4_1b1665f8-9798-44a2-b59e-4ea48426e85d">1,491</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5868b67b67224406aa46fb0e8471fa5e_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzItMTAtMS0xLTU0NzA5OA_ac4471e5-9bcc-4515-9e5a-962040bda723">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, including current maturities, excluding finance leases</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30053fba320b4d05beed1c1e1964b4b6_I20230331" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzMtNC0xLTEtNTQ3MDk4_9f9e35d4-58bd-4a86-a2d6-e884965c77f0">30,679</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia35e6eb5dace45a085e40ef481f10932_I20230331" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzMtNi0xLTEtNTQ3MDk4_96832169-022e-4012-a5da-219c81ee004a">32,439</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c2e14e07b54fc488c910392b015f3e_I20221231" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzMtOC0xLTEtNTQ3MDk4_36a6aa11-faf8-4d23-9bb0-95464fa15efb">28,653</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5868b67b67224406aa46fb0e8471fa5e_I20221231" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzMtMTAtMS0xLTU0NzA5OA_b51a3ab2-a314-4699-8b0c-97745a06e73b">30,994</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_793"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTMvZnJhZzpjMTE2YThmMzVlZDA0ZDExYWJlZWNlM2JjMzEyYWMzMC90ZXh0cmVnaW9uOmMxMTZhOGYzNWVkMDRkMTFhYmVlY2UzYmMzMTJhYzMwXzEy_0ed8d348-885e-4719-9c33-4ba263acc07c" continuedAt="i07a2fafdf1c5402a8260b0d35b5601d1" escape="true">Note 13 &#8211; Variable Interest Entities</ix:nonNumeric></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_796"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i07a2fafdf1c5402a8260b0d35b5601d1">We perform ongoing qualitative analyses of our involvement with variable interest entities to determine if consolidation is required. The Company determined that it was <ix:nonFraction unitRef="entity" contextRef="i18bbba0896f543cb9afd321606482dda_I20230331" decimals="0" name="ci:VariableInterestEntitiesNumberOfEntities" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTYvZnJhZzo1ZmY1NTUyYmRiOWU0OTdiOGNmZWFmMTQ5NGU2OTRkMy90ZXh0cmVnaW9uOjVmZjU1NTJiZGI5ZTQ5N2I4Y2ZlYWYxNDk0ZTY5NGQzXzE3NA_3cb9330d-e186-4726-8789-3f70f0b2caa9"><ix:nonFraction unitRef="entity" contextRef="i699bc3f219a0454d9541076c3ff72173_I20221231" decimals="0" name="ci:VariableInterestEntitiesNumberOfEntities" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTYvZnJhZzo1ZmY1NTUyYmRiOWU0OTdiOGNmZWFmMTQ5NGU2OTRkMy90ZXh0cmVnaW9uOjVmZjU1NTJiZGI5ZTQ5N2I4Y2ZlYWYxNDk0ZTY5NGQzXzE3NA_6eeafa07-3506-4854-ba3a-56c100e0ea15">no</ix:nonFraction></ix:nonFraction>t a primary beneficiary in any material variable interest entity as of March&#160;31, 2023 or December&#160;31, 2022. The Company's involvement with variable interest entities for which it is not the primary beneficiary has not changed materially from December&#160;31, 2022. <ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTYvZnJhZzo1ZmY1NTUyYmRiOWU0OTdiOGNmZWFmMTQ5NGU2OTRkMy90ZXh0cmVnaW9uOjVmZjU1NTJiZGI5ZTQ5N2I4Y2ZlYWYxNDk0ZTY5NGQzXzc1MA_f44e5c8d-0f48-40ff-9fc9-bb319552385a" escape="true">For details of our accounting policy for variable interest entities and the composition of variable interest entities with which the Company is involved, refer to Note 13 in the Company's 2022 Form 10-K.</ix:nonNumeric> The Company has not provided, and does not intend to provide, financial support to any of these variable interest entities in excess of its maximum exposure.</ix:continuation></span></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_811"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="ci:AccumulatedOtherComprehensiveIncomeDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90ZXh0cmVnaW9uOmQ2ZGIzNThhY2JiZTQ1ZGRiNjY2ZmFhZmM5YzU1ODc1XzU0OTc1NTgxNTM5OQ_b05b6bd8-3358-41f0-8b3e-5a3f4e056adc" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14 &#8211; Accumulated Other Comprehensive Income (Loss) ("AOCI")</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">AOCI includes net unrealized (depreciation) appreciation on securities and derivatives, change in discount rate and instrument specific credit risk for certain long-duration insurance contractholder liabilities (Note 9 to the Consolidated Financial Statements), foreign currency translation and the net postretirement benefits liability adjustment. AOCI includes the Company's share from unconsolidated entities reported on the equity method. Generally, tax effects in AOCI are established at the currently enacted tax rate and reclassified to Shareholders' net income in the same period that the related pre-tax AOCI reclassifications are recognized. Changes in the components of AOCI, including the impact of adopting amended accounting guidance for long-duration insurance contracts (discussed in Note 2 to the Consolidated Financial Statements), were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.316%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities and Derivatives</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance, as retrospectively restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74213a55ce4840b39cb8ba80e171a3c6_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzMtNi0xLTEtNTQ3MDk4_ebfecc33-3df1-432c-85c3-fb2064b30ad0">332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e2a8ecd49b468db83c7246a6233f79_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzMtOC0xLTEtNTQ3MDk4_810f5856-6cae-4caf-a64a-216e8b9b801e">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized appreciation (depreciation) on securities and derivatives</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQtNi0xLTEtNTQ3MDk4_65d450cf-605f-4991-b459-4ad3a884e893">252</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27a2c2fd471047389035115e103c4803_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQtOC0xLTEtNTQ3MDk4_0156a8f0-75ae-4403-b188-2a20370b9ac3">1,065</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax (expense) benefit</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzUtNi0xLTEtNTQ3MDk4_f73a5ed5-405a-4200-bf40-528136ccf0ae">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2c2fd471047389035115e103c4803_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzUtOC0xLTEtNTQ3MDk4_ccdfc641-265e-4b62-a56c-5d3d8416cf13">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net unrealized appreciation (depreciation) on securities and derivatives</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzYtNi0xLTEtNTQ3MDk4_e03d2721-aa17-457b-b00d-6fdf3fe72160">198</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27a2c2fd471047389035115e103c4803_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzYtOC0xLTEtNTQ3MDk4_3a100373-eb99-412c-b238-8c12069431e7">834</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification adjustment for (gains) included in Shareholders' net income (Net realized investment losses)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ec41b20522442a78d304f69275d1f6f_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzgtNi0xLTEtNTQ3MDk4_8a1c8d08-1749-4d04-8462-d8144c893526">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib47e378add8046febeed46402863f4f0_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzgtOC0xLTEtNTQ3MDk4_1a7861d1-035c-40f7-9734-4d4c1ed0f1b3">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification adjustment for tax expense included in Shareholders' net income</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzEwLTYtMS0xLTU0NzA5OA_e8033f1c-6b4b-40cc-9712-b05d460da0ce">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2c2fd471047389035115e103c4803_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzEwLTgtMS0xLTU0NzA5OA_64dca594-cc3c-46f1-9b03-1792c394e67f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (gains) reclassified from AOCI to Shareholders' net income</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzExLTYtMS0xLTU0NzA5OA_fcddc4b3-1b0e-4e55-9e96-2591ebd35efe">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27a2c2fd471047389035115e103c4803_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzExLTgtMS0xLTU0NzA5OA_f2c3c503-7f50-4337-8f30-41067ab822c0">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzEyLTYtMS0xLTU0NzA5OA_52677bfe-2d34-4719-879a-95df7751ea8a">194</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27a2c2fd471047389035115e103c4803_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzEyLTgtMS0xLTU0NzA5OA_06da0bef-bc0e-494c-acf3-c3955e461e84">843</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eedce94285e450ea3c9ec311118b0dc_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzEzLTYtMS0xLTU0NzA5OA_f1dd272e-e3ff-4558-8a8c-78cb6c040e8d">138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf6aec08fb614f1f9373704db9a45990_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzEzLTgtMS0xLTU0NzA5OA_b8ed6c3e-3800-47d9-aabc-8b4ccaf4bf50">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net long-duration insurance and contractholder liabilities measurement adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3574069d949f4ff58e5ed013efd6e44e_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE1LTYtMS0xLTU0NzA5OA_1f73f14c-d84e-47e9-a0be-97fc7c2f0bc2">256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie315d35584a941c298193aa052832950_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE1LTgtMS0xLTU0NzA5OA_158ba139-5daf-4536-b0f3-0f7af99e7961">765</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current period change in discount rate for certain long duration liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9da4771b623549e5a758939e8718e0c6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE2LTYtMS0xLTU0NzA5OA_f6045a23-cecd-4250-8f3f-e843ad44a9e6">411</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0e583ccd0840039ba45ea866313d48_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE2LTgtMS0xLTU0NzA5OA_63cf78c0-4ea0-4b74-a359-4f967b091f61">584</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax benefit (expense)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da4771b623549e5a758939e8718e0c6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE3LTYtMS0xLTU0NzA5OA_a8dbea50-3b67-4f53-9c06-f12e4cf23e0e">101</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f0e583ccd0840039ba45ea866313d48_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE3LTgtMS0xLTU0NzA5OA_a271efb8-bfd0-4bf3-befa-bc78a45c537a">130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net current period change in discount rate for certain long duration liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9da4771b623549e5a758939e8718e0c6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE4LTYtMS0xLTU0NzA5OA_01e4b535-d103-4be4-98ab-487218ac462f">310</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0e583ccd0840039ba45ea866313d48_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE4LTgtMS0xLTU0NzA5OA_1d37fff2-c336-43dc-9cab-559d1e9a612d">454</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current period change in instrument-specific credit risk for market risk benefits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b0fa25db54c4cd5b97bf60ce65ce025_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE5LTYtMS0xLTU0NzA5OA_6ecb2946-6e78-46a0-bb35-e8882b841902">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc43d6d65d948eabf0c43a48194633f_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE5LTgtMS0xLTU0NzA5OA_9b68be17-a827-4e5e-a395-b2c9c114e263">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax benefit (expense)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b0fa25db54c4cd5b97bf60ce65ce025_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIwLTYtMS0xLTU0NzA5OA_86c2dbef-067a-4ec6-a40f-6fed72afefce">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc43d6d65d948eabf0c43a48194633f_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIwLTgtMS0xLTU0NzA5OA_2502a562-475b-46ca-87dc-7503f77ab041">1</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net current period change in instrument-specific credit risk for market risk benefits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b0fa25db54c4cd5b97bf60ce65ce025_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIxLTYtMS0xLTU0NzA5OA_cdfb67f5-0ad2-4468-8076-5b0c493f20fb">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc43d6d65d948eabf0c43a48194633f_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIxLTgtMS0xLTU0NzA5OA_99a512ed-f058-4bbf-9f1c-8512d22acec4">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f5efb187a364a69a0332046f8b9dc86_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIyLTYtMS0xLTU0NzA5OA_9402019f-9999-4238-99c2-07a2020f65aa">331</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dfb7b298e8348bebbdbb2ffbb195fc5_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIyLTgtMS0xLTU0NzA5OA_0057d70f-8570-462c-9364-a3360991b501">459</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id43a85e5eb1645de94bf7c939c4071e2_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIzLTYtMS0xLTU0NzA5OA_c05a83c1-70f3-4599-95b6-0d7705fae3e0">587</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f42f5791c2144cbba874ff9a5058d6e_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIzLTgtMS0xLTU0NzA5OA_80eb6535-7429-483c-b9dc-fbf623d2ad01">306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Translation of foreign currencies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance, as retrospectively restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32d3eff65f84a3d9776350854ae8231_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI1LTYtMS0xLTU0NzA5OA_eb167783-6f84-4332-8fe1-7e92b5b7d5ff">154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id05c2da7d3ae4ceeb35fccff9cd109a3_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI1LTgtMS0xLTU0NzA5OA_fa396256-f070-4a03-99be-6d20efac530b">233</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Translation of foreign currencies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12523f50e770418e8cf76bec13c9b6f9_D20230101-20230331" decimals="-6" name="ci:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI2LTYtMS0xLTU0NzA5OA_6ad32ff3-f5fc-46a3-ab52-30b86fc97878">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57486b0895474a619153155e196783bb_D20220101-20220331" decimals="-6" sign="-" name="ci:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI2LTgtMS0xLTU0NzA5OA_013831e0-246d-4f3f-80c6-54f93ee63d66">60</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax benefit (expense)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12523f50e770418e8cf76bec13c9b6f9_D20230101-20230331" decimals="-6" sign="-" name="ci:OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI3LTYtMS0xLTU0NzA5OA_261daacc-5a6f-4be9-aa78-ac5d6ee14492">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57486b0895474a619153155e196783bb_D20220101-20220331" decimals="-6" name="ci:OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI3LTgtMS0xLTU0NzA5OA_5b5dca32-fdc3-4e5a-a65a-898b68c6199a">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net translation of foreign currencies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12523f50e770418e8cf76bec13c9b6f9_D20230101-20230331" decimals="-6" name="ci:OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI4LTYtMS0xLTU0NzA5OA_dc6be23e-703e-4927-9278-0230cc9f332b">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57486b0895474a619153155e196783bb_D20220101-20220331" decimals="-6" sign="-" name="ci:OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI4LTgtMS0xLTU0NzA5OA_3a43b1aa-e3cb-416f-9427-89a6ba764a20">63</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Net translation (loss) on foreign currencies attributable to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d4659b2e374fa3b6fa858f21168b54_D20230101-20230331" decimals="-6" name="ci:TemporaryEquityOtherComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM1LTYtMS0xLTU0NzA5OA_c40d1fac-51a4-4d3a-81e2-55d774dcff15">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f152f9fd42e4e7bb1d7e7e7177095a5_D20220101-20220331" decimals="-6" sign="-" name="ci:TemporaryEquityOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM1LTgtMS0xLTU0NzA5OA_3e743bb5-f27c-49d2-82ac-1ffe7b16a2ae">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shareholders' other comprehensive income (loss), net of tax</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fe44d65b564dfb91c260cbd59420f9_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM2LTYtMS0xLTU0NzA5OA_592e09fd-6f40-40b8-8a61-9d6e5e4d09e5">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32dd55f2fefd4ac7af712ac3651d80a0_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM2LTgtMS0xLTU0NzA5OA_b8145114-1c4d-4e53-8725-eb47d024be08">61</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae231709f2154539b08738af3e5159cc_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM3LTYtMS0xLTU0NzA5OA_0af8c856-fd16-4abe-a44e-15c060deb9d6">138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5730b56e2aba4bf0b30069589628b932_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM3LTgtMS0xLTU0NzA5OA_6591b52d-b375-4d2d-b269-14117b717fcb">294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Postretirement benefits liability</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49e8b987a931474faf2d5c0788c6dd63_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM5LTYtMS0xLTU0NzA5OA_49750946-63a4-40dc-9a0e-5a9a3fc9b3e0">916</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i947635db683b4b3daa054f199155a2d0_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM5LTgtMS0xLTU0NzA5OA_826a5c34-fd75-4655-9873-cad177a8aaaf">1,336</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification adjustment for amortization of net prior actuarial losses and prior service costs (Interest expense and other)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i382b1889e4f048a797548743cf8e44d8_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQwLTYtMS0xLTU0NzA5OA_f71c507e-0b46-4da9-be89-7a20871b11c4">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i500856a7a2f34b819a1cf711b4cbedd5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQwLTgtMS0xLTU0NzA5OA_0af37a25-76b9-464a-937f-14c1e4507c38">16</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification adjustment for tax (benefit) included in Shareholders' net income</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0deee6eee2ee46eeafe6188d0a931786_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQzLTYtMS0xLTU0NzA5OA_0fe1c5d7-5d72-4e1b-bdc2-6ba76ffaf85f">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9329656f7a714f9e906a28f984a13e6d_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQzLTgtMS0xLTU0NzA5OA_be2d7c36-58fa-46b8-a39f-1603dce0eeda">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net adjustments reclassified from AOCI to Shareholders' net income</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deee6eee2ee46eeafe6188d0a931786_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQ0LTYtMS0xLTU0NzA5OA_88eff44f-1df4-4bb1-8f34-779f206be328">10</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9329656f7a714f9e906a28f984a13e6d_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQ0LTgtMS0xLTU0NzA5OA_50455c5b-6556-4084-a54e-ec6ae5d8fa63">13</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deee6eee2ee46eeafe6188d0a931786_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQ4LTYtMS0xLTU0NzA5OA_39600754-0848-449f-bd7e-f241ec0c0eb3">10</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9329656f7a714f9e906a28f984a13e6d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQ4LTgtMS0xLTU0NzA5OA_75e407d6-9d50-4e04-acf7-91ca5d284b44">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7bdac56a5c747909f091b44b4679bf5_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQ5LTYtMS0xLTU0NzA5OA_025d8295-b251-4e23-868a-480b0834b19c">906</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida787829236f4e5b915c9415a14edb54_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQ5LTgtMS0xLTU0NzA5OA_205491b1-694a-4f5f-ae01-b96b4286686b">1,323</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance, as retrospectively restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b7588439a24468b996c973b3308b0f_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzU3LTYtMS0xLTU4NjYwMw_7cc07ddf-8c5e-42e7-b1c3-c98c26233a43">1,658</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c898b920ca42a186661453324aadcd_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzU3LTgtMS0xLTU4NjYwMw_72b136a2-703e-49df-9a1d-576393840f9f">1,068</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shareholders' other comprehensive (loss), net of tax</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c0abb6b8064491c945d2af1005f4e61_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzU4LTYtMS0xLTU4NjYwMw_c24bed45-b527-4642-bc67-be0321735abd">111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e9fa809dec40e4a4434d5f6b246b71_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzU4LTgtMS0xLTU4NjYwMw_8d969008-8021-4aaa-974d-e80fa672ce97">432</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ca2b0796c79476594136b360600f553_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzU5LTYtMS0xLTU4NjYwMw_10fae0ef-b3bd-4e06-a2b0-67c1dea3223b">1,769</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e8477b53954f2eb5c8d27ecfddb379_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzU5LTgtMS0xLTU4NjYwMw_f2293a62-108d-498f-8bb7-ede60597ab4b">1,500</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.94pt">Established upon the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</span></div></ix:nonNumeric><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_859"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NTkvZnJhZzpjNzgxN2FmY2FlNzM0NDVmYjU1OTJiYjA0Zjc0Y2E2NC90ZXh0cmVnaW9uOmM3ODE3YWZjYWU3MzQ0NWZiNTU5MmJiMDRmNzRjYTY0XzEx_b644f664-09bd-4e6f-a875-fa0c21bf28c4" continuedAt="iec16d52f4fc446e7844c296a9a0c0c12" escape="true">Note 15 &#8211; Income Taxes</ix:nonNumeric></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_862"></div><ix:continuation id="iec16d52f4fc446e7844c296a9a0c0c12" continuedAt="if4ca90db66f346b0a1889dfb3cc76f2c"><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Income Tax Expense</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The <ix:nonFraction unitRef="number" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NjIvZnJhZzo3YWZiYzE3NDQ3MDg0OTA1YjQ0MjY1M2UzYzE1NTUxYy90ZXh0cmVnaW9uOjdhZmJjMTc0NDcwODQ5MDViNDQyNjUzZTNjMTU1NTFjXzg4_6d251a54-555a-4eae-b220-4b72f4028fe9">18.4</ix:nonFraction>% effective tax rate for the three months ended March&#160;31, 2023 was lower than the <ix:nonFraction unitRef="number" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NjIvZnJhZzo3YWZiYzE3NDQ3MDg0OTA1YjQ0MjY1M2UzYzE1NTUxYy90ZXh0cmVnaW9uOjdhZmJjMTc0NDcwODQ5MDViNDQyNjUzZTNjMTU1NTFjXzE5NQ_51312052-7c7d-4859-b982-37bc2bb8a8fd">22.7</ix:nonFraction>% rate for the three months ended March&#160;31, 2022. This decrease was driven largely by favorable results relative to the Company's foreign operations, partially offset by an increase pertaining to the year over year impact of remeasurement of deferred taxes. </span></div></ix:continuation><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_5573"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="if4ca90db66f346b0a1889dfb3cc76f2c">As of March&#160;31, 2023, we had approximately $<ix:nonFraction unitRef="usd" contextRef="icfbd026f02e243f087fcef41ca300348_I20230331" decimals="-6" name="ci:DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTczL2ZyYWc6ODkzMDJiZjk1OTAyNDk0OTlhYjA5ODRlMmMxOTdmZWYvdGV4dHJlZ2lvbjo4OTMwMmJmOTU5MDI0OTQ5OWFiMDk4NGUyYzE5N2ZlZl8zNg_2c512830-96bd-40cc-8ee2-33a522794fc2">255</ix:nonFraction>&#160;million in deferred tax assets ("DTAs") associated with unrealized investment losses that are partially recorded in Accumulated other comprehensive loss. We have determined that a valuation allowance against the DTAs is not currently required based on the Company's ability to carryback losses and our ability and intent to hold certain securities until recovery. We continue to monitor and evaluate the need for any valuation allowance in the future.</ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_871"></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NzEvZnJhZzo1NjJlNTVkMTdkMDY0Mzg3ODYxZjEyNGFiYzgzMTFmNC90ZXh0cmVnaW9uOjU2MmU1NWQxN2QwNjQzODc4NjFmMTI0YWJjODMxMWY0XzI5MTA_8e2d96e8-48d0-47bb-a1c1-810c0ca03da8" continuedAt="i58f3cf4c88974a57bc2d5aad0afbd449" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 16 &#8211; Contingencies and Other Matters</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company, through its subsidiaries, is contingently liable for various guarantees provided in the ordinary course of business.</span></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NzEvZnJhZzo1NjJlNTVkMTdkMDY0Mzg3ODYxZjEyNGFiYzgzMTFmNC90ZXh0cmVnaW9uOjU2MmU1NWQxN2QwNjQzODc4NjFmMTI0YWJjODMxMWY0XzI5MDI_80c9654f-2985-4e6f-9dfe-e899dd45db34" continuedAt="i8f9645bc3cf64d648452ac5df4177636" escape="true">Financial Guarantees: Retiree and Life Insurance Benefits</ix:nonNumeric></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i8f9645bc3cf64d648452ac5df4177636" continuedAt="ib3d507107ece4c75a54488488c2ad56c">The Company guarantees that separate account assets will be sufficient to pay certain life insurance or retiree benefits. For the majority of these benefits, the sponsoring employers are primarily responsible for ensuring that assets are sufficient to pay these benefits and are required to maintain assets that exceed a certain percentage of benefit obligations. If employers fail to do so, the Company or an affiliate of the buyer of the retirement benefits business has the right to redirect the management of the related assets to provide for benefit payments.</ix:continuation> As of March&#160;31, 2023, employers maintained assets that generally exceeded the benefit obligations under these arrangements of approximately $<ix:nonFraction unitRef="usd" contextRef="i854c62090cb94df2a90a243d3b2a0448_I20230331" decimals="-6" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NzEvZnJhZzo1NjJlNTVkMTdkMDY0Mzg3ODYxZjEyNGFiYzgzMTFmNC90ZXh0cmVnaW9uOjU2MmU1NWQxN2QwNjQzODc4NjFmMTI0YWJjODMxMWY0Xzg5NQ_eb9361f8-5555-43d7-a4ba-0377392cb863"><ix:nonFraction unitRef="usd" contextRef="i003bcebd887e4bdcb34dc4edd5766fda_D20230101-20230331" decimals="-6" name="us-gaap:GuaranteeObligationsLiquidationProceeds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NzEvZnJhZzo1NjJlNTVkMTdkMDY0Mzg3ODYxZjEyNGFiYzgzMTFmNC90ZXh0cmVnaW9uOjU2MmU1NWQxN2QwNjQzODc4NjFmMTI0YWJjODMxMWY0Xzg5NQ_f95ff50a-fb76-434f-bd09-57de323008be">420</ix:nonFraction></ix:nonFraction> million. <ix:continuation id="ib3d507107ece4c75a54488488c2ad56c" continuedAt="ia323414e81b64113bf0f1bce903340b1">An additional liability is established if management believes that the Company will be required to make payments under the guarantees;</ix:continuation> there were <ix:nonFraction unitRef="usd" contextRef="i854c62090cb94df2a90a243d3b2a0448_I20230331" decimals="INF" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NzEvZnJhZzo1NjJlNTVkMTdkMDY0Mzg3ODYxZjEyNGFiYzgzMTFmNC90ZXh0cmVnaW9uOjU2MmU1NWQxN2QwNjQzODc4NjFmMTI0YWJjODMxMWY0XzEwNDU_bf786559-90b4-4004-bb93-597d0b13ca4c">no</ix:nonFraction> additional liabilities required for these guarantees, net of reinsurance, as of March&#160;31, 2023. <ix:continuation id="ia323414e81b64113bf0f1bce903340b1" continuedAt="i8f70dccbc376411382ce1a84364f66c5">Separate account assets supporting these guarantees are classified in Levels 1 and 2 of the GAAP fair value hierarchy.</ix:continuation></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company does not expect that these financial guarantees will have a material effect on the Company's consolidated results of operations, liquidity or financial condition.</span></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.84pt;text-decoration:underline"><ix:continuation id="i8f70dccbc376411382ce1a84364f66c5" continuedAt="i63ea13c6499b4fc49b23bb2eb12f1d58">Certain Other Guarantees</ix:continuation></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i63ea13c6499b4fc49b23bb2eb12f1d58" continuedAt="iee6d3ec4ccfa49bfa07501beef16414d">The Company had indemnification obligations as of March&#160;31, 2023 in connection with acquisition and disposition transactions. These indemnification obligations are triggered by the breach of representations or covenants provided by the Company, such as representations for the presentation of financial statements, filing of tax returns, compliance with law or identification of outstanding litigation. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential amount due is subject to contractual limitations based on a percentage of the transaction purchase price, while in other cases limitations are not specified or applicable. The Company does not believe that it is possible to determine the maximum potential amount due under these obligations because not all amounts due under these indemnification obligations are subject to limitation.</ix:continuation> There were <ix:nonFraction unitRef="usd" contextRef="i6ffe330f5d2e42feb4023beb365c915f_I20230331" decimals="INF" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NzEvZnJhZzo1NjJlNTVkMTdkMDY0Mzg3ODYxZjEyNGFiYzgzMTFmNC90ZXh0cmVnaW9uOjU2MmU1NWQxN2QwNjQzODc4NjFmMTI0YWJjODMxMWY0XzI0MjU_dca831f8-0886-49b3-9c06-2b059818581a">no</ix:nonFraction> liabilities for these indemnification obligations as of March&#160;31, 2023.</span></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">C.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline"><ix:continuation id="iee6d3ec4ccfa49bfa07501beef16414d" continuedAt="i41508b19f8604602aff435e63ad6d557">Guaranty Fund Assessments</ix:continuation></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i41508b19f8604602aff435e63ad6d557">The Company operates in a regulatory environment that may require its participation in assessments under state insurance guaranty association laws. The Company's exposure to assessments for certain obligations of insolvent insurance companies to policyholders and claimants is based on its share of business written in the relevant jurisdictions.</ix:continuation></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There were no material charges or credits resulting from existing or new guaranty fund assessments for the three months ended March&#160;31, 2023.</span></div></ix:nonNumeric><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_877"></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt;text-decoration:underline"><ix:continuation id="i58f3cf4c88974a57bc2d5aad0afbd449" continuedAt="iafd93eb93fda4a2cb19a3939d2073ba0">Legal and Regulatory Matters</ix:continuation></span></div><div><ix:continuation id="iafd93eb93fda4a2cb19a3939d2073ba0" continuedAt="if7070c0616314c0a863f1c84817bb5b7"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is routinely involved in numerous claims, lawsuits, regulatory inquiries and audits, government investigations, including under the federal False Claims Act and state false claims acts initiated by a government investigating body or by a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> relator's filing of a complaint under court seal, and other legal matters arising, for the most part, in the ordinary course of managing a global health services business. Additionally, the Company has received and is cooperating with subpoenas or similar processes from various governmental agencies requesting information, all arising in the normal course of its business. Disputed tax matters arising </span></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="if7070c0616314c0a863f1c84817bb5b7" continuedAt="i611021f1957749699f71822e6c280021">from audits by the Internal Revenue Service or other state and foreign jurisdictions, including those resulting in litigation, are accounted for under GAAP guidance for uncertain tax positions.</ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_880"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i611021f1957749699f71822e6c280021" continuedAt="i0c0d5a071b654f12aaa6152cb40b57b3">Pending litigation and legal or regulatory matters that the Company has identified with a reasonably possible material loss and certain other material litigation matters are described below. For those matters that the Company has identified with a reasonably possible material loss, the Company provides disclosure in the aggregate of accruals and range of loss, or a statement that such information cannot be estimated. The Company's accruals for the matters discussed below under "Litigation Matters" and "Regulatory Matters" are not material. Due to numerous uncertain factors presented in these cases, it is not possible to estimate an aggregate range of loss (if any) for these matters at this time. In light of the uncertainties involved in these matters, there is no assurance that their ultimate resolution will not exceed the amounts currently accrued by the Company. An adverse outcome in one or more of these matters could be material to the Company's results of operations, financial condition or liquidity for any particular period. The outcomes of lawsuits are inherently unpredictable and we may be unsuccessful in these ongoing litigation matters or any future claims or litigation.</ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_883"></div><ix:continuation id="i0c0d5a071b654f12aaa6152cb40b57b3"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Litigation Matters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Express Scripts Litigation with Elevance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In March 2016, Elevance filed a lawsuit in the United States District Court for the Southern District of New York alleging various breach of contract claims against Express Scripts relating to the parties' rights and obligations under the periodic pricing review section of the pharmacy benefit management agreement between the parties including allegations that Express Scripts failed to negotiate new pricing concessions in good faith, as well as various alleged service issues. Elevance also requested that the court enter declaratory judgment that Express Scripts is required to provide Elevance competitive benchmark pricing, that Elevance can terminate the agreement and that Express Scripts is required to provide Elevance with post-termination services at competitive benchmark pricing for one year following any termination by Elevance. Elevance claimed it is entitled to $<ix:nonFraction unitRef="usd" contextRef="ie05d40387e70450eb97782a7626bd016_D20160301-20160331" decimals="-9" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1Xzk0Nw_588bb41a-5001-4f07-8e37-ad53965c6141">13</ix:nonFraction> billion in additional pricing concessions over the remaining term of the agreement, as well as $<ix:nonFraction unitRef="usd" contextRef="i2602421334c748649e7b6a705dad545e_D20160301-20160331" decimals="-8" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzEwMzc_5efa5e24-6801-4a67-87af-fbcd8a154d68">1.8</ix:nonFraction> billion for one year following any contract termination by Elevance and $<ix:nonFraction unitRef="usd" contextRef="i3e3b74c468ff4912bbea80db07b86240_D20160301-20160331" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzExMDQ_2dc714cf-814e-4882-8a17-63e28868de6d">150</ix:nonFraction> million damages for service issues ("Elevance's Allegations"). On April 19, 2016, in response to Elevance's complaint, Express Scripts filed its answer denying Elevance's Allegations in their entirety and asserting affirmative defenses and counterclaims against Elevance. The court subsequently granted Elevance's motion to dismiss <ix:nonFraction unitRef="claim" contextRef="i41708a20f5d543b49694e126b9d63ab6_D20160419-20160419" decimals="INF" name="us-gaap:LossContingencyClaimsDismissedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzE0MzE_5eae7fe8-4a6d-4c5d-a7d8-7265c851abc6">two</ix:nonFraction> of <ix:nonFraction unitRef="claim" contextRef="i4776d8e52c934378b5373425506ecca3_I20160419" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzE0Mzc_61c7eac7-e8bd-42ef-a7fe-7e2a083010d8">six</ix:nonFraction> counts of Express Scripts' amended counterclaims. Express Scripts filed its Motion for Summary Judgment on August 27, 2021. Elevance completed filing of its Response to Express Scripts' Motion for Summary Judgment on October 16, 2021. Express Scripts filed its Reply in Support of its Motion for Summary Judgment on November 19, 2021. On March 31, 2022, the court granted summary judgment in favor of Express Scripts on all of Elevance's pricing claims for damages totaling $<ix:nonFraction unitRef="usd" contextRef="i6bd9f07d9d3a43dab2134f8b473b3aa9_D20220331-20220331" decimals="-8" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzE5MTQ_ee342915-b87a-45cb-b01b-5c1acd9135cc">14.8</ix:nonFraction> billion and on most of Elevance's claims relating to service issues. Elevance's only remaining service claims relate to the review or processing of prior authorizations. On June 10, 2022, Express Scripts filed a Motion for Partial Summary Judgment seeking to limit Elevance's remaining prior authorization claims and a Motion to Exclude certain opinions offered by its experts. Elevance filed its opposition to both motions, and a cross-motion to submit a supplemental expert report, on July 9, 2022. Express Scripts' pending Motions were fully briefed at the end of July 2022. On March 8, 2023, the Court granted Express Scripts' Motion for Partial Summary Judgement, excluding in full the testimony of <ix:nonFraction unitRef="expert" contextRef="ife782ca69c664ec9a42a195307da9dad_I20230308" decimals="INF" name="ci:CommitmentsAndContingenciesNumberOfExpert" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzQxNzgxNDQxODYwMzY2_e3bae527-5800-4bcf-a3a1-8e4bd570cf71">four</ix:nonFraction> of Elevance's experts and in part the testimony of <ix:nonFraction unitRef="expert" contextRef="ife782ca69c664ec9a42a195307da9dad_I20230308" decimals="INF" name="ci:CommitmentsAndContingenciesNumberOfAdditionalExpert" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzQxNzgxNDQxODYwMzY3_8596592f-6340-4a18-ac98-e05e51cd2054">two</ix:nonFraction> additional experts, and granted Elevance leave to submit a supplemental expert report. On April 5, 2023, the Court entered a scheduling order setting a trial on Elevance's remaining prior authorization claims to commence on December 4, 2023.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Medicare Advantage. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> action that was filed by a private individual on behalf of the government in the United States District Court for the Southern District of New York in 2017 was unsealed on August 6, 2020. The action asserts claims related to risk adjustment practices arising from certain health exams conducted as part of the Company's Medicare Advantage business. In September 2021, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> action was transferred to the United States District Court for the Middle District of Tennessee. On January 11, 2022, the U.S. Department of Justice ("DOJ") (U.S. Attorney's Offices for the Southern District of New York and the Middle District of Tennessee) filed a motion to partially intervene, which was granted on August 2, 2022. On October 14, 2022, the DOJ filed its complaint-in-intervention alleging that certain diagnoses made during in-home exams were invalid for risk adjustment purposes, seeking unspecified damages and penalties under the federal False Claims Act. The Company filed motions to dismiss the DOJ's complaint and the remainder of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> complaint on December 16, 2022. Briefing is complete and the matter is pending before the court.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Regulatory Matters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Civil Investigative Demand</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The DOJ is conducting industry-wide investigations of Medicare Advantage organizations' risk adjustment practices. For certain Medicare Advantage organizations, including The Cigna Group, those investigations have resulted in litigation (see "Litigation Matters&#8212;Medicare Advantage" above). The Company has responded to information requests (civil investigative demands) from the DOJ (U.S. Attorney's Office for the Eastern District of Pennsylvania) and is continuing to cooperate with the DOJ.</span></div></ix:continuation><div style="margin-bottom:10pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_889"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODkvZnJhZzozY2IwZmQzMjY5N2M0YWM5OWM1YjQ0NGU1NzNkZWZiYi90ZXh0cmVnaW9uOjNjYjBmZDMyNjk3YzRhYzk5YzViNDQ0ZTU3M2RlZmJiXzU5Nw_ba23af6b-8910-41f9-b919-687bf464495a" continuedAt="if61881648c3c4cb9bd826a3601e6a660" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 17 &#8211; Segment Information</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See Note 1 to the Consolidated Financial Statements for a description of our segments. A description of our basis for reporting segment operating results is outlined below. <ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODkvZnJhZzozY2IwZmQzMjY5N2M0YWM5OWM1YjQ0NGU1NzNkZWZiYi90ZXh0cmVnaW9uOjNjYjBmZDMyNjk3YzRhYzk5YzViNDQ0ZTU3M2RlZmJiXzYwMA_2971c4aa-58fc-40f5-89c0-06c378b69539" continuedAt="ic7bb711ef97540e9961cff7708d3467c" escape="true">Intersegment revenues primarily reflect pharmacy and care services transactions between the Evernorth Health Services and Cigna Healthcare segments.</ix:nonNumeric></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ic7bb711ef97540e9961cff7708d3467c" continuedAt="iefb28b609ee9462ea3094622497dea83">The Company uses "pre-tax adjusted income (loss) from operations" and "adjusted revenues" as its principal financial measures of segment operating performance because management believes these metrics best reflect the underlying results of business operations and permit analysis of trends in underlying revenue, expenses and profitability. We define pre-tax adjusted income from operations as income before income taxes excluding pre-tax income (loss) attributable to noncontrolling interests, net realized investment results, amortization of acquired intangible assets, and special items. The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. Adjusted income (loss) from operations is measured on an after-tax basis for consolidated results and on a pre-tax basis for segment results. </ix:continuation></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="iefb28b609ee9462ea3094622497dea83">The Company defines adjusted revenues as total revenues excluding the following adjustments: special items and The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. We exclude these items from this measure because management believes they are not indicative of past or future underlying performance of the business.</ix:continuation> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company does not report total assets by segment because this is not a metric used to allocate resources or evaluate segment performance.</span></div></ix:nonNumeric><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_549755819942"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="if61881648c3c4cb9bd826a3601e6a660" continuedAt="i452309bc974a49809a4793a5f706e611">Special items charges (benefits) recorded by the Company were $<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDk3NTU4MTk5NDIvZnJhZzpiYTU5MzQzZWMwODY0NThhYjNjYWRmODc4NGZkMjA5Ny90ZXh0cmVnaW9uOmJhNTkzNDNlYzA4NjQ1OGFiM2NhZGY4Nzg0ZmQyMDk3XzU0OTc1NTgxNDA5Ng_4855afe8-d852-4748-95a4-0ddbde0d0a8a"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDk3NTU4MTk5NDIvZnJhZzpiYTU5MzQzZWMwODY0NThhYjNjYWRmODc4NGZkMjA5Ny90ZXh0cmVnaW9uOmJhNTkzNDNlYzA4NjQ1OGFiM2NhZGY4Nzg0ZmQyMDk3XzU0OTc1NTgxNDA5Ng_c8ee9758-1611-44e0-812f-74f04482cb28">1</ix:nonFraction></ix:nonFraction> million both pre-tax and after-tax for the three months ended March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDk3NTU4MTk5NDIvZnJhZzpiYTU5MzQzZWMwODY0NThhYjNjYWRmODc4NGZkMjA5Ny90ZXh0cmVnaW9uOmJhNTkzNDNlYzA4NjQ1OGFiM2NhZGY4Nzg0ZmQyMDk3XzU0OTc1NTgxNDE3Ng_91a83145-5e09-4c44-97eb-b28c40d6b8bb">52</ix:nonFraction> million pre-tax ($<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDk3NTU4MTk5NDIvZnJhZzpiYTU5MzQzZWMwODY0NThhYjNjYWRmODc4NGZkMjA5Ny90ZXh0cmVnaW9uOmJhNTkzNDNlYzA4NjQ1OGFiM2NhZGY4Nzg0ZmQyMDk3XzU0OTc1NTgxNDE5Mg_49be9318-5f4f-4089-bffb-73f784a3423f">37</ix:nonFraction> million after-tax) for the three months ended March&#160;31, 2022. </ix:continuation></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_895"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i452309bc974a49809a4793a5f706e611" continuedAt="iebb768e6c55648f9aba36c2390d66fa1"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84OTUvZnJhZzpjNGJkNmYzNjlhZTA0NGI3ODQwM2ZhYzg3OGYxOTk4NS90ZXh0cmVnaW9uOmM0YmQ2ZjM2OWFlMDQ0Yjc4NDAzZmFjODc4ZjE5OTg1XzYw_1fcdd39a-ff6a-4e51-82d7-e5a3dcb10263" continuedAt="i26d7103bdbd54c9d812217cce279a1c5" escape="true">Effective January 1, 2023, we adopted amended accounting guidance for long-duration insurance contracts. See Note 2 to the Consolidated Financial Statements for further information. Prior period summarized segment information has been retrospectively adjusted to conform to this new basis of accounting. Summarized segment financial information was as follows:</ix:nonNumeric></ix:continuation></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">32</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_901"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span><ix:continuation id="iebb768e6c55648f9aba36c2390d66fa1" continuedAt="i42eed22cb5f04fd296a1e631263df5af"><ix:continuation id="i26d7103bdbd54c9d812217cce279a1c5" continuedAt="i3cd29715ba9c4779a75388bf26efd6f0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Evernorth Health Services</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cigna Healthcare</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Operations</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate and Eliminations</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="33" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ea40c1add1f432fa8308f993c435e87_D20230101-20230331" decimals="-6" name="ci:NonInvestmentRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzItMi0xLTEtNTQ3MDk4_a649ce32-548e-4d40-94ae-6264bfe5ce4d">34,511</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331" decimals="-6" name="ci:NonInvestmentRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzItNC0xLTEtNTQ3MDk4_3263963b-cc42-4d21-9b97-a1527e1c20b5">11,650</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69df325bba59494fa467077df69372c4_D20230101-20230331" decimals="-6" name="ci:NonInvestmentRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzItNi0xLTEtNTQ3MDk4_6b17051a-cef8-40e9-ad5e-907820f46c3a">79</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477f7b8fc897444eb3eebca010f1c1a0_D20230101-20230331" decimals="-6" name="ci:NonInvestmentRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzItOC0xLTEtNTQ3MDk4_a8956a44-463c-4174-961a-0ab698e5f521">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:NonInvestmentRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzItMTAtMS0xLTU0NzA5OA_3cf2cf9a-f5e8-4d6b-b9e5-d697ab990397">46,240</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aa4b4d327cd427280e23f867e7643d7_D20230101-20230331" decimals="-6" sign="-" name="ci:NonInvestmentRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMtMi0xLTEtNTQ3MDk4_74f2ea28-20e9-4a01-ba6b-c63ccfe96637">1,618</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070491a32c554309b0445a4d7d37f76a_D20230101-20230331" decimals="-6" sign="-" name="ci:NonInvestmentRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMtNC0xLTEtNTQ3MDk4_218caaa9-bcea-4e13-af02-a3c53f76ee58">963</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b088ac82fa046b686f50cf0918542f7_D20230101-20230331" decimals="-6" name="ci:NonInvestmentRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMtNi0xLTEtNTQ3MDk4_c31d0006-412a-47e9-83a7-b8da65774554">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06b3a5cafe1847468ebadf3df7edea80_D20230101-20230331" decimals="-6" sign="-" name="ci:NonInvestmentRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMtOC0xLTEtNTQ3MDk4_83851408-73e0-4cc3-a19d-d69f686c82a3">2,581</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net investment income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQtMi0xLTEtNTQ3MDk4_e014c3bc-a2ce-4159-84be-397f4ff1d68d">50</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQtNC0xLTEtNTQ3MDk4_2fd613d4-6194-4a30-9fc2-b989ca3d105e">143</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQtNi0xLTEtNTQ3MDk4_68a69127-9d0f-4010-a565-4151ae2d5dd2">78</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQtOC0xLTEtNTQ3MDk4_88410f9f-244a-426e-b584-42d99a58f187">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQtMTAtMS0xLTU0NzA5OA_f2c2aa6d-0e4b-483c-b35e-4b6b5c05444e">277</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUtMi0xLTEtNTQ3MDk4_77cf4103-606f-476b-b9bc-e0c6385effb2">36,179</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUtNC0xLTEtNTQ3MDk4_3915a51d-a360-4174-9382-b21563d1f4b5">12,756</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUtNi0xLTEtNTQ3MDk4_26701e7e-d24b-4296-b3e1-690204c40fcb">157</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUtOC0xLTEtNTQ3MDk4_3a71a27e-8172-4a2f-a3f9-a72af5bddc99">2,575</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUtMTAtMS0xLTU0NzA5OA_b1fa3dea-7f5e-48e2-b2f2-265498154538">46,517</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net realized investment results from certain equity method investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331" decimals="-6" name="ci:RealizedInvestmentGainsLossesEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzYtMi0xLTEtNTQ3MDk4_9e6a75e3-59f8-4a24-bca6-c259c750ac6e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331" decimals="-6" name="ci:RealizedInvestmentGainsLossesEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzYtNC0xLTEtNTQ3MDk4_904268d4-0d9c-40a8-aada-1f3178d56f12">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331" decimals="-6" name="ci:RealizedInvestmentGainsLossesEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzYtNi0xLTEtNTQ3MDk4_0bfdfb6d-1315-49c7-b546-6b7cc17eec6a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331" decimals="-6" name="ci:RealizedInvestmentGainsLossesEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzYtOC0xLTEtNTQ3MDk4_29143155-3ae7-484a-9692-19a6c9420ae8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:RealizedInvestmentGainsLossesEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzYtMTAtMS0xLTU0NzA5OA_c6b551de-87ec-4c31-b694-34fcbeba6513">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331" decimals="-6" name="ci:SegmentRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzgtMi0xLTEtNTQ3MDk4_00fa4f40-0b55-405a-8dbb-a458d8a7cbf4">36,179</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331" decimals="-6" name="ci:SegmentRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzgtNC0xLTEtNTQ3MDk4_f5afbe6b-c245-4858-b085-d45438d014ae">12,718</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331" decimals="-6" name="ci:SegmentRevenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzgtNi0xLTEtNTQ3MDk4_86647f5e-380f-42d0-b31e-9882b6ca3f3d">157</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331" decimals="-6" sign="-" name="ci:SegmentRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzgtOC0xLTEtNTQ3MDk4_d1b27e4e-7227-41f2-a2da-7bfae49fc1bb">2,575</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:SegmentRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzgtMTAtMS0xLTU0NzA5OA_296d3757-0b98-4e06-b535-3e0b6166cf5f">46,479</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEwLTItMS0xLTU0NzA5OA_8dda3df1-7395-4496-9b1a-77adc33844de">918</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEwLTQtMS0xLTU0NzA5OA_9fca3e26-3c33-477e-988a-e14d71a391b2">1,077</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEwLTYtMS0xLTU0NzA5OA_29e2a362-6289-4a45-8bc9-4c2274e74676">21</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEwLTgtMS0xLTU0NzA5OA_38dadec9-7cf5-4ca9-948e-88c9f7566670">415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEwLTEwLTEtMS01NDcwOTg_f25abd6e-c73a-4be9-bc8d-0359417f7b88">1,601</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-tax adjustments to reconcile to adjusted income from operations</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Income) attributable to noncontrolling interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331" decimals="-6" name="ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEyLTItMS0xLTU0NzA5OA_8e9d4205-0b96-4cc2-af93-24536ffd0e56">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331" decimals="-6" name="ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEyLTQtMS0xLTU0NzA5OA_7a31bc9c-10ad-4d52-a850-1e8fc206bf7d">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331" decimals="-6" name="ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEyLTYtMS0xLTU0NzA5OA_d0e0bd50-5f0f-4e67-af19-ede7308f37c5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477f7b8fc897444eb3eebca010f1c1a0_D20230101-20230331" decimals="-6" name="ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEyLTgtMS0xLTU0NzA5OA_b6528e38-f29e-499c-80d5-4a40028ec761">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEyLTEwLTEtMS01NDcwOTg_be51d583-2e19-4824-a393-39ffab511d60">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment losses (gains) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331" decimals="-6" name="ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEzLTItMS0xLTU0NzA5OA_47088b60-d3b8-4664-b00c-f2d632fcc90c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEzLTQtMS0xLTU0NzA5OA_20344983-f4ea-4d23-9a4e-583c1c675679">24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331" decimals="-6" name="ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEzLTYtMS0xLTU0NzA5OA_3b5c09cd-013f-42c7-9fe0-19e41e09f044">6</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477f7b8fc897444eb3eebca010f1c1a0_D20230101-20230331" decimals="-6" name="ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEzLTgtMS0xLTU0NzA5OA_6f2ac3a6-65aa-4700-88cb-6c8a60115827">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEzLTEwLTEtMS01NDcwOTg_b24b9efd-7734-4620-ad28-af771f595d49">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE0LTItMS0xLTU0NzA5OA_ebdd075e-ba0a-4d2f-a11b-b1e4d2c8f16f">444</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE0LTQtMS0xLTU0NzA5OA_290838fb-13dc-428f-a34a-5154f42c771e">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE0LTYtMS0xLTU0NzA5OA_43e5c31a-3ed3-4a34-8feb-252678e6d1f3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477f7b8fc897444eb3eebca010f1c1a0_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE0LTgtMS0xLTU0NzA5OA_8e45632b-9ced-4e13-92b7-a433572565e1">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE0LTEwLTEtMS01NDcwOTg_ae32cc59-b395-4cc0-a6d1-6c57776ba05a">459</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Special items</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integration and transaction-related costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331" decimals="-6" name="ci:TransactionRelatedCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE2LTItMS0xLTU0NzA5OA_01ab55cd-0d66-4d2c-915b-1c4cb33599d4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331" decimals="-6" name="ci:TransactionRelatedCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE2LTQtMS0xLTU0NzA5OA_d117ac11-bf13-4a9e-9954-bbe1476ef253">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331" decimals="-6" name="ci:TransactionRelatedCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE2LTYtMS0xLTU0NzA5OA_86548429-8dc2-4533-9c00-497f4df22f84">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477f7b8fc897444eb3eebca010f1c1a0_D20230101-20230331" decimals="-6" name="ci:TransactionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE2LTgtMS0xLTU0NzA5OA_f33b77d0-6ccf-4060-8f95-13107dc816ae">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:TransactionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE2LTEwLTEtMS01NDcwOTg_4fe784a1-6e42-4ada-bb5d-f989fa748a9b">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted income (loss) from operations</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331" decimals="-6" name="ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI0LTItMS0xLTU0NzA5OA_fdb0f6cb-8835-4187-a9db-05372d14c8fb">1,320</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331" decimals="-6" name="ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI0LTQtMS0xLTU0NzA5OA_e3eb771a-5c53-45cb-80d6-fd3d1ffaf958">1,115</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331" decimals="-6" name="ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI0LTYtMS0xLTU0NzA5OA_6186b18d-90d0-4d7a-afc0-06f656a59051">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331" decimals="-6" sign="-" name="ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI0LTgtMS0xLTU0NzA5OA_e1561ae1-2bdf-47ab-ab2d-c0559e899bad">414</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI0LTEwLTEtMS01NDcwOTg_15391f32-081a-4ecf-9a29-5d32dc5924e4">2,036</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Evernorth Health Services</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cigna Healthcare</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Operations</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate and Eliminations</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="33" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues from external customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21521b1995554ec8b02652d45c45d285_D20220101-20220331" decimals="-6" name="ci:NonInvestmentRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI4LTItMS0xLTU0NzA5OA_bdca7244-feed-44c4-b684-2d3b69fa3580">32,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331" decimals="-6" name="ci:NonInvestmentRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI4LTQtMS0xLTU0NzA5OA_83ef90b5-2e29-4848-91fa-9c12bcf1c60e">10,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95c34c40cb7248e783ae13fc742a640d_D20220101-20220331" decimals="-6" name="ci:NonInvestmentRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI4LTYtMS0xLTU0NzA5OA_952c1a1d-e104-4462-b4a3-666a8f6d7e39">841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95354c853bf4761a405bfd3190f1ed6_D20220101-20220331" decimals="-6" name="ci:NonInvestmentRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI4LTgtMS0xLTU0NzA5OA_f3204551-baaa-473b-be25-ad6a7f8e76ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:NonInvestmentRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI4LTEwLTEtMS01NDcwOTg_c8b71c6f-c04b-450c-938c-b0f8a4b03c07">43,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4127249d3cc243de9f905eb276897d65_D20220101-20220331" decimals="-6" sign="-" name="ci:NonInvestmentRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI5LTItMS0xLTU0NzA5OA_dc3df917-6a3e-4a78-9c3e-2b7bb82a06ab">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i569d8e14804541b9a5e8a0e5a286a5bc_D20220101-20220331" decimals="-6" sign="-" name="ci:NonInvestmentRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI5LTQtMS0xLTU0NzA5OA_890a540b-a528-4281-aa28-ff99cff572f9">562</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i724c42af69b6448fb2e4a5b6e6c155f7_D20220101-20220331" decimals="-6" name="ci:NonInvestmentRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI5LTYtMS0xLTU0NzA5OA_5c434ee1-88cb-4d33-8933-5fd54738b232">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098db1bf768848acb5c35d20817215a9_D20220101-20220331" decimals="-6" sign="-" name="ci:NonInvestmentRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI5LTgtMS0xLTU0NzA5OA_54a6a52a-fa77-4fdc-9469-637e67a58024">1,849</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net investment income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMwLTItMS0xLTU0NzA5OA_0fd5bb88-68a7-4aba-8e3c-290ebc52ddb9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMwLTQtMS0xLTU0NzA5OA_00fa5f5b-79d2-4024-bf6f-6489c641375d">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMwLTYtMS0xLTU0NzA5OA_952b5c75-79c3-47cb-9728-1d483e934a94">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMwLTgtMS0xLTU0NzA5OA_5b1b8b90-3573-4ad3-a275-5549c3834d87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMwLTEwLTEtMS01NDcwOTg_9a03e151-a664-4f9e-9390-e148c0df0368">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMxLTItMS0xLTU0NzA5OA_c6d58d90-2d70-4231-8d3a-803d230bfaf1">33,586</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMxLTQtMS0xLTU0NzA5OA_2a73b2ac-d30c-4a69-b586-52bd4d63fb05">11,290</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMxLTYtMS0xLTU0NzA5OA_c64b9727-ee95-461c-8139-c27c28081840">979</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMxLTgtMS0xLTU0NzA5OA_8a04ada7-3c51-463c-b8ad-77e6dabb945e">1,849</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMxLTEwLTEtMS01NDcwOTg_e135917b-3c0f-4ffe-90a1-07a8cccf6a62">44,006</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net realized investment results from certain equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331" decimals="-6" name="ci:RealizedInvestmentGainsLossesEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMzLTItMS0xLTU0NzA5OA_d479ef98-7e45-4de2-b9f1-64bd10ea9a7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainsLossesEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMzLTQtMS0xLTU0NzA5OA_3d1e1ed8-dad1-4982-a276-7099063ae4a2">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331" decimals="-6" name="ci:RealizedInvestmentGainsLossesEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMzLTYtMS0xLTU0NzA5OA_bac537bb-91b5-4f27-9aa9-4ea9a46933ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331" decimals="-6" name="ci:RealizedInvestmentGainsLossesEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMzLTgtMS0xLTU0NzA5OA_3f417c00-2490-410a-a51d-e33a3aa8e5c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainsLossesEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMzLTEwLTEtMS01NDcwOTg_22d200c4-6566-492d-a9b4-df7e5ae5a08d">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331" decimals="-6" name="ci:SegmentRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM1LTItMS0xLTU0NzA5OA_43c8d5ef-6ae2-46d3-ae00-1c9ba6bbad0c">33,586</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331" decimals="-6" name="ci:SegmentRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM1LTQtMS0xLTU0NzA5OA_fd782bab-3c9a-4fb4-9b42-5b41fc50e9f3">11,393</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331" decimals="-6" name="ci:SegmentRevenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM1LTYtMS0xLTU0NzA5OA_c61921e5-992e-4626-99db-4ed8e49697a1">979</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331" decimals="-6" sign="-" name="ci:SegmentRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM1LTgtMS0xLTU0NzA5OA_d44b7b18-358d-44f0-92ed-823a7d170cbb">1,849</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:SegmentRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM1LTEwLTEtMS01NDcwOTg_1f85ba07-8b7e-4443-b19c-6a68e740b4c3">44,109</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM3LTItMS0xLTU0NzA5OA_d9e85f97-782a-40ec-ab0b-8184326d76ee">870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM3LTQtMS0xLTU0NzA5OA_c61bf8d8-56b9-413d-8e4e-3409be4f9c04">877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM3LTYtMS0xLTU0NzA5OA_51c929a9-220a-42f4-a7c5-01d22302dd4b">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM3LTgtMS0xLTU0NzA5OA_539af87c-c276-412f-a227-5ed75c6faea0">395</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM3LTEwLTEtMS01NDcwOTg_ebe48a11-10df-4be9-9b9e-f8b680c40851">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-tax adjustments to reconcile to adjusted income from operations</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Income) attributable to noncontrolling interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331" decimals="-6" name="ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM5LTItMS0xLTU0NzA5OA_30ce66bd-d798-402b-bc2f-118d757b4790">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331" decimals="-6" name="ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM5LTQtMS0xLTU0NzA5OA_2b87a580-757b-44aa-b41f-a6479f8955af">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331" decimals="-6" name="ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM5LTYtMS0xLTU0NzA5OA_b160ff20-ae7b-44da-b970-3376ef99ea8a">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95354c853bf4761a405bfd3190f1ed6_D20220101-20220331" decimals="-6" name="ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM5LTgtMS0xLTU0NzA5OA_b84414d8-b048-481d-9331-10b6e7917753">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM5LTEwLTEtMS01NDcwOTg_1ea7cfb9-d849-456d-849e-58b76c0abfbc">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment losses (gains) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331" decimals="-6" name="ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQwLTItMS0xLTU0NzA5OA_3efe93d9-7ac2-41a1-b848-643f867f9738">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQwLTQtMS0xLTU0NzA5OA_2f48cf94-8521-473c-90cb-7437557be277">406</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQwLTYtMS0xLTU0NzA5OA_54a55416-a2e2-4345-ac01-23ba97c0a759">19</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95354c853bf4761a405bfd3190f1ed6_D20220101-20220331" decimals="-6" name="ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQwLTgtMS0xLTU0NzA5OA_c8a1fede-9b0f-4585-805c-9031a1f5f6d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" sign="-" name="ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQwLTEwLTEtMS01NDcwOTg_56cc7f5f-b5d4-45ba-9155-36a97e3335ee">425</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQxLTItMS0xLTU0NzA5OA_924b49db-e142-4230-8b01-810cbeda3f0c">443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQxLTQtMS0xLTU0NzA5OA_0882db20-9a3a-4e02-a7f0-6a507a6b440a">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQxLTYtMS0xLTU0NzA5OA_3b24d079-35e5-4c65-b8cb-328828360f41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95354c853bf4761a405bfd3190f1ed6_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQxLTgtMS0xLTU0NzA5OA_114022a2-14cb-4f1f-9f2f-bd7025e7ec10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQxLTEwLTEtMS01NDcwOTg_10f0a0d8-89d7-45de-9262-6c5808694169">458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Special items</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integration and transaction-related costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331" decimals="-6" name="ci:TransactionRelatedCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQzLTItMS0xLTU0NzA5OA_cfbb4865-f2c3-4d4a-8184-b00c4746ae9a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331" decimals="-6" name="ci:TransactionRelatedCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQzLTQtMS0xLTU0NzA5OA_e7bb06ab-e061-40ef-a88e-16b55b18cf25">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331" decimals="-6" name="ci:TransactionRelatedCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQzLTYtMS0xLTU0NzA5OA_2cdea456-c691-4669-a0ab-e0fd26413bf6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95354c853bf4761a405bfd3190f1ed6_D20220101-20220331" decimals="-6" name="ci:TransactionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQzLTgtMS0xLTU0NzA5OA_e3a2e65a-96d1-453e-993d-ffb8537abdb8">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:TransactionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQzLTEwLTEtMS01NDcwOTg_b2e38d57-f232-47e7-b152-a00cb1c5f8e8">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted income (loss) from operations</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331" decimals="-6" name="ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUxLTItMS0xLTU0NzA5OA_047e5e41-947b-47ca-8f9d-b217f91f2954">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331" decimals="-6" name="ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUxLTQtMS0xLTU0NzA5OA_8e07f05d-3153-4f3b-9d77-f1f2005495e8">1,297</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331" decimals="-6" name="ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUxLTYtMS0xLTU0NzA5OA_143feff4-55f7-48bb-b19c-852496243635">229</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331" decimals="-6" sign="-" name="ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUxLTgtMS0xLTU0NzA5OA_95a5fe98-58db-4bf0-89da-a529dc049f79">343</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUxLTEwLTEtMS01NDcwOTg_fe87b11f-d52c-4c0f-b656-cb673da34641">2,485</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="padding-left:9pt;text-indent:-9pt"><ix:continuation id="i42eed22cb5f04fd296a1e631263df5af" continuedAt="i1995ee963a654d1aa09c54fe919f6b47"><ix:continuation id="i3cd29715ba9c4779a75388bf26efd6f0"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_910"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1995ee963a654d1aa09c54fe919f6b47" continuedAt="i6a4febb77baf455ca14ce1429f294dbc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenue from external customers includes Pharmacy revenues, Premiums and Fees and other revenues. Prior period amounts have been retrospectively adjusted to reflect adoption of amended accounting guidance for long-duration insurance contracts, as discussed in Note 2 to the Consolidated Financial Statements. The following table presents these revenues by product, premium and service type:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Products (Pharmacy revenues) (ASC 606)</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Network revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d60420098854826bb75b05e15a8dd62_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzQtNi0xLTEtNTQ3MDk4_ba00f80b-dfda-455b-8513-6b30d3ebb392">15,748</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb14631940d478e80234443fdde93c4_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzQtOC0xLTEtNTQ3MDk4_3c9521a7-e3a3-4317-870d-7d8ba805dae7">15,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Home delivery and specialty revenues</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b73e14198fb493797caa14157f4db48_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzUtNi0xLTEtNTQ3MDk4_921bd8c3-eb6f-4191-a98a-4c19db6e3f6c">16,025</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1d9f3a8c7e244afaeef48f7c0e28797_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzUtOC0xLTEtNTQ3MDk4_26194a18-221d-4a42-8249-57c720f3fb4d">14,699</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc2e436d3a3436ca9bb0c3657718683_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzYtNi0xLTEtNTQ3MDk4_e9b514b0-8d94-41cd-8ef0-3ec9877d8f4d">1,867</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib360b82d50b24f408baf926cbd36d43a_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzYtOC0xLTEtNTQ3MDk4_3331403e-6302-4a4f-af1b-8ce135a0b738">1,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intercompany eliminations</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie39a13614111404c93bbc50726bc2979_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzctNi0xLTEtNTQ3MDk4_f0b39aee-f7e9-48e1-9c5b-73d5f310d3a0">1,496</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46b371195fbd4772a749aa7a8dd2fd45_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzctOC0xLTEtNTQ3MDk4_f07d30f9-3b55-406c-9776-3f610bbba1cb">1,245</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total pharmacy revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i933d49a7caa5445f9359253b5b0b5023_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzgtNi0xLTEtNTQ3MDk4_907b1c32-cdcc-42b0-9f8c-2c8193eb68d9">32,144</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2699cfc415ab4727a3246be3ce9a03fb_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzgtOC0xLTEtNTQ3MDk4_3b5fe53f-f511-47b3-96a7-5b79c5833cfb">30,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance premiums (ASC 944)</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Commercial</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insured</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e34d7cd37940d9be3d86d7521f5686_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzEyLTYtMS0xLTU0NzA5OA_e779c04c-de0f-4fbd-bc0e-bc33be20c06a">4,080</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1dd8e92561043ffbfbeda8cee9c928f_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzEyLTgtMS0xLTU0NzA5OA_23f7e682-2a84-4a60-a472-dfda512699b3">3,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stop loss</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e9e00387384de780ea3b39d4254134_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzEzLTYtMS0xLTU0NzA5OA_ac3b0663-895f-4238-a44a-430348593271">1,503</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33cfaac4439f45c89db679459cae7478_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzEzLTgtMS0xLTU0NzA5OA_437dbe8d-bddc-4454-91bd-5afa79114f57">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834a123ddeb74d1eaa0c05c2490b66b9_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE0LTYtMS0xLTU0NzA5OA_f7d47d7c-61a2-4ead-ad97-43dfc3c571bb">368</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3733229295b04395a86ff23f3d3e14d6_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE0LTgtMS0xLTU0NzA5OA_3a3b255f-ff84-4b46-b036-a1defa67af20">360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd3caeb6fdf54d798d5192a6b8874b10_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE2LTYtMS0xLTU0NzA5OA_b950d83e-dbe6-47d8-ade9-47a1cdbd9ccb">2,236</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f66cd5ef874b81984fce532b63f71b_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE2LTgtMS0xLTU0NzA5OA_9739a9a3-a05f-4cdf-8280-fe1cd82ba17e">2,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24d316520f741b8aeeb8ece569a197f_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE3LTYtMS0xLTU0NzA5OA_04609c9c-4a14-47bf-9d5c-6fbca7b483a6">415</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300f527e494a4843be09f505c8e493ff_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE3LTgtMS0xLTU0NzA5OA_f11995cd-b4f2-4f37-86ce-a6050777b736">401</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1), (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-duration (Individual and family plans)</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i700e68e0f51a4716a2d3851471d18417_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE5LTYtMS0xLTU0NzA5OA_eacedf20-a8a9-4a86-8c5c-7d7040e98324">1,208</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ae8fc97f3b4994bbaf95a5fe2b78d5_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE5LTgtMS0xLTU0NzA5OA_e5387150-f006-4ca1-9e8b-fbe006cfa721">611</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-duration (Individual Medicare supplement and limited benefit health products)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36971d451ade4af1a50bd70e7bb2a491_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzIwLTYtMS0xLTU0NzA5OA_63e30f91-c63c-44de-bf18-1f521f459790">334</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2336928c4ea49a6bc4d4b5d15ee8bb8_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzIwLTgtMS0xLTU0NzA5OA_c279e9fb-b2f1-4e4b-9182-0fa0cba40842">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">International Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-duration (Group medical insurance)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaf7a109b0e34a0b924d846bbfe77c7a_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzIyLTYtMS0xLTU0NzA5OA_75bde9e6-a14b-45f7-bff2-28f18fd128ee">700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b8b552cfe8495aa3582c0783a57614_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzIyLTgtMS0xLTU0NzA5OA_32b14a90-8026-421d-a3cf-561a97a357ee">620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-duration (Individual private medical insurance)</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c721be6f0264a54b1ef23c9b0206b6e_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzIzLTYtMS0xLTU0NzA5OA_f9cfe49e-e410-47fa-a62b-b1fb777fbb1f">86</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9dbc603d392490aa593c0ee390a23ae_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzIzLTgtMS0xLTU0NzA5OA_1c941c06-26a5-4c4c-a3eb-38a0e0ae199f">82</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Cigna Healthcare</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2847aa537584cefa3f2f5652bedb86f_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI0LTYtMS0xLTU0NzA5OA_5a714504-31b1-4391-b41f-840968eb4d12">10,930</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92eee19a6c741c3adc4a9c5ace7b113_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI0LTgtMS0xLTU0NzA5OA_73777da8-02f0-43a2-ac41-4382254b1c45">9,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Divested International businesses</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11f9b58557a432b96d0a2ff40cf82c3_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI1LTYtMS0xLTU0NzA5OA_018d01fd-022a-4113-809a-6dfd05f01b84">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idccd94a3f926401c88f9bd7436ab16f5_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI1LTgtMS0xLTU0NzA5OA_72e36c55-f606-467f-a0d4-6b08c100b0ec">763</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bccbb16e5d84306923a81662d3ea9ab_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI3LTYtMS0xLTYxOTkyMA_2a5850c2-fc22-471e-90c1-2d2b66619700">79</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d10ac7a0e94fe7b6f88281dfc04939_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI3LTgtMS0xLTYxOTkyMA_bb3128a4-387e-407b-a4ba-48356bd0e1ce">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intercompany eliminations</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b3a5cafe1847468ebadf3df7edea80_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI4LTYtMS0xLTU0NzA5OA_271dced2-1c40-44f4-b87a-194a4eccae20">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098db1bf768848acb5c35d20817215a9_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI4LTgtMS0xLTU0NzA5OA_da9be9a8-1c9c-4846-b37e-6a0919e65120">2</ix:nonFraction>)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI5LTYtMS0xLTU0NzA5OA_97df2651-0fed-44f3-8d98-93f7fc6a9151">11,025</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI5LTgtMS0xLTU0NzA5OA_f649c7ff-cd76-47fd-be7b-b46bfcb64699">10,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Services (Fees) (ASC 606)</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evernorth Health Services</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d6a700163d4c319d21beade0fbcc04_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzMyLTYtMS0xLTU0NzA5OA_4282095d-1ab2-4ce9-a475-f3a5c67c5436">2,499</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1627e82149974da486e8f3cc3f75d2ab_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzMyLTgtMS0xLTU0NzA5OA_5e1df0fa-fb2b-4caf-879a-d64c6d98046c">1,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a92f9eb139e45b58b6841d00343544b_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzMzLTYtMS0xLTU0NzA5OA_1faf4a13-a0aa-47a0-9776-c20adea10792">1,606</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idffd5dd03d124226bb773704874daf86_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzMzLTgtMS0xLTU0NzA5OA_72e6d793-7a30-411e-83d7-f3216b0d31e6">1,496</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b6cacd9b87c4887ab34f6e65fe9d106_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM0LTYtMS0xLTU0NzA5OA_2ba73519-e3ec-4988-9db0-66bcb94d54f7">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3577cdfec471463b8b1da0e53a0c050c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM0LTgtMS0xLTU0NzA5OA_0221901f-4df7-4578-9d61-2b99a31abb11">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22cd581f72e445d8916b2124487b2977_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM1LTYtMS0xLTU0NzA5OA_5fcd1344-2984-47b0-94de-b14e875260ae">66</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e8cce4152f1403bace3946d48f2b9f5_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM1LTgtMS0xLTU0NzA5OA_9ff3f121-134e-4ed6-ab45-19ed11af7750">16</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intercompany eliminations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10032a6591314de5846c1184b289a4b8_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM2LTYtMS0xLTU0NzA5OA_f320d87f-69bd-4806-aa77-6bf9b7dea9ba">1,101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e80ce4c0d14006b2d6a845fa506e93_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM2LTgtMS0xLTU0NzA5OA_57505bb3-8115-4775-88f5-ae91ae9e6dd2">602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fees and other revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf64ff3b0a2466f81f78f097b7c8d5d_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM3LTYtMS0xLTU0NzA5OA_a037a379-ee93-4ddc-ac73-bd2c6a573826">3,071</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530643094c274242bf05d8df55f63659_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM3LTgtMS0xLTU0NzA5OA_054c4657-58d7-44bf-b47c-e151feee5702">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" decimals="-6" name="ci:NonInvestmentRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM4LTYtMS0xLTU0NzA5OA_f608adf4-c48a-4a94-bfc1-b5c13df7d8ba">46,240</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331" decimals="-6" name="ci:NonInvestmentRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM4LTgtMS0xLTU0NzA5OA_312d3fa0-e101-47b2-8cda-7d380e0421c9">43,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Other than supplemental benefits, all of U.S. Commercial and U.S. Government are short duration.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">U.S. Government and International Health recognize premium revenue on long-duration insurance contracts (coverage greater than one year or guaranteed to be renewed at the option of the policyholder beyond one year) related to certain medicare supplement, supplemental health and life products. All other premium revenue recognized as of March&#160;31, 2023 and March&#160;31, 2022 is primarily related to short-duration insurance contracts.</span></div></ix:continuation><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_913"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i6a4febb77baf455ca14ce1429f294dbc"><ix:nonNumeric contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTMvZnJhZzphYzhiMzU0NDMyZjE0MDA2OWZjMTA2ZDI5MmM5OTg0NC90ZXh0cmVnaW9uOmFjOGIzNTQ0MzJmMTQwMDY5ZmMxMDZkMjkyYzk5ODQ0XzY1Mw_f4d4a11f-adc5-42ac-934e-ae32f8ff690c" escape="true">Evernorth Health Services may also provide certain financial and performance guarantees, including a minimum level of discounts a client may receive, generic utilization rates and various service levels. Clients may be entitled to receive compensation if we fail to meet the guarantees. Actual performance is compared to the contractual guarantee for each measure throughout the period and the Company defers revenue for any estimated payouts within Accrued expenses and other liabilities (current). These estimates are adjusted and paid following the end of the annual guarantee period.</ix:nonNumeric> Historically, adjustments to original estimates have not been material. This guarantee liability was $<ix:nonFraction unitRef="usd" contextRef="i9556a32ddbb54ebeb4e7256d387ed702_I20230331" decimals="-8" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTMvZnJhZzphYzhiMzU0NDMyZjE0MDA2OWZjMTA2ZDI5MmM5OTg0NC90ZXh0cmVnaW9uOmFjOGIzNTQ0MzJmMTQwMDY5ZmMxMDZkMjkyYzk5ODQ0XzYzNQ_81858e51-d1e0-4512-9985-e4951ecdba14">1.5</ix:nonFraction> billion as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i63fb1e4d8af94facb895426daf4d4db1_I20221231" decimals="-8" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTMvZnJhZzphYzhiMzU0NDMyZjE0MDA2OWZjMTA2ZDI5MmM5OTg0NC90ZXh0cmVnaW9uOmFjOGIzNTQ0MzJmMTQwMDY5ZmMxMDZkMjkyYzk5ODQ0XzE2NDkyNjc0NDIzMjA_833272c8-1772-4a06-8ef1-040a5d2ad77a">1.3</ix:nonFraction> billion as of December&#160;31, 2022.</ix:continuation></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_97"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.567%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PAGE</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_118">Executive Overview</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_118">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_199">Liquidity and Capital Resources</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_199">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_232">Critical Accounting Estimates</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_232">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_244">Segment Reporting</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_244">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_250">Evernorth Health Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_250">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_256">Cigna Healthcare</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_256">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_262">Other Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_262">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_268">Corporate</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_268">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_274">Investment Assets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id1800413722c4e30b53ad5d464cab4e8_274">48</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&amp;A") is intended to provide information to assist you in better understanding and evaluating our financial condition as of March&#160;31, 2023, compared with December&#160;31, 2022 and our results of operations for the three months ended March&#160;31, 2023, compared with the same period last year and is intended to help you understand the ongoing trends in our business. We encourage you to read this MD&amp;A in conjunction with our Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q and our Annual Report on Form 10-K for the year ended December&#160;31, 2022 ("2022 Form 10-K"). In particular, we encourage you to refer to the "Risk Factors" contained in Part I, Item 1A of our 2022 Form 10-K.</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Unless otherwise indicated, financial information in this MD&amp;A is presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"). See Note 2 to the Consolidated Financial Statements in our 2022 Form 10-K for additional information regarding the Company's significant accounting policies and see Notes 2 and 9 to the Consolidated Financial Statements in this Form 10-Q for updates to those policies resulting from adopting Accounting Standards Update 2018-12, Targeted Improvements to the Accounting for Long-Duration Contracts ("LDTI"), and related amendments, effective January 1, 2023. The preparation of interim consolidated financial statements necessarily relies heavily on estimates. This and certain other factors call for caution in estimating full-year results based on interim results of operations. In some of our financial tables in this MD&amp;A, we present either percentage changes or "N/M" when those changes are so large as to become not meaningful. Changes in percentages are expressed in basis points ("bps").</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_112"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In this MD&amp;A, our consolidated measures "adjusted income from operations," earnings per share on that same basis and "adjusted revenues" are not determined in accordance with GAAP and should not be viewed as substitutes for the most directly comparable GAAP measures of "shareholders' net income," "earnings per share" and "total revenues." We also use pre-tax adjusted income (loss) from operations and adjusted revenues to measure the results of our segments.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The Company uses "pre-tax adjusted income (loss) from operations" and "adjusted revenues" as its principal financial measures of segment operating performance because management believes these metrics best reflect the underlying results of business operations and permit analysis of trends in underlying revenue, expenses and profitability. We define adjusted income from operations as shareholders' net income (or income before income taxes less pre-tax income (loss) attributable to noncontrolling interests for the segment metric) excluding net realized investment results, amortization of acquired intangible assets, and special items. The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. Adjusted income (loss) from operations is measured on an after-tax basis for consolidated results and on a pre-tax basis for segment results. Consolidated adjusted income (loss) from operations is not determined in accordance with GAAP and should not be viewed as a substitute for the most directly comparable GAAP measure, shareholders' net income. See the below Financial Highlights section for a reconciliation of consolidated adjusted income from operations to shareholders' net income. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The Company defines adjusted revenues as total revenues excluding the following adjustments: special items and The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. We exclude these items from this measure because management believes they are not indicative of past or future underlying performance of the business. Adjusted revenues is not determined in accordance with GAAP and should not be viewed as a </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">substitute for the most directly comparable GAAP measure, total revenues. See the below Financial Highlights section for a reconciliation of consolidated adjusted revenues to total revenues.</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_115"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on The Cigna Group's current expectations and projections about future trends, events and uncertainties. These statements are not historical facts. Forward-looking statements may include, among others, statements concerning future financial or operating performance, including our ability to improve the health and vitality of those we serve; future growth, business strategy, and strategic or operational initiatives; economic, regulatory or competitive environments, particularly with respect to the pace and extent of change in these areas and the impact of developing inflationary and interest rate pressures; financing or capital deployment plans and amounts available for future deployment; our prospects for growth in the coming years; strategic transactions; expectations related to our Medicare Advantage Capitation Rates; and other statements regarding The Cigna Group's future beliefs, expectations, plans, intentions, liquidity, cash flows, financial condition or performance. You may identify forward-looking statements by the use of words such as "believe," "expect," "project," "plan," "intend," "anticipate," "estimate," "predict," "potential," "may," "should," "will" or other words or expressions of similar meaning, although not all forward-looking statements contain such terms.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Forward-looking statements are subject to risks and uncertainties, both known and unknown, that could cause actual results to differ materially from those expressed or implied in forward-looking statements. Such risks and uncertainties include, but are not limited to: our ability to achieve our strategic and operational initiatives; our ability to adapt to changes in an evolving and rapidly changing industry; our ability to compete effectively, differentiate our products and services from those of our competitors and maintain or increase market share; price competition, inflation and other pressures that could compress our margins or result in premiums that are insufficient to cover the cost of services delivered to our customers; the potential for actual claims to exceed our estimates related to expected medical claims; our ability to develop and maintain satisfactory relationships with physicians, hospitals, other health service providers and with producers and consultants; our ability to maintain relationships with one or more key pharmaceutical manufacturers or if payments made or discounts provided decline; changes in the pharmacy provider marketplace or pharmacy networks; changes in drug pricing or industry pricing benchmarks; our ability to invest in and properly maintain our information technology and other business systems; our ability to prevent or contain effects of a potential cyberattack or other privacy or data security incident; political, legal, operational, regulatory, economic and other risks that could affect our multinational operations, including currency exchange rates; risks related to strategic transactions and realization of the expected benefits of such transactions, as well as integration or separation difficulties or underperformance relative to expectations; dependence on success of relationships with third parties; risk of significant disruption within our operations or among key suppliers or third parties; potential liability in connection with managing medical practices and operating pharmacies, onsite clinics and other types of medical facilities; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; uncertainties surrounding participation in government-sponsored programs such as Medicare; the outcome of litigation, regulatory audits and investigations; compliance with applicable privacy, security and data laws, regulations and standards; potential failure of our prevention, detection and control systems; unfavorable economic and market conditions, including bank failures, the risk of a recession or other economic downturn and resulting impact on employment metrics, stock market or changes in interest rates and risks related to a downgrade in financial strength ratings of our insurance subsidiaries; the impact of our significant indebtedness and the potential for further indebtedness in the future; credit risk related to our reinsurers; as well as more specific risks and uncertainties discussed in Part I, Item 1A &#8211; Risk Factors in our 2022 Form 10-K, Part II, Item 7 &#8211; Management's Discussion and Analysis of Financial Condition and Results of Operations in our 2022 Form 10-K, and as described from time to time in our future reports filed with the Securities and Exchange Commission.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">You should not place undue reliance on forward-looking statements, which speak only as of the date they are made, are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. The Cigna Group undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by law.</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_118"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">EXECUTIVE OVERVIEW</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Cigna Group, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," us" or "our") is a global health company with a mission of helping those we serve improve their health and vitality. Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental and related products and services. For further information on our business and strategy, see Item 1, "Business" of our 2022 Form 10-K. </span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_121"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Financial Highlights</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See Note 1 to the Consolidated Financial Statements for a description of our segments. Effective January 1, 2023, we adopted amended accounting guidance for long-duration insurance contracts. Prior period Financial highlights and Results of operations have </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">been retrospectively adjusted to conform to this new basis of accounting. For the three months ended March&#160;31, 2023, the impact of this amended guidance is immaterial. See Note 2 to the Consolidated Financial Statements for additional information.</span></div><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Summarized below are certain key measures of our performance by segment:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.886%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial highlights by segment</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="18" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted revenues by segment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evernorth Health Services</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36,179</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,586&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,718</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate, net of eliminations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46,479</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,109&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment results from certain equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,006&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholders' net income</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted income from operations</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,618</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings per share (diluted)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shareholders' net income</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.73&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted income from operations</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.06&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="21" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-tax adjusted income (loss) from operations by segment</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evernorth Health Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,115</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate, net of eliminations</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(414)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consolidated pre-tax adjusted income from operations</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,036</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">43</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(425)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(459)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Special items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,601</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For further analysis and explanation of each segment's results, see the "Segment Reporting" section of this MD&amp;A.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">37</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_130"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.720%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Results of Operations (GAAP basis)</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="18" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmacy revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">32,144</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,697&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fees and other revenues</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">277</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,006&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmacy and other service costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">31,459</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,813&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical costs and other benefit expenses</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,046</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,272&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,538</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">459</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total benefits and expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">44,502</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,818&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,188&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment losses</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(56)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,601</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total income taxes</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">295</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholders' net income</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consolidated effective tax rate</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(430)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical customers (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">19,473</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,779&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_133"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.263%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reconciliation of Shareholders' Net Income (GAAP) to Adjusted Income from Operations</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-tax</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After-tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-tax</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After-tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholders' net income</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments to reconcile to adjusted income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">459</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">344</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Special items</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integration and transaction-related costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total special items</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted income from operations</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,618</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.263%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reconciliation of Shareholders' Net Income (GAAP) to Adjusted Income from Operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Diluted Earnings Per Share)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-tax</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After-tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-tax</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After-tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholders' net income</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.73&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments to reconcile to adjusted income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.06</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.54</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Special items</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integration and transaction-related costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total special items</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.16&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted income from operations</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.06&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Recent Events</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_139"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Economic Conditions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We continue to monitor global economic conditions, including inflation, labor market dynamics and the recent banking failures. We did not have a material exposure to banks recently impacted by the financial environment. We continue to proactively address impacts to our pricing with third parties (including vendors, health care providers and drug providers), our investment portfolio and our workforce. We are also monitoring the potential impact on client and customer health care needs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our results of operations or cash flows for the three months ended March&#160;31, 2023, were not materially impacted by inflation, labor market dynamics, or the recent banking failures. For further information regarding risks we encounter in our business due to economic conditions, see "Risk Factors" contained in Part I, Item 1A of our 2022 Form 10-K.</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_148"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Commentary: Three Months Ended March 31, 2023 versus Three Months Ended March 31, 2022</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The commentary presented below, and in the segment discussions that follow, compare results for the three months ended March&#160;31, 2023 with results for the three months ended March&#160;31, 2022. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Shareholders' net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 6% due primarily to improved realized investment results reflecting lower mark to market losses on equity securities. This favorable effect was partially offset by lower adjusted income from operations. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Adjusted income from operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> declined 17%, driven primarily by the absence of earnings from our life, accident and supplemental health benefits business in six countries sold in 2022 (the "Chubb transaction") and lower net investment income (see below). </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Medical customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 10%, reflecting growth in fee-based products as well as a higher customer base in our Individual and Medicare Advantage businesses. See Part I, Item 1 of our 2022 Form 10-K for definitions of Cigna Healthcare's market segments.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pharmacy revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">increased 5%, reflecting higher specialty claims volume as well as inflation on, and higher sales of, branded drugs. See the "Segment Reporting - Evernorth Health Services Segment" section of this MD&amp;A for further discussion.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Premiums</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 6%, reflecting growth in the insured customer base (primarily within our Individual business), the favorable impact of increased specialty contributions and higher premium rates in Cigna Healthcare due to anticipated underlying medical cost trend. See the "Segment Reporting - Cigna Healthcare Segment" section of this MD&amp;A for further discussion. These favorable effects were partially offset by a decline in premiums due to the Chubb transaction.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Fees and other revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">increased 21%, primarily reflecting client growth from our continued contract affordability services within Evernorth Health Services and higher net realized investment results in certain equity method investments within Cigna Healthcare.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">decreased 33%, primarily reflecting lower returns on our partnership investments and the unfavorable impact of the Chubb transaction. See the "Investment Assets" section of this MD&amp;A for further discussion.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pharmacy and other service costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 6%, reflecting higher specialty claims volume as well as inflation on, and higher sales of, branded drugs.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Medical costs and other benefit expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">increased 9%, primarily reflecting an increased insured customer base (primarily within our Individual business) and trend in Cigna Healthcare, partially offset by the impact of the Chubb transaction.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Selling, general and administrative expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">increased 8%, primarily driven by volume-related expenses in Cigna Healthcare and Evernorth Health Services due to business growth, as well as strategic investments to support business growth and continued advancement of our capabilities in Evernorth Health Services and Cigna Healthcare. These increases were partially offset by the impact of the Chubb transaction.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Interest expense and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 20%, primarily reflecting higher interest rates on our indebtedness and increased pension costs.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Realized investment results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were substantially improved, primarily due to lower mark to market losses on equity securities. See Note 11 to the Consolidated Financial Statements for further discussion.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The effective tax rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> decreased by 430 basis points, driven by favorable results relative to the Company's foreign operations, partially offset by an increase pertaining to the year over year impact of remeasurement of deferred taxes.</span></div><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_151"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Developments</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_1099511633499"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Medicare Advantage Rates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 31, 2023, Centers for Medicare and Medicaid Services ("CMS") released the final Calendar Year 2024 Medicare Advantage Program and Part D Payment Policies (the "2024 Final Notice"). The 2024 Final Notice rates were improved from the advance notice rates (previously released on February 1, 2023). We do not expect the final rates to have a material impact on our consolidated results of operations in 2024.</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_193"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LIQUIDITY AND CAPITAL RESOURCES</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_199"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Liquidity</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We maintain liquidity at two levels: the subsidiary level and the parent company level.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash requirements at the subsidiary level generally consist of:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">pharmacy, medical costs and other benefit payments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">expense requirements, primarily for employee compensation and benefits, information technology and facilities costs; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">income taxes; and</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">debt service. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our subsidiaries normally meet their liquidity requirements by:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">maintaining appropriate levels of cash, cash equivalents and short-term investments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">using cash flows from operating activities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">matching investment durations to those estimated for the related insurance and contractholder liabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">selling investments; and</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">borrowing from affiliates, subject to applicable regulatory limits.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash requirements at the parent company level generally consist of:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">debt service; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">payment of declared dividends to shareholders;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">lending to subsidiaries as needed; and</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">pension plan funding.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The parent company normally meets its liquidity requirements by:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">maintaining appropriate levels of cash and various types of marketable investments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">collecting dividends from its subsidiaries;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">using proceeds from issuing debt and common stock; and</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">borrowing from its subsidiaries, subject to applicable regulatory limits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dividends from our insurance, Health Maintenance Organization ("HMO") and certain foreign subsidiaries are subject to regulatory restrictions. See Note 21 to the Consolidated Financial Statements in our 2022 Form 10-K for additional information regarding these </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">restrictions. Most of the Evernorth Health Services segment operations are not subject to regulatory restrictions regarding dividends and therefore provide significant financial flexibility to The Cigna Group.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">With respect to our investment portfolio, we support the liquidity needs of our businesses by managing the duration of assets to be consistent with the duration of liabilities. We manage the portfolio to both optimize returns in the current economic environment and meet our liquidity needs.</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_202"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash flows for the three months ended March 31 were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,028</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,030&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(37)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,171)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following discussion explains variances in the various categories of cash flows for the three months ended March&#160;31, 2023 compared with the same period in 2022.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_208"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating activities</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash flows from operating activities consist principally of cash receipts and disbursements for pharmacy revenues and costs, premiums, fees, investment income, taxes, benefit costs and other expenses.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating cash flows for the three months ended March 31, 2023 included the benefits from the early receipt of April Medicare premiums from CMS and a higher CMS Medicare Part D annual settlement. The remaining increase was driven by higher insurance liabilities, timing of pharmacy and services cost payable and lower inventory purchases.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing activities</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company invested $2.5 billion in VillageMD in 2023, which resulted in an increase in cash used in investing activities.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing activities</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company issued new debt, had lower payments for commercial paper and lower share repurchases. These factors resulted in a decrease in cash used in financing activities in 2023.</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_211"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Capital Resources</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our capital resources consist primarily of cash, cash equivalents and investments maintained at regulated subsidiaries required to underwrite insurance risks, cash flows from operating activities, our commercial paper program, credit agreements and the issuance of long-term debt and equity securities. Our businesses generate significant cash flow from operations, some of which is subject to regulatory restrictions relative to the amount and timing of dividend payments to the parent company. Dividends from U.S. regulated subsidiaries were $258 million for the three months ended March&#160;31, 2023 and $475 million for the three months ended March&#160;31, 2022. Non-regulated subsidiaries also generate significant cash flow from operating activities, which is typically available immediately to the parent company for general corporate purposes. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We prioritize our use of capital resources to:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">invest in capital expenditures, primarily related to technology to support innovative solutions for our clients and customers, provide the capital necessary to maintain or improve the financial strength ratings of subsidiaries and to repay debt and fund pension obligations if necessary;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">pay dividends to shareholders;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">consider acquisitions and investments that are strategically and economically advantageous; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">return capital to shareholders through share repurchases.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Funds Available</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Commercial Paper Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Cigna Group maintains a commercial paper program and may issue short-term, unsecured commercial paper notes privately placed on a discount basis through certain broker-dealers at any time not to exceed an aggregate amount of $5.0 billion. The net proceeds of issuances have been and are expected to be used for general corporate purposes. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revolving Credit Agreements. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our revolving credit agreements provide us with the ability to borrow amounts for general corporate purposes, including for the purpose of providing liquidity support if necessary under our commercial paper program discussed above. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of April 2023, The Cigna Group's revolving credit agreements include: a $4.0 billion five-year revolving credit and letter of credit agreement that expires in April 2028; and a $1.0 billion 364-day revolving credit agreement that expires in April 2024. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2023, we had $5.0 billion of undrawn committed capacity under our revolving credit agreements that have since been replaced with the revolving credit agreements described above (these amounts are available for general corporate purposes, including providing liquidity support for our commercial paper program), $5.0 billion of remaining capacity under our commercial paper program and $8.1 billion in cash and short-term investments, approximately $1.1 billion of which was held by the parent company or certain non-regulated subsidiaries. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See Note 7 to the Consolidated Financial Statements for further information on our credit agreements and commercial paper program. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our debt-to-capitalization ratio was 42.2% at March&#160;31, 2023 and 41.0% at December&#160;31, 2022.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We actively monitor our debt obligations and engage in issuance or redemption activities as needed in accordance with our capital management strategy.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Subsidiary Borrowings. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to the sources of liquidity discussed above, the parent company can borrow an additional $2.8 billion from its subsidiaries without further approvals as of March&#160;31, 2023.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Use of Capital Resources</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Capital expenditures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Capital expenditures for property, equipment and computer software were $0.4 billion in the three months ended March 31, 2023 compared to $0.3 billion in the three months ended March&#160;31, 2022. This increase reflects our continued strategic investment in technology for future growth. We expect to deploy approximately $1.4 billion to capital expenditures in 2023. Anticipated capital expenditures will be funded primarily from operating cash flow.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> In the first quarter of 2023, The Cigna Group declared and paid quarterly cash dividends of $1.23 per share of its common stock, compared to $1.12 per share in first quarter 2022. See Note 8 to the Consolidated Financial Statements for further information on our dividend payments. On April&#160;26, 2023, the Board of Directors declared the second quarter cash dividend of $1.23 per share of The Cigna Group common stock to be paid on June&#160;22, 2023 to shareholders of record on June&#160;7, 2023. The Cigna Group currently intends to pay regular quarterly dividends, with future declarations subject to approval by its Board of Directors and the Board's determination that the declaration of dividends remains in the best interests of the Company and its shareholders. The decision of whether to pay future dividends and the amount of any such dividends will be based on the Company's financial position, results of operations, cash flows, capital requirements, the requirements of applicable law and any other factors the Board may deem relevant.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share repurchases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We maintain a share repurchase program authorized by our Board of Directors, under which we may repurchase shares of our common stock from time to time. The timing and actual number of shares repurchased will depend on a variety of factors including price, general business and market conditions and alternate uses of capital. The share repurchase program may be effected through open market purchases in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including through Rule 10b5-1 trading plans or privately negotiated transactions. The program may be suspended or discontinued at any time. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We repurchased 3.2&#160;million shares for approximately $1.0 billion during the three months ended March&#160;31, 2023, compared to 5.8 million shares for approximately $1.3 billion during the three months ended March&#160;31, 2022. From April&#160;1, 2023, through May&#160;4, 2023, we repurchased 0.5 million shares for approximately $139 million. Share repurchase authority was $2.5 billion as of May&#160;4, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Strategic investments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In January 2023, we became a minority owner in VillageMD by investing $2.5 billion in VillageMD preferred equity. In April 2023, the Company invested an additional $200 million for a total investment of $2.7 billion. VillageMD provides health care services for individuals and communities across the United States, with primary, multi-specialty and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_217"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Risks to our liquidity and capital resources outlook include cash projections that may not be realized and the demand for funds could exceed available cash if our ongoing businesses experience unexpected shortfalls in earnings or we experience material adverse effects from one or more risks or uncertainties described more fully in the "Risk Factors" section of our 2022 Form 10-K. Though we believe we have adequate sources of liquidity, significant disruption or volatility in the capital and credit markets could affect our ability to access those markets for additional borrowings or increase costs.</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_226"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Guarantees and Contractual Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are contingently liable for various contractual obligations and financial and other guarantees entered into in the ordinary course of business. See Note 16 to the Consolidated Financial Statements for discussion of various guarantees. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company adopted amended accounting guidance for long-duration insurance contracts effective January 1, 2023, which impacted the amounts presented on our Consolidated Balance Sheets. Within our Consolidated Financial Statements, see Note 2 for a summary of this accounting change and Note 9 for a summary of the insurance liabilities on our Consolidated Balance Sheets as well as future expected cash flow information. With the adoption of amended accounting guidance for long-duration insurance contracts and enhanced disclosure within Note 9 to the Consolidated Financial Statements, we will no longer present additional information regarding insurance liabilities within this section.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our long-term debt obligations previously provided in our 2022 Form 10-K have been updated as of March 31, 2023 due to the issuance of $700 million in aggregate principal amount of our 5.685% senior notes due March 2026 and $800 million in aggregate principal amount of our 5.400% senior notes due March 2033. See Note 7 to the Consolidated Financial Statements for a discussion of the debt issuance.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Total scheduled payments on long-term debt are $48.5 billion through March 2051, which include scheduled interest payments and maturities of long-term debt. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">We expect $3.9 billion of long-term debt payments (including scheduled interest payments) to be paid for the remainder of 2023. </span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There have been no other material changes to other information presented in guarantees and contractual obligations set forth in our 2022 Form 10-K. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div id="id1800413722c4e30b53ad5d464cab4e8_232"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect reported amounts and related disclosures in the Consolidated Financial Statements. Management considers an accounting estimate to be critical if:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">it requires assumptions to be made that were uncertain at the time the estimate was made; and</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">changes in the estimate or different estimates that could have been selected could have a material effect on our consolidated results of operations or financial condition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management has discussed how critical accounting estimates are developed and selected with the Audit Committee of our Board of Directors and the Audit Committee has reviewed the disclosures presented in our 2022 Form 10-K. We regularly evaluate items that may impact critical accounting estimates.</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_235"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our most critical accounting estimates, as well as the effect of hypothetical changes in material assumptions used to develop each estimate, are described in our 2022 Form 10-K. As of March&#160;31, 2023, there were no significant changes to the critical accounting estimates from what was reported in our 2022 Form 10-K.</span></div><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_244"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEGMENT REPORTING</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following section of this MD&amp;A discusses the results of each of our segments. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See Note 1 to the Consolidated Financial Statements for further description of our segments.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In segment discussions, we present "adjusted revenues" and "pre-tax adjusted income (loss) from operations," defined as income (loss) before income taxes excluding pre-tax income (loss) attributable to noncontrolling interests, net realized investment results, amortization of acquired intangible assets and special items. The Cigna Group's share of certain realized investment results of its joint </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. Ratios presented in this segment discussion exclude the same items as adjusted revenues and pre-tax adjusted income (loss) from operations. See Note 17 to the Consolidated Financial Statements for additional discussion of these metrics and a reconciliation of Income before income taxes to pre-tax adjusted income from operations, as well as a reconciliation of Total revenues to adjusted revenues. Note 17 to the Consolidated Financial Statements also explains that segment revenues include both external revenues and sales between segments that are eliminated in Corporate.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In these segment discussions, we also present "pre-tax adjusted margin," defined as pre-tax adjusted income (loss) from operations divided by adjusted revenues.</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_250"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Evernorth Health Services Segment</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Evernorth Health Services includes a broad range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in Pharmacy Benefits, Home Delivery Pharmacy, Specialty Pharmacy, Distribution and Care Delivery and Management Solutions. As described in the introduction to Segment Reporting, Evernorth Health Services' performance is measured using adjusted revenues and pre-tax adjusted income (loss) from operations.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The key factors that impact Evernorth Health Services' Pharmacy revenues, Fee and other revenues and Pharmacy and other service costs are volume, mix of claims and price. These key factors are discussed further below. See Note 2 to the Consolidated Financial Statements included in our 2022 Form 10-K for additional information on revenue and cost recognition policies for this segment.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">As our clients' claim volumes increase or decrease, our resulting revenues and cost of revenues correspondingly increase or decrease. Our gross profit, defined as Total revenues less Pharmacy and other service costs, could also increase or decrease as a result of changes in purchasing discounts.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The mix of claims generally considers the type of drug and distribution method used for dispensing and fulfilling. Types of drugs can have an impact on our Pharmacy revenues, Pharmacy and other service costs and gross profit, including amounts payable under certain financial and performance guarantees with our clients. In addition to the types of drugs, the mix of generic claims (i.e., generic fill rate) also impacts our gross profit. Generally, higher generic fill rates reduce revenues, as generic drugs are typically priced lower than the branded drugs they replace. However, as ingredient cost paid to pharmacies on generic drugs is incrementally lower than the price charged to our clients, higher generic fill rates generally have a favorable impact on our gross profit. The home delivery generic fill rate is currently lower than the network generic fill rate as fewer generic substitutions are available among maintenance medications (such as therapies for chronic conditions) commonly dispensed from home delivery pharmacies as compared to acute medications that are primarily dispensed by pharmacies in our retail networks. Furthermore, our gross profit differs among network, home delivery and specialty distribution methods and can impact our profitability.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Our client contract pricing is impacted by our ongoing ability to negotiate favorable contracts for pharmacy network, pharmaceutical and wholesaler purchasing and manufacturer rebates on our clients' behalf. Through these contract affordability services, we seek to improve the effectiveness of our integrated solutions for the benefit of our clients by continuously innovating, improving affordability and implementing drug purchasing contract initiatives. Our revenues, cost of revenues and gross profit could increase or decrease as a result of these contract affordability services. Inflation also impacts our pricing because most of our contracts provide that we bill clients and pay pharmacies based on a generally recognized price index for pharmaceuticals. Therefore, the rate of inflation for prescription drugs and our efforts to manage this inflation for our clients continues to be a significant driver of our revenues and cost of revenues in the current environment.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In this MD&amp;A, we present revenues and gross profit, as well as adjusted revenues and adjusted gross profit, consistent with our segment reporting metrics, which exclude special items.</span></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">44</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_253"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Results of Operations</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.983%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.885%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Summary</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change Favorable<br/>(Unfavorable)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36,179</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,586&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36,179</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmacy and other service costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">33,973</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,575&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,011&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted gross profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1),(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,011&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted income from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted margin</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted expense ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.375%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Selected Financial Information</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change Favorable<br/>(Unfavorable)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars and adjusted scripts in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmacy revenue by distribution channel</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted network revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,748</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted home delivery and specialty revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,699&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other pharmacy revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,867</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total adjusted pharmacy revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">33,640</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,942&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted fees and other revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,489</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36,179</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pharmacy script volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted network scripts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">315</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted home delivery and specialty scripts</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total adjusted scripts</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">381</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Generic fill rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Network</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">88.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Home delivery</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">84.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85.4&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Overall generic fill rate</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">87.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Total revenues and gross profit were equal to adjusted revenues and adjusted gross profit as there were no special items in the periods presented.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Gross profit and adjusted gross profit are calculated as total revenues or adjusted total revenues less pharmacy and other services costs.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Adjusted expense ratio is calculated as selling, general and administrative expenses as a percentage of adjusted revenues.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Non-specialty network scripts filled through 90-day programs and home delivery scripts are multiplied by three. All other network and specialty scripts are counted as one script.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Generic fill rate is defined as the total number of generic scripts divided by the total overall scripts filled.</span></div><div style="text-indent:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended March 31, 2023 versus Three Months Ended March 31, 2022</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Adjusted network revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">slightly increased, reflecting inflation on branded drugs, partially offset by a decrease in mix and an increase in the generic fill rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Adjusted home delivery and specialty revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">increased 9%, reflecting higher specialty claims volume and inflation on, and higher sales of, branded drugs. These increases were partially offset by lower home delivery claims volume.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other pharmacy revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 9%, reflecting higher volume from our CuraScript Specialty Distribution business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Adjusted fees and other revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 52%, reflecting client growth of our Care Delivery and Management Solutions, including cross-enterprise leverage, and client growth from our continued contract affordability services.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Adjusted gross profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">pre-tax adjusted income from operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">increased 10% and 1%, respectively, reflecting growth in specialty pharmacy, partially offset by strategic investments to support business growth and continued advancement of our capabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">adjusted expense ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">increased 20 bps, reflecting increased strategic investments to support business growth and continued advancement of our capabilities.</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_256"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cigna Healthcare Segment</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cigna Healthcare includes the U.S. Commercial, U.S. Government and International Health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. As described in the introduction to Segment Reporting, performance of the Cigna Healthcare segment is measured using adjusted revenues and pre-tax adjusted income from operations. Key factors affecting results for this segment include:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">customer growth;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">revenue growth;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">percentage of Medicare Advantage customers in plans eligible for quality bonus payments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">medical costs as a percentage of premiums (medical care ratio or "MCR") for our insured businesses; and</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">selling, general and administrative expenses as a percentage of adjusted revenues (adjusted expense ratio).</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective January 1, 2023, we adopted amended accounting guidance for long-duration insurance contracts. For the Cigna Healthcare segment, prior period results of operations have been retrospectively adjusted to conform to this new basis of accounting. For the three months ended March&#160;31, 2023, the impact of this amended guidance is immaterial. See Note 2 to the Consolidated Financial Statements for additional information.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.580%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Summary</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change Favorable<br/>(Unfavorable)</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,718</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,393&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted income from operations</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,115</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted margin</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(260)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical care ratio</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">81.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted expense ratio</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2023 versus Three Months Ended March 31, 2022</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Adjusted revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">increased 12%, reflecting customer growth in U.S. Government and U.S. Commercial mostly driven by our Individual business, increased specialty contributions and higher premium rates due to anticipated underlying medical cost trend, partially offset by lower net investment income.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pre-tax adjusted income from operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> decreased 14%, primarily due to a higher adjusted expense ratio and lower net investment income, partially offset by a lower medical care ratio.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"> medical care ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">decreased 20 bps, reflecting effective pricing execution and favorable cost trends, inclusive of lower COVID-19 costs.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"> adjusted expense ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">increased 90 bps, primarily due to volume-related expenses, higher spend on investments to support growth and lower net investment income, partially offset by revenue growth across all segments.</span></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">46</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_259"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Medical Customers</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A medical customer is defined as a person meeting any one of the following criteria:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">is covered under a medical insurance policy, managed care arrangement or service agreement issued by us;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">has access to our provider network for covered services under their medical plan; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">has medical claims that are administered by us.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.886%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cigna Healthcare Medical Customers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,682&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. Commercial</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. Government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,837</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International Health </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,150</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Services only</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,097&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. Commercial</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13,808</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,455&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. Government</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International Health </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">454</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">19,473</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,779&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:3.71pt">International Health excludes medical customers served by less than 100% owned subsidiaries. International Health lives as of March 31, 2023 reflect the transition of certain run-off business to Other Operations beginning January 1, 2023.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our medical customer base increased 10%, primarily driven by growth in fee-based customers as well as growth in Individual and Medicare Advantage customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See Part I, Item 1 of our 2022 Form 10-K for definitions of Cigna Healthcare's market segments.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Unpaid Claims and Claim Expenses</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.372%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:3.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.886%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unpaid claims and claim expenses &#8211; Cigna Healthcare</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,959</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,176&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our unpaid claims and claim expenses liability increased 19%, driven by stop loss seasonality and higher volumes in our Individual and Medicare Advantage businesses.</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_262"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other Operations</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other Operations includes corporate owned life insurance ("COLI") and the Company's run-off operations. In the prior period, Other Operations also included the International businesses sold in July 2022 and our interest in a joint venture in T&#252;rkiye sold in December 2022. As described in the introduction of Segment Reporting, performance of Other Operations is measured using adjusted revenues and pre-tax adjusted income from operations. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective January 1, 2023, we adopted amended accounting guidance for long-duration insurance contracts. For the Other Operations segment, prior period results of operations have been retrospectively adjusted to conform to this new basis of accounting. For the three months ended March&#160;31, 2023, the impact of this amended guidance is immaterial. See Note 2 to the Consolidated Financial Statements for additional information.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:69.611%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.892%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.505%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Summary</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change<br/>Favorable<br/>(Unfavorable)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted income from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted margin</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,380)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2023 versus Three Months Ended March 31, 2022</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Adjusted revenues and pre-tax adjusted income from operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">decreased</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> 84% and 93%, respectively, primarily</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> due to the absence of revenues and earnings from the businesses divested in the Chubb transaction.</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_268"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Corporate</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Corporate reflects amounts not allocated to operating segments, including net interest expense (defined as interest on corporate debt less net investment income on investments not supporting segment and other operations), certain litigation matters, expense associated with our frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs and intersegment eliminations for products and services sold between segments.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.288%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.887%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Summary</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change Favorable (Unfavorable)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted loss from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(414)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended March 31, 2023 versus Three Months Ended March 31, 2022</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pre-tax adjusted loss from operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 21%, primarily due to higher interest rates on our indebtedness and increased pension costs due to lower asset returns and a higher discount rate. While our pension expense has increased year-over-year, we continue to expect the required contributions for 2023 to be immaterial.</span></div><div><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_274"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INVESTMENT ASSETS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents our investment asset portfolio excluding separate account assets. Additional information regarding our investment assets is included in Notes 11, 12, 13 and 14 to the Consolidated Financial Statements. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,872&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Policy loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,211</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term investments</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,936</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,728&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">19,924</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,193&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Investment Outlook</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We continue to actively monitor economic conditions including the impact of inflation, higher interest rates and the potential for a recession in 2023 on the investment portfolio. Although there has been very limited impact to date on our investment portfolio as a result of recent banking failures, we are also monitoring this situation and any potential impacts on our investments. Future realized and unrealized investment results will be driven largely by market conditions and these future conditions are not reasonably predictable. We believe that the vast majority of our investments will continue to perform under their contractual terms. We manage the portfolio for long-term economics and therefore we expect to hold a significant portion of these assets for the long term. The following discussion addresses the strategies and risks associated with our various classes of investment assets. Although future declines in investment fair values remain possible due to interest rate movements and credit deterioration due to both investment-specific uncertainties and global economic uncertainties as discussed below, we do not expect these losses to have a material adverse effect on our financial condition or liquidity.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Debt Securities</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Investments in debt securities include publicly traded and privately placed bonds, mortgage and other asset-backed securities and preferred stocks redeemable by the investor. These investments are classified as available for sale and are carried at fair value in our Consolidated Balance Sheets. Additional information regarding valuation methodologies, key inputs and controls is included in Note 12 to the Consolidated Financial Statements. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table reflects our portfolio of debt securities by type of issuer:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal government and agency</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">297</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local government</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,856</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">344</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our debt securities portfolio increased during the three months ended March&#160;31, 2023 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">primarily due to an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increase in valuations due to a slight decrease in interest rates. Our portfolio remains in a net unrealized depreciation position due to generally increasing interest rates over the last several quarters. More detailed information about debt securities by type of issuer, maturity dates and net unrealized position is included in Note 11 to the Consolidated Financial Statements.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2023, $8.1&#160;billion, or 82%, of the debt securities in our investment portfolio were investment grade (Baa and above, or equivalent) and the remaining $1.8&#160;billion were below investment grade. The majority of the bonds that are below investment grade were rated at the higher end of the non-investment grade spectrum. These quality characteristics have not materially changed since the prior year and remain consistent with our investment strategy. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Debt securities include private placement assets of $4.2&#160;billion. These investments are generally less marketable than publicly traded bonds; however, yields on these investments tend to be higher than yields on publicly traded bonds with comparable credit risk. We perform a credit analysis of each issuer and require financial and other covenants that allow us to monitor issuers for deteriorating financial strength and pursue remedial actions, if warranted.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Investments in debt securities are diversified by issuer, geography and industry. On an aggregate basis, the debt securities portfolio continues to perform according to original expectations, which includes a long-term economic investment strategy. Elevated global inflation, higher interest rates, continuing supply chain disruptions and potential fallout from the current stress in the banking system are the primary risks that many of the issuers in our portfolio are facing. To date, most issuers have been successful in managing the cost escalation and product shortages without undue margin pressure. We continue to monitor the economic environment and its effect on our portfolio and consider the impact of various factors in determining the allowance for credit losses on debt securities, which is discussed in Note 11 to the Consolidated Financial Statements.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Commercial Mortgage Loans</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2023, our $1.6 billion commercial mortgage loan portfolio consisted of approximately 50 fixed-rate loans, diversified by property type, location and borrower. These loans are carried in our Consolidated Balance Sheets at their unpaid principal balance, net of an allowance for expected credit losses. As a result of increasing market interest rates since the majority of these loans were made, the carrying value exceeds the market value of these loans as of March 31, 2023. See Note 12 to the Consolidated Financial Statements for further details. Given the quality and diversity of the underlying real estate, positive debt service coverage and significant borrower cash invested in the property generally ranging between 30 and 40%, we remain confident that the vast majority of borrowers will continue to perform as expected under their contract terms. For further discussion of the results and changes in key loan metrics, see Note 11 to the Consolidated Financial Statements.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Loans are secured by high quality commercial properties, located in strong institutional markets and are generally made at less than 65% of the property's value at origination of the loan. Property value, debt service coverage, quality, building tenancy and stability of cash flows are all important financial underwriting considerations. We hold no direct residential mortgage loans and do not originate or service securitized mortgage loans.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We assess the credit quality of our commercial mortgage loan portfolio annually, generally in the second fiscal quarter by reviewing each holding's most recent financial statements, rent rolls, budgets and relevant market reports. The review performed in the second quarter of 2022 confirmed ongoing strong overall credit quality in line with the previous year's results.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Office sector fundamentals have been and continue to be weak and values are experiencing stress due to multiple headwinds: expanded work from home flexibility, shorter term leases, elevated tenant improvement allowances and corporate migration to lower cost states. Additionally, the current macroeconomic headwinds are impacting capital markets and reducing investor appetite for capital intensive assets (e.g., offices and regional shopping malls). Our commercial mortgage loan portfolio has no exposure to regional shopping malls and less than 30% exposure to office properties.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Other Long-term Investments</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other long-term investments of $3.9 billion as of March&#160;31, 2023 included investments in securities limited partnerships and real estate limited partnerships, direct investments in real estate joint ventures and other deposit activity that is required to support various insurance and health services businesses. Accounting policies for these investments are discussed in Note 11 to the Consolidated Financial Statements. The increase in other long-term investments of $0.2 billion since December 31, 2022 is primarily driven by net additional funding activity. These limited partnership entities typically invest in mezzanine debt or equity of privately-held companies and equity real estate. Given our subordinate position in the capital structure of these underlying entities, we assume a higher level of risk for higher expected returns. To mitigate risk, these investments are diversified across approximately 200 separate partnerships and 90 general partners who manage one or more of these partnerships. Also, the underlying investments are diversified by industry sector or property type and geographic region. No single partnership investment exceeded 4% of our securities and real estate limited partnership portfolio.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Income from our limited partnership investments is generally reported on a one quarter lag due to the timing of when financial information is received from the general partner or manager of the investments. Accordingly, our net investment income in the first quarter largely reflects the underlying financial information from the fourth quarter of 2022. We expect continued volatility in private equity and real estate fund performance going forward as fair market valuations are adjusted to reflect market and portfolio transactions. Less than 5% of our other long-term investments are exposed to real estate in the office sector.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We participate in an insurance joint venture in China with a 50% ownership interest. We account for this joint venture under the equity method of accounting and report our share of the net assets of $0.4 billion in Other assets. Our 50% share of the investment portfolio supporting the joint venture's liabilities is approximately $10.3 billion as of March&#160;31, 2023. These investments were comprised of approximately 70% debt securities, including government and corporate debt diversified by issuer, industry and geography; 20% equities, including mutual funds, equity securities and private equity partnerships; and 10% long-term deposits and policy loans. We participate in the approval of the joint venture's investment strategy and continuously review its execution. There were no investments with a material unrealized loss as of March&#160;31, 2023.</span></div><div style="margin-bottom:10pt"><span><br/></span></div><div id="id1800413722c4e30b53ad5d464cab4e8_277"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">MARKET RISK</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Financial Instruments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our assets and liabilities include financial instruments subject to the risk of potential losses from adverse changes in market rates and prices. Our primary market risk exposure is interest rate risk. We encourage you to read this in conjunction with "Market Risk &#8211; Financial Instruments" included in the MD&amp;A section of our 2022 Form 10-K. As of March&#160;31, 2023, there were no material changes in our risk exposures from those reported in our 2022 Form 10-K.</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_1024"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Information responsive to this item is contained under the caption "Market Risk" in Item 2 above, Management's Discussion and Analysis of Financial Condition and Results of Operations and is incorporated herein by reference.</span></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">50</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_925"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">CONTROLS AND PROCEDURES</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_931"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Based on an evaluation of the effectiveness of The Cigna Group's disclosure controls and procedures conducted under the supervision and with the participation of The Cigna Group's management (including The Cigna Group's Chief Executive Officer and Chief Financial Officer), The Cigna Group's Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, The Cigna Group's disclosure controls and procedures are effective to ensure that information required to be disclosed by The Cigna Group in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms and is accumulated and communicated to The Cigna Group's management, including The Cigna Group's Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_937"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Change in Internal Control over Financial Reporting</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There have been no changes in our internal control over financial reporting during the quarter ended March&#160;31, 2023 that have materially affected, or are reasonably likely to materially affect, The Cigna Group's internal control over financial reporting.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">51</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_1027"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_1030"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The information contained under "Legal and Regulatory Matters" in Note 16 to the Consolidated Financial Statements is incorporated herein by reference.</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_1033"></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RISK FACTORS</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For information regarding factors that could affect the Company's results of operations, financial condition and liquidity, see the risk factors discussed in Part I, Item 1A. "Risk Factors" in our Annual Report on Form 10-K for the year ended December&#160;31, 2022.</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_82"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_88"></div><div style="margin-bottom:12pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about The Cigna Group's share repurchase activity for the quarter ended March&#160;31, 2023:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.764%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total # of shares purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average price paid per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total # of shares purchased as part of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">publicly announced program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Approximate dollar value of shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">that may yet be purchased as part</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of publicly announced program </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1-31, 2023</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,645,320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">312.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,645,228</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,060</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 1-28, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">836,644</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">297.60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">675,164</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,860</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 1-31, 2023</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,070,256</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">279.47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">878,786</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,619</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,552,220</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">298.82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,199,178</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes shares tendered by employees under the Company's equity compensation plans as follows: 1) payment of taxes on vesting of restricted stock (grants and units) and strategic performance shares and 2) payment of the exercise price and taxes for certain stock options exercised. Employees tendered 92 shares in January, 161,480 shares in February and 191,470 shares in March 2023.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Additionally, the Company maintains a share repurchase program authorized by the Board. Under this program, the Company may repurchase shares from time to time, depending on market conditions and alternate uses of capital. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions and alternate uses of capital. The share repurchase program may be effected through Rule 10b5-1 plans, open market purchases, each in compliance with Rule 10b-18 under the Exchange Act, or privately negotiated transactions. The program may be suspended or discontinued at any time and does not have an expiration date. From April&#160;1, 2023 through May&#160;4, 2023, the Company repurchased 0.5 million shares for approximately $139 million, leaving repurchase authority at $2.5 billion as of May&#160;4, 2023.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Approximate dollar value of shares is as of the last date of the applicable month and excludes the impact of excise tax.</span></div><div id="id1800413722c4e30b53ad5d464cab4e8_1036"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The information contained under "Supplemental Pharmacy Benefit Management Model Disclosure" in Exhibit 20.1 to this Form 10-Q is incorporated herein by reference.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">52</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_1039"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EXHIBITS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.290%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Method of Filing</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31-thecignagroupxre.htm">Restated Certificate of Incorporation of The Cigna Group</a></span></div></td><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1739940/000095015923000019/ex3-3.htm">Amended and Restated By-laws of The Cigna Group</a></span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed by the registrant as Exhibit 3.3 to the Current Report on Form 8-K on February 13, 2023.</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1(g)</span></td><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1739940/000114036123010511/ny20007738x4_ex4-1.htm">Supplemental Indenture No. 6 dated as of March 7, 2023, between The Cigna Group and U.S. Bank Trust Company, National Association, as trustee</a></span></div></td><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed by the registrant as Exhibit 4.1 to the Current Report on Form 8-K on March 7, 2023 and incorporated herein by reference. </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ederofferletter.htm">Offer letter for Noelle Eder dated July 22, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ederofferletter.htm">0</a></span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1</span></td><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit201-supplementalpbm.htm">Supplemental Pharmacy Benefit Management Model Disclosure</a></span></div></td><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-2023_q1.htm">Certification of Chief Executive Officer of The Cigna Group pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934</a></span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-2023_q1.htm">Certification of Chief Financial Officer of The Cigna Group pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934</a></span></div></td><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-2023_q1.htm">Certification of Chief Executive Officer of The Cigna Group pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350</a></span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-2023_q1.htm">Certification of Chief Financial Officer of The Cigna Group pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350</a></span></div></td><td colspan="3" style="background-color:#e6e0ec;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from The Cigna Group's Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Consolidated Statements of Income; (ii) the Consolidated Statements of Comprehensive Income; (iii) the Consolidated Balance Sheets; (iv) the Consolidated Statements of Total Equity; (v) the Consolidated Statements of Cash Flows; and (vi) the Notes to the Consolidated Financial Statements</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr></table></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">53</span></div></div></div><div id="id1800413722c4e30b53ad5d464cab4e8_1042"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: May&#160;5, 2023</span></div><div style="margin-bottom:10pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.250%"><tr><td style="width:1.0%"></td><td style="width:3.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">THE CIGNA GROUP</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brian C. Evanko</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian C. Evanko</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Authorized Signatory)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt;text-align:right"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">54</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>exhibit31-thecignagroupxre.htm
<DESCRIPTION>EX-3.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i22f450c0fcd9429b9662b5d12ee88696_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 3.1</font></div></div><div style="margin-top:4.5pt;padding-left:8.82pt;padding-right:8.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTATED CERTIFICATE OF INCORPORATION OF THE CIGNA GROUP</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The undersigned hereby certifies on behalf of The Cigna Group as follows&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;The present name of the corporation is The Cigna Group. The corporation was incorporated under the name &#34;Halfmoon Parent, Inc.&#34; by the filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware on March 6, 2018.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;This Restated Certificate of Incorporation was duly adopted in accordance with the provisions of Sections 242 and 245 of the Delaware General Corporation Law.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;The Certificate of Incorporation of the corporation is hereby integrated and restated to read in its entirety as follows&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:8pt;padding-left:47.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">First</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; The name of the Corporation is The Cigna Group.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:11.8pt;padding-right:6.7pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%;text-decoration:underline">Second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">&#58; The address of the Corporation&#8217;s registered office in the State of Delaware is 1209 Orange Street in the City of Wilmington, County of New Castle, Delaware 19801. The name of its registered agent at such address is The Corporation Trust Company.</font></div><div style="margin-top:11.5pt;padding-left:11.7pt;padding-right:7.4pt;text-align:justify;text-indent:36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;text-decoration:underline">Third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">&#58; The nature of the business or purposes to be conducted or promoted is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:11.45pt;padding-right:7.6pt;text-align:justify;text-indent:36.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; The total number of shares of all classes of capital stock which the Corporation shall have the authority to issue is 625,000,000 shares divided into two classes as follows&#58; 600,000,000 shares of Common Stock of the par value of $0.01 per share and 25,000,000 shares of Preferred Stock of the par value of $1.00 per share.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:47.95pt;text-indent:-36pt"><font style="color:#090909;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:24.34pt">PREFERRED STOCK</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:8pt;padding-left:11.45pt;padding-right:5.15pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Board of Directors is expressly authorized to provide for the issue of all or any shares of the Preferred Stock, in one or more series, and to fix for each such series such voting powers, full or limited, or no voting powers, and such designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the Board of Directors providing for the issue of such series and as may be permitted by the General Corporation Law of the State of Delaware, including, without limitation, the authority to provide that any such series may be (i) subject to redemption at such time or times and at such price or prices&#59; (ii) entitled to receive dividends (which may be cumulative or non-cumulative) at such rates, on such conditions, and at such times, and payable in preference to, or in such relation to, the dividends payable on any other class or classes or any other series&#59; (iii) entitled to such rights upon the dissolution of, or upon any distribution of the assets of, the Corporation&#59; or (iv) convertible into, or exchangeable for, shares of any other class or classes of stock, or of any other series of the same or any other class or classes of stock, of the Corporation at such price or prices or at such rates of exchange and with such adjustments&#59; all as may be stated in such resolution or resolutions.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:47.7pt;text-indent:-35.9pt"><font style="color:#090909;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:24.9pt">COMMON STOCK</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:83.7pt;padding-right:6.95pt;text-align:justify;text-indent:-35.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:26.9pt;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">. Except as provided by law or this Certificate of Incorporation, each holder of Common Stock shall have one vote in respect of each share of stock held by him of record on the books of the Corporation for the election of directors and on all matters submitted to a vote of stockholders of the Corporation.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:84.05pt;text-indent:-35.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.75pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the preferential rights of the Preferred Stock, the holders of shares of Common Stock shall be entitled to receive, when and if declared by the Board of Directors, out of the assets of the Corporation which are by law available therefor, dividends payable either in cash, in property, or in shares of capital stock.</font></div><div style="margin-top:11.5pt;padding-left:85.5pt;padding-right:5.8pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Dissolution, Liquidation or Winding Up</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the event of any dissolution, liquidation or winding up of the affairs of the Corporation, after distribution in full of the preferential amounts, if any, to be distributed to the holders of shares of Preferred Stock, holders of Common Stock shall be entitled to receive all of the remaining assets of the Corporation of whatever kind available for distribution to stockholders ratably in proportion to the number of shares of Common Stock held by them respectively. The Board of Directors may distribute in kind to the holders of Common Stock such remaining assets of the Corporation or may sell, transfer or otherwise dispose of all or any part of such remaining assets to any other corporation, trust or other entity and receive payment therefor in cash, stock or obligations of such other corporation, trust or entity, or any combination thereof, and may sell all or any part of the consideration so received and distribute any balance thereof in kind to holders of Common Stock. Neither the merger or consolidation of the Corporation into or with any other corporation, nor the merger of any other corporation into it, nor any purchase or redemption of shares of stock of the Corporation of any class, shall be deemed to be a dissolution, liquidation or winding up of the Corporation for the purpose of this paragraph.</font></div><div style="margin-top:8pt;padding-left:13.5pt;padding-right:7.95pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;text-decoration:underline">Fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">&#58; The By-Laws of the Corporation may be adopted, amended or repealed by the affirmative vote of the holders of a majority of the voting power of the capital stock of the Corporation outstanding and entitled to vote thereon. The Board of Directors shall also have the power to adopt, amend or repeal any provision of the By-Laws of the Corporation without any vote of the stockholders of the Corporation.</font></div><div style="margin-top:8pt;padding-left:13.5pt;padding-right:7.95pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;text-decoration:underline">Sixth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">&#58; Elections of directors need not be by written ballot unless the By-Laws of the Corporation shall otherwise provide.</font></div><div style="margin-top:8pt;padding-left:13.5pt;padding-right:7.95pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;text-decoration:underline">Seventh</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">&#58; Notwithstanding any provision of the General Corporation Law of the State of Delaware, no action may be taken by stockholders without a meeting, without prior notice and without a vote, unless a consent in writing setting forth the action so taken shall be signed by the holders of all the outstanding stock who would be entitled to vote thereon.</font></div><div style="margin-top:8pt;padding-left:13.5pt;padding-right:7.95pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;text-decoration:underline">Eighth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">&#58; Whenever a compromise or arrangement is proposed between this Corporation and its creditors or any class of them and&#47;or between this Corporation and its stockholders or any class of them, any court of equitable jurisdiction within the State of Delaware may, on the application in a summary way of this Corporation or of any creditor or stockholder thereof or on the application of any receiver or receivers appointed for this Corporation under the provisions of Section 291 of Title 8 of the Delaware Code or on the application of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;padding-left:13.5pt;padding-right:7.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">trustees in dissolution or of any receiver or receivers appointed for this Corporation under the provisions of Section 279 of Title 8 of the Delaware Code order a meeting of the creditors or class of creditors, and&#47;or of the stockholders or class of stockholders of this Corporation, as the case may be, to be summoned in such manner as the said court directs. If a majority in number representing three-fourths in value of the creditors or class of creditors, and&#47;or of the stockholders or class of stockholders of this Corporation, as the case may be, agree to any compromise or arrangement and to any reorganization of this Corporation as consequence of such compromise or arrangement, the said compromise or arrangement and the said reorganization shall, if sanctioned by the court to which the said application has been made, be binding on all the creditors or class of creditors, and&#47;or on all of the stockholders or class of stockholders, of this Corporation, as the case may be, and also on this Corporation.</font></div><div style="margin-top:8pt;padding-left:13.5pt;padding-right:7.95pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;text-decoration:underline">Ninth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">&#58; The Corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by statute, and all rights conferred upon stockholders herein are granted subject to this reservation.</font></div><div style="margin-top:8pt;padding-left:13.5pt;padding-right:6.15pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tenth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vote for Certain Business Combinations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to any affirmative vote of holders of a class or series of capital stock of the Corporation required by law or this Certificate, a Business Combination (as hereinafter defined) with or upon a proposal by a Related Person (as hereinafter defined) shall require the affirmative vote of the holders of at least a majority of the voting power of all outstanding Voting Stock (as hereinafter defined) of the Corporation, voting together as a single class. Such affirmative votes shall be required notwithstanding the fact that no vote may be required, or that a lesser percentage may be specified, by law or the Board.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:78.05pt;padding-right:6.8pt;text-align:justify;text-indent:-35.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.75pt;text-decoration:underline">When Vote Is Not Required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The provisions of this Article shall not be applicable to a particular Business Combination, and such Business Combination shall require only such affirmative vote as is required by law and any other provision of this Certificate or the By-Laws of the Corporation, if all of the conditions specified in any one of the following Paragraphs (A), (B) or (C) are met&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:114.3pt;padding-right:6.5pt;text-align:justify;text-indent:-36.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.61pt;text-decoration:underline">Approval by Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Business Combination has been approved by a vote of a majority of all the Continuing Directors (as hereinafter defined)&#59; or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:114.2pt;padding-right:6.6pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Combination with Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Business Combination is solely between the Corporation and a subsidiary of the Corporation and such Business Combination does not have the direct or indirect effect set forth in Paragraph 3(B)(v) of this Article Tenth&#59; or</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:114.3pt;padding-right:7.35pt;text-align:justify;text-indent:-36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.12pt;text-decoration:underline">Price and Procedural Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The proposed Business Combination will be consummated within three years after the date the Related Person became a Related Person (the &#8220;Determination Date&#8221;) and all of the following conditions have been met&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.55pt;padding-left:72pt"><font><br></font></div><div style="padding-left:184.5pt;padding-right:5.05pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:24.69pt">The aggregate amount of (x) cash and (y) fair market value (as of the date of the consummation of the Business </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:184.5pt;padding-right:5.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">Combination) of consideration other than cash, to be received per share of Common or Preferred Stock of the Corporation in such Business Combination by holders thereof shall be at least equal to the highest per share price (including any brokerage commissions, transfer taxes and soliciting dealers&#8217; fees) paid by the Related Person for any shares of such class or series of stock acquired by it&#59; provided, that if either (a) the highest preferential amount per share of a series of Preferred Stock to which the holders thereof would be entitled in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Corporation (regardless of whether the Business Combination to be consummated constitutes such an event) or (b) the highest reported sales price per share for any shares of such series of Preferred Stock on any national securities exchange on which such series is traded and if not traded on any such exchange, the highest reported closing bid quotation per share with respect to shares of such series on the National Association of Securities Dealers, Inc. Automated Quotation System or on any system then in use, at any time after the Related Person became a holder of any shares of Common Stock, is greater than such aggregate amount, holders of such series of Preferred Stock shall receive an amount for each such share at least equal to the greater of (a) or (b).</font></div><div style="padding-left:189pt;padding-right:5.05pt"><font><br></font></div><div style="padding-left:186.2pt;padding-right:21.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">The consideration to be received by holders of a particular class or series of outstanding Common or Preferred Stock shall be in cash or in the same form as the Related Person has previously paid for shares of such class or series of stock. If the Related Person has paid for shares of any class or series of stock with varying forms of consideration, the form of consideration given for such class or series of stock in the Business Combination shall be either cash or the form used to acquire the largest number of shares of such class or series of stock previously acquired by it.</font></div><div style="margin-top:0.55pt;padding-left:72pt"><font><br></font></div><div style="padding-left:186.3pt;padding-right:24.35pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:18.03pt">No Extraordinary Event (as hereinafter defined) occurs after the Determination Date and prior to the consummation of the Business Combination.</font></div><div style="margin-top:0.3pt;padding-left:72pt"><font><br></font></div><div style="padding-left:186.2pt;padding-right:23.65pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">A proxy or information statement describing the proposed Business Combination and complying with the requirements of the Securities Exchange Act of 1934, as amended, and the rules and regulations </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:186.2pt;padding-right:23.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">thereunder (or any subsequent provisions replacing such Act, rules or regulations) is mailed to public stockholders of the Corporation at least 30 days prior to the consummation of such Business Combination (whether or not such proxy or information statement is required pursuant to such Act or subsequent provisions).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:42.2pt;text-indent:-36.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.25pt;text-decoration:underline">Certain Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For purposes of this Article Tenth&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:81.25pt;padding-right:5.65pt;text-align:justify;text-indent:-36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.46pt">A &#8220;person&#8221; shall mean any individual, firm, corporation or other entity, or a group of &#8220;persons&#8221; acting or agreeing to act together in the manner set forth in Rule 13d-5 under the Securities Exchange Act of 1934, as in effect on April 24, 1985.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:81.25pt;padding-right:5.5pt;text-align:justify;text-indent:-36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:20.12pt">The term &#8220;Business Combination&#8221; shall mean any of the following transactions, when entered into by the Corporation or a subsidiary of the Corporation with, or upon a proposal by, a Related Person&#58;</font></div><div style="margin-top:11.45pt;padding-left:114.3pt;padding-right:5.75pt;text-align:justify;text-indent:-36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%;padding-left:24.79pt">the merger or consolidation of the Corporation or any subsidiary of the Corporation&#59; or</font></div><div style="margin-top:11.45pt;padding-left:114.3pt;padding-right:5.95pt;text-align:justify;text-indent:-36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.46pt">the sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one or a series of transactions) of any assets of the Corporation or any subsidiary of the Corporation having an aggregate fair market value of $100 million or more&#59; or</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:114.3pt;padding-right:5.6pt;text-align:justify;text-indent:-36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.13pt">the issuance or transfer by the Corporation or any subsidiary of the Corporation (in one or a series of transactions) of securities of the Corporation or any subsidiary having an aggregate fair market value of$50 million or more&#59; or</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:114.3pt;padding-right:5.5pt;text-align:justify;text-indent:-36.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.94pt">the adoption of a plan or proposal for the liquidation or dissolution of the Corporation&#59; or</font></div><div style="padding-left:114.3pt;padding-right:5.5pt;text-align:justify"><font><br></font></div><div style="margin-top:3pt;padding-left:114.05pt;padding-right:7.8pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the reclassification of securities (including a reverse stock split), recapitalization, consolidation or any other transaction (whether or not involving a Related Person) which has the direct or indirect effect of increasing the voting power, whether or not then exercisable, of a Related Person in any class or series of capital stock of the Corporation or any subsidiary of the Corporation&#59; or</font></div><div style="margin-top:8pt"><font><br></font></div><div style="padding-left:114.25pt;padding-right:8pt;text-align:justify;text-indent:-36.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.89pt">any agreement, contract or other arrangement providing directly or indirectly for any of the foregoing. </font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:76.5pt;padding-right:7.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">The term &#8220;Related Person&#8221; shall mean any person (other than the Corporation, a subsidiary of the Corporation or any profit sharing, employee stock ownership or other employee benefit plan of the Corporation or of a subsidiary of the Corporation or any trustee of or fiduciary with respect to any such plan acting in such capacity) that is the direct or indirect beneficial owner (as defined in Rule 13d-3 and Rule 13d-5 under the Securities Exchange Act of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:76.5pt;padding-right:7.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1934) of more than ten percent (10%) of the outstanding Voting Stock of the Corporation, and any Affiliate or Associate of any such person.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:76.5pt;padding-right:7.8pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:19.36pt">The term &#8220;Continuing Director&#8221; shall mean any member of the Board of Directors who is not affiliated with a Related Person and who was a member of the Board of Directors immediately prior to the time that the Related Person became a Related Person, and any successor to a Continuing Director who is not affiliated with the Related Person and is recommended to succeed a Continuing Director by a majority of Continuing Directors who are then members of the Board of Directors.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:76.5pt;padding-right:8.6pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.69pt">&#8220;Affiliate&#8221; and &#8220;Associate&#8221; shall have the respective meanings ascribed to such terms in Rule 12b-2 under the Securities Exchange Act of 1934.</font></div><div style="margin-top:8pt"><font><br></font></div><div style="padding-left:76.5pt;padding-right:5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:21.35pt">The term &#8220;Extraordinary Event&#8221; shall mean, as to any Business Combination and Related Person, any of the following events that is not approved by a majority of all Continuing Directors&#58;</font></div><div style="margin-top:11.5pt;padding-left:112.5pt;padding-right:7.55pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:24.69pt">any failure to declare and pay at the regular date therefor any full quarterly dividend (whether or not cumulative) on outstanding Preferred Stock&#59; or</font></div><div style="margin-top:0.45pt;padding-left:112.5pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:112.5pt;padding-right:7.85pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">any reduction in the annual rate of dividends paid on the Common Stock (except as necessary to reflect any subdivision of the Common Stock)&#59; or</font></div><div style="margin-top:0.45pt;padding-left:112.5pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:112.5pt;padding-right:7.95pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">any failure to increase the annual rate of dividends paid on the Common Stock as necessary to reflect any reclassification (including any reverse stock split), recapitalization, reorganization or any similar transaction that has the effect of reducing the number of outstanding shares of the Common Stock&#59; or</font></div><div style="margin-top:0.1pt;padding-left:112.5pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:112.5pt;padding-right:7.7pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">the receipt by the Related Person, after the Determination Date, of a direct or indirect benefit (except proportionately as a stockholder) from any loans, advances, guarantees, pledges or other financial assistance or any tax credits or other tax advantages provided by the Corporation or any subsidiary of the Corporation, whether in anticipation of or in connection with the Business Combination or otherwise.</font></div><div style="margin-top:3pt;padding-left:76.5pt;padding-right:7.8pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">A majority of all Continuing Directors shall have the power to make all determinations with respect to this Article Tenth, including, without limitation, the transactions that are Business Combinations, the persons who are Related Persons, the time at which a Related Person became a Related Person, and the fair market value of any assets, securities or other property, and any such determinations of such directors shall be conclusive and binding.</font></div><div style="margin-top:0.45pt;padding-left:76.5pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:76.5pt;padding-right:5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">The term &#8220;Voting Stock&#8221; shall mean all outstanding shares of the Common or Preferred Stock of the Corporation entitled to vote generally and each reference to a proportion of Voting Stock shall refer to shares having such proportion of the number of shares entitled to be cast.</font></div><div style="margin-top:0.5pt;padding-left:76.5pt;text-indent:-36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt;padding-left:40.5pt;padding-right:7.95pt;text-indent:-35.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.8pt;text-decoration:underline">No Effect on Fiduciary Obligations of Related Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Nothing contained in this Article Tenth shall be construed to relieve any Related Person from any fiduciary obligation imposed by law.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:13.5pt;padding-right:8pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eleventh</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; To the fullest extent permitted by the General Corporation Law of the State of Delaware as the same exists or may hereafter be amended, no director or officer of the Corporation shall be liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer. Any repeal or modification of the preceding sentence shall not adversely affect any right or protection of a director or officer existing at the time of such repeal or modification. For purposes of this Article Eleventh, &#8220;officer&#8221; shall have the meaning provided in Section 102(b)(7) of the General Corporation Law of the State of Delaware as the same exists or may hereafter be amended.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature page follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></div></div><div id="i22f450c0fcd9429b9662b5d12ee88696_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Corporation has caused this Restated Certificate of Incorporation to be signed in its name by the undersigned officer on the 26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day of April, 2023.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:288pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THE CIGNA GROUP</font></div><div style="padding-left:288pt"><font><br></font></div><div style="padding-left:288pt"><font><br></font></div><div style="padding-left:288pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.737%"><tr><td style="width:1.0%"></td><td style="width:12.801%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.999%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;&#47;s&#47; Kari K. Stevens</font></td></tr></table></div><div style="padding-left:288pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Kari K. Stevens</font></div><div style="padding-left:324pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; &#160;&#160;&#160;&#160;Secretary</font></div><div style="padding-left:288pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to Restated Certificate of Incorporation&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.31
<SEQUENCE>3
<FILENAME>ederofferletter.htm
<DESCRIPTION>EX-10.31
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ederofferletter</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ederofferletter001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ederofferletter001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ederofferletter002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ederofferletter002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ederofferletter003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ederofferletter003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ederofferletter004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ederofferletter004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-20.1
<SEQUENCE>4
<FILENAME>exhibit201-supplementalpbm.htm
<DESCRIPTION>EX-20.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if6d2b78157bc4d529ffb6639247a2fed_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 20.1</font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">Supplemental Pharmacy Benefit Management Model Disclosure</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">On each of April 13 and 20, 2023, Express Scripts, Inc. (&#8220;Express Scripts&#8221;) issued a press release announcing several actions to further evolve its pharmacy benefit management (&#8220;PBM&#8221;) model. The purpose of this disclosure is to provide additional information regarding Express Scripts&#8217; business model that is described in the 2022 Annual Report on Form 10-K of The Cigna Group. We do not consider the information contained herein to be material to making an investment decision in The Cigna Group. We do, however, believe it may be helpful to our various stakeholders who are looking to understand more about our recent announcements and our PBM model more generally. Additional information regarding Express Scripts&#8217; PBM model can be accessed at www.ExpressScriptsFacts.com. Information on, or accessible through, this site is expressly not incorporated by reference into this disclosure beyond the information provided below. The industry metrics referenced below are based on what we believe is the most recent information that is publicly available. All financial and operational information for Express Scripts is presented on a stand-alone basis separate from the other operations of The Cigna Group.</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Overview</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Innovation in the pharmaceutical industry has resulted in a growing number of drugs that provide valuable medical benefits, but these same drugs are also expensive and contribute to rising health care costs for the private sector and the government.&#160;According to an article in the American Journal of Health-System Pharmacy, prescription drug spending in the United States totaled $576.9 billion in 2021, which was up 7.7% from the prior year.&#160;At the same time, the American population is aging, which is a well</font><font style="color:#000000;font-family:'Cambria Math',serif;font-size:11pt;font-weight:400;line-height:125%">&#8208;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">established risk factor for the development of multiple chronic diseases that in turn increase the demand for new and expensive drugs. PBMs help ensure access to these important, often life-saving drugs, while ensuring they can be obtained in an affordable way.&#160;PBMs&#160;are a key part of the health care system, working with health plans, as well as employers and other plan sponsors who provide health benefits to their employees to help drive down the cost of prescription drugs and help coordinate care programs.&#160;Most importantly, PBMs provide these benefits at a cost which is significantly lower than the benefit PBMs bring to the health care system.&#160;In 2022, based on publicly available information, the average pre-tax adjusted</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">operating margin of PBMs was between 4.0% and 4.5%, well below any other healthcare subsectors (including pharmaceutical manufacturers), and below the 5-year average net profit margin for the S&#38;P 500 of 11.4%.&#160;</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Express Scripts&#8217; PBM is within the Evernorth Health Services (&#8220;Evernorth&#8221;) segment of The Cigna Group. Express Scripts serves a diverse base of approximately 2,500 clients representing nearly 100 million people. In 2022 alone, Express Scripts saved consumers and clients more than $37 billion (including savings from Home Delivery Services and Specialty Services). It achieves these savings in four primary ways&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%;padding-left:14.15pt;text-decoration:underline">Helping clients (employers, health plans and government programs) and customers (individuals) afford and finance their drug spend</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medications can be expensive.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PBMs, including Express Scripts, aggregate the buying power of the multiple clients they serve to negotiate more affordable costs for medications that their respective populations need. This allows each client and customer that Express Scripts serves to save more on necessary and in some cases life-saving medications than they could ever achieve on their own.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 20.1</font></div></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%;padding-left:14.15pt;text-decoration:underline">Providing clinical support to help ensure our clients and customers receive the outcomes they expect</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. Unique to Express Scripts are its </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">SafeGuardRx</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">SM</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;programs that use available evidence to facilitate appropriate and effective treatments for eleven complex and costly disease states, including </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">oncology, inflammatory conditions, multiple sclerosis and rare conditions. Not only do our programs help to limit our clients&#8217; financial exposure through innovative value-based arrangements, they also provide proactive medication adherence coaching services to customers. Through this service, Express Scripts pharmacists are available to talk through topics such as&#58; medication options, side effects, barriers to medication adherence and possible interactions. In 2022, approximately 86 million customers were enrolled in </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">SafeGuardRx</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">SM</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;programs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> and, as a result, achieved </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">better medication adherence, lower costs, higher therapy completion rates and greater clinical compliance.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%;padding-left:14.15pt;text-decoration:underline">Helping our clients decide which medications to offer as part of their benefit plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. Express Scripts clients have to make a number of decisions when creating a pharmacy benefit plan, including deciding which of the hundreds of thousands of available drugs they will offer to their covered population. PBMs, including Express Scripts, utilize their expertise to support clients with designing a pharmacy benefit that works for them, including through the use of drug formulary options. A drug formulary, or preferred drug list, is a continually updated list of medications and related products supported by current evidence-based medicine, judgment of physicians, pharmacists and other experts in the diagnosis and treatment of disease and preservation of health. The primary purpose of the formulary is to encourage the use of safe, effective and affordable medications while maintaining or improving quality patient care.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%;padding-left:14.15pt;text-decoration:underline">Providing administrative and care coordination services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In addition to processing claims, Express Scripts can analyze claim data to improve patient care and safety by, for example, monitoring patient drug adherence, detecting fraud, waste and abuse (which, according to a study by the Academy of Managed Care Pharmacists accounts for approximately 1%, or billions of dollars in unnecessary costs) and using models that inform prescribing doctors of the medication options that are therapeutically similar (i.e., drugs that provide similar treatment outcomes) but that would be more cost-effective for their patients&#8217; specific situations, with the doctor and patient making the ultimate determination of what is best.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Driving Cost Savings and Transparency for Consumers and Clients</font></div><div><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Express Scripts believes that all individuals should have access to the medications they need at affordable prices. That means special care should be taken to&#58; (1) remove barriers to routine care and treatment for those with conditions that can be effectively managed to optimize health (e.g., chronic conditions) and (2) create programs that put more complex and costly treatments in the hands of those who need them most. In furtherance of this belief, Express Scripts has announced a series of actions designed to increase access to affordable medicines and drive greater transparency and predictability for the thousands of clients and millions of customers it serves every day.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 20.1</font></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Cost Savings</font></div><div><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In April 2023, Express Scripts announced a new and innovative solution, the Copay Assurance plan</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">,</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> which caps consumer out-of-pocket costs for prescription drugs under a client&#8217;s prescription drug benefit. This means customers enrolled in the program will pay no more than $5 for generics and specialty generics, $25 for preferred brand drugs and $45 for preferred specialty brand drugs every time they fill their prescription. The program will immediately guarantee these lower out-of-pocket rates &#8211; customers will not have to wait to meet any deductible levels.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Additionally, Express Scripts is working with employer and health plan clients offering high deductible health plans to offer consultative options to bring better affordability and predictability. This includes&#58; adopting the broadest lists of preventive prescription drugs that are either fully covered or covered at a discount, lowering premiums and deductibles, and increasing Health Savings Account contributions for lower-income consumers based on Internal Revenue Service income requirements. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">All of this is in addition to existing programs and initiatives that Express Scripts offers, including&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Express Scripts Patient Assurance Program, launched in 2020, caps out of pocket costs for eligible customers for select diabetes and cardiovascular medications. Customers taking insulin saved more than $18 million with point-of-sale discounts in 2022 alone, part of more than $45 million in customer savings on insulin since the program launched.&#160;In addition to capping the cost of insulin, the Patient Assurance Program has helped improve adherence by removing cost as a barrier to care.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Express Scripts &#8220;lesser of&#8221; logic when processing a prescription claim ensures customers pay the lowest price available when picking up their medication at the pharmacy, whether that price is their co-payment or the pharmacy&#8217;s cash price for the medication. The key to &#8220;lesser of&#8221; logic is that it doesn&#8217;t require customers to take any action or price shop. In most cases, the best prescription medication price comes from our negotiated price within the benefit, but there are instances where cash discount pricing is lower, particularly for customers in high deductible health plans where the customer is responsible for the full cost of the medication until they meet their deductible.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Transparency</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Express Scripts also believes in providing our clients and customers the transparency they need to understand the value they are getting. We have developed several innovations, including those described below, for our customers and clients to increase transparency and help them to better understand the value we deliver. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Express Scripts recently announced that starting in 2024, all prescriptions will include an easy-to-understand digital pharmacy benefits statement for consumers that will share drug price information, out-of-pocket costs and the value delivered by Express Scripts. This benefit will be implemented across all of the nearly 64,000 pharmacies in Express Scripts&#8217; networks, including </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 20.1</font></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Accredo</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> specialty pharmacy and Express Scripts Pharmacy, which are not part of the Express Scripts&#8217; PBM business.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">This is in addition to the transparency initiatives that Express Scripts has already implemented, including&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Express Scripts Real Time Prescription Benefit helps to simplify the patient&#8217;s experience with their prescriber and improve transparency of drug costs. Express Scripts uploads patient-specific information and pricing information directly into the physician&#8217;s Electronic Health Record within seconds. Physicians using electronic prescribing have access to the following information to inform prescribing decisions&#58; alternative drugs and associated details, such as generic versus brand pricing&#59; coverage information, including electronic prior authorization requirements, step therapy requirements, or quantity limits&#59; and the patient&#8217;s cost through each pharmacy dispensing channel&#58; retail, home delivery or specialty pharmacy.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Express Scripts also directly provides customers real-time pricing information, customized to their individual plans, via the Express Scripts website and mobile app, so patients can choose the pharmacy that provides the most affordable dispensing option. Express Scripts&#8217; medication pricing tool allows customers to compare prescription options, based on health care needs, real-time costs and plan benefits. Customers can then determine if a medication is covered under their plan, and how much it will cost at local participating retail pharmacies, as well as through home delivery (if available). Additionally, costs for generic medications, when available, are displayed when searching for brand-name drugs. Cost estimates for 30- and 90-day supplies are personalized, based on the customer&#8217;s benefits. Finally, alerts appear for medications with coverage limitations (e.g., quantity limits and prior authorizations). Express Scripts&#8217; innovations help better inform patients of their cost sharing and treatment options, thereby improving affordability and predictability.</font></div><div><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Our New Transparent Client Offering</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Express Scripts&#8217; new ClearCareRx program offers employer, health plan and government employer clients the option of a transparent economic model by providing clear and predictable costs for prescription drug benefits&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Clients pay exactly what Express Scripts pays pharmacies for a prescription. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Clients receive 100% of drug rebates that Express Scripts receives.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Clients pay one simple fee to cover the administration of pharmacy benefits, PBM product services and, reporting and analytics.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Provides guarantees that keep Express Scripts accountable to clinical and financial performance measures, including improvements in drug performance, adherence, and overall patient outcomes.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">This new offering will add to the choices already available to clients to finance the cost of the services that Express Scripts provides. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 20.1</font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Clients not participating in ClearCareRx will continue to customize the pricing model they select for the value that Express Scripts delivers. A key principle underlying Express Scripts&#8217; overall pricing models is client choice.&#160;Clients&#8217; needs vary significantly.&#160;Some prefer predictability, some value cash flow, while others prioritize visibility into discounts that Express Scripts negotiates with its network of retail pharmacies and other providers. Generally, clients will issue requests for proposal (RFPs) that specify the financing mechanism and other features&#160;that will meet their particular needs. Express Scripts responds to&#160;those RFPs with a package of products and&#160;services to best address those needs.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The marketplace for the services Express Scripts provides is highly competitive and the majority of clients are sophisticated purchasers that are utilizing the services of consultants and brokers to secure the highest service levels and savings available to them.&#160;Clients typically have three-year contracts with terms that allow them to ensure that pricing remains competitive throughout the life of the contract.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Clients can choose to finance the services provided by Express Scripts through any of following mechanisms&#58; (1) administrative fees&#59; (2) value-sharing arrangements on the discounted pricing Express Scripts negotiates with retail pharmacies (&#8220;spread pricing&#8221;)&#59; and&#47;or (3) value sharing arrangements on rebate savings.&#160;Many of these arrangements include a &#8220;guarantee&#8221; in which Express Scripts guarantees a minimum discount that a client will receive from drug manufacturers and&#47;or retail pharmacies, which represents the maximum price that a client will pay for prescription drugs. If Express Scripts is not able to secure the discount that has been guaranteed, Express Scripts recognizes a loss&#59; and therefore is at risk based on its ability to perform.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Each of these pricing arrangements is described more fully below.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:125%">Pass Through Pricing Model</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. In this model, Express Scripts passes through the discounted pricing that it has negotiated for prescription drugs with its network of retail pharmacies and other providers.&#160;In a pass through arrangement, the client typically pays Express Scripts administrative fees for the services it provides, such as claims adjudication, retail network management, formulary management, clinical programs and utilization management programs.&#160;The amount of fees Express Scripts earns is driven by the specific services and customization it provides to clients in a highly competitive marketplace.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:125%">Spread Pricing Model</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> Clients select the pricing model that determines how and whether they will share in the discounts that Express Scripts negotiates with retail pharmacies. In the spread pricing model, the client elects predictable aggregate pricing guarantees (and Express Scripts takes on the pricing risk) for prescription drugs dispensed by Express Scripts&#8217; contracted retail pharmacies. The client does not generally pay administrative fees for claims adjudication, network management, formulary management and other core administrative services the PBM provides.&#160;Under a spread arrangement, if the rate paid by a client for prescription drug claims exceeds the rate contracted with a particular pharmacy, ESI will realize a positive margin on the applicable claim. The reverse also may be true, resulting in negative margin for ESI. Incremental value retained by Express Scripts under a spread arrangement represents value sharing and Express Scripts&#8217; compensation for providing a number of services. The actual discount secured by Express Scripts is dependent upon its negotiations with its network of pharmacies.&#160;The actual amount of gain or loss experienced by Express Scripts is further impacted by the client&#8217;s drug utilization mix. Express Scripts&#8217; clients have the option to choose either a spread or a pass through pricing model. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 20.1</font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In April 2023, Express Scripts committed to provide clients who choose spread pricing arrangements with enhanced financial and fee disclosure regarding their spread pricing arrangements for Form 5500 reporting and other plan administration functions beginning with the 2023 plan year.&#160;The Form 5500 Series is a compliance, research and disclosure tool for the U.S. Department of Labor, other Federal agencies and Congress, as well as for plan participants and beneficiaries, and the private sector to assess employee benefit, tax and economic trends and policies. Express Scripts will provide the same level of increased disclosure to its non-ERISA (Employee Retirement Income Security Act of 1974) clients to help support them in understanding the services Express Scripts provides.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:125%">Value Sharing Arrangements on Rebate Model. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Express Scripts negotiates to obtain additional discounts based on the utilization of certain prescription drugs and supplies.&#160;These additional discounts can be paid to Express Scripts in the form of a rebate. While clients have options with respect to their rebate arrangements, in 2022, Express Scripts shared over 95% of the rebates it received with its PBM clients,&#160;and two-thirds of Express Scripts&#8217; clients received 100% of rebates. In most rebate pricing arrangements, clients receive the greater of a minimum rebate guarantee or a contractually agreed upon percentage of rebates. Some clients have elected to receive less than 100% of rebates, or to receive only a&#160;minimum guaranteed rebate amount.&#160;In most rebate arrangements, Express Scripts takes on the risk of securing the rebate value necessary to meet the value guaranteed to its client. The actual amount of value secured by Express Scripts is dependent upon the result of its negotiations for rebates.&#160;The actual amount of gain or loss experienced by Express Scripts is further impacted by the client&#8217;s drug utilization mix.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%">Rebates</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">A rebate is a retrospective discount off of a manufacturer&#8217;s list price based on utilization of a particular drug by a member. Pharmaceutical manufacturers decide whether to offer a rebate on any particular drug, and if so, the amount to offer. Many factors can affect the amount of the rebate including aggregate volume and purchasing power, but in general, higher rebates are achieved when a client adopts a formulary and plan design that provides greater incentives to its participants to use a formulary (preferred) drug (see description of formulary below). Rebates are not typically offered for drugs without market competition or drugs that have obtained &#8220;orphan&#8221; designation (drugs used to prevent, diagnose or treat a rare disease or condition). Rebates are also not typically offered for generic medications, which comprise the majority of medications dispensed by volume. In the first quarter of 2023, approximately 88% of all prescriptions processed by Express Scripts were generics and the vast majority of these were not subject to any rebate. In the first quarter 2023, approximately 93% of all prescriptions processed by Express Scripts had no rebate associated with them.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Rebate discounts are an important tool to drive down drug cost, and can translate into lower premiums for consumers. In May 2019, the nonpartisan Congressional Budget Office found that a proposed rule to limit the use of rebates would increase federal spending in Medicare and Medicaid by $177 billion from 2020 through 2029 due to premium increases driven by higher drug prices. A similar report from the Centers for Medicare &#38; Medicaid Services actuaries concluded that the same proposed rule would increase government spending by $196.1 billion over a decade. A United States Government Accountability Office study in 2019 found that 99.6% of prescription drug rebates in Medicare Part D are passed through to plan sponsors and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 20.1</font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">used to lower costs for Medicare beneficiaries. These savings have contributed to reductions in Part D basic premiums, from $34.70 in 2017 to a projected $31.50 in 2023</font><font style="background-color:#fafafa;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In 2019, Express Scripts and a co-founder established Ascent Health Services (&#8220;Ascent&#8221;), a group purchasing organization. Since inception, a number of additional participants have joined Ascent. Ascent&#8217;s mission is to aggregate commercial lives across health plans and pharmacy benefit management companies to negotiate greater discounts with pharmaceutical manufacturers than any of the participants in Ascent could achieve alone. Ascent negotiates directly with pharmaceutical manufacturers for rebates. For non-commercial lives, Express Scripts contracts directly with pharmaceutical manufacturers for rebates. Ascent receives limited information from participants and has robust and strict firewalls in place to ensure that any one participant&#8217;s discount or other information is not shared with other participants. By enabling commercial payers to directly contract with Ascent, payers realize the savings benefits of aggregating their purchasing volume with Express Scripts and other participants, without engaging in a direct client relationship with Express Scripts. This model drives down premiums and other costs for more customers.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ascent is subject to regular audits from its participants, who have a contractual right to audit the operations of Ascent and its firewalls. Ascent&#8217;s annual financial results are separately audited by a leading international auditing firm.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Formularies</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Express Scripts works with its clients to provide affordable access to clinically sound, high-quality medications. Drug formularies are one method of achieving this result. </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The Express Scripts formulary development process is based on the following principles&#58; </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:124%;padding-left:14.15pt">Clinical appropriateness of the drug, safety and effectiveness, not cost, are Express Scripts&#8217; foremost considerations. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:124%;padding-left:14.15pt">The prescribing physician always makes the final decision regarding an individual patient&#8217;s drug therapy. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:124%;padding-left:14.15pt">Express Scripts will develop clinically sound formularies based on evaluations of independent physicians. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Consistent with these principles, Express Scripts offers a variety of standard formularies. Clients, based on their own unique situation, can select a formulary that is most appropriate for their population. A medication&#8217;s placement on a formulary generally determines the availability of any rebate payable with respect to the medicine.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Express Scripts develops formularies through a four-step process involving the work of three distinct committees&#58; </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:8.84pt">The </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Therapeutic Assessment Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> (&#8220;TAC&#8221;) is an internal clinical review body, consisting of clinical pharmacists and physicians who are employed by Express Scripts. From a formulary development perspective, the committee is tasked to review specific medications following approval by the Food and Drug Administration (&#8220;FDA&#8221;). Before discussing a new drug at TAC, Express Scripts&#8217; clinical team conducts a search of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 20.1</font></div></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">medical literature, evaluates published data from clinical trials and develops comprehensive drug evaluation summary documents. The drug evaluation documents are developed with the aid of a wide range of resources including, but not limited to&#58; primary literature, clinical practice guidelines and FDA-approved package inserts. The drug evaluation documents include, at a minimum&#58; a summary of the pharmacology, safety, efficacy, dosage, mode of administration and the relative place in therapy of the medication under review compared to other pharmacologic alternatives. Following a review of the drug evaluation summary document, TAC ultimately provides a formulary placement recommendation which is shared with the Express Scripts&#8217; National Pharmacy and Therapeutics Committee (described below). TAC formulary recommendations are merely a suggestion and cannot be formally implemented without the approval of the P&#38;T.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:8.84pt">The </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">National Pharmacy &#38; Therapeutics Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> (P&#38;T&#8221;) is a group of independent, actively practicing physicians and pharmacists who are not employed by Express Scripts. The P&#38;T is tasked to review medications from a purely clinical perspective. The committee does not have access to, nor does it consider, any information regarding Express Scripts' rebates&#47;negotiated discounts, or the net cost of the drug after application of all discounts. The committee does not use price, in any way, to make formulary placement decisions. The P&#38;T reviews a much broader range of formulary placement topics than TAC, including&#58; new drug evaluations, new FDA-approved indications for existing drugs, new clinical line extensions and new published or clinical practice trends that may impact previous formulary placement decisions. The P&#38;T can establish one of the following four formulary placement designations&#58; include, access, optional or exclude from a formulary.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:8.84pt">The </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Value Assessment Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> (&#8220;VAC&#8221;) considers the value of drugs by evaluating the net cost, market share and drug utilization trends of clinically similar medications. VAC consists of Express Scripts' employees from formulary management, product management, finance and clinical account management. No member of VAC can serve in any capacity on TAC (and vice-versa). VAC reviews drugs designated as &#8220;access&#8221; or &#8220;optional&#8221; by the P&#38;T, and develops a formulary placement recommendation. VAC is required to add medications with an &#8220;include&#8221; designation to formulary, while drugs with an &#8220;exclude&#8221; designation may not be preferred on the formulary. In both cases, economic considerations are superseded by the clinical requirements of the P&#38;T. Once complete, formulary and tier placement recommendations are then forwarded to the P&#38;T for final approval. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:8.84pt;text-decoration:underline">Annual Review</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. On an annual basis, the P&#38;T will review the final formulary recommendations, by drug class, for the upcoming plan year. The committee uses this opportunity to ensure adherence to previously established formulary placement recommendations, and to validate continued alignment with best medical practices. The committee also ensures that all Express Scripts national formularies cover a broad distribution of therapeutic classes and categories and that the formularies provide all enrollees and patient populations a comprehensive, clinically sound formulary.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Express Scripts&#8217; clients often adopt Express Scripts-developed formularies as their own or use them as the foundation to create their own custom formularies. The decision to cover non-formulary medications, as well as the mechanism by which it is administered, is entirely determined by the client, not Express Scripts. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 20.1</font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Our Enhanced Reimbursements and Other Initiatives to Support Independent Pharmacists</font></div><div style="margin-top:15pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Industry commentators sometimes categorize retail pharmacies into four types&#58;</font></div><div style="margin-top:15pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt;text-decoration:underline">Chain pharmacies</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. Chain pharmacies are the largest and most prevalent of the four pharmacy types, representing approximately 37% of stores and 34% of prescription drug revenues in 2021. Express Scripts does not own or operate this type of pharmacy.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt;text-decoration:underline">Regional pharmacies (Grocers, retailers and other partners)</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. This group can be segmented into two types&#58; grocers (supermarkets that also have a pharmacy) and mass retail (large consumer goods retailers that also have a pharmacy). In 2021, regional pharmacies represented around 29% of stores and 15% of prescription drug revenues. Express Scripts does not own or operate this type of pharmacy.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt;text-decoration:underline">Independent pharmacies</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. Independent pharmacies handle approximately 900 million prescriptions per year generating approximately $60 billion in annual prescription revenue. In 2021, independent pharmacies represented around 34% of stores and 12% of prescription drug revenues. Most independent community pharmacies are part of collective bargaining groups called pharmacy services administrative organizations (&#8220;PSAOs&#8221;) that negotiate contracts with other parties in the pharmaceutical supply and payment chain on behalf of the pharmacies they represent. PSAOs also provide a wide range of business services to all types of pharmacies, which are necessary to run a successful pharmacy. About 83% of independent pharmacies contract with a PSAO. Over 75% of independent and small chain pharmacies contract with PSAOs owned by one of the top wholesalers (AmerisourceBergen, Cardinal Health and McKesson). Express Scripts does not own or operate this type of pharmacy.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt;text-decoration:underline">Home delivery pharmacies</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. Mail order (or home delivery) pharmacies are generally owned by PBMs and fill maintenance and specialty prescriptions. In the past 15 years, many direct-to-consumer online pharmacies have been established. In 2021, these organizations accounted for about 10% of total U.S. prescriptions. Evernorth, the parent company of Express Scripts, owns and operates a mail order pharmacy that primarily dispenses a 90-day supply of maintenance medication (e.g., medication to treat diabetes, high blood pressure and high cholesterol). Clients have the ability to choose the Evernorth mail order pharmacy as a sole and required option. Express Scripts offers clients an option to choose an Evernorth mail order pharmacy as the sole prescription fulfillment supplier. Today, approximately 3.5% of all individuals covered by Express Scripts are enrolled in this program. This excludes the Department of Defense which has its own unique benefits design. In all other cases, the Express Scripts Pharmacy is available to customers at their election, subject to applicable state regulation. Evernorth also owns and operates specialty pharmacies focused on providing medications for people with serious health conditions requiring complex therapies.&#160;These services use a unique combination of digital tools and compassionate clinical services to deliver fertility medication, nurse-administered home infusions, and care for people living with everything from rheumatoid arthritis, cancer and HIV to the rarest of rare conditions.&#160;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 20.1</font></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Express Scripts contracts with all of these types of pharmacies. The chart below depicts the mix of retail pharmacies in Express Scripts&#8217; retail pharmacy network in 2022.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:344px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In April 2023, Express Scripts announced that it will increase reimbursements to pharmacies that are independently owned and unaffiliated with a drug wholesaler in areas with only one pharmacy within 10 or more miles from an Express Scripts customer. This includes enhancing performance- and incentive-based programs that pay pharmacies more when they drive better outcomes, such as dispensing 90-day supplies of prescription drugs that improve adherence. In addition, all independent rural pharmacies will have increased opportunities to participate in Express Scripts&#8217; retail pharmacy networks.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Retail networks are critical to the ability of an employer, a health plan or a government program to deliver an affordable, accessible pharmacy benefit for their covered population. Assisting them in creating and executing a holistic pharmacy network strategy is an important service that Express Scripts provides.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pharmacy networks are a group of pharmacies that Express Scripts contracts with to provide medication at a discounted price. Pharmacy networks are set up to help customers and clients save money, and can be any size. They can include any type of retail pharmacy.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In order for pharmacies to become a part of a pharmacy network, they have to meet certain industry standards that all PBMs require, such as patient safety, meeting government agency requirements and providing best-in-class patient care. Prospective network pharmacies complete initial credentialing as well as re-credentialing at least every three years. Once credentialing is complete, the pharmacy has to agree to a contracted fee that might also be tied to an individual&#8217;s health outcomes.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 20.1</font></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Just like physician networks, pharmacy networks are designed to achieve optimal access, quality and savings for clients and customers. A well-designed network strategy is more than just a list of in- and out-of-network pharmacies, but rather it is comprised of the right coverage to account for population size, geographic area, clinical goals and utilization patterns. Optimizing a pharmacy network does not equate to limiting access. In fact, there are nearly 64,000 pharmacies in the Express Scripts PBM network. By way of reference, that is more locations in the United States than McDonalds and Starbucks combined.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Express Scripts has also announced, in collaboration with other Evernorth businesses, that it will increase access to certain routine, preventive and chronic care services at independent pharmacies &#8211; driving new business growth opportunities for pharmacy owners and providing convenient care options for consumers. This includes reimbursing independent pharmacists for a variety of health screenings, testing and clinical services, such as&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">COVID-19 and other routine vaccinations&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Trainings to empower pharmacists to recognize and combat substance use disorders, including opioid addiction and naloxone administration&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Additional prescriptions for acute infections&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Acute viral condition testing (i.e., influenza and strep A)&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Lifestyle counseling, such as nutrition and smoking cessation&#59; and </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Annual behavioral health screenings.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Additionally, to fully realize the vision and potential of this initiative, Express Scripts will establish the industry&#8217;s first Independent Pharmacy Advisory Committee. The newly established committee will convene a diverse group of pharmacy leaders across rural, urban and suburban areas &#8211; all focused on continuing to drive competitive reimbursement practices, learning from each other&#8217;s business models and creating new solutions that leverage independent pharmacists to alleviate provider shortages across the health care delivery system.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>exhibit311-2023_q1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id5ced2998a7644a8b662ba7851f56c49_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, DAVID M. CORDANI, certify that&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of The Cigna Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;&#160;&#160;May&#160;5, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David M. Cordani</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>exhibit312-2023_q1.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if7056789afdf46949c34cda3ed6aad13_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, BRIAN C. EVANKO, certify that&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of The Cigna Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;&#160;&#160;May&#160;5, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian C. Evanko</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>exhibit321-2023_q1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i21c4d0281e6e43cbaac7958e6a7f8681_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification of Chief Executive Officer of </font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cigna Group pursuant to 18 U.S.C. Section 1350</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I certify that, to the best of my knowledge and belief, the Quarterly Report on Form 10-Q of The Cigna Group for the fiscal period ending March&#160;31, 2023 (the &#8220;Report&#8221;)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of The Cigna Group.</font></div><div style="margin-bottom:12pt;text-align:right;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David M. Cordani</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David M. Cordani</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May&#160;5, 2023</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>exhibit322-2023_q1.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6a51c9e725f54dc5a69bbdda582d5caf_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification of Chief Financial Officer of</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cigna Group pursuant to 18 U.S.C. Section 1350</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I certify that, to the best of my knowledge and belief, the Quarterly Report on Form 10-Q of The Cigna Group for the fiscal period ending March&#160;31, 2023 (the &#8220;Report&#8221;)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of The Cigna Group.</font></div><div style="margin-bottom:12pt;text-align:right;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian C. Evanko</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian C. Evanko</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May&#160;5, 2023</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>ci-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:aba5d1e1-3c5d-49dc-8b95-aefd0f7f3078,g:b4e2c703-69a2-450e-a66f-edc6453c1c81-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ci="http://www.thecignagroup.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.thecignagroup.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ci-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ci-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ci-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ci-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.thecignagroup.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome">
        <link:definition>0000002 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000003 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.thecignagroup.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000004 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.thecignagroup.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000005 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinTotalEquity" roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity">
        <link:definition>0000006 - Statement - Consolidated Statements of Changes in Total Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinTotalEquityParenthetical" roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquityParenthetical">
        <link:definition>0000007 - Statement - Consolidated Statements of Changes in Total Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsParenthetical" roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlowsParenthetical">
        <link:definition>0000009 - Statement - Consolidated Statements of Cash Flows (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusiness" roleURI="http://www.thecignagroup.com/role/DescriptionofBusiness">
        <link:definition>0000010 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.thecignagroup.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000011 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsReceivableNet" roleURI="http://www.thecignagroup.com/role/AccountsReceivableNet">
        <link:definition>0000012 - Disclosure - Accounts Receivable, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplierFinanceProgram" roleURI="http://www.thecignagroup.com/role/SupplierFinanceProgram">
        <link:definition>0000013 - Disclosure - Supplier Finance Program</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergersAcquisitionsandDivestitures" roleURI="http://www.thecignagroup.com/role/MergersAcquisitionsandDivestitures">
        <link:definition>0000014 - Disclosure - Mergers, Acquisitions and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.thecignagroup.com/role/EarningsPerShare">
        <link:definition>0000015 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.thecignagroup.com/role/Debt">
        <link:definition>0000016 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonandPreferredStock" roleURI="http://www.thecignagroup.com/role/CommonandPreferredStock">
        <link:definition>0000017 - Disclosure - Common and Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InsuranceandContractholderLiabilities" roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilities">
        <link:definition>0000018 - Disclosure - Insurance and Contractholder Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Reinsurance" roleURI="http://www.thecignagroup.com/role/Reinsurance">
        <link:definition>0000019 - Disclosure - Reinsurance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.thecignagroup.com/role/Investments">
        <link:definition>0000020 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.thecignagroup.com/role/FairValueMeasurements">
        <link:definition>0000021 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntities" roleURI="http://www.thecignagroup.com/role/VariableInterestEntities">
        <link:definition>0000022 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLoss" roleURI="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>0000023 - Disclosure - Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.thecignagroup.com/role/IncomeTaxes">
        <link:definition>0000024 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandOtherMatters" roleURI="http://www.thecignagroup.com/role/ContingenciesandOtherMatters">
        <link:definition>0000025 - Disclosure - Contingencies and Other Matters</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.thecignagroup.com/role/SegmentInformation">
        <link:definition>0000026 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000027 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsReceivableNetTables" roleURI="http://www.thecignagroup.com/role/AccountsReceivableNetTables">
        <link:definition>0000028 - Disclosure - Accounts Receivable, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.thecignagroup.com/role/EarningsPerShareTables">
        <link:definition>0000029 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.thecignagroup.com/role/DebtTables">
        <link:definition>0000030 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonandPreferredStockTables" roleURI="http://www.thecignagroup.com/role/CommonandPreferredStockTables">
        <link:definition>0000031 - Disclosure - Common and Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InsuranceandContractholderLiabilitiesTables" roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesTables">
        <link:definition>0000032 - Disclosure - Insurance and Contractholder Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceTables" roleURI="http://www.thecignagroup.com/role/ReinsuranceTables">
        <link:definition>0000033 - Disclosure - Reinsurance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.thecignagroup.com/role/InvestmentsTables">
        <link:definition>0000034 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsTables">
        <link:definition>0000035 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>0000036 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.thecignagroup.com/role/SegmentInformationTables">
        <link:definition>0000037 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessDetails" roleURI="http://www.thecignagroup.com/role/DescriptionofBusinessDetails">
        <link:definition>0000038 - Disclosure - Description of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>0000039 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsReceivableNetSummaryofAccountsReceivableNetDetails" roleURI="http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails">
        <link:definition>0000040 - Disclosure - Accounts Receivable, Net - Summary of Accounts Receivable, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsReceivableNetNarrativeDetails" roleURI="http://www.thecignagroup.com/role/AccountsReceivableNetNarrativeDetails">
        <link:definition>0000041 - Disclosure - Accounts Receivable, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplierFinanceProgramDetails" roleURI="http://www.thecignagroup.com/role/SupplierFinanceProgramDetails">
        <link:definition>0000042 - Disclosure - Supplier Finance Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergersAcquisitionsandDivestituresNarrativeDetails" roleURI="http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails">
        <link:definition>0000043 - Disclosure - Mergers, Acquisitions and Divestitures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails" roleURI="http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails">
        <link:definition>0000044 - Disclosure - Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails" roleURI="http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails">
        <link:definition>0000045 - Disclosure - Earnings Per Share - Outstanding Employee Stock Options Not Included in the Computation of Diluted Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareSharesofCommonStockHeldinTreasuryDetails" roleURI="http://www.thecignagroup.com/role/EarningsPerShareSharesofCommonStockHeldinTreasuryDetails">
        <link:definition>0000046 - Disclosure - Earnings Per Share - Shares of Common Stock Held in Treasury (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtOutstandingAmountsofDebtandFinanceLeasesDetails" roleURI="http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails">
        <link:definition>0000047 - Disclosure - Debt - Outstanding Amounts of Debt and Finance Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDebtIssuancesandRedemptionsDetails" roleURI="http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails">
        <link:definition>0000048 - Disclosure - Debt - Debt Issuances and Redemptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.thecignagroup.com/role/DebtNarrativeDetails">
        <link:definition>0000049 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonandPreferredStockDividendsDetails" roleURI="http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails">
        <link:definition>0000050 - Disclosure - Common and Preferred Stock - Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails" roleURI="http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails">
        <link:definition>0000051 - Disclosure - Common and Preferred Stock - Accelerated Share Repurchase Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InsuranceandContractholderLiabilitiesAccountBalancesDetails" roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails">
        <link:definition>0000052 - Disclosure - Insurance and Contractholder Liabilities - Account Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InsuranceandContractholderLiabilitiesAccountBalancesDetails_1" roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1">
        <link:definition>0000052 - Disclosure - Insurance and Contractholder Liabilities - Account Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails" roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails">
        <link:definition>0000053 - Disclosure - Insurance and Contractholder Liabilities - Unpaid Claims and Claim Expenses - Cigna Healthcare - Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails" roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails">
        <link:definition>0000054 - Disclosure - Insurance and Contractholder Liabilities - Unpaid Claims and Claims Expenses - Cigna Healthcare - Variances in Incurred Costs Related to Prior Years' Unpaid Claims and Claims Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails" roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails">
        <link:definition>0000055 - Disclosure - Insurance and Contractholder Liabilities - Future Policy Benefits - Interest Rates and Duration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails" roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails">
        <link:definition>0000056 - Disclosure - Insurance and Contractholder Liabilities - Future Policy Benefits - Present Value of Expected Premiums and Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails" roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails">
        <link:definition>0000057 - Disclosure - Insurance and Contractholder Liabilities - Contractholder Deposit Funds (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails" roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails">
        <link:definition>0000058 - Disclosure - Insurance and Contractholder Liabilities - Summary of Market Risk Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails" roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails">
        <link:definition>0000059 - Disclosure - Insurance and Contractholder Liabilities - Net Amount of Risk and Average Age of Contractholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceReinsuranceRecoverablesDetails" roleURI="http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails">
        <link:definition>0000060 - Disclosure - Reinsurance - Reinsurance Recoverables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails" roleURI="http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails">
        <link:definition>0000061 - Disclosure - Reinsurance - Effective Exit of Variable Annuity Reinsurance Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInvestmentsbyCategoryDetails" roleURI="http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails">
        <link:definition>0000062 - Disclosure - Investments - Investments by Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInvestmentsbyCategoryDetails_1" roleURI="http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails_1">
        <link:definition>0000062 - Disclosure - Investments - Investments by Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails" roleURI="http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails">
        <link:definition>0000063 - Disclosure - Investments - Debt Securities by Contractual Maturity Periods (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.thecignagroup.com/role/InvestmentsNarrativeDetails">
        <link:definition>0000064 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails" roleURI="http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails">
        <link:definition>0000065 - Disclosure - Investments - Gross Unrealized Appreciation (Depreciation) on Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails" roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails">
        <link:definition>0000066 - Disclosure - Investments - Summary of Debt Securities with a Decline in Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails_1" roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails_1">
        <link:definition>0000066 - Disclosure - Investments - Summary of Debt Securities with a Decline in Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsEquitySecurityInvestmentsDetails" roleURI="http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails">
        <link:definition>0000067 - Disclosure - Investments - Equity Security Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails" roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails">
        <link:definition>0000068 - Disclosure - Investments - Summary of the Credit Risk Profile of the Commercial Mortgage Loan Portfolio (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails" roleURI="http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails">
        <link:definition>0000069 - Disclosure - Investments - Carrying Values of Other Long-Term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsSummaryofDerivativeInstrumentsDetails" roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails">
        <link:definition>0000070 - Disclosure - Investments - Summary of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsComponentsofNetInvestmentIncomeDetails" roleURI="http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails">
        <link:definition>0000071 - Disclosure - Investments - Components of Net Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsRealizedGainsandLossesonInvestmentsDetails" roleURI="http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails">
        <link:definition>0000072 - Disclosure - Investments - Realized Gains and Losses on Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails">
        <link:definition>0000073 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>0000074 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails" roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails">
        <link:definition>0000075 - Disclosure - Fair Value Measurements - Quantitative Information About Unobservable Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails" roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails">
        <link:definition>0000076 - Disclosure - Fair Value Measurements - Changes in Level 3 Financial Assets and Financial Liabilities Carried at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails" roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails">
        <link:definition>0000077 - Disclosure - Fair Value Measurements - Fair Values of Separate Account Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails_1" roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails_1">
        <link:definition>0000077 - Disclosure - Fair Value Measurements - Fair Values of Separate Account Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails" roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails">
        <link:definition>0000078 - Disclosure - Fair Value Measurements - Additional Information on Separate Account Assets Priced at Net Asset Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails" roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails">
        <link:definition>0000079 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value under Certain Conditions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails" roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails">
        <link:definition>0000080 - Disclosure - Fair Value Measurements - Fair Value Disclosures for Financial Instruments Not Carried at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesDetails" roleURI="http://www.thecignagroup.com/role/VariableInterestEntitiesDetails">
        <link:definition>0000081 - Disclosure - Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>0000082 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossDetails_1" roleURI="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails_1">
        <link:definition>0000082 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.thecignagroup.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000083 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandOtherMattersDetails" roleURI="http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails">
        <link:definition>0000084 - Disclosure - Contingencies and Other Matters (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSummaryofSpecialItemsDetails" roleURI="http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails">
        <link:definition>0000085 - Disclosure - Segment Information - Summary of Special Items (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSummarizedSegmentFinancialInformationDetails" roleURI="http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails">
        <link:definition>0000086 - Disclosure - Segment Information - Summarized Segment Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationRevenuefromExternalCustomersDetails" roleURI="http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails">
        <link:definition>0000087 - Disclosure - Segment Information - Revenue from External Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationFinancialandPerformanceGuaranteesDetails" roleURI="http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails">
        <link:definition>0000088 - Disclosure - Segment Information - Financial and Performance Guarantees (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ci_VariableInterestEntitiesNumberOfEntities" abstract="false" name="VariableInterestEntitiesNumberOfEntities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ci_CommitmentsAndContingenciesNumberOfAdditionalExpert" abstract="false" name="CommitmentsAndContingenciesNumberOfAdditionalExpert" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity" abstract="false" name="OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue203024InterestMember" abstract="true" name="NotesDue203024InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_StepDownNotesDueJanuary2033Member" abstract="true" name="StepDownNotesDueJanuary2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_DebenturesDue20277875InterestMember" abstract="true" name="DebenturesDue20277875InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_SpecialItemsAfterTaxAbstract" abstract="true" name="SpecialItemsAfterTaxAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges" abstract="false" name="LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue202734InterestMember" abstract="true" name="NotesDue202734InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_GuaranteedSeparateAccountAssets" abstract="false" name="GuaranteedSeparateAccountAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax" abstract="false" name="OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" abstract="false" name="NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_EquitySecuritiesFVNIMember" abstract="true" name="EquitySecuritiesFVNIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_AllowanceForReceivablesCurrent" abstract="false" name="AllowanceForReceivablesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember" abstract="true" name="NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold" abstract="false" name="SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_USGroupDisabilityAndLifeInsuranceBusinessMember" abstract="true" name="USGroupDisabilityAndLifeInsuranceBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity" abstract="false" name="OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther" abstract="false" name="LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_IndividualPrivateMedicalInsuranceLongDurationMember" abstract="true" name="IndividualPrivateMedicalInsuranceLongDurationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" abstract="false" name="AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes" abstract="false" name="SpecialItemGainLossOnSaleOfBusinessBeforeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups" abstract="false" name="UnearnedPremiumsNoncurrentIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue" abstract="false" name="InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity" abstract="false" name="OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_MeasurementInputLiquidityMember" abstract="true" name="MeasurementInputLiquidityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_InsuranceAndContractholderLiabilitiesAbstract" abstract="true" name="InsuranceAndContractholderLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups" abstract="false" name="InsuranceAndContractholderLiabilitiesIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InternationalHealthMember" abstract="true" name="InternationalHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_UnobservableInputsNotDevelopedByCompanyMember" abstract="true" name="UnobservableInputsNotDevelopedByCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_ReinsuranceRecoverablesNonCurrent" abstract="false" name="ReinsuranceRecoverablesNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_AssetBackedAndCorporateSecuritiesMember" abstract="true" name="AssetBackedAndCorporateSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member" abstract="true" name="PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes" abstract="false" name="SpecialItemGainLossFromContractAdjustmentBeforeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue203848InterestMember" abstract="true" name="NotesDue203848InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" abstract="false" name="EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_AdministrativeServicesOnlyHealthCareServicesMember" abstract="true" name="AdministrativeServicesOnlyHealthCareServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax" abstract="false" name="IncomeLossAttributableToNoncontrollingInterestBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_AnnuitizationElectionPeriod" abstract="false" name="AnnuitizationElectionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ci_ImpairmentsOnInvestmentsTotal" abstract="false" name="ImpairmentsOnInvestmentsTotal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_MedicalRiskProductsMember" abstract="true" name="MedicalRiskProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_OngoingOperationsMember" abstract="true" name="OngoingOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities" abstract="false" name="ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue205134InterestMember" abstract="true" name="NotesDue205134InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_NotesDue20425375InterestMember" abstract="true" name="NotesDue20425375InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OrganizationalEfficiencyPlanChargesNetOfTax" abstract="false" name="OrganizationalEfficiencyPlanChargesNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue20473875Member" abstract="true" name="NotesDue20473875Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups" abstract="false" name="LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherPharmacyMember" abstract="true" name="OtherPharmacyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember" abstract="true" name="LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity" abstract="false" name="SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InvestmentIncomeAndGainsAndLossesAbstract" abstract="true" name="InvestmentIncomeAndGainsAndLossesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax" abstract="false" name="SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_CommitmentsAndContingenciesNumberOfExpert" abstract="false" name="CommitmentsAndContingenciesNumberOfExpert" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups" abstract="false" name="LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember" abstract="true" name="OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_RealizedInvestmentGainLossExcludingImpairments" abstract="false" name="RealizedInvestmentGainLossExcludingImpairments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_A364DayRevolvingCreditAgreementMaturingApril2023Member" abstract="true" name="A364DayRevolvingCreditAgreementMaturingApril2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember" abstract="true" name="InternationalLifeAccidentSupplementalBenefitsBusinessesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_CompletionFactorsMember" abstract="true" name="CompletionFactorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract" abstract="true" name="InsuranceAndContractholderLiabilitiesNoncurrentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_NotesDue2023375InterestMember" abstract="true" name="NotesDue2023375InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_A364DayRevolvingCreditAgreementMaturingApril2024Member" abstract="true" name="A364DayRevolvingCreditAgreementMaturingApril2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax" abstract="false" name="SpecialItemChargesDebtExtinguishmentCostsBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_ContractholderDepositFundsPolicyPolicyTextBlock" abstract="false" name="ContractholderDepositFundsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_TransactionRelatedCostsAfterTax" abstract="false" name="TransactionRelatedCostsAfterTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_LineOfCreditFacilityConversionToTermLoanTerm" abstract="false" name="LineOfCreditFacilityConversionToTermLoanTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ci_OrganizationalEfficiencyPlanCharges" abstract="false" name="OrganizationalEfficiencyPlanCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_PolicyholderContractDepositsAttributableToDisposalGroups" abstract="false" name="PolicyholderContractDepositsAttributableToDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock" abstract="false" name="AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_ProceedsFromRepaymentsOfOtherShortTermDebt" abstract="false" name="ProceedsFromRepaymentsOfOtherShortTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InvestmentGradeMember" abstract="true" name="InvestmentGradeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_CededCreditCollateralizationRiskMember" abstract="true" name="CededCreditCollateralizationRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups" abstract="false" name="LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity" abstract="false" name="ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SpecialItemsBeforeTaxAbstract" abstract="true" name="SpecialItemsBeforeTaxAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis" abstract="true" name="CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_PolicyholderContractBalancePercentReinsuredExternally" abstract="false" name="PolicyholderContractBalancePercentReinsuredExternally" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable" abstract="false" name="NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member" abstract="true" name="RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SpecialItemChargeBenefitBeforeTaxLitigation" abstract="false" name="SpecialItemChargeBenefitBeforeTaxLitigation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_PolicyholderContractDepositCurrent" abstract="false" name="PolicyholderContractDepositCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract" abstract="true" name="EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_InvestmentsCreditRatingAxis" abstract="true" name="InvestmentsCreditRatingAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ci_LibertyMutualInsuranceMember" abstract="true" name="LibertyMutualInsuranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm" abstract="false" name="FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity" abstract="false" name="OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity" abstract="false" name="OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SunLifeAssuranceCompanyOfCanadaMember" abstract="true" name="SunLifeAssuranceCompanyOfCanadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent" abstract="false" name="LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage" abstract="false" name="PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitOther" abstract="false" name="LiabilityForFuturePolicyBenefitOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember" abstract="true" name="AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_AccruedExpensesAndOtherLiabilities" abstract="false" name="AccruedExpensesAndOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_BelowInvestmentGradeMember" abstract="true" name="BelowInvestmentGradeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal" abstract="false" name="DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_PharmacyAndServiceCostsPayable" abstract="false" name="PharmacyAndServiceCostsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_ContractualAllowancePharmaceuticalManufacturersReceivables" abstract="false" name="ContractualAllowancePharmaceuticalManufacturersReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_CommitmentsToContributeAdditionalEquityAndCapital" abstract="false" name="CommitmentsToContributeAdditionalEquityAndCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock" abstract="false" name="OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_NotesDue20312375InterestMember" abstract="true" name="NotesDue20312375InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LtvGreaterThan100PercentMember" abstract="true" name="LtvGreaterThan100PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_CorporateAndEliminationsMember" abstract="true" name="CorporateAndEliminationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember" abstract="true" name="AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_NonInvestmentRevenue" abstract="false" name="NonInvestmentRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_OtherGovernmentProductsMember" abstract="true" name="OtherGovernmentProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" abstract="true" name="AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_Ltv60To79PercentMember" abstract="true" name="Ltv60To79PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement" abstract="false" name="NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ci_RetirementAndLifeInsuranceContractsMember" abstract="true" name="RetirementAndLifeInsuranceContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SCORSEMember" abstract="true" name="SCORSEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_PaymentsForProceedsFromPropertyPlantAndEquipment" abstract="false" name="PaymentsForProceedsFromPropertyPlantAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InsuranceAndContractholderLiabilities" abstract="false" name="InsuranceAndContractholderLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock" abstract="false" name="CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_ShortTermAndLongTermInvestmentsAbstract" abstract="true" name="ShortTermAndLongTermInvestmentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_ExpressScriptsCounterclaimsAgainstElevanceMember" abstract="true" name="ExpressScriptsCounterclaimsAgainstElevanceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember" abstract="true" name="BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_ProceedsFromSaleOfDebtAndEquitySecurities" abstract="false" name="ProceedsFromSaleOfDebtAndEquitySecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_GroupMedicalInsuranceShortDurationMember" abstract="true" name="GroupMedicalInsuranceShortDurationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_NotesDue204849InterestMember" abstract="true" name="NotesDue204849InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_TemporaryEquityOtherComprehensiveIncome" abstract="false" name="TemporaryEquityOtherComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities" abstract="false" name="IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_FairValueMeasurementNonPerformanceRiskAdjustment" abstract="false" name="FairValueMeasurementNonPerformanceRiskAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups" abstract="false" name="LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" abstract="false" name="MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition" abstract="false" name="LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_AcquisitionDispositionRunoffActivitiesMember" abstract="true" name="AcquisitionDispositionRunoffActivitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_CashCashEquivalentsAndShortTermInvestmentsMember" abstract="true" name="CashCashEquivalentsAndShortTermInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups" abstract="false" name="LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember" abstract="true" name="CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ci_ForwardsSwapsOptionsMember" abstract="true" name="ForwardsSwapsOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent" abstract="false" name="LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes" abstract="false" name="SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput" abstract="false" name="DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="ci_NotesDue202645InterestMember" abstract="true" name="NotesDue202645InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups" abstract="false" name="LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_RealEstateJointVenturesMember" abstract="true" name="RealEstateJointVenturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable" abstract="false" name="IncreaseDecreaseInPharmacyAndServiceCostsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_CommitmentToFundPartnershipMember" abstract="true" name="CommitmentToFundPartnershipMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_NotesDue20265685Member" abstract="true" name="NotesDue20265685Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups" abstract="false" name="LiabilityForFuturePolicyBenefitsIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity" abstract="false" name="SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_RevolvingCreditAgreementsApril2023Member" abstract="true" name="RevolvingCreditAgreementsApril2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio" abstract="false" name="FinancingReceivableCreditQualityDebtServiceCoverageRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" abstract="false" name="LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_ExpressScriptsLitigationWithAnthemMember" abstract="true" name="ExpressScriptsLitigationWithAnthemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_CededReinsuranceAgreementCoverageLimitAmountRemaining" abstract="false" name="CededReinsuranceAgreementCoverageLimitAmountRemaining" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue" abstract="false" name="PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ci_ContractualAllowanceNoninsuranceCustomerReceivables" abstract="false" name="ContractualAllowanceNoninsuranceCustomerReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent" abstract="false" name="OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember" abstract="true" name="InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability" abstract="false" name="LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate" abstract="false" name="DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ci_CignaHealthcareMember" abstract="true" name="CignaHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_CommitmentToPurchaseEquitySecuritiesMember" abstract="true" name="CommitmentToPurchaseEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_CededReinsuranceAgreementReinsuredRiskPercentage" abstract="false" name="CededReinsuranceAgreementReinsuredRiskPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_EmpowerAnnuityInsuranceCompanyMember" abstract="true" name="EmpowerAnnuityInsuranceCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant" abstract="false" name="LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ci_FinancingReceivableCreditQualityLoanToValueRatio" abstract="false" name="FinancingReceivableCreditQualityLoanToValueRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ci_NotesDue2024613InterestMember" abstract="true" name="NotesDue2024613InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_SupplierFinanceProgramTextBlock" abstract="false" name="SupplierFinanceProgramTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_MarketRiskBenefitLiabilityAmountCurrent" abstract="false" name="MarketRiskBenefitLiabilityAmountCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount" abstract="false" name="AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="ci_PricingConcessionsMember" abstract="true" name="PricingConcessionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_PharmaceuticalManufacturerReceivable" abstract="false" name="PharmaceuticalManufacturerReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition" abstract="false" name="LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount" abstract="false" name="EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue20233InterestMember" abstract="true" name="NotesDue20233InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_DebtAndEquitySecuritiesMember" abstract="true" name="DebtAndEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent" abstract="false" name="LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member" abstract="true" name="RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_UnearnedPremiumsNoncurrent" abstract="false" name="UnearnedPremiumsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups" abstract="false" name="InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock" abstract="false" name="AccumulatedOtherComprehensiveIncomeDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember" abstract="true" name="BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_NotesDue202435InterestMember" abstract="true" name="NotesDue202435InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_NotesDue20284375InterestMember" abstract="true" name="NotesDue20284375InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_OtherCommercialMedicalProductsMember" abstract="true" name="OtherCommercialMedicalProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_GuaranteedMinimumDeathBenefitsTotalContractholders" abstract="false" name="GuaranteedMinimumDeathBenefitsTotalContractholders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules" abstract="false" name="DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_ServiceFeesMember" abstract="true" name="ServiceFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InsuranceUnearnedPremiumsPolicyTextBlock" abstract="false" name="InsuranceUnearnedPremiumsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_RealizedInvestmentGainsLossesEquityMethodInvestments" abstract="false" name="RealizedInvestmentGainsLossesEquityMethodInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember" abstract="true" name="NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_SupplierFinanceProgramPaymentTimingPeriod" abstract="false" name="SupplierFinanceProgramPaymentTimingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ci_PaymentsToAcquireDebtAndEquitySecurities" abstract="false" name="PaymentsToAcquireDebtAndEquitySecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue20335400InterestMember" abstract="true" name="NotesDue20335400InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember" abstract="true" name="IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_NotesDue2022305InterestMember" abstract="true" name="NotesDue2022305InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_UnearnedPremiumsIncludingDisposalGroups" abstract="false" name="UnearnedPremiumsIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_MedicalCostTrendMember" abstract="true" name="MedicalCostTrendMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_IndividualAndFamilyPlansShortDurationMember" abstract="true" name="IndividualAndFamilyPlansShortDurationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_InsuranceAndContractholderLiabilitiesLineItems" abstract="true" name="InsuranceAndContractholderLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_PolicyholderContractDepositNoncurrent" abstract="false" name="PolicyholderContractDepositNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_LtvLessThan60PercentMember" abstract="true" name="LtvLessThan60PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_AllowanceForReceivablesOther" abstract="false" name="AllowanceForReceivablesOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember" abstract="true" name="InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_SpecialItemChargeBenefitAfterTaxLitigation" abstract="false" name="SpecialItemChargeBenefitAfterTaxLitigation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_UnearnedPremiumsCurrentIncludingDisposalGroups" abstract="false" name="UnearnedPremiumsCurrentIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue202383InterestMember" abstract="true" name="NotesDue202383InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_SeparateAccountAssetsClassifiedInFairValueHierarchy" abstract="false" name="SeparateAccountAssetsClassifiedInFairValueHierarchy" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DisposalGroupIncludingDiscontinuedOperationInvestments" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue2036615InterestMember" abstract="true" name="NotesDue2036615InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax" abstract="false" name="DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock" abstract="false" name="RedeemableNoncontrollingInterestsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember" abstract="true" name="MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue204032InterestMember" abstract="true" name="NotesDue204032InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_RealizedInvestmentGainLoss" abstract="false" name="RealizedInvestmentGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue2026125Member" abstract="true" name="NotesDue2026125Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue20416125InterestMember" abstract="true" name="NotesDue20416125InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_RestructuringChargesNetOfTaxExpense" abstract="false" name="RestructuringChargesNetOfTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember" abstract="true" name="PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent" abstract="false" name="LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_GroupDisabilityAndLifeMember" abstract="true" name="GroupDisabilityAndLifeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InsuranceCustomerReceivables" abstract="false" name="InsuranceCustomerReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DebtInstrumentExtensionTerm" abstract="false" name="DebtInstrumentExtensionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups" abstract="false" name="InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InsuranceAndContractholderLiabilitiesCurrentAbstract" abstract="true" name="InsuranceAndContractholderLiabilitiesCurrentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost" abstract="false" name="EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherOperationsSegmentOtherMember" abstract="true" name="OtherOperationsSegmentOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_EarningsPerShareEffectOfDilution" abstract="false" name="EarningsPerShareEffectOfDilution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock" abstract="false" name="ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_NoncontrollingInterestOtherChanges" abstract="false" name="NoncontrollingInterestOtherChanges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax" abstract="false" name="SpecialItemChargesDebtExtinguishmentCostsNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue2027305Member" abstract="true" name="NotesDue2027305Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups" abstract="false" name="LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SegmentRevenues" abstract="false" name="SegmentRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember" abstract="true" name="SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience" abstract="false" name="LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract" abstract="true" name="PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_SpecialItemGainLossFromContractAdjustmentNetOfTax" abstract="false" name="SpecialItemGainLossFromContractAdjustmentNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" abstract="false" name="FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" abstract="false" name="LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ci_NotesDue205034InterestMember" abstract="true" name="NotesDue205034InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LitigationMattersAndRegulatoryMattersMember" abstract="true" name="LitigationMattersAndRegulatoryMattersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage" abstract="false" name="DebtAndEquitySecuritiesClassifiedInLevel3Percentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ci_MarketRiskBenefitLiabilityAmountNoncurrent" abstract="false" name="MarketRiskBenefitLiabilityAmountNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock" abstract="false" name="ScheduleOfShortTermDebtLongTermDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember" abstract="true" name="NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_EvernorthMember" abstract="true" name="EvernorthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_NotesDue2025325InterestMember" abstract="true" name="NotesDue2025325InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_InsuranceAndContractholderLiabilitiesNoncurrent" abstract="false" name="InsuranceAndContractholderLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_UnobservableInputsDevelopedByCompanyMember" abstract="true" name="UnobservableInputsDevelopedByCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_ReinsuranceRecoverablesIncludingDisposalGroups" abstract="false" name="ReinsuranceRecoverablesIncludingDisposalGroups" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock" abstract="false" name="ScheduleOfOtherLongTermInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges" abstract="false" name="LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue2023FloatingRateInterestMember" abstract="true" name="NotesDue2023FloatingRateInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_UnearnedPremiumsCurrent" abstract="false" name="UnearnedPremiumsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember" abstract="true" name="NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DamagesForServiceIssuesMember" abstract="true" name="DamagesForServiceIssuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_NetworkPharmacyMember" abstract="true" name="NetworkPharmacyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_MedicarePartDMember" abstract="true" name="MedicarePartDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_NotesDue204648InterestMember" abstract="true" name="NotesDue204648InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability" abstract="false" name="LiabilityForFuturePolicyBenefitsDeferredProfitLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue" abstract="false" name="RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception" abstract="false" name="FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ci_SupplierFinanceProgramObligationCurrent" abstract="false" name="SupplierFinanceProgramObligationCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax" abstract="false" name="SpecialItemGainLossOnSaleOfBusinessNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member" abstract="true" name="RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_PricingConcessionsAfterRemainingTermOfAgreementMember" abstract="true" name="PricingConcessionsAfterRemainingTermOfAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff" abstract="false" name="MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherVariableInterestEntitiesMember" abstract="true" name="OtherVariableInterestEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_NumberOfRevolvingCreditFacility" abstract="false" name="NumberOfRevolvingCreditFacility" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ci_NotesDue20254125InterestMember" abstract="true" name="NotesDue20254125InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_InsuranceAndContractholderLiabilitiesCurrent" abstract="false" name="InsuranceAndContractholderLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_PricingConcessionsThroughRemainingContractTermMember" abstract="true" name="PricingConcessionsThroughRemainingContractTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_TransactionRelatedCosts" abstract="false" name="TransactionRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient" abstract="false" name="NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock" abstract="false" name="ScheduleOfIssuancesOfLongTermDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue2023765InterestMember" abstract="true" name="NotesDue2023765InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_RevolvingCreditFacilityMaturingApril2025Member" abstract="true" name="RevolvingCreditFacilityMaturingApril2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_SeparateAccountAssetsMember" abstract="true" name="SeparateAccountAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract" abstract="true" name="EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_PharmacyBenefitsManagementServicesMember" abstract="true" name="PharmacyBenefitsManagementServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_MedicareAdvantageMember" abstract="true" name="MedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain" abstract="true" name="CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_OtherOperationsSegmentMember" abstract="true" name="OtherOperationsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_PrudentialInsuranceCompanyOfAmericaMember" abstract="true" name="PrudentialInsuranceCompanyOfAmericaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember" abstract="true" name="CededCreditRiskSecuredContractuallyRequiredFairValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_HomeDeliveryAndSpecialtyMember" abstract="true" name="HomeDeliveryAndSpecialtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_OtherOperationsInternationalBusinessesToBeSoldMember" abstract="true" name="OtherOperationsInternationalBusinessesToBeSoldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" abstract="false" name="EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_USMedicalProductsMember" abstract="true" name="USMedicalProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_InterestInJointVentureInTurkeyMember" abstract="true" name="InterestInJointVentureInTurkeyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LifeInsuranceCompanyOfNorthAmericaMember" abstract="true" name="LifeInsuranceCompanyOfNorthAmericaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_ScheduleOfSpecialItemsTableTextBlock" abstract="false" name="ScheduleOfSpecialItemsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale" abstract="false" name="DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity" abstract="false" name="OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_VariableInterestEntitiesAbstract" abstract="true" name="VariableInterestEntitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees" abstract="false" name="ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_InsuranceAndContractholderLiabilitiesTable" abstract="true" name="InsuranceAndContractholderLiabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ci_InvestmentsCreditRatingDomain" abstract="true" name="InvestmentsCreditRatingDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange" abstract="false" name="MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_FairValueOfSeparateAccountAssetsTableTextBlock" abstract="false" name="FairValueOfSeparateAccountAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ci_CorporateAndGovernmentDebtSecuritiesMember" abstract="true" name="CorporateAndGovernmentDebtSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_StopLossMember" abstract="true" name="StopLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses" abstract="false" name="LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_GainLossOnExtinguishmentOfDebtNetOfTax" abstract="false" name="GainLossOnExtinguishmentOfDebtNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear" abstract="false" name="UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" abstract="false" name="RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ci_NotesDue20415875InterestMember" abstract="true" name="NotesDue20415875InterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>ci-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:aba5d1e1-3c5d-49dc-8b95-aefd0f7f3078,g:b4e2c703-69a2-450e-a66f-edc6453c1c81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_adfc8ad2-dc64-4d5d-9d2c-3912e8f59d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6fe3a751-64b4-4a56-8c42-9922cc7de93b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_adfc8ad2-dc64-4d5d-9d2c-3912e8f59d24" xlink:to="loc_us-gaap_Revenues_6fe3a751-64b4-4a56-8c42-9922cc7de93b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_8ac64633-6de1-4b10-b44f-dd829d82cba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_adfc8ad2-dc64-4d5d-9d2c-3912e8f59d24" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_8ac64633-6de1-4b10-b44f-dd829d82cba5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_310149b3-f893-489f-8a1a-0ba90c990f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_79c253bd-e71a-4031-830b-210c1ff4aa27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_310149b3-f893-489f-8a1a-0ba90c990f27" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_79c253bd-e71a-4031-830b-210c1ff4aa27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_17195f52-1ddb-47c7-b10e-8ef43a5829ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_310149b3-f893-489f-8a1a-0ba90c990f27" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_17195f52-1ddb-47c7-b10e-8ef43a5829ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_19d071bc-a25d-4eec-ad36-1d5f7008992d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_310149b3-f893-489f-8a1a-0ba90c990f27" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_19d071bc-a25d-4eec-ad36-1d5f7008992d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_09848113-1414-4d3f-881a-3d354f1a3d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_310149b3-f893-489f-8a1a-0ba90c990f27" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_09848113-1414-4d3f-881a-3d354f1a3d0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_576807ff-3ca8-473d-9a57-2ade063f575e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_13c7d777-a51b-41c3-804e-6d0dbba3e221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_576807ff-3ca8-473d-9a57-2ade063f575e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_13c7d777-a51b-41c3-804e-6d0dbba3e221" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_3c4f748d-4e60-45c3-b5cd-a0f30c7b6e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_576807ff-3ca8-473d-9a57-2ade063f575e" xlink:to="loc_us-gaap_PremiumsEarnedNet_3c4f748d-4e60-45c3-b5cd-a0f30c7b6e12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_4a831b68-4e0f-483a-848a-8f88484254e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_576807ff-3ca8-473d-9a57-2ade063f575e" xlink:to="loc_us-gaap_NetInvestmentIncome_4a831b68-4e0f-483a-848a-8f88484254e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3d56b090-18b3-4a85-bb29-bf689d71af89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86989589-e4df-4428-b56b-e482dad1f859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_3d56b090-18b3-4a85-bb29-bf689d71af89" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86989589-e4df-4428-b56b-e482dad1f859" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b3c5c679-6ca3-4a32-816c-408550b08549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_3d56b090-18b3-4a85-bb29-bf689d71af89" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b3c5c679-6ca3-4a32-816c-408550b08549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a081ea95-18aa-475c-bd37-810ac4251fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c85d5dab-508d-41fa-a6f2-5dbf211f0cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a081ea95-18aa-475c-bd37-810ac4251fbd" xlink:to="loc_us-gaap_ProfitLoss_c85d5dab-508d-41fa-a6f2-5dbf211f0cd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eb637d53-c779-4a9e-83aa-d6be2cceff7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a081ea95-18aa-475c-bd37-810ac4251fbd" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eb637d53-c779-4a9e-83aa-d6be2cceff7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9e0187c0-0732-488e-9dfd-de945c74bec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLoss_6df3937a-1d4c-4d33-97d1-a1a85f1d37d7" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9e0187c0-0732-488e-9dfd-de945c74bec0" xlink:to="loc_ci_RealizedInvestmentGainLoss_6df3937a-1d4c-4d33-97d1-a1a85f1d37d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2bf64024-4498-42d8-9bcf-ae0de38e4666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9e0187c0-0732-488e-9dfd-de945c74bec0" xlink:to="loc_us-gaap_OperatingIncomeLoss_2bf64024-4498-42d8-9bcf-ae0de38e4666" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2096193b-b82c-427d-b9db-6d0aab5d6b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9e0187c0-0732-488e-9dfd-de945c74bec0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2096193b-b82c-427d-b9db-6d0aab5d6b7e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity_a8f33f85-91ac-4560-abbe-8261c268feb9" xlink:href="ci-20230331.xsd#ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_696dca2d-3207-4c55-b04f-d77a9318b47a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity_a8f33f85-91ac-4560-abbe-8261c268feb9" xlink:to="loc_us-gaap_ProfitLoss_696dca2d-3207-4c55-b04f-d77a9318b47a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_c9209a38-30af-4c11-afb3-a7be05ca4061" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity_a8f33f85-91ac-4560-abbe-8261c268feb9" xlink:to="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_c9209a38-30af-4c11-afb3-a7be05ca4061" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_801e9fd7-2c51-4cf9-a028-7597518e6a62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity_558f6846-2d8a-414e-9dc3-3983fd19de73" xlink:href="ci-20230331.xsd#ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_801e9fd7-2c51-4cf9-a028-7597518e6a62" xlink:to="loc_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity_558f6846-2d8a-414e-9dc3-3983fd19de73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a800c15e-3397-4c2a-bfa4-d1f820ab29f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_801e9fd7-2c51-4cf9-a028-7597518e6a62" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a800c15e-3397-4c2a-bfa4-d1f820ab29f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_df45f02e-d68c-4ecd-ab53-6118ecfddbc7" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax_e9f1c87e-a96d-479c-8c02-ebfeaf93a7ac" xlink:href="ci-20230331.xsd#ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_df45f02e-d68c-4ecd-ab53-6118ecfddbc7" xlink:to="loc_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax_e9f1c87e-a96d-479c-8c02-ebfeaf93a7ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax_478921e9-3f2d-43eb-bd7c-e8e7df51ea84" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_df45f02e-d68c-4ecd-ab53-6118ecfddbc7" xlink:to="loc_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax_478921e9-3f2d-43eb-bd7c-e8e7df51ea84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8be8cb3d-0fb8-48d6-be8e-35b9ea959684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_df45f02e-d68c-4ecd-ab53-6118ecfddbc7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8be8cb3d-0fb8-48d6-be8e-35b9ea959684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity_013a6b39-b42b-4b9e-8142-06191331844a" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_df45f02e-d68c-4ecd-ab53-6118ecfddbc7" xlink:to="loc_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity_013a6b39-b42b-4b9e-8142-06191331844a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3b49bda7-aba8-453d-bbce-507cd7c589e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TemporaryEquityOtherComprehensiveIncome_53315c6f-b98b-4e83-a269-ed584a6b8599" xlink:href="ci-20230331.xsd#ci_TemporaryEquityOtherComprehensiveIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3b49bda7-aba8-453d-bbce-507cd7c589e3" xlink:to="loc_ci_TemporaryEquityOtherComprehensiveIncome_53315c6f-b98b-4e83-a269-ed584a6b8599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_c375370d-3ca2-4868-a680-920d5341dbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3b49bda7-aba8-453d-bbce-507cd7c589e3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_c375370d-3ca2-4868-a680-920d5341dbb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_01cb6cd3-2176-4aed-a6be-629a2868811e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3b49bda7-aba8-453d-bbce-507cd7c589e3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_01cb6cd3-2176-4aed-a6be-629a2868811e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3b709a2b-d38e-4e4f-b77b-d6d9ae0ba919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_3d5dabc3-c8d9-410f-84c3-544b7071914f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b709a2b-d38e-4e4f-b77b-d6d9ae0ba919" xlink:to="loc_us-gaap_OtherAssetsCurrent_3d5dabc3-c8d9-410f-84c3-544b7071914f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_af1f3312-5dcb-4a8e-986c-de26b95abdae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b709a2b-d38e-4e4f-b77b-d6d9ae0ba919" xlink:to="loc_us-gaap_InventoryNet_af1f3312-5dcb-4a8e-986c-de26b95abdae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_714b73f9-ba5b-47e0-b111-370cfae7dd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b709a2b-d38e-4e4f-b77b-d6d9ae0ba919" xlink:to="loc_us-gaap_ShortTermInvestments_714b73f9-ba5b-47e0-b111-370cfae7dd1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_7fb2cab3-e1a4-4c8c-8210-e86e0119f366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b709a2b-d38e-4e4f-b77b-d6d9ae0ba919" xlink:to="loc_us-gaap_ReceivablesNetCurrent_7fb2cab3-e1a4-4c8c-8210-e86e0119f366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d9088518-5171-49e8-96ab-d5b9aab19a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b709a2b-d38e-4e4f-b77b-d6d9ae0ba919" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d9088518-5171-49e8-96ab-d5b9aab19a47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_36567ce7-0c26-4d29-b30c-9c53e3d647a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_88494dc7-96b0-4963-b529-6bf5993a305b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_36567ce7-0c26-4d29-b30c-9c53e3d647a7" xlink:to="loc_us-gaap_CommonStockValue_88494dc7-96b0-4963-b529-6bf5993a305b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_309e52f7-57b1-48d6-8330-25cabff37e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_36567ce7-0c26-4d29-b30c-9c53e3d647a7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_309e52f7-57b1-48d6-8330-25cabff37e9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7e199444-51e9-4211-9846-d01759be9901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_36567ce7-0c26-4d29-b30c-9c53e3d647a7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7e199444-51e9-4211-9846-d01759be9901" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a83e94d7-4b28-4244-a444-6f8a7369dc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_36567ce7-0c26-4d29-b30c-9c53e3d647a7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a83e94d7-4b28-4244-a444-6f8a7369dc6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f3c783be-9480-4028-8ed9-8298b44bf61a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_36567ce7-0c26-4d29-b30c-9c53e3d647a7" xlink:to="loc_us-gaap_TreasuryStockValue_f3c783be-9480-4028-8ed9-8298b44bf61a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_02ad3b92-66da-4164-90c9-b54982eedd9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7284973b-f520-47cd-a3a7-73fb6f42e814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_02ad3b92-66da-4164-90c9-b54982eedd9a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7284973b-f520-47cd-a3a7-73fb6f42e814" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d9c40b48-b921-4325-b015-d3bc1fe160a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_02ad3b92-66da-4164-90c9-b54982eedd9a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d9c40b48-b921-4325-b015-d3bc1fe160a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_bbf8bc61-0265-4930-ba35-c436f503b0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_02ad3b92-66da-4164-90c9-b54982eedd9a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_bbf8bc61-0265-4930-ba35-c436f503b0d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ed2724ea-5973-412b-99da-a045bea59097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_02ad3b92-66da-4164-90c9-b54982eedd9a" xlink:to="loc_us-gaap_Liabilities_ed2724ea-5973-412b-99da-a045bea59097" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_93c8f152-6472-4a0e-9d41-3bd53f62ab90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6e67bf39-d646-4820-8c86-5891c5118191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_93c8f152-6472-4a0e-9d41-3bd53f62ab90" xlink:to="loc_us-gaap_LiabilitiesCurrent_6e67bf39-d646-4820-8c86-5891c5118191" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_9f9f03aa-5d48-4c21-9f0e-fa3185aa4c34" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_93c8f152-6472-4a0e-9d41-3bd53f62ab90" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_9f9f03aa-5d48-4c21-9f0e-fa3185aa4c34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_cdab8031-1e1b-4ff2-8d18-65986c9e0578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_93c8f152-6472-4a0e-9d41-3bd53f62ab90" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_cdab8031-1e1b-4ff2-8d18-65986c9e0578" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a1d2eddb-e950-4b89-8465-cc22e0756718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_93c8f152-6472-4a0e-9d41-3bd53f62ab90" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a1d2eddb-e950-4b89-8465-cc22e0756718" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c859ac13-9431-4798-928a-b6859095c059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_93c8f152-6472-4a0e-9d41-3bd53f62ab90" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c859ac13-9431-4798-928a-b6859095c059" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_b57f2d84-4099-49ca-b7ad-56ba75562268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_93c8f152-6472-4a0e-9d41-3bd53f62ab90" xlink:to="loc_us-gaap_SeparateAccountsLiability_b57f2d84-4099-49ca-b7ad-56ba75562268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fa0e1ff0-cbb1-4f34-8c0a-606d4e6beacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8d03a988-3585-4900-b406-03eeb0a2d078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fa0e1ff0-cbb1-4f34-8c0a-606d4e6beacc" xlink:to="loc_us-gaap_AssetsCurrent_8d03a988-3585-4900-b406-03eeb0a2d078" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_0c45dad9-8ce1-43f1-96bb-515b14b6ba3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fa0e1ff0-cbb1-4f34-8c0a-606d4e6beacc" xlink:to="loc_us-gaap_LongTermInvestments_0c45dad9-8ce1-43f1-96bb-515b14b6ba3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ReinsuranceRecoverablesNonCurrent_8c147f70-6ebf-4770-a12a-75d59e72d48d" xlink:href="ci-20230331.xsd#ci_ReinsuranceRecoverablesNonCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fa0e1ff0-cbb1-4f34-8c0a-606d4e6beacc" xlink:to="loc_ci_ReinsuranceRecoverablesNonCurrent_8c147f70-6ebf-4770-a12a-75d59e72d48d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a1e1d121-4fdd-4b5e-82c0-3270d2e63fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fa0e1ff0-cbb1-4f34-8c0a-606d4e6beacc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a1e1d121-4fdd-4b5e-82c0-3270d2e63fe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6968cb71-b83a-4b1f-958c-a533c5141a43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fa0e1ff0-cbb1-4f34-8c0a-606d4e6beacc" xlink:to="loc_us-gaap_Goodwill_6968cb71-b83a-4b1f-958c-a533c5141a43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0eaed946-21d4-4518-8566-e8fc0aca1e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fa0e1ff0-cbb1-4f34-8c0a-606d4e6beacc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0eaed946-21d4-4518-8566-e8fc0aca1e35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f6428faf-b608-4406-b7b7-5867708db0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fa0e1ff0-cbb1-4f34-8c0a-606d4e6beacc" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f6428faf-b608-4406-b7b7-5867708db0ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_8f8ffcf0-f97e-400a-bcca-0976599f9556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fa0e1ff0-cbb1-4f34-8c0a-606d4e6beacc" xlink:to="loc_us-gaap_SeparateAccountAssets_8f8ffcf0-f97e-400a-bcca-0976599f9556" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6d372c2a-3ae7-4569-92da-f1d19cc89d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_224f65ab-a9b1-4369-ba49-948180fe5268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6d372c2a-3ae7-4569-92da-f1d19cc89d20" xlink:to="loc_us-gaap_AccountsPayableCurrent_224f65ab-a9b1-4369-ba49-948180fe5268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_9f4ff836-a677-4f32-88d9-db195e0ee7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6d372c2a-3ae7-4569-92da-f1d19cc89d20" xlink:to="loc_us-gaap_DebtCurrent_9f4ff836-a677-4f32-88d9-db195e0ee7b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_0e846808-fba8-4169-af57-504b1e49be0b" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6d372c2a-3ae7-4569-92da-f1d19cc89d20" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_0e846808-fba8-4169-af57-504b1e49be0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmacyAndServiceCostsPayable_77665819-d7ed-42ef-9b58-e650e4bdcf26" xlink:href="ci-20230331.xsd#ci_PharmacyAndServiceCostsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6d372c2a-3ae7-4569-92da-f1d19cc89d20" xlink:to="loc_ci_PharmacyAndServiceCostsPayable_77665819-d7ed-42ef-9b58-e650e4bdcf26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AccruedExpensesAndOtherLiabilities_ba7a5b59-498e-43ff-b21e-914c3ab703e5" xlink:href="ci-20230331.xsd#ci_AccruedExpensesAndOtherLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6d372c2a-3ae7-4569-92da-f1d19cc89d20" xlink:to="loc_ci_AccruedExpensesAndOtherLiabilities_ba7a5b59-498e-43ff-b21e-914c3ab703e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fb33a574-fe64-4f59-9557-037ff6a9fa2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0a951a9b-df28-415d-8619-199875190ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fb33a574-fe64-4f59-9557-037ff6a9fa2e" xlink:to="loc_us-gaap_StockholdersEquity_0a951a9b-df28-415d-8619-199875190ca0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d9f57395-52b5-401c-9a1f-ed6e48e0fa5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fb33a574-fe64-4f59-9557-037ff6a9fa2e" xlink:to="loc_us-gaap_MinorityInterest_d9f57395-52b5-401c-9a1f-ed6e48e0fa5d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1e5a661d-592b-4440-8bd2-bacfd7b10116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ddffc37-a7ac-4014-8dab-957945937cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1e5a661d-592b-4440-8bd2-bacfd7b10116" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ddffc37-a7ac-4014-8dab-957945937cec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e2f7a31d-380a-476a-9566-8af3bb24c57e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1e5a661d-592b-4440-8bd2-bacfd7b10116" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e2f7a31d-380a-476a-9566-8af3bb24c57e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f4ff9ec7-822e-4b6b-a8b2-26548e96b25e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1e5a661d-592b-4440-8bd2-bacfd7b10116" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f4ff9ec7-822e-4b6b-a8b2-26548e96b25e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1a18235d-6efb-4216-a671-e7412b3387a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1e5a661d-592b-4440-8bd2-bacfd7b10116" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1a18235d-6efb-4216-a671-e7412b3387a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8b03aaa-bc08-45a4-b13e-06183e0a54eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_78f7e50d-d178-4064-9c65-e0a501fa852f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8b03aaa-bc08-45a4-b13e-06183e0a54eb" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_78f7e50d-d178-4064-9c65-e0a501fa852f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_90b384e6-d89b-4e42-bcf5-7b3f4d1e8549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8b03aaa-bc08-45a4-b13e-06183e0a54eb" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_90b384e6-d89b-4e42-bcf5-7b3f4d1e8549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_c4d7d0ce-1396-4cb6-b733-fd7b117c18ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8b03aaa-bc08-45a4-b13e-06183e0a54eb" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_c4d7d0ce-1396-4cb6-b733-fd7b117c18ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities_6d5ecbd3-d2e9-40d9-baf2-1b6227012c84" xlink:href="ci-20230331.xsd#ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8b03aaa-bc08-45a4-b13e-06183e0a54eb" xlink:to="loc_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities_6d5ecbd3-d2e9-40d9-baf2-1b6227012c84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMortgageNotesReceivable_69ca1ad0-45e6-4239-8058-2831f1e0a533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMortgageNotesReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8b03aaa-bc08-45a4-b13e-06183e0a54eb" xlink:to="loc_us-gaap_PaymentsToAcquireMortgageNotesReceivable_69ca1ad0-45e6-4239-8058-2831f1e0a533" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PaymentsForProceedsFromPropertyPlantAndEquipment_9ec895f6-e3eb-4e69-91ef-0b586c12c28f" xlink:href="ci-20230331.xsd#ci_PaymentsForProceedsFromPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8b03aaa-bc08-45a4-b13e-06183e0a54eb" xlink:to="loc_ci_PaymentsForProceedsFromPropertyPlantAndEquipment_9ec895f6-e3eb-4e69-91ef-0b586c12c28f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ProceedsFromSaleOfDebtAndEquitySecurities_4b08b91d-f583-416d-91e5-c9c3cb5f6930" xlink:href="ci-20230331.xsd#ci_ProceedsFromSaleOfDebtAndEquitySecurities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8b03aaa-bc08-45a4-b13e-06183e0a54eb" xlink:to="loc_ci_ProceedsFromSaleOfDebtAndEquitySecurities_4b08b91d-f583-416d-91e5-c9c3cb5f6930" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PaymentsToAcquireDebtAndEquitySecurities_c89d12b7-99f3-4c4c-a2e3-bf865196160b" xlink:href="ci-20230331.xsd#ci_PaymentsToAcquireDebtAndEquitySecurities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8b03aaa-bc08-45a4-b13e-06183e0a54eb" xlink:to="loc_ci_PaymentsToAcquireDebtAndEquitySecurities_c89d12b7-99f3-4c4c-a2e3-bf865196160b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_d6266c1e-c9ad-47a7-b95b-b9f0a11c5845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8b03aaa-bc08-45a4-b13e-06183e0a54eb" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_d6266c1e-c9ad-47a7-b95b-b9f0a11c5845" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_60476db8-c238-4ece-989b-d2d65242aa38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8b03aaa-bc08-45a4-b13e-06183e0a54eb" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_60476db8-c238-4ece-989b-d2d65242aa38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ed41bd6-e8b5-4e2e-8942-754eb2bd1d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1d73038b-fede-4ffa-b631-5475c97827e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ed41bd6-e8b5-4e2e-8942-754eb2bd1d5f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1d73038b-fede-4ffa-b631-5475c97827e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities_17c88d8d-f5ae-4c20-9757-b4835d101b4c" xlink:href="ci-20230331.xsd#ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ed41bd6-e8b5-4e2e-8942-754eb2bd1d5f" xlink:to="loc_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities_17c88d8d-f5ae-4c20-9757-b4835d101b4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a17fa6f7-6ca3-4fc7-83ae-91a9be863faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ed41bd6-e8b5-4e2e-8942-754eb2bd1d5f" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a17fa6f7-6ca3-4fc7-83ae-91a9be863faf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_95203c38-5764-4fa5-b5d0-ea22c87495af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ed41bd6-e8b5-4e2e-8942-754eb2bd1d5f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_95203c38-5764-4fa5-b5d0-ea22c87495af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_07bf6823-4fed-4ff2-b0bb-098349d9118e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ed41bd6-e8b5-4e2e-8942-754eb2bd1d5f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_07bf6823-4fed-4ff2-b0bb-098349d9118e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_82f107f1-41e0-49a3-a026-85bdc61b7759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ed41bd6-e8b5-4e2e-8942-754eb2bd1d5f" xlink:to="loc_us-gaap_ProfitLoss_82f107f1-41e0-49a3-a026-85bdc61b7759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_2427c790-5d01-487f-8167-586a67bf41e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ed41bd6-e8b5-4e2e-8942-754eb2bd1d5f" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_2427c790-5d01-487f-8167-586a67bf41e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_1cc41e79-79ea-4ac8-80e3-fb15aee9286f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ed41bd6-e8b5-4e2e-8942-754eb2bd1d5f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_1cc41e79-79ea-4ac8-80e3-fb15aee9286f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLoss_1a20768e-a3ff-4d32-af94-1fa6ff87ac58" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLoss"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ed41bd6-e8b5-4e2e-8942-754eb2bd1d5f" xlink:to="loc_ci_RealizedInvestmentGainLoss_1a20768e-a3ff-4d32-af94-1fa6ff87ac58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable_1c9471e3-2234-4999-b9a5-4dcb6e2a1ab6" xlink:href="ci-20230331.xsd#ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ed41bd6-e8b5-4e2e-8942-754eb2bd1d5f" xlink:to="loc_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable_1c9471e3-2234-4999-b9a5-4dcb6e2a1ab6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReinsuranceRecoverable_5c9d4744-17c2-47c9-b4d7-a9c27753aeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReinsuranceRecoverable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ed41bd6-e8b5-4e2e-8942-754eb2bd1d5f" xlink:to="loc_us-gaap_IncreaseDecreaseInReinsuranceRecoverable_5c9d4744-17c2-47c9-b4d7-a9c27753aeeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_018b2dac-3903-4429-93d0-288dc2a9ed5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ProceedsFromRepaymentsOfOtherShortTermDebt_04bec819-fbe6-4f62-8735-e206db885955" xlink:href="ci-20230331.xsd#ci_ProceedsFromRepaymentsOfOtherShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_018b2dac-3903-4429-93d0-288dc2a9ed5f" xlink:to="loc_ci_ProceedsFromRepaymentsOfOtherShortTermDebt_04bec819-fbe6-4f62-8735-e206db885955" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0f9bd733-7011-478f-9b64-3e726213f6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_018b2dac-3903-4429-93d0-288dc2a9ed5f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0f9bd733-7011-478f-9b64-3e726213f6bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_092b6121-7ce1-4264-b2f5-20cdf790468b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_018b2dac-3903-4429-93d0-288dc2a9ed5f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_092b6121-7ce1-4264-b2f5-20cdf790468b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_835088fa-87f5-4ab3-964b-a3e9d60dcfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_018b2dac-3903-4429-93d0-288dc2a9ed5f" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_835088fa-87f5-4ab3-964b-a3e9d60dcfb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WithdrawalFromContractHoldersFunds_4f87c4de-cd16-4aa8-883e-163f2863c047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WithdrawalFromContractHoldersFunds"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_018b2dac-3903-4429-93d0-288dc2a9ed5f" xlink:to="loc_us-gaap_WithdrawalFromContractHoldersFunds_4f87c4de-cd16-4aa8-883e-163f2863c047" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_bf85832b-6703-4914-ac80-e2cdacaa8e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_018b2dac-3903-4429-93d0-288dc2a9ed5f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_bf85832b-6703-4914-ac80-e2cdacaa8e33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_7b7fd64e-0521-41e7-bf6b-5b74086aa42d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_018b2dac-3903-4429-93d0-288dc2a9ed5f" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_7b7fd64e-0521-41e7-bf6b-5b74086aa42d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_74f8eb40-2e79-4a1b-99d3-2385187fbe15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_018b2dac-3903-4429-93d0-288dc2a9ed5f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_74f8eb40-2e79-4a1b-99d3-2385187fbe15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionsToContractHoldersFunds_a41cba97-1342-4cae-af82-73ca20c89184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionsToContractHoldersFunds"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_018b2dac-3903-4429-93d0-288dc2a9ed5f" xlink:to="loc_us-gaap_AdditionsToContractHoldersFunds_a41cba97-1342-4cae-af82-73ca20c89184" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_00818107-60ea-4cf2-8022-a9990acdf917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2d370baa-4305-4a5e-9554-57099382d1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_00818107-60ea-4cf2-8022-a9990acdf917" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2d370baa-4305-4a5e-9554-57099382d1d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_21419955-4da1-4a8f-ae61-41379e6fc4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_00818107-60ea-4cf2-8022-a9990acdf917" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_21419955-4da1-4a8f-ae61-41379e6fc4e3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#AccountsReceivableNetSummaryofAccountsReceivableNetDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale_640282ea-fbf8-4e80-8b72-dc1b8af0140a" xlink:href="ci-20230331.xsd#ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceCustomerReceivables_71552abe-1d10-4ab5-a603-ce1bcbb29992" xlink:href="ci-20230331.xsd#ci_InsuranceCustomerReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale_640282ea-fbf8-4e80-8b72-dc1b8af0140a" xlink:to="loc_ci_InsuranceCustomerReceivables_71552abe-1d10-4ab5-a603-ce1bcbb29992" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_0ba0f802-577e-4b5c-b94f-3764f8bea36a" xlink:href="ci-20230331.xsd#ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale_640282ea-fbf8-4e80-8b72-dc1b8af0140a" xlink:to="loc_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_0ba0f802-577e-4b5c-b94f-3764f8bea36a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_ac68cbec-1da3-40ca-b25b-192d1783258f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale_640282ea-fbf8-4e80-8b72-dc1b8af0140a" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_ac68cbec-1da3-40ca-b25b-192d1783258f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_b4395292-f115-4b9a-8ee1-adec8d55174f" xlink:href="ci-20230331.xsd#ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale_640282ea-fbf8-4e80-8b72-dc1b8af0140a" xlink:to="loc_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_b4395292-f115-4b9a-8ee1-adec8d55174f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_9f4d1964-5be7-46de-8406-4dd90dd70b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceCustomerReceivables_fba94451-9c0c-42d5-8335-9d831cb07180" xlink:href="ci-20230331.xsd#ci_InsuranceCustomerReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_9f4d1964-5be7-46de-8406-4dd90dd70b36" xlink:to="loc_ci_InsuranceCustomerReceivables_fba94451-9c0c-42d5-8335-9d831cb07180" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmaceuticalManufacturerReceivable_01ceceb6-403a-46b8-b4cb-d576ad46500a" xlink:href="ci-20230331.xsd#ci_PharmaceuticalManufacturerReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_9f4d1964-5be7-46de-8406-4dd90dd70b36" xlink:to="loc_ci_PharmaceuticalManufacturerReceivable_01ceceb6-403a-46b8-b4cb-d576ad46500a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_6fb20332-bebf-4ce7-b712-2607aa24c1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_9f4d1964-5be7-46de-8406-4dd90dd70b36" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_6fb20332-bebf-4ce7-b712-2607aa24c1c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable_c6fe95cf-2104-4873-8f81-25b4bee9ab88" xlink:href="ci-20230331.xsd#ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_9f4d1964-5be7-46de-8406-4dd90dd70b36" xlink:to="loc_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable_c6fe95cf-2104-4873-8f81-25b4bee9ab88" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1ea28177-33d0-4162-bffb-4d578d455040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7c3ed8ce-2d74-45c6-9cfa-305b13ee7b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_1ea28177-33d0-4162-bffb-4d578d455040" xlink:to="loc_us-gaap_EarningsPerShareBasic_7c3ed8ce-2d74-45c6-9cfa-305b13ee7b98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EarningsPerShareEffectOfDilution_b4ce1636-1d93-476c-b91c-86f94e9c8a07" xlink:href="ci-20230331.xsd#ci_EarningsPerShareEffectOfDilution"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_1ea28177-33d0-4162-bffb-4d578d455040" xlink:to="loc_ci_EarningsPerShareEffectOfDilution_b4ce1636-1d93-476c-b91c-86f94e9c8a07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_13908dcd-38c8-4a38-a760-059350384578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_60bb9281-b1eb-47dc-9d62-8492f5d01259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_13908dcd-38c8-4a38-a760-059350384578" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_60bb9281-b1eb-47dc-9d62-8492f5d01259" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a8c33dd3-8bc8-4857-a132-d1a02ca8cb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_13908dcd-38c8-4a38-a760-059350384578" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a8c33dd3-8bc8-4857-a132-d1a02ca8cb1c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#DebtOutstandingAmountsofDebtandFinanceLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_4f2c3733-1e66-42fa-91a6-7873d2186239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_0a70d629-185f-4fc4-a447-df474a507401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_4f2c3733-1e66-42fa-91a6-7873d2186239" xlink:to="loc_us-gaap_LongTermDebtCurrent_0a70d629-185f-4fc4-a447-df474a507401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent_1ea50b10-8f6f-458b-9f59-f8abf011e3fe" xlink:href="ci-20230331.xsd#ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_4f2c3733-1e66-42fa-91a6-7873d2186239" xlink:to="loc_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent_1ea50b10-8f6f-458b-9f59-f8abf011e3fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_3fbdd439-675b-4a5b-a43f-8c784107f3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_bec5ca5a-e42a-4a4a-b21b-fb18d5101e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_3fbdd439-675b-4a5b-a43f-8c784107f3d0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_bec5ca5a-e42a-4a4a-b21b-fb18d5101e8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_10ca654a-ec34-4370-b55d-376cad95028f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_3fbdd439-675b-4a5b-a43f-8c784107f3d0" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_10ca654a-ec34-4370-b55d-376cad95028f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesAccountBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilities_10244b9c-00b4-460d-8101-8eecc208d035" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_eea25b3e-cc00-45e7-a82c-d977db4101cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilities_10244b9c-00b4-460d-8101-8eecc208d035" xlink:to="loc_us-gaap_UnearnedPremiums_eea25b3e-cc00-45e7-a82c-d977db4101cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_060b0e84-d813-47f8-b6a0-d685d5eb7838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilities_10244b9c-00b4-460d-8101-8eecc208d035" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_060b0e84-d813-47f8-b6a0-d685d5eb7838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_139e17ed-c371-4a90-8b31-987d5eac9abc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilities_10244b9c-00b4-460d-8101-8eecc208d035" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_139e17ed-c371-4a90-8b31-987d5eac9abc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitLiabilityAmount_57760994-96ff-4522-b42f-1daeef78b4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitLiabilityAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilities_10244b9c-00b4-460d-8101-8eecc208d035" xlink:to="loc_us-gaap_MarketRiskBenefitLiabilityAmount_57760994-96ff-4522-b42f-1daeef78b4c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderContractDeposits_ae4e0921-cdef-4df3-bbfb-0153302650d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderContractDeposits"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilities_10244b9c-00b4-460d-8101-8eecc208d035" xlink:to="loc_us-gaap_PolicyholderContractDeposits_ae4e0921-cdef-4df3-bbfb-0153302650d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderContractDeposits_65c8d0f3-9b76-48a5-9472-ab769cd916f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderContractDeposits"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositNoncurrent_8a453c14-bf7a-4ca4-a63d-f4fc45c5554a" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderContractDeposits_65c8d0f3-9b76-48a5-9472-ab769cd916f8" xlink:to="loc_ci_PolicyholderContractDepositNoncurrent_8a453c14-bf7a-4ca4-a63d-f4fc45c5554a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositCurrent_0db9d530-a1ac-4057-a8a7-b04018f00e03" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderContractDeposits_65c8d0f3-9b76-48a5-9472-ab769cd916f8" xlink:to="loc_ci_PolicyholderContractDepositCurrent_0db9d530-a1ac-4057-a8a7-b04018f00e03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_4d86b97c-3b9c-4807-b842-1262af567881" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities_14acbd13-a0be-4b83-a048-8150c92e5955" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_4d86b97c-3b9c-4807-b842-1262af567881" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities_14acbd13-a0be-4b83-a048-8150c92e5955" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilities_08729757-3d52-4f3b-80b3-8e2dcfe97e8a" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_4d86b97c-3b9c-4807-b842-1262af567881" xlink:to="loc_ci_InsuranceAndContractholderLiabilities_08729757-3d52-4f3b-80b3-8e2dcfe97e8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_ce19c479-3111-4ac7-826a-f73d95a8e413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsNoncurrent_0ff112b0-fe12-4d27-9bb1-aa4c12eaf345" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnearnedPremiums_ce19c479-3111-4ac7-826a-f73d95a8e413" xlink:to="loc_ci_UnearnedPremiumsNoncurrent_0ff112b0-fe12-4d27-9bb1-aa4c12eaf345" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsCurrent_a4144352-3991-42e3-96a9-5216ed730713" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnearnedPremiums_ce19c479-3111-4ac7-826a-f73d95a8e413" xlink:to="loc_ci_UnearnedPremiumsCurrent_a4144352-3991-42e3-96a9-5216ed730713" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitLiabilityAmount_f19149d4-1143-4f9e-8d33-e6e6301e0cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitLiabilityAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitLiabilityAmountNoncurrent_12ec9af4-492d-4844-ba55-8f7481c69fd2" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitLiabilityAmountNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketRiskBenefitLiabilityAmount_f19149d4-1143-4f9e-8d33-e6e6301e0cda" xlink:to="loc_ci_MarketRiskBenefitLiabilityAmountNoncurrent_12ec9af4-492d-4844-ba55-8f7481c69fd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitLiabilityAmountCurrent_89d1c41c-10e3-43a6-9416-a74e20f9e690" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitLiabilityAmountCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketRiskBenefitLiabilityAmount_f19149d4-1143-4f9e-8d33-e6e6301e0cda" xlink:to="loc_ci_MarketRiskBenefitLiabilityAmountCurrent_89d1c41c-10e3-43a6-9416-a74e20f9e690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_94c16542-858c-40bc-a459-8b5552abf81b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent_237f4fae-d7f4-4824-9018-3037a9173e5d" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_94c16542-858c-40bc-a459-8b5552abf81b" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent_237f4fae-d7f4-4824-9018-3037a9173e5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent_f9b60a09-06d3-4748-9eb1-2cfae8221ace" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_94c16542-858c-40bc-a459-8b5552abf81b" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent_f9b60a09-06d3-4748-9eb1-2cfae8221ace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_396a1c0c-7df8-481d-b45f-c1c143b0272c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent_b59dfa7b-5ade-40ff-b3c0-1ab21ee6a62e" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits_396a1c0c-7df8-481d-b45f-c1c143b0272c" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent_b59dfa7b-5ade-40ff-b3c0-1ab21ee6a62e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent_8b9d115d-9c5a-4215-9122-3c0e9043dfc2" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits_396a1c0c-7df8-481d-b45f-c1c143b0272c" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent_8b9d115d-9c5a-4215-9122-3c0e9043dfc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_ef6a2bc8-8c42-4118-add9-0a57b5a4202b" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitLiabilityAmountNoncurrent_853f5899-366a-445b-87af-4bd27f76870c" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitLiabilityAmountNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_ef6a2bc8-8c42-4118-add9-0a57b5a4202b" xlink:to="loc_ci_MarketRiskBenefitLiabilityAmountNoncurrent_853f5899-366a-445b-87af-4bd27f76870c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositNoncurrent_2ef14236-d56d-4f11-957e-4dc92ff08bf1" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_ef6a2bc8-8c42-4118-add9-0a57b5a4202b" xlink:to="loc_ci_PolicyholderContractDepositNoncurrent_2ef14236-d56d-4f11-957e-4dc92ff08bf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent_e5bd5d94-21e0-4a5f-98af-c5b5d9c7ef47" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_ef6a2bc8-8c42-4118-add9-0a57b5a4202b" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent_e5bd5d94-21e0-4a5f-98af-c5b5d9c7ef47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent_5e7bd63a-b4d7-403f-a5c3-c8132c69a32f" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_ef6a2bc8-8c42-4118-add9-0a57b5a4202b" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent_5e7bd63a-b4d7-403f-a5c3-c8132c69a32f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsNoncurrent_2d375f21-0f15-41ef-bcbd-8fa6bcea8f2d" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_ef6a2bc8-8c42-4118-add9-0a57b5a4202b" xlink:to="loc_ci_UnearnedPremiumsNoncurrent_2d375f21-0f15-41ef-bcbd-8fa6bcea8f2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_89f50e57-ea6e-4b51-9064-bd20894cb3d8" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositCurrent_27185cb2-deaf-4e99-bfa3-4f310f9eb047" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_89f50e57-ea6e-4b51-9064-bd20894cb3d8" xlink:to="loc_ci_PolicyholderContractDepositCurrent_27185cb2-deaf-4e99-bfa3-4f310f9eb047" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitLiabilityAmountCurrent_f6bd465a-1d33-4622-b7a5-533bb90c3257" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitLiabilityAmountCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_89f50e57-ea6e-4b51-9064-bd20894cb3d8" xlink:to="loc_ci_MarketRiskBenefitLiabilityAmountCurrent_f6bd465a-1d33-4622-b7a5-533bb90c3257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent_cfe5dce6-ec8a-4141-bec2-d69a9469de01" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_89f50e57-ea6e-4b51-9064-bd20894cb3d8" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent_cfe5dce6-ec8a-4141-bec2-d69a9469de01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent_027feaf2-ce74-4b69-8c4e-6ea7ca1dc8cd" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_89f50e57-ea6e-4b51-9064-bd20894cb3d8" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent_027feaf2-ce74-4b69-8c4e-6ea7ca1dc8cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsCurrent_502adc4e-fb1a-49a0-b61d-85f81f116bcd" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_89f50e57-ea6e-4b51-9064-bd20894cb3d8" xlink:to="loc_ci_UnearnedPremiumsCurrent_502adc4e-fb1a-49a0-b61d-85f81f116bcd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesAccountBalancesDetails_1"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilities_c546b48e-ce5c-4cb6-bb92-2798c9f08438" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_772ede37-57f0-4203-b142-0a0bffe8313e" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilities_c546b48e-ce5c-4cb6-bb92-2798c9f08438" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_772ede37-57f0-4203-b142-0a0bffe8313e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_cd9b6b87-5cdd-4d75-bb7c-eecaaae03c2f" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilities_c546b48e-ce5c-4cb6-bb92-2798c9f08438" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_cd9b6b87-5cdd-4d75-bb7c-eecaaae03c2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_c2dd3cfe-d97a-467f-a63d-35914aff0a96" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups_a31b7513-26cc-4a47-8bd2-e5178e79e3e4" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_c2dd3cfe-d97a-467f-a63d-35914aff0a96" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups_a31b7513-26cc-4a47-8bd2-e5178e79e3e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderContractDeposits_345eca92-c05b-41fc-9963-3d3ebf8bfe06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderContractDeposits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_c2dd3cfe-d97a-467f-a63d-35914aff0a96" xlink:to="loc_us-gaap_PolicyholderContractDeposits_345eca92-c05b-41fc-9963-3d3ebf8bfe06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsIncludingDisposalGroups_6c124c61-9ce0-4e29-91cf-c7242567db6a" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsIncludingDisposalGroups"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_c2dd3cfe-d97a-467f-a63d-35914aff0a96" xlink:to="loc_ci_UnearnedPremiumsIncludingDisposalGroups_6c124c61-9ce0-4e29-91cf-c7242567db6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups_5249dc05-283d-487d-b141-c6412ff13238" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_c2dd3cfe-d97a-467f-a63d-35914aff0a96" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups_5249dc05-283d-487d-b141-c6412ff13238" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitLiabilityAmount_4f925198-a09b-4c64-802a-102d1da580cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitLiabilityAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_c2dd3cfe-d97a-467f-a63d-35914aff0a96" xlink:to="loc_us-gaap_MarketRiskBenefitLiabilityAmount_4f925198-a09b-4c64-802a-102d1da580cb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_56e41056-d5dd-4620-b6e2-5beaea80114a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_619fa242-3bcb-4a1b-91fd-4f1dda99da10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_56e41056-d5dd-4620-b6e2-5beaea80114a" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_619fa242-3bcb-4a1b-91fd-4f1dda99da10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_94ba3b42-2a86-450b-a58d-3c28c1496a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_56e41056-d5dd-4620-b6e2-5beaea80114a" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_94ba3b42-2a86-450b-a58d-3c28c1496a66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_0576f197-ade3-4987-87f3-8b2cae459c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_913699bf-38e0-4326-9973-75a43a850ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_0576f197-ade3-4987-87f3-8b2cae459c0f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_913699bf-38e0-4326-9973-75a43a850ab3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_016b83d9-ced5-427d-a6be-13a8055162f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_0576f197-ade3-4987-87f3-8b2cae459c0f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_016b83d9-ced5-427d-a6be-13a8055162f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_d2bdb716-9f52-40cc-a3ca-78f88b298776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_bd7d9edc-7921-4739-83fa-7ab3079cdeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_d2bdb716-9f52-40cc-a3ca-78f88b298776" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_bd7d9edc-7921-4739-83fa-7ab3079cdeb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_01847923-9716-40c6-a088-f9823285095c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_d2bdb716-9f52-40cc-a3ca-78f88b298776" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_01847923-9716-40c6-a088-f9823285095c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_3c710019-7ae2-4442-a36b-03815323c922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitOther_115d165b-ab20-4017-b43c-ef9789f8a94e" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits_3c710019-7ae2-4442-a36b-03815323c922" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitOther_115d165b-ab20-4017-b43c-ef9789f8a94e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther_df420129-8e43-449a-b3ff-f0d6f0ca5e5f" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits_3c710019-7ae2-4442-a36b-03815323c922" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther_df420129-8e43-449a-b3ff-f0d6f0ca5e5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_8da3bf95-be1d-4524-8b9d-84d51f703065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_68bb99b0-1a06-48e6-962c-dc081777ded2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_8da3bf95-be1d-4524-8b9d-84d51f703065" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_68bb99b0-1a06-48e6-962c-dc081777ded2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_01fc026f-be12-4f9a-b15e-e757053d5805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_8da3bf95-be1d-4524-8b9d-84d51f703065" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_01fc026f-be12-4f9a-b15e-e757053d5805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_5d2c0ce1-2aa1-4d9e-8849-19b543be5177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_985f48c7-ffd6-4cbf-8dac-ef8c3b83b037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_5d2c0ce1-2aa1-4d9e-8849-19b543be5177" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_985f48c7-ffd6-4cbf-8dac-ef8c3b83b037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_70fc97ec-b48d-4aa5-9b42-5063b44b15a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_5d2c0ce1-2aa1-4d9e-8849-19b543be5177" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_70fc97ec-b48d-4aa5-9b42-5063b44b15a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange_fc25e151-1e21-4410-9df0-8a36cb263b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax_75abfe7c-9cf1-4514-a438-6ff2707aa75f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange_fc25e151-1e21-4410-9df0-8a36cb263b46" xlink:to="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax_75abfe7c-9cf1-4514-a438-6ff2707aa75f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk_0edd8a7b-93f0-4307-9dc5-55830e89c0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange_fc25e151-1e21-4410-9df0-8a36cb263b46" xlink:to="loc_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk_0edd8a7b-93f0-4307-9dc5-55830e89c0ba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#ReinsuranceReinsuranceRecoverablesDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_5bedf04f-13a6-40c0-b024-4b53e4ec8c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesGross_c7e35500-6c85-4b6e-84ad-829932ce1917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReinsuranceRecoverables_5bedf04f-13a6-40c0-b024-4b53e4ec8c59" xlink:to="loc_us-gaap_ReinsuranceRecoverablesGross_c7e35500-6c85-4b6e-84ad-829932ce1917" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_fe755862-8986-4333-9428-f71a8b9cfbd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReinsuranceRecoverables_5bedf04f-13a6-40c0-b024-4b53e4ec8c59" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_fe755862-8986-4333-9428-f71a8b9cfbd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_072ff763-4b4a-4330-b744-3bca57d8182a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReinsuranceRecoverables_5bedf04f-13a6-40c0-b024-4b53e4ec8c59" xlink:to="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_072ff763-4b4a-4330-b744-3bca57d8182a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsInvestmentsbyCategoryDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_b68da39b-7d26-486d-803a-d15fa5195c55" xlink:href="ci-20230331.xsd#ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_f537ce7b-2fda-4a65-b96b-3bff03d5352c" xlink:href="ci-20230331.xsd#ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_b68da39b-7d26-486d-803a-d15fa5195c55" xlink:to="loc_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_f537ce7b-2fda-4a65-b96b-3bff03d5352c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_9dec2a6d-f84e-4426-8b9a-86702bc47ae5" xlink:href="ci-20230331.xsd#ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_b68da39b-7d26-486d-803a-d15fa5195c55" xlink:to="loc_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_9dec2a6d-f84e-4426-8b9a-86702bc47ae5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationInvestments_8c5b2613-2b8f-4827-9122-9d08bcf6df88" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent_a8e3d668-7947-4108-b655-3512ac148a3a" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DisposalGroupIncludingDiscontinuedOperationInvestments_8c5b2613-2b8f-4827-9122-9d08bcf6df88" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent_a8e3d668-7947-4108-b655-3512ac148a3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent_e47e55a1-d65e-4417-8e39-0bc156594ea7" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DisposalGroupIncludingDiscontinuedOperationInvestments_8c5b2613-2b8f-4827-9122-9d08bcf6df88" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent_e47e55a1-d65e-4417-8e39-0bc156594ea7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_e222b77e-b195-493c-926e-a9e8642cdbc5" xlink:href="ci-20230331.xsd#ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent_7dc5a648-5c4c-4128-9e2a-baa4ecc0445f" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_e222b77e-b195-493c-926e-a9e8642cdbc5" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent_7dc5a648-5c4c-4128-9e2a-baa4ecc0445f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_5c6eb2af-5f83-4564-a3fb-3131aa8bb664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_e222b77e-b195-493c-926e-a9e8642cdbc5" xlink:to="loc_us-gaap_LongTermInvestments_5c6eb2af-5f83-4564-a3fb-3131aa8bb664" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_e833c251-f5bb-489e-b8a9-5f7eb17d1eda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_c0fb8d7c-388e-4daa-9aae-46b3b161927c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_e833c251-f5bb-489e-b8a9-5f7eb17d1eda" xlink:to="loc_us-gaap_ShortTermInvestments_c0fb8d7c-388e-4daa-9aae-46b3b161927c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_be25772b-85b2-424c-b505-59458313de1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_e833c251-f5bb-489e-b8a9-5f7eb17d1eda" xlink:to="loc_us-gaap_LongTermInvestments_be25772b-85b2-424c-b505-59458313de1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_315287cb-715d-4175-b6fd-c5d14e4a8f25" xlink:href="ci-20230331.xsd#ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent_e4100e90-09ee-48b1-9299-5400659c2423" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_315287cb-715d-4175-b6fd-c5d14e4a8f25" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent_e4100e90-09ee-48b1-9299-5400659c2423" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_17da80fd-ec77-4800-b4a7-a394a42526b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_315287cb-715d-4175-b6fd-c5d14e4a8f25" xlink:to="loc_us-gaap_ShortTermInvestments_17da80fd-ec77-4800-b4a7-a394a42526b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails_1" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsInvestmentsbyCategoryDetails_1"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_7ad88a56-ad63-486a-8dfa-e7300330b3bd" xlink:href="ci-20230331.xsd#ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_9dc20818-18ef-4756-a536-a91f598cf09d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_7ad88a56-ad63-486a-8dfa-e7300330b3bd" xlink:to="loc_us-gaap_Investments_9dc20818-18ef-4756-a536-a91f598cf09d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationInvestments_7c543b82-91b3-43eb-83ee-a2f8da31e370" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_7ad88a56-ad63-486a-8dfa-e7300330b3bd" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationInvestments_7c543b82-91b3-43eb-83ee-a2f8da31e370" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_46410d6b-6e7d-4425-923a-f57ec64a0995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_f61df704-a469-45c7-8600-150f0b5ecdfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_46410d6b-6e7d-4425-923a-f57ec64a0995" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_f61df704-a469-45c7-8600-150f0b5ecdfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_8f872cd0-d5ac-4da8-a057-99dc2fd80c75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_46410d6b-6e7d-4425-923a-f57ec64a0995" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_8f872cd0-d5ac-4da8-a057-99dc2fd80c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_35beac55-d9bb-4db6-9db5-61cbce0a603d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_46410d6b-6e7d-4425-923a-f57ec64a0995" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_35beac55-d9bb-4db6-9db5-61cbce0a603d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_6a51839e-24b1-4bb9-9186-03eb8012ad3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_46410d6b-6e7d-4425-923a-f57ec64a0995" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_6a51839e-24b1-4bb9-9186-03eb8012ad3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_8d8ab7e0-25a8-4bcd-996c-68a5935f0603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_46410d6b-6e7d-4425-923a-f57ec64a0995" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_8d8ab7e0-25a8-4bcd-996c-68a5935f0603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_aff5462e-9477-429e-860f-c01967634af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_976ef1fa-5a54-4b26-a015-a7bfc6ddee73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_aff5462e-9477-429e-860f-c01967634af3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_976ef1fa-5a54-4b26-a015-a7bfc6ddee73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_571e15c6-2d41-477e-a196-80a02e259a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_aff5462e-9477-429e-860f-c01967634af3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_571e15c6-2d41-477e-a196-80a02e259a09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_992eec26-7db4-48d2-ab64-2d31b36e87da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_aff5462e-9477-429e-860f-c01967634af3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_992eec26-7db4-48d2-ab64-2d31b36e87da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_95fca035-14c5-4d87-978b-209e40f812ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_aff5462e-9477-429e-860f-c01967634af3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_95fca035-14c5-4d87-978b-209e40f812ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_a252f209-c50e-4d06-8e3a-4e4eaf87af78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_aff5462e-9477-429e-860f-c01967634af3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_a252f209-c50e-4d06-8e3a-4e4eaf87af78" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c2fac508-2616-465d-be86-4a8c15d98c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ba45c2c9-6f81-46d8-a164-4467924a2877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c2fac508-2616-465d-be86-4a8c15d98c6d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ba45c2c9-6f81-46d8-a164-4467924a2877" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_ff32ec67-1252-4655-94ce-1058b58f485b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c2fac508-2616-465d-be86-4a8c15d98c6d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_ff32ec67-1252-4655-94ce-1058b58f485b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost_22b92cf5-cd31-4ce4-a190-dd288cd72773" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_d38c5f81-85db-47fa-9555-35311f51d657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost_22b92cf5-cd31-4ce4-a190-dd288cd72773" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_d38c5f81-85db-47fa-9555-35311f51d657" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_34a8e1fc-2b41-4783-a7ac-13b62e1106bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost_22b92cf5-cd31-4ce4-a190-dd288cd72773" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_34a8e1fc-2b41-4783-a7ac-13b62e1106bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_8772f6cd-5d16-483a-8b8b-f9bfc7721187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_5112c5bc-5f36-4d52-9823-58db2024fe45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_8772f6cd-5d16-483a-8b8b-f9bfc7721187" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_5112c5bc-5f36-4d52-9823-58db2024fe45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_8048512f-4a52-4de3-8597-633ec3d09ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_8772f6cd-5d16-483a-8b8b-f9bfc7721187" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_8048512f-4a52-4de3-8597-633ec3d09ccd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_be0859d4-69e9-4ffa-9e12-e6772bed6231" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_9eefc708-1b9d-4cbd-9ade-f4db0eecf6a4" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_be0859d4-69e9-4ffa-9e12-e6772bed6231" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_9eefc708-1b9d-4cbd-9ade-f4db0eecf6a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_a073330d-b0c2-41e8-8489-c3c58aa4f164" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_be0859d4-69e9-4ffa-9e12-e6772bed6231" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_a073330d-b0c2-41e8-8489-c3c58aa4f164" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_3fc8edd9-4416-4cb5-b1e2-0ae4eb3eb86c" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_7b4edd05-8b20-4e20-82a4-9a3e0f2295c1" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_3fc8edd9-4416-4cb5-b1e2-0ae4eb3eb86c" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_7b4edd05-8b20-4e20-82a4-9a3e0f2295c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale_f19350bb-4ecc-4416-ad9e-0c333242ffd5" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_3fc8edd9-4416-4cb5-b1e2-0ae4eb3eb86c" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale_f19350bb-4ecc-4416-ad9e-0c333242ffd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_926bd3c1-9298-4735-8316-d9ae3c266196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_55402d23-aab9-4262-ba17-375bf3bbe8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_926bd3c1-9298-4735-8316-d9ae3c266196" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_55402d23-aab9-4262-ba17-375bf3bbe8cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_62d19356-5bf2-4fb7-921c-9b105af88735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_926bd3c1-9298-4735-8316-d9ae3c266196" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_62d19356-5bf2-4fb7-921c-9b105af88735" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale_fcb71156-5757-47c1-861d-f7a43eb28c61" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_92c69a0a-d720-4ff6-af55-46de5c966dfe" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale_fcb71156-5757-47c1-861d-f7a43eb28c61" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_92c69a0a-d720-4ff6-af55-46de5c966dfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_fde43912-5d27-4de3-82fa-bd2ef4f8d749" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale_fcb71156-5757-47c1-861d-f7a43eb28c61" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_fde43912-5d27-4de3-82fa-bd2ef4f8d749" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost_ac4e304f-b99d-40dd-a870-2f65114bed0d" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost_483aed75-72b5-48b5-be3f-e2c9ecd4a211" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost_ac4e304f-b99d-40dd-a870-2f65114bed0d" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost_483aed75-72b5-48b5-be3f-e2c9ecd4a211" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost_127c7748-d3ad-409b-a527-a5faf1b484a0" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost_ac4e304f-b99d-40dd-a870-2f65114bed0d" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost_127c7748-d3ad-409b-a527-a5faf1b484a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1c8d7978-3530-46c6-993a-302af93f6d84" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_fb48838a-eec5-466f-afd7-43f932a564e6" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1c8d7978-3530-46c6-993a-302af93f6d84" xlink:to="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_fb48838a-eec5-466f-afd7-43f932a564e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_23faaf66-085b-464f-9210-cc141e910def" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1c8d7978-3530-46c6-993a-302af93f6d84" xlink:to="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_23faaf66-085b-464f-9210-cc141e910def" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_d7076ece-190f-4c52-ad1c-9f91caf5ccca" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_43868475-fb0a-4f06-a7eb-6e9d681acb19" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_d7076ece-190f-4c52-ad1c-9f91caf5ccca" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_43868475-fb0a-4f06-a7eb-6e9d681acb19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_f27081d2-2385-4882-8cfb-f382c761baba" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_d7076ece-190f-4c52-ad1c-9f91caf5ccca" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_f27081d2-2385-4882-8cfb-f382c761baba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_940e988e-264d-4334-bd0a-6c9127d262c3" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_5519b1cd-6ded-4152-9563-fb21affe785b" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_940e988e-264d-4334-bd0a-6c9127d262c3" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_5519b1cd-6ded-4152-9563-fb21affe785b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_99d5c2cd-9232-40bc-8263-32e28417d6b1" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_940e988e-264d-4334-bd0a-6c9127d262c3" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_99d5c2cd-9232-40bc-8263-32e28417d6b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost_0477d586-87eb-46ba-ab2b-eb4c6412e00c" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_476e4e83-0651-4cd8-81a1-0d98af1aa897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost_0477d586-87eb-46ba-ab2b-eb4c6412e00c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_476e4e83-0651-4cd8-81a1-0d98af1aa897" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_448d6c91-8482-4519-b9f3-1f861b4e2e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost_0477d586-87eb-46ba-ab2b-eb4c6412e00c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_448d6c91-8482-4519-b9f3-1f861b4e2e36" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails_1" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails_1"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_153676d1-4b9a-4364-89cf-2794336e301d" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_d5e19c47-344b-4673-9868-753a4a0460d3" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_153676d1-4b9a-4364-89cf-2794336e301d" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_d5e19c47-344b-4673-9868-753a4a0460d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_ffbb1d3e-b31c-4669-9e0e-78d60588903b" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_153676d1-4b9a-4364-89cf-2794336e301d" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_ffbb1d3e-b31c-4669-9e0e-78d60588903b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsEquitySecurityInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_54b8793c-a9b2-4607-8420-6d4077ac0bc5" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_6f0291bb-a5e8-496d-9fd1-f410db510db5" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_54b8793c-a9b2-4607-8420-6d4077ac0bc5" xlink:to="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_6f0291bb-a5e8-496d-9fd1-f410db510db5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_b8e5eee4-5d0b-4c1f-9684-2fa4f88af0b1" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_54b8793c-a9b2-4607-8420-6d4077ac0bc5" xlink:to="loc_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_b8e5eee4-5d0b-4c1f-9684-2fa4f88af0b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_333056e5-8b64-492a-bc60-0aacd02cd1f1" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_99894be7-c5a4-4fc0-95b7-66b6b543ac29" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_333056e5-8b64-492a-bc60-0aacd02cd1f1" xlink:to="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_99894be7-c5a4-4fc0-95b7-66b6b543ac29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale_a9997d24-83db-497f-956d-a4e49f855721" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_333056e5-8b64-492a-bc60-0aacd02cd1f1" xlink:to="loc_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale_a9997d24-83db-497f-956d-a4e49f855721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost_56e25c19-f95c-41cc-8708-4f88f8ea3c75" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_d099f908-0c40-4ecc-bc18-58f189c55dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost_56e25c19-f95c-41cc-8708-4f88f8ea3c75" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_d099f908-0c40-4ecc-bc18-58f189c55dc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost_38ec537c-ea26-4591-80aa-559087341f68" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost_56e25c19-f95c-41cc-8708-4f88f8ea3c75" xlink:to="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost_38ec537c-ea26-4591-80aa-559087341f68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount_25a8e542-cadf-4fbe-9756-480ea1d80bb4" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_6f76700a-ac6a-48e5-aac4-79a14f1086d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount_25a8e542-cadf-4fbe-9756-480ea1d80bb4" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_6f76700a-ac6a-48e5-aac4-79a14f1086d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e9e88a33-aef2-4d91-a72e-1328e6220821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount_25a8e542-cadf-4fbe-9756-480ea1d80bb4" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e9e88a33-aef2-4d91-a72e-1328e6220821" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsComponentsofNetInvestmentIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_bca76805-abdc-450e-941e-36f51ea6f7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue_04896123-d7e9-4eb8-9f31-62afe9bf8f21" xlink:href="ci-20230331.xsd#ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetInvestmentIncome_bca76805-abdc-450e-941e-36f51ea6f7cc" xlink:to="loc_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue_04896123-d7e9-4eb8-9f31-62afe9bf8f21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_6879eb0a-53b2-48a3-af5a-df6f412094d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetInvestmentIncome_bca76805-abdc-450e-941e-36f51ea6f7cc" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_6879eb0a-53b2-48a3-af5a-df6f412094d3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsRealizedGainsandLossesonInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLoss_b99b533f-18ab-4620-a0f3-4f2b8af22157" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal_456a9d43-aa7e-44da-91f9-0f8e4c8948f6" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_RealizedInvestmentGainLoss_b99b533f-18ab-4620-a0f3-4f2b8af22157" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal_456a9d43-aa7e-44da-91f9-0f8e4c8948f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ImpairmentsOnInvestmentsTotal_262578d9-3eba-427b-8f87-fb9d8dcd4e58" xlink:href="ci-20230331.xsd#ci_ImpairmentsOnInvestmentsTotal"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_RealizedInvestmentGainLoss_b99b533f-18ab-4620-a0f3-4f2b8af22157" xlink:to="loc_ci_ImpairmentsOnInvestmentsTotal_262578d9-3eba-427b-8f87-fb9d8dcd4e58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLossExcludingImpairments_edead3f7-e104-464b-b0cd-cce5ed474b73" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLossExcludingImpairments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_RealizedInvestmentGainLoss_b99b533f-18ab-4620-a0f3-4f2b8af22157" xlink:to="loc_ci_RealizedInvestmentGainLossExcludingImpairments_edead3f7-e104-464b-b0cd-cce5ed474b73" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3bbbfd38-f719-45a7-bfeb-4e8c39c516c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_84b2066d-e486-494c-a781-cacd06b0b36f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3bbbfd38-f719-45a7-bfeb-4e8c39c516c1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_84b2066d-e486-494c-a781-cacd06b0b36f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_0f9ad7ee-490f-404f-bb3e-ce306bc822ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3bbbfd38-f719-45a7-bfeb-4e8c39c516c1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_0f9ad7ee-490f-404f-bb3e-ce306bc822ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_83aa88c5-1951-4a61-b83a-854b19d0967f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_4d795861-4504-4eeb-b0e2-3ad37380e76a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_83aa88c5-1951-4a61-b83a-854b19d0967f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_4d795861-4504-4eeb-b0e2-3ad37380e76a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_690cadba-c616-40b4-9e7a-93789a167a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_83aa88c5-1951-4a61-b83a-854b19d0967f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_690cadba-c616-40b4-9e7a-93789a167a9b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_7d69eae7-cf2f-494c-a6ff-5bc3c7ebf6f0" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent_e5a2a05b-ab6c-4c82-8845-c454300ce6bc" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_7d69eae7-cf2f-494c-a6ff-5bc3c7ebf6f0" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent_e5a2a05b-ab6c-4c82-8845-c454300ce6bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_31089ecf-1a58-4b96-ae8d-becfd97f53db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_7d69eae7-cf2f-494c-a6ff-5bc3c7ebf6f0" xlink:to="loc_us-gaap_SeparateAccountAssets_31089ecf-1a58-4b96-ae8d-becfd97f53db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_04fb60d1-a733-4b76-bdbf-5b42ce1746ce" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_83806415-a6a7-4507-9087-1deaf78f09e1" xlink:href="ci-20230331.xsd#ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_04fb60d1-a733-4b76-bdbf-5b42ce1746ce" xlink:to="loc_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_83806415-a6a7-4507-9087-1deaf78f09e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_4c3d4dd0-9ba8-476d-82f8-276413b4117b" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_04fb60d1-a733-4b76-bdbf-5b42ce1746ce" xlink:to="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_4c3d4dd0-9ba8-476d-82f8-276413b4117b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_eccaefc4-e6ed-407b-bcd7-c8ab450125c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient_94e661c5-7da3-4f0e-8893-c3c4c488b0e3" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SeparateAccountAssets_eccaefc4-e6ed-407b-bcd7-c8ab450125c7" xlink:to="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient_94e661c5-7da3-4f0e-8893-c3c4c488b0e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy_d7d26232-6a3e-4992-8721-61cb88f175ae" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsClassifiedInFairValueHierarchy"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SeparateAccountAssets_eccaefc4-e6ed-407b-bcd7-c8ab450125c7" xlink:to="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy_d7d26232-6a3e-4992-8721-61cb88f175ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy_a33847d8-fb4e-4f94-86cc-db82294ed443" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsClassifiedInFairValueHierarchy"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy_1abe4ce6-bce6-4602-a62d-551a41db4367" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy_a33847d8-fb4e-4f94-86cc-db82294ed443" xlink:to="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy_1abe4ce6-bce6-4602-a62d-551a41db4367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GuaranteedSeparateAccountAssets_0e7dddef-4c3a-496e-a90f-8eefa8c40264" xlink:href="ci-20230331.xsd#ci_GuaranteedSeparateAccountAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy_a33847d8-fb4e-4f94-86cc-db82294ed443" xlink:to="loc_ci_GuaranteedSeparateAccountAssets_0e7dddef-4c3a-496e-a90f-8eefa8c40264" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails_1" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_4a5168cc-ec12-4086-9687-2c3c4c4cd2d2" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale_08eb650a-80e6-4735-8398-801db1e42b24" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_4a5168cc-ec12-4086-9687-2c3c4c4cd2d2" xlink:to="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale_08eb650a-80e6-4735-8398-801db1e42b24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_8d22b02f-f4e8-474a-9530-ca41d8b3caff" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_4a5168cc-ec12-4086-9687-2c3c4c4cd2d2" xlink:to="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_8d22b02f-f4e8-474a-9530-ca41d8b3caff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_7cd493b6-188a-4e2e-812b-70d1b768a3ee" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity_f6886fa2-ebad-48d3-8316-2dbfe51074ba" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_7cd493b6-188a-4e2e-812b-70d1b768a3ee" xlink:to="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity_f6886fa2-ebad-48d3-8316-2dbfe51074ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_244681a1-e174-4bf1-aa8c-a2d960379fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_7cd493b6-188a-4e2e-812b-70d1b768a3ee" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_244681a1-e174-4bf1-aa8c-a2d960379fe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e177d669-1a5c-456c-a166-8ce0b4e87181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TemporaryEquityOtherComprehensiveIncome_e7810e75-5fd9-4850-880b-905c4ae4f9c6" xlink:href="ci-20230331.xsd#ci_TemporaryEquityOtherComprehensiveIncome"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e177d669-1a5c-456c-a166-8ce0b4e87181" xlink:to="loc_ci_TemporaryEquityOtherComprehensiveIncome_e7810e75-5fd9-4850-880b-905c4ae4f9c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_be79bf48-09a9-43ba-8661-7b9b64f017d5" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e177d669-1a5c-456c-a166-8ce0b4e87181" xlink:to="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_be79bf48-09a9-43ba-8661-7b9b64f017d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity_f4bf6c0f-8e9d-4af9-9f4f-2c7ef3f3f8ff" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity_9b74054b-2b42-4121-b0f9-2832e9b773ca" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity_f4bf6c0f-8e9d-4af9-9f4f-2c7ef3f3f8ff" xlink:to="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity_9b74054b-2b42-4121-b0f9-2832e9b773ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity_79a80a29-24b4-40b7-8b46-b63176c53326" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity_f4bf6c0f-8e9d-4af9-9f4f-2c7ef3f3f8ff" xlink:to="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity_79a80a29-24b4-40b7-8b46-b63176c53326" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_12a8a907-2276-4273-b847-12f23e40e9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_89250104-c3d3-4dab-a2d1-e17c143f711b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_12a8a907-2276-4273-b847-12f23e40e9ab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_89250104-c3d3-4dab-a2d1-e17c143f711b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_3ed0d658-c434-478f-ab17-0ac8e86ba0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_12a8a907-2276-4273-b847-12f23e40e9ab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_3ed0d658-c434-478f-ab17-0ac8e86ba0ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_d8e9d48d-d85b-4c54-bcf7-94fac8810122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_8ce586f9-8317-4120-a9ac-36eaa4144a43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_d8e9d48d-d85b-4c54-bcf7-94fac8810122" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_8ce586f9-8317-4120-a9ac-36eaa4144a43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3f0a9b0c-7483-4843-8ae0-97861098e73a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_d8e9d48d-d85b-4c54-bcf7-94fac8810122" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3f0a9b0c-7483-4843-8ae0-97861098e73a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails_1" xlink:type="simple" xlink:href="ci-20230331.xsd#AccumulatedOtherComprehensiveIncomeLossDetails_1"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_de502ebe-36cd-414a-b9f2-23c5d0249957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8c68c996-4605-4c54-be13-cf950963cfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_de502ebe-36cd-414a-b9f2-23c5d0249957" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8c68c996-4605-4c54-be13-cf950963cfb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6f2e2d30-58b6-4c48-8688-3a3bc2e2c5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_de502ebe-36cd-414a-b9f2-23c5d0249957" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6f2e2d30-58b6-4c48-8688-3a3bc2e2c5ee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SegmentInformationSummaryofSpecialItemsDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity_84bb4f9a-5558-4a76-957a-e20e84d3083e" xlink:href="ci-20230331.xsd#ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TransactionRelatedCostsAfterTax_fc07da93-ef24-420b-ab1c-fd09ed40e39a" xlink:href="ci-20230331.xsd#ci_TransactionRelatedCostsAfterTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity_84bb4f9a-5558-4a76-957a-e20e84d3083e" xlink:to="loc_ci_TransactionRelatedCostsAfterTax_fc07da93-ef24-420b-ab1c-fd09ed40e39a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity_cacd5b41-fe50-4049-a23b-b7e66b4cec73" xlink:href="ci-20230331.xsd#ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TransactionRelatedCosts_5ee35527-5d91-4341-b4da-2ba0a86511a3" xlink:href="ci-20230331.xsd#ci_TransactionRelatedCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity_cacd5b41-fe50-4049-a23b-b7e66b4cec73" xlink:to="loc_ci_TransactionRelatedCosts_5ee35527-5d91-4341-b4da-2ba0a86511a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SegmentInformationSummarizedSegmentFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ddecdeb6-9ec0-4dde-8e47-491d80dff439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonInvestmentRevenue_60322c61-8f08-48bf-bbc5-eda3df9ba9fe" xlink:href="ci-20230331.xsd#ci_NonInvestmentRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_ddecdeb6-9ec0-4dde-8e47-491d80dff439" xlink:to="loc_ci_NonInvestmentRevenue_60322c61-8f08-48bf-bbc5-eda3df9ba9fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_ec927ab4-d245-4078-9700-911425b0bde4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_ddecdeb6-9ec0-4dde-8e47-491d80dff439" xlink:to="loc_us-gaap_NetInvestmentIncome_ec927ab4-d245-4078-9700-911425b0bde4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51d7c2d8-a703-41c6-a862-a91b038f2742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90e09539-36f2-4d7d-a3cf-d34aa3048389" xlink:href="ci-20230331.xsd#ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51d7c2d8-a703-41c6-a862-a91b038f2742" xlink:to="loc_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90e09539-36f2-4d7d-a3cf-d34aa3048389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries_7cb8740a-aaa1-43ec-860d-daa94d71f745" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51d7c2d8-a703-41c6-a862-a91b038f2742" xlink:to="loc_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries_7cb8740a-aaa1-43ec-860d-daa94d71f745" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax_e83846ea-4fbb-443c-baaf-848a69c89a63" xlink:href="ci-20230331.xsd#ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51d7c2d8-a703-41c6-a862-a91b038f2742" xlink:to="loc_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax_e83846ea-4fbb-443c-baaf-848a69c89a63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TransactionRelatedCosts_70826cb3-154d-49a5-8a88-04439aa0e8e0" xlink:href="ci-20230331.xsd#ci_TransactionRelatedCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51d7c2d8-a703-41c6-a862-a91b038f2742" xlink:to="loc_ci_TransactionRelatedCosts_70826cb3-154d-49a5-8a88-04439aa0e8e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_59b6ca1c-79ec-477a-89d5-5a19fffeeda0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_51d7c2d8-a703-41c6-a862-a91b038f2742" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_59b6ca1c-79ec-477a-89d5-5a19fffeeda0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SegmentRevenues_07cccb81-63a7-48c0-808b-7aabb51d0bf1" xlink:href="ci-20230331.xsd#ci_SegmentRevenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e7463572-f2ea-4f5e-83fb-510daf68a98c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_SegmentRevenues_07cccb81-63a7-48c0-808b-7aabb51d0bf1" xlink:to="loc_us-gaap_Revenues_e7463572-f2ea-4f5e-83fb-510daf68a98c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainsLossesEquityMethodInvestments_55d88037-5e7a-4279-8ad3-4ac4edd81bc6" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainsLossesEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_SegmentRevenues_07cccb81-63a7-48c0-808b-7aabb51d0bf1" xlink:to="loc_ci_RealizedInvestmentGainsLossesEquityMethodInvestments_55d88037-5e7a-4279-8ad3-4ac4edd81bc6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SegmentInformationRevenuefromExternalCustomersDetails"/>
  <link:calculationLink xlink:role="http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonInvestmentRevenue_7ab75b59-25e8-4a75-8ae9-9b50f0634434" xlink:href="ci-20230331.xsd#ci_NonInvestmentRevenue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_d492d42f-5be3-424a-b218-06e4769b8797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_NonInvestmentRevenue_7ab75b59-25e8-4a75-8ae9-9b50f0634434" xlink:to="loc_us-gaap_PremiumsEarnedNet_d492d42f-5be3-424a-b218-06e4769b8797" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b9646417-b13e-4f0c-9178-392388333b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ci_NonInvestmentRevenue_7ab75b59-25e8-4a75-8ae9-9b50f0634434" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b9646417-b13e-4f0c-9178-392388333b59" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>ci-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:aba5d1e1-3c5d-49dc-8b95-aefd0f7f3078,g:b4e2c703-69a2-450e-a66f-edc6453c1c81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedStatementsofIncome"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome" xlink:type="extended" id="ib06b00d54e974c04bceed2c69d794a59_ConsolidatedStatementsofIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_bbb84709-a493-433b-8fae-07c90d8fbd58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_RevenuesAbstract_bbb84709-a493-433b-8fae-07c90d8fbd58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4c7112e-27e0-4205-8f4f-1a394e7bbe92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_bbb84709-a493-433b-8fae-07c90d8fbd58" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4c7112e-27e0-4205-8f4f-1a394e7bbe92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_99669bf1-89a5-4b1b-baa0-0f7b28ec0479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_bbb84709-a493-433b-8fae-07c90d8fbd58" xlink:to="loc_us-gaap_PremiumsEarnedNet_99669bf1-89a5-4b1b-baa0-0f7b28ec0479" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_21fe52a3-f731-4f41-b488-6da4b191c403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_bbb84709-a493-433b-8fae-07c90d8fbd58" xlink:to="loc_us-gaap_NetInvestmentIncome_21fe52a3-f731-4f41-b488-6da4b191c403" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4ac83a85-e507-4ff0-9dc5-8838912aa23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_bbb84709-a493-433b-8fae-07c90d8fbd58" xlink:to="loc_us-gaap_Revenues_4ac83a85-e507-4ff0-9dc5-8838912aa23f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_85f9b45a-4340-4e43-8cd0-06c68523f494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_85f9b45a-4340-4e43-8cd0-06c68523f494" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_8fe73eda-8db6-4ece-b130-fb6d800595d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_8fe73eda-8db6-4ece-b130-fb6d800595d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7d32c276-6927-4edc-a6b1-72d0081ba17f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7d32c276-6927-4edc-a6b1-72d0081ba17f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8e884d93-eafc-4064-9756-b620b5a3d557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8e884d93-eafc-4064-9756-b620b5a3d557" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_c4feead7-4340-471b-9fb2-e7900f4f4346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_c4feead7-4340-471b-9fb2-e7900f4f4346" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fc4634d5-bdfe-4e07-a954-1701cda4ece0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_OperatingIncomeLoss_fc4634d5-bdfe-4e07-a954-1701cda4ece0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9d6eb46b-d280-46e5-b9f9-f72eec7c181f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9d6eb46b-d280-46e5-b9f9-f72eec7c181f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLoss_bfbcb991-3321-47a7-8344-733ba1cba042" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_ci_RealizedInvestmentGainLoss_bfbcb991-3321-47a7-8344-733ba1cba042" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_532a1de0-1f3f-40d7-9f5e-91a37c7510fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_532a1de0-1f3f-40d7-9f5e-91a37c7510fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b5a58cbe-ca1f-4938-83ab-8d0ae401d995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b5a58cbe-ca1f-4938-83ab-8d0ae401d995" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_46e65a25-8582-419d-8106-160a1a77b1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_ProfitLoss_46e65a25-8582-419d-8106-160a1a77b1f3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09ecf1ae-c86b-4e4c-850b-715bcb85ae8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09ecf1ae-c86b-4e4c-850b-715bcb85ae8e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_de3c1ab8-0356-479d-8a22-19bd353d669a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_de3c1ab8-0356-479d-8a22-19bd353d669a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_29e16a29-b667-4c86-a3dd-7ce779f055ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_EarningsPerShareAbstract_29e16a29-b667-4c86-a3dd-7ce779f055ce" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_108ac7c4-72f1-40fa-b3fd-4343d39d2492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_29e16a29-b667-4c86-a3dd-7ce779f055ce" xlink:to="loc_us-gaap_EarningsPerShareBasic_108ac7c4-72f1-40fa-b3fd-4343d39d2492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_393a8208-87ab-4bd3-8409-7c8bf0a79a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_29e16a29-b667-4c86-a3dd-7ce779f055ce" xlink:to="loc_us-gaap_EarningsPerShareDiluted_393a8208-87ab-4bd3-8409-7c8bf0a79a1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5f5e7cdb-4e61-48ca-9d3f-80f023f40100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_StatementTable_5f5e7cdb-4e61-48ca-9d3f-80f023f40100" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c5846a00-2bdc-46ed-bbaf-9a967ced01bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5f5e7cdb-4e61-48ca-9d3f-80f023f40100" xlink:to="loc_srt_ProductOrServiceAxis_c5846a00-2bdc-46ed-bbaf-9a967ced01bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c5846a00-2bdc-46ed-bbaf-9a967ced01bb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c5846a00-2bdc-46ed-bbaf-9a967ced01bb" xlink:to="loc_srt_ProductsAndServicesDomain_c5846a00-2bdc-46ed-bbaf-9a967ced01bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6a18f449-ae02-4a13-a876-75353ad77e49" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c5846a00-2bdc-46ed-bbaf-9a967ced01bb" xlink:to="loc_srt_ProductsAndServicesDomain_6a18f449-ae02-4a13-a876-75353ad77e49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_72cd48d3-fb08-471d-bb85-fc05674200bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6a18f449-ae02-4a13-a876-75353ad77e49" xlink:to="loc_us-gaap_ProductMember_72cd48d3-fb08-471d-bb85-fc05674200bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_8273db28-f5ed-498b-a6e0-c682b562a6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6a18f449-ae02-4a13-a876-75353ad77e49" xlink:to="loc_us-gaap_ServiceMember_8273db28-f5ed-498b-a6e0-c682b562a6d5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedStatementsofChangesinTotalEquity"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity" xlink:type="extended" id="i9d6f29ce3fb240f1bedb3615bbf72645_ConsolidatedStatementsofChangesinTotalEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ad4d46c6-49fb-42a8-8237-b6f84a50fdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad4d46c6-49fb-42a8-8237-b6f84a50fdcd" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a3a0de78-19fb-4633-b36a-74f9da419b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a3a0de78-19fb-4633-b36a-74f9da419b9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_687080aa-d70f-49a4-9936-bb2aae41ca76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_687080aa-d70f-49a4-9936-bb2aae41ca76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_75ee0997-2df2-4247-833b-3f8a44e15c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_75ee0997-2df2-4247-833b-3f8a44e15c5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_1135185e-4b24-44f4-99a1-313293c4e62d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_1135185e-4b24-44f4-99a1-313293c4e62d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_0347299e-322e-4a30-baf9-4d3cc9d6e0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_DividendsCommonStockCash_0347299e-322e-4a30-baf9-4d3cc9d6e0ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_60074f19-fbd6-4e54-a9d2-d961f5630dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_60074f19-fbd6-4e54-a9d2-d961f5630dbb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NoncontrollingInterestOtherChanges_f6e62bae-17ea-4ba9-b4b0-7c43de01f2a8" xlink:href="ci-20230331.xsd#ci_NoncontrollingInterestOtherChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_ci_NoncontrollingInterestOtherChanges_f6e62bae-17ea-4ba9-b4b0-7c43de01f2a8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a1d4f213-fad1-4502-9963-d64a4a311192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad4d46c6-49fb-42a8-8237-b6f84a50fdcd" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3982608f-49df-400e-8154-4b94c7b0b88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3982608f-49df-400e-8154-4b94c7b0b88b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TemporaryEquityOtherComprehensiveIncome_cf792210-b124-4edf-88f5-8e757d8be80e" xlink:href="ci-20230331.xsd#ci_TemporaryEquityOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:to="loc_ci_TemporaryEquityOtherComprehensiveIncome_cf792210-b124-4edf-88f5-8e757d8be80e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_c76541c9-1e37-4d0e-852f-b5de8b23802e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_c76541c9-1e37-4d0e-852f-b5de8b23802e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityOtherChanges_0e744d76-69b0-4f5f-bc3f-2d11277ee19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:to="loc_us-gaap_TemporaryEquityOtherChanges_0e744d76-69b0-4f5f-bc3f-2d11277ee19b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_c4dc91a9-53bb-4db7-a0f8-3c355b089383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_1005eb0f-0be6-48d0-b682-eda368375e58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad4d46c6-49fb-42a8-8237-b6f84a50fdcd" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_1005eb0f-0be6-48d0-b682-eda368375e58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4a915954-1d3a-45d2-b073-55d0351aa9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ad4d46c6-49fb-42a8-8237-b6f84a50fdcd" xlink:to="loc_us-gaap_StatementTable_4a915954-1d3a-45d2-b073-55d0351aa9ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1a6f1504-5559-48b3-906d-6a09e2ebc91d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4a915954-1d3a-45d2-b073-55d0351aa9ae" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1a6f1504-5559-48b3-906d-6a09e2ebc91d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1a6f1504-5559-48b3-906d-6a09e2ebc91d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1a6f1504-5559-48b3-906d-6a09e2ebc91d" xlink:to="loc_us-gaap_EquityComponentDomain_1a6f1504-5559-48b3-906d-6a09e2ebc91d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d58d3a00-fa63-45de-8857-19675c619e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1a6f1504-5559-48b3-906d-6a09e2ebc91d" xlink:to="loc_us-gaap_EquityComponentDomain_d58d3a00-fa63-45de-8857-19675c619e2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d58d3a00-fa63-45de-8857-19675c619e2c" xlink:to="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6e63733a-3170-408f-adae-88a4b4e1e17b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:to="loc_us-gaap_CommonStockMember_6e63733a-3170-408f-adae-88a4b4e1e17b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_cb2ca65c-92d7-4609-8b5b-66176d1f01c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_cb2ca65c-92d7-4609-8b5b-66176d1f01c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b12e499d-e92f-4bb7-8028-209205ad7947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b12e499d-e92f-4bb7-8028-209205ad7947" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1f505282-3cef-4b9c-84c1-4e73be82e37f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:to="loc_us-gaap_RetainedEarningsMember_1f505282-3cef-4b9c-84c1-4e73be82e37f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7c77aab5-39b6-43e6-ab86-940a6ec2ffb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:to="loc_us-gaap_TreasuryStockMember_7c77aab5-39b6-43e6-ab86-940a6ec2ffb1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_d1626aa5-65ab-4c97-84de-7a850225be3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d58d3a00-fa63-45de-8857-19675c619e2c" xlink:to="loc_us-gaap_NoncontrollingInterestMember_d1626aa5-65ab-4c97-84de-7a850225be3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_84382d7f-e745-4f74-a169-66adc894aedc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4a915954-1d3a-45d2-b073-55d0351aa9ae" xlink:to="loc_srt_RestatementAxis_84382d7f-e745-4f74-a169-66adc894aedc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_84382d7f-e745-4f74-a169-66adc894aedc_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_84382d7f-e745-4f74-a169-66adc894aedc" xlink:to="loc_srt_RestatementDomain_84382d7f-e745-4f74-a169-66adc894aedc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c55ec9fd-3e08-41e3-b103-7c9e8848903b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_84382d7f-e745-4f74-a169-66adc894aedc" xlink:to="loc_srt_RestatementDomain_c55ec9fd-3e08-41e3-b103-7c9e8848903b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_b3f2ddd3-95d5-478c-aed9-805773776c77" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_c55ec9fd-3e08-41e3-b103-7c9e8848903b" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_b3f2ddd3-95d5-478c-aed9-805773776c77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_58be68e4-a97d-4b0e-9792-e4ed6a6324ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_c55ec9fd-3e08-41e3-b103-7c9e8848903b" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_58be68e4-a97d-4b0e-9792-e4ed6a6324ce" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/DescriptionofBusinessDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#DescriptionofBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/DescriptionofBusinessDetails" xlink:type="extended" id="i778523edb1b34218b7dd777ea1d6f2ae_DescriptionofBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_295b7978-2a90-4c45-bd2f-d933f7c22a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_bd78511d-9334-4800-b221-67e4f4442085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_295b7978-2a90-4c45-bd2f-d933f7c22a54" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_bd78511d-9334-4800-b221-67e4f4442085" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_20926d82-c759-4346-ae9a-9787c1ab0257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_295b7978-2a90-4c45-bd2f-d933f7c22a54" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_20926d82-c759-4346-ae9a-9787c1ab0257" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2c98e77d-59d6-4756-9201-c9d352e36d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_20926d82-c759-4346-ae9a-9787c1ab0257" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2c98e77d-59d6-4756-9201-c9d352e36d2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2c98e77d-59d6-4756-9201-c9d352e36d2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2c98e77d-59d6-4756-9201-c9d352e36d2b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2c98e77d-59d6-4756-9201-c9d352e36d2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b465423-dc9d-46b6-9a9a-b6993cc0054a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2c98e77d-59d6-4756-9201-c9d352e36d2b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b465423-dc9d-46b6-9a9a-b6993cc0054a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_8527d3e5-43ce-4e61-b740-e04933acd028" xlink:href="ci-20230331.xsd#ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b465423-dc9d-46b6-9a9a-b6993cc0054a" xlink:to="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_8527d3e5-43ce-4e61-b740-e04933acd028" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember_6dcbe68d-6b07-4897-a232-5cc70669b384" xlink:href="ci-20230331.xsd#ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_8527d3e5-43ce-4e61-b740-e04933acd028" xlink:to="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember_6dcbe68d-6b07-4897-a232-5cc70669b384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_0799f071-df91-4cde-addd-8d4d78b77b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_20926d82-c759-4346-ae9a-9787c1ab0257" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_0799f071-df91-4cde-addd-8d4d78b77b7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0799f071-df91-4cde-addd-8d4d78b77b7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_0799f071-df91-4cde-addd-8d4d78b77b7c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0799f071-df91-4cde-addd-8d4d78b77b7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1563d3ee-b9ec-484f-a9f4-792e837b4d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_0799f071-df91-4cde-addd-8d4d78b77b7c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1563d3ee-b9ec-484f-a9f4-792e837b4d9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_11524a60-26b7-486d-bffb-12415693d312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1563d3ee-b9ec-484f-a9f4-792e837b4d9c" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_11524a60-26b7-486d-bffb-12415693d312" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_459489cc-5f7b-4a49-bb3b-4f9bd3a85970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1563d3ee-b9ec-484f-a9f4-792e837b4d9c" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_459489cc-5f7b-4a49-bb3b-4f9bd3a85970" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_713d82b0-7a95-4934-afc6-37f39183da92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_20926d82-c759-4346-ae9a-9787c1ab0257" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_713d82b0-7a95-4934-afc6-37f39183da92" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_713d82b0-7a95-4934-afc6-37f39183da92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_713d82b0-7a95-4934-afc6-37f39183da92" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_713d82b0-7a95-4934-afc6-37f39183da92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_be650def-d729-41dd-bc26-3ed299a7358a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_713d82b0-7a95-4934-afc6-37f39183da92" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_be650def-d729-41dd-bc26-3ed299a7358a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3165477e-9d17-417d-9ded-7492941d0dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_be650def-d729-41dd-bc26-3ed299a7358a" xlink:to="loc_us-gaap_SubsequentEventMember_3165477e-9d17-417d-9ded-7492941d0dee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended" id="i3498dd26fb5c49eba82d788a9c6f0eba_SummaryofSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3b52123f-99e2-4d8d-9a52-10c43234a763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3b52123f-99e2-4d8d-9a52-10c43234a763" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_eef4c443-e425-4574-becd-6cc2c24d07a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_eef4c443-e425-4574-becd-6cc2c24d07a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bd66f780-e621-4ead-ab55-9cf07fd2cb99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bd66f780-e621-4ead-ab55-9cf07fd2cb99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_10cac73f-9246-4a11-a8a0-2b24861041c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_10cac73f-9246-4a11-a8a0-2b24861041c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7516a2b3-92b2-4561-b637-8a78945a94cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7516a2b3-92b2-4561-b637-8a78945a94cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_b0b6f9d4-9f14-4501-abde-6d9997b64bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_b0b6f9d4-9f14-4501-abde-6d9997b64bb9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_ff724b2a-6819-4872-8bbc-1e7e989bc6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_ff724b2a-6819-4872-8bbc-1e7e989bc6dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9ac48b0d-8010-4343-8104-8f4e7f38f591" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:to="loc_srt_ProductOrServiceAxis_9ac48b0d-8010-4343-8104-8f4e7f38f591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9ac48b0d-8010-4343-8104-8f4e7f38f591_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9ac48b0d-8010-4343-8104-8f4e7f38f591" xlink:to="loc_srt_ProductsAndServicesDomain_9ac48b0d-8010-4343-8104-8f4e7f38f591_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c651a4ab-c05a-4672-b3bc-49de718ba721" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9ac48b0d-8010-4343-8104-8f4e7f38f591" xlink:to="loc_srt_ProductsAndServicesDomain_c651a4ab-c05a-4672-b3bc-49de718ba721" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmacyBenefitsManagementServicesMember_55347c81-e9be-43a2-b6ee-ca2aaa292959" xlink:href="ci-20230331.xsd#ci_PharmacyBenefitsManagementServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c651a4ab-c05a-4672-b3bc-49de718ba721" xlink:to="loc_ci_PharmacyBenefitsManagementServicesMember_55347c81-e9be-43a2-b6ee-ca2aaa292959" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AdministrativeServicesOnlyHealthCareServicesMember_8912972c-7099-4fa5-916b-a34ed686b15e" xlink:href="ci-20230331.xsd#ci_AdministrativeServicesOnlyHealthCareServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c651a4ab-c05a-4672-b3bc-49de718ba721" xlink:to="loc_ci_AdministrativeServicesOnlyHealthCareServicesMember_8912972c-7099-4fa5-916b-a34ed686b15e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_195d8661-0910-4fa5-858e-b849479a7e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_195d8661-0910-4fa5-858e-b849479a7e9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_195d8661-0910-4fa5-858e-b849479a7e9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_195d8661-0910-4fa5-858e-b849479a7e9b" xlink:to="loc_us-gaap_LossContingencyNatureDomain_195d8661-0910-4fa5-858e-b849479a7e9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_cd7ca670-67d7-46ca-b0aa-8549c480dccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_195d8661-0910-4fa5-858e-b849479a7e9b" xlink:to="loc_us-gaap_LossContingencyNatureDomain_cd7ca670-67d7-46ca-b0aa-8549c480dccf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceGuaranteeMember_1aa7c2bc-eb38-4e37-8ee7-47631a3e9d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceGuaranteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_cd7ca670-67d7-46ca-b0aa-8549c480dccf" xlink:to="loc_us-gaap_PerformanceGuaranteeMember_1aa7c2bc-eb38-4e37-8ee7-47631a3e9d97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesMember_21e620b3-12ab-4a29-8e18-0810354c6ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_cd7ca670-67d7-46ca-b0aa-8549c480dccf" xlink:to="loc_us-gaap_GuaranteesMember_21e620b3-12ab-4a29-8e18-0810354c6ee0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0d26a03d-34fb-4bc4-94fd-2c523fefd762" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0d26a03d-34fb-4bc4-94fd-2c523fefd762" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0d26a03d-34fb-4bc4-94fd-2c523fefd762_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0d26a03d-34fb-4bc4-94fd-2c523fefd762" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0d26a03d-34fb-4bc4-94fd-2c523fefd762_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9185688f-c771-44c9-9d7a-492b80a10830" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0d26a03d-34fb-4bc4-94fd-2c523fefd762" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9185688f-c771-44c9-9d7a-492b80a10830" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bdbe4e5f-dabd-454d-95ce-846ce58a0c52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9185688f-c771-44c9-9d7a-492b80a10830" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bdbe4e5f-dabd-454d-95ce-846ce58a0c52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_4b6700ee-e1c6-4fb8-9c2f-fda1125d0fb8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:to="loc_srt_RestatementAxis_4b6700ee-e1c6-4fb8-9c2f-fda1125d0fb8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_4b6700ee-e1c6-4fb8-9c2f-fda1125d0fb8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_4b6700ee-e1c6-4fb8-9c2f-fda1125d0fb8" xlink:to="loc_srt_RestatementDomain_4b6700ee-e1c6-4fb8-9c2f-fda1125d0fb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_40334730-27e3-4257-a8cb-b005005e67fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_4b6700ee-e1c6-4fb8-9c2f-fda1125d0fb8" xlink:to="loc_srt_RestatementDomain_40334730-27e3-4257-a8cb-b005005e67fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_f3822a64-7be5-4f89-98c2-957d56db4326" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_40334730-27e3-4257-a8cb-b005005e67fe" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_f3822a64-7be5-4f89-98c2-957d56db4326" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#MergersAcquisitionsandDivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails" xlink:type="extended" id="i9b2f1782e1db463b8ce555f9336e6e92_MergersAcquisitionsandDivestituresNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f25e3dbd-d16b-4b38-873e-5e1db84de569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f25e3dbd-d16b-4b38-873e-5e1db84de569" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7f106051-0654-470a-b174-bb7958f3a7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7f106051-0654-470a-b174-bb7958f3a7db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_71af8d39-e132-4ecb-9eef-2b759240cea1" xlink:href="ci-20230331.xsd#ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:to="loc_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_71af8d39-e132-4ecb-9eef-2b759240cea1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_a2217649-5e76-43c3-8b1d-69eb26434f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_a2217649-5e76-43c3-8b1d-69eb26434f93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax_de2fa375-a598-4ad4-8986-30381b85eb3b" xlink:href="ci-20230331.xsd#ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:to="loc_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax_de2fa375-a598-4ad4-8986-30381b85eb3b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b48c8893-04ad-4c23-b3c6-d593c50560f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b48c8893-04ad-4c23-b3c6-d593c50560f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bb8c13e-80fd-4ea2-9f41-4eff1db90b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b48c8893-04ad-4c23-b3c6-d593c50560f4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bb8c13e-80fd-4ea2-9f41-4eff1db90b27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6bb8c13e-80fd-4ea2-9f41-4eff1db90b27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bb8c13e-80fd-4ea2-9f41-4eff1db90b27" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6bb8c13e-80fd-4ea2-9f41-4eff1db90b27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_607121ab-539b-40dc-9a72-61529ff0b7be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bb8c13e-80fd-4ea2-9f41-4eff1db90b27" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_607121ab-539b-40dc-9a72-61529ff0b7be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_USGroupDisabilityAndLifeInsuranceBusinessMember_00afab5b-0d7b-42ab-b49a-be56321ba928" xlink:href="ci-20230331.xsd#ci_USGroupDisabilityAndLifeInsuranceBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_607121ab-539b-40dc-9a72-61529ff0b7be" xlink:to="loc_ci_USGroupDisabilityAndLifeInsuranceBusinessMember_00afab5b-0d7b-42ab-b49a-be56321ba928" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_412c85cd-713a-4bdc-971e-647b3588dff7" xlink:href="ci-20230331.xsd#ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_607121ab-539b-40dc-9a72-61529ff0b7be" xlink:to="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_412c85cd-713a-4bdc-971e-647b3588dff7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember_ac1219d8-4bfe-4e60-b7ea-eeb226df853f" xlink:href="ci-20230331.xsd#ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_412c85cd-713a-4bdc-971e-647b3588dff7" xlink:to="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember_ac1219d8-4bfe-4e60-b7ea-eeb226df853f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_fc4dac6c-da5e-411b-885e-fea1844803cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b48c8893-04ad-4c23-b3c6-d593c50560f4" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_fc4dac6c-da5e-411b-885e-fea1844803cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fc4dac6c-da5e-411b-885e-fea1844803cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_fc4dac6c-da5e-411b-885e-fea1844803cc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fc4dac6c-da5e-411b-885e-fea1844803cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fa29e5ed-a69d-4203-8a6e-75b152b3149a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_fc4dac6c-da5e-411b-885e-fea1844803cc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fa29e5ed-a69d-4203-8a6e-75b152b3149a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_37e7e0d3-8746-43f0-a5a2-f7ac37a3a42b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fa29e5ed-a69d-4203-8a6e-75b152b3149a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_37e7e0d3-8746-43f0-a5a2-f7ac37a3a42b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails" xlink:type="extended" id="i2e8d3da0c6154d25b0f08d9c6a533738_EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_305eb39c-202a-48b0-a2e3-bf4c1a535f99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bdc2ab7d-e125-4cd8-8523-4e9ab915263b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_305eb39c-202a-48b0-a2e3-bf4c1a535f99" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bdc2ab7d-e125-4cd8-8523-4e9ab915263b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea7bb7e7-8ce9-45d0-8970-444176f1f41d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_305eb39c-202a-48b0-a2e3-bf4c1a535f99" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea7bb7e7-8ce9-45d0-8970-444176f1f41d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53631b39-7b67-407f-9000-ccbf18ab949c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea7bb7e7-8ce9-45d0-8970-444176f1f41d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53631b39-7b67-407f-9000-ccbf18ab949c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_53631b39-7b67-407f-9000-ccbf18ab949c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53631b39-7b67-407f-9000-ccbf18ab949c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_53631b39-7b67-407f-9000-ccbf18ab949c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c3c75a5a-bb26-4bc2-902a-44d16fe888a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53631b39-7b67-407f-9000-ccbf18ab949c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c3c75a5a-bb26-4bc2-902a-44d16fe888a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9d26de1b-07e7-4e82-9b98-edddd36f611b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c3c75a5a-bb26-4bc2-902a-44d16fe888a3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9d26de1b-07e7-4e82-9b98-edddd36f611b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#DebtOutstandingAmountsofDebtandFinanceLeasesDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails" xlink:type="extended" id="id37225f0b07542a7b4e7eac2bb41b8ec_DebtOutstandingAmountsofDebtandFinanceLeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2afc6a0e-9587-45e3-80ad-5a328af3c22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrentAbstract_49a54349-8fdc-4cf6-9c58-e437526fc202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2afc6a0e-9587-45e3-80ad-5a328af3c22c" xlink:to="loc_us-gaap_DebtCurrentAbstract_49a54349-8fdc-4cf6-9c58-e437526fc202" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_776ff385-d383-445a-99d7-3f2716e6f359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtCurrentAbstract_49a54349-8fdc-4cf6-9c58-e437526fc202" xlink:to="loc_us-gaap_CommercialPaper_776ff385-d383-445a-99d7-3f2716e6f359" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_51c0efff-2e5e-4ee2-a7d5-5ec5fb93e8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtCurrentAbstract_49a54349-8fdc-4cf6-9c58-e437526fc202" xlink:to="loc_us-gaap_LongTermDebtCurrent_51c0efff-2e5e-4ee2-a7d5-5ec5fb93e8ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent_010e829d-d797-4f6f-b04d-8577372bccdf" xlink:href="ci-20230331.xsd#ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtCurrentAbstract_49a54349-8fdc-4cf6-9c58-e437526fc202" xlink:to="loc_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent_010e829d-d797-4f6f-b04d-8577372bccdf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_911a9f26-135d-4b6f-a253-bf2ca189a17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtCurrentAbstract_49a54349-8fdc-4cf6-9c58-e437526fc202" xlink:to="loc_us-gaap_DebtCurrent_911a9f26-135d-4b6f-a253-bf2ca189a17d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract_39c3ec6f-04ad-4e3c-a180-1535c496a192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2afc6a0e-9587-45e3-80ad-5a328af3c22c" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract_39c3ec6f-04ad-4e3c-a180-1535c496a192" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f1216d5b-a26a-4ce7-b342-33414d758368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract_39c3ec6f-04ad-4e3c-a180-1535c496a192" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f1216d5b-a26a-4ce7-b342-33414d758368" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_72f2dd7e-d657-4b6a-9f56-1d68b1596844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract_39c3ec6f-04ad-4e3c-a180-1535c496a192" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_72f2dd7e-d657-4b6a-9f56-1d68b1596844" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_39719762-b29c-4928-9609-365df22e87be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract_39c3ec6f-04ad-4e3c-a180-1535c496a192" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_39719762-b29c-4928-9609-365df22e87be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_45df8519-235e-4d05-987d-70cc8de1cbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2afc6a0e-9587-45e3-80ad-5a328af3c22c" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_45df8519-235e-4d05-987d-70cc8de1cbb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f747e70b-0692-43d1-b9e5-7b4330572ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2afc6a0e-9587-45e3-80ad-5a328af3c22c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f747e70b-0692-43d1-b9e5-7b4330572ff5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_97d5c3ac-7b8b-467e-b3b8-a007b153571e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2afc6a0e-9587-45e3-80ad-5a328af3c22c" xlink:to="loc_us-gaap_DebtInstrumentTable_97d5c3ac-7b8b-467e-b3b8-a007b153571e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_37850adb-883c-42c0-aead-55d4dba0fe18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_97d5c3ac-7b8b-467e-b3b8-a007b153571e" xlink:to="loc_us-gaap_DebtInstrumentAxis_37850adb-883c-42c0-aead-55d4dba0fe18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_37850adb-883c-42c0-aead-55d4dba0fe18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_37850adb-883c-42c0-aead-55d4dba0fe18" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_37850adb-883c-42c0-aead-55d4dba0fe18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_37850adb-883c-42c0-aead-55d4dba0fe18" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2022305InterestMember_116bef80-9c70-4d10-a2a3-d3a754b4a742" xlink:href="ci-20230331.xsd#ci_NotesDue2022305InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2022305InterestMember_116bef80-9c70-4d10-a2a3-d3a754b4a742" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue202383InterestMember_59421bf0-88fc-4f48-bfb9-de3ade54f862" xlink:href="ci-20230331.xsd#ci_NotesDue202383InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue202383InterestMember_59421bf0-88fc-4f48-bfb9-de3ade54f862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2023765InterestMember_c4a80ba0-ce96-48cc-aef3-5febc89b6ba7" xlink:href="ci-20230331.xsd#ci_NotesDue2023765InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2023765InterestMember_c4a80ba0-ce96-48cc-aef3-5febc89b6ba7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2023FloatingRateInterestMember_67ad5d2d-6104-4f83-bfbd-3113b03c9a4e" xlink:href="ci-20230331.xsd#ci_NotesDue2023FloatingRateInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2023FloatingRateInterestMember_67ad5d2d-6104-4f83-bfbd-3113b03c9a4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20233InterestMember_b83b576d-e9fe-4002-be81-8348c3039055" xlink:href="ci-20230331.xsd#ci_NotesDue20233InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20233InterestMember_b83b576d-e9fe-4002-be81-8348c3039055" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2023375InterestMember_201a1bf1-dda1-4047-93ec-143633f9159b" xlink:href="ci-20230331.xsd#ci_NotesDue2023375InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2023375InterestMember_201a1bf1-dda1-4047-93ec-143633f9159b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2024613InterestMember_a99b4d38-1990-4573-91a0-f4a58f176b94" xlink:href="ci-20230331.xsd#ci_NotesDue2024613InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2024613InterestMember_a99b4d38-1990-4573-91a0-f4a58f176b94" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue202435InterestMember_e8d2e80a-b679-40fb-ace3-93c710425057" xlink:href="ci-20230331.xsd#ci_NotesDue202435InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue202435InterestMember_e8d2e80a-b679-40fb-ace3-93c710425057" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2025325InterestMember_32ad86ab-c2e7-4154-8dd6-978b8abed590" xlink:href="ci-20230331.xsd#ci_NotesDue2025325InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2025325InterestMember_32ad86ab-c2e7-4154-8dd6-978b8abed590" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20254125InterestMember_268e2b2d-c3b3-48bc-844a-35cc075c2a41" xlink:href="ci-20230331.xsd#ci_NotesDue20254125InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20254125InterestMember_268e2b2d-c3b3-48bc-844a-35cc075c2a41" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue202645InterestMember_2ff00499-e62c-4627-9e70-98cb8cad4567" xlink:href="ci-20230331.xsd#ci_NotesDue202645InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue202645InterestMember_2ff00499-e62c-4627-9e70-98cb8cad4567" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2026125Member_6d975424-ad14-4eb6-a07b-ab032ab870c1" xlink:href="ci-20230331.xsd#ci_NotesDue2026125Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2026125Member_6d975424-ad14-4eb6-a07b-ab032ab870c1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20265685Member_46a692a6-269e-4b97-9198-2179c3b58b81" xlink:href="ci-20230331.xsd#ci_NotesDue20265685Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20265685Member_46a692a6-269e-4b97-9198-2179c3b58b81" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue202734InterestMember_d4dcd179-8de9-4b63-b162-882c6a23ff5f" xlink:href="ci-20230331.xsd#ci_NotesDue202734InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue202734InterestMember_d4dcd179-8de9-4b63-b162-882c6a23ff5f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebenturesDue20277875InterestMember_7dcca031-7d52-494e-b4d0-33e611358f7b" xlink:href="ci-20230331.xsd#ci_DebenturesDue20277875InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_DebenturesDue20277875InterestMember_7dcca031-7d52-494e-b4d0-33e611358f7b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2027305Member_d0bbc4b1-cf4b-4188-bccb-e38add5b5b42" xlink:href="ci-20230331.xsd#ci_NotesDue2027305Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2027305Member_d0bbc4b1-cf4b-4188-bccb-e38add5b5b42" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20284375InterestMember_19e12408-23d0-4ca5-bf51-f15bdb7c9e8d" xlink:href="ci-20230331.xsd#ci_NotesDue20284375InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20284375InterestMember_19e12408-23d0-4ca5-bf51-f15bdb7c9e8d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue203024InterestMember_372572f6-e099-43b0-9709-7d8ef2d6e75a" xlink:href="ci-20230331.xsd#ci_NotesDue203024InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue203024InterestMember_372572f6-e099-43b0-9709-7d8ef2d6e75a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20312375InterestMember_9b26ce8e-3f35-433d-b3e0-7952e2a51d87" xlink:href="ci-20230331.xsd#ci_NotesDue20312375InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20312375InterestMember_9b26ce8e-3f35-433d-b3e0-7952e2a51d87" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_StepDownNotesDueJanuary2033Member_7ca9f447-b54f-4452-b320-393227072dd8" xlink:href="ci-20230331.xsd#ci_StepDownNotesDueJanuary2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_StepDownNotesDueJanuary2033Member_7ca9f447-b54f-4452-b320-393227072dd8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20335400InterestMember_59241c8b-8a65-4e52-a6b8-12d9c4575a1a" xlink:href="ci-20230331.xsd#ci_NotesDue20335400InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20335400InterestMember_59241c8b-8a65-4e52-a6b8-12d9c4575a1a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2036615InterestMember_0938990e-52a0-4f9c-8b6b-8f41b23c95d2" xlink:href="ci-20230331.xsd#ci_NotesDue2036615InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2036615InterestMember_0938990e-52a0-4f9c-8b6b-8f41b23c95d2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue203848InterestMember_28078d0c-52df-4871-8224-bf32d9fb35d0" xlink:href="ci-20230331.xsd#ci_NotesDue203848InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue203848InterestMember_28078d0c-52df-4871-8224-bf32d9fb35d0" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue204032InterestMember_ec3c0c8f-73a4-4886-a0d4-06431ccde319" xlink:href="ci-20230331.xsd#ci_NotesDue204032InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue204032InterestMember_ec3c0c8f-73a4-4886-a0d4-06431ccde319" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20415875InterestMember_ccf58647-7d35-4cb9-a8b6-9d3d793cfc91" xlink:href="ci-20230331.xsd#ci_NotesDue20415875InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20415875InterestMember_ccf58647-7d35-4cb9-a8b6-9d3d793cfc91" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20416125InterestMember_41b1852d-7736-4a14-aebf-499fa34f58d3" xlink:href="ci-20230331.xsd#ci_NotesDue20416125InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20416125InterestMember_41b1852d-7736-4a14-aebf-499fa34f58d3" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20425375InterestMember_e9e5631a-8852-45ea-afc1-a8183cd930e8" xlink:href="ci-20230331.xsd#ci_NotesDue20425375InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20425375InterestMember_e9e5631a-8852-45ea-afc1-a8183cd930e8" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue204648InterestMember_c6a90b38-2485-4ec9-8dde-c2459797bb5b" xlink:href="ci-20230331.xsd#ci_NotesDue204648InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue204648InterestMember_c6a90b38-2485-4ec9-8dde-c2459797bb5b" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20473875Member_03fb3e22-8e6b-4226-b1c2-a623b73d782a" xlink:href="ci-20230331.xsd#ci_NotesDue20473875Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20473875Member_03fb3e22-8e6b-4226-b1c2-a623b73d782a" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue204849InterestMember_523ed23c-3423-4bc8-900c-95e4e7595f9a" xlink:href="ci-20230331.xsd#ci_NotesDue204849InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue204849InterestMember_523ed23c-3423-4bc8-900c-95e4e7595f9a" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue205034InterestMember_b9561108-5d2a-4f5e-90c6-be9c322b0781" xlink:href="ci-20230331.xsd#ci_NotesDue205034InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue205034InterestMember_b9561108-5d2a-4f5e-90c6-be9c322b0781" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue205134InterestMember_f3011a4f-f683-40b8-a88c-a64449c63d62" xlink:href="ci-20230331.xsd#ci_NotesDue205134InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue205134InterestMember_f3011a4f-f683-40b8-a88c-a64449c63d62" xlink:type="arc" order="31"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#DebtDebtIssuancesandRedemptionsDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails" xlink:type="extended" id="ia8f9fb739ca440ea83c88dcd777f4d66_DebtDebtIssuancesandRedemptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_92bc9c3a-1a78-403f-8156-1cff125c9cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_92bc9c3a-1a78-403f-8156-1cff125c9cdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d66d5c4a-e18a-46ae-b6aa-4c81ee7e2900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d66d5c4a-e18a-46ae-b6aa-4c81ee7e2900" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees_e993ad05-e399-424e-84ac-dc0b5dbcfd65" xlink:href="ci-20230331.xsd#ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees_e993ad05-e399-424e-84ac-dc0b5dbcfd65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_b3edf444-161e-4ef5-a72f-148838270714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_b3edf444-161e-4ef5-a72f-148838270714" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_73cdd988-9aaf-4641-97b9-388acaf2e4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_73cdd988-9aaf-4641-97b9-388acaf2e4af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GainLossOnExtinguishmentOfDebtNetOfTax_3264fb90-bb12-4e8b-9674-8d52405d359f" xlink:href="ci-20230331.xsd#ci_GainLossOnExtinguishmentOfDebtNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_ci_GainLossOnExtinguishmentOfDebtNetOfTax_3264fb90-bb12-4e8b-9674-8d52405d359f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate_ab5421ac-a7e1-4f80-9d56-7223d30d1f1d" xlink:href="ci-20230331.xsd#ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate_ab5421ac-a7e1-4f80-9d56-7223d30d1f1d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5f2ae84a-106b-4b7c-b3da-fdb729cfeffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_us-gaap_DebtInstrumentTable_5f2ae84a-106b-4b7c-b3da-fdb729cfeffd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1637353e-d852-475a-8d7f-1754ee599b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5f2ae84a-106b-4b7c-b3da-fdb729cfeffd" xlink:to="loc_us-gaap_DebtInstrumentAxis_1637353e-d852-475a-8d7f-1754ee599b4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1637353e-d852-475a-8d7f-1754ee599b4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1637353e-d852-475a-8d7f-1754ee599b4f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1637353e-d852-475a-8d7f-1754ee599b4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_921165ad-5442-4320-b1bb-88e400213638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1637353e-d852-475a-8d7f-1754ee599b4f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_921165ad-5442-4320-b1bb-88e400213638" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20265685Member_f4d6547b-e783-4a03-82bc-c2f2ed9c13d2" xlink:href="ci-20230331.xsd#ci_NotesDue20265685Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_921165ad-5442-4320-b1bb-88e400213638" xlink:to="loc_ci_NotesDue20265685Member_f4d6547b-e783-4a03-82bc-c2f2ed9c13d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20335400InterestMember_a3e00025-debb-4d9c-b403-10106fe3ad13" xlink:href="ci-20230331.xsd#ci_NotesDue20335400InterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_921165ad-5442-4320-b1bb-88e400213638" xlink:to="loc_ci_NotesDue20335400InterestMember_a3e00025-debb-4d9c-b403-10106fe3ad13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0746bceb-322e-409d-8d56-0bb6f24cc374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5f2ae84a-106b-4b7c-b3da-fdb729cfeffd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0746bceb-322e-409d-8d56-0bb6f24cc374" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0746bceb-322e-409d-8d56-0bb6f24cc374_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0746bceb-322e-409d-8d56-0bb6f24cc374" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0746bceb-322e-409d-8d56-0bb6f24cc374_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f245b11a-464c-497a-9977-d39add34fe17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0746bceb-322e-409d-8d56-0bb6f24cc374" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f245b11a-464c-497a-9977-d39add34fe17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3635b606-195c-446a-b0b1-1572adb301b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f245b11a-464c-497a-9977-d39add34fe17" xlink:to="loc_us-gaap_SeniorNotesMember_3635b606-195c-446a-b0b1-1572adb301b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_64882f5b-42ee-4702-8f5d-764ffaf95b76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5f2ae84a-106b-4b7c-b3da-fdb729cfeffd" xlink:to="loc_us-gaap_VariableRateAxis_64882f5b-42ee-4702-8f5d-764ffaf95b76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_64882f5b-42ee-4702-8f5d-764ffaf95b76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_64882f5b-42ee-4702-8f5d-764ffaf95b76" xlink:to="loc_us-gaap_VariableRateDomain_64882f5b-42ee-4702-8f5d-764ffaf95b76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b501ff96-3028-4fb2-ba27-922fd07fcfc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_64882f5b-42ee-4702-8f5d-764ffaf95b76" xlink:to="loc_us-gaap_VariableRateDomain_b501ff96-3028-4fb2-ba27-922fd07fcfc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember_b4132625-a1de-4109-80db-ab329b058984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b501ff96-3028-4fb2-ba27-922fd07fcfc0" xlink:to="loc_us-gaap_UsTreasuryUstInterestRateMember_b4132625-a1de-4109-80db-ab329b058984" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/DebtNarrativeDetails" xlink:type="extended" id="i164c4f23e2cb4edb85b5d7ec378b0796_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b5353ade-09b9-4e2f-9679-5a779a395c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b5353ade-09b9-4e2f-9679-5a779a395c42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_8247d695-ad22-4770-8185-0ea887689d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_us-gaap_DebtInstrumentTerm_8247d695-ad22-4770-8185-0ea887689d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtInstrumentExtensionTerm_d598d550-efc7-4490-9f28-d317872fd838" xlink:href="ci-20230331.xsd#ci_DebtInstrumentExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_DebtInstrumentExtensionTerm_d598d550-efc7-4490-9f28-d317872fd838" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LineOfCreditFacilityConversionToTermLoanTerm_a8c66046-4e49-4b03-bf97-30052c0a15c8" xlink:href="ci-20230331.xsd#ci_LineOfCreditFacilityConversionToTermLoanTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_LineOfCreditFacilityConversionToTermLoanTerm_a8c66046-4e49-4b03-bf97-30052c0a15c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_d5330e87-f52d-492a-923f-78d49369a015" xlink:href="ci-20230331.xsd#ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_d5330e87-f52d-492a-923f-78d49369a015" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_7007a1e4-d4fe-44b2-9a4f-6717e40865a6" xlink:href="ci-20230331.xsd#ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_7007a1e4-d4fe-44b2-9a4f-6717e40865a6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_adf88da7-9a41-4850-b6cf-b445c34a1aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_us-gaap_LineOfCredit_adf88da7-9a41-4850-b6cf-b445c34a1aaf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NumberOfRevolvingCreditFacility_d6b582e2-928b-45ed-8a3f-eaf8a3feb548" xlink:href="ci-20230331.xsd#ci_NumberOfRevolvingCreditFacility"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_NumberOfRevolvingCreditFacility_d6b582e2-928b-45ed-8a3f-eaf8a3feb548" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement_c8cc01ce-92c9-49f3-aa9a-a370cda0a11b" xlink:href="ci-20230331.xsd#ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement_c8cc01ce-92c9-49f3-aa9a-a370cda0a11b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant_bdb01c42-15d2-4892-8f05-73449c40a91e" xlink:href="ci-20230331.xsd#ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant_bdb01c42-15d2-4892-8f05-73449c40a91e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CommercialPaperAverageRatePaid_2c950d46-4301-41a8-a44f-62408cf100e0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CommercialPaperAverageRatePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_srt_CommercialPaperAverageRatePaid_2c950d46-4301-41a8-a44f-62408cf100e0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_1553f69a-e573-4d30-89d9-2f65ad1a9b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_us-gaap_InterestExpenseDebt_1553f69a-e573-4d30-89d9-2f65ad1a9b78" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9e38714f-7c18-47f4-bf7c-38bde86520a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_us-gaap_DebtInstrumentTable_9e38714f-7c18-47f4-bf7c-38bde86520a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_eb3eebc1-0f52-4a71-8dc0-e002ae085ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9e38714f-7c18-47f4-bf7c-38bde86520a8" xlink:to="loc_us-gaap_DebtInstrumentAxis_eb3eebc1-0f52-4a71-8dc0-e002ae085ca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eb3eebc1-0f52-4a71-8dc0-e002ae085ca7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_eb3eebc1-0f52-4a71-8dc0-e002ae085ca7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eb3eebc1-0f52-4a71-8dc0-e002ae085ca7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ae14d57f-1ec5-4a55-9be9-e1993aa92e72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_eb3eebc1-0f52-4a71-8dc0-e002ae085ca7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ae14d57f-1ec5-4a55-9be9-e1993aa92e72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditAgreementsApril2023Member_fde2cf52-b596-4cbc-870e-9f4bfbb696f2" xlink:href="ci-20230331.xsd#ci_RevolvingCreditAgreementsApril2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ae14d57f-1ec5-4a55-9be9-e1993aa92e72" xlink:to="loc_ci_RevolvingCreditAgreementsApril2023Member_fde2cf52-b596-4cbc-870e-9f4bfbb696f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member_77272873-b308-4273-8b27-19c8c719a645" xlink:href="ci-20230331.xsd#ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_RevolvingCreditAgreementsApril2023Member_fde2cf52-b596-4cbc-870e-9f4bfbb696f2" xlink:to="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member_77272873-b308-4273-8b27-19c8c719a645" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member_44b262eb-8dd7-417a-afed-2bb9876d9a2b" xlink:href="ci-20230331.xsd#ci_A364DayRevolvingCreditAgreementMaturingApril2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_RevolvingCreditAgreementsApril2023Member_fde2cf52-b596-4cbc-870e-9f4bfbb696f2" xlink:to="loc_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member_44b262eb-8dd7-417a-afed-2bb9876d9a2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_dcb30f49-f387-4dac-9fa8-4f9ecdccc1b9" xlink:href="ci-20230331.xsd#ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ae14d57f-1ec5-4a55-9be9-e1993aa92e72" xlink:to="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_dcb30f49-f387-4dac-9fa8-4f9ecdccc1b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member_d2c803c8-f004-4bd2-b219-b19ddcc049ea" xlink:href="ci-20230331.xsd#ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_dcb30f49-f387-4dac-9fa8-4f9ecdccc1b9" xlink:to="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member_d2c803c8-f004-4bd2-b219-b19ddcc049ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditFacilityMaturingApril2025Member_10c71780-bb79-4647-a5aa-b29392484f29" xlink:href="ci-20230331.xsd#ci_RevolvingCreditFacilityMaturingApril2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_dcb30f49-f387-4dac-9fa8-4f9ecdccc1b9" xlink:to="loc_ci_RevolvingCreditFacilityMaturingApril2025Member_10c71780-bb79-4647-a5aa-b29392484f29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member_302827c0-6722-4291-a7a2-c45f4373beef" xlink:href="ci-20230331.xsd#ci_A364DayRevolvingCreditAgreementMaturingApril2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_dcb30f49-f387-4dac-9fa8-4f9ecdccc1b9" xlink:to="loc_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member_302827c0-6722-4291-a7a2-c45f4373beef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5483854a-9e6d-4390-89d7-0e0c742c3b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9e38714f-7c18-47f4-bf7c-38bde86520a8" xlink:to="loc_us-gaap_CreditFacilityAxis_5483854a-9e6d-4390-89d7-0e0c742c3b24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5483854a-9e6d-4390-89d7-0e0c742c3b24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_5483854a-9e6d-4390-89d7-0e0c742c3b24" xlink:to="loc_us-gaap_CreditFacilityDomain_5483854a-9e6d-4390-89d7-0e0c742c3b24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_195b1976-7828-4149-871c-dd1ce676cccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_5483854a-9e6d-4390-89d7-0e0c742c3b24" xlink:to="loc_us-gaap_CreditFacilityDomain_195b1976-7828-4149-871c-dd1ce676cccf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_428f203a-fd9d-4bd8-8baf-b26f45e3b300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_195b1976-7828-4149-871c-dd1ce676cccf" xlink:to="loc_us-gaap_LetterOfCreditMember_428f203a-fd9d-4bd8-8baf-b26f45e3b300" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_1f8d2882-7ded-470c-aa71-d2c5fb29e384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_195b1976-7828-4149-871c-dd1ce676cccf" xlink:to="loc_us-gaap_CommercialPaperMember_1f8d2882-7ded-470c-aa71-d2c5fb29e384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_84c68084-a6ba-4d0d-b456-ebe16944d31e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9e38714f-7c18-47f4-bf7c-38bde86520a8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_84c68084-a6ba-4d0d-b456-ebe16944d31e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_84c68084-a6ba-4d0d-b456-ebe16944d31e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_84c68084-a6ba-4d0d-b456-ebe16944d31e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_84c68084-a6ba-4d0d-b456-ebe16944d31e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d4ef0ae2-f9b3-473b-a3c5-c5ac797c925f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_84c68084-a6ba-4d0d-b456-ebe16944d31e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d4ef0ae2-f9b3-473b-a3c5-c5ac797c925f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_eab07cbf-bdb6-4146-b403-76044bb9d93c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d4ef0ae2-f9b3-473b-a3c5-c5ac797c925f" xlink:to="loc_us-gaap_SubsequentEventMember_eab07cbf-bdb6-4146-b403-76044bb9d93c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#CommonandPreferredStockDividendsDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails" xlink:type="extended" id="icc5ce370326a456ea32fb9648a9e3010_CommonandPreferredStockDividendsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_628ab29c-ab24-4111-9300-d57f6028715a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_82b64d7e-2643-4973-9275-a563c53dfa5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_628ab29c-ab24-4111-9300-d57f6028715a" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_82b64d7e-2643-4973-9275-a563c53dfa5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_2f410e76-73cf-406c-9ce2-ed9f6237668b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_628ab29c-ab24-4111-9300-d57f6028715a" xlink:to="loc_us-gaap_SubsequentEventTable_2f410e76-73cf-406c-9ce2-ed9f6237668b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5f4fa6f1-e51a-479b-a192-f4a4c7dce8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_2f410e76-73cf-406c-9ce2-ed9f6237668b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5f4fa6f1-e51a-479b-a192-f4a4c7dce8cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5f4fa6f1-e51a-479b-a192-f4a4c7dce8cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5f4fa6f1-e51a-479b-a192-f4a4c7dce8cb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5f4fa6f1-e51a-479b-a192-f4a4c7dce8cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2c51166f-9cb0-49d5-a6a8-b0f192f5dea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5f4fa6f1-e51a-479b-a192-f4a4c7dce8cb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2c51166f-9cb0-49d5-a6a8-b0f192f5dea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c55e21ae-7315-49db-961f-39a146d3bada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2c51166f-9cb0-49d5-a6a8-b0f192f5dea6" xlink:to="loc_us-gaap_SubsequentEventMember_c55e21ae-7315-49db-961f-39a146d3bada" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails" xlink:type="extended" id="i2f03a59151d34d81896002cb02a52d36_CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_23ef9935-52f9-4c95-bf0c-70d1c8c09d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_23ef9935-52f9-4c95-bf0c-70d1c8c09d7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_8311a52a-ddcb-4968-a0eb-a65e2da3fec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_8311a52a-ddcb-4968-a0eb-a65e2da3fec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_dd7ecef3-1daf-45a0-918b-bf27f26a209b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_dd7ecef3-1daf-45a0-918b-bf27f26a209b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_32c33ca1-ed0b-4e53-b042-d303e891acc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_32c33ca1-ed0b-4e53-b042-d303e891acc8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount_b94f5b52-3c47-410a-b59d-d579db4960f1" xlink:href="ci-20230331.xsd#ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:to="loc_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount_b94f5b52-3c47-410a-b59d-d579db4960f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_e7c5b1bb-4e36-4bfe-ab1a-a373d41af480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_e7c5b1bb-4e36-4bfe-ab1a-a373d41af480" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3f4abc3f-f715-4f8c-9bbf-55440d7f60d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_e7c5b1bb-4e36-4bfe-ab1a-a373d41af480" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3f4abc3f-f715-4f8c-9bbf-55440d7f60d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3f4abc3f-f715-4f8c-9bbf-55440d7f60d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3f4abc3f-f715-4f8c-9bbf-55440d7f60d7" xlink:to="loc_us-gaap_EquityComponentDomain_3f4abc3f-f715-4f8c-9bbf-55440d7f60d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5527fba6-8fd5-47f1-a8af-7af6ece19fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3f4abc3f-f715-4f8c-9bbf-55440d7f60d7" xlink:to="loc_us-gaap_EquityComponentDomain_5527fba6-8fd5-47f1-a8af-7af6ece19fd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_72d7a6ce-0440-403a-87d4-eb9d1b26ff30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5527fba6-8fd5-47f1-a8af-7af6ece19fd3" xlink:to="loc_us-gaap_TreasuryStockMember_72d7a6ce-0440-403a-87d4-eb9d1b26ff30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_fa977af5-6848-4e39-b272-51a945168ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5527fba6-8fd5-47f1-a8af-7af6ece19fd3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_fa977af5-6848-4e39-b272-51a945168ed8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bab1adaa-ef51-43aa-b9fb-b7fdd0395163" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_e7c5b1bb-4e36-4bfe-ab1a-a373d41af480" xlink:to="loc_srt_StatementScenarioAxis_bab1adaa-ef51-43aa-b9fb-b7fdd0395163" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_bab1adaa-ef51-43aa-b9fb-b7fdd0395163_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_bab1adaa-ef51-43aa-b9fb-b7fdd0395163" xlink:to="loc_srt_ScenarioUnspecifiedDomain_bab1adaa-ef51-43aa-b9fb-b7fdd0395163_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6006c9fd-685f-4e4b-b438-d9798d76d75a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_bab1adaa-ef51-43aa-b9fb-b7fdd0395163" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6006c9fd-685f-4e4b-b438-d9798d76d75a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_a94a34d0-999d-47f1-befd-ade3d927cd86" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_6006c9fd-685f-4e4b-b438-d9798d76d75a" xlink:to="loc_srt_ScenarioForecastMember_a94a34d0-999d-47f1-befd-ade3d927cd86" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesAccountBalancesDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails" xlink:type="extended" id="i0c78734db7d843b4bfcf9e5b97b89310_InsuranceandContractholderLiabilitiesAccountBalancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent_66a4537e-88b6-4f3c-a2ab-832075897066" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent_66a4537e-88b6-4f3c-a2ab-832075897066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups_8302ec1b-ddf4-4930-824e-6deb7500bc76" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups_8302ec1b-ddf4-4930-824e-6deb7500bc76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent_61ceb2d7-c464-4546-a1f3-713603d1b9c9" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent_61ceb2d7-c464-4546-a1f3-713603d1b9c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups_e1c6d67b-bb26-46eb-aff5-d4a6de60e435" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups_e1c6d67b-bb26-46eb-aff5-d4a6de60e435" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositCurrent_063603d0-4305-4f54-9bd8-4f7f4908726e" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_PolicyholderContractDepositCurrent_063603d0-4305-4f54-9bd8-4f7f4908726e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitLiabilityAmountCurrent_63f23e8a-48fa-4456-a415-63f890956bee" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitLiabilityAmountCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_MarketRiskBenefitLiabilityAmountCurrent_63f23e8a-48fa-4456-a415-63f890956bee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsCurrent_ad8f0d38-0f25-420f-b1b7-494d7959df44" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_UnearnedPremiumsCurrent_ad8f0d38-0f25-420f-b1b7-494d7959df44" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsCurrentIncludingDisposalGroups_e1547396-d52e-4cdd-b8b5-ae4ccbc9353f" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsCurrentIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_UnearnedPremiumsCurrentIncludingDisposalGroups_e1547396-d52e-4cdd-b8b5-ae4ccbc9353f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups_c9c13f7c-57c1-4f46-bfa5-76604d526576" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups_c9c13f7c-57c1-4f46-bfa5-76604d526576" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities_eabd63ce-99ab-446d-a6c1-78f2a16ac2c2" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities_eabd63ce-99ab-446d-a6c1-78f2a16ac2c2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_625e2100-f7e2-4b7d-b290-8237a9a4b16a" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_625e2100-f7e2-4b7d-b290-8237a9a4b16a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent_d5b2c8c7-a8a1-4df8-bf64-0684afcead50" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent_d5b2c8c7-a8a1-4df8-bf64-0684afcead50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups_749a737a-5852-463d-a054-ceebcce13db2" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups_749a737a-5852-463d-a054-ceebcce13db2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent_09de6d83-a602-4bde-8cbd-151fa0612b72" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent_09de6d83-a602-4bde-8cbd-151fa0612b72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups_2f2d2403-a6cf-4d82-9d74-d2d4ee9b97e3" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups_2f2d2403-a6cf-4d82-9d74-d2d4ee9b97e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositNoncurrent_e3216e07-a73f-4999-b47b-fbb5035d8ccf" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_PolicyholderContractDepositNoncurrent_e3216e07-a73f-4999-b47b-fbb5035d8ccf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitLiabilityAmountNoncurrent_3a497425-a217-41cc-89f5-21510c0cbf67" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitLiabilityAmountNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_MarketRiskBenefitLiabilityAmountNoncurrent_3a497425-a217-41cc-89f5-21510c0cbf67" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsNoncurrent_fb0b359c-18cc-4c20-8c2d-19a7915553f3" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_UnearnedPremiumsNoncurrent_fb0b359c-18cc-4c20-8c2d-19a7915553f3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups_e12bd44c-3c00-42fc-b427-f31c316ef2ce" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups_e12bd44c-3c00-42fc-b427-f31c316ef2ce" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups_cd0623c9-00b2-4a6a-b748-ee54b9eecfae" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups_cd0623c9-00b2-4a6a-b748-ee54b9eecfae" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities_8d329dff-f94f-4ba2-bbe3-8dae272989b1" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities_8d329dff-f94f-4ba2-bbe3-8dae272989b1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_158820fc-009f-4462-8cb8-349a9356b986" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_158820fc-009f-4462-8cb8-349a9356b986" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_2176dc79-ef45-4526-9752-e202fbef15df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_2176dc79-ef45-4526-9752-e202fbef15df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups_f2bb7c2d-b733-439e-ab72-1d08509841e6" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups_f2bb7c2d-b733-439e-ab72-1d08509841e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_c785cb57-df05-48dc-9f8d-1e4576cef1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_c785cb57-df05-48dc-9f8d-1e4576cef1a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups_2c3c73fb-035a-4022-a676-a42b1f12a7dc" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups_2c3c73fb-035a-4022-a676-a42b1f12a7dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderContractDeposits_03b8ea10-8461-46b7-81e8-6d286e18aeca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderContractDeposits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_us-gaap_PolicyholderContractDeposits_03b8ea10-8461-46b7-81e8-6d286e18aeca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitLiabilityAmount_12451063-e7f3-4343-a4bc-16da896820f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitLiabilityAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_us-gaap_MarketRiskBenefitLiabilityAmount_12451063-e7f3-4343-a4bc-16da896820f6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_7837245d-ada4-4e44-97ed-72f8165c681c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_us-gaap_UnearnedPremiums_7837245d-ada4-4e44-97ed-72f8165c681c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsIncludingDisposalGroups_d0c9a5d1-23be-47ca-82d0-aa7e8b9efa2e" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_ci_UnearnedPremiumsIncludingDisposalGroups_d0c9a5d1-23be-47ca-82d0-aa7e8b9efa2e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_c15ede1c-1a6d-4916-8a3b-5fb90c526bab" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_c15ede1c-1a6d-4916-8a3b-5fb90c526bab" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities_a9a09944-8ee9-4782-b5bb-5fc12f131a81" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities_a9a09944-8ee9-4782-b5bb-5fc12f131a81" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilities_b61a31cb-76a2-48ae-986c-dad0147ac568" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_ci_InsuranceAndContractholderLiabilities_b61a31cb-76a2-48ae-986c-dad0147ac568" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups_78fe7f83-8518-43f8-b4ef-bae60c8ba511" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups_78fe7f83-8518-43f8-b4ef-bae60c8ba511" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups_d207c40b-8645-4e79-a045-425ff9ed5e04" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups_d207c40b-8645-4e79-a045-425ff9ed5e04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositsAttributableToDisposalGroups_fe967100-d678-4f78-a332-cfeb6d530e80" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositsAttributableToDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_PolicyholderContractDepositsAttributableToDisposalGroups_fe967100-d678-4f78-a332-cfeb6d530e80" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesTable_1c2a1301-38e4-4c13-957d-7c8922074470" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesTable_1c2a1301-38e4-4c13-957d-7c8922074470" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d084fed2-1a31-4cd6-82aa-33987f5ec3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_1c2a1301-38e4-4c13-957d-7c8922074470" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d084fed2-1a31-4cd6-82aa-33987f5ec3e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d084fed2-1a31-4cd6-82aa-33987f5ec3e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d084fed2-1a31-4cd6-82aa-33987f5ec3e0" xlink:to="loc_us-gaap_SegmentDomain_d084fed2-1a31-4cd6-82aa-33987f5ec3e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b7e9992a-7ef0-4dd8-86df-74c5b3ab30f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d084fed2-1a31-4cd6-82aa-33987f5ec3e0" xlink:to="loc_us-gaap_SegmentDomain_b7e9992a-7ef0-4dd8-86df-74c5b3ab30f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_39d24839-8368-4c8a-9ea4-7f45dac4260b" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b7e9992a-7ef0-4dd8-86df-74c5b3ab30f2" xlink:to="loc_ci_CignaHealthcareMember_39d24839-8368-4c8a-9ea4-7f45dac4260b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember_b684af7a-0f89-493e-a5f1-ee55afce9ce2" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b7e9992a-7ef0-4dd8-86df-74c5b3ab30f2" xlink:to="loc_ci_OtherOperationsSegmentMember_b684af7a-0f89-493e-a5f1-ee55afce9ce2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails" xlink:type="extended" id="ib6bec95e2b3c485194094a1b5f82b393_InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4012a804-beae-4267-b6e1-94de8bdc4450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses_c00d4333-3d20-4a43-9eb9-b1d8a99c3e49" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4012a804-beae-4267-b6e1-94de8bdc4450" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses_c00d4333-3d20-4a43-9eb9-b1d8a99c3e49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4012a804-beae-4267-b6e1-94de8bdc4450" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_a79bf912-b893-45d9-b2d2-c54d9d77e716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_a79bf912-b893-45d9-b2d2-c54d9d77e716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_5783e7a8-649f-4a6b-b431-209132804ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_5783e7a8-649f-4a6b-b431-209132804ef6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_afaedd2e-f1e8-4c32-9058-47d40af648e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_afaedd2e-f1e8-4c32-9058-47d40af648e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_64c2a534-f328-4770-957a-d13cc2118c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_64c2a534-f328-4770-957a-d13cc2118c2d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_dedcf11e-aa38-4f22-89d2-a53ee74d8736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_64c2a534-f328-4770-957a-d13cc2118c2d" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_dedcf11e-aa38-4f22-89d2-a53ee74d8736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_287ea250-1310-4d13-9a30-9683ad04e80d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_64c2a534-f328-4770-957a-d13cc2118c2d" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_287ea250-1310-4d13-9a30-9683ad04e80d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_a3d7365c-e4ef-4aa3-942b-c390eadc5008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_64c2a534-f328-4770-957a-d13cc2118c2d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_a3d7365c-e4ef-4aa3-942b-c390eadc5008" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_fa6874ab-9ad8-4f8c-bb5e-19d089ee1e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_fa6874ab-9ad8-4f8c-bb5e-19d089ee1e7d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_c08be58b-bda8-4b89-82f8-27464fcf6f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_fa6874ab-9ad8-4f8c-bb5e-19d089ee1e7d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_c08be58b-bda8-4b89-82f8-27464fcf6f13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_f510a3e3-5d0e-4025-b959-4e4a64e92dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_fa6874ab-9ad8-4f8c-bb5e-19d089ee1e7d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_f510a3e3-5d0e-4025-b959-4e4a64e92dd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_73b91d0f-7906-4eed-a253-f2c759fe9547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_fa6874ab-9ad8-4f8c-bb5e-19d089ee1e7d" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_73b91d0f-7906-4eed-a253-f2c759fe9547" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e5e6d934-326b-4905-aaba-fac1dee5a7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_e4ec1f7e-d5f9-41bc-be45-d4958f7ecbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_42595dc0-bd26-41d9-b307-d883a9c9c9de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_18548bea-6da7-47d9-ba27-7995c8ded0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4012a804-beae-4267-b6e1-94de8bdc4450" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_18548bea-6da7-47d9-ba27-7995c8ded0b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5ab63e22-a839-4d8e-99cb-fd9f22b9d131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_18548bea-6da7-47d9-ba27-7995c8ded0b0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5ab63e22-a839-4d8e-99cb-fd9f22b9d131" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5ab63e22-a839-4d8e-99cb-fd9f22b9d131_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5ab63e22-a839-4d8e-99cb-fd9f22b9d131" xlink:to="loc_us-gaap_SegmentDomain_5ab63e22-a839-4d8e-99cb-fd9f22b9d131_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e86f4a8e-e6d2-49c4-87dd-f0248095feae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5ab63e22-a839-4d8e-99cb-fd9f22b9d131" xlink:to="loc_us-gaap_SegmentDomain_e86f4a8e-e6d2-49c4-87dd-f0248095feae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_af8ee0be-12c3-4fee-9350-49db857b6569" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e86f4a8e-e6d2-49c4-87dd-f0248095feae" xlink:to="loc_ci_CignaHealthcareMember_af8ee0be-12c3-4fee-9350-49db857b6569" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails" xlink:type="extended" id="iba69b459b1774aae994e3caa003f31f3_InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_9102fb86-5b31-428e-9f5f-63c4fd8bacfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_33160d92-9f5e-45bd-bb4e-7620608050bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_9102fb86-5b31-428e-9f5f-63c4fd8bacfc" xlink:to="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_33160d92-9f5e-45bd-bb4e-7620608050bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_5fe5beea-baac-4d7e-9143-e83547173d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_33160d92-9f5e-45bd-bb4e-7620608050bc" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_5fe5beea-baac-4d7e-9143-e83547173d3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage_d4613233-3f9f-4557-abfe-574e67ff43e2" xlink:href="ci-20230331.xsd#ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_33160d92-9f5e-45bd-bb4e-7620608050bc" xlink:to="loc_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage_d4613233-3f9f-4557-abfe-574e67ff43e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_a26b0a3c-fb68-42ce-a0eb-87aab376befe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_9102fb86-5b31-428e-9f5f-63c4fd8bacfc" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_a26b0a3c-fb68-42ce-a0eb-87aab376befe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f0b02e40-53de-4403-b08d-73e27a4053e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_a26b0a3c-fb68-42ce-a0eb-87aab376befe" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f0b02e40-53de-4403-b08d-73e27a4053e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f0b02e40-53de-4403-b08d-73e27a4053e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f0b02e40-53de-4403-b08d-73e27a4053e9" xlink:to="loc_us-gaap_SegmentDomain_f0b02e40-53de-4403-b08d-73e27a4053e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5d49a4a1-4a69-485a-8fe4-5fa49717f5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f0b02e40-53de-4403-b08d-73e27a4053e9" xlink:to="loc_us-gaap_SegmentDomain_5d49a4a1-4a69-485a-8fe4-5fa49717f5d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_6ceec60a-0916-45fe-b5de-9adc0d850a79" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5d49a4a1-4a69-485a-8fe4-5fa49717f5d1" xlink:to="loc_ci_CignaHealthcareMember_6ceec60a-0916-45fe-b5de-9adc0d850a79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncatastrophicEventAxis_b6b9b651-ba0d-4109-bf8e-58cf57e7f200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncatastrophicEventAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_a26b0a3c-fb68-42ce-a0eb-87aab376befe" xlink:to="loc_us-gaap_NoncatastrophicEventAxis_b6b9b651-ba0d-4109-bf8e-58cf57e7f200" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncatastrophicEventDomain_b6b9b651-ba0d-4109-bf8e-58cf57e7f200_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncatastrophicEventDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NoncatastrophicEventAxis_b6b9b651-ba0d-4109-bf8e-58cf57e7f200" xlink:to="loc_us-gaap_NoncatastrophicEventDomain_b6b9b651-ba0d-4109-bf8e-58cf57e7f200_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncatastrophicEventDomain_d97d257e-aaa4-4a1d-9747-4f452252b1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncatastrophicEventDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NoncatastrophicEventAxis_b6b9b651-ba0d-4109-bf8e-58cf57e7f200" xlink:to="loc_us-gaap_NoncatastrophicEventDomain_d97d257e-aaa4-4a1d-9747-4f452252b1b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CompletionFactorsMember_c136db81-e7f5-46cf-bc36-4dfb520d207f" xlink:href="ci-20230331.xsd#ci_CompletionFactorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncatastrophicEventDomain_d97d257e-aaa4-4a1d-9747-4f452252b1b6" xlink:to="loc_ci_CompletionFactorsMember_c136db81-e7f5-46cf-bc36-4dfb520d207f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MedicalCostTrendMember_06756745-2147-448f-aba7-3fa4f9853ff8" xlink:href="ci-20230331.xsd#ci_MedicalCostTrendMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncatastrophicEventDomain_d97d257e-aaa4-4a1d-9747-4f452252b1b6" xlink:to="loc_ci_MedicalCostTrendMember_06756745-2147-448f-aba7-3fa4f9853ff8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails" xlink:type="extended" id="i8c26410cb1e64c2fa74c699d4c948b64_InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_56709d6a-8fce-4333-8a26-7ad686612598" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_bff42e3d-1401-4d08-8fce-d1a8e2c5042b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_56709d6a-8fce-4333-8a26-7ad686612598" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_bff42e3d-1401-4d08-8fce-d1a8e2c5042b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_70aacd5f-3b34-433e-8669-0e186dd143e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_56709d6a-8fce-4333-8a26-7ad686612598" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_70aacd5f-3b34-433e-8669-0e186dd143e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_2e22c931-f150-49e0-9054-6faa1f46b8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_56709d6a-8fce-4333-8a26-7ad686612598" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_2e22c931-f150-49e0-9054-6faa1f46b8fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesTable_52539de9-fa59-4aaa-b975-45f35de94651" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_56709d6a-8fce-4333-8a26-7ad686612598" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesTable_52539de9-fa59-4aaa-b975-45f35de94651" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_11ad0889-afe3-408f-b538-b06362a4a8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_52539de9-fa59-4aaa-b975-45f35de94651" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_11ad0889-afe3-408f-b538-b06362a4a8e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_11ad0889-afe3-408f-b538-b06362a4a8e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_11ad0889-afe3-408f-b538-b06362a4a8e4" xlink:to="loc_us-gaap_SegmentDomain_11ad0889-afe3-408f-b538-b06362a4a8e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c608e75b-8801-4008-a60b-5a8787e84f40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_11ad0889-afe3-408f-b538-b06362a4a8e4" xlink:to="loc_us-gaap_SegmentDomain_c608e75b-8801-4008-a60b-5a8787e84f40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_a28d854a-3730-4610-993f-f0ecdda30f77" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c608e75b-8801-4008-a60b-5a8787e84f40" xlink:to="loc_ci_CignaHealthcareMember_a28d854a-3730-4610-993f-f0ecdda30f77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember_6cb197f9-a105-45c1-803c-c741f93ce6b8" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c608e75b-8801-4008-a60b-5a8787e84f40" xlink:to="loc_ci_OtherOperationsSegmentMember_6cb197f9-a105-45c1-803c-c741f93ce6b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails" xlink:type="extended" id="i2b8f94f534ba4ac7b7060a7c1d5c8324_InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_b63ab158-79b4-41b6-98c4-1c6ed72ddc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_b63ab158-79b4-41b6-98c4-1c6ed72ddc5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_fa3e6a6c-f685-45a4-a72c-7db866b103bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_fa3e6a6c-f685-45a4-a72c-7db866b103bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience_602be608-6d82-442f-af65-8d4f34736d34" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience_602be608-6d82-442f-af65-8d4f34736d34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition_09fceef6-ab9e-4599-817f-fdad0921eefc" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition_09fceef6-ab9e-4599-817f-fdad0921eefc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_53565b3e-a833-4cac-b99c-4b1d6d1a75a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_53565b3e-a833-4cac-b99c-4b1d6d1a75a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges_cd9be906-b81b-4562-ac27-7358e577edbf" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges_cd9be906-b81b-4562-ac27-7358e577edbf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_faf8d49a-4a83-4935-a727-664c9f501772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_faf8d49a-4a83-4935-a727-664c9f501772" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_073d5cfa-ff95-410e-bf18-97335cfc8e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_74389c38-2712-4c51-a5df-c15fd8caa2de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_c14c0c9a-bf4e-43b5-b518-6b1b14b26b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_c14c0c9a-bf4e-43b5-b518-6b1b14b26b7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_1c3494d0-92b6-4928-bf99-f6e7ec6ad52b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_1c3494d0-92b6-4928-bf99-f6e7ec6ad52b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience_6f6a0ae8-429f-4bcc-8c12-6492d45496d9" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition_0f9e2b91-1d7d-409b-9448-f7c93e405431" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition_0f9e2b91-1d7d-409b-9448-f7c93e405431" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_436ea7be-ded1-4454-958c-3ba57ecaace1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_436ea7be-ded1-4454-958c-3ba57ecaace1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges_364f5c19-aa4d-4c9c-9ec5-1361366ebe06" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges_364f5c19-aa4d-4c9c-9ec5-1361366ebe06" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_591da472-c985-4619-bccc-e20ea9ee06f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_591da472-c985-4619-bccc-e20ea9ee06f6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_434ddcaf-22b8-4b2a-8238-ad821fdae4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_a5c56ca9-d0d7-411a-9946-c08f309f0891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther_f2ba644e-0520-40ae-84a8-a9b0f555406a" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther_f2ba644e-0520-40ae-84a8-a9b0f555406a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitOther_3ca26d78-1965-46de-abe6-863a63f332b7" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitOther_3ca26d78-1965-46de-abe6-863a63f332b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_30f3e5b3-8548-43a3-ac4f-c35cd37bc800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_30f3e5b3-8548-43a3-ac4f-c35cd37bc800" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_34630469-0edb-43e7-9145-4cc70b371920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_34630469-0edb-43e7-9145-4cc70b371920" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance_b9cb22a7-c48e-475c-b07d-52f18886e324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance_b9cb22a7-c48e-475c-b07d-52f18886e324" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_c9a2fd2d-a286-499a-b26f-3faea0efc49a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_c9a2fd2d-a286-499a-b26f-3faea0efc49a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_445d07fc-2b6c-44d9-b369-22ba8ee585ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_445d07fc-2b6c-44d9-b369-22ba8ee585ce" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm_e4fb0d0b-fc95-4ea5-980e-fda2cb56851b" xlink:href="ci-20230331.xsd#ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm_e4fb0d0b-fc95-4ea5-980e-fda2cb56851b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability_8c2e4070-4005-409f-b2ef-2ae6522ffdb0" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability_8c2e4070-4005-409f-b2ef-2ae6522ffdb0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability_24be1bc6-2737-4471-9dc0-cb32578da45b" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability_24be1bc6-2737-4471-9dc0-cb32578da45b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups_72639a20-265c-4310-a7d3-a5bdc78f9f5a" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups_72639a20-265c-4310-a7d3-a5bdc78f9f5a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesTable_0b474b18-205e-4d62-95eb-9699575a3ebc" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesTable_0b474b18-205e-4d62-95eb-9699575a3ebc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_54ed9b65-32f5-4669-81dd-183b2c768666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_0b474b18-205e-4d62-95eb-9699575a3ebc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_54ed9b65-32f5-4669-81dd-183b2c768666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_54ed9b65-32f5-4669-81dd-183b2c768666_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_54ed9b65-32f5-4669-81dd-183b2c768666" xlink:to="loc_us-gaap_SegmentDomain_54ed9b65-32f5-4669-81dd-183b2c768666_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8813051e-d5a6-4125-86f8-73030c869d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_54ed9b65-32f5-4669-81dd-183b2c768666" xlink:to="loc_us-gaap_SegmentDomain_8813051e-d5a6-4125-86f8-73030c869d05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_d71345ae-67ca-4ebc-aa67-ae21c7c0d535" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8813051e-d5a6-4125-86f8-73030c869d05" xlink:to="loc_ci_CignaHealthcareMember_d71345ae-67ca-4ebc-aa67-ae21c7c0d535" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember_deb265c0-7031-401a-bd6a-211a397de045" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8813051e-d5a6-4125-86f8-73030c869d05" xlink:to="loc_ci_OtherOperationsSegmentMember_deb265c0-7031-401a-bd6a-211a397de045" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails" xlink:type="extended" id="i07589aab3b60412da0e003772a9cb4f3_InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderContractDeposits_35793329-0508-4caf-89c4-1517b6fe604e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderContractDeposits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_us-gaap_PolicyholderContractDeposits_35793329-0508-4caf-89c4-1517b6fe604e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractBalancePercentReinsuredExternally_57711bca-de6f-41e0-ba96-51f155ef1efe" xlink:href="ci-20230331.xsd#ci_PolicyholderContractBalancePercentReinsuredExternally"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_ci_PolicyholderContractBalancePercentReinsuredExternally_57711bca-de6f-41e0-ba96-51f155ef1efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_bfe7722f-ef24-43ea-af08-490e5b06f81c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_bfe7722f-ef24-43ea-af08-490e5b06f81c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_346ed202-d9c3-48d0-a370-88a593984892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceNetAmountAtRisk"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_346ed202-d9c3-48d0-a370-88a593984892" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount_177d2236-f87d-4e1a-a585-6d4c6d371914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueDuePolicyholdersAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount_177d2236-f87d-4e1a-a585-6d4c6d371914" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage_4c902268-772d-470e-bb52-b40b374f1866" xlink:href="ci-20230331.xsd#ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage_4c902268-772d-470e-bb52-b40b374f1866" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderFunds_7ded55be-d019-4e04-a62d-e60658a2cf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_us-gaap_PolicyholderFunds_7ded55be-d019-4e04-a62d-e60658a2cf2c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating_3ef3524f-f4ed-4e8a-95fc-1747f1b035bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating_3ef3524f-f4ed-4e8a-95fc-1747f1b035bc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue_cb7f0d05-199f-4e19-96c8-f22ab58d80e9" xlink:href="ci-20230331.xsd#ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue_cb7f0d05-199f-4e19-96c8-f22ab58d80e9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fcdab999-f6d6-4541-b7c1-d5b90377dca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fcdab999-f6d6-4541-b7c1-d5b90377dca8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fcdab999-f6d6-4541-b7c1-d5b90377dca8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fcdab999-f6d6-4541-b7c1-d5b90377dca8" xlink:to="loc_us-gaap_SegmentDomain_fcdab999-f6d6-4541-b7c1-d5b90377dca8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_37090074-be81-4186-a001-80b059400068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fcdab999-f6d6-4541-b7c1-d5b90377dca8" xlink:to="loc_us-gaap_SegmentDomain_37090074-be81-4186-a001-80b059400068" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_74d528bf-c738-4e8f-8e93-14319bcc7056" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_37090074-be81-4186-a001-80b059400068" xlink:to="loc_ci_CignaHealthcareMember_74d528bf-c738-4e8f-8e93-14319bcc7056" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember_f0271ba6-8189-4d97-aa5d-a9ca38b137c5" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_37090074-be81-4186-a001-80b059400068" xlink:to="loc_ci_OtherOperationsSegmentMember_f0271ba6-8189-4d97-aa5d-a9ca38b137c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4e21d98c-e04b-4f54-a744-30af0cd24a81" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:to="loc_srt_RangeAxis_4e21d98c-e04b-4f54-a744-30af0cd24a81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4e21d98c-e04b-4f54-a744-30af0cd24a81_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4e21d98c-e04b-4f54-a744-30af0cd24a81" xlink:to="loc_srt_RangeMember_4e21d98c-e04b-4f54-a744-30af0cd24a81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7978e154-99a5-46ee-abe6-57a7fa5754bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4e21d98c-e04b-4f54-a744-30af0cd24a81" xlink:to="loc_srt_RangeMember_7978e154-99a5-46ee-abe6-57a7fa5754bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_41028985-c8d4-4ddb-9e64-56690dde582b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7978e154-99a5-46ee-abe6-57a7fa5754bb" xlink:to="loc_srt_MinimumMember_41028985-c8d4-4ddb-9e64-56690dde582b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cacd52ba-5856-4900-aa7f-9722dd265838" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7978e154-99a5-46ee-abe6-57a7fa5754bb" xlink:to="loc_srt_MaximumMember_cacd52ba-5856-4900-aa7f-9722dd265838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis_9b255a90-3eed-4deb-a69a-5889017dd7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:to="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis_9b255a90-3eed-4deb-a69a-5889017dd7ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain_9b255a90-3eed-4deb-a69a-5889017dd7ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis_9b255a90-3eed-4deb-a69a-5889017dd7ed" xlink:to="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain_9b255a90-3eed-4deb-a69a-5889017dd7ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain_71b60dd0-4b54-438b-88c4-5ad7a0023ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis_9b255a90-3eed-4deb-a69a-5889017dd7ed" xlink:to="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain_71b60dd0-4b54-438b-88c4-5ad7a0023ad4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member_7776bbd0-2539-4922-870a-fd71c2325c19" xlink:href="ci-20230331.xsd#ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain_71b60dd0-4b54-438b-88c4-5ad7a0023ad4" xlink:to="loc_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member_7776bbd0-2539-4922-870a-fd71c2325c19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember_b3eaf3a4-2623-46bc-9694-68767676d7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain_71b60dd0-4b54-438b-88c4-5ad7a0023ad4" xlink:to="loc_us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember_b3eaf3a4-2623-46bc-9694-68767676d7f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis_58259607-a173-47e0-a035-aa2474bcc1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:to="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis_58259607-a173-47e0-a035-aa2474bcc1fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain_58259607-a173-47e0-a035-aa2474bcc1fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis_58259607-a173-47e0-a035-aa2474bcc1fc" xlink:to="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain_58259607-a173-47e0-a035-aa2474bcc1fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain_13fcb10f-edbd-43a9-905c-0acb0e7727ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis_58259607-a173-47e0-a035-aa2474bcc1fc" xlink:to="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain_13fcb10f-edbd-43a9-905c-0acb0e7727ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member_22d8dfeb-2f24-4496-a47b-dddd6bf25839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain_13fcb10f-edbd-43a9-905c-0acb0e7727ec" xlink:to="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member_22d8dfeb-2f24-4496-a47b-dddd6bf25839" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember_d41dcd44-0b68-49e8-905e-99e718c481f8" xlink:href="ci-20230331.xsd#ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain_13fcb10f-edbd-43a9-905c-0acb0e7727ec" xlink:to="loc_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember_d41dcd44-0b68-49e8-905e-99e718c481f8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails" xlink:type="extended" id="i3d5deb4fe4ce427985243103b2a25721_InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_0ba27858-9867-48aa-ba80-906e39343bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax_5c388c51-c1cd-4a38-ad2a-67b23fdafba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_0ba27858-9867-48aa-ba80-906e39343bf6" xlink:to="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax_5c388c51-c1cd-4a38-ad2a-67b23fdafba9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1_d0348025-d129-4192-9829-b114b0d026ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_0ba27858-9867-48aa-ba80-906e39343bf6" xlink:to="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1_d0348025-d129-4192-9829-b114b0d026ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue_ca2a4b4c-4aa7-41ad-b1c4-d04287da3c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_0ba27858-9867-48aa-ba80-906e39343bf6" xlink:to="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue_ca2a4b4c-4aa7-41ad-b1c4-d04287da3c01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GuaranteedMinimumDeathBenefitsTotalContractholders_0e461556-1e3f-4ecf-ad27-ef2f46ec6632" xlink:href="ci-20230331.xsd#ci_GuaranteedMinimumDeathBenefitsTotalContractholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_0ba27858-9867-48aa-ba80-906e39343bf6" xlink:to="loc_ci_GuaranteedMinimumDeathBenefitsTotalContractholders_0e461556-1e3f-4ecf-ad27-ef2f46ec6632" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable_ea225d5e-3da9-4be8-9f61-31ec26440c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_0ba27858-9867-48aa-ba80-906e39343bf6" xlink:to="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable_ea225d5e-3da9-4be8-9f61-31ec26440c53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_09a85fb8-f3f2-4e96-8a5b-0997c93180b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable_ea225d5e-3da9-4be8-9f61-31ec26440c53" xlink:to="loc_srt_ProductOrServiceAxis_09a85fb8-f3f2-4e96-8a5b-0997c93180b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_09a85fb8-f3f2-4e96-8a5b-0997c93180b6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_09a85fb8-f3f2-4e96-8a5b-0997c93180b6" xlink:to="loc_srt_ProductsAndServicesDomain_09a85fb8-f3f2-4e96-8a5b-0997c93180b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b40504f2-23c2-4e01-bbd2-e7fe1bcbd6de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_09a85fb8-f3f2-4e96-8a5b-0997c93180b6" xlink:to="loc_srt_ProductsAndServicesDomain_b40504f2-23c2-4e01-bbd2-e7fe1bcbd6de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember_490d7e96-7c37-4960-aedd-5329963eaa85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b40504f2-23c2-4e01-bbd2-e7fe1bcbd6de" xlink:to="loc_us-gaap_VariableAnnuityMember_490d7e96-7c37-4960-aedd-5329963eaa85" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#ReinsuranceReinsuranceRecoverablesDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="extended" id="i1a0d336bbed742f2bc51eecee9f8f9b0_ReinsuranceReinsuranceRecoverablesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ReinsuranceRecoverablesIncludingDisposalGroups_5cb8a019-8595-4d71-9a63-4a6dfb26ecdf" xlink:href="ci-20230331.xsd#ci_ReinsuranceRecoverablesIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:to="loc_ci_ReinsuranceRecoverablesIncludingDisposalGroups_5cb8a019-8595-4d71-9a63-4a6dfb26ecdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesGross_2bdbd928-54ee-4600-9d1c-9c5264958a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:to="loc_us-gaap_ReinsuranceRecoverablesGross_2bdbd928-54ee-4600-9d1c-9c5264958a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_aabf0a66-c8f2-45ff-90cc-4115be9a59f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_aabf0a66-c8f2-45ff-90cc-4115be9a59f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_edc58964-f55f-41d4-bcda-f08269bddd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:to="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_edc58964-f55f-41d4-bcda-f08269bddd6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_dcbf58ca-2842-474c-b690-aef32ad17db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:to="loc_us-gaap_ReinsuranceRecoverables_dcbf58ca-2842-474c-b690-aef32ad17db9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:to="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d576be70-0470-4dd4-9fe8-e9986849261a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_srt_ProductOrServiceAxis_d576be70-0470-4dd4-9fe8-e9986849261a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d576be70-0470-4dd4-9fe8-e9986849261a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d576be70-0470-4dd4-9fe8-e9986849261a" xlink:to="loc_srt_ProductsAndServicesDomain_d576be70-0470-4dd4-9fe8-e9986849261a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a420a02b-133d-48a0-b56d-982cf2c90da5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d576be70-0470-4dd4-9fe8-e9986849261a" xlink:to="loc_srt_ProductsAndServicesDomain_a420a02b-133d-48a0-b56d-982cf2c90da5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OngoingOperationsMember_8d63b7b0-d3b5-49b2-af1a-91d280cea7e0" xlink:href="ci-20230331.xsd#ci_OngoingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a420a02b-133d-48a0-b56d-982cf2c90da5" xlink:to="loc_ci_OngoingOperationsMember_8d63b7b0-d3b5-49b2-af1a-91d280cea7e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AcquisitionDispositionRunoffActivitiesMember_4b7476f1-f1b9-453d-97a4-c6567342b463" xlink:href="ci-20230331.xsd#ci_AcquisitionDispositionRunoffActivitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a420a02b-133d-48a0-b56d-982cf2c90da5" xlink:to="loc_ci_AcquisitionDispositionRunoffActivitiesMember_4b7476f1-f1b9-453d-97a4-c6567342b463" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember_60468ea7-48f0-41c9-9093-faae291a690d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a420a02b-133d-48a0-b56d-982cf2c90da5" xlink:to="loc_us-gaap_VariableAnnuityMember_60468ea7-48f0-41c9-9093-faae291a690d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskCollateralizationAxis_c8ffc6cb-c344-46fd-82f3-ffca2068f885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskCollateralizationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_us-gaap_CededCreditRiskCollateralizationAxis_c8ffc6cb-c344-46fd-82f3-ffca2068f885" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskCollateralizationDomain_c8ffc6cb-c344-46fd-82f3-ffca2068f885_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskCollateralizationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationAxis_c8ffc6cb-c344-46fd-82f3-ffca2068f885" xlink:to="loc_us-gaap_CededCreditRiskCollateralizationDomain_c8ffc6cb-c344-46fd-82f3-ffca2068f885_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskCollateralizationDomain_7d8fc5ef-c81c-4de2-a04b-8280dc3eadbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskCollateralizationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationAxis_c8ffc6cb-c344-46fd-82f3-ffca2068f885" xlink:to="loc_us-gaap_CededCreditRiskCollateralizationDomain_7d8fc5ef-c81c-4de2-a04b-8280dc3eadbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember_6d6fba6c-5483-4e4f-8d72-c58bc3a2a17b" xlink:href="ci-20230331.xsd#ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationDomain_7d8fc5ef-c81c-4de2-a04b-8280dc3eadbb" xlink:to="loc_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember_6d6fba6c-5483-4e4f-8d72-c58bc3a2a17b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember_ad67546f-dbc8-436d-a9ce-2b174b0cb71b" xlink:href="ci-20230331.xsd#ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationDomain_7d8fc5ef-c81c-4de2-a04b-8280dc3eadbb" xlink:to="loc_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember_ad67546f-dbc8-436d-a9ce-2b174b0cb71b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskUnsecuredMember_8b9e4678-d987-4acf-acb6-633764ceb0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskUnsecuredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationDomain_7d8fc5ef-c81c-4de2-a04b-8280dc3eadbb" xlink:to="loc_us-gaap_CededCreditRiskUnsecuredMember_8b9e4678-d987-4acf-acb6-633764ceb0e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis_a8cc1013-45c0-4d99-bc05-71f445dba1ec" xlink:href="ci-20230331.xsd#ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis_a8cc1013-45c0-4d99-bc05-71f445dba1ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_a8cc1013-45c0-4d99-bc05-71f445dba1ec_default" xlink:href="ci-20230331.xsd#ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis_a8cc1013-45c0-4d99-bc05-71f445dba1ec" xlink:to="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_a8cc1013-45c0-4d99-bc05-71f445dba1ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_c95abd8c-eb81-432d-816b-459ff6e6ab8b" xlink:href="ci-20230331.xsd#ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis_a8cc1013-45c0-4d99-bc05-71f445dba1ec" xlink:to="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_c95abd8c-eb81-432d-816b-459ff6e6ab8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember_cde3c1d1-cfe9-49fb-86f4-4f5c2414c0ff" xlink:href="ci-20230331.xsd#ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_c95abd8c-eb81-432d-816b-459ff6e6ab8b" xlink:to="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember_cde3c1d1-cfe9-49fb-86f4-4f5c2414c0ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember_80e8ef99-110c-4b6a-a7e3-9cfc7646f193" xlink:href="ci-20230331.xsd#ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember_cde3c1d1-cfe9-49fb-86f4-4f5c2414c0ff" xlink:to="loc_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember_80e8ef99-110c-4b6a-a7e3-9cfc7646f193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember_49207a3f-7e57-46f1-b265-f5e954d64748" xlink:href="ci-20230331.xsd#ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_c95abd8c-eb81-432d-816b-459ff6e6ab8b" xlink:to="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember_49207a3f-7e57-46f1-b265-f5e954d64748" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember_f20ab6d4-4924-4cd2-a5a9-202126a1b95e" xlink:href="ci-20230331.xsd#ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_c95abd8c-eb81-432d-816b-459ff6e6ab8b" xlink:to="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember_f20ab6d4-4924-4cd2-a5a9-202126a1b95e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis_50f65790-0374-4bb3-98a5-284127b12279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_us-gaap_CededCreditRiskAxis_50f65790-0374-4bb3-98a5-284127b12279" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_50f65790-0374-4bb3-98a5-284127b12279_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CededCreditRiskAxis_50f65790-0374-4bb3-98a5-284127b12279" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_50f65790-0374-4bb3-98a5-284127b12279_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CededCreditRiskAxis_50f65790-0374-4bb3-98a5-284127b12279" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember_489601c2-c03a-429e-9e4a-34a0e63218bd" xlink:href="ci-20230331.xsd#ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember_489601c2-c03a-429e-9e4a-34a0e63218bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember_1aa575bb-65a6-48ed-915a-c963f2170d6a" xlink:href="ci-20230331.xsd#ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember_1aa575bb-65a6-48ed-915a-c963f2170d6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EmpowerAnnuityInsuranceCompanyMember_ce0ac1d5-5be5-4908-af35-5f85903aa6ba" xlink:href="ci-20230331.xsd#ci_EmpowerAnnuityInsuranceCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_ci_EmpowerAnnuityInsuranceCompanyMember_ce0ac1d5-5be5-4908-af35-5f85903aa6ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PrudentialInsuranceCompanyOfAmericaMember_8599f40d-293a-4301-b003-b1e7069dc32d" xlink:href="ci-20230331.xsd#ci_PrudentialInsuranceCompanyOfAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_ci_PrudentialInsuranceCompanyOfAmericaMember_8599f40d-293a-4301-b003-b1e7069dc32d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LifeInsuranceCompanyOfNorthAmericaMember_e1762773-7e84-4419-8a27-ee54f026f4d6" xlink:href="ci-20230331.xsd#ci_LifeInsuranceCompanyOfNorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_ci_LifeInsuranceCompanyOfNorthAmericaMember_e1762773-7e84-4419-8a27-ee54f026f4d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReinsurerMember_78b6f82e-20e7-467c-b707-c46eeb3c728a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReinsurerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_us-gaap_OtherReinsurerMember_78b6f82e-20e7-467c-b707-c46eeb3c728a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember_c61bd084-7825-46a7-bd47-9a1b9ae81c24" xlink:href="ci-20230331.xsd#ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember_c61bd084-7825-46a7-bd47-9a1b9ae81c24" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f3ff77ac-230c-45c7-bf63-3eb4720aabaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f3ff77ac-230c-45c7-bf63-3eb4720aabaa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f3ff77ac-230c-45c7-bf63-3eb4720aabaa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f3ff77ac-230c-45c7-bf63-3eb4720aabaa" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f3ff77ac-230c-45c7-bf63-3eb4720aabaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2a35202a-bc6d-45ae-9263-a70d9718e460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f3ff77ac-230c-45c7-bf63-3eb4720aabaa" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2a35202a-bc6d-45ae-9263-a70d9718e460" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_fcf9037c-3fdf-4f95-b46f-8460a061edf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2a35202a-bc6d-45ae-9263-a70d9718e460" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_fcf9037c-3fdf-4f95-b46f-8460a061edf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_02e3d64e-c0f2-4e6d-882d-74a18136223e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_02e3d64e-c0f2-4e6d-882d-74a18136223e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_02e3d64e-c0f2-4e6d-882d-74a18136223e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_02e3d64e-c0f2-4e6d-882d-74a18136223e" xlink:to="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_02e3d64e-c0f2-4e6d-882d-74a18136223e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_35c33524-a6e4-4a2f-80eb-4163dfa68d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_02e3d64e-c0f2-4e6d-882d-74a18136223e" xlink:to="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_35c33524-a6e4-4a2f-80eb-4163dfa68d98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedMinimumDeathBenefitMember_263b209c-0092-4d6d-82e2-e1d1f0d167aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedMinimumDeathBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_35c33524-a6e4-4a2f-80eb-4163dfa68d98" xlink:to="loc_us-gaap_GuaranteedMinimumDeathBenefitMember_263b209c-0092-4d6d-82e2-e1d1f0d167aa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails" xlink:type="extended" id="i906c50d2ec27435faaa800cedb2134fa_ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededReinsuranceAgreementReinsuredRiskPercentage_c838a753-a2b1-4751-8d2f-38d7621bb556" xlink:href="ci-20230331.xsd#ci_CededReinsuranceAgreementReinsuredRiskPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_ci_CededReinsuranceAgreementReinsuredRiskPercentage_c838a753-a2b1-4751-8d2f-38d7621bb556" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining_ed73b99a-fe92-447b-addd-9663a1002a6d" xlink:href="ci-20230331.xsd#ci_CededReinsuranceAgreementCoverageLimitAmountRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining_ed73b99a-fe92-447b-addd-9663a1002a6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_736d7acb-ca38-4f82-996e-9fad2907823b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_736d7acb-ca38-4f82-996e-9fad2907823b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances_5012f821-483d-4051-96bf-b6e6a0bce8bd" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances_5012f821-483d-4051-96bf-b6e6a0bce8bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_ade0214b-70fb-41ab-b8bb-d2e4f4393b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_ade0214b-70fb-41ab-b8bb-d2e4f4393b6a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims_e501345e-47e5-4c00-a98f-87d0ea746819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims_e501345e-47e5-4c00-a98f-87d0ea746819" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_d268687c-8748-4276-b1cb-bafee8339c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_d268687c-8748-4276-b1cb-bafee8339c09" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementNonPerformanceRiskAdjustment_7ee7a78f-7c96-4ab5-8a05-4fe08d510b3c" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementNonPerformanceRiskAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_ci_FairValueMeasurementNonPerformanceRiskAdjustment_7ee7a78f-7c96-4ab5-8a05-4fe08d510b3c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6b765871-df55-4d7b-a657-dbeda510a1f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_srt_ProductOrServiceAxis_6b765871-df55-4d7b-a657-dbeda510a1f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6b765871-df55-4d7b-a657-dbeda510a1f3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6b765871-df55-4d7b-a657-dbeda510a1f3" xlink:to="loc_srt_ProductsAndServicesDomain_6b765871-df55-4d7b-a657-dbeda510a1f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_87a86b17-19b8-414d-b45c-74d9bbcb0ef0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6b765871-df55-4d7b-a657-dbeda510a1f3" xlink:to="loc_srt_ProductsAndServicesDomain_87a86b17-19b8-414d-b45c-74d9bbcb0ef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember_c6221d64-de31-41f2-a535-5cb9415f8440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_87a86b17-19b8-414d-b45c-74d9bbcb0ef0" xlink:to="loc_us-gaap_VariableAnnuityMember_c6221d64-de31-41f2-a535-5cb9415f8440" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis_c3cf5189-5013-4f68-bad7-da6a978c95b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_us-gaap_CededCreditRiskAxis_c3cf5189-5013-4f68-bad7-da6a978c95b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_c3cf5189-5013-4f68-bad7-da6a978c95b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CededCreditRiskAxis_c3cf5189-5013-4f68-bad7-da6a978c95b6" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_c3cf5189-5013-4f68-bad7-da6a978c95b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_b06f0e9d-d1c3-4c04-a360-0eb1e46030a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CededCreditRiskAxis_c3cf5189-5013-4f68-bad7-da6a978c95b6" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_b06f0e9d-d1c3-4c04-a360-0eb1e46030a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember_36f2fe81-b429-4946-9c48-be633c505506" xlink:href="ci-20230331.xsd#ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_b06f0e9d-d1c3-4c04-a360-0eb1e46030a0" xlink:to="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember_36f2fe81-b429-4946-9c48-be633c505506" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SunLifeAssuranceCompanyOfCanadaMember_c9872668-6e2d-4912-865f-e8234c136bc7" xlink:href="ci-20230331.xsd#ci_SunLifeAssuranceCompanyOfCanadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_b06f0e9d-d1c3-4c04-a360-0eb1e46030a0" xlink:to="loc_ci_SunLifeAssuranceCompanyOfCanadaMember_c9872668-6e2d-4912-865f-e8234c136bc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LibertyMutualInsuranceMember_3c90e7a3-b11e-49cc-b8ce-19c3747aa5f3" xlink:href="ci-20230331.xsd#ci_LibertyMutualInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_b06f0e9d-d1c3-4c04-a360-0eb1e46030a0" xlink:to="loc_ci_LibertyMutualInsuranceMember_3c90e7a3-b11e-49cc-b8ce-19c3747aa5f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SCORSEMember_df902522-393b-4212-9c8a-998bf2916e7e" xlink:href="ci-20230331.xsd#ci_SCORSEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_b06f0e9d-d1c3-4c04-a360-0eb1e46030a0" xlink:to="loc_ci_SCORSEMember_df902522-393b-4212-9c8a-998bf2916e7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskCollateralizationAxis_f3da2aa3-19e7-4155-9c24-39897216d180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskCollateralizationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_us-gaap_CededCreditRiskCollateralizationAxis_f3da2aa3-19e7-4155-9c24-39897216d180" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskCollateralizationDomain_f3da2aa3-19e7-4155-9c24-39897216d180_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskCollateralizationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationAxis_f3da2aa3-19e7-4155-9c24-39897216d180" xlink:to="loc_us-gaap_CededCreditRiskCollateralizationDomain_f3da2aa3-19e7-4155-9c24-39897216d180_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskCollateralizationDomain_4b9a7f0e-1019-4709-9886-0b1690c58112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskCollateralizationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationAxis_f3da2aa3-19e7-4155-9c24-39897216d180" xlink:to="loc_us-gaap_CededCreditRiskCollateralizationDomain_4b9a7f0e-1019-4709-9886-0b1690c58112" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskSecuredMember_75da0205-c925-4bc2-b7a9-562a34cd9fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskSecuredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationDomain_4b9a7f0e-1019-4709-9886-0b1690c58112" xlink:to="loc_us-gaap_CededCreditRiskSecuredMember_75da0205-c925-4bc2-b7a9-562a34cd9fd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ca4c0575-c186-446b-baae-4559d6598a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ca4c0575-c186-446b-baae-4559d6598a4f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ca4c0575-c186-446b-baae-4559d6598a4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ca4c0575-c186-446b-baae-4559d6598a4f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ca4c0575-c186-446b-baae-4559d6598a4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ed6605f7-ad8b-451b-8918-c1e5c1399e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ca4c0575-c186-446b-baae-4559d6598a4f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ed6605f7-ad8b-451b-8918-c1e5c1399e12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember_c27347a3-29ac-469a-99b6-93ae9ea5de7c" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ed6605f7-ad8b-451b-8918-c1e5c1399e12" xlink:to="loc_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember_c27347a3-29ac-469a-99b6-93ae9ea5de7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_5fa050de-ab01-4091-a217-1d4df6348e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_5fa050de-ab01-4091-a217-1d4df6348e74" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5fa050de-ab01-4091-a217-1d4df6348e74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5fa050de-ab01-4091-a217-1d4df6348e74" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5fa050de-ab01-4091-a217-1d4df6348e74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_242b84ac-314e-45e3-a95e-09fba5ae4b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5fa050de-ab01-4091-a217-1d4df6348e74" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_242b84ac-314e-45e3-a95e-09fba5ae4b4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededCreditCollateralizationRiskMember_c1bf65e7-924e-462b-bb4b-625044ee2c9f" xlink:href="ci-20230331.xsd#ci_CededCreditCollateralizationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_242b84ac-314e-45e3-a95e-09fba5ae4b4c" xlink:to="loc_ci_CededCreditCollateralizationRiskMember_c1bf65e7-924e-462b-bb4b-625044ee2c9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_cad5ca38-a5e6-4bdf-a426-d810d14f8efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_cad5ca38-a5e6-4bdf-a426-d810d14f8efc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_cad5ca38-a5e6-4bdf-a426-d810d14f8efc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_cad5ca38-a5e6-4bdf-a426-d810d14f8efc" xlink:to="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_cad5ca38-a5e6-4bdf-a426-d810d14f8efc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_80b35ef2-7023-4c0c-99bc-9955eaaf3523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_cad5ca38-a5e6-4bdf-a426-d810d14f8efc" xlink:to="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_80b35ef2-7023-4c0c-99bc-9955eaaf3523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember_7d7b5f69-5d11-4e2c-9ae1-776084b21e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_80b35ef2-7023-4c0c-99bc-9955eaaf3523" xlink:to="loc_us-gaap_VariableAnnuityMember_7d7b5f69-5d11-4e2c-9ae1-776084b21e99" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsInvestmentsbyCategoryDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails" xlink:type="extended" id="i9bd2f82efd3f444b88e235ec48bf2551_InvestmentsInvestmentsbyCategoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_898cf91f-fdbf-4a35-9651-9d40394b33bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsAbstract_62c1963e-a74a-4e38-8a98-bba8b77cfb03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_898cf91f-fdbf-4a35-9651-9d40394b33bb" xlink:to="loc_us-gaap_ShortTermInvestmentsAbstract_62c1963e-a74a-4e38-8a98-bba8b77cfb03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1c620fc7-4914-4607-8d85-dfcc40f2da56" xlink:href="ci-20230331.xsd#ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermInvestmentsAbstract_62c1963e-a74a-4e38-8a98-bba8b77cfb03" xlink:to="loc_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1c620fc7-4914-4607-8d85-dfcc40f2da56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent_a7113b13-f43f-4fed-9926-ee403f994dd4" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermInvestmentsAbstract_62c1963e-a74a-4e38-8a98-bba8b77cfb03" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent_a7113b13-f43f-4fed-9926-ee403f994dd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_3f6a6180-e53f-4897-94aa-e72d5129f048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermInvestmentsAbstract_62c1963e-a74a-4e38-8a98-bba8b77cfb03" xlink:to="loc_us-gaap_ShortTermInvestments_3f6a6180-e53f-4897-94aa-e72d5129f048" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestmentsAbstract_320055cf-2cfc-4257-b287-6951c9ea6f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_898cf91f-fdbf-4a35-9651-9d40394b33bb" xlink:to="loc_us-gaap_LongTermInvestmentsAbstract_320055cf-2cfc-4257-b287-6951c9ea6f8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_9cf28c5b-0f51-4531-946c-b5514fe723a9" xlink:href="ci-20230331.xsd#ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermInvestmentsAbstract_320055cf-2cfc-4257-b287-6951c9ea6f8d" xlink:to="loc_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_9cf28c5b-0f51-4531-946c-b5514fe723a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent_e1e2e7eb-fd3f-4ffc-b3b7-85c86b5eac87" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermInvestmentsAbstract_320055cf-2cfc-4257-b287-6951c9ea6f8d" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent_e1e2e7eb-fd3f-4ffc-b3b7-85c86b5eac87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_1fb9c676-fb61-4a0f-9215-faa9a3de16e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermInvestmentsAbstract_320055cf-2cfc-4257-b287-6951c9ea6f8d" xlink:to="loc_us-gaap_LongTermInvestments_1fb9c676-fb61-4a0f-9215-faa9a3de16e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ShortTermAndLongTermInvestmentsAbstract_ee36d01b-0aa1-4bb9-a6f3-ea476ddcea1d" xlink:href="ci-20230331.xsd#ci_ShortTermAndLongTermInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_898cf91f-fdbf-4a35-9651-9d40394b33bb" xlink:to="loc_ci_ShortTermAndLongTermInvestmentsAbstract_ee36d01b-0aa1-4bb9-a6f3-ea476ddcea1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_5f638edb-98a2-4370-9069-f20c8d5d6ca3" xlink:href="ci-20230331.xsd#ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_ShortTermAndLongTermInvestmentsAbstract_ee36d01b-0aa1-4bb9-a6f3-ea476ddcea1d" xlink:to="loc_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_5f638edb-98a2-4370-9069-f20c8d5d6ca3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationInvestments_e8bd6126-c94d-4a31-9392-ecf4ecb264b7" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_ShortTermAndLongTermInvestmentsAbstract_ee36d01b-0aa1-4bb9-a6f3-ea476ddcea1d" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationInvestments_e8bd6126-c94d-4a31-9392-ecf4ecb264b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_d6a1c216-309a-423c-b2c3-4e1c76f18b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_ShortTermAndLongTermInvestmentsAbstract_ee36d01b-0aa1-4bb9-a6f3-ea476ddcea1d" xlink:to="loc_us-gaap_Investments_d6a1c216-309a-423c-b2c3-4e1c76f18b6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_f09cf1e8-d500-4dab-a290-1796f61a3bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_898cf91f-fdbf-4a35-9651-9d40394b33bb" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_f09cf1e8-d500-4dab-a290-1796f61a3bef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_1ca86c46-c286-420d-b51a-1f01131b09ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f09cf1e8-d500-4dab-a290-1796f61a3bef" xlink:to="loc_us-gaap_InvestmentTypeAxis_1ca86c46-c286-420d-b51a-1f01131b09ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_1ca86c46-c286-420d-b51a-1f01131b09ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_1ca86c46-c286-420d-b51a-1f01131b09ca" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_1ca86c46-c286-420d-b51a-1f01131b09ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_1ca86c46-c286-420d-b51a-1f01131b09ca" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_827860de-9efe-492b-a09b-fdd1e8cb2c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:to="loc_us-gaap_DebtSecuritiesMember_827860de-9efe-492b-a09b-fdd1e8cb2c11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_2a1b8cff-5c21-443b-9933-5ebe95e0f968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:to="loc_us-gaap_EquitySecuritiesMember_2a1b8cff-5c21-443b-9933-5ebe95e0f968" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_514c7111-3d75-4f87-b005-c6afbbe58b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:to="loc_us-gaap_MortgagesMember_514c7111-3d75-4f87-b005-c6afbbe58b44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyLoansMember_ae82ed06-08c3-4cf4-938e-fa67fe039815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:to="loc_us-gaap_PolicyLoansMember_ae82ed06-08c3-4cf4-938e-fa67fe039815" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_42348972-4867-4fda-ad57-e7f790c18003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_42348972-4867-4fda-ad57-e7f790c18003" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e26572ac-3d52-4bcc-9c55-5dc2122e764d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e26572ac-3d52-4bcc-9c55-5dc2122e764d" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InvestmentsNarrativeDetails" xlink:type="extended" id="ia236931124fa45a9bbdcf360a43504ab_InvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c0487c9-0916-4b0b-b8c9-0295ba1da3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_f5d86ed7-8697-4e6f-9734-d05888225414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c0487c9-0916-4b0b-b8c9-0295ba1da3b0" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_f5d86ed7-8697-4e6f-9734-d05888225414" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5d10f70f-6ed9-466b-b0a3-283b82eb0ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c0487c9-0916-4b0b-b8c9-0295ba1da3b0" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5d10f70f-6ed9-466b-b0a3-283b82eb0ebe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_650a1e97-8dfc-495d-803f-dadfbfac6209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c0487c9-0916-4b0b-b8c9-0295ba1da3b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_650a1e97-8dfc-495d-803f-dadfbfac6209" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_eb44dbba-37ca-4469-a57d-123748155b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c0487c9-0916-4b0b-b8c9-0295ba1da3b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_eb44dbba-37ca-4469-a57d-123748155b7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_07e6885a-f32d-4d43-a88f-2e6644774ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c0487c9-0916-4b0b-b8c9-0295ba1da3b0" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_07e6885a-f32d-4d43-a88f-2e6644774ca3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_91fa4e39-a2e6-4039-8449-00b73f5d53f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_07e6885a-f32d-4d43-a88f-2e6644774ca3" xlink:to="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_91fa4e39-a2e6-4039-8449-00b73f5d53f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_91fa4e39-a2e6-4039-8449-00b73f5d53f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_91fa4e39-a2e6-4039-8449-00b73f5d53f1" xlink:to="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_91fa4e39-a2e6-4039-8449-00b73f5d53f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_39aae08b-a639-46e7-baca-e12b51bcb367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_91fa4e39-a2e6-4039-8449-00b73f5d53f1" xlink:to="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_39aae08b-a639-46e7-baca-e12b51bcb367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPortfolioSegmentMember_8278291d-8eec-4702-bb96-11e05d66a41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPortfolioSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_39aae08b-a639-46e7-baca-e12b51bcb367" xlink:to="loc_us-gaap_CommercialPortfolioSegmentMember_8278291d-8eec-4702-bb96-11e05d66a41e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_d65f4cdb-b4b4-48bb-a8c3-b03e247a6c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_07e6885a-f32d-4d43-a88f-2e6644774ca3" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_d65f4cdb-b4b4-48bb-a8c3-b03e247a6c57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_d65f4cdb-b4b4-48bb-a8c3-b03e247a6c57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_d65f4cdb-b4b4-48bb-a8c3-b03e247a6c57" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_d65f4cdb-b4b4-48bb-a8c3-b03e247a6c57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_66eff2da-eb33-4cb3-87a6-91bd6c0eb104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_d65f4cdb-b4b4-48bb-a8c3-b03e247a6c57" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_66eff2da-eb33-4cb3-87a6-91bd6c0eb104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLoanMember_a2c7533c-aa36-4222-bac9-43abb341eae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_66eff2da-eb33-4cb3-87a6-91bd6c0eb104" xlink:to="loc_us-gaap_RealEstateLoanMember_a2c7533c-aa36-4222-bac9-43abb341eae7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails" xlink:type="extended" id="i6480f7c377304a46852d825feb9e8553_InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_cb77fb5b-d977-4b44-b73e-943da689fa26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_cb77fb5b-d977-4b44-b73e-943da689fa26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_b8ade10a-a20d-4ac7-a2ed-685fa3339358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_b8ade10a-a20d-4ac7-a2ed-685fa3339358" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_800c7619-485c-40e7-8789-bcf8fa8d35d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_800c7619-485c-40e7-8789-bcf8fa8d35d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e44d3529-e391-4b90-b0aa-8f3ff71ad26e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e44d3529-e391-4b90-b0aa-8f3ff71ad26e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_4d696052-95aa-4073-bfab-157728426178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_4d696052-95aa-4073-bfab-157728426178" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale_188245f5-7e48-44aa-a0ba-af030bfec1cb" xlink:href="ci-20230331.xsd#ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale_188245f5-7e48-44aa-a0ba-af030bfec1cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_d895ef64-0c17-439c-b221-1207ff08fcb3" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_d895ef64-0c17-439c-b221-1207ff08fcb3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_b406f9bd-300a-4998-b92b-7a90e9c0451e" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_b406f9bd-300a-4998-b92b-7a90e9c0451e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_40266104-bce4-420a-81ff-d2af98176c0a" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_40266104-bce4-420a-81ff-d2af98176c0a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_d38abfbd-c45b-47a1-a709-cb6b3ea143da" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_d38abfbd-c45b-47a1-a709-cb6b3ea143da" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_8cd70511-1189-4378-9c5d-8c335f5275bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_8cd70511-1189-4378-9c5d-8c335f5275bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cd2ae345-1b8d-4b96-b992-df0ef8d6b5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_8cd70511-1189-4378-9c5d-8c335f5275bc" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cd2ae345-1b8d-4b96-b992-df0ef8d6b5e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd2ae345-1b8d-4b96-b992-df0ef8d6b5e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cd2ae345-1b8d-4b96-b992-df0ef8d6b5e3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd2ae345-1b8d-4b96-b992-df0ef8d6b5e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cd2ae345-1b8d-4b96-b992-df0ef8d6b5e3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_bec4848e-5033-476e-b3b3-8b17c3ddea3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_bec4848e-5033-476e-b3b3-8b17c3ddea3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_b88078c8-071c-4910-9056-fb4f00f73130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_b88078c8-071c-4910-9056-fb4f00f73130" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_ad4d54b2-a35f-4273-8bd8-79ff4b812c14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_ad4d54b2-a35f-4273-8bd8-79ff4b812c14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_47dd2323-a2a4-451b-8c61-cb0b74b01240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_47dd2323-a2a4-451b-8c61-cb0b74b01240" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_b3497ed7-847d-4f76-91ed-e4914d8b6ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_b3497ed7-847d-4f76-91ed-e4914d8b6ec2" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails" xlink:type="extended" id="i9ad1bd17f33847ab8b966aa393830086_InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b1c8574f-861b-4b9a-a942-1b7c8dd09717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b1c8574f-861b-4b9a-a942-1b7c8dd09717" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_7f26b5ae-b8fb-4045-9146-6f898def3f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_7f26b5ae-b8fb-4045-9146-6f898def3f4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost_429af36e-d290-4581-ac1f-8cbcc0486c3a" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost_429af36e-d290-4581-ac1f-8cbcc0486c3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0e93630e-7218-4795-995d-aee6401d35ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0e93630e-7218-4795-995d-aee6401d35ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_a2df8052-6bd4-4eef-a024-afb6d3c2d8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_a2df8052-6bd4-4eef-a024-afb6d3c2d8db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_e992d555-b35b-4818-a876-5db963120ece" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_e992d555-b35b-4818-a876-5db963120ece" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_d55f36b9-5851-4798-895d-fafc85e20386" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_d55f36b9-5851-4798-895d-fafc85e20386" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_0e48aeb8-2139-4554-bf1a-1ed6ce12715f" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_0e48aeb8-2139-4554-bf1a-1ed6ce12715f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_59db894e-4353-4273-b616-326bae4d7c18" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_59db894e-4353-4273-b616-326bae4d7c18" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b1c8574f-861b-4b9a-a942-1b7c8dd09717" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_a22c3e40-de08-4d7d-b36c-8c8d00add737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_a22c3e40-de08-4d7d-b36c-8c8d00add737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost_45f77635-b1ba-4411-8342-9c0fd62bff0d" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost_45f77635-b1ba-4411-8342-9c0fd62bff0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_bb6db6ce-5580-4b09-8b01-0ebf6f3cf703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_bb6db6ce-5580-4b09-8b01-0ebf6f3cf703" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_828c4fc4-1598-42bb-a60d-22d6ee9d646c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_828c4fc4-1598-42bb-a60d-22d6ee9d646c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_6faaddfa-1522-4020-88d2-58918bfb4484" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_6faaddfa-1522-4020-88d2-58918bfb4484" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_fc61c31b-6e80-45fe-9f83-f8be28bd68c0" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_fc61c31b-6e80-45fe-9f83-f8be28bd68c0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_fe5d1959-1fc2-4061-a407-50c29a03d359" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_fe5d1959-1fc2-4061-a407-50c29a03d359" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_d230b9c3-108f-433d-8c24-9c246d100eaf" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_d230b9c3-108f-433d-8c24-9c246d100eaf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b1c8574f-861b-4b9a-a942-1b7c8dd09717" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7669b4bd-9ff2-4434-b9b4-ddfaff7d2b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7669b4bd-9ff2-4434-b9b4-ddfaff7d2b9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost_25792234-7044-4058-9192-bffc59bbee6e" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost_25792234-7044-4058-9192-bffc59bbee6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_58b1f884-1062-41df-b77d-2848e899daab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_58b1f884-1062-41df-b77d-2848e899daab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ecb8ae12-6869-44a7-b44f-72278302099e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ecb8ae12-6869-44a7-b44f-72278302099e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale_e3ad8634-d471-419b-8999-3f800827adce" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale_e3ad8634-d471-419b-8999-3f800827adce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_82712b7a-e623-47b5-8f2d-a988dd9d5ead" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_82712b7a-e623-47b5-8f2d-a988dd9d5ead" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_b8e852c1-add3-4af5-be52-9f40520a5112" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_b8e852c1-add3-4af5-be52-9f40520a5112" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_f3695ea2-7434-473b-b712-7dd6c1e7d9cf" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_f3695ea2-7434-473b-b712-7dd6c1e7d9cf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be261efb-b682-471b-852f-5ed697b5c5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b1c8574f-861b-4b9a-a942-1b7c8dd09717" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be261efb-b682-471b-852f-5ed697b5c5d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentsCreditRatingAxis_68b080d8-8236-45a2-a664-d6544fc1c4fa" xlink:href="ci-20230331.xsd#ci_InvestmentsCreditRatingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be261efb-b682-471b-852f-5ed697b5c5d4" xlink:to="loc_ci_InvestmentsCreditRatingAxis_68b080d8-8236-45a2-a664-d6544fc1c4fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentsCreditRatingDomain_68b080d8-8236-45a2-a664-d6544fc1c4fa_default" xlink:href="ci-20230331.xsd#ci_InvestmentsCreditRatingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ci_InvestmentsCreditRatingAxis_68b080d8-8236-45a2-a664-d6544fc1c4fa" xlink:to="loc_ci_InvestmentsCreditRatingDomain_68b080d8-8236-45a2-a664-d6544fc1c4fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentsCreditRatingDomain_831ec162-065d-4769-8ec8-5b7b1f808b8a" xlink:href="ci-20230331.xsd#ci_InvestmentsCreditRatingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ci_InvestmentsCreditRatingAxis_68b080d8-8236-45a2-a664-d6544fc1c4fa" xlink:to="loc_ci_InvestmentsCreditRatingDomain_831ec162-065d-4769-8ec8-5b7b1f808b8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentGradeMember_7becd578-07f1-4072-81e6-ee93a5cfec6f" xlink:href="ci-20230331.xsd#ci_InvestmentGradeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InvestmentsCreditRatingDomain_831ec162-065d-4769-8ec8-5b7b1f808b8a" xlink:to="loc_ci_InvestmentGradeMember_7becd578-07f1-4072-81e6-ee93a5cfec6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_BelowInvestmentGradeMember_2f287c09-5776-40b1-93cb-4132525f8187" xlink:href="ci-20230331.xsd#ci_BelowInvestmentGradeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InvestmentsCreditRatingDomain_831ec162-065d-4769-8ec8-5b7b1f808b8a" xlink:to="loc_ci_BelowInvestmentGradeMember_2f287c09-5776-40b1-93cb-4132525f8187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_65e5d62f-6d4b-4c44-8208-b94ccc68ac81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be261efb-b682-471b-852f-5ed697b5c5d4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_65e5d62f-6d4b-4c44-8208-b94ccc68ac81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_65e5d62f-6d4b-4c44-8208-b94ccc68ac81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_65e5d62f-6d4b-4c44-8208-b94ccc68ac81" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_65e5d62f-6d4b-4c44-8208-b94ccc68ac81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_230fbf90-8913-4e6c-952a-ae7e395a9076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_65e5d62f-6d4b-4c44-8208-b94ccc68ac81" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_230fbf90-8913-4e6c-952a-ae7e395a9076" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_29cd3338-9387-4090-a3a6-86cfd575fcf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_230fbf90-8913-4e6c-952a-ae7e395a9076" xlink:to="loc_us-gaap_DebtSecuritiesMember_29cd3338-9387-4090-a3a6-86cfd575fcf9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsEquitySecurityInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails" xlink:type="extended" id="ic3c56651cf31496b80c6d01ab5d6b7bc_InvestmentsEquitySecurityInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_4079a826-31b9-47b0-894a-9b7eb3452b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_67658ccb-f16f-4a56-b187-54912c94644f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4079a826-31b9-47b0-894a-9b7eb3452b0e" xlink:to="loc_us-gaap_OtherCommitment_67658ccb-f16f-4a56-b187-54912c94644f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PaymentsToAcquireDebtAndEquitySecurities_f756a956-f0d7-4da5-b58c-f7d191cb3ccd" xlink:href="ci-20230331.xsd#ci_PaymentsToAcquireDebtAndEquitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4079a826-31b9-47b0-894a-9b7eb3452b0e" xlink:to="loc_ci_PaymentsToAcquireDebtAndEquitySecurities_f756a956-f0d7-4da5-b58c-f7d191cb3ccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f1a10ec0-b083-46a2-9288-df49f06f8158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4079a826-31b9-47b0-894a-9b7eb3452b0e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f1a10ec0-b083-46a2-9288-df49f06f8158" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4079a826-31b9-47b0-894a-9b7eb3452b0e" xlink:to="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_f94b0e11-dedf-449e-b90a-e83ca88be242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:to="loc_us-gaap_OtherCommitmentsAxis_f94b0e11-dedf-449e-b90a-e83ca88be242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_f94b0e11-dedf-449e-b90a-e83ca88be242_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_f94b0e11-dedf-449e-b90a-e83ca88be242" xlink:to="loc_us-gaap_OtherCommitmentsDomain_f94b0e11-dedf-449e-b90a-e83ca88be242_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_1944527f-3f91-41ad-a96d-b97e7b1951b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_f94b0e11-dedf-449e-b90a-e83ca88be242" xlink:to="loc_us-gaap_OtherCommitmentsDomain_1944527f-3f91-41ad-a96d-b97e7b1951b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentToPurchaseEquitySecuritiesMember_89949958-6295-4c87-8d33-309027dc5712" xlink:href="ci-20230331.xsd#ci_CommitmentToPurchaseEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1944527f-3f91-41ad-a96d-b97e7b1951b3" xlink:to="loc_ci_CommitmentToPurchaseEquitySecuritiesMember_89949958-6295-4c87-8d33-309027dc5712" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d01d5db-ec48-45ee-b6c9-cdbf74fb6495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d01d5db-ec48-45ee-b6c9-cdbf74fb6495" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2d01d5db-ec48-45ee-b6c9-cdbf74fb6495_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d01d5db-ec48-45ee-b6c9-cdbf74fb6495" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2d01d5db-ec48-45ee-b6c9-cdbf74fb6495_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_523e5029-8dbf-40e9-b44c-e7b3af961948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d01d5db-ec48-45ee-b6c9-cdbf74fb6495" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_523e5029-8dbf-40e9-b44c-e7b3af961948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIMember_8c22a32e-7414-4969-af13-4c23d5ba4067" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_523e5029-8dbf-40e9-b44c-e7b3af961948" xlink:to="loc_ci_EquitySecuritiesFVNIMember_8c22a32e-7414-4969-af13-4c23d5ba4067" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ccf23851-aad6-42b7-8a64-336a6ac2a3e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ccf23851-aad6-42b7-8a64-336a6ac2a3e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ccf23851-aad6-42b7-8a64-336a6ac2a3e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ccf23851-aad6-42b7-8a64-336a6ac2a3e6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ccf23851-aad6-42b7-8a64-336a6ac2a3e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_93d26fa9-0183-4c41-9dd4-13d2fd847968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ccf23851-aad6-42b7-8a64-336a6ac2a3e6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_93d26fa9-0183-4c41-9dd4-13d2fd847968" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_9010e4f7-a1a7-4e8f-8028-59101dff30cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_93d26fa9-0183-4c41-9dd4-13d2fd847968" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_9010e4f7-a1a7-4e8f-8028-59101dff30cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesByIndustryAxis_ce5427be-d1e7-4760-a5b9-1924d3390b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesByIndustryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:to="loc_us-gaap_EquitySecuritiesByIndustryAxis_ce5427be-d1e7-4760-a5b9-1924d3390b65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember_ce5427be-d1e7-4760-a5b9-1924d3390b65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis_ce5427be-d1e7-4760-a5b9-1924d3390b65" xlink:to="loc_us-gaap_EquitySecuritiesIndustryMember_ce5427be-d1e7-4760-a5b9-1924d3390b65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember_6380e44c-656e-4d8c-a1fe-7acf35fe6a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis_ce5427be-d1e7-4760-a5b9-1924d3390b65" xlink:to="loc_us-gaap_EquitySecuritiesIndustryMember_6380e44c-656e-4d8c-a1fe-7acf35fe6a78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthcareSectorMember_92a09180-e377-43bc-a79b-c840a608e9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthcareSectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_6380e44c-656e-4d8c-a1fe-7acf35fe6a78" xlink:to="loc_us-gaap_HealthcareSectorMember_92a09180-e377-43bc-a79b-c840a608e9a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f7f458e8-9239-4a16-804f-0aacc27740f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f7f458e8-9239-4a16-804f-0aacc27740f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f7f458e8-9239-4a16-804f-0aacc27740f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f7f458e8-9239-4a16-804f-0aacc27740f6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f7f458e8-9239-4a16-804f-0aacc27740f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7a4794ac-9378-44f6-9ee5-79613a8e6403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f7f458e8-9239-4a16-804f-0aacc27740f6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7a4794ac-9378-44f6-9ee5-79613a8e6403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_16c5172a-23ad-44a6-99f4-2f4578325249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7a4794ac-9378-44f6-9ee5-79613a8e6403" xlink:to="loc_us-gaap_SubsequentEventMember_16c5172a-23ad-44a6-99f4-2f4578325249" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails" xlink:type="extended" id="i736f42298ca345b5bd044090c92db7fe_InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_c87c6b80-3daa-4486-a943-13dc1676a9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_c87c6b80-3daa-4486-a943-13dc1676a9b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_f3da6f22-ba9a-4931-9ddd-331f7d952df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_f3da6f22-ba9a-4931-9ddd-331f7d952df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_ee1b9655-f97d-4424-af31-5920dfee9327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_ee1b9655-f97d-4424-af31-5920dfee9327" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio_e0435209-24ad-41b0-95c8-4d3af83d6bc9" xlink:href="ci-20230331.xsd#ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:to="loc_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio_e0435209-24ad-41b0-95c8-4d3af83d6bc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FinancingReceivableCreditQualityLoanToValueRatio_b9c7ffdb-21fe-46aa-95c9-6f0befc05f8c" xlink:href="ci-20230331.xsd#ci_FinancingReceivableCreditQualityLoanToValueRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:to="loc_ci_FinancingReceivableCreditQualityLoanToValueRatio_b9c7ffdb-21fe-46aa-95c9-6f0befc05f8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_f1f78a11-f5cd-4971-a34a-fe1766420951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_f1f78a11-f5cd-4971-a34a-fe1766420951" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_f1f78a11-f5cd-4971-a34a-fe1766420951_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_f1f78a11-f5cd-4971-a34a-fe1766420951" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_f1f78a11-f5cd-4971-a34a-fe1766420951_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_8322c65b-a12f-44b5-87fa-2abd99caef7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_f1f78a11-f5cd-4971-a34a-fe1766420951" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_8322c65b-a12f-44b5-87fa-2abd99caef7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLoanMember_c411ed34-8619-44bc-99df-c23f6414228d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_8322c65b-a12f-44b5-87fa-2abd99caef7c" xlink:to="loc_us-gaap_RealEstateLoanMember_c411ed34-8619-44bc-99df-c23f6414228d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_5582fe66-2d19-4ef8-91de-f498f5a5dee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:to="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_5582fe66-2d19-4ef8-91de-f498f5a5dee6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_5582fe66-2d19-4ef8-91de-f498f5a5dee6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_5582fe66-2d19-4ef8-91de-f498f5a5dee6" xlink:to="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_5582fe66-2d19-4ef8-91de-f498f5a5dee6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_9ed497e3-f17c-4751-9d75-c0cb674a9be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_5582fe66-2d19-4ef8-91de-f498f5a5dee6" xlink:to="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_9ed497e3-f17c-4751-9d75-c0cb674a9be9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPortfolioSegmentMember_d344d6e0-ea71-400d-92f0-b288681ecec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPortfolioSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_9ed497e3-f17c-4751-9d75-c0cb674a9be9" xlink:to="loc_us-gaap_CommercialPortfolioSegmentMember_d344d6e0-ea71-400d-92f0-b288681ecec4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueAxis_04f3d0b3-6f14-4a4c-8dc9-881d98d187ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:to="loc_us-gaap_LoanToValueAxis_04f3d0b3-6f14-4a4c-8dc9-881d98d187ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_04f3d0b3-6f14-4a4c-8dc9-881d98d187ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LoanToValueAxis_04f3d0b3-6f14-4a4c-8dc9-881d98d187ac" xlink:to="loc_us-gaap_LoanToValueDomain_04f3d0b3-6f14-4a4c-8dc9-881d98d187ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_81164d73-a26c-4d88-b75c-118676123f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LoanToValueAxis_04f3d0b3-6f14-4a4c-8dc9-881d98d187ac" xlink:to="loc_us-gaap_LoanToValueDomain_81164d73-a26c-4d88-b75c-118676123f2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LtvLessThan60PercentMember_c6fedcb6-430b-408d-8daa-b001ef5fd743" xlink:href="ci-20230331.xsd#ci_LtvLessThan60PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_81164d73-a26c-4d88-b75c-118676123f2b" xlink:to="loc_ci_LtvLessThan60PercentMember_c6fedcb6-430b-408d-8daa-b001ef5fd743" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_Ltv60To79PercentMember_fd493e3d-849d-41c6-8222-96b8c5770613" xlink:href="ci-20230331.xsd#ci_Ltv60To79PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_81164d73-a26c-4d88-b75c-118676123f2b" xlink:to="loc_ci_Ltv60To79PercentMember_fd493e3d-849d-41c6-8222-96b8c5770613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Ltv80To100PercentMember_697b47fd-2dd1-4ee5-9f6f-d42e1b5fe9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Ltv80To100PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_81164d73-a26c-4d88-b75c-118676123f2b" xlink:to="loc_us-gaap_Ltv80To100PercentMember_697b47fd-2dd1-4ee5-9f6f-d42e1b5fe9a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LtvGreaterThan100PercentMember_5e676d98-2201-4229-a33d-a1bf32c28af2" xlink:href="ci-20230331.xsd#ci_LtvGreaterThan100PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LoanToValueDomain_81164d73-a26c-4d88-b75c-118676123f2b" xlink:to="loc_ci_LtvGreaterThan100PercentMember_5e676d98-2201-4229-a33d-a1bf32c28af2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e0a7a14e-b755-40f0-9d33-0c9268511369" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:to="loc_srt_RangeAxis_e0a7a14e-b755-40f0-9d33-0c9268511369" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e0a7a14e-b755-40f0-9d33-0c9268511369_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e0a7a14e-b755-40f0-9d33-0c9268511369" xlink:to="loc_srt_RangeMember_e0a7a14e-b755-40f0-9d33-0c9268511369_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6ffa6548-5554-4cbe-b5ae-d16fabf676ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e0a7a14e-b755-40f0-9d33-0c9268511369" xlink:to="loc_srt_RangeMember_6ffa6548-5554-4cbe-b5ae-d16fabf676ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_11cd2fc8-53a9-4c41-bf79-4d807649dd1a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6ffa6548-5554-4cbe-b5ae-d16fabf676ba" xlink:to="loc_srt_WeightedAverageMember_11cd2fc8-53a9-4c41-bf79-4d807649dd1a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails" xlink:type="extended" id="ic056ef1fbc7c4e998baf8240aa2d5493_InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear_28d1afdd-fb98-441e-9262-95ef59cfb4e7" xlink:href="ci-20230331.xsd#ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:to="loc_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear_28d1afdd-fb98-441e-9262-95ef59cfb4e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_31d24a1e-b91f-4c27-9ffa-0cca845769b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_31d24a1e-b91f-4c27-9ffa-0cca845769b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_7b319e9e-6c2a-44c4-a696-e1110287be58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:to="loc_us-gaap_OtherLongTermInvestments_7b319e9e-6c2a-44c4-a696-e1110287be58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1af39b0e-08c1-4737-8576-3b0b4a649cc9" xlink:href="ci-20230331.xsd#ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:to="loc_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1af39b0e-08c1-4737-8576-3b0b4a649cc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsToContributeAdditionalEquityAndCapital_558c877d-2f4a-434a-8eb1-ffe074a2bc73" xlink:href="ci-20230331.xsd#ci_CommitmentsToContributeAdditionalEquityAndCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:to="loc_ci_CommitmentsToContributeAdditionalEquityAndCapital_558c877d-2f4a-434a-8eb1-ffe074a2bc73" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_29a57044-3775-46c5-80ef-e6bc8111628d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_29a57044-3775-46c5-80ef-e6bc8111628d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_c38c52ab-9dec-4d35-a8e3-380bff1ebac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_29a57044-3775-46c5-80ef-e6bc8111628d" xlink:to="loc_us-gaap_InvestmentTypeAxis_c38c52ab-9dec-4d35-a8e3-380bff1ebac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c38c52ab-9dec-4d35-a8e3-380bff1ebac2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_c38c52ab-9dec-4d35-a8e3-380bff1ebac2" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c38c52ab-9dec-4d35-a8e3-380bff1ebac2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_46ce1804-8de6-4353-9706-86953bdd27bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_c38c52ab-9dec-4d35-a8e3-380bff1ebac2" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_46ce1804-8de6-4353-9706-86953bdd27bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentMember_7a187182-e702-4bf6-8dbc-55740a7fc2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_46ce1804-8de6-4353-9706-86953bdd27bb" xlink:to="loc_us-gaap_RealEstateInvestmentMember_7a187182-e702-4bf6-8dbc-55740a7fc2cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PartnershipInterestMember_9f061c27-6c00-4976-9e4d-75a44e45e0c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_PartnershipInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_46ce1804-8de6-4353-9706-86953bdd27bb" xlink:to="loc_srt_PartnershipInterestMember_9f061c27-6c00-4976-9e4d-75a44e45e0c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_082e0dcc-29ad-402b-80ee-23a2cab1d64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_46ce1804-8de6-4353-9706-86953bdd27bb" xlink:to="loc_us-gaap_OtherInvestmentsMember_082e0dcc-29ad-402b-80ee-23a2cab1d64d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsSummaryofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails" xlink:type="extended" id="i20734e88190c4729b67f214cbe623247_InvestmentsSummaryofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_243ef271-d00f-4f6f-bf27-5797157da247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_0940a32f-4a18-4268-97c6-21ef48988c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_243ef271-d00f-4f6f-bf27-5797157da247" xlink:to="loc_us-gaap_DerivativeNotionalAmount_0940a32f-4a18-4268-97c6-21ef48988c87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_c8b19f27-a8a9-461c-aa6a-5d561fe4704f" xlink:href="ci-20230331.xsd#ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_243ef271-d00f-4f6f-bf27-5797157da247" xlink:to="loc_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_c8b19f27-a8a9-461c-aa6a-5d561fe4704f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c5bdbec7-7375-4c83-bebc-a719f67d058e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_243ef271-d00f-4f6f-bf27-5797157da247" xlink:to="loc_us-gaap_DerivativeTable_c5bdbec7-7375-4c83-bebc-a719f67d058e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1af8cfb5-71b3-4d49-9d42-246075b08cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c5bdbec7-7375-4c83-bebc-a719f67d058e" xlink:to="loc_us-gaap_HedgingDesignationAxis_1af8cfb5-71b3-4d49-9d42-246075b08cd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1af8cfb5-71b3-4d49-9d42-246075b08cd2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_1af8cfb5-71b3-4d49-9d42-246075b08cd2" xlink:to="loc_us-gaap_HedgingDesignationDomain_1af8cfb5-71b3-4d49-9d42-246075b08cd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7d2582d9-caee-466d-95f8-825eec4468bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_1af8cfb5-71b3-4d49-9d42-246075b08cd2" xlink:to="loc_us-gaap_HedgingDesignationDomain_7d2582d9-caee-466d-95f8-825eec4468bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_92c98d7f-d62f-4c0c-9c66-bd7851d95a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_7d2582d9-caee-466d-95f8-825eec4468bc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_92c98d7f-d62f-4c0c-9c66-bd7851d95a76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember_3bef384d-4ea7-470b-9c5f-ac8f2257e45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_7d2582d9-caee-466d-95f8-825eec4468bc" xlink:to="loc_us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember_3bef384d-4ea7-470b-9c5f-ac8f2257e45a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2da7b04-e17f-4cb5-8701-cdd7b7cf689c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c5bdbec7-7375-4c83-bebc-a719f67d058e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2da7b04-e17f-4cb5-8701-cdd7b7cf689c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d2da7b04-e17f-4cb5-8701-cdd7b7cf689c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2da7b04-e17f-4cb5-8701-cdd7b7cf689c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d2da7b04-e17f-4cb5-8701-cdd7b7cf689c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bdbc4a07-ce3c-4e70-bca6-07886a8a9748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2da7b04-e17f-4cb5-8701-cdd7b7cf689c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bdbc4a07-ce3c-4e70-bca6-07886a8a9748" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_9cedee8c-36f0-4443-ae83-b7c29239992c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bdbc4a07-ce3c-4e70-bca6-07886a8a9748" xlink:to="loc_us-gaap_FairValueHedgingMember_9cedee8c-36f0-4443-ae83-b7c29239992c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d518f47b-4a37-4047-a023-6fb75255315d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bdbc4a07-ce3c-4e70-bca6-07886a8a9748" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d518f47b-4a37-4047-a023-6fb75255315d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_40a798c1-338b-4071-9a5c-dbd572fd7508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c5bdbec7-7375-4c83-bebc-a719f67d058e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_40a798c1-338b-4071-9a5c-dbd572fd7508" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_40a798c1-338b-4071-9a5c-dbd572fd7508_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_40a798c1-338b-4071-9a5c-dbd572fd7508" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_40a798c1-338b-4071-9a5c-dbd572fd7508_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a1722524-1be5-4f9b-9acc-cce375e3fa77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_40a798c1-338b-4071-9a5c-dbd572fd7508" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a1722524-1be5-4f9b-9acc-cce375e3fa77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_bb5e0786-c45d-44a4-bb96-2817f7ed933b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a1722524-1be5-4f9b-9acc-cce375e3fa77" xlink:to="loc_us-gaap_CurrencySwapMember_bb5e0786-c45d-44a4-bb96-2817f7ed933b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e0ce76c9-9e76-4cc8-8f49-61d3aec536f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a1722524-1be5-4f9b-9acc-cce375e3fa77" xlink:to="loc_us-gaap_InterestRateSwapMember_e0ce76c9-9e76-4cc8-8f49-61d3aec536f4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsComponentsofNetInvestmentIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails" xlink:type="extended" id="i500990c1296e4a7e9593e6e696445563_InvestmentsComponentsofNetInvestmentIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_76a29f04-5ef7-4a10-a80f-be775f5de21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue_fc5f04bb-c78a-4d9c-a0d2-f580c21589cd" xlink:href="ci-20230331.xsd#ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_76a29f04-5ef7-4a10-a80f-be775f5de21f" xlink:to="loc_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue_fc5f04bb-c78a-4d9c-a0d2-f580c21589cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_9a5b084b-3da9-4f5c-8bd3-9dbc99f86ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_76a29f04-5ef7-4a10-a80f-be775f5de21f" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_9a5b084b-3da9-4f5c-8bd3-9dbc99f86ec1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_70e1cafa-799b-4332-920d-18d02ebc4ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_76a29f04-5ef7-4a10-a80f-be775f5de21f" xlink:to="loc_us-gaap_NetInvestmentIncome_70e1cafa-799b-4332-920d-18d02ebc4ec7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_e01242ad-92e9-4dcc-a0c4-3e95ce512a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_76a29f04-5ef7-4a10-a80f-be775f5de21f" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_e01242ad-92e9-4dcc-a0c4-3e95ce512a2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4da12ce7-044b-4c91-9935-671adabf0127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_e01242ad-92e9-4dcc-a0c4-3e95ce512a2a" xlink:to="loc_us-gaap_InvestmentTypeAxis_4da12ce7-044b-4c91-9935-671adabf0127" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4da12ce7-044b-4c91-9935-671adabf0127_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_4da12ce7-044b-4c91-9935-671adabf0127" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4da12ce7-044b-4c91-9935-671adabf0127_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_4da12ce7-044b-4c91-9935-671adabf0127" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_af172443-a22e-41e3-b603-5a50d5469f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:to="loc_us-gaap_DebtSecuritiesMember_af172443-a22e-41e3-b603-5a50d5469f51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_9d6de117-21ec-46ea-b36a-22cecd08575e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:to="loc_us-gaap_EquitySecuritiesMember_9d6de117-21ec-46ea-b36a-22cecd08575e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_71583217-96fb-45ea-8364-44f54c0a0b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:to="loc_us-gaap_MortgagesMember_71583217-96fb-45ea-8364-44f54c0a0b06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyLoansMember_1f8a50c2-6f27-4154-b890-846070cc4e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:to="loc_us-gaap_PolicyLoansMember_1f8a50c2-6f27-4154-b890-846070cc4e52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_f4afcf25-7bb5-4318-8485-8a6437b1897c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_f4afcf25-7bb5-4318-8485-8a6437b1897c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CashCashEquivalentsAndShortTermInvestmentsMember_1b12f986-a790-4eef-aaa2-31dad8b7b3c8" xlink:href="ci-20230331.xsd#ci_CashCashEquivalentsAndShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:to="loc_ci_CashCashEquivalentsAndShortTermInvestmentsMember_1b12f986-a790-4eef-aaa2-31dad8b7b3c8" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="extended" id="if6b40524cf8a493eb3d86b0b130e741a_FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_92ead5af-926b-433d-8427-ab12d0838722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_92ead5af-926b-433d-8427-ab12d0838722" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71d22f6c-2ea6-4f00-bcb1-ef5bbf6e2c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71d22f6c-2ea6-4f00-bcb1-ef5bbf6e2c54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_27a7db23-3975-487b-8f86-fcff8a2663a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_27a7db23-3975-487b-8f86-fcff8a2663a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments_3c561dea-273a-48a5-97de-391a9ea95e58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_us-gaap_OtherShortTermInvestments_3c561dea-273a-48a5-97de-391a9ea95e58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_9521497f-5a93-4e9e-a9fb-fbe2768a55c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_us-gaap_DerivativeAssets_9521497f-5a93-4e9e-a9fb-fbe2768a55c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_68364c48-02c4-45a4-856a-8bcee96ea596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_68364c48-02c4-45a4-856a-8bcee96ea596" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_724c3dfc-d1ea-494b-bd67-aeaa7b700d70" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_724c3dfc-d1ea-494b-bd67-aeaa7b700d70" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale_e2fc0a6d-ed55-495f-9883-57de189fe7d2" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale_e2fc0a6d-ed55-495f-9883-57de189fe7d2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_ee8b78f1-f5a4-4fcb-a6c3-6075e7b5e027" xlink:href="ci-20230331.xsd#ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_ee8b78f1-f5a4-4fcb-a6c3-6075e7b5e027" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_da1b7fd0-cb8b-4ee9-b40a-0fd86dfb00e3" xlink:href="ci-20230331.xsd#ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_da1b7fd0-cb8b-4ee9-b40a-0fd86dfb00e3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5b78b1d9-1330-4907-aba6-97c6996a87f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_92ead5af-926b-433d-8427-ab12d0838722" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5b78b1d9-1330-4907-aba6-97c6996a87f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_d422353a-143d-41ec-923a-3b371a18de02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5b78b1d9-1330-4907-aba6-97c6996a87f4" xlink:to="loc_us-gaap_DerivativeLiabilities_d422353a-143d-41ec-923a-3b371a18de02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale_eb477adc-17e1-4399-ab60-d6fb7c4a75c0" xlink:href="ci-20230331.xsd#ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5b78b1d9-1330-4907-aba6-97c6996a87f4" xlink:to="loc_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale_eb477adc-17e1-4399-ab60-d6fb7c4a75c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_92ead5af-926b-433d-8427-ab12d0838722" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e5f25a1d-982a-4d4d-bc52-d977b01fd8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e5f25a1d-982a-4d4d-bc52-d977b01fd8ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e5f25a1d-982a-4d4d-bc52-d977b01fd8ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e5f25a1d-982a-4d4d-bc52-d977b01fd8ba" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e5f25a1d-982a-4d4d-bc52-d977b01fd8ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e5f25a1d-982a-4d4d-bc52-d977b01fd8ba" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_0f2cb5cf-8190-476a-824b-13a08e085b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_0f2cb5cf-8190-476a-824b-13a08e085b31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f058e53c-cd20-4103-a311-6f02bc84ff5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f058e53c-cd20-4103-a311-6f02bc84ff5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_323f8681-c13d-45ae-8c16-15e5d6592258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_323f8681-c13d-45ae-8c16-15e5d6592258" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_8d48114f-e8de-429f-ab12-8ecb11122655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_8d48114f-e8de-429f-ab12-8ecb11122655" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_7d2bba9e-e02b-4f29-aade-ef2b176b65cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_7d2bba9e-e02b-4f29-aade-ef2b176b65cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be315465-512b-44ee-8067-36ef91342b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be315465-512b-44ee-8067-36ef91342b0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be315465-512b-44ee-8067-36ef91342b0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be315465-512b-44ee-8067-36ef91342b0f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be315465-512b-44ee-8067-36ef91342b0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6181e5d7-3149-44a3-ba20-e4f6774bf944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be315465-512b-44ee-8067-36ef91342b0f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6181e5d7-3149-44a3-ba20-e4f6774bf944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e5b5cfd7-60bd-4174-920d-a7bdf9916944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6181e5d7-3149-44a3-ba20-e4f6774bf944" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e5b5cfd7-60bd-4174-920d-a7bdf9916944" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6b4d239c-561e-4ae1-b4d3-bef24af70ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6181e5d7-3149-44a3-ba20-e4f6774bf944" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6b4d239c-561e-4ae1-b4d3-bef24af70ddc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d5459f25-026f-4047-94cd-1d24faf5d9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6181e5d7-3149-44a3-ba20-e4f6774bf944" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d5459f25-026f-4047-94cd-1d24faf5d9ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_225d1c2d-5500-4b3d-9b5c-eaf92ceaae6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_225d1c2d-5500-4b3d-9b5c-eaf92ceaae6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_225d1c2d-5500-4b3d-9b5c-eaf92ceaae6f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_225d1c2d-5500-4b3d-9b5c-eaf92ceaae6f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_225d1c2d-5500-4b3d-9b5c-eaf92ceaae6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_77267339-be5c-4846-9305-9a5094580b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_225d1c2d-5500-4b3d-9b5c-eaf92ceaae6f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_77267339-be5c-4846-9305-9a5094580b99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7c5cf837-0214-4ee5-bb7d-cf33f5d90c12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_77267339-be5c-4846-9305-9a5094580b99" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7c5cf837-0214-4ee5-bb7d-cf33f5d90c12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_69527bd1-ac51-4e54-8712-846841d96581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_69527bd1-ac51-4e54-8712-846841d96581" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_69527bd1-ac51-4e54-8712-846841d96581_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_69527bd1-ac51-4e54-8712-846841d96581" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_69527bd1-ac51-4e54-8712-846841d96581_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9a54f1bc-86b5-4c1e-8b2f-1d3bd0a1bfd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_69527bd1-ac51-4e54-8712-846841d96581" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9a54f1bc-86b5-4c1e-8b2f-1d3bd0a1bfd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ForwardsSwapsOptionsMember_d6ed0037-1d8c-4fee-91a8-6db932110801" xlink:href="ci-20230331.xsd#ci_ForwardsSwapsOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a54f1bc-86b5-4c1e-8b2f-1d3bd0a1bfd6" xlink:to="loc_ci_ForwardsSwapsOptionsMember_d6ed0037-1d8c-4fee-91a8-6db932110801" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwapMember_c1f38951-a5bf-4c6d-b84a-dbf3a07e559a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_ForwardsSwapsOptionsMember_d6ed0037-1d8c-4fee-91a8-6db932110801" xlink:to="loc_us-gaap_SwapMember_c1f38951-a5bf-4c6d-b84a-dbf3a07e559a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i78feafd3dd3c4fd8b13d7cd89b6ab7af_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale_65fffec7-271a-4739-9f93-608e114fd800" xlink:href="ci-20230331.xsd#ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale_65fffec7-271a-4739-9f93-608e114fd800" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale_f8d54690-8e61-4d5c-b3eb-acb30df75dbf" xlink:href="ci-20230331.xsd#ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale_f8d54690-8e61-4d5c-b3eb-acb30df75dbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_3fe7f903-e15a-4a1b-b4e2-8c133dc9b260" xlink:href="ci-20230331.xsd#ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_3fe7f903-e15a-4a1b-b4e2-8c133dc9b260" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage_d464022e-6f6f-4509-85bf-1e2e2631517f" xlink:href="ci-20230331.xsd#ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage_d464022e-6f6f-4509-85bf-1e2e2631517f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets_41a85811-79f1-4b2f-87b3-3eee053a7693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets_41a85811-79f1-4b2f-87b3-3eee053a7693" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_8d0d2fe5-3aa6-4d2f-8832-aaa12bb6de34" xlink:href="ci-20230331.xsd#ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_8d0d2fe5-3aa6-4d2f-8832-aaa12bb6de34" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities_fca40c7f-e5b3-425b-b838-7208734ff021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities_fca40c7f-e5b3-425b-b838-7208734ff021" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_46bf6d60-bf10-4cbe-9aa1-9383f053700b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_46bf6d60-bf10-4cbe-9aa1-9383f053700b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups_9c8b3178-4436-4e65-b954-47de605ee36e" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups_9c8b3178-4436-4e65-b954-47de605ee36e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception_43c1d20f-0cd7-4127-b89e-3769f03849ad" xlink:href="ci-20230331.xsd#ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception_43c1d20f-0cd7-4127-b89e-3769f03849ad" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88136f14-0956-4ac2-a9e1-7b0c8c06def7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88136f14-0956-4ac2-a9e1-7b0c8c06def7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88136f14-0956-4ac2-a9e1-7b0c8c06def7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88136f14-0956-4ac2-a9e1-7b0c8c06def7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88136f14-0956-4ac2-a9e1-7b0c8c06def7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ca31b6a-a76f-4751-86cf-14290e9ac035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88136f14-0956-4ac2-a9e1-7b0c8c06def7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ca31b6a-a76f-4751-86cf-14290e9ac035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_11f47f9e-32bf-4b54-a3dd-593dae0350fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ca31b6a-a76f-4751-86cf-14290e9ac035" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_11f47f9e-32bf-4b54-a3dd-593dae0350fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_62924400-8c39-4605-b1c3-9a4e53da446c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_62924400-8c39-4605-b1c3-9a4e53da446c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_62924400-8c39-4605-b1c3-9a4e53da446c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_62924400-8c39-4605-b1c3-9a4e53da446c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_62924400-8c39-4605-b1c3-9a4e53da446c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6ba50504-b0b9-466b-84f3-c970305cbdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_62924400-8c39-4605-b1c3-9a4e53da446c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6ba50504-b0b9-466b-84f3-c970305cbdcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsMember_4949be65-6a94-46f4-8717-d4c3e0739511" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6ba50504-b0b9-466b-84f3-c970305cbdcd" xlink:to="loc_ci_SeparateAccountAssetsMember_4949be65-6a94-46f4-8717-d4c3e0739511" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9cc604a-a143-418b-ac89-13aac624a5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9cc604a-a143-418b-ac89-13aac624a5a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e9cc604a-a143-418b-ac89-13aac624a5a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9cc604a-a143-418b-ac89-13aac624a5a3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e9cc604a-a143-418b-ac89-13aac624a5a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_09226758-93c7-46f7-a919-8fb4e2c096dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9cc604a-a143-418b-ac89-13aac624a5a3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_09226758-93c7-46f7-a919-8fb4e2c096dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f2a7f025-3ccb-4e4e-b646-c87a4b0d6de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_09226758-93c7-46f7-a919-8fb4e2c096dc" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f2a7f025-3ccb-4e4e-b646-c87a4b0d6de8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_d0227a80-e097-40ac-a4f1-3a6a0f40bd34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_us-gaap_InvestmentTypeAxis_d0227a80-e097-40ac-a4f1-3a6a0f40bd34" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_d0227a80-e097-40ac-a4f1-3a6a0f40bd34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_d0227a80-e097-40ac-a4f1-3a6a0f40bd34" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_d0227a80-e097-40ac-a4f1-3a6a0f40bd34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3e311f0f-dc52-4164-ae4a-aa26d0de92e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_d0227a80-e097-40ac-a4f1-3a6a0f40bd34" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3e311f0f-dc52-4164-ae4a-aa26d0de92e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PartnershipInterestMember_b80831e7-506b-4a7e-9f2d-a04c62c52b40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_PartnershipInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3e311f0f-dc52-4164-ae4a-aa26d0de92e4" xlink:to="loc_srt_PartnershipInterestMember_b80831e7-506b-4a7e-9f2d-a04c62c52b40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b17f2947-6ee2-4fb9-9de7-1a9db66d8d5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_srt_RangeAxis_b17f2947-6ee2-4fb9-9de7-1a9db66d8d5c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b17f2947-6ee2-4fb9-9de7-1a9db66d8d5c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b17f2947-6ee2-4fb9-9de7-1a9db66d8d5c" xlink:to="loc_srt_RangeMember_b17f2947-6ee2-4fb9-9de7-1a9db66d8d5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19ff5450-a623-404c-9e79-9ec70e57a9fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b17f2947-6ee2-4fb9-9de7-1a9db66d8d5c" xlink:to="loc_srt_RangeMember_19ff5450-a623-404c-9e79-9ec70e57a9fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d870af3c-882d-454e-b348-f37d684e7ada" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_19ff5450-a623-404c-9e79-9ec70e57a9fb" xlink:to="loc_srt_MaximumMember_d870af3c-882d-454e-b348-f37d684e7ada" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8f1486f6-2921-49f3-8e5e-13db345e2588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8f1486f6-2921-49f3-8e5e-13db345e2588" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8f1486f6-2921-49f3-8e5e-13db345e2588_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8f1486f6-2921-49f3-8e5e-13db345e2588" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8f1486f6-2921-49f3-8e5e-13db345e2588_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e26ff519-f505-44b3-8826-ad7acd49ea5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8f1486f6-2921-49f3-8e5e-13db345e2588" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e26ff519-f505-44b3-8826-ad7acd49ea5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwapMember_360573f0-1b6c-42cf-bbdd-b39de338a92e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e26ff519-f505-44b3-8826-ad7acd49ea5f" xlink:to="loc_us-gaap_SwapMember_360573f0-1b6c-42cf-bbdd-b39de338a92e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails" xlink:type="extended" id="ib515da04968f435091babaa99649ef71_FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9b9bf55-20c4-4995-8ce6-13f6d55b3c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_31f4a7c8-83c9-4e81-81ec-5ab489796cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9b9bf55-20c4-4995-8ce6-13f6d55b3c6b" xlink:to="loc_us-gaap_MarketableSecurities_31f4a7c8-83c9-4e81-81ec-5ab489796cc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_25c08cce-1d84-4334-90b6-0f18563e75a2" xlink:href="ci-20230331.xsd#ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9b9bf55-20c4-4995-8ce6-13f6d55b3c6b" xlink:to="loc_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_25c08cce-1d84-4334-90b6-0f18563e75a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput_a40c060f-1e2b-44e3-9955-36d911e567d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9b9bf55-20c4-4995-8ce6-13f6d55b3c6b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput_a40c060f-1e2b-44e3-9955-36d911e567d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput_7134ccb0-63f1-43c1-a8aa-58e8bbea9932" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9b9bf55-20c4-4995-8ce6-13f6d55b3c6b" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput_7134ccb0-63f1-43c1-a8aa-58e8bbea9932" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9b9bf55-20c4-4995-8ce6-13f6d55b3c6b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_147a9d81-73c5-4449-8738-02925e3cd317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_147a9d81-73c5-4449-8738-02925e3cd317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_147a9d81-73c5-4449-8738-02925e3cd317_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_147a9d81-73c5-4449-8738-02925e3cd317" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_147a9d81-73c5-4449-8738-02925e3cd317_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_90a49a75-645d-4f2d-8db5-71e7f9050d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_147a9d81-73c5-4449-8738-02925e3cd317" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_90a49a75-645d-4f2d-8db5-71e7f9050d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_eff26177-35fd-4009-a8bb-8b9558ea2cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_90a49a75-645d-4f2d-8db5-71e7f9050d6c" xlink:to="loc_us-gaap_DebtSecuritiesMember_eff26177-35fd-4009-a8bb-8b9558ea2cbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CorporateAndGovernmentDebtSecuritiesMember_d27133cc-3326-479b-aa9a-fb170ffa30e5" xlink:href="ci-20230331.xsd#ci_CorporateAndGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_eff26177-35fd-4009-a8bb-8b9558ea2cbb" xlink:to="loc_ci_CorporateAndGovernmentDebtSecuritiesMember_d27133cc-3326-479b-aa9a-fb170ffa30e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_e6f968f6-3792-4360-aaa2-29bf93d375ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_eff26177-35fd-4009-a8bb-8b9558ea2cbb" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_e6f968f6-3792-4360-aaa2-29bf93d375ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_7f6054c5-0872-40d2-adc1-a7d7a45a5aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_eff26177-35fd-4009-a8bb-8b9558ea2cbb" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_7f6054c5-0872-40d2-adc1-a7d7a45a5aef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_0f551f4f-e22e-4ee7-948e-e24ad02f8a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_us-gaap_ValuationTechniqueAxis_0f551f4f-e22e-4ee7-948e-e24ad02f8a52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_0f551f4f-e22e-4ee7-948e-e24ad02f8a52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_0f551f4f-e22e-4ee7-948e-e24ad02f8a52" xlink:to="loc_us-gaap_ValuationTechniqueDomain_0f551f4f-e22e-4ee7-948e-e24ad02f8a52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_79fe8340-ec43-4667-8f11-30c08dc80334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_0f551f4f-e22e-4ee7-948e-e24ad02f8a52" xlink:to="loc_us-gaap_ValuationTechniqueDomain_79fe8340-ec43-4667-8f11-30c08dc80334" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnobservableInputsDevelopedByCompanyMember_b28cf900-0470-4152-b37b-8674b71c4ce8" xlink:href="ci-20230331.xsd#ci_UnobservableInputsDevelopedByCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_79fe8340-ec43-4667-8f11-30c08dc80334" xlink:to="loc_ci_UnobservableInputsDevelopedByCompanyMember_b28cf900-0470-4152-b37b-8674b71c4ce8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnobservableInputsNotDevelopedByCompanyMember_e0803c26-d1bc-4d61-9b8c-7063b87f895b" xlink:href="ci-20230331.xsd#ci_UnobservableInputsNotDevelopedByCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_79fe8340-ec43-4667-8f11-30c08dc80334" xlink:to="loc_ci_UnobservableInputsNotDevelopedByCompanyMember_e0803c26-d1bc-4d61-9b8c-7063b87f895b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968b93ae-a701-4bd0-8828-23a48a03b394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968b93ae-a701-4bd0-8828-23a48a03b394" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_968b93ae-a701-4bd0-8828-23a48a03b394_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968b93ae-a701-4bd0-8828-23a48a03b394" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_968b93ae-a701-4bd0-8828-23a48a03b394_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_514afe6e-65c2-4c0b-a3d4-ea29b122ee2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968b93ae-a701-4bd0-8828-23a48a03b394" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_514afe6e-65c2-4c0b-a3d4-ea29b122ee2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_07a7f021-7721-49e9-b534-6e9ffbaf4b70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_514afe6e-65c2-4c0b-a3d4-ea29b122ee2b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_07a7f021-7721-49e9-b534-6e9ffbaf4b70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec0db558-4c5a-4ae0-aee2-15a86b78c013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec0db558-4c5a-4ae0-aee2-15a86b78c013" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ec0db558-4c5a-4ae0-aee2-15a86b78c013_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec0db558-4c5a-4ae0-aee2-15a86b78c013" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ec0db558-4c5a-4ae0-aee2-15a86b78c013_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bffd0354-7a6f-4f0a-9f5f-902556c75250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec0db558-4c5a-4ae0-aee2-15a86b78c013" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bffd0354-7a6f-4f0a-9f5f-902556c75250" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_dacfc57d-2a20-449f-a55f-b9ed663783a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bffd0354-7a6f-4f0a-9f5f-902556c75250" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_dacfc57d-2a20-449f-a55f-b9ed663783a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_99308cba-bdfd-4342-876c-69e1c47b2a64" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_srt_RangeAxis_99308cba-bdfd-4342-876c-69e1c47b2a64" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_99308cba-bdfd-4342-876c-69e1c47b2a64_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_99308cba-bdfd-4342-876c-69e1c47b2a64" xlink:to="loc_srt_RangeMember_99308cba-bdfd-4342-876c-69e1c47b2a64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_39ab071b-b56f-4a25-ac6d-cdf118a64857" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_99308cba-bdfd-4342-876c-69e1c47b2a64" xlink:to="loc_srt_RangeMember_39ab071b-b56f-4a25-ac6d-cdf118a64857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_429bd2cc-6a9a-4c09-852b-8c9949e40840" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_39ab071b-b56f-4a25-ac6d-cdf118a64857" xlink:to="loc_srt_MinimumMember_429bd2cc-6a9a-4c09-852b-8c9949e40840" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a742ded0-6229-45d0-898e-d622aefa0145" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_39ab071b-b56f-4a25-ac6d-cdf118a64857" xlink:to="loc_srt_MaximumMember_a742ded0-6229-45d0-898e-d622aefa0145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_440b0cdc-9b7d-4d57-b550-57ed121acfe9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_39ab071b-b56f-4a25-ac6d-cdf118a64857" xlink:to="loc_srt_WeightedAverageMember_440b0cdc-9b7d-4d57-b550-57ed121acfe9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_7d38e5df-99ed-4712-ae54-08761f78ab25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_7d38e5df-99ed-4712-ae54-08761f78ab25" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_7d38e5df-99ed-4712-ae54-08761f78ab25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7d38e5df-99ed-4712-ae54-08761f78ab25" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_7d38e5df-99ed-4712-ae54-08761f78ab25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_d36bad20-82f9-46f9-9fa6-91ac04383b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7d38e5df-99ed-4712-ae54-08761f78ab25" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_d36bad20-82f9-46f9-9fa6-91ac04383b49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MeasurementInputLiquidityMember_69c79599-b79c-4475-888a-f0e5f819a928" xlink:href="ci-20230331.xsd#ci_MeasurementInputLiquidityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_d36bad20-82f9-46f9-9fa6-91ac04383b49" xlink:to="loc_ci_MeasurementInputLiquidityMember_69c79599-b79c-4475-888a-f0e5f819a928" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails" xlink:type="extended" id="i96b33f7af6f44bdb9157fdae70944168_FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_efedf546-3a13-422d-954d-86980a8ceb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_efedf546-3a13-422d-954d-86980a8ceb8a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_907b287c-a73b-4717-9792-caeca861425d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_907b287c-a73b-4717-9792-caeca861425d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_8f4253e7-334a-44c7-9676-a9df50ef5eed" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_8f4253e7-334a-44c7-9676-a9df50ef5eed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_5aa8c365-7131-4197-81db-3151bb93a8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_5aa8c365-7131-4197-81db-3151bb93a8f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ea97ab82-6f63-4ff5-99ee-a16317605f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ea97ab82-6f63-4ff5-99ee-a16317605f0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits_bde58c26-559f-46a6-98ea-21ef5a4c70a4" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits_bde58c26-559f-46a6-98ea-21ef5a4c70a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_9b69dda7-98a9-4e08-ba8c-ba780b09781d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_9b69dda7-98a9-4e08-ba8c-ba780b09781d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_6d2c3d7c-b780-4dbb-9823-4a893f6ddd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_9b69dda7-98a9-4e08-ba8c-ba780b09781d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_6d2c3d7c-b780-4dbb-9823-4a893f6ddd8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_6f60cdaf-ec60-4968-94f5-8097cb668b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_9b69dda7-98a9-4e08-ba8c-ba780b09781d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_6f60cdaf-ec60-4968-94f5-8097cb668b4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_391e8149-500c-44c3-aa85-17ed81e17f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_9b69dda7-98a9-4e08-ba8c-ba780b09781d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_391e8149-500c-44c3-aa85-17ed81e17f9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_b15fda92-e277-42e0-92fd-c83bede083b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_9b69dda7-98a9-4e08-ba8c-ba780b09781d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_b15fda92-e277-42e0-92fd-c83bede083b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract_e918896d-463d-499e-b44b-f116ae8289c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract_e918896d-463d-499e-b44b-f116ae8289c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_344ded81-6bc0-4419-9260-140b17ffa937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract_e918896d-463d-499e-b44b-f116ae8289c1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_344ded81-6bc0-4419-9260-140b17ffa937" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2611db21-f2ea-49d7-a9c7-b18f8fc3e225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract_e918896d-463d-499e-b44b-f116ae8289c1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2611db21-f2ea-49d7-a9c7-b18f8fc3e225" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_c534f4b7-27f0-48d2-b616-858e510db194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract_e918896d-463d-499e-b44b-f116ae8289c1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_c534f4b7-27f0-48d2-b616-858e510db194" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_ef2b6834-3d7e-4b89-9a45-33e069e476a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_b3afeea9-0ecd-4c77-91f8-3e8723dd785e" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings_978b007f-4858-40be-991e-c49608547b76" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_efedf546-3a13-422d-954d-86980a8ceb8a" xlink:to="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings_978b007f-4858-40be-991e-c49608547b76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss_154e8236-018f-4e03-9e62-87f9fe412296" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_efedf546-3a13-422d-954d-86980a8ceb8a" xlink:to="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss_154e8236-018f-4e03-9e62-87f9fe412296" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_25866057-e550-4082-a56d-6a44d1bd7e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_efedf546-3a13-422d-954d-86980a8ceb8a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_25866057-e550-4082-a56d-6a44d1bd7e9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_115a98a5-9044-4fc2-ada4-2acf446d21ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_25866057-e550-4082-a56d-6a44d1bd7e9b" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_115a98a5-9044-4fc2-ada4-2acf446d21ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_115a98a5-9044-4fc2-ada4-2acf446d21ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_115a98a5-9044-4fc2-ada4-2acf446d21ab" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_115a98a5-9044-4fc2-ada4-2acf446d21ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1fce55ed-f94d-48cf-a8ba-cbfeb1f76353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_115a98a5-9044-4fc2-ada4-2acf446d21ab" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1fce55ed-f94d-48cf-a8ba-cbfeb1f76353" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtAndEquitySecuritiesMember_1568cf08-1f27-4457-89a6-f7ddadaba20f" xlink:href="ci-20230331.xsd#ci_DebtAndEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1fce55ed-f94d-48cf-a8ba-cbfeb1f76353" xlink:to="loc_ci_DebtAndEquitySecuritiesMember_1568cf08-1f27-4457-89a6-f7ddadaba20f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b142b19-52d8-4527-8858-73c5c908a1da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_25866057-e550-4082-a56d-6a44d1bd7e9b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b142b19-52d8-4527-8858-73c5c908a1da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0b142b19-52d8-4527-8858-73c5c908a1da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b142b19-52d8-4527-8858-73c5c908a1da" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0b142b19-52d8-4527-8858-73c5c908a1da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee44fc0d-cfd9-4e23-9b08-2bdc467cab15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b142b19-52d8-4527-8858-73c5c908a1da" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee44fc0d-cfd9-4e23-9b08-2bdc467cab15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b7ba6273-59cd-4de6-a37a-c222f204e873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee44fc0d-cfd9-4e23-9b08-2bdc467cab15" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b7ba6273-59cd-4de6-a37a-c222f204e873" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails" xlink:type="extended" id="i91f25e7440f8448091dfe6c29c983f26_FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GuaranteedSeparateAccountAssets_9bb36bdd-b88a-4bac-892f-1fd47a801b56" xlink:href="ci-20230331.xsd#ci_GuaranteedSeparateAccountAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_GuaranteedSeparateAccountAssets_9bb36bdd-b88a-4bac-892f-1fd47a801b56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy_1aa30cbf-abbd-4b37-9a24-dd77d3c5e1ce" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy_1aa30cbf-abbd-4b37-9a24-dd77d3c5e1ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy_948b1fe2-846d-42b7-a83e-26a5f67456b2" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsClassifiedInFairValueHierarchy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy_948b1fe2-846d-42b7-a83e-26a5f67456b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_dd922d04-60a3-4569-b2f9-8d520e9f7603" xlink:href="ci-20230331.xsd#ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_dd922d04-60a3-4569-b2f9-8d520e9f7603" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_444e370c-8a7d-42e4-acd9-afccc8967eaa" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_444e370c-8a7d-42e4-acd9-afccc8967eaa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_4aa05d2c-a432-477f-829e-a7f4d2db942d" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_4aa05d2c-a432-477f-829e-a7f4d2db942d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient_06616834-05f9-4f21-8648-20976c3befbd" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient_06616834-05f9-4f21-8648-20976c3befbd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale_34949d63-ec0d-45c8-9676-97403b57907b" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale_34949d63-ec0d-45c8-9676-97403b57907b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_df81a2a0-2991-4d9e-8e9f-eb9f8b4bf259" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_df81a2a0-2991-4d9e-8e9f-eb9f8b4bf259" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent_e29b00f8-6388-4400-a6dc-d6f53d7ef0c8" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent_e29b00f8-6388-4400-a6dc-d6f53d7ef0c8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_61e293f6-52b6-47e0-954d-4fd52cd795d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_us-gaap_SeparateAccountAssets_61e293f6-52b6-47e0-954d-4fd52cd795d3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09e2ef60-80ea-4675-ab43-6af3b3a2edb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09e2ef60-80ea-4675-ab43-6af3b3a2edb5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c53982aa-61df-4977-b909-bc5522a51b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09e2ef60-80ea-4675-ab43-6af3b3a2edb5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c53982aa-61df-4977-b909-bc5522a51b61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c53982aa-61df-4977-b909-bc5522a51b61_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c53982aa-61df-4977-b909-bc5522a51b61" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c53982aa-61df-4977-b909-bc5522a51b61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28319a20-9f99-48e6-9e77-f477d7201619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c53982aa-61df-4977-b909-bc5522a51b61" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28319a20-9f99-48e6-9e77-f477d7201619" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_63836775-ec8e-4e44-890c-965939109097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28319a20-9f99-48e6-9e77-f477d7201619" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_63836775-ec8e-4e44-890c-965939109097" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7151eb0e-9674-478c-a123-36580d7b4e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28319a20-9f99-48e6-9e77-f477d7201619" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7151eb0e-9674-478c-a123-36580d7b4e3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ba1c5b40-afa3-4ba9-8847-ecced99d0b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28319a20-9f99-48e6-9e77-f477d7201619" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ba1c5b40-afa3-4ba9-8847-ecced99d0b64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_87ef7d87-65ba-4ba7-a22f-08c1981172fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09e2ef60-80ea-4675-ab43-6af3b3a2edb5" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_87ef7d87-65ba-4ba7-a22f-08c1981172fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_87ef7d87-65ba-4ba7-a22f-08c1981172fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_87ef7d87-65ba-4ba7-a22f-08c1981172fe" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_87ef7d87-65ba-4ba7-a22f-08c1981172fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_39fdbe27-bbbc-486d-97e0-a943f306a8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_87ef7d87-65ba-4ba7-a22f-08c1981172fe" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_39fdbe27-bbbc-486d-97e0-a943f306a8f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_1d66078e-bf32-4aa4-a713-2baf19cc93a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_39fdbe27-bbbc-486d-97e0-a943f306a8f4" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_1d66078e-bf32-4aa4-a713-2baf19cc93a2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails" xlink:type="extended" id="i82586582131e4f65a3d4280b8fd5bfeb_FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_3cc2369f-f556-4caa-91e1-b2c4a77a7dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AlternativeInvestment_1bea1d29-d034-48cb-9fb4-7f60491e8fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AlternativeInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_3cc2369f-f556-4caa-91e1-b2c4a77a7dc9" xlink:to="loc_us-gaap_AlternativeInvestment_1bea1d29-d034-48cb-9fb4-7f60491e8fdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale_c5584cea-935a-4abf-b39e-be92716366c8" xlink:href="ci-20230331.xsd#ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_3cc2369f-f556-4caa-91e1-b2c4a77a7dc9" xlink:to="loc_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale_c5584cea-935a-4abf-b39e-be92716366c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments_a3e33b2e-d97e-4654-b04c-982ac48fc9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_3cc2369f-f556-4caa-91e1-b2c4a77a7dc9" xlink:to="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments_a3e33b2e-d97e-4654-b04c-982ac48fc9b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1_e57c2328-4b0b-4619-a5e3-28a9a6c31f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_3cc2369f-f556-4caa-91e1-b2c4a77a7dc9" xlink:to="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1_e57c2328-4b0b-4619-a5e3-28a9a6c31f97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_3cc2369f-f556-4caa-91e1-b2c4a77a7dc9" xlink:to="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_045d49f7-f217-4ac9-a0e4-d64f8fb12fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:to="loc_us-gaap_InvestmentTypeAxis_045d49f7-f217-4ac9-a0e4-d64f8fb12fbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_045d49f7-f217-4ac9-a0e4-d64f8fb12fbc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_045d49f7-f217-4ac9-a0e4-d64f8fb12fbc" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_045d49f7-f217-4ac9-a0e4-d64f8fb12fbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_13dc0bc9-8aed-47ce-87ca-5cea3790c255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_045d49f7-f217-4ac9-a0e4-d64f8fb12fbc" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_13dc0bc9-8aed-47ce-87ca-5cea3790c255" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PartnershipInterestMember_de1def97-eee2-4a2c-9e16-f1d5840893c0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_PartnershipInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_13dc0bc9-8aed-47ce-87ca-5cea3790c255" xlink:to="loc_srt_PartnershipInterestMember_de1def97-eee2-4a2c-9e16-f1d5840893c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_3202fc30-ac93-44fa-86e6-9923f671ef5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_13dc0bc9-8aed-47ce-87ca-5cea3790c255" xlink:to="loc_us-gaap_RealEstateFundsMember_3202fc30-ac93-44fa-86e6-9923f671ef5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_74904e82-6f1b-487a-8640-00e724347052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_13dc0bc9-8aed-47ce-87ca-5cea3790c255" xlink:to="loc_us-gaap_HedgeFundsMember_74904e82-6f1b-487a-8640-00e724347052" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_5f9b152f-d758-4a89-bd96-c2bf90bfce02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_5f9b152f-d758-4a89-bd96-c2bf90bfce02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5f9b152f-d758-4a89-bd96-c2bf90bfce02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_5f9b152f-d758-4a89-bd96-c2bf90bfce02" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5f9b152f-d758-4a89-bd96-c2bf90bfce02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f8c340e5-1232-4038-9e3d-59440b7b8d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_5f9b152f-d758-4a89-bd96-c2bf90bfce02" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f8c340e5-1232-4038-9e3d-59440b7b8d8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsMember_23075229-bcbf-413b-bd6f-4eac36436f2c" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f8c340e5-1232-4038-9e3d-59440b7b8d8c" xlink:to="loc_ci_SeparateAccountAssetsMember_23075229-bcbf-413b-bd6f-4eac36436f2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d9a6b38b-550f-4f40-a2b3-8cf06028e1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d9a6b38b-550f-4f40-a2b3-8cf06028e1f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9a6b38b-550f-4f40-a2b3-8cf06028e1f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d9a6b38b-550f-4f40-a2b3-8cf06028e1f3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9a6b38b-550f-4f40-a2b3-8cf06028e1f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_369f0bc7-886b-4a59-866f-b3fc1ad6b01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d9a6b38b-550f-4f40-a2b3-8cf06028e1f3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_369f0bc7-886b-4a59-866f-b3fc1ad6b01d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_62805e1f-4c1a-43b4-81b2-fa95160bef18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_369f0bc7-886b-4a59-866f-b3fc1ad6b01d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_62805e1f-4c1a-43b4-81b2-fa95160bef18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f00bb521-7a91-40c4-8018-2070da72d010" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:to="loc_srt_RangeAxis_f00bb521-7a91-40c4-8018-2070da72d010" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f00bb521-7a91-40c4-8018-2070da72d010_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f00bb521-7a91-40c4-8018-2070da72d010" xlink:to="loc_srt_RangeMember_f00bb521-7a91-40c4-8018-2070da72d010_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4077dca9-eebe-490d-a75e-ad5ed01fe4fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f00bb521-7a91-40c4-8018-2070da72d010" xlink:to="loc_srt_RangeMember_4077dca9-eebe-490d-a75e-ad5ed01fe4fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ceec75ca-5620-4664-9a37-56b9efc42f2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4077dca9-eebe-490d-a75e-ad5ed01fe4fb" xlink:to="loc_srt_MinimumMember_ceec75ca-5620-4664-9a37-56b9efc42f2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a7dfcc1a-7eba-42b6-ba6c-ec1dca4cec5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4077dca9-eebe-490d-a75e-ad5ed01fe4fb" xlink:to="loc_srt_MaximumMember_a7dfcc1a-7eba-42b6-ba6c-ec1dca4cec5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a466fa5-1e13-40c7-8dbd-48fd5ffc4b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a466fa5-1e13-40c7-8dbd-48fd5ffc4b2f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1a466fa5-1e13-40c7-8dbd-48fd5ffc4b2f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a466fa5-1e13-40c7-8dbd-48fd5ffc4b2f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1a466fa5-1e13-40c7-8dbd-48fd5ffc4b2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84ca8b60-3c3b-4d7f-af88-edb31e5f1101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a466fa5-1e13-40c7-8dbd-48fd5ffc4b2f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84ca8b60-3c3b-4d7f-af88-edb31e5f1101" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_9bd176b3-d44b-4c5c-a2ea-d4685f2d83d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84ca8b60-3c3b-4d7f-af88-edb31e5f1101" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_9bd176b3-d44b-4c5c-a2ea-d4685f2d83d1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails" xlink:type="extended" id="i6ba825968cef4f5e8529773bba79211f_FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_55f41a57-dace-41ed-aba3-bf3f4378f086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue_fb2f6c91-fc55-40d0-9cc1-f183d4055880" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_55f41a57-dace-41ed-aba3-bf3f4378f086" xlink:to="loc_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue_fb2f6c91-fc55-40d0-9cc1-f183d4055880" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_0c90ac97-bcbc-47ba-8c7f-239b439cba0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_55f41a57-dace-41ed-aba3-bf3f4378f086" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_0c90ac97-bcbc-47ba-8c7f-239b439cba0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ab50f602-beaf-4459-b533-237847b11887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_55f41a57-dace-41ed-aba3-bf3f4378f086" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ab50f602-beaf-4459-b533-237847b11887" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_db257854-69c3-46da-a47a-0383d714a24e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ab50f602-beaf-4459-b533-237847b11887" xlink:to="loc_srt_RangeAxis_db257854-69c3-46da-a47a-0383d714a24e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db257854-69c3-46da-a47a-0383d714a24e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_db257854-69c3-46da-a47a-0383d714a24e" xlink:to="loc_srt_RangeMember_db257854-69c3-46da-a47a-0383d714a24e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ef89ce5b-b366-43a1-9298-3a4b82d8ab07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_db257854-69c3-46da-a47a-0383d714a24e" xlink:to="loc_srt_RangeMember_ef89ce5b-b366-43a1-9298-3a4b82d8ab07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_633cd355-64ce-4f15-8896-b1bf68a30ff1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ef89ce5b-b366-43a1-9298-3a4b82d8ab07" xlink:to="loc_srt_MaximumMember_633cd355-64ce-4f15-8896-b1bf68a30ff1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails" xlink:type="extended" id="i6837bc428169488d9ab1d3fd2dc2f8df_FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1552cda3-b875-45f9-8770-91fe850fe2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_f39512f1-4d95-4160-96ec-4e0d1887e2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1552cda3-b875-45f9-8770-91fe850fe2e9" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_f39512f1-4d95-4160-96ec-4e0d1887e2d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_04b47791-e303-4de7-a482-81c6e4921f15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1552cda3-b875-45f9-8770-91fe850fe2e9" xlink:to="loc_us-gaap_LongTermDebtFairValue_04b47791-e303-4de7-a482-81c6e4921f15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2c5703a6-1399-429d-a1e3-1e16735f657d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1552cda3-b875-45f9-8770-91fe850fe2e9" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2c5703a6-1399-429d-a1e3-1e16735f657d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d3718796-8879-483a-b754-66c951c6b9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2c5703a6-1399-429d-a1e3-1e16735f657d" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d3718796-8879-483a-b754-66c951c6b9d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d3718796-8879-483a-b754-66c951c6b9d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d3718796-8879-483a-b754-66c951c6b9d1" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d3718796-8879-483a-b754-66c951c6b9d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e0584557-c6b2-4ce1-9933-88a9795deaef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d3718796-8879-483a-b754-66c951c6b9d1" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e0584557-c6b2-4ce1-9933-88a9795deaef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a38a34a9-3aa3-4e04-89ff-9b4e1d70b58f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e0584557-c6b2-4ce1-9933-88a9795deaef" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a38a34a9-3aa3-4e04-89ff-9b4e1d70b58f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_11086ce8-272d-4102-901d-7b83c887b435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a38a34a9-3aa3-4e04-89ff-9b4e1d70b58f" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_11086ce8-272d-4102-901d-7b83c887b435" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_93b6e99b-4e4e-4f93-a2c1-6a71480c92b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a38a34a9-3aa3-4e04-89ff-9b4e1d70b58f" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_93b6e99b-4e4e-4f93-a2c1-6a71480c92b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_301f6a50-3288-4137-8e83-dc9392fb962d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2c5703a6-1399-429d-a1e3-1e16735f657d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_301f6a50-3288-4137-8e83-dc9392fb962d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_301f6a50-3288-4137-8e83-dc9392fb962d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_301f6a50-3288-4137-8e83-dc9392fb962d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_301f6a50-3288-4137-8e83-dc9392fb962d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20092e64-2bc9-4226-8b81-349440867964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_301f6a50-3288-4137-8e83-dc9392fb962d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20092e64-2bc9-4226-8b81-349440867964" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_bc861317-194b-4ba5-a692-da6bf3a534ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20092e64-2bc9-4226-8b81-349440867964" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_bc861317-194b-4ba5-a692-da6bf3a534ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_037de924-2f8f-4a35-a1b0-ca23dc5afb76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20092e64-2bc9-4226-8b81-349440867964" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_037de924-2f8f-4a35-a1b0-ca23dc5afb76" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#VariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/VariableInterestEntitiesDetails" xlink:type="extended" id="i2c2848033c1c4226981bf6d217b869e1_VariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_VariableInterestEntitiesNumberOfEntities_ae297f31-8383-4d0f-aa3c-94cfaddf3d57" xlink:href="ci-20230331.xsd#ci_VariableInterestEntitiesNumberOfEntities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_ci_VariableInterestEntitiesNumberOfEntities_ae297f31-8383-4d0f-aa3c-94cfaddf3d57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity_cb57c8f3-ef0f-4cbf-8c9d-7fd1dbed93ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestInVariableInterestEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity_cb57c8f3-ef0f-4cbf-8c9d-7fd1dbed93ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_378cc0d2-97ab-41f2-8be5-7595e60c5af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_OtherCommitment_378cc0d2-97ab-41f2-8be5-7595e60c5af0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_a34771e0-f635-437c-ba52-ea364bfd818a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_a34771e0-f635-437c-ba52-ea364bfd818a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_87ebe571-fefb-4383-ad80-4248c2996a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_87ebe571-fefb-4383-ad80-4248c2996a4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_363ecaec-41a5-492c-ac5f-2a977c861f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_GuarantyLiabilities_363ecaec-41a5-492c-ac5f-2a977c861f0b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_9e95f8f5-03e8-4462-adfe-8875201d30a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_9e95f8f5-03e8-4462-adfe-8875201d30a9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_468f4c97-ee63-4d11-bda6-849bf40f7234" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:to="loc_srt_ConsolidatedEntitiesAxis_468f4c97-ee63-4d11-bda6-849bf40f7234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_468f4c97-ee63-4d11-bda6-849bf40f7234_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_468f4c97-ee63-4d11-bda6-849bf40f7234" xlink:to="loc_srt_ConsolidatedEntitiesDomain_468f4c97-ee63-4d11-bda6-849bf40f7234_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_aea70bca-650f-4054-b135-a01d2c004a45" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_468f4c97-ee63-4d11-bda6-849bf40f7234" xlink:to="loc_srt_ConsolidatedEntitiesDomain_aea70bca-650f-4054-b135-a01d2c004a45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_d290f50e-ff14-45ec-a882-b946b78253c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_aea70bca-650f-4054-b135-a01d2c004a45" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_d290f50e-ff14-45ec-a882-b946b78253c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_dff20884-f975-4c2b-86dd-e3a2980ca28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_aea70bca-650f-4054-b135-a01d2c004a45" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_dff20884-f975-4c2b-86dd-e3a2980ca28f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_c2eea955-b00e-49d9-ad4b-e7e61125d325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:to="loc_us-gaap_OtherCommitmentsAxis_c2eea955-b00e-49d9-ad4b-e7e61125d325" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_c2eea955-b00e-49d9-ad4b-e7e61125d325_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_c2eea955-b00e-49d9-ad4b-e7e61125d325" xlink:to="loc_us-gaap_OtherCommitmentsDomain_c2eea955-b00e-49d9-ad4b-e7e61125d325_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_743c8853-33e2-4570-bdcc-734c3182d082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_c2eea955-b00e-49d9-ad4b-e7e61125d325" xlink:to="loc_us-gaap_OtherCommitmentsDomain_743c8853-33e2-4570-bdcc-734c3182d082" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentToFundPartnershipMember_485c9734-9cca-4287-9e61-edeea6a592f2" xlink:href="ci-20230331.xsd#ci_CommitmentToFundPartnershipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_743c8853-33e2-4570-bdcc-734c3182d082" xlink:to="loc_ci_CommitmentToFundPartnershipMember_485c9734-9cca-4287-9e61-edeea6a592f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ef220171-5c57-4e71-878c-5cff51226768" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ef220171-5c57-4e71-878c-5cff51226768" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ef220171-5c57-4e71-878c-5cff51226768_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ef220171-5c57-4e71-878c-5cff51226768" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ef220171-5c57-4e71-878c-5cff51226768_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_446dc013-f1df-44e7-ba51-5b8a56d0345b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ef220171-5c57-4e71-878c-5cff51226768" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_446dc013-f1df-44e7-ba51-5b8a56d0345b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember_8293a1c8-5854-4d46-a7b3-0ee9fdbaf58c" xlink:href="ci-20230331.xsd#ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_446dc013-f1df-44e7-ba51-5b8a56d0345b" xlink:to="loc_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember_8293a1c8-5854-4d46-a7b3-0ee9fdbaf58c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_a4fc9471-9073-42b4-800e-63172e47aeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:to="loc_us-gaap_InvestmentTypeAxis_a4fc9471-9073-42b4-800e-63172e47aeb1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a4fc9471-9073-42b4-800e-63172e47aeb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_a4fc9471-9073-42b4-800e-63172e47aeb1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a4fc9471-9073-42b4-800e-63172e47aeb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_63a977f6-7f79-4a1e-bcaf-ce5c12cd56bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_a4fc9471-9073-42b4-800e-63172e47aeb1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_63a977f6-7f79-4a1e-bcaf-ce5c12cd56bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember_e2c9ead7-a515-401f-b6c6-12763458ac88" xlink:href="ci-20230331.xsd#ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_63a977f6-7f79-4a1e-bcaf-ce5c12cd56bf" xlink:to="loc_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember_e2c9ead7-a515-401f-b6c6-12763458ac88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealEstateJointVenturesMember_0c3611f6-aec7-4d06-a132-663edad922f1" xlink:href="ci-20230331.xsd#ci_RealEstateJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_63a977f6-7f79-4a1e-bcaf-ce5c12cd56bf" xlink:to="loc_ci_RealEstateJointVenturesMember_0c3611f6-aec7-4d06-a132-663edad922f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AssetBackedAndCorporateSecuritiesMember_52dcf388-e3b6-4307-9f79-1471cbb57b05" xlink:href="ci-20230331.xsd#ci_AssetBackedAndCorporateSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_63a977f6-7f79-4a1e-bcaf-ce5c12cd56bf" xlink:to="loc_ci_AssetBackedAndCorporateSecuritiesMember_52dcf388-e3b6-4307-9f79-1471cbb57b05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherVariableInterestEntitiesMember_bc129023-4539-4423-b2de-026503486ce0" xlink:href="ci-20230331.xsd#ci_OtherVariableInterestEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_63a977f6-7f79-4a1e-bcaf-ce5c12cd56bf" xlink:to="loc_ci_OtherVariableInterestEntitiesMember_bc129023-4539-4423-b2de-026503486ce0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_be192c06-efb7-447b-8895-3146907d0b92" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:to="loc_srt_RangeAxis_be192c06-efb7-447b-8895-3146907d0b92" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_be192c06-efb7-447b-8895-3146907d0b92_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_be192c06-efb7-447b-8895-3146907d0b92" xlink:to="loc_srt_RangeMember_be192c06-efb7-447b-8895-3146907d0b92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_84f32e9c-a077-41ca-a135-9ef9e2d2c146" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_be192c06-efb7-447b-8895-3146907d0b92" xlink:to="loc_srt_RangeMember_84f32e9c-a077-41ca-a135-9ef9e2d2c146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c8fc2f36-e1e0-4509-a1d7-b4f1a6e74958" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_84f32e9c-a077-41ca-a135-9ef9e2d2c146" xlink:to="loc_srt_MaximumMember_c8fc2f36-e1e0-4509-a1d7-b4f1a6e74958" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i75ba808583f4407c8761478e42d3aeb1_AccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_32b5b072-2d44-4464-a4ff-1346521e3db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_32b5b072-2d44-4464-a4ff-1346521e3db6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_e0a282c1-daec-43dd-890e-a487aadb824f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_e0a282c1-daec-43dd-890e-a487aadb824f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e709aace-52d0-48bb-b5a1-b73a3a91c3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e709aace-52d0-48bb-b5a1-b73a3a91c3b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c1d4aedc-be59-4a27-895b-57e86789fa91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c1d4aedc-be59-4a27-895b-57e86789fa91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity_643cfcd7-b271-4ccb-8454-e69735cc8037" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity_643cfcd7-b271-4ccb-8454-e69735cc8037" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity_8603c43c-b0f9-48f7-b92b-ee364564d1e2" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity_8603c43c-b0f9-48f7-b92b-ee364564d1e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity_e5e148fd-03bf-42a7-82ac-6eaaa85ae143" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity_e5e148fd-03bf-42a7-82ac-6eaaa85ae143" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_d748117f-acaa-4b41-bcde-2b107ff702ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_d748117f-acaa-4b41-bcde-2b107ff702ea" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_cddedc00-d9e0-4641-bc40-684e0134b36f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_cddedc00-d9e0-4641-bc40-684e0134b36f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3553e175-a480-4df3-a657-324120486dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3553e175-a480-4df3-a657-324120486dcf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity_939ee074-6151-446d-abc4-42ce1e675760" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity_939ee074-6151-446d-abc4-42ce1e675760" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity_21211ec2-2a97-4c72-9eb1-99c47a3c75de" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity_21211ec2-2a97-4c72-9eb1-99c47a3c75de" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_b394d91b-5c5b-483c-891d-236671d54f0e" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_b394d91b-5c5b-483c-891d-236671d54f0e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TemporaryEquityOtherComprehensiveIncome_c80b83cb-3df5-47fc-9592-d0835762382e" xlink:href="ci-20230331.xsd#ci_TemporaryEquityOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_TemporaryEquityOtherComprehensiveIncome_c80b83cb-3df5-47fc-9592-d0835762382e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d6f9d30d-3f8f-48f0-a79d-ffb25ef36b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d6f9d30d-3f8f-48f0-a79d-ffb25ef36b36" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5bcde693-2d7c-41eb-8f4c-6d87e936ac3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_25db35fc-5ee5-45e5-a43f-d2da3531daac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_25db35fc-5ee5-45e5-a43f-d2da3531daac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_52cce4f3-61a0-462a-ae25-a4d6924f26b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_25db35fc-5ee5-45e5-a43f-d2da3531daac" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_52cce4f3-61a0-462a-ae25-a4d6924f26b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_52cce4f3-61a0-462a-ae25-a4d6924f26b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_52cce4f3-61a0-462a-ae25-a4d6924f26b8" xlink:to="loc_us-gaap_EquityComponentDomain_52cce4f3-61a0-462a-ae25-a4d6924f26b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d0c14053-a4d8-4488-a671-388758b63fab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_52cce4f3-61a0-462a-ae25-a4d6924f26b8" xlink:to="loc_us-gaap_EquityComponentDomain_d0c14053-a4d8-4488-a671-388758b63fab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fe9b6a9-3b97-40a2-8e31-215a829b4f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d0c14053-a4d8-4488-a671-388758b63fab" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fe9b6a9-3b97-40a2-8e31-215a829b4f6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember_b7612a84-f0ab-4bcb-a3aa-4d6931e1b965" xlink:href="ci-20230331.xsd#ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fe9b6a9-3b97-40a2-8e31-215a829b4f6e" xlink:to="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember_b7612a84-f0ab-4bcb-a3aa-4d6931e1b965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember_0726f12c-c224-4fff-be24-5107b942008d" xlink:href="ci-20230331.xsd#ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember_b7612a84-f0ab-4bcb-a3aa-4d6931e1b965" xlink:to="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember_0726f12c-c224-4fff-be24-5107b942008d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_1d5ec43f-1204-4dac-8220-69bea20cd2a5" xlink:href="ci-20230331.xsd#ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fe9b6a9-3b97-40a2-8e31-215a829b4f6e" xlink:to="loc_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_1d5ec43f-1204-4dac-8220-69bea20cd2a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitParentMember_a0c056c2-4eb3-426e-b624-01268d811333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_1d5ec43f-1204-4dac-8220-69bea20cd2a5" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitParentMember_a0c056c2-4eb3-426e-b624-01268d811333" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_2af843ad-b46b-4109-9d75-2941387c87b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_1d5ec43f-1204-4dac-8220-69bea20cd2a5" xlink:to="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_2af843ad-b46b-4109-9d75-2941387c87b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_22e5c968-31c0-42f1-9827-6ac181fad6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fe9b6a9-3b97-40a2-8e31-215a829b4f6e" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_22e5c968-31c0-42f1-9827-6ac181fad6bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_c7ea3cd3-d330-4873-96bf-bff1b5e8829e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember_22e5c968-31c0-42f1-9827-6ac181fad6bd" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_c7ea3cd3-d330-4873-96bf-bff1b5e8829e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember_f7d6de74-bd30-4476-b31e-f002d91343b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember_22e5c968-31c0-42f1-9827-6ac181fad6bd" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember_f7d6de74-bd30-4476-b31e-f002d91343b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2bae7e9e-600d-4ad0-b335-c6dcee06b5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fe9b6a9-3b97-40a2-8e31-215a829b4f6e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2bae7e9e-600d-4ad0-b335-c6dcee06b5b0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_8bee1232-83b9-4885-b74c-faeb85756c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2bae7e9e-600d-4ad0-b335-c6dcee06b5b0" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_8bee1232-83b9-4885-b74c-faeb85756c9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_134da573-fe38-42a8-b31b-4b66f3803f4d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_25db35fc-5ee5-45e5-a43f-d2da3531daac" xlink:to="loc_srt_RestatementAxis_134da573-fe38-42a8-b31b-4b66f3803f4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_134da573-fe38-42a8-b31b-4b66f3803f4d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_134da573-fe38-42a8-b31b-4b66f3803f4d" xlink:to="loc_srt_RestatementDomain_134da573-fe38-42a8-b31b-4b66f3803f4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c40a0bd5-fd2c-40a6-b5e3-0bd58025ab25" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_134da573-fe38-42a8-b31b-4b66f3803f4d" xlink:to="loc_srt_RestatementDomain_c40a0bd5-fd2c-40a6-b5e3-0bd58025ab25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_37db99e2-030b-4f8a-a6f6-7200b50b7f51" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_c40a0bd5-fd2c-40a6-b5e3-0bd58025ab25" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_37db99e2-030b-4f8a-a6f6-7200b50b7f51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_1a6082e0-a70d-4c0c-a0ef-dc686f5bcd79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_c40a0bd5-fd2c-40a6-b5e3-0bd58025ab25" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_1a6082e0-a70d-4c0c-a0ef-dc686f5bcd79" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#ContingenciesandOtherMattersDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails" xlink:type="extended" id="i0b179534fe354addafa9f9b4636746ba_ContingenciesandOtherMattersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:href="ci-20230331.xsd#ci_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_f0022205-d345-4dd2-88da-e3668829653b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_f0022205-d345-4dd2-88da-e3668829653b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLiquidationProceeds_a9fb3be1-166a-4e00-892c-4c119a2d9586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsLiquidationProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_GuaranteeObligationsLiquidationProceeds_a9fb3be1-166a-4e00-892c-4c119a2d9586" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_93f59468-ed77-4bd0-ab75-01b62cff8eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_93f59468-ed77-4bd0-ab75-01b62cff8eba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_a33ed27f-e2be-4264-bac1-a481db8460a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_a33ed27f-e2be-4264-bac1-a481db8460a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_87476b1a-784f-4f1b-b2e7-21a1956ebf0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_87476b1a-784f-4f1b-b2e7-21a1956ebf0c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_396720bf-e6e4-4cc2-afe9-59e7e210bd9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_396720bf-e6e4-4cc2-afe9-59e7e210bd9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_5a33f3cb-bee4-4fef-a2cc-e0580fb86f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_5a33f3cb-bee4-4fef-a2cc-e0580fb86f31" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_9517b786-ed9b-4fe2-a02b-9442e7c18e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_9517b786-ed9b-4fe2-a02b-9442e7c18e3d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsAndContingenciesNumberOfExpert_e6e281cb-995b-4bee-8af0-a4c9d85030d9" xlink:href="ci-20230331.xsd#ci_CommitmentsAndContingenciesNumberOfExpert"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_ci_CommitmentsAndContingenciesNumberOfExpert_e6e281cb-995b-4bee-8af0-a4c9d85030d9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert_6264ed2e-2583-40a9-bfef-afba60313c6d" xlink:href="ci-20230331.xsd#ci_CommitmentsAndContingenciesNumberOfAdditionalExpert"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert_6264ed2e-2583-40a9-bfef-afba60313c6d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:href="ci-20230331.xsd#ci_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f6fdb115-eb34-4271-8455-31211b9a2750" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:to="loc_srt_ProductOrServiceAxis_f6fdb115-eb34-4271-8455-31211b9a2750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f6fdb115-eb34-4271-8455-31211b9a2750_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f6fdb115-eb34-4271-8455-31211b9a2750" xlink:to="loc_srt_ProductsAndServicesDomain_f6fdb115-eb34-4271-8455-31211b9a2750_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1e27e639-3bdc-48dc-b30a-4a0fec693fa3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f6fdb115-eb34-4271-8455-31211b9a2750" xlink:to="loc_srt_ProductsAndServicesDomain_1e27e639-3bdc-48dc-b30a-4a0fec693fa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RetirementAndLifeInsuranceContractsMember_7585ae86-4eee-41fe-9cd5-5a0ab87a6a65" xlink:href="ci-20230331.xsd#ci_RetirementAndLifeInsuranceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e27e639-3bdc-48dc-b30a-4a0fec693fa3" xlink:to="loc_ci_RetirementAndLifeInsuranceContractsMember_7585ae86-4eee-41fe-9cd5-5a0ab87a6a65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_d0db33e4-eb04-4840-9e50-202630bf3f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_d0db33e4-eb04-4840-9e50-202630bf3f39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_d0db33e4-eb04-4840-9e50-202630bf3f39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_d0db33e4-eb04-4840-9e50-202630bf3f39" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_d0db33e4-eb04-4840-9e50-202630bf3f39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_3d0a256f-d111-4856-9a03-185f6414c9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_d0db33e4-eb04-4840-9e50-202630bf3f39" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_3d0a256f-d111-4856-9a03-185f6414c9fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeMember_24e9a345-a6a1-420f-bc31-78d07bf7f989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_3d0a256f-d111-4856-9a03-185f6414c9fd" xlink:to="loc_us-gaap_FinancialGuaranteeMember_24e9a345-a6a1-420f-bc31-78d07bf7f989" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember_dd3876f1-6854-49d6-a86b-99d9584c8f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_3d0a256f-d111-4856-9a03-185f6414c9fd" xlink:to="loc_us-gaap_IndemnificationGuaranteeMember_dd3876f1-6854-49d6-a86b-99d9584c8f2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f338cade-41f6-40bd-8db6-43c3800ddea5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:to="loc_srt_LitigationCaseAxis_f338cade-41f6-40bd-8db6-43c3800ddea5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f338cade-41f6-40bd-8db6-43c3800ddea5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_f338cade-41f6-40bd-8db6-43c3800ddea5" xlink:to="loc_srt_LitigationCaseTypeDomain_f338cade-41f6-40bd-8db6-43c3800ddea5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1a43f734-64c2-43f7-a271-19457539882f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_f338cade-41f6-40bd-8db6-43c3800ddea5" xlink:to="loc_srt_LitigationCaseTypeDomain_1a43f734-64c2-43f7-a271-19457539882f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ExpressScriptsLitigationWithAnthemMember_29b5b62e-313e-4099-a365-aa5f8cc69d80" xlink:href="ci-20230331.xsd#ci_ExpressScriptsLitigationWithAnthemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1a43f734-64c2-43f7-a271-19457539882f" xlink:to="loc_ci_ExpressScriptsLitigationWithAnthemMember_29b5b62e-313e-4099-a365-aa5f8cc69d80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ExpressScriptsCounterclaimsAgainstElevanceMember_422f4bed-057b-4741-ade3-f4d9922a7ec1" xlink:href="ci-20230331.xsd#ci_ExpressScriptsCounterclaimsAgainstElevanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_ExpressScriptsLitigationWithAnthemMember_29b5b62e-313e-4099-a365-aa5f8cc69d80" xlink:to="loc_ci_ExpressScriptsCounterclaimsAgainstElevanceMember_422f4bed-057b-4741-ade3-f4d9922a7ec1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_f38b27f7-353b-4bbd-9639-18f7c3c39ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:to="loc_us-gaap_LitigationStatusAxis_f38b27f7-353b-4bbd-9639-18f7c3c39ab7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_f38b27f7-353b-4bbd-9639-18f7c3c39ab7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_f38b27f7-353b-4bbd-9639-18f7c3c39ab7" xlink:to="loc_us-gaap_LitigationStatusDomain_f38b27f7-353b-4bbd-9639-18f7c3c39ab7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_5535a00d-09a8-4053-bc79-c44ad019ce9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_f38b27f7-353b-4bbd-9639-18f7c3c39ab7" xlink:to="loc_us-gaap_LitigationStatusDomain_5535a00d-09a8-4053-bc79-c44ad019ce9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember_fea57c9f-a84d-464b-8f71-8107a147eeca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_JudicialRulingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_5535a00d-09a8-4053-bc79-c44ad019ce9e" xlink:to="loc_us-gaap_JudicialRulingMember_fea57c9f-a84d-464b-8f71-8107a147eeca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_3f289045-b038-4834-a016-f7340cec2ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_5535a00d-09a8-4053-bc79-c44ad019ce9e" xlink:to="loc_us-gaap_PendingLitigationMember_3f289045-b038-4834-a016-f7340cec2ada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8cce109f-5407-41d0-b13c-dc0fd244de5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8cce109f-5407-41d0-b13c-dc0fd244de5c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_8cce109f-5407-41d0-b13c-dc0fd244de5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8cce109f-5407-41d0-b13c-dc0fd244de5c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_8cce109f-5407-41d0-b13c-dc0fd244de5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_df6a1189-296d-4362-8aef-a2f8e8731574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8cce109f-5407-41d0-b13c-dc0fd244de5c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_df6a1189-296d-4362-8aef-a2f8e8731574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PricingConcessionsMember_eb430388-1df3-4ab1-9a35-401a7998140e" xlink:href="ci-20230331.xsd#ci_PricingConcessionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_df6a1189-296d-4362-8aef-a2f8e8731574" xlink:to="loc_ci_PricingConcessionsMember_eb430388-1df3-4ab1-9a35-401a7998140e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PricingConcessionsThroughRemainingContractTermMember_6cd4a013-890d-49ab-b487-a975d55e0c4c" xlink:href="ci-20230331.xsd#ci_PricingConcessionsThroughRemainingContractTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_PricingConcessionsMember_eb430388-1df3-4ab1-9a35-401a7998140e" xlink:to="loc_ci_PricingConcessionsThroughRemainingContractTermMember_6cd4a013-890d-49ab-b487-a975d55e0c4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PricingConcessionsAfterRemainingTermOfAgreementMember_e39fdcc3-eeb2-485d-82b9-125913c658f0" xlink:href="ci-20230331.xsd#ci_PricingConcessionsAfterRemainingTermOfAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_PricingConcessionsMember_eb430388-1df3-4ab1-9a35-401a7998140e" xlink:to="loc_ci_PricingConcessionsAfterRemainingTermOfAgreementMember_e39fdcc3-eeb2-485d-82b9-125913c658f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DamagesForServiceIssuesMember_3631dcb9-124a-4f71-998d-27c224569932" xlink:href="ci-20230331.xsd#ci_DamagesForServiceIssuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_df6a1189-296d-4362-8aef-a2f8e8731574" xlink:to="loc_ci_DamagesForServiceIssuesMember_3631dcb9-124a-4f71-998d-27c224569932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRelatedAssessmentsMember_cbb577db-b59f-4b14-b7c7-871d761d3566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceRelatedAssessmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_df6a1189-296d-4362-8aef-a2f8e8731574" xlink:to="loc_us-gaap_InsuranceRelatedAssessmentsMember_cbb577db-b59f-4b14-b7c7-871d761d3566" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LitigationMattersAndRegulatoryMattersMember_0a828178-d27b-491e-ab2e-2b6dd3bc5fd6" xlink:href="ci-20230331.xsd#ci_LitigationMattersAndRegulatoryMattersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_df6a1189-296d-4362-8aef-a2f8e8731574" xlink:to="loc_ci_LitigationMattersAndRegulatoryMattersMember_0a828178-d27b-491e-ab2e-2b6dd3bc5fd6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SegmentInformationSummarizedSegmentFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails" xlink:type="extended" id="ieb92d2b5b904492aa041cac8724b3a57_SegmentInformationSummarizedSegmentFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonInvestmentRevenue_59e76e20-acba-42a4-b753-2cab3e3c05bf" xlink:href="ci-20230331.xsd#ci_NonInvestmentRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_ci_NonInvestmentRevenue_59e76e20-acba-42a4-b753-2cab3e3c05bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_f8645065-54ee-4261-81af-0ce9f385869d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_us-gaap_NetInvestmentIncome_f8645065-54ee-4261-81af-0ce9f385869d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ab1ed9e4-d367-4887-bb54-f61e7be46613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_us-gaap_Revenues_ab1ed9e4-d367-4887-bb54-f61e7be46613" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainsLossesEquityMethodInvestments_ecb729b7-ac20-4641-a32f-5a1c7c8c0465" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainsLossesEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_ci_RealizedInvestmentGainsLossesEquityMethodInvestments_ecb729b7-ac20-4641-a32f-5a1c7c8c0465" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SegmentRevenues_20c65cdb-a4b9-491b-a2b2-bc446fde17bc" xlink:href="ci-20230331.xsd#ci_SegmentRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_ci_SegmentRevenues_20c65cdb-a4b9-491b-a2b2-bc446fde17bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4fe716ec-d521-4840-9514-75bb8611d08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4fe716ec-d521-4840-9514-75bb8611d08a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_25672801-06c6-44e3-953d-d99ef7c5d6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_25672801-06c6-44e3-953d-d99ef7c5d6c6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:href="ci-20230331.xsd#ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax_55e85744-9dbb-420a-91d6-57f8b33629a6" xlink:href="ci-20230331.xsd#ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:to="loc_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax_55e85744-9dbb-420a-91d6-57f8b33629a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries_3866f815-c9ac-4051-80dd-cf77101dcba2" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:to="loc_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries_3866f815-c9ac-4051-80dd-cf77101dcba2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a00d2589-83f3-426a-a67d-208845df8c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a00d2589-83f3-426a-a67d-208845df8c2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:href="ci-20230331.xsd#ci_SpecialItemsBeforeTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:to="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TransactionRelatedCosts_330cda8f-dd36-468a-8ec1-0e2a948c3ad8" xlink:href="ci-20230331.xsd#ci_TransactionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_TransactionRelatedCosts_330cda8f-dd36-468a-8ec1-0e2a948c3ad8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_86430f46-ad01-4921-ab38-dac7927afedd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_us-gaap_RestructuringCharges_86430f46-ad01-4921-ab38-dac7927afedd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OrganizationalEfficiencyPlanCharges_266f1e63-9aed-4941-b1bf-8b5bb1554a5b" xlink:href="ci-20230331.xsd#ci_OrganizationalEfficiencyPlanCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_OrganizationalEfficiencyPlanCharges_266f1e63-9aed-4941-b1bf-8b5bb1554a5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemChargeBenefitBeforeTaxLitigation_bddc5c8c-2ab2-4254-887c-9f29e80d2366" xlink:href="ci-20230331.xsd#ci_SpecialItemChargeBenefitBeforeTaxLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_SpecialItemChargeBenefitBeforeTaxLitigation_bddc5c8c-2ab2-4254-887c-9f29e80d2366" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes_755d0b17-26c0-4e34-8083-6e013c12e0f9" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes_755d0b17-26c0-4e34-8083-6e013c12e0f9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax_203f6df9-b406-46df-8829-4357564c9070" xlink:href="ci-20230331.xsd#ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax_203f6df9-b406-46df-8829-4357564c9070" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes_d9e8b127-b87d-4539-9346-f2efb404a85b" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes_d9e8b127-b87d-4539-9346-f2efb404a85b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes_d3744923-4b65-4266-b6d0-1dfbc09fdc1e" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes_d3744923-4b65-4266-b6d0-1dfbc09fdc1e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_446821ca-a5fe-43b9-a61b-268022024883" xlink:href="ci-20230331.xsd#ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:to="loc_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_446821ca-a5fe-43b9-a61b-268022024883" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29a7deb9-c7ca-4657-9b29-06c4ce9f06ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29a7deb9-c7ca-4657-9b29-06c4ce9f06ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b45ccf70-5c02-40f3-9104-a2a6a951ca0a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29a7deb9-c7ca-4657-9b29-06c4ce9f06ee" xlink:to="loc_srt_ConsolidationItemsAxis_b45ccf70-5c02-40f3-9104-a2a6a951ca0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b45ccf70-5c02-40f3-9104-a2a6a951ca0a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b45ccf70-5c02-40f3-9104-a2a6a951ca0a" xlink:to="loc_srt_ConsolidationItemsDomain_b45ccf70-5c02-40f3-9104-a2a6a951ca0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0a137f70-1107-457f-a4f0-ed8d26bd450e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b45ccf70-5c02-40f3-9104-a2a6a951ca0a" xlink:to="loc_srt_ConsolidationItemsDomain_0a137f70-1107-457f-a4f0-ed8d26bd450e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6b1c09d4-32c5-4e7e-8eac-5fc9d9d64a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_0a137f70-1107-457f-a4f0-ed8d26bd450e" xlink:to="loc_us-gaap_OperatingSegmentsMember_6b1c09d4-32c5-4e7e-8eac-5fc9d9d64a3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CorporateAndEliminationsMember_e84b43c1-557f-4028-a1ee-f6075f5a9919" xlink:href="ci-20230331.xsd#ci_CorporateAndEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_0a137f70-1107-457f-a4f0-ed8d26bd450e" xlink:to="loc_ci_CorporateAndEliminationsMember_e84b43c1-557f-4028-a1ee-f6075f5a9919" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f544fbe9-825f-4bdd-a470-f6d325dce40a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CorporateAndEliminationsMember_e84b43c1-557f-4028-a1ee-f6075f5a9919" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f544fbe9-825f-4bdd-a470-f6d325dce40a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_beefc1d8-8558-4a74-9d47-4c38f44c2433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_CorporateAndEliminationsMember_e84b43c1-557f-4028-a1ee-f6075f5a9919" xlink:to="loc_us-gaap_IntersegmentEliminationMember_beefc1d8-8558-4a74-9d47-4c38f44c2433" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0045dd6a-0419-4774-9803-f74984aeefbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29a7deb9-c7ca-4657-9b29-06c4ce9f06ee" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0045dd6a-0419-4774-9803-f74984aeefbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0045dd6a-0419-4774-9803-f74984aeefbe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0045dd6a-0419-4774-9803-f74984aeefbe" xlink:to="loc_us-gaap_SegmentDomain_0045dd6a-0419-4774-9803-f74984aeefbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9267f97a-3456-4478-9365-65307401d7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0045dd6a-0419-4774-9803-f74984aeefbe" xlink:to="loc_us-gaap_SegmentDomain_9267f97a-3456-4478-9365-65307401d7f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EvernorthMember_bc011df4-addf-4d71-8b2c-12ca7cb640e2" xlink:href="ci-20230331.xsd#ci_EvernorthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9267f97a-3456-4478-9365-65307401d7f0" xlink:to="loc_ci_EvernorthMember_bc011df4-addf-4d71-8b2c-12ca7cb640e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_2d1940c1-c305-4c72-9480-ea951f393a2d" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9267f97a-3456-4478-9365-65307401d7f0" xlink:to="loc_ci_CignaHealthcareMember_2d1940c1-c305-4c72-9480-ea951f393a2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember_068bae7c-d881-420f-b8d2-458b4dea9f8d" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9267f97a-3456-4478-9365-65307401d7f0" xlink:to="loc_ci_OtherOperationsSegmentMember_068bae7c-d881-420f-b8d2-458b4dea9f8d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SegmentInformationRevenuefromExternalCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails" xlink:type="extended" id="icc514c0d02554c6990ee23ddbe368045_SegmentInformationRevenuefromExternalCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_a3a97e9a-6e99-48ea-8237-96641c4457e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d83ad3ed-e222-4d2d-b0d9-9c2cd14e5043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_a3a97e9a-6e99-48ea-8237-96641c4457e7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d83ad3ed-e222-4d2d-b0d9-9c2cd14e5043" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_be7e5528-ef43-4bb4-9942-bf590a1aabe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_a3a97e9a-6e99-48ea-8237-96641c4457e7" xlink:to="loc_us-gaap_PremiumsEarnedNet_be7e5528-ef43-4bb4-9942-bf590a1aabe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonInvestmentRevenue_585f7b44-c6f0-4c35-81f3-6fd39fb96fc7" xlink:href="ci-20230331.xsd#ci_NonInvestmentRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_a3a97e9a-6e99-48ea-8237-96641c4457e7" xlink:to="loc_ci_NonInvestmentRevenue_585f7b44-c6f0-4c35-81f3-6fd39fb96fc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_a3a97e9a-6e99-48ea-8237-96641c4457e7" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_39421d7d-5c8b-4055-baa8-f6beea2d1d26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:to="loc_srt_ProductOrServiceAxis_39421d7d-5c8b-4055-baa8-f6beea2d1d26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_39421d7d-5c8b-4055-baa8-f6beea2d1d26_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_39421d7d-5c8b-4055-baa8-f6beea2d1d26" xlink:to="loc_srt_ProductsAndServicesDomain_39421d7d-5c8b-4055-baa8-f6beea2d1d26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5508126a-bf44-42b9-91d5-d3b4eef04499" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_39421d7d-5c8b-4055-baa8-f6beea2d1d26" xlink:to="loc_srt_ProductsAndServicesDomain_5508126a-bf44-42b9-91d5-d3b4eef04499" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_d41e3419-bdf1-43db-aa65-1a6e93c5e154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5508126a-bf44-42b9-91d5-d3b4eef04499" xlink:to="loc_us-gaap_ProductMember_d41e3419-bdf1-43db-aa65-1a6e93c5e154" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NetworkPharmacyMember_782eefab-361e-45c7-a235-d7b19242ddd2" xlink:href="ci-20230331.xsd#ci_NetworkPharmacyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_d41e3419-bdf1-43db-aa65-1a6e93c5e154" xlink:to="loc_ci_NetworkPharmacyMember_782eefab-361e-45c7-a235-d7b19242ddd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_HomeDeliveryAndSpecialtyMember_24146718-6df2-436a-9ba7-1155e011f74a" xlink:href="ci-20230331.xsd#ci_HomeDeliveryAndSpecialtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_d41e3419-bdf1-43db-aa65-1a6e93c5e154" xlink:to="loc_ci_HomeDeliveryAndSpecialtyMember_24146718-6df2-436a-9ba7-1155e011f74a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherPharmacyMember_22c001ce-40ed-470e-911a-558985ff2b4b" xlink:href="ci-20230331.xsd#ci_OtherPharmacyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_d41e3419-bdf1-43db-aa65-1a6e93c5e154" xlink:to="loc_ci_OtherPharmacyMember_22c001ce-40ed-470e-911a-558985ff2b4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:href="ci-20230331.xsd#ci_USMedicalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5508126a-bf44-42b9-91d5-d3b4eef04499" xlink:to="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MedicalRiskProductsMember_dc89312f-bb42-49ca-a5b2-a373f7715509" xlink:href="ci-20230331.xsd#ci_MedicalRiskProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_MedicalRiskProductsMember_dc89312f-bb42-49ca-a5b2-a373f7715509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_StopLossMember_024e08ef-66cb-44f0-9514-b46e92170996" xlink:href="ci-20230331.xsd#ci_StopLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_StopLossMember_024e08ef-66cb-44f0-9514-b46e92170996" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherCommercialMedicalProductsMember_8ef27d38-f3e5-4bd0-acd5-1fbbc03ea8c1" xlink:href="ci-20230331.xsd#ci_OtherCommercialMedicalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_OtherCommercialMedicalProductsMember_8ef27d38-f3e5-4bd0-acd5-1fbbc03ea8c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MedicareAdvantageMember_1607d60e-7c38-40c6-b2e6-ecb2d2a77ce5" xlink:href="ci-20230331.xsd#ci_MedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_MedicareAdvantageMember_1607d60e-7c38-40c6-b2e6-ecb2d2a77ce5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MedicarePartDMember_2324980c-2be1-406e-81fa-b0bf673ff1c9" xlink:href="ci-20230331.xsd#ci_MedicarePartDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_MedicarePartDMember_2324980c-2be1-406e-81fa-b0bf673ff1c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherGovernmentProductsMember_a5c59398-890f-4080-a02d-407261172148" xlink:href="ci-20230331.xsd#ci_OtherGovernmentProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_OtherGovernmentProductsMember_a5c59398-890f-4080-a02d-407261172148" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IndividualAndFamilyPlansShortDurationMember_abeb8d00-57e7-4baa-82fd-8d2c2b25c158" xlink:href="ci-20230331.xsd#ci_IndividualAndFamilyPlansShortDurationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_OtherGovernmentProductsMember_a5c59398-890f-4080-a02d-407261172148" xlink:to="loc_ci_IndividualAndFamilyPlansShortDurationMember_abeb8d00-57e7-4baa-82fd-8d2c2b25c158" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember_ec5db7e3-7a7e-499e-9a16-1349a5b2a4bd" xlink:href="ci-20230331.xsd#ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_OtherGovernmentProductsMember_a5c59398-890f-4080-a02d-407261172148" xlink:to="loc_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember_ec5db7e3-7a7e-499e-9a16-1349a5b2a4bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalHealthMember_36c94562-46ff-4130-a695-06d9b26974bd" xlink:href="ci-20230331.xsd#ci_InternationalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_InternationalHealthMember_36c94562-46ff-4130-a695-06d9b26974bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GroupMedicalInsuranceShortDurationMember_8d7f73b9-12ba-432a-8bf6-d8ddd1c57dda" xlink:href="ci-20230331.xsd#ci_GroupMedicalInsuranceShortDurationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InternationalHealthMember_36c94562-46ff-4130-a695-06d9b26974bd" xlink:to="loc_ci_GroupMedicalInsuranceShortDurationMember_8d7f73b9-12ba-432a-8bf6-d8ddd1c57dda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IndividualPrivateMedicalInsuranceLongDurationMember_dd2ebce2-a61b-4bfa-bc3a-0ceb33de89de" xlink:href="ci-20230331.xsd#ci_IndividualPrivateMedicalInsuranceLongDurationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InternationalHealthMember_36c94562-46ff-4130-a695-06d9b26974bd" xlink:to="loc_ci_IndividualPrivateMedicalInsuranceLongDurationMember_dd2ebce2-a61b-4bfa-bc3a-0ceb33de89de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_9bd7fb01-6eb2-4d28-8c15-ce13af09914c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5508126a-bf44-42b9-91d5-d3b4eef04499" xlink:to="loc_us-gaap_ServiceMember_9bd7fb01-6eb2-4d28-8c15-ce13af09914c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ServiceFeesMember_11090849-70e5-4066-856b-6aadbea799c1" xlink:href="ci-20230331.xsd#ci_ServiceFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ServiceMember_9bd7fb01-6eb2-4d28-8c15-ce13af09914c" xlink:to="loc_ci_ServiceFeesMember_11090849-70e5-4066-856b-6aadbea799c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember_bd1b8d23-b92a-4e40-82e2-d6fe22118b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ServiceMember_9bd7fb01-6eb2-4d28-8c15-ce13af09914c" xlink:to="loc_us-gaap_ServiceOtherMember_bd1b8d23-b92a-4e40-82e2-d6fe22118b7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3a2546cd-7398-4ec7-8671-36346dd7724c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3a2546cd-7398-4ec7-8671-36346dd7724c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3a2546cd-7398-4ec7-8671-36346dd7724c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3a2546cd-7398-4ec7-8671-36346dd7724c" xlink:to="loc_us-gaap_SegmentDomain_3a2546cd-7398-4ec7-8671-36346dd7724c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b85faec7-26d3-4177-a836-b1294afb0b41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3a2546cd-7398-4ec7-8671-36346dd7724c" xlink:to="loc_us-gaap_SegmentDomain_b85faec7-26d3-4177-a836-b1294afb0b41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EvernorthMember_6d0d1ba6-e576-4213-9e96-ffc5b25cbcd5" xlink:href="ci-20230331.xsd#ci_EvernorthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b85faec7-26d3-4177-a836-b1294afb0b41" xlink:to="loc_ci_EvernorthMember_6d0d1ba6-e576-4213-9e96-ffc5b25cbcd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_462175f2-266d-4e3c-a4b6-16404af31c52" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b85faec7-26d3-4177-a836-b1294afb0b41" xlink:to="loc_ci_CignaHealthcareMember_462175f2-266d-4e3c-a4b6-16404af31c52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember_2a53e056-b2ed-45af-86d3-f142378a4dfd" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b85faec7-26d3-4177-a836-b1294afb0b41" xlink:to="loc_ci_OtherOperationsSegmentMember_2a53e056-b2ed-45af-86d3-f142378a4dfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f9e2ce08-0732-4b22-a277-552440a0d203" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:to="loc_srt_ConsolidationItemsAxis_f9e2ce08-0732-4b22-a277-552440a0d203" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f9e2ce08-0732-4b22-a277-552440a0d203_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_f9e2ce08-0732-4b22-a277-552440a0d203" xlink:to="loc_srt_ConsolidationItemsDomain_f9e2ce08-0732-4b22-a277-552440a0d203_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_89dc1ee4-c782-4e34-b827-29dbca89aa72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_f9e2ce08-0732-4b22-a277-552440a0d203" xlink:to="loc_srt_ConsolidationItemsDomain_89dc1ee4-c782-4e34-b827-29dbca89aa72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_e2f560cc-4b81-43bf-9f06-e07eee416d52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_89dc1ee4-c782-4e34-b827-29dbca89aa72" xlink:to="loc_us-gaap_IntersegmentEliminationMember_e2f560cc-4b81-43bf-9f06-e07eee416d52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_54d1201a-4a5b-4d66-9689-fc331c265884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_89dc1ee4-c782-4e34-b827-29dbca89aa72" xlink:to="loc_us-gaap_OperatingSegmentsMember_54d1201a-4a5b-4d66-9689-fc331c265884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_e4ec27b4-afdb-4f5f-84ec-8c8f7afbc9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:to="loc_us-gaap_SubsegmentsAxis_e4ec27b4-afdb-4f5f-84ec-8c8f7afbc9b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_e4ec27b4-afdb-4f5f-84ec-8c8f7afbc9b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_e4ec27b4-afdb-4f5f-84ec-8c8f7afbc9b6" xlink:to="loc_us-gaap_SubsegmentsDomain_e4ec27b4-afdb-4f5f-84ec-8c8f7afbc9b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_1c67e0c6-53c4-4d1f-8fb3-12df29c101e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_e4ec27b4-afdb-4f5f-84ec-8c8f7afbc9b6" xlink:to="loc_us-gaap_SubsegmentsDomain_1c67e0c6-53c4-4d1f-8fb3-12df29c101e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember_2571358c-32c5-48e1-aade-bc6095d2f1e3" xlink:href="ci-20230331.xsd#ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_1c67e0c6-53c4-4d1f-8fb3-12df29c101e8" xlink:to="loc_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember_2571358c-32c5-48e1-aade-bc6095d2f1e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember_ceb3817f-4806-45d3-83e3-61ec39e1e8fd" xlink:href="ci-20230331.xsd#ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember_2571358c-32c5-48e1-aade-bc6095d2f1e3" xlink:to="loc_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember_ceb3817f-4806-45d3-83e3-61ec39e1e8fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsInternationalBusinessesToBeSoldMember_d1c4a914-3af2-4d8e-ac33-3b9b2d341bd5" xlink:href="ci-20230331.xsd#ci_OtherOperationsInternationalBusinessesToBeSoldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember_ceb3817f-4806-45d3-83e3-61ec39e1e8fd" xlink:to="loc_ci_OtherOperationsInternationalBusinessesToBeSoldMember_d1c4a914-3af2-4d8e-ac33-3b9b2d341bd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InterestInJointVentureInTurkeyMember_c49b6f0b-77a9-4e72-a276-badb52210c44" xlink:href="ci-20230331.xsd#ci_InterestInJointVentureInTurkeyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember_ceb3817f-4806-45d3-83e3-61ec39e1e8fd" xlink:to="loc_ci_InterestInJointVentureInTurkeyMember_c49b6f0b-77a9-4e72-a276-badb52210c44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GroupDisabilityAndLifeMember_64a5e298-f1dc-4d54-8059-7314c2065f33" xlink:href="ci-20230331.xsd#ci_GroupDisabilityAndLifeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember_2571358c-32c5-48e1-aade-bc6095d2f1e3" xlink:to="loc_ci_GroupDisabilityAndLifeMember_64a5e298-f1dc-4d54-8059-7314c2065f33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentOtherMember_cd9ec30b-ca9c-4224-8536-44ebf3e85dbb" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_1c67e0c6-53c4-4d1f-8fb3-12df29c101e8" xlink:to="loc_ci_OtherOperationsSegmentOtherMember_cd9ec30b-ca9c-4224-8536-44ebf3e85dbb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SegmentInformationFinancialandPerformanceGuaranteesDetails"/>
  <link:definitionLink xlink:role="http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails" xlink:type="extended" id="i0ec6a17fe80e4769a6b5e1d06780434e_SegmentInformationFinancialandPerformanceGuaranteesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_aedc01a5-5aef-4029-9fdc-836f71b9cdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_f096a8bc-fe2e-49f7-860a-b0d51492e5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_aedc01a5-5aef-4029-9fdc-836f71b9cdf0" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_f096a8bc-fe2e-49f7-860a-b0d51492e5ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_7e2b3245-9bce-4e6b-905b-5d6b9220ffdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_aedc01a5-5aef-4029-9fdc-836f71b9cdf0" xlink:to="loc_us-gaap_LossContingenciesTable_7e2b3245-9bce-4e6b-905b-5d6b9220ffdb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e2dc352b-104d-4338-98c2-430ba57cbe09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7e2b3245-9bce-4e6b-905b-5d6b9220ffdb" xlink:to="loc_srt_ProductOrServiceAxis_e2dc352b-104d-4338-98c2-430ba57cbe09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e2dc352b-104d-4338-98c2-430ba57cbe09_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e2dc352b-104d-4338-98c2-430ba57cbe09" xlink:to="loc_srt_ProductsAndServicesDomain_e2dc352b-104d-4338-98c2-430ba57cbe09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5ddced1f-dd95-4532-b37e-704f1abff83c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e2dc352b-104d-4338-98c2-430ba57cbe09" xlink:to="loc_srt_ProductsAndServicesDomain_5ddced1f-dd95-4532-b37e-704f1abff83c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmacyBenefitsManagementServicesMember_9d6d0ae7-ec0d-4daf-be9f-059cd1942e58" xlink:href="ci-20230331.xsd#ci_PharmacyBenefitsManagementServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5ddced1f-dd95-4532-b37e-704f1abff83c" xlink:to="loc_ci_PharmacyBenefitsManagementServicesMember_9d6d0ae7-ec0d-4daf-be9f-059cd1942e58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_235281bf-86c1-43ee-84ee-07ef8d938428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7e2b3245-9bce-4e6b-905b-5d6b9220ffdb" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_235281bf-86c1-43ee-84ee-07ef8d938428" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_235281bf-86c1-43ee-84ee-07ef8d938428_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_235281bf-86c1-43ee-84ee-07ef8d938428" xlink:to="loc_us-gaap_LossContingencyNatureDomain_235281bf-86c1-43ee-84ee-07ef8d938428_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_6e0d0e94-735b-43de-86d4-959bb952049f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_235281bf-86c1-43ee-84ee-07ef8d938428" xlink:to="loc_us-gaap_LossContingencyNatureDomain_6e0d0e94-735b-43de-86d4-959bb952049f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesMember_f85b2679-4b6e-4ad5-a67f-1c4fe73e1cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_6e0d0e94-735b-43de-86d4-959bb952049f" xlink:to="loc_us-gaap_GuaranteesMember_f85b2679-4b6e-4ad5-a67f-1c4fe73e1cf2" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>ci-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:aba5d1e1-3c5d-49dc-8b95-aefd0f7f3078,g:b4e2c703-69a2-450e-a66f-edc6453c1c81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_ci_InvestmentGradeMember_5e5d4f20-3094-4ec4-955d-c1654e08f7a8_terseLabel_en-US" xlink:label="lab_ci_InvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment grade</link:label>
    <link:label id="lab_ci_InvestmentGradeMember_label_en-US" xlink:label="lab_ci_InvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Grade [Member]</link:label>
    <link:label id="lab_ci_InvestmentGradeMember_documentation_en-US" xlink:label="lab_ci_InvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External credit-ratings or internal groupings that could be used to describe the current status of the payment and performance risk of debt and securities investments that connote investment grade.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentGradeMember" xlink:href="ci-20230331.xsd#ci_InvestmentGradeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InvestmentGradeMember" xlink:to="lab_ci_InvestmentGradeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReinsuranceRecoverable_9d58af93-f291-4c02-9f36-39219b338162_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReinsuranceRecoverable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverable and Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReinsuranceRecoverable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReinsuranceRecoverable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Reinsurance Recoverable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReinsuranceRecoverable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReinsuranceRecoverable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReinsuranceRecoverable" xlink:to="lab_us-gaap_IncreaseDecreaseInReinsuranceRecoverable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_38533645-be7b-474e-8508-fd1127c69440_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_4dd496df-10a6-4498-9c7c-d55ede886238_terseLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_4b3ceb20-957e-4edb-a142-c00a0ee0e827_verboseLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Securities Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Securities Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndemnificationGuaranteeMember_8857e66e-6ae7-4609-b960-0e01add80209_terseLabel_en-US" xlink:label="lab_us-gaap_IndemnificationGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification obligations</link:label>
    <link:label id="lab_us-gaap_IndemnificationGuaranteeMember_label_en-US" xlink:label="lab_us-gaap_IndemnificationGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndemnificationGuaranteeMember" xlink:to="lab_us-gaap_IndemnificationGuaranteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1289926e-5baf-455f-8d5c-fe8836dda562_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation of Foreign Currencies</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax_08385d85-f6c8-464c-a54f-8a90f5b5af51_negatedLabel_en-US" xlink:label="lab_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax_label_en-US" xlink:label="lab_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss Attributable To Noncontrolling Interest Before Tax</link:label>
    <link:label id="lab_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax_documentation_en-US" xlink:label="lab_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of pre-tax income (loss) attributable to noncontrolling interest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax" xlink:href="ci-20230331.xsd#ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax" xlink:to="lab_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_c1709f42-02b2-4477-a99d-aefe14995240_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of counts</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_3d4e41f5-33cb-4fd5-9d98-06d00ce7fa16_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs and other benefit expenses</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale_b1fc83bc-da62-40da-b5eb-7d44d061d58f_terseLabel_en-US" xlink:label="lab_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities with readily determinable fair values, including held for sale assets</link:label>
    <link:label id="lab_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale_d1d11c65-4297-4b83-969b-fe6b3045c04d_verboseLabel_en-US" xlink:label="lab_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, including held for sale assets</link:label>
    <link:label id="lab_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Fv Ni Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Fv Ni Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups_90e61972-61f6-4eab-9cb0-98a6aff9bfc9_terseLabel_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid claims and claim expenses, including held for sale liabilities</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Claims And Claims Adjustment Expense Current Including Disposal Groups</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount (expected to be paid within one year) needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups" xlink:to="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_cc6220b2-e5d1-480c-ade4-3cd81463b8e8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_778a2750-ef26-490d-a93b-048243a2a27a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Debt Securities with a Decline in Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost_ca40bbe5-ee01-4db8-90c5-df288d36638b_totalLabel_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost_label_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost" xlink:to="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_fea662a3-6ca0-4c93-823b-1731a8b09cfb_terseLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities, Noncurrent [Abstract]</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_documentation_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract" xlink:to="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity_a4d775ca-7faa-4b19-863a-748df6f74af6_totalLabel_en-US" xlink:label="lab_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity_label_en-US" xlink:label="lab_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest, Including Temporary Equity</link:label>
    <link:label id="lab_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity_documentation_en-US" xlink:label="lab_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest, Including Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity" xlink:href="ci-20230331.xsd#ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity" xlink:to="lab_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_b82d3d95-95af-442d-8634-c5cd11018ca8_periodStartLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of effect of discount rate assumptions</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_411389ae-2ffe-448d-b478-cb3fb4a2c7cb_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of discount rate assumptions</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_label_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:to="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_USGroupDisabilityAndLifeInsuranceBusinessMember_27bc4bf4-bfee-4948-8eb6-8122dea3d4cf_terseLabel_en-US" xlink:label="lab_ci_USGroupDisabilityAndLifeInsuranceBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S Group Disability and Life Insurance</link:label>
    <link:label id="lab_ci_USGroupDisabilityAndLifeInsuranceBusinessMember_label_en-US" xlink:label="lab_ci_USGroupDisabilityAndLifeInsuranceBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S Group Disability And Life Insurance Business [Member]</link:label>
    <link:label id="lab_ci_USGroupDisabilityAndLifeInsuranceBusinessMember_documentation_en-US" xlink:label="lab_ci_USGroupDisabilityAndLifeInsuranceBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S Group Disability And Life Insurance Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_USGroupDisabilityAndLifeInsuranceBusinessMember" xlink:href="ci-20230331.xsd#ci_USGroupDisabilityAndLifeInsuranceBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_USGroupDisabilityAndLifeInsuranceBusinessMember" xlink:to="lab_ci_USGroupDisabilityAndLifeInsuranceBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_UnobservableInputsDevelopedByCompanyMember_af6dbbbd-0f04-4d96-9a27-8e6672ab623a_terseLabel_en-US" xlink:label="lab_ci_UnobservableInputsDevelopedByCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Priced by the Company</link:label>
    <link:label id="lab_ci_UnobservableInputsDevelopedByCompanyMember_label_en-US" xlink:label="lab_ci_UnobservableInputsDevelopedByCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unobservable Inputs Developed By Company [Member]</link:label>
    <link:label id="lab_ci_UnobservableInputsDevelopedByCompanyMember_documentation_en-US" xlink:label="lab_ci_UnobservableInputsDevelopedByCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs used in pricing Level 3 securities that were developed directly by the Company.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnobservableInputsDevelopedByCompanyMember" xlink:href="ci-20230331.xsd#ci_UnobservableInputsDevelopedByCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_UnobservableInputsDevelopedByCompanyMember" xlink:to="lab_ci_UnobservableInputsDevelopedByCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OngoingOperationsMember_595f3790-799f-4b38-b4e9-d487d8471b7e_terseLabel_en-US" xlink:label="lab_ci_OngoingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ongoing Operations</link:label>
    <link:label id="lab_ci_OngoingOperationsMember_label_en-US" xlink:label="lab_ci_OngoingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ongoing Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OngoingOperationsMember" xlink:href="ci-20230331.xsd#ci_OngoingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OngoingOperationsMember" xlink:to="lab_ci_OngoingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_b3713462-cc1a-455f-80e3-6cc4039ae606_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Insurance and Contractholder Liabilities, Activity in the Unpaid Claims Liability and Liability Details for Unpaid Claims and Claim Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FuturePolicyBenefitsLiabilityPolicy_13e8cad8-04bc-4587-becf-97083092aeda_terseLabel_en-US" xlink:label="lab_us-gaap_FuturePolicyBenefitsLiabilityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Policy Benefits</link:label>
    <link:label id="lab_us-gaap_FuturePolicyBenefitsLiabilityPolicy_label_en-US" xlink:label="lab_us-gaap_FuturePolicyBenefitsLiabilityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FuturePolicyBenefitsLiabilityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FuturePolicyBenefitsLiabilityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FuturePolicyBenefitsLiabilityPolicy" xlink:to="lab_us-gaap_FuturePolicyBenefitsLiabilityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CededCreditCollateralizationRiskMember_fd0f5833-0543-41c8-9fef-fd53e6c6f6eb_terseLabel_en-US" xlink:label="lab_ci_CededCreditCollateralizationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateralization risk</link:label>
    <link:label id="lab_ci_CededCreditCollateralizationRiskMember_label_en-US" xlink:label="lab_ci_CededCreditCollateralizationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Collateralization Risk [Member]</link:label>
    <link:label id="lab_ci_CededCreditCollateralizationRiskMember_documentation_en-US" xlink:label="lab_ci_CededCreditCollateralizationRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk related to collateralization of a specified benchmark, such as reinsurance recoverables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededCreditCollateralizationRiskMember" xlink:href="ci-20230331.xsd#ci_CededCreditCollateralizationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CededCreditCollateralizationRiskMember" xlink:to="lab_ci_CededCreditCollateralizationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_890572c7-16fc-4c6d-9937-c6115b8630e8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_efcfbef0-50f8-4df1-8a69-827b10183242_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock dividend paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_5ec52144-4c31-4d3b-bd6a-e725d7f86fb0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amount paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_2b7e7267-f813-4341-ae65-c9e30184d275_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to other noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NonInvestmentRevenue_40188907-6b71-4b56-81f5-5d09c0165183_verboseLabel_en-US" xlink:label="lab_ci_NonInvestmentRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from customers</link:label>
    <link:label id="lab_ci_NonInvestmentRevenue_463cada7-3a04-4548-bacf-63969c02548a_totalLabel_en-US" xlink:label="lab_ci_NonInvestmentRevenue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues from external customers</link:label>
    <link:label id="lab_ci_NonInvestmentRevenue_label_en-US" xlink:label="lab_ci_NonInvestmentRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Investment Revenue</link:label>
    <link:label id="lab_ci_NonInvestmentRevenue_documentation_en-US" xlink:label="lab_ci_NonInvestmentRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue excluding net investment income and realized investment results.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonInvestmentRevenue" xlink:href="ci-20230331.xsd#ci_NonInvestmentRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NonInvestmentRevenue" xlink:to="lab_ci_NonInvestmentRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes_7a909b7d-c843-4a6e-bb89-7149f9ba179e_negatedLabel_en-US" xlink:label="lab_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual adjustment for a former client (Pharmacy revenues)</link:label>
    <link:label id="lab_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes_ba19f199-91aa-4a78-9d98-f220740044c3_negatedTerseLabel_en-US" xlink:label="lab_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual adjustment for a former client</link:label>
    <link:label id="lab_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes_label_en-US" xlink:label="lab_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item, Gain (Loss) From Contract Adjustment, Before Taxes</link:label>
    <link:label id="lab_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes_documentation_en-US" xlink:label="lab_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item, Gain (Loss) From Contract Adjustment, Before Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes" xlink:to="lab_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpensesAbstract_ead80e88-ea84-4e4c-b819-100d63be8cca_terseLabel_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits and expenses</link:label>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits, Losses and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:to="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember_72a89d71-fd35-40b4-a9b2-25fd120e256e_terseLabel_en-US" xlink:label="lab_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BBB+ equivalent and higher current ratings</link:label>
    <link:label id="lab_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember_label_en-US" xlink:label="lab_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nationally Recognized Statistical Rating Organizations (NRSRO), BBB+ Or Higher [Member]</link:label>
    <link:label id="lab_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember_documentation_en-US" xlink:label="lab_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nationally Recognized Statistical Rating Organizations (NRSRO), BBB+ Or Higher</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember" xlink:href="ci-20230331.xsd#ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember" xlink:to="lab_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_47322bb7-9543-4c86-a31b-0fc2e91bb585_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_89e0fa58-3e3d-451f-b544-180c3d556dd1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid claims and claim expenses</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c723edb1-b72e-4cae-9508-4bcf21966302_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_8f624cab-c151-4611-bb27-4bb5b13d3dd3_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_45c26e36-4e07-4135-88c0-ed7acad9c36b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue_c7c97bf3-61c0-4c97-9282-ce9a5a874b22_terseLabel_en-US" xlink:label="lab_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized investment losses on assets measured at fair value under certain conditions, after-tax</link:label>
    <link:label id="lab_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue_label_en-US" xlink:label="lab_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Losses Commercial Mortgage Loans And Real Estate Entities With No Readily Determinable Fair Value</link:label>
    <link:label id="lab_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue_documentation_en-US" xlink:label="lab_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized investment losses on impaired real estate, partnership entities, commercial mortgage loans and certain equity securities with no readily determinable fair value, after-tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue" xlink:to="lab_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange_6eee73ed-9aa0-487b-93b1-7fe2a7074cac_periodStartLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of year, before the effect of nonperformance risk (own credit risk)</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange_ac7027a5-c80f-44f5-b9fa-e787ee90f94e_periodEndLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of year, before the effect of changes in nonperformance risk (own credit risk)</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange_label_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, before Reinsurance and Cumulative Increase (Decrease) from Instrument-Specific Credit Risk Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange" xlink:to="lab_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_112615ce-2297-4c30-9a37-9629dafd01d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8731351a-dac3-4807-b96c-4c15d7bd95ee_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskSecuredMember_5c36c04f-4f13-4fdc-9428-35c83fa9d218_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskSecuredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskSecuredMember_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskSecuredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Secured [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskSecuredMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskSecuredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskSecuredMember" xlink:to="lab_us-gaap_CededCreditRiskSecuredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock_001fdb5f-3cf5-41fd-af32-b854eda313d1_terseLabel_en-US" xlink:label="lab_ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets (Current and Non-Current)</link:label>
    <link:label id="lab_ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock_label_en-US" xlink:label="lab_ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets Current And Noncurrent Policy [Policy Text Block]</link:label>
    <link:label id="lab_ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting policies related to Other Assets, Current and Noncurrent and the items included therein.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock" xlink:href="ci-20230331.xsd#ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock" xlink:to="lab_ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_40115f61-d15e-4476-978b-52d6dce76684_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Financing Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Financing Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:to="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_c1453f20-e608-415f-b0cd-0ceeab79fd37_terseLabel_en-US" xlink:label="lab_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long term investments, including held for sale assets</link:label>
    <link:label id="lab_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue203024InterestMember_e1c17239-d0f9-4e56-a81b-12d8d985716b_terseLabel_en-US" xlink:label="lab_ci_NotesDue203024InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,500&#160;million, 2.400% Notes due March 2030</link:label>
    <link:label id="lab_ci_NotesDue203024InterestMember_label_en-US" xlink:label="lab_ci_NotesDue203024InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2030, 2.4% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue203024InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue203024InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2030, 2.4% Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue203024InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue203024InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue203024InterestMember" xlink:to="lab_ci_NotesDue203024InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_134cbef4-10f8-43ba-a5b0-069f67076556_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_12bb145c-0cec-42f0-a8cf-935a92006952_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_b1c7e0fb-b8e4-4afd-8df2-f4e24e3cf123_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign and U.S. Revenues from External Customers</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_95ff7f20-509a-407c-b847-6679600306e2_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue204648InterestMember_16936529-1b8d-4284-8e2f-780b606811c0_terseLabel_en-US" xlink:label="lab_ci_NotesDue204648InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,500&#160;million, 4.800% Notes due July 2046</link:label>
    <link:label id="lab_ci_NotesDue204648InterestMember_label_en-US" xlink:label="lab_ci_NotesDue204648InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2046, 4.8% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue204648InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue204648InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable bearing interest at 4.8% due in 2046. Debt assumed acquisition from Express Scripts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue204648InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue204648InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue204648InterestMember" xlink:to="lab_ci_NotesDue204648InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CommitmentsAndContingenciesLineItems_801e8a46-af3e-4460-af98-576a9be740f2_terseLabel_en-US" xlink:label="lab_ci_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_ci_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_ci_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_ci_CommitmentsAndContingenciesLineItems_documentation_en-US" xlink:label="lab_ci_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsAndContingenciesLineItems" xlink:href="ci-20230331.xsd#ci_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems" xlink:to="lab_ci_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_a75bfc9a-c0de-4ae3-9cb1-43dd8278553b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_d4c0b9ac-c253-4c41-bea3-641ab43c3762_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_89b937f2-4e59-4a12-865d-5b9b7e945afe_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale_b6e7fbf8-09c2-472c-b34e-e2fb9b0dead0_terseLabel_en-US" xlink:label="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-guaranteed separate accounts priced at NAV as a practical expedient, including held for sale assets</link:label>
    <link:label id="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The fair value of the assets held by the Entity for the benefit of separate account policyholders without guarantees and priced at net asset value as a practical expedient.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CommitmentToPurchaseEquitySecuritiesMember_4e5b7cde-bd16-4be3-98ea-dbdb0f684ad9_terseLabel_en-US" xlink:label="lab_ci_CommitmentToPurchaseEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment to purchase equity securities</link:label>
    <link:label id="lab_ci_CommitmentToPurchaseEquitySecuritiesMember_label_en-US" xlink:label="lab_ci_CommitmentToPurchaseEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment To Purchase Equity Securities [Member]</link:label>
    <link:label id="lab_ci_CommitmentToPurchaseEquitySecuritiesMember_documentation_en-US" xlink:label="lab_ci_CommitmentToPurchaseEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment To Purchase Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentToPurchaseEquitySecuritiesMember" xlink:href="ci-20230331.xsd#ci_CommitmentToPurchaseEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CommitmentToPurchaseEquitySecuritiesMember" xlink:to="lab_ci_CommitmentToPurchaseEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_1375100e-667c-45ae-b37c-22fe15e9e337_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7e354124-a09f-491b-83c7-3e8f3c79fc09_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_56d8df11-1f2d-4c6a-91b1-f7255a234518_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive options (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_b14b4405-487d-4b72-b23c-2e9acccc6a19_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems" xlink:to="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_42291857-6816-458e-8d8b-e4358b9b397c_terseLabel_en-US" xlink:label="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:to="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_a14277aa-19a3-4e08-a0f7-f39ccba5b501_totalLabel_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortized Cost, including held for sale assets</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Amortized Cost, Before Reclassification To Disposal Group, Assets Held-For-Sale</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Amortized Cost, Before Reclassification To Disposal Group, Assets Held-For-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis_8d1186bc-3db1-49e1-a4e2-93790ae7fedd_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, above Guaranteed Minimum Crediting Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, above Guaranteed Minimum Crediting Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis" xlink:to="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_4299db9d-cd82-4a8e-8a89-256225dec8bb_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_54343667-8309-4a2e-8c2c-9ed9880fc8d4_totalLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_a81e75b4-cb2b-4475-917b-c755ca948956_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (loss)</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_5f775331-5603-44c9-ba93-5f9f83409740_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_65cd5fdc-cbf9-438a-b48d-1415eaccdf47_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskCollateralizationDomain_af988b6a-c73a-4060-8ed3-91e0d6b9f4fd_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskCollateralizationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Collateralization [Domain]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskCollateralizationDomain_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskCollateralizationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Collateralization [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskCollateralizationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskCollateralizationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationDomain" xlink:to="lab_us-gaap_CededCreditRiskCollateralizationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember_1693b30e-c722-474b-b97c-bb0c64b62884_terseLabel_en-US" xlink:label="lab_us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument, Economic Hedge</link:label>
    <link:label id="lab_us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember_label_en-US" xlink:label="lab_us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument, Economic Hedge [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember" xlink:to="lab_us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember_bd2c2c40-384e-40aa-87e8-d2bb59cdd2e7_terseLabel_en-US" xlink:label="lab_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International businesses to be sold and Group Disability and Life business</link:label>
    <link:label id="lab_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember_label_en-US" xlink:label="lab_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Businesses To Be Sold Group Disability And Life [Member]</link:label>
    <link:label id="lab_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember_documentation_en-US" xlink:label="lab_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Businesses to be Sold and Group Disability And Life subsegments of Other Operations segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember" xlink:href="ci-20230331.xsd#ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember" xlink:to="lab_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_aaa3a22d-2261-4388-a0af-71750d813eff_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_aab2074a-e9df-40fc-b990-7fcb76120ef7_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LifeInsuranceCompanyOfNorthAmericaMember_f853c74f-f7f1-4e25-a373-0fb7e10bf950_terseLabel_en-US" xlink:label="lab_ci_LifeInsuranceCompanyOfNorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Insurance Company of North America</link:label>
    <link:label id="lab_ci_LifeInsuranceCompanyOfNorthAmericaMember_label_en-US" xlink:label="lab_ci_LifeInsuranceCompanyOfNorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Insurance Company Of North America [Member]</link:label>
    <link:label id="lab_ci_LifeInsuranceCompanyOfNorthAmericaMember_documentation_en-US" xlink:label="lab_ci_LifeInsuranceCompanyOfNorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Insurance Company Of North America</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LifeInsuranceCompanyOfNorthAmericaMember" xlink:href="ci-20230331.xsd#ci_LifeInsuranceCompanyOfNorthAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LifeInsuranceCompanyOfNorthAmericaMember" xlink:to="lab_ci_LifeInsuranceCompanyOfNorthAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_d576a915-8248-4ce4-bb44-86fab33b5e1a_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of impairments or value changes resulting from observable price changes on equity securities with no readily available fair value still held</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups_9501ae96-3078-4190-8a62-5696323f6f9c_terseLabel_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid claims and claim expenses, including held for sale liabilities</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Claims And Claims Adjustment Expense Noncurrent Including Disposal Groups</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount (expected to be paid after one year) needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups" xlink:to="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_30f9679e-2d9f-42e6-8f5b-42bfc2b84215_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate account liabilities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_label_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountsLiability" xlink:to="lab_us-gaap_SeparateAccountsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2bc764ff-a520-48f9-9c7b-84545bc2b4b3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_8b07a0f9-179b-4f4e-871b-c4719b03be9d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_ed3f43cd-5ea7-45b9-a8bb-73dd18a0ae96_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosure of Cash Information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_554c7e75-c88c-49bd-a763-d47c2835ffa8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undiscounted expected future gross premiums</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Gross Premium, Undiscounted, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_VariableInterestEntitiesNumberOfEntities_7a7730eb-3788-49b8-86bb-999cc280e4df_terseLabel_en-US" xlink:label="lab_ci_VariableInterestEntitiesNumberOfEntities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of VIEs</link:label>
    <link:label id="lab_ci_VariableInterestEntitiesNumberOfEntities_label_en-US" xlink:label="lab_ci_VariableInterestEntitiesNumberOfEntities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities, Number Of Entities</link:label>
    <link:label id="lab_ci_VariableInterestEntitiesNumberOfEntities_documentation_en-US" xlink:label="lab_ci_VariableInterestEntitiesNumberOfEntities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities, Number Of Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_VariableInterestEntitiesNumberOfEntities" xlink:href="ci-20230331.xsd#ci_VariableInterestEntitiesNumberOfEntities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_VariableInterestEntitiesNumberOfEntities" xlink:to="lab_ci_VariableInterestEntitiesNumberOfEntities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets_2d321ccc-b43b-4716-ba8c-47be404275bc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment for credit risk on derivatives assets</link:label>
    <link:label id="lab_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Credit Risk Valuation Adjustment, Derivative Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets" xlink:to="lab_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketRiskBenefitPolicyTextBlock_2b0eb113-6edd-47c6-917b-e6d2d61fda29_terseLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefits</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketRiskBenefitPolicyTextBlock" xlink:to="lab_us-gaap_MarketRiskBenefitPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_e2d6e2d8-0799-4fde-b57a-2078c9936090_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding balances</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_48e056ea-8a82-476b-96f4-e25db0ac2259_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_b25a689b-93b1-4cf1-a7dc-26c4158f12b1_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1_ca30e37d-d697-460c-99a5-6537c088e5b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption Notice Period</link:label>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1_label_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Investment Redemption, Notice Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1" xlink:to="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverables_65ed76d1-452a-45bf-83d2-a55fe618b56a_totalLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverables" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverables_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Including Reinsurance Premium Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverables" xlink:to="lab_us-gaap_ReinsuranceRecoverables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrentAbstract_9358df26-c5d1-4d24-8411-aec3e4fb425f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_DebtCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrentAbstract" xlink:to="lab_us-gaap_DebtCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient_0d770e65-d175-4900-a1c8-157bbdaad4ba_terseLabel_en-US" xlink:label="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-guaranteed separate accounts priced at NAV as a practical expedient</link:label>
    <link:label id="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient_label_en-US" xlink:label="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient</link:label>
    <link:label id="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient_documentation_en-US" xlink:label="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The fair value of the assets held by the Entity for the benefit of separate account policyholders without guarantees and priced at net asset value as a practical expedient.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient" xlink:to="lab_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput_cb5dff29-0fe0-4e02-9b7e-a4c7c7ee1fec_terseLabel_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unobservable Adjustment, including held for sale assets</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput_label_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Including Disposal Group, Measurement Input</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput_documentation_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Including Disposal Group, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput" xlink:to="lab_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue205034InterestMember_3b97ce74-c79f-42b7-aa0f-9d178a376bae_terseLabel_en-US" xlink:label="lab_ci_NotesDue205034InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,250&#160;million, 3.400% Notes due March 2050</link:label>
    <link:label id="lab_ci_NotesDue205034InterestMember_label_en-US" xlink:label="lab_ci_NotesDue205034InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2050, 3.4% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue205034InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue205034InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2050, 3.4% Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue205034InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue205034InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue205034InterestMember" xlink:to="lab_ci_NotesDue205034InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_e4a5c1c9-f731-45ad-840d-d04990a18c78_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds from sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9b078f2b-21e2-4c13-97b2-98e82233304f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue2023FloatingRateInterestMember_e81d300c-0a45-4866-a2bd-263f93704a3b_terseLabel_en-US" xlink:label="lab_ci_NotesDue2023FloatingRateInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$700&#160;million, Floating Rate Notes due July 2023</link:label>
    <link:label id="lab_ci_NotesDue2023FloatingRateInterestMember_label_en-US" xlink:label="lab_ci_NotesDue2023FloatingRateInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2023 Floating Rate Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue2023FloatingRateInterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue2023FloatingRateInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable with floating interest due in 2023. Debt issued to finance acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2023FloatingRateInterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue2023FloatingRateInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue2023FloatingRateInterestMember" xlink:to="lab_ci_NotesDue2023FloatingRateInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_0b5ffa4a-4588-4967-8b4c-f0216e1fe026_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_2e9479f3-a85d-4f02-b38f-cd96d0724b41_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherShortTermInvestments_ad29dddb-8507-4331-9532-9ce87708d913_terseLabel_en-US" xlink:label="lab_us-gaap_OtherShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_OtherShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherShortTermInvestments" xlink:to="lab_us-gaap_OtherShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AcquisitionDispositionRunoffActivitiesMember_5dc2df08-a50f-4389-a3ed-542920785849_terseLabel_en-US" xlink:label="lab_ci_AcquisitionDispositionRunoffActivitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, disposition or run-off activities</link:label>
    <link:label id="lab_ci_AcquisitionDispositionRunoffActivitiesMember_label_en-US" xlink:label="lab_ci_AcquisitionDispositionRunoffActivitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Disposition Runoff Activities [Member]</link:label>
    <link:label id="lab_ci_AcquisitionDispositionRunoffActivitiesMember_documentation_en-US" xlink:label="lab_ci_AcquisitionDispositionRunoffActivitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products related to acquisition, disposition or runoff activities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AcquisitionDispositionRunoffActivitiesMember" xlink:href="ci-20230331.xsd#ci_AcquisitionDispositionRunoffActivitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AcquisitionDispositionRunoffActivitiesMember" xlink:to="lab_ci_AcquisitionDispositionRunoffActivitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesTable_d696da11-18ba-4adc-9d49-7cad690250ad_terseLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities [Table]</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesTable_label_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesTable" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable" xlink:to="lab_ci_InsuranceAndContractholderLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_5164a51c-e901-422a-ac9e-b7fc484c06bf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_14cdabd6-4835-485b-9691-37b030c1e5e1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_0bdc27ef-f582-4054-93e8-f254f5db5ed9_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherCommercialMedicalProductsMember_b10ce346-80b3-4f8e-b025-43945bafe6de_terseLabel_en-US" xlink:label="lab_ci_OtherCommercialMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commercial Medical Products</link:label>
    <link:label id="lab_ci_OtherCommercialMedicalProductsMember_label_en-US" xlink:label="lab_ci_OtherCommercialMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commercial Medical Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherCommercialMedicalProductsMember" xlink:href="ci-20230331.xsd#ci_OtherCommercialMedicalProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherCommercialMedicalProductsMember" xlink:to="lab_ci_OtherCommercialMedicalProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience_9b348ffd-3342-4b81-8caf-11576781f0fd_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of assumption changes and actual variances from expected experience</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) From Cash Flow Change And Actual Variance From Expected Experience</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) From Cash Flow Change And Actual Variance From Expected Experience</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08c58590-939f-449e-acc3-02cf69a8f22c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount_4471579f-4451-4fae-9cab-fff532325789_terseLabel_en-US" xlink:label="lab_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated stock repurchase, volume weighted average share price (in dollars per share)</link:label>
    <link:label id="lab_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount_label_en-US" xlink:label="lab_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Volume Weighted Average Share Price, Less Discount</link:label>
    <link:label id="lab_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount_documentation_en-US" xlink:label="lab_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Volume Weighted Average Share Price, Less Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount" xlink:href="ci-20230331.xsd#ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount" xlink:to="lab_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CorporateAndGovernmentDebtSecuritiesMember_d0bc3739-408d-4c97-b922-17099b934627_terseLabel_en-US" xlink:label="lab_ci_CorporateAndGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and government debt securities</link:label>
    <link:label id="lab_ci_CorporateAndGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_ci_CorporateAndGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate And Government Debt Securities [Member]</link:label>
    <link:label id="lab_ci_CorporateAndGovernmentDebtSecuritiesMember_documentation_en-US" xlink:label="lab_ci_CorporateAndGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This category includes information about debt securities that are issued by either a domestic or foreign corporate business entity with a promise of repayment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CorporateAndGovernmentDebtSecuritiesMember" xlink:href="ci-20230331.xsd#ci_CorporateAndGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CorporateAndGovernmentDebtSecuritiesMember" xlink:to="lab_ci_CorporateAndGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_42ae5c87-2ba4-4a9b-a1bb-efc47b8dffb3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6af7c142-bc11-433e-8246-a47b9e7d19e0_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_13651a9f-bde1-4324-8b00-4b69184bfb3d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts assets classified in Level 3, period increase (decrease), including transfers in and out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a7c458b-cf96-424e-ab54-47aeaf802691_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue20312375InterestMember_3467d0f4-6faf-4225-b186-c4f23c016283_terseLabel_en-US" xlink:label="lab_ci_NotesDue20312375InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,500 million, 2.375% Notes due 2031</link:label>
    <link:label id="lab_ci_NotesDue20312375InterestMember_label_en-US" xlink:label="lab_ci_NotesDue20312375InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2031, 2.375% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue20312375InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue20312375InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable bearing interest at 2.375% due in 2031.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20312375InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue20312375InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue20312375InterestMember" xlink:to="lab_ci_NotesDue20312375InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_029eab36-5269-40ff-bc21-c2dd5827a15a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax_3dd62cd8-e442-4dbe-97a1-12cce8352f04_terseLabel_en-US" xlink:label="lab_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net long-duration insurance and contractholder liabilities measurement adjustments</link:label>
    <link:label id="lab_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax_label_en-US" xlink:label="lab_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Liability For Future Policy Benefit And Market Risk Benefit, Instrument-Specific Credit Risk, Gain (Loss), After Reclassification Adjustment And Tax</link:label>
    <link:label id="lab_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax_documentation_en-US" xlink:label="lab_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Liability For Future Policy Benefit And Market Risk Benefit, Instrument-Specific Credit Risk, Gain (Loss), After Reclassification Adjustment And Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax" xlink:href="ci-20230331.xsd#ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax" xlink:to="lab_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_617cc288-4cef-4cf6-8963-0ac3ef48eb4b_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_71192e6b-3e54-4b8e-974b-113e5a8f5aa5_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other sales, maturities and repayments (primarily short-term and other long-term investments)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_81f7f8b8-8744-4ee9-aa6a-1733fbd90292_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets at fair value:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes_560b8006-18b4-44a7-bace-41e84cea66ed_negatedLabel_en-US" xlink:label="lab_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) on sale of business</link:label>
    <link:label id="lab_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes_label_en-US" xlink:label="lab_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item, Gain (Loss) On Sale Of Business, Before Taxes</link:label>
    <link:label id="lab_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes_documentation_en-US" xlink:label="lab_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item, Gain (Loss) On Sale Of Business, Before Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes" xlink:to="lab_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_db54afb8-2963-4669-94b1-1b306dd563aa_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue2022305InterestMember_3ddbc1f3-a1b8-40d6-bc38-ab79dfd22d36_terseLabel_en-US" xlink:label="lab_ci_NotesDue2022305InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2022, 3.05% Interest</link:label>
    <link:label id="lab_ci_NotesDue2022305InterestMember_label_en-US" xlink:label="lab_ci_NotesDue2022305InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2022, 3.05% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue2022305InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue2022305InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable bearing interest at 3.05% due in 2022. Debt assumed acquisition from Express Scripts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2022305InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue2022305InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue2022305InterestMember" xlink:to="lab_ci_NotesDue2022305InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4c1efe06-5ff3-473f-a30a-a08439208e5f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_FairValueMeasurementNonPerformanceRiskAdjustment_0a76fddd-9ad6-4ffa-bab7-436167ad1918_terseLabel_en-US" xlink:label="lab_ci_FairValueMeasurementNonPerformanceRiskAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of non-performance risk</link:label>
    <link:label id="lab_ci_FairValueMeasurementNonPerformanceRiskAdjustment_label_en-US" xlink:label="lab_ci_FairValueMeasurementNonPerformanceRiskAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Non-Performance Risk Adjustment</link:label>
    <link:label id="lab_ci_FairValueMeasurementNonPerformanceRiskAdjustment_documentation_en-US" xlink:label="lab_ci_FairValueMeasurementNonPerformanceRiskAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Non-Performance Risk Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementNonPerformanceRiskAdjustment" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementNonPerformanceRiskAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_FairValueMeasurementNonPerformanceRiskAdjustment" xlink:to="lab_ci_FairValueMeasurementNonPerformanceRiskAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsAbstract_7e18b9b9-9744-423b-9519-05a6847d70b6_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsAbstract" xlink:to="lab_us-gaap_ShortTermInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_424aeb9d-69d9-4f46-82e5-659f63566783_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains included in Shareholders' net income</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NumberOfRevolvingCreditFacility_887a3941-d9b4-45b3-ae2d-e3b877634e0b_terseLabel_en-US" xlink:label="lab_ci_NumberOfRevolvingCreditFacility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of revolving credit facilities</link:label>
    <link:label id="lab_ci_NumberOfRevolvingCreditFacility_label_en-US" xlink:label="lab_ci_NumberOfRevolvingCreditFacility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Revolving Credit Facility</link:label>
    <link:label id="lab_ci_NumberOfRevolvingCreditFacility_documentation_en-US" xlink:label="lab_ci_NumberOfRevolvingCreditFacility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Revolving Credit Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NumberOfRevolvingCreditFacility" xlink:href="ci-20230331.xsd#ci_NumberOfRevolvingCreditFacility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NumberOfRevolvingCreditFacility" xlink:to="lab_ci_NumberOfRevolvingCreditFacility" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable_61966336-3f7a-4109-a9a2-1f8f2b11f22f_terseLabel_en-US" xlink:label="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturers receivables</link:label>
    <link:label id="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable_label_en-US" xlink:label="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable</link:label>
    <link:label id="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable_documentation_en-US" xlink:label="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables due from customers that are not under insurance contracts. These include pharmacy sales and fees due from employer clients.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable" xlink:href="ci-20230331.xsd#ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable" xlink:to="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ForwardsSwapsOptionsMember_8e65c773-1aa7-465b-9243-688a23e2f7d1_terseLabel_en-US" xlink:label="lab_ci_ForwardsSwapsOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forwards, swaps, options</link:label>
    <link:label id="lab_ci_ForwardsSwapsOptionsMember_label_en-US" xlink:label="lab_ci_ForwardsSwapsOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forwards Swaps Options [Member]</link:label>
    <link:label id="lab_ci_ForwardsSwapsOptionsMember_documentation_en-US" xlink:label="lab_ci_ForwardsSwapsOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forwards Swaps Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ForwardsSwapsOptionsMember" xlink:href="ci-20230331.xsd#ci_ForwardsSwapsOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ForwardsSwapsOptionsMember" xlink:to="lab_ci_ForwardsSwapsOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_6479bedc-926a-477a-b18b-bd015ec2f324_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_24e2c119-c6f7-45df-93cd-8deb1ad9983f_terseLabel_en-US" xlink:label="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment for credit risk on derivatives liabilities</link:label>
    <link:label id="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Credit Risk Valuation Adjustment, Derivative Liabilities, Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Credit Risk Valuation Adjustment, Derivative Liabilities, Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_953ca10e-774c-49f9-800e-a757498450b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PolicyholderContractDepositCurrent_f7948ad7-7ea4-46d9-842d-4296465fce58_terseLabel_en-US" xlink:label="lab_ci_PolicyholderContractDepositCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractholder deposit funds, current</link:label>
    <link:label id="lab_ci_PolicyholderContractDepositCurrent_label_en-US" xlink:label="lab_ci_PolicyholderContractDepositCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Contract Deposit, Current</link:label>
    <link:label id="lab_ci_PolicyholderContractDepositCurrent_documentation_en-US" xlink:label="lab_ci_PolicyholderContractDepositCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Contract Deposit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositCurrent" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PolicyholderContractDepositCurrent" xlink:to="lab_ci_PolicyholderContractDepositCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_8bb73596-b284-4e01-a95d-b267366c2970_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_b90e2cb7-382d-42aa-a4a9-796ad1c0939a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentMember_7c767500-0cbc-4a25-beaf-10dade7ccc4c_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate investments</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentMember_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentMember" xlink:to="lab_us-gaap_RealEstateInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_01e1f0a2-5930-4736-87d0-024917a042fd_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncatastrophicEventAxis_e55a4354-c79c-4181-8e5b-3230d0090c4c_terseLabel_en-US" xlink:label="lab_us-gaap_NoncatastrophicEventAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncatastrophic Event [Axis]</link:label>
    <link:label id="lab_us-gaap_NoncatastrophicEventAxis_label_en-US" xlink:label="lab_us-gaap_NoncatastrophicEventAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncatastrophic Event [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncatastrophicEventAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncatastrophicEventAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncatastrophicEventAxis" xlink:to="lab_us-gaap_NoncatastrophicEventAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue20265685Member_821dfbdb-710a-4da8-aebc-caa7ec484999_terseLabel_en-US" xlink:label="lab_ci_NotesDue20265685Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$700 million, 5.685% Notes due March 2026</link:label>
    <link:label id="lab_ci_NotesDue20265685Member_label_en-US" xlink:label="lab_ci_NotesDue20265685Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes due 2026, 5.685% [Member]</link:label>
    <link:label id="lab_ci_NotesDue20265685Member_documentation_en-US" xlink:label="lab_ci_NotesDue20265685Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes due 2026, 5.685%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20265685Member" xlink:href="ci-20230331.xsd#ci_NotesDue20265685Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue20265685Member" xlink:to="lab_ci_NotesDue20265685Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_3617b478-ad31-48c6-bf29-bad8ba602d79_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_bfa5d4a0-18de-48fa-8abb-56825c1d423b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH USED IN FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_34eb1526-8b1c-4b16-82a5-4f6f615514fb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_0e3bcc3b-4d71-4cf2-a4c2-240c88b907b0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on long-term and short-term debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ContractualAllowanceNoninsuranceCustomerReceivables_3aa3da06-a63e-4536-8c2a-99b861643e73_terseLabel_en-US" xlink:label="lab_ci_ContractualAllowanceNoninsuranceCustomerReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noninsurance customer receivables allowance</link:label>
    <link:label id="lab_ci_ContractualAllowanceNoninsuranceCustomerReceivables_label_en-US" xlink:label="lab_ci_ContractualAllowanceNoninsuranceCustomerReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Allowance, Noninsurance Customer Receivables</link:label>
    <link:label id="lab_ci_ContractualAllowanceNoninsuranceCustomerReceivables_documentation_en-US" xlink:label="lab_ci_ContractualAllowanceNoninsuranceCustomerReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of contractual allowances from third-party payors based upon the contractual payment terms.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ContractualAllowanceNoninsuranceCustomerReceivables" xlink:href="ci-20230331.xsd#ci_ContractualAllowanceNoninsuranceCustomerReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ContractualAllowanceNoninsuranceCustomerReceivables" xlink:to="lab_ci_ContractualAllowanceNoninsuranceCustomerReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_bcb05414-c83c-478f-af51-19c0e38a7b4f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_24c592a0-4c96-4c10-be22-f23a3b80f685_terseLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_documentation_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract" xlink:to="lab_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_5f44867a-8892-4dc4-b053-af577bd87474_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period Of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale_5b94a1b8-7415-43f4-9af4-f91c13ce012e_terseLabel_en-US" xlink:label="lab_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_4f72f9d7-613a-4ee4-b1c3-426dd1ef468b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation of foreign currencies including portion attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis_9efba631-8400-47d3-8c65-c98a35d1aa0b_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Guaranteed Minimum Crediting Rate Range [Axis]</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Guaranteed Minimum Crediting Rate Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis" xlink:to="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_6c63e418-5baf-4ff9-bf7c-de27e71eda2c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_TransactionRelatedCosts_b22529f9-bb2d-4bd8-af4f-ea4dafb094d6_verboseLabel_en-US" xlink:label="lab_ci_TransactionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration and transaction-related costs, pre-tax</link:label>
    <link:label id="lab_ci_TransactionRelatedCosts_3238bdce-babf-4386-b804-df146b3e7ed7_terseLabel_en-US" xlink:label="lab_ci_TransactionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration and transaction-related costs</link:label>
    <link:label id="lab_ci_TransactionRelatedCosts_label_en-US" xlink:label="lab_ci_TransactionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Related Costs</link:label>
    <link:label id="lab_ci_TransactionRelatedCosts_documentation_en-US" xlink:label="lab_ci_TransactionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax transaction-related costs primarily consisting of fees for legal, advisory and other professional services, as well as employee costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TransactionRelatedCosts" xlink:href="ci-20230331.xsd#ci_TransactionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_TransactionRelatedCosts" xlink:to="lab_ci_TransactionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ScheduleOfSpecialItemsTableTextBlock_d841bc33-a7ea-4667-a92b-dba3f1e241bf_terseLabel_en-US" xlink:label="lab_ci_ScheduleOfSpecialItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Special Items</link:label>
    <link:label id="lab_ci_ScheduleOfSpecialItemsTableTextBlock_label_en-US" xlink:label="lab_ci_ScheduleOfSpecialItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Special Items [Table Text Block]</link:label>
    <link:label id="lab_ci_ScheduleOfSpecialItemsTableTextBlock_documentation_en-US" xlink:label="lab_ci_ScheduleOfSpecialItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of pre- and after-tax amounts reported as special items, attributable to the parent. Special items are amounts that management does not believe are representative of underlying results of operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ScheduleOfSpecialItemsTableTextBlock" xlink:href="ci-20230331.xsd#ci_ScheduleOfSpecialItemsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ScheduleOfSpecialItemsTableTextBlock" xlink:to="lab_ci_ScheduleOfSpecialItemsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CorporateAndEliminationsMember_61a2fb3e-7e9f-4eb6-98fa-fb9ed7b67dac_terseLabel_en-US" xlink:label="lab_ci_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Eliminations</link:label>
    <link:label id="lab_ci_CorporateAndEliminationsMember_label_en-US" xlink:label="lab_ci_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate And Eliminations [Member]</link:label>
    <link:label id="lab_ci_CorporateAndEliminationsMember_documentation_en-US" xlink:label="lab_ci_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reflects amounts not allocated to other segments, such as net interest expense (defined as interest on corporate debt less net investment income on investments not supporting segment operations), interest on uncertain tax positions, certain litigation matters, intersegment eliminations, compensation cost for stock options, expense associated with its frozen pension plans, certain corporate project and overhead costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CorporateAndEliminationsMember" xlink:href="ci-20230331.xsd#ci_CorporateAndEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CorporateAndEliminationsMember" xlink:to="lab_ci_CorporateAndEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_de3aeea1-d998-4157-b50c-243c3325f9b6_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Depreciation</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PharmaceuticalManufacturerReceivable_912d6c68-92bd-4ea3-9c94-7d7a5f1122b0_terseLabel_en-US" xlink:label="lab_ci_PharmaceuticalManufacturerReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noninsurance customer receivables</link:label>
    <link:label id="lab_ci_PharmaceuticalManufacturerReceivable_label_en-US" xlink:label="lab_ci_PharmaceuticalManufacturerReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Manufacturer Receivable</link:label>
    <link:label id="lab_ci_PharmaceuticalManufacturerReceivable_documentation_en-US" xlink:label="lab_ci_PharmaceuticalManufacturerReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables due from pharmaceutical manufacturers related to rebate contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmaceuticalManufacturerReceivable" xlink:href="ci-20230331.xsd#ci_PharmaceuticalManufacturerReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PharmaceuticalManufacturerReceivable" xlink:to="lab_ci_PharmaceuticalManufacturerReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_a0f31c55-3824-4430-ab25-760f6297092a_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, after-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_6ca8317b-7dcb-4fb5-aaad-f3b986282b29_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures for Financial Instruments Not Carried at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_b07db14d-6033-4c03-b340-e7dde20da987_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (primarily short-term and other long-term investments)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_80ccd207-8523-4d5e-bde2-c9f4f3af3217_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_e26db821-3818-4247-b86e-58d003baa669_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_9d2c8f6d-7dfc-45d7-95ab-5fe36e71db5a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount of outstanding debt securities redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitParentMember_9055991e-e142-48a3-a9d1-3d7609b210df_terseLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Liability for Future Policy Benefit, Parent</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitParentMember_label_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Liability for Future Policy Benefit, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLiabilityForFuturePolicyBenefitParentMember" xlink:to="lab_us-gaap_AociLiabilityForFuturePolicyBenefitParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_e810b980-f10b-4e10-b58f-f0c482cc78de_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value, after allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups_5d4a59b2-c915-4b12-a43a-ae5ce9623cd1_terseLabel_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts assets classified in Level 3, including disposal groups, period increase (decrease), including transfers in and out of Level 3</link:label>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease), Including Disposal Groups</link:label>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease), Including Disposal Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups" xlink:to="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtInstrumentExtensionTerm_774b809f-7f47-4233-a72e-8a8d94e99403_terseLabel_en-US" xlink:label="lab_ci_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit agreement extension term</link:label>
    <link:label id="lab_ci_DebtInstrumentExtensionTerm_label_en-US" xlink:label="lab_ci_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Term</link:label>
    <link:label id="lab_ci_DebtInstrumentExtensionTerm_documentation_en-US" xlink:label="lab_ci_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtInstrumentExtensionTerm" xlink:href="ci-20230331.xsd#ci_DebtInstrumentExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtInstrumentExtensionTerm" xlink:to="lab_ci_DebtInstrumentExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock_23ba1a8b-5770-40be-8fb8-b19a49c8c521_terseLabel_en-US" xlink:label="lab_ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs</link:label>
    <link:label id="lab_ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalization Of Deferred Policy Acquisition Costs Policy [Policy Text Block]</link:label>
    <link:label id="lab_ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Describes an insurance entity's accounting policy for deferred policy acquisition costs, including the nature and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock" xlink:href="ci-20230331.xsd#ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock" xlink:to="lab_ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_4f19012d-c3a7-4425-84d1-258fa296851f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage and other asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_bb32d442-b5fb-4d0c-b35b-259c7381e02e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f98fa00c-ab21-4c17-aa38-d725682319fd_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_43dad478-bf7c-4cde-a11f-0ada716dce31_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0b92753e-8a18-4dac-9e2c-e4b834e44ea3_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9bc28f2e-0486-496b-a8d0-ad1f221c7259_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease to shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue20473875Member_27e7dc7b-1cda-49f6-aa73-99336bb87a7e_terseLabel_en-US" xlink:label="lab_ci_NotesDue20473875Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,000&#160;million, 3.875% Notes due October 2047</link:label>
    <link:label id="lab_ci_NotesDue20473875Member_label_en-US" xlink:label="lab_ci_NotesDue20473875Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2047, 3.875% [Member]</link:label>
    <link:label id="lab_ci_NotesDue20473875Member_documentation_en-US" xlink:label="lab_ci_NotesDue20473875Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable bearing interest at 3.875% due October 15, 2047.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20473875Member" xlink:href="ci-20230331.xsd#ci_NotesDue20473875Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue20473875Member" xlink:to="lab_ci_NotesDue20473875Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity_4e4de0a4-0606-4f11-87b4-f872bb4439dc_terseLabel_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation of foreign currencies, tax</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity_label_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Including Temporary Equity</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity_documentation_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Including Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity" xlink:to="lab_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_3636ae60-3306-4f7c-8bea-295e357efd30_negatedLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Depreciation, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesAbstract_599e4730-2a65-4354-bdef-e76f1295393d_terseLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesAbstract_label_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities [Abstract]</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesAbstract_documentation_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesAbstract" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract" xlink:to="lab_ci_InsuranceAndContractholderLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d65453e7-861f-48d2-b88b-aa93b12729fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_b5999599-0f06-4806-b123-0ae3ec9036ef_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_125e8aa1-0c24-43cc-8c70-393b8fc8c9c4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c2109084-e187-4c4c-bf40-f6157776bfe6_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SegmentRevenues_5d676ea6-ac49-4740-8ab3-c16f7570bcb6_totalLabel_en-US" xlink:label="lab_ci_SegmentRevenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted revenues</link:label>
    <link:label id="lab_ci_SegmentRevenues_label_en-US" xlink:label="lab_ci_SegmentRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenues</link:label>
    <link:label id="lab_ci_SegmentRevenues_documentation_en-US" xlink:label="lab_ci_SegmentRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues less realized investment gains from equity method subsidiaries, special items and other reconciling items determined by management.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SegmentRevenues" xlink:href="ci-20230331.xsd#ci_SegmentRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SegmentRevenues" xlink:to="lab_ci_SegmentRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_86fed16e-13fb-4de2-9e82-188f8d76af11_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_92500f0a-65df-44e9-9e96-20dc239b65a3_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), before reclassifications, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c39d60f6-5394-46c6-b6f5-f7229b9f9123_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0c6be750-f0d5-49fd-a15d-0ed8dffde55d_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_f3b9bec7-7a7a-4d6f-9e7c-45e2335ee8a0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract_f6be1d87-4fa5-474a-8af4-b9d2a6946f60_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_3388e530-542b-4c07-8425-c02be2256006_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_8575fbad-8a7b-4917-a47f-a1d313d5d103_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InterestInJointVentureInTurkeyMember_6c95f4b8-c073-454d-b1e3-c861e59bd3f2_terseLabel_en-US" xlink:label="lab_ci_InterestInJointVentureInTurkeyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest in Turkiye Joint Venture</link:label>
    <link:label id="lab_ci_InterestInJointVentureInTurkeyMember_label_en-US" xlink:label="lab_ci_InterestInJointVentureInTurkeyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest In Joint Venture In Turkey [Member]</link:label>
    <link:label id="lab_ci_InterestInJointVentureInTurkeyMember_documentation_en-US" xlink:label="lab_ci_InterestInJointVentureInTurkeyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest In Joint Venture In Turkey</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InterestInJointVentureInTurkeyMember" xlink:href="ci-20230331.xsd#ci_InterestInJointVentureInTurkeyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InterestInJointVentureInTurkeyMember" xlink:to="lab_ci_InterestInJointVentureInTurkeyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert_69642fac-b6a5-4b96-9b8b-06b5d552151f_terseLabel_en-US" xlink:label="lab_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional experts</link:label>
    <link:label id="lab_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert_label_en-US" xlink:label="lab_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies, Number Of Additional Expert</link:label>
    <link:label id="lab_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert_documentation_en-US" xlink:label="lab_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies, Number Of Additional Expert</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert" xlink:href="ci-20230331.xsd#ci_CommitmentsAndContingenciesNumberOfAdditionalExpert"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert" xlink:to="lab_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue20233InterestMember_19f91964-5894-4820-84b4-2a61e31d3694_terseLabel_en-US" xlink:label="lab_ci_NotesDue20233InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,000&#160;million, 3% Notes due July 2023</link:label>
    <link:label id="lab_ci_NotesDue20233InterestMember_label_en-US" xlink:label="lab_ci_NotesDue20233InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2023, 3% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue20233InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue20233InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable bearing interest at 3% due in 2023. Debt assumed acquisition from Express Scripts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20233InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue20233InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue20233InterestMember" xlink:to="lab_ci_NotesDue20233InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_2e3f58a9-291d-477e-8c48-7054070febbd_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Accounting Standards Update, Adjustment</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskReinsurerDomain_a0c21b14-adb9-45d2-8eed-7697b2dd2e0b_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskReinsurerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Reinsurer [Domain]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskReinsurerDomain_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskReinsurerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurer, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain" xlink:to="lab_us-gaap_CededCreditRiskReinsurerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5ca8e4d9-98c7-4ab3-bedb-d069474a1455_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_GuaranteedSeparateAccountAssets_c9d8b312-b36b-47fb-aa65-c964983861d0_terseLabel_en-US" xlink:label="lab_ci_GuaranteedSeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranteed separate accounts</link:label>
    <link:label id="lab_ci_GuaranteedSeparateAccountAssets_label_en-US" xlink:label="lab_ci_GuaranteedSeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranteed Separate Account Assets</link:label>
    <link:label id="lab_ci_GuaranteedSeparateAccountAssets_documentation_en-US" xlink:label="lab_ci_GuaranteedSeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranteed Separate Account Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GuaranteedSeparateAccountAssets" xlink:href="ci-20230331.xsd#ci_GuaranteedSeparateAccountAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_GuaranteedSeparateAccountAssets" xlink:to="lab_ci_GuaranteedSeparateAccountAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceUnearnedPremiumsPolicyTextBlock_48fbf6b5-4470-414b-9735-c94adc4becd4_terseLabel_en-US" xlink:label="lab_ci_InsuranceUnearnedPremiumsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premium</link:label>
    <link:label id="lab_ci_InsuranceUnearnedPremiumsPolicyTextBlock_label_en-US" xlink:label="lab_ci_InsuranceUnearnedPremiumsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance, Unearned Premiums [Policy Text Block]</link:label>
    <link:label id="lab_ci_InsuranceUnearnedPremiumsPolicyTextBlock_documentation_en-US" xlink:label="lab_ci_InsuranceUnearnedPremiumsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance, Unearned Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceUnearnedPremiumsPolicyTextBlock" xlink:href="ci-20230331.xsd#ci_InsuranceUnearnedPremiumsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceUnearnedPremiumsPolicyTextBlock" xlink:to="lab_ci_InsuranceUnearnedPremiumsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b2d21e13-5408-4826-970c-1388bc4f2553_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_ea9bb81a-c9c3-4cd3-855f-44db7de2b948_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_97582855-5c73-4f8e-b01c-8d09847e096e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_98c228da-b40e-4bbe-8e55-1fde1cc57f34_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity_3d1b725f-c28c-418c-9f6e-25269519ac66_totalLabel_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) including temporary equity, before reclassifications, after-tax</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity_label_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Before Reclassifications, After Tax, Including Temporary Equity</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity_documentation_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Before Reclassifications, After Tax, Including Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity" xlink:to="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue204032InterestMember_975902fa-345a-4c9e-95fd-fe9bcc30d8d0_terseLabel_en-US" xlink:label="lab_ci_NotesDue204032InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750&#160;million, 3.200% Notes due March 2040</link:label>
    <link:label id="lab_ci_NotesDue204032InterestMember_label_en-US" xlink:label="lab_ci_NotesDue204032InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2040, 3.2% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue204032InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue204032InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2040, 3.2% Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue204032InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue204032InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue204032InterestMember" xlink:to="lab_ci_NotesDue204032InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_090c72ee-5029-443c-b2e2-2718cedca148_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefit reserve, reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_85d14022-a907-4ce3-aca9-7c1f0f620595_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups_2d15a57d-f81a-4715-bd41-67cd7dab0fc9_terseLabel_en-US" xlink:label="lab_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned premiums, including held for sale liabilities</link:label>
    <link:label id="lab_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums Noncurrent Including Disposal Groups</link:label>
    <link:label id="lab_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date, expected to be paid after one year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups" xlink:to="lab_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses_c31dd53e-651f-4d1e-acdc-d764fd7f13d4_verboseLabel_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total of incurred but not reported liabilities plus expected claim development on reported claims, including reported claims in process</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses_label_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Claims And Claims Adjustment Expense Excluding Physician Incentives And Other Expenses</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses_documentation_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the total liability for incurred but not reported claims plus expected claim development on reported claims, including reported claims in process. Excludes amounts due for physician incentives and other medical care expenses and services payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses" xlink:to="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncatastrophicEventDomain_9a0350ec-8e23-4954-953f-180fc3b0281d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncatastrophicEventDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncatastrophic Event [Domain]</link:label>
    <link:label id="lab_us-gaap_NoncatastrophicEventDomain_label_en-US" xlink:label="lab_us-gaap_NoncatastrophicEventDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncatastrophic Event [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncatastrophicEventDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncatastrophicEventDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncatastrophicEventDomain" xlink:to="lab_us-gaap_NoncatastrophicEventDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_31ffc177-ba97-416d-8c5a-365882734076_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_3aaed3f4-bf2e-4cab-a44a-18a76844f45f_terseLabel_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year or less</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_label_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less Than 12 Months [Abstract]</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_documentation_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less Than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract" xlink:to="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_038bb3de-cdf5-4ec5-939c-70f03ab63f4d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceAccountingPolicy_20a5ee58-6738-411c-a536-b36a8df2f379_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance</link:label>
    <link:label id="lab_us-gaap_ReinsuranceAccountingPolicy_label_en-US" xlink:label="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Accounting Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceAccountingPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceAccountingPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceAccountingPolicy" xlink:to="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_7f5fcef8-753d-4a50-901e-f546b482c88c_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Gains and Losses on Investments</link:label>
    <link:label id="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Gain (Loss) on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_705c8b51-85d1-426b-bfa0-d2df3e8fe2cf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PaymentsToAcquireDebtAndEquitySecurities_ca43c45e-3cbc-42df-9518-b9ab033e707f_negatedLabel_en-US" xlink:label="lab_ci_PaymentsToAcquireDebtAndEquitySecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities and equity securities</link:label>
    <link:label id="lab_ci_PaymentsToAcquireDebtAndEquitySecurities_05b0182b-6eed-4901-abbe-419bd129b164_terseLabel_en-US" xlink:label="lab_ci_PaymentsToAcquireDebtAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount funded</link:label>
    <link:label id="lab_ci_PaymentsToAcquireDebtAndEquitySecurities_label_en-US" xlink:label="lab_ci_PaymentsToAcquireDebtAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Debt And Equity Securities</link:label>
    <link:label id="lab_ci_PaymentsToAcquireDebtAndEquitySecurities_documentation_en-US" xlink:label="lab_ci_PaymentsToAcquireDebtAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Debt And Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PaymentsToAcquireDebtAndEquitySecurities" xlink:href="ci-20230331.xsd#ci_PaymentsToAcquireDebtAndEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PaymentsToAcquireDebtAndEquitySecurities" xlink:to="lab_ci_PaymentsToAcquireDebtAndEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_d9142371-a470-4ae7-827b-6ae0cedb8bcb_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_74930ee9-6edf-4622-a84b-39f63bd5177b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average duration</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Weighted-Average Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_2b6feac7-8c59-4950-a64f-77de0e596780_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a84e95d0-3fcb-440b-9d79-121017eeeca3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPS, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1_4732ae97-be7f-4050-8eeb-4d15b74d7c98_terseLabel_en-US" xlink:label="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average attained age of contractholders (weighted by exposure)</link:label>
    <link:label id="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1_label_en-US" xlink:label="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount at Risk by Product and Guarantee, Weighted Average Attained Age</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1" xlink:to="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_85ab171b-299c-4ecb-afc1-af341f615657_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest accretion rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_079a8c02-bdc4-4815-be2f-f6342badadfe_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment, before tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_32c6e938-8870-4f5d-b9d5-855fbce57845_totalLabel_en-US" xlink:label="lab_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments including held for sale assets</link:label>
    <link:label id="lab_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01ec0ac6-8f66-47bc-a305-9141754be155_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_b255da2e-a54f-4e83-8165-9ed47a3f25ba_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_BelowInvestmentGradeMember_9724ae5e-8510-49ff-ba52-b1476552d17d_terseLabel_en-US" xlink:label="lab_ci_BelowInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Below investment grade</link:label>
    <link:label id="lab_ci_BelowInvestmentGradeMember_label_en-US" xlink:label="lab_ci_BelowInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Below Investment Grade [Member]</link:label>
    <link:label id="lab_ci_BelowInvestmentGradeMember_documentation_en-US" xlink:label="lab_ci_BelowInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External credit-ratings or internal groupings that could be used to describe the current status of the payment and performance risk of debt and securities investments that connote non-investment grade.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_BelowInvestmentGradeMember" xlink:href="ci-20230331.xsd#ci_BelowInvestmentGradeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_BelowInvestmentGradeMember" xlink:to="lab_ci_BelowInvestmentGradeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_c01857a5-2e63-43cf-9374-2a9631fc07ac_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought by Elevance</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_FairValueOfSeparateAccountAssetsTableTextBlock_12211858-088a-457a-a5d2-454c2401302e_terseLabel_en-US" xlink:label="lab_ci_FairValueOfSeparateAccountAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values of Separate Account Assets</link:label>
    <link:label id="lab_ci_FairValueOfSeparateAccountAssetsTableTextBlock_label_en-US" xlink:label="lab_ci_FairValueOfSeparateAccountAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Separate Account Assets [Table Text Block]</link:label>
    <link:label id="lab_ci_FairValueOfSeparateAccountAssetsTableTextBlock_documentation_en-US" xlink:label="lab_ci_FairValueOfSeparateAccountAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclose the aggregate fair value of separate account assets, by fair value level.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueOfSeparateAccountAssetsTableTextBlock" xlink:href="ci-20230331.xsd#ci_FairValueOfSeparateAccountAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_FairValueOfSeparateAccountAssetsTableTextBlock" xlink:to="lab_ci_FairValueOfSeparateAccountAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_8099a9ff-1748-4e17-a38c-4eea5614e7cd_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_25186045-07e8-4692-abd5-62ce0fecf68a_terseLabel_en-US" xlink:label="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities with no readily determinable fair value, including held for sale assets</link:label>
    <link:label id="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Amount Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Amount Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock_cd52353e-ba57-45fa-a968-07db52339c54_terseLabel_en-US" xlink:label="lab_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Debt Issuances</link:label>
    <link:label id="lab_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Issuances Of Long-Term Debt [Table Text Block]</link:label>
    <link:label id="lab_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock_documentation_en-US" xlink:label="lab_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Issuances Of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock" xlink:href="ci-20230331.xsd#ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock" xlink:to="lab_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateLoanMember_cfd528b4-8096-46c6-9c6b-dfab2a9a5ee7_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan</link:label>
    <link:label id="lab_us-gaap_RealEstateLoanMember_label_en-US" xlink:label="lab_us-gaap_RealEstateLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLoanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateLoanMember" xlink:to="lab_us-gaap_RealEstateLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther_dabf23b6-c2da-4963-8139-65bbf8ccf626_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Before Reinsurance And Other</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Before Reinsurance And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_0dbfae1e-aff5-4c12-b671-174f776767ae_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_7db05b51-4910-42b6-ae50-ff63e8fb982f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SCORSEMember_a8c7a233-d586-4f26-832e-90cf29891688_terseLabel_en-US" xlink:label="lab_ci_SCORSEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCOR SE</link:label>
    <link:label id="lab_ci_SCORSEMember_label_en-US" xlink:label="lab_ci_SCORSEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCOR SE [Member]</link:label>
    <link:label id="lab_ci_SCORSEMember_documentation_en-US" xlink:label="lab_ci_SCORSEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCOR SE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SCORSEMember" xlink:href="ci-20230331.xsd#ci_SCORSEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SCORSEMember" xlink:to="lab_ci_SCORSEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d6443389-7b5e-465d-8834-8e42e535aa2e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net changes in assets and liabilities, net of non-operating effects:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax_5d7cbcd7-8c67-48dd-9f99-425447c59213_terseLabel_en-US" xlink:label="lab_ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment costs</link:label>
    <link:label id="lab_ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax_label_en-US" xlink:label="lab_ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item Charges Debt Extinguishment Costs Net Of Tax</link:label>
    <link:label id="lab_ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax_documentation_en-US" xlink:label="lab_ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item Charges Debt Extinguishment Costs Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax" xlink:href="ci-20230331.xsd#ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax" xlink:to="lab_ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_ea71c68e-5bc7-44ac-8fe7-519a0f93ce79_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_7acbcdbd-3b6f-4215-aa9d-d250a155a2a5_terseLabel_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">More than one year</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_label_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months Or Longer [Abstract]</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_documentation_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months Or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract" xlink:to="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_31aa8c2d-37ee-4bd0-b9bd-45e48aeffff9_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_PartnershipInterestMember_14c067b9-e651-4a6c-b1bb-883d084a841c_terseLabel_en-US" xlink:label="lab_srt_PartnershipInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities partnerships</link:label>
    <link:label id="lab_srt_PartnershipInterestMember_277215d7-c283-460c-91cd-b3f96b1828a9_verboseLabel_en-US" xlink:label="lab_srt_PartnershipInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities partnerships</link:label>
    <link:label id="lab_srt_PartnershipInterestMember_label_en-US" xlink:label="lab_srt_PartnershipInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PartnershipInterestMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_PartnershipInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_PartnershipInterestMember" xlink:to="lab_srt_PartnershipInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue20415875InterestMember_4150ec8f-02d3-4928-aa31-5d4b57f14e6f_terseLabel_en-US" xlink:label="lab_ci_NotesDue20415875InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$121&#160;million, 5.875% Notes due March 2041</link:label>
    <link:label id="lab_ci_NotesDue20415875InterestMember_label_en-US" xlink:label="lab_ci_NotesDue20415875InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2041, 5.875% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue20415875InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue20415875InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable bearing interest at 5.875% due in 2041.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20415875InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue20415875InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue20415875InterestMember" xlink:to="lab_ci_NotesDue20415875InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f1c8fe33-4837-4ed0-a91d-bc4debe1fa9d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of issuing stock for employee benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_e5a5535b-51e0-4b4a-bca2-5c756b681155_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_cc9d177f-a314-40cb-8bff-942cb26bb836_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_384c0e7a-203f-4e01-80c4-3b44ee4ba04b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract_5a0b7388-4f7b-41cd-a2b6-38f9985aca14_terseLabel_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract_label_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost [Abstract]</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract" xlink:to="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ReinsuranceRecoverablesIncludingDisposalGroups_c6f274ed-6d9b-4d76-8cd9-f122ad73ff7f_terseLabel_en-US" xlink:label="lab_ci_ReinsuranceRecoverablesIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables, including held for sale assets</link:label>
    <link:label id="lab_ci_ReinsuranceRecoverablesIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_ReinsuranceRecoverablesIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables Including Disposal Groups</link:label>
    <link:label id="lab_ci_ReinsuranceRecoverablesIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_ReinsuranceRecoverablesIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables Including Disposal Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ReinsuranceRecoverablesIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_ReinsuranceRecoverablesIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ReinsuranceRecoverablesIncludingDisposalGroups" xlink:to="lab_ci_ReinsuranceRecoverablesIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_e44c1fdc-e40c-4f0b-8a1a-ecb97df0d5e6_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_be29fc0b-4723-405f-b450-879e795765d8_totalLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_fd46c9bb-fa1c-489b-ad09-ade5e5774074_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue2025325InterestMember_af71939b-b6e0-4f0a-8093-605310aa896a_terseLabel_en-US" xlink:label="lab_ci_NotesDue2025325InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$900&#160;million, 3.250% Notes due April 2025 (1)</link:label>
    <link:label id="lab_ci_NotesDue2025325InterestMember_label_en-US" xlink:label="lab_ci_NotesDue2025325InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2025 3.25% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue2025325InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue2025325InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable bearing interest at 3.25% due in 2025.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2025325InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue2025325InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue2025325InterestMember" xlink:to="lab_ci_NotesDue2025325InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_69b10ae5-426f-4ae7-b6ac-469435b007bf_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_78322819-fbb9-4ccf-a455-144917ffc778_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated stock repurchase, amount remitted</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Settlement (Payment) or Receipt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherGovernmentProductsMember_a04c8a9b-7b90-46c0-a5df-3b9ef4afcd24_terseLabel_en-US" xlink:label="lab_ci_OtherGovernmentProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Government Products</link:label>
    <link:label id="lab_ci_OtherGovernmentProductsMember_label_en-US" xlink:label="lab_ci_OtherGovernmentProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Government Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherGovernmentProductsMember" xlink:href="ci-20230331.xsd#ci_OtherGovernmentProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherGovernmentProductsMember" xlink:to="lab_ci_OtherGovernmentProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_59144abc-c624-46bb-9e8d-679e60331e9c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_27274961-30de-4aea-8be1-a947ba63404a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers into Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_a79f0150-c775-4734-a2e7-8abc1dcbebb7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ServiceFeesMember_1c5e698d-a886-47af-9551-2f37e93166c8_terseLabel_en-US" xlink:label="lab_ci_ServiceFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fees</link:label>
    <link:label id="lab_ci_ServiceFeesMember_label_en-US" xlink:label="lab_ci_ServiceFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service, Fees [Member]</link:label>
    <link:label id="lab_ci_ServiceFeesMember_documentation_en-US" xlink:label="lab_ci_ServiceFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service, Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ServiceFeesMember" xlink:href="ci-20230331.xsd#ci_ServiceFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ServiceFeesMember" xlink:to="lab_ci_ServiceFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_09337290-4b2a-4abc-9e08-c665d0f110aa_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_0c820fb4-ca44-4274-a849-3d181e2be841_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount_c5cb6b0f-66c6-41ba-9473-421667388d4f_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Cash Surrender Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueDuePolicyholdersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:to="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d8adcbb6-93b2-4962-8ee6-bcc1ffcb99c0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_ebdc8e66-fc5d-438e-a181-6a9178c0852f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CommitmentsToContributeAdditionalEquityAndCapital_86866113-b621-413e-8c59-95d48eae8e3e_terseLabel_en-US" xlink:label="lab_ci_CommitmentsToContributeAdditionalEquityAndCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded commitments</link:label>
    <link:label id="lab_ci_CommitmentsToContributeAdditionalEquityAndCapital_label_en-US" xlink:label="lab_ci_CommitmentsToContributeAdditionalEquityAndCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments To Contribute Additional Equity And Capital</link:label>
    <link:label id="lab_ci_CommitmentsToContributeAdditionalEquityAndCapital_documentation_en-US" xlink:label="lab_ci_CommitmentsToContributeAdditionalEquityAndCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment commitments of estimated payments required under contractual arrangements diversified by issuer, property type and geographic regions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsToContributeAdditionalEquityAndCapital" xlink:href="ci-20230331.xsd#ci_CommitmentsToContributeAdditionalEquityAndCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CommitmentsToContributeAdditionalEquityAndCapital" xlink:to="lab_ci_CommitmentsToContributeAdditionalEquityAndCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MedicareAdvantageMember_324951de-856a-4edf-855c-f254b5c29c47_terseLabel_en-US" xlink:label="lab_ci_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Advantage</link:label>
    <link:label id="lab_ci_MedicareAdvantageMember_label_en-US" xlink:label="lab_ci_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Advantage [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MedicareAdvantageMember" xlink:href="ci-20230331.xsd#ci_MedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MedicareAdvantageMember" xlink:to="lab_ci_MedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a247d39e-e8dc-4e63-8d35-39ede3d5e6c7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_1a923315-3dd0-4c40-a649-46e26c6be4ed_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale price</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups_bea690c8-fbfe-4bac-b66a-58ffaf90171b_terseLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities, Current, Including Disposal Groups</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities, Current, Including Disposal Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups" xlink:to="lab_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_855b6319-ea2c-4d3c-866a-b3c43605d46e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_316d32ef-11fe-443a-b2ef-6716b64b8420_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue20284375InterestMember_ee7d4969-7d36-4847-806c-086643051c43_terseLabel_en-US" xlink:label="lab_ci_NotesDue20284375InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$3,800&#160;million, 4.375% Notes due October 2028</link:label>
    <link:label id="lab_ci_NotesDue20284375InterestMember_label_en-US" xlink:label="lab_ci_NotesDue20284375InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2028, 4.375% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue20284375InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue20284375InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable bearing interest at 4.375% due in 2028. Debt issued to finance acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20284375InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue20284375InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue20284375InterestMember" xlink:to="lab_ci_NotesDue20284375InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrent_b502134b-15f4-4883-87da-3e5cba170208_terseLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current insurance and contractholder liabilities</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrent_e86aa9e2-88c0-4042-a906-f29878a73297_totalLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current insurance and contractholder liabilities</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrent_label_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities Noncurrent</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The carrying amounts as of the balance sheet date of all current insurance and contractholder liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent" xlink:to="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_756ced05-e562-435f-8da9-1492d3776ffd_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy revenues</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_726f8a5b-25d8-434d-8d73-ad9b952d788f_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average crediting rate</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Weighted Average Crediting Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:to="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_628b63c4-a82a-4348-85eb-5620f0854562_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the Credit Risk Profile of the Commercial Mortgage Loan Portfolio</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable Credit Quality Indicators [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:to="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm_3f3b7493-5ed4-460d-b189-12794c7c64ac_terseLabel_en-US" xlink:label="lab_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Observable inputs from published spot rate curve term (in years)</link:label>
    <link:label id="lab_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm_label_en-US" xlink:label="lab_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Policy Benefits, Domestic Contracts, Observable Inputs From Published Spot Rate Curve, Maximum Term</link:label>
    <link:label id="lab_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm_documentation_en-US" xlink:label="lab_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Policy Benefits, Domestic Contracts, Observable Inputs From Published Spot Rate Curve, Maximum Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm" xlink:href="ci-20230331.xsd#ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm" xlink:to="lab_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_3de976f4-f3da-46b2-9709-ed8b7a585eb0_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities of Businesses Held for Sale</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UsTreasuryUstInterestRateMember_0ffc468d-10eb-4905-88f8-48abd74362d7_terseLabel_en-US" xlink:label="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury rate</link:label>
    <link:label id="lab_us-gaap_UsTreasuryUstInterestRateMember_label_en-US" xlink:label="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury (UST) Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UsTreasuryUstInterestRateMember" xlink:to="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio_b80fe774-1c66-428b-bb03-eb36d4f9d033_terseLabel_en-US" xlink:label="lab_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Debt Service Coverage Ratio</link:label>
    <link:label id="lab_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio_label_en-US" xlink:label="lab_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Debt Service Coverage Ratio</link:label>
    <link:label id="lab_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio_documentation_en-US" xlink:label="lab_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Debt Service Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio" xlink:href="ci-20230331.xsd#ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio" xlink:to="lab_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_83702ce9-5065-4119-abf4-3d5240aa4ab1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_28e6b509-1d98-4ba7-ba68-d0184d3546ef_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CommercialPaperAverageRatePaid_b63e24e2-bd0f-4605-a52f-7020b90d167e_terseLabel_en-US" xlink:label="lab_srt_CommercialPaperAverageRatePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper average interest rate</link:label>
    <link:label id="lab_srt_CommercialPaperAverageRatePaid_label_en-US" xlink:label="lab_srt_CommercialPaperAverageRatePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Average Rate Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CommercialPaperAverageRatePaid" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CommercialPaperAverageRatePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CommercialPaperAverageRatePaid" xlink:to="lab_srt_CommercialPaperAverageRatePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_4caaea8a-f353-456e-acac-34a0b8e7f9af_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities with no readily determinable fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_84646add-6e43-4144-a52d-ad43679fdf41_terseLabel_en-US" xlink:label="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sale of business, location not disclosed</link:label>
    <link:label id="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag</link:label>
    <link:label id="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:href="ci-20230331.xsd#ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_519321ca-dc7e-4696-94a9-33bada10b9b0_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_f0ccd9e3-04c8-442f-bc78-5a1b5b9100ac_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_28dccae2-7386-4a1e-a51c-f4ab6babefc6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_830182be-44b2-4434-9215-8d4d06d4b487_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PaymentsForProceedsFromPropertyPlantAndEquipment_05196d55-8f9f-4523-a5ca-5b773efa0ef3_negatedLabel_en-US" xlink:label="lab_ci_PaymentsForProceedsFromPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment purchases, net</link:label>
    <link:label id="lab_ci_PaymentsForProceedsFromPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ci_PaymentsForProceedsFromPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Property, Plant, And Equipment</link:label>
    <link:label id="lab_ci_PaymentsForProceedsFromPropertyPlantAndEquipment_documentation_en-US" xlink:label="lab_ci_PaymentsForProceedsFromPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Property, Plant, And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PaymentsForProceedsFromPropertyPlantAndEquipment" xlink:href="ci-20230331.xsd#ci_PaymentsForProceedsFromPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PaymentsForProceedsFromPropertyPlantAndEquipment" xlink:to="lab_ci_PaymentsForProceedsFromPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_0037b675-f311-41b8-8319-d0b52e2e4dae_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_0762e19f-a92e-436a-b8d5-7d721e902e29_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_27a475b0-cd0d-4589-835d-1ae811dff6dc_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy and other service costs</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesLineItems_edfa2de5-2f28-48d9-b783-fe00e20fedca_terseLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and Contractholder Liabilities [Line Items]</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesLineItems_label_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and Contractholder Liabilities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesLineItems" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems" xlink:to="lab_ci_InsuranceAndContractholderLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_f0b1b733-13c5-4a8c-872a-f52334e034bb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock_ab074c7a-efe1-461c-96ed-73abe738ebb9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variances in Incurred Costs Related to Prior Years' Unpaid Claims and Claims Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock" xlink:to="lab_us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_18c29d51-53d2-4675-8ee7-fff11d232c99_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member_2be591ab-5b6b-4b69-a378-985991c4ead1_terseLabel_en-US" xlink:label="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five-year Revolving Credit Agreement, Maturing April 2028</link:label>
    <link:label id="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member_label_en-US" xlink:label="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit And Letter Of Credit Facility Maturing April 2028 [Member]</link:label>
    <link:label id="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member_documentation_en-US" xlink:label="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit And Letter Of Credit Facility Maturing April 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member" xlink:href="ci-20230331.xsd#ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member" xlink:to="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_7090bace-1e7c-4951-88f6-a09971b185a2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases, sales and settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_b0c082a7-9232-441c-b41c-260687a34935_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of effect of beginning of period discount rate assumptions</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_11aece18-be65-4825-b4b0-036f08e05db2_periodEndLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of end of period discount rate assumptions</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_label_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:to="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput_944730ca-4390-4009-93c0-77766e6c8fd9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unobservable Adjustment</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CededReinsuranceAgreementReinsuredRiskPercentage_92d1c9f9-3283-4fb1-ab73-79272bf34aad_terseLabel_en-US" xlink:label="lab_ci_CededReinsuranceAgreementReinsuredRiskPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of future claim payments reinsured</link:label>
    <link:label id="lab_ci_CededReinsuranceAgreementReinsuredRiskPercentage_label_en-US" xlink:label="lab_ci_CededReinsuranceAgreementReinsuredRiskPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Reinsurance Agreement Reinsured Risk Percentage</link:label>
    <link:label id="lab_ci_CededReinsuranceAgreementReinsuredRiskPercentage_documentation_en-US" xlink:label="lab_ci_CededReinsuranceAgreementReinsuredRiskPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of future claim payments reinsured under reinsurance agreement(s), net of existing retrocessional arrangements at the time agreement was made.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededReinsuranceAgreementReinsuredRiskPercentage" xlink:href="ci-20230331.xsd#ci_CededReinsuranceAgreementReinsuredRiskPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CededReinsuranceAgreementReinsuredRiskPercentage" xlink:to="lab_ci_CededReinsuranceAgreementReinsuredRiskPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_68de0ac9-18ad-4af3-9f9d-d23797f2f8b9_terseLabel_en-US" xlink:label="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit agreements, April 2022</link:label>
    <link:label id="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_label_en-US" xlink:label="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit And Letter Of Credit Facility Maturing April 2027, Revolving Credit Facility Maturing April 2025, And 364 Day Revolving Credit Agreement, Maturing April 2023 [Member]</link:label>
    <link:label id="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_documentation_en-US" xlink:label="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit And Letter Of Credit Facility Maturing April 2027, Revolving Credit Facility Maturing April 2025, And 364 Day Revolving Credit Agreement, Maturing April 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member" xlink:href="ci-20230331.xsd#ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member" xlink:to="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_a8e21467-6877-461c-973f-cdf7697cb967_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments per Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1c57b87a-e52b-406b-9878-d702bd06d4da_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_e33694dc-4d74-47ac-aae5-32f9817ee788_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_6844d99c-fd5b-451d-b582-1527ea55484e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_cda0203a-ffef-47a2-9801-9c23e44144f6_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_dc6c2468-f3d2-404e-b626-0811b17f7f71_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_554f3c48-12af-4a8e-91ad-f3c2c314d5b2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_25be424c-a60a-4d8d-9205-7cc99a963b63_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Employee Stock Options Not Included in the Computation of Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_ee206930-04cc-45e3-b275-c6502366a6da_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_1f3593bd-8757-4ee3-8e2a-1ea9e0b0899c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance at original discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_e439c7cb-4fdd-402b-b78c-e467e27a03fa_totalLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchases, sales and settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_f8062ebb-3b51-47e4-8880-5fa93b67c827_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5a852bc4-4ea7-4636-8535-f1a081424731_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash and cash equivalents January 1,</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_522f81f9-dd7a-49c0-8b39-92b0ff704f8a_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash and cash equivalents December 31,</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_ca5ee22c-d191-4ba4-a71f-c655c410dff3_totalLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Number of Issues, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities In Unrealized Loss Positions, Qualitative Disclosure, Number Of Positions, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities In Unrealized Loss Positions, Qualitative Disclosure, Number Of Positions, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CommitmentsAndContingenciesNumberOfExpert_993ffa7d-8038-46a7-a47b-35f705ec7b69_terseLabel_en-US" xlink:label="lab_ci_CommitmentsAndContingenciesNumberOfExpert" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of experts</link:label>
    <link:label id="lab_ci_CommitmentsAndContingenciesNumberOfExpert_label_en-US" xlink:label="lab_ci_CommitmentsAndContingenciesNumberOfExpert" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies, Number Of Expert</link:label>
    <link:label id="lab_ci_CommitmentsAndContingenciesNumberOfExpert_documentation_en-US" xlink:label="lab_ci_CommitmentsAndContingenciesNumberOfExpert" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies, Number Of Expert</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsAndContingenciesNumberOfExpert" xlink:href="ci-20230331.xsd#ci_CommitmentsAndContingenciesNumberOfExpert"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CommitmentsAndContingenciesNumberOfExpert" xlink:to="lab_ci_CommitmentsAndContingenciesNumberOfExpert" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectsOfReinsuranceTableTextBlock_366befd4-f13a-4fac-9057-08d1a4f0f232_terseLabel_en-US" xlink:label="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Reinsurance</link:label>
    <link:label id="lab_us-gaap_EffectsOfReinsuranceTableTextBlock_label_en-US" xlink:label="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Reinsurance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectsOfReinsuranceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:to="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent_978ab238-a89b-42d4-88ff-7bd2933ca4d2_terseLabel_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid claims and claim expenses, current</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent_label_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Claims And Claims Adjustment Expense, Current</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent_documentation_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Claims And Claims Adjustment Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent" xlink:to="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock_bd0117bd-1626-49d5-ae6d-7f067721202b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Account Value, Net Amount at Risk and the Number of Contractholders for Guarantees Assumed in the Event of Death</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Amount of Risk by Product and Guarantee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract_216b510b-5afd-4ab5-9b61-d2ba8fd2acaf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment maturities and repayments:</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Held-to-Maturity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_1c54a84d-4fa6-49ef-8b05-dacd2e82c0d7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Appreciation (Depreciation) on Debt Securities</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_43afbe14-ee6c-4ec9-9f51-501939c05eaa_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_0072ae71-5c91-479d-84b8-d448565cbbd3_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_31d5a58c-feff-4ceb-b60f-a1850a5fdbab_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Issues</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7398586a-b98a-4ca4-a02d-931c2ffa5e16_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_d43f1917-8cf6-4d44-8824-b7de3d7e3d8d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_53d57036-8137-48aa-800f-cec5f92d01bc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_4ec136e9-de10-4ffd-84ec-97cc289830be_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cf719e4a-a6b3-4229-bbab-ca6a1a084c7d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6da71e2d-39a5-4f29-bab1-f1b36af7ab14_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_33d78eb8-17d0-409c-8076-0b90cd5259e0_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InvestmentsCreditRatingDomain_0bf8635a-a473-44e2-97c0-13f7f43bec0f_terseLabel_en-US" xlink:label="lab_ci_InvestmentsCreditRatingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Credit Rating [Domain]</link:label>
    <link:label id="lab_ci_InvestmentsCreditRatingDomain_label_en-US" xlink:label="lab_ci_InvestmentsCreditRatingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Credit Rating [Domain]</link:label>
    <link:label id="lab_ci_InvestmentsCreditRatingDomain_documentation_en-US" xlink:label="lab_ci_InvestmentsCreditRatingDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External credit-ratings or internal groupings that could be used to describe the current status of the payment and performance risk of debt and securities investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentsCreditRatingDomain" xlink:href="ci-20230331.xsd#ci_InvestmentsCreditRatingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InvestmentsCreditRatingDomain" xlink:to="lab_ci_InvestmentsCreditRatingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_57a5722d-732f-45ff-8eb5-8f677383ca8c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Appreciation</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue2036615InterestMember_002ebcf6-1e85-414f-a843-91eae5b17ca3_terseLabel_en-US" xlink:label="lab_ci_NotesDue2036615InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$190&#160;million, 6.150% Notes due November 2036</link:label>
    <link:label id="lab_ci_NotesDue2036615InterestMember_label_en-US" xlink:label="lab_ci_NotesDue2036615InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes due 2036 6.15% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue2036615InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue2036615InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable bearing interest at 6.15% due in 2036.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2036615InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue2036615InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue2036615InterestMember" xlink:to="lab_ci_NotesDue2036615InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_2290a3a9-b266-4630-a78f-5a7d8c3a4055_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member_2cf65bef-c765-4164-ad3f-6c4f35eeda44_terseLabel_en-US" xlink:label="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 To 0400</link:label>
    <link:label id="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member_label_en-US" xlink:label="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 To 0400 [Member]</link:label>
    <link:label id="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member_documentation_en-US" xlink:label="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 To 0400</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member" xlink:href="ci-20230331.xsd#ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member" xlink:to="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_d3068432-8271-4ab2-9220-180fc6b281e3_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ShortTermAndLongTermInvestmentsAbstract_857f33f3-ce6b-4afe-b6c7-df89c06eda19_terseLabel_en-US" xlink:label="lab_ci_ShortTermAndLongTermInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ci_ShortTermAndLongTermInvestmentsAbstract_label_en-US" xlink:label="lab_ci_ShortTermAndLongTermInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term And Long-Term Investments [Abstract]</link:label>
    <link:label id="lab_ci_ShortTermAndLongTermInvestmentsAbstract_documentation_en-US" xlink:label="lab_ci_ShortTermAndLongTermInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term And Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ShortTermAndLongTermInvestmentsAbstract" xlink:href="ci-20230331.xsd#ci_ShortTermAndLongTermInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ShortTermAndLongTermInvestmentsAbstract" xlink:to="lab_ci_ShortTermAndLongTermInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6fbea42d-e064-4bcf-b437-9fe5580630ca_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid costs related to:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_eac05b61-a743-440c-841c-097243410902_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f6f19c41-e8bf-4189-8e70-2fa20cd20aff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4e11bbfb-369d-4404-b186-38ac7fcf817b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_db0093e4-4471-4a8f-893a-846c6bb4a284_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Current Weighted-Average Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PharmacyAndServiceCostsPayable_022b5bee-988d-46e5-97da-d601bb96d9a7_terseLabel_en-US" xlink:label="lab_ci_PharmacyAndServiceCostsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy and other service costs payable</link:label>
    <link:label id="lab_ci_PharmacyAndServiceCostsPayable_label_en-US" xlink:label="lab_ci_PharmacyAndServiceCostsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy And Service Costs Payable</link:label>
    <link:label id="lab_ci_PharmacyAndServiceCostsPayable_documentation_en-US" xlink:label="lab_ci_PharmacyAndServiceCostsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reflects amounts due to pharmacies for prescriptions filled through our retail network of pharmacies. Also includes amounts due to clients for their portion of rebates that must be contractually shared.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmacyAndServiceCostsPayable" xlink:href="ci-20230331.xsd#ci_PharmacyAndServiceCostsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PharmacyAndServiceCostsPayable" xlink:to="lab_ci_PharmacyAndServiceCostsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_eb7c8408-c8b1-40e8-940e-9e2d1231dcbe_terseLabel_en-US" xlink:label="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment for credit risk on derivatives assets</link:label>
    <link:label id="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Credit Risk Valuation Adjustment, Derivative Assets, Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Credit Risk Valuation Adjustment, Derivative Assets, Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5c9cd35c-42f7-480d-8473-6dd09ff9a374_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_4ade36ed-4900-4f01-ab98-2913cbce2372_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits_24ee58d3-cf73-4134-99bf-ea757efdb025_terseLabel_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) required to adjust future policy benefits for settlement annuities</link:label>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits_label_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Required To Adjust Future Policy Benefits</link:label>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits_documentation_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents total gains or losses for the period (realized and unrealized), arising from assets measured at fair value on a recurring basis using unobservable inputs (Level 3), which are included in gains or losses required to adjust future policy benefits for settlement annuities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits" xlink:to="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_5b1dd0b5-6653-4e72-a8e5-f0d3b3a58c9d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Issues</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_0774d44f-2352-4781-8b11-9caa62b16606_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_bf76451b-8164-4d63-8493-14cb6b3e05ab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net premiums collected</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost_f9c5ceb5-660c-410e-8615-5f2eb707dfa8_totalLabel_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost_label_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, 12 Months Or Longer, Amortized Cost</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost_documentation_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, 12 Months Or Longer, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost" xlink:to="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_0c9328b9-86ae-432c-ad27-36bd47bad00f_terseLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Appreciation, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_c027d63c-52c7-4183-8d15-7bf1ed331bd5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_01ea21a5-8028-40b0-8817-a0496f2b5f1d_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_20795f09-c131-4774-bdba-3b34d319dad4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_4563a415-9496-499f-a82a-b741cc6bc5f1_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Payments</link:label>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:to="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_0da369e6-31e4-4e46-b61f-d93fa40729d7_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Treasury stock, at cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_91749b0d-87a3-4e48-be08-0f9a2fd6f0b7_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement benefits liability adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f03e4614-ea3c-4fdf-8293-ed1363fd8cd0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sale of business, pre-tax</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemChargeBenefitBeforeTaxLitigation_899c1f3c-f23b-462b-b6e6-588e00db361f_verboseLabel_en-US" xlink:label="lab_ci_SpecialItemChargeBenefitBeforeTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Benefits) charges associated with litigation matters (Selling, general and administrative expenses)</link:label>
    <link:label id="lab_ci_SpecialItemChargeBenefitBeforeTaxLitigation_543331cd-eac3-4af9-965f-50bdc2e4aef1_terseLabel_en-US" xlink:label="lab_ci_SpecialItemChargeBenefitBeforeTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Benefits) charges associated with litigation matters</link:label>
    <link:label id="lab_ci_SpecialItemChargeBenefitBeforeTaxLitigation_label_en-US" xlink:label="lab_ci_SpecialItemChargeBenefitBeforeTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item Charge (Benefit) Before Tax Litigation</link:label>
    <link:label id="lab_ci_SpecialItemChargeBenefitBeforeTaxLitigation_documentation_en-US" xlink:label="lab_ci_SpecialItemChargeBenefitBeforeTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax charges associated with litigation matters that are classified as special items, attributable to the parent. Special items reflect amounts that management does not believe are representative of underlying results of operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemChargeBenefitBeforeTaxLitigation" xlink:href="ci-20230331.xsd#ci_SpecialItemChargeBenefitBeforeTaxLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemChargeBenefitBeforeTaxLitigation" xlink:to="lab_ci_SpecialItemChargeBenefitBeforeTaxLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_48f13121-abee-4eb0-866e-327534604efa_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for current expected credit losses on accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_0bbfa812-5ec0-425a-8f70-636776eba2b6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_d29dcaf1-5685-4361-8893-fe5c50412c4b_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember_658d7ae3-48bb-465a-a461-d082891d576b_terseLabel_en-US" xlink:label="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BBB- to BBB+ equivalent current credit ratings</link:label>
    <link:label id="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember_label_en-US" xlink:label="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nationally Recognized Statisical Rating Organizations (NRSRO), BBB- To BBB+ Rating [Member]</link:label>
    <link:label id="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember_documentation_en-US" xlink:label="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nationally Recognized Statisical Rating Organizations (NRSRO), BBB- To BBB+ Rating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember" xlink:href="ci-20230331.xsd#ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember" xlink:to="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea444e6b-1bf9-4064-b49b-fa77f7d1aac3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_IndividualAndFamilyPlansShortDurationMember_3b1495ec-6498-4014-a30b-1f7f2365c784_terseLabel_en-US" xlink:label="lab_ci_IndividualAndFamilyPlansShortDurationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration (Individual and family plans)</link:label>
    <link:label id="lab_ci_IndividualAndFamilyPlansShortDurationMember_label_en-US" xlink:label="lab_ci_IndividualAndFamilyPlansShortDurationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual And Family Plans, Short-Duration [Member]</link:label>
    <link:label id="lab_ci_IndividualAndFamilyPlansShortDurationMember_documentation_en-US" xlink:label="lab_ci_IndividualAndFamilyPlansShortDurationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual And Family Plans, Short-Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IndividualAndFamilyPlansShortDurationMember" xlink:href="ci-20230331.xsd#ci_IndividualAndFamilyPlansShortDurationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_IndividualAndFamilyPlansShortDurationMember" xlink:to="lab_ci_IndividualAndFamilyPlansShortDurationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPortfolioSegmentMember_3c554cbe-aa1f-4936-be8b-dbdd52920cb0_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPortfolioSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Portfolio Segment</link:label>
    <link:label id="lab_us-gaap_CommercialPortfolioSegmentMember_label_en-US" xlink:label="lab_us-gaap_CommercialPortfolioSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Portfolio Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPortfolioSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPortfolioSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPortfolioSegmentMember" xlink:to="lab_us-gaap_CommercialPortfolioSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_a506b187-d506-441d-9121-4fa0a321710a_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteedMinimumDeathBenefitMember_55353efc-de2c-4b2c-bc8c-99768004caa8_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteedMinimumDeathBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GMDB</link:label>
    <link:label id="lab_us-gaap_GuaranteedMinimumDeathBenefitMember_label_en-US" xlink:label="lab_us-gaap_GuaranteedMinimumDeathBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranteed Minimum Death Benefit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedMinimumDeathBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedMinimumDeathBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteedMinimumDeathBenefitMember" xlink:to="lab_us-gaap_GuaranteedMinimumDeathBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception_075c14df-517f-486c-94b5-a5b8872fed6f_terseLabel_en-US" xlink:label="lab_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected liquidation period after inception</link:label>
    <link:label id="lab_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception_label_en-US" xlink:label="lab_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Investments Entities That Calculate Net Asset Value Per Share Liquidating Investment Period From Inception</link:label>
    <link:label id="lab_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception_documentation_en-US" xlink:label="lab_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected liquidation period after inception of the underlying assets measured at net asset value per share or unit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception" xlink:href="ci-20230331.xsd#ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception" xlink:to="lab_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining_984c6f9f-97f0-4a39-815d-76156ab9b452_terseLabel_en-US" xlink:label="lab_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining overall limit under reinsurance agreement</link:label>
    <link:label id="lab_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining_label_en-US" xlink:label="lab_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Reinsurance Agreement, Coverage Limit, Amount Remaining</link:label>
    <link:label id="lab_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining_documentation_en-US" xlink:label="lab_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount remaining of overall limit to claims covered under ceded reinsurance agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining" xlink:href="ci-20230331.xsd#ci_CededReinsuranceAgreementCoverageLimitAmountRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining" xlink:to="lab_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6577307f-07f7-4f2d-808d-6c4c6534ad66_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant_5bd30a2d-75c0-48c7-bd7e-59aade7ecd0f_terseLabel_en-US" xlink:label="lab_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio covenant</link:label>
    <link:label id="lab_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant_label_en-US" xlink:label="lab_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Debt To Adjusted Capital Ratio Covenant</link:label>
    <link:label id="lab_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant_documentation_en-US" xlink:label="lab_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The debt-to adjusted capital ratio which the Company must not exceed in accordance with the terms of the line of credit facility agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant" xlink:href="ci-20230331.xsd#ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant" xlink:to="lab_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_97824b3a-1aa9-4e70-9cea-c5261f560016_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebenturesDue20277875InterestMember_fccc1975-d105-4eab-ac89-6051edf2d877_terseLabel_en-US" xlink:label="lab_ci_DebenturesDue20277875InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$259&#160;million, 7.875% Debentures due May 2027</link:label>
    <link:label id="lab_ci_DebenturesDue20277875InterestMember_label_en-US" xlink:label="lab_ci_DebenturesDue20277875InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debentures due 2027 7.875% Interest [Member]</link:label>
    <link:label id="lab_ci_DebenturesDue20277875InterestMember_documentation_en-US" xlink:label="lab_ci_DebenturesDue20277875InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debentures bearing interest at 7.875% due in 2027.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebenturesDue20277875InterestMember" xlink:href="ci-20230331.xsd#ci_DebenturesDue20277875InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebenturesDue20277875InterestMember" xlink:to="lab_ci_DebenturesDue20277875InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings_e1a77fa1-03ba-488b-a469-460ebd101788_terseLabel_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gains included in Shareholders' net income attributable to instruments held at the reporting date</link:label>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings_label_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Attributed To Instruments Held Included In Earnings</link:label>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings_documentation_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents total gains or losses for the period (realized and unrealized), arising from assets included in income attributable to instruments held at the reporting date, measured at fair value on a recurring basis using unobservable inputs (Level 3), which are included in earnings or resulted in a change in asset value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings" xlink:to="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_2916027b-b740-4187-bab8-9b9fd07ff516_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountsPolicy_dc61bd76-0c60-403b-8aa1-31b22703128a_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Accounts</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountsPolicy" xlink:to="lab_us-gaap_PolicyholderAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_5e74865c-bf4e-44b1-8fd1-c7c1d258050f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_03aa427e-f90d-4f53-a2bd-0a9897033eaf_terseLabel_en-US" xlink:label="lab_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Liability For Future Policy Benefit And Market Risk Benefit, Instrument-Specific Credit Risk, Parent</link:label>
    <link:label id="lab_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_label_en-US" xlink:label="lab_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Liability For Future Policy Benefit And Market Risk Benefit, Instrument-Specific Credit Risk, Parent [Member]</link:label>
    <link:label id="lab_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_documentation_en-US" xlink:label="lab_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Liability For Future Policy Benefit And Market Risk Benefit, Instrument-Specific Credit Risk, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" xlink:href="ci-20230331.xsd#ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" xlink:to="lab_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_ff9a24f8-643f-4012-8caf-7f88594a0934_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesCurrent_e7d0b4e6-1d86-48c7-abf6-95a78bcce97a_terseLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current insurance and contractholder liabilities</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesCurrent_16447abc-b57b-4c7d-83f7-42e4e90a1f82_totalLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current insurance and contractholder liabilities</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesCurrent_label_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities Current</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesCurrent_documentation_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The carrying amounts as of the balance sheet date of all current insurance and contractholder liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrent" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrent" xlink:to="lab_ci_InsuranceAndContractholderLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AllowanceForReceivablesOther_e946eaef-5b2c-4d92-a1e7-7378e5bd95a0_terseLabel_en-US" xlink:label="lab_ci_AllowanceForReceivablesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining allowances</link:label>
    <link:label id="lab_ci_AllowanceForReceivablesOther_label_en-US" xlink:label="lab_ci_AllowanceForReceivablesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Receivables, Other</link:label>
    <link:label id="lab_ci_AllowanceForReceivablesOther_documentation_en-US" xlink:label="lab_ci_AllowanceForReceivablesOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of other allowances classified as current, including allowances, discounts and claims adjustments issued to customers in the form of client credits, allowance for current expected credit losses and other non-credit adjustments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AllowanceForReceivablesOther" xlink:href="ci-20230331.xsd#ci_AllowanceForReceivablesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AllowanceForReceivablesOther" xlink:to="lab_ci_AllowanceForReceivablesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_937a9d4e-b04f-4bbb-87d1-12205417105b_terseLabel_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Outstanding Long-Term Debt</link:label>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_label_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:to="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_786cf254-28bd-4aac-8c6d-93d01ed7634c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term investments</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestments" xlink:to="lab_us-gaap_OtherLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock_cb0a9dc0-ce38-4e81-be16-df1d868768a3_terseLabel_en-US" xlink:label="lab_ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests Policy [Policy Text Block]</link:label>
    <link:label id="lab_ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for noncontrolling shareholders' preferred and common stock interests of consolidated, less than fully owned subsidiaries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock" xlink:href="ci-20230331.xsd#ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock" xlink:to="lab_ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_704823aa-18d7-4a01-a7e6-3dedf0df77ee_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage and other asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_1d1d9328-9973-4ce5-bece-7b385bbdb85f_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PricingConcessionsAfterRemainingTermOfAgreementMember_6adf5fe2-8d2a-4591-8763-973dd36c7548_terseLabel_en-US" xlink:label="lab_ci_PricingConcessionsAfterRemainingTermOfAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Concessions After Remaining Term of Agreement</link:label>
    <link:label id="lab_ci_PricingConcessionsAfterRemainingTermOfAgreementMember_label_en-US" xlink:label="lab_ci_PricingConcessionsAfterRemainingTermOfAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Concessions After Remaining Term Of Agreement [Member]</link:label>
    <link:label id="lab_ci_PricingConcessionsAfterRemainingTermOfAgreementMember_documentation_en-US" xlink:label="lab_ci_PricingConcessionsAfterRemainingTermOfAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing concessions sought in litigation for one year arfter contract termination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PricingConcessionsAfterRemainingTermOfAgreementMember" xlink:href="ci-20230331.xsd#ci_PricingConcessionsAfterRemainingTermOfAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PricingConcessionsAfterRemainingTermOfAgreementMember" xlink:to="lab_ci_PricingConcessionsAfterRemainingTermOfAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebtNoncurrent_5aeff5e0-1ea6-4b9b-a128-d47f39f3c0d4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, including finance leases</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebtNoncurrent" xlink:to="lab_us-gaap_OtherLongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules_aa63964d-8f72-40ac-916e-e6a5daa468d8_terseLabel_en-US" xlink:label="lab_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets associated with unrealized investment losses</link:label>
    <link:label id="lab_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules_label_en-US" xlink:label="lab_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Investments Subject To Federal Capital Loss Utilization Rules</link:label>
    <link:label id="lab_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules_documentation_en-US" xlink:label="lab_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets relative to investments subject to Federal capital loss utilization rules. Capital losses can only be utilized to extent there are capital gains in a given year. If capital losses exceed capital gains, the taxpayer can utilize capital losses to the extent there are capital gains in the applicable carryback period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules" xlink:href="ci-20230331.xsd#ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules" xlink:to="lab_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_6e943d16-168b-4960-bde7-1c4b95b8cf8e_verboseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskAxis_7e23d992-a5dd-481e-bfd3-f62d1a5f4362_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Reinsurer [Axis]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskAxis_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurer, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskAxis" xlink:to="lab_us-gaap_CededCreditRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_26a1c751-f3b5-440b-b428-878ac50e3ff9_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_287d0e66-0f58-4ab2-84cf-77b3caca68f5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments per Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MedicalRiskProductsMember_d52d70e0-1e02-4963-b5e8-96978d684403_terseLabel_en-US" xlink:label="lab_ci_MedicalRiskProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insured</link:label>
    <link:label id="lab_ci_MedicalRiskProductsMember_label_en-US" xlink:label="lab_ci_MedicalRiskProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Risk Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MedicalRiskProductsMember" xlink:href="ci-20230331.xsd#ci_MedicalRiskProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MedicalRiskProductsMember" xlink:to="lab_ci_MedicalRiskProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale_05afe30c-2384-4ea0-83f6-9a29f651c8a3_totalLabel_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Fair Value, including held for sale assets</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_f16a4a12-779b-41e8-81fd-69aa0f3650c2_totalLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total transfers into/(out of) Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity_a0c4371d-7c99-4497-9b6a-5bed83653a04_negatedTerseLabel_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) including temporary equity, before reclassifications, tax</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity_label_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax, Including Temporary Equity</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity_documentation_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax, Including Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity" xlink:to="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_f8fd4a54-e59b-4a81-962f-8bb3500d2173_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialGuaranteeMember_6440cd1f-87d9-4813-95b4-3d80b46373de_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees</link:label>
    <link:label id="lab_us-gaap_FinancialGuaranteeMember_label_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialGuaranteeMember" xlink:to="lab_us-gaap_FinancialGuaranteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PharmacyBenefitsManagementServicesMember_4bd3ba6e-1798-4990-a02f-545d681c2bbb_terseLabel_en-US" xlink:label="lab_ci_PharmacyBenefitsManagementServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Benefits Management Services</link:label>
    <link:label id="lab_ci_PharmacyBenefitsManagementServicesMember_label_en-US" xlink:label="lab_ci_PharmacyBenefitsManagementServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Benefits Management Services [Member]</link:label>
    <link:label id="lab_ci_PharmacyBenefitsManagementServicesMember_documentation_en-US" xlink:label="lab_ci_PharmacyBenefitsManagementServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy benefit management services provided to corporate client, other employer groups and their employees. These services include pharmacy home delivery, retail network administration and specialty pharmacy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmacyBenefitsManagementServicesMember" xlink:href="ci-20230331.xsd#ci_PharmacyBenefitsManagementServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PharmacyBenefitsManagementServicesMember" xlink:to="lab_ci_PharmacyBenefitsManagementServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_1dc56a02-5951-40e8-bddc-7c1780d00606_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Depreciation</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_3de8c156-b7f1-4965-9b69-486b11c4e84c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_9d1227bf-d6c6-43b4-960e-c539d3583b33_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LitigationMattersAndRegulatoryMattersMember_b761596b-d654-4c65-8f85-b09cc476569e_terseLabel_en-US" xlink:label="lab_ci_LitigationMattersAndRegulatoryMattersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Matters and Regulatory Matters</link:label>
    <link:label id="lab_ci_LitigationMattersAndRegulatoryMattersMember_label_en-US" xlink:label="lab_ci_LitigationMattersAndRegulatoryMattersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Matters And Regulatory Matters [Member]</link:label>
    <link:label id="lab_ci_LitigationMattersAndRegulatoryMattersMember_documentation_en-US" xlink:label="lab_ci_LitigationMattersAndRegulatoryMattersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Matters And Regulatory Matters</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LitigationMattersAndRegulatoryMattersMember" xlink:href="ci-20230331.xsd#ci_LitigationMattersAndRegulatoryMattersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LitigationMattersAndRegulatoryMattersMember" xlink:to="lab_ci_LitigationMattersAndRegulatoryMattersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthcareSectorMember_e8d20b6d-1382-4ed5-a8fd-6b35ecc59e02_terseLabel_en-US" xlink:label="lab_us-gaap_HealthcareSectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Sector</link:label>
    <link:label id="lab_us-gaap_HealthcareSectorMember_label_en-US" xlink:label="lab_us-gaap_HealthcareSectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Sector [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthcareSectorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthcareSectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthcareSectorMember" xlink:to="lab_us-gaap_HealthcareSectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_e8149ab8-ffb1-4845-ab6f-1a5b6c8876f8_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_70575d00-2c2e-4b1c-9580-671dde4c9272_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Depreciation</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DamagesForServiceIssuesMember_89c74345-7508-45f3-8226-6305dc5b28a6_terseLabel_en-US" xlink:label="lab_ci_DamagesForServiceIssuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages for Service Issues</link:label>
    <link:label id="lab_ci_DamagesForServiceIssuesMember_label_en-US" xlink:label="lab_ci_DamagesForServiceIssuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages For Service Issues [Member]</link:label>
    <link:label id="lab_ci_DamagesForServiceIssuesMember_documentation_en-US" xlink:label="lab_ci_DamagesForServiceIssuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought in litigation for service issues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DamagesForServiceIssuesMember" xlink:href="ci-20230331.xsd#ci_DamagesForServiceIssuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DamagesForServiceIssuesMember" xlink:to="lab_ci_DamagesForServiceIssuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ContractholderDepositFundsPolicyPolicyTextBlock_e3a00195-1a89-44fb-aea7-36f24aec9b09_terseLabel_en-US" xlink:label="lab_ci_ContractholderDepositFundsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractholder Deposit Funds</link:label>
    <link:label id="lab_ci_ContractholderDepositFundsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_ci_ContractholderDepositFundsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractholder Deposit Funds, Policy [Policy Text Block]</link:label>
    <link:label id="lab_ci_ContractholderDepositFundsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_ci_ContractholderDepositFundsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Describes an entity's accounting policy for contractholder deposit funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ContractholderDepositFundsPolicyPolicyTextBlock" xlink:href="ci-20230331.xsd#ci_ContractholderDepositFundsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ContractholderDepositFundsPolicyPolicyTextBlock" xlink:to="lab_ci_ContractholderDepositFundsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MarketRiskBenefitLiabilityAmountNoncurrent_8a7a278f-282e-4373-83ea-a7a4057ef655_terseLabel_en-US" xlink:label="lab_ci_MarketRiskBenefitLiabilityAmountNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market risk benefits, noncurrent</link:label>
    <link:label id="lab_ci_MarketRiskBenefitLiabilityAmountNoncurrent_label_en-US" xlink:label="lab_ci_MarketRiskBenefitLiabilityAmountNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Liability, Amount, Noncurrent</link:label>
    <link:label id="lab_ci_MarketRiskBenefitLiabilityAmountNoncurrent_documentation_en-US" xlink:label="lab_ci_MarketRiskBenefitLiabilityAmountNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Liability, Amount, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitLiabilityAmountNoncurrent" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitLiabilityAmountNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MarketRiskBenefitLiabilityAmountNoncurrent" xlink:to="lab_ci_MarketRiskBenefitLiabilityAmountNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LibertyMutualInsuranceMember_2e4c462d-30fb-47ed-8ad2-7db71e307e91_verboseLabel_en-US" xlink:label="lab_ci_LibertyMutualInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liberty Re (Bermuda) Ltd.</link:label>
    <link:label id="lab_ci_LibertyMutualInsuranceMember_label_en-US" xlink:label="lab_ci_LibertyMutualInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liberty Mutual Insurance [Member]</link:label>
    <link:label id="lab_ci_LibertyMutualInsuranceMember_documentation_en-US" xlink:label="lab_ci_LibertyMutualInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liberty Mutual Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LibertyMutualInsuranceMember" xlink:href="ci-20230331.xsd#ci_LibertyMutualInsuranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LibertyMutualInsuranceMember" xlink:to="lab_ci_LibertyMutualInsuranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d899e22f-5a28-4644-84b5-7159d42fdf87_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyLoansMember_c5c64c32-44c8-415b-89e0-03483e6a273b_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policy loans</link:label>
    <link:label id="lab_us-gaap_PolicyLoansMember_a3cd1944-7a02-4e59-9b6e-dbd495518b5a_verboseLabel_en-US" xlink:label="lab_us-gaap_PolicyLoansMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policy loans</link:label>
    <link:label id="lab_us-gaap_PolicyLoansMember_label_en-US" xlink:label="lab_us-gaap_PolicyLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policy Loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyLoansMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyLoansMember" xlink:to="lab_us-gaap_PolicyLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_83a3acb1-2370-41f9-abdd-3270f0371a18_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CommitmentsAndContingenciesTable_2a664183-9a97-4355-b2ab-40b010e062fc_terseLabel_en-US" xlink:label="lab_ci_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_ci_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_ci_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_ci_CommitmentsAndContingenciesTable_documentation_en-US" xlink:label="lab_ci_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsAndContingenciesTable" xlink:href="ci-20230331.xsd#ci_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CommitmentsAndContingenciesTable" xlink:to="lab_ci_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_d19a2ac8-107b-44aa-8776-5baed36eadf4_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_GainLossOnExtinguishmentOfDebtNetOfTax_6bbf8c20-4a52-4b00-a42c-bb29068c12c8_negatedTerseLabel_en-US" xlink:label="lab_ci_GainLossOnExtinguishmentOfDebtNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on repurchase of debt, after-tax</link:label>
    <link:label id="lab_ci_GainLossOnExtinguishmentOfDebtNetOfTax_label_en-US" xlink:label="lab_ci_GainLossOnExtinguishmentOfDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Extinguishment Of Debt, Net Of Tax</link:label>
    <link:label id="lab_ci_GainLossOnExtinguishmentOfDebtNetOfTax_documentation_en-US" xlink:label="lab_ci_GainLossOnExtinguishmentOfDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Extinguishment Of Debt, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GainLossOnExtinguishmentOfDebtNetOfTax" xlink:href="ci-20230331.xsd#ci_GainLossOnExtinguishmentOfDebtNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_GainLossOnExtinguishmentOfDebtNetOfTax" xlink:to="lab_ci_GainLossOnExtinguishmentOfDebtNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SunLifeAssuranceCompanyOfCanadaMember_ee0ca80a-9bd6-4002-835e-a6a5eb598809_verboseLabel_en-US" xlink:label="lab_ci_SunLifeAssuranceCompanyOfCanadaMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sun Life Assurance Company of Canada</link:label>
    <link:label id="lab_ci_SunLifeAssuranceCompanyOfCanadaMember_label_en-US" xlink:label="lab_ci_SunLifeAssuranceCompanyOfCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sun Life Assurance Company Of Canada [Member]</link:label>
    <link:label id="lab_ci_SunLifeAssuranceCompanyOfCanadaMember_documentation_en-US" xlink:label="lab_ci_SunLifeAssuranceCompanyOfCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sun Life Assurance Company of Canada</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SunLifeAssuranceCompanyOfCanadaMember" xlink:href="ci-20230331.xsd#ci_SunLifeAssuranceCompanyOfCanadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SunLifeAssuranceCompanyOfCanadaMember" xlink:to="lab_ci_SunLifeAssuranceCompanyOfCanadaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_631a1862-6851-4e53-8988-e85863411314_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_36ed4f41-3891-48da-91b5-c951363d1bab_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCost_9a5d34f8-070f-4b72-903f-3a36c7b25aab_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities with readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCost_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCost" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition_91c7035a-7fa5-4b8a-81ec-15a8afd9a5ac_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances and lapses</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Net Premium, Issuance And Derecognition</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Net Premium, Issuance And Derecognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_fde20b9d-24a4-4ccc-aef9-4d88f23e5fdf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue203848InterestMember_972a2310-5674-4250-ac6d-00af816cd602_terseLabel_en-US" xlink:label="lab_ci_NotesDue203848InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200&#160;million, 4.800% Notes due August 2038</link:label>
    <link:label id="lab_ci_NotesDue203848InterestMember_label_en-US" xlink:label="lab_ci_NotesDue203848InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2038, 4.8% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue203848InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue203848InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable bearing interest at 4.8% due in 2038. Debt issued to finance acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue203848InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue203848InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue203848InterestMember" xlink:to="lab_ci_NotesDue203848InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_82c3df7d-9409-43ec-87e0-b199cfa899c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CashCashEquivalentsAndShortTermInvestmentsMember_f3bd7d40-c6d7-47e2-adf3-2752b672d2cb_verboseLabel_en-US" xlink:label="lab_ci_CashCashEquivalentsAndShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments and cash</link:label>
    <link:label id="lab_ci_CashCashEquivalentsAndShortTermInvestmentsMember_label_en-US" xlink:label="lab_ci_CashCashEquivalentsAndShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Cash Equivalents And Short Term Investments [Member]</link:label>
    <link:label id="lab_ci_CashCashEquivalentsAndShortTermInvestmentsMember_documentation_en-US" xlink:label="lab_ci_CashCashEquivalentsAndShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate of cash, cash equivalents and short-term investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CashCashEquivalentsAndShortTermInvestmentsMember" xlink:href="ci-20230331.xsd#ci_CashCashEquivalentsAndShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CashCashEquivalentsAndShortTermInvestmentsMember" xlink:to="lab_ci_CashCashEquivalentsAndShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_33cd1cbc-90a3-4192-9397-7459a1806de7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance guarantee liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_df76d1d2-7e8f-44ed-b31d-ee891d5e40d2_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for litigation matters, pre-tax</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_703f6ce6-9c25-4b4b-85a1-10b3e04d754f_netLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_1fbdaf5b-fa8a-4b7c-8502-a2174b4dfc03_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_f8b9aa16-7c3f-465f-9291-d68063804d6a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Favorable (unfavorable) variance, amount</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_2ab1fc44-8ed5-451a-902a-30722bbaecf9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage, less than</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember_f59ba948-d907-4ba5-a5d1-5b7a56a52730_terseLabel_en-US" xlink:label="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Berkshire Hathway Life Insurance Company Of Nebraska and Other Recoverables</link:label>
    <link:label id="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember_label_en-US" xlink:label="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Berkshire Hathway Life Insurance Company Of Nebraska And Other Recoverables [Member]</link:label>
    <link:label id="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember_documentation_en-US" xlink:label="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Berkshire Hathway Life Insurance Company Of Nebraska And Other Recoverables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember" xlink:href="ci-20230331.xsd#ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember" xlink:to="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_fca1dc5a-57d0-4a60-be07-91fcd46f20c9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance at original discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_b50d1c63-3d4d-4878-900c-588d58859b47_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Value</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember_e213e944-8f25-4a9b-8778-eb8b4dd23bc8_terseLabel_en-US" xlink:label="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market risk benefits reinsurance recoverable, including IBNR and outstanding claims, less premiums due</link:label>
    <link:label id="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember_label_en-US" xlink:label="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit Reinsurance Recoverable After Allowance And Related Balances [Member]</link:label>
    <link:label id="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember_documentation_en-US" xlink:label="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market risk benefit reinsurance recoverable, including IBNR and outstanding claims, less premiums due.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember" xlink:to="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities_68bf5278-e553-4fa4-93a7-317bfd316754_negatedLabel_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and contractholder liabilities classified as held for sale</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities_label_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Noncurrent Insurance And Contractholder Liabilities</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities_documentation_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Noncurrent Insurance And Contractholder Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities" xlink:to="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue205134InterestMember_b9ff3aee-8fcd-4ebc-8eda-70bea3f9b407_terseLabel_en-US" xlink:label="lab_ci_NotesDue205134InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,500 million, 3.400% Notes due March 2051</link:label>
    <link:label id="lab_ci_NotesDue205134InterestMember_label_en-US" xlink:label="lab_ci_NotesDue205134InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2051, 3.4% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue205134InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue205134InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable bearing interest at 3.4% due 2051.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue205134InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue205134InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue205134InterestMember" xlink:to="lab_ci_NotesDue205134InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_faf1654e-537b-4545-91fd-5bfcec463be8_verboseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_c91059a3-dfb0-4637-bc0c-52ae1d38b5db_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_e36ee534-3e9f-43bf-9ec3-3b88166b664a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) included in Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_a97d8b67-55fd-444c-b77c-2ef981dc2628_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_4d0b2cbe-29b6-4bda-b87f-0c91e2512d97_totalLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total short-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_IndividualPrivateMedicalInsuranceLongDurationMember_dab2692a-9d2a-4808-afa3-488104a71421_terseLabel_en-US" xlink:label="lab_ci_IndividualPrivateMedicalInsuranceLongDurationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-duration (Individual private medical insurance)</link:label>
    <link:label id="lab_ci_IndividualPrivateMedicalInsuranceLongDurationMember_label_en-US" xlink:label="lab_ci_IndividualPrivateMedicalInsuranceLongDurationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Private Medical Insurance, Long-Duration [Member]</link:label>
    <link:label id="lab_ci_IndividualPrivateMedicalInsuranceLongDurationMember_documentation_en-US" xlink:label="lab_ci_IndividualPrivateMedicalInsuranceLongDurationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Private Medical Insurance, Long-Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IndividualPrivateMedicalInsuranceLongDurationMember" xlink:href="ci-20230331.xsd#ci_IndividualPrivateMedicalInsuranceLongDurationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_IndividualPrivateMedicalInsuranceLongDurationMember" xlink:to="lab_ci_IndividualPrivateMedicalInsuranceLongDurationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_6b4c27b2-fe65-4aae-8465-7868e9c73b1d_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_0f034ebe-1074-4482-947e-a5b32a9de335_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_8817fa13-1758-473e-af53-3beeb1ac8997_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_47fa0117-7a03-45c4-9346-905eec37fe19_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InvestmentsCreditRatingAxis_66ef159e-ff88-499d-967e-f8bb77d66f70_terseLabel_en-US" xlink:label="lab_ci_InvestmentsCreditRatingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Credit Rating [Axis]</link:label>
    <link:label id="lab_ci_InvestmentsCreditRatingAxis_label_en-US" xlink:label="lab_ci_InvestmentsCreditRatingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Credit Rating [Axis]</link:label>
    <link:label id="lab_ci_InvestmentsCreditRatingAxis_documentation_en-US" xlink:label="lab_ci_InvestmentsCreditRatingAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information by credit rating of debt and securities investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentsCreditRatingAxis" xlink:href="ci-20230331.xsd#ci_InvestmentsCreditRatingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InvestmentsCreditRatingAxis" xlink:to="lab_ci_InvestmentsCreditRatingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_UnearnedPremiumsCurrentIncludingDisposalGroups_df7aebb8-4984-43c7-be0b-b6960039a274_terseLabel_en-US" xlink:label="lab_ci_UnearnedPremiumsCurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned premiums, current, including held for sale liabilities</link:label>
    <link:label id="lab_ci_UnearnedPremiumsCurrentIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_UnearnedPremiumsCurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums Current Including Disposal Groups</link:label>
    <link:label id="lab_ci_UnearnedPremiumsCurrentIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_UnearnedPremiumsCurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date, expected to be paid in one year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsCurrentIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsCurrentIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_UnearnedPremiumsCurrentIncludingDisposalGroups" xlink:to="lab_ci_UnearnedPremiumsCurrentIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9d11cdce-98ff-4952-b41e-1481a5ddd163_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember_94d47b7a-c4f2-4ef0-8bbf-2c3346ed8bae_terseLabel_en-US" xlink:label="lab_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divested International businesses</link:label>
    <link:label id="lab_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember_label_en-US" xlink:label="lab_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operations, International Businesses To Be Sold And Interest In Joint Venture In Turkey [Member]</link:label>
    <link:label id="lab_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember_documentation_en-US" xlink:label="lab_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operations, International Businesses To Be Sold And Interest In Joint Venture In Turkey</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember" xlink:href="ci-20230331.xsd#ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember" xlink:to="lab_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_37c56964-798c-48b3-b9d7-39448183c0cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_292882ef-8986-4121-80cc-0dd24f2ad7ac_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non- controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_f7866189-6293-4455-be3a-6990ec45349b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual provision</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock_a5f58978-e0d2-4b1e-ad71-3b362b1b27e9_terseLabel_en-US" xlink:label="lab_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock_label_en-US" xlink:label="lab_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Text Block]</link:label>
    <link:label id="lab_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock_documentation_en-US" xlink:label="lab_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclousre of the changes in the componenets of other comprehensive income/loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock" xlink:href="ci-20230331.xsd#ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock" xlink:to="lab_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_79500b35-5d4b-4e19-8304-48f7c236f83e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit agreement term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups_da5b57a5-7fff-4b29-9df2-194b615e9de6_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefits, including held for sale liabilities</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefits Noncurrent Including Disposal Groups</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of accrued obligation to policyholders that relates to insured events for long-duration contracts, expected to be paid after one year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_ce628fd2-f030-431a-afdd-e40d3747db22_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:to="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_677c185c-2bfc-4fd8-b06a-157355255479_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SupplierFinanceProgramPaymentTimingPeriod_04876186-c7f4-4b63-a028-31d664d3707e_terseLabel_en-US" xlink:label="lab_ci_SupplierFinanceProgramPaymentTimingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment term (in months)</link:label>
    <link:label id="lab_ci_SupplierFinanceProgramPaymentTimingPeriod_label_en-US" xlink:label="lab_ci_SupplierFinanceProgramPaymentTimingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program, Payment Timing, Period</link:label>
    <link:label id="lab_ci_SupplierFinanceProgramPaymentTimingPeriod_documentation_en-US" xlink:label="lab_ci_SupplierFinanceProgramPaymentTimingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period when payment is expected to be made to finance provider or intermediary in supplier finance program, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SupplierFinanceProgramPaymentTimingPeriod" xlink:href="ci-20230331.xsd#ci_SupplierFinanceProgramPaymentTimingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SupplierFinanceProgramPaymentTimingPeriod" xlink:to="lab_ci_SupplierFinanceProgramPaymentTimingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0387db9d-5a6f-42f0-83f8-3defce3e82ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock equivalents (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_8a2ca24f-31d0-41c7-a420-b5063eb8a8e3_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost_3218e494-9ca5-4eac-9187-5962d3798c3e_terseLabel_en-US" xlink:label="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities with no readily determinable fair value</link:label>
    <link:label id="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost_label_en-US" xlink:label="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Amortized Cost</link:label>
    <link:label id="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost" xlink:to="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8a176170-5bd4-49c5-8faf-0db7d92ebe3b_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_058c92e8-f143-48b0-9b0e-875fcc4fb213_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_09f17bf0-bf8e-44f3-85bb-bbea4c2025c4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_7f4b7294-cec5-4d71-bd26-8e0165e31b83_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesFVNIMember_305d7d98-eb84-455a-a060-2c23871da58b_terseLabel_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities FV NI</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIMember_label_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities FV NI [Member]</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIMember_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities FV NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIMember" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesFVNIMember" xlink:to="lab_ci_EquitySecuritiesFVNIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_b23703aa-da6b-4a73-8a12-92eec5f2d2ea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_a5f44bba-098b-449d-bc97-30869418fb2d_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_af006f7f-8401-4f76-b974-8ecdef0d7baa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_59fd5abc-0fc9-44ba-b7df-f9e3cfe6a735_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_fcde7964-4d7f-4ebb-9526-1581a3127d66_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable_56c0adf1-d7cf-4f36-b3c6-e527507ddd7c_terseLabel_en-US" xlink:label="lab_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy and other service costs payable</link:label>
    <link:label id="lab_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable_label_en-US" xlink:label="lab_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Pharmacy And Service Costs Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable" xlink:href="ci-20230331.xsd#ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable" xlink:to="lab_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_73b2fff7-d867-43ce-95ac-5ad446a5a482_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_d4041a12-214e-4454-96de-1ecf6bf8a663_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity_791b1650-1b8a-4395-8f8a-c0c5ded308a9_negatedTotalLabel_en-US" xlink:label="lab_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total impact from special items</link:label>
    <link:label id="lab_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity_label_en-US" xlink:label="lab_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item Gain Or Loss Before Tax Attributable To Reportng Entity</link:label>
    <link:label id="lab_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity_documentation_en-US" xlink:label="lab_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sum of before-tax tax amounts classified as special items, attributable to the parent. Special items are excluded from the calculation of 'adjusted income (loss) from operations' because management believes they are not representative of the underlying results of operations. This is generally because the nature and size of these matters are not indicative of our ongoing business operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity" xlink:href="ci-20230331.xsd#ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity" xlink:to="lab_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_78ff171d-b94e-4639-bdc1-a5b5c16ead2a_terseLabel_en-US" xlink:label="lab_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, including held for sale assets</link:label>
    <link:label id="lab_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_b9c8deb7-39b6-4a48-bc77-f7ee50ac7279_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_9069ceee-871c-4fc9-b6cb-1e903fb4dac6_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale_d8ad1c12-2826-42fb-97a2-5df3414ff79c_terseLabel_en-US" xlink:label="lab_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, including held for sale assets</link:label>
    <link:label id="lab_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative Investment, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:label id="lab_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative Investment, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_54a3a3ba-7040-4d64-8959-0969e102a8e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Derivative Instruments Held</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_180e7df1-f481-4983-8913-2a9ac18ad1e9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_4a438ad0-1813-4f8d-a57a-475bea3a94b2_terseLabel_en-US" xlink:label="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-guaranteed separate accounts, including held for sale assets</link:label>
    <link:label id="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_fa95a610-9071-4301-980b-a90a607a383d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign government</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Government, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue2027305Member_6199f27b-f3ff-4ea5-accc-5e8e2478cc4c_terseLabel_en-US" xlink:label="lab_ci_NotesDue2027305Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$600&#160;million, 3.050% Notes due October 2027</link:label>
    <link:label id="lab_ci_NotesDue2027305Member_label_en-US" xlink:label="lab_ci_NotesDue2027305Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2027, 3.05% [Member]</link:label>
    <link:label id="lab_ci_NotesDue2027305Member_documentation_en-US" xlink:label="lab_ci_NotesDue2027305Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable bearing interest at 3.05% due October 15, 2027.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2027305Member" xlink:href="ci-20230331.xsd#ci_NotesDue2027305Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue2027305Member" xlink:to="lab_ci_NotesDue2027305Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_6949973e-8474-4ba1-9a54-66c7bdd86d77_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net classified as Assets of businesses held for sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceTextBlock_be3419eb-dad6-40d1-96bb-474b975790d3_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance</link:label>
    <link:label id="lab_us-gaap_ReinsuranceTextBlock_label_en-US" xlink:label="lab_us-gaap_ReinsuranceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceTextBlock" xlink:to="lab_us-gaap_ReinsuranceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability_a99763d9-a299-4173-b179-5d83272ef81d_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefits, DPL</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefits, Deferred Profit Liability</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefits, Deferred Profit Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_74bb2434-17ad-400a-a4ee-5ee3c3e8e3e3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_c22872fa-1223-4be3-82f9-db50c677a28f_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_f94543b1-7d30-4b1b-8db0-e14a49ea1035_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_13aaff6a-8643-4227-b098-60234f49db33_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_12583b8b-3449-4b79-9abb-441b567f6f79_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RevolvingCreditFacilityMaturingApril2025Member_c7cf8b11-2da7-40e8-98b0-2e3cdb4396e5_terseLabel_en-US" xlink:label="lab_ci_RevolvingCreditFacilityMaturingApril2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Maturing April 2025</link:label>
    <link:label id="lab_ci_RevolvingCreditFacilityMaturingApril2025Member_label_en-US" xlink:label="lab_ci_RevolvingCreditFacilityMaturingApril2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Maturing April 2025 [Member]</link:label>
    <link:label id="lab_ci_RevolvingCreditFacilityMaturingApril2025Member_documentation_en-US" xlink:label="lab_ci_RevolvingCreditFacilityMaturingApril2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Maturing April 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditFacilityMaturingApril2025Member" xlink:href="ci-20230331.xsd#ci_RevolvingCreditFacilityMaturingApril2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RevolvingCreditFacilityMaturingApril2025Member" xlink:to="lab_ci_RevolvingCreditFacilityMaturingApril2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_97d3357b-26fe-445f-a43b-b0392a7bf327_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_84da6bc5-e876-4463-9820-e209609a2ff8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_b5cf3f5a-bb42-470e-af58-cf3f3c2794da_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_76e1b7e2-72c4-4041-b4b0-0f947f934547_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_4a18b005-0fdc-4986-9823-d1dd8b9b9aa4_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_e1899ed4-264d-4541-bc2f-7d88accb810b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis_b98a5e8e-e593-412a-a79d-c2a81fb77e6e_terseLabel_en-US" xlink:label="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, Nationally Recognized Statistical Rating Organization (NRSRO) [Axis]</link:label>
    <link:label id="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis_label_en-US" xlink:label="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, Nationally Recognized Statistical Rating Organization (NRSRO) [Axis]</link:label>
    <link:label id="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis_documentation_en-US" xlink:label="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, Nationally Recognized Statistical Rating Organization (NRSRO)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis" xlink:href="ci-20230331.xsd#ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis" xlink:to="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_17b027d0-46ec-4f16-97b9-3e003f6a7518_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and Contractholder Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceDisclosuresAbstract_68751c1d-89c6-4181-9ea6-90a6ea5a63f5_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReinsuranceDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract" xlink:to="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock_87fbd893-915e-4653-a49f-6200e3e9dd9f_terseLabel_en-US" xlink:label="lab_ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Current and Non-Current Liabilities</link:label>
    <link:label id="lab_ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable Accrued Expenses Other Liabilities Policy [Policy Text Block]</link:label>
    <link:label id="lab_ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Describes an entity's accounting policy for accounts payable, accrued expenses and other liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock" xlink:href="ci-20230331.xsd#ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock" xlink:to="lab_ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_598b1737-92ae-4a98-8997-961f2b527fa4_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member_89f4c0b0-e33e-4292-86d5-e80c3d5d31d9_terseLabel_en-US" xlink:label="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit And Letter Of Credit Facility Maturing April 2027</link:label>
    <link:label id="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member_label_en-US" xlink:label="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit And Letter Of Credit Facility Maturing April 2027 [Member]</link:label>
    <link:label id="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member_documentation_en-US" xlink:label="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit And Letter Of Credit Facility Maturing April 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member" xlink:href="ci-20230331.xsd#ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member" xlink:to="lab_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_cf359429-6e57-412c-b7f8-34341829c176_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_92f05489-3ca1-4b4a-9390-a04ee14a3307_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum guarantee exposure</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ac065554-3668-488d-b25d-34a4a501a9fc_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationInvestments_0af9d0fe-c819-4a42-b24a-54090b3f0e92_negatedTotalLabel_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments classified as assets of business held for sale</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationInvestments_label_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Investments</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationInvestments_documentation_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationInvestments" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DisposalGroupIncludingDiscontinuedOperationInvestments" xlink:to="lab_ci_DisposalGroupIncludingDiscontinuedOperationInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent_df579bbf-a388-41ec-a5e1-e6283d689f28_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefits, current</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Before Reinsurance, Current</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Before Reinsurance, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_f8c1efd7-0c6b-4b37-8eed-110f0a588ef8_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsured market risk benefit, end of period</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_015fd26f-8f06-45c2-bde0-c735d27a463c_terseLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market risk benefits</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_label_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Reinsurance Recoverable, after Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance" xlink:to="lab_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ProceedsFromSaleOfDebtAndEquitySecurities_d99c9f89-6131-4a50-9950-5fea4a731b38_terseLabel_en-US" xlink:label="lab_ci_ProceedsFromSaleOfDebtAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities and equity securities</link:label>
    <link:label id="lab_ci_ProceedsFromSaleOfDebtAndEquitySecurities_label_en-US" xlink:label="lab_ci_ProceedsFromSaleOfDebtAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Debt And Equity Securities</link:label>
    <link:label id="lab_ci_ProceedsFromSaleOfDebtAndEquitySecurities_documentation_en-US" xlink:label="lab_ci_ProceedsFromSaleOfDebtAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of debt and equity securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ProceedsFromSaleOfDebtAndEquitySecurities" xlink:href="ci-20230331.xsd#ci_ProceedsFromSaleOfDebtAndEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ProceedsFromSaleOfDebtAndEquitySecurities" xlink:to="lab_ci_ProceedsFromSaleOfDebtAndEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d03e1272-ef12-45c6-b796-7e1e0fc630d5_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_63c2b904-bf30-4bf1-b5e5-e87fa6e5c3e3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskCollateralizationAxis_fc36c9a2-e3a3-4142-b1fa-7a8e960c56e8_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskCollateralizationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Collateralization [Axis]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskCollateralizationAxis_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskCollateralizationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Collateralization [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskCollateralizationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskCollateralizationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationAxis" xlink:to="lab_us-gaap_CededCreditRiskCollateralizationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_b690884b-83ff-4fce-8af9-57ef92a982be_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_0c7088e8-d4d2-4489-bb36-3d9da33ef4fc_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_83377d60-6164-4ad7-808b-b531dfc090dd_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_57c0d7fc-8b7c-4ebb-93cb-53fc56e40e4a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_a4788662-5a31-427e-b328-190fdfe77733_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:to="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WithdrawalFromContractHoldersFunds_40d0cd30-0f18-4764-b5a2-502964b0dc0b_negatedLabel_en-US" xlink:label="lab_us-gaap_WithdrawalFromContractHoldersFunds" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Withdrawals and benefit payments from contractholder deposit funds</link:label>
    <link:label id="lab_us-gaap_WithdrawalFromContractHoldersFunds_label_en-US" xlink:label="lab_us-gaap_WithdrawalFromContractHoldersFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Withdrawal from Contract Holders Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WithdrawalFromContractHoldersFunds" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WithdrawalFromContractHoldersFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WithdrawalFromContractHoldersFunds" xlink:to="lab_us-gaap_WithdrawalFromContractHoldersFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_b4768ea0-47e3-4c95-aa7c-36054081e414_totalLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_UnearnedPremiumsIncludingDisposalGroups_bcc730df-36e1-4d25-b314-0d19ded5de65_terseLabel_en-US" xlink:label="lab_ci_UnearnedPremiumsIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned premiums, including held for sale liabilities</link:label>
    <link:label id="lab_ci_UnearnedPremiumsIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_UnearnedPremiumsIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums Including Disposal Groups</link:label>
    <link:label id="lab_ci_UnearnedPremiumsIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_UnearnedPremiumsIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums Including Disposal Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_UnearnedPremiumsIncludingDisposalGroups" xlink:to="lab_ci_UnearnedPremiumsIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments_025555fa-ef9e-42d4-b908-bf9f81a40995_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded Commitments</link:label>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments_label_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments" xlink:to="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_e2eeb86d-de78-4e79-8448-9bc69ce50983_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_73aecaca-3047-4841-b7f1-6fea09c84299_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_JudicialRulingMember_d1f48114-ab08-410b-add8-ec74000fef5c_terseLabel_en-US" xlink:label="lab_us-gaap_JudicialRulingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judicial Ruling</link:label>
    <link:label id="lab_us-gaap_JudicialRulingMember_label_en-US" xlink:label="lab_us-gaap_JudicialRulingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judicial Ruling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_JudicialRulingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_JudicialRulingMember" xlink:to="lab_us-gaap_JudicialRulingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue202645InterestMember_8da572bb-aeec-419e-a2a4-e27593be7328_terseLabel_en-US" xlink:label="lab_ci_NotesDue202645InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,500&#160;million, 4.500% Notes due February 2026</link:label>
    <link:label id="lab_ci_NotesDue202645InterestMember_label_en-US" xlink:label="lab_ci_NotesDue202645InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2026, 4.5% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue202645InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue202645InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable bearing interest at 4.5% due in 2026. Debt assumed acquisition from Express Scripts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue202645InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue202645InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue202645InterestMember" xlink:to="lab_ci_NotesDue202645InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember_ffac1c9f-34c8-46c4-975a-6ad3ee6dd53b_terseLabel_en-US" xlink:label="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment for (gains) included in Shareholders' net income (Net realized investment losses)</link:label>
    <link:label id="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember_label_en-US" xlink:label="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-For-Sale And Derivatives, Realized Investment (Gains) Losses, Parent [Member]</link:label>
    <link:label id="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember_documentation_en-US" xlink:label="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-For-Sale And Derivatives, Realized Investment (Gains) Losses, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember" xlink:href="ci-20230331.xsd#ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember" xlink:to="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LtvLessThan60PercentMember_fde3a0dd-8faf-4349-9be9-1faab8c78810_terseLabel_en-US" xlink:label="lab_ci_LtvLessThan60PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Below 60%</link:label>
    <link:label id="lab_ci_LtvLessThan60PercentMember_label_en-US" xlink:label="lab_ci_LtvLessThan60PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTV Less Than 60 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LtvLessThan60PercentMember" xlink:href="ci-20230331.xsd#ci_LtvLessThan60PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LtvLessThan60PercentMember" xlink:to="lab_ci_LtvLessThan60PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_c7346a80-4b39-411b-8957-f8a4b21b04b0_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_cfd27246-4431-4869-9fe8-4bc6f9db7075_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6eb19fff-9658-4123-b362-3e2b8158465f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims_c0dd2c5f-e931-4e2f-9af8-839dbc4b3c74_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred but not yet paid and outstanding claims</link:label>
    <link:label id="lab_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims_label_en-US" xlink:label="lab_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Incurred but Not Reported Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims" xlink:to="lab_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_73e7b01a-8911-44c3-8ec5-a57e9afd6ff1_terseLabel_en-US" xlink:label="lab_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax adjustments to reconcile to adjusted income from operations</link:label>
    <link:label id="lab_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_label_en-US" xlink:label="lab_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pretax Adjustments To Reconcile Adjusted Income From Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract" xlink:href="ci-20230331.xsd#ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract" xlink:to="lab_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_GroupDisabilityAndLifeMember_f7a4c8ff-28bd-40ed-967e-e266e0ae96fe_terseLabel_en-US" xlink:label="lab_ci_GroupDisabilityAndLifeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Disability and Life</link:label>
    <link:label id="lab_ci_GroupDisabilityAndLifeMember_label_en-US" xlink:label="lab_ci_GroupDisabilityAndLifeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Disability And Life [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GroupDisabilityAndLifeMember" xlink:href="ci-20230331.xsd#ci_GroupDisabilityAndLifeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_GroupDisabilityAndLifeMember" xlink:to="lab_ci_GroupDisabilityAndLifeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestmentsAbstract_a10b838d-bc56-4853-999e-5a4d98ffa72f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments purchased or originated:</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestmentsAbstract" xlink:to="lab_us-gaap_PaymentsToAcquireInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_86280694-d331-41bf-93e0-f1d9de26f5b9_totalLabel_en-US" xlink:label="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal, including held for sale assets</link:label>
    <link:label id="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Assets Classified In Fair Value Hierarchy Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The fair value of the assets held by the Entity for the benefit of separate account policyholders classified in the fair value hierarchy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemGainLossFromContractAdjustmentNetOfTax_ff073bf6-b3dd-4677-aad8-9c04b167cf5c_negatedLabel_en-US" xlink:label="lab_ci_SpecialItemGainLossFromContractAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual adjustment for a former client (Pharmacy revenues)</link:label>
    <link:label id="lab_ci_SpecialItemGainLossFromContractAdjustmentNetOfTax_label_en-US" xlink:label="lab_ci_SpecialItemGainLossFromContractAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item, Gain (Loss) From Contract Adjustment, Net Of Tax</link:label>
    <link:label id="lab_ci_SpecialItemGainLossFromContractAdjustmentNetOfTax_documentation_en-US" xlink:label="lab_ci_SpecialItemGainLossFromContractAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item, Gain (Loss) From Contract Adjustment, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossFromContractAdjustmentNetOfTax" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossFromContractAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemGainLossFromContractAdjustmentNetOfTax" xlink:to="lab_ci_SpecialItemGainLossFromContractAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_9c07dd56-2fc6-4c11-b215-cfa36dd99c38_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payments</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_afd391b9-043b-4892-9ee0-b8700ed0598a_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability_e06b7dcc-9dcf-480a-b9f0-0983676977e4_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefit, excluding DPL</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Excluding Deferred Profit Liability</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Excluding Deferred Profit Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ExpressScriptsCounterclaimsAgainstElevanceMember_0952c083-e976-415f-b9c4-865898448fff_terseLabel_en-US" xlink:label="lab_ci_ExpressScriptsCounterclaimsAgainstElevanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Express Scripts counterclaims against Elevance</link:label>
    <link:label id="lab_ci_ExpressScriptsCounterclaimsAgainstElevanceMember_label_en-US" xlink:label="lab_ci_ExpressScriptsCounterclaimsAgainstElevanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Express Scripts Counterclaims Against Elevance [Member]</link:label>
    <link:label id="lab_ci_ExpressScriptsCounterclaimsAgainstElevanceMember_documentation_en-US" xlink:label="lab_ci_ExpressScriptsCounterclaimsAgainstElevanceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Express Scripts Counterclaims Against Elevance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ExpressScriptsCounterclaimsAgainstElevanceMember" xlink:href="ci-20230331.xsd#ci_ExpressScriptsCounterclaimsAgainstElevanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ExpressScriptsCounterclaimsAgainstElevanceMember" xlink:to="lab_ci_ExpressScriptsCounterclaimsAgainstElevanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CompletionFactorsMember_17a8b41c-de84-4fc9-bdf1-d2924b554134_terseLabel_en-US" xlink:label="lab_ci_CompletionFactorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual completion factors</link:label>
    <link:label id="lab_ci_CompletionFactorsMember_label_en-US" xlink:label="lab_ci_CompletionFactorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completion Factors [Member]</link:label>
    <link:label id="lab_ci_CompletionFactorsMember_documentation_en-US" xlink:label="lab_ci_CompletionFactorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts relating to actual claims emerging differently from assumptions about claim payment speed used to set reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CompletionFactorsMember" xlink:href="ci-20230331.xsd#ci_CompletionFactorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CompletionFactorsMember" xlink:to="lab_ci_CompletionFactorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_951be3c7-89d5-4ccb-9c8c-2686df9218d3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnearnedPremiums_e5d6a975-d49f-4b1b-9218-545cfc034553_totalLabel_en-US" xlink:label="lab_us-gaap_UnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned premiums</link:label>
    <link:label id="lab_us-gaap_UnearnedPremiums_label_en-US" xlink:label="lab_us-gaap_UnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnearnedPremiums" xlink:to="lab_us-gaap_UnearnedPremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember_7b1fb1a5-d600-4601-9368-8d68e7d2543f_terseLabel_en-US" xlink:label="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities and Derivatives</link:label>
    <link:label id="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember_label_en-US" xlink:label="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-For-Sale And Derivatives, Parent [Member]</link:label>
    <link:label id="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember_documentation_en-US" xlink:label="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-For-Sale And Derivatives, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember" xlink:href="ci-20230331.xsd#ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember" xlink:to="lab_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_8248b18e-bd5b-4c8c-accc-d0fca3faf768_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_01c91757-d4a6-40b8-95f8-b6bf0896a1e5_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amounts reclassified from AOCI to net income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue2023765InterestMember_203a2e91-60bf-4151-b1da-d2f7188cecfc_terseLabel_en-US" xlink:label="lab_ci_NotesDue2023765InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$63&#160;million, 7.65% Notes due March 2023</link:label>
    <link:label id="lab_ci_NotesDue2023765InterestMember_label_en-US" xlink:label="lab_ci_NotesDue2023765InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes due 2023 7.65% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue2023765InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue2023765InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable bearing interest at 7.65% due in 2023.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2023765InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue2023765InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue2023765InterestMember" xlink:to="lab_ci_NotesDue2023765InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear_ef7a0a07-c129-4ce3-a521-1cd06f1cecd8_terseLabel_en-US" xlink:label="lab_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded commitments, percentage expected to fund in next fiscal year</link:label>
    <link:label id="lab_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear_label_en-US" xlink:label="lab_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded Commitments, Percentage Expected To Fund In Next Fiscal Year</link:label>
    <link:label id="lab_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear_documentation_en-US" xlink:label="lab_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded Commitments, Percentage Expected To Fund In Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear" xlink:href="ci-20230331.xsd#ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear" xlink:to="lab_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_de1dc111-a594-4830-8d44-ec7b16f119f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Total Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_7b0ce310-8278-488b-9150-8aa0585a6cc5_totalLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_0d4566b6-994c-4a84-a16d-53d210ec5ea0_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_c90d1175-f5e9-4441-ace7-86efc4ca8f0b_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_8da8395d-1fda-4597-aa13-d4fcef081db1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue202383InterestMember_1016ba4a-029e-4e55-a553-948023ab700a_terseLabel_en-US" xlink:label="lab_ci_NotesDue202383InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$17&#160;million, 8.3% Notes due January 2023</link:label>
    <link:label id="lab_ci_NotesDue202383InterestMember_label_en-US" xlink:label="lab_ci_NotesDue202383InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2023, 8.3% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue202383InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue202383InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable bearing interest at 8.3% due in 2023.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue202383InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue202383InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue202383InterestMember" xlink:to="lab_ci_NotesDue202383InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherPharmacyMember_b2f3c2e2-c923-4112-813d-d23aac21f899_terseLabel_en-US" xlink:label="lab_ci_OtherPharmacyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_ci_OtherPharmacyMember_label_en-US" xlink:label="lab_ci_OtherPharmacyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Pharmacy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherPharmacyMember" xlink:href="ci-20230331.xsd#ci_OtherPharmacyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherPharmacyMember" xlink:to="lab_ci_OtherPharmacyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_8ecd6d07-a3b5-4ef5-aae0-fe9687272409_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_Ltv60To79PercentMember_0b925808-4788-49b9-ba87-c8eb80a2ae33_terseLabel_en-US" xlink:label="lab_ci_Ltv60To79PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">60% to 79%</link:label>
    <link:label id="lab_ci_Ltv60To79PercentMember_label_en-US" xlink:label="lab_ci_Ltv60To79PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTV 60 to 79 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_Ltv60To79PercentMember" xlink:href="ci-20230331.xsd#ci_Ltv60To79PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_Ltv60To79PercentMember" xlink:to="lab_ci_Ltv60To79PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue_34b8561e-381a-4a13-a3be-ea6ccd9a8c82_terseLabel_en-US" xlink:label="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Account value</link:label>
    <link:label id="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue_label_en-US" xlink:label="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount at Risk by Product and Guarantee, General Account Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue" xlink:to="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement_351658bf-78b3-4ff6-8937-6e835e2853ed_terseLabel_en-US" xlink:label="lab_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of participating banks</link:label>
    <link:label id="lab_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement_label_en-US" xlink:label="lab_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Banks Participating In Revolving Credit And Letter Of Credit Agreement</link:label>
    <link:label id="lab_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement_documentation_en-US" xlink:label="lab_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of banks participating in revolving credit and letter of credit agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement" xlink:href="ci-20230331.xsd#ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement" xlink:to="lab_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketRiskBenefitActivityTableTextBlock_2e5a4594-8a58-491a-84aa-7701d3a5d370_terseLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Market Risk Benefit</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitActivityTableTextBlock_ffcb33f2-c4f5-4add-84d9-ef42777c478b_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables for Variable Annuity Business</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketRiskBenefitActivityTableTextBlock" xlink:to="lab_us-gaap_MarketRiskBenefitActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_7fde64d0-5bc0-4728-838c-6247584c2297_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity_3a950587-a324-4516-ad0b-99746cf51f24_negatedTotalLabel_en-US" xlink:label="lab_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total impact from special items</link:label>
    <link:label id="lab_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity_label_en-US" xlink:label="lab_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item Gain Or Loss Net Of Tax Attributable To Reportng Entity</link:label>
    <link:label id="lab_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity_documentation_en-US" xlink:label="lab_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sum of after-tax amounts classified as special items, attributable to the parent. Special items are excluded from the calculation of 'adjusted income (loss) from operations' because management believes they are not representative of the underlying results of operations. This is generally because the nature and size of these matters are not indicative of our ongoing business operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity" xlink:href="ci-20230331.xsd#ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity" xlink:to="lab_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ExpressScriptsLitigationWithAnthemMember_36f852c9-0e3d-4bd6-a861-010f38663ace_terseLabel_en-US" xlink:label="lab_ci_ExpressScriptsLitigationWithAnthemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Express Scripts Litigation with Elevance</link:label>
    <link:label id="lab_ci_ExpressScriptsLitigationWithAnthemMember_label_en-US" xlink:label="lab_ci_ExpressScriptsLitigationWithAnthemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Express Scripts Litigation With Anthem [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ExpressScriptsLitigationWithAnthemMember" xlink:href="ci-20230331.xsd#ci_ExpressScriptsLitigationWithAnthemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ExpressScriptsLitigationWithAnthemMember" xlink:to="lab_ci_ExpressScriptsLitigationWithAnthemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f9d05d8f-5678-4be5-a602-11222c83fd04_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_0d26c9f8-58ec-44dc-bc2d-0baf840da36f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OrganizationalEfficiencyPlanChargesNetOfTax_b66dcae0-3050-49d8-9da8-36a4b8997a0c_terseLabel_en-US" xlink:label="lab_ci_OrganizationalEfficiencyPlanChargesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge for organizational efficiency plan, 2020 (Selling, general and administrative expenses)</link:label>
    <link:label id="lab_ci_OrganizationalEfficiencyPlanChargesNetOfTax_label_en-US" xlink:label="lab_ci_OrganizationalEfficiencyPlanChargesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Efficiency Plan Charges, Net Of Tax</link:label>
    <link:label id="lab_ci_OrganizationalEfficiencyPlanChargesNetOfTax_documentation_en-US" xlink:label="lab_ci_OrganizationalEfficiencyPlanChargesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Efficiency Plan Charges, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OrganizationalEfficiencyPlanChargesNetOfTax" xlink:href="ci-20230331.xsd#ci_OrganizationalEfficiencyPlanChargesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OrganizationalEfficiencyPlanChargesNetOfTax" xlink:to="lab_ci_OrganizationalEfficiencyPlanChargesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue20254125InterestMember_fd804d82-d21e-4550-8fb5-91fcb7732c81_terseLabel_en-US" xlink:label="lab_ci_NotesDue20254125InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200&#160;million, 4.125% Notes due November 2025</link:label>
    <link:label id="lab_ci_NotesDue20254125InterestMember_label_en-US" xlink:label="lab_ci_NotesDue20254125InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2025, 4.125% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue20254125InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue20254125InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable bearing interest at 4.125% due in 2025. Debt issued to finance acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20254125InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue20254125InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue20254125InterestMember" xlink:to="lab_ci_NotesDue20254125InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_StopLossMember_a3d9e9dd-8c68-43e7-8b1e-d6eb153851b8_terseLabel_en-US" xlink:label="lab_ci_StopLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stop loss</link:label>
    <link:label id="lab_ci_StopLossMember_label_en-US" xlink:label="lab_ci_StopLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stop Loss [Member]</link:label>
    <link:label id="lab_ci_StopLossMember_documentation_en-US" xlink:label="lab_ci_StopLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An insurance product that provides additional coverage on Administrative Services Only plans that provides reimbursement for claims in excess of a predetermined amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_StopLossMember" xlink:href="ci-20230331.xsd#ci_StopLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_StopLossMember" xlink:to="lab_ci_StopLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent_5ef836ad-f251-4a43-a275-8f3ff51a780c_negatedLabel_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate account assets of business classified as held for sale</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent_label_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Separate Account Assets, Current</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent_documentation_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Separate Account Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent" xlink:to="lab_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketRiskBenefitRollForward_e8538e7b-e6fa-4b6a-b85a-e44abacf1eaf_terseLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitRollForward_label_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketRiskBenefitRollForward" xlink:to="lab_us-gaap_MarketRiskBenefitRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bd78bc25-6a05-4d62-991d-3cb2b9e6ce22_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_8e743e8a-0a4e-4650-95bc-6fcbca0922fe_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock_f66c47b6-dec5-4721-a346-d1233fd724b8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Information on Separate Account Assets Priced at NAV</link:label>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock" xlink:to="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member_0c614091-93df-473b-ab52-ea0b9c6c461c_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member" xlink:to="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_f2a478eb-529f-4353-ba5e-5e27200ffd38_terseLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Issues, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities In Unrealized Loss Positions, Qualitative Disclosure, Twelve Months Or Longer, Number Of Positions, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities In Unrealized Loss Positions, Qualitative Disclosure, Twelve Months Or Longer, Number Of Positions, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PolicyholderContractDepositsAttributableToDisposalGroups_9a8a31e1-035e-47c3-a041-24a3fbbff41e_terseLabel_en-US" xlink:label="lab_ci_PolicyholderContractDepositsAttributableToDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractholder deposit funds classified as liabilities of business held for sale</link:label>
    <link:label id="lab_ci_PolicyholderContractDepositsAttributableToDisposalGroups_label_en-US" xlink:label="lab_ci_PolicyholderContractDepositsAttributableToDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Contract Deposits Attributable To Disposal Groups</link:label>
    <link:label id="lab_ci_PolicyholderContractDepositsAttributableToDisposalGroups_documentation_en-US" xlink:label="lab_ci_PolicyholderContractDepositsAttributableToDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Contract Deposits Attributable To Disposal Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositsAttributableToDisposalGroups" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositsAttributableToDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PolicyholderContractDepositsAttributableToDisposalGroups" xlink:to="lab_ci_PolicyholderContractDepositsAttributableToDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_93a55a5d-4891-4f24-9f09-ce2a9eee03e8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_cc1f4e92-72f4-4eeb-83cb-9ccd4cfe9dd7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities_8cd1369d-05bf-4b7b-a3ef-79e7ce4bbd22_negatedLabel_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and contractholder liabilities classified as held for sale</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities_label_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Current Insurance And Contractholder Liabilities</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities_documentation_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Current Insurance And Contractholder Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities" xlink:to="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_a595d6e9-995b-4e5c-97fc-eb3a312fa719_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees</link:label>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_label_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:to="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_52902485-87a3-4cce-92dc-30bc2a4797d4_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_dab9fd60-723c-48ab-8ea7-638084cd690e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_c852c5b2-3429-4dab-b901-8da01776db8d_terseLabel_en-US" xlink:label="lab_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturers receivable, including held for sale assets</link:label>
    <link:label id="lab_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0664810d-b9ce-4625-bc72-3435071e780d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_d7854fd0-fdbd-415a-8fe5-99fce22de44e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_837637f5-7736-4183-92b5-86cbb2f61222_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period Of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemsAfterTaxAbstract_eb08e156-7b2c-4518-acb3-8ea35a49330a_terseLabel_en-US" xlink:label="lab_ci_SpecialItemsAfterTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax</link:label>
    <link:label id="lab_ci_SpecialItemsAfterTaxAbstract_label_en-US" xlink:label="lab_ci_SpecialItemsAfterTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Items After Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemsAfterTaxAbstract" xlink:href="ci-20230331.xsd#ci_SpecialItemsAfterTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemsAfterTaxAbstract" xlink:to="lab_ci_SpecialItemsAfterTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_840fd134-a416-4f99-be27-e8e26ac9affd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_133f9786-a1e8-43b7-9bfe-e93da21a5748_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_label_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable" xlink:to="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent_94c013d4-ff4b-4d39-b9d3-0d292e87c97a_negatedLabel_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments classified as assets of business held for sale</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent_label_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Noncurrent Investments Current</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent_documentation_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Noncurrent Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent" xlink:to="lab_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PrudentialInsuranceCompanyOfAmericaMember_b75a2b07-124e-411a-a724-10cf37edba5b_terseLabel_en-US" xlink:label="lab_ci_PrudentialInsuranceCompanyOfAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prudential Insurance Company of America</link:label>
    <link:label id="lab_ci_PrudentialInsuranceCompanyOfAmericaMember_label_en-US" xlink:label="lab_ci_PrudentialInsuranceCompanyOfAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prudential Insurance Company Of America [Member]</link:label>
    <link:label id="lab_ci_PrudentialInsuranceCompanyOfAmericaMember_documentation_en-US" xlink:label="lab_ci_PrudentialInsuranceCompanyOfAmericaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prudential Insurance Company Of America</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PrudentialInsuranceCompanyOfAmericaMember" xlink:href="ci-20230331.xsd#ci_PrudentialInsuranceCompanyOfAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PrudentialInsuranceCompanyOfAmericaMember" xlink:to="lab_ci_PrudentialInsuranceCompanyOfAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy_5b447f0d-5c95-4e02-889d-26c0e36bdae4_terseLabel_en-US" xlink:label="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-guaranteed separate accounts</link:label>
    <link:label id="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy_label_en-US" xlink:label="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy</link:label>
    <link:label id="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy_documentation_en-US" xlink:label="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The fair value of the assets held by the Entity for the benefit of separate account policyholders without guarantees classified in the fair value hierarchy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" xlink:to="lab_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_d742005a-9788-4d97-a549-1472cc9b00ab_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_8ea64c2a-4752-405e-ae29-d5c4aa16f7cd_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount at risk</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Net Amount at Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceNetAmountAtRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:to="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c01675c5-8a18-4b65-a6d7-f513e786f247_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_4ba9050f-37c8-400a-894b-261483a48bd5_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_98f8e598-3b0a-49a6-a0a1-fca116c7ff89_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NetworkPharmacyMember_80280de5-3725-43a2-b2ff-4a89360d7272_terseLabel_en-US" xlink:label="lab_ci_NetworkPharmacyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Network revenues</link:label>
    <link:label id="lab_ci_NetworkPharmacyMember_label_en-US" xlink:label="lab_ci_NetworkPharmacyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Network Pharmacy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NetworkPharmacyMember" xlink:href="ci-20230331.xsd#ci_NetworkPharmacyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NetworkPharmacyMember" xlink:to="lab_ci_NetworkPharmacyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_d59148c3-2221-4b06-91bc-230f6c6a2e04_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local government</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember_37791168-5515-4168-9488-761728422770_terseLabel_en-US" xlink:label="lab_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-duration (Individual Medicare supplement and limited benefit health products)</link:label>
    <link:label id="lab_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember_label_en-US" xlink:label="lab_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Medicare Supplement And Limited Benefit Health Products, Long-Duration [Member]</link:label>
    <link:label id="lab_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember_documentation_en-US" xlink:label="lab_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Medicare Supplement And Limited Benefit Health Products, Long-Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember" xlink:href="ci-20230331.xsd#ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember" xlink:to="lab_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_b58ff953-fa59-4d5f-9dcb-54a002815d73_terseLabel_en-US" xlink:label="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount at Risk by Product and Guarantee [Line Items]</link:label>
    <link:label id="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_label_en-US" xlink:label="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount at Risk by Product and Guarantee [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems" xlink:to="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderContractDeposits_9201c69b-465a-4ea7-baa9-21e7d801aa1f_totalLabel_en-US" xlink:label="lab_us-gaap_PolicyholderContractDeposits" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractholder deposit funds</link:label>
    <link:label id="lab_us-gaap_PolicyholderContractDeposits_043b5992-1b39-40b7-80eb-9a14a62436c0_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderContractDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractholder deposit funds</link:label>
    <link:label id="lab_us-gaap_PolicyholderContractDeposits_label_en-US" xlink:label="lab_us-gaap_PolicyholderContractDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Contract Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderContractDeposits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderContractDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderContractDeposits" xlink:to="lab_us-gaap_PolicyholderContractDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_cd74cb11-f2b0-4659-936c-8669e881b99b_terseLabel_en-US" xlink:label="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International life, accident and supplemental benefits businesses</link:label>
    <link:label id="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_label_en-US" xlink:label="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Life Accident Supplemental Benefits Businesses [Member]</link:label>
    <link:label id="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_documentation_en-US" xlink:label="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life, accident and supplemental benefits businesses in Hong Kong, Indonesia, New Zealand, South Korea, Taiwan, Thailand and interest in a joint venture in Turkey.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember" xlink:href="ci-20230331.xsd#ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember" xlink:to="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_ccafede4-728d-4b7f-93bd-7cd62ea7a79c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketRiskBenefitLiabilityAmount_bad73081-8a89-4db3-9b58-f757952599cb_totalLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitLiabilityAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market risk benfits</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitLiabilityAmount_label_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitLiabilityAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Liability, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitLiabilityAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitLiabilityAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketRiskBenefitLiabilityAmount" xlink:to="lab_us-gaap_MarketRiskBenefitLiabilityAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_TransactionRelatedCostsAfterTax_32ba4cb8-5be8-49b8-b2f1-73b4ae122711_verboseLabel_en-US" xlink:label="lab_ci_TransactionRelatedCostsAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration and transaction-related costs, after-tax</link:label>
    <link:label id="lab_ci_TransactionRelatedCostsAfterTax_1feb42c7-0d48-4cf3-b4b8-6eb32bf8a36c_terseLabel_en-US" xlink:label="lab_ci_TransactionRelatedCostsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration and transaction-related costs, after-tax</link:label>
    <link:label id="lab_ci_TransactionRelatedCostsAfterTax_label_en-US" xlink:label="lab_ci_TransactionRelatedCostsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Related Costs After Tax</link:label>
    <link:label id="lab_ci_TransactionRelatedCostsAfterTax_documentation_en-US" xlink:label="lab_ci_TransactionRelatedCostsAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax transaction-related costs including the impact of tax benefits realized from termination of merger agreement. Transaction-related costs consist primarily of fees for legal, advisory and other professional services as well as employee costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TransactionRelatedCostsAfterTax" xlink:href="ci-20230331.xsd#ci_TransactionRelatedCostsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_TransactionRelatedCostsAfterTax" xlink:to="lab_ci_TransactionRelatedCostsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating_dbf96316-3506-4cd7-bec3-5cd7d0681542_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranteed minimum credit rating</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Guaranteed Minimum Credit Rating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating" xlink:to="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_bfc77cc3-8808-4c61-9dc7-a2ef963c1251_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes_8f7c4209-8d05-4fef-9827-c55c94e1ee6f_negatedLabel_en-US" xlink:label="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk corridors recovery (Selling, general and administrative expenses)</link:label>
    <link:label id="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes_a60c1e69-cf5c-49f8-8f43-ee1f0dfcb9ce_negatedTerseLabel_en-US" xlink:label="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk corridors recovery</link:label>
    <link:label id="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes_label_en-US" xlink:label="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item, Gain (Loss) On Risk Corridor Allowance Adjustment, Before Taxes</link:label>
    <link:label id="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes_documentation_en-US" xlink:label="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item, Gain (Loss) On Risk Corridor Allowance Adjustment, Before Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes" xlink:to="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_f2a3b426-2220-4085-b748-dd952c3fa7d3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_d3f9dfdd-5c86-4f68-ad78-d96be1481b3b_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherOperationsSegmentMember_0bd4ac5d-d4b5-4be6-9388-d08764a52f05_terseLabel_en-US" xlink:label="lab_ci_OtherOperationsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operations</link:label>
    <link:label id="lab_ci_OtherOperationsSegmentMember_label_en-US" xlink:label="lab_ci_OtherOperationsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operations Segment [Member]</link:label>
    <link:label id="lab_ci_OtherOperationsSegmentMember_documentation_en-US" xlink:label="lab_ci_OtherOperationsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operations Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherOperationsSegmentMember" xlink:to="lab_ci_OtherOperationsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_e345665d-3905-4da3-b468-278cb6b7b85f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undiscounted expected future policy benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_bf859266-bbc9-4264-b75c-eb206a78789e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts and Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SupplierFinanceProgramObligationCurrent_4bc20e16-7643-4294-82cd-da0275ca001b_terseLabel_en-US" xlink:label="lab_ci_SupplierFinanceProgramObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding payment obligations, current</link:label>
    <link:label id="lab_ci_SupplierFinanceProgramObligationCurrent_label_en-US" xlink:label="lab_ci_SupplierFinanceProgramObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program, Obligation, Current</link:label>
    <link:label id="lab_ci_SupplierFinanceProgramObligationCurrent_documentation_en-US" xlink:label="lab_ci_SupplierFinanceProgramObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program, Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SupplierFinanceProgramObligationCurrent" xlink:href="ci-20230331.xsd#ci_SupplierFinanceProgramObligationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SupplierFinanceProgramObligationCurrent" xlink:to="lab_ci_SupplierFinanceProgramObligationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_3767ed2b-a29e-44df-aded-888444e389b2_negatedLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Depreciation, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Ltv80To100PercentMember_bac1a771-ecc2-4ce0-b8bc-60c3fd695692_terseLabel_en-US" xlink:label="lab_us-gaap_Ltv80To100PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">80% to 100%</link:label>
    <link:label id="lab_us-gaap_Ltv80To100PercentMember_label_en-US" xlink:label="lab_us-gaap_Ltv80To100PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt-to-Value Ratio, 80 to 100 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Ltv80To100PercentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Ltv80To100PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Ltv80To100PercentMember" xlink:to="lab_us-gaap_Ltv80To100PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fcaaedcf-4bc8-4090-b827-3772a590158d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbf2c444-185d-4b19-9082-39ff5ec56247_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH PROVIDED BY OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_aeab478b-20a4-4c51-ac29-cc60d143c079_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax_91a1f877-1d3c-4f1c-a53d-4c4513cde77a_terseLabel_en-US" xlink:label="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sale of business, after-tax</link:label>
    <link:label id="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax_label_en-US" xlink:label="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Net Of Tax</link:label>
    <link:label id="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax_documentation_en-US" xlink:label="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax" xlink:href="ci-20230331.xsd#ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax" xlink:to="lab_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_bffab444-5152-4645-a4c8-5d86258b7839_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Incurred and Paid Claims Development, Claims Frequency Metrics and Incurred but Not Yet Reported Liabilities</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Claims Development [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceCustomerReceivables_fef80b48-3101-4cc0-985c-228f266a7ab6_terseLabel_en-US" xlink:label="lab_ci_InsuranceCustomerReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance customer receivables</link:label>
    <link:label id="lab_ci_InsuranceCustomerReceivables_label_en-US" xlink:label="lab_ci_InsuranceCustomerReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Customer Receivables</link:label>
    <link:label id="lab_ci_InsuranceCustomerReceivables_documentation_en-US" xlink:label="lab_ci_InsuranceCustomerReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables due from customers under insurance contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceCustomerReceivables" xlink:href="ci-20230331.xsd#ci_InsuranceCustomerReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceCustomerReceivables" xlink:to="lab_ci_InsuranceCustomerReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss_edd55b70-cabd-4cf6-9f66-1356648eaea8_terseLabel_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized gain or (loss) included in Other comprehensive loss for assets held at the end of the reporting period</link:label>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included In Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss_documentation_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included In Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_92380fc4-1ea9-48fd-9e65-f88eeda0392a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_4389cb41-81e7-4b6f-8578-6fc495a63531_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMortgageNotesReceivable_92982b80-fa05-4822-8d74-515a8c7c7643_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMortgageNotesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage loans</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMortgageNotesReceivable_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMortgageNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Mortgage Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMortgageNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMortgageNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMortgageNotesReceivable" xlink:to="lab_us-gaap_PaymentsToAcquireMortgageNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy_bc160d34-0a68-4836-915d-2a9dda5073f6_totalLabel_en-US" xlink:label="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy_label_en-US" xlink:label="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Assets Classified In Fair Value Hierarchy</link:label>
    <link:label id="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy_documentation_en-US" xlink:label="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The fair value of the assets held by the Entity for the benefit of separate account policyholders classified in the fair value hierarchy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsClassifiedInFairValueHierarchy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy" xlink:to="lab_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_034e20cd-0cda-480e-b2ee-7e7002341f9d_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Net</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities_7cd567c6-13c4-4944-983e-10ef804f92a9_terseLabel_en-US" xlink:label="lab_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and Accrued expenses and other liabilities</link:label>
    <link:label id="lab_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities</link:label>
    <link:label id="lab_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities_documentation_en-US" xlink:label="lab_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in the aggregate amount of accounts payable, accrued liabilities and other operating obligations not separately disclosed in the statement of cash flows.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities" xlink:href="ci-20230331.xsd#ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities" xlink:to="lab_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_31d6d145-a6a1-4498-af16-b792919b3e98_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Issued, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesIndustryMember_8a6f8350-4ac7-42db-a8fc-03425b13ac07_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesIndustryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industry Sector [Domain]</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesIndustryMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesIndustryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industry Sector [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember" xlink:to="lab_us-gaap_EquitySecuritiesIndustryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_19b508cb-3345-4353-a2e8-29aef8022f3c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_56f87de2-17c4-4581-bf5d-da312b882c97_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_6cdf45ee-97bf-49e7-8f2b-a9387d0d5369_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum exposure to loss, variable interest entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected_3ee65c2f-01c8-447c-8012-fbf1c719723c_terseLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes due to policyholder behavior versus expected</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected_label_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Increase (Decrease) from Actual Policyholder Behavior Different from Expected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected" xlink:to="lab_us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3da70bf1-18fe-44ae-ac86-ef8d40646a36_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_1703eea1-28d3-4675-859f-3e63cb4c3cf5_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue202435InterestMember_59351c03-0472-462f-96ab-009cd3815fc7_terseLabel_en-US" xlink:label="lab_ci_NotesDue202435InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,000&#160;million, 3.500% Notes due June 2024</link:label>
    <link:label id="lab_ci_NotesDue202435InterestMember_label_en-US" xlink:label="lab_ci_NotesDue202435InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2024 3.5% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue202435InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue202435InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable bearing interest at 3.5% due in 2024. Debt assumed acquisition from Express Scripts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue202435InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue202435InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue202435InterestMember" xlink:to="lab_ci_NotesDue202435InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_06f033a9-ca2f-46e2-b73d-de3836f2888a_terseLabel_en-US" xlink:label="lab_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, including held for sale assets</link:label>
    <link:label id="lab_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_c5e7016f-7cc8-4007-bc26-85ff18e6637a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RestructuringChargesNetOfTaxExpense_9ffdf487-c0a1-4e00-97df-11ce943278ff_terseLabel_en-US" xlink:label="lab_ci_RestructuringChargesNetOfTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge for organizational efficiency plan (Selling, general and administrative expenses)</link:label>
    <link:label id="lab_ci_RestructuringChargesNetOfTaxExpense_label_en-US" xlink:label="lab_ci_RestructuringChargesNetOfTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Net Of Tax Expense</link:label>
    <link:label id="lab_ci_RestructuringChargesNetOfTaxExpense_documentation_en-US" xlink:label="lab_ci_RestructuringChargesNetOfTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Net Of Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RestructuringChargesNetOfTaxExpense" xlink:href="ci-20230331.xsd#ci_RestructuringChargesNetOfTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RestructuringChargesNetOfTaxExpense" xlink:to="lab_ci_RestructuringChargesNetOfTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_UnearnedPremiumsNoncurrent_2adc68c3-6e25-4497-9b9b-6301bc42b77c_terseLabel_en-US" xlink:label="lab_ci_UnearnedPremiumsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned premiums, noncurrent</link:label>
    <link:label id="lab_ci_UnearnedPremiumsNoncurrent_label_en-US" xlink:label="lab_ci_UnearnedPremiumsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums, Noncurrent</link:label>
    <link:label id="lab_ci_UnearnedPremiumsNoncurrent_documentation_en-US" xlink:label="lab_ci_UnearnedPremiumsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsNoncurrent" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_UnearnedPremiumsNoncurrent" xlink:to="lab_ci_UnearnedPremiumsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskLineItems_dbc0bc70-c88f-4278-943c-ce8571b38261_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskLineItems_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskLineItems" xlink:to="lab_us-gaap_CededCreditRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups_e2458ceb-c707-4c7b-9f42-bc443c02cb9f_terseLabel_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid claims and claim expenses, including held for sale liabilities</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Claims And Claims Adjustment Expense Including Disposal Groups</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Claims And Claims Adjustment Expense Including Disposal Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups" xlink:to="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_21d04226-fc77-409a-8041-553cc96c398e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_738bf24a-beab-476e-a9ae-d516118b82c2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EarningsPerShareEffectOfDilution_dfabff7d-02e7-4e7d-8911-5f48fec8e70d_terseLabel_en-US" xlink:label="lab_ci_EarningsPerShareEffectOfDilution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPS, effect of dilution (in dollars per share)</link:label>
    <link:label id="lab_ci_EarningsPerShareEffectOfDilution_label_en-US" xlink:label="lab_ci_EarningsPerShareEffectOfDilution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Effect Of Dilution</link:label>
    <link:label id="lab_ci_EarningsPerShareEffectOfDilution_documentation_en-US" xlink:label="lab_ci_EarningsPerShareEffectOfDilution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The decrease in net income (loss) on a per share basis when the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period is assumed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EarningsPerShareEffectOfDilution" xlink:href="ci-20230331.xsd#ci_EarningsPerShareEffectOfDilution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EarningsPerShareEffectOfDilution" xlink:to="lab_ci_EarningsPerShareEffectOfDilution" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_26b567be-f786-42cf-ae96-9d02485d47c1_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue202734InterestMember_cecb2d7c-d131-4de8-8f52-1213ecf0b0d9_terseLabel_en-US" xlink:label="lab_ci_NotesDue202734InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,500&#160;million, 3.400% Notes due March 2027</link:label>
    <link:label id="lab_ci_NotesDue202734InterestMember_label_en-US" xlink:label="lab_ci_NotesDue202734InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2027, 3.4% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue202734InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue202734InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable bearing interest at 3.4% due in 2027. Debt assumed acquisition from Express Scripts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue202734InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue202734InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue202734InterestMember" xlink:to="lab_ci_NotesDue202734InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1da0d50c-fe39-4245-accf-eec1ff3f7139_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_51e09800-edb1-4625-a610-fd49cc4880d2_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_34e95273-3009-4ef4-8107-03f26dfa99bf_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Investment Income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeTextBlock" xlink:to="lab_us-gaap_InvestmentIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NoncontrollingInterestOtherChanges_e2235872-5929-4c1f-b5a3-181c99175ecf_verboseLabel_en-US" xlink:label="lab_ci_NoncontrollingInterestOtherChanges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other transactions impacting noncontrolling interests</link:label>
    <link:label id="lab_ci_NoncontrollingInterestOtherChanges_label_en-US" xlink:label="lab_ci_NoncontrollingInterestOtherChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Other Changes</link:label>
    <link:label id="lab_ci_NoncontrollingInterestOtherChanges_documentation_en-US" xlink:label="lab_ci_NoncontrollingInterestOtherChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other activity associated with noncontrolling interest that is not separately disclosed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NoncontrollingInterestOtherChanges" xlink:href="ci-20230331.xsd#ci_NoncontrollingInterestOtherChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NoncontrollingInterestOtherChanges" xlink:to="lab_ci_NoncontrollingInterestOtherChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskUnsecuredMember_af50a3f0-d4c0-4a1c-8cbb-d5b62b3ac756_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskUnsecuredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No collateral</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskUnsecuredMember_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskUnsecuredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Unsecured [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskUnsecuredMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskUnsecuredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskUnsecuredMember" xlink:to="lab_us-gaap_CededCreditRiskUnsecuredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_32ccb460-0f31-4d25-950a-769379ed69f7_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemChargeBenefitAfterTaxLitigation_dee5f7f0-24c7-4907-a273-1f13f83cd5f7_verboseLabel_en-US" xlink:label="lab_ci_SpecialItemChargeBenefitAfterTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Benefits) charges associated with litigation matters (Selling, general and administrative expenses)</link:label>
    <link:label id="lab_ci_SpecialItemChargeBenefitAfterTaxLitigation_label_en-US" xlink:label="lab_ci_SpecialItemChargeBenefitAfterTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item Charge (Benefit) After Tax Litigation</link:label>
    <link:label id="lab_ci_SpecialItemChargeBenefitAfterTaxLitigation_documentation_en-US" xlink:label="lab_ci_SpecialItemChargeBenefitAfterTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax charges associated with litigation matters that are classified as special items, attributable to the parent. Special items reflect amounts that management does not believe are representative of underlying results of operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemChargeBenefitAfterTaxLitigation" xlink:href="ci-20230331.xsd#ci_SpecialItemChargeBenefitAfterTaxLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemChargeBenefitAfterTaxLitigation" xlink:to="lab_ci_SpecialItemChargeBenefitAfterTaxLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_9bac93eb-f138-450c-afb1-d28d748b6c82_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage_2f09d9db-91c4-4849-8c78-aa48c59346d4_terseLabel_en-US" xlink:label="lab_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Favorable (unfavorable) variance, percentage</link:label>
    <link:label id="lab_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage_label_en-US" xlink:label="lab_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Medical Claims And Claims Adjustment Expense Incurred Claims Prior Years Percentage</link:label>
    <link:label id="lab_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage_documentation_en-US" xlink:label="lab_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of payments made in the reporting period to settle claims incurred in prior periods and related claims settlement costs as a percentage of incurred claims as reported in the prior year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" xlink:href="ci-20230331.xsd#ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" xlink:to="lab_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilities_94e22e60-6faa-4129-a2f0-b01f7339f944_totalLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total insurance and contractholder liabilities</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilities_label_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilities_documentation_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilities" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceAndContractholderLiabilities" xlink:to="lab_ci_InsuranceAndContractholderLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_032f487b-dcde-4dd9-b21b-3b74ee2948ec_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_304c83dd-86fe-47be-8a34-35a113bd74bc_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax_2d47dd34-3ef6-412d-abf8-8d3979467a08_terseLabel_en-US" xlink:label="lab_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment costs</link:label>
    <link:label id="lab_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax_label_en-US" xlink:label="lab_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item Charges Debt Extinguishment Costs Before Tax</link:label>
    <link:label id="lab_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax_documentation_en-US" xlink:label="lab_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item Charges Debt Extinguishment Costs Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax" xlink:href="ci-20230331.xsd#ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax" xlink:to="lab_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_782ce8fd-7ac2-4a58-be0e-cea103085ea4_terseLabel_en-US" xlink:label="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noninsurance customer receivables, including held for sale assets</link:label>
    <link:label id="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssets_00dc1355-3888-4103-98ba-cc0846ddd0ba_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate account assets</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssets_bfdfdec2-52e4-440a-80a8-7ea4213b7a9b_totalLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate account assets</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssets_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssets" xlink:to="lab_us-gaap_SeparateAccountAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_7a17f660-6a9a-4435-8327-646379df8f21_terseLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Issues, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities In Unrealized Loss Positions, Qualitative Disclosure, Less Than 12 Months, Number Of Positions, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities In Unrealized Loss Positions, Qualitative Disclosure, Less Than 12 Months, Number Of Positions, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4ce9f2aa-2f5b-4ed4-ac4a-998f1726af0c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in the Components of AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f37ef700-08c4-4ad2-b027-fe72c484213f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_d805cc5a-38f5-492c-a264-2b3558c67c44_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' net income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_f84e98c6-c626-4fa3-ad94-d4a18fb16375_negatedLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Depreciation, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_e5cd6fa6-3fda-4d0b-8836-9ad599582717_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets and Financial Liabilities Carried at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_699c243a-08c0-41c0-afee-e151e0ba967f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold_0871f3d8-5890-406b-9e1a-7560cd23f053_terseLabel_en-US" xlink:label="lab_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding payment obligations, current, voluntarily elected by suppliers to be sold to the financial institution</link:label>
    <link:label id="lab_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold_label_en-US" xlink:label="lab_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program, Outstanding Payment Obligation, Current, Voluntarily Elected To Be Sold</link:label>
    <link:label id="lab_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold_documentation_en-US" xlink:label="lab_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program, Outstanding Payment Obligation, Current, Voluntarily Elected To Be Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold" xlink:href="ci-20230331.xsd#ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold" xlink:to="lab_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_6c18d1c8-bb86-4824-9fb1-b15d35db6b20_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity_7f724a4e-106a-4edc-8674-ef37b7476931_terseLabel_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) including temporary equity, before reclassifications, before tax</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity_label_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax, Including Temporary Equity</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity_documentation_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax, Including Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity" xlink:to="lab_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember_370765a8-408a-4bd7-8222-90fca35f9e8c_terseLabel_en-US" xlink:label="lab_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of collateral contractually required to meet or exceed carrying value of recoverable</link:label>
    <link:label id="lab_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember_label_en-US" xlink:label="lab_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Secured, Contractually Required Fair Value [Member]</link:label>
    <link:label id="lab_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember_documentation_en-US" xlink:label="lab_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Secured, Contractually Required Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember" xlink:href="ci-20230331.xsd#ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember" xlink:to="lab_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue20416125InterestMember_64e3adad-26a5-483e-af35-94fab5239a23_terseLabel_en-US" xlink:label="lab_ci_NotesDue20416125InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$448&#160;million, 6.125% Notes due November 2041</link:label>
    <link:label id="lab_ci_NotesDue20416125InterestMember_label_en-US" xlink:label="lab_ci_NotesDue20416125InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2041, 6.125% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue20416125InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue20416125InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable bearing interest at 6.125% due in 2041. Debt assumed acquisition from Express Scripts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20416125InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue20416125InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue20416125InterestMember" xlink:to="lab_ci_NotesDue20416125InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesMember_440ff7f4-70e7-4bdd-b5ac-3cc5d7473726_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees</link:label>
    <link:label id="lab_us-gaap_GuaranteesMember_label_en-US" xlink:label="lab_us-gaap_GuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesMember" xlink:to="lab_us-gaap_GuaranteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_783c2a96-ee5c-41c8-a384-3a2048c0cc81_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, including current maturities, excluding finance leases</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_ed55fe67-a003-4c3e-81a4-6f0d61ba3d82_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_ccdb4825-6b52-48ac-af33-1973e4d3fc37_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments per Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b8025013-4424-4d0b-8f71-68140dd7f436_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated stock repurchase, amount authorized</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff_5e6298dc-02b9-41de-b2bb-190941e2e57d_terseLabel_en-US" xlink:label="lab_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes due to expected run-off</link:label>
    <link:label id="lab_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff_label_en-US" xlink:label="lab_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Increase (Decrease) Due to Expected Run-Off</link:label>
    <link:label id="lab_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff_documentation_en-US" xlink:label="lab_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Increase (Decrease) Due to Expected Run-Off</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff" xlink:to="lab_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MeasurementInputLiquidityMember_c4a86580-5e4d-45a3-8257-d0816e2e3c4d_terseLabel_en-US" xlink:label="lab_ci_MeasurementInputLiquidityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity</link:label>
    <link:label id="lab_ci_MeasurementInputLiquidityMember_label_en-US" xlink:label="lab_ci_MeasurementInputLiquidityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Liquidity [Member]</link:label>
    <link:label id="lab_ci_MeasurementInputLiquidityMember_documentation_en-US" xlink:label="lab_ci_MeasurementInputLiquidityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Liquidity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MeasurementInputLiquidityMember" xlink:href="ci-20230331.xsd#ci_MeasurementInputLiquidityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MeasurementInputLiquidityMember" xlink:to="lab_ci_MeasurementInputLiquidityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_3c23f1ab-014f-4ca0-8a8b-0a9bc5614df1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage and other asset-backed</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_b47e2177-89ba-4d6d-903e-05e2f38c9b36_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage and other asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1c5b0cac-c863-478e-a8ad-4ba8eb6ea8de_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_cdf3f280-8c30-4d90-9a06-8c3c8bf788a3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9aef66bb-a0d1-45f7-8de6-d3243c5db644_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_d4833797-1ff3-4925-9dd6-b9abfa1b1560_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance and other amounts recoverable</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_186a597e-7b45-4309-8f77-daa469f4d9f9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Reinsurance and other amounts recoverable</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_0316c4af-e1c6-4253-9c7d-da24fa8038df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_76581279-636f-4b10-afd0-7ec43230423b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock_c09070eb-a82b-4127-8cae-c3e9fddba842_terseLabel_en-US" xlink:label="lab_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value Information for Other Long-Term Investments</link:label>
    <link:label id="lab_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Long-Term Investments [Table Text Block]</link:label>
    <link:label id="lab_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock" xlink:href="ci-20230331.xsd#ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock" xlink:to="lab_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_740ba4d0-8b34-4947-a01f-d134d61dc154_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_f50e9853-4751-4d6d-83a0-655f692bfe2c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax_f8a69c16-75ba-4706-876b-d371e8d051e7_negatedLabel_en-US" xlink:label="lab_ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) on sale of business</link:label>
    <link:label id="lab_ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax_label_en-US" xlink:label="lab_ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item, Gain (Loss) On Sale Of Business, Net Of Tax</link:label>
    <link:label id="lab_ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax_documentation_en-US" xlink:label="lab_ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item, Gain (Loss) On Sale Of Business, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax" xlink:to="lab_ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemsBeforeTaxAbstract_375abeb9-decd-4cc6-bd54-eff740a4db14_verboseLabel_en-US" xlink:label="lab_ci_SpecialItemsBeforeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax</link:label>
    <link:label id="lab_ci_SpecialItemsBeforeTaxAbstract_4815eef4-8624-498e-9a94-3fa1756846dd_terseLabel_en-US" xlink:label="lab_ci_SpecialItemsBeforeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special items</link:label>
    <link:label id="lab_ci_SpecialItemsBeforeTaxAbstract_label_en-US" xlink:label="lab_ci_SpecialItemsBeforeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Items Before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemsBeforeTaxAbstract" xlink:href="ci-20230331.xsd#ci_SpecialItemsBeforeTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract" xlink:to="lab_ci_SpecialItemsBeforeTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_b4372363-9804-4438-869e-e459d1b3dd98_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on repurchase of debt, pre-tax</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue2023375InterestMember_8009d22d-afc9-49b7-aa35-b33114fb9f9b_terseLabel_en-US" xlink:label="lab_ci_NotesDue2023375InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,187&#160;million, 3.75% Notes due July 2023</link:label>
    <link:label id="lab_ci_NotesDue2023375InterestMember_label_en-US" xlink:label="lab_ci_NotesDue2023375InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2023, 3.75% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue2023375InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue2023375InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable bearing interest at 3.75% due in 2023. Debt issued to finance acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2023375InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue2023375InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue2023375InterestMember" xlink:to="lab_ci_NotesDue2023375InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities_1daf126c-7e26-4aee-8ac2-1d55bcb117b4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment for credit risk on derivatives liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Credit Risk Valuation Adjustment, Derivative Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_40f8090d-7060-454f-823d-a0bd8e282f5a_terseLabel_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Security Investments</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_label_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Equity Securities Without Readily Determinable Fair Value [Table Text Block]</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Equity Securities Without Readily Determinable Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:to="lab_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_009fb32b-1f7a-47a9-88c4-2202e6b0c951_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fb4a224b-c070-4edd-8f67-6aa35aca9542_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_93dab413-184b-4982-9194-43ce0220d3ed_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesMember_f93a2f51-1f67-4e9d-b9a1-85621d682a67_verboseLabel_en-US" xlink:label="lab_us-gaap_MortgagesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgagesMember_label_en-US" xlink:label="lab_us-gaap_MortgagesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesMember" xlink:to="lab_us-gaap_MortgagesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_51ac69b8-e172-4d5a-abca-2d0f65ae58d4_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Commercial and Consumer, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_3c1848a6-c2df-4fa2-bd8e-9fa12917a830_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation of foreign currencies attributable to parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember_e3a86e35-f4ed-4b4d-839f-c6d0422d51d7_terseLabel_en-US" xlink:label="lab_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Above Guaranteed Minimum Crediting Rate, Based On Greater Of Guaranteed Minimum Cash Value Or Actual Cash Value</link:label>
    <link:label id="lab_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember_label_en-US" xlink:label="lab_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Above Guaranteed Minimum Crediting Rate, Based On Greater Of Guaranteed Minimum Cash Value Or Actual Cash Value [Member]</link:label>
    <link:label id="lab_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember_documentation_en-US" xlink:label="lab_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Above Guaranteed Minimum Crediting Rate, Based On Greater Of Guaranteed Minimum Cash Value Or Actual Cash Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember" xlink:href="ci-20230331.xsd#ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember" xlink:to="lab_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue2026125Member_c13d5ab4-0137-45aa-a91c-f21830f74e1f_terseLabel_en-US" xlink:label="lab_ci_NotesDue2026125Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$800 million, 1.250% Notes due March 2026</link:label>
    <link:label id="lab_ci_NotesDue2026125Member_label_en-US" xlink:label="lab_ci_NotesDue2026125Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes due 2026, 1.25% [Member]</link:label>
    <link:label id="lab_ci_NotesDue2026125Member_documentation_en-US" xlink:label="lab_ci_NotesDue2026125Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable bearing interest at 1.25% due in 2026.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2026125Member" xlink:href="ci-20230331.xsd#ci_NotesDue2026125Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue2026125Member" xlink:to="lab_ci_NotesDue2026125Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c7513529-b50a-4906-9f26-41f965777f5b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember_60870197-4e45-4ed6-b039-82e2a1a90cce_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, at Guaranteed Minimum Crediting Rate</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, at Guaranteed Minimum Crediting Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember" xlink:to="lab_us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_5817d7d9-6683-4ffa-a789-c3f5674c93db_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PricingConcessionsMember_514bbc00-3aad-41ea-964f-d5b01298764a_terseLabel_en-US" xlink:label="lab_ci_PricingConcessionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Concessions</link:label>
    <link:label id="lab_ci_PricingConcessionsMember_label_en-US" xlink:label="lab_ci_PricingConcessionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Concessions [Member]</link:label>
    <link:label id="lab_ci_PricingConcessionsMember_documentation_en-US" xlink:label="lab_ci_PricingConcessionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Concessions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PricingConcessionsMember" xlink:href="ci-20230331.xsd#ci_PricingConcessionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PricingConcessionsMember" xlink:to="lab_ci_PricingConcessionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesByIndustryAxis_2861a638-c003-47e4-ab69-92b985013998_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesByIndustryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industry Sector [Axis]</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesByIndustryAxis_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesByIndustryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industry Sector [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesByIndustryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesByIndustryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis" xlink:to="lab_us-gaap_EquitySecuritiesByIndustryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_USMedicalProductsMember_5753441e-ddf9-439f-b417-426b1b8fb355_terseLabel_en-US" xlink:label="lab_ci_USMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cigna Healthcare</link:label>
    <link:label id="lab_ci_USMedicalProductsMember_label_en-US" xlink:label="lab_ci_USMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Medical Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_USMedicalProductsMember" xlink:href="ci-20230331.xsd#ci_USMedicalProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_USMedicalProductsMember" xlink:to="lab_ci_USMedicalProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_cd1850f0-4612-4ad6-bb3b-7efb0e9ccbfc_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ae0981ad-dd26-4973-8072-1db3f483b8a9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_78196c63-7a89-4f8c-bbc7-ef8e5fe084d1_totalLabel_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, including held for sale assets</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_34e8df0e-8027-4b1c-ab3c-d40fd0a09d29_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_951d8c4f-49e0-4a7e-abd4-3dd7a0c595b0_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_b52ff40e-5a12-45c2-8571-53d87cff442a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock held in treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_689ff704-1e34-4c96-99f0-4902ad34658b_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment, tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_38e9c1ae-b105-4dcb-92fa-715bbe19632b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsLiquidationProceeds_d6b99ce0-faac-4060-a53d-2db7da64955a_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsLiquidationProceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets maintained by employers (minimum)</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsLiquidationProceeds_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsLiquidationProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Liquidation Proceeds, Monetary Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLiquidationProceeds" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsLiquidationProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsLiquidationProceeds" xlink:to="lab_us-gaap_GuaranteeObligationsLiquidationProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_24269ccc-664b-45b2-a4fb-f6862c5569a0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_ef04b15b-522e-4c1b-8a42-ece8c2c23238_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_ba6137be-a93b-481a-a02e-3e23b5747f90_terseLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_b0116d5a-aec2-4a09-992f-fb9c60facc8e_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value, before allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member_c87d23e8-1d1a-49c7-bcf5-529b5370ac94_terseLabel_en-US" xlink:label="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364-day Revolving Credit Agreement, Maturing April 2024</link:label>
    <link:label id="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member_label_en-US" xlink:label="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364 Day Revolving Credit Agreement, Maturing April 2024 [Member]</link:label>
    <link:label id="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member_documentation_en-US" xlink:label="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364 Day Revolving Credit Agreement, Maturing April 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member" xlink:href="ci-20230331.xsd#ci_A364DayRevolvingCreditAgreementMaturingApril2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member" xlink:to="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_a3f38ba4-4dee-4d56-bbc6-90db52d3188c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities_80e748ab-3fcc-4d02-8c41-7f3437ffea3f_terseLabel_en-US" xlink:label="lab_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities and equity securities</link:label>
    <link:label id="lab_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities_label_en-US" xlink:label="lab_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities</link:label>
    <link:label id="lab_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities_documentation_en-US" xlink:label="lab_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities, repayments and calls of debt and equity securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities" xlink:href="ci-20230331.xsd#ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities" xlink:to="lab_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_82584ad1-a7d6-4568-a323-dee2b173cd4e_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL REVENUES</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2bff5478-32b6-4898-a246-243fb509d809_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative gain (loss) recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_08a91799-6f57-4eef-bcf0-c6d571b54ad5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Issues</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_92c827f4-a2df-4628-b4b5-4cb02586b75d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PricingConcessionsThroughRemainingContractTermMember_02871f0f-f03b-41d2-a0a9-da567f524fef_terseLabel_en-US" xlink:label="lab_ci_PricingConcessionsThroughRemainingContractTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Concessions Through Remaining Contract Term</link:label>
    <link:label id="lab_ci_PricingConcessionsThroughRemainingContractTermMember_label_en-US" xlink:label="lab_ci_PricingConcessionsThroughRemainingContractTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Concessions Through Remaining Contract Term [Member]</link:label>
    <link:label id="lab_ci_PricingConcessionsThroughRemainingContractTermMember_documentation_en-US" xlink:label="lab_ci_PricingConcessionsThroughRemainingContractTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing concessions sought in litigation for remainder of contract term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PricingConcessionsThroughRemainingContractTermMember" xlink:href="ci-20230331.xsd#ci_PricingConcessionsThroughRemainingContractTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PricingConcessionsThroughRemainingContractTermMember" xlink:to="lab_ci_PricingConcessionsThroughRemainingContractTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_7340cf15-16ab-40d9-9619-84641362f679_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage_9ee9046d-5fb3-4021-9e69-a287418d7d42_terseLabel_en-US" xlink:label="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum crediting rate</link:label>
    <link:label id="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage_label_en-US" xlink:label="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Percentage</link:label>
    <link:label id="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage_documentation_en-US" xlink:label="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage" xlink:href="ci-20230331.xsd#ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage" xlink:to="lab_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_40466973-438f-425a-8388-665b8534c9af_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_b3d012a6-33d0-4d92-9049-75f9506a9e76_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_8f2802ae-9884-486e-92c5-f2ef8d259adc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceOtherMember_f4854af6-1d53-4c2b-9e92-738a37538954_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_ServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceOtherMember" xlink:to="lab_us-gaap_ServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_85e76ec6-6094-4a7d-ba4f-74bb4d9e65b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement benefits liability</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent_d5c1112f-5fbd-4f9e-8be5-fa30b4488f61_terseLabel_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid claims and claim expenses, noncurrent</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent_label_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Claims And Claims Adjustment Expense, Noncurrent</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent_documentation_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Claims And Claims Adjustment Expense, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent" xlink:to="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_08a6b0f2-d98b-4b14-bafb-884b46b81514_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_b9c58b71-5348-4170-aee9-2266b56b6ff5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_9ea96fcd-b6f5-46b8-89b6-99baefa0b166_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f215fb26-86f1-480d-b218-2904c179532c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_4cda5042-91f6-4bed-aa7f-ed1cd873af66_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash January 1, including held for sale assets</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1af6e4b2-a940-46cc-b53d-960ae0ead2e1_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash December 31, including held for sale assets</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivablePortfolioSegmentDomain_d1352f8c-7566-4576-86bd-ab4e2a3af709_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivablePortfolioSegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable Portfolio Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivablePortfolioSegmentDomain_label_en-US" xlink:label="lab_us-gaap_FinancingReceivablePortfolioSegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable Portfolio Segment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain" xlink:to="lab_us-gaap_FinancingReceivablePortfolioSegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesGross_287afd95-fcbf-41ee-8f71-ac85ffb606f2_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesGross_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverablesGross" xlink:to="lab_us-gaap_ReinsuranceRecoverablesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b8769b3f-2b26-4c41-bf43-46bd68a00392_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_db058e20-fa4a-413a-b8b3-3dc1397e69f5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_bd113896-a36c-40c7-b7ee-6e6d3798952a_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax_9c088fb6-dc14-4cc5-a5cb-807768227ef4_negatedTerseLabel_en-US" xlink:label="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk corridors recovery (Selling, general and administrative expenses)</link:label>
    <link:label id="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax_label_en-US" xlink:label="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item, Gain (Loss) On Risk Corridor Allowance Adjustment, Net Of Tax</link:label>
    <link:label id="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax_documentation_en-US" xlink:label="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Item, Gain (Loss) On Risk Corridor Allowance Adjustment, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax" xlink:to="lab_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_acb84355-a9ca-4f29-b323-b69714e8e7cd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_e841cb06-e344-4a1d-b0e8-7d275d2995d0_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums due</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:to="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_5a3ab679-3cbf-4f12-ab50-ee0258420e5f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_5e192d8d-7746-46d7-a2b5-cfff12dceb2d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_5d1a3cfc-5410-436e-98e7-7e1f79588528_terseLabel_en-US" xlink:label="lab_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities with readily determinable fair values, including held for sale assets</link:label>
    <link:label id="lab_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Fv Ni Cost Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Fv Ni Cost Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_GroupMedicalInsuranceShortDurationMember_97afaa76-63c0-4a78-b1d7-20ef5ec9cd64_terseLabel_en-US" xlink:label="lab_ci_GroupMedicalInsuranceShortDurationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration (Group medical insurance)</link:label>
    <link:label id="lab_ci_GroupMedicalInsuranceShortDurationMember_label_en-US" xlink:label="lab_ci_GroupMedicalInsuranceShortDurationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Medical Insurance, Short-Duration [Member]</link:label>
    <link:label id="lab_ci_GroupMedicalInsuranceShortDurationMember_documentation_en-US" xlink:label="lab_ci_GroupMedicalInsuranceShortDurationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Medical Insurance, Short-Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GroupMedicalInsuranceShortDurationMember" xlink:href="ci-20230331.xsd#ci_GroupMedicalInsuranceShortDurationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_GroupMedicalInsuranceShortDurationMember" xlink:to="lab_ci_GroupMedicalInsuranceShortDurationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_GuaranteedMinimumDeathBenefitsTotalContractholders_fc0f0c42-f999-42ce-98a1-c01012d3ea4f_terseLabel_en-US" xlink:label="lab_ci_GuaranteedMinimumDeathBenefitsTotalContractholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of contractholders (estimated)</link:label>
    <link:label id="lab_ci_GuaranteedMinimumDeathBenefitsTotalContractholders_label_en-US" xlink:label="lab_ci_GuaranteedMinimumDeathBenefitsTotalContractholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranteed Minimum Death Benefits Total Contractholders</link:label>
    <link:label id="lab_ci_GuaranteedMinimumDeathBenefitsTotalContractholders_documentation_en-US" xlink:label="lab_ci_GuaranteedMinimumDeathBenefitsTotalContractholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number of underlying contractholders for the Guaranteed Minimum Death Benefit business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GuaranteedMinimumDeathBenefitsTotalContractholders" xlink:href="ci-20230331.xsd#ci_GuaranteedMinimumDeathBenefitsTotalContractholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_GuaranteedMinimumDeathBenefitsTotalContractholders" xlink:to="lab_ci_GuaranteedMinimumDeathBenefitsTotalContractholders" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitOther_08f9d421-885c-438f-8312-038e1cf2f587_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitOther_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Other</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitOther_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitOther" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitOther" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_cf96164d-2daf-467d-b40d-66bdd3073830_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_53894a82-3493-4e5b-b8ad-3561c7cd6015_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value and Significant Unobservable Inputs Used in Pricing Debt Securities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember_796d9db9-b950-41a3-aa6c-060c6aaf9a49_terseLabel_en-US" xlink:label="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A- equivalent and higher current ratings</link:label>
    <link:label id="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember_label_en-US" xlink:label="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nationally Recognized Statisical Rating Organizations (NRSRO), A- Or Higher [Member]</link:label>
    <link:label id="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember_documentation_en-US" xlink:label="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nationally Recognized Statisical Rating Organizations (NRSRO), A- Or Higher</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember" xlink:href="ci-20230331.xsd#ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember" xlink:to="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_3a33723f-f618-4e1d-84ac-bbc95b940bcd_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_11a039e9-c311-4f5f-8dd0-37e628552b80_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AssetBackedAndCorporateSecuritiesMember_44052860-df6c-4c0b-8571-581a3f4b4174_terseLabel_en-US" xlink:label="lab_ci_AssetBackedAndCorporateSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed and corporate securities</link:label>
    <link:label id="lab_ci_AssetBackedAndCorporateSecuritiesMember_label_en-US" xlink:label="lab_ci_AssetBackedAndCorporateSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Backed And Corporate Securities [Member]</link:label>
    <link:label id="lab_ci_AssetBackedAndCorporateSecuritiesMember_documentation_en-US" xlink:label="lab_ci_AssetBackedAndCorporateSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Backed And Corporate Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AssetBackedAndCorporateSecuritiesMember" xlink:href="ci-20230331.xsd#ci_AssetBackedAndCorporateSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AssetBackedAndCorporateSecuritiesMember" xlink:to="lab_ci_AssetBackedAndCorporateSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_78f2df33-0933-4eaa-957d-a6c64851fb8e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_7a7422b1-2e27-4ad3-8308-3be691e565a9_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal government and agency</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b03361df-3715-40d7-8b22-791ade6bbe0c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_62a2e810-d2f9-4e87-9480-98a670ef43cf_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_301fc4dc-86c8-424c-8753-8f7135572edb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_2ad5647f-c4e4-4199-bc81-cb803d25aace_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_fdc28ce0-5524-4ba4-bb43-f1246410d2e7_negatedTerseLabel_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, including held for sale assets</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, Allowance For Credit Loss, Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, Allowance For Credit Loss, Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RealizedInvestmentGainLossExcludingImpairments_cebb4d40-167f-4034-bf9a-8fe1758b088f_verboseLabel_en-US" xlink:label="lab_ci_RealizedInvestmentGainLossExcludingImpairments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized investment (losses), excluding credit loss expense and asset write-downs</link:label>
    <link:label id="lab_ci_RealizedInvestmentGainLossExcludingImpairments_label_en-US" xlink:label="lab_ci_RealizedInvestmentGainLossExcludingImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gain Loss Excluding Impairments</link:label>
    <link:label id="lab_ci_RealizedInvestmentGainLossExcludingImpairments_documentation_en-US" xlink:label="lab_ci_RealizedInvestmentGainLossExcludingImpairments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net realized gains or (losses) on investments during the period before impairments, including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLossExcludingImpairments" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLossExcludingImpairments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RealizedInvestmentGainLossExcludingImpairments" xlink:to="lab_ci_RealizedInvestmentGainLossExcludingImpairments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_6eafe8a5-3966-4caa-acdf-3ef7a93d79b4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MedicarePartDMember_5e3abbf7-6c1a-4a9e-bdcd-11eb910fbd71_terseLabel_en-US" xlink:label="lab_ci_MedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D</link:label>
    <link:label id="lab_ci_MedicarePartDMember_label_en-US" xlink:label="lab_ci_MedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D [Member]</link:label>
    <link:label id="lab_ci_MedicarePartDMember_documentation_en-US" xlink:label="lab_ci_MedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A government health plan for prescription drugs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MedicarePartDMember" xlink:href="ci-20230331.xsd#ci_MedicarePartDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MedicarePartDMember" xlink:to="lab_ci_MedicarePartDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RevolvingCreditAgreementsApril2023Member_23840f9d-6fad-4151-95c9-3780c1551616_terseLabel_en-US" xlink:label="lab_ci_RevolvingCreditAgreementsApril2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit agreements, April 2023</link:label>
    <link:label id="lab_ci_RevolvingCreditAgreementsApril2023Member_label_en-US" xlink:label="lab_ci_RevolvingCreditAgreementsApril2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreements April 2023 [Member]</link:label>
    <link:label id="lab_ci_RevolvingCreditAgreementsApril2023Member_documentation_en-US" xlink:label="lab_ci_RevolvingCreditAgreementsApril2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit agreements entered into in April 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditAgreementsApril2023Member" xlink:href="ci-20230331.xsd#ci_RevolvingCreditAgreementsApril2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RevolvingCreditAgreementsApril2023Member" xlink:to="lab_ci_RevolvingCreditAgreementsApril2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_bbd7625a-bd6a-4910-9db5-464e9ed4fb33_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_66451681-a6af-409b-8e3b-1c61eb6e2667_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_a18de3de-06fc-409e-9561-c9386c68405e_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_d12fab6d-c341-41e6-beeb-f2237aa74d1c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage_87551434-e65c-42b7-9941-5203bee1688c_terseLabel_en-US" xlink:label="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of debt and equity securities classified in Level 3</link:label>
    <link:label id="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage_label_en-US" xlink:label="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities Classified In Level 3 Percentage</link:label>
    <link:label id="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage_documentation_en-US" xlink:label="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of debt and equity securities classified in Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage" xlink:href="ci-20230331.xsd#ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage" xlink:to="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_10b98e6f-c989-4620-9c82-8840b809110d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Depreciation</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReinsurerMember_ea550705-072c-4a86-9e9e-9680cc76b102_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReinsurerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherReinsurerMember_label_en-US" xlink:label="lab_us-gaap_OtherReinsurerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurer, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReinsurerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReinsurerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReinsurerMember" xlink:to="lab_us-gaap_OtherReinsurerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0116af01-9166-46a6-a8fc-7960a776f3b3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivablePortfolioSegmentAxis_39e823e4-d65f-497a-8cfa-2dbdf8b2e0c5_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivablePortfolioSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable Portfolio Segment [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivablePortfolioSegmentAxis_label_en-US" xlink:label="lab_us-gaap_FinancingReceivablePortfolioSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable Portfolio Segment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis" xlink:to="lab_us-gaap_FinancingReceivablePortfolioSegmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock_97ea23de-725c-4f93-8cdf-a46490a38f38_terseLabel_en-US" xlink:label="lab_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common and Preferred Stock</link:label>
    <link:label id="lab_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock_label_en-US" xlink:label="lab_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Common Stock By Class Schedule Of Preferred Stock By Class [Text Block]</link:label>
    <link:label id="lab_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock_documentation_en-US" xlink:label="lab_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element may be used to capture the complete disclosure pertaining to an entity's common stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation. B Preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued and outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock" xlink:href="ci-20230331.xsd#ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock" xlink:to="lab_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_0b182375-f1e7-4e62-8ad9-c8d69a9fc8ac_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a497f1db-a3b1-4709-825c-75d2e25749eb_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees_5a915aff-2458-476a-8a9a-a4503b373766_terseLabel_en-US" xlink:label="lab_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds</link:label>
    <link:label id="lab_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees_label_en-US" xlink:label="lab_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Long-term Debt, Net Of Discounts And Underwriting Fees</link:label>
    <link:label id="lab_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees_documentation_en-US" xlink:label="lab_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Long-term Debt, Net Of Discounts And Underwriting Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees" xlink:href="ci-20230331.xsd#ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees" xlink:to="lab_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_12989c44-b39b-400a-a011-e7b8114ba112_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4962bcfe-e9a7-436a-9283-a7ecf169504e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements, Recently Adopted Accounting Guidance and Accounting Guidance Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_32eeb925-9e37-4c88-a042-602446aa8c46_terseLabel_en-US" xlink:label="lab_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax adjusted income (loss) from operations</link:label>
    <link:label id="lab_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="ci-20230331.xsd#ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_d0b6ffec-5c0d-4965-b356-f8e99ad6a868_terseLabel_en-US" xlink:label="lab_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amount of options to increase commitments</link:label>
    <link:label id="lab_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_label_en-US" xlink:label="lab_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Accordion Feature, Incremental Increase In Maximum Borrowing Capacity</link:label>
    <link:label id="lab_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Accordion Feature, Incremental Increase In Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" xlink:href="ci-20230331.xsd#ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" xlink:to="lab_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_91126452-b969-4bcd-b445-d697a0259e65_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8725ca2f-2831-4378-aac6-5b7ed2d33687_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_c34495e7-0cef-4b4d-96e5-c06f0b50a255_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fees and other revenues</link:label>
    <link:label id="lab_us-gaap_ServiceMember_1b957282-7846-4829-bcf2-2cb89dddb6d7_verboseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges_ca7e9953-4804-48f7-9639-461ab08210c7_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Future Policy Benefit, Interest Expense And Other Changes</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Future Policy Benefit, Interest Expense And Other Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_3d8d0633-103b-467d-9c1d-39d2446bdfb1_periodStartLabel_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, including held for sale assets</link:label>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_02c0a884-9c98-4a4c-886d-159d95098b47_periodEndLabel_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, including held for sale assets</link:label>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AccruedExpensesAndOtherLiabilities_e1e263db-3524-4722-a4bc-b628cbdd245f_terseLabel_en-US" xlink:label="lab_ci_AccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_ci_AccruedExpensesAndOtherLiabilities_label_en-US" xlink:label="lab_ci_AccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Liabilities</link:label>
    <link:label id="lab_ci_AccruedExpensesAndOtherLiabilities_documentation_en-US" xlink:label="lab_ci_AccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of other current liabilities and obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AccruedExpensesAndOtherLiabilities" xlink:href="ci-20230331.xsd#ci_AccruedExpensesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AccruedExpensesAndOtherLiabilities" xlink:to="lab_ci_AccruedExpensesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_98302b50-a8b3-4ca6-b3e3-53ebf2e58a4a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_HomeDeliveryAndSpecialtyMember_ec0852ec-a478-4773-b288-ab320400016d_terseLabel_en-US" xlink:label="lab_ci_HomeDeliveryAndSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home delivery and specialty revenues</link:label>
    <link:label id="lab_ci_HomeDeliveryAndSpecialtyMember_label_en-US" xlink:label="lab_ci_HomeDeliveryAndSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Delivery And Specialty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_HomeDeliveryAndSpecialtyMember" xlink:href="ci-20230331.xsd#ci_HomeDeliveryAndSpecialtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_HomeDeliveryAndSpecialtyMember" xlink:to="lab_ci_HomeDeliveryAndSpecialtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_fdb0c36c-50a6-4270-8f5c-176f448bc7e5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_33e39a8b-dfc9-4022-a76e-7f848c9ee69e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_c02e9e92-c31c-4b11-87c7-59eb1de6bcd9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Policy Benefit Activity</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_40d66ebc-3e22-403d-96cc-60d2b324a4ca_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_StepDownNotesDueJanuary2033Member_86c62ae6-3405-4ed0-b751-ee4fe998d8b7_terseLabel_en-US" xlink:label="lab_ci_StepDownNotesDueJanuary2033Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$45&#160;million, 8.080% Step Down Notes due January 2033 (2)</link:label>
    <link:label id="lab_ci_StepDownNotesDueJanuary2033Member_label_en-US" xlink:label="lab_ci_StepDownNotesDueJanuary2033Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Step Down Notes Due January 2033 [Member]</link:label>
    <link:label id="lab_ci_StepDownNotesDueJanuary2033Member_documentation_en-US" xlink:label="lab_ci_StepDownNotesDueJanuary2033Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Step-down debt due in January 2033.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_StepDownNotesDueJanuary2033Member" xlink:href="ci-20230331.xsd#ci_StepDownNotesDueJanuary2033Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_StepDownNotesDueJanuary2033Member" xlink:to="lab_ci_StepDownNotesDueJanuary2033Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_55280c90-b093-4562-babe-e1560d5c9524_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember_39c7550c-add5-4f24-8e91-762d7c3e9e16_terseLabel_en-US" xlink:label="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International life, accident, supplemental benefits businesses sold to Chubb</link:label>
    <link:label id="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember_label_en-US" xlink:label="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Life Accident Supplemental Benefits Businesses Excluding Turkey Joint Venture [Member]</link:label>
    <link:label id="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember_documentation_en-US" xlink:label="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sold life, accident and supplemental benefits businesses in Hong Kong, Indonesia, New Zealand, South Korea, Taiwan and Thailand.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember" xlink:href="ci-20230331.xsd#ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember" xlink:to="lab_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_846418ca-674d-4ddc-a312-e6716ecb511c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk_ea1cc3d6-3931-45f8-8749-da3804b6bf91_periodStartLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of year</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk_67da6261-6158-4191-9543-0c39d2d304d4_periodEndLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk_label_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, after Increase (Decrease) from Instrument-Specific Credit Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk" xlink:to="lab_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ecdb8949-1f05-4910-a6c6-b1bf69108f69_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_853fd20a-4470-480e-a2c9-fb86753bded9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_560c036b-44a4-4a1f-9a75-03bb02cb82da_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities with readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_c0232683-e210-4cde-bba4-81aacefb361a_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_bdc9ae9d-cd9a-4aeb-94d9-9562d5987f18_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_494a75e1-915a-410b-aae3-0283703555e9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceLossReservesAbstract_a09b02cf-e805-4970-88f7-06c91a9b7511_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceLossReservesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Loss Reserves [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceLossReservesAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceLossReservesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Loss Reserves [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceLossReservesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceLossReservesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract" xlink:to="lab_us-gaap_InsuranceLossReservesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember_8a8519f7-ce01-44d5-b641-327388ee3b0c_terseLabel_en-US" xlink:label="lab_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities limited partnerships and real estate limited partnerships</link:label>
    <link:label id="lab_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember_label_en-US" xlink:label="lab_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Limited Partnerships And Real Estate Limited Partnerships [Member]</link:label>
    <link:label id="lab_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember_documentation_en-US" xlink:label="lab_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Limited Partnerships And Real Estate Limited Partnerships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember" xlink:href="ci-20230331.xsd#ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember" xlink:to="lab_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_11d0625f-4665-46f7-bc9f-e3c7a5d5c9de_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_3b8dfbf0-22f7-4b4f-8fef-e9f03cde1a80_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups_3717928e-4bd4-41e4-903e-f7f47e87ed88_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefits, including held for sale liabilities</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefits Including Disposal Groups</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefits Including Disposal Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate_c8f16302-a1ae-4402-88ef-6db31719a803_terseLabel_en-US" xlink:label="lab_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price discount, spread on variable rate</link:label>
    <link:label id="lab_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate_label_en-US" xlink:label="lab_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Discount, Spread On Variable Rate</link:label>
    <link:label id="lab_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate_documentation_en-US" xlink:label="lab_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Discount, Spread On Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate" xlink:href="ci-20230331.xsd#ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate" xlink:to="lab_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_4a463ee0-510b-4461-87c7-66378d170bc7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AnnuitizationElectionPeriod_d0855786-7d4b-4727-afac-d1c784294b38_terseLabel_en-US" xlink:label="lab_ci_AnnuitizationElectionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annuitization election period</link:label>
    <link:label id="lab_ci_AnnuitizationElectionPeriod_label_en-US" xlink:label="lab_ci_AnnuitizationElectionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annuitization Election Period</link:label>
    <link:label id="lab_ci_AnnuitizationElectionPeriod_documentation_en-US" xlink:label="lab_ci_AnnuitizationElectionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The period of time prior to a policy anniversary when an annuitization election must occur.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AnnuitizationElectionPeriod" xlink:href="ci-20230331.xsd#ci_AnnuitizationElectionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AnnuitizationElectionPeriod" xlink:to="lab_ci_AnnuitizationElectionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange_bac67824-ad60-41de-92fa-39a0f5e97387_terseLabel_en-US" xlink:label="lab_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes due to capital markets versus expected</link:label>
    <link:label id="lab_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange_label_en-US" xlink:label="lab_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Increase (Decrease) From Interest Rate Change And Equity Market Change</link:label>
    <link:label id="lab_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange_documentation_en-US" xlink:label="lab_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Increase (Decrease) From Interest Rate Change And Equity Market Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange" xlink:to="lab_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent_85cf2f86-4b0c-440c-af07-0eb1daf02c5d_verboseLabel_en-US" xlink:label="lab_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, including finance leases</link:label>
    <link:label id="lab_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent_label_en-US" xlink:label="lab_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-Term Debt, Current Maturities Of Long-Term Debt, And Lease Obligations, Current</link:label>
    <link:label id="lab_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent_documentation_en-US" xlink:label="lab_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-Term Debt, Current Maturities Of Long-Term Debt, And Lease Obligations, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent" xlink:href="ci-20230331.xsd#ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent" xlink:to="lab_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_b847352e-33b0-4b52-a469-e37848d5470d_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_a6e65e8b-de57-4e04-916b-e9fdd1c5cd8f_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranteed Insurance Contract, Type of Benefit [Axis]</link:label>
    <link:label id="lab_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_label_en-US" xlink:label="lab_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranteed Insurance Contract, Type of Benefit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis" xlink:to="lab_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8bcdc3e4-ce22-4cf9-94dd-6538b3fcc553_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_ca2ec998-3d70-49ed-8636-0494861e4129_terseLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities, Including Disposal Groups</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities, Including Disposal Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups" xlink:to="lab_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_cf9ebe0e-3656-4fa7-a282-f667d381c811_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies and Other Matters</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_dbf9e5d6-4440-4540-89d9-ae0245c869de_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds on issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_47faea28-2fb4-4ac6-83cd-b94ceb555696_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHAREHOLDERS' NET INCOME</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3e418815-9856-4bbc-a184-88c6d6b7e49f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to shareholders' net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_36c08c4f-8550-4669-8db0-4ac4906e05d6_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_f9e5a55a-4c53-417c-a8d9-ef12d99e5aa9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionsToContractHoldersFunds_9780479e-ad51-4e84-bbd9-3d827783b7e6_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionsToContractHoldersFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits and interest credited to contractholder deposit funds</link:label>
    <link:label id="lab_us-gaap_AdditionsToContractHoldersFunds_label_en-US" xlink:label="lab_us-gaap_AdditionsToContractHoldersFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to Contract Holders Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionsToContractHoldersFunds" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionsToContractHoldersFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionsToContractHoldersFunds" xlink:to="lab_us-gaap_AdditionsToContractHoldersFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtAndEquitySecuritiesMember_aa8a7212-1ad8-47b7-bacf-144700fc5666_terseLabel_en-US" xlink:label="lab_ci_DebtAndEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities</link:label>
    <link:label id="lab_ci_DebtAndEquitySecuritiesMember_label_en-US" xlink:label="lab_ci_DebtAndEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities [Member]</link:label>
    <link:label id="lab_ci_DebtAndEquitySecuritiesMember_documentation_en-US" xlink:label="lab_ci_DebtAndEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal of debt and equity securities carried at fair value on the balance sheet.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtAndEquitySecuritiesMember" xlink:href="ci-20230331.xsd#ci_DebtAndEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtAndEquitySecuritiesMember" xlink:to="lab_ci_DebtAndEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_12c37efd-086f-42c0-a22c-87d3288da8a4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CommitmentToFundPartnershipMember_93d75dc4-aabe-4b92-b0f6-a33853477704_terseLabel_en-US" xlink:label="lab_ci_CommitmentToFundPartnershipMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment to fund partnership</link:label>
    <link:label id="lab_ci_CommitmentToFundPartnershipMember_label_en-US" xlink:label="lab_ci_CommitmentToFundPartnershipMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment To Fund Partnership [Member]</link:label>
    <link:label id="lab_ci_CommitmentToFundPartnershipMember_documentation_en-US" xlink:label="lab_ci_CommitmentToFundPartnershipMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment To Fund Partnership</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentToFundPartnershipMember" xlink:href="ci-20230331.xsd#ci_CommitmentToFundPartnershipMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CommitmentToFundPartnershipMember" xlink:to="lab_ci_CommitmentToFundPartnershipMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_c97bf672-112d-47e6-a390-cfbabbdf79bc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH USED IN INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_7ac67d80-fde4-4e4f-acd4-bf64e501ac65_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption_f9e3a6c9-1449-4edc-aa9a-22072d46fa13_terseLabel_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumption changes</link:label>
    <link:label id="lab_us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption_label_en-US" xlink:label="lab_us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Increase (Decrease) from Other Assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption" xlink:to="lab_us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember_7c57e1cb-ce49-4dee-ad43-dcf00abb674b_terseLabel_en-US" xlink:label="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Berkshire Hathaway Life Insurance Company of Nebraska</link:label>
    <link:label id="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember_e5b5f4c8-e264-4930-903d-e30df3ec54b2_verboseLabel_en-US" xlink:label="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Berkshire</link:label>
    <link:label id="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember_label_en-US" xlink:label="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Berkshire Hathway Life Insurance Company Of Nebraska [Member]</link:label>
    <link:label id="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember_documentation_en-US" xlink:label="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Berkshire Hathway Life Insurance Company Of Nebraska</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember" xlink:href="ci-20230331.xsd#ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember" xlink:to="lab_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_1832affc-def5-4c4f-a549-e9bba81511b0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e76be005-af3e-47e8-afa9-a84f6665d2d3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHAREHOLDERS' COMPREHENSIVE INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_156b0dd1-9c51-43d9-a562-d0a61cf61214_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for guarantees</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:to="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember_d1e82022-525b-46b8-b83a-ac99db34ef47_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation of foreign currencies attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_a6ca11e7-561a-4005-a7a0-04bb4f5fe7c1_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b23aa1dd-74f0-4275-a8dd-45abdb09aac4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarized Segment Financial Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable_71f7de89-24ea-4657-a508-987cbb30d1a9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Loans Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract_edabb22f-5d3c-4734-9d6c-d0523c0aa697_terseLabel_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract_label_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount, Before Reclassification To Disposal Group, Assets Held For Sale [Abstract]</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract" xlink:to="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_f76a20dc-6cf9-44e3-8693-7fa08a6e81a0_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity_b05c65b3-c9d3-44d9-b522-347b5e31e36a_terseLabel_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation of foreign currencies, before tax</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity_label_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Before Tax, Including Temporary Equity</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity_documentation_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Before Tax, Including Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity" xlink:to="lab_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue2024613InterestMember_ca46965b-d947-493c-911a-86902d7bc57f_terseLabel_en-US" xlink:label="lab_ci_NotesDue2024613InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500 million, 0.613% Notes due March 2024</link:label>
    <link:label id="lab_ci_NotesDue2024613InterestMember_label_en-US" xlink:label="lab_ci_NotesDue2024613InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2024 .613% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue2024613InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue2024613InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable bearing .613% interest due in 2024.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2024613InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue2024613InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue2024613InterestMember" xlink:to="lab_ci_NotesDue2024613InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AllowanceForReceivablesCurrent_040dd1d5-5f62-4180-845f-9ecd422c7da3_terseLabel_en-US" xlink:label="lab_ci_AllowanceForReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for receivables, current</link:label>
    <link:label id="lab_ci_AllowanceForReceivablesCurrent_label_en-US" xlink:label="lab_ci_AllowanceForReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Receivables Current</link:label>
    <link:label id="lab_ci_AllowanceForReceivablesCurrent_documentation_en-US" xlink:label="lab_ci_AllowanceForReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of allowance for receivables, classified as current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AllowanceForReceivablesCurrent" xlink:href="ci-20230331.xsd#ci_AllowanceForReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AllowanceForReceivablesCurrent" xlink:to="lab_ci_AllowanceForReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SwapMember_4cbaf0e4-ffb7-4c25-a444-438e1d7d0f9f_terseLabel_en-US" xlink:label="lab_us-gaap_SwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swaps</link:label>
    <link:label id="lab_us-gaap_SwapMember_label_en-US" xlink:label="lab_us-gaap_SwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SwapMember" xlink:to="lab_us-gaap_SwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_14c62be4-15ac-4f35-a8dc-6c6cde586672_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member_0b8ba907-3f0d-4db6-82b8-2a7e8015352b_terseLabel_en-US" xlink:label="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364 Day Revolving Credit Agreement, Maturing April 2023</link:label>
    <link:label id="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member_label_en-US" xlink:label="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364 Day Revolving Credit Agreement, Maturing April 2023 [Member]</link:label>
    <link:label id="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member_documentation_en-US" xlink:label="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364 Day Revolving Credit Agreement, Maturing April 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member" xlink:href="ci-20230331.xsd#ci_A364DayRevolvingCreditAgreementMaturingApril2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member" xlink:to="lab_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d4b5b3b5-85f8-4cd8-a525-f65799db2bc8_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SupplierFinanceProgramTextBlock_2bb0ff5d-71fc-4796-bca1-4d1b11f1ceb5_terseLabel_en-US" xlink:label="lab_ci_SupplierFinanceProgramTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program</link:label>
    <link:label id="lab_ci_SupplierFinanceProgramTextBlock_label_en-US" xlink:label="lab_ci_SupplierFinanceProgramTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program [Text Block]</link:label>
    <link:label id="lab_ci_SupplierFinanceProgramTextBlock_documentation_en-US" xlink:label="lab_ci_SupplierFinanceProgramTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for supplier finance program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SupplierFinanceProgramTextBlock" xlink:href="ci-20230331.xsd#ci_SupplierFinanceProgramTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SupplierFinanceProgramTextBlock" xlink:to="lab_ci_SupplierFinanceProgramTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_861d04b5-306c-48a5-8b16-3542a7370fb3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_345431c7-e434-45ef-9ae0-8773f29a88b7_terseLabel_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_label_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Total [Abstract]</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_documentation_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract" xlink:to="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_aa97e738-f244-4067-8fe6-c3905df62a8d_terseLabel_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain_38f034ef-cc4e-4e19-99ee-7af8836991d4_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Guaranteed Minimum Crediting Rate Range [Domain]</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Guaranteed Minimum Crediting Rate Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain" xlink:to="lab_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity_eb7c29a4-1112-4e77-a9e7-60865a67037f_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIEs, Carrying value</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Variable Interest Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestInVariableInterestEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:to="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5d0dd49a-06bf-4802-b568-8c6b557d6294_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense and other</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_4beff103-ca98-44e8-b739-935c1f42c71c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity_f451f1a0-6f25-4db2-9e27-3dd4c85ffa1d_terseLabel_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net translation gains (losses) on foreign currencies</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity_label_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Including Temporary Equity</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity_documentation_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Including Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity" xlink:to="lab_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_d13f4996-5281-4199-9558-1890f3c80bf6_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:to="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceGuaranteeMember_03462cd7-7ebc-4026-9ede-1d6775c8059c_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Guarantee</link:label>
    <link:label id="lab_us-gaap_PerformanceGuaranteeMember_label_en-US" xlink:label="lab_us-gaap_PerformanceGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Guarantee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceGuaranteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceGuaranteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceGuaranteeMember" xlink:to="lab_us-gaap_PerformanceGuaranteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_871dcb06-f8f9-4c64-aaee-1e3ae4ff5c56_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5098ef58-08f0-4b0f-b99c-3ba5be28947a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderFunds_bf75f2da-1357-4204-baeb-e261d8a367f8_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder account balance</link:label>
    <link:label id="lab_us-gaap_PolicyholderFunds_label_en-US" xlink:label="lab_us-gaap_PolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderFunds" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderFunds" xlink:to="lab_us-gaap_PolicyholderFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_400a30db-8280-40c4-a28e-96b4f6d21813_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_3dbe4d53-cd49-4d8a-9d3c-df5ea72b91f7_terseLabel_en-US" xlink:label="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities with no readily determinable fair values including held for sale assets</link:label>
    <link:label id="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Amortized Cost, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:label id="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Amortized Cost, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_6d278068-8d70-4338-a774-a9924a5820e7_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranteed Insurance Contract, Type of Benefit [Domain]</link:label>
    <link:label id="lab_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_label_en-US" xlink:label="lab_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranteed Insurance Contract, Type of Benefit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain" xlink:to="lab_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EmpowerAnnuityInsuranceCompanyMember_1e1ceede-6549-4a56-994f-aba76c296331_terseLabel_en-US" xlink:label="lab_ci_EmpowerAnnuityInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Empower Annuity Insurance Company</link:label>
    <link:label id="lab_ci_EmpowerAnnuityInsuranceCompanyMember_label_en-US" xlink:label="lab_ci_EmpowerAnnuityInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Empower Annuity Insurance Company [Member]</link:label>
    <link:label id="lab_ci_EmpowerAnnuityInsuranceCompanyMember_documentation_en-US" xlink:label="lab_ci_EmpowerAnnuityInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Empower Annuity Insurance Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EmpowerAnnuityInsuranceCompanyMember" xlink:href="ci-20230331.xsd#ci_EmpowerAnnuityInsuranceCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EmpowerAnnuityInsuranceCompanyMember" xlink:to="lab_ci_EmpowerAnnuityInsuranceCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_0dbc83bb-8827-49dc-8199-e3b4e189a621_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherOperationsInternationalBusinessesToBeSoldMember_d1bdb5ee-596b-48ad-95c4-40062deb143c_terseLabel_en-US" xlink:label="lab_ci_OtherOperationsInternationalBusinessesToBeSoldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International businesses [to be] sold to Chubb</link:label>
    <link:label id="lab_ci_OtherOperationsInternationalBusinessesToBeSoldMember_label_en-US" xlink:label="lab_ci_OtherOperationsInternationalBusinessesToBeSoldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operations, International Businesses To Be Sold [Member]</link:label>
    <link:label id="lab_ci_OtherOperationsInternationalBusinessesToBeSoldMember_documentation_en-US" xlink:label="lab_ci_OtherOperationsInternationalBusinessesToBeSoldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International businesses to be sold to Chubb (excludes interest in Turkiye joint venture).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsInternationalBusinessesToBeSoldMember" xlink:href="ci-20230331.xsd#ci_OtherOperationsInternationalBusinessesToBeSoldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherOperationsInternationalBusinessesToBeSoldMember" xlink:to="lab_ci_OtherOperationsInternationalBusinessesToBeSoldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_fb9d5c56-062a-480a-b0a6-2a1b5601f7fb_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_b31e625d-0662-4008-9fdf-cff362108694_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax_87f0c439-5ed2-436b-879d-02e5966caad0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonperformance risk (own credit risk), end of period</link:label>
    <link:label id="lab_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax_31a16473-767f-436d-b2d6-45233290d263_terseLabel_en-US" xlink:label="lab_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount at risk</link:label>
    <link:label id="lab_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax_label_en-US" xlink:label="lab_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax" xlink:to="lab_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_ee1a389c-1658-4853-b134-774a6e2574a0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ProceedsFromRepaymentsOfOtherShortTermDebt_ba0edebf-7a86-4518-a09d-e19919271e7b_terseLabel_en-US" xlink:label="lab_ci_ProceedsFromRepaymentsOfOtherShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in short-term debt</link:label>
    <link:label id="lab_ci_ProceedsFromRepaymentsOfOtherShortTermDebt_label_en-US" xlink:label="lab_ci_ProceedsFromRepaymentsOfOtherShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From (Repayments Of) Other Short-Term Debt</link:label>
    <link:label id="lab_ci_ProceedsFromRepaymentsOfOtherShortTermDebt_documentation_en-US" xlink:label="lab_ci_ProceedsFromRepaymentsOfOtherShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of cash outflow for principal payment on finance lease and the net proceeds from (repayments of) short-term debt, defined as borrowing having initial term of repayment of one year or less.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ProceedsFromRepaymentsOfOtherShortTermDebt" xlink:href="ci-20230331.xsd#ci_ProceedsFromRepaymentsOfOtherShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ProceedsFromRepaymentsOfOtherShortTermDebt" xlink:to="lab_ci_ProceedsFromRepaymentsOfOtherShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_cbc5c766-af1c-4761-aa84-04d7b7104808_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common dividends declared (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_69ff6001-15e1-451f-a71f-5baa67672e67_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InvestmentIncomeAndGainsAndLossesAbstract_label_en-US" xlink:label="lab_ci_InvestmentIncomeAndGainsAndLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income And Gains And Losses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentIncomeAndGainsAndLossesAbstract" xlink:href="ci-20230331.xsd#ci_InvestmentIncomeAndGainsAndLossesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InvestmentIncomeAndGainsAndLossesAbstract" xlink:to="lab_ci_InvestmentIncomeAndGainsAndLossesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_a677e566-b6c9-4e42-a091-b7818e129c2b_totalLabel_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_label_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Including Temporary Equity</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_documentation_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Including Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity" xlink:to="lab_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember_72f3b3ab-fb15-4e7d-b721-486acbfa1e37_terseLabel_en-US" xlink:label="lab_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral provisions exist that may mitigate risk of credit loss</link:label>
    <link:label id="lab_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember_label_en-US" xlink:label="lab_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Secured, Collateral Provisions Exist That May Mitigate Risk [Member]</link:label>
    <link:label id="lab_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember_documentation_en-US" xlink:label="lab_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Secured, Collateral Provisions Exist That May Mitigate Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember" xlink:href="ci-20230331.xsd#ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember" xlink:to="lab_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_458cebaf-f6ce-47b4-a4fe-be015e5dd490_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_3ad37f25-2ebb-43e5-843a-83e33192a724_terseLabel_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid Claims and Claims Expenses</link:label>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:to="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OrganizationalEfficiencyPlanCharges_f76ee8e2-36ba-479f-ae50-9738d0e0e90c_terseLabel_en-US" xlink:label="lab_ci_OrganizationalEfficiencyPlanCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge for organizational efficiency plan, 2020 (Selling, general and administrative expenses)</link:label>
    <link:label id="lab_ci_OrganizationalEfficiencyPlanCharges_19e80117-d22b-4a4b-aab4-b3f71eeaf7a1_verboseLabel_en-US" xlink:label="lab_ci_OrganizationalEfficiencyPlanCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge for organizational efficiency plan, 2020</link:label>
    <link:label id="lab_ci_OrganizationalEfficiencyPlanCharges_label_en-US" xlink:label="lab_ci_OrganizationalEfficiencyPlanCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Efficiency Plan Charges</link:label>
    <link:label id="lab_ci_OrganizationalEfficiencyPlanCharges_documentation_en-US" xlink:label="lab_ci_OrganizationalEfficiencyPlanCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organizational Efficiency Plan Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OrganizationalEfficiencyPlanCharges" xlink:href="ci-20230331.xsd#ci_OrganizationalEfficiencyPlanCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OrganizationalEfficiencyPlanCharges" xlink:to="lab_ci_OrganizationalEfficiencyPlanCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_6aae267a-186c-43dc-bdf7-def0140e6a7d_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RealizedInvestmentGainLoss_7cc2fe46-b891-420b-9e5e-5431dff7fe8a_terseLabel_en-US" xlink:label="lab_ci_RealizedInvestmentGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized investment losses</link:label>
    <link:label id="lab_ci_RealizedInvestmentGainLoss_7e7d1570-139e-4db0-b691-ae90601b32d0_negatedLabel_en-US" xlink:label="lab_ci_RealizedInvestmentGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized investment losses, net</link:label>
    <link:label id="lab_ci_RealizedInvestmentGainLoss_b7028aa3-561c-4047-94fe-f53013b875e2_totalLabel_en-US" xlink:label="lab_ci_RealizedInvestmentGainLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized investment (losses), before income taxes</link:label>
    <link:label id="lab_ci_RealizedInvestmentGainLoss_label_en-US" xlink:label="lab_ci_RealizedInvestmentGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gain Loss</link:label>
    <link:label id="lab_ci_RealizedInvestmentGainLoss_documentation_en-US" xlink:label="lab_ci_RealizedInvestmentGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net realized gains or (losses) on investments during the period, including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLoss" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RealizedInvestmentGainLoss" xlink:to="lab_ci_RealizedInvestmentGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_ebb4feaf-ae18-4944-b9cf-c9fdc960239f_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherOperationsSegmentOtherMember_aacf408b-27de-431a-b437-1f37a4375265_terseLabel_en-US" xlink:label="lab_ci_OtherOperationsSegmentOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ci_OtherOperationsSegmentOtherMember_label_en-US" xlink:label="lab_ci_OtherOperationsSegmentOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operations Segment, Other [Member]</link:label>
    <link:label id="lab_ci_OtherOperationsSegmentOtherMember_documentation_en-US" xlink:label="lab_ci_OtherOperationsSegmentOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operations Segment, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentOtherMember" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherOperationsSegmentOtherMember" xlink:to="lab_ci_OtherOperationsSegmentOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_a860e856-62a8-4ca7-a05e-3aa903adb8f0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized depreciation on investments and foreign currency translation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:to="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EvernorthMember_e9888a3d-3e40-4026-803d-7d0523a527b2_terseLabel_en-US" xlink:label="lab_ci_EvernorthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evernorth Health Services</link:label>
    <link:label id="lab_ci_EvernorthMember_label_en-US" xlink:label="lab_ci_EvernorthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evernorth [Member]</link:label>
    <link:label id="lab_ci_EvernorthMember_documentation_en-US" xlink:label="lab_ci_EvernorthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Services includes pharmacy benefits management (PBM), pharmacy home delivery, and certain medical management services. This segment includes Express Scripts business from the date of acquisition with the exception of Express Scripts Medicare Part D business that is reported in the Government operating segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EvernorthMember" xlink:href="ci-20230331.xsd#ci_EvernorthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EvernorthMember" xlink:to="lab_ci_EvernorthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoanToValueAxis_851d1d5f-cb64-48ca-91f7-fc1fb9ea5ac0_terseLabel_en-US" xlink:label="lab_us-gaap_LoanToValueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt-to-Value [Axis]</link:label>
    <link:label id="lab_us-gaap_LoanToValueAxis_label_en-US" xlink:label="lab_us-gaap_LoanToValueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt-to-Value [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoanToValueAxis" xlink:to="lab_us-gaap_LoanToValueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember_feb5026f-8433-49d7-989e-e722fc1b9230_terseLabel_en-US" xlink:label="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not rated</link:label>
    <link:label id="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember_label_en-US" xlink:label="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nationally Recognized Statisical Rating Organizations (NRSRO), Not Rated [Member]</link:label>
    <link:label id="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember_documentation_en-US" xlink:label="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nationally Recognized Statisical Rating Organizations (NRSRO), Not Rated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember" xlink:href="ci-20230331.xsd#ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember" xlink:to="lab_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LtvGreaterThan100PercentMember_d4ddd30b-bd65-4922-96a9-8650dabbf092_terseLabel_en-US" xlink:label="lab_ci_LtvGreaterThan100PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than 100%</link:label>
    <link:label id="lab_ci_LtvGreaterThan100PercentMember_label_en-US" xlink:label="lab_ci_LtvGreaterThan100PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ltv Greater Than 100 Percent [Member]</link:label>
    <link:label id="lab_ci_LtvGreaterThan100PercentMember_documentation_en-US" xlink:label="lab_ci_LtvGreaterThan100PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt-to-value ratio greater than 100 percent. Element name an standard label in DTV [numeric lower end] to [numeric higher end] Percent [Member] format.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LtvGreaterThan100PercentMember" xlink:href="ci-20230331.xsd#ci_LtvGreaterThan100PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LtvGreaterThan100PercentMember" xlink:to="lab_ci_LtvGreaterThan100PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups_c507bbfc-510f-4f08-9016-839c8772b751_terseLabel_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid claims classified as liabilities of business held for sale</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups_label_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Claims And Claims Adjustment Expense Attributable To Disposal Groups</link:label>
    <link:label id="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups_documentation_en-US" xlink:label="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Claims And Claims Adjustment Expense Attributable To Disposal Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups" xlink:to="lab_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_6990a3e7-5768-443f-aece-bbb063b8335b_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_7095430e-4b4b-4dcd-a084-454be32e71a6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income distributions</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain_91ee968a-fd93-4b71-a294-f399abe237f3_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, above Guaranteed Minimum Crediting Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, above Guaranteed Minimum Crediting Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain" xlink:to="lab_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax_b084b010-2bc4-40d4-a4ba-a720b4bc1f9e_verboseLabel_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized appreciation (depreciation) on securities and derivatives</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax_label_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-For-Sale Securities And Derivatives Adjustment, Net Of Tax</link:label>
    <link:label id="lab_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax_documentation_en-US" xlink:label="lab_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-For-Sale Securities And Derivatives Adjustment, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax" xlink:to="lab_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale_2b7a90e4-d545-4f7e-a119-22962e1c9b16_terseLabel_en-US" xlink:label="lab_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities, including held for sale liabilities</link:label>
    <link:label id="lab_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale_label_en-US" xlink:label="lab_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liabilities Before Reclassification To Disposal Group Liabilities Held For Sale</link:label>
    <link:label id="lab_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale_documentation_en-US" xlink:label="lab_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liabilities Before Reclassification To Disposal Group Liabilities Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale" xlink:href="ci-20230331.xsd#ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale" xlink:to="lab_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskTable_7974cf44-c32e-41e8-a1ff-eddc46851fca_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Table]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskTable_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskTable" xlink:to="lab_us-gaap_CededCreditRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_5c5a4860-872b-4862-8cc6-3ee4ed3301ca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_d0db1ccc-562e-447d-bbfd-636537f854ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables by Range of External Credit Rating and Collateral Level</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:to="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition_b6165aef-16f9-4767-b409-c4e828bfcd3a_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances and lapses</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Future Policy Benefit, Issuance And Derecognition</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Future Policy Benefit, Issuance And Derecognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_22361800-3856-4ea2-9f3c-0ae6ac556ca9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_3c6e73a5-1ae3-412a-beb8-8bcd3cd011a2_totalLabel_en-US" xlink:label="lab_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments including held for sale assets</link:label>
    <link:label id="lab_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance_6006efba-d343-4ae9-a17b-6a6d72e7f8cb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted expected future gross premiums</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Gross Premium, Discounted, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_9ddb69f5-d651-486e-844d-cdcc83cdb49d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Incentive Plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_a4952e03-07e4-4f94-9891-65d3e4a617ef_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative gain (loss) recognized in the income statement</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract_ff12a6e7-826d-4869-8633-8866673de41c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers into/(out of) Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_32ffc948-a65c-45d7-8a6b-fb67d8a5b4a1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LineOfCreditFacilityConversionToTermLoanTerm_b34efeaf-000d-4814-894a-a9cc7b16b529_terseLabel_en-US" xlink:label="lab_ci_LineOfCreditFacilityConversionToTermLoanTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility, conversion to term loan, term</link:label>
    <link:label id="lab_ci_LineOfCreditFacilityConversionToTermLoanTerm_label_en-US" xlink:label="lab_ci_LineOfCreditFacilityConversionToTermLoanTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Conversion To Term Loan, Term</link:label>
    <link:label id="lab_ci_LineOfCreditFacilityConversionToTermLoanTerm_documentation_en-US" xlink:label="lab_ci_LineOfCreditFacilityConversionToTermLoanTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Conversion To Term Loan, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LineOfCreditFacilityConversionToTermLoanTerm" xlink:href="ci-20230331.xsd#ci_LineOfCreditFacilityConversionToTermLoanTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LineOfCreditFacilityConversionToTermLoanTerm" xlink:to="lab_ci_LineOfCreditFacilityConversionToTermLoanTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1f52ba5d-1138-40a0-8108-491ec83aa7e6_totalLabel_en-US" xlink:label="lab_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments including held for sale assets</link:label>
    <link:label id="lab_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_2dafe540-8613-4c97-83ec-1e2bba004af7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge for organizational efficiency plan (Selling, general and administrative expenses)</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_9985d830-a6a4-4543-a6d0-1bb67ab4bcfc_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge for organizational efficiency plan</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue204849InterestMember_423a9d0a-82f4-4501-ab53-34fbcfebe7f8_terseLabel_en-US" xlink:label="lab_ci_NotesDue204849InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$3,000&#160;million, 4.900% Notes due December 2048</link:label>
    <link:label id="lab_ci_NotesDue204849InterestMember_label_en-US" xlink:label="lab_ci_NotesDue204849InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2048, 4.9% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue204849InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue204849InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes payable bearing interest at 4.9% due in 2048. Debt issued to finance acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue204849InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue204849InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue204849InterestMember" xlink:to="lab_ci_NotesDue204849InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock_5fab1ae9-5fe7-46df-befe-d8340d47a5c3_terseLabel_en-US" xlink:label="lab_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Amounts of Debt and Finance Leases</link:label>
    <link:label id="lab_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Short Term Debt Long Term Debt [Table Text Block]</link:label>
    <link:label id="lab_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock_documentation_en-US" xlink:label="lab_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance-sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation. Also, Pertinent information about each long-term debt arrangement including the carrying amount as of the balance sheet date, by type of long-term debt. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock" xlink:href="ci-20230331.xsd#ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock" xlink:to="lab_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups_3e862b5c-71b1-4c8a-94bc-a03087a9c304_terseLabel_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities, Noncurrent, Including Disposal Groups</link:label>
    <link:label id="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Contractholder Liabilities, Noncurrent, Including Disposal Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups" xlink:to="lab_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_5a45242b-23ae-4a9d-8665-65ba045e316a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_7d8febd9-5ab8-4486-ab2e-81ad3937ece3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_194acfe4-cd50-43ab-a992-c41a08ebbad0_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_711e663f-18e7-4e22-94e1-d9b2d1e54899_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityOtherChanges_9871f6f0-2f3b-4998-b566-159d794b13d3_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityOtherChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other transactions impacting noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityOtherChanges_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityOtherChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Other Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityOtherChanges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityOtherChanges" xlink:to="lab_us-gaap_TemporaryEquityOtherChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e7fc9525-f83b-4e14-a14d-258d2a0e242c_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_12fb8b31-d319-474e-bbf6-83042c0fb96e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ReinsuranceRecoverablesNonCurrent_7652263c-7e04-4e81-b958-d894e4300d62_terseLabel_en-US" xlink:label="lab_ci_ReinsuranceRecoverablesNonCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables</link:label>
    <link:label id="lab_ci_ReinsuranceRecoverablesNonCurrent_label_en-US" xlink:label="lab_ci_ReinsuranceRecoverablesNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Noncurrent</link:label>
    <link:label id="lab_ci_ReinsuranceRecoverablesNonCurrent_documentation_en-US" xlink:label="lab_ci_ReinsuranceRecoverablesNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount, after valuation allowance, recoverable after one year under reinsurance contracts including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ReinsuranceRecoverablesNonCurrent" xlink:href="ci-20230331.xsd#ci_ReinsuranceRecoverablesNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ReinsuranceRecoverablesNonCurrent" xlink:to="lab_ci_ReinsuranceRecoverablesNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_FinancingReceivableCreditQualityLoanToValueRatio_0643560e-8f21-4b4a-9c94-51fc6935525c_terseLabel_en-US" xlink:label="lab_ci_FinancingReceivableCreditQualityLoanToValueRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Loan-to-Value Ratio</link:label>
    <link:label id="lab_ci_FinancingReceivableCreditQualityLoanToValueRatio_label_en-US" xlink:label="lab_ci_FinancingReceivableCreditQualityLoanToValueRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable Credit Quality Loan To Value Ratio</link:label>
    <link:label id="lab_ci_FinancingReceivableCreditQualityLoanToValueRatio_documentation_en-US" xlink:label="lab_ci_FinancingReceivableCreditQualityLoanToValueRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable Credit Quality Loan To Value Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FinancingReceivableCreditQualityLoanToValueRatio" xlink:href="ci-20230331.xsd#ci_FinancingReceivableCreditQualityLoanToValueRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_FinancingReceivableCreditQualityLoanToValueRatio" xlink:to="lab_ci_FinancingReceivableCreditQualityLoanToValueRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AlternativeInvestment_a7c3fc2b-5b15-4ff4-be53-3f0c8bea5009_terseLabel_en-US" xlink:label="lab_us-gaap_AlternativeInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AlternativeInvestment_label_en-US" xlink:label="lab_us-gaap_AlternativeInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AlternativeInvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AlternativeInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AlternativeInvestment" xlink:to="lab_us-gaap_AlternativeInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_a5f81551-1855-436b-8482-19d3e2a5dac1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_c6199f53-559a-4861-b707-c02aba3d9820_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies &#8212; Note 16</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RetirementAndLifeInsuranceContractsMember_c63badd0-62d5-43b0-93ff-e9de2bc31afe_terseLabel_en-US" xlink:label="lab_ci_RetirementAndLifeInsuranceContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retiree and Life Insurance Benefits</link:label>
    <link:label id="lab_ci_RetirementAndLifeInsuranceContractsMember_label_en-US" xlink:label="lab_ci_RetirementAndLifeInsuranceContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement And Life Insurance Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RetirementAndLifeInsuranceContractsMember" xlink:href="ci-20230331.xsd#ci_RetirementAndLifeInsuranceContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RetirementAndLifeInsuranceContractsMember" xlink:to="lab_ci_RetirementAndLifeInsuranceContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_bd870bd8-5de6-4e5b-8520-fefa9434f416_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments by category and current or long-term classification</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings, Schedule of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:to="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_918af587-2b3b-4de9-a0f3-455c0b053e88_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents reclassified to Assets of businesses held for sale</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_df799227-e011-4107-b53a-c447b47dc58e_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, reported in Assets of businesses held for sale</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_9d30d863-fec3-42b9-a7aa-dece517b6d2c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale_105ff35b-a27a-4cea-b5a5-7f2c266fe21d_terseLabel_en-US" xlink:label="lab_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum percentage of investments classified in Level 2 representing foreign bonds priced using unadjusted broker quotes</link:label>
    <link:label id="lab_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Percent Level2 Investments Foreign Bonds Broker Quote Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Percent Level2 Investments Foreign Bonds Broker Quote Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_bfb81edd-6656-46a6-9497-ba21f9738e5f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred policy acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8ad7539a-698e-488b-83bd-d664636afdc1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ffac281f-c068-4e8f-9b17-d692faeb169f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative gain (loss) reclassified from other comprehensive income into shareholders' net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4632228e-8a1b-4e91-9806-1c3dd70b4a83_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal_ac13b0a2-1c51-491c-8a78-a0419dbf4ba8_negatedLabel_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss recoveries</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal_label_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, And Commercial Mortgage Loans, Allowance For Credit Loss, Expense (Reversal)</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal_documentation_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, And Commercial Mortgage Loans, Allowance For Credit Loss, Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal" xlink:to="lab_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ImpairmentsOnInvestmentsTotal_eaba6d4e-ef1d-4670-b676-1ce909b2723b_negatedLabel_en-US" xlink:label="lab_ci_ImpairmentsOnInvestmentsTotal" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investment asset write-downs</link:label>
    <link:label id="lab_ci_ImpairmentsOnInvestmentsTotal_label_en-US" xlink:label="lab_ci_ImpairmentsOnInvestmentsTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments On Investments Total</link:label>
    <link:label id="lab_ci_ImpairmentsOnInvestmentsTotal_documentation_en-US" xlink:label="lab_ci_ImpairmentsOnInvestmentsTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total impairments recorded in pre-tax realized investment losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ImpairmentsOnInvestmentsTotal" xlink:href="ci-20230331.xsd#ci_ImpairmentsOnInvestmentsTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ImpairmentsOnInvestmentsTotal" xlink:to="lab_ci_ImpairmentsOnInvestmentsTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b7add0fc-1d37-4d86-9265-b49042e94892_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_bcf7824d-2567-4c3f-8710-eee1240351ab_terseLabel_en-US" xlink:label="lab_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Level 3 Financial Assets and Financial Liabilities Carried at Fair Value</link:label>
    <link:label id="lab_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_label_en-US" xlink:label="lab_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_documentation_en-US" xlink:label="lab_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the fair value measurement of assets and liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3, by class of assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:href="ci-20230331.xsd#ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:to="lab_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_531770e4-6503-499c-b972-4b7259a92018_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment for amortization of net prior actuarial losses and prior service costs (Interest expense and other)</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c90fc59f-4a0e-44ce-84f1-3c873a72acaf_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MarketRiskBenefitLiabilityAmountCurrent_4d2d9707-585e-4192-aaca-f874a7553018_terseLabel_en-US" xlink:label="lab_ci_MarketRiskBenefitLiabilityAmountCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market risk benefits, current</link:label>
    <link:label id="lab_ci_MarketRiskBenefitLiabilityAmountCurrent_label_en-US" xlink:label="lab_ci_MarketRiskBenefitLiabilityAmountCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Liability, Amount, Current</link:label>
    <link:label id="lab_ci_MarketRiskBenefitLiabilityAmountCurrent_documentation_en-US" xlink:label="lab_ci_MarketRiskBenefitLiabilityAmountCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit, Liability, Amount, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitLiabilityAmountCurrent" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitLiabilityAmountCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MarketRiskBenefitLiabilityAmountCurrent" xlink:to="lab_ci_MarketRiskBenefitLiabilityAmountCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_a4e479ee-c58b-4d32-af3a-7d4388b7c1fd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred costs related to:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale_9c71912e-c446-42d3-ad11-36ae71ad8396_terseLabel_en-US" xlink:label="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of debt and equity securities classified in Level 2</link:label>
    <link:label id="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities Classified In Level2 Percentage Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities Classified In Level2 Percentage Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_1dab8e89-d04f-4c16-b46b-0deb0596349e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_18a46fef-116b-4b54-aebf-0e28057da22f_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_8d801949-0cfb-4423-89cd-36c9e950db38_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_4f105ac1-f0dc-4df7-a41a-fb268e1669f7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent_e6d42071-0990-4011-9151-9c2d134a8de8_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefits, noncurrent</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Before Reinsurance, Noncurrent</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Before Reinsurance, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue20425375InterestMember_1f6da512-07ae-40d8-8a23-422ddec44a90_terseLabel_en-US" xlink:label="lab_ci_NotesDue20425375InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$317&#160;million, 5.375% Notes due February 2042</link:label>
    <link:label id="lab_ci_NotesDue20425375InterestMember_label_en-US" xlink:label="lab_ci_NotesDue20425375InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2042, 5.375% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue20425375InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue20425375InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable bearing interest at 5.375% due in 2042.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20425375InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue20425375InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue20425375InterestMember" xlink:to="lab_ci_NotesDue20425375InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_fdf2dfb4-5fd5-4ba4-ba4b-543cc8ee5e89_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups_d94704cd-65c5-4db3-b152-f020e7e33e5f_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefits classified as liabilities of business held for sale</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefits Attributable To Disposal Groups</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefits Attributable To Disposal Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_7dbef196-d9f8-4af4-ae40-533397f84aae_terseLabel_en-US" xlink:label="lab_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, Parent</link:label>
    <link:label id="lab_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_label_en-US" xlink:label="lab_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" xlink:to="lab_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent_fe5d1bf3-bd2e-4912-8cdd-66a21848607d_negatedLabel_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments classified as assets of business held for sale</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent_label_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Current Investments, Current</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent_documentation_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Current Investments, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent" xlink:to="lab_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ed2e7728-8b82-4f50-887b-892b433ccbfb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7ce72439-19a6-43bd-96b0-bf63857a1f88_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to diluted earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_75a6c530-4c6c-4dc2-9bd8-64c32fb9e1ac_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPS, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_OtherVariableInterestEntitiesMember_dbb20570-64b1-493f-a847-be247596268d_terseLabel_en-US" xlink:label="lab_ci_OtherVariableInterestEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Variable Interest Entities</link:label>
    <link:label id="lab_ci_OtherVariableInterestEntitiesMember_label_en-US" xlink:label="lab_ci_OtherVariableInterestEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Variable Interest Entities [Member]</link:label>
    <link:label id="lab_ci_OtherVariableInterestEntitiesMember_documentation_en-US" xlink:label="lab_ci_OtherVariableInterestEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Variable Interest Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherVariableInterestEntitiesMember" xlink:href="ci-20230331.xsd#ci_OtherVariableInterestEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_OtherVariableInterestEntitiesMember" xlink:to="lab_ci_OtherVariableInterestEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable_24211ff5-b8d4-46ec-804a-33ca793499f5_terseLabel_en-US" xlink:label="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount at Risk, by Product and Guarantee [Table]</link:label>
    <link:label id="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable_label_en-US" xlink:label="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount at Risk, by Product and Guarantee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable" xlink:to="lab_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_f47f1bf8-39a0-49b8-9134-14d5b784f661_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_acdb540f-63a0-4072-be5e-ed7d8b40e5f7_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_9a9cdf1b-3ef5-41ac-b1cc-e075ab4b0085_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized investment gains on equity securities with no readily determinable fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember_f32366c3-339a-4ef6-8a7e-f077051ef74f_terseLabel_en-US" xlink:label="lab_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln National Life and Lincoln Life &amp; Annuity of New York</link:label>
    <link:label id="lab_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember_label_en-US" xlink:label="lab_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Lincoln National Life Insurance Company And Lincoln Life And Annuity Of New York [Member]</link:label>
    <link:label id="lab_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember_documentation_en-US" xlink:label="lab_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables resulting from the 1998 sale of the Companys individual life insurance and annuity business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember" xlink:href="ci-20230331.xsd#ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember" xlink:to="lab_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuarantyLiabilities_d425d6bd-c4aa-4fa8-98e0-184c764ef374_terseLabel_en-US" xlink:label="lab_us-gaap_GuarantyLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty liability</link:label>
    <link:label id="lab_us-gaap_GuarantyLiabilities_label_en-US" xlink:label="lab_us-gaap_GuarantyLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuarantyLiabilities" xlink:to="lab_us-gaap_GuarantyLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_d665017b-3a11-4aac-8f4a-2d7cd3fa2ddd_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_94c84f66-6c00-49de-83a3-00a8fae51ab0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SeparateAccountAssetsMember_20403edc-5a94-48b0-8a23-ce0522f06e7f_terseLabel_en-US" xlink:label="lab_ci_SeparateAccountAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Assets</link:label>
    <link:label id="lab_ci_SeparateAccountAssetsMember_label_en-US" xlink:label="lab_ci_SeparateAccountAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Assets [Member]</link:label>
    <link:label id="lab_ci_SeparateAccountAssetsMember_documentation_en-US" xlink:label="lab_ci_SeparateAccountAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A separate investment account established and maintained by an insurance entity under relevant state insurance law to which funds have been allocated for certain contracts of the insurance entity. Funds in a separate account are not commingled with other assets of the insurance entity for investment purposes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsMember" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SeparateAccountAssetsMember" xlink:to="lab_ci_SeparateAccountAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestmentsAbstract_e3e4a00d-ab39-4ddb-82e9-66d2457847b3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term</link:label>
    <link:label id="lab_us-gaap_LongTermInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestmentsAbstract" xlink:to="lab_us-gaap_LongTermInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_7fcc4295-0fb4-4b53-9515-95644cf0c763_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_265a0f4d-6779-40fa-a573-979859ed5351_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_65031c66-9b56-41b6-93bb-005c7d4749d7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceRelatedAssessmentsMember_746cc5f5-9808-4dc3-9412-c47c0569996a_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceRelatedAssessmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty Fund Assessments</link:label>
    <link:label id="lab_us-gaap_InsuranceRelatedAssessmentsMember_label_en-US" xlink:label="lab_us-gaap_InsuranceRelatedAssessmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance-related Assessments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRelatedAssessmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceRelatedAssessmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceRelatedAssessmentsMember" xlink:to="lab_us-gaap_InsuranceRelatedAssessmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_3183a8b6-fa96-4b94-8f81-f24d2be156d0_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CignaHealthcareMember_85ff8a4d-8f90-44df-a067-6c51e143ef3a_terseLabel_en-US" xlink:label="lab_ci_CignaHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cigna Healthcare</link:label>
    <link:label id="lab_ci_CignaHealthcareMember_label_en-US" xlink:label="lab_ci_CignaHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cigna Healthcare [Member]</link:label>
    <link:label id="lab_ci_CignaHealthcareMember_documentation_en-US" xlink:label="lab_ci_CignaHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cigna Healthcare</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CignaHealthcareMember" xlink:to="lab_ci_CignaHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_a01394cd-c3b4-48a1-a478-e9eb94acc763_totalLabel_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, including held for sale assets</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount, Before Reclassification To Disposal Group, Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_VariableInterestEntitiesAbstract_34f37e99-af9d-4ef8-bdaf-92af257b736a_terseLabel_en-US" xlink:label="lab_ci_VariableInterestEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Abstract]</link:label>
    <link:label id="lab_ci_VariableInterestEntitiesAbstract_label_en-US" xlink:label="lab_ci_VariableInterestEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_VariableInterestEntitiesAbstract" xlink:href="ci-20230331.xsd#ci_VariableInterestEntitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_VariableInterestEntitiesAbstract" xlink:to="lab_ci_VariableInterestEntitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities_1d2f1c1e-e3ca-4bcc-a4fd-05cd2beadfa0_negatedTerseLabel_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and contractholder liabilities classified as held for sale</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities_label_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group,Including Discontinued Operation, Insurance And Contractholder Liabilities</link:label>
    <link:label id="lab_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities_documentation_en-US" xlink:label="lab_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group,Including Discontinued Operation, Insurance And Contractholder Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities" xlink:to="lab_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_f387e7c8-b3ff-4241-87d9-776a6846f14a_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_efc5d35f-c557-49fb-9be3-53d6a489a963_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less investment expenses</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Investment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_33d7f53e-532e-4f90-8221-667bb0319c3b_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment upon Adoption</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_1ca867d5-a78a-4fc2-8820-233a79b421b7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_46d002e3-38bf-426f-9d1a-372aa31690cf_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Financing Receivable [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Financing Receivable [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:to="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue_857dde3f-b818-4e23-972b-d9652dd25b36_terseLabel_en-US" xlink:label="lab_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage with cash values at more than 110% of guaranteed cash value</link:label>
    <link:label id="lab_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue_label_en-US" xlink:label="lab_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Percentage With Cash Values At More Than 110 Percent Of Guaranteed Cash Value</link:label>
    <link:label id="lab_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue_documentation_en-US" xlink:label="lab_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Percentage With Cash Values At More Than 110 Percent Of Guaranteed Cash Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue" xlink:href="ci-20230331.xsd#ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue" xlink:to="lab_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_59a6f49b-f88c-4b00-8cd5-184152940164_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpenses_d4688103-57d5-4e66-9d98-c3f2e00d847a_totalLabel_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL BENEFITS AND EXPENSES</link:label>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpenses_label_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits, Losses and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses" xlink:to="lab_us-gaap_BenefitsLossesAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateFundsMember_c7a86143-1059-4a2a-9144-cd328dadfcb7_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate funds</link:label>
    <link:label id="lab_us-gaap_RealEstateFundsMember_label_en-US" xlink:label="lab_us-gaap_RealEstateFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateFundsMember" xlink:to="lab_us-gaap_RealEstateFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableAnnuityMember_ba947dc7-27a4-4a79-bd9f-4aa9709d6759_terseLabel_en-US" xlink:label="lab_us-gaap_VariableAnnuityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Annuity</link:label>
    <link:label id="lab_us-gaap_VariableAnnuityMember_label_en-US" xlink:label="lab_us-gaap_VariableAnnuityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Annuity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableAnnuityMember" xlink:to="lab_us-gaap_VariableAnnuityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_d9624d52-b579-4c8b-91ee-ddc120e40773_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_22053ed4-5055-4f63-8a2f-c5951acd013f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of counts dismissed</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Dismissed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:to="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgeFundsMember_3b773249-3227-4792-9df1-9c9c41047ac5_terseLabel_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge funds</link:label>
    <link:label id="lab_us-gaap_HedgeFundsMember_label_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgeFundsMember" xlink:to="lab_us-gaap_HedgeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale_1a40d570-d073-48a9-b690-da447e183c9a_terseLabel_en-US" xlink:label="lab_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost, including held for sale assets</link:label>
    <link:label id="lab_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Debt Securities Amortized Cost Basis Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Debt Securities Amortized Cost Basis Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost_5c2c8c97-8861-4147-be0c-b050f902d48e_totalLabel_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortized Cost</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost_label_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Amortized Cost</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost_documentation_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost" xlink:to="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_5efcd5d1-adea-4c4e-ae0a-89b8c0291d47_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Operating Joint Ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoanToValueDomain_e9dc27fc-a511-4888-9efb-92fd95019062_terseLabel_en-US" xlink:label="lab_us-gaap_LoanToValueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt-to-Value [Domain]</link:label>
    <link:label id="lab_us-gaap_LoanToValueDomain_label_en-US" xlink:label="lab_us-gaap_LoanToValueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt-to-Value [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoanToValueDomain" xlink:to="lab_us-gaap_LoanToValueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost_30725368-1fb1-4b3f-8731-d21852a9e3f5_totalLabel_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost_label_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Less Than 12 Months, Amortized Cost</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost_documentation_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Less Than 12 Months, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost" xlink:to="lab_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_a466b040-9611-47b4-a1ed-043b206454f6_negatedTotalLabel_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Unrealized Depreciation, including held for sale assets</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Accumulated Loss, Before Reclassification To Disposal Group, Assets Held-For-Sale</link:label>
    <link:label id="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Accumulated Loss, Before Reclassification To Disposal Group, Assets Held-For-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_f61ef553-c612-40b4-a9a5-845388a2bdda_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue_c3cfdf52-5f4f-4409-a4ec-52c7b881d60d_terseLabel_en-US" xlink:label="lab_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income</link:label>
    <link:label id="lab_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue_label_en-US" xlink:label="lab_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest And Dividend Income Operating And Operating Leases Income Statement Lease Revenue</link:label>
    <link:label id="lab_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue_documentation_en-US" xlink:label="lab_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein. Also includes the total amount of revenue recognized for the period from operating leases, including minimum lease revenue, contingent revenue, percentage revenue and sublease revenue.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue" xlink:href="ci-20230331.xsd#ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue" xlink:to="lab_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_916b542c-08bd-4dc2-b90b-fc73b3a90dd1_terseLabel_en-US" xlink:label="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, Nationally Recognized Statistical Rating Organization (NRSRO) [Domain]</link:label>
    <link:label id="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_label_en-US" xlink:label="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, Nationally Recognized Statistical Rating Organization (NRSRO) [Domain]</link:label>
    <link:label id="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_documentation_en-US" xlink:label="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, Nationally Recognized Statistical Rating Organization (NRSRO)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain" xlink:href="ci-20230331.xsd#ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain" xlink:to="lab_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_5a985a9d-0c57-48b9-8f55-51df1fa8c5f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term investments</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_c54818fb-98c8-4521-ba11-2a3810ade9e9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term investments</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:to="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_AdministrativeServicesOnlyHealthCareServicesMember_b83c3017-1155-4964-8483-639d47b58e48_terseLabel_en-US" xlink:label="lab_ci_AdministrativeServicesOnlyHealthCareServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administrative Services Only Health Care Services</link:label>
    <link:label id="lab_ci_AdministrativeServicesOnlyHealthCareServicesMember_label_en-US" xlink:label="lab_ci_AdministrativeServicesOnlyHealthCareServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administrative Services Only Health Care Services [Member]</link:label>
    <link:label id="lab_ci_AdministrativeServicesOnlyHealthCareServicesMember_documentation_en-US" xlink:label="lab_ci_AdministrativeServicesOnlyHealthCareServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administrative Services Only Health Care Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AdministrativeServicesOnlyHealthCareServicesMember" xlink:href="ci-20230331.xsd#ci_AdministrativeServicesOnlyHealthCareServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_AdministrativeServicesOnlyHealthCareServicesMember" xlink:to="lab_ci_AdministrativeServicesOnlyHealthCareServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_ddecc10c-75b4-4d10-ac62-3f930fb10459_terseLabel_en-US" xlink:label="lab_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum total commitment</link:label>
    <link:label id="lab_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_label_en-US" xlink:label="lab_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity And Accordion Feature, Incremental Increase In Maximum Borrowing Capacity</link:label>
    <link:label id="lab_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity And Accordion Feature, Incremental Increase In Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" xlink:href="ci-20230331.xsd#ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" xlink:to="lab_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_4b2d4c2e-1fde-4a9f-99f0-d3c48b3990ae_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_TemporaryEquityOtherComprehensiveIncome_08d98226-0781-49d8-804c-6f5b8075b665_verboseLabel_en-US" xlink:label="lab_ci_TemporaryEquityOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss attributable to redeemable noncontrolling interests</link:label>
    <link:label id="lab_ci_TemporaryEquityOtherComprehensiveIncome_7ca36710-0fc2-419d-ab21-ceba4dd9d09b_netLabel_en-US" xlink:label="lab_ci_TemporaryEquityOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_ci_TemporaryEquityOtherComprehensiveIncome_bc7b0874-f528-4626-bb9b-3382e8fc1e56_terseLabel_en-US" xlink:label="lab_ci_TemporaryEquityOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net translation (loss) on foreign currencies attributable to noncontrolling interests</link:label>
    <link:label id="lab_ci_TemporaryEquityOtherComprehensiveIncome_label_en-US" xlink:label="lab_ci_TemporaryEquityOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Other Comprehensive Income</link:label>
    <link:label id="lab_ci_TemporaryEquityOtherComprehensiveIncome_documentation_en-US" xlink:label="lab_ci_TemporaryEquityOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The portion of other comprehensive income or(loss) attributable to temporary equity interest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TemporaryEquityOtherComprehensiveIncome" xlink:href="ci-20230331.xsd#ci_TemporaryEquityOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_TemporaryEquityOtherComprehensiveIncome" xlink:to="lab_ci_TemporaryEquityOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_829bacaf-cded-49f7-b716-fa971c3d342d_terseLabel_en-US" xlink:label="lab_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Value, including held for sale assets</link:label>
    <link:label id="lab_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Notional Amount Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Notional Amount Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_60a55130-7a6e-44e3-aaba-8dd7afc9adc6_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency swap contracts</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_InternationalHealthMember_45dea085-0372-4571-8c9a-afc24e9b10b6_terseLabel_en-US" xlink:label="lab_ci_InternationalHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Health</link:label>
    <link:label id="lab_ci_InternationalHealthMember_label_en-US" xlink:label="lab_ci_InternationalHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Health [Member]</link:label>
    <link:label id="lab_ci_InternationalHealthMember_documentation_en-US" xlink:label="lab_ci_InternationalHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalHealthMember" xlink:href="ci-20230331.xsd#ci_InternationalHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_InternationalHealthMember" xlink:to="lab_ci_InternationalHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_NotesDue20335400InterestMember_e1221c85-6153-4095-936b-4682d87aac66_terseLabel_en-US" xlink:label="lab_ci_NotesDue20335400InterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$800 million, 5.400% Notes due March 2033</link:label>
    <link:label id="lab_ci_NotesDue20335400InterestMember_label_en-US" xlink:label="lab_ci_NotesDue20335400InterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2033, 5.400% Interest [Member]</link:label>
    <link:label id="lab_ci_NotesDue20335400InterestMember_documentation_en-US" xlink:label="lab_ci_NotesDue20335400InterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due 2033, 5.400% Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20335400InterestMember" xlink:href="ci-20230331.xsd#ci_NotesDue20335400InterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_NotesDue20335400InterestMember" xlink:to="lab_ci_NotesDue20335400InterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_ContractualAllowancePharmaceuticalManufacturersReceivables_0ae04b5c-84c6-4129-a48c-7ec00371ab49_terseLabel_en-US" xlink:label="lab_ci_ContractualAllowancePharmaceuticalManufacturersReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturers receivables allowance</link:label>
    <link:label id="lab_ci_ContractualAllowancePharmaceuticalManufacturersReceivables_label_en-US" xlink:label="lab_ci_ContractualAllowancePharmaceuticalManufacturersReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Allowance, Pharmaceutical Manufacturers Receivables</link:label>
    <link:label id="lab_ci_ContractualAllowancePharmaceuticalManufacturersReceivables_documentation_en-US" xlink:label="lab_ci_ContractualAllowancePharmaceuticalManufacturersReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of contractual allowances for certain rebates receivables with pharmaceutical manufacturers, classified as current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ContractualAllowancePharmaceuticalManufacturersReceivables" xlink:href="ci-20230331.xsd#ci_ContractualAllowancePharmaceuticalManufacturersReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_ContractualAllowancePharmaceuticalManufacturersReceivables" xlink:to="lab_ci_ContractualAllowancePharmaceuticalManufacturersReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MedicalCostTrendMember_65ae6820-ca11-449a-acbd-a3684a74987a_terseLabel_en-US" xlink:label="lab_ci_MedicalCostTrendMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical cost trend</link:label>
    <link:label id="lab_ci_MedicalCostTrendMember_label_en-US" xlink:label="lab_ci_MedicalCostTrendMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Cost Trend [Member]</link:label>
    <link:label id="lab_ci_MedicalCostTrendMember_documentation_en-US" xlink:label="lab_ci_MedicalCostTrendMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts relating to actual claims emerging differently from assumptions about the level of claims per member used to set reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MedicalCostTrendMember" xlink:href="ci-20230331.xsd#ci_MedicalCostTrendMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MedicalCostTrendMember" xlink:to="lab_ci_MedicalCostTrendMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_7cd43403-114c-4904-8b09-bad1b61b36c8_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_a1034e02-1837-4eaf-8ab2-8bdbdbaa22ef_totalLabel_en-US" xlink:label="lab_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, including held for sale assets</link:label>
    <link:label id="lab_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Assets Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Assets Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_ff820314-88c3-4ba9-986b-10170802a0a9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract_aa44998c-8e80-45fa-abb4-d9c430775a80_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from investments sold:</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_f4722eaf-9050-488f-ba05-6961e9f80ddb_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesAllowance_dd9fd9d8-0c39-41a0-b4b8-9b8d98ca13f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for uncollectible reinsurance</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesAllowance_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverablesAllowance" xlink:to="lab_us-gaap_ReinsuranceRecoverablesAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges_5f841882-bbc2-465f-b7c7-0d059ef49ab7_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Net Premium, Interest Income And Other Changes</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Net Premium, Interest Income And Other Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_0d1b4bb5-c541-4367-850c-ac45adb30df2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_60038e30-1cd0-42d7-a21e-85be7dd53506_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other debt securities</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_9184ac92-00e2-417b-a6f3-d8caebdcdd42_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_86a4ec9f-fe7f-474c-a394-f6640e603150_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_194cb2f1-76bc-4f28-ae50-d43bb42e3a16_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_7cbcfd59-f1e6-4f39-9c3a-172771a0e274_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances_e90a5685-9778-4375-b023-79e1b0b8fcff_terseLabel_en-US" xlink:label="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market risk benefits reinsurance recoverable, including IBNR and outstanding claims, less premiums due</link:label>
    <link:label id="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances_label_en-US" xlink:label="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Risk Benefit Reinsurance Recoverable After Allowance And Related Balances</link:label>
    <link:label id="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances_documentation_en-US" xlink:label="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Includes incurred but not reported claims and outstanding claims,off-set by premiums due, related to market risk benefit contracts, as a well as reinsurance recoverable, defined as amount, after allowance for credit loss, recoverable under reinsurance for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" xlink:to="lab_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups_aa003328-b3ba-445a-955d-74b58996f5ce_terseLabel_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefits, including held for sale liabilities</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups_label_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefits Current Including Disposal Groups</link:label>
    <link:label id="lab_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups_documentation_en-US" xlink:label="lab_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of accrued obligation to policyholders that relates to insured events for long-duration contracts, expected to be paid within one year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups" xlink:to="lab_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries_2e963128-fa33-4d1a-b8a3-afefb2c7da19_negatedLabel_en-US" xlink:label="lab_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized investment (gains) losses</link:label>
    <link:label id="lab_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries_label_en-US" xlink:label="lab_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gain Loss Including Equity Method Subsidiaries</link:label>
    <link:label id="lab_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries_documentation_en-US" xlink:label="lab_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net realized gains or (losses) on investments during the period, including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity. Includes gains (losses) on investments held by equity method subsidiaries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" xlink:to="lab_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RealizedInvestmentGainsLossesEquityMethodInvestments_8534668e-03c8-4035-a6bc-4fdc8da612e5_negatedLabel_en-US" xlink:label="lab_ci_RealizedInvestmentGainsLossesEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized investment results from certain equity method investments</link:label>
    <link:label id="lab_ci_RealizedInvestmentGainsLossesEquityMethodInvestments_label_en-US" xlink:label="lab_ci_RealizedInvestmentGainsLossesEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains Losses Equity Method Investments</link:label>
    <link:label id="lab_ci_RealizedInvestmentGainsLossesEquityMethodInvestments_documentation_en-US" xlink:label="lab_ci_RealizedInvestmentGainsLossesEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to exclude net realized gains (losses) from equity method subsidiaries (recorded in Other revenues) from Operating revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainsLossesEquityMethodInvestments" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainsLossesEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RealizedInvestmentGainsLossesEquityMethodInvestments" xlink:to="lab_ci_RealizedInvestmentGainsLossesEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_UnobservableInputsNotDevelopedByCompanyMember_48e62b06-254b-45d4-9017-7b599ca731e1_terseLabel_en-US" xlink:label="lab_ci_UnobservableInputsNotDevelopedByCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Not Priced by the Company</link:label>
    <link:label id="lab_ci_UnobservableInputsNotDevelopedByCompanyMember_label_en-US" xlink:label="lab_ci_UnobservableInputsNotDevelopedByCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unobservable Inputs Not Developed By Company [Member]</link:label>
    <link:label id="lab_ci_UnobservableInputsNotDevelopedByCompanyMember_documentation_en-US" xlink:label="lab_ci_UnobservableInputsNotDevelopedByCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs used in pricing Level 3 securities that were not developed directly by the Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnobservableInputsNotDevelopedByCompanyMember" xlink:href="ci-20230331.xsd#ci_UnobservableInputsNotDevelopedByCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_UnobservableInputsNotDevelopedByCompanyMember" xlink:to="lab_ci_UnobservableInputsNotDevelopedByCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PolicyholderContractDepositNoncurrent_7c3a5625-5871-471d-8a7a-cad2ae47d25c_terseLabel_en-US" xlink:label="lab_ci_PolicyholderContractDepositNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractholder deposit funds, noncurrent</link:label>
    <link:label id="lab_ci_PolicyholderContractDepositNoncurrent_label_en-US" xlink:label="lab_ci_PolicyholderContractDepositNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Contract Deposit, Noncurrent</link:label>
    <link:label id="lab_ci_PolicyholderContractDepositNoncurrent_documentation_en-US" xlink:label="lab_ci_PolicyholderContractDepositNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Contract Deposit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositNoncurrent" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PolicyholderContractDepositNoncurrent" xlink:to="lab_ci_PolicyholderContractDepositNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount_8aaecfbe-34f7-4930-94cc-26477bac5e2d_totalLabel_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount_label_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount</link:label>
    <link:label id="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount_documentation_en-US" xlink:label="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount" xlink:to="lab_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_RealEstateJointVenturesMember_4986ee80-f19b-4fad-8384-bd5d8c5d3579_terseLabel_en-US" xlink:label="lab_ci_RealEstateJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate joint ventures</link:label>
    <link:label id="lab_ci_RealEstateJointVenturesMember_label_en-US" xlink:label="lab_ci_RealEstateJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Joint Ventures [Member]</link:label>
    <link:label id="lab_ci_RealEstateJointVenturesMember_documentation_en-US" xlink:label="lab_ci_RealEstateJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealEstateJointVenturesMember" xlink:href="ci-20230331.xsd#ci_RealEstateJointVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_RealEstateJointVenturesMember" xlink:to="lab_ci_RealEstateJointVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_PolicyholderContractBalancePercentReinsuredExternally_8ee2631c-728b-4e96-bcb5-fcf21ceaad1e_terseLabel_en-US" xlink:label="lab_ci_PolicyholderContractBalancePercentReinsuredExternally" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractholder deposit fund liabilities, approximate percent reinsured externally</link:label>
    <link:label id="lab_ci_PolicyholderContractBalancePercentReinsuredExternally_label_en-US" xlink:label="lab_ci_PolicyholderContractBalancePercentReinsuredExternally" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Contract Balance, Percent Reinsured Externally</link:label>
    <link:label id="lab_ci_PolicyholderContractBalancePercentReinsuredExternally_documentation_en-US" xlink:label="lab_ci_PolicyholderContractBalancePercentReinsuredExternally" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Contract Balance, Percent Reinsured Externally</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractBalancePercentReinsuredExternally" xlink:href="ci-20230331.xsd#ci_PolicyholderContractBalancePercentReinsuredExternally"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_PolicyholderContractBalancePercentReinsuredExternally" xlink:to="lab_ci_PolicyholderContractBalancePercentReinsuredExternally" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_ac7063c2-c21a-4ad0-9927-b6b902fb24e8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts paid for loss contigency</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualPayments" xlink:to="lab_us-gaap_LossContingencyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_ec231ff7-8232-48c8-91a7-37b5289a1661_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_032dfb2d-3081-414f-89b0-c60ec322cb90_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_b26d6213-feff-49f0-bb46-b2751c1cec9d_terseLabel_en-US" xlink:label="lab_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets, including held for sale assets</link:label>
    <link:label id="lab_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_UnearnedPremiumsCurrent_80dbc5ee-a11c-429d-8a71-4dddc265fbea_terseLabel_en-US" xlink:label="lab_ci_UnearnedPremiumsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums, Current</link:label>
    <link:label id="lab_ci_UnearnedPremiumsCurrent_label_en-US" xlink:label="lab_ci_UnearnedPremiumsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums, Current</link:label>
    <link:label id="lab_ci_UnearnedPremiumsCurrent_documentation_en-US" xlink:label="lab_ci_UnearnedPremiumsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsCurrent" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_UnearnedPremiumsCurrent" xlink:to="lab_ci_UnearnedPremiumsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_04d4da65-11c8-4456-bcbb-8e1c4c0e0b14_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures, net of cash sold</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1a635fcf-c502-4e2f-b9b0-7f3676ef6a2c_terseLabel_en-US" xlink:label="lab_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranteed separate accounts, including held for sale assets</link:label>
    <link:label id="lab_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_label_en-US" xlink:label="lab_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranteed Separate Account Assets Before Reclassification To Disposal Group Assets Held For Sale</link:label>
    <link:label id="lab_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_documentation_en-US" xlink:label="lab_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The fair value of the assets held by the Entity for the benefit of separate account policyholders with guarantees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:href="ci-20230331.xsd#ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:to="lab_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_890d97fa-959b-42fe-9a54-bce0d63fc910_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>ci-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:aba5d1e1-3c5d-49dc-8b95-aefd0f7f3078,g:b4e2c703-69a2-450e-a66f-edc6453c1c81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.thecignagroup.com/role/CoverPage" xlink:type="simple" xlink:href="ci-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2278839e-1185-48e1-a74f-90f0f5c3dbef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_DocumentType_2278839e-1185-48e1-a74f-90f0f5c3dbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_1bb5cf5d-365b-4d66-b30b-5e1ad32885ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_DocumentQuarterlyReport_1bb5cf5d-365b-4d66-b30b-5e1ad32885ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a1a72419-97a0-4707-95e7-faf8be97fde8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_DocumentPeriodEndDate_a1a72419-97a0-4707-95e7-faf8be97fde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5a995a51-85ed-4afb-bbc7-76d37da83d19" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_DocumentTransitionReport_5a995a51-85ed-4afb-bbc7-76d37da83d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0064fab5-8ead-4277-bba3-d762fe65034e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityFileNumber_0064fab5-8ead-4277-bba3-d762fe65034e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_420b9fd4-8118-41d9-872d-88bd90a04ac2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityRegistrantName_420b9fd4-8118-41d9-872d-88bd90a04ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8eb72d27-4c6f-497d-86b9-d7f90f7ed06d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8eb72d27-4c6f-497d-86b9-d7f90f7ed06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_385ea204-0f6a-4fce-9a45-45aacbbef756" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityTaxIdentificationNumber_385ea204-0f6a-4fce-9a45-45aacbbef756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3bcd5574-6c18-4dbf-8474-d857d88a3033" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityAddressAddressLine1_3bcd5574-6c18-4dbf-8474-d857d88a3033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a774a63d-ac2d-44b2-a927-17dec00fad45" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityAddressCityOrTown_a774a63d-ac2d-44b2-a927-17dec00fad45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7be5caed-ac71-4052-be40-6ce31fd834d8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityAddressStateOrProvince_7be5caed-ac71-4052-be40-6ce31fd834d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e286c52e-5215-4210-af63-42f3b5d61c9f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityAddressPostalZipCode_e286c52e-5215-4210-af63-42f3b5d61c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_56dbfaa6-27f5-4c36-90b2-3a7fad35d885" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_CityAreaCode_56dbfaa6-27f5-4c36-90b2-3a7fad35d885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5f39a3a9-5c06-4a3c-ac55-9d2d6edd7f59" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_LocalPhoneNumber_5f39a3a9-5c06-4a3c-ac55-9d2d6edd7f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d56dd62d-6480-4d9c-8f7c-22496629b5e4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_Security12bTitle_d56dd62d-6480-4d9c-8f7c-22496629b5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_bd773155-9123-4419-bca5-d93576ae16bd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_TradingSymbol_bd773155-9123-4419-bca5-d93576ae16bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c39f1c39-60d9-4b3c-9953-bef3013ba0d9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_SecurityExchangeName_c39f1c39-60d9-4b3c-9953-bef3013ba0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_0931407b-2b85-462e-bc77-36bc8d1772d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityCurrentReportingStatus_0931407b-2b85-462e-bc77-36bc8d1772d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_61e25491-f37d-469c-8e4f-a6ba4fb34c53" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityInteractiveDataCurrent_61e25491-f37d-469c-8e4f-a6ba4fb34c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_ad2aea3b-a232-4a44-85f0-639f4af483b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityFilerCategory_ad2aea3b-a232-4a44-85f0-639f4af483b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_d0bf6f16-d0c9-4b35-bc5a-1966a7cf2294" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntitySmallBusiness_d0bf6f16-d0c9-4b35-bc5a-1966a7cf2294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3c23d348-8cf1-49a5-b5ba-a3ced7509e7f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityEmergingGrowthCompany_3c23d348-8cf1-49a5-b5ba-a3ced7509e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_31d2d294-8e34-46b2-ada9-7d6a48181642" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityShellCompany_31d2d294-8e34-46b2-ada9-7d6a48181642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_70996645-3aaf-4fe1-a35c-880978d5cf18" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_70996645-3aaf-4fe1-a35c-880978d5cf18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_ed06b759-d24e-4b0f-8996-14772c8a34fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_ed06b759-d24e-4b0f-8996-14772c8a34fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e4bd9d42-0cd4-45a9-95b8-6c3cd4a04f8b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_DocumentFiscalYearFocus_e4bd9d42-0cd4-45a9-95b8-6c3cd4a04f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_1e1d97fd-11e6-42de-8753-59f4624c9d90" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_CurrentFiscalYearEndDate_1e1d97fd-11e6-42de-8753-59f4624c9d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_203ded6d-6d7b-4828-ab8c-47d7f72dc797" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_AmendmentFlag_203ded6d-6d7b-4828-ab8c-47d7f72dc797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7e297439-f8af-4ed6-86df-84c76613ec67" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcf0cfd4-6425-41be-a7e3-c5be1b20c69f" xlink:to="loc_dei_EntityCentralIndexKey_7e297439-f8af-4ed6-86df-84c76613ec67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_1c1ecd7f-73fa-4b3c-bbbe-dcd7b6f217ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5f5e7cdb-4e61-48ca-9d3f-80f023f40100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c1ecd7f-73fa-4b3c-bbbe-dcd7b6f217ab" xlink:to="loc_us-gaap_StatementTable_5f5e7cdb-4e61-48ca-9d3f-80f023f40100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c5846a00-2bdc-46ed-bbaf-9a967ced01bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5f5e7cdb-4e61-48ca-9d3f-80f023f40100" xlink:to="loc_srt_ProductOrServiceAxis_c5846a00-2bdc-46ed-bbaf-9a967ced01bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6a18f449-ae02-4a13-a876-75353ad77e49" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c5846a00-2bdc-46ed-bbaf-9a967ced01bb" xlink:to="loc_srt_ProductsAndServicesDomain_6a18f449-ae02-4a13-a876-75353ad77e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_72cd48d3-fb08-471d-bb85-fc05674200bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6a18f449-ae02-4a13-a876-75353ad77e49" xlink:to="loc_us-gaap_ProductMember_72cd48d3-fb08-471d-bb85-fc05674200bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_8273db28-f5ed-498b-a6e0-c682b562a6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6a18f449-ae02-4a13-a876-75353ad77e49" xlink:to="loc_us-gaap_ServiceMember_8273db28-f5ed-498b-a6e0-c682b562a6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5f5e7cdb-4e61-48ca-9d3f-80f023f40100" xlink:to="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_bbb84709-a493-433b-8fae-07c90d8fbd58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_RevenuesAbstract_bbb84709-a493-433b-8fae-07c90d8fbd58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4c7112e-27e0-4205-8f4f-1a394e7bbe92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bbb84709-a493-433b-8fae-07c90d8fbd58" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4c7112e-27e0-4205-8f4f-1a394e7bbe92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_99669bf1-89a5-4b1b-baa0-0f7b28ec0479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bbb84709-a493-433b-8fae-07c90d8fbd58" xlink:to="loc_us-gaap_PremiumsEarnedNet_99669bf1-89a5-4b1b-baa0-0f7b28ec0479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_21fe52a3-f731-4f41-b488-6da4b191c403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bbb84709-a493-433b-8fae-07c90d8fbd58" xlink:to="loc_us-gaap_NetInvestmentIncome_21fe52a3-f731-4f41-b488-6da4b191c403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4ac83a85-e507-4ff0-9dc5-8838912aa23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bbb84709-a493-433b-8fae-07c90d8fbd58" xlink:to="loc_us-gaap_Revenues_4ac83a85-e507-4ff0-9dc5-8838912aa23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_85f9b45a-4340-4e43-8cd0-06c68523f494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_85f9b45a-4340-4e43-8cd0-06c68523f494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_8fe73eda-8db6-4ece-b130-fb6d800595d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_8fe73eda-8db6-4ece-b130-fb6d800595d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7d32c276-6927-4edc-a6b1-72d0081ba17f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7d32c276-6927-4edc-a6b1-72d0081ba17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8e884d93-eafc-4064-9756-b620b5a3d557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8e884d93-eafc-4064-9756-b620b5a3d557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_c4feead7-4340-471b-9fb2-e7900f4f4346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_8efdee95-b438-406f-b352-81bb0e3f928f" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_c4feead7-4340-471b-9fb2-e7900f4f4346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fc4634d5-bdfe-4e07-a954-1701cda4ece0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_OperatingIncomeLoss_fc4634d5-bdfe-4e07-a954-1701cda4ece0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9d6eb46b-d280-46e5-b9f9-f72eec7c181f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9d6eb46b-d280-46e5-b9f9-f72eec7c181f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLoss_bfbcb991-3321-47a7-8344-733ba1cba042" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_ci_RealizedInvestmentGainLoss_bfbcb991-3321-47a7-8344-733ba1cba042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_532a1de0-1f3f-40d7-9f5e-91a37c7510fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_532a1de0-1f3f-40d7-9f5e-91a37c7510fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b5a58cbe-ca1f-4938-83ab-8d0ae401d995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b5a58cbe-ca1f-4938-83ab-8d0ae401d995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_46e65a25-8582-419d-8106-160a1a77b1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_ProfitLoss_46e65a25-8582-419d-8106-160a1a77b1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09ecf1ae-c86b-4e4c-850b-715bcb85ae8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09ecf1ae-c86b-4e4c-850b-715bcb85ae8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_de3c1ab8-0356-479d-8a22-19bd353d669a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_de3c1ab8-0356-479d-8a22-19bd353d669a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_29e16a29-b667-4c86-a3dd-7ce779f055ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4e69ed7b-03c1-4d13-9733-1eac3f1e57f5" xlink:to="loc_us-gaap_EarningsPerShareAbstract_29e16a29-b667-4c86-a3dd-7ce779f055ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_108ac7c4-72f1-40fa-b3fd-4343d39d2492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_29e16a29-b667-4c86-a3dd-7ce779f055ce" xlink:to="loc_us-gaap_EarningsPerShareBasic_108ac7c4-72f1-40fa-b3fd-4343d39d2492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_393a8208-87ab-4bd3-8409-7c8bf0a79a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_29e16a29-b667-4c86-a3dd-7ce779f055ce" xlink:to="loc_us-gaap_EarningsPerShareDiluted_393a8208-87ab-4bd3-8409-7c8bf0a79a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_de15d062-c7f1-4572-8dec-85b2ad147fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_76045ea6-efdd-4126-a3df-37de64227534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_de15d062-c7f1-4572-8dec-85b2ad147fa5" xlink:to="loc_us-gaap_ProfitLoss_76045ea6-efdd-4126-a3df-37de64227534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_a6a62666-2bdd-40d8-a795-02fdcee4a2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_de15d062-c7f1-4572-8dec-85b2ad147fa5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_a6a62666-2bdd-40d8-a795-02fdcee4a2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax_b1d741dd-aeb5-4a0d-af97-9c4145f60161" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_a6a62666-2bdd-40d8-a795-02fdcee4a2b6" xlink:to="loc_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax_b1d741dd-aeb5-4a0d-af97-9c4145f60161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax_b56ae859-d881-4e46-bfd4-ca3cd9124334" xlink:href="ci-20230331.xsd#ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_a6a62666-2bdd-40d8-a795-02fdcee4a2b6" xlink:to="loc_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax_b56ae859-d881-4e46-bfd4-ca3cd9124334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity_fe187bc4-cab7-4a0b-80dd-42a6b3947349" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_a6a62666-2bdd-40d8-a795-02fdcee4a2b6" xlink:to="loc_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity_fe187bc4-cab7-4a0b-80dd-42a6b3947349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8b3d20d9-f43d-4fb6-8a55-c81d3914894b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_a6a62666-2bdd-40d8-a795-02fdcee4a2b6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8b3d20d9-f43d-4fb6-8a55-c81d3914894b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_8d375073-a21a-4500-b37f-2aafc276b246" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_a6a62666-2bdd-40d8-a795-02fdcee4a2b6" xlink:to="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_8d375073-a21a-4500-b37f-2aafc276b246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity_84d09804-805b-467a-a098-0edbc7008e93" xlink:href="ci-20230331.xsd#ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_de15d062-c7f1-4572-8dec-85b2ad147fa5" xlink:to="loc_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity_84d09804-805b-467a-a098-0edbc7008e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_c10cce92-aef6-4fdc-89a5-54c96d778eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_de15d062-c7f1-4572-8dec-85b2ad147fa5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_c10cce92-aef6-4fdc-89a5-54c96d778eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_010897e1-f93a-4d3e-83cd-0969936adcab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_c10cce92-aef6-4fdc-89a5-54c96d778eb2" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_010897e1-f93a-4d3e-83cd-0969936adcab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_25db3797-2821-46a2-9222-7ae3529a0faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_c10cce92-aef6-4fdc-89a5-54c96d778eb2" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_25db3797-2821-46a2-9222-7ae3529a0faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TemporaryEquityOtherComprehensiveIncome_3542cf83-5984-4dca-8d25-43080fc87918" xlink:href="ci-20230331.xsd#ci_TemporaryEquityOtherComprehensiveIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_c10cce92-aef6-4fdc-89a5-54c96d778eb2" xlink:to="loc_ci_TemporaryEquityOtherComprehensiveIncome_3542cf83-5984-4dca-8d25-43080fc87918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_063ff608-924e-46f6-ad29-540148ec4fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract_c10cce92-aef6-4fdc-89a5-54c96d778eb2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_063ff608-924e-46f6-ad29-540148ec4fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d15e6873-a0ac-44b4-bbff-818446bc27cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_de15d062-c7f1-4572-8dec-85b2ad147fa5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d15e6873-a0ac-44b4-bbff-818446bc27cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e0b3c964-24a6-4aba-9bef-59b0d0ccb57a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0b3c964-24a6-4aba-9bef-59b0d0ccb57a" xlink:to="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4c501d1a-72a4-4fc6-94a5-3034261b5b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4c501d1a-72a4-4fc6-94a5-3034261b5b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_9f592c70-65c6-4ff6-8a5f-3b5996db9bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_ShortTermInvestments_9f592c70-65c6-4ff6-8a5f-3b5996db9bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_f43e5acf-dacc-4716-b44d-419e15c6aeef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_ReceivablesNetCurrent_f43e5acf-dacc-4716-b44d-419e15c6aeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9abad7b2-bec8-42ac-ad71-01b33c089029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_InventoryNet_9abad7b2-bec8-42ac-ad71-01b33c089029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_efce8301-53b7-408d-bdd7-42182ec0a787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_OtherAssetsCurrent_efce8301-53b7-408d-bdd7-42182ec0a787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d78c08fa-768e-4d85-8321-61811a50f4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_AssetsCurrent_d78c08fa-768e-4d85-8321-61811a50f4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_ce92c34c-018a-4c19-834e-b163600a2e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_LongTermInvestments_ce92c34c-018a-4c19-834e-b163600a2e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ReinsuranceRecoverablesNonCurrent_d5392766-8f27-4777-87a5-3330833f7315" xlink:href="ci-20230331.xsd#ci_ReinsuranceRecoverablesNonCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_ci_ReinsuranceRecoverablesNonCurrent_d5392766-8f27-4777-87a5-3330833f7315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_42b6fe18-6ce8-4a48-836f-f8af20b83a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_42b6fe18-6ce8-4a48-836f-f8af20b83a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a89241f4-0b1b-4419-bc50-202646453442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_Goodwill_a89241f4-0b1b-4419-bc50-202646453442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ecb11119-1529-42b0-a140-15d98b2f0a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ecb11119-1529-42b0-a140-15d98b2f0a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1f8fbcc0-dab8-451e-a59c-38f9af9e53c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1f8fbcc0-dab8-451e-a59c-38f9af9e53c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_4a368c2f-d06d-4741-9b6b-31294c0d01e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_SeparateAccountAssets_4a368c2f-d06d-4741-9b6b-31294c0d01e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a906b822-49f0-4cb2-9529-1d11309495e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb73de15-92cd-4c58-8216-1735c155e1b4" xlink:to="loc_us-gaap_Assets_a906b822-49f0-4cb2-9529-1d11309495e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0b3c964-24a6-4aba-9bef-59b0d0ccb57a" xlink:to="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_7cf911d9-1b47-4498-b38c-041ec07dfe59" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_7cf911d9-1b47-4498-b38c-041ec07dfe59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmacyAndServiceCostsPayable_8150e471-dd49-40c5-a7bd-3b19323a21fc" xlink:href="ci-20230331.xsd#ci_PharmacyAndServiceCostsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:to="loc_ci_PharmacyAndServiceCostsPayable_8150e471-dd49-40c5-a7bd-3b19323a21fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c178dc2a-2e50-4238-9a6b-2a5880397f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:to="loc_us-gaap_AccountsPayableCurrent_c178dc2a-2e50-4238-9a6b-2a5880397f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AccruedExpensesAndOtherLiabilities_f6dcee33-37d6-46f3-85d4-b4cfe8cb3a60" xlink:href="ci-20230331.xsd#ci_AccruedExpensesAndOtherLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:to="loc_ci_AccruedExpensesAndOtherLiabilities_f6dcee33-37d6-46f3-85d4-b4cfe8cb3a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_d9b2ea37-4311-4df7-aa8d-32d244e90b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:to="loc_us-gaap_DebtCurrent_d9b2ea37-4311-4df7-aa8d-32d244e90b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_69aeeac2-2629-4b00-b3e2-6607c70ea035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:to="loc_us-gaap_LiabilitiesCurrent_69aeeac2-2629-4b00-b3e2-6607c70ea035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_af44583e-06ad-4909-9283-868fbb8552f3" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_af44583e-06ad-4909-9283-868fbb8552f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3a5be6d1-e802-4d0d-85b7-07cca6af89e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3a5be6d1-e802-4d0d-85b7-07cca6af89e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d33b9eab-f67e-44da-9202-da1eb9488f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d33b9eab-f67e-44da-9202-da1eb9488f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e9465900-7f0f-4a26-a443-4477a7188a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e9465900-7f0f-4a26-a443-4477a7188a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_1c21553f-f2a6-47e8-935c-bf2348092a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:to="loc_us-gaap_SeparateAccountsLiability_1c21553f-f2a6-47e8-935c-bf2348092a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_233cf38a-a43e-4ecf-959c-e2878b81061c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_3923d753-12f0-4613-8362-4a17c8971fe5" xlink:to="loc_us-gaap_Liabilities_233cf38a-a43e-4ecf-959c-e2878b81061c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_bafca432-f769-4dc8-8237-cda2bae1b9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0b3c964-24a6-4aba-9bef-59b0d0ccb57a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_bafca432-f769-4dc8-8237-cda2bae1b9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_a53bef40-970e-4d74-90fd-4e27c60ecddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0b3c964-24a6-4aba-9bef-59b0d0ccb57a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_a53bef40-970e-4d74-90fd-4e27c60ecddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_21d6ac93-1789-4426-a9e3-72c8236eb2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0b3c964-24a6-4aba-9bef-59b0d0ccb57a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_21d6ac93-1789-4426-a9e3-72c8236eb2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_e2bd93dd-164f-4f61-9cde-fda2e042ad15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_21d6ac93-1789-4426-a9e3-72c8236eb2c8" xlink:to="loc_us-gaap_CommonStockValue_e2bd93dd-164f-4f61-9cde-fda2e042ad15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bc6b463b-8c91-4e39-9b23-a4974167faa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_21d6ac93-1789-4426-a9e3-72c8236eb2c8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bc6b463b-8c91-4e39-9b23-a4974167faa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c59c38af-217a-462a-879b-0004fb071fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_21d6ac93-1789-4426-a9e3-72c8236eb2c8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c59c38af-217a-462a-879b-0004fb071fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_de00bf20-7d10-441e-9dcd-1c3c2cc8b20e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_21d6ac93-1789-4426-a9e3-72c8236eb2c8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_de00bf20-7d10-441e-9dcd-1c3c2cc8b20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_84f8c7b3-527d-4f84-bfc4-03b2c0d4a313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_21d6ac93-1789-4426-a9e3-72c8236eb2c8" xlink:to="loc_us-gaap_TreasuryStockValue_84f8c7b3-527d-4f84-bfc4-03b2c0d4a313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_87c8081b-5fb6-483f-abca-9ad375d1c81d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_21d6ac93-1789-4426-a9e3-72c8236eb2c8" xlink:to="loc_us-gaap_StockholdersEquity_87c8081b-5fb6-483f-abca-9ad375d1c81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_38fd85d0-ad62-40fe-8698-e7bce0a5748a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_21d6ac93-1789-4426-a9e3-72c8236eb2c8" xlink:to="loc_us-gaap_MinorityInterest_38fd85d0-ad62-40fe-8698-e7bce0a5748a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_099a241f-b784-401c-a80e-940c1e5de010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_21d6ac93-1789-4426-a9e3-72c8236eb2c8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_099a241f-b784-401c-a80e-940c1e5de010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_994aa0bd-335e-427a-8fc0-6270050cd405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0b3c964-24a6-4aba-9bef-59b0d0ccb57a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_994aa0bd-335e-427a-8fc0-6270050cd405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9bf52442-585f-4f29-b128-5db1c63bbabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_6c16ad29-4395-45fb-a16a-f9f8a4fe10b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9bf52442-585f-4f29-b128-5db1c63bbabc" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_6c16ad29-4395-45fb-a16a-f9f8a4fe10b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f9a78649-3740-4861-96da-158a9efacb82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9bf52442-585f-4f29-b128-5db1c63bbabc" xlink:to="loc_us-gaap_CommonStockSharesIssued_f9a78649-3740-4861-96da-158a9efacb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b5c6c8ba-a94b-4248-b1ec-017f9ec906a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9bf52442-585f-4f29-b128-5db1c63bbabc" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b5c6c8ba-a94b-4248-b1ec-017f9ec906a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedStatementsofChangesinTotalEquity"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e85c69e2-cf1a-4513-8a84-f705ca27b0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4a915954-1d3a-45d2-b073-55d0351aa9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e85c69e2-cf1a-4513-8a84-f705ca27b0cc" xlink:to="loc_us-gaap_StatementTable_4a915954-1d3a-45d2-b073-55d0351aa9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1a6f1504-5559-48b3-906d-6a09e2ebc91d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a915954-1d3a-45d2-b073-55d0351aa9ae" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1a6f1504-5559-48b3-906d-6a09e2ebc91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d58d3a00-fa63-45de-8857-19675c619e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1a6f1504-5559-48b3-906d-6a09e2ebc91d" xlink:to="loc_us-gaap_EquityComponentDomain_d58d3a00-fa63-45de-8857-19675c619e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d58d3a00-fa63-45de-8857-19675c619e2c" xlink:to="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6e63733a-3170-408f-adae-88a4b4e1e17b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:to="loc_us-gaap_CommonStockMember_6e63733a-3170-408f-adae-88a4b4e1e17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_cb2ca65c-92d7-4609-8b5b-66176d1f01c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_cb2ca65c-92d7-4609-8b5b-66176d1f01c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b12e499d-e92f-4bb7-8028-209205ad7947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b12e499d-e92f-4bb7-8028-209205ad7947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1f505282-3cef-4b9c-84c1-4e73be82e37f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:to="loc_us-gaap_RetainedEarningsMember_1f505282-3cef-4b9c-84c1-4e73be82e37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7c77aab5-39b6-43e6-ab86-940a6ec2ffb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7286a6c8-bbea-44d7-b9a7-1d5b24bda7b8" xlink:to="loc_us-gaap_TreasuryStockMember_7c77aab5-39b6-43e6-ab86-940a6ec2ffb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_d1626aa5-65ab-4c97-84de-7a850225be3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d58d3a00-fa63-45de-8857-19675c619e2c" xlink:to="loc_us-gaap_NoncontrollingInterestMember_d1626aa5-65ab-4c97-84de-7a850225be3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_84382d7f-e745-4f74-a169-66adc894aedc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a915954-1d3a-45d2-b073-55d0351aa9ae" xlink:to="loc_srt_RestatementAxis_84382d7f-e745-4f74-a169-66adc894aedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c55ec9fd-3e08-41e3-b103-7c9e8848903b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_84382d7f-e745-4f74-a169-66adc894aedc" xlink:to="loc_srt_RestatementDomain_c55ec9fd-3e08-41e3-b103-7c9e8848903b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_b3f2ddd3-95d5-478c-aed9-805773776c77" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_c55ec9fd-3e08-41e3-b103-7c9e8848903b" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_b3f2ddd3-95d5-478c-aed9-805773776c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_58be68e4-a97d-4b0e-9792-e4ed6a6324ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_c55ec9fd-3e08-41e3-b103-7c9e8848903b" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_58be68e4-a97d-4b0e-9792-e4ed6a6324ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ad4d46c6-49fb-42a8-8237-b6f84a50fdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4a915954-1d3a-45d2-b073-55d0351aa9ae" xlink:to="loc_us-gaap_StatementLineItems_ad4d46c6-49fb-42a8-8237-b6f84a50fdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad4d46c6-49fb-42a8-8237-b6f84a50fdcd" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a3a0de78-19fb-4633-b36a-74f9da419b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a3a0de78-19fb-4633-b36a-74f9da419b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_687080aa-d70f-49a4-9936-bb2aae41ca76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_687080aa-d70f-49a4-9936-bb2aae41ca76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_75ee0997-2df2-4247-833b-3f8a44e15c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_75ee0997-2df2-4247-833b-3f8a44e15c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_1135185e-4b24-44f4-99a1-313293c4e62d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_1135185e-4b24-44f4-99a1-313293c4e62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_0347299e-322e-4a30-baf9-4d3cc9d6e0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_DividendsCommonStockCash_0347299e-322e-4a30-baf9-4d3cc9d6e0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_60074f19-fbd6-4e54-a9d2-d961f5630dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_60074f19-fbd6-4e54-a9d2-d961f5630dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NoncontrollingInterestOtherChanges_f6e62bae-17ea-4ba9-b4b0-7c43de01f2a8" xlink:href="ci-20230331.xsd#ci_NoncontrollingInterestOtherChanges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_ci_NoncontrollingInterestOtherChanges_f6e62bae-17ea-4ba9-b4b0-7c43de01f2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a1d4f213-fad1-4502-9963-d64a4a311192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48f79a52-ccb2-491d-867a-b19f2410bddc" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a1d4f213-fad1-4502-9963-d64a4a311192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad4d46c6-49fb-42a8-8237-b6f84a50fdcd" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3982608f-49df-400e-8154-4b94c7b0b88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3982608f-49df-400e-8154-4b94c7b0b88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TemporaryEquityOtherComprehensiveIncome_cf792210-b124-4edf-88f5-8e757d8be80e" xlink:href="ci-20230331.xsd#ci_TemporaryEquityOtherComprehensiveIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:to="loc_ci_TemporaryEquityOtherComprehensiveIncome_cf792210-b124-4edf-88f5-8e757d8be80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_c76541c9-1e37-4d0e-852f-b5de8b23802e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_c76541c9-1e37-4d0e-852f-b5de8b23802e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityOtherChanges_0e744d76-69b0-4f5f-bc3f-2d11277ee19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:to="loc_us-gaap_TemporaryEquityOtherChanges_0e744d76-69b0-4f5f-bc3f-2d11277ee19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_c4dc91a9-53bb-4db7-a0f8-3c355b089383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_742c1e3f-864f-4a03-9df6-8b1cf1f07c94" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_c4dc91a9-53bb-4db7-a0f8-3c355b089383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_1005eb0f-0be6-48d0-b682-eda368375e58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad4d46c6-49fb-42a8-8237-b6f84a50fdcd" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_1005eb0f-0be6-48d0-b682-eda368375e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquityParenthetical" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedStatementsofChangesinTotalEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_51ba060f-3ce8-4670-aa9c-b060bc9794a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_4abf43bc-0aac-4a45-b357-c46b5d8fc4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_51ba060f-3ce8-4670-aa9c-b060bc9794a3" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_4abf43bc-0aac-4a45-b357-c46b5d8fc4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_3fca0741-31af-4d9a-8f11-5e3ce913d801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_d3aacd82-1808-46fc-bf04-7d57aaf608b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fca0741-31af-4d9a-8f11-5e3ce913d801" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_d3aacd82-1808-46fc-bf04-7d57aaf608b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_287d10de-54fc-48e6-b87d-c91577545d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_d3aacd82-1808-46fc-bf04-7d57aaf608b0" xlink:to="loc_us-gaap_ProfitLoss_287d10de-54fc-48e6-b87d-c91577545d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cbca7c5f-9316-40d8-862b-199b2cc1cb06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_d3aacd82-1808-46fc-bf04-7d57aaf608b0" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cbca7c5f-9316-40d8-862b-199b2cc1cb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f4153d05-9802-4c07-87c2-9be3965f6fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cbca7c5f-9316-40d8-862b-199b2cc1cb06" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f4153d05-9802-4c07-87c2-9be3965f6fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLoss_d2e97d7a-e461-456a-8371-b779c6fd9956" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cbca7c5f-9316-40d8-862b-199b2cc1cb06" xlink:to="loc_ci_RealizedInvestmentGainLoss_d2e97d7a-e461-456a-8371-b779c6fd9956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_022fd03c-2f16-4f1c-a2cc-013e9dffb120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cbca7c5f-9316-40d8-862b-199b2cc1cb06" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_022fd03c-2f16-4f1c-a2cc-013e9dffb120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_29d002a7-0cdc-42db-9581-9f80882d232c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_d3aacd82-1808-46fc-bf04-7d57aaf608b0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_29d002a7-0cdc-42db-9581-9f80882d232c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_317d4ec3-5773-41fa-a0dd-edade9a79430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_29d002a7-0cdc-42db-9581-9f80882d232c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_317d4ec3-5773-41fa-a0dd-edade9a79430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_2295ddc4-edc0-45a1-8c4a-9fa979d0952e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_29d002a7-0cdc-42db-9581-9f80882d232c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_2295ddc4-edc0-45a1-8c4a-9fa979d0952e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReinsuranceRecoverable_c05171d6-2c67-445c-871a-4e36ae66eab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReinsuranceRecoverable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_29d002a7-0cdc-42db-9581-9f80882d232c" xlink:to="loc_us-gaap_IncreaseDecreaseInReinsuranceRecoverable_c05171d6-2c67-445c-871a-4e36ae66eab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_7b25b5dd-29da-4a99-aef7-73c7ddb81233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_29d002a7-0cdc-42db-9581-9f80882d232c" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_7b25b5dd-29da-4a99-aef7-73c7ddb81233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable_102bdf87-526a-404d-b011-f7a6d09cf7cf" xlink:href="ci-20230331.xsd#ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_29d002a7-0cdc-42db-9581-9f80882d232c" xlink:to="loc_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable_102bdf87-526a-404d-b011-f7a6d09cf7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities_a8cf5e8c-6bd7-4714-b049-8407377371ba" xlink:href="ci-20230331.xsd#ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_29d002a7-0cdc-42db-9581-9f80882d232c" xlink:to="loc_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities_a8cf5e8c-6bd7-4714-b049-8407377371ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_54b853cb-f2ec-4142-81ad-9845f4b6d5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_29d002a7-0cdc-42db-9581-9f80882d232c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_54b853cb-f2ec-4142-81ad-9845f4b6d5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a0270e-3855-449c-932b-f6ce1b0a2e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_d3aacd82-1808-46fc-bf04-7d57aaf608b0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a0270e-3855-449c-932b-f6ce1b0a2e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4aac100d-9034-4f46-86a1-5ba3beefdc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fca0741-31af-4d9a-8f11-5e3ce913d801" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4aac100d-9034-4f46-86a1-5ba3beefdc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract_c9ef6128-0af3-4924-86c8-68af35a02484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4aac100d-9034-4f46-86a1-5ba3beefdc60" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract_c9ef6128-0af3-4924-86c8-68af35a02484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ProceedsFromSaleOfDebtAndEquitySecurities_9f9e1c61-bde0-4dd9-8cc3-16704ebd3420" xlink:href="ci-20230331.xsd#ci_ProceedsFromSaleOfDebtAndEquitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract_c9ef6128-0af3-4924-86c8-68af35a02484" xlink:to="loc_ci_ProceedsFromSaleOfDebtAndEquitySecurities_9f9e1c61-bde0-4dd9-8cc3-16704ebd3420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract_0f4c7755-c08d-4487-8ea2-0d7b7744e3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4aac100d-9034-4f46-86a1-5ba3beefdc60" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract_0f4c7755-c08d-4487-8ea2-0d7b7744e3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities_a9e5baf8-d47f-4f7d-95fa-6c4de02fda84" xlink:href="ci-20230331.xsd#ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract_0f4c7755-c08d-4487-8ea2-0d7b7744e3bd" xlink:to="loc_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities_a9e5baf8-d47f-4f7d-95fa-6c4de02fda84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_5f3c74d1-61d1-4c96-ad56-cc5cfc8bed43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract_0f4c7755-c08d-4487-8ea2-0d7b7744e3bd" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_5f3c74d1-61d1-4c96-ad56-cc5cfc8bed43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_1dc97d56-9dc9-4426-8f4d-e05a8c22aa4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract_0f4c7755-c08d-4487-8ea2-0d7b7744e3bd" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_1dc97d56-9dc9-4426-8f4d-e05a8c22aa4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestmentsAbstract_1edb6267-9a67-46ca-98d1-04222c85c2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestmentsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4aac100d-9034-4f46-86a1-5ba3beefdc60" xlink:to="loc_us-gaap_PaymentsToAcquireInvestmentsAbstract_1edb6267-9a67-46ca-98d1-04222c85c2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PaymentsToAcquireDebtAndEquitySecurities_30d52556-b764-4622-be85-21c0dd4f26df" xlink:href="ci-20230331.xsd#ci_PaymentsToAcquireDebtAndEquitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsToAcquireInvestmentsAbstract_1edb6267-9a67-46ca-98d1-04222c85c2cf" xlink:to="loc_ci_PaymentsToAcquireDebtAndEquitySecurities_30d52556-b764-4622-be85-21c0dd4f26df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMortgageNotesReceivable_1292bc2a-c803-44a8-ba5e-577b054482e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMortgageNotesReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsToAcquireInvestmentsAbstract_1edb6267-9a67-46ca-98d1-04222c85c2cf" xlink:to="loc_us-gaap_PaymentsToAcquireMortgageNotesReceivable_1292bc2a-c803-44a8-ba5e-577b054482e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_46f79f1f-21ff-4569-a4ec-06e79e7d6f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsToAcquireInvestmentsAbstract_1edb6267-9a67-46ca-98d1-04222c85c2cf" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_46f79f1f-21ff-4569-a4ec-06e79e7d6f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PaymentsForProceedsFromPropertyPlantAndEquipment_a6b96bf1-7e60-4fb6-bc68-d77aeb957db6" xlink:href="ci-20230331.xsd#ci_PaymentsForProceedsFromPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4aac100d-9034-4f46-86a1-5ba3beefdc60" xlink:to="loc_ci_PaymentsForProceedsFromPropertyPlantAndEquipment_a6b96bf1-7e60-4fb6-bc68-d77aeb957db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_e1492c87-59ee-44f0-b386-89f98d2678fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4aac100d-9034-4f46-86a1-5ba3beefdc60" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_e1492c87-59ee-44f0-b386-89f98d2678fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_05b77309-da9b-4aad-93b1-315d19bdcc73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4aac100d-9034-4f46-86a1-5ba3beefdc60" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_05b77309-da9b-4aad-93b1-315d19bdcc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35051869-f8b8-46fd-9b08-a9fc80fb6f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4aac100d-9034-4f46-86a1-5ba3beefdc60" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35051869-f8b8-46fd-9b08-a9fc80fb6f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_bd3ad425-0c9f-41d7-b01f-88b5e9c85d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fca0741-31af-4d9a-8f11-5e3ce913d801" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_bd3ad425-0c9f-41d7-b01f-88b5e9c85d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionsToContractHoldersFunds_03f10887-12bd-478c-8911-fc34d22e95e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionsToContractHoldersFunds"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_bd3ad425-0c9f-41d7-b01f-88b5e9c85d02" xlink:to="loc_us-gaap_AdditionsToContractHoldersFunds_03f10887-12bd-478c-8911-fc34d22e95e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WithdrawalFromContractHoldersFunds_f277ffcf-eab0-45ed-a9fd-038ab8d3996f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WithdrawalFromContractHoldersFunds"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_bd3ad425-0c9f-41d7-b01f-88b5e9c85d02" xlink:to="loc_us-gaap_WithdrawalFromContractHoldersFunds_f277ffcf-eab0-45ed-a9fd-038ab8d3996f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ProceedsFromRepaymentsOfOtherShortTermDebt_42d21bdd-7c1f-4d24-9822-67be486963fc" xlink:href="ci-20230331.xsd#ci_ProceedsFromRepaymentsOfOtherShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_bd3ad425-0c9f-41d7-b01f-88b5e9c85d02" xlink:to="loc_ci_ProceedsFromRepaymentsOfOtherShortTermDebt_42d21bdd-7c1f-4d24-9822-67be486963fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_28b56221-136c-4da8-9be7-cd24553fed3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_bd3ad425-0c9f-41d7-b01f-88b5e9c85d02" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_28b56221-136c-4da8-9be7-cd24553fed3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_24cc8add-8371-43bf-9365-ffa50b4db16b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_bd3ad425-0c9f-41d7-b01f-88b5e9c85d02" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_24cc8add-8371-43bf-9365-ffa50b4db16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ad14ccbd-81d9-49d3-815d-2a3026c86f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_bd3ad425-0c9f-41d7-b01f-88b5e9c85d02" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ad14ccbd-81d9-49d3-815d-2a3026c86f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a657dc53-2e0b-4395-bb9a-e42a1d5d3d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_bd3ad425-0c9f-41d7-b01f-88b5e9c85d02" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a657dc53-2e0b-4395-bb9a-e42a1d5d3d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_e8c80d52-2290-4a09-9717-f6ba32f45489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_bd3ad425-0c9f-41d7-b01f-88b5e9c85d02" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_e8c80d52-2290-4a09-9717-f6ba32f45489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bc0ab8a6-0e64-4caf-962d-e3aa45a3aaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_bd3ad425-0c9f-41d7-b01f-88b5e9c85d02" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bc0ab8a6-0e64-4caf-962d-e3aa45a3aaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0245b1fe-7492-4ae8-8eee-76157329343c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_bd3ad425-0c9f-41d7-b01f-88b5e9c85d02" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0245b1fe-7492-4ae8-8eee-76157329343c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6fcf7a41-3511-4a1f-8133-9fd9e46544df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fca0741-31af-4d9a-8f11-5e3ce913d801" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6fcf7a41-3511-4a1f-8133-9fd9e46544df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1fdb8fea-ba2a-4122-a050-c6a2f8d88878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fca0741-31af-4d9a-8f11-5e3ce913d801" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1fdb8fea-ba2a-4122-a050-c6a2f8d88878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2c0c8cfc-b7bb-476c-90ef-ed80bbdd91af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fca0741-31af-4d9a-8f11-5e3ce913d801" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2c0c8cfc-b7bb-476c-90ef-ed80bbdd91af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_00abe7d9-14b6-4412-9b84-ecb44c454338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fca0741-31af-4d9a-8f11-5e3ce913d801" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_00abe7d9-14b6-4412-9b84-ecb44c454338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_2de110c4-542f-4da2-a280-350d1db70f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fca0741-31af-4d9a-8f11-5e3ce913d801" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_2de110c4-542f-4da2-a280-350d1db70f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1091d200-8aef-4095-9b78-e6d6fffb5c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fca0741-31af-4d9a-8f11-5e3ce913d801" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1091d200-8aef-4095-9b78-e6d6fffb5c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_36f9f5fc-9d69-431f-95cd-0bb9eba32617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fca0741-31af-4d9a-8f11-5e3ce913d801" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_36f9f5fc-9d69-431f-95cd-0bb9eba32617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_44751baf-aaf2-4840-99c3-1058740960a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fca0741-31af-4d9a-8f11-5e3ce913d801" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_44751baf-aaf2-4840-99c3-1058740960a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_c90c329a-fcf7-4f64-b581-e22c26b75ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_44751baf-aaf2-4840-99c3-1058740960a3" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_c90c329a-fcf7-4f64-b581-e22c26b75ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_fe44b85e-1e7c-4894-bbb7-6f9ab6fe18e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_44751baf-aaf2-4840-99c3-1058740960a3" xlink:to="loc_us-gaap_InterestPaidNet_fe44b85e-1e7c-4894-bbb7-6f9ab6fe18e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="ci-20230331.xsd#ConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_b6d73409-f24a-4939-af19-00bafc4d6a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_368706fc-a661-4584-b594-67fc2944b8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b6d73409-f24a-4939-af19-00bafc4d6a4a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_368706fc-a661-4584-b594-67fc2944b8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/DescriptionofBusiness" xlink:type="simple" xlink:href="ci-20230331.xsd#DescriptionofBusiness"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/DescriptionofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b9168a46-5983-45f1-a938-3ca3fde8b841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_fbc087b7-4031-46cd-b1e8-1f2dddcf6666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b9168a46-5983-45f1-a938-3ca3fde8b841" xlink:to="loc_us-gaap_NatureOfOperations_fbc087b7-4031-46cd-b1e8-1f2dddcf6666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="ci-20230331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3fbeb479-4de6-44e5-822c-6207e8eeb91b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_0cc30278-60bd-4734-930e-4907b5202d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3fbeb479-4de6-44e5-822c-6207e8eeb91b" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_0cc30278-60bd-4734-930e-4907b5202d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/AccountsReceivableNet" xlink:type="simple" xlink:href="ci-20230331.xsd#AccountsReceivableNet"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/AccountsReceivableNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_62c6b5dd-f777-477e-abaa-833a21552a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_968b0723-15fa-4fa3-9fd5-1e5334585483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_62c6b5dd-f777-477e-abaa-833a21552a2c" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_968b0723-15fa-4fa3-9fd5-1e5334585483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SupplierFinanceProgram" xlink:type="simple" xlink:href="ci-20230331.xsd#SupplierFinanceProgram"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/SupplierFinanceProgram" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_b3d45008-d0cf-4813-973d-6d8087996f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SupplierFinanceProgramTextBlock_072959b7-d20f-4465-b6c2-1b99fb0a29a7" xlink:href="ci-20230331.xsd#ci_SupplierFinanceProgramTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b3d45008-d0cf-4813-973d-6d8087996f1b" xlink:to="loc_ci_SupplierFinanceProgramTextBlock_072959b7-d20f-4465-b6c2-1b99fb0a29a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/MergersAcquisitionsandDivestitures" xlink:type="simple" xlink:href="ci-20230331.xsd#MergersAcquisitionsandDivestitures"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/MergersAcquisitionsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5685aef4-f2df-4d50-bbbd-5c24ae383622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_4d9835e3-018c-4711-b32c-9869cd4fb336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5685aef4-f2df-4d50-bbbd-5c24ae383622" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_4d9835e3-018c-4711-b32c-9869cd4fb336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/EarningsPerShare" xlink:type="simple" xlink:href="ci-20230331.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dbf14bc2-5cc3-42c7-9e65-1f5d97d7af02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_2e7c0780-78ba-4f9f-96ae-e493d8783e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dbf14bc2-5cc3-42c7-9e65-1f5d97d7af02" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_2e7c0780-78ba-4f9f-96ae-e493d8783e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/Debt" xlink:type="simple" xlink:href="ci-20230331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_002c5469-8876-40a7-8cb9-88235f029656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_3afc8dd2-75a5-478c-af14-3acb3c087269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_002c5469-8876-40a7-8cb9-88235f029656" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_3afc8dd2-75a5-478c-af14-3acb3c087269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/CommonandPreferredStock" xlink:type="simple" xlink:href="ci-20230331.xsd#CommonandPreferredStock"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/CommonandPreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f61b9815-27f5-4490-b144-dd949df4568d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock_b29f8920-07c6-4e1c-ac11-e3b8770def06" xlink:href="ci-20230331.xsd#ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f61b9815-27f5-4490-b144-dd949df4568d" xlink:to="loc_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock_b29f8920-07c6-4e1c-ac11-e3b8770def06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilities" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilities"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceLossReservesAbstract_59aebcc4-abbc-44fa-9e14-a145e6ef8e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceLossReservesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_271b2261-4280-45a2-99b3-12e45466084c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_59aebcc4-abbc-44fa-9e14-a145e6ef8e75" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_271b2261-4280-45a2-99b3-12e45466084c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/Reinsurance" xlink:type="simple" xlink:href="ci-20230331.xsd#Reinsurance"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/Reinsurance" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_3d9a334a-9d8a-4adc-8a4e-574aed33df1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock_392d5d8a-e77d-4581-a4b3-30eaf5435e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_3d9a334a-9d8a-4adc-8a4e-574aed33df1d" xlink:to="loc_us-gaap_ReinsuranceTextBlock_392d5d8a-e77d-4581-a4b3-30eaf5435e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/Investments" xlink:type="simple" xlink:href="ci-20230331.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_565150c2-2ace-4b48-8116-6d812645c689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_6fdbbae4-fbb8-4d29-adbd-bd3022448a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_565150c2-2ace-4b48-8116-6d812645c689" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_6fdbbae4-fbb8-4d29-adbd-bd3022448a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4d1549ff-1338-4764-8c81-8c7256b96a00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_5438be4c-adf7-4240-b04d-1f72cb5c915b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4d1549ff-1338-4764-8c81-8c7256b96a00" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_5438be4c-adf7-4240-b04d-1f72cb5c915b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="ci-20230331.xsd#VariableInterestEntities"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/VariableInterestEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_VariableInterestEntitiesAbstract_91723b96-bef5-4e3d-89d6-d0f4a3897daf" xlink:href="ci-20230331.xsd#ci_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_b9d89b59-621b-49a8-b07a-9ef261f7e8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_VariableInterestEntitiesAbstract_91723b96-bef5-4e3d-89d6-d0f4a3897daf" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_b9d89b59-621b-49a8-b07a-9ef261f7e8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="ci-20230331.xsd#AccumulatedOtherComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_fc396289-0600-4985-ae2e-057ff3e36ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock_25e3273f-c7ab-4553-8b35-7b8ed211ca2c" xlink:href="ci-20230331.xsd#ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_fc396289-0600-4985-ae2e-057ff3e36ae7" xlink:to="loc_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock_25e3273f-c7ab-4553-8b35-7b8ed211ca2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/IncomeTaxes" xlink:type="simple" xlink:href="ci-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e1da98f7-65f5-427b-84df-01ded190876d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_21894458-7045-4d2c-8b76-8046fee2647c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e1da98f7-65f5-427b-84df-01ded190876d" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_21894458-7045-4d2c-8b76-8046fee2647c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ContingenciesandOtherMatters" xlink:type="simple" xlink:href="ci-20230331.xsd#ContingenciesandOtherMatters"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ContingenciesandOtherMatters" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7ce6800e-08b4-437d-a62a-4bc8616bb65d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ac2fe312-5da2-4f55-8d56-bb198b0d44d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7ce6800e-08b4-437d-a62a-4bc8616bb65d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ac2fe312-5da2-4f55-8d56-bb198b0d44d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SegmentInformation" xlink:type="simple" xlink:href="ci-20230331.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6b8b3f6c-a28a-4063-9225-00a9ad49d75a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_aa962efd-c1e9-4c90-a03a-7c6f8d13bba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6b8b3f6c-a28a-4063-9225-00a9ad49d75a" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_aa962efd-c1e9-4c90-a03a-7c6f8d13bba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="ci-20230331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_afeabae9-1f45-4145-9487-bea8a05a33eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_afeabae9-1f45-4145-9487-bea8a05a33eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a30b3477-a13d-4336-9951-a68c5fb4751a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a30b3477-a13d-4336-9951-a68c5fb4751a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_433e0bce-577b-4f09-be06-9c462dd03859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_433e0bce-577b-4f09-be06-9c462dd03859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_60af19e0-3275-40ea-9d5a-3a0e9a607be7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_60af19e0-3275-40ea-9d5a-3a0e9a607be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock_975a03bb-bf6a-4f13-b29c-f840a1287dc2" xlink:href="ci-20230331.xsd#ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock_975a03bb-bf6a-4f13-b29c-f840a1287dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock_0162c5df-3020-47c4-97c3-be95a094744e" xlink:href="ci-20230331.xsd#ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock_0162c5df-3020-47c4-97c3-be95a094744e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock_9b6c7e47-f7c7-4414-a7da-08973817317c" xlink:href="ci-20230331.xsd#ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock_9b6c7e47-f7c7-4414-a7da-08973817317c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock_d170b7c7-94cb-4568-9004-3b4d9f08186f" xlink:href="ci-20230331.xsd#ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock_d170b7c7-94cb-4568-9004-3b4d9f08186f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_879f70a8-eaff-4ac8-a0ef-0a11275d8f24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_879f70a8-eaff-4ac8-a0ef-0a11275d8f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_ae51a85c-77f0-4b3d-a9d4-a7f4eddc3900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_ae51a85c-77f0-4b3d-a9d4-a7f4eddc3900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_69cdc4c0-ba72-46c3-ad6b-d200fbf81049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_69cdc4c0-ba72-46c3-ad6b-d200fbf81049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_3d886f11-aa50-4e59-8752-5e8868ac548d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_3d886f11-aa50-4e59-8752-5e8868ac548d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_b7651a43-2985-40db-a34f-710c577d6644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_b7651a43-2985-40db-a34f-710c577d6644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_e2e9b02d-168a-443d-8c64-56bc2b64dda4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_e2e9b02d-168a-443d-8c64-56bc2b64dda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_c2bbbe00-b861-4260-bef2-2e844f322492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_c2bbbe00-b861-4260-bef2-2e844f322492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceUnearnedPremiumsPolicyTextBlock_c1f23eb7-a316-429c-91fe-e39f238beafd" xlink:href="ci-20230331.xsd#ci_InsuranceUnearnedPremiumsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_ci_InsuranceUnearnedPremiumsPolicyTextBlock_c1f23eb7-a316-429c-91fe-e39f238beafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_36a134bc-3c8f-4168-b3f8-6ee10b4cda20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_36a134bc-3c8f-4168-b3f8-6ee10b4cda20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FuturePolicyBenefitsLiabilityPolicy_4ce71ec5-f13b-4987-b463-3c61277737f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FuturePolicyBenefitsLiabilityPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_FuturePolicyBenefitsLiabilityPolicy_4ce71ec5-f13b-4987-b463-3c61277737f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ContractholderDepositFundsPolicyPolicyTextBlock_1dae1c3e-fb23-4d64-acd0-de88aac8ba25" xlink:href="ci-20230331.xsd#ci_ContractholderDepositFundsPolicyPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_ci_ContractholderDepositFundsPolicyPolicyTextBlock_1dae1c3e-fb23-4d64-acd0-de88aac8ba25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitPolicyTextBlock_7217cba3-12d2-4b43-abe2-6141cc50733e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_MarketRiskBenefitPolicyTextBlock_7217cba3-12d2-4b43-abe2-6141cc50733e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceAccountingPolicy_851ccac8-be69-40a0-8beb-51ce41c35799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceAccountingPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_ReinsuranceAccountingPolicy_851ccac8-be69-40a0-8beb-51ce41c35799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_2251de1c-8279-415b-8dc2-bdba84e07dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_2251de1c-8279-415b-8dc2-bdba84e07dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_00a95189-e3d6-4f56-bca3-5225ebe5a40f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_00a95189-e3d6-4f56-bca3-5225ebe5a40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_538036af-5651-48b9-93e7-0bdaf197f8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_538036af-5651-48b9-93e7-0bdaf197f8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountsPolicy_b36df339-5b33-43ce-b526-d4becc34de30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountsPolicy"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_PolicyholderAccountsPolicy_b36df339-5b33-43ce-b526-d4becc34de30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_dc740790-790d-4eee-8bc2-97511831bed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_dc740790-790d-4eee-8bc2-97511831bed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_7569e8cd-b78c-466c-bbc9-c96d66548cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_7569e8cd-b78c-466c-bbc9-c96d66548cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock_cc07073c-0756-4868-8d06-f8dd722e3feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_StockholdersEquityPolicyTextBlock_cc07073c-0756-4868-8d06-f8dd722e3feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_9d6d73b0-92aa-4fa9-a64f-4f5326b051f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_9d6d73b0-92aa-4fa9-a64f-4f5326b051f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_4965fbd5-f459-4156-89f4-2a3c7ca1e5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_4965fbd5-f459-4156-89f4-2a3c7ca1e5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_dd2d099a-7f2f-466a-8a6f-f7ea8d1218cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_dd2d099a-7f2f-466a-8a6f-f7ea8d1218cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_f73ed30c-1de8-4c68-a445-2e25ed2e6eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_f73ed30c-1de8-4c68-a445-2e25ed2e6eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_410ff4ef-86a4-4d20-8963-551882e4fb70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_410ff4ef-86a4-4d20-8963-551882e4fb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_63d70622-2268-4944-90cd-bb780b07fdb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_63d70622-2268-4944-90cd-bb780b07fdb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_bae7a052-c2a6-4e1b-bf7e-fa6884bdf6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_bae7a052-c2a6-4e1b-bf7e-fa6884bdf6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_d4e62225-ac6d-452e-a560-b2f3c36c71f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_d4e62225-ac6d-452e-a560-b2f3c36c71f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_dc25cd44-7cf1-40f7-b8a0-e2eada8546c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_dc25cd44-7cf1-40f7-b8a0-e2eada8546c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_afa82676-dc08-428d-b796-acecb917022a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1be5c01f-a4c4-472e-8769-719a782ddbc2" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_afa82676-dc08-428d-b796-acecb917022a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/AccountsReceivableNetTables" xlink:type="simple" xlink:href="ci-20230331.xsd#AccountsReceivableNetTables"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/AccountsReceivableNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_599a66c0-3811-4af7-bd87-d75bddcc5a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_4e20d5f6-15ce-402e-8465-4d4256fd4b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_599a66c0-3811-4af7-bd87-d75bddcc5a6f" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_4e20d5f6-15ce-402e-8465-4d4256fd4b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="ci-20230331.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_17347d0c-5e65-46ad-8bac-8125d859770b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_acba3a7d-a6df-4ac2-9680-682ad74e52ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_17347d0c-5e65-46ad-8bac-8125d859770b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_acba3a7d-a6df-4ac2-9680-682ad74e52ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c41e4bae-3f61-4d7e-85c2-356f8f7dca16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_17347d0c-5e65-46ad-8bac-8125d859770b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c41e4bae-3f61-4d7e-85c2-356f8f7dca16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/DebtTables" xlink:type="simple" xlink:href="ci-20230331.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5ce9dc6c-43ff-49d8-b2b8-55f6a261cd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock_c6fdd1d0-5667-4142-9b37-023a3d423537" xlink:href="ci-20230331.xsd#ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5ce9dc6c-43ff-49d8-b2b8-55f6a261cd2f" xlink:to="loc_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock_c6fdd1d0-5667-4142-9b37-023a3d423537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock_5ac6d17e-93e2-45d4-9fa3-2b2d7be05211" xlink:href="ci-20230331.xsd#ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5ce9dc6c-43ff-49d8-b2b8-55f6a261cd2f" xlink:to="loc_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock_5ac6d17e-93e2-45d4-9fa3-2b2d7be05211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_62628318-e356-4ea8-b3ba-c175841acc7f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5ce9dc6c-43ff-49d8-b2b8-55f6a261cd2f" xlink:to="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_62628318-e356-4ea8-b3ba-c175841acc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/CommonandPreferredStockTables" xlink:type="simple" xlink:href="ci-20230331.xsd#CommonandPreferredStockTables"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/CommonandPreferredStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a0c4f9fa-dbee-4b3c-83ab-68fd2bbbee3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_52a0ee42-52b7-42a6-932b-d43faeedfd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a0c4f9fa-dbee-4b3c-83ab-68fd2bbbee3a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_52a0ee42-52b7-42a6-932b-d43faeedfd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock_40d39b47-bc47-4b87-b598-ccc1f7c00ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a0c4f9fa-dbee-4b3c-83ab-68fd2bbbee3a" xlink:to="loc_us-gaap_DividendsDeclaredTableTextBlock_40d39b47-bc47-4b87-b598-ccc1f7c00ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesTables" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceLossReservesAbstract_8daaac9f-89c4-4268-8429-90c241789ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceLossReservesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_879c8313-cb9e-4162-81b9-03b46196f743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_8daaac9f-89c4-4268-8429-90c241789ccb" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_879c8313-cb9e-4162-81b9-03b46196f743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock_7e5255f9-0a2f-4ce9-9e18-d217b630b562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_8daaac9f-89c4-4268-8429-90c241789ccb" xlink:to="loc_us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock_7e5255f9-0a2f-4ce9-9e18-d217b630b562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_b2f9604e-1472-4c40-b41b-afdc3ab0075e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_8daaac9f-89c4-4268-8429-90c241789ccb" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_b2f9604e-1472-4c40-b41b-afdc3ab0075e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_31c156de-ac69-4101-95b4-c2a4191beca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_8daaac9f-89c4-4268-8429-90c241789ccb" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_31c156de-ac69-4101-95b4-c2a4191beca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitActivityTableTextBlock_255ee648-552e-40f9-ad23-e9d327d9e8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_8daaac9f-89c4-4268-8429-90c241789ccb" xlink:to="loc_us-gaap_MarketRiskBenefitActivityTableTextBlock_255ee648-552e-40f9-ad23-e9d327d9e8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock_8577f7c3-1858-45f3-88f4-754c975eff4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_8daaac9f-89c4-4268-8429-90c241789ccb" xlink:to="loc_us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock_8577f7c3-1858-45f3-88f4-754c975eff4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ReinsuranceTables" xlink:type="simple" xlink:href="ci-20230331.xsd#ReinsuranceTables"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ReinsuranceTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_f488cd64-30a1-453f-bed4-17276e12d64a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_921719e5-6b27-40cf-b079-43e17ebc5b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_f488cd64-30a1-453f-bed4-17276e12d64a" xlink:to="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_921719e5-6b27-40cf-b079-43e17ebc5b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceTableTextBlock_7fa00e95-03ed-40c6-8842-7f57d1a7b533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectsOfReinsuranceTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_f488cd64-30a1-453f-bed4-17276e12d64a" xlink:to="loc_us-gaap_EffectsOfReinsuranceTableTextBlock_7fa00e95-03ed-40c6-8842-7f57d1a7b533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitActivityTableTextBlock_47394829-b205-4003-8a2d-2929a1332797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_f488cd64-30a1-453f-bed4-17276e12d64a" xlink:to="loc_us-gaap_MarketRiskBenefitActivityTableTextBlock_47394829-b205-4003-8a2d-2929a1332797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsTables" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_37301636-6858-4899-a881-de0d6c77febc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_1806a91c-38fc-40c4-90de-81d6757502ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_37301636-6858-4899-a881-de0d6c77febc" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_1806a91c-38fc-40c4-90de-81d6757502ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_dd90c0f6-d580-4b49-aa97-31f4db99d958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_37301636-6858-4899-a881-de0d6c77febc" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_dd90c0f6-d580-4b49-aa97-31f4db99d958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_036fcd90-b8ac-4684-8f57-c2df206b3a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_37301636-6858-4899-a881-de0d6c77febc" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_036fcd90-b8ac-4684-8f57-c2df206b3a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_732dc678-d6a5-49fa-9b34-3799dfdbdb3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_37301636-6858-4899-a881-de0d6c77febc" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_732dc678-d6a5-49fa-9b34-3799dfdbdb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_5a0c9a65-64f6-4403-ae3c-da3880a08d8d" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_37301636-6858-4899-a881-de0d6c77febc" xlink:to="loc_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock_5a0c9a65-64f6-4403-ae3c-da3880a08d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_20a7bcca-717e-4b83-8e7c-2db36f12fed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_37301636-6858-4899-a881-de0d6c77febc" xlink:to="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_20a7bcca-717e-4b83-8e7c-2db36f12fed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock_6539c867-9389-47d9-9d81-1d50031b984e" xlink:href="ci-20230331.xsd#ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_37301636-6858-4899-a881-de0d6c77febc" xlink:to="loc_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock_6539c867-9389-47d9-9d81-1d50031b984e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_2baee30d-de12-47f0-90c7-e412cd4fc2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_37301636-6858-4899-a881-de0d6c77febc" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_2baee30d-de12-47f0-90c7-e412cd4fc2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock_20266481-d100-42dc-b130-ebe9f23973dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_37301636-6858-4899-a881-de0d6c77febc" xlink:to="loc_us-gaap_InvestmentIncomeTextBlock_20266481-d100-42dc-b130-ebe9f23973dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_2cf5ad3e-8993-40cc-aeb8-886a931b6b97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_37301636-6858-4899-a881-de0d6c77febc" xlink:to="loc_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock_2cf5ad3e-8993-40cc-aeb8-886a931b6b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_be325251-e52b-460c-8921-4545f32ab767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_28ede1e3-39ae-4b19-b0c2-d086b07a6408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_be325251-e52b-460c-8921-4545f32ab767" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_28ede1e3-39ae-4b19-b0c2-d086b07a6408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_6c3b2377-9f4b-469e-b0c7-7a5df5f778d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_be325251-e52b-460c-8921-4545f32ab767" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_6c3b2377-9f4b-469e-b0c7-7a5df5f778d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_3790e008-18c3-4c64-99d9-33d7d1df6323" xlink:href="ci-20230331.xsd#ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_be325251-e52b-460c-8921-4545f32ab767" xlink:to="loc_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_3790e008-18c3-4c64-99d9-33d7d1df6323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueOfSeparateAccountAssetsTableTextBlock_bc1804e7-eef0-44f2-8c8b-df05cd47c398" xlink:href="ci-20230331.xsd#ci_FairValueOfSeparateAccountAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_be325251-e52b-460c-8921-4545f32ab767" xlink:to="loc_ci_FairValueOfSeparateAccountAssetsTableTextBlock_bc1804e7-eef0-44f2-8c8b-df05cd47c398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock_69cb8626-4127-442c-982e-e9cbcfbcf051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_be325251-e52b-460c-8921-4545f32ab767" xlink:to="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock_69cb8626-4127-442c-982e-e9cbcfbcf051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_525e3327-0f9a-4101-a502-10e19afa3a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_be325251-e52b-460c-8921-4545f32ab767" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_525e3327-0f9a-4101-a502-10e19afa3a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="ci-20230331.xsd#AccumulatedOtherComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_732dcd22-076d-4fc3-9fab-c2b0244cbc9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ed401032-27ab-4576-827e-c049aa1ae3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_732dcd22-076d-4fc3-9fab-c2b0244cbc9f" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ed401032-27ab-4576-827e-c049aa1ae3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="ci-20230331.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6943c81b-2863-4865-b30d-0b0095b2a47b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ScheduleOfSpecialItemsTableTextBlock_5a21b900-cdc4-404d-98e5-f4d89f5197c7" xlink:href="ci-20230331.xsd#ci_ScheduleOfSpecialItemsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6943c81b-2863-4865-b30d-0b0095b2a47b" xlink:to="loc_ci_ScheduleOfSpecialItemsTableTextBlock_5a21b900-cdc4-404d-98e5-f4d89f5197c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b16c2ebf-4bfb-4a5f-a1ea-d1314aa6d470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6943c81b-2863-4865-b30d-0b0095b2a47b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b16c2ebf-4bfb-4a5f-a1ea-d1314aa6d470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_c0d32670-503b-45f2-80f5-c04b8158db09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6943c81b-2863-4865-b30d-0b0095b2a47b" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_c0d32670-503b-45f2-80f5-c04b8158db09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_79e9d20f-32ff-40a2-b38b-bbc1e18291ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6943c81b-2863-4865-b30d-0b0095b2a47b" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_79e9d20f-32ff-40a2-b38b-bbc1e18291ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/DescriptionofBusinessDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#DescriptionofBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/DescriptionofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e0b33006-81d6-43d1-acfa-3612cb2c97c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_20926d82-c759-4346-ae9a-9787c1ab0257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e0b33006-81d6-43d1-acfa-3612cb2c97c3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_20926d82-c759-4346-ae9a-9787c1ab0257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2c98e77d-59d6-4756-9201-c9d352e36d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_20926d82-c759-4346-ae9a-9787c1ab0257" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2c98e77d-59d6-4756-9201-c9d352e36d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b465423-dc9d-46b6-9a9a-b6993cc0054a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2c98e77d-59d6-4756-9201-c9d352e36d2b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b465423-dc9d-46b6-9a9a-b6993cc0054a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_8527d3e5-43ce-4e61-b740-e04933acd028" xlink:href="ci-20230331.xsd#ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b465423-dc9d-46b6-9a9a-b6993cc0054a" xlink:to="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_8527d3e5-43ce-4e61-b740-e04933acd028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember_6dcbe68d-6b07-4897-a232-5cc70669b384" xlink:href="ci-20230331.xsd#ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_8527d3e5-43ce-4e61-b740-e04933acd028" xlink:to="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember_6dcbe68d-6b07-4897-a232-5cc70669b384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_0799f071-df91-4cde-addd-8d4d78b77b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_20926d82-c759-4346-ae9a-9787c1ab0257" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_0799f071-df91-4cde-addd-8d4d78b77b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1563d3ee-b9ec-484f-a9f4-792e837b4d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_0799f071-df91-4cde-addd-8d4d78b77b7c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1563d3ee-b9ec-484f-a9f4-792e837b4d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_11524a60-26b7-486d-bffb-12415693d312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1563d3ee-b9ec-484f-a9f4-792e837b4d9c" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_11524a60-26b7-486d-bffb-12415693d312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_459489cc-5f7b-4a49-bb3b-4f9bd3a85970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1563d3ee-b9ec-484f-a9f4-792e837b4d9c" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_459489cc-5f7b-4a49-bb3b-4f9bd3a85970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_713d82b0-7a95-4934-afc6-37f39183da92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_20926d82-c759-4346-ae9a-9787c1ab0257" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_713d82b0-7a95-4934-afc6-37f39183da92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_be650def-d729-41dd-bc26-3ed299a7358a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_713d82b0-7a95-4934-afc6-37f39183da92" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_be650def-d729-41dd-bc26-3ed299a7358a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3165477e-9d17-417d-9ded-7492941d0dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_be650def-d729-41dd-bc26-3ed299a7358a" xlink:to="loc_us-gaap_SubsequentEventMember_3165477e-9d17-417d-9ded-7492941d0dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_295b7978-2a90-4c45-bd2f-d933f7c22a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_20926d82-c759-4346-ae9a-9787c1ab0257" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_295b7978-2a90-4c45-bd2f-d933f7c22a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_bd78511d-9334-4800-b221-67e4f4442085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_295b7978-2a90-4c45-bd2f-d933f7c22a54" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_bd78511d-9334-4800-b221-67e4f4442085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_de5340da-6ebe-452b-b7ad-d87f643f2244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_de5340da-6ebe-452b-b7ad-d87f643f2244" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9ac48b0d-8010-4343-8104-8f4e7f38f591" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:to="loc_srt_ProductOrServiceAxis_9ac48b0d-8010-4343-8104-8f4e7f38f591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c651a4ab-c05a-4672-b3bc-49de718ba721" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9ac48b0d-8010-4343-8104-8f4e7f38f591" xlink:to="loc_srt_ProductsAndServicesDomain_c651a4ab-c05a-4672-b3bc-49de718ba721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmacyBenefitsManagementServicesMember_55347c81-e9be-43a2-b6ee-ca2aaa292959" xlink:href="ci-20230331.xsd#ci_PharmacyBenefitsManagementServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c651a4ab-c05a-4672-b3bc-49de718ba721" xlink:to="loc_ci_PharmacyBenefitsManagementServicesMember_55347c81-e9be-43a2-b6ee-ca2aaa292959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AdministrativeServicesOnlyHealthCareServicesMember_8912972c-7099-4fa5-916b-a34ed686b15e" xlink:href="ci-20230331.xsd#ci_AdministrativeServicesOnlyHealthCareServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c651a4ab-c05a-4672-b3bc-49de718ba721" xlink:to="loc_ci_AdministrativeServicesOnlyHealthCareServicesMember_8912972c-7099-4fa5-916b-a34ed686b15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_195d8661-0910-4fa5-858e-b849479a7e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_195d8661-0910-4fa5-858e-b849479a7e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_cd7ca670-67d7-46ca-b0aa-8549c480dccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_195d8661-0910-4fa5-858e-b849479a7e9b" xlink:to="loc_us-gaap_LossContingencyNatureDomain_cd7ca670-67d7-46ca-b0aa-8549c480dccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceGuaranteeMember_1aa7c2bc-eb38-4e37-8ee7-47631a3e9d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceGuaranteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_cd7ca670-67d7-46ca-b0aa-8549c480dccf" xlink:to="loc_us-gaap_PerformanceGuaranteeMember_1aa7c2bc-eb38-4e37-8ee7-47631a3e9d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesMember_21e620b3-12ab-4a29-8e18-0810354c6ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_cd7ca670-67d7-46ca-b0aa-8549c480dccf" xlink:to="loc_us-gaap_GuaranteesMember_21e620b3-12ab-4a29-8e18-0810354c6ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0d26a03d-34fb-4bc4-94fd-2c523fefd762" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0d26a03d-34fb-4bc4-94fd-2c523fefd762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9185688f-c771-44c9-9d7a-492b80a10830" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0d26a03d-34fb-4bc4-94fd-2c523fefd762" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9185688f-c771-44c9-9d7a-492b80a10830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bdbe4e5f-dabd-454d-95ce-846ce58a0c52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9185688f-c771-44c9-9d7a-492b80a10830" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bdbe4e5f-dabd-454d-95ce-846ce58a0c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_4b6700ee-e1c6-4fb8-9c2f-fda1125d0fb8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:to="loc_srt_RestatementAxis_4b6700ee-e1c6-4fb8-9c2f-fda1125d0fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_40334730-27e3-4257-a8cb-b005005e67fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_4b6700ee-e1c6-4fb8-9c2f-fda1125d0fb8" xlink:to="loc_srt_RestatementDomain_40334730-27e3-4257-a8cb-b005005e67fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_f3822a64-7be5-4f89-98c2-957d56db4326" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_40334730-27e3-4257-a8cb-b005005e67fe" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_f3822a64-7be5-4f89-98c2-957d56db4326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_347b8d42-1552-4908-960c-633d86e7f07f" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3b52123f-99e2-4d8d-9a52-10c43234a763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3b52123f-99e2-4d8d-9a52-10c43234a763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_eef4c443-e425-4574-becd-6cc2c24d07a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_eef4c443-e425-4574-becd-6cc2c24d07a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bd66f780-e621-4ead-ab55-9cf07fd2cb99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bd66f780-e621-4ead-ab55-9cf07fd2cb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_10cac73f-9246-4a11-a8a0-2b24861041c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_10cac73f-9246-4a11-a8a0-2b24861041c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7516a2b3-92b2-4561-b637-8a78945a94cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7516a2b3-92b2-4561-b637-8a78945a94cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_b0b6f9d4-9f14-4501-abde-6d9997b64bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_b0b6f9d4-9f14-4501-abde-6d9997b64bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_ff724b2a-6819-4872-8bbc-1e7e989bc6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_507994b6-b874-41f0-8a33-0b4cca61ef34" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_ff724b2a-6819-4872-8bbc-1e7e989bc6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#AccountsReceivableNetSummaryofAccountsReceivableNetDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_b169cb83-c57e-4f6a-bd60-95bf727db6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmaceuticalManufacturerReceivable_4e0e7a78-0cc0-48d3-9095-91420bf7fbc3" xlink:href="ci-20230331.xsd#ci_PharmaceuticalManufacturerReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b169cb83-c57e-4f6a-bd60-95bf727db6a6" xlink:to="loc_ci_PharmaceuticalManufacturerReceivable_4e0e7a78-0cc0-48d3-9095-91420bf7fbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable_8d9fdd39-2548-48bb-9880-2d1854a87b85" xlink:href="ci-20230331.xsd#ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b169cb83-c57e-4f6a-bd60-95bf727db6a6" xlink:to="loc_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable_8d9fdd39-2548-48bb-9880-2d1854a87b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceCustomerReceivables_61bdf3c5-1a90-4495-a84f-c0aa46acd83c" xlink:href="ci-20230331.xsd#ci_InsuranceCustomerReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b169cb83-c57e-4f6a-bd60-95bf727db6a6" xlink:to="loc_ci_InsuranceCustomerReceivables_61bdf3c5-1a90-4495-a84f-c0aa46acd83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_325910fa-72e4-4fe8-a99b-ac33ef71cc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b169cb83-c57e-4f6a-bd60-95bf727db6a6" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_325910fa-72e4-4fe8-a99b-ac33ef71cc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_d21f403f-99d0-47fd-a877-76f29275e256" xlink:href="ci-20230331.xsd#ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b169cb83-c57e-4f6a-bd60-95bf727db6a6" xlink:to="loc_ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_d21f403f-99d0-47fd-a877-76f29275e256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_5042bd0a-21d9-4320-a14a-14d7e8f9e406" xlink:href="ci-20230331.xsd#ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b169cb83-c57e-4f6a-bd60-95bf727db6a6" xlink:to="loc_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale_5042bd0a-21d9-4320-a14a-14d7e8f9e406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale_4aadc701-52dc-4215-aff2-daca42955b0b" xlink:href="ci-20230331.xsd#ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b169cb83-c57e-4f6a-bd60-95bf727db6a6" xlink:to="loc_ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale_4aadc701-52dc-4215-aff2-daca42955b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_6b9d2ff3-5b0b-496e-a264-26c6ef5c29c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b169cb83-c57e-4f6a-bd60-95bf727db6a6" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_6b9d2ff3-5b0b-496e-a264-26c6ef5c29c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_19d9ab3d-d5c8-46c7-acbc-11be5fc5f9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b169cb83-c57e-4f6a-bd60-95bf727db6a6" xlink:to="loc_us-gaap_ReceivablesNetCurrent_19d9ab3d-d5c8-46c7-acbc-11be5fc5f9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/AccountsReceivableNetNarrativeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#AccountsReceivableNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/AccountsReceivableNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_b3fa7c94-1deb-457d-b82a-1e48b2ff0d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AllowanceForReceivablesCurrent_b667371b-288f-42d3-97e4-8a84edfb22c9" xlink:href="ci-20230331.xsd#ci_AllowanceForReceivablesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b3fa7c94-1deb-457d-b82a-1e48b2ff0d0b" xlink:to="loc_ci_AllowanceForReceivablesCurrent_b667371b-288f-42d3-97e4-8a84edfb22c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ContractualAllowancePharmaceuticalManufacturersReceivables_07c4616e-b9d7-47be-bcf2-12b9c1f2fd25" xlink:href="ci-20230331.xsd#ci_ContractualAllowancePharmaceuticalManufacturersReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b3fa7c94-1deb-457d-b82a-1e48b2ff0d0b" xlink:to="loc_ci_ContractualAllowancePharmaceuticalManufacturersReceivables_07c4616e-b9d7-47be-bcf2-12b9c1f2fd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ContractualAllowanceNoninsuranceCustomerReceivables_d70a5bae-8ffd-45a0-a4f3-187801c5722b" xlink:href="ci-20230331.xsd#ci_ContractualAllowanceNoninsuranceCustomerReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b3fa7c94-1deb-457d-b82a-1e48b2ff0d0b" xlink:to="loc_ci_ContractualAllowanceNoninsuranceCustomerReceivables_d70a5bae-8ffd-45a0-a4f3-187801c5722b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AllowanceForReceivablesOther_b7abddb2-5d3b-4ebc-84ea-1b06164fb4b3" xlink:href="ci-20230331.xsd#ci_AllowanceForReceivablesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b3fa7c94-1deb-457d-b82a-1e48b2ff0d0b" xlink:to="loc_ci_AllowanceForReceivablesOther_b7abddb2-5d3b-4ebc-84ea-1b06164fb4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c405c293-dcf4-438a-839e-aba1cd372a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b3fa7c94-1deb-457d-b82a-1e48b2ff0d0b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c405c293-dcf4-438a-839e-aba1cd372a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SupplierFinanceProgramDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SupplierFinanceProgramDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/SupplierFinanceProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_e62e89cd-15aa-4eeb-b7d5-b03b93bdde31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SupplierFinanceProgramPaymentTimingPeriod_ff46d2d1-81f6-4c7a-969b-62ee0594a91b" xlink:href="ci-20230331.xsd#ci_SupplierFinanceProgramPaymentTimingPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e62e89cd-15aa-4eeb-b7d5-b03b93bdde31" xlink:to="loc_ci_SupplierFinanceProgramPaymentTimingPeriod_ff46d2d1-81f6-4c7a-969b-62ee0594a91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SupplierFinanceProgramObligationCurrent_6734b146-ae1b-4946-bdad-24d62da614c6" xlink:href="ci-20230331.xsd#ci_SupplierFinanceProgramObligationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e62e89cd-15aa-4eeb-b7d5-b03b93bdde31" xlink:to="loc_ci_SupplierFinanceProgramObligationCurrent_6734b146-ae1b-4946-bdad-24d62da614c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold_15c0658a-fee4-4b4d-a337-dc84fc471856" xlink:href="ci-20230331.xsd#ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e62e89cd-15aa-4eeb-b7d5-b03b93bdde31" xlink:to="loc_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold_15c0658a-fee4-4b4d-a337-dc84fc471856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#MergersAcquisitionsandDivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2049b7db-6f1d-4e75-ab5a-2cd1bdb5af32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b48c8893-04ad-4c23-b3c6-d593c50560f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2049b7db-6f1d-4e75-ab5a-2cd1bdb5af32" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b48c8893-04ad-4c23-b3c6-d593c50560f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bb8c13e-80fd-4ea2-9f41-4eff1db90b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b48c8893-04ad-4c23-b3c6-d593c50560f4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bb8c13e-80fd-4ea2-9f41-4eff1db90b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_607121ab-539b-40dc-9a72-61529ff0b7be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6bb8c13e-80fd-4ea2-9f41-4eff1db90b27" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_607121ab-539b-40dc-9a72-61529ff0b7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_USGroupDisabilityAndLifeInsuranceBusinessMember_00afab5b-0d7b-42ab-b49a-be56321ba928" xlink:href="ci-20230331.xsd#ci_USGroupDisabilityAndLifeInsuranceBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_607121ab-539b-40dc-9a72-61529ff0b7be" xlink:to="loc_ci_USGroupDisabilityAndLifeInsuranceBusinessMember_00afab5b-0d7b-42ab-b49a-be56321ba928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_412c85cd-713a-4bdc-971e-647b3588dff7" xlink:href="ci-20230331.xsd#ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_607121ab-539b-40dc-9a72-61529ff0b7be" xlink:to="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_412c85cd-713a-4bdc-971e-647b3588dff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember_ac1219d8-4bfe-4e60-b7ea-eeb226df853f" xlink:href="ci-20230331.xsd#ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember_412c85cd-713a-4bdc-971e-647b3588dff7" xlink:to="loc_ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember_ac1219d8-4bfe-4e60-b7ea-eeb226df853f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_fc4dac6c-da5e-411b-885e-fea1844803cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b48c8893-04ad-4c23-b3c6-d593c50560f4" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_fc4dac6c-da5e-411b-885e-fea1844803cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fa29e5ed-a69d-4203-8a6e-75b152b3149a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_fc4dac6c-da5e-411b-885e-fea1844803cc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fa29e5ed-a69d-4203-8a6e-75b152b3149a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_37e7e0d3-8746-43f0-a5a2-f7ac37a3a42b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fa29e5ed-a69d-4203-8a6e-75b152b3149a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_37e7e0d3-8746-43f0-a5a2-f7ac37a3a42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b48c8893-04ad-4c23-b3c6-d593c50560f4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f25e3dbd-d16b-4b38-873e-5e1db84de569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f25e3dbd-d16b-4b38-873e-5e1db84de569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7f106051-0654-470a-b174-bb7958f3a7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7f106051-0654-470a-b174-bb7958f3a7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_71af8d39-e132-4ecb-9eef-2b759240cea1" xlink:href="ci-20230331.xsd#ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:to="loc_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_71af8d39-e132-4ecb-9eef-2b759240cea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_a2217649-5e76-43c3-8b1d-69eb26434f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_a2217649-5e76-43c3-8b1d-69eb26434f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax_de2fa375-a598-4ad4-8986-30381b85eb3b" xlink:href="ci-20230331.xsd#ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_68f43182-77c1-4ec2-868c-b4eb2aded68e" xlink:to="loc_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax_de2fa375-a598-4ad4-8986-30381b85eb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TransactionRelatedCosts_91cb940c-6810-4cb4-88a9-ed0a5a0c374a" xlink:href="ci-20230331.xsd#ci_TransactionRelatedCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2049b7db-6f1d-4e75-ab5a-2cd1bdb5af32" xlink:to="loc_ci_TransactionRelatedCosts_91cb940c-6810-4cb4-88a9-ed0a5a0c374a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TransactionRelatedCostsAfterTax_0e72e8b5-4dba-4e16-a631-8fa69abf3c54" xlink:href="ci-20230331.xsd#ci_TransactionRelatedCostsAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2049b7db-6f1d-4e75-ab5a-2cd1bdb5af32" xlink:to="loc_ci_TransactionRelatedCostsAfterTax_0e72e8b5-4dba-4e16-a631-8fa69abf3c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_be3453ba-cdb3-4588-9e5c-53ceb78460f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1377fde0-fba7-4f00-94be-f0916e0263a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_be3453ba-cdb3-4588-9e5c-53ceb78460f7" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1377fde0-fba7-4f00-94be-f0916e0263a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_23751a21-33eb-4acb-b7da-41eff857d9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_be3453ba-cdb3-4588-9e5c-53ceb78460f7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_23751a21-33eb-4acb-b7da-41eff857d9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_144aa575-7e39-46f0-8806-3e61bb77bf50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_23751a21-33eb-4acb-b7da-41eff857d9c7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_144aa575-7e39-46f0-8806-3e61bb77bf50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_71f2d2ac-21ba-4d85-b0f3-ca1406f6a005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_23751a21-33eb-4acb-b7da-41eff857d9c7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_71f2d2ac-21ba-4d85-b0f3-ca1406f6a005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_47f9e252-bc55-47cd-9099-c0c1904b7b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_23751a21-33eb-4acb-b7da-41eff857d9c7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_47f9e252-bc55-47cd-9099-c0c1904b7b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e152f9e4-8745-4eda-877c-64331d1f5afa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_be3453ba-cdb3-4588-9e5c-53ceb78460f7" xlink:to="loc_us-gaap_EarningsPerShareBasic_e152f9e4-8745-4eda-877c-64331d1f5afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EarningsPerShareEffectOfDilution_a3131774-6353-4147-b287-605b439ce0aa" xlink:href="ci-20230331.xsd#ci_EarningsPerShareEffectOfDilution"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_be3453ba-cdb3-4588-9e5c-53ceb78460f7" xlink:to="loc_ci_EarningsPerShareEffectOfDilution_a3131774-6353-4147-b287-605b439ce0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_dc4fe6ca-0f7d-400e-b8c7-6b406dd741a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_be3453ba-cdb3-4588-9e5c-53ceb78460f7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_dc4fe6ca-0f7d-400e-b8c7-6b406dd741a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_883f8f19-6284-4ca4-bedf-2ed7f9644eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea7bb7e7-8ce9-45d0-8970-444176f1f41d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_883f8f19-6284-4ca4-bedf-2ed7f9644eb8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea7bb7e7-8ce9-45d0-8970-444176f1f41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53631b39-7b67-407f-9000-ccbf18ab949c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea7bb7e7-8ce9-45d0-8970-444176f1f41d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53631b39-7b67-407f-9000-ccbf18ab949c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c3c75a5a-bb26-4bc2-902a-44d16fe888a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_53631b39-7b67-407f-9000-ccbf18ab949c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c3c75a5a-bb26-4bc2-902a-44d16fe888a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9d26de1b-07e7-4e82-9b98-edddd36f611b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c3c75a5a-bb26-4bc2-902a-44d16fe888a3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9d26de1b-07e7-4e82-9b98-edddd36f611b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_305eb39c-202a-48b0-a2e3-bf4c1a535f99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea7bb7e7-8ce9-45d0-8970-444176f1f41d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_305eb39c-202a-48b0-a2e3-bf4c1a535f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bdc2ab7d-e125-4cd8-8523-4e9ab915263b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_305eb39c-202a-48b0-a2e3-bf4c1a535f99" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bdc2ab7d-e125-4cd8-8523-4e9ab915263b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/EarningsPerShareSharesofCommonStockHeldinTreasuryDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#EarningsPerShareSharesofCommonStockHeldinTreasuryDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/EarningsPerShareSharesofCommonStockHeldinTreasuryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_62edaec1-9d98-401c-80e6-8b13861ce721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_11e8a8bc-65f8-4755-a474-15399cc3004f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_62edaec1-9d98-401c-80e6-8b13861ce721" xlink:to="loc_us-gaap_TreasuryStockCommonShares_11e8a8bc-65f8-4755-a474-15399cc3004f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_479cd301-3a37-4a76-89da-a7ff83a44345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_62edaec1-9d98-401c-80e6-8b13861ce721" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_479cd301-3a37-4a76-89da-a7ff83a44345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#DebtOutstandingAmountsofDebtandFinanceLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_49e1ade6-4eca-43d2-a38f-970e467f3c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_97d5c3ac-7b8b-467e-b3b8-a007b153571e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_49e1ade6-4eca-43d2-a38f-970e467f3c71" xlink:to="loc_us-gaap_DebtInstrumentTable_97d5c3ac-7b8b-467e-b3b8-a007b153571e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_37850adb-883c-42c0-aead-55d4dba0fe18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_97d5c3ac-7b8b-467e-b3b8-a007b153571e" xlink:to="loc_us-gaap_DebtInstrumentAxis_37850adb-883c-42c0-aead-55d4dba0fe18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_37850adb-883c-42c0-aead-55d4dba0fe18" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2022305InterestMember_116bef80-9c70-4d10-a2a3-d3a754b4a742" xlink:href="ci-20230331.xsd#ci_NotesDue2022305InterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2022305InterestMember_116bef80-9c70-4d10-a2a3-d3a754b4a742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue202383InterestMember_59421bf0-88fc-4f48-bfb9-de3ade54f862" xlink:href="ci-20230331.xsd#ci_NotesDue202383InterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue202383InterestMember_59421bf0-88fc-4f48-bfb9-de3ade54f862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2023765InterestMember_c4a80ba0-ce96-48cc-aef3-5febc89b6ba7" xlink:href="ci-20230331.xsd#ci_NotesDue2023765InterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2023765InterestMember_c4a80ba0-ce96-48cc-aef3-5febc89b6ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2023FloatingRateInterestMember_67ad5d2d-6104-4f83-bfbd-3113b03c9a4e" xlink:href="ci-20230331.xsd#ci_NotesDue2023FloatingRateInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2023FloatingRateInterestMember_67ad5d2d-6104-4f83-bfbd-3113b03c9a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20233InterestMember_b83b576d-e9fe-4002-be81-8348c3039055" xlink:href="ci-20230331.xsd#ci_NotesDue20233InterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20233InterestMember_b83b576d-e9fe-4002-be81-8348c3039055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2023375InterestMember_201a1bf1-dda1-4047-93ec-143633f9159b" xlink:href="ci-20230331.xsd#ci_NotesDue2023375InterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2023375InterestMember_201a1bf1-dda1-4047-93ec-143633f9159b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2024613InterestMember_a99b4d38-1990-4573-91a0-f4a58f176b94" xlink:href="ci-20230331.xsd#ci_NotesDue2024613InterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2024613InterestMember_a99b4d38-1990-4573-91a0-f4a58f176b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue202435InterestMember_e8d2e80a-b679-40fb-ace3-93c710425057" xlink:href="ci-20230331.xsd#ci_NotesDue202435InterestMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue202435InterestMember_e8d2e80a-b679-40fb-ace3-93c710425057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2025325InterestMember_32ad86ab-c2e7-4154-8dd6-978b8abed590" xlink:href="ci-20230331.xsd#ci_NotesDue2025325InterestMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2025325InterestMember_32ad86ab-c2e7-4154-8dd6-978b8abed590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20254125InterestMember_268e2b2d-c3b3-48bc-844a-35cc075c2a41" xlink:href="ci-20230331.xsd#ci_NotesDue20254125InterestMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20254125InterestMember_268e2b2d-c3b3-48bc-844a-35cc075c2a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue202645InterestMember_2ff00499-e62c-4627-9e70-98cb8cad4567" xlink:href="ci-20230331.xsd#ci_NotesDue202645InterestMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue202645InterestMember_2ff00499-e62c-4627-9e70-98cb8cad4567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2026125Member_6d975424-ad14-4eb6-a07b-ab032ab870c1" xlink:href="ci-20230331.xsd#ci_NotesDue2026125Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2026125Member_6d975424-ad14-4eb6-a07b-ab032ab870c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20265685Member_46a692a6-269e-4b97-9198-2179c3b58b81" xlink:href="ci-20230331.xsd#ci_NotesDue20265685Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20265685Member_46a692a6-269e-4b97-9198-2179c3b58b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue202734InterestMember_d4dcd179-8de9-4b63-b162-882c6a23ff5f" xlink:href="ci-20230331.xsd#ci_NotesDue202734InterestMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue202734InterestMember_d4dcd179-8de9-4b63-b162-882c6a23ff5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebenturesDue20277875InterestMember_7dcca031-7d52-494e-b4d0-33e611358f7b" xlink:href="ci-20230331.xsd#ci_DebenturesDue20277875InterestMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_DebenturesDue20277875InterestMember_7dcca031-7d52-494e-b4d0-33e611358f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2027305Member_d0bbc4b1-cf4b-4188-bccb-e38add5b5b42" xlink:href="ci-20230331.xsd#ci_NotesDue2027305Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2027305Member_d0bbc4b1-cf4b-4188-bccb-e38add5b5b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20284375InterestMember_19e12408-23d0-4ca5-bf51-f15bdb7c9e8d" xlink:href="ci-20230331.xsd#ci_NotesDue20284375InterestMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20284375InterestMember_19e12408-23d0-4ca5-bf51-f15bdb7c9e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue203024InterestMember_372572f6-e099-43b0-9709-7d8ef2d6e75a" xlink:href="ci-20230331.xsd#ci_NotesDue203024InterestMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue203024InterestMember_372572f6-e099-43b0-9709-7d8ef2d6e75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20312375InterestMember_9b26ce8e-3f35-433d-b3e0-7952e2a51d87" xlink:href="ci-20230331.xsd#ci_NotesDue20312375InterestMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20312375InterestMember_9b26ce8e-3f35-433d-b3e0-7952e2a51d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_StepDownNotesDueJanuary2033Member_7ca9f447-b54f-4452-b320-393227072dd8" xlink:href="ci-20230331.xsd#ci_StepDownNotesDueJanuary2033Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_StepDownNotesDueJanuary2033Member_7ca9f447-b54f-4452-b320-393227072dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20335400InterestMember_59241c8b-8a65-4e52-a6b8-12d9c4575a1a" xlink:href="ci-20230331.xsd#ci_NotesDue20335400InterestMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20335400InterestMember_59241c8b-8a65-4e52-a6b8-12d9c4575a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue2036615InterestMember_0938990e-52a0-4f9c-8b6b-8f41b23c95d2" xlink:href="ci-20230331.xsd#ci_NotesDue2036615InterestMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue2036615InterestMember_0938990e-52a0-4f9c-8b6b-8f41b23c95d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue203848InterestMember_28078d0c-52df-4871-8224-bf32d9fb35d0" xlink:href="ci-20230331.xsd#ci_NotesDue203848InterestMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue203848InterestMember_28078d0c-52df-4871-8224-bf32d9fb35d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue204032InterestMember_ec3c0c8f-73a4-4886-a0d4-06431ccde319" xlink:href="ci-20230331.xsd#ci_NotesDue204032InterestMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue204032InterestMember_ec3c0c8f-73a4-4886-a0d4-06431ccde319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20415875InterestMember_ccf58647-7d35-4cb9-a8b6-9d3d793cfc91" xlink:href="ci-20230331.xsd#ci_NotesDue20415875InterestMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20415875InterestMember_ccf58647-7d35-4cb9-a8b6-9d3d793cfc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20416125InterestMember_41b1852d-7736-4a14-aebf-499fa34f58d3" xlink:href="ci-20230331.xsd#ci_NotesDue20416125InterestMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20416125InterestMember_41b1852d-7736-4a14-aebf-499fa34f58d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20425375InterestMember_e9e5631a-8852-45ea-afc1-a8183cd930e8" xlink:href="ci-20230331.xsd#ci_NotesDue20425375InterestMember"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20425375InterestMember_e9e5631a-8852-45ea-afc1-a8183cd930e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue204648InterestMember_c6a90b38-2485-4ec9-8dde-c2459797bb5b" xlink:href="ci-20230331.xsd#ci_NotesDue204648InterestMember"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue204648InterestMember_c6a90b38-2485-4ec9-8dde-c2459797bb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20473875Member_03fb3e22-8e6b-4226-b1c2-a623b73d782a" xlink:href="ci-20230331.xsd#ci_NotesDue20473875Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue20473875Member_03fb3e22-8e6b-4226-b1c2-a623b73d782a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue204849InterestMember_523ed23c-3423-4bc8-900c-95e4e7595f9a" xlink:href="ci-20230331.xsd#ci_NotesDue204849InterestMember"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue204849InterestMember_523ed23c-3423-4bc8-900c-95e4e7595f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue205034InterestMember_b9561108-5d2a-4f5e-90c6-be9c322b0781" xlink:href="ci-20230331.xsd#ci_NotesDue205034InterestMember"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue205034InterestMember_b9561108-5d2a-4f5e-90c6-be9c322b0781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue205134InterestMember_f3011a4f-f683-40b8-a88c-a64449c63d62" xlink:href="ci-20230331.xsd#ci_NotesDue205134InterestMember"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96954da4-5aa1-4a37-a166-42844b507f4b" xlink:to="loc_ci_NotesDue205134InterestMember_f3011a4f-f683-40b8-a88c-a64449c63d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2afc6a0e-9587-45e3-80ad-5a328af3c22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_97d5c3ac-7b8b-467e-b3b8-a007b153571e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2afc6a0e-9587-45e3-80ad-5a328af3c22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrentAbstract_49a54349-8fdc-4cf6-9c58-e437526fc202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2afc6a0e-9587-45e3-80ad-5a328af3c22c" xlink:to="loc_us-gaap_DebtCurrentAbstract_49a54349-8fdc-4cf6-9c58-e437526fc202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_776ff385-d383-445a-99d7-3f2716e6f359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtCurrentAbstract_49a54349-8fdc-4cf6-9c58-e437526fc202" xlink:to="loc_us-gaap_CommercialPaper_776ff385-d383-445a-99d7-3f2716e6f359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_51c0efff-2e5e-4ee2-a7d5-5ec5fb93e8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtCurrentAbstract_49a54349-8fdc-4cf6-9c58-e437526fc202" xlink:to="loc_us-gaap_LongTermDebtCurrent_51c0efff-2e5e-4ee2-a7d5-5ec5fb93e8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent_010e829d-d797-4f6f-b04d-8577372bccdf" xlink:href="ci-20230331.xsd#ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtCurrentAbstract_49a54349-8fdc-4cf6-9c58-e437526fc202" xlink:to="loc_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent_010e829d-d797-4f6f-b04d-8577372bccdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_911a9f26-135d-4b6f-a253-bf2ca189a17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtCurrentAbstract_49a54349-8fdc-4cf6-9c58-e437526fc202" xlink:to="loc_us-gaap_DebtCurrent_911a9f26-135d-4b6f-a253-bf2ca189a17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract_39c3ec6f-04ad-4e3c-a180-1535c496a192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2afc6a0e-9587-45e3-80ad-5a328af3c22c" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract_39c3ec6f-04ad-4e3c-a180-1535c496a192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f1216d5b-a26a-4ce7-b342-33414d758368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract_39c3ec6f-04ad-4e3c-a180-1535c496a192" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f1216d5b-a26a-4ce7-b342-33414d758368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_72f2dd7e-d657-4b6a-9f56-1d68b1596844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract_39c3ec6f-04ad-4e3c-a180-1535c496a192" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_72f2dd7e-d657-4b6a-9f56-1d68b1596844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_39719762-b29c-4928-9609-365df22e87be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract_39c3ec6f-04ad-4e3c-a180-1535c496a192" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_39719762-b29c-4928-9609-365df22e87be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_45df8519-235e-4d05-987d-70cc8de1cbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2afc6a0e-9587-45e3-80ad-5a328af3c22c" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_45df8519-235e-4d05-987d-70cc8de1cbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f747e70b-0692-43d1-b9e5-7b4330572ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2afc6a0e-9587-45e3-80ad-5a328af3c22c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f747e70b-0692-43d1-b9e5-7b4330572ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#DebtDebtIssuancesandRedemptionsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cf07de5f-c499-49f7-a4b0-6093b73627b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5f2ae84a-106b-4b7c-b3da-fdb729cfeffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cf07de5f-c499-49f7-a4b0-6093b73627b7" xlink:to="loc_us-gaap_DebtInstrumentTable_5f2ae84a-106b-4b7c-b3da-fdb729cfeffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1637353e-d852-475a-8d7f-1754ee599b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5f2ae84a-106b-4b7c-b3da-fdb729cfeffd" xlink:to="loc_us-gaap_DebtInstrumentAxis_1637353e-d852-475a-8d7f-1754ee599b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_921165ad-5442-4320-b1bb-88e400213638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1637353e-d852-475a-8d7f-1754ee599b4f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_921165ad-5442-4320-b1bb-88e400213638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20265685Member_f4d6547b-e783-4a03-82bc-c2f2ed9c13d2" xlink:href="ci-20230331.xsd#ci_NotesDue20265685Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_921165ad-5442-4320-b1bb-88e400213638" xlink:to="loc_ci_NotesDue20265685Member_f4d6547b-e783-4a03-82bc-c2f2ed9c13d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NotesDue20335400InterestMember_a3e00025-debb-4d9c-b403-10106fe3ad13" xlink:href="ci-20230331.xsd#ci_NotesDue20335400InterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_921165ad-5442-4320-b1bb-88e400213638" xlink:to="loc_ci_NotesDue20335400InterestMember_a3e00025-debb-4d9c-b403-10106fe3ad13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0746bceb-322e-409d-8d56-0bb6f24cc374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5f2ae84a-106b-4b7c-b3da-fdb729cfeffd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0746bceb-322e-409d-8d56-0bb6f24cc374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f245b11a-464c-497a-9977-d39add34fe17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0746bceb-322e-409d-8d56-0bb6f24cc374" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f245b11a-464c-497a-9977-d39add34fe17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3635b606-195c-446a-b0b1-1572adb301b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f245b11a-464c-497a-9977-d39add34fe17" xlink:to="loc_us-gaap_SeniorNotesMember_3635b606-195c-446a-b0b1-1572adb301b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_64882f5b-42ee-4702-8f5d-764ffaf95b76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5f2ae84a-106b-4b7c-b3da-fdb729cfeffd" xlink:to="loc_us-gaap_VariableRateAxis_64882f5b-42ee-4702-8f5d-764ffaf95b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b501ff96-3028-4fb2-ba27-922fd07fcfc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_64882f5b-42ee-4702-8f5d-764ffaf95b76" xlink:to="loc_us-gaap_VariableRateDomain_b501ff96-3028-4fb2-ba27-922fd07fcfc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember_b4132625-a1de-4109-80db-ab329b058984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b501ff96-3028-4fb2-ba27-922fd07fcfc0" xlink:to="loc_us-gaap_UsTreasuryUstInterestRateMember_b4132625-a1de-4109-80db-ab329b058984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5f2ae84a-106b-4b7c-b3da-fdb729cfeffd" xlink:to="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_92bc9c3a-1a78-403f-8156-1cff125c9cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_92bc9c3a-1a78-403f-8156-1cff125c9cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d66d5c4a-e18a-46ae-b6aa-4c81ee7e2900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d66d5c4a-e18a-46ae-b6aa-4c81ee7e2900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees_e993ad05-e399-424e-84ac-dc0b5dbcfd65" xlink:href="ci-20230331.xsd#ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees_e993ad05-e399-424e-84ac-dc0b5dbcfd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_b3edf444-161e-4ef5-a72f-148838270714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_b3edf444-161e-4ef5-a72f-148838270714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_73cdd988-9aaf-4641-97b9-388acaf2e4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_73cdd988-9aaf-4641-97b9-388acaf2e4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GainLossOnExtinguishmentOfDebtNetOfTax_3264fb90-bb12-4e8b-9674-8d52405d359f" xlink:href="ci-20230331.xsd#ci_GainLossOnExtinguishmentOfDebtNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_ci_GainLossOnExtinguishmentOfDebtNetOfTax_3264fb90-bb12-4e8b-9674-8d52405d359f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate_ab5421ac-a7e1-4f80-9d56-7223d30d1f1d" xlink:href="ci-20230331.xsd#ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_381c6946-c516-48af-b002-27b3d8f71fd2" xlink:to="loc_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate_ab5421ac-a7e1-4f80-9d56-7223d30d1f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a77bfa4f-2714-41a8-97a9-e42356d1eaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9e38714f-7c18-47f4-bf7c-38bde86520a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a77bfa4f-2714-41a8-97a9-e42356d1eaf4" xlink:to="loc_us-gaap_DebtInstrumentTable_9e38714f-7c18-47f4-bf7c-38bde86520a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_eb3eebc1-0f52-4a71-8dc0-e002ae085ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9e38714f-7c18-47f4-bf7c-38bde86520a8" xlink:to="loc_us-gaap_DebtInstrumentAxis_eb3eebc1-0f52-4a71-8dc0-e002ae085ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ae14d57f-1ec5-4a55-9be9-e1993aa92e72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_eb3eebc1-0f52-4a71-8dc0-e002ae085ca7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ae14d57f-1ec5-4a55-9be9-e1993aa92e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditAgreementsApril2023Member_fde2cf52-b596-4cbc-870e-9f4bfbb696f2" xlink:href="ci-20230331.xsd#ci_RevolvingCreditAgreementsApril2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ae14d57f-1ec5-4a55-9be9-e1993aa92e72" xlink:to="loc_ci_RevolvingCreditAgreementsApril2023Member_fde2cf52-b596-4cbc-870e-9f4bfbb696f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member_77272873-b308-4273-8b27-19c8c719a645" xlink:href="ci-20230331.xsd#ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_RevolvingCreditAgreementsApril2023Member_fde2cf52-b596-4cbc-870e-9f4bfbb696f2" xlink:to="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member_77272873-b308-4273-8b27-19c8c719a645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member_44b262eb-8dd7-417a-afed-2bb9876d9a2b" xlink:href="ci-20230331.xsd#ci_A364DayRevolvingCreditAgreementMaturingApril2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_RevolvingCreditAgreementsApril2023Member_fde2cf52-b596-4cbc-870e-9f4bfbb696f2" xlink:to="loc_ci_A364DayRevolvingCreditAgreementMaturingApril2024Member_44b262eb-8dd7-417a-afed-2bb9876d9a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_dcb30f49-f387-4dac-9fa8-4f9ecdccc1b9" xlink:href="ci-20230331.xsd#ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ae14d57f-1ec5-4a55-9be9-e1993aa92e72" xlink:to="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_dcb30f49-f387-4dac-9fa8-4f9ecdccc1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member_d2c803c8-f004-4bd2-b219-b19ddcc049ea" xlink:href="ci-20230331.xsd#ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_dcb30f49-f387-4dac-9fa8-4f9ecdccc1b9" xlink:to="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member_d2c803c8-f004-4bd2-b219-b19ddcc049ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RevolvingCreditFacilityMaturingApril2025Member_10c71780-bb79-4647-a5aa-b29392484f29" xlink:href="ci-20230331.xsd#ci_RevolvingCreditFacilityMaturingApril2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_dcb30f49-f387-4dac-9fa8-4f9ecdccc1b9" xlink:to="loc_ci_RevolvingCreditFacilityMaturingApril2025Member_10c71780-bb79-4647-a5aa-b29392484f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member_302827c0-6722-4291-a7a2-c45f4373beef" xlink:href="ci-20230331.xsd#ci_A364DayRevolvingCreditAgreementMaturingApril2023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member_dcb30f49-f387-4dac-9fa8-4f9ecdccc1b9" xlink:to="loc_ci_A364DayRevolvingCreditAgreementMaturingApril2023Member_302827c0-6722-4291-a7a2-c45f4373beef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5483854a-9e6d-4390-89d7-0e0c742c3b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9e38714f-7c18-47f4-bf7c-38bde86520a8" xlink:to="loc_us-gaap_CreditFacilityAxis_5483854a-9e6d-4390-89d7-0e0c742c3b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_195b1976-7828-4149-871c-dd1ce676cccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_5483854a-9e6d-4390-89d7-0e0c742c3b24" xlink:to="loc_us-gaap_CreditFacilityDomain_195b1976-7828-4149-871c-dd1ce676cccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_428f203a-fd9d-4bd8-8baf-b26f45e3b300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_195b1976-7828-4149-871c-dd1ce676cccf" xlink:to="loc_us-gaap_LetterOfCreditMember_428f203a-fd9d-4bd8-8baf-b26f45e3b300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_1f8d2882-7ded-470c-aa71-d2c5fb29e384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_195b1976-7828-4149-871c-dd1ce676cccf" xlink:to="loc_us-gaap_CommercialPaperMember_1f8d2882-7ded-470c-aa71-d2c5fb29e384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_84c68084-a6ba-4d0d-b456-ebe16944d31e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9e38714f-7c18-47f4-bf7c-38bde86520a8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_84c68084-a6ba-4d0d-b456-ebe16944d31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d4ef0ae2-f9b3-473b-a3c5-c5ac797c925f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_84c68084-a6ba-4d0d-b456-ebe16944d31e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d4ef0ae2-f9b3-473b-a3c5-c5ac797c925f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_eab07cbf-bdb6-4146-b403-76044bb9d93c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d4ef0ae2-f9b3-473b-a3c5-c5ac797c925f" xlink:to="loc_us-gaap_SubsequentEventMember_eab07cbf-bdb6-4146-b403-76044bb9d93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9e38714f-7c18-47f4-bf7c-38bde86520a8" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b5353ade-09b9-4e2f-9679-5a779a395c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b5353ade-09b9-4e2f-9679-5a779a395c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_8247d695-ad22-4770-8185-0ea887689d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_us-gaap_DebtInstrumentTerm_8247d695-ad22-4770-8185-0ea887689d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtInstrumentExtensionTerm_d598d550-efc7-4490-9f28-d317872fd838" xlink:href="ci-20230331.xsd#ci_DebtInstrumentExtensionTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_DebtInstrumentExtensionTerm_d598d550-efc7-4490-9f28-d317872fd838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LineOfCreditFacilityConversionToTermLoanTerm_a8c66046-4e49-4b03-bf97-30052c0a15c8" xlink:href="ci-20230331.xsd#ci_LineOfCreditFacilityConversionToTermLoanTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_LineOfCreditFacilityConversionToTermLoanTerm_a8c66046-4e49-4b03-bf97-30052c0a15c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_d5330e87-f52d-492a-923f-78d49369a015" xlink:href="ci-20230331.xsd#ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_d5330e87-f52d-492a-923f-78d49369a015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_7007a1e4-d4fe-44b2-9a4f-6717e40865a6" xlink:href="ci-20230331.xsd#ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity_7007a1e4-d4fe-44b2-9a4f-6717e40865a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_adf88da7-9a41-4850-b6cf-b445c34a1aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_us-gaap_LineOfCredit_adf88da7-9a41-4850-b6cf-b445c34a1aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NumberOfRevolvingCreditFacility_d6b582e2-928b-45ed-8a3f-eaf8a3feb548" xlink:href="ci-20230331.xsd#ci_NumberOfRevolvingCreditFacility"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_NumberOfRevolvingCreditFacility_d6b582e2-928b-45ed-8a3f-eaf8a3feb548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement_c8cc01ce-92c9-49f3-aa9a-a370cda0a11b" xlink:href="ci-20230331.xsd#ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement_c8cc01ce-92c9-49f3-aa9a-a370cda0a11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant_bdb01c42-15d2-4892-8f05-73449c40a91e" xlink:href="ci-20230331.xsd#ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant_bdb01c42-15d2-4892-8f05-73449c40a91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CommercialPaperAverageRatePaid_2c950d46-4301-41a8-a44f-62408cf100e0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CommercialPaperAverageRatePaid"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_srt_CommercialPaperAverageRatePaid_2c950d46-4301-41a8-a44f-62408cf100e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_1553f69a-e573-4d30-89d9-2f65ad1a9b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f50ba925-1601-450d-8cd6-a69c2f3fc727" xlink:to="loc_us-gaap_InterestExpenseDebt_1553f69a-e573-4d30-89d9-2f65ad1a9b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#CommonandPreferredStockDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_cacf9c7b-1ce4-4e30-98eb-8319bc4c221b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_2f410e76-73cf-406c-9ce2-ed9f6237668b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cacf9c7b-1ce4-4e30-98eb-8319bc4c221b" xlink:to="loc_us-gaap_SubsequentEventTable_2f410e76-73cf-406c-9ce2-ed9f6237668b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5f4fa6f1-e51a-479b-a192-f4a4c7dce8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2f410e76-73cf-406c-9ce2-ed9f6237668b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5f4fa6f1-e51a-479b-a192-f4a4c7dce8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2c51166f-9cb0-49d5-a6a8-b0f192f5dea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5f4fa6f1-e51a-479b-a192-f4a4c7dce8cb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2c51166f-9cb0-49d5-a6a8-b0f192f5dea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c55e21ae-7315-49db-961f-39a146d3bada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2c51166f-9cb0-49d5-a6a8-b0f192f5dea6" xlink:to="loc_us-gaap_SubsequentEventMember_c55e21ae-7315-49db-961f-39a146d3bada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_628ab29c-ab24-4111-9300-d57f6028715a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2f410e76-73cf-406c-9ce2-ed9f6237668b" xlink:to="loc_us-gaap_SubsequentEventLineItems_628ab29c-ab24-4111-9300-d57f6028715a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_82b64d7e-2643-4973-9275-a563c53dfa5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_628ab29c-ab24-4111-9300-d57f6028715a" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_82b64d7e-2643-4973-9275-a563c53dfa5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_a711901d-6873-4beb-8968-0fb0a0cc643f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cacf9c7b-1ce4-4e30-98eb-8319bc4c221b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_a711901d-6873-4beb-8968-0fb0a0cc643f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_c0d2cd55-91c1-4438-9a17-4ab816f94ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cacf9c7b-1ce4-4e30-98eb-8319bc4c221b" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_c0d2cd55-91c1-4438-9a17-4ab816f94ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d92ac1c3-bea1-4ba9-bd7c-723c393ebda6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_e7c5b1bb-4e36-4bfe-ab1a-a373d41af480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d92ac1c3-bea1-4ba9-bd7c-723c393ebda6" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_e7c5b1bb-4e36-4bfe-ab1a-a373d41af480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3f4abc3f-f715-4f8c-9bbf-55440d7f60d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_e7c5b1bb-4e36-4bfe-ab1a-a373d41af480" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3f4abc3f-f715-4f8c-9bbf-55440d7f60d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5527fba6-8fd5-47f1-a8af-7af6ece19fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3f4abc3f-f715-4f8c-9bbf-55440d7f60d7" xlink:to="loc_us-gaap_EquityComponentDomain_5527fba6-8fd5-47f1-a8af-7af6ece19fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_72d7a6ce-0440-403a-87d4-eb9d1b26ff30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5527fba6-8fd5-47f1-a8af-7af6ece19fd3" xlink:to="loc_us-gaap_TreasuryStockMember_72d7a6ce-0440-403a-87d4-eb9d1b26ff30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_fa977af5-6848-4e39-b272-51a945168ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5527fba6-8fd5-47f1-a8af-7af6ece19fd3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_fa977af5-6848-4e39-b272-51a945168ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bab1adaa-ef51-43aa-b9fb-b7fdd0395163" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_e7c5b1bb-4e36-4bfe-ab1a-a373d41af480" xlink:to="loc_srt_StatementScenarioAxis_bab1adaa-ef51-43aa-b9fb-b7fdd0395163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6006c9fd-685f-4e4b-b438-d9798d76d75a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_bab1adaa-ef51-43aa-b9fb-b7fdd0395163" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6006c9fd-685f-4e4b-b438-d9798d76d75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_a94a34d0-999d-47f1-befd-ade3d927cd86" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_6006c9fd-685f-4e4b-b438-d9798d76d75a" xlink:to="loc_srt_ScenarioForecastMember_a94a34d0-999d-47f1-befd-ade3d927cd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_e7c5b1bb-4e36-4bfe-ab1a-a373d41af480" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_23ef9935-52f9-4c95-bf0c-70d1c8c09d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_23ef9935-52f9-4c95-bf0c-70d1c8c09d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_8311a52a-ddcb-4968-a0eb-a65e2da3fec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_8311a52a-ddcb-4968-a0eb-a65e2da3fec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_dd7ecef3-1daf-45a0-918b-bf27f26a209b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_dd7ecef3-1daf-45a0-918b-bf27f26a209b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_32c33ca1-ed0b-4e53-b042-d303e891acc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_32c33ca1-ed0b-4e53-b042-d303e891acc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount_b94f5b52-3c47-410a-b59d-d579db4960f1" xlink:href="ci-20230331.xsd#ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_a951bece-36e0-48ad-b383-816d8305a918" xlink:to="loc_ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount_b94f5b52-3c47-410a-b59d-d579db4960f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesAccountBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceLossReservesAbstract_c6157aed-caac-4f6f-a1e9-8652eab5a8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceLossReservesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesTable_1c2a1301-38e4-4c13-957d-7c8922074470" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_c6157aed-caac-4f6f-a1e9-8652eab5a8d9" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesTable_1c2a1301-38e4-4c13-957d-7c8922074470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d084fed2-1a31-4cd6-82aa-33987f5ec3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_1c2a1301-38e4-4c13-957d-7c8922074470" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d084fed2-1a31-4cd6-82aa-33987f5ec3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b7e9992a-7ef0-4dd8-86df-74c5b3ab30f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d084fed2-1a31-4cd6-82aa-33987f5ec3e0" xlink:to="loc_us-gaap_SegmentDomain_b7e9992a-7ef0-4dd8-86df-74c5b3ab30f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_39d24839-8368-4c8a-9ea4-7f45dac4260b" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b7e9992a-7ef0-4dd8-86df-74c5b3ab30f2" xlink:to="loc_ci_CignaHealthcareMember_39d24839-8368-4c8a-9ea4-7f45dac4260b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember_b684af7a-0f89-493e-a5f1-ee55afce9ce2" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b7e9992a-7ef0-4dd8-86df-74c5b3ab30f2" xlink:to="loc_ci_OtherOperationsSegmentMember_b684af7a-0f89-493e-a5f1-ee55afce9ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_1c2a1301-38e4-4c13-957d-7c8922074470" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent_66a4537e-88b6-4f3c-a2ab-832075897066" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent_66a4537e-88b6-4f3c-a2ab-832075897066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups_8302ec1b-ddf4-4930-824e-6deb7500bc76" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups_8302ec1b-ddf4-4930-824e-6deb7500bc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent_61ceb2d7-c464-4546-a1f3-713603d1b9c9" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent_61ceb2d7-c464-4546-a1f3-713603d1b9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups_e1c6d67b-bb26-46eb-aff5-d4a6de60e435" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups_e1c6d67b-bb26-46eb-aff5-d4a6de60e435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositCurrent_063603d0-4305-4f54-9bd8-4f7f4908726e" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_PolicyholderContractDepositCurrent_063603d0-4305-4f54-9bd8-4f7f4908726e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitLiabilityAmountCurrent_63f23e8a-48fa-4456-a415-63f890956bee" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitLiabilityAmountCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_MarketRiskBenefitLiabilityAmountCurrent_63f23e8a-48fa-4456-a415-63f890956bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsCurrent_ad8f0d38-0f25-420f-b1b7-494d7959df44" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_UnearnedPremiumsCurrent_ad8f0d38-0f25-420f-b1b7-494d7959df44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsCurrentIncludingDisposalGroups_e1547396-d52e-4cdd-b8b5-ae4ccbc9353f" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsCurrentIncludingDisposalGroups"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_UnearnedPremiumsCurrentIncludingDisposalGroups_e1547396-d52e-4cdd-b8b5-ae4ccbc9353f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups_c9c13f7c-57c1-4f46-bfa5-76604d526576" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups_c9c13f7c-57c1-4f46-bfa5-76604d526576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities_eabd63ce-99ab-446d-a6c1-78f2a16ac2c2" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities_eabd63ce-99ab-446d-a6c1-78f2a16ac2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_625e2100-f7e2-4b7d-b290-8237a9a4b16a" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract_86ed511b-df1e-4bb2-9a22-ce85c47d22e2" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesCurrent_625e2100-f7e2-4b7d-b290-8237a9a4b16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent_d5b2c8c7-a8a1-4df8-bf64-0684afcead50" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent_d5b2c8c7-a8a1-4df8-bf64-0684afcead50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups_749a737a-5852-463d-a054-ceebcce13db2" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups_749a737a-5852-463d-a054-ceebcce13db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent_09de6d83-a602-4bde-8cbd-151fa0612b72" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent_09de6d83-a602-4bde-8cbd-151fa0612b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups_2f2d2403-a6cf-4d82-9d74-d2d4ee9b97e3" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups_2f2d2403-a6cf-4d82-9d74-d2d4ee9b97e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositNoncurrent_e3216e07-a73f-4999-b47b-fbb5035d8ccf" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_PolicyholderContractDepositNoncurrent_e3216e07-a73f-4999-b47b-fbb5035d8ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitLiabilityAmountNoncurrent_3a497425-a217-41cc-89f5-21510c0cbf67" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitLiabilityAmountNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_MarketRiskBenefitLiabilityAmountNoncurrent_3a497425-a217-41cc-89f5-21510c0cbf67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsNoncurrent_fb0b359c-18cc-4c20-8c2d-19a7915553f3" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_UnearnedPremiumsNoncurrent_fb0b359c-18cc-4c20-8c2d-19a7915553f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups_e12bd44c-3c00-42fc-b427-f31c316ef2ce" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups_e12bd44c-3c00-42fc-b427-f31c316ef2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups_cd0623c9-00b2-4a6a-b748-ee54b9eecfae" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups_cd0623c9-00b2-4a6a-b748-ee54b9eecfae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities_8d329dff-f94f-4ba2-bbe3-8dae272989b1" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities_8d329dff-f94f-4ba2-bbe3-8dae272989b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_158820fc-009f-4462-8cb8-349a9356b986" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract_94dfe063-3df6-4f33-8f8a-7a11601b4cf9" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesNoncurrent_158820fc-009f-4462-8cb8-349a9356b986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_2176dc79-ef45-4526-9752-e202fbef15df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_2176dc79-ef45-4526-9752-e202fbef15df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups_f2bb7c2d-b733-439e-ab72-1d08509841e6" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups_f2bb7c2d-b733-439e-ab72-1d08509841e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_c785cb57-df05-48dc-9f8d-1e4576cef1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_c785cb57-df05-48dc-9f8d-1e4576cef1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups_2c3c73fb-035a-4022-a676-a42b1f12a7dc" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups_2c3c73fb-035a-4022-a676-a42b1f12a7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderContractDeposits_03b8ea10-8461-46b7-81e8-6d286e18aeca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderContractDeposits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_us-gaap_PolicyholderContractDeposits_03b8ea10-8461-46b7-81e8-6d286e18aeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitLiabilityAmount_12451063-e7f3-4343-a4bc-16da896820f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitLiabilityAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_us-gaap_MarketRiskBenefitLiabilityAmount_12451063-e7f3-4343-a4bc-16da896820f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_7837245d-ada4-4e44-97ed-72f8165c681c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_us-gaap_UnearnedPremiums_7837245d-ada4-4e44-97ed-72f8165c681c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnearnedPremiumsIncludingDisposalGroups_d0c9a5d1-23be-47ca-82d0-aa7e8b9efa2e" xlink:href="ci-20230331.xsd#ci_UnearnedPremiumsIncludingDisposalGroups"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_ci_UnearnedPremiumsIncludingDisposalGroups_d0c9a5d1-23be-47ca-82d0-aa7e8b9efa2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_c15ede1c-1a6d-4916-8a3b-5fb90c526bab" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups_c15ede1c-1a6d-4916-8a3b-5fb90c526bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities_a9a09944-8ee9-4782-b5bb-5fc12f131a81" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities_a9a09944-8ee9-4782-b5bb-5fc12f131a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilities_b61a31cb-76a2-48ae-986c-dad0147ac568" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesAbstract_32ad3bcb-54ee-4309-8e03-d669c9adf10b" xlink:to="loc_ci_InsuranceAndContractholderLiabilities_b61a31cb-76a2-48ae-986c-dad0147ac568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups_78fe7f83-8518-43f8-b4ef-bae60c8ba511" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups_78fe7f83-8518-43f8-b4ef-bae60c8ba511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups_d207c40b-8645-4e79-a045-425ff9ed5e04" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups_d207c40b-8645-4e79-a045-425ff9ed5e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractDepositsAttributableToDisposalGroups_fe967100-d678-4f78-a332-cfeb6d530e80" xlink:href="ci-20230331.xsd#ci_PolicyholderContractDepositsAttributableToDisposalGroups"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_2a68f9b6-0661-4acc-892b-d00978de74e0" xlink:to="loc_ci_PolicyholderContractDepositsAttributableToDisposalGroups_fe967100-d678-4f78-a332-cfeb6d530e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesAccountBalancesDetails_1"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceLossReservesAbstract_3212b105-995b-4cb6-b2b4-cd9d430f2855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceLossReservesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_18548bea-6da7-47d9-ba27-7995c8ded0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_3212b105-995b-4cb6-b2b4-cd9d430f2855" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_18548bea-6da7-47d9-ba27-7995c8ded0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5ab63e22-a839-4d8e-99cb-fd9f22b9d131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_18548bea-6da7-47d9-ba27-7995c8ded0b0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5ab63e22-a839-4d8e-99cb-fd9f22b9d131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e86f4a8e-e6d2-49c4-87dd-f0248095feae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5ab63e22-a839-4d8e-99cb-fd9f22b9d131" xlink:to="loc_us-gaap_SegmentDomain_e86f4a8e-e6d2-49c4-87dd-f0248095feae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_af8ee0be-12c3-4fee-9350-49db857b6569" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e86f4a8e-e6d2-49c4-87dd-f0248095feae" xlink:to="loc_ci_CignaHealthcareMember_af8ee0be-12c3-4fee-9350-49db857b6569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4012a804-beae-4267-b6e1-94de8bdc4450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_18548bea-6da7-47d9-ba27-7995c8ded0b0" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4012a804-beae-4267-b6e1-94de8bdc4450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses_c00d4333-3d20-4a43-9eb9-b1d8a99c3e49" xlink:href="ci-20230331.xsd#ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4012a804-beae-4267-b6e1-94de8bdc4450" xlink:to="loc_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses_c00d4333-3d20-4a43-9eb9-b1d8a99c3e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4012a804-beae-4267-b6e1-94de8bdc4450" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_a79bf912-b893-45d9-b2d2-c54d9d77e716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_a79bf912-b893-45d9-b2d2-c54d9d77e716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_5783e7a8-649f-4a6b-b431-209132804ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_5783e7a8-649f-4a6b-b431-209132804ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_afaedd2e-f1e8-4c32-9058-47d40af648e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_afaedd2e-f1e8-4c32-9058-47d40af648e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_64c2a534-f328-4770-957a-d13cc2118c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_64c2a534-f328-4770-957a-d13cc2118c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_dedcf11e-aa38-4f22-89d2-a53ee74d8736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_64c2a534-f328-4770-957a-d13cc2118c2d" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_dedcf11e-aa38-4f22-89d2-a53ee74d8736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_287ea250-1310-4d13-9a30-9683ad04e80d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_64c2a534-f328-4770-957a-d13cc2118c2d" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_287ea250-1310-4d13-9a30-9683ad04e80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_a3d7365c-e4ef-4aa3-942b-c390eadc5008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_64c2a534-f328-4770-957a-d13cc2118c2d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_a3d7365c-e4ef-4aa3-942b-c390eadc5008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_fa6874ab-9ad8-4f8c-bb5e-19d089ee1e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_fa6874ab-9ad8-4f8c-bb5e-19d089ee1e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_c08be58b-bda8-4b89-82f8-27464fcf6f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_fa6874ab-9ad8-4f8c-bb5e-19d089ee1e7d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_c08be58b-bda8-4b89-82f8-27464fcf6f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_f510a3e3-5d0e-4025-b959-4e4a64e92dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_fa6874ab-9ad8-4f8c-bb5e-19d089ee1e7d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_f510a3e3-5d0e-4025-b959-4e4a64e92dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_73b91d0f-7906-4eed-a253-f2c759fe9547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_fa6874ab-9ad8-4f8c-bb5e-19d089ee1e7d" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_73b91d0f-7906-4eed-a253-f2c759fe9547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e5e6d934-326b-4905-aaba-fac1dee5a7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e5e6d934-326b-4905-aaba-fac1dee5a7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_e4ec1f7e-d5f9-41bc-be45-d4958f7ecbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_e4ec1f7e-d5f9-41bc-be45-d4958f7ecbdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_42595dc0-bd26-41d9-b307-d883a9c9c9de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c857e322-dce2-4436-a80f-27c3ae4ada57" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_42595dc0-bd26-41d9-b307-d883a9c9c9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceLossReservesAbstract_0a13a671-db75-4757-bcc5-56612edef877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceLossReservesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_a26b0a3c-fb68-42ce-a0eb-87aab376befe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_0a13a671-db75-4757-bcc5-56612edef877" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_a26b0a3c-fb68-42ce-a0eb-87aab376befe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f0b02e40-53de-4403-b08d-73e27a4053e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_a26b0a3c-fb68-42ce-a0eb-87aab376befe" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f0b02e40-53de-4403-b08d-73e27a4053e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5d49a4a1-4a69-485a-8fe4-5fa49717f5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f0b02e40-53de-4403-b08d-73e27a4053e9" xlink:to="loc_us-gaap_SegmentDomain_5d49a4a1-4a69-485a-8fe4-5fa49717f5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_6ceec60a-0916-45fe-b5de-9adc0d850a79" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5d49a4a1-4a69-485a-8fe4-5fa49717f5d1" xlink:to="loc_ci_CignaHealthcareMember_6ceec60a-0916-45fe-b5de-9adc0d850a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncatastrophicEventAxis_b6b9b651-ba0d-4109-bf8e-58cf57e7f200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncatastrophicEventAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_a26b0a3c-fb68-42ce-a0eb-87aab376befe" xlink:to="loc_us-gaap_NoncatastrophicEventAxis_b6b9b651-ba0d-4109-bf8e-58cf57e7f200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncatastrophicEventDomain_d97d257e-aaa4-4a1d-9747-4f452252b1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncatastrophicEventDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncatastrophicEventAxis_b6b9b651-ba0d-4109-bf8e-58cf57e7f200" xlink:to="loc_us-gaap_NoncatastrophicEventDomain_d97d257e-aaa4-4a1d-9747-4f452252b1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CompletionFactorsMember_c136db81-e7f5-46cf-bc36-4dfb520d207f" xlink:href="ci-20230331.xsd#ci_CompletionFactorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncatastrophicEventDomain_d97d257e-aaa4-4a1d-9747-4f452252b1b6" xlink:to="loc_ci_CompletionFactorsMember_c136db81-e7f5-46cf-bc36-4dfb520d207f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MedicalCostTrendMember_06756745-2147-448f-aba7-3fa4f9853ff8" xlink:href="ci-20230331.xsd#ci_MedicalCostTrendMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncatastrophicEventDomain_d97d257e-aaa4-4a1d-9747-4f452252b1b6" xlink:to="loc_ci_MedicalCostTrendMember_06756745-2147-448f-aba7-3fa4f9853ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_9102fb86-5b31-428e-9f5f-63c4fd8bacfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_a26b0a3c-fb68-42ce-a0eb-87aab376befe" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_9102fb86-5b31-428e-9f5f-63c4fd8bacfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_33160d92-9f5e-45bd-bb4e-7620608050bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_9102fb86-5b31-428e-9f5f-63c4fd8bacfc" xlink:to="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_33160d92-9f5e-45bd-bb4e-7620608050bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_5fe5beea-baac-4d7e-9143-e83547173d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_33160d92-9f5e-45bd-bb4e-7620608050bc" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_5fe5beea-baac-4d7e-9143-e83547173d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage_d4613233-3f9f-4557-abfe-574e67ff43e2" xlink:href="ci-20230331.xsd#ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_33160d92-9f5e-45bd-bb4e-7620608050bc" xlink:to="loc_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage_d4613233-3f9f-4557-abfe-574e67ff43e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_fbe9beb6-87db-4edc-9d91-ca74958cd74c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesTable_52539de9-fa59-4aaa-b975-45f35de94651" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_fbe9beb6-87db-4edc-9d91-ca74958cd74c" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesTable_52539de9-fa59-4aaa-b975-45f35de94651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_11ad0889-afe3-408f-b538-b06362a4a8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_52539de9-fa59-4aaa-b975-45f35de94651" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_11ad0889-afe3-408f-b538-b06362a4a8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c608e75b-8801-4008-a60b-5a8787e84f40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_11ad0889-afe3-408f-b538-b06362a4a8e4" xlink:to="loc_us-gaap_SegmentDomain_c608e75b-8801-4008-a60b-5a8787e84f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_a28d854a-3730-4610-993f-f0ecdda30f77" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c608e75b-8801-4008-a60b-5a8787e84f40" xlink:to="loc_ci_CignaHealthcareMember_a28d854a-3730-4610-993f-f0ecdda30f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember_6cb197f9-a105-45c1-803c-c741f93ce6b8" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c608e75b-8801-4008-a60b-5a8787e84f40" xlink:to="loc_ci_OtherOperationsSegmentMember_6cb197f9-a105-45c1-803c-c741f93ce6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_56709d6a-8fce-4333-8a26-7ad686612598" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_52539de9-fa59-4aaa-b975-45f35de94651" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_56709d6a-8fce-4333-8a26-7ad686612598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_bff42e3d-1401-4d08-8fce-d1a8e2c5042b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_56709d6a-8fce-4333-8a26-7ad686612598" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_bff42e3d-1401-4d08-8fce-d1a8e2c5042b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_70aacd5f-3b34-433e-8669-0e186dd143e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_56709d6a-8fce-4333-8a26-7ad686612598" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_70aacd5f-3b34-433e-8669-0e186dd143e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_2e22c931-f150-49e0-9054-6faa1f46b8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_56709d6a-8fce-4333-8a26-7ad686612598" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_2e22c931-f150-49e0-9054-6faa1f46b8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_c145665e-735c-4ec4-808d-62a90d78f942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesTable_0b474b18-205e-4d62-95eb-9699575a3ebc" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c145665e-735c-4ec4-808d-62a90d78f942" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesTable_0b474b18-205e-4d62-95eb-9699575a3ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_54ed9b65-32f5-4669-81dd-183b2c768666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_0b474b18-205e-4d62-95eb-9699575a3ebc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_54ed9b65-32f5-4669-81dd-183b2c768666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8813051e-d5a6-4125-86f8-73030c869d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_54ed9b65-32f5-4669-81dd-183b2c768666" xlink:to="loc_us-gaap_SegmentDomain_8813051e-d5a6-4125-86f8-73030c869d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_d71345ae-67ca-4ebc-aa67-ae21c7c0d535" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8813051e-d5a6-4125-86f8-73030c869d05" xlink:to="loc_ci_CignaHealthcareMember_d71345ae-67ca-4ebc-aa67-ae21c7c0d535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember_deb265c0-7031-401a-bd6a-211a397de045" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8813051e-d5a6-4125-86f8-73030c869d05" xlink:to="loc_ci_OtherOperationsSegmentMember_deb265c0-7031-401a-bd6a-211a397de045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_0b474b18-205e-4d62-95eb-9699575a3ebc" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_b63ab158-79b4-41b6-98c4-1c6ed72ddc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_b63ab158-79b4-41b6-98c4-1c6ed72ddc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_fa3e6a6c-f685-45a4-a72c-7db866b103bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_fa3e6a6c-f685-45a4-a72c-7db866b103bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience_602be608-6d82-442f-af65-8d4f34736d34" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience_602be608-6d82-442f-af65-8d4f34736d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition_09fceef6-ab9e-4599-817f-fdad0921eefc" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition_09fceef6-ab9e-4599-817f-fdad0921eefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_53565b3e-a833-4cac-b99c-4b1d6d1a75a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_53565b3e-a833-4cac-b99c-4b1d6d1a75a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges_cd9be906-b81b-4562-ac27-7358e577edbf" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges_cd9be906-b81b-4562-ac27-7358e577edbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_faf8d49a-4a83-4935-a727-664c9f501772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_faf8d49a-4a83-4935-a727-664c9f501772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_073d5cfa-ff95-410e-bf18-97335cfc8e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_073d5cfa-ff95-410e-bf18-97335cfc8e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_74389c38-2712-4c51-a5df-c15fd8caa2de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_e7cebfb1-ab05-4dcf-a3fc-49130e73b031" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_74389c38-2712-4c51-a5df-c15fd8caa2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_c14c0c9a-bf4e-43b5-b518-6b1b14b26b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_c14c0c9a-bf4e-43b5-b518-6b1b14b26b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_1c3494d0-92b6-4928-bf99-f6e7ec6ad52b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_1c3494d0-92b6-4928-bf99-f6e7ec6ad52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience_6f6a0ae8-429f-4bcc-8c12-6492d45496d9" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience_6f6a0ae8-429f-4bcc-8c12-6492d45496d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition_0f9e2b91-1d7d-409b-9448-f7c93e405431" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition_0f9e2b91-1d7d-409b-9448-f7c93e405431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_436ea7be-ded1-4454-958c-3ba57ecaace1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_436ea7be-ded1-4454-958c-3ba57ecaace1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges_364f5c19-aa4d-4c9c-9ec5-1361366ebe06" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges_364f5c19-aa4d-4c9c-9ec5-1361366ebe06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_591da472-c985-4619-bccc-e20ea9ee06f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_591da472-c985-4619-bccc-e20ea9ee06f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_434ddcaf-22b8-4b2a-8238-ad821fdae4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_434ddcaf-22b8-4b2a-8238-ad821fdae4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_a5c56ca9-d0d7-411a-9946-c08f309f0891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_e73617d5-2c3f-466a-a538-533460018117" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_a5c56ca9-d0d7-411a-9946-c08f309f0891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther_f2ba644e-0520-40ae-84a8-a9b0f555406a" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther_f2ba644e-0520-40ae-84a8-a9b0f555406a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitOther_3ca26d78-1965-46de-abe6-863a63f332b7" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitOther_3ca26d78-1965-46de-abe6-863a63f332b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_30f3e5b3-8548-43a3-ac4f-c35cd37bc800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_30f3e5b3-8548-43a3-ac4f-c35cd37bc800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_34630469-0edb-43e7-9145-4cc70b371920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_34630469-0edb-43e7-9145-4cc70b371920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance_b9cb22a7-c48e-475c-b07d-52f18886e324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance_b9cb22a7-c48e-475c-b07d-52f18886e324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_c9a2fd2d-a286-499a-b26f-3faea0efc49a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_c9a2fd2d-a286-499a-b26f-3faea0efc49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_445d07fc-2b6c-44d9-b369-22ba8ee585ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_445d07fc-2b6c-44d9-b369-22ba8ee585ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm_e4fb0d0b-fc95-4ea5-980e-fda2cb56851b" xlink:href="ci-20230331.xsd#ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm_e4fb0d0b-fc95-4ea5-980e-fda2cb56851b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability_8c2e4070-4005-409f-b2ef-2ae6522ffdb0" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability_8c2e4070-4005-409f-b2ef-2ae6522ffdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability_24be1bc6-2737-4471-9dc0-cb32578da45b" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability_24be1bc6-2737-4471-9dc0-cb32578da45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups_72639a20-265c-4310-a7d3-a5bdc78f9f5a" xlink:href="ci-20230331.xsd#ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_5b98f864-f6c5-4b1d-9531-155593b3885a" xlink:to="loc_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups_72639a20-265c-4310-a7d3-a5bdc78f9f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_b793febb-6306-4d51-8581-324e2320272e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b793febb-6306-4d51-8581-324e2320272e" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fcdab999-f6d6-4541-b7c1-d5b90377dca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fcdab999-f6d6-4541-b7c1-d5b90377dca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_37090074-be81-4186-a001-80b059400068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fcdab999-f6d6-4541-b7c1-d5b90377dca8" xlink:to="loc_us-gaap_SegmentDomain_37090074-be81-4186-a001-80b059400068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_74d528bf-c738-4e8f-8e93-14319bcc7056" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_37090074-be81-4186-a001-80b059400068" xlink:to="loc_ci_CignaHealthcareMember_74d528bf-c738-4e8f-8e93-14319bcc7056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember_f0271ba6-8189-4d97-aa5d-a9ca38b137c5" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_37090074-be81-4186-a001-80b059400068" xlink:to="loc_ci_OtherOperationsSegmentMember_f0271ba6-8189-4d97-aa5d-a9ca38b137c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4e21d98c-e04b-4f54-a744-30af0cd24a81" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:to="loc_srt_RangeAxis_4e21d98c-e04b-4f54-a744-30af0cd24a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7978e154-99a5-46ee-abe6-57a7fa5754bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4e21d98c-e04b-4f54-a744-30af0cd24a81" xlink:to="loc_srt_RangeMember_7978e154-99a5-46ee-abe6-57a7fa5754bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_41028985-c8d4-4ddb-9e64-56690dde582b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7978e154-99a5-46ee-abe6-57a7fa5754bb" xlink:to="loc_srt_MinimumMember_41028985-c8d4-4ddb-9e64-56690dde582b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cacd52ba-5856-4900-aa7f-9722dd265838" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7978e154-99a5-46ee-abe6-57a7fa5754bb" xlink:to="loc_srt_MaximumMember_cacd52ba-5856-4900-aa7f-9722dd265838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis_9b255a90-3eed-4deb-a69a-5889017dd7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:to="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis_9b255a90-3eed-4deb-a69a-5889017dd7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain_71b60dd0-4b54-438b-88c4-5ad7a0023ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis_9b255a90-3eed-4deb-a69a-5889017dd7ed" xlink:to="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain_71b60dd0-4b54-438b-88c4-5ad7a0023ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member_7776bbd0-2539-4922-870a-fd71c2325c19" xlink:href="ci-20230331.xsd#ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain_71b60dd0-4b54-438b-88c4-5ad7a0023ad4" xlink:to="loc_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member_7776bbd0-2539-4922-870a-fd71c2325c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember_b3eaf3a4-2623-46bc-9694-68767676d7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain_71b60dd0-4b54-438b-88c4-5ad7a0023ad4" xlink:to="loc_us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember_b3eaf3a4-2623-46bc-9694-68767676d7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis_58259607-a173-47e0-a035-aa2474bcc1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:to="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis_58259607-a173-47e0-a035-aa2474bcc1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain_13fcb10f-edbd-43a9-905c-0acb0e7727ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis_58259607-a173-47e0-a035-aa2474bcc1fc" xlink:to="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain_13fcb10f-edbd-43a9-905c-0acb0e7727ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member_22d8dfeb-2f24-4496-a47b-dddd6bf25839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain_13fcb10f-edbd-43a9-905c-0acb0e7727ec" xlink:to="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member_22d8dfeb-2f24-4496-a47b-dddd6bf25839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember_d41dcd44-0b68-49e8-905e-99e718c481f8" xlink:href="ci-20230331.xsd#ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain_13fcb10f-edbd-43a9-905c-0acb0e7727ec" xlink:to="loc_ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember_d41dcd44-0b68-49e8-905e-99e718c481f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:href="ci-20230331.xsd#ci_InsuranceAndContractholderLiabilitiesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesTable_4e71e4ce-dd55-4859-81bf-f522f372b300" xlink:to="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderContractDeposits_35793329-0508-4caf-89c4-1517b6fe604e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderContractDeposits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_us-gaap_PolicyholderContractDeposits_35793329-0508-4caf-89c4-1517b6fe604e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderContractBalancePercentReinsuredExternally_57711bca-de6f-41e0-ba96-51f155ef1efe" xlink:href="ci-20230331.xsd#ci_PolicyholderContractBalancePercentReinsuredExternally"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_ci_PolicyholderContractBalancePercentReinsuredExternally_57711bca-de6f-41e0-ba96-51f155ef1efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_bfe7722f-ef24-43ea-af08-490e5b06f81c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_bfe7722f-ef24-43ea-af08-490e5b06f81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_346ed202-d9c3-48d0-a370-88a593984892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceNetAmountAtRisk"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_346ed202-d9c3-48d0-a370-88a593984892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount_177d2236-f87d-4e1a-a585-6d4c6d371914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueDuePolicyholdersAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount_177d2236-f87d-4e1a-a585-6d4c6d371914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage_4c902268-772d-470e-bb52-b40b374f1866" xlink:href="ci-20230331.xsd#ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage_4c902268-772d-470e-bb52-b40b374f1866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderFunds_7ded55be-d019-4e04-a62d-e60658a2cf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderFunds"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_us-gaap_PolicyholderFunds_7ded55be-d019-4e04-a62d-e60658a2cf2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating_3ef3524f-f4ed-4e8a-95fc-1747f1b035bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating_3ef3524f-f4ed-4e8a-95fc-1747f1b035bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue_cb7f0d05-199f-4e19-96c8-f22ab58d80e9" xlink:href="ci-20230331.xsd#ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InsuranceAndContractholderLiabilitiesLineItems_0b64dbf5-3855-42dd-b1ca-edcbdc29543b" xlink:to="loc_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue_cb7f0d05-199f-4e19-96c8-f22ab58d80e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceLossReservesAbstract_c6593ec7-a03c-41ea-92cd-0946ddd2c87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceLossReservesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AnnuitizationElectionPeriod_7a628409-1fbf-4f59-98aa-78eea4d5c7c1" xlink:href="ci-20230331.xsd#ci_AnnuitizationElectionPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_c6593ec7-a03c-41ea-92cd-0946ddd2c87e" xlink:to="loc_ci_AnnuitizationElectionPeriod_7a628409-1fbf-4f59-98aa-78eea4d5c7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitRollForward_c6d4366b-4c82-4e49-a8e5-fd8339da0aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_c6593ec7-a03c-41ea-92cd-0946ddd2c87e" xlink:to="loc_us-gaap_MarketRiskBenefitRollForward_c6d4366b-4c82-4e49-a8e5-fd8339da0aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk_38c33c1b-b8d1-4f54-b3f6-0466994b2c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketRiskBenefitRollForward_c6d4366b-4c82-4e49-a8e5-fd8339da0aaf" xlink:to="loc_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk_38c33c1b-b8d1-4f54-b3f6-0466994b2c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange_d284138e-8931-41b5-824f-e53d6b6bb11f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketRiskBenefitRollForward_c6d4366b-4c82-4e49-a8e5-fd8339da0aaf" xlink:to="loc_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange_d284138e-8931-41b5-824f-e53d6b6bb11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff_cb338989-70b7-4521-8ddc-e52b1507cab3" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketRiskBenefitRollForward_c6d4366b-4c82-4e49-a8e5-fd8339da0aaf" xlink:to="loc_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff_cb338989-70b7-4521-8ddc-e52b1507cab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange_e0be2283-a8f7-4ce0-b36b-7444ab9ec73b" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketRiskBenefitRollForward_c6d4366b-4c82-4e49-a8e5-fd8339da0aaf" xlink:to="loc_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange_e0be2283-a8f7-4ce0-b36b-7444ab9ec73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected_a74658af-9a2e-4d56-8128-384298cf286f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketRiskBenefitRollForward_c6d4366b-4c82-4e49-a8e5-fd8339da0aaf" xlink:to="loc_us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected_a74658af-9a2e-4d56-8128-384298cf286f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption_a34ba8da-904e-41b9-b4b4-3aaccb728faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketRiskBenefitRollForward_c6d4366b-4c82-4e49-a8e5-fd8339da0aaf" xlink:to="loc_us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption_a34ba8da-904e-41b9-b4b4-3aaccb728faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange_aba2043e-6f45-4ac3-a746-ea8331f3efa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketRiskBenefitRollForward_c6d4366b-4c82-4e49-a8e5-fd8339da0aaf" xlink:to="loc_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange_aba2043e-6f45-4ac3-a746-ea8331f3efa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax_40a31d3f-b5e3-447f-a3d6-8c331d5f8c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketRiskBenefitRollForward_c6d4366b-4c82-4e49-a8e5-fd8339da0aaf" xlink:to="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax_40a31d3f-b5e3-447f-a3d6-8c331d5f8c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk_c354bf8e-bd70-425f-ab81-1f6b1f2d2636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketRiskBenefitRollForward_c6d4366b-4c82-4e49-a8e5-fd8339da0aaf" xlink:to="loc_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk_c354bf8e-bd70-425f-ab81-1f6b1f2d2636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_ee6ba07f-0460-4d6e-b193-c200fdf4efeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketRiskBenefitRollForward_c6d4366b-4c82-4e49-a8e5-fd8339da0aaf" xlink:to="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_ee6ba07f-0460-4d6e-b193-c200fdf4efeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceLossReservesAbstract_e8b88a75-0450-4ebb-9975-4e0b9ea9bf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceLossReservesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable_ea225d5e-3da9-4be8-9f61-31ec26440c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceLossReservesAbstract_e8b88a75-0450-4ebb-9975-4e0b9ea9bf7c" xlink:to="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable_ea225d5e-3da9-4be8-9f61-31ec26440c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_09a85fb8-f3f2-4e96-8a5b-0997c93180b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable_ea225d5e-3da9-4be8-9f61-31ec26440c53" xlink:to="loc_srt_ProductOrServiceAxis_09a85fb8-f3f2-4e96-8a5b-0997c93180b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b40504f2-23c2-4e01-bbd2-e7fe1bcbd6de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_09a85fb8-f3f2-4e96-8a5b-0997c93180b6" xlink:to="loc_srt_ProductsAndServicesDomain_b40504f2-23c2-4e01-bbd2-e7fe1bcbd6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember_490d7e96-7c37-4960-aedd-5329963eaa85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b40504f2-23c2-4e01-bbd2-e7fe1bcbd6de" xlink:to="loc_us-gaap_VariableAnnuityMember_490d7e96-7c37-4960-aedd-5329963eaa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_0ba27858-9867-48aa-ba80-906e39343bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeTable_ea225d5e-3da9-4be8-9f61-31ec26440c53" xlink:to="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_0ba27858-9867-48aa-ba80-906e39343bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax_5c388c51-c1cd-4a38-ad2a-67b23fdafba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_0ba27858-9867-48aa-ba80-906e39343bf6" xlink:to="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax_5c388c51-c1cd-4a38-ad2a-67b23fdafba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1_d0348025-d129-4192-9829-b114b0d026ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_0ba27858-9867-48aa-ba80-906e39343bf6" xlink:to="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1_d0348025-d129-4192-9829-b114b0d026ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue_ca2a4b4c-4aa7-41ad-b1c4-d04287da3c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_0ba27858-9867-48aa-ba80-906e39343bf6" xlink:to="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue_ca2a4b4c-4aa7-41ad-b1c4-d04287da3c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GuaranteedMinimumDeathBenefitsTotalContractholders_0e461556-1e3f-4ecf-ad27-ef2f46ec6632" xlink:href="ci-20230331.xsd#ci_GuaranteedMinimumDeathBenefitsTotalContractholders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems_0ba27858-9867-48aa-ba80-906e39343bf6" xlink:to="loc_ci_GuaranteedMinimumDeathBenefitsTotalContractholders_0e461556-1e3f-4ecf-ad27-ef2f46ec6632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#ReinsuranceReinsuranceRecoverablesDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_a328c60d-8891-428e-8c68-08a2e438d418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_a328c60d-8891-428e-8c68-08a2e438d418" xlink:to="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d576be70-0470-4dd4-9fe8-e9986849261a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_srt_ProductOrServiceAxis_d576be70-0470-4dd4-9fe8-e9986849261a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a420a02b-133d-48a0-b56d-982cf2c90da5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d576be70-0470-4dd4-9fe8-e9986849261a" xlink:to="loc_srt_ProductsAndServicesDomain_a420a02b-133d-48a0-b56d-982cf2c90da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OngoingOperationsMember_8d63b7b0-d3b5-49b2-af1a-91d280cea7e0" xlink:href="ci-20230331.xsd#ci_OngoingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a420a02b-133d-48a0-b56d-982cf2c90da5" xlink:to="loc_ci_OngoingOperationsMember_8d63b7b0-d3b5-49b2-af1a-91d280cea7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AcquisitionDispositionRunoffActivitiesMember_4b7476f1-f1b9-453d-97a4-c6567342b463" xlink:href="ci-20230331.xsd#ci_AcquisitionDispositionRunoffActivitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a420a02b-133d-48a0-b56d-982cf2c90da5" xlink:to="loc_ci_AcquisitionDispositionRunoffActivitiesMember_4b7476f1-f1b9-453d-97a4-c6567342b463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember_60468ea7-48f0-41c9-9093-faae291a690d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a420a02b-133d-48a0-b56d-982cf2c90da5" xlink:to="loc_us-gaap_VariableAnnuityMember_60468ea7-48f0-41c9-9093-faae291a690d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskCollateralizationAxis_c8ffc6cb-c344-46fd-82f3-ffca2068f885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskCollateralizationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_us-gaap_CededCreditRiskCollateralizationAxis_c8ffc6cb-c344-46fd-82f3-ffca2068f885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskCollateralizationDomain_7d8fc5ef-c81c-4de2-a04b-8280dc3eadbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskCollateralizationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationAxis_c8ffc6cb-c344-46fd-82f3-ffca2068f885" xlink:to="loc_us-gaap_CededCreditRiskCollateralizationDomain_7d8fc5ef-c81c-4de2-a04b-8280dc3eadbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember_6d6fba6c-5483-4e4f-8d72-c58bc3a2a17b" xlink:href="ci-20230331.xsd#ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationDomain_7d8fc5ef-c81c-4de2-a04b-8280dc3eadbb" xlink:to="loc_ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember_6d6fba6c-5483-4e4f-8d72-c58bc3a2a17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember_ad67546f-dbc8-436d-a9ce-2b174b0cb71b" xlink:href="ci-20230331.xsd#ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationDomain_7d8fc5ef-c81c-4de2-a04b-8280dc3eadbb" xlink:to="loc_ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember_ad67546f-dbc8-436d-a9ce-2b174b0cb71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskUnsecuredMember_8b9e4678-d987-4acf-acb6-633764ceb0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskUnsecuredMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationDomain_7d8fc5ef-c81c-4de2-a04b-8280dc3eadbb" xlink:to="loc_us-gaap_CededCreditRiskUnsecuredMember_8b9e4678-d987-4acf-acb6-633764ceb0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis_a8cc1013-45c0-4d99-bc05-71f445dba1ec" xlink:href="ci-20230331.xsd#ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis_a8cc1013-45c0-4d99-bc05-71f445dba1ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_c95abd8c-eb81-432d-816b-459ff6e6ab8b" xlink:href="ci-20230331.xsd#ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis_a8cc1013-45c0-4d99-bc05-71f445dba1ec" xlink:to="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_c95abd8c-eb81-432d-816b-459ff6e6ab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember_cde3c1d1-cfe9-49fb-86f4-4f5c2414c0ff" xlink:href="ci-20230331.xsd#ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_c95abd8c-eb81-432d-816b-459ff6e6ab8b" xlink:to="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember_cde3c1d1-cfe9-49fb-86f4-4f5c2414c0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember_80e8ef99-110c-4b6a-a7e3-9cfc7646f193" xlink:href="ci-20230331.xsd#ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember_cde3c1d1-cfe9-49fb-86f4-4f5c2414c0ff" xlink:to="loc_ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember_80e8ef99-110c-4b6a-a7e3-9cfc7646f193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember_49207a3f-7e57-46f1-b265-f5e954d64748" xlink:href="ci-20230331.xsd#ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_c95abd8c-eb81-432d-816b-459ff6e6ab8b" xlink:to="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember_49207a3f-7e57-46f1-b265-f5e954d64748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember_f20ab6d4-4924-4cd2-a5a9-202126a1b95e" xlink:href="ci-20230331.xsd#ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain_c95abd8c-eb81-432d-816b-459ff6e6ab8b" xlink:to="loc_ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember_f20ab6d4-4924-4cd2-a5a9-202126a1b95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis_50f65790-0374-4bb3-98a5-284127b12279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_us-gaap_CededCreditRiskAxis_50f65790-0374-4bb3-98a5-284127b12279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskAxis_50f65790-0374-4bb3-98a5-284127b12279" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember_489601c2-c03a-429e-9e4a-34a0e63218bd" xlink:href="ci-20230331.xsd#ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember_489601c2-c03a-429e-9e4a-34a0e63218bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember_1aa575bb-65a6-48ed-915a-c963f2170d6a" xlink:href="ci-20230331.xsd#ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember_1aa575bb-65a6-48ed-915a-c963f2170d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EmpowerAnnuityInsuranceCompanyMember_ce0ac1d5-5be5-4908-af35-5f85903aa6ba" xlink:href="ci-20230331.xsd#ci_EmpowerAnnuityInsuranceCompanyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_ci_EmpowerAnnuityInsuranceCompanyMember_ce0ac1d5-5be5-4908-af35-5f85903aa6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PrudentialInsuranceCompanyOfAmericaMember_8599f40d-293a-4301-b003-b1e7069dc32d" xlink:href="ci-20230331.xsd#ci_PrudentialInsuranceCompanyOfAmericaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_ci_PrudentialInsuranceCompanyOfAmericaMember_8599f40d-293a-4301-b003-b1e7069dc32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LifeInsuranceCompanyOfNorthAmericaMember_e1762773-7e84-4419-8a27-ee54f026f4d6" xlink:href="ci-20230331.xsd#ci_LifeInsuranceCompanyOfNorthAmericaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_ci_LifeInsuranceCompanyOfNorthAmericaMember_e1762773-7e84-4419-8a27-ee54f026f4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReinsurerMember_78b6f82e-20e7-467c-b707-c46eeb3c728a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReinsurerMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_us-gaap_OtherReinsurerMember_78b6f82e-20e7-467c-b707-c46eeb3c728a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember_c61bd084-7825-46a7-bd47-9a1b9ae81c24" xlink:href="ci-20230331.xsd#ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_802cbb7e-9f90-4db8-91d3-02539d3715ec" xlink:to="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember_c61bd084-7825-46a7-bd47-9a1b9ae81c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f3ff77ac-230c-45c7-bf63-3eb4720aabaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f3ff77ac-230c-45c7-bf63-3eb4720aabaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2a35202a-bc6d-45ae-9263-a70d9718e460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f3ff77ac-230c-45c7-bf63-3eb4720aabaa" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2a35202a-bc6d-45ae-9263-a70d9718e460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_fcf9037c-3fdf-4f95-b46f-8460a061edf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2a35202a-bc6d-45ae-9263-a70d9718e460" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_fcf9037c-3fdf-4f95-b46f-8460a061edf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_02e3d64e-c0f2-4e6d-882d-74a18136223e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_02e3d64e-c0f2-4e6d-882d-74a18136223e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_35c33524-a6e4-4a2f-80eb-4163dfa68d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_02e3d64e-c0f2-4e6d-882d-74a18136223e" xlink:to="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_35c33524-a6e4-4a2f-80eb-4163dfa68d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedMinimumDeathBenefitMember_263b209c-0092-4d6d-82e2-e1d1f0d167aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedMinimumDeathBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_35c33524-a6e4-4a2f-80eb-4163dfa68d98" xlink:to="loc_us-gaap_GuaranteedMinimumDeathBenefitMember_263b209c-0092-4d6d-82e2-e1d1f0d167aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_21cf14c8-80e9-40c2-a2e4-804e19659553" xlink:to="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ReinsuranceRecoverablesIncludingDisposalGroups_5cb8a019-8595-4d71-9a63-4a6dfb26ecdf" xlink:href="ci-20230331.xsd#ci_ReinsuranceRecoverablesIncludingDisposalGroups"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:to="loc_ci_ReinsuranceRecoverablesIncludingDisposalGroups_5cb8a019-8595-4d71-9a63-4a6dfb26ecdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesGross_2bdbd928-54ee-4600-9d1c-9c5264958a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:to="loc_us-gaap_ReinsuranceRecoverablesGross_2bdbd928-54ee-4600-9d1c-9c5264958a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesAllowance_aabf0a66-c8f2-45ff-90cc-4115be9a59f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:to="loc_us-gaap_ReinsuranceRecoverablesAllowance_aabf0a66-c8f2-45ff-90cc-4115be9a59f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_edc58964-f55f-41d4-bcda-f08269bddd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:to="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_edc58964-f55f-41d4-bcda-f08269bddd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_dcbf58ca-2842-474c-b690-aef32ad17db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_92b3a868-2981-4298-bae5-f5384e1e8a5c" xlink:to="loc_us-gaap_ReinsuranceRecoverables_dcbf58ca-2842-474c-b690-aef32ad17db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_88c023d6-9b77-47f2-98e1-69dec823d54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_88c023d6-9b77-47f2-98e1-69dec823d54e" xlink:to="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6b765871-df55-4d7b-a657-dbeda510a1f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_srt_ProductOrServiceAxis_6b765871-df55-4d7b-a657-dbeda510a1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_87a86b17-19b8-414d-b45c-74d9bbcb0ef0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6b765871-df55-4d7b-a657-dbeda510a1f3" xlink:to="loc_srt_ProductsAndServicesDomain_87a86b17-19b8-414d-b45c-74d9bbcb0ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember_c6221d64-de31-41f2-a535-5cb9415f8440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_87a86b17-19b8-414d-b45c-74d9bbcb0ef0" xlink:to="loc_us-gaap_VariableAnnuityMember_c6221d64-de31-41f2-a535-5cb9415f8440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis_c3cf5189-5013-4f68-bad7-da6a978c95b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_us-gaap_CededCreditRiskAxis_c3cf5189-5013-4f68-bad7-da6a978c95b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_b06f0e9d-d1c3-4c04-a360-0eb1e46030a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskAxis_c3cf5189-5013-4f68-bad7-da6a978c95b6" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_b06f0e9d-d1c3-4c04-a360-0eb1e46030a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember_36f2fe81-b429-4946-9c48-be633c505506" xlink:href="ci-20230331.xsd#ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_b06f0e9d-d1c3-4c04-a360-0eb1e46030a0" xlink:to="loc_ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember_36f2fe81-b429-4946-9c48-be633c505506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SunLifeAssuranceCompanyOfCanadaMember_c9872668-6e2d-4912-865f-e8234c136bc7" xlink:href="ci-20230331.xsd#ci_SunLifeAssuranceCompanyOfCanadaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_b06f0e9d-d1c3-4c04-a360-0eb1e46030a0" xlink:to="loc_ci_SunLifeAssuranceCompanyOfCanadaMember_c9872668-6e2d-4912-865f-e8234c136bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LibertyMutualInsuranceMember_3c90e7a3-b11e-49cc-b8ce-19c3747aa5f3" xlink:href="ci-20230331.xsd#ci_LibertyMutualInsuranceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_b06f0e9d-d1c3-4c04-a360-0eb1e46030a0" xlink:to="loc_ci_LibertyMutualInsuranceMember_3c90e7a3-b11e-49cc-b8ce-19c3747aa5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SCORSEMember_df902522-393b-4212-9c8a-998bf2916e7e" xlink:href="ci-20230331.xsd#ci_SCORSEMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_b06f0e9d-d1c3-4c04-a360-0eb1e46030a0" xlink:to="loc_ci_SCORSEMember_df902522-393b-4212-9c8a-998bf2916e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskCollateralizationAxis_f3da2aa3-19e7-4155-9c24-39897216d180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskCollateralizationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_us-gaap_CededCreditRiskCollateralizationAxis_f3da2aa3-19e7-4155-9c24-39897216d180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskCollateralizationDomain_4b9a7f0e-1019-4709-9886-0b1690c58112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskCollateralizationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationAxis_f3da2aa3-19e7-4155-9c24-39897216d180" xlink:to="loc_us-gaap_CededCreditRiskCollateralizationDomain_4b9a7f0e-1019-4709-9886-0b1690c58112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskSecuredMember_75da0205-c925-4bc2-b7a9-562a34cd9fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskSecuredMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskCollateralizationDomain_4b9a7f0e-1019-4709-9886-0b1690c58112" xlink:to="loc_us-gaap_CededCreditRiskSecuredMember_75da0205-c925-4bc2-b7a9-562a34cd9fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ca4c0575-c186-446b-baae-4559d6598a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ca4c0575-c186-446b-baae-4559d6598a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ed6605f7-ad8b-451b-8918-c1e5c1399e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ca4c0575-c186-446b-baae-4559d6598a4f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ed6605f7-ad8b-451b-8918-c1e5c1399e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember_c27347a3-29ac-469a-99b6-93ae9ea5de7c" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ed6605f7-ad8b-451b-8918-c1e5c1399e12" xlink:to="loc_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember_c27347a3-29ac-469a-99b6-93ae9ea5de7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_5fa050de-ab01-4091-a217-1d4df6348e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_5fa050de-ab01-4091-a217-1d4df6348e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_242b84ac-314e-45e3-a95e-09fba5ae4b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5fa050de-ab01-4091-a217-1d4df6348e74" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_242b84ac-314e-45e3-a95e-09fba5ae4b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededCreditCollateralizationRiskMember_c1bf65e7-924e-462b-bb4b-625044ee2c9f" xlink:href="ci-20230331.xsd#ci_CededCreditCollateralizationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_242b84ac-314e-45e3-a95e-09fba5ae4b4c" xlink:to="loc_ci_CededCreditCollateralizationRiskMember_c1bf65e7-924e-462b-bb4b-625044ee2c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_cad5ca38-a5e6-4bdf-a426-d810d14f8efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_cad5ca38-a5e6-4bdf-a426-d810d14f8efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_80b35ef2-7023-4c0c-99bc-9955eaaf3523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis_cad5ca38-a5e6-4bdf-a426-d810d14f8efc" xlink:to="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_80b35ef2-7023-4c0c-99bc-9955eaaf3523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember_7d7b5f69-5d11-4e2c-9ae1-776084b21e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain_80b35ef2-7023-4c0c-99bc-9955eaaf3523" xlink:to="loc_us-gaap_VariableAnnuityMember_7d7b5f69-5d11-4e2c-9ae1-776084b21e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_ed4aa63b-bbfe-4069-8e1b-31b355bb013e" xlink:to="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededReinsuranceAgreementReinsuredRiskPercentage_c838a753-a2b1-4751-8d2f-38d7621bb556" xlink:href="ci-20230331.xsd#ci_CededReinsuranceAgreementReinsuredRiskPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_ci_CededReinsuranceAgreementReinsuredRiskPercentage_c838a753-a2b1-4751-8d2f-38d7621bb556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining_ed73b99a-fe92-447b-addd-9663a1002a6d" xlink:href="ci-20230331.xsd#ci_CededReinsuranceAgreementCoverageLimitAmountRemaining"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining_ed73b99a-fe92-447b-addd-9663a1002a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_736d7acb-ca38-4f82-996e-9fad2907823b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_736d7acb-ca38-4f82-996e-9fad2907823b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances_5012f821-483d-4051-96bf-b6e6a0bce8bd" xlink:href="ci-20230331.xsd#ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances_5012f821-483d-4051-96bf-b6e6a0bce8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_ade0214b-70fb-41ab-b8bb-d2e4f4393b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance_ade0214b-70fb-41ab-b8bb-d2e4f4393b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims_e501345e-47e5-4c00-a98f-87d0ea746819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims_e501345e-47e5-4c00-a98f-87d0ea746819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_d268687c-8748-4276-b1cb-bafee8339c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_d268687c-8748-4276-b1cb-bafee8339c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementNonPerformanceRiskAdjustment_7ee7a78f-7c96-4ab5-8a05-4fe08d510b3c" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementNonPerformanceRiskAdjustment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_0e875987-209c-41bf-b96d-a7da167cbd7b" xlink:to="loc_ci_FairValueMeasurementNonPerformanceRiskAdjustment_7ee7a78f-7c96-4ab5-8a05-4fe08d510b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsInvestmentsbyCategoryDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_5ddf80d9-4851-4ae3-8b84-4aeffd599b81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_f09cf1e8-d500-4dab-a290-1796f61a3bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_5ddf80d9-4851-4ae3-8b84-4aeffd599b81" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_f09cf1e8-d500-4dab-a290-1796f61a3bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_1ca86c46-c286-420d-b51a-1f01131b09ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f09cf1e8-d500-4dab-a290-1796f61a3bef" xlink:to="loc_us-gaap_InvestmentTypeAxis_1ca86c46-c286-420d-b51a-1f01131b09ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_1ca86c46-c286-420d-b51a-1f01131b09ca" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_827860de-9efe-492b-a09b-fdd1e8cb2c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:to="loc_us-gaap_DebtSecuritiesMember_827860de-9efe-492b-a09b-fdd1e8cb2c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_2a1b8cff-5c21-443b-9933-5ebe95e0f968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:to="loc_us-gaap_EquitySecuritiesMember_2a1b8cff-5c21-443b-9933-5ebe95e0f968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_514c7111-3d75-4f87-b005-c6afbbe58b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:to="loc_us-gaap_MortgagesMember_514c7111-3d75-4f87-b005-c6afbbe58b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyLoansMember_ae82ed06-08c3-4cf4-938e-fa67fe039815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyLoansMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:to="loc_us-gaap_PolicyLoansMember_ae82ed06-08c3-4cf4-938e-fa67fe039815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_42348972-4867-4fda-ad57-e7f790c18003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_42348972-4867-4fda-ad57-e7f790c18003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e26572ac-3d52-4bcc-9c55-5dc2122e764d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_aff788b3-4589-4ed8-a9b7-9620e6958306" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e26572ac-3d52-4bcc-9c55-5dc2122e764d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_898cf91f-fdbf-4a35-9651-9d40394b33bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_f09cf1e8-d500-4dab-a290-1796f61a3bef" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_898cf91f-fdbf-4a35-9651-9d40394b33bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsAbstract_62c1963e-a74a-4e38-8a98-bba8b77cfb03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_898cf91f-fdbf-4a35-9651-9d40394b33bb" xlink:to="loc_us-gaap_ShortTermInvestmentsAbstract_62c1963e-a74a-4e38-8a98-bba8b77cfb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1c620fc7-4914-4607-8d85-dfcc40f2da56" xlink:href="ci-20230331.xsd#ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermInvestmentsAbstract_62c1963e-a74a-4e38-8a98-bba8b77cfb03" xlink:to="loc_ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1c620fc7-4914-4607-8d85-dfcc40f2da56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent_a7113b13-f43f-4fed-9926-ee403f994dd4" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermInvestmentsAbstract_62c1963e-a74a-4e38-8a98-bba8b77cfb03" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent_a7113b13-f43f-4fed-9926-ee403f994dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_3f6a6180-e53f-4897-94aa-e72d5129f048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermInvestmentsAbstract_62c1963e-a74a-4e38-8a98-bba8b77cfb03" xlink:to="loc_us-gaap_ShortTermInvestments_3f6a6180-e53f-4897-94aa-e72d5129f048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestmentsAbstract_320055cf-2cfc-4257-b287-6951c9ea6f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestmentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_898cf91f-fdbf-4a35-9651-9d40394b33bb" xlink:to="loc_us-gaap_LongTermInvestmentsAbstract_320055cf-2cfc-4257-b287-6951c9ea6f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_9cf28c5b-0f51-4531-946c-b5514fe723a9" xlink:href="ci-20230331.xsd#ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermInvestmentsAbstract_320055cf-2cfc-4257-b287-6951c9ea6f8d" xlink:to="loc_ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_9cf28c5b-0f51-4531-946c-b5514fe723a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent_e1e2e7eb-fd3f-4ffc-b3b7-85c86b5eac87" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermInvestmentsAbstract_320055cf-2cfc-4257-b287-6951c9ea6f8d" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent_e1e2e7eb-fd3f-4ffc-b3b7-85c86b5eac87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_1fb9c676-fb61-4a0f-9215-faa9a3de16e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermInvestmentsAbstract_320055cf-2cfc-4257-b287-6951c9ea6f8d" xlink:to="loc_us-gaap_LongTermInvestments_1fb9c676-fb61-4a0f-9215-faa9a3de16e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ShortTermAndLongTermInvestmentsAbstract_ee36d01b-0aa1-4bb9-a6f3-ea476ddcea1d" xlink:href="ci-20230331.xsd#ci_ShortTermAndLongTermInvestmentsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_898cf91f-fdbf-4a35-9651-9d40394b33bb" xlink:to="loc_ci_ShortTermAndLongTermInvestmentsAbstract_ee36d01b-0aa1-4bb9-a6f3-ea476ddcea1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_5f638edb-98a2-4370-9069-f20c8d5d6ca3" xlink:href="ci-20230331.xsd#ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_ShortTermAndLongTermInvestmentsAbstract_ee36d01b-0aa1-4bb9-a6f3-ea476ddcea1d" xlink:to="loc_ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_5f638edb-98a2-4370-9069-f20c8d5d6ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationInvestments_e8bd6126-c94d-4a31-9392-ecf4ecb264b7" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_ShortTermAndLongTermInvestmentsAbstract_ee36d01b-0aa1-4bb9-a6f3-ea476ddcea1d" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationInvestments_e8bd6126-c94d-4a31-9392-ecf4ecb264b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_d6a1c216-309a-423c-b2c3-4e1c76f18b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_ShortTermAndLongTermInvestmentsAbstract_ee36d01b-0aa1-4bb9-a6f3-ea476ddcea1d" xlink:to="loc_us-gaap_Investments_d6a1c216-309a-423c-b2c3-4e1c76f18b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails_1" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsInvestmentsbyCategoryDetails_1"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_f126497b-d052-492e-ba53-04f5b4e5348c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_6e1f6c4b-fb10-409b-aa51-4d1ce26410fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_f126497b-d052-492e-ba53-04f5b4e5348c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_6e1f6c4b-fb10-409b-aa51-4d1ce26410fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_cf8a1792-a94a-4c89-a5d2-56ccec6857b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_6e1f6c4b-fb10-409b-aa51-4d1ce26410fc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_cf8a1792-a94a-4c89-a5d2-56ccec6857b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_4d56332d-8086-45f9-a9dc-b225305ca9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_6e1f6c4b-fb10-409b-aa51-4d1ce26410fc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_4d56332d-8086-45f9-a9dc-b225305ca9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_1935e413-f4be-478b-8755-27be81c82e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_6e1f6c4b-fb10-409b-aa51-4d1ce26410fc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_1935e413-f4be-478b-8755-27be81c82e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_5b624988-4400-48f7-ae34-f853592ca00d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_6e1f6c4b-fb10-409b-aa51-4d1ce26410fc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_5b624988-4400-48f7-ae34-f853592ca00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_38963695-8045-46ab-94a4-d7ca4dcdefa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_6e1f6c4b-fb10-409b-aa51-4d1ce26410fc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_38963695-8045-46ab-94a4-d7ca4dcdefa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_9887a6d1-83c1-4b21-a5d6-28a34bab155c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_6e1f6c4b-fb10-409b-aa51-4d1ce26410fc" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_9887a6d1-83c1-4b21-a5d6-28a34bab155c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b0848fbe-727c-4a8d-ad6b-101e0843564a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_f126497b-d052-492e-ba53-04f5b4e5348c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b0848fbe-727c-4a8d-ad6b-101e0843564a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d2e02153-7306-4745-b0fe-213f5858765c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b0848fbe-727c-4a8d-ad6b-101e0843564a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d2e02153-7306-4745-b0fe-213f5858765c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_96aa6764-20a2-4f02-ad5e-77de571151f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b0848fbe-727c-4a8d-ad6b-101e0843564a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_96aa6764-20a2-4f02-ad5e-77de571151f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_f15ca800-ca1b-450f-8815-2384ae22d2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b0848fbe-727c-4a8d-ad6b-101e0843564a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_f15ca800-ca1b-450f-8815-2384ae22d2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_f663ce30-dcda-4083-b828-f567d966cc08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b0848fbe-727c-4a8d-ad6b-101e0843564a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_f663ce30-dcda-4083-b828-f567d966cc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_9d573cd6-4d00-4463-8da3-4385e0da5e04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b0848fbe-727c-4a8d-ad6b-101e0843564a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_9d573cd6-4d00-4463-8da3-4385e0da5e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_dfdf779f-da25-4036-b6d4-60e737bf71e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b0848fbe-727c-4a8d-ad6b-101e0843564a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_dfdf779f-da25-4036-b6d4-60e737bf71e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_a17967f1-3bfc-4ff8-b0da-ef6075c04993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_07e6885a-f32d-4d43-a88f-2e6644774ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_a17967f1-3bfc-4ff8-b0da-ef6075c04993" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_07e6885a-f32d-4d43-a88f-2e6644774ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_91fa4e39-a2e6-4039-8449-00b73f5d53f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_07e6885a-f32d-4d43-a88f-2e6644774ca3" xlink:to="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_91fa4e39-a2e6-4039-8449-00b73f5d53f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_39aae08b-a639-46e7-baca-e12b51bcb367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_91fa4e39-a2e6-4039-8449-00b73f5d53f1" xlink:to="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_39aae08b-a639-46e7-baca-e12b51bcb367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPortfolioSegmentMember_8278291d-8eec-4702-bb96-11e05d66a41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPortfolioSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_39aae08b-a639-46e7-baca-e12b51bcb367" xlink:to="loc_us-gaap_CommercialPortfolioSegmentMember_8278291d-8eec-4702-bb96-11e05d66a41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_d65f4cdb-b4b4-48bb-a8c3-b03e247a6c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_07e6885a-f32d-4d43-a88f-2e6644774ca3" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_d65f4cdb-b4b4-48bb-a8c3-b03e247a6c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_66eff2da-eb33-4cb3-87a6-91bd6c0eb104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_d65f4cdb-b4b4-48bb-a8c3-b03e247a6c57" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_66eff2da-eb33-4cb3-87a6-91bd6c0eb104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLoanMember_a2c7533c-aa36-4222-bac9-43abb341eae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_66eff2da-eb33-4cb3-87a6-91bd6c0eb104" xlink:to="loc_us-gaap_RealEstateLoanMember_a2c7533c-aa36-4222-bac9-43abb341eae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c0487c9-0916-4b0b-b8c9-0295ba1da3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_07e6885a-f32d-4d43-a88f-2e6644774ca3" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c0487c9-0916-4b0b-b8c9-0295ba1da3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_f5d86ed7-8697-4e6f-9734-d05888225414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c0487c9-0916-4b0b-b8c9-0295ba1da3b0" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_f5d86ed7-8697-4e6f-9734-d05888225414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5d10f70f-6ed9-466b-b0a3-283b82eb0ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c0487c9-0916-4b0b-b8c9-0295ba1da3b0" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5d10f70f-6ed9-466b-b0a3-283b82eb0ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_650a1e97-8dfc-495d-803f-dadfbfac6209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c0487c9-0916-4b0b-b8c9-0295ba1da3b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_650a1e97-8dfc-495d-803f-dadfbfac6209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_eb44dbba-37ca-4469-a57d-123748155b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2c0487c9-0916-4b0b-b8c9-0295ba1da3b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_eb44dbba-37ca-4469-a57d-123748155b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_4820c94b-3bb8-49d5-9073-aa0682c90689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_8cd70511-1189-4378-9c5d-8c335f5275bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_4820c94b-3bb8-49d5-9073-aa0682c90689" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_8cd70511-1189-4378-9c5d-8c335f5275bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cd2ae345-1b8d-4b96-b992-df0ef8d6b5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_8cd70511-1189-4378-9c5d-8c335f5275bc" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cd2ae345-1b8d-4b96-b992-df0ef8d6b5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cd2ae345-1b8d-4b96-b992-df0ef8d6b5e3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_bec4848e-5033-476e-b3b3-8b17c3ddea3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_bec4848e-5033-476e-b3b3-8b17c3ddea3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_b88078c8-071c-4910-9056-fb4f00f73130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_b88078c8-071c-4910-9056-fb4f00f73130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_ad4d54b2-a35f-4273-8bd8-79ff4b812c14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_ad4d54b2-a35f-4273-8bd8-79ff4b812c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_47dd2323-a2a4-451b-8c61-cb0b74b01240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_47dd2323-a2a4-451b-8c61-cb0b74b01240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_b3497ed7-847d-4f76-91ed-e4914d8b6ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_54bb69e8-ca40-499e-8079-ccfef5336516" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_b3497ed7-847d-4f76-91ed-e4914d8b6ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_8cd70511-1189-4378-9c5d-8c335f5275bc" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_cb77fb5b-d977-4b44-b73e-943da689fa26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_cb77fb5b-d977-4b44-b73e-943da689fa26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_b8ade10a-a20d-4ac7-a2ed-685fa3339358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_b8ade10a-a20d-4ac7-a2ed-685fa3339358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_800c7619-485c-40e7-8789-bcf8fa8d35d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_800c7619-485c-40e7-8789-bcf8fa8d35d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e44d3529-e391-4b90-b0aa-8f3ff71ad26e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e44d3529-e391-4b90-b0aa-8f3ff71ad26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_4d696052-95aa-4073-bfab-157728426178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_4d696052-95aa-4073-bfab-157728426178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale_188245f5-7e48-44aa-a0ba-af030bfec1cb" xlink:href="ci-20230331.xsd#ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale_188245f5-7e48-44aa-a0ba-af030bfec1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_d895ef64-0c17-439c-b221-1207ff08fcb3" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_d895ef64-0c17-439c-b221-1207ff08fcb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_b406f9bd-300a-4998-b92b-7a90e9c0451e" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_b406f9bd-300a-4998-b92b-7a90e9c0451e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_40266104-bce4-420a-81ff-d2af98176c0a" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale_40266104-bce4-420a-81ff-d2af98176c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_d38abfbd-c45b-47a1-a709-cb6b3ea143da" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e5aff1c5-4334-4ad9-8664-f353a4c84888" xlink:to="loc_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_d38abfbd-c45b-47a1-a709-cb6b3ea143da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_7678cca7-106a-4bb0-9d2c-bf050b7f6413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be261efb-b682-471b-852f-5ed697b5c5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7678cca7-106a-4bb0-9d2c-bf050b7f6413" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be261efb-b682-471b-852f-5ed697b5c5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentsCreditRatingAxis_68b080d8-8236-45a2-a664-d6544fc1c4fa" xlink:href="ci-20230331.xsd#ci_InvestmentsCreditRatingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be261efb-b682-471b-852f-5ed697b5c5d4" xlink:to="loc_ci_InvestmentsCreditRatingAxis_68b080d8-8236-45a2-a664-d6544fc1c4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentsCreditRatingDomain_831ec162-065d-4769-8ec8-5b7b1f808b8a" xlink:href="ci-20230331.xsd#ci_InvestmentsCreditRatingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InvestmentsCreditRatingAxis_68b080d8-8236-45a2-a664-d6544fc1c4fa" xlink:to="loc_ci_InvestmentsCreditRatingDomain_831ec162-065d-4769-8ec8-5b7b1f808b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentGradeMember_7becd578-07f1-4072-81e6-ee93a5cfec6f" xlink:href="ci-20230331.xsd#ci_InvestmentGradeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InvestmentsCreditRatingDomain_831ec162-065d-4769-8ec8-5b7b1f808b8a" xlink:to="loc_ci_InvestmentGradeMember_7becd578-07f1-4072-81e6-ee93a5cfec6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_BelowInvestmentGradeMember_2f287c09-5776-40b1-93cb-4132525f8187" xlink:href="ci-20230331.xsd#ci_BelowInvestmentGradeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InvestmentsCreditRatingDomain_831ec162-065d-4769-8ec8-5b7b1f808b8a" xlink:to="loc_ci_BelowInvestmentGradeMember_2f287c09-5776-40b1-93cb-4132525f8187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_65e5d62f-6d4b-4c44-8208-b94ccc68ac81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be261efb-b682-471b-852f-5ed697b5c5d4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_65e5d62f-6d4b-4c44-8208-b94ccc68ac81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_230fbf90-8913-4e6c-952a-ae7e395a9076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_65e5d62f-6d4b-4c44-8208-b94ccc68ac81" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_230fbf90-8913-4e6c-952a-ae7e395a9076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_29cd3338-9387-4090-a3a6-86cfd575fcf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_230fbf90-8913-4e6c-952a-ae7e395a9076" xlink:to="loc_us-gaap_DebtSecuritiesMember_29cd3338-9387-4090-a3a6-86cfd575fcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b1c8574f-861b-4b9a-a942-1b7c8dd09717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be261efb-b682-471b-852f-5ed697b5c5d4" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b1c8574f-861b-4b9a-a942-1b7c8dd09717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b1c8574f-861b-4b9a-a942-1b7c8dd09717" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_7f26b5ae-b8fb-4045-9146-6f898def3f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_7f26b5ae-b8fb-4045-9146-6f898def3f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost_429af36e-d290-4581-ac1f-8cbcc0486c3a" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost_429af36e-d290-4581-ac1f-8cbcc0486c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0e93630e-7218-4795-995d-aee6401d35ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0e93630e-7218-4795-995d-aee6401d35ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_a2df8052-6bd4-4eef-a024-afb6d3c2d8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_a2df8052-6bd4-4eef-a024-afb6d3c2d8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_e992d555-b35b-4818-a876-5db963120ece" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_e992d555-b35b-4818-a876-5db963120ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_d55f36b9-5851-4798-895d-fafc85e20386" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_d55f36b9-5851-4798-895d-fafc85e20386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_0e48aeb8-2139-4554-bf1a-1ed6ce12715f" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_0e48aeb8-2139-4554-bf1a-1ed6ce12715f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_59db894e-4353-4273-b616-326bae4d7c18" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract_5e8203df-8101-4f91-ad4c-a050c36e24d0" xlink:to="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_59db894e-4353-4273-b616-326bae4d7c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b1c8574f-861b-4b9a-a942-1b7c8dd09717" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_a22c3e40-de08-4d7d-b36c-8c8d00add737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_a22c3e40-de08-4d7d-b36c-8c8d00add737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost_45f77635-b1ba-4411-8342-9c0fd62bff0d" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost_45f77635-b1ba-4411-8342-9c0fd62bff0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_bb6db6ce-5580-4b09-8b01-0ebf6f3cf703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_bb6db6ce-5580-4b09-8b01-0ebf6f3cf703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_828c4fc4-1598-42bb-a60d-22d6ee9d646c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_828c4fc4-1598-42bb-a60d-22d6ee9d646c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_6faaddfa-1522-4020-88d2-58918bfb4484" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_6faaddfa-1522-4020-88d2-58918bfb4484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_fc61c31b-6e80-45fe-9f83-f8be28bd68c0" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_fc61c31b-6e80-45fe-9f83-f8be28bd68c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_fe5d1959-1fc2-4061-a407-50c29a03d359" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_fe5d1959-1fc2-4061-a407-50c29a03d359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_d230b9c3-108f-433d-8c24-9c246d100eaf" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract_2191e94d-ab06-48a8-9319-7c5c993e76f2" xlink:to="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_d230b9c3-108f-433d-8c24-9c246d100eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b1c8574f-861b-4b9a-a942-1b7c8dd09717" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7669b4bd-9ff2-4434-b9b4-ddfaff7d2b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7669b4bd-9ff2-4434-b9b4-ddfaff7d2b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost_25792234-7044-4058-9192-bffc59bbee6e" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost_25792234-7044-4058-9192-bffc59bbee6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_58b1f884-1062-41df-b77d-2848e899daab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_58b1f884-1062-41df-b77d-2848e899daab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ecb8ae12-6869-44a7-b44f-72278302099e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ecb8ae12-6869-44a7-b44f-72278302099e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale_e3ad8634-d471-419b-8999-3f800827adce" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale_e3ad8634-d471-419b-8999-3f800827adce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_82712b7a-e623-47b5-8f2d-a988dd9d5ead" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_82712b7a-e623-47b5-8f2d-a988dd9d5ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_b8e852c1-add3-4af5-be52-9f40520a5112" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale_b8e852c1-add3-4af5-be52-9f40520a5112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_f3695ea2-7434-473b-b712-7dd6c1e7d9cf" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract_a623a63f-ee8d-48e2-85c2-6a0fca3514f1" xlink:to="loc_ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale_f3695ea2-7434-473b-b712-7dd6c1e7d9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails_1" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails_1"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsEquitySecurityInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58a77481-dd74-4dee-b383-2025be6766fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract_37fc8e18-cf91-499a-b496-8907ab1b49e0" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58a77481-dd74-4dee-b383-2025be6766fa" xlink:to="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract_37fc8e18-cf91-499a-b496-8907ab1b49e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_ebf0750d-2465-4506-a5c7-796d5707cdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract_37fc8e18-cf91-499a-b496-8907ab1b49e0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_ebf0750d-2465-4506-a5c7-796d5707cdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost_305e21ba-f296-4d1c-8def-d3bff7797ed4" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract_37fc8e18-cf91-499a-b496-8907ab1b49e0" xlink:to="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost_305e21ba-f296-4d1c-8def-d3bff7797ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost_8f87f89d-ca25-46ed-a7cd-a221f61d8078" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract_37fc8e18-cf91-499a-b496-8907ab1b49e0" xlink:to="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost_8f87f89d-ca25-46ed-a7cd-a221f61d8078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_b8188b78-2155-4db9-9a3a-c3161b35ac0d" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract_37fc8e18-cf91-499a-b496-8907ab1b49e0" xlink:to="loc_ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_b8188b78-2155-4db9-9a3a-c3161b35ac0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_7058449d-77d2-4d65-9963-4835c42a168d" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract_37fc8e18-cf91-499a-b496-8907ab1b49e0" xlink:to="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_7058449d-77d2-4d65-9963-4835c42a168d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_fadc8433-f442-4ef0-b9c3-d60f90dc1e4c" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract_37fc8e18-cf91-499a-b496-8907ab1b49e0" xlink:to="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale_fadc8433-f442-4ef0-b9c3-d60f90dc1e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract_c49ef116-8949-42c0-8f68-756622a653cc" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58a77481-dd74-4dee-b383-2025be6766fa" xlink:to="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract_c49ef116-8949-42c0-8f68-756622a653cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_45cbd916-d6c4-4859-8fa5-463bc6b9f51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract_c49ef116-8949-42c0-8f68-756622a653cc" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_45cbd916-d6c4-4859-8fa5-463bc6b9f51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_86e40e66-29e3-46f3-b4ef-484c3d6dab2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract_c49ef116-8949-42c0-8f68-756622a653cc" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_86e40e66-29e3-46f3-b4ef-484c3d6dab2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount_7b725148-5f94-41a1-86f1-3611b527dbec" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract_c49ef116-8949-42c0-8f68-756622a653cc" xlink:to="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount_7b725148-5f94-41a1-86f1-3611b527dbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale_9aef5083-0741-4215-b1ef-1e3bfa164639" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract_c49ef116-8949-42c0-8f68-756622a653cc" xlink:to="loc_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale_9aef5083-0741-4215-b1ef-1e3bfa164639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_b576f019-dd68-4bf5-9cd3-793644508a9c" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract_c49ef116-8949-42c0-8f68-756622a653cc" xlink:to="loc_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_b576f019-dd68-4bf5-9cd3-793644508a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_e19c2899-6110-4491-bad5-9f18e9418c45" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract_c49ef116-8949-42c0-8f68-756622a653cc" xlink:to="loc_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_e19c2899-6110-4491-bad5-9f18e9418c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58a77481-dd74-4dee-b383-2025be6766fa" xlink:to="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_f94b0e11-dedf-449e-b90a-e83ca88be242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:to="loc_us-gaap_OtherCommitmentsAxis_f94b0e11-dedf-449e-b90a-e83ca88be242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_1944527f-3f91-41ad-a96d-b97e7b1951b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_f94b0e11-dedf-449e-b90a-e83ca88be242" xlink:to="loc_us-gaap_OtherCommitmentsDomain_1944527f-3f91-41ad-a96d-b97e7b1951b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentToPurchaseEquitySecuritiesMember_89949958-6295-4c87-8d33-309027dc5712" xlink:href="ci-20230331.xsd#ci_CommitmentToPurchaseEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1944527f-3f91-41ad-a96d-b97e7b1951b3" xlink:to="loc_ci_CommitmentToPurchaseEquitySecuritiesMember_89949958-6295-4c87-8d33-309027dc5712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d01d5db-ec48-45ee-b6c9-cdbf74fb6495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d01d5db-ec48-45ee-b6c9-cdbf74fb6495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_523e5029-8dbf-40e9-b44c-e7b3af961948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d01d5db-ec48-45ee-b6c9-cdbf74fb6495" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_523e5029-8dbf-40e9-b44c-e7b3af961948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFVNIMember_8c22a32e-7414-4969-af13-4c23d5ba4067" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFVNIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_523e5029-8dbf-40e9-b44c-e7b3af961948" xlink:to="loc_ci_EquitySecuritiesFVNIMember_8c22a32e-7414-4969-af13-4c23d5ba4067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ccf23851-aad6-42b7-8a64-336a6ac2a3e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ccf23851-aad6-42b7-8a64-336a6ac2a3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_93d26fa9-0183-4c41-9dd4-13d2fd847968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ccf23851-aad6-42b7-8a64-336a6ac2a3e6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_93d26fa9-0183-4c41-9dd4-13d2fd847968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_9010e4f7-a1a7-4e8f-8028-59101dff30cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_93d26fa9-0183-4c41-9dd4-13d2fd847968" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_9010e4f7-a1a7-4e8f-8028-59101dff30cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesByIndustryAxis_ce5427be-d1e7-4760-a5b9-1924d3390b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesByIndustryAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:to="loc_us-gaap_EquitySecuritiesByIndustryAxis_ce5427be-d1e7-4760-a5b9-1924d3390b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesIndustryMember_6380e44c-656e-4d8c-a1fe-7acf35fe6a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesIndustryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesByIndustryAxis_ce5427be-d1e7-4760-a5b9-1924d3390b65" xlink:to="loc_us-gaap_EquitySecuritiesIndustryMember_6380e44c-656e-4d8c-a1fe-7acf35fe6a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthcareSectorMember_92a09180-e377-43bc-a79b-c840a608e9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthcareSectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesIndustryMember_6380e44c-656e-4d8c-a1fe-7acf35fe6a78" xlink:to="loc_us-gaap_HealthcareSectorMember_92a09180-e377-43bc-a79b-c840a608e9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f7f458e8-9239-4a16-804f-0aacc27740f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f7f458e8-9239-4a16-804f-0aacc27740f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7a4794ac-9378-44f6-9ee5-79613a8e6403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f7f458e8-9239-4a16-804f-0aacc27740f6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7a4794ac-9378-44f6-9ee5-79613a8e6403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_16c5172a-23ad-44a6-99f4-2f4578325249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7a4794ac-9378-44f6-9ee5-79613a8e6403" xlink:to="loc_us-gaap_SubsequentEventMember_16c5172a-23ad-44a6-99f4-2f4578325249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_4079a826-31b9-47b0-894a-9b7eb3452b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_7f1f9ba3-0fc5-438a-90b7-80cb6eab4485" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_4079a826-31b9-47b0-894a-9b7eb3452b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_67658ccb-f16f-4a56-b187-54912c94644f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4079a826-31b9-47b0-894a-9b7eb3452b0e" xlink:to="loc_us-gaap_OtherCommitment_67658ccb-f16f-4a56-b187-54912c94644f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PaymentsToAcquireDebtAndEquitySecurities_f756a956-f0d7-4da5-b58c-f7d191cb3ccd" xlink:href="ci-20230331.xsd#ci_PaymentsToAcquireDebtAndEquitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4079a826-31b9-47b0-894a-9b7eb3452b0e" xlink:to="loc_ci_PaymentsToAcquireDebtAndEquitySecurities_f756a956-f0d7-4da5-b58c-f7d191cb3ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f1a10ec0-b083-46a2-9288-df49f06f8158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_4079a826-31b9-47b0-894a-9b7eb3452b0e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f1a10ec0-b083-46a2-9288-df49f06f8158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_5ab0650c-0612-4049-a4b0-6b35eeb982db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_5ab0650c-0612-4049-a4b0-6b35eeb982db" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_f1f78a11-f5cd-4971-a34a-fe1766420951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_f1f78a11-f5cd-4971-a34a-fe1766420951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_8322c65b-a12f-44b5-87fa-2abd99caef7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_f1f78a11-f5cd-4971-a34a-fe1766420951" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_8322c65b-a12f-44b5-87fa-2abd99caef7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLoanMember_c411ed34-8619-44bc-99df-c23f6414228d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_8322c65b-a12f-44b5-87fa-2abd99caef7c" xlink:to="loc_us-gaap_RealEstateLoanMember_c411ed34-8619-44bc-99df-c23f6414228d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_5582fe66-2d19-4ef8-91de-f498f5a5dee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:to="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_5582fe66-2d19-4ef8-91de-f498f5a5dee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_9ed497e3-f17c-4751-9d75-c0cb674a9be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivablePortfolioSegmentAxis_5582fe66-2d19-4ef8-91de-f498f5a5dee6" xlink:to="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_9ed497e3-f17c-4751-9d75-c0cb674a9be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPortfolioSegmentMember_d344d6e0-ea71-400d-92f0-b288681ecec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPortfolioSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivablePortfolioSegmentDomain_9ed497e3-f17c-4751-9d75-c0cb674a9be9" xlink:to="loc_us-gaap_CommercialPortfolioSegmentMember_d344d6e0-ea71-400d-92f0-b288681ecec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueAxis_04f3d0b3-6f14-4a4c-8dc9-881d98d187ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:to="loc_us-gaap_LoanToValueAxis_04f3d0b3-6f14-4a4c-8dc9-881d98d187ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoanToValueDomain_81164d73-a26c-4d88-b75c-118676123f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoanToValueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueAxis_04f3d0b3-6f14-4a4c-8dc9-881d98d187ac" xlink:to="loc_us-gaap_LoanToValueDomain_81164d73-a26c-4d88-b75c-118676123f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LtvLessThan60PercentMember_c6fedcb6-430b-408d-8daa-b001ef5fd743" xlink:href="ci-20230331.xsd#ci_LtvLessThan60PercentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_81164d73-a26c-4d88-b75c-118676123f2b" xlink:to="loc_ci_LtvLessThan60PercentMember_c6fedcb6-430b-408d-8daa-b001ef5fd743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_Ltv60To79PercentMember_fd493e3d-849d-41c6-8222-96b8c5770613" xlink:href="ci-20230331.xsd#ci_Ltv60To79PercentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_81164d73-a26c-4d88-b75c-118676123f2b" xlink:to="loc_ci_Ltv60To79PercentMember_fd493e3d-849d-41c6-8222-96b8c5770613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Ltv80To100PercentMember_697b47fd-2dd1-4ee5-9f6f-d42e1b5fe9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Ltv80To100PercentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_81164d73-a26c-4d88-b75c-118676123f2b" xlink:to="loc_us-gaap_Ltv80To100PercentMember_697b47fd-2dd1-4ee5-9f6f-d42e1b5fe9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LtvGreaterThan100PercentMember_5e676d98-2201-4229-a33d-a1bf32c28af2" xlink:href="ci-20230331.xsd#ci_LtvGreaterThan100PercentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LoanToValueDomain_81164d73-a26c-4d88-b75c-118676123f2b" xlink:to="loc_ci_LtvGreaterThan100PercentMember_5e676d98-2201-4229-a33d-a1bf32c28af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e0a7a14e-b755-40f0-9d33-0c9268511369" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:to="loc_srt_RangeAxis_e0a7a14e-b755-40f0-9d33-0c9268511369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6ffa6548-5554-4cbe-b5ae-d16fabf676ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e0a7a14e-b755-40f0-9d33-0c9268511369" xlink:to="loc_srt_RangeMember_6ffa6548-5554-4cbe-b5ae-d16fabf676ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_11cd2fc8-53a9-4c41-bf79-4d807649dd1a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6ffa6548-5554-4cbe-b5ae-d16fabf676ba" xlink:to="loc_srt_WeightedAverageMember_11cd2fc8-53a9-4c41-bf79-4d807649dd1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_5cec50cd-edc4-45e4-b45f-ff5e225a7497" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_c87c6b80-3daa-4486-a943-13dc1676a9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_c87c6b80-3daa-4486-a943-13dc1676a9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_f3da6f22-ba9a-4931-9ddd-331f7d952df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_f3da6f22-ba9a-4931-9ddd-331f7d952df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_ee1b9655-f97d-4424-af31-5920dfee9327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_ee1b9655-f97d-4424-af31-5920dfee9327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio_e0435209-24ad-41b0-95c8-4d3af83d6bc9" xlink:href="ci-20230331.xsd#ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:to="loc_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio_e0435209-24ad-41b0-95c8-4d3af83d6bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FinancingReceivableCreditQualityLoanToValueRatio_b9c7ffdb-21fe-46aa-95c9-6f0befc05f8c" xlink:href="ci-20230331.xsd#ci_FinancingReceivableCreditQualityLoanToValueRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f4b0f3ad-0814-413e-a0b9-14b95213f5c2" xlink:to="loc_ci_FinancingReceivableCreditQualityLoanToValueRatio_b9c7ffdb-21fe-46aa-95c9-6f0befc05f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_7f8b3dd7-d763-43da-a174-4643107103dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_29a57044-3775-46c5-80ef-e6bc8111628d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_7f8b3dd7-d763-43da-a174-4643107103dc" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_29a57044-3775-46c5-80ef-e6bc8111628d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_c38c52ab-9dec-4d35-a8e3-380bff1ebac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_29a57044-3775-46c5-80ef-e6bc8111628d" xlink:to="loc_us-gaap_InvestmentTypeAxis_c38c52ab-9dec-4d35-a8e3-380bff1ebac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_46ce1804-8de6-4353-9706-86953bdd27bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_c38c52ab-9dec-4d35-a8e3-380bff1ebac2" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_46ce1804-8de6-4353-9706-86953bdd27bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentMember_7a187182-e702-4bf6-8dbc-55740a7fc2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_46ce1804-8de6-4353-9706-86953bdd27bb" xlink:to="loc_us-gaap_RealEstateInvestmentMember_7a187182-e702-4bf6-8dbc-55740a7fc2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PartnershipInterestMember_9f061c27-6c00-4976-9e4d-75a44e45e0c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_PartnershipInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_46ce1804-8de6-4353-9706-86953bdd27bb" xlink:to="loc_srt_PartnershipInterestMember_9f061c27-6c00-4976-9e4d-75a44e45e0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_082e0dcc-29ad-402b-80ee-23a2cab1d64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_46ce1804-8de6-4353-9706-86953bdd27bb" xlink:to="loc_us-gaap_OtherInvestmentsMember_082e0dcc-29ad-402b-80ee-23a2cab1d64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_29a57044-3775-46c5-80ef-e6bc8111628d" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear_28d1afdd-fb98-441e-9262-95ef59cfb4e7" xlink:href="ci-20230331.xsd#ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:to="loc_ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear_28d1afdd-fb98-441e-9262-95ef59cfb4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_31d24a1e-b91f-4c27-9ffa-0cca845769b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_31d24a1e-b91f-4c27-9ffa-0cca845769b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_7b319e9e-6c2a-44c4-a696-e1110287be58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:to="loc_us-gaap_OtherLongTermInvestments_7b319e9e-6c2a-44c4-a696-e1110287be58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1af39b0e-08c1-4737-8576-3b0b4a649cc9" xlink:href="ci-20230331.xsd#ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:to="loc_ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_1af39b0e-08c1-4737-8576-3b0b4a649cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsToContributeAdditionalEquityAndCapital_558c877d-2f4a-434a-8eb1-ffe074a2bc73" xlink:href="ci-20230331.xsd#ci_CommitmentsToContributeAdditionalEquityAndCapital"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_2e833d6f-076c-4083-b7ee-b48fde3dcaeb" xlink:to="loc_ci_CommitmentsToContributeAdditionalEquityAndCapital_558c877d-2f4a-434a-8eb1-ffe074a2bc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsSummaryofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_e2e930fd-84a6-4afc-9587-eb2e8494ae41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c5bdbec7-7375-4c83-bebc-a719f67d058e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e2e930fd-84a6-4afc-9587-eb2e8494ae41" xlink:to="loc_us-gaap_DerivativeTable_c5bdbec7-7375-4c83-bebc-a719f67d058e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1af8cfb5-71b3-4d49-9d42-246075b08cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c5bdbec7-7375-4c83-bebc-a719f67d058e" xlink:to="loc_us-gaap_HedgingDesignationAxis_1af8cfb5-71b3-4d49-9d42-246075b08cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7d2582d9-caee-466d-95f8-825eec4468bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_1af8cfb5-71b3-4d49-9d42-246075b08cd2" xlink:to="loc_us-gaap_HedgingDesignationDomain_7d2582d9-caee-466d-95f8-825eec4468bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_92c98d7f-d62f-4c0c-9c66-bd7851d95a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_7d2582d9-caee-466d-95f8-825eec4468bc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_92c98d7f-d62f-4c0c-9c66-bd7851d95a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember_3bef384d-4ea7-470b-9c5f-ac8f2257e45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_7d2582d9-caee-466d-95f8-825eec4468bc" xlink:to="loc_us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember_3bef384d-4ea7-470b-9c5f-ac8f2257e45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2da7b04-e17f-4cb5-8701-cdd7b7cf689c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c5bdbec7-7375-4c83-bebc-a719f67d058e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2da7b04-e17f-4cb5-8701-cdd7b7cf689c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bdbc4a07-ce3c-4e70-bca6-07886a8a9748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2da7b04-e17f-4cb5-8701-cdd7b7cf689c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bdbc4a07-ce3c-4e70-bca6-07886a8a9748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_9cedee8c-36f0-4443-ae83-b7c29239992c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bdbc4a07-ce3c-4e70-bca6-07886a8a9748" xlink:to="loc_us-gaap_FairValueHedgingMember_9cedee8c-36f0-4443-ae83-b7c29239992c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d518f47b-4a37-4047-a023-6fb75255315d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bdbc4a07-ce3c-4e70-bca6-07886a8a9748" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d518f47b-4a37-4047-a023-6fb75255315d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_40a798c1-338b-4071-9a5c-dbd572fd7508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c5bdbec7-7375-4c83-bebc-a719f67d058e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_40a798c1-338b-4071-9a5c-dbd572fd7508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a1722524-1be5-4f9b-9acc-cce375e3fa77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_40a798c1-338b-4071-9a5c-dbd572fd7508" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a1722524-1be5-4f9b-9acc-cce375e3fa77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_bb5e0786-c45d-44a4-bb96-2817f7ed933b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a1722524-1be5-4f9b-9acc-cce375e3fa77" xlink:to="loc_us-gaap_CurrencySwapMember_bb5e0786-c45d-44a4-bb96-2817f7ed933b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e0ce76c9-9e76-4cc8-8f49-61d3aec536f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a1722524-1be5-4f9b-9acc-cce375e3fa77" xlink:to="loc_us-gaap_InterestRateSwapMember_e0ce76c9-9e76-4cc8-8f49-61d3aec536f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_243ef271-d00f-4f6f-bf27-5797157da247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c5bdbec7-7375-4c83-bebc-a719f67d058e" xlink:to="loc_us-gaap_DerivativeLineItems_243ef271-d00f-4f6f-bf27-5797157da247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_0940a32f-4a18-4268-97c6-21ef48988c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_243ef271-d00f-4f6f-bf27-5797157da247" xlink:to="loc_us-gaap_DerivativeNotionalAmount_0940a32f-4a18-4268-97c6-21ef48988c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_c8b19f27-a8a9-461c-aa6a-5d561fe4704f" xlink:href="ci-20230331.xsd#ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_243ef271-d00f-4f6f-bf27-5797157da247" xlink:to="loc_ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale_c8b19f27-a8a9-461c-aa6a-5d561fe4704f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsComponentsofNetInvestmentIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_InvestmentIncomeAndGainsAndLossesAbstract_7d99e59e-7bbe-41a7-8004-88fb05531bab" xlink:href="ci-20230331.xsd#ci_InvestmentIncomeAndGainsAndLossesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_e01242ad-92e9-4dcc-a0c4-3e95ce512a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InvestmentIncomeAndGainsAndLossesAbstract_7d99e59e-7bbe-41a7-8004-88fb05531bab" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_e01242ad-92e9-4dcc-a0c4-3e95ce512a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4da12ce7-044b-4c91-9935-671adabf0127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_e01242ad-92e9-4dcc-a0c4-3e95ce512a2a" xlink:to="loc_us-gaap_InvestmentTypeAxis_4da12ce7-044b-4c91-9935-671adabf0127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_4da12ce7-044b-4c91-9935-671adabf0127" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_af172443-a22e-41e3-b603-5a50d5469f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:to="loc_us-gaap_DebtSecuritiesMember_af172443-a22e-41e3-b603-5a50d5469f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_9d6de117-21ec-46ea-b36a-22cecd08575e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:to="loc_us-gaap_EquitySecuritiesMember_9d6de117-21ec-46ea-b36a-22cecd08575e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_71583217-96fb-45ea-8364-44f54c0a0b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:to="loc_us-gaap_MortgagesMember_71583217-96fb-45ea-8364-44f54c0a0b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyLoansMember_1f8a50c2-6f27-4154-b890-846070cc4e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyLoansMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:to="loc_us-gaap_PolicyLoansMember_1f8a50c2-6f27-4154-b890-846070cc4e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_f4afcf25-7bb5-4318-8485-8a6437b1897c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_f4afcf25-7bb5-4318-8485-8a6437b1897c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CashCashEquivalentsAndShortTermInvestmentsMember_1b12f986-a790-4eef-aaa2-31dad8b7b3c8" xlink:href="ci-20230331.xsd#ci_CashCashEquivalentsAndShortTermInvestmentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_0da2df2c-45fb-4000-85bd-b81389a137f4" xlink:to="loc_ci_CashCashEquivalentsAndShortTermInvestmentsMember_1b12f986-a790-4eef-aaa2-31dad8b7b3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_76a29f04-5ef7-4a10-a80f-be775f5de21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_e01242ad-92e9-4dcc-a0c4-3e95ce512a2a" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_76a29f04-5ef7-4a10-a80f-be775f5de21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue_fc5f04bb-c78a-4d9c-a0d2-f580c21589cd" xlink:href="ci-20230331.xsd#ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_76a29f04-5ef7-4a10-a80f-be775f5de21f" xlink:to="loc_ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue_fc5f04bb-c78a-4d9c-a0d2-f580c21589cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_9a5b084b-3da9-4f5c-8bd3-9dbc99f86ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_76a29f04-5ef7-4a10-a80f-be775f5de21f" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_9a5b084b-3da9-4f5c-8bd3-9dbc99f86ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_70e1cafa-799b-4332-920d-18d02ebc4ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_76a29f04-5ef7-4a10-a80f-be775f5de21f" xlink:to="loc_us-gaap_NetInvestmentIncome_70e1cafa-799b-4332-920d-18d02ebc4ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#InvestmentsRealizedGainsandLossesonInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_d7f8d415-cd88-4857-9504-383900b17322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLossExcludingImpairments_04c4cb19-a805-49eb-946a-68b5f165e31e" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLossExcludingImpairments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_d7f8d415-cd88-4857-9504-383900b17322" xlink:to="loc_ci_RealizedInvestmentGainLossExcludingImpairments_04c4cb19-a805-49eb-946a-68b5f165e31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal_d6a26088-bcb8-4f4b-b66f-e150fe9666a5" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_d7f8d415-cd88-4857-9504-383900b17322" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal_d6a26088-bcb8-4f4b-b66f-e150fe9666a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ImpairmentsOnInvestmentsTotal_fe7be2ec-1a02-4b95-9855-58f3ae4b11a9" xlink:href="ci-20230331.xsd#ci_ImpairmentsOnInvestmentsTotal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_d7f8d415-cd88-4857-9504-383900b17322" xlink:to="loc_ci_ImpairmentsOnInvestmentsTotal_fe7be2ec-1a02-4b95-9855-58f3ae4b11a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLoss_9592f117-df55-45fb-a13b-930318771351" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_d7f8d415-cd88-4857-9504-383900b17322" xlink:to="loc_ci_RealizedInvestmentGainLoss_9592f117-df55-45fb-a13b-930318771351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_44597255-201f-4e96-8d9e-ccf2e848aa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_44597255-201f-4e96-8d9e-ccf2e848aa4e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e5f25a1d-982a-4d4d-bc52-d977b01fd8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e5f25a1d-982a-4d4d-bc52-d977b01fd8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e5f25a1d-982a-4d4d-bc52-d977b01fd8ba" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_0f2cb5cf-8190-476a-824b-13a08e085b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_0f2cb5cf-8190-476a-824b-13a08e085b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f058e53c-cd20-4103-a311-6f02bc84ff5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f058e53c-cd20-4103-a311-6f02bc84ff5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_323f8681-c13d-45ae-8c16-15e5d6592258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_323f8681-c13d-45ae-8c16-15e5d6592258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_8d48114f-e8de-429f-ab12-8ecb11122655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_8d48114f-e8de-429f-ab12-8ecb11122655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_7d2bba9e-e02b-4f29-aade-ef2b176b65cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_794fe866-5b3f-4c8b-9b81-269ee08ab5c4" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_7d2bba9e-e02b-4f29-aade-ef2b176b65cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be315465-512b-44ee-8067-36ef91342b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be315465-512b-44ee-8067-36ef91342b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6181e5d7-3149-44a3-ba20-e4f6774bf944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_be315465-512b-44ee-8067-36ef91342b0f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6181e5d7-3149-44a3-ba20-e4f6774bf944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e5b5cfd7-60bd-4174-920d-a7bdf9916944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6181e5d7-3149-44a3-ba20-e4f6774bf944" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e5b5cfd7-60bd-4174-920d-a7bdf9916944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6b4d239c-561e-4ae1-b4d3-bef24af70ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6181e5d7-3149-44a3-ba20-e4f6774bf944" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6b4d239c-561e-4ae1-b4d3-bef24af70ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d5459f25-026f-4047-94cd-1d24faf5d9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6181e5d7-3149-44a3-ba20-e4f6774bf944" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d5459f25-026f-4047-94cd-1d24faf5d9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_225d1c2d-5500-4b3d-9b5c-eaf92ceaae6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_225d1c2d-5500-4b3d-9b5c-eaf92ceaae6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_77267339-be5c-4846-9305-9a5094580b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_225d1c2d-5500-4b3d-9b5c-eaf92ceaae6f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_77267339-be5c-4846-9305-9a5094580b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7c5cf837-0214-4ee5-bb7d-cf33f5d90c12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_77267339-be5c-4846-9305-9a5094580b99" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7c5cf837-0214-4ee5-bb7d-cf33f5d90c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_69527bd1-ac51-4e54-8712-846841d96581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_69527bd1-ac51-4e54-8712-846841d96581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9a54f1bc-86b5-4c1e-8b2f-1d3bd0a1bfd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_69527bd1-ac51-4e54-8712-846841d96581" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9a54f1bc-86b5-4c1e-8b2f-1d3bd0a1bfd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ForwardsSwapsOptionsMember_d6ed0037-1d8c-4fee-91a8-6db932110801" xlink:href="ci-20230331.xsd#ci_ForwardsSwapsOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a54f1bc-86b5-4c1e-8b2f-1d3bd0a1bfd6" xlink:to="loc_ci_ForwardsSwapsOptionsMember_d6ed0037-1d8c-4fee-91a8-6db932110801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwapMember_c1f38951-a5bf-4c6d-b84a-dbf3a07e559a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_ForwardsSwapsOptionsMember_d6ed0037-1d8c-4fee-91a8-6db932110801" xlink:to="loc_us-gaap_SwapMember_c1f38951-a5bf-4c6d-b84a-dbf3a07e559a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_92ead5af-926b-433d-8427-ab12d0838722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a639b019-2ea3-491d-ae21-c37f43ad3bae" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_92ead5af-926b-433d-8427-ab12d0838722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_92ead5af-926b-433d-8427-ab12d0838722" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71d22f6c-2ea6-4f00-bcb1-ef5bbf6e2c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71d22f6c-2ea6-4f00-bcb1-ef5bbf6e2c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_27a7db23-3975-487b-8f86-fcff8a2663a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_27a7db23-3975-487b-8f86-fcff8a2663a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermInvestments_3c561dea-273a-48a5-97de-391a9ea95e58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_us-gaap_OtherShortTermInvestments_3c561dea-273a-48a5-97de-391a9ea95e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_9521497f-5a93-4e9e-a9fb-fbe2768a55c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_us-gaap_DerivativeAssets_9521497f-5a93-4e9e-a9fb-fbe2768a55c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_68364c48-02c4-45a4-856a-8bcee96ea596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_68364c48-02c4-45a4-856a-8bcee96ea596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_724c3dfc-d1ea-494b-bd67-aeaa7b700d70" xlink:href="ci-20230331.xsd#ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_724c3dfc-d1ea-494b-bd67-aeaa7b700d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale_e2fc0a6d-ed55-495f-9883-57de189fe7d2" xlink:href="ci-20230331.xsd#ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale_e2fc0a6d-ed55-495f-9883-57de189fe7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_ee8b78f1-f5a4-4fcb-a6c3-6075e7b5e027" xlink:href="ci-20230331.xsd#ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale_ee8b78f1-f5a4-4fcb-a6c3-6075e7b5e027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_da1b7fd0-cb8b-4ee9-b40a-0fd86dfb00e3" xlink:href="ci-20230331.xsd#ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7e51ff37-225b-4e06-ad54-2401d74583a3" xlink:to="loc_ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_da1b7fd0-cb8b-4ee9-b40a-0fd86dfb00e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5b78b1d9-1330-4907-aba6-97c6996a87f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_92ead5af-926b-433d-8427-ab12d0838722" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5b78b1d9-1330-4907-aba6-97c6996a87f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_d422353a-143d-41ec-923a-3b371a18de02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5b78b1d9-1330-4907-aba6-97c6996a87f4" xlink:to="loc_us-gaap_DerivativeLiabilities_d422353a-143d-41ec-923a-3b371a18de02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale_eb477adc-17e1-4399-ab60-d6fb7c4a75c0" xlink:href="ci-20230331.xsd#ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5b78b1d9-1330-4907-aba6-97c6996a87f4" xlink:to="loc_ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale_eb477adc-17e1-4399-ab60-d6fb7c4a75c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bea07781-1f0d-482e-8067-9bad611d88c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bea07781-1f0d-482e-8067-9bad611d88c6" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88136f14-0956-4ac2-a9e1-7b0c8c06def7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88136f14-0956-4ac2-a9e1-7b0c8c06def7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ca31b6a-a76f-4751-86cf-14290e9ac035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88136f14-0956-4ac2-a9e1-7b0c8c06def7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ca31b6a-a76f-4751-86cf-14290e9ac035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_11f47f9e-32bf-4b54-a3dd-593dae0350fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ca31b6a-a76f-4751-86cf-14290e9ac035" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_11f47f9e-32bf-4b54-a3dd-593dae0350fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_62924400-8c39-4605-b1c3-9a4e53da446c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_62924400-8c39-4605-b1c3-9a4e53da446c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6ba50504-b0b9-466b-84f3-c970305cbdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_62924400-8c39-4605-b1c3-9a4e53da446c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6ba50504-b0b9-466b-84f3-c970305cbdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsMember_4949be65-6a94-46f4-8717-d4c3e0739511" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6ba50504-b0b9-466b-84f3-c970305cbdcd" xlink:to="loc_ci_SeparateAccountAssetsMember_4949be65-6a94-46f4-8717-d4c3e0739511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9cc604a-a143-418b-ac89-13aac624a5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9cc604a-a143-418b-ac89-13aac624a5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_09226758-93c7-46f7-a919-8fb4e2c096dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9cc604a-a143-418b-ac89-13aac624a5a3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_09226758-93c7-46f7-a919-8fb4e2c096dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f2a7f025-3ccb-4e4e-b646-c87a4b0d6de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_09226758-93c7-46f7-a919-8fb4e2c096dc" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f2a7f025-3ccb-4e4e-b646-c87a4b0d6de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_d0227a80-e097-40ac-a4f1-3a6a0f40bd34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_us-gaap_InvestmentTypeAxis_d0227a80-e097-40ac-a4f1-3a6a0f40bd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3e311f0f-dc52-4164-ae4a-aa26d0de92e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_d0227a80-e097-40ac-a4f1-3a6a0f40bd34" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3e311f0f-dc52-4164-ae4a-aa26d0de92e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PartnershipInterestMember_b80831e7-506b-4a7e-9f2d-a04c62c52b40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_PartnershipInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3e311f0f-dc52-4164-ae4a-aa26d0de92e4" xlink:to="loc_srt_PartnershipInterestMember_b80831e7-506b-4a7e-9f2d-a04c62c52b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b17f2947-6ee2-4fb9-9de7-1a9db66d8d5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_srt_RangeAxis_b17f2947-6ee2-4fb9-9de7-1a9db66d8d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19ff5450-a623-404c-9e79-9ec70e57a9fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b17f2947-6ee2-4fb9-9de7-1a9db66d8d5c" xlink:to="loc_srt_RangeMember_19ff5450-a623-404c-9e79-9ec70e57a9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d870af3c-882d-454e-b348-f37d684e7ada" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_19ff5450-a623-404c-9e79-9ec70e57a9fb" xlink:to="loc_srt_MaximumMember_d870af3c-882d-454e-b348-f37d684e7ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8f1486f6-2921-49f3-8e5e-13db345e2588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8f1486f6-2921-49f3-8e5e-13db345e2588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e26ff519-f505-44b3-8826-ad7acd49ea5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8f1486f6-2921-49f3-8e5e-13db345e2588" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e26ff519-f505-44b3-8826-ad7acd49ea5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwapMember_360573f0-1b6c-42cf-bbdd-b39de338a92e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e26ff519-f505-44b3-8826-ad7acd49ea5f" xlink:to="loc_us-gaap_SwapMember_360573f0-1b6c-42cf-bbdd-b39de338a92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e39ad1c3-53de-4af8-8d13-8658025529cc" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale_65fffec7-271a-4739-9f93-608e114fd800" xlink:href="ci-20230331.xsd#ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale_65fffec7-271a-4739-9f93-608e114fd800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale_f8d54690-8e61-4d5c-b3eb-acb30df75dbf" xlink:href="ci-20230331.xsd#ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale_f8d54690-8e61-4d5c-b3eb-acb30df75dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_3fe7f903-e15a-4a1b-b4e2-8c133dc9b260" xlink:href="ci-20230331.xsd#ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_3fe7f903-e15a-4a1b-b4e2-8c133dc9b260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage_d464022e-6f6f-4509-85bf-1e2e2631517f" xlink:href="ci-20230331.xsd#ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage_d464022e-6f6f-4509-85bf-1e2e2631517f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets_41a85811-79f1-4b2f-87b3-3eee053a7693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets_41a85811-79f1-4b2f-87b3-3eee053a7693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_8d0d2fe5-3aa6-4d2f-8832-aaa12bb6de34" xlink:href="ci-20230331.xsd#ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_8d0d2fe5-3aa6-4d2f-8832-aaa12bb6de34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities_fca40c7f-e5b3-425b-b838-7208734ff021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities_fca40c7f-e5b3-425b-b838-7208734ff021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_46bf6d60-bf10-4cbe-9aa1-9383f053700b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_46bf6d60-bf10-4cbe-9aa1-9383f053700b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups_9c8b3178-4436-4e65-b954-47de605ee36e" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups_9c8b3178-4436-4e65-b954-47de605ee36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception_43c1d20f-0cd7-4127-b89e-3769f03849ad" xlink:href="ci-20230331.xsd#ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8343e113-772f-42db-924d-5503c6030dd8" xlink:to="loc_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception_43c1d20f-0cd7-4127-b89e-3769f03849ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_050f34c6-66f8-4cb0-b722-33b40b0356a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_050f34c6-66f8-4cb0-b722-33b40b0356a6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_147a9d81-73c5-4449-8738-02925e3cd317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_147a9d81-73c5-4449-8738-02925e3cd317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_90a49a75-645d-4f2d-8db5-71e7f9050d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_147a9d81-73c5-4449-8738-02925e3cd317" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_90a49a75-645d-4f2d-8db5-71e7f9050d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_eff26177-35fd-4009-a8bb-8b9558ea2cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_90a49a75-645d-4f2d-8db5-71e7f9050d6c" xlink:to="loc_us-gaap_DebtSecuritiesMember_eff26177-35fd-4009-a8bb-8b9558ea2cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CorporateAndGovernmentDebtSecuritiesMember_d27133cc-3326-479b-aa9a-fb170ffa30e5" xlink:href="ci-20230331.xsd#ci_CorporateAndGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_eff26177-35fd-4009-a8bb-8b9558ea2cbb" xlink:to="loc_ci_CorporateAndGovernmentDebtSecuritiesMember_d27133cc-3326-479b-aa9a-fb170ffa30e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_e6f968f6-3792-4360-aaa2-29bf93d375ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_eff26177-35fd-4009-a8bb-8b9558ea2cbb" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_e6f968f6-3792-4360-aaa2-29bf93d375ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_7f6054c5-0872-40d2-adc1-a7d7a45a5aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_eff26177-35fd-4009-a8bb-8b9558ea2cbb" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_7f6054c5-0872-40d2-adc1-a7d7a45a5aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_0f551f4f-e22e-4ee7-948e-e24ad02f8a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_us-gaap_ValuationTechniqueAxis_0f551f4f-e22e-4ee7-948e-e24ad02f8a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_79fe8340-ec43-4667-8f11-30c08dc80334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_0f551f4f-e22e-4ee7-948e-e24ad02f8a52" xlink:to="loc_us-gaap_ValuationTechniqueDomain_79fe8340-ec43-4667-8f11-30c08dc80334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnobservableInputsDevelopedByCompanyMember_b28cf900-0470-4152-b37b-8674b71c4ce8" xlink:href="ci-20230331.xsd#ci_UnobservableInputsDevelopedByCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_79fe8340-ec43-4667-8f11-30c08dc80334" xlink:to="loc_ci_UnobservableInputsDevelopedByCompanyMember_b28cf900-0470-4152-b37b-8674b71c4ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_UnobservableInputsNotDevelopedByCompanyMember_e0803c26-d1bc-4d61-9b8c-7063b87f895b" xlink:href="ci-20230331.xsd#ci_UnobservableInputsNotDevelopedByCompanyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_79fe8340-ec43-4667-8f11-30c08dc80334" xlink:to="loc_ci_UnobservableInputsNotDevelopedByCompanyMember_e0803c26-d1bc-4d61-9b8c-7063b87f895b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968b93ae-a701-4bd0-8828-23a48a03b394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968b93ae-a701-4bd0-8828-23a48a03b394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_514afe6e-65c2-4c0b-a3d4-ea29b122ee2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_968b93ae-a701-4bd0-8828-23a48a03b394" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_514afe6e-65c2-4c0b-a3d4-ea29b122ee2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_07a7f021-7721-49e9-b534-6e9ffbaf4b70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_514afe6e-65c2-4c0b-a3d4-ea29b122ee2b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_07a7f021-7721-49e9-b534-6e9ffbaf4b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec0db558-4c5a-4ae0-aee2-15a86b78c013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec0db558-4c5a-4ae0-aee2-15a86b78c013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bffd0354-7a6f-4f0a-9f5f-902556c75250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec0db558-4c5a-4ae0-aee2-15a86b78c013" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bffd0354-7a6f-4f0a-9f5f-902556c75250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_dacfc57d-2a20-449f-a55f-b9ed663783a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bffd0354-7a6f-4f0a-9f5f-902556c75250" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_dacfc57d-2a20-449f-a55f-b9ed663783a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_99308cba-bdfd-4342-876c-69e1c47b2a64" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_srt_RangeAxis_99308cba-bdfd-4342-876c-69e1c47b2a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_39ab071b-b56f-4a25-ac6d-cdf118a64857" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_99308cba-bdfd-4342-876c-69e1c47b2a64" xlink:to="loc_srt_RangeMember_39ab071b-b56f-4a25-ac6d-cdf118a64857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_429bd2cc-6a9a-4c09-852b-8c9949e40840" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_39ab071b-b56f-4a25-ac6d-cdf118a64857" xlink:to="loc_srt_MinimumMember_429bd2cc-6a9a-4c09-852b-8c9949e40840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a742ded0-6229-45d0-898e-d622aefa0145" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_39ab071b-b56f-4a25-ac6d-cdf118a64857" xlink:to="loc_srt_MaximumMember_a742ded0-6229-45d0-898e-d622aefa0145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_440b0cdc-9b7d-4d57-b550-57ed121acfe9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_39ab071b-b56f-4a25-ac6d-cdf118a64857" xlink:to="loc_srt_WeightedAverageMember_440b0cdc-9b7d-4d57-b550-57ed121acfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_7d38e5df-99ed-4712-ae54-08761f78ab25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_7d38e5df-99ed-4712-ae54-08761f78ab25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_d36bad20-82f9-46f9-9fa6-91ac04383b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7d38e5df-99ed-4712-ae54-08761f78ab25" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_d36bad20-82f9-46f9-9fa6-91ac04383b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MeasurementInputLiquidityMember_69c79599-b79c-4475-888a-f0e5f819a928" xlink:href="ci-20230331.xsd#ci_MeasurementInputLiquidityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_d36bad20-82f9-46f9-9fa6-91ac04383b49" xlink:to="loc_ci_MeasurementInputLiquidityMember_69c79599-b79c-4475-888a-f0e5f819a928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9b9bf55-20c4-4995-8ce6-13f6d55b3c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_a2cb740e-4764-4226-b5af-a05a8868d64d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9b9bf55-20c4-4995-8ce6-13f6d55b3c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_31f4a7c8-83c9-4e81-81ec-5ab489796cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9b9bf55-20c4-4995-8ce6-13f6d55b3c6b" xlink:to="loc_us-gaap_MarketableSecurities_31f4a7c8-83c9-4e81-81ec-5ab489796cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_25c08cce-1d84-4334-90b6-0f18563e75a2" xlink:href="ci-20230331.xsd#ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9b9bf55-20c4-4995-8ce6-13f6d55b3c6b" xlink:to="loc_ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale_25c08cce-1d84-4334-90b6-0f18563e75a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput_a40c060f-1e2b-44e3-9955-36d911e567d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9b9bf55-20c4-4995-8ce6-13f6d55b3c6b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput_a40c060f-1e2b-44e3-9955-36d911e567d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput_7134ccb0-63f1-43c1-a8aa-58e8bbea9932" xlink:href="ci-20230331.xsd#ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9b9bf55-20c4-4995-8ce6-13f6d55b3c6b" xlink:to="loc_ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput_7134ccb0-63f1-43c1-a8aa-58e8bbea9932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5ca65c7e-b8dc-422b-884b-bb60086b51cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_25866057-e550-4082-a56d-6a44d1bd7e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5ca65c7e-b8dc-422b-884b-bb60086b51cf" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_25866057-e550-4082-a56d-6a44d1bd7e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_115a98a5-9044-4fc2-ada4-2acf446d21ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_25866057-e550-4082-a56d-6a44d1bd7e9b" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_115a98a5-9044-4fc2-ada4-2acf446d21ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1fce55ed-f94d-48cf-a8ba-cbfeb1f76353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_115a98a5-9044-4fc2-ada4-2acf446d21ab" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1fce55ed-f94d-48cf-a8ba-cbfeb1f76353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DebtAndEquitySecuritiesMember_1568cf08-1f27-4457-89a6-f7ddadaba20f" xlink:href="ci-20230331.xsd#ci_DebtAndEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1fce55ed-f94d-48cf-a8ba-cbfeb1f76353" xlink:to="loc_ci_DebtAndEquitySecuritiesMember_1568cf08-1f27-4457-89a6-f7ddadaba20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b142b19-52d8-4527-8858-73c5c908a1da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_25866057-e550-4082-a56d-6a44d1bd7e9b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b142b19-52d8-4527-8858-73c5c908a1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee44fc0d-cfd9-4e23-9b08-2bdc467cab15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b142b19-52d8-4527-8858-73c5c908a1da" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee44fc0d-cfd9-4e23-9b08-2bdc467cab15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b7ba6273-59cd-4de6-a37a-c222f204e873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee44fc0d-cfd9-4e23-9b08-2bdc467cab15" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b7ba6273-59cd-4de6-a37a-c222f204e873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_efedf546-3a13-422d-954d-86980a8ceb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_25866057-e550-4082-a56d-6a44d1bd7e9b" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_efedf546-3a13-422d-954d-86980a8ceb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_efedf546-3a13-422d-954d-86980a8ceb8a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_907b287c-a73b-4717-9792-caeca861425d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_907b287c-a73b-4717-9792-caeca861425d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_8f4253e7-334a-44c7-9676-a9df50ef5eed" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_8f4253e7-334a-44c7-9676-a9df50ef5eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_5aa8c365-7131-4197-81db-3151bb93a8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_5aa8c365-7131-4197-81db-3151bb93a8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ea97ab82-6f63-4ff5-99ee-a16317605f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ea97ab82-6f63-4ff5-99ee-a16317605f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits_bde58c26-559f-46a6-98ea-21ef5a4c70a4" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits_bde58c26-559f-46a6-98ea-21ef5a4c70a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_9b69dda7-98a9-4e08-ba8c-ba780b09781d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_9b69dda7-98a9-4e08-ba8c-ba780b09781d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_6d2c3d7c-b780-4dbb-9823-4a893f6ddd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_9b69dda7-98a9-4e08-ba8c-ba780b09781d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_6d2c3d7c-b780-4dbb-9823-4a893f6ddd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_6f60cdaf-ec60-4968-94f5-8097cb668b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_9b69dda7-98a9-4e08-ba8c-ba780b09781d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_6f60cdaf-ec60-4968-94f5-8097cb668b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_391e8149-500c-44c3-aa85-17ed81e17f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_9b69dda7-98a9-4e08-ba8c-ba780b09781d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_391e8149-500c-44c3-aa85-17ed81e17f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_b15fda92-e277-42e0-92fd-c83bede083b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract_9b69dda7-98a9-4e08-ba8c-ba780b09781d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_b15fda92-e277-42e0-92fd-c83bede083b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract_e918896d-463d-499e-b44b-f116ae8289c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract_e918896d-463d-499e-b44b-f116ae8289c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_344ded81-6bc0-4419-9260-140b17ffa937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract_e918896d-463d-499e-b44b-f116ae8289c1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_344ded81-6bc0-4419-9260-140b17ffa937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2611db21-f2ea-49d7-a9c7-b18f8fc3e225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract_e918896d-463d-499e-b44b-f116ae8289c1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2611db21-f2ea-49d7-a9c7-b18f8fc3e225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_c534f4b7-27f0-48d2-b616-858e510db194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract_e918896d-463d-499e-b44b-f116ae8289c1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_c534f4b7-27f0-48d2-b616-858e510db194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_ef2b6834-3d7e-4b89-9a45-33e069e476a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_ef2b6834-3d7e-4b89-9a45-33e069e476a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_b3afeea9-0ecd-4c77-91f8-3e8723dd785e" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_972d7a30-48a2-494e-afc4-836ba9716f7c" xlink:to="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale_b3afeea9-0ecd-4c77-91f8-3e8723dd785e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings_978b007f-4858-40be-991e-c49608547b76" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_efedf546-3a13-422d-954d-86980a8ceb8a" xlink:to="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings_978b007f-4858-40be-991e-c49608547b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss_154e8236-018f-4e03-9e62-87f9fe412296" xlink:href="ci-20230331.xsd#ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_efedf546-3a13-422d-954d-86980a8ceb8a" xlink:to="loc_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss_154e8236-018f-4e03-9e62-87f9fe412296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_05f07810-0e52-42e5-8436-c586dbd18e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09e2ef60-80ea-4675-ab43-6af3b3a2edb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_05f07810-0e52-42e5-8436-c586dbd18e91" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09e2ef60-80ea-4675-ab43-6af3b3a2edb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c53982aa-61df-4977-b909-bc5522a51b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09e2ef60-80ea-4675-ab43-6af3b3a2edb5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c53982aa-61df-4977-b909-bc5522a51b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28319a20-9f99-48e6-9e77-f477d7201619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c53982aa-61df-4977-b909-bc5522a51b61" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28319a20-9f99-48e6-9e77-f477d7201619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_63836775-ec8e-4e44-890c-965939109097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28319a20-9f99-48e6-9e77-f477d7201619" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_63836775-ec8e-4e44-890c-965939109097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7151eb0e-9674-478c-a123-36580d7b4e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28319a20-9f99-48e6-9e77-f477d7201619" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7151eb0e-9674-478c-a123-36580d7b4e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ba1c5b40-afa3-4ba9-8847-ecced99d0b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28319a20-9f99-48e6-9e77-f477d7201619" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ba1c5b40-afa3-4ba9-8847-ecced99d0b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_87ef7d87-65ba-4ba7-a22f-08c1981172fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09e2ef60-80ea-4675-ab43-6af3b3a2edb5" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_87ef7d87-65ba-4ba7-a22f-08c1981172fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_39fdbe27-bbbc-486d-97e0-a943f306a8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_87ef7d87-65ba-4ba7-a22f-08c1981172fe" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_39fdbe27-bbbc-486d-97e0-a943f306a8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_1d66078e-bf32-4aa4-a713-2baf19cc93a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_39fdbe27-bbbc-486d-97e0-a943f306a8f4" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_1d66078e-bf32-4aa4-a713-2baf19cc93a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09e2ef60-80ea-4675-ab43-6af3b3a2edb5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GuaranteedSeparateAccountAssets_9bb36bdd-b88a-4bac-892f-1fd47a801b56" xlink:href="ci-20230331.xsd#ci_GuaranteedSeparateAccountAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_GuaranteedSeparateAccountAssets_9bb36bdd-b88a-4bac-892f-1fd47a801b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy_1aa30cbf-abbd-4b37-9a24-dd77d3c5e1ce" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy_1aa30cbf-abbd-4b37-9a24-dd77d3c5e1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy_948b1fe2-846d-42b7-a83e-26a5f67456b2" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsClassifiedInFairValueHierarchy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy_948b1fe2-846d-42b7-a83e-26a5f67456b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_dd922d04-60a3-4569-b2f9-8d520e9f7603" xlink:href="ci-20230331.xsd#ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_dd922d04-60a3-4569-b2f9-8d520e9f7603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_444e370c-8a7d-42e4-acd9-afccc8967eaa" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_444e370c-8a7d-42e4-acd9-afccc8967eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_4aa05d2c-a432-477f-829e-a7f4d2db942d" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale_4aa05d2c-a432-477f-829e-a7f4d2db942d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient_06616834-05f9-4f21-8648-20976c3befbd" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient_06616834-05f9-4f21-8648-20976c3befbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale_34949d63-ec0d-45c8-9676-97403b57907b" xlink:href="ci-20230331.xsd#ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale_34949d63-ec0d-45c8-9676-97403b57907b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_df81a2a0-2991-4d9e-8e9f-eb9f8b4bf259" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale_df81a2a0-2991-4d9e-8e9f-eb9f8b4bf259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent_e29b00f8-6388-4400-a6dc-d6f53d7ef0c8" xlink:href="ci-20230331.xsd#ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent_e29b00f8-6388-4400-a6dc-d6f53d7ef0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_61e293f6-52b6-47e0-954d-4fd52cd795d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_95414fb0-6125-4a62-9da6-0db7b5b2b699" xlink:to="loc_us-gaap_SeparateAccountAssets_61e293f6-52b6-47e0-954d-4fd52cd795d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails_1" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails_1"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_371f976c-0136-4738-80a4-a13e480a3c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_371f976c-0136-4738-80a4-a13e480a3c6c" xlink:to="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_045d49f7-f217-4ac9-a0e4-d64f8fb12fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:to="loc_us-gaap_InvestmentTypeAxis_045d49f7-f217-4ac9-a0e4-d64f8fb12fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_13dc0bc9-8aed-47ce-87ca-5cea3790c255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_045d49f7-f217-4ac9-a0e4-d64f8fb12fbc" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_13dc0bc9-8aed-47ce-87ca-5cea3790c255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PartnershipInterestMember_de1def97-eee2-4a2c-9e16-f1d5840893c0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_PartnershipInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_13dc0bc9-8aed-47ce-87ca-5cea3790c255" xlink:to="loc_srt_PartnershipInterestMember_de1def97-eee2-4a2c-9e16-f1d5840893c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_3202fc30-ac93-44fa-86e6-9923f671ef5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_13dc0bc9-8aed-47ce-87ca-5cea3790c255" xlink:to="loc_us-gaap_RealEstateFundsMember_3202fc30-ac93-44fa-86e6-9923f671ef5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_74904e82-6f1b-487a-8640-00e724347052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_13dc0bc9-8aed-47ce-87ca-5cea3790c255" xlink:to="loc_us-gaap_HedgeFundsMember_74904e82-6f1b-487a-8640-00e724347052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_5f9b152f-d758-4a89-bd96-c2bf90bfce02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_5f9b152f-d758-4a89-bd96-c2bf90bfce02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f8c340e5-1232-4038-9e3d-59440b7b8d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_5f9b152f-d758-4a89-bd96-c2bf90bfce02" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f8c340e5-1232-4038-9e3d-59440b7b8d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SeparateAccountAssetsMember_23075229-bcbf-413b-bd6f-4eac36436f2c" xlink:href="ci-20230331.xsd#ci_SeparateAccountAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f8c340e5-1232-4038-9e3d-59440b7b8d8c" xlink:to="loc_ci_SeparateAccountAssetsMember_23075229-bcbf-413b-bd6f-4eac36436f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d9a6b38b-550f-4f40-a2b3-8cf06028e1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d9a6b38b-550f-4f40-a2b3-8cf06028e1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_369f0bc7-886b-4a59-866f-b3fc1ad6b01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d9a6b38b-550f-4f40-a2b3-8cf06028e1f3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_369f0bc7-886b-4a59-866f-b3fc1ad6b01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_62805e1f-4c1a-43b4-81b2-fa95160bef18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_369f0bc7-886b-4a59-866f-b3fc1ad6b01d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_62805e1f-4c1a-43b4-81b2-fa95160bef18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f00bb521-7a91-40c4-8018-2070da72d010" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:to="loc_srt_RangeAxis_f00bb521-7a91-40c4-8018-2070da72d010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4077dca9-eebe-490d-a75e-ad5ed01fe4fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f00bb521-7a91-40c4-8018-2070da72d010" xlink:to="loc_srt_RangeMember_4077dca9-eebe-490d-a75e-ad5ed01fe4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ceec75ca-5620-4664-9a37-56b9efc42f2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4077dca9-eebe-490d-a75e-ad5ed01fe4fb" xlink:to="loc_srt_MinimumMember_ceec75ca-5620-4664-9a37-56b9efc42f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a7dfcc1a-7eba-42b6-ba6c-ec1dca4cec5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4077dca9-eebe-490d-a75e-ad5ed01fe4fb" xlink:to="loc_srt_MaximumMember_a7dfcc1a-7eba-42b6-ba6c-ec1dca4cec5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a466fa5-1e13-40c7-8dbd-48fd5ffc4b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a466fa5-1e13-40c7-8dbd-48fd5ffc4b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84ca8b60-3c3b-4d7f-af88-edb31e5f1101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a466fa5-1e13-40c7-8dbd-48fd5ffc4b2f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84ca8b60-3c3b-4d7f-af88-edb31e5f1101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_9bd176b3-d44b-4c5c-a2ea-d4685f2d83d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84ca8b60-3c3b-4d7f-af88-edb31e5f1101" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_9bd176b3-d44b-4c5c-a2ea-d4685f2d83d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_3cc2369f-f556-4caa-91e1-b2c4a77a7dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_e2512bab-284d-4fba-8509-4231189780a6" xlink:to="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_3cc2369f-f556-4caa-91e1-b2c4a77a7dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AlternativeInvestment_1bea1d29-d034-48cb-9fb4-7f60491e8fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AlternativeInvestment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_3cc2369f-f556-4caa-91e1-b2c4a77a7dc9" xlink:to="loc_us-gaap_AlternativeInvestment_1bea1d29-d034-48cb-9fb4-7f60491e8fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale_c5584cea-935a-4abf-b39e-be92716366c8" xlink:href="ci-20230331.xsd#ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_3cc2369f-f556-4caa-91e1-b2c4a77a7dc9" xlink:to="loc_ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale_c5584cea-935a-4abf-b39e-be92716366c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments_a3e33b2e-d97e-4654-b04c-982ac48fc9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_3cc2369f-f556-4caa-91e1-b2c4a77a7dc9" xlink:to="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments_a3e33b2e-d97e-4654-b04c-982ac48fc9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1_e57c2328-4b0b-4619-a5e3-28a9a6c31f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_3cc2369f-f556-4caa-91e1-b2c4a77a7dc9" xlink:to="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1_e57c2328-4b0b-4619-a5e3-28a9a6c31f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_86aec0b4-9e46-448b-9b64-abda987956f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ab50f602-beaf-4459-b533-237847b11887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_86aec0b4-9e46-448b-9b64-abda987956f7" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ab50f602-beaf-4459-b533-237847b11887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_db257854-69c3-46da-a47a-0383d714a24e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ab50f602-beaf-4459-b533-237847b11887" xlink:to="loc_srt_RangeAxis_db257854-69c3-46da-a47a-0383d714a24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ef89ce5b-b366-43a1-9298-3a4b82d8ab07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_db257854-69c3-46da-a47a-0383d714a24e" xlink:to="loc_srt_RangeMember_ef89ce5b-b366-43a1-9298-3a4b82d8ab07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_633cd355-64ce-4f15-8896-b1bf68a30ff1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ef89ce5b-b366-43a1-9298-3a4b82d8ab07" xlink:to="loc_srt_MaximumMember_633cd355-64ce-4f15-8896-b1bf68a30ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_55f41a57-dace-41ed-aba3-bf3f4378f086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ab50f602-beaf-4459-b533-237847b11887" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_55f41a57-dace-41ed-aba3-bf3f4378f086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue_fb2f6c91-fc55-40d0-9cc1-f183d4055880" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_55f41a57-dace-41ed-aba3-bf3f4378f086" xlink:to="loc_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue_fb2f6c91-fc55-40d0-9cc1-f183d4055880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_0c90ac97-bcbc-47ba-8c7f-239b439cba0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_55f41a57-dace-41ed-aba3-bf3f4378f086" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_0c90ac97-bcbc-47ba-8c7f-239b439cba0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_3acd2118-12d3-4e1f-8da2-39711ba38c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_86aec0b4-9e46-448b-9b64-abda987956f7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_3acd2118-12d3-4e1f-8da2-39711ba38c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ff19e7c2-025b-41ce-8d80-69b30967d641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2c5703a6-1399-429d-a1e3-1e16735f657d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ff19e7c2-025b-41ce-8d80-69b30967d641" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2c5703a6-1399-429d-a1e3-1e16735f657d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d3718796-8879-483a-b754-66c951c6b9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2c5703a6-1399-429d-a1e3-1e16735f657d" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d3718796-8879-483a-b754-66c951c6b9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e0584557-c6b2-4ce1-9933-88a9795deaef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d3718796-8879-483a-b754-66c951c6b9d1" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e0584557-c6b2-4ce1-9933-88a9795deaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a38a34a9-3aa3-4e04-89ff-9b4e1d70b58f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e0584557-c6b2-4ce1-9933-88a9795deaef" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a38a34a9-3aa3-4e04-89ff-9b4e1d70b58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_11086ce8-272d-4102-901d-7b83c887b435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a38a34a9-3aa3-4e04-89ff-9b4e1d70b58f" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_11086ce8-272d-4102-901d-7b83c887b435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_93b6e99b-4e4e-4f93-a2c1-6a71480c92b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a38a34a9-3aa3-4e04-89ff-9b4e1d70b58f" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_93b6e99b-4e4e-4f93-a2c1-6a71480c92b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_301f6a50-3288-4137-8e83-dc9392fb962d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2c5703a6-1399-429d-a1e3-1e16735f657d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_301f6a50-3288-4137-8e83-dc9392fb962d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20092e64-2bc9-4226-8b81-349440867964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_301f6a50-3288-4137-8e83-dc9392fb962d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20092e64-2bc9-4226-8b81-349440867964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_bc861317-194b-4ba5-a692-da6bf3a534ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20092e64-2bc9-4226-8b81-349440867964" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_bc861317-194b-4ba5-a692-da6bf3a534ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_037de924-2f8f-4a35-a1b0-ca23dc5afb76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20092e64-2bc9-4226-8b81-349440867964" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_037de924-2f8f-4a35-a1b0-ca23dc5afb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1552cda3-b875-45f9-8770-91fe850fe2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2c5703a6-1399-429d-a1e3-1e16735f657d" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1552cda3-b875-45f9-8770-91fe850fe2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_f39512f1-4d95-4160-96ec-4e0d1887e2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1552cda3-b875-45f9-8770-91fe850fe2e9" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_f39512f1-4d95-4160-96ec-4e0d1887e2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_04b47791-e303-4de7-a482-81c6e4921f15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1552cda3-b875-45f9-8770-91fe850fe2e9" xlink:to="loc_us-gaap_LongTermDebtFairValue_04b47791-e303-4de7-a482-81c6e4921f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#VariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/VariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ci_VariableInterestEntitiesAbstract_0a9dd010-fdad-4d28-ba3e-62b4dcff954d" xlink:href="ci-20230331.xsd#ci_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_VariableInterestEntitiesAbstract_0a9dd010-fdad-4d28-ba3e-62b4dcff954d" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_468f4c97-ee63-4d11-bda6-849bf40f7234" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:to="loc_srt_ConsolidatedEntitiesAxis_468f4c97-ee63-4d11-bda6-849bf40f7234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_aea70bca-650f-4054-b135-a01d2c004a45" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_468f4c97-ee63-4d11-bda6-849bf40f7234" xlink:to="loc_srt_ConsolidatedEntitiesDomain_aea70bca-650f-4054-b135-a01d2c004a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_d290f50e-ff14-45ec-a882-b946b78253c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_aea70bca-650f-4054-b135-a01d2c004a45" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_d290f50e-ff14-45ec-a882-b946b78253c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_dff20884-f975-4c2b-86dd-e3a2980ca28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_aea70bca-650f-4054-b135-a01d2c004a45" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_dff20884-f975-4c2b-86dd-e3a2980ca28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_c2eea955-b00e-49d9-ad4b-e7e61125d325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:to="loc_us-gaap_OtherCommitmentsAxis_c2eea955-b00e-49d9-ad4b-e7e61125d325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_743c8853-33e2-4570-bdcc-734c3182d082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_c2eea955-b00e-49d9-ad4b-e7e61125d325" xlink:to="loc_us-gaap_OtherCommitmentsDomain_743c8853-33e2-4570-bdcc-734c3182d082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentToFundPartnershipMember_485c9734-9cca-4287-9e61-edeea6a592f2" xlink:href="ci-20230331.xsd#ci_CommitmentToFundPartnershipMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_743c8853-33e2-4570-bdcc-734c3182d082" xlink:to="loc_ci_CommitmentToFundPartnershipMember_485c9734-9cca-4287-9e61-edeea6a592f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ef220171-5c57-4e71-878c-5cff51226768" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ef220171-5c57-4e71-878c-5cff51226768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_446dc013-f1df-44e7-ba51-5b8a56d0345b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ef220171-5c57-4e71-878c-5cff51226768" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_446dc013-f1df-44e7-ba51-5b8a56d0345b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember_8293a1c8-5854-4d46-a7b3-0ee9fdbaf58c" xlink:href="ci-20230331.xsd#ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_446dc013-f1df-44e7-ba51-5b8a56d0345b" xlink:to="loc_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember_8293a1c8-5854-4d46-a7b3-0ee9fdbaf58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_a4fc9471-9073-42b4-800e-63172e47aeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:to="loc_us-gaap_InvestmentTypeAxis_a4fc9471-9073-42b4-800e-63172e47aeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_63a977f6-7f79-4a1e-bcaf-ce5c12cd56bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_a4fc9471-9073-42b4-800e-63172e47aeb1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_63a977f6-7f79-4a1e-bcaf-ce5c12cd56bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember_e2c9ead7-a515-401f-b6c6-12763458ac88" xlink:href="ci-20230331.xsd#ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_63a977f6-7f79-4a1e-bcaf-ce5c12cd56bf" xlink:to="loc_ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember_e2c9ead7-a515-401f-b6c6-12763458ac88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealEstateJointVenturesMember_0c3611f6-aec7-4d06-a132-663edad922f1" xlink:href="ci-20230331.xsd#ci_RealEstateJointVenturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_63a977f6-7f79-4a1e-bcaf-ce5c12cd56bf" xlink:to="loc_ci_RealEstateJointVenturesMember_0c3611f6-aec7-4d06-a132-663edad922f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AssetBackedAndCorporateSecuritiesMember_52dcf388-e3b6-4307-9f79-1471cbb57b05" xlink:href="ci-20230331.xsd#ci_AssetBackedAndCorporateSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_63a977f6-7f79-4a1e-bcaf-ce5c12cd56bf" xlink:to="loc_ci_AssetBackedAndCorporateSecuritiesMember_52dcf388-e3b6-4307-9f79-1471cbb57b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherVariableInterestEntitiesMember_bc129023-4539-4423-b2de-026503486ce0" xlink:href="ci-20230331.xsd#ci_OtherVariableInterestEntitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_63a977f6-7f79-4a1e-bcaf-ce5c12cd56bf" xlink:to="loc_ci_OtherVariableInterestEntitiesMember_bc129023-4539-4423-b2de-026503486ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_be192c06-efb7-447b-8895-3146907d0b92" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:to="loc_srt_RangeAxis_be192c06-efb7-447b-8895-3146907d0b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_84f32e9c-a077-41ca-a135-9ef9e2d2c146" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_be192c06-efb7-447b-8895-3146907d0b92" xlink:to="loc_srt_RangeMember_84f32e9c-a077-41ca-a135-9ef9e2d2c146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c8fc2f36-e1e0-4509-a1d7-b4f1a6e74958" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_84f32e9c-a077-41ca-a135-9ef9e2d2c146" xlink:to="loc_srt_MaximumMember_c8fc2f36-e1e0-4509-a1d7-b4f1a6e74958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_25234243-d87a-4e32-8b3f-2846148b611d" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_VariableInterestEntitiesNumberOfEntities_ae297f31-8383-4d0f-aa3c-94cfaddf3d57" xlink:href="ci-20230331.xsd#ci_VariableInterestEntitiesNumberOfEntities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_ci_VariableInterestEntitiesNumberOfEntities_ae297f31-8383-4d0f-aa3c-94cfaddf3d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity_cb57c8f3-ef0f-4cbf-8c9d-7fd1dbed93ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestInVariableInterestEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity_cb57c8f3-ef0f-4cbf-8c9d-7fd1dbed93ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_378cc0d2-97ab-41f2-8be5-7595e60c5af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_OtherCommitment_378cc0d2-97ab-41f2-8be5-7595e60c5af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_a34771e0-f635-437c-ba52-ea364bfd818a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_a34771e0-f635-437c-ba52-ea364bfd818a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_87ebe571-fefb-4383-ad80-4248c2996a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_87ebe571-fefb-4383-ad80-4248c2996a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_363ecaec-41a5-492c-ac5f-2a977c861f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_GuarantyLiabilities_363ecaec-41a5-492c-ac5f-2a977c861f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_9e95f8f5-03e8-4462-adfe-8875201d30a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_22f79483-9276-4839-880e-0cb7b6c40deb" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_9e95f8f5-03e8-4462-adfe-8875201d30a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_e069bed1-2b6a-4edc-9017-bd74587f8016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_25db35fc-5ee5-45e5-a43f-d2da3531daac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_e069bed1-2b6a-4edc-9017-bd74587f8016" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_25db35fc-5ee5-45e5-a43f-d2da3531daac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_52cce4f3-61a0-462a-ae25-a4d6924f26b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_25db35fc-5ee5-45e5-a43f-d2da3531daac" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_52cce4f3-61a0-462a-ae25-a4d6924f26b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d0c14053-a4d8-4488-a671-388758b63fab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_52cce4f3-61a0-462a-ae25-a4d6924f26b8" xlink:to="loc_us-gaap_EquityComponentDomain_d0c14053-a4d8-4488-a671-388758b63fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fe9b6a9-3b97-40a2-8e31-215a829b4f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d0c14053-a4d8-4488-a671-388758b63fab" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fe9b6a9-3b97-40a2-8e31-215a829b4f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember_b7612a84-f0ab-4bcb-a3aa-4d6931e1b965" xlink:href="ci-20230331.xsd#ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fe9b6a9-3b97-40a2-8e31-215a829b4f6e" xlink:to="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember_b7612a84-f0ab-4bcb-a3aa-4d6931e1b965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember_0726f12c-c224-4fff-be24-5107b942008d" xlink:href="ci-20230331.xsd#ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember_b7612a84-f0ab-4bcb-a3aa-4d6931e1b965" xlink:to="loc_ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember_0726f12c-c224-4fff-be24-5107b942008d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_1d5ec43f-1204-4dac-8220-69bea20cd2a5" xlink:href="ci-20230331.xsd#ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fe9b6a9-3b97-40a2-8e31-215a829b4f6e" xlink:to="loc_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_1d5ec43f-1204-4dac-8220-69bea20cd2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitParentMember_a0c056c2-4eb3-426e-b624-01268d811333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_1d5ec43f-1204-4dac-8220-69bea20cd2a5" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitParentMember_a0c056c2-4eb3-426e-b624-01268d811333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_2af843ad-b46b-4109-9d75-2941387c87b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_1d5ec43f-1204-4dac-8220-69bea20cd2a5" xlink:to="loc_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember_2af843ad-b46b-4109-9d75-2941387c87b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_22e5c968-31c0-42f1-9827-6ac181fad6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fe9b6a9-3b97-40a2-8e31-215a829b4f6e" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_22e5c968-31c0-42f1-9827-6ac181fad6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_c7ea3cd3-d330-4873-96bf-bff1b5e8829e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember_22e5c968-31c0-42f1-9827-6ac181fad6bd" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_c7ea3cd3-d330-4873-96bf-bff1b5e8829e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember_f7d6de74-bd30-4476-b31e-f002d91343b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember_22e5c968-31c0-42f1-9827-6ac181fad6bd" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember_f7d6de74-bd30-4476-b31e-f002d91343b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2bae7e9e-600d-4ad0-b335-c6dcee06b5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fe9b6a9-3b97-40a2-8e31-215a829b4f6e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2bae7e9e-600d-4ad0-b335-c6dcee06b5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_8bee1232-83b9-4885-b74c-faeb85756c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2bae7e9e-600d-4ad0-b335-c6dcee06b5b0" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_8bee1232-83b9-4885-b74c-faeb85756c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_134da573-fe38-42a8-b31b-4b66f3803f4d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_25db35fc-5ee5-45e5-a43f-d2da3531daac" xlink:to="loc_srt_RestatementAxis_134da573-fe38-42a8-b31b-4b66f3803f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c40a0bd5-fd2c-40a6-b5e3-0bd58025ab25" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_134da573-fe38-42a8-b31b-4b66f3803f4d" xlink:to="loc_srt_RestatementDomain_c40a0bd5-fd2c-40a6-b5e3-0bd58025ab25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_37db99e2-030b-4f8a-a6f6-7200b50b7f51" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_c40a0bd5-fd2c-40a6-b5e3-0bd58025ab25" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_37db99e2-030b-4f8a-a6f6-7200b50b7f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_1a6082e0-a70d-4c0c-a0ef-dc686f5bcd79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_c40a0bd5-fd2c-40a6-b5e3-0bd58025ab25" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_1a6082e0-a70d-4c0c-a0ef-dc686f5bcd79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_25db35fc-5ee5-45e5-a43f-d2da3531daac" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_32b5b072-2d44-4464-a4ff-1346521e3db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_32b5b072-2d44-4464-a4ff-1346521e3db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_e0a282c1-daec-43dd-890e-a487aadb824f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_e0a282c1-daec-43dd-890e-a487aadb824f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e709aace-52d0-48bb-b5a1-b73a3a91c3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e709aace-52d0-48bb-b5a1-b73a3a91c3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c1d4aedc-be59-4a27-895b-57e86789fa91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c1d4aedc-be59-4a27-895b-57e86789fa91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity_643cfcd7-b271-4ccb-8454-e69735cc8037" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity_643cfcd7-b271-4ccb-8454-e69735cc8037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity_8603c43c-b0f9-48f7-b92b-ee364564d1e2" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity_8603c43c-b0f9-48f7-b92b-ee364564d1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity_e5e148fd-03bf-42a7-82ac-6eaaa85ae143" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity_e5e148fd-03bf-42a7-82ac-6eaaa85ae143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_d748117f-acaa-4b41-bcde-2b107ff702ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_d748117f-acaa-4b41-bcde-2b107ff702ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_cddedc00-d9e0-4641-bc40-684e0134b36f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_cddedc00-d9e0-4641-bc40-684e0134b36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3553e175-a480-4df3-a657-324120486dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3553e175-a480-4df3-a657-324120486dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity_939ee074-6151-446d-abc4-42ce1e675760" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity_939ee074-6151-446d-abc4-42ce1e675760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity_21211ec2-2a97-4c72-9eb1-99c47a3c75de" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity_21211ec2-2a97-4c72-9eb1-99c47a3c75de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_b394d91b-5c5b-483c-891d-236671d54f0e" xlink:href="ci-20230331.xsd#ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity_b394d91b-5c5b-483c-891d-236671d54f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TemporaryEquityOtherComprehensiveIncome_c80b83cb-3df5-47fc-9592-d0835762382e" xlink:href="ci-20230331.xsd#ci_TemporaryEquityOtherComprehensiveIncome"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_ci_TemporaryEquityOtherComprehensiveIncome_c80b83cb-3df5-47fc-9592-d0835762382e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d6f9d30d-3f8f-48f0-a79d-ffb25ef36b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d6f9d30d-3f8f-48f0-a79d-ffb25ef36b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5bcde693-2d7c-41eb-8f4c-6d87e936ac3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7efdfc57-9978-4c14-80eb-6672852b6851" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5bcde693-2d7c-41eb-8f4c-6d87e936ac3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails_1" xlink:type="simple" xlink:href="ci-20230331.xsd#AccumulatedOtherComprehensiveIncomeLossDetails_1"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6f1a165e-982b-4c07-8e6b-6667cbd55c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d08aaa6-1fe4-46a7-a75b-389489a35607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6f1a165e-982b-4c07-8e6b-6667cbd55c5d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d08aaa6-1fe4-46a7-a75b-389489a35607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules_da5b9166-84a1-4838-9a76-1f45e22fdcd1" xlink:href="ci-20230331.xsd#ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6f1a165e-982b-4c07-8e6b-6667cbd55c5d" xlink:to="loc_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules_da5b9166-84a1-4838-9a76-1f45e22fdcd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_07dbe472-b2bb-473a-bda9-2e4e42597afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6f1a165e-982b-4c07-8e6b-6667cbd55c5d" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_07dbe472-b2bb-473a-bda9-2e4e42597afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#ContingenciesandOtherMattersDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f0d08e42-ec34-4485-b3b4-adb8a76bb8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:href="ci-20230331.xsd#ci_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f0d08e42-ec34-4485-b3b4-adb8a76bb8ea" xlink:to="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f6fdb115-eb34-4271-8455-31211b9a2750" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:to="loc_srt_ProductOrServiceAxis_f6fdb115-eb34-4271-8455-31211b9a2750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1e27e639-3bdc-48dc-b30a-4a0fec693fa3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f6fdb115-eb34-4271-8455-31211b9a2750" xlink:to="loc_srt_ProductsAndServicesDomain_1e27e639-3bdc-48dc-b30a-4a0fec693fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RetirementAndLifeInsuranceContractsMember_7585ae86-4eee-41fe-9cd5-5a0ab87a6a65" xlink:href="ci-20230331.xsd#ci_RetirementAndLifeInsuranceContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e27e639-3bdc-48dc-b30a-4a0fec693fa3" xlink:to="loc_ci_RetirementAndLifeInsuranceContractsMember_7585ae86-4eee-41fe-9cd5-5a0ab87a6a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_d0db33e4-eb04-4840-9e50-202630bf3f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_d0db33e4-eb04-4840-9e50-202630bf3f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_3d0a256f-d111-4856-9a03-185f6414c9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_d0db33e4-eb04-4840-9e50-202630bf3f39" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_3d0a256f-d111-4856-9a03-185f6414c9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeMember_24e9a345-a6a1-420f-bc31-78d07bf7f989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_3d0a256f-d111-4856-9a03-185f6414c9fd" xlink:to="loc_us-gaap_FinancialGuaranteeMember_24e9a345-a6a1-420f-bc31-78d07bf7f989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember_dd3876f1-6854-49d6-a86b-99d9584c8f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_3d0a256f-d111-4856-9a03-185f6414c9fd" xlink:to="loc_us-gaap_IndemnificationGuaranteeMember_dd3876f1-6854-49d6-a86b-99d9584c8f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f338cade-41f6-40bd-8db6-43c3800ddea5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:to="loc_srt_LitigationCaseAxis_f338cade-41f6-40bd-8db6-43c3800ddea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1a43f734-64c2-43f7-a271-19457539882f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_f338cade-41f6-40bd-8db6-43c3800ddea5" xlink:to="loc_srt_LitigationCaseTypeDomain_1a43f734-64c2-43f7-a271-19457539882f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ExpressScriptsLitigationWithAnthemMember_29b5b62e-313e-4099-a365-aa5f8cc69d80" xlink:href="ci-20230331.xsd#ci_ExpressScriptsLitigationWithAnthemMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1a43f734-64c2-43f7-a271-19457539882f" xlink:to="loc_ci_ExpressScriptsLitigationWithAnthemMember_29b5b62e-313e-4099-a365-aa5f8cc69d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ExpressScriptsCounterclaimsAgainstElevanceMember_422f4bed-057b-4741-ade3-f4d9922a7ec1" xlink:href="ci-20230331.xsd#ci_ExpressScriptsCounterclaimsAgainstElevanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_ExpressScriptsLitigationWithAnthemMember_29b5b62e-313e-4099-a365-aa5f8cc69d80" xlink:to="loc_ci_ExpressScriptsCounterclaimsAgainstElevanceMember_422f4bed-057b-4741-ade3-f4d9922a7ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_f38b27f7-353b-4bbd-9639-18f7c3c39ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:to="loc_us-gaap_LitigationStatusAxis_f38b27f7-353b-4bbd-9639-18f7c3c39ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_5535a00d-09a8-4053-bc79-c44ad019ce9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_f38b27f7-353b-4bbd-9639-18f7c3c39ab7" xlink:to="loc_us-gaap_LitigationStatusDomain_5535a00d-09a8-4053-bc79-c44ad019ce9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember_fea57c9f-a84d-464b-8f71-8107a147eeca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_JudicialRulingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_5535a00d-09a8-4053-bc79-c44ad019ce9e" xlink:to="loc_us-gaap_JudicialRulingMember_fea57c9f-a84d-464b-8f71-8107a147eeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_3f289045-b038-4834-a016-f7340cec2ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_5535a00d-09a8-4053-bc79-c44ad019ce9e" xlink:to="loc_us-gaap_PendingLitigationMember_3f289045-b038-4834-a016-f7340cec2ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8cce109f-5407-41d0-b13c-dc0fd244de5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8cce109f-5407-41d0-b13c-dc0fd244de5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_df6a1189-296d-4362-8aef-a2f8e8731574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8cce109f-5407-41d0-b13c-dc0fd244de5c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_df6a1189-296d-4362-8aef-a2f8e8731574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PricingConcessionsMember_eb430388-1df3-4ab1-9a35-401a7998140e" xlink:href="ci-20230331.xsd#ci_PricingConcessionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_df6a1189-296d-4362-8aef-a2f8e8731574" xlink:to="loc_ci_PricingConcessionsMember_eb430388-1df3-4ab1-9a35-401a7998140e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PricingConcessionsThroughRemainingContractTermMember_6cd4a013-890d-49ab-b487-a975d55e0c4c" xlink:href="ci-20230331.xsd#ci_PricingConcessionsThroughRemainingContractTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_PricingConcessionsMember_eb430388-1df3-4ab1-9a35-401a7998140e" xlink:to="loc_ci_PricingConcessionsThroughRemainingContractTermMember_6cd4a013-890d-49ab-b487-a975d55e0c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PricingConcessionsAfterRemainingTermOfAgreementMember_e39fdcc3-eeb2-485d-82b9-125913c658f0" xlink:href="ci-20230331.xsd#ci_PricingConcessionsAfterRemainingTermOfAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_PricingConcessionsMember_eb430388-1df3-4ab1-9a35-401a7998140e" xlink:to="loc_ci_PricingConcessionsAfterRemainingTermOfAgreementMember_e39fdcc3-eeb2-485d-82b9-125913c658f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_DamagesForServiceIssuesMember_3631dcb9-124a-4f71-998d-27c224569932" xlink:href="ci-20230331.xsd#ci_DamagesForServiceIssuesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_df6a1189-296d-4362-8aef-a2f8e8731574" xlink:to="loc_ci_DamagesForServiceIssuesMember_3631dcb9-124a-4f71-998d-27c224569932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRelatedAssessmentsMember_cbb577db-b59f-4b14-b7c7-871d761d3566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceRelatedAssessmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_df6a1189-296d-4362-8aef-a2f8e8731574" xlink:to="loc_us-gaap_InsuranceRelatedAssessmentsMember_cbb577db-b59f-4b14-b7c7-871d761d3566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_LitigationMattersAndRegulatoryMattersMember_0a828178-d27b-491e-ab2e-2b6dd3bc5fd6" xlink:href="ci-20230331.xsd#ci_LitigationMattersAndRegulatoryMattersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_df6a1189-296d-4362-8aef-a2f8e8731574" xlink:to="loc_ci_LitigationMattersAndRegulatoryMattersMember_0a828178-d27b-491e-ab2e-2b6dd3bc5fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:href="ci-20230331.xsd#ci_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesTable_1c328da6-1caa-4736-805f-d36380c6e17e" xlink:to="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_f0022205-d345-4dd2-88da-e3668829653b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_f0022205-d345-4dd2-88da-e3668829653b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLiquidationProceeds_a9fb3be1-166a-4e00-892c-4c119a2d9586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsLiquidationProceeds"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_GuaranteeObligationsLiquidationProceeds_a9fb3be1-166a-4e00-892c-4c119a2d9586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_93f59468-ed77-4bd0-ab75-01b62cff8eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_93f59468-ed77-4bd0-ab75-01b62cff8eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_a33ed27f-e2be-4264-bac1-a481db8460a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_a33ed27f-e2be-4264-bac1-a481db8460a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_87476b1a-784f-4f1b-b2e7-21a1956ebf0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_87476b1a-784f-4f1b-b2e7-21a1956ebf0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_396720bf-e6e4-4cc2-afe9-59e7e210bd9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_396720bf-e6e4-4cc2-afe9-59e7e210bd9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_5a33f3cb-bee4-4fef-a2cc-e0580fb86f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_5a33f3cb-bee4-4fef-a2cc-e0580fb86f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_9517b786-ed9b-4fe2-a02b-9442e7c18e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_9517b786-ed9b-4fe2-a02b-9442e7c18e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsAndContingenciesNumberOfExpert_e6e281cb-995b-4bee-8af0-a4c9d85030d9" xlink:href="ci-20230331.xsd#ci_CommitmentsAndContingenciesNumberOfExpert"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_ci_CommitmentsAndContingenciesNumberOfExpert_e6e281cb-995b-4bee-8af0-a4c9d85030d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert_6264ed2e-2583-40a9-bfef-afba60313c6d" xlink:href="ci-20230331.xsd#ci_CommitmentsAndContingenciesNumberOfAdditionalExpert"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CommitmentsAndContingenciesLineItems_98363751-5808-4fe8-b232-94f04b63b81b" xlink:to="loc_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert_6264ed2e-2583-40a9-bfef-afba60313c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SegmentInformationSummaryofSpecialItemsDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_86d484da-7092-4fba-8402-5633b957c06d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemsBeforeTaxAbstract_744da5af-4f21-476a-b6f7-a42e111b2f18" xlink:href="ci-20230331.xsd#ci_SpecialItemsBeforeTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_86d484da-7092-4fba-8402-5633b957c06d" xlink:to="loc_ci_SpecialItemsBeforeTaxAbstract_744da5af-4f21-476a-b6f7-a42e111b2f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TransactionRelatedCosts_d5638fae-cd21-47dd-9709-0490b4237b66" xlink:href="ci-20230331.xsd#ci_TransactionRelatedCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_744da5af-4f21-476a-b6f7-a42e111b2f18" xlink:to="loc_ci_TransactionRelatedCosts_d5638fae-cd21-47dd-9709-0490b4237b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_edb8523b-d531-4a03-a4d7-a9ed70422cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_744da5af-4f21-476a-b6f7-a42e111b2f18" xlink:to="loc_us-gaap_RestructuringCharges_edb8523b-d531-4a03-a4d7-a9ed70422cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OrganizationalEfficiencyPlanCharges_96e878ed-5a8f-4c55-8264-67465c0ab502" xlink:href="ci-20230331.xsd#ci_OrganizationalEfficiencyPlanCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_744da5af-4f21-476a-b6f7-a42e111b2f18" xlink:to="loc_ci_OrganizationalEfficiencyPlanCharges_96e878ed-5a8f-4c55-8264-67465c0ab502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemChargeBenefitBeforeTaxLitigation_545e408e-2379-4b02-8313-3f0d9777faa4" xlink:href="ci-20230331.xsd#ci_SpecialItemChargeBenefitBeforeTaxLitigation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_744da5af-4f21-476a-b6f7-a42e111b2f18" xlink:to="loc_ci_SpecialItemChargeBenefitBeforeTaxLitigation_545e408e-2379-4b02-8313-3f0d9777faa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes_1a1db3de-74e1-4040-90b1-251c013f428f" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_744da5af-4f21-476a-b6f7-a42e111b2f18" xlink:to="loc_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes_1a1db3de-74e1-4040-90b1-251c013f428f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax_c0f7a5ba-a7fd-4848-8440-405f9b1b2256" xlink:href="ci-20230331.xsd#ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_744da5af-4f21-476a-b6f7-a42e111b2f18" xlink:to="loc_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax_c0f7a5ba-a7fd-4848-8440-405f9b1b2256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes_8b22adad-e232-4f87-99ed-2f34d1ec720b" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_744da5af-4f21-476a-b6f7-a42e111b2f18" xlink:to="loc_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes_8b22adad-e232-4f87-99ed-2f34d1ec720b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes_996822f7-c5d9-40ba-957d-d1ef7658ca0a" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_744da5af-4f21-476a-b6f7-a42e111b2f18" xlink:to="loc_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes_996822f7-c5d9-40ba-957d-d1ef7658ca0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity_3e739e62-03d7-4042-9310-9299d9e2a80d" xlink:href="ci-20230331.xsd#ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_744da5af-4f21-476a-b6f7-a42e111b2f18" xlink:to="loc_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity_3e739e62-03d7-4042-9310-9299d9e2a80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemsAfterTaxAbstract_60a3904e-2c9b-4e8f-92db-d6be8d6b1917" xlink:href="ci-20230331.xsd#ci_SpecialItemsAfterTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_86d484da-7092-4fba-8402-5633b957c06d" xlink:to="loc_ci_SpecialItemsAfterTaxAbstract_60a3904e-2c9b-4e8f-92db-d6be8d6b1917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TransactionRelatedCostsAfterTax_672aa14d-f6dd-4d7e-8b43-e5b7df1542cd" xlink:href="ci-20230331.xsd#ci_TransactionRelatedCostsAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsAfterTaxAbstract_60a3904e-2c9b-4e8f-92db-d6be8d6b1917" xlink:to="loc_ci_TransactionRelatedCostsAfterTax_672aa14d-f6dd-4d7e-8b43-e5b7df1542cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RestructuringChargesNetOfTaxExpense_a0e8949f-0e94-4073-911a-03e670c32281" xlink:href="ci-20230331.xsd#ci_RestructuringChargesNetOfTaxExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsAfterTaxAbstract_60a3904e-2c9b-4e8f-92db-d6be8d6b1917" xlink:to="loc_ci_RestructuringChargesNetOfTaxExpense_a0e8949f-0e94-4073-911a-03e670c32281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OrganizationalEfficiencyPlanChargesNetOfTax_8a5d9844-d2ec-48db-9ee5-101ebc7a2343" xlink:href="ci-20230331.xsd#ci_OrganizationalEfficiencyPlanChargesNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsAfterTaxAbstract_60a3904e-2c9b-4e8f-92db-d6be8d6b1917" xlink:to="loc_ci_OrganizationalEfficiencyPlanChargesNetOfTax_8a5d9844-d2ec-48db-9ee5-101ebc7a2343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemChargeBenefitAfterTaxLitigation_b5d96ab0-1307-4d1a-adb3-ebba9244d155" xlink:href="ci-20230331.xsd#ci_SpecialItemChargeBenefitAfterTaxLitigation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsAfterTaxAbstract_60a3904e-2c9b-4e8f-92db-d6be8d6b1917" xlink:to="loc_ci_SpecialItemChargeBenefitAfterTaxLitigation_b5d96ab0-1307-4d1a-adb3-ebba9244d155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax_81492e1a-0b47-4ecb-8774-34145101ae17" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsAfterTaxAbstract_60a3904e-2c9b-4e8f-92db-d6be8d6b1917" xlink:to="loc_ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax_81492e1a-0b47-4ecb-8774-34145101ae17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax_7ea04ed9-ae5c-4e69-955a-f989f43f51e1" xlink:href="ci-20230331.xsd#ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsAfterTaxAbstract_60a3904e-2c9b-4e8f-92db-d6be8d6b1917" xlink:to="loc_ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax_7ea04ed9-ae5c-4e69-955a-f989f43f51e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax_9549e7b1-5385-4ac1-af18-2a8d41e912f2" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsAfterTaxAbstract_60a3904e-2c9b-4e8f-92db-d6be8d6b1917" xlink:to="loc_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax_9549e7b1-5385-4ac1-af18-2a8d41e912f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossFromContractAdjustmentNetOfTax_23719536-0476-4760-aff7-3746f97bf9cc" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossFromContractAdjustmentNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsAfterTaxAbstract_60a3904e-2c9b-4e8f-92db-d6be8d6b1917" xlink:to="loc_ci_SpecialItemGainLossFromContractAdjustmentNetOfTax_23719536-0476-4760-aff7-3746f97bf9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity_2f789693-9c6a-4b49-b788-af7c330cf5dc" xlink:href="ci-20230331.xsd#ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsAfterTaxAbstract_60a3904e-2c9b-4e8f-92db-d6be8d6b1917" xlink:to="loc_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity_2f789693-9c6a-4b49-b788-af7c330cf5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SegmentInformationSummarizedSegmentFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5cb10788-37d8-47cf-b908-2c9be1fbdd44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29a7deb9-c7ca-4657-9b29-06c4ce9f06ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5cb10788-37d8-47cf-b908-2c9be1fbdd44" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29a7deb9-c7ca-4657-9b29-06c4ce9f06ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b45ccf70-5c02-40f3-9104-a2a6a951ca0a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29a7deb9-c7ca-4657-9b29-06c4ce9f06ee" xlink:to="loc_srt_ConsolidationItemsAxis_b45ccf70-5c02-40f3-9104-a2a6a951ca0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0a137f70-1107-457f-a4f0-ed8d26bd450e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b45ccf70-5c02-40f3-9104-a2a6a951ca0a" xlink:to="loc_srt_ConsolidationItemsDomain_0a137f70-1107-457f-a4f0-ed8d26bd450e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6b1c09d4-32c5-4e7e-8eac-5fc9d9d64a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_0a137f70-1107-457f-a4f0-ed8d26bd450e" xlink:to="loc_us-gaap_OperatingSegmentsMember_6b1c09d4-32c5-4e7e-8eac-5fc9d9d64a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CorporateAndEliminationsMember_e84b43c1-557f-4028-a1ee-f6075f5a9919" xlink:href="ci-20230331.xsd#ci_CorporateAndEliminationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_0a137f70-1107-457f-a4f0-ed8d26bd450e" xlink:to="loc_ci_CorporateAndEliminationsMember_e84b43c1-557f-4028-a1ee-f6075f5a9919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f544fbe9-825f-4bdd-a470-f6d325dce40a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CorporateAndEliminationsMember_e84b43c1-557f-4028-a1ee-f6075f5a9919" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f544fbe9-825f-4bdd-a470-f6d325dce40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_beefc1d8-8558-4a74-9d47-4c38f44c2433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_CorporateAndEliminationsMember_e84b43c1-557f-4028-a1ee-f6075f5a9919" xlink:to="loc_us-gaap_IntersegmentEliminationMember_beefc1d8-8558-4a74-9d47-4c38f44c2433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0045dd6a-0419-4774-9803-f74984aeefbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29a7deb9-c7ca-4657-9b29-06c4ce9f06ee" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0045dd6a-0419-4774-9803-f74984aeefbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9267f97a-3456-4478-9365-65307401d7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0045dd6a-0419-4774-9803-f74984aeefbe" xlink:to="loc_us-gaap_SegmentDomain_9267f97a-3456-4478-9365-65307401d7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EvernorthMember_bc011df4-addf-4d71-8b2c-12ca7cb640e2" xlink:href="ci-20230331.xsd#ci_EvernorthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9267f97a-3456-4478-9365-65307401d7f0" xlink:to="loc_ci_EvernorthMember_bc011df4-addf-4d71-8b2c-12ca7cb640e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_2d1940c1-c305-4c72-9480-ea951f393a2d" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9267f97a-3456-4478-9365-65307401d7f0" xlink:to="loc_ci_CignaHealthcareMember_2d1940c1-c305-4c72-9480-ea951f393a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember_068bae7c-d881-420f-b8d2-458b4dea9f8d" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9267f97a-3456-4478-9365-65307401d7f0" xlink:to="loc_ci_OtherOperationsSegmentMember_068bae7c-d881-420f-b8d2-458b4dea9f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29a7deb9-c7ca-4657-9b29-06c4ce9f06ee" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonInvestmentRevenue_59e76e20-acba-42a4-b753-2cab3e3c05bf" xlink:href="ci-20230331.xsd#ci_NonInvestmentRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_ci_NonInvestmentRevenue_59e76e20-acba-42a4-b753-2cab3e3c05bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_f8645065-54ee-4261-81af-0ce9f385869d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_us-gaap_NetInvestmentIncome_f8645065-54ee-4261-81af-0ce9f385869d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ab1ed9e4-d367-4887-bb54-f61e7be46613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_us-gaap_Revenues_ab1ed9e4-d367-4887-bb54-f61e7be46613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainsLossesEquityMethodInvestments_ecb729b7-ac20-4641-a32f-5a1c7c8c0465" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainsLossesEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_ci_RealizedInvestmentGainsLossesEquityMethodInvestments_ecb729b7-ac20-4641-a32f-5a1c7c8c0465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SegmentRevenues_20c65cdb-a4b9-491b-a2b2-bc446fde17bc" xlink:href="ci-20230331.xsd#ci_SegmentRevenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_ci_SegmentRevenues_20c65cdb-a4b9-491b-a2b2-bc446fde17bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4fe716ec-d521-4840-9514-75bb8611d08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4fe716ec-d521-4840-9514-75bb8611d08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_25672801-06c6-44e3-953d-d99ef7c5d6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_25672801-06c6-44e3-953d-d99ef7c5d6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:href="ci-20230331.xsd#ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3344ea4f-05cc-44d0-b204-646ea6afe732" xlink:to="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax_55e85744-9dbb-420a-91d6-57f8b33629a6" xlink:href="ci-20230331.xsd#ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:to="loc_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax_55e85744-9dbb-420a-91d6-57f8b33629a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries_3866f815-c9ac-4051-80dd-cf77101dcba2" xlink:href="ci-20230331.xsd#ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:to="loc_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries_3866f815-c9ac-4051-80dd-cf77101dcba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a00d2589-83f3-426a-a67d-208845df8c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a00d2589-83f3-426a-a67d-208845df8c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:href="ci-20230331.xsd#ci_SpecialItemsBeforeTaxAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:to="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_TransactionRelatedCosts_330cda8f-dd36-468a-8ec1-0e2a948c3ad8" xlink:href="ci-20230331.xsd#ci_TransactionRelatedCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_TransactionRelatedCosts_330cda8f-dd36-468a-8ec1-0e2a948c3ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_86430f46-ad01-4921-ab38-dac7927afedd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_us-gaap_RestructuringCharges_86430f46-ad01-4921-ab38-dac7927afedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OrganizationalEfficiencyPlanCharges_266f1e63-9aed-4941-b1bf-8b5bb1554a5b" xlink:href="ci-20230331.xsd#ci_OrganizationalEfficiencyPlanCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_OrganizationalEfficiencyPlanCharges_266f1e63-9aed-4941-b1bf-8b5bb1554a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemChargeBenefitBeforeTaxLitigation_bddc5c8c-2ab2-4254-887c-9f29e80d2366" xlink:href="ci-20230331.xsd#ci_SpecialItemChargeBenefitBeforeTaxLitigation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_SpecialItemChargeBenefitBeforeTaxLitigation_bddc5c8c-2ab2-4254-887c-9f29e80d2366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes_755d0b17-26c0-4e34-8083-6e013c12e0f9" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes_755d0b17-26c0-4e34-8083-6e013c12e0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax_203f6df9-b406-46df-8829-4357564c9070" xlink:href="ci-20230331.xsd#ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax_203f6df9-b406-46df-8829-4357564c9070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes_d9e8b127-b87d-4539-9346-f2efb404a85b" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes_d9e8b127-b87d-4539-9346-f2efb404a85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes_d3744923-4b65-4266-b6d0-1dfbc09fdc1e" xlink:href="ci-20230331.xsd#ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_SpecialItemsBeforeTaxAbstract_da4c5bcb-fb27-41e6-8bd6-3a5e01a1fe69" xlink:to="loc_ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes_d3744923-4b65-4266-b6d0-1dfbc09fdc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_446821ca-a5fe-43b9-a61b-268022024883" xlink:href="ci-20230331.xsd#ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract_c18fd9fe-926d-41c2-9708-067e305d85f1" xlink:to="loc_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_446821ca-a5fe-43b9-a61b-268022024883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SegmentInformationRevenuefromExternalCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d8f19bdd-580a-4699-8f52-3be091261a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d8f19bdd-580a-4699-8f52-3be091261a5c" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_39421d7d-5c8b-4055-baa8-f6beea2d1d26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:to="loc_srt_ProductOrServiceAxis_39421d7d-5c8b-4055-baa8-f6beea2d1d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5508126a-bf44-42b9-91d5-d3b4eef04499" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_39421d7d-5c8b-4055-baa8-f6beea2d1d26" xlink:to="loc_srt_ProductsAndServicesDomain_5508126a-bf44-42b9-91d5-d3b4eef04499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_d41e3419-bdf1-43db-aa65-1a6e93c5e154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5508126a-bf44-42b9-91d5-d3b4eef04499" xlink:to="loc_us-gaap_ProductMember_d41e3419-bdf1-43db-aa65-1a6e93c5e154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NetworkPharmacyMember_782eefab-361e-45c7-a235-d7b19242ddd2" xlink:href="ci-20230331.xsd#ci_NetworkPharmacyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_d41e3419-bdf1-43db-aa65-1a6e93c5e154" xlink:to="loc_ci_NetworkPharmacyMember_782eefab-361e-45c7-a235-d7b19242ddd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_HomeDeliveryAndSpecialtyMember_24146718-6df2-436a-9ba7-1155e011f74a" xlink:href="ci-20230331.xsd#ci_HomeDeliveryAndSpecialtyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_d41e3419-bdf1-43db-aa65-1a6e93c5e154" xlink:to="loc_ci_HomeDeliveryAndSpecialtyMember_24146718-6df2-436a-9ba7-1155e011f74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherPharmacyMember_22c001ce-40ed-470e-911a-558985ff2b4b" xlink:href="ci-20230331.xsd#ci_OtherPharmacyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_d41e3419-bdf1-43db-aa65-1a6e93c5e154" xlink:to="loc_ci_OtherPharmacyMember_22c001ce-40ed-470e-911a-558985ff2b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:href="ci-20230331.xsd#ci_USMedicalProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5508126a-bf44-42b9-91d5-d3b4eef04499" xlink:to="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MedicalRiskProductsMember_dc89312f-bb42-49ca-a5b2-a373f7715509" xlink:href="ci-20230331.xsd#ci_MedicalRiskProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_MedicalRiskProductsMember_dc89312f-bb42-49ca-a5b2-a373f7715509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_StopLossMember_024e08ef-66cb-44f0-9514-b46e92170996" xlink:href="ci-20230331.xsd#ci_StopLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_StopLossMember_024e08ef-66cb-44f0-9514-b46e92170996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherCommercialMedicalProductsMember_8ef27d38-f3e5-4bd0-acd5-1fbbc03ea8c1" xlink:href="ci-20230331.xsd#ci_OtherCommercialMedicalProductsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_OtherCommercialMedicalProductsMember_8ef27d38-f3e5-4bd0-acd5-1fbbc03ea8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MedicareAdvantageMember_1607d60e-7c38-40c6-b2e6-ecb2d2a77ce5" xlink:href="ci-20230331.xsd#ci_MedicareAdvantageMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_MedicareAdvantageMember_1607d60e-7c38-40c6-b2e6-ecb2d2a77ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_MedicarePartDMember_2324980c-2be1-406e-81fa-b0bf673ff1c9" xlink:href="ci-20230331.xsd#ci_MedicarePartDMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_MedicarePartDMember_2324980c-2be1-406e-81fa-b0bf673ff1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherGovernmentProductsMember_a5c59398-890f-4080-a02d-407261172148" xlink:href="ci-20230331.xsd#ci_OtherGovernmentProductsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_OtherGovernmentProductsMember_a5c59398-890f-4080-a02d-407261172148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IndividualAndFamilyPlansShortDurationMember_abeb8d00-57e7-4baa-82fd-8d2c2b25c158" xlink:href="ci-20230331.xsd#ci_IndividualAndFamilyPlansShortDurationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_OtherGovernmentProductsMember_a5c59398-890f-4080-a02d-407261172148" xlink:to="loc_ci_IndividualAndFamilyPlansShortDurationMember_abeb8d00-57e7-4baa-82fd-8d2c2b25c158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember_ec5db7e3-7a7e-499e-9a16-1349a5b2a4bd" xlink:href="ci-20230331.xsd#ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_OtherGovernmentProductsMember_a5c59398-890f-4080-a02d-407261172148" xlink:to="loc_ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember_ec5db7e3-7a7e-499e-9a16-1349a5b2a4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalHealthMember_36c94562-46ff-4130-a695-06d9b26974bd" xlink:href="ci-20230331.xsd#ci_InternationalHealthMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_USMedicalProductsMember_66fcbcc4-5970-42eb-b1cc-4e460f09a7aa" xlink:to="loc_ci_InternationalHealthMember_36c94562-46ff-4130-a695-06d9b26974bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GroupMedicalInsuranceShortDurationMember_8d7f73b9-12ba-432a-8bf6-d8ddd1c57dda" xlink:href="ci-20230331.xsd#ci_GroupMedicalInsuranceShortDurationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InternationalHealthMember_36c94562-46ff-4130-a695-06d9b26974bd" xlink:to="loc_ci_GroupMedicalInsuranceShortDurationMember_8d7f73b9-12ba-432a-8bf6-d8ddd1c57dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_IndividualPrivateMedicalInsuranceLongDurationMember_dd2ebce2-a61b-4bfa-bc3a-0ceb33de89de" xlink:href="ci-20230331.xsd#ci_IndividualPrivateMedicalInsuranceLongDurationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InternationalHealthMember_36c94562-46ff-4130-a695-06d9b26974bd" xlink:to="loc_ci_IndividualPrivateMedicalInsuranceLongDurationMember_dd2ebce2-a61b-4bfa-bc3a-0ceb33de89de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_9bd7fb01-6eb2-4d28-8c15-ce13af09914c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5508126a-bf44-42b9-91d5-d3b4eef04499" xlink:to="loc_us-gaap_ServiceMember_9bd7fb01-6eb2-4d28-8c15-ce13af09914c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_ServiceFeesMember_11090849-70e5-4066-856b-6aadbea799c1" xlink:href="ci-20230331.xsd#ci_ServiceFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ServiceMember_9bd7fb01-6eb2-4d28-8c15-ce13af09914c" xlink:to="loc_ci_ServiceFeesMember_11090849-70e5-4066-856b-6aadbea799c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember_bd1b8d23-b92a-4e40-82e2-d6fe22118b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ServiceMember_9bd7fb01-6eb2-4d28-8c15-ce13af09914c" xlink:to="loc_us-gaap_ServiceOtherMember_bd1b8d23-b92a-4e40-82e2-d6fe22118b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3a2546cd-7398-4ec7-8671-36346dd7724c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3a2546cd-7398-4ec7-8671-36346dd7724c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b85faec7-26d3-4177-a836-b1294afb0b41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3a2546cd-7398-4ec7-8671-36346dd7724c" xlink:to="loc_us-gaap_SegmentDomain_b85faec7-26d3-4177-a836-b1294afb0b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_EvernorthMember_6d0d1ba6-e576-4213-9e96-ffc5b25cbcd5" xlink:href="ci-20230331.xsd#ci_EvernorthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b85faec7-26d3-4177-a836-b1294afb0b41" xlink:to="loc_ci_EvernorthMember_6d0d1ba6-e576-4213-9e96-ffc5b25cbcd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_CignaHealthcareMember_462175f2-266d-4e3c-a4b6-16404af31c52" xlink:href="ci-20230331.xsd#ci_CignaHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b85faec7-26d3-4177-a836-b1294afb0b41" xlink:to="loc_ci_CignaHealthcareMember_462175f2-266d-4e3c-a4b6-16404af31c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentMember_2a53e056-b2ed-45af-86d3-f142378a4dfd" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b85faec7-26d3-4177-a836-b1294afb0b41" xlink:to="loc_ci_OtherOperationsSegmentMember_2a53e056-b2ed-45af-86d3-f142378a4dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f9e2ce08-0732-4b22-a277-552440a0d203" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:to="loc_srt_ConsolidationItemsAxis_f9e2ce08-0732-4b22-a277-552440a0d203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_89dc1ee4-c782-4e34-b827-29dbca89aa72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_f9e2ce08-0732-4b22-a277-552440a0d203" xlink:to="loc_srt_ConsolidationItemsDomain_89dc1ee4-c782-4e34-b827-29dbca89aa72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_e2f560cc-4b81-43bf-9f06-e07eee416d52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_89dc1ee4-c782-4e34-b827-29dbca89aa72" xlink:to="loc_us-gaap_IntersegmentEliminationMember_e2f560cc-4b81-43bf-9f06-e07eee416d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_54d1201a-4a5b-4d66-9689-fc331c265884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_89dc1ee4-c782-4e34-b827-29dbca89aa72" xlink:to="loc_us-gaap_OperatingSegmentsMember_54d1201a-4a5b-4d66-9689-fc331c265884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_e4ec27b4-afdb-4f5f-84ec-8c8f7afbc9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:to="loc_us-gaap_SubsegmentsAxis_e4ec27b4-afdb-4f5f-84ec-8c8f7afbc9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_1c67e0c6-53c4-4d1f-8fb3-12df29c101e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_e4ec27b4-afdb-4f5f-84ec-8c8f7afbc9b6" xlink:to="loc_us-gaap_SubsegmentsDomain_1c67e0c6-53c4-4d1f-8fb3-12df29c101e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember_2571358c-32c5-48e1-aade-bc6095d2f1e3" xlink:href="ci-20230331.xsd#ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_1c67e0c6-53c4-4d1f-8fb3-12df29c101e8" xlink:to="loc_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember_2571358c-32c5-48e1-aade-bc6095d2f1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember_ceb3817f-4806-45d3-83e3-61ec39e1e8fd" xlink:href="ci-20230331.xsd#ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember_2571358c-32c5-48e1-aade-bc6095d2f1e3" xlink:to="loc_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember_ceb3817f-4806-45d3-83e3-61ec39e1e8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsInternationalBusinessesToBeSoldMember_d1c4a914-3af2-4d8e-ac33-3b9b2d341bd5" xlink:href="ci-20230331.xsd#ci_OtherOperationsInternationalBusinessesToBeSoldMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember_ceb3817f-4806-45d3-83e3-61ec39e1e8fd" xlink:to="loc_ci_OtherOperationsInternationalBusinessesToBeSoldMember_d1c4a914-3af2-4d8e-ac33-3b9b2d341bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_InterestInJointVentureInTurkeyMember_c49b6f0b-77a9-4e72-a276-badb52210c44" xlink:href="ci-20230331.xsd#ci_InterestInJointVentureInTurkeyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember_ceb3817f-4806-45d3-83e3-61ec39e1e8fd" xlink:to="loc_ci_InterestInJointVentureInTurkeyMember_c49b6f0b-77a9-4e72-a276-badb52210c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_GroupDisabilityAndLifeMember_64a5e298-f1dc-4d54-8059-7314c2065f33" xlink:href="ci-20230331.xsd#ci_GroupDisabilityAndLifeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember_2571358c-32c5-48e1-aade-bc6095d2f1e3" xlink:to="loc_ci_GroupDisabilityAndLifeMember_64a5e298-f1dc-4d54-8059-7314c2065f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_OtherOperationsSegmentOtherMember_cd9ec30b-ca9c-4224-8536-44ebf3e85dbb" xlink:href="ci-20230331.xsd#ci_OtherOperationsSegmentOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_1c67e0c6-53c4-4d1f-8fb3-12df29c101e8" xlink:to="loc_ci_OtherOperationsSegmentOtherMember_cd9ec30b-ca9c-4224-8536-44ebf3e85dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_a3a97e9a-6e99-48ea-8237-96641c4457e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_3b5781c5-d714-4441-9e92-eee8eb1bdfbd" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_a3a97e9a-6e99-48ea-8237-96641c4457e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d83ad3ed-e222-4d2d-b0d9-9c2cd14e5043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_a3a97e9a-6e99-48ea-8237-96641c4457e7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d83ad3ed-e222-4d2d-b0d9-9c2cd14e5043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_be7e5528-ef43-4bb4-9942-bf590a1aabe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_a3a97e9a-6e99-48ea-8237-96641c4457e7" xlink:to="loc_us-gaap_PremiumsEarnedNet_be7e5528-ef43-4bb4-9942-bf590a1aabe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_NonInvestmentRevenue_585f7b44-c6f0-4c35-81f3-6fd39fb96fc7" xlink:href="ci-20230331.xsd#ci_NonInvestmentRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_a3a97e9a-6e99-48ea-8237-96641c4457e7" xlink:to="loc_ci_NonInvestmentRevenue_585f7b44-c6f0-4c35-81f3-6fd39fb96fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails" xlink:type="simple" xlink:href="ci-20230331.xsd#SegmentInformationFinancialandPerformanceGuaranteesDetails"/>
  <link:presentationLink xlink:role="http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_56caf0ff-97c8-4909-aa88-f5265b8755d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_7e2b3245-9bce-4e6b-905b-5d6b9220ffdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_56caf0ff-97c8-4909-aa88-f5265b8755d0" xlink:to="loc_us-gaap_LossContingenciesTable_7e2b3245-9bce-4e6b-905b-5d6b9220ffdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e2dc352b-104d-4338-98c2-430ba57cbe09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7e2b3245-9bce-4e6b-905b-5d6b9220ffdb" xlink:to="loc_srt_ProductOrServiceAxis_e2dc352b-104d-4338-98c2-430ba57cbe09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5ddced1f-dd95-4532-b37e-704f1abff83c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e2dc352b-104d-4338-98c2-430ba57cbe09" xlink:to="loc_srt_ProductsAndServicesDomain_5ddced1f-dd95-4532-b37e-704f1abff83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ci_PharmacyBenefitsManagementServicesMember_9d6d0ae7-ec0d-4daf-be9f-059cd1942e58" xlink:href="ci-20230331.xsd#ci_PharmacyBenefitsManagementServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5ddced1f-dd95-4532-b37e-704f1abff83c" xlink:to="loc_ci_PharmacyBenefitsManagementServicesMember_9d6d0ae7-ec0d-4daf-be9f-059cd1942e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_235281bf-86c1-43ee-84ee-07ef8d938428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7e2b3245-9bce-4e6b-905b-5d6b9220ffdb" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_235281bf-86c1-43ee-84ee-07ef8d938428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_6e0d0e94-735b-43de-86d4-959bb952049f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_235281bf-86c1-43ee-84ee-07ef8d938428" xlink:to="loc_us-gaap_LossContingencyNatureDomain_6e0d0e94-735b-43de-86d4-959bb952049f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesMember_f85b2679-4b6e-4ad5-a67f-1c4fe73e1cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_6e0d0e94-735b-43de-86d4-959bb952049f" xlink:to="loc_us-gaap_GuaranteesMember_f85b2679-4b6e-4ad5-a67f-1c4fe73e1cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_aedc01a5-5aef-4029-9fdc-836f71b9cdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7e2b3245-9bce-4e6b-905b-5d6b9220ffdb" xlink:to="loc_us-gaap_LossContingenciesLineItems_aedc01a5-5aef-4029-9fdc-836f71b9cdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_f096a8bc-fe2e-49f7-860a-b0d51492e5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_aedc01a5-5aef-4029-9fdc-836f71b9cdf0" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_f096a8bc-fe2e-49f7-860a-b0d51492e5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ci-20230331_g1.jpg
<TEXT>
begin 644 ci-20230331_g1.jpg
M_]C_X0U717AI9@  34T *@    @ # $   ,    ! X0   $!  ,    ! 5P
M  $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5  ,    !
M  ,   $:  4    !    I $;  4    !    K $H  ,    !  (   $Q  (
M   A    M $R  (    4    U8=I  0    !    [    20 "  (  @ 6XV
M   G$ !;C8   "<0061O8F4@4&AO=&]S:&]P(#(T+C$@*$UA8VEN=&]S:"D
M,C R,SHP-#HP-" Q,SHQ,3HQ,       !)    <    $,#(S,: !  ,    !
M  $  * "  0    !   #P* #  0    !   !F          & 0,  P    $
M!@   1H !0    $   %R 1L !0    $   %Z 2@  P    $  @   @$ !
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M @4 '6-I9VYA9W)O=7!?;&]G;U]C;VQO<E]P;W-?<F=B #A"24T$)0
M$/OV!AQI$41.NTUJ)PV%.;LX0DE-!#H      .4    0     0      "W!R
M:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT
M90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).
M86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '(
M;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N
M96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "
M+0   !     !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N
M8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;
M    0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL
M1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#
M     P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M    0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M  !";&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q @L
M      IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !0
M9U!#     $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
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M0DE-!!D       0    >.$))30/S       )           ! #A"24TG$
M    "@ !          $X0DE- _4      $@ +V9F  $ ;&9F  8       $
M+V9F  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $ +0
M  8       $X0DE- _@      '   /____________________________\#
MZ     #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z   .$))
M300(       0     0   D    )      #A"24T$1       $     (   )
M   "0      X0DE-!!X       0     .$))300:      -]    !@
M       !F    \     D &, :0!G &X 80!G '( ;P!U '  7P!L &\ 9P!O
M %\ 8P!O &P ;P!R %\ < !O ', 7P!R &< 8@!? #8 ,  P '  < !I
M 0                         !              /    !F
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !F     !29VAT
M;&]N9P   \     &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M    5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B
M:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L
M;VYG          !"=&]M;&]N9P   9@     4F=H=&QO;F<   /      W5R
M;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53
M;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /
M15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N
M9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO
M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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MO5;\C)P,XC(Z9ELL]+.8&[*VPYU=AMJVU^V-CF6_X1,G.M*U/\AQ,&?.,=1
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M>OU\'J_2;K?\2[W8NZWJH&:X;G15NKW1+F;W6-N?[_\ #?\ @*TQT;KO2/\
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MJ22GZJ27RJDDI^JDE\JI)*?JI)?*J22G_]D .$))300A      !7     0$
M   / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    % !! &0 ;P!B
M &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ #( ,  R #,    ! #A"24T$!@
M    !P (     0$ _^$0W&AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
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M1T(@6%E:( ?.  ( "0 & #$  &%C<W!-4T94     $E%0R!S4D="
M          #VU@ !     -,M2% @(
M                                $6-P<G0   %0    ,V1E<V,   &$
M    ;'=T<'0   'P    %&)K<'0   ($    %')865H   (8    %&=865H
M  (L    %&)865H   )     %&1M;F0   )4    <&1M9&0   +$    B'9U
M960   -,    AG9I97<   /4    )&QU;6D   /X    %&UE87,   0,
M)'1E8V@   0P    #')44D,   0\   (#&=44D,   0\   (#&)44D,   0\
M   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R
M9"!#;VUP86YY  !D97-C         !)S4D="($E%0S8Q.38V+3(N,0
M        $G-21T(@245#-C$Y-C8M,BXQ
M                                      !865H@        \U$  0
M  $6S%A96B                      6%E:(        &^B   X]0   Y!8
M65H@        8ID  +>%   8VEA96B         DH   #X0  +;/9&5S8P
M       6245#(&AT=' Z+R]W=W<N:65C+F-H               6245#(&AT
M=' Z+R]W=W<N:65C+F-H
M                     &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F
M875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@              +DE%0R V
M,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M                      !D97-C         "Q2969E<F5N8V4@5FEE=VEN
M9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ               L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M                        =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03
M"P #7)X    !6%E:(       3 E6 %    !7'^=M96%S          $
M                   "CP    )S:6<@     $-25"!C=7)V        !
M   %  H #P 4 !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M
M '( =P!\ ($ A@"+ )  E0": )\ I "I *X L@"W +P P0#& ,L T #5 -L
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M<: 7<4XK\Y0SS$<*E-J-E5B(Y]S[%KKEOZI!FWF5S_I2"A_FRD^@%>'# O\
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M]??1'V[Y?ON5>1.4^7-S,9W&QV^&&0QDLA>- K:20"148-!CI*QU.3UN3_\
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M&2+#U<]9ZEU4N&KI:?(D<G71J0"18B?D[=3L_,6W75:0L_AO_I7[37Y*:/\
M[4=9%?=5]RF]K??;D/F"2X\/:+BZ%E=YHAMKPB%V<>:PNT=QQXPK0&@!W*P>
M>?\ ??X#Z'Z>\J>OI/Z2V^]F8/L796[-A;FION]O[RV]E]M9B :/(V/S-#/0
M5+P-(DBQ544<Y>*2Q,<JJPY ]IKVTAOK2YLKA:P2HR,/DPH?SSCY]$'-?+6U
M<Y<L\P<I;Y!XFS[E9S6TRXJ8YD:-BI((# -5&IVL PR.M*'OCIC=G0':N[^J
MMX02#);9R<L-'D5@EAH]PX.8F7";BQHD'KH<Q0%)5L6,;EHFM)&ZKB5O.TW.
MR;G<[==_VD1(!I0,I/:P^1&?M)!R".OF,]V/;3F#VCY^YCY YDC/UMC/I22A
M5+B!LPW$=204F0AP*DHQ,;4=6 ""Q]EI-./4<4)X#HPOQ;Z"S_R2[LV=U=AX
MJA*#(5J9'=V5A6ZX#9N-DCFS^5DD(:.*84I\%*'LLM9-#'_;]GG+NS3;]N]I
MMT0.@MJ<C\,8-6/[,#U8@>?4P^P_M)NWO5[G<M\B[=&XM)I1)=R@?[CV<9#3
MRDG .GLBKAIGC3\76ZAA\3C\!BL7@\1214&(PN.HL3BZ&$D0T6.QU-'1T-)"
M&+-XJ:FA5%N2; ?7WEA%%'!%%#$H6)%"@>@ H /RI^SKZ;-NV^SVFPL-JVZ!
M8MNMH4BBC7X4CC4(B"N:*J@#->@!^6W>M-\<^@.P>T==,<WC<5_#-G4E3I9*
M[>6<<8W;T1@8'[J"DK)ONZB,6+4M-*;@ D$O,V\#8MEOMQQXRK1 ?.1L+]H!
M-2/X0>HB^\)[JP^S/M'SASV&3]YP6_A6:M0A[R<^%;C3G6J.WBR*.,4<F0!4
M:6V4R>0S.2R&8RM;59+*9:NJLED\C6S25-;7Y"NGDJJRMK*F5FEJ*FJJ96DD
M=B2SL2?>*#N\LDDLC$R,223Q))J2?6IS7CZ]?,U?7]YN=W=[AN-T\^X7$KR2
MR.2SR22,7=W9LLS,2S$FI)J>H'NO2/KWOW7NN_>NMCJP?^5M2SU'S@Z?EA<+
M'1479%55@LRF2G?K#>-$J  ?N?Y75QMI/ TW^H'L;^W:EN;]K(. LI/_ #B<
M?Y1UF%]P^"67[T?MU)&U%BBW%G%>*_NR\0#\G=<'TKQ'6W#[R9Z^A?KWOW7N
MO>_=>ZU>/^%<O_;JS;O_ (MCU%_[QG;'O*K[GG_3VKC_ *5%Q_U<M^FIO@/7
MS:.KO^9F==?^'UM'_P!Z#'^^F^[?\DK<_P#GGD_XX>DJ_$/MZ^X][X/=+^O>
M_=>Z][]U[K2-_P"%HG_,L_@%_P"'U\@__>?ZF]YT_<B_Y*ON%_SSVG_'[CIB
M?X5^WK1&V%L+>O:>]=K=<=<;6SF]]^[WSF/VUM#:&VL?49;<&Y-P9:H2DQF'
MP^,I$DJ:[(5U3(J11(I9V( 'O/S<-PL=IL;O<]SNXX-O@C+R2.0J(BBK,S'
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MK^7Y#CUQ"Y@_O%_O![M(YVE=DVJ(' @M#*:8(#-=2SAC04)"(,F@';1/X?\
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M*/\ :3/;0KYLC13U<G]FIRF%W"L48OZH\<; :23!/NOMQCW';]T5>R6(H?\
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MW%)./W1<_P#5L],Q_&O7V,[^^+O2WKWOW7NOCE_SB_\ MZE_,$_Q^6'=%O\
MT,\G[[0^R_\ TZ7V\_Z5%M_U:7I%)\;=;87_  B[_P"99_/W_P /KX^?^Z#M
MGWB-]]S_ )*GM[_S0O/^/P=/0<&^WK=R]X+]/]:O'_"N4C_AJW;O_BV/47_O
M&=K_ /%?>57W/"/]=JX%<_NBX_ZN6_34WP=?,O5F1E=&9'1E9'4E65E(*LK
M@JP(X(Y'OJ,14$=(^EQ_I1[,^@[%WW_A_O[L_P#[;_BX?C_;>RX;1M8P-M@I
M_P TT_S'K>IO4]>_TH]F_P#/Q=]?^A=G_P#ZX>_?NC;/^C;;_P#.-/\ H'K>
MH^IZ]_I1[,_/8N^K?G_?W9__ .N'O1VC:Z&NVV__ #C3_H$?X>O%CZGK['7\
ML2KJJ[^6O_+TK:VIGK*RL^#?Q-JJRKJII*BKJJJHZ%V#-45-3/,SRSSSRL6=
MV)9V))-_?%SW31(_<_W'C10JKOVX  "E +N4 8Q0#T'2Y<J.CR^P)UOKWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z_]/?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW71^A]^^
MWKW6F;\XNEJKHCY-=G;-%&]-M_)YJ?>NRY#%X::?:6[9ILK0)1^E%>GPU7)4
M8QV  \]#)^!SBKS?M+;1S#N%J%(A9O$CQ^!\BGJ%)*?:IZ^:O[TOMG<>U/OC
MSSRT+<IM$]T;RS-*!K2Z)EC">96%S);$TIK@>GET4K_??[[_ &WL,]8]4Q7R
MZZ][ZUU[WKK8P>A@Z)[JWE\?>T-K]I[&JVBR^WJP&KQ[S2Q4&X<+46BR^W<N
MD?\ GL=E:6Z,""8I-$T>F6.-E,]HW:ZV3<8-QLS25&R/)U/Q*U.((Q3UH1D=
M2-[4^YO,GM!SUL//?*D^G<+*3NCJ1'<0MB6WE XQRK@U!TMID0:XT8;HW5'9
M>V.X^NMG]G[-JC5[;WGA*;,8]GL*BF:0O!78RM12RQY'#Y&":DJ4!(2HA=02
M!<Y7[9N$&ZV%IN%J:V\J!A7B*\0?FIJ#\QU],?('.^Q^Y/)G+?/7+<WB;+N=
MJLT9/Q*359(G' 20R*\4@%:2(P\J]"$?I[6GAQZ&'6L'_-,^']1T_P!C5/>&
MR,6W^C'L[*R3YR"CAM3;-W]6^:JR%&\<2Z*?$;G9)*RE;A$J6G@LB+ &Q[]Q
M.5SM5^^\6:?[K[AR6 &$E.2/D'RP^9*^E>&'W\_NYS>W/.4_NERM8G^HV^W!
M:=47ML[]ZM(I ';%=$--$>"R>+$ JB(-4I;W&E14BN>N>M".(ZZ][ZUU[W[K
MW78^O^^_Y'[UUL9('^K_ %?X>MT'X1[<EVK\2?CWB9HA#+)UAMO-R1")82C[
MII?[SLLD8=R)P<Q^X39B]RP5B5&5W*,!MN6=DB84;Z=6I_IN[_+U],/W7]ED
MV#[O?M!M\L>B0[%;3E::2#=+]3D?Q?K=U<ZJD@&H!IC]/8B/4\=$_P#F%\P=
MB_$C8:9S,QIN'?&X!44FQMBTU7#!69>LBA=GRN48N9\?M?'2Z%J:I8Y'+R)%
M&K.UU"_-'--GRU9K/*-=V]1'&#EC3B?1!@$TXT'6.GWCOO'<J?=ZY37=-S07
MG-5YJ6QL5=5>5P#664UU1VL9H)) K&K*B*6;&LWD/GG\H\AW&G=_^D[+4>Z(
M6-/38.A:2/8M-@3.)VVK'M"66?&2X%K#6)A+4R2 3M,:D"88_OSES&^Z#=_W
M@RW X*/[/3QT:*D:?+A4\:ZJ'KB!=_>R]][SW)7W1'/%Q%OP[5@2HL5@U:C:
MBT):,P>H8-(S#Q3*9OU>MC7X2_.39GRWVW-05,%)M/M[;E#%/NW9*SNU-74J
M^&GDW3M)ZEVJ:S;TU5*JR1.TE3CY9$BF9U>&>>=N4N;[3F:!D($6YH.^/R(X
M:T\RIQ4$U4D UJ">SOW8?O3\L_>%V22SFBCV_P!Q;*(-=V6HZ76H4W5H6)9[
M=F(#(2TENS*DI8-%+*>\D?[Z_/\ AQ_7V,NLK>M3[^;%05%'\SMYU$R@1Y7:
M>P*^D(U>JGCVS1XQVY51_P "\;*."PX_!N/>-GN4A7FR\8C#1QD?9H _P@]?
M/Y_>!6DMM]Y;F::50%N+"PD3_2BUCB)SYZXG&,4'K7JMCV ^L*.O>_=>Z][]
MU[[!T8+XP_'_ ')\ENYMI]6;?6H@I<C4KD-V9N*+R1[9V=02129W.2ED>$2Q
M4[B&E22R3ULT,1(\E_9UR]LL^_[K;;;""%8U=J?#&/B;]F!Y%B!Y]2_[%^T6
M]>]ON5L'(>T!T@F?Q+N<"HMK.,@SSFH*U"D)$&P\[Q1U&L'K=(VOMG"[,VYM
M_:.VJ"'%;>VOAL;M_!XVGN(:#$XBBAH,?21W)9E@I:=5N22UKFYY]Y76UO%:
M6\%K;II@C0*H] HH!^0Z^F;8MDVSEK9-HY=V2T6WV>PMHK>"-?A2*%!'&@^2
MHH%3D^>3T_\ M_HUZ][]U[KWOQ%<=>Z 7Y%_%_H#Y;[ AZL^275>U^X.O*?<
M..W9!M/=\%348J+<>(I<A18W+K'25-)**NCI<K4HAUVTS-Q[/^6N:N8^3MQ?
M=^6-VELMR:,QF2,@,48J2N0<$J#P\NM$ BA&.B1T'\CW^4QBZZBR>/\ @GT;
M25^.JZ>NHJJ+%YH2TU723)44T\9.;($D,T:L/\1['4GOO[P31R12<_7YC8$$
M:ER"*$?!YCK6A/X>K5?]M_Q/Y]Q+3(/5NN_>^O=>]Z(J*=>Z*S\G/A+\4OF=
M0;/QGREZ,V1W90; JLQ7;-I=YTM;4Q;>J]P0XZGS4^/%'6T91\C#B:99-6JX
MA6UO8LY6YYYNY(DO)>4]^GL9+A5$AB(&L)4J#4'X2S4^WK14-Q'1>^M?Y._\
ML;I[L#9W:G6/PQZ<V9V'U_N'&;LV9NS#8W+QY7;NX\+4I6XO+X^2;+S1)5T-
M5$KH61@&'T/L1[G[T>ZF\[=>[3NO.U[-MMS$T<L;,I5T8493VC!!H>M!$&0N
M>K*?]]_L/<8 4_U?ZO\ 4.K==^]]>ZK5[*_D[_RQ^XNP-X]J=G?#'IS>?878
M&X<GNO>FZ\SC<M+E=Q;BS53)6Y3+9"2',0PO5UM5*SN5106)L/<F[9[S>Z>R
M[?9;5M7.U[!MMM$L<4:E:(BBBJO:< 8 ZJ54UJ.C"?&+X2_%+X8T.[\9\6NC
M=D=)T&_JO#UV\J79=+6TL>X:O;\.1@PM1D!65M:7DQT.6J5CTE;"9KW]ASFC
MGGF_G9[*7FS?I[Z2W#",RD$H'H6 H!QTK7[.MA57@.C3>PJ17'6^@%^1?Q?Z
M ^6^P(>K/DEU7M?N#KRGW#CMV0;3W?!4U&*BW'B*7(46-RZQTE322BKHZ7*U
M*(==M,S<>S_EKFKF/D[<7W?EC=I;+<FC,9DC(#%&*DKD'!*@\/+K1 (H1CHC
M'_#%W\HS_O OHK_SU9O_ .OGL>_Z_?O'_P"% O\ _>E_Z ZKX:?PCKW_  Q=
M_*,_[P+Z*_\ /5F__KY[]_K]^\?_ (4"_P#]Z7_H#KWAI_".O?\ #%W\HS_O
M OHK_P ]6;_^OGOW^OW[Q_\ A0+_ /WI?^@.O>&G\(Z]_P ,7?RC/^\"^BO_
M #U9O_Z^>_'WZ]XS@^X%_P#[TO\ T!U[PT_A'5FFP=B[1ZNV+LOK/K_ T&U=
MA]=[3VYL79&U\6CQXS;>T-HX>CP&V\#CDD>65*'#X;'P4\(9F(CC%R3S[BZ_
MO[S=;^]W3<;AI;^YF>65V^)Y)&+N[?-F)8_;U?I6^TG7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__U-_C
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=='Z>_=>ZK8_F3?#^
MH^2G5E/NK9&/6H[=ZQ@KJ[;U-#$AJMW[<G"S9G9WD!1Y:YGA6KQNLN%JD>%0
MOW3R* >?>5VW_;5N;2,'=+<$J/XUXLGV^:?.HIW'K"G[Z_W=)O>SD.+?^5K0
M/[B;&KR6ZJ!JN[<]TUG7!+U EMJU E#Q@+]0SKJC3P34\TU-40RT]33R205%
M/.C1303Q/XY89HY LD<L;J596 8$6//O&Y@59E:H(]?*GK\Q4CK@#+#+#))#
M-$R3(=+*P((()!4@Y!!P0>!\L=8/]]_OO]M[U4>O35#2OEUU[WUKKL>]'@:\
M.MCB.MAW^2SV_593:G:?1^4JQ*NU<ACM_;3AD=WF3&;@\F*W320 G1#0X_*T
M5%.J@<S9"5C^KW.'M/NK26VX[-(V(B)$^QB0X^0#!3\RY/78O^[,]Q9[[8.?
M?:V_N-0L)H]PM%))(BN*PW2K7A&DJ0N !\=Q(3QZO+/N8.NIW22WSL;:G96T
M<_L3?6#HMR;3W/0/C<WALA&7IJRE=DE0ZD:.:GJJ6HB2:">)DFIYXTEC99$5
M@FO+2VO[::SNX5>VD%&4\"/\F<@C(.0:]$'-/*_+_.W+V[<J\U;5%>\OWT)C
MGAD%5=201P(975@KQNA#QR*KHRNJD:G?S5^"&_\ XI9^;,T*UV[^FLM6NNWM
M\14I>;#O4SRBEVYO1:=%@QV;CC"A*D*E)D+ZHM#B2GBQKYLY.O>6I_%75+M3
M&BR4^&O!)/1@.#8#<13('S]_>;^ZAS?[ [M)N-HLNY>V]Q+_ (O>JE6B+$Z;
M>]"BD<XP%DHL5Q@QZ7#1(0C_  _WW]/][]@SK$FAXTZ]8_T_WWT]^QPKUZAZ
M7/6.P\MVCV+L?KG!1M)EM[[JP6V:(JNH029C(T]$U9+^$IZ&*9II7-ECCC9B
M0 3[6;?9R;C?6=C#_:S2*@_VQ K]@K4_($]"OD7E+<.>^<N5N3-K0F_W2_AM
MDI^$S2*A<^BQAB[$X"J22 #UO-8/#T.WL-B,#BX?M\9@\908C'07U>"@QM+%
M14<5]*W\=/"H^GX]Y?PQ)#''%&*1HH4#T % /V=?5!MFW6FS[9MVT6$>BQM8
M(X8U_ACB0(@_)5 Z9=_;YVWUILK=/8&[JX8[;.SL'D=P9JKTAY$H<;3O42QT
MT1934UM04$4$*G7-,ZHMV8#VU>WEOM]I<WMU)IMXD+,?D,FGJ?(#S-!Q/19S
M;S3LO)'+&_<W\Q77@['MMK)<3/2I"1J6(5:C4[4TQH,NY51DCK2Y^1G?.[_D
MCVQN;M/=\KQRY:H--@L(L[ST>U]L4DLHPNWJ L$7Q4,#ZI755^XJI)9F4-(?
M>*.^[S=;]N=QN5VV6-$7B$0$Z5'V#]I)) J>OF<]Y_=CF'WJ]P-\Y\YB=A)<
M/I@AU$I:VRD^%;I7%(U/>P"^)*SR$5<] 8/K_OC[*.HJ'$5X5Z7_ %9V;O#I
MS?\ MCLK8>4EQ&Z-J9*'(T%2A9H9T0E:S&Y"$,@K,7E*21Z>IA;TRP2,IM?V
MLV^_N=JO+>^LGTW$3!@?(^H(\P1@@X(QZ$"_D/GGF+VXYNV'G7E2_:VWVPG6
M1&'PMFCQR*/CBE6L<J<'0E?.O6Z%\?\ NC;GR$ZAV3VSMBT%%NG%B6OQ;3+-
M/@L]1R/09_ U,FB-GDQ66IY8E<HGGB"3*-$BWRNV3=8-ZVRTW.W^&1<BN585
M#*?F#45\Q0^?7TP>T'N9LOO![=<L>X.Q=MKN%N#)%74T%PA*7$#'!K%*KJ&(
M&M LBC2XZH]_G6]<3T7873_;-/3?Y%N/:63V%DJB*,K'#DMJY:7.XPUD@41_
M<9&AW5.L5R7:.B8?I1?<0^[-B4O=KW)1V21-&3\T;4/VAS^SKEM_>=<ERVW.
M'MQ[@PP_XM>[?+82,!A9+64SQZSPU2)=N%.25A(PJ#JD"Q_I_OO^*^XBXF@Z
MY<T/7K?CWO\ +KU#TK=B;$W?V7NW![&V)@*_<NZ]Q5L>/Q&'QT7DJ*F>2Y9W
M=BD-)24\0:2>HE>.&GA1I)'1%9@HM+.YW"YAL[.$R7+L %7)-?7T%.)- !DF
MG0AY4Y4YCYVYAVOE;E3:)K[?[V41PPQK5F8\:UHJHHJSR.52- SNRHI(VW?@
MW\.L#\2NMFH:N2CS?:6[DI:WL/=%,A-,9X!(U%MK O-%'4)M_""=@'<"2LJ6
MDG945HX8<F.3^5HN6;#0Y#[C* 97\L<$6N=*UXG+&II2@'T+?=9^[?M'W>^2
MC:SO%=<^;@%?<+I<K45*6T!(#"WAJ<D!II"TK!04CC.][%_6477O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7_]7?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7OI[]U[KJX]^Z]UZX]^Z]YT\
M^O7''^/T]^Z]UT3?@?7_ 'Q]^Z]]O5/_ ,\/Y9V-[JJ,QV]T7#CMN]KU'FR&
MY=IS218_;_8M58/+6TM22E+M_=]4%8O*]J/(3,&J&AD,E2\7<Y>W\6ZF7<]G
M14W+)9/A64^9!_"Y]>#'XJ98\Y_O8?<@L?<Z;<O<3VK2&SY_?5)<VC$1V^X-
M05=6PMO=M0U=@(KAB#*8W+S-K@[QV5N[KW<62VCOG;>9VGN;$S&'(83/8^HQ
MN0IFN=#F"I1&DIYU :.5-44T>ET9E()@>ZM+JQG>VO8&BG0Y5@5(_+_+P/$5
MZXN<R<L<P\H[Q>\O\T[)=;?OMNVF2">-HY%/"NE@*J0*JXJK@ZE8K0E+V-[?
M[[_?'VQ4#CT0Z2<@8Z\/Q_3^O_$_T^OOV:$CK8!SCR_U?ZO+JTO^4#E*F@^7
M:TD!TQ9SJ_>F+K1J8%J>*HP.:5;*5#'[S#Q&S _2_P!0#[D3VOD9.9P@/Q6[
M@_9VL/\ CHZSR_NZ;ZXL_O$_3Q&D=UL5[%)QRJM!,!Y?CB3C48]:$;3OO(SK
MO-U[W[KW33F<'A]QXC(X#<.*QN>P>7HY\?EL-F:*FR>+R=!5(8JBBKZ"LCFI
M:NEGC;2\<B,K#@CVW-#%<1O#/$KQ,*,I%5(/$$&H(^WI!N>U[;O6W7NT;QM\
M-UM5S&T<L,R+)%+&PHR21N"KJP)!5@01BG5)/R7_ ).^"SM1D=U_&K<-+M2L
MG9ZJ3K/=U163[;>5B6DCV[N<??9/$!K6CIJR*JB+M;[B",!1$?,'M;#,S7.P
M3"-ZU\)R=/\ M6RP^0:H_I 4ZY@>]_\ =P[5NLU[S![([Q'M]RQ+';;MG-N3
MZ6USWR0_T8YUE74U/&B0 "ECMCXS]]='U$\/:'5F[=KT<,KQ#.RXU\CM>H>,
ME2*3=.):NVY5DBS6CJ2VEE) O[B?<N7]YVAF7<-NDC7^*E4/^W4E3^VO7,KW
M ]D/=GVMFD3GSD/<+"W5BOCF(R6K$&G9=PZ[=_(]LI:A!(%1U9U_)W^.51N7
M?V?^1VX*.VW]@QUVU=C&:,::_>F7QZQ9K)4Y=6#0[=VY7-"38:ILDI5M4+CW
M(/M;L+3WLV_3I^A#5(Z^<C#N;[%0T'S<4X&F<W]W#[,2[US=NWO1O%J/W1M"
MO:V)(_M+V9*3R"M<6]M(4)\WN%*M6-AUL;D?[[_B?]?W.XXX'79WJF?^<MW'
M4;6Z?V)TYBZMHJGM+<-1FMQ+%+S)M38[4-7#05,6DWAR.YLE13HQ87;',+'D
MB*O=3=#;[79;5$0&N'U/Q^".AI^;%3_M3US6_O*/<F;8?;GE7VWV^X*3;]>-
M-<4)S:V6AA&P X2W,D,@-<FW(R*]:V1_//\ C^>3^>3SS[@0?9_J_P!G/7%"
MN*5_U?ZO\'7'WOJO78_X@_[U[T>MBM<=7F_R7>Z*FAW5V7T%DZQCC,[C$['V
MI3S2$14^;Q,E%AMT4]*A_5/F,354<Q'%H\:Q_K>8/:C=72ZW'99'_3<>*E?X
ME[7 ^U2A_P!J3Y]=4_[L[W,EM=^YW]I;^Y)L;N#]Y6BD]JS0E(+I4]6EB>%S
M\K9C3)ZM3^=WQ^D^1_QPWGLS%4HJ=Y8)8M[[!70'FEW3MR*HD3%P7((FW%B*
MFKQR'4JK)5J[$JI'N1N<MD._;#=VL:5NT_4C]=:9H/\ 3#4GVD'K/;[UWM _
MO1[+<S<M[? 'YGM +VPQ5C=6ZL1$N,-<0M+;@U #2JQPO6G)X9?)X/%)YO)X
M? $8R^;5H,7BX?6)+KIM>_'%_>+.E@2M,^@_P=?-WX<GB&/0QF)TTIW5X4I3
MC7M XU^9Z/I\>OY<?R3[[JZ"MEVK5=8;%J1#//O3L&BJ\0):*7UK-@-MS+3Y
M[<$M1!=H'2*&BDL-=3&&!]C/8^1-^WID8VIMK,T/B2 K@_PI\3'T- I]?/K+
M+V?^Y?[V>[5Q:74O+\FQ<J/I9KS<(VA!0\&M[9@)YRRY0A4A;&J=*@];'?Q9
M^&O4/Q0V^])LG'OF=Y92D2GW/V-G8:>3<N:&J.:6BI#&IBP.WS51JZ4%-Z3H
M1IY)Y4$IG?ESE7:^6X2MI&7NF%'E:FIOD*?"M>"CY:B2*]=H/8;[MGMU[ ;.
MUORQ:&ZYEGC"W.XSJIN9N!*(0*06^H B",T.E#*TTB^(39 6_P!]]?8EZR"Z
MY>]]>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z__];?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW4+(9''XJ
MBJLEE:ZCQN.HH7J*W(9"IAHJ*DIT%Y)ZFKJ7C@@A1?J[,%']?=7=(U+R.%0"
MI)( 'VD])KN\M-OMI[V_NHX+.)2SR2,J(BCBS,Q"J!YDD >?1)^Q/YCGP[ZW
MJ9:#(=OXO<^3AD,;4&P,?E-ZI<6$A.:P=)/MD&.X!5JT/SPIL;!*_P"?.5]O
M8QONBR2#RC#2?L91H_XT.L8N<OOG_=PY*F>TN_<6"^OE/P6$<MZ,8-)X%:V[
M3@CQ]1\@:'HNM7_.:^*]-,8X=H=YY!-*M]S1[4V2D)+?5 M?V/15&I+<W2W]
M"?9$WNKRXI(%I>,/4)'G]LH/\NH;N/[RSV$@E,<?+O-4R4'<EI9!<^7?N*-C
MS[:>G2PVS_-S^'N>FBBRF5["V8LJQ,]1N78U55Q0%UU.DJ[.KMUSEH#PWC1U
M)_26'/M5;^YO*\Q4223Q'U>,FG^\%S_A_9T(MC_O$/NY;M)$E_?;QMH8+5KF
MQ9@*BI!%F]VU5X'2K GX:C/1U.L/D9T3W-I3K'M?9.\*W2TC8?'9RECW%%&J
MEO+4;;K7I<_3PV#6>2F53I:QNK6%FW;]LV[ ?N[<H96/X0PU?FAHP_,=9-\C
M>\_M3[E47D;W VO<;FA/@QSH+@ 9U-;2:+A5_I-&!@BN#T-1/'^^_P!?Z?GV
M:GJ3?MX= UV_\?NFN_,0F&[;Z]P&\8*>.2/'UU9!)2Y[$K,0\HPVY,;+1Y[$
MK*X!=:>IC20J-:D#V5[ILFU;U&(]RLDE X$BC+_I6%&'K@CY]1M[C^T'MK[M
M;<NV^X7*%GN<2*1&[J5N(@34^#<QE)X:D581R*&(&H&@ZJP[$_DJ=:96>HJN
ML.X-W[.5R\L6*W9A,;O6CC<\BGIZV@J]I5M/3?@-+]U*!]2_N.+[VEV^0EMM
MW66$5^%U$@^P$%"/M-3ZUZP+YQ_NQ^1]PEFGY&]Q=QVX&I$5W#'>H"?PAXWM
M)%7T+>*P\RW0%)_)+[(^YT/WILE:,S:6G3:V=:J$&JPE%(:Z.(S% #X_/IOQ
MJ/U]DX]H[[7W;Q%IKQ"M7]E:?S_/J*5_NP.=#.%?W5VKZ75Q^DG+::\='B :
MJ9TZP*XU4ST?/X>?RUMK_%7?@[0K>R\SO[>,>"R>#I8H<!2[7VY10YC[<5DY
MH3DL_DJZJCAI_%&[54<=F9C%JTZ!GRMR#;<N7O[Q?<'GN]!444(@U4KVU8D^
M0.H?9Y]98_=P^Y-L7L'S6.>KGG>ZW?F06DL"@0):VZ";3K.CQ+B21P 55C*B
MT9B8ZZ=-FU_<@]9Q=>N#[]\O/KW7KCW[KW71(-Q^?]]_Q3W[KWV]<'1'5HW4
M.CAE9' 975A9U<,"&5@;$$&_O6"*$5'^'JK*KJR.H*D4(.01Y@^H^74'$X?$
MX*D7'X3%8W#8]9JBH6AQ-%2X^C6HK)Y*FKF%+210PB:JJ96DD8"[R,6)))/N
MD<,4*:(45$J30  5.3@8R34^IR>DEAMNW;3;"SVNP@MK0,S:(D6--3L6=M*
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MW3GJ^F(X^%!%"#CR#O-3.<DU&,'/53/Z+T!66_X6,?S&YJLO@_C]\)\=0>-
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M;?\ 6WKWBQ_Q=>_Z"B?Y-G_>06^__1!=S_\ V&>_?\"I[U_],Y;_ /97;?\
M6WKWBQ_Q=>_Z"B?Y-O\ WD%OO_T07<__ -AGOW_ I^]1Q_5RW_[*[;_K9U[Q
M8_XO\/5YW4?:.S>\.J>L>ZNN<A/ENO>W^O=E]H[$RM5CZS$U.3V;O_;>-W9M
M?(5.+R4--D<;/6X3+02/3SQQS0LQ1U5@0($W?:;W8=WW38]RB";C9W,D$JA@
MP62%S'( RDJP#(14$@\02,].<<]"'[+^O=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO==7']?]\?I_M_>JCKW2;W?O/9_7^WZ_=>_-V;:V1M;%1B7)[EW=G<
M7MO 8V-CI62OS&9JJ+'4B%C8&2103[56=E>[E<QV>W6<MQ>.>V.-&=V^0506
M)^P=>K3CU2E\B/\ A1[_ "C?CO-78R3Y+1=V[DH68-M[X[[8S':,-4!_;HM]
MTT>+ZIJP3P-.X"?S:W/N<.6_NT>\7,BQRKRQ]#;-^.\D6"G^FB.JX'YP]4,B
M#BW5.O;7_"SCI3&25L/1/PA[3WM"S5,6/R7;7:VTNK9(U,;"DKJS![.VYW"L
MS+-I,E*F00,H(6H!.H3/M'W)=^E56W_GJT@;%5MX))_M :1[?\CH^>GILSCR
M7HD.Y_\ A9;\MZNM\FS?B%\<\!CO).?M=S;D[,W=6^)G4TR&OQ68V3!Y(4N'
M;[:TA-PJ 6(\M/N4<H(@%[SCN<CT&42",?TL,LI^S./4]5\<_P /01M_PL3_
M )F!9M'1?P75"3H5NM>_695N2JLZ_)F,,5%@3I /UL/I[.!]R_VP %=^W[73
M)\:T )^SZ(_X>M>.W\(Z$/#_ /"R;YLP5%(V?^*WQ:R5&D9%=!AY>V<'45$O
M@=5>DJJW?FX(J)%JBKE7AG)C!34"0ZEL_P!RKD=E?Z;FO=D8\-7T[@>M0(4)
MQZ$=;$Y\UQT9G87_  M%R*/24W9_\OVBJ(V6!:[,["^1,U$T3+ !4R4NVMP]
M/UXG6>J!9$?+1^*,Z2TA&HA>_P#N1(=3;7[AL#Y++9@^> 72X%*#TC-3Y &@
MMXX_A/5D'3'_  KF_EE=@STF/[0VI\D.@ZR1(#79;='7^$WSLZEDD1C*E-D>
MLMU[HWA61T\JD%FP$)964@$EE2,M\^YU[I;:KR;7>;9N,8X*DS12'TJ)HXXQ
M7_FJ?/-*5L)D/''5WWQK_F1_ WY@-1TWQP^5W2W9V<KUUTVRZ#>%%@^R&CT(
M_EEZQW7_  'L*FA.NVN7&(NH,M]2L!!7,_MG[@<F%SS-RC>VL*\9#&6A^SQX
M]4)_)^G RG@>CMW]@?K?7?O5>O=>][Z]U[W[KW7O?NO=>]^Z]U[W[KW1%_G-
M_,<^)_\ +DVIL7>ORPWSFMC;>[(W#D=K[3JL+LC=N]I:[,XK&KEJVGGI=HXG
M+5%#'%0N&$DRJC'@$GCV/.0O;3F_W+O+^QY1L$N+FUC$D@:6.(!6.D$&1E!S
MBF3Y]59E7+'JM;_H*)_DV?\ >06^_P#T07<__P!AGN3_ /@5/>O_ *9RW_[*
M[;_K;U7Q8_XNO?\ 043_ ";/^\@M]_\ H@NY_P#[#/?O^!4]Z_\ IG+?_LKM
MO^MO7O%C_BZ]_P!!1/\ )L_[R"WW_P"B"[G_ /L,]^_X%3WK_P"F<M_^RNV_
MZV]>\6/^+KH_\*B/Y-EO^R@M]_\ H@NY_P#[#/?C]U3WKH?^0Y!_V5VW_6WK
MWBQ_Q=; &(RE'G,5B\WCI&FQV8QU%E:&9HWB:6CR%-'5TLK12A9(F>"9258!
MEO8_3WCQ-#);S2V\H_5C8J?M!(-*<<].=.7MOKW2+["['Z]ZEVAF>P.U-];/
MZVV)MV 56>WGOS<N&VCM7"T[.L2393/Y^LH,501O*X13+*NIR%%R0/:W;MMW
M'>+V#;MIL)KG<)31(XD:21CZ*B L?R'7JTR>M?3Y,?\ "IG^5;T)69/!;%W=
MV5\G]S8_73M#T?LD_P!TDR !*PR[[[$R.QL#D*"Q4M58<Y>(!K('8.JY$<K_
M '4/=GF&.*>_L[;:[9A7_&I?U*?\TH1*X/\ 1D\/IHS(.&3U3KV9_P +0-R3
M5<E/TY\#<)CZ**4B'+]F=YU^8JZV#4A!DV[M;KG"0XN;2&! RE8MR#<6(,T[
M7]R.V5 V\^X$C2$?##:JH!_T\DS%O^<:_P"7ILW&<+CHJV7_ .%CO\P&>E"8
M'XW?#K&UOF0FHR^ [JS=+X KAXUHZ/N?;\JS.Y4A_.54 @H;W LB^Y9[>!ZW
M',N]/'3@KVJFN*&IMG'K44/VXS[Z@_P]*O"_\+*?F5!6B3<7Q-^,N4QPC(-)
MA<EVG@:TRET*N,A7;LW'"(Q&&!7[:Y8@Z@!8I9_N4<EM'2VYOW1)?5E@=?/%
M!&A],U]<=>^H/\'1WNG_ /A9UU/D:NBI>_?@]V'LZA\Q7(9WJ#MK;79568"U
MUGH]J[TVOU3$LRJ=/B?,D,5U>0:M"@/>ON2;Q&KMR]SW:S/^%;FW>$5\JR1R
M7!I\Q%7Y&F;"<>8ZO$^+/_"@G^5-\KZG%83:_P FL-U5O?+ND,&Q/D'C*SJ'
M+)4RD+344>Y\_KZQRE=52'1%3T&?JYG>RA;LMX(YJ^[M[M<HK-/=<K/=V"#,
MUHPN%H.)\-/UU XDM$HIGR-+K*C8!SU<[25=+7TM-74-3!64593PU=)5TLL=
M1355+41K-3U--/"SQ3P3Q.&1U)5E((-B/<)L&1VC=2K@T((H01@@@YP>/ITY
MU(]ZZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>N/>J]>Z
M"#N/Y ]$?'G;O][>^NY^K.E]L$2&+/=I;^VML/&5+0F,/#15>Y\IC8JZJU2H
MJQ0EY7=U55+,H)SLO+V_\R7/T?+VRW=]=>:V\+RL/F0BM0<<F@H"?+K1(''J
MDWO3_A3Y_*)Z6EKZ##=S;Y[ZS&,619\5T5U?N+-0S3QABM-C]U;\/7>Q,H9=
M(TRTV6EI^1>06:TY;!]UCWBWQ8Y)MDM]OA;@UU.BX]3'%XTHIYAHP?EU0RH*
MYJ>JL^S/^%G?2V-GJH^G/@QVAO2FX6BK>S.X=I]8S&Z"\U5B]K;/[;C7QR$_
MMI5GR #UH3<2QM7W(]\E"'>^?+6$^8AMWG''R9Y+?CZE<>G5#<#R7/1-]U?\
M+,ODY6&7^Y'PQZ(VZ"U/X!NK?G8&\3$JH!5"4XF/8PF,KW,941^,<$/]2-+/
M[DW*Z!/WASK?RMY^'%#'4^5-7BT'YFORZKXY_AZ"?,_\+&_YB$[TYV]\=_AA
MBT59/NES6T^\,\TSDKXFIWH>]MN"E5 &U!EF+7%BMC<X@^Y;[<J'%SS)O;GR
MTR6J#\ZVK]>\<_P]2</_ ,+'/Y@<%,ZY_P".'PYR=89W:.?#[>[KP=-'3&.$
M)"U)6]T[AEDG642$R"9%964: 5+-2?[EGMX67Z;F;>E2F=3VSFOR(MD%/R/K
M7KWCG^$=#_LO_A9_V]130?Z1/@?UON6G#+]R-E]W[GV1,R_;NC&!LYU]V"B'
M[LK( P:\8,=]1$JAZ^^Y'L\@;]V\_743>7BVT<OGYZ)8?+'VYX"A\)SYKCJP
MCJ#_ (6)?!;=4U+1=R_'GY(]15-3*L4F2VY%L/M7;-!&1'>HR%;%N39.YC$A
M+7%-AZF2RBRDL0L<[S]S#G^T#/LO,>V7B ?"_BP2-\@NB5*_;(!\^KB=3Q%.
MKP?C%_.&_EH?+^;'8WH[Y?\ 4N4W5E)H*2AV%O;*5G4W8==D9@%.-Q.R>TZ'
M9VXMQ544OH9L93UD+$721D*L8(YI]F?=#DT2R;]R;>):I4F6)1<0@#S:6 RH
M@_TY4^H'3@=6X'JRR_N,N'5NO>]5Z]U[WOKW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U__0W^/?NO=>]^Z]U[W[KW7O?NO=='Z>_=>ZUQOYS_3]3A>S>N^[*"E<
MXC>^W3LK.SQQ_M0;GVM+/68V2JE_%1F=O9 1PK^4Q<A_'N"?=;:VCW#;]WC7
M]&:/PV_TZ9%?F5-!_I3UQA_O+_;F;;>=^3_<^TA/[OW2S^CG(':MS:EGC+'^
M*:WDTH/,6S'RZI1((^O^^_Y'[B;KF)0CRQUU[]UKKWOW7NO>_=>Z['U]^Z\.
MEWUMV7OCJ/>.%W]UUN/([7W7@:E:B@RF.F9&*7!J*&N@8-3Y+%5T8,=32SI)
M3U$1*2(RD@J["_O-LNH[RPF,<Z&H(_P'U!_$#4$8Z%O)7/'-/MYS+MO-O)N]
M36&_6LFJ.6-B"1C4DBGMDB<#2\4@:-U)5PRGK;.^$OS1VE\M]CR2F*FVYVGM
M6EI%W[LU96,0,]XH=R[;,TCSUFV\E.A!5F>:@F/@F+ P33Y*\H\UVW,UF6TB
M/<HP/$3_ )^2N2A/YJ<'R)^@W[L/WF.7OO"\J/(8TLN?;"-!?V8)IGM%S;:N
MY[:5@<$EX'(BE+!HI9CO7'^^_P!O[%_64'7C]/?NO=:MW\X?!S8OY8T&2=9!
M#N3JC:&5A=K&)FI,IN7 RQQ%5&DQMB 65CJ&L']++[QW]T83'S+'(0:26R-^
MPLO^3KA#_>/;5+8_>"M;YU;P;WE^SD4GAV2W,! /R\*I'$5KP(K51[CCK /K
MWOW7NNQP?]]_L/>NMC!Z&_H3Y#=H_&W?%-OOJ_/OC:R\$.:PM9YJK;FZ\9#-
MY3A]RXI)J<5]&^I@CH\533EB\$L4GK]FVR[WN.PWBWFW3:7QJ4UTN!^%A7(_
MF.(()/4H^TOO%SW[*<T0<U<B;N8+D$+-"]6MKJ(-J\&YBU+K3C0@K)'4M%(C
MYZVT_B=\J]A_*_KJ+>.U2<5N'%&FQ^^MEU4PER.ULW-"9 BRA(AD<+D?&\E#
M6JBB>,%66.:.6&/)?EKF.RYEL1=VPT3IB2,G*,?\*FATMY@' -0/H1^[][^\
MI_> Y+CYDV"MOO%N5COK)CJDM9R"::@!XD,E&:"90 Z@A@DJ21H:6X_WW_$>
MQ'YTZG?K62_G+[*GPGR,V9O-(77';XZRQT'W#:S'+F]JYK+T.1@B+,R#[?$5
MV-9E72+R7MS<X^^ZMH8=^M+H+VRVZY]60L"/R!7KAW_>5<L2[9[S\M\S+$PL
M]UV*-=7DT]K/,D@'^EBDMR:?QY'$FH6WN,NN=5#GY==>_=:Z[^OO77OET;SX
M$[.GWO\ ,+H'%0PF48W?M!O"4G6$AAV%3U6]6ED9 =&EL" H-@SE5_M>Q1R9
M:&\YIV6(#X9A(?\ FU63_GWK(K[I?+<G-'WCO:2PCCU"#=DO#Z!;!6O:D_;
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M0@@@D$&_O%H@@E2"".G>LE_>NO=>]^Z]U[W[KW6KQ_PKE_[=6;=_\6QZB_\
M>,[8]Y5?<\_Z>U<?]*BX_P"KEOTU-\!Z^9;[ZC](^O>_=>Z][]U[KWOW7NOL
MW_RNO^W9O\NO_P 44^(__O@.OO?$SW6_Z>C[D_\ 2_W#_M+FZ,!P'V='J]@'
MK?7O?NO=>]^Z]U[W[KW7O?NO==7'O51U[HO/R:^6/QQ^&_660[?^3?;VSNG]
M@T+/!%E=U9 I7YW(I"]0,'M';E#%6;EWGN.6GC:1,=BJ2LK7C1G$1168"/E?
ME'F7G7=(]FY6V>>]W!LZ8QA16FN1S1(TK0:Y&5*D"M2.M,P45)QUI2?S O\
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MQ"PTFX*;"3232+!3-5R$%L&O<G[KG/W(XNMRV51O.P)4EX%(N(U J3);U9B
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MGEM;F,I<1L58'B"#0@CKYI=]V+=.6M[W7EW>[![;>;*X>&:)\-'+&Q1U/S#
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M! /M/<VT%W#+;7<"2VTBE71U#*RL*,K*:AE()!!K4$BG7A]M.OH__P#">O\
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M4.FNH-Z][=C[;ZQV#C7R&?W'6+#Y&63[#$8V,ALEG<S/$K_:8C%4MY9I#R0
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M>/I(XX(0S-8R/([]:N4^4M@Y)V.RY=Y:VY+;:X!A1\3,?BDD;B\CT&IFR?L
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MNKZZLF>HJZVMJZAY*BJJZJHD9Y)'9G=V+,23[ZKQ1)"D<<486)5  & H
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M:7\#6U[;1S0'BKJ&'Y5KGT/$<1T'N9^4^5^==IGV+F[EZSW+9Y?BAN84F2O
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MC<D2)K>]N]&=L]$;A?;':^QLWL[)%I11S9"F$F(R\4#:):G YZE:?#9ND4D
MR4L\JJ3I;2UQ[@?<]GW/9KCZ;<[1XGS2O!OFI^%OF03^1KUQ8]Q?:OW ]J-X
M.P\_\JW6VWM6\-I%K%,%-"T$Z:H9T]6B=@#AJ,".@E_WW^/^V^OLLJ,]1[0\
M?+KUC_R(@^_5Z]0Y^71WOY;\,LWS8Z'2**25QF]RS%8T9V$5/L/=<\\A502(
MX88F=S]%5238 ^Q=R'GFS9J?Q.?R$;D_RZRB^Y;%)+]Y[VH6-&9A=7)P*FBV
M%TS'@<*H+'T )-*5&X0/K^./Z?[Q?\'CWE%2E/3KZ-\8I_JX]=D7%O?NO==
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M]M_O/_&O?-L#I3UR][Z]U[W[KW7O?NO=>]^Z]UID?\+-/^R9OAA_XG7?W_O
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M?+U.IT :2I<*S %8^:?WS]G6UY_Y;WF-:)=;6(V.>YX)I*G[=$L:T]!\ZE7
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M[$<S7.\;#:3W/M9?3%K:XH6^E=R3]%<,*Z60#]&1](GC%03(DBK7E_OOJ/\
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MQ.76IX]7[>\?.G.O>_=>ZTR/^%FG_9,WPP_\3KO[_P!X"#WFS]R;_E:>=_\
MI7Q?]7CTQ/\ "OV]?/=]]&.DO7O?NO=>]^Z]U[W[KW7W#>EL51X/IWJ;"XZ-
MH<=A^M-B8N@A:1Y6CH\?M;%4E*CRR%I)62"%1J8DDBYN??"'>Y9)]ZW>:7^T
M>ZE8GADNQ./+)X=& X#H3/99UOKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NOB-_*+_LIGY%?^)U[<_P#>_P!P?7Z^^Z'*G_*K\M?\\%O^7Z*=(&^)
MOMZ KV(>J]>]^Z]U[WH\#UOK=Q_X1=_\S-^?O_AB?'W_ -Z#MCW@M]]S_DE>
MWO\ ST7G_'8.GX.+=;]'OGQTIZ][]U[KWOW7NO>_=>Z+M\H_E?\ 'WX8=09_
MO3Y*]F[>ZNZXP%J<Y3-SM)D,]F9::IJJ+:^T,!1I/F]W[LR<%',U-C<=!45<
ML<4DF@112.@CY5Y1YBYWWFWV#EC:I;O<I/PJ.U%J 9)'-$CC4D:G<A02!6I
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MA6JW!F\1@J9M6FIS&2HL9 UFCC:TU;-!&UI)D7@\%E'Y'MJ6:&!2\\RHOJQ
M'[3T7;CN^T[/$)]VW2WM8#^*:5(E.0.+D#B0./F/4=,=)V7UQ7SK34._]DUM
M2X8I3TFZL%4SL$4NQ6&&O>1@JJ2;#@#VRM_8.P5+V$L?(.I/^'HI@YWY,N9%
MAMN;MKDF-:*MU Q-,F@$E<#)^72UN/Z^U?0GZ]<'_?'_ 'OWXCUZ]7HI?R>^
M&?3/RIP\<6^L5+B=X8^F:# =A;=$%+N?%J"SQT=4\D3TV<PPE8DTE4KJFIC"
MT,C>3V&>8>5=KYCB NTT72BBRI\2U\CY,OR/J:%2:G'WWT^[3[:>_NVK'S5M
MYM^9(4TV^X6^E;F(<0C$@K-%7C%*K 58QF-SJZUYN^_Y8'R;Z:JJVMVWMU^Y
M=FQ%Y*?<'7M)-5YN.$,0@RVQS)/N*FJV12[BB7(TL8^M1?CW!^\^WF_[4[/;
M0?56GDT0JP^3)74#YXUCY]<=O=K[BWOC[:SW5ULNRMS+RV,K<;>K/.!F@EL>
MZX5Z9/@BXB4<9:XZKRR.,R6(KJG&9;'UN,R5%*T%9C\C2ST5=23)^J*II*F.
M*H@D6_*LH(]@B1'B=HY4*R Y!%"/M!R.L.[RPO=NNI['<+22"]B;2\<BE'1A
MQ#(P#*?D0#U"L?Z?[ZU_]Z]U^?26A]#U[WH4/GUL#)P<=&XZ,^#OR5^0-31R
M[-ZZR>)VU4NBOOC><51M;:,$#$AJF"NKH/O<Y%&19UQE/6RJ2+H!R!-M'*&_
M[V4-K8,MN3_:2=B?;4Y8?Z0-UD/[5_=:][/=Z:!^6^39[?8W;-[>AK:T53Q9
M7D&N<#@1;1S,"150*D;#WP__ )=75OQ?-'O#+3)V-V^(&U;PR-$M-B]M25$1
MCJJ;9>&=YQ0$QNT35T[25DR%M)@CD: 3CRMR+MO+NBZE/C[I_&1A<9\-36GI
MJ/=3A05'78O[N7W->0?8KZ;F/<9!O7N-IS>2(%BMBPHRV<)+>'BJF=V:9P20
M8E<Q"Q  W_WW]/\ 7]CG\L=9C?X.N7OW7NO>_=>Z][]U[KWOW7NO>_=>Z)?_
M #(,T^V_Y>'STW%'3K5R8'X8?*/-)2M(85J6Q?1^^:Y8&E57,2S&#26 )%[V
M]C;VT@%S[C^W]L6H)-[L5KZ:KJ(5_GUH\#]G7Q=1[[<+]O2#KOW?K77O?NO=
M>]Z:A!KPZ]UMZ_\ "-VG@;YW_)RJ:"%JJ'XDU]/#4&-#/%!4]Q]625,,4I!>
M.&HDI(F=00',:DWTBV&OWTRW]0N5UJ=/[X!IY5^FN,TX5XT\\GR/2BWXMU]&
M3WS9Z4]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:O'_  KE_P"W5FW?_%L>HO\ WC.V
M/>57W//^GM7'_2HN/^KEOTU-\!Z^9;[ZC](^O>_=>Z][]U[KWOW7NOLW_P K
MK_MV;_+K_P#%%/B/_P"^ Z^]\3/=;_IZ/N3_ -+_ '#_ +2YNC <!]G1ZO8!
MZWUI3_\ "SO-/!T?\%]N^!63*]K=QYIJHR$-"V!VALVA2G6+2P=:I=QERVH%
M3".#JXSA^Y)#JW[GVYU4*6ELM/77)*?^?.F)_A7[>OG_ 'OHATEZ][]U[KWO
MW7NO>]&M#3KW7U?_ /A-'04]%_)4^&LD-/20S9"3Y#5]9+2BF+5D[_*3NRGA
MJ*N6F+":KCQ]-!"=;&2-(5B;3HTCD5]YYRWOCSJ"S%%^D"UK@?0VIH*\!4DX
MP:EO.O2V+X!U>U[@3ISKWOW7NO>_=>Z][]U[KWOW7NOGN?\ "S3_ +*:^&'_
M (@G?W_OP(/?1?[D_P#RK'.W_/?%_P!6NDT_%>M,GWFUTGZ][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][T>!ZWU]%S_A&W_P!D,_*'_P 6PG_]]!UK[YL?
M?3_Y7SE7_I4?]K,_2F#X3]O6W[[PVZ?Z][]U[K3(_P"%FG_9,WPP_P#$Z[^_
M]X"#WFS]R;_E:>=_^E?%_P!7CTQ/\*_;U\]WWT8Z2]>]^Z]U[W[KW7O?NO=?
M<>ZM_P"99==?^&)M'_WG\?[X/;M_R5=S_P">B3_CYZ,!P'2[]E_6^O>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^(W\H_^RF?D5_XG;MS_ -[_ '![
M[H<J?\JORU_SP6__ %93I WQ-T!7L0]5Z][]U[KWO1X'K?6[C_PB[_YF;\_?
M_#$^/O\ [T';'O!;[[G_ "2O;W_GHO/^.P=/P<6ZWZ/?/CI3U[W[KW7O?NO=
M$._F+?S#>AOY:?QQW!\@^\:^6L83-@.M^N</44\>[>U=_P!123U.+VCMU9UD
MCI(O'3M49#(RHU/C*&.29UD?Q03#_P!MO;CF#W/YEMN7=@C _'-,P/AP0@@-
M(]./&B(,NY"B@JPJS!14]?*._F&_S'_DQ_,N[OK.Y/D+NEGH<>U;1=:]68"H
MKZ?K?J;;=6\#2879N$JJJH"5F0%)"^3R<YDR&4FA1IY#'%3Q0];O;CVRY9]K
M]BCV7EVTI(U#-.P!GN'%>Z1P!4"IT(*)&"=*U+%D;NSG/1"/]M]/<@@$$8QU
M3KWN_7NO>_=>Z][]U[KWOW7NO>]:EXUZ]U[WX$'AU[KWOP(/7NO>]]>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NOK!_\)I/^W)OPK_\N-_^"T[X]\BOO/\ _3\^
M>/\ J#_[M]ITMB_LU_U>?5ZWN ^G.O>_=>Z][]U[K__2W^/?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW6.66**.2661(XHD:2621U2...,%G>1V*JB(HN22 !
M[T2*&O#JKND:.\CA44$DDT  XDD\ /,^753WR9_FQ=/=155?M/J.@@[FWG2-
M44M5DZ')FBZ^PM9%>-?)GH8*F;=$D4I#&/'J*:1 5^\1OI&O,'N3M6V,]MM:
M?5W(P2#2)3_IA761Z+C^E7KG][X_W@?MQ[=7%WR_[>6B\S<RQEE:5)/#V^%A
MC,X#FY(;BMN/#85 N5;JE7MS^8;\LNX9JE,IVGEMF86H9M&V^M&EV1BX(FU!
MJ5J[%U!W+D:5@Q#)6U]4&'!]Q/N?/',VZ%O$W%HH2?@BK&/V@ZB/D6;KF/[A
M_?%^\%[CR3KN'/D^V[6Y-+;;:V42J>*ZXC]3(IK2DUQ*"./1,\ADJ_+5DV0R
ME?6Y.OJ7+U-=D*J>MK*AR23)/55+RSRN;_5B3_B?85=VD=GD8LY\R:D_:3GK
M&N\OKS<9Y+O<+N6>[<U9Y&9W8GB69B2Q/J>H=_\ '^O^W/\ O1]T^T5Z3*2#
M@]"WUSWYW3U'4PU'6O:6^=FB%T8T.'W%D8L-4>.Y1*[!232X7(P(22(YZ>1
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M\O67-7)6^V^X[#<#MEB:H#4!9)%-'BE2H#Q2*DB'#*#TNQS]/Z?X?[#^E_\
M#VM^?0K'2-W?UQU]V! E-OS8>S-[4\2-'%3[NVO@]RPQQO?5&D69H:V-4:YN
M +&Y]I+JPL;Y0M[9Q3 ?QHK_ /'@>@SS%R7R=S=$L/-?*>V[I$JD!;NU@N0!
MZ 3(X -3BE.@9E^&/Q.EDDE?XZ=/AI&9V";%P,2:F)8A(H:-8HE!/"JH"C@
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MOKV6Q]K8V*,PU1S[E2H+STHR6K?Z';&A9:/< N5BAJO_ !]?];_D=OQ_O/\
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MGJ[,Q_:37K!+F'FSF?FV];<N:N8[[<MP/&6ZN)9Y#_MI6<_SI_@Z2O\ K?\
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MW[KW7O?NO=>]^Z]UJ\?\*Y?^W5FW?_%L>HO_ 'C.V/>57W//^GM7'_2HN/\
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M&;B9[D\FW7('/',/*EPC>';7#>$Q_' _?#)7@=49753@X9>*GI<C:E!Z.U[
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M3IT__P#8=[]_K@<^?]-MN_\ V67'_6SKU!Z=>_V0GX,?]X7_ !._])TZ?_\
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M[Z,=)>O>_=>Z][]U[KWOW7NON/=6_P#,LNNO_#$VC_[S^/\ ?![=O^2KN?\
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M0U7A@HMOT-2&(D@Q\-,LRA1,92H;W+>P\I;+R\-=C;EKLBAE?N<_82**/4*
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MU[KWOW7NO>_=>Z^X]U;_ ,RRZZ_\,3:/_O/X_P!\'MV_Y*NY_P#/1)_Q\]&
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M=DJR9UI\;AL53R/&M5E<O72)! A95+O=V5 S*AW3<K3:+"XW"\>D$8K\R?(
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MBY5^_GL#NWMYNEWS%R[927'(LSE@45F:S)(_2FI4B($TBE-12B.0]"ZN.0,
M">[K91N/>,E0.G>N_?JCKW75Q[]4=>Z[/OQI2AIU[JC'^:U_/E^)?\L[!9K9
M--EL5WK\K6HG3!=!;-SE/(=L5LT*O2Y/N3<E#'D:7KO%1)-'.*"57SE=%)&U
M/2"!VJXIY]H_8#F_W1N+>_:%[#E*O?=R+_: '*VR-I,S'AK!$2&NI]0T&CR*
ME<]W7S%?F'\Q_D!\[>]=T?(?Y([UGWEO_<OAHZ:&&-Z#;.SMM433-A]E;&P
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MPP"*<"1:P_WW]./Q;_;6]Q;FM3Q_U8'7-PG]O_%?+KH?\5_WKWOJHXCJY_\
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M]OY7??4^X=D8_+;C^'G;^>R55TGOAA79*79=8Z')5?36_LE*LII]T;=A,O\
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M6\>SIJF."ITL\;24FS,!64U6*=PJO%+/E(I"& DIE/'N*-V]UZ,\>R[>"O\
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MMS_WO]P>^Z'*G_*K\M?\\%O_ -64Z0-\3= 5[$/5>O>_=>Z][T>!ZWUNX_\
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MRX :5L1H#0NPI\L*,%CF@\B2 <COO >_'*OL!R1-S3OU+C=IM4=E9!PLMW.
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M7<TA((L8Z-*_HODBG@';@#Y"K4[>LE_NP?=\WCW_ /<*UVIH9(>2;!DFW*Y
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M;V@N-]Y9Y:]X=GM"]SM ^COM()(M)G+P2GT2"X9T;YW0; 5CUKG^X+^77&4
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M /\ 8_[Z9_UKY6_Z:7;_ /LHA_Z#Z2:6_A/7O]E<^3/_ 'CKWK_Z*/?_ /\
M8_[]_6OE;_II=O\ ^RB'_H/KVEOX3U[_ &5SY,_]XZ]Z_P#HH]__ /V/^_?U
MKY6_Z:7;_P#LHA_Z#Z]I;^$]=_[*Y\F?^\=>]?\ T4?8'_V/^_?UKY6_Z:6P
M_P"RB'_H/KVEO0]?8'_EG8O)X/\ EP?R_,+FL=78?,X?X1_%+%Y;$Y2DJ,?D
M\7D\?T1L*DK\=D:"KCBJJ*NHJJ%XIH9462.12K $$>^,_NA+%/[F>XD\$JO
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M&,IF9?M,+M_L4_;]=;WJ 68F?*C:BQ1J 6G>[-G3R!]\C8[U+>Q]Q=G>RO*
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M'^]*M?G\NLOON+<RS<N_>7Y$A2?1:;C'=V<N0-:R6TLD:DDBO^,10,!Q)&D
MDCK;B!Y_WQ_K_3WDT/,UZ^AKUQT'?;?9^V>FNM-Z=H[OG:';^R<%5YJM2-D6
MIK98@L6/Q%%Y62)LEF\E-#1TRN55JB= 2 ;^T&Y[C;[5M]WN-T?T84+'YTX
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M]UU?W[KW7=_?NO=>]^Z]UZ_^^_V__%/?NO=>]^Z]U[W[KW75Q_7\7_V']?\
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MGJ*NMK*NI>6>JJZJ>5GDD=F=W8LQ)-_?5*...%$AA14C4!0%H  ,4 & !0
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M+2UV4J(TC6KS&3%(:FLG*AIZJ621O4Q]\8>8=\ON9M]WCF+<W#;A>W,DTE.
M:1BQ"CR5:Z5'DH \NEP%  .A>]D_6^O>_=>Z][]U[K__U-_CW[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[WH]>Z^9'_ ,*KOA1GOC]_,+J/DKB<.\?5
M/S!V]C=V463IH7_A^-[8V-A,)M#L?;L[:6$-?DJ>CQN?N[?Y1)EY_'Q!($ZC
M?=*YX@YB]N%Y8EF!W;9I&C92>YH)6:2!P/X5J\5!2GA+6FH523+1Z^1ZJ)_E
M??S M^?RT/F%U_\ )W9N-DW+A<?3UVS.U=AI6C'KV#U/N>>@?=6UUKM$B4>3
MAJ,929/&3.KQ09?'4LDJ21(\;3'[J>W5A[H<F;CRM?S>%,Q$L$M*^#<)JT2:
M1Q%"T;@$$QNZBC4(;1]# ]?6C^'_ ,VOC/\ .WJ7"]R_&?M';W8&VLC04%1F
M<+35]%%O?8&5K8#*^UNQMHK4S9?9^Y:*1'1H*E?'.$\U-)44SQ3/R$YSY&YI
MY W>?9.:-IEMKE68*Q4^%,H-/$ADIIEC.""IJ/A<*P*A<K!A4'HUO^V''^!'
MUO?_ &-O80\P".M]?-4_X5O=U]0]N_/;IG&]5]E;*[&J^L?CK3[*[!&R=Q8W
M<T&T-X#L_L'*R[4SU;B*BKHJ'<5'CZV&6HHFD^YIA,GE1"R@]._N>;'O.R^W
M^]R[OM=Q;1W6Y&6+Q49#)'X$*^(H8 E"0:-2A(-">DLY!84/ = ]_P )2/\
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=U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ederofferletter001.jpg
<TEXT>
begin 644 ederofferletter001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9!S%XUT?3K6653G;)$4W,?\ MDV*U/'EI<)J_C:UTN.0>7H-DOEP_>\E9?G
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M6D5K.[R*8HKA9U 5RH.]>#D 'VSCM6M7"?!W_DF=A_UWNO\ T?)7=T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU#:1+<WJSQW4VWYYD-O(VQS_ !*"JX!X&!BNJ^&L-CI_P]MVM88HE#3/,($
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M=\N,?I77Z-:RV6AZ?:3MNF@MHXY#G.650#^HH NT444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 455O[I;2RFN.OEH6QZUBZ%XGC
MU:QGEDC$<L +.@/4>HJ'4BI<KW,Y58QDHO=G245P&A^++J[U\PW./L\Y(0#^
M#TK7N_%:0^(H=+ABWJ6"2/GH3Z5E'$PE'F^1E'%4Y1YO.QU%%-5O6G5T'2%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $<,$-
MM'Y<$211Y+;44*,DDDX'<DDGW-"6\$;2LD,:F9MTI50-YP!EO4X '/8"I**
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\!MK4(OKYFCLR?D4<&0?X5S>HR-?^))RYYEN=I_/%>_Z?;QVNGV\,:@(D8
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MH.0MS@'Z9KZ"'2L,;AXT))1>YT8#%2Q$6Y*UA:***XSO"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7-Z[X1BUW6['4)[DK';#F$)G?SD<YXKI**
MN%24'>+(J4XU%RS6A1U32X=5TN:QFXCD7;D#IZ&J?AC0/^$<TE;'[2;C:Q;?
MLV]?;)K:HH]I+EY+Z"]E#G4[:A1114&@4444 %%%% !1110 4444 %)BEHH
M0#BEHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!*)*TM(\,Z'H,DLFD:39V+R@+(UO"J%@.@.*OVMI;V5NMO:PI#"I)"1K@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML=$@$>A>&I&!N 21),(VB$*$\L%#DLWJ .3F@#N:*** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^V\':9:ZT-1CDNRJS/<1V;3DV\4S@[I%3LQW-[ L2 ":PM7\8:Q9ZMJ4MO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MC;+3[VXA\=V\2O#->7DBVTC J"3:0J&!]-P//L:[%F"J68@*!DD]JB2[MI7"
M1W$3L>BJX)- 'C5O927FDVMHL_B2ZN].TJZ5[2XLXXHK-OLS1>66$2E\DX4*
MQS@'M3;2SO-)MO\ B87>OV27VC6*00V%BDPN"EN$:!MT3E7#9X) ^?/K7MM%
M 'D%O=6VAZAXCT:XTV_GN;C1[*T@00&=I7$#+Y3N@VAN1R< \GM5F?1+ZU\*
M^.+.6VEFNCI-M K+&6,SI:A3M_O?-GIWKT>WTRULM5OM15V$]]Y2R!F&WY 0
MN/SJ_0!Y9K,CV6G>,M"N=-O+C4-:9FL#';.Z7 D@2-1O PNQE.=Q&  :DO-)
MNU\,^-(FM99+B75+<J1&290L5K\PXY (;GV->ERSQ0(7FE2-%4L6=@  !DGG
ML!3HY$EC62-U>-P&5E.0P/0@T >0:MIUS'>^(])N[WQ"LVI7S2P65C:QF*[2
M0*%(F:)MNT#!)8;=F1VKV$=**CDN((I(XY)HT>0X168 L?8=Z /)]<L(Y-6U
MPSZ;>R>+FOE;1;I;>1@L8">65D V*BG=O!(_BSG--U'2;2T?5-+CT>=O$MUK
M0O+*\6T9OE>82"03 854!8,,CH>/FY]:DN(8I(XY)HT>0X168 L?8=Z'GACE
M2)Y4623.Q"P!;'7 [T >:7*3KI]_X-%G=F^N=:,\;B!C%]F>Y$YE,F-N%4LN
M,YW#&.:V_$WC*XM- EETVPOTN6OVT\2263R>3MSNGV*"60 ?+ZDCMFNT) &3
MP*CBN()X?.BFCDBY^=&!''7F@#S9_$=KH/@V*W\-VVK--<79BFO;K39VD1V&
MZ2X="FYSZ<8R0. *KFR\.FVT'48].U"\TC3+F=+PWEC*9&DE4'SY$9=T@W 9
M(!P2/[O'J,=Q!-!YT4T;Q8)WJP*\>]+#-%<1++#(DD;='1@0?Q% '$^#;M=*
ML/*73;Z&QU/5I_[.B%N5$$)&X%E.#&A*N0"/XAQS6GI45U=>*/$NH/&T1C,5
MA:-*AQL2/S"P]07E(R.NSVKHC<0BX%N9HQ,1N$>X;B/7'7%!GA$X@,J><5W"
M/<-Q'KCKB@#S+2?#GBS1?&/AR&>\TVY@AM[PRW$=G*"V]X6D+L7(\QSR#P.&
MX/:EX9LH8+[0I;?3;^'Q5%.[:]<R6\@WH5?S=[D;7#-L* $]L< UZT)X3.8!
M*GG!=QCW#=CUQZ4">$SF 2H9E&XQAAN ]<>E 'G7ACQ#;:]XGCU35K;5(M1<
MO!86DNG3K%9Q'J2Y3;YC #<V< 84=\^DT44 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@<:IH&EZO%=:#J+3W&JW-U#&GEC>CME>2X _$UW5U>VEBBO=W4-NK':K2R!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRUA\LB0D%FC1VSC:A8]!DX7I@YUM5T2YO_$VAZK'/$D>F-,QB923+YB;.O\
M#CKT.?:@#=HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!)_05G:/J^HZE/&TVDB"QGM4N8+I+D."6Q^[9< JV#GC(]Z -JBBB@ HHHH
M**Q-+\0G4O$VN:,;3RCI7D?O?,W>;YJEAQCC  [GK6W0 4444 %%%% !115<
M7ULVH-8"93=+$)FB'4(20"?J0?R- %BBLS7=:@T*P2YF4N\T\5M#&#C?)(P5
M1GL,G)/8 ]:=I5WJ5T;I-2TQ;)X9=D;)<"5)DP"'4X!'7!! Y'>@#1HHHZ4
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M:@#T*S\66E[XPO\ P['#<"6SBC=Y&A<*6;=P#C& %^]G!S@=*A\4^(I]-O\
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MUC%I)NF4B(!E&WD95N?;-;FKQWJ^.S?VFCW%W&GAB>%4>W<12REU9868C )
M/!]: .KL_%6BW\HCM;SS': W,:^4X,L0ZO'D?O![KGJ/6L ^,K+Q#X$O=5CU
M2?0(A*\2WLD!+1A92@(##!+!>0,D;L=:PO#\=VWC#PIJ#6&J"'^RIK:7?8/#
M%:R?N\1!,#8HP0"<YQ]YJH266HGX(:OH0TK4CJ,=U*/)%I(2^Z[+C9Q\PV\Y
M&1[T >JWVLV.FMY=S,WF!/,9(XFD94Z;BJ D+P>3QQ5>X\4Z%:K8-+JEL%U
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M50IVHP#;54=2!DGC/6J'AR&YA\+>-%FL;Z-[G4]0F@C>TD#2I)]PJNW)S[4
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MH\;CDJRL 5/(ZCO7F:+J&GV&N2?V'=2QS>+?M!=[!Y'B@(3_ $B)"OS$,O!
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M$5P@N56=FX+"*/!+[0W<KD@@9Q0!U^] XCW+NQD+GG'KBJU_9VUXL(G.R1)
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M36#RZ/JGVZ9Q(X#KND.U?E//[SOZ>]>BO]QOI2TUT61&1U#*PP5(R"* /*_
M6BWWB'X7>&+&[6V33HI([II$D8R2".0NJ;-N!\P )W'@=.>.Q\,:'J&BWWB&
M:Z-LR:CJ#7D(BD8E045=K948^Z#QGK[5NV5A9Z;:K:V%K!:VZ9VQ01A$&>N
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M-U9+900K*QCC12S<OM!)+.<_+P *L>#-'N_#_A#3-(O6A:>SA$)>%BRMCOR
M:W:* .;U3PJ+_P 8Z;KJ7'E+! ]O=Q ?\?";E>-3[*X)_3H35+2O 4&GZ'K^
MC27+-9:D9HH%7_EVMY Q\M?HTDA_$5V-% '&6WAC5KO2-#TG6GLW@TJ>&8SP
M2,6N3#_J\J5 3)"EN6Z$#KD)IOA75+3PSXITV9K/S]6NKR> I*Q5!.. Q*@\
M9[ UVE-=UC1G=@J*"69C@ >IH X+PSX*U7PIJ6G7&G26*VTME';ZO;>:X226
M-0JS1?)PQ .<XS]>:Z[7M'M_$&@7^D70_<W<+1,<9VY'##W!P?PI]SJD5KJU
MCIS07+R7@D*2)$6C38 3O;HN<\>M1:1KMEKC7XLS+_H-VUG-YD93]XH4G /.
M/F'- ',IX D=O#5S<Z@9+[3P5U&;O>(5!*GU&](\9_A!%:NH:%?W7CW2-<C-
MM]DLK6>!U9V$C&3;R!MQ@;?7O7244 ><W/@76I_!'B#1!)8"XU/59+Z-_.?8
MB-,LN#\F<C;CIWKO[F%KJPE@8A&EB*$CD*2,>V:GHH X72O!NI#0?#NB:H]F
M+719XIO,MY&9K@Q9\O(*C8,X)Y;ICOFDT/PSXK\/74VE66IZ<WAQ[AYH7E1S
M=0([%FC7'RGDG#$\9S@]*[NLK5/$%KI<KP&*>ZN4@-R]O;('D6('!?&1GG@
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MPVJE;C5KV:WNY/(C.]5\W!QC (V#I^.:H^*-2U:Y^'_C>QN]5N)FTK4$@BN
MJ(\L3^6=C[5 /WR. ,_S[NT\!Z18V>C6MM)=I%H\S3VH,H;#MG).1S]YN.!S
M3[CP-I-W9:Y:3O=/%K4@ENAY@!#C&"N!QC:OY4 5]1U#4=.\>>%M)2_EEM+V
M"\:X61(\R-&J%3D*,??/3'057^'W_'[XR_[&*?\ ]%Q5M-X7M'U72M2ENKR6
MZTQ9%@>24-N\P /NXYS@>PQQBIM&T"UT.74)+62=S?W37<_FL#^\8 $C &.
M./:@#(BU*]\0>)?$.D6^H2Z<NE""-&A1&=GD3?O;>I!49  XZ-GMC!T3QAK&
MJW_@@S2B%=1-_#?0HB[)'@! 921N&67. ?:NQN?#=I-K+ZM!/<V5[+$()Y+9
MP/.0?=# @C(R<,,$9ZU!=^#M*N+?2HH!/8G2F+6<EI)L>/(*L,G.0P)SG.:
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MD*NN]CZ [E3ZN*Z=?$&G'PTOB SD::;871E"%L1[=V2%!/ Z^E &G17,:?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***ANK:.\LY[67=Y<T;1OM.#@C!P
M>W6@#A[G0Y/&1\027\^J:?;SI]B2W-HHW6Z@D,-Z$Y9BY^4@X"9Y KE?!EKX
MDL_A1XE\*:II%^)X;6YBTYS V)TD5@%'&0=QSSCAO8UTO_"EO"/IJ?\ X'R?
MXT?\*6\(^FI_^!\G^- '$:/X<UN"Z^&/F:-?H-)\\7V8&Q#ODXSQ^/&:-8\.
MZW/>_$UHM&OW&JB%;$BW;]]M<;L''X\]J[?_ (4MX1]-3_\  ^3_ !H_X4MX
M1]-3_P# ^3_&@#G-:T'63IOPLO(M)O)O[&:);Z&.+,L1"Q Y4]@4;GIT]:S+
M/1M?L?#?CXS>#Y;ZXO\ 5?M%M9W46Y64NQWC:?FV\' /Z5VW_"EO"/IJ?_@?
M)_C1_P *6\(^FI_^!\G^- &'X2TK6K'XLZEK-_I>J"SO-'11<3Q)G>!'D$1G
M"GY" HYZ<5L?!/2-1T/P(]AJMC/9W2WDC^7,A4E2%P1Z]#4G_"EO"/IJ?_@?
M)_C1_P *6\(^FI_^!\G^- &>WAW4_"/Q@O/%=M83W^C:M 8KG[,N^6WD^4YV
M=6&4[9^\?09[#49;GQ-HNJZ;9VEU:Q7-C-"EW<H83YC+M4*C#=@9))(';&><
M<_\ \*6\(^FI_P#@?)_C1_PI;PCZ:G_X'R?XT <KI_A36[W1_A]HITZZL[G0
M[]KB_DDC*I$J/N&U_NN6[;2>O.*K7_A[6Y+GXHE-'OF&K"(6)$#?O]KD'''N
M#SVKL_\ A2WA'TU/_P #Y/\ &C_A2WA'TU/_ ,#Y/\: .7TO0M8C\9?#:Z?2
M;Y(-,TK[->2- P$,AC=,'CU(YZ<YK,TY9[BZ^,-A:V5S=7-Y<&"%((R^78R@
M XZ=<Y/'!YKN_P#A2WA'TU/_ ,#Y/\:K6_P*\(6\TDHEU9C)RP-Z1D^N0 3^
M)H Y.#P?KWA;Q/X<O;[2]1U2P.BIIUT-.D;S+=^25^5@2N<=\=?2M?Q#X6GM
M=:^'$>CZ#>0Z=I5W++/$NZ?[,CR(PW-DY/#$@$X[9&"=[_A2WA'TU/\ \#Y/
M\:/^%+>$?34__ ^3_&@#D-&\+W$VC^,;#6_#VIRVFJ:UYT8BC*2")F8B9,CJ
MO!P>W&.<4LVB>*M)\ ZIIQTMO$L*:C"-->\M29EB"\R&-L,=IPH#>_\ #Q77
M?\*6\(^FI_\ @?)_C1_PI;PCZ:G_ .!\G^- '/>'O#VNKXT\;R7&FZBL>K::
M$M[F["?.QCQ\Q4[0<]AT]!6)/X>U^?\ 9ZMO#:Z#J*ZI;W>#"T/+?OG<D>P!
M')P.>,UWG_"EO"/IJ?\ X'R?XT?\*6\(^FI_^!\G^- &8=)U/2?B!J>OR6-[
M<V&IZ"L$/DP,[1S*J#RF4#*YVDY( R>M<U>>"?$&F_#_ ,"Z4]A<W5W9:G]L
MNHX4,@MXRY8@D<<;N@[YQ7<?\*6\(^FI_P#@?)_C1_PI;PCZ:G_X'R?XT 5_
MA]I>HV7Q%\<WMW875O:ZA<1R6LLL15954ODC/^\.OK3_ !QX2U&3Q[X>\:Z5
M ;M].(AN[5" [0Y;YDS@$@._&>>,5+_PI;PCZ:G_ .!\G^-'_"EO"/IJ?_@?
M)_C0!5^(FBWGQ(32-!L+6[@T]+L75]>W,#0B-0I4*JN 68[CT&!@9-9(FCTS
M]H35F6UGGCBT *(H(S(Q \O "CDYQC\?3FN@_P"%+>$?34__  /D_P :K#X%
M>$!>FY$NK;CP1]M/3TSC=C\: /.M?\.ZEX7^"7AJRU6)H[M_$"3F#()C#))A
M?3/&?QKL-9\(:SXI\:^+M2L[>:SM;C1/[/@>X4Q?:)CM.,'G;\NTGIZ9K6N_
M@7X0NU16?55"G.!>LW/_  (&IU^"OA)4 )U1B!@L;^3)]^#0!@:?X<UC5+[X
M;0BQN[/_ (1V!CJ$D\1C"L%10BD\/N*'[N1@UJ?#[0KNW\<^.KO4M+FCM[^]
M26TDN("%E57D.1D>I4^OY5<_X4MX1]-3_P# ^3_&C_A2WA'TU/\ \#Y/\: *
MOA/2=5TGXL^,9KK2[H6FIF.2WN@H\HJH;.6SUR0,=?PKSBQ\*>)[?P7H.CR^
M'=1$^G^(/M5PPC!41X'*X.6'!Y QQ7J/_"EO"/IJ?_@?)_C1_P *6\(^FI_^
M!\G^- &!K^C:I-\4O$FI1Z5>R64_AZ6SAE6!BLDQ084<?49Z5A1>&M>C\'_#
M>T;1K_[1I6J-/>H(&)A3S]V3QS\ISQFN\_X4MX1]-3_\#Y/\:/\ A2WA'TU/
M_P #Y/\ &@"M9:5JNG_'W5=7?3+J33K_ $U(8KJ-08U8>7G<<\?<;CJ>/6HM
M!\(7FC_%G68K9U'AVZ6+56A'($Y+!5QV&X.__ 5]*O?\*6\(^FI_^!\G^-1P
M_!'PA"@4?VHQ QN-\X..W3 H Z?QS!-=>!-=M+:&6>XN+&:&*.)"S,[(0!@>
MYZUYG!X7UH>%OAQ=FPNU;0+S-_:>4?,52X.\+U; '\.3\W'>NI_X4MX1]-3_
M / ^3_&C_A2WA'TU/_P/D_QH YRY\,:S<67Q*U5;*Y":V%BL+7RR))=H(WE.
MJYSQG!ZDXKO/AWI9TSP)H<%Q8FUO(+012K)'M=6SEAZX+<^_6L;_ (4MX1]-
M3_\  ^3_ !H_X4MX1]-3_P# ^3_&@"MXSTK5%^+7A#7[;3+J]L;6.:&8VRAB
MC,K 9R1@?,.3QP:YK7- UJ;Q7\2)XM(OGAU/3T@LY%@8B9P$4@<>H//3C-==
M_P *6\(^FI_^!\G^-'_"EO"/IJ?_ ('R?XT <G=Z#K+Z?\*D72+XMI$R/?CR
M&S  T8.>/]DGCL*N:1X5U/3?'MCJ^@07]E;7EX\FK:;>Q$PQCYOWL;D8YSP!
M\PW8Z9 Z#_A2WA'TU/\ \#Y/\:/^%+>$?34__ ^3_&@#0^*MG=:G\.M5TVPM
M9[J\N518HH8RQ)$BDYQP. >M>=W/@G6-*T?PGXO\-:5*NNZ7;PV^H:<\)0SX
M4*Q (Y/)!(Z@YZK7:?\ "EO"/IJ?_@?)_C1_PI;PCZ:G_P"!\G^- %66UU!/
MBEIWC.33M0.FW.CM;/$+=GEMI0V[8R $X/J 1GVYKAY/ WB33OA]X9L9--N9
MKP:[_:,T$*%_LT6,8..,]\>Y]#7H7_"EO"/IJ?\ X'R?XT?\*6\(^FI_^!\G
M^- '+1>%[RU\;^+;#6_#FJZMI6O3K<6\MI,R1'YBP24AU"@9 R>FW@'->T01
MB&WBB VA$"@;BV,#U/)^M<!_PI;PCZ:G_P"!\G^-=SIFGP:3IEMI]KO\BVC$
M4>]BS8 P,D]: +5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!SR>+[2X;4&LK*]O
M+;3IF@N;BW165)% +J%+!V*Y&=JGVS6QI][%J6FVM_!N\FYA2:/<,':P!&??
M!KQS4_#7B+P_=ZEXR^'>KB:RGGEGO=*GY5G5F$F!T."&XX88P":T9O%L^K0^
M'GMKEK6WO]&DD71;,M'.K@'$HD4J%C7:<9(S@X#'H =WXO\ &&G^"M+BU'4X
M;E[>2809MU5BK$$C(+#C@UT%?-_B/6]0\0?LZZ-?:I<M<W7]K"-IG^\P4R 9
M]3CC/M77?$/Q#JME)XMCM=:DEDL[:WFMHK!VB;3^0&,S @,7SPOS'&. * /8
MJ*\9\5>(]?.F?#&XL]5FMKO5Y+=;IT.$E+B(G<@X(RQX]\59\?Z3XF\(^$O[
M:TWQ-JU^]E?&XN$FF*[[9B/D.W'"D=1CAFZ8& #UVBN6T+7+&?29O%5W?-::
M=?E'@^V7!1(TP .&.%);=TZ@BNH!#*"""#R".] &#XA\66GAJ[TV"]M+MDU"
MX6VBGC5/+61NBL2PV_\ UC5W4]933+JPMC:7-S+>RF*-8 AVD*6);<PPH //
MT'4C+?$6@V7B;0;O2+]-T%PF-P^\C=59?<'!%<K\,)+[6-(.L:Q<BZO[<OIL
M<@7&(XFPS?[SLH+'OM7TH [ZBN AO+OQ'I_BVX;4+JRN],OKBVM!!,4$ B0%
M691P^XY8[@1@X[5#X<U[4=9\7Z&UU++%%J'A<7DULKL$\TR(-RC/!PQZ>M '
MHM%>0:?J^LWGA#P/(=9O$FO=;EM;B429:2,//P2>N B@9].AKTRWL9]+\/M9
MQ:C-//%$X2[OG#OGD@N<#.,C\!0!ITC$A20I8@=!U->6VWB&;3[74[/6;K4_
M#^LV^E.[R7<K7=O(<JOVB$Y.2&(^0 ?> Q6IX:O-1@^(D^DS27RV9T6*Z$%Y
M<&5_,\UD+G).PD#[H)'XT =3X:U^#Q/H46JVT$L$4KR((YL;AL=D.<$CJOK6
MM7D?A*Y(\&>%[!+VYCDN=0OC]CM24DNE264D>8&7RU4E6)SSC'.<4P:WKDG@
MVQ!U6ZAN8_%8TTRK)O8Q?:"NUF(R^!QD]<<T >OT5YUK4=]X'UC0]6?6M2O-
M#,[6NH+>7!<1>:Q\N4]!A6(4Y[8KM='5WM'NY'E)NY#.J2.3L0_=4 _=^4 D
M>I- &A17F>HW6IVOB;Q)X8.I7BW&J6R76AR^>P,;'Y'0'T5L.0/X<^E:G@C6
MIO%=A9W+R7$,EE:&VO4\QLB[SM<-SR5V$\YXD!H TY_%XL](TB^OM(OK634K
MV*R%O)LWPN[[5+_-TXSQFKUEX@AO?$VIZ&MO,D^GQ0RO(^W:XDW8VX)/\)ZX
MKS2*_O-3^&?@6\O[F6YNI/$5KYDTIRS8N7 S^ %=;HO_ "5OQ7_UXV/_ +5H
M W=0\0PZ?XCT?19+>=I=4\[RI5V[%\M-S \YSTQQ6Q7!^,K8W?Q!\$0">:#>
MU^#)"VUP/(YP>WUZ^E<\?$&LZ+J4_AR349+JS778K*._N[@HYC>W,ODF4 G<
M&VKNQG![<$ 'KM%<_P"'+75K&\U.WU&\BF@+I+:P"=YI+=&!!5I' + LI(SR
M.1V%<_+;W^N?$/Q%H[Z[J=I9PV-M)$EK,(RCMYF2#C(Z#Z]^* /0*HZG?S6
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M6WMP2VT$L68]2S$DL>G)/:K]% &3=^&]*O;^6^EMW6XFC$4SQ3/'YR#HKA2
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?)4E&&.5^;IQSS7*W,UWJFCZ8=0O[RXDB\;_ &0/Y[(3&LI &%('&T8].V*
M/9V.U20"<#.!U-4])OI=3TJWO)K&XL9)5RUM<@"2/G&#@GZ_C4[1;+0PI)(N
MU-H?=N8<=<G.3[G->4Z7K6LWOA/X>3/K%XDVI7K17<JL"TJ[93SD'^Z/;VH
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M.RQ;U\M& &X_,WS4 96J^%/M_BG4;O4_"UY>^?(GV>]T[4_( C5 H$B^:AW
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MSA6N4!,N =G7[WS#CKR* *"^!?#JVAM!92"W-R+L1BZE"K*&+@J-WRC<2<#
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M$ZY:[@D0"+R_[Y  7 R00*]+HH \GL-0D\'ZM#;^-4N)(+[0[2T6Z6!YT\Q
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MCE@@@MU1$G?<Z(!P&/J!UKS?3723X/\ C1.KR2ZH40CEMY?9@>^1CUS7K%%
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M)LC:J5DN[60.UV<8!5=HV#N<G/;'/ !OZGK,>G7=G9K!)<7=YO\ )AC9%)"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,S0,Z<KO7[P![X/%7: "BBLGQ)K$V@:%=:I%I\E\+9#))#$X#[!U(SUP.<4
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M.RGLUL8/L\Z[9D*Y$@QC#9ZC''/;B@#&\"Z3#:>'K#4A<7<US?V%JT[3W#2
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M)4G=N&0!R>]<[8>']0TJ[\%1265R8XM4O;MT2%G6TBE$AC5B 0N-ZCV.?3-
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MM!83+8W;QW7C)=46%+=F-O;\@LP .W)&[!Z;O7-2ZOI&HW\WQ/AM["Z)O[2
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MUS;W<+0O[!AC(]QUKS*WT#Q<NDZ!K;Q?\5!I4PTWRR25DMLM"TC#ODE9,^B
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M6;O',OVL2>:L@&TY4\C.>O& :]&\<Z7>Z]X%U;3M-.V[N+<B)6.W<>#L/IN
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M6FZC<Z1XR^(NIS6$ GM+"SN&ABF.V0+',V=VW.2!W7K^==+#XP:74?"UM]@
M37[1[A7\[)A*QK(5(V_-]X#.1]* .HIB312,ZQR([1G:X5@2IQG!].#7'V/C
MJ:;7=&TV^TG[$VK>?Y,;S_Z1#Y8+ RQ%1MW*I(P34?@*-(];\:K&BJO]ML<*
M,#_4QT =O6/KOAZWU^33'GN;F$Z=>)>1>04&Z100 VY3D88],54U#Q)=K/JT
M.CZ6-1ETI%,Z&;RR[LN\1Q_*<MM(/.!\P'KB4^()KG4CING62/>QVD=W.EU*
M8A$')"H<*QW':W;C'O0!O45Q#?$/?9Z1+;:3))/>ZD^ESP/.%:VG7=N4G&&'
MRGGC@@^U9WB+QUJZ>"?%<UM906.KZ-)]GE_?F5%#*I62-MHR<," 0,'\B >D
M5";NW$DL9N(@\*AY%+C**>A([#@_E7*ZAXMU>TUV/0K;P_'>:B^G-?*J7VU#
MM<+M+,@QG/7'7 Z<C#\67UG=P>/K%]%A@O8-"$LMWN#-,#'(5!XXVE3WH ]+
M1UD171@R,,JRG((]12UP>B>*[ZP;PWI6H:,(+74K58[.[6Y#DR+$&VR*%^3(
M!Q@M_A+#\0'F\-:3K/\ 9:@7^J#37B^TY\LF9HMX.SYN5SCB@#MB0JEF( ')
M)[4R&>*YA2:"5)8G&5=&#*P]01UKC=-UW5[[Q/XNL;NTM);+3?*C2(3'E6B+
M]"G);=@],8[]U\/>)[,^'?#%OI6E16TFJP/):V0DVQPQH-S$L%Z#(' Y+?4T
M =K17#:K\0GTC1]?GN-)SJ.B/$+BT2X^5TE(V2(Y7D'/< C!'UU].\2W,_BZ
MY\/7^FK:S+9K>P2)<>:)(B^PAOE&U@<<#<.>M '145B:WK5UIMW;6]O8)(DD
M<DLMW<S&&W@"8P&?:V&8MP/8GM6%;_$-[W3/"UY::.TG]ON\:1M<!3"RJQY.
M.1\IYXX['I0!W%,\Z+S_ "?,3S=N_9N&[;TSCTKDK7QT&TW4)+VP$&H6>I#2
M_LL<_F+-.VW9M<J.#O&25&,'CBL_33='XV7AO+2WMY3X?C/[B4R!QYYY)*J<
M]NG84 >@45CZAKAM]:M-&LX$N-0N(9+C:\FQ(XD(!9B 3RS* ,<\^E<]?_$*
M2QT/4;]](!GTF\6UU*W-R1Y*DKB52$.],,&Z XSZ4 =S16%JWB:'1XKVZGB5
MK*SM4G>5),EF<D(BC&,G'7/<>M9J>-I!>7=K)IT<C16+WD<MM.SQ-L^]&S%!
MM;N.#D9]* .OIKNL:,[L%11DLQP *XW3_&>LW^A6VK)X6E,-Y%;/:;+H/N,I
MPV_"Y1$ZEL'CG / S]9\21>)O /CJUEMH!+IEK<0N8IA-$Y\DNK*V!Z],<$4
M =^+F F(":/,PS%\X^?C/R^O'/%.EFB@3?-(D:9 W.P R> .:\W"(/%/PPDV
MKO.GW*EL<X^S)QFM+XJJO_"+V4AB\QX]5LV0 #.?.4<9Z$]* .YHKBYO'%[8
MW6LV&I:(EO?V.GOJ5NB7>^.Y@7AL/L!5@>",'KZ5;@\8--J/A6V_L\"/7[1[
MA7\_)@*Q+(5(V_-]X#.1]* .IJ.">&YB$L$L<L9) >-@PR#@\CW&*YS0?%<W
MB!DEM+2U>U+R1N8[O=+;LN<+*FP;2<>IQ[UAZ5XQMM/\(:#=Z7X=C@M]3U5[
M!+2&8*(G,L@+?= .2C'''6@#T.BN.3QXMM#KZZO8+:W6CSPPO'#/YJ2F8+Y6
MUBJ]2P!R.*&\>+;_ -JBZL=WV&Q-\LMK(TL4BC(*;BB[6!QQ@\'/J* -B\\.
M07VOP:K-?:AB&,)]B6X(MG*MN5VC[L#CGV'I6S7)S>,S::%>:Q<P63V,2PF*
MZM+PS0R>8^PY;8"H0[2QP>#GVK;T?4)]2MY)I8K81[AY,MM<>=',A4'<K;1W
M)'X4 :-%<E<>+=3/BR^T'3]!%V]FEO*\INQ&#'(Q!."O4 9QGG!Y'&:\7Q#M
M[AK*XM[,3V%W=_9E>*0M,@+%1(T87 3(_O9 (..H !VM%<SI7BMM9U2>VLH+
M5X[>[EM;A?M1$\!3< [Q[.%8J,<]&!]0,X?$!_\ A&8M9.E+SJO]FO%]I^Z?
M.\K>#LYYYQ@?6@#M!-$9FA$B&50&*!AN /0X].*?7F\]S/IGC_QK>Z?# US#
MHUM,JRDJK,/-.3@9/ _'ID=:MZ1XSNK?PYX474OL0O\ 5[)94GN;LQQR$1QD
MY;9Q(Q?A<8X/)Z$ Z2[\.0WNOP:M-?ZCB% OV);@BV<AMP=H^[ XYSV%;)('
M4XJ"RFFN+&":X@^SSN@:2'=NV-CD9P,X]:KW^C:=JES;SW]G#<M;AQ$LR!U4
MMC)P>_&,^Y]: +VX>H_.FQS13;_*D1]C;&VL#M;T/H:\U^&.@:3>>&[F6;3[
M8S0ZU<212^4N]"DV5PV,C&!^'%4] \0S^%-,\27J:7'+I<7B>XCN'$^QHU>5
M$!1 IW8+#()7VSV /6:*X_5_'26$NJI9VD=V=,8)/&9RDDC;0Y6-0IW$*PZD
M9/'O70W&KVEKH,FLSEX[..V-TY9<,$"[CD>N.U %^L>^\.PZAKEMJ<U]J 6!
M-ALH[@K;2\Y#.G\1!]^W.:K6^N:M)>6T<VAE+>ZM6N([A)RZQL,$1R_*-I(/
M4;N0?K699^/C=Z-X5U(:8%CUZY%OL^T9,!(<@_=^8?(?3K0!VE%<?8^,-4U+
M4M1M[/P\'@TZ^DL[F=KP*!MC#!@-O.20".V0>><4]/\ B)<7/A^UUV[T/[+I
M]['$+60W:L7F>38$8;05'\6[G@'C/% '>45PM]\1&T_3=<N'TL32:7;K<J89
MV,,Z'C D*## ]1CT/TO)XLOVUZ31Y=)B@GETUK^S9KK<'"L%*R +\ARPZ;A[
MT =917,?#_5]1U[P9IVJ:FL(FNH_-W1N3NR2>00-N.@&3QWJIKGCF;0IIY+G
M2=EC#>Q68DFG\N6??M!DB0KAU4N!][LW3% &QJOAR/4]1@U&'4M0TZ]AC,(F
MM)%^9"<[65U93SSG&?>K]AIZV*-F>:YG?'F7$Y!=\=,X   R>  .3QR:YG4/
M&6H0:OX@T^RT6.X?1[6*Z9Y+SRUD5E=L?<)#83CJ#W([B^.)KN^T&VT[2A-_
M;6G-?0/+<>6$ "G:^%/]\<C/T- '8T5Q,/Q :71-)U!M+"O>:N-)N(?M'^HD
M\QD+*=OSC*Y_AZU<D\831WWB>S31YKF;1(X72.V<R/=>:I90%VC:>.>M '54
MR*:.>(20R))&W1D8$'\17,:=XE&LZOK'AZ]M+83VELDCF"X\^-U?<"IRJD,"
MI!!%5_A3_P DM\/_ /7K_P"S&@#KXYHIM_E2(^QBK;6!VL.Q]Z?7D>@^(K[P
MIH?B:_@T,76E6FOWK7+I<"-XT\S!,:;3NVCDY*^V:[K_ (26>_N=0@T*RBOG
ML$C,IEN#$'=TWA%.UN=I4G. -P]\ '145Q47Q &H3>'$TG3#<KKD$\D32S^5
MY31 ;E<;3T)P2,]#@&FK\09/[!BU"32@LZZP-(NH!<9$<GF^665MOS#D'D"@
M#MZ*Y.^\;KIM_P")+>XL3Y>BVD5T9$E+>:LF[J-ORXV\GGCFM?1=5GU5'E:*
MT-N55X;FTNO/CE!SG!VCD8'YB@#5H/(Q7(2ZUK'_  M:'142W.G#26NL>:P8
MDRHI8_*>1@@+[DY[4RR\<S3:WH^FWNDBS?5A,8(GN/W\/EJ6'FQE1MW*"1@G
M'2@#:T#P[!X?@D1+[4+Z60\SZA<&:3;DD*">BC)_.MBN*TOQU>:A:7>I2:$T
M.DV37:W-R+H,R& G[J8!8-@\]C^=36GC.YFO] MY]+BC36[5KJ"1;HMY:JJL
MP8;!R%8'C@\C/J =?17%6GQ"BO7TR:WLA-9:E,(8GBD9I8]V=CR)LPJ'')W'
M;D9[XL>!=;U;7(M7FU*.V40ZE<6R>5*3M\M@FT J..,YSR3T% '6T5B3ZY/+
MK%YI6E6T-S=64,<MQYTYB53)NV+D*QR0I/3@$=<UAO\ $,2Z?H5S8Z3).^J7
MCV+0O,(VMYD#;E;@@X*$9].?:@#MZ*X"\^)%QIFD>(I;_0Q'J>AF(SVB76Y)
M(Y3\CI)M&1UR-O&*NS^.VTC69;+Q#I?]G0FSEO;:=)Q,)$B&75@ -K@$' +#
MWH [*BN7D\67%G+HTFHZ:D%CJTB0P3)<;VBE==R+(NT ;L8R"<'CWK%N/'FN
MW>B:U?:7X?A6+36O(9;F>\&U'@!.0FW+ X/ISCW( /0J*XO1_%5]%'X-L-0M
M(Y)M;M68W"W!)4I )-Q!09+?7CWJ.Z^(4EKX;US5CI =M)U0Z<\*W/\ K#N1
M0X)7CF0<8[=: .XJ.">&YA6:WECEB;.'C8,#@X/(]ZP-/\275QXGOM O--2W
MNH;1+V I<>8LL3,RX;Y1M8,O(&X>YKD+'Q1=?V'X*/AW2;+3M/U2^EC:T\XK
MMVF0[00F "5))QWQCO0!ZE17,6'BYI=9U_3=1LH[*72(UGSYY<3PLI(D'RCC
MC!ZX/%;UK-=3:;%-/;)!=O$&:#S-P1B/NEL>O&<4 .>]M8[I+5[F%;B092%I
M '8>H'4U/7EFA:C&-)\0:MXAL;:X6T\0SM PE+R"X618HE7*C@?*H;/3J *[
M$^([FT\16VBZC810SWT,DEE)#<%TE:, O&Q**58 @]"",^F* .BHKE?!WBO4
M/%EG;:BVA_8]-N8&DCG-T'.]7*["F >@SN]C[9LR>)9;?QS!X=NK%8HKJU>X
MM+OSL^<R$;H]NWA@#GKTH T-<T@:YIK61O[^QRZOY]C-Y4HP<XW8/![BK5G:
M16-I';0[MD8QEV+,Q[DD\DDY)/<FL-?%#RS6-K#:1-=W[SFU0SD*T$1P96;;
MP#E<  YW#GJ1EZA\06TS2=:GGTL?;]&N88;NU%Q\I65E"2(^WD$-G! /!':@
M#MZ*YN[\526OB>_T7[ KFVTK^TDE$^/,&]EV$;?E.5/.31X2\1ZCXEL8-0GT
M7[%8W-K'<02_:1(6+9W*5P",<$'N#VZ4 =)17)MXLU*;Q5J6A6&@_:6T]K4S
M3&["#RY=V6 *]5 SM[\\C S'<>.3%X>;Q+#IPFT*.5EDF$V)A&LA1I1'MP5!
M!.-P.WGKQ0!UOG1>=Y/F)YNW=LW#=CUQZ4^O.Y=0L-&^*>NZO.RI:Q>'(;F:
M1!G<!+)S[G  _*MK3?&+WNNV>FRV"JMY \L<UO*95B90"4E^4!3@\$$@D$?4
M ZJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH \_U/P/JM]I_C.V2XLD/B"1&B8LW[H!%0[OEY.%SQZUH
MWGA.ZU'Q/!?W3V_V+^QY=,FB5VWGS""S [<8PN/QKH+'58K^^O[5+>ZC:RD$
M;O-"420D9RA/WA[U?H \ZA\%>)?[/\.Z7<ZEILEKH5_#/!.(W\R:*-6559>@
M;! X)SU[<]'I&A7EAXQ\0ZQ,\#6^J"W\M$8ED\I"O.1CG.?;WJSJ?BG2=)N_
MLEQ-+)= *S0V\#S.BL=JE@@.,GIW/;-9NL?$GPGH6GV%]?ZJ$MK\.;9TA=]^
MP@-PJDC!('..: )?"/A/_A%EU&-;CSH9;AVM(^@MX"Q<1CZ,[\^A'I6 O@#5
M8],#PWUI#JUKK4VK6DF&:(^83NB<8!P0Q&1S6]IGQ"\+ZOH-[K=IJ6=-LFVS
MW$D+QA6P#@;@"3R.!GJ/6M*P\1Z9J#7L<=QY4UB ;J&X4QO""NX%@W0$<YZ=
M?0T <_;^$-4N=1\3W>J75F@UVQCM&CME9O**HZYW-C/WSV_*JUCX.U\7?A6:
M\O[!!H5K-:_Z.CDR!HUC5QG&#\N<=!COGCH]*\6Z-K-W%:V=TQEFA^T0"2-D
M\^+.-Z9 W#/]#T(J]JVKV&AZ>]]J-PL%NI"[B"2S$X"@#DDGH!S0!PVE^!M?
MLIO#4L]YICRZ/<3/+*%D+W0D1D,C$]7YY'MU[5TGAK0KS1]2U^YN7@=-2OC=
MQB)B2@V*NTY _NYS[U<LO$NDWT%_*EVL?]GL5O%F&QK<@9.\'H,<YZ&H])\5
MZ/K5VEK9W+>?);+=Q1RQM&98&.!(NX#*Y_IZB@#%O?#7B*Q\5WVL>&=2T^*'
M5!']MM[^%Y KHNT21[2.=H ()QQ^5L>'-0T[Q3_;FG7$-R\]E':7D-VY3S#&
M25E#*IPW)!&,<]JM0>,]!N+^*TCO06FN'M8I2C"*29?O1J^,%A^O(&2*WZ .
M&E\#7*'1WMY[=I+?67UB]=]R^;(X;*J #@#?@9[*/6H=3\":AJ=AXUMFNK6,
MZ^Z/ P+'RBB*H#<=]HY'K7?T4 <K;:#JY\;VGB&\DL=J:8]C+%"7ZM('RN1R
M!M YQGKQTJKJ/@V]U+5_%,\ES!%;ZUIBV$97+/%A7&XC !^_TSVKH=9UVRT)
M+-KWS<7=U':1>6A;]Y(VU<^@SW-:= ')V/AF^GET!]7>U"Z(G[E+9F832[/+
M#MN V@*3\O/)Z\<X:^ =<32;71X[_3ULK'65U*WD*.9'3S6EVL.@(+8X//MC
MGTBJ.H:I'IT]C%)!<RF\G$"&&(N$)!.7(^ZO'6@#!M_#FJ67B?Q)J$$UF]IK
M"QL%?<'1TA\O''&#@'/7MCO6=IW@;4=,TSPH\%U:MJ?A^.2'#%A#<Q.-K*3C
M*GA2#@X(Z&NB_P"$JTT7.MP'S]^BHCW?[EN REAM[MP,\5H:9J,&K:3::E;;
M_L]W D\>X8;:RAAD>N#0!Q_B'P/>ZYI'B +-:Q:GK7V='8EC'#%$054'&6/W
MCG ^][<ZZ:%?'X@CQ$[6XM_[+^PF)78N&\SS"W3!';]?:M+1-=L]?M9[FQ\W
MRX;B2V?S$*'>APW!YZUI4 <SK.A:I>>+=,U:UN+1[2V@>)[6[5B(W8@B9 .K
M@#'.."<$9K T;P'K&F6'A&UENK&4:#<RRLREQYB.&4 <=</G\,>]>BT4 >?W
M7@'4+N#7"+VWM[JYU>/5["907$,J!0H<$#(^7G'K[<ZFEZ!K?_":GQ'JD^GJ
M6TQ;%H+4.?F$A?<&;''/I[=LGK** .<UC0+N7Q/IWB+2Y(1>6T,EK-#.2J3P
MN0V-P!*D,H(.#W%+:>%8&M]>_M$)++KCDW83[H3RQ&J+GKA1UXR23@=!T5%
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MA)9[>2 #:Q! !Y4'K[>]:VF67B\:?-_:^HZ7+>JFR 6T#K$W(RTF3DDXQA0
M,GUXZ:N=U+QGI^G&<_9K^ZBMY_LTTMI;F4)-M#!"!\V<$#(! ) )!H RM/\
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MP.*Z;5-(AU;P_=Z/<R2&&ZMFMWDS\^&7:3GU[U:N[F.RLYKJ;=Y4*%WVJ6.
M,G ')J#2-4M];T>SU2TW_9KN)9HMXP=K#(R* ,'PUI'BJR2"TUW5K"YLK1/+
MA:UA=)9QMV@RDG P.<*.3@YXYP[#P%KMKIGAK3'U#3_LV@Z@+B*18W+S1 .
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M;2":2$[HFDC#%#Z@D<?A0!YK\0]$EL_ _C'6[UXOMVHQ6\9CB)*0QQNH502
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M>)+J<\=Q.ZRX(="-I7 X^Z!CH0.:NZ;HUOIMQ=W2O+-=WC*9[B8C>^T84?*
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MLN,;& 5@W'.0J_E0!Y_J][>Z]X2\'^(+B_D/V[7;&;[(JIY4:M-\J@[=V5&
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MF(&+#<.YR3[>V>: .$A\<ZO'X<T/4KF]E$^G7QM/$<(CCPJJ_ELY^7Y?F9&
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M&47)9O.<$$_-D$88\$'/?-:>DZ1;:/#.EOO9[B=KB>60@M+(V,L< #L!P ,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWX;N-*U>&VT[5]:O;?Q19:H\TEDD<:SM.)&((8IN9"IY.<;>#@"NO^+T:/\
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M6D-/JU_HNJSZC;WDJ222800"4+AO+"JHW$!2WOCOF@#K:*** "BBB@ HHHH
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M0&4JP!!X(/>HX[:"*'R8X8TB_N*@"_E7#^.O%6H:#J>G75IC^RM.N8FUAO\
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M;:R8Q)L>9;:(QQXR>=JY)_7CK79ZEX@L],>9&2>=[>'[1.MO'O,4?/S-]<'
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M$2%]JEF.<C;][ISQC)JTWA[4= \3WRGPI#XDTS48X!'.S1!X'2)8BKB3^$A
M<CI[UWVCZ%9Z']M^Q^;_ *9<O=S;WW;I6^\WMG X'%:5 '%V6CWMI\2K:]&G
M+%IT>@K8^9 %6))1+NV*N<A<=.,=JQ-<\*ZWJ][X[6VM6A-_]@DL)964),T&
M"RG!R,D8Y ZYKT^B@#BM5TF\\7:GI%TUG<Z8MC%<EVG*[A)+$8P@VDY W$D]
M/E&,YXYV+3?$<OAKPCH<WAVY2XT/4[1KB998C%)%#D;T.\$Y&#@@>E>KT4 4
M;*\N[B^OX9].DMH;>15AF>16%P"H)8 <C!XYJW*YCB=PC2%02$3&6]AFGT4
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M+VEBY.[=G))Q[UZ?10!YSIFG:WH&NZ1JITBYO+>70[?3;B&!X_-MI8R3DAF
M*G)&0>HJYX-AUKP[X5@MI]"G>XFU6;S(UFC'E0R2NWFYSR "..M=U10 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!R-C\0+._\<W?A%-+
MU%-2M(Q+,S^5Y:H0IW9#DGAUX SS775XYH'_ "='XI_[!B?^@6U;/Q9\67>E
M:']AT>YEANWO+6"ZFA.&ACE\P\,.58^7^ 8>M 'I5%>5_P!K:A8?$/Q3X:M[
MF[DTN/13>1EYW=[:4*!\KDEAG.<9Z].]</H6OZ^NG?#;4I-?U2:;4=6EMKE9
M;EF22+SE7:5/!X)Y.3SUX& #Z,HKPWQ#_P )C>7GC.WAEUIM6%[;IHPL)I1"
MD.[)!*'8IV$%M^#R#7;?VYXRT:>#2K?P3-J5M"D2-J!U=?G)4%SAP7.&+#DD
MG% !KWQ2LO#FG2ZEJ&@ZRM@EZ]BMP%AQ)(I8$JIDW;?D;!(%=%I7B%M2U*:P
MFTB_L)8X$G5KGRRLB,2/E*.W(QR#CM7G?[12A?AU9A0 /[4C/'_7.6NA^)^N
M:AX<^&%UJ6E,8KP)%$LZC)B5F )'\OJ10!WM%>96D>N6VC:O>_VM$VDW6A&X
MM$3499[A9E3F57900IR"<'@X]36'X5MM7U/X21>+;KQ1K3W<.F:A^Z^U,$<@
MR!&)ZEE*Y!SGH.@Q0![317SQIVKZ[]B^&%V?$6KM-K%S/;W9:Z9@Z>:J@;3P
M2 QY()]^!CNOA5J-_/KWC?3+J_NKNVT[56BMOM4S2M&FYQC<Q)Q\HH Z+QIX
M]L? R6<FHV%_/%=R>5&]L(R-_7!W.#741.TD2N\31,1RC$$C\B17C_[0G_($
M\/?]A,?^@FM'QG=:@?C'X2TF#5+^ULKZ";[1%;W#(LF%<] < \=1SZ'(!H ]
M2HKYSL_'>OZ?\'VN)-2NY6;Q ;"2]>0O+%;[ Y <\YZ@'J,\=JZ_QY=:SX&\
M%Z[J6D>(+B[AU"X@-HKN9&L(GSN979B2&/ /0=N: /7:*\IU%-=T[PMXGU"+
M6$_LJ;2!=:<(=2EGGBD1!F19&53M;@GG&?J:YSPSK.M1>*OAPTNMZC<KJUA*
M;R.>Y9TDP'P=N<9''/7B@#VU]3M5EO(8W,UQ9Q++-!$-S@,&*C'J=IP/\:AT
M#6%U[0[75$L[JS6X4L(+N/9*F"1R/PR/8BO'_!MJ(M6^*TR7-ZDUI-*(7%Y*
M&&!-@GYOF(P,%LD=JSWU#Q(?@MX:\90:QJDUQ8W+MJ$?VR0?:8/M#CYL'G&%
M&?0GTH ^@J*\E\>>)]1TSX<WOBK1;B\C_M:>%(&=V/V>W*XWJI)"EB"<@?QC
MN*ZGPE;:O!JUU/+J%O/HEY;1364/VZ2ZE0@ ,^YU!VMD'J>?J: -/Q%XNT[P
MW-8VMPL]S?W\GE6EG;*&EE/?J0 !GDD@57G\:6FFZW8:3K-G<Z;-J!*VDLI1
MHI7&/DW*3AN1P0,YX)K@_$\,]I^TAX4OKP'[#/:M#;N?NB3;*-OURR_]]"E^
M/EO/J-CX9TO3U+ZI<ZE_HZI][A<$_0$KSVH ]AHKQZ5]0U/XP^+M%EUK5(K"
M#21/%##>R1K'(4B^9<'CEB<#C\.*YF?Q9XAU#X9>"-0?5K^WO9]6^QRW$,S(
MT\>XC+8X8\ 9.>A]30!]#T5X;K7BC7O"'B'Q[INF7EY=VMIIT5W;?:IFG:UD
M<QJ<,Y)QB1FP3CY:U=-U?4])\9^ K&&_O+J#6=*+WZ3SO+O<1[_,&XG:<^F!
MCB@#UVJT6H6D^H7-A%.CW5LB/-&.J!]VW/UVGC_$5Y#X!M-8\5:EXC6Z\4:S
M#!I>N$0)'=,=R*QS&Q;)*X &/KG-1^ +")?&7Q-*S7BO;W&R)A>2@\B8<_-\
MQ&."V2.V* /:Z*^<M+\3:[+X6^'MU)KFHM<7>NM!<,;IR9H_-4;6Y^8=N?6M
M?Q+J.K-XX^(MI'KFJPVNGZ0+JVAAO'58Y/+C;(YX&2>!CKZ4 >P:QKRZ/=Z7
M;M87UT=0N1;A[:+>L)/\4A[+[_7TJ\+ZU;4&L!.ANUB$S1 _,J$X!/H"<_D:
M\5OO$6M/HOPHN_[5O5FO[R&*\*3LHN%WH"' .&[]?4U>\)Z7!=?&OQU#)/>J
M$CB"M'>RHPW*,\ALG&>,YQQC&* /9**\:\$7>LMKVJ>!-9U#5+B_L-16Z^W-
M=2;GM ,CYL]&.P8])#_=KUFSU;3M1N+JWLKZWN)K23R[A(I QB;T8#H>#^1H
M RM0\76VF>+--\/W-C=K+J(;[-=?)Y+%1DKDMG=[8YR,5>N-9$.OVVD)97$T
MLT+3M+&4V0H"!E\L",D\8!S@^AK-\>:#;Z_X3NXY':&XM5-W:7*??@FC!967
M\L?0FH/A[)-J7A:V\0WSB74M6B2>=U7:  ,*BCLH';U+'O0!UE%>4OJ]_??"
MB?QBE_=0ZW;R2S[!,XC1DF*^0T6=I7: N",GKUYJ_)J%Z=9^(43WEU&EMI=O
M/!']H8?9W,,C,4Y^7D#ICI0!Z/16'X0FEO? VA37,LDLT^G0-)(SG<S&-223
MUR<]:\TN;W7[;1]8\/P7NH7&N^']0:^21KN3=<V0'F*'.?FR#Y>WUQ[T >MZ
MK=W%AI=Q=6EC)?SQ)N2VB8*TA] 3Q5"[\1+9^(]&T62SF$NJ1S.LFY=L?EJ&
M8'G)/(]O>N3\4ZQ)J'PQU[Q/I=[=P)-:JUD\4SH51<?, #P2Q89'4!:O:X2?
MB5X#).28+_G_ +91T =!X>\0Q^(1J9CM9;<V%_)8NLI!+,@7+<9&/FHLO$$=
MYXIU/0A;2QR6$,,S2L1M<2;L8 ]-O>L/X=_ZSQ=_V,=U_*.LTZ.FM?%#Q3;R
M7U]:I_9]D=UG<-"V?WN#N7!X],X]0: /1Z*\B\/>)-9U:'PGINI7BAKRPN9?
M,EG>#[9)',$3YDY)\OYL=]V>PKT'PK;7UEI+VFH:FNHS03R*)@2Q5,Y5&8\L
MR@XR>3CGG- &Y6%;^)1=:]KFD16$QGTJ&*7EE_?F0,5"\\?=QSCK7%Z)?ZMX
METD:TFM0V5W;:DXN0UQ(?*592OD-#]WE, <9)(/6KT>\>.OB"8Y7BD&FV962
M,X93Y<N"#ZT =SIMS/>:;;7-S9R6<\L8=[>1@S1$CE21P<5'K%[=:=I<MU9Z
M=+J$Z%=MM$ZJSY8 X+<< D_A7 :3J.IW&A_#Y[FXNY[*ZLV>_,3NTTDGE HS
M;?G9<DY(XR5S5751KND?";4[RZOM2AO?MZ_9GEN7\Y;<W*J@;G()1N1UY&>:
M .^C\0QR>,IO#GV6598K%;WSF(VLI<H  .>H/7'2CQ!XACT"32DDM99AJ-_'
M8JR$ 1L^<%LG..#T%<KJ6EIJ_P 8;FUENKRWC;P['EK2=H7_ ./A\?,O(_ _
M7-89O=0O?"7@\ZE</=2P^+([=+I_O7$<<DJJY]<@=>^,T >OTA(52S$  9)/
M:O+[2_U;Q)::S>PZU#I][IVIRHQ>XDQ:QQR8"-",*P9!R3G)8GL /1M4A2XT
MJZB<R!6B;)CD9#TSU4@B@#*TCQ-)K,EE-:Z9,VEWT3R07RN" %/&]>"N[J,9
M]\5T%>1>%KN33O!WP]L(YKB&UU=_+NIA._&V-V2-23\FY@!\N.AIWC*_U/0X
M/&>FV.H7HM8-*@O[>7[0YDM96D9"BN3NP0F[!/'..* /6Z*R]%THZ;%,[7][
M=O<L)7^U3%PC;0"$'\*G&=HX&>*Y'3KEO$]IK=U-KEUIU_INK21MY<I"V\43
M_*ICR%9709)(.=Q]   >A45PEG)-XGN/%T=W?WEG/I]XUK:K!</%Y"+$K))A
M2 2S,S?-D$#'2L71=3U/Q+K?A'^T;V]@34=!EGNH;>=HED<-& WRD%20<Y&#
MSUH ]5JCJ-[=6<MDMMITMXL]PL4K1NJ^0A!)D.>H&!P.>:\YTB[\17O@?3I+
M5YM5DL]0NHY[5KUH;BZ@CD=%Q)D$LORGD\XY-3W.N?:M&\&7>EWNIQ13^(%M
MIX[F5A*!F4M%+R=VUE Y)^[0!WFOZNF@:!?:M)!+/'9PM,\<6-Q51DXR0*L:
M?=B_TVUO%0H+B%)0I.<;@#C]:\RUJX?Q'X0^(EQ=7=RDVG2W5K##%.Z+'%'$
M",H#@[\L22#D''85)IE]?:UJC^'EO%MC;:-:/:1_:I(&;?'EY5V8+8.T<\#'
MN: /4J*\P:#4M3\6Z'HUUXCO7CFT*<W-Q83-")I%=%$BXZ'OD?R-4M9U&]MH
MKC4M.U;4+K[-X@@M#<R7#1HBATC> 1@D2#[VYB%R3D9Q0!ZM]IA:XEMT=6GB
M19'C!Y"MN"G\2K?E4&D7ESJ&E6]U>:?+I]Q(N7M96#-&<D8)''O^-<7X>TZ$
M_%#QPP>Y5E6R(VW,@Y:)\\9P?;/3MBLCPMX@U"[T/P!87M[<M'JWVMKJY:5O
M,E:,,40OG(SG/!S\F.F: /6**\@\6:AJNCZ5X]T^TU*^%O8P6ES9S?:',MNT
MI(=!(3N(XR 3QGZ5U-B;C3OBS)IB7]Y-:7.B_:Y([B=I!YRS!-R@\)D'D* /
M:@#IM9UBWT2Q6YN S&2:.WBC7K))(P5%'U)'/89I-*O[R]^U)>Z9)8RV\QC&
M9 Z3+@$.C#&1SW .0:Y7XGVL<]EX>9VF!_MZR3Y)G08,HSP".?0]1VQ4M@6U
MKQ9XET.ZN;V*WTQ+:.U6*[D1PLD98R%@VYFW<9).-OUR =M17D-AJ&M:[<^"
M+2_U2^@^V+J4%U);2F(W*P_*DG'0D<Y'KD=L>@ZW)'H'@>\,FJW%NMI8E/[0
ME7SI5(7:)".-[9P?<T ;M8VN>(8]#N](MY+667^TKQ;-'4@"-BI;)SST4]!7
M+>&Y]0L_B*-*DEO%LY="2Z\FZNVG8R"79O.20C$$Y"DCIS5WQ]_R$O!G_8?B
M_P#14M ':T5YS%=76O\ ASQ9J,FH7=I?Z;?7D-LT4[(MN(1\@* [6! !.X'.
MX]L8KZ;<:AXD\7P6^HWFH6L5UX7M[V:UM[EX@D[NP8C:05/ Z$=.>] 'IU%>
M6:'J^LZAX,\!7=U=75Q;W,C+J+0LWGR@(^S[OS,H8 MCG R>,UJZ/)XHT71[
M^ZBTJ_UJ2;5)5M+:YOA$\=GSL8F4^HQ@_,01GI0!W$MU!!-!#+*J27#E(E)Y
M=@I8@?@I/X5-7F>JI<:KX[\!W6JZ=<:9>2F^62V6^+% L1*X:,@<]>/7!SBH
M;"^U;Q+8ZEJ,.M1:?>V&IR++ON),6R1RD"-H1\I#(._)+9ZC  /4J*\]TRQN
M=7^(GBF"XUG54M].N;.6WAANV1!NBW,I'=22<C_ZV.:TZYU)O!?@W5SK6J&^
MNM=^Q2R&[9@T+SRH5*$E3P!@D$C YP * /9ZHW-[=0ZM8VD6G2S6]P)#-=*Z
MA;?: 5W \G<>!CTKFO"<D]OXU\7:1]KNI[*T>TDMTN9WF:,R1DN SDG!(SC/
M':G^(+JYA^(_@^WBNITM[E;WSH5D(23;$"N5Z'!)H ["BO&9[O4H_!^J:R-9
MU/[98^)FM[<F[?:L7VI8]A7.'&TXPV?;%=2)F\4:QXLTN?5[K3;S3Y4CM?(G
M:,P1F-7$VT$!\L6SGC  XH [VBO-Y=0O?$?BK6M#AU187M;*!K-Q<R0,P>/<
M9U"8W88@<\# X&3DMA?:AXZTG2[S6[JXMY/#K2W#6<[PQW$@E1?,&T@KGKE2
M/K@G(!Z)-<0V_E^;(J>8XC3)^\QZ >]5(KZZDUNXL7TV6.UBA21+TNNR1B3E
M .H(KR2P:?6-'^'4^HWEY<3G5KFW:9KEU=E3SU7)!'S84#=U]^:Z]8[F_P#B
M%XDT;^T;Z*V;2+<Q;+AP8'9I!O3G@\#ZXYH [NBO.O!.L7VKZ59Z;>2W#ZIH
M3RQZGB9MTDD>4C#'.6#YW\\?)57PM>:IXAT;0O$2:Y!#(UTOVT&XD<2;B5:W
M,1^1#D@#C(P#SDD@'I]%<YXTNEM]&@B.H7-F]U>P6\?V5<RS%G!\I3E=I8 C
M=D8&37*65OK6KP^/- AU"\M+BUEB-@R7LCO [0JX42'#;2W4=!D@4 >G45Y#
M;>-+A[GPWXL:2[72#$-.U6 S.4CNF!P=F<95E"DGKY@[BNDOTF.K:/I37U]+
M?/;3W4^GQ73QJ2Q4;WF#;E1"Q55 ;.1Q\N: .ZJ*YF^SVTLWEM)Y:%MBXRV!
MT&2!7D.C:AJNM:3\-UN=8U!6U W<5V\5PRM,JQR8W$=3QUZ]^O-=%9J;[6O$
M/A^YU#4&CT6RMXK8M=NLLF^,LTSE2-[9PN3Q\ON<@'6^'-;C\1^';'6(86AC
MO(A*L;G)4'UQ6I7(_"[_ ))AX=_Z\U_K774 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!SK>!?#;ZI
M+JAT[_3Y>)+D3R"1N@P6W9Z ?E4L7@SP[#8WUDNE0&WOF#W*/E_-8="223D=
MC65\0?%R^'_#=[)INI6::K"\2B%R';YG4$;<]=I)^@SBNF;5M.6:YA:_M1+:
MH'N$,J[H5/0L,_*/<T 5K;PWI-I%>)%:<WJA+F1Y7>250-H#.26( X'/%9\?
M@#PM%#90QZ3&L=C*9K51(^(7)!++\W!R >*TI?$>B00032ZO8)%/&98G:X0"
M1 ,EE.>0 ,Y'%5H]22?Q$DD.OV#Z>=/\[[$I4N?F!$^_.=FT@=,<YS0!P%]\
M-K^YU_6K[[5K]I)>7;SP?V1J2108( #.'.X/QS@$>E>E:!9WVG^'["TU.\^V
M7T,"I/<?\]' Y//)^IY--MO$>B7EU#:VNKV$UQ.A>**.X1FD4=2H!Y'!Z4^X
MUS2;.X:"YU.TAE4A66295*DC(!R>"1R!WH AUSPSH_B6&.'6;);R&-MRQR.V
MP-SSM!QGD\^]69-)L9M);2I[=9[%H_+:&8F0,OH=Q)-/N]3LK'3)-2N;F-+*
M./S6FSE=N,Y&.OX=:X_4O&YGL/"6IZ3=0+9ZI?PPW2OAFC1XFD*DYPI&!G^E
M &[IO@SP]H^F76G:?I<5O:W2E)T1FRZG/RELYQR>,XY/K5BU\-:19:"^AVUF
ML6F.K(;97;;M;[P'.0#DY ]3ZU-9ZWI6HV,M]9ZE:7%I$2LD\4RLB$=02#@8
MJ6RU.PU+S/L5Y!<>4VV012!MAQD XZ<<T 8R^ _#*1Z?&NE1A-.<R6:B1\0,
M6#$I\W!R :O:5X;TC1+N\N].LU@GO6WW+AV)E;).YLDY.2>?<U+>ZYI.FRM%
M?:G9VTB1F9DFG52$! W$$],D#/O4G]JZ<=/CU 7UL;*0 I<"4;'STPW0YH I
M:WX5T3Q(T)UBP6\\DYC61VVH?4 ' /O1<^%=&N]2M-1N+1I;VT7;;W#3R%XQ
MST.[/<_6K#>(-&2V@N6U6R6"X?RX9#.H61\XVJ<\G/&.M0:SXHT?0M/O[R\O
M80+%-\T:N"ZDC*C;UR>U %>#P1X:MM'NM(BTB :?=OYD]NV61VX^;!/!X'(Y
MX'I4EIX.\.V6B3:-;Z1;+ITXVRP%=P<=LDY)QVYX[5IV%];ZE9175M+'+'(N
M0T;AAGN,CTJ&+7-)GO\ [!#J5I)=Y8>2LRE\K]X8SU'?T[T 9]GX)\-Z?HUS
MI%II4,5C=#;/$K-^\'H6SDCKQG')]320>"/#EM<Z?<0Z8B3:<NVT82/^Y&2<
M+SP.3Q[U;/B;01,D)UK3_-DF-NB?:4RT@QE!S][D<>XIU[XBT33GF2]U>QMG
MA"F59;A5* ],@GC.#CZ4 5CX/\/G4-0OQID*W6H(8[J12P,JD8.<'C(SDCDY
M-36GAG1K'0)-"MK"--+D5T:UR2FU_O 9/ .3T]:M_P!IV'VFWMOMMMY]PAD@
MC\U=TJ@9+*,\C'<5&-<TDV4EZ-3LS:Q2&*283KL5\XVDYP#D@8ZT /NM)T^^
MTIM+NK.&:P:,1FW= 4VCH,>V!CTQ570O#.C>&;=X-&T^*TC<@MLR2V.@)))P
M,G [9-9'C'Q.UG\/]6UOP_?6LLUHAVR+B558$ @@'J,]^GI73M.D-F;B=PD:
M1[W<]  ,DT 0ZGI.GZS:BVU&TBN8@P=5D7.UAT93U!'J.:@M/#VEV=_]OCMB
M]Z$\M;FXE>:15_NAG)('L#61X?U76/%6EKK5M-!86-P2UE#);F1VC!(#R'</
MO8SM&, CDUJV&HSP:,EQK[6UI<B22-]K;4.'8+MW<\J 1WYH XB'P7?7/Q@U
M[6M1TYFT74+%;5)%N K9"Q@Y"L&"D*P_'D4[XC>"KO5-+\-Z;X>TJ(V>FWR3
MO"C)&BQKU4!B,DY/ZYKNCKND#3O[1.IV8LMVW[09UV;LXQNSC.>,5"WBGP^J
M7;G6]."V;!;D_:4_=$] W/'0_E0 MGX=TBU6]:/3X]^H#_3#,3*\PQC:[,3D
M <8S@=J;IOA?1=)N4N+*Q5)HX?(B=G9S%%G.Q-Q.Q?9<"K$VN:3;QV\DVJ64
M<=RI>!GG4"50NXE3GD8&<CM1::WI5_IS:C9ZE:3V2YW7$<RM&N.N6!P,4 1:
M/X<TG0'NGTNS6V:Z?S)RKL?,;^\<D\\]:;:^&-$LM:NM8MM.ACU"[_U\R@Y?
MWQTS[@<Y-2C7M'-C/>_VI9BU@.V:8SJ%C/HQSP>1U]:?::SI=_>3VEGJ-K<7
M, !FABF5GCSZ@'(H Q(_AQX0A$7E:%;1F*;SXBA8&-\YRI!R.>PX%6[CP7X>
MNKZ_O9]-5[F_C\J[D\QP9DX^5N>1\HXZ<5?M=<TF]E>*UU*TFD1#(RQS*Q"
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M*F75-/?43IRWUNUZ(_--L)1Y@3^]MSG'O4T-Q#=0^9;3)(A)4.C!AD'!_(T
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M9U9$,<EPJL&?.T$$]3@X'?% #1X<TA=4?4DLD2\>)86E0E25 (' .,@$@'J
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MX;#3K9+:UA7;'$@X45;HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGWLEO;#YYXD2,R;!_$<KS[K78>$)M$U?5[K7-(&IS22VZ0SW5XDD8.TDJ@#
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M7WLJ[L@ =#7%01QR>$M/LYHY7,/C/?(L\)4^7Y[$L1@ #:<GC SSC->Y49H
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M; 6]B!%XE&JILG(4PB7S-N-O!Z #^5 '40^-[-#KB:E:7%A+HXC>>.0JY9)
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MMY9ZK'$+JVO9&C,4D:[5=6 .1MQD>U=C$EU'IJH\B278BY<+M4OCL.PSV]*
M,73_ !7_ &EIHU*WL'>QEM'NX9DF1@RKCY&Q]UR&Z<]#DC%16WC:UN8O#,JV
M<XC\0 ^025S$?+,F'&?0=LUDZ7X+N;?7I+Z"TM]&ANK*6+4;>TG+PW$S8VNJ
M8 7;\W. 3G&.IJGI/A/Q+##X,M[J#3XX_#TK+(ZW+,9D\IHPR_)QU!P?S'<
MJ>'O$Y\+V/BBYETF]N=.@\0W?VFYA*$6\>Y1G:6W,!WP#@5U":EH4/CZ]?[+
M)'?#1TNI;]I,Q/;!S@ ;CT.XYP#]:R_^$4UB/1_%.AL+5;36KZXN/MWG?ZJ&
M;&X%"/O@9QSCW%-;1X;[XAWVGQ,?L,GA2.S\U#NPKRR*O/T!/X4 :UG\0M)N
MM1TZV<K$FI(SVLGGHWW5W8D4',9*\C/I@X/%6;?Q:;J73'ATF\DLM3#FTNE
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MM/;R3ZW%9VT[X"VUHY=8P,\ER!DG/I@8'N:UJ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BO.[KQ;K-CK&G"6>VFCN]<.G/;PQ%HHHCN"'S?^>OR@E<
MG&<8%,GU_P 6W8\726%YIT0T*X80QO:LWGJL2R;&._Y<Y(SSR>V.0#T>J.I:
MS8:0;3[=/Y7VNX2U@^1FWRN<*O .,^]<7:^*->\1>(+"QTRXM-/MK[0(M45Y
M;8RO$SN!C[P#?IWZUD:AKM[K_AGPW+J4<27]IXMM[*Y\D$(SQ2LI9<] >M '
MI=OK%C=:O>:5#,6O+-(WGCV,-H<$KR1@YP>AJ]7!:IXWO=%U;Q>+E8);72;2
MTEM4"E,O*6'SMD\9V\C&!VK='_"0V%[<2375E=V'V%I%:0>4RW(/3C@1$=R2
M1CJ: -]V"(S'.%&3@9_2J>DZM8Z[ID.I:;/Y]I-N\N3:5W;6*G@@'J#7'^'_
M !1JDWBK3-*O+F*[BOM+:[DDC@V(DRL@81-_''\W!YZ Y-<OX7U?7?#?PPT+
M6X+BUETJ*Y,-Q9& ^8R27+)O$F[[P+#C&,4 >KV>LV%_J-]I]M/ONK H+F/8
MP\LN"5Y(P<@9XJ]7F$VN-X;\2_$;54B$LD3:<L:,>"SQA%STXRP)Y%=5I%WX
MB_M][:^LI3I;V^]+J;R4=)@>4VHYRI'(.,C!!)H Z6J&KZS8:#I[7^I3^1;*
MRJ7V,V"Q  X!ZD@?C7/^(M7UJ'QIHFAZ;<VL$.HV]R[R2P&1D,83!'S '[W3
MC\>E<EXFUO4=3^&?B>PU<PO?Z5J=O://"FQ)E\^%E?;D[20PR,T >N45Y]XV
M\5ZQH*ZY<VMS; :?;136ULD7G-)G.\SX_P!6O9>1G!.3TJ[<ZQKMYX[?0;*\
MM;6W;1EOEE:V,CHYD*?W@#T]OH>M ':50UC6;#0=.?4-2G\BU0JK2;&;!)P.
M%!/)('XUG>!]=N/$O@K2M8NT1+BYAW2"/[NX$J2/8XS7">,M6OO$OPJU/6TN
M4BL7O%CBM1$#F)+I8PQ;KO)7=Z <8[T >M,JNI5@&4C!!&01638>%= TJZ^T
MV&C65M,"2'BA5=I/7'I^%4!JMYK/B36M'T^[6S_LJ.$-(8@Y>612XR#_   8
MX&"23R,<Y.@>-;OQ*VE:< MA?SP7,MVZ#<$:"41,L>[CYF.<G. ".O( .\HK
MB+W6O$FD'PQ!J,ED;F]U4V5UY"$J\95V5AGE6PJY'(Y-9>M^,]=T[2/'4UO+
M:M+HEQ$EJTD.?D=$8@X(R1O.#[=* /2Z*X8ZGXE_X3F3P[_:-F([G3#?13_9
M#FW(D"%0-WS#Y@<GT/%4=(\=ZGJ^D^&H?L__ !,=42Y:=[94^58'V,4$C 98
MD'DG SP: .YO]&TS5)[6:_L+:ZEM'\RW>:,,8F]5ST/ _(>E7J\\U'Q'XNTW
M1].-U;6UK=S:_%IX:9%;SK=V 63".0C$<$9/0XQD54UK7=>&C?$#2YM11;C1
M[1+BWO+>$1L4DB9]N"2 05(R.<'UYH ].SD9%%97AI)8_#6FB68RM]FC.XJ%
MXVC XKC['Q=K(\0Z!:W5Q:W"ZG<W,%Q';Q$PP%%9D$<O\9 7#<GG/W: /1:@
MO+N"PLIKRY?9! ADD?:3M4#).!S7FEQXR\2P:!K&MFXL6CTK76L6MQ;$>=$)
MDC^]N.T_-GOS^5:NMZMJ&NZ?XR@L;J.VM])ADM@IB#&:3R=[[B>BX8*,8.03
MD]* .UL+VWU/3[:_M)/,MKF)9HGP1N1@"#@\C@CK5BL#P+_R3[PW_P!@NV_]
M%+7-6?B[6%U[P_!<W%M<1ZI=7-O<1V\>Z&':KLGER_QD!0&Z\YZ4 >B45YE?
M>+O$5EIGBBS\V)]=TJ\3[)&L (N;=UWIA<\ML$A)!X*5T-QXBN+S0KS5]#N;
M5X([!)87O&"1&1UW@NW& JE21_M=L4 =917G</B[5H[SQ/:)<)<+IVE+?VL]
MQ:&(LQ#Y!7*Y7*<'CKU/6BV\2>(X=#T&[O+NQDE\0FSAM52W(^S,\9>1F^;Y
M_E&0..3CI0!VL&M:?=:Q=:3#/NOK1$DGBV,-BMG:<D8.<'I5^N!\.Q74/Q;\
M2I=7 N"-.L]DFP*Q7,GWL<9SGH!QBM/Q/J^I66I+;VEW#;Q"QEG4)'YT\DJD
M;1LQQ'C.6XY(&10!U,D:31/%*BO&X*LK#(8'J"*JZ;I.GZ/;^1IUG#:Q8 VQ
M(%&!T'T%<A9^,-0U.R\%$JEH->A9[FX1<B-UBW!$W9 +'.,YX4CKS6;)XR\2
MKX5BU$/I[2OKJZ;&XMF"S1><8_,!WG[V.H&.N.V #TVBN(?5_$$&N)X=EE^U
M7:VKWLEU96\:'89"L:[)'P,8.X\]NG6HX?$_B"2;2-&OM->UU>XMY[BZ%J8G
M*K&ZJI3<^T;MX;DL0!C!Z@ [NBO/;SQ'XMLK?P_#=VUK9W5YK!L)3(@?S(MK
M,D@".0I(7E<]>A%4KKQ-XKM--\8_Z?8/-X<D$B2FT/\ I$9C$NQ@&PO!(R.O
M'3'(!Z?17#R^*=4U?4[JPT>WF5[6Q@N&:-8G)EF5F56WLOR #G')SU7',<FO
M^*)->\-:5,EGIL^I6,\MW&8_.,,L87.TAL$?-P.W<GI0!WF<45Y)J.OZWK'A
M/1I)[\0747B>+3KEK>(!9]EQ@-@YP/E!P#R?;BO68U98D5WWN  S8QN/KB@!
M20 2> *PQXRT!GM46_):[!:V ADS, ,DI\OS8'/':MQ@&4JPR",$5P?BA%C^
M*7P[1%"HIU *H&  +<<4 =+'XIT:6\LK1+S,][))% GEN-SQJ6=3Q\I !ZXK
M8K@_&4,@\>>"?LABBGDN[L[V3<,_9F&2!C)P/T%5;7QMJL5C/97(2YU%?$#Z
M-'-%&%WJ$\S?M+ ;MN1C(&<?2@#T:L2V?0M-\2RV%NJPZM?QFZE4*V9E7"EB
MW0D9 ZYJ/P]<Z])?:E;ZO9NEK&R-97$AC$DJD?,'5&(!4CKQD$<<5A:Y=QV'
MQ6T^\FSY5OH%Y*^T9.%DC)Q^5 '8#2;$:N=5%LOV\Q>29\G=Y><[?IGG'KS5
MRN!E\4ZO9^%M$\5S20R6=\]N;JS6/B**<@*4;J64NN<Y!YP%JAJGBWQ+!I_C
M*^@NK%$T"[ BC-J3YR!$8JQW<?>/(Y^F,$ ]-HKC]1\0WS^)1I<4\>GVYT=M
M02XD0-OD#8*Y/&U1@L!S\PY%4+'XE6]AX;T>]\3QS0WNHVPN1%:6,K*BGL<%
MOKR1P1Q0!W_>BO.H=:NE\?Z[J#W\SZ;::+!>QVYB PA\QBH!Y!.T9)Y[=A6A
MHVM>)[^71KW[ SZ??P[[HOY*I;[DW(T9$A9ADX((R<YXZ4 =K17F5CXF\6W/
M@?5/$[7NFA+."_Q;_9&^9X7;8V=_ PI&.?7)[78->\2'Q!X=LGO;-HM;TV2?
M_CV/^CNBHQ(^;YL[\<X]?:@#T"J$>LV$NN3:,DQ-_# MQ)%L; 1B0#NQCJ.F
M<UD^"-:O=;T2X?43&]U:7UQ9/+&FQ9?+<J&VY.,C'%4[OQ#JL7B[7M+B>V\F
MST=+VVW1'B0EQ\_S<CY.V.M '8T5YSHOBO7Y)/!-S?7%I-;>((66:&. H8G$
M)D#!L\YP01C'/XUJZ-J^N>(M+TK7]-GM!9W5R3-:2C 6UW,N0PY,HP#V7J,<
M9H [&BN!7Q/XCU2"ZU#1-.DN$M]0DMEMCY*QRQ1R;')=G#*_#,.,#@8/6J^J
M^)O$B7/C@6MY90Q^'XHYX ;4L9 8?-*M\W?IG\@.X!Z-5'3=8L=6:\6RF,AL
M[EK6?*,NV1<9'(&>HY'%<4FH:CJ?Q'\.R+?/!:W.AO=_9@@*JQ:+/N2<XSV[
M=3F.?Q/XFE\,^+;^S>V>\T35)8HXU@^62WC5&88))W;68YSU[4 >CT5QVJ>,
MEM-'O?$%FWVG3+334N0.!YTLG*+G^'"X)_WU]*L:5>>)O[>@BO+-Y-,FMRTL
M\HA0Q3#! 0([$H1G@Y(QU- '4YQ17#^.7OQXF\'PVVH26\,^H,KQJ@(8B)R"
M<]<8Z=._IBEX@\7:SH]W<SBXMI$@U2WM5M(8O,7R'**6ED'W)"6)"YX '!SF
M@#T6BN)BU7Q)J?CG7-(L[NP@M-,:RD!>V9F=) Q=/O=2 ?F[8'')-9TOC#79
M+62[M6@6Z77SI?\ 9\D&[$6_:&P"&+[?WF<[<=L<T >CT=ZX.?Q'XCU&36AH
M5DT\VEW7V6.,+$(YW549]Y9PR@[B!CI@$EN@70;C4[OXH:ZMQ>R+!#8V;K:E
M5(C#^82H(]#U/?Z8H [.]O;;3[8W%W*(H@RKD\Y9B H ')))  '))JOI6M6&
MM)<-8RLQMIC!,CQM&\;C!*LK $<$'WS7*_$M+AH_#/DW1B5M?LT*A >=Y(//
MICI6A!J5_JNO:QHUG?+;2:3' ))S K&6:1"V2#QM"[>!@G)Y&* .JHKS2'QM
MK^L'PG#9FSLI]4FO+6\WPF01RP(^63YAE=RYQ]!GK7;RPZS_ ,(V8DN[?^V1
M;X$XB_=-,!UVDYVD^] &I17&^&O%%UKVB:.YD\K4-\BZI&4&8FA&)5QV^<H!
MWPV>:SIO&.JKX"B\<QO$UGO$TFG^6/\ CV,FWANOF!<-GID$8[T >AT5PMUX
MGU6*Y\>PI-'C1+6.XLV,8SEH&D(;U&1CMQ^=5G\1>)=0U+P[IUA=6-L^J:(U
MZ\LEL7V2@1G.-W(RW3C'7GI0!Z'16#XIU+4-$\$:GJ<#P&_L[)YMS1DQEU7)
M^7.<<>OYUB1:[KMM)HEO?7EF\NO2(+?R[<C[*HA,DN23\YX !P.6SC Q0!V-
M_?6VF6$]]>2>5;6\9DEDVD[5 R3@<\"ELKN#4+&WO;9]]O<1++$^"-RL,@X/
M(X-<-K6L7T</B_PWJ+K<&+1)+VUN0@5GB9'0JX'&X,O48R#TXYBT77[YK+0/
M#^G13AX_#]M>2RPK&S_,H1 !(P&,JQ/4]!QUH ]%JCI^L6.J3WT%I,9)+&?[
M/< HR['P#CD<\$<CBH/#ESJUWH-K+KMFEGJ9!$\,;AE!!(!&">H .,G&<5RZ
M>*M>:Q\72);+=SZ5J2V\$=K"2_DXC+,%)^=PK,<9Y(Q0!WM9VIZ[I>CF-;^]
MCA>3&R/EG89"Y"C)QD@9Q@9K/\(ZY#K]A<7-MJJ:A LVQ&\KRY8OE&4E7 PP
M;/8<8^M<3\2-'U_1_$47C;0L7T:+;V][IS?>=4F5T\L\\EMHP.>>^30!WE]X
MP\.Z;H\6KW6LV::?,=L4XE#+(?1<9R>#P.F*T=-U.RUBPBO].NHKJUE&4EB;
M<K5Q.FZIX,\1^"6\4/I,4EJ1*'MYX0[+*[?/&J\C<[$=.6)%6?A3X6N/"'@F
M+3KU@+R:5KJ:$-GR2^ $_ *,^^: .QN[NWL;.:[NIDAMX4,DDCG 50,DFJDF
MO:7%IEIJ+7B?9;P)]F8 DS;QE0B@;F)'. ,UY;\9?%NCSZ#KGAZ354AO+:./
M%H-P>>5BC#.!C:%.?<G_ &><BTU==1\1_""*VF\RSBL2I*YQYRQA''U4KB@#
MVI-<TN31VU9;^W_L]5+-<%P$4 X.2>A!X(/.>*=IVKV&J^<+*X$CP,%EC*E7
MC)&1N5@",@@C(Y%?,NM7]]%X1\76:%Q9/XO"D#ISYC$?FD9KU32IIT_:1UV&
M//D2Z1&TH'3(\O:3[\D?C0!Z1J&JV6EK$;R<1F9_+B0 L\C=<*HR6. 3@#M4
M7]OZ3_8HUC^T;?\ LXKN%R'&P\XQGUSQCKGCK7G7BV:<_M >!X&+?9UMIW0=
MMQ20-^. M>5"]O?[#CL59_[.3QG\GIGKM_KCWH ^G;+6-/U"">:VND9+=BD^
M[*&%AR0X;!4XYY XJ/3?$&E:O,8K&]CFD\L3!.06C)P'4$#<A(X89!]:\!\:
MZA?V7B/XJP6+.+>6UM#-M[$M"I_-7D%=#82RVOQ6^&L4!.R3PVD4@'=/*<_S
M4'\* /;Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHEI_+4/+Y:LJR;'8-@YQAB/7%;% ',WO@N"\TNPMO[2OEN[*[6]COV97E:8
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M)I2S+&6<D)YK18*<@9WXQW%>MT4 <<W@%)-;?6(M8U+3KB\5#J-O8S!8;EP
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M/-<H%RV2#R2O?UILO@;37T_0+>*26*?00GV*Z&TN-JA3N&,$, ,\#VQ73T4
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MA!!YD'B"U:S6/&5%ZG,>?0."0?\ =R:[$>'-#%O);_V-IWDR2^<\?V5-K/\
MWB,8+>_6KTEM!,83)!&YA??%N4'8V",KZ'!(S[F@#SC5Y+;2_&.F^'=0O+"V
MTO\ LG-L=1@WPS3[R)"?G5=^W:><_>..M=CX1M_LGAFTMUU5M5CCW+'>,/\
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MC3O\MJT_SD\X']W<!D!CS6W<V>G6WQ)UJ'3KJ#3(I?"N[[1!@+ 3*P\P <#
MPW'UKT:+2]/AT\Z?%8VL=DRE3;)"HC(/4;<8P:KVWAO0[.-DMM&T^%&B,)6.
MU108R22G ^Z23QTY- '+>"Y9['Q#=Z+JFCVMCJ:64<OGZ>V;:ZB#%0X7 *OD
MD'/)]< 5!XR:QO\ Q%?63D2W-KHDDI2[8"WA5F($B+C)ERN,@C [YXKN++2]
M/TTN;&QMK4R8W^1"J;L=,X'.*;=:/IE]>17=WIUI<7,(*Q32P*[H#U 8C(%
M'EEH@UZ7X80W]S/.EYI5RMV//8&7%O&?F(.<_,>>IS4DHL)M:\1>'-1UJQTH
MV*0Q:<UZ&,L-N(4VR0R-(N&#;B3R<XR3P*],AT'1[<VI@TFQB-IG[-LMT'DY
MZ[,#Y?PIUWHVEZA=P7=[IMG<W-N<PS30*[Q_[I(R/PH HZE;I=>![F&\Q>!M
M//F&>(#S#Y><LAZ'/..QKSJ+24@^$_A?Q'H]M$VH:+;P7TT,0 ^TQ[!YJMCJ
M2O()YRM>P$ @@@$'J#7-WFB:C;-;Z=X>BT?3M$E5Q>HL!24%N\03"YQGD^QY
MZ4 <IXYECU#X6Z]XC@:2,7RP/;N"480!T"Y_WLLW/9@#TK272HM'^*&FQZ.T
MPM]0T^X?4X_.9PVTIY<IR3\Q+,-W4\UL>-O#MSKW@>\T'2Q;123+&D?G,4C1
M5=3V4GHN.E;-CI5A8QN+;3[2U,H'FK!$JAO8X R.3UH \E\/:Q'9>&?!<>KS
MD:)=7VH)=RSOF,R"23R5D8]5)W=>,J,]*W;]?#UK8V6EZ=?SWL%YKNZ&W2X7
M[,9"I<P,V"!".NT G. ,]!W7]@Z/_9CZ;_95C]@<Y:U^SIY3'.>5QCK[4DF@
M:--IL6FRZ38/81$-':M;H8D(Z$+C ZF@#R6XF;_A4WQ$M6FC9+;4;F.&.(_)
M&G[H[4&>%!8X'O77W\4=Q\4_#\,J!XWT2Z5E/0@M%Q75MH&C-'<QMI-@4NF#
M3J;9,2D="PQ\Q';-%UI5N%:ZL;&P74H8&CM)I8!^[.#M&1R%SU /2@#A?#%K
M-975UX NXWDCL;L7D=PX)\ZR9BZ98]6$@$9SU /I73?$!KE/ >KM9WB6<XA&
MV9Y-@QN&5W=BPRH/JPJ]H5GJ<4+7>N/9OJDR*DOV-6$2JN<*N[D\LQR?7VI/
M%&EW>L:')9V3VHD9T9H[N,O%,BL"8VQR P&">?I0!QMK9P7FN:UJM@4M=-_L
M<1K:PW2Y\\!]SA8W(&%*KGN1^-96GV.DV7PPT#4;J2]-[JL5C:.R7)'V@EPR
MQN6RJH>0QQG;D<]#UND^"[1;^*]N_#?A_39(@PVZ:N_S@RE2')C3Y<$_+@Y.
M.>.>C?1-)ETO^RWTNR;3_P#GU,"F+KG[F,=>>E 'D&K2/;^&_BA9K-%"MLT#
MQ06DA6.$M$A8(!CC/7@9.>!TKJX-/M;7XHPV,<>ZUO\ 0)'NXI&+K.RRH SA
ML[CAB,GL<5V#>'=#83!M&T\B9%24&U3YU7[H;CD# P#TJPNE:<EU%=+86JW$
M2>7'*(5#HG]T'&0/:@#QC0[ZWT?X:>!F,EI9V-Y<E-2GDAW(W$OEB8 J2I<#
MJ<<<\9%;6IS1Z)I6+;78KO1KS6[5+TV@V6]G"^=Z*P9MJL0FX9X#G^]7I":#
MH\=E/9)I-BMI<,7F@%N@25CR2RXP3]:DCTC38=,.F1:?:)8%2IM5A418/4;,
M8Q^% '%:%::?8_&/68M/2&*)M'MW,<6 JMYC] .!Q@X'KGO5SQ>2OC?P.5D<
M;KZ=64.0K#R'/(Z&NFL=#TG2V#:?I=E:,$\L&"!4(7).W@=,DG'O4UQIUC>3
MPSW-E;SS0',,DL2LT9]5)&1^% 'C%_;I%X(\7:LLDWVZP\4.+69IF)AQ<Q+\
MN3Q\I(/J/H*]?U^"*Y\.ZE#/$DL;6T@9'4,#\IZ@T'0-&-M-;'2+ P3/YDL7
MV9-LC_WF&,$^YK0"*J! H"@8"@<8H \9L+.Q?PK\+H8HXT\ZZB:?R?D9S]G?
M)8KSDXQFBZOY/#MGXEM+67[-I%MXDMHYLAG2VMY$1GX!!"%B,@$<,1WKU2'P
MYH=ND20:-IT2PR&6():H CGJRX'!XZBIUTC34^U;-.M%^U_\?&(5'G?[_'S?
MC0!SOA*VM(=5U&?3];LKVVN$C<VNGQA;>!L$;EP[ %AU'?;FL[Q7I]A<_%+P
M6+BSMI3,E]Y@DB5MX6)<9R.<=O2NUT_3+#2;7[-IMC;6=ODMY5O$L:Y/4X4
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MX?T46T=L-(L!;QR>:D0MDVJ_]X#& ?>@#S/5(QIZ?%2QLWD@M[>P@N8HXY&
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MV5U?!;N*'[0\*1N[^7G&0%!)Z'IZ'TJ7_A(]*:SL[J*Y:>*\C\VW^SQ/,TB
M E@J G R,G'!('4URFF:==Z?\1 \\%S+!!X;ALVNQ Y1Y4D8L V.3@@U@Z+H
M<P\"^%[>Y37='UBPM9A%>VEI([0-O&8Y(PIW*WRG!&#MZCN >KVMU#>VD-U;
M/YD$R"2-\$;E(R#S7->/_$<WAC1[*[1V@MIKZ*"[O%CWFUA;.9,8(Z@#D$#=
MT/2CP]X@ODBT32=<TN[@U*ZL_,>:.WQ;*X!.PMGY7*J6V]JU]<NGMH;53ITE
M]:SS^5=I'%YA2(HYW%?XAN"@@ GGH: *-O?RV=O-JS:JVJ:(+3SHY(85DD+
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MXX^;C]>E9%Q::O%\,IO"4^B:G+JUIJ"/YL=LSQ3H;L2>:L@&#P>1G<.<C&:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB'Q3#H.IV<4,MU;O<6DT,QD2380'0Y4$,-P/<$>G2E\<0QS^!-?65 P&GSL
M?41L0?SH U;^QMM6TRYL+I?,M;J)HI%#$;D88/(YZ'M67IOA^.V9%EUO4M1B
MB(*0W4R,JD="=J@MC_:)]>M101:A/\/+6'2FA6^DTZ)(FF=D524 )RH)'&<<
M=<5R>F7EEX9T#Q7]F\,6NA:_IM@UQ*EOAXYU".8Y$? W+E6R",@C!H ](E2W
MN\PR;9/+8,R;NA[9'Z\U*LB,S*KJ67A@#R/K7ET8_L'3_AO?VHQ=WLT5K>2=
M[@3PEW+G^([P&R>].\.V>H>&+VVOM0LYD^RZ;+:WC@#=?W;W ,>SGYR?F(/;
MS,''. #U#<N\IN&X#.,\XI:Y;0]0L+74I;:]NUDUV\EVW!5&,:R*F\0*^-OR
M(<A<Y/+8R36IK>MQZ.+*/R_.NKZY6UMHMVW<Y!))/.%"JQ)P>E &K5>._LY;
MN2TCNX'N8QEX5D!=1ZE>HKG)O$]\EYJVC2V4$.K6UE]MMR)R8IH22I8'9D%6
M&"I'ISSQ4^'%DMWX,\.ZG?6=N;R*R'D7(<O(1(,N22HP6/)Y/UH [:BN'L?$
MVMGQ'XP2:Q2ZM]($0AM[5V:1\Q&0!5V_,S;@#R,8'7%6=.\9SW6MWNCW%A;"
M^M]/6^VV]WYBC)*F)R5!5P1Z'@]J -G7_#]OXA@M(KFXN(1:W<=W&8"H/F1G
M*YW*>,UK5P-G\0[V7PFOB6[T%8-.FMXGMBMV&9Y7D$81AM&T9(.[GCMGBK\_
MC9M-U;6+/5;**&+2K);Z6XBG+[XV#8"J5'S;E(P3Z'O@ '7T5Q\/C&]FU%;$
M:7&9)[22>&5)':*-U&?+E.P;>#P1G."*L_#_ %;4==\%Z=J>IK%YUU'YNZ-R
M=V23R"!MQT R>* .C2>&262))8VDCQYB*P)3/3([5)7E]I?ZIH_C#Q]<:/H\
M-\(;BVFEC:X\G*BW4D)A6RQY/.![UM7WC]TT<:O8::KZ=_9BZB+B[G\E9"<D
M0(=I!DPIR.W'7- '8FVA:Z6Y9 9E4JK$YV@]<>F>^.N!4M<C-XWC:;2H+6*U
M2;4K!;V!;ZY\CS,XQ&AVD%^>?3CKV2_\;/;SW-I;V2/>VEK'/<0RRLN'=2PB
M7:C9; ZG Y'7)P =?4<,\-S'YD$J2IDKN1@PR#@C(]""*YRV\5/K$MM9Z;8
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M7)\N/&5P,<[ANQR/NF@#>HKDM/\ &<EUJMC:2Z<WE7L#RI+;EY/)95W;),H
M"1G!!()!'H3%IGC*[UW0YM3TRWTZ6+[').I%V6,$JXQ%,H4%6P2>/[I'H: .
MRHKG/ >HZAJW@K2M0U+RS/<6R2ET<L7W#.2"!@^PS]:AN?%ERUEJ]_I>G)>6
MNDS20S[I]CRM& 9/+&T@[>1R1D@CCK0!U-9>NZ(FNVD-N]_J%D(IEF$EA<&%
MVP"-I(ZJ<\CZ5DVOC-;KQ+I.GI:H-/U>P-Y8WIE.92 I,>S;PVUMW7I2W7C
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MMSZC;36;P2V4BKYB[C%,K#*LC,HSW!&.".];M !1110 4444 %%%% !1110
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M5GFTI/*TAM.:W@C=4!+A@5/ID>G&>AZU%9>!M1M-$\'Z>;FU8Z#<B:1\L/.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK;*D)$UN >>5<Y9F<\$'&WN*Y;P/I?BG2?ASXA\+:GH]V?+@N%TV0E/WJNI
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MEF';) P#SQS7>T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
*4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ederofferletter002.jpg
<TEXT>
begin 644 ederofferletter002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?LD[99D+!?NA@1USGVK1TKQ':S^&]'U+4[JTLY=0M(IPCRA 69%8A=QYP6H
MVZ*:CI+&LD;*Z, RLIR"#T(-.H **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'.F?95NYY_-+2#:>2S%STQD_RK>NOA7X.O5O$N-*=H[NX^U2QBZE5/-[L%#
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M?LB>;I<;1V;#_EDK*%('X "LW4? 7AO5M<GUB]T\RWD]N;:9O.=5DC(QAE!
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MU!XXZ5N6=_9ZA$9;*[@N8PQ4O#(' /ID=Z2]U&QTZ,27U[;VJ'HT\JH#^)-
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MN$EB65XR P)PKLH8CJ VTD9ZB@"WI.E6NBZ=%86?F^1$ J^;,TC    ;F).
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M)69(6U.R$KRF!4-PFYI!@E ,\MR..O(H O4444 %%%% !1110 4444 %%%%
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M7!<VJJN3/#$TH+KZC$N0>^TUT>M>&;KQOX\\6W^ED2V8T,6EO<(?W<T[*K!
MW0]#GTR,U[C10!X+H^EW.M:I\+K>VC;S-&@E?4%QS;%"HVN/X22I !YKUSQE
MH1\1^%+[3XB%NBHEM7_N3(=T9_[Z _ FMZB@#RF&XU^YU/1O&$%C+;RZW"-+
MGMMH!@!7=',P_P!F02'_ '&4=:VM;CMK3XG^!X8]B"*VO8ASR!Y:!03^!Q^-
M=Y10!XS=3Q-\,_B6%D4E]7O-@!Y;=L"X]<]J]=T]UDTVU=&#*8E((.0>!5FB
M@#P_1=,L[_X9>'M,L8(1XEM]2C<JJ 3VS+<$N\G\2@1@\GU4=Q5JRNM/NY-3
M\+^);C5TUD:K)<1VD,(_TH^;OBDC<1D@ ;1DL  O85[-10!ROQ%N[:S\&7+W
MEF+JV::!)%9V5$!E7YW*\[5."0.N,=ZYK0(;/7/&GC?3KJ[6\@U.QL\R)'M6
M53'(K,@_NC( .3VY->GT4 >.0+XABT'1_$$UE*U]X4F-A)"BC=>Q!_*F9?4;
M1&P]U;VKI-=N(-(UKPI;7PCAO)#<.-2E+&.&5E^=54$!G<L0N[IS@'I7?T4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M20%$4]^'!3(_#D=1K>"=#O=!M+^VFDN%L&N=UA;7,_G26\6U1M+9/&[<0,G
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M/$EQ;P_%?1[>]U&6UT^;3)Y)5^VO!&SJPVDX8#.":ZCPVFJO#)<:KI5EI4C
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS'T &30 ^BO)O"'QSL/%?C)-"_LB6UBN&9;6X:4,6(!/S+CY<@=B>?SKUF@
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M!'#-@\[S@ #G!/&*B/Q$+V6C2P:+-)-J-Z]@8C*%$<JACPQ'S*=N0PXP<^U
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M3N&0&X)4^O'%8>A>+GUWP_::A'IXBNY[QK1[-Y_FA=68.&;;U559L8YQUYH
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M;J\JEEPKJS*0"#@@$?C6--X>N]4\6:3KVH065O)I23"$6\K2-*TB[<,Q1<*
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MM*ZJ TC=6/<_C7/:3X5_LKQ;K&K1W&;2^*S1VH'$<Y&V5_JP5/\ Q[UKI:*
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M!-S_ &;!9VMOG^%71I'Q]6*Y_P!T>E;>A>'+/P^U\]K+<R/?3FXG:>4N6<@
MGVX JN-)?3?%]QK=LC/#J,$<%XB]5>,GRY .XPS*<<\*?6@#B)M>\6'PMXD\
M00ZXH;1-2N42U:UCV3Q1/@JYQGE<X*X.?7M/XK\6ZSI]CK&JV.H?\>8M9(;.
M")'2)7V;Q<,RYW'<<*K9 VG'6K?A#PPUY;>(8=4&H0VMUK=S.UG*FR*XC+AD
M;YEW;3@9 (!Q@CDYV=0^'ND:E_;"27%_';ZNRR7-O%/MC\P8Q(!CAOE'<CCI
M0!%K/B&^TKQ];VK3[M+_ +'N;R2!4&2\;+SNZ]">*YC5Y]1U71_A_KEWJ+2?
M;]9L[A[41H(X]ZLRA2!N^4<<DYYKOF\,V<FNVNKRSW,ES;VK6BB1PRM&Q!;<
M".22!^594'PYTBWBL[=+O4_L=C>+>6EJ;G]W XS@+QG;\QX)..V.<@$6JW3Z
M?\6O#J0DA=4L;J"X4=&$6UT)]P6<?\"-6_&6K7^E7'AO[%<>4EYK,-I<+L5M
M\;*Y(Y''W1TJS%HSWOC+_A(+I"B6ML;2RC;K\S9DD/IG"J!UP#GKQ;UK0+77
M7T]KF6=#87:7D/E,!^\4$ G(.1@GCWH X/5]?\2)!X[N+;63"-!D22U06T9#
M#RED*/D'*G)'&#[]J](M9%U#2X998U*W$*LR'D89>1^M8DW@K3IX=>BDN+LI
MKAS>?.O/R[<+\O'R@"MR"T%OIT=G'+(%CB$2R<;P , ],9_"@#&U;38M<UK2
M81&ODZ5<B\DE'\+A"J1CW^;<?90/XA7%6Y\WPK\5Y;WE_MEZAW=?+6V4)^F,
M5U-IX L[2:)O[;U^:*.42FWFU!FB<[MWS+W!/)'?O5^^\):;?W-Y+(TZ17^S
M[;;QL!'=;.!O&,]  <$9  .10!5T*>2W\!:5<2VXFU*ZT^#=$1\T\QB48;\N
M2>@!-5;[15\._!W4-'63S/LFBSQ%_P"\1$V3],YJ_JW@^#5M3%^VL:U:2+&(
MD2RO#"B+Z  =R,G\/05;'ARU'AF;0FN;R2WGCDBEFEEWS2!\[LNP.2<GGM0!
M-X>_Y%K2O^O.'_T 5S%S=:_J?CW6-"L]<:PM8-/@N(G2VC=T=V<?Q Y'RC.?
MPQ78:?9IIVG6]E')))';QK$C2$%BH&!D@#L*XQ=(O+GXKZM>+)J-E ^F01)<
MPQX20AG++EU*DC*GU]#UH S-!\;ZSK\>AZ=(CQWT]K<S74EKY:M(T,WD_)YG
MR@$@L>">F.,U8O-5\76@\-6%Y?0VUY>:G):3O'''(7B\MG1B,85\ $@<9]CB
MM[5/A_H>IZ?IMJJW-B^F?\>=S93&.:'/WL/R3GOG.3S5AO!NG$:3^_O=VF3F
MYB=IM[R2D$%I&8$L2"1U[^PP 6)K6_M_"4UO<ZK+-?1VSAKZ*-8G9@#\P7D
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M:*1HR VUA@X)!QP:R7\'Z<^C:7IWFW*_V44-C<JX$T!1=HP<8/R\$$$$=<T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME<)'&I9V;HH'))KQ[5=&U[3?"F@> )$LYY)-0C2WNH)6\PV\<GF&1H]OR[0
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M\"DG).V)@<^^1S0!T=C=QW]A;7D081W$2RH&&" P!&??FIZR_#7_ "*VD?\
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M4,N.2.HZ8(]SG*\*>(]2U#2? NG7U]<-_:RWLES<F0B28Q%ML>\<KUSQ@X3
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M]3R0  22 *J1^*M+.G:G>W,CVBZ6S)>QS@;X2 &Y"D@Y!!&"<Y]>*PO&2/\
M\)OX$G8G[(M_.CGMYC0-Y?ZAJXKQM;W,EQ\2)DW?9%FTGS<=PFUI/R4J3[4
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M19'8,R[OG^8X!(8#   VCK6S110 4444 %%%% !1110 4444 %%%% !1110
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M"J%SP" .1V(KURB@#/GLH+30;BSL;:.&)8'6.&% JC(/  ]S7DUA<V5YX/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHJ.>%+B"2&3.R12C8..",&@#F]'^(GA37]=ET;3
M-8BGOH\_(%8!\==C$8;'L3Z]*ZBO&_!?P+'A7QM%K<VL"YMK1F:VB6+:Y)!
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MGC+RK*X5+[0X[6WD>,JCR[9,J&Z<;U[T =>GB+2I+G3+=+K,NJ0F:R'EOB9
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M:.>36!KG@Z]\6+XTODC>$ZE:06FGI.IC9_*^?<P/*AGX&<' SCD5KO;76O\
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MHZKJ>G_8+VVDL74%[B+:DZMG#QG/S+E6&?:M6@ HHHH **** "BBB@ HHHH
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MVJ6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO8PFU:T^TF(;MAR,XSC.#0 R'7]1U.]_LO3/LD-U#I<-[))-&60O)N"(%##
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M.I:+#Y%O?QQHQ:,@ HZ$;67@<'TKK-,L7L+)89KN:\G)W2W$P :1O7"@ =@
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MOW=OXUT+>,M:OH+B^T73&NX(+YK9;86[;ID23RY&$NX*IX9@,'@ =3Q8M?
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MLXVD!#&NT*HSD $'/?DYRQ\/88++34LM0:UN;'49-161(%*%Y-V]1'G"KAL
M9XQWH 2RUSQ/J7C'6-)MQI2VNE7-LLKR))ODBDCWMMPW##/&>./QJMI7C*\G
ML$1H+..^N]>GTN$I&1& A<F1AG).U#QD9)%=#I'AUM*U[6M5-Z9WU1HF=&B"
M[#&FP8(/.0.>.OI6*_PYADT*>P.JSQW']IOJMK>0H$>VG9B>!D@CDC!['\:
M*7C74?%6G^$=3::6TMRE];PP7,"'_2())$4Y7=E""Q!Y.0.,=:U+WQ'JG]KW
MNC6(CDO+&UCEEF6R>17DDW[5VA_E&$Y))SGC&*6]\$W&J^%[O3-3U^ZN[ZY:
M)S?M"B[#&X= L:@+@$<]SD\],-U'P3>W.LP:UI_B2[TW5?(%O=S0P1LER@)(
MS&P*@C) /.!ZT +8^)M6U74+#2!:1Z7J;:=]NODN$,ODY?8J* PSE@QSG@ <
M<\5_A5YG_"*77G%3+_:M[O*#"[O.;.,]JO7G@UCJ]AJ^EZM/9:E;6YM99I$$
MPN8BVXB0''.[+9&,$FKWA;PXOAC39K-;V6[$MU+<EY552#(Q8@ #U- &.GB^
M:7Q?<:')<VEC=1W*I#9W4#*UU!QF2.3<%8\L< <8Q[UC:/XGU32[+Q1?ZC=P
MWC)K[:?;Q^24_>'RHTYW'"#.2,9X)R2:Z?4/"<FK7%N+_4!/:V]^M_"C6X\V
M-E;<J+)GA<\=,XXR!5*;X>VUS:Z]93ZC<&RU:[-\$1%5[><E3O5^IP4! ^N<
MT /U/Q5>>&=<BM-9\BXL[FRN+F&>WB,;(T"[W1E+-D%>0<CH1[U<TJ^\17DV
MD7<D-C)IM];&6X$>5>U8J&0 ECY@.2IX'K[5+_PC(OKB.XURY34)8K:2UC"P
M^4H60 2$C<<LP &<@ 9P!DU1\.^#;S03#!)XDO;_ $ZT&VRLYXD A&,+N8 -
M)M' !( ].!@ Y[X6ZP+G08-%L+FW2ZM9[F>[2:-F/EM<2A=@R,\CEN0.F,GC
MMO%5YJNG^&+^^T6."6_MHC-'%.C,L@7DK@$')&<<]:Y^Q^'2Z;;:5]CU5HK[
M3;B66.[$ W21RLS/"XS@H2WX8&,'FNW'3!P?6@#B(O'#2>)]!@$]JVCZM8B9
M9A$P9)BI9%+;MH#*KD#&<KBI]2\0:C:S^%M\5HZ:K?F)MT+!HXRCNA'S<-M
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M&ZXQV]1U[4 ;]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO0V=Y#J)^UH99&*_O"IMFBW;1D8 XST/).: /5*B-S"+M;4RKY[(9!'GG:"
M3],D5X]JUQ?Q>$_'NJIJVI+=:3K3_8B+R3;$%$/&,X9?F(VMD>@&3GJ+>RA;
MXW7TI,P;^Q()>)W +><XZ9P1@#CI[4 =]16?HNGQ:9IJVL%Y<WB!W;SKF;S7
M)+$D;O0$X [8KS;Q[J5U':^+=1TO4KV2?3!;@.MPT,5BXVDH@4_O&;=EL@#!
MQDXQ0!ZS17GU];RZG\3-4TV;4-02R_L*.<0PW<D:B0RNNX;2"#A1TQG'.:RO
M">O7NO#P7INJWD_E7>CS74CB5D:ZF1E0*6!!.%+,1GG@GI0!WGAWQ"GB%=3*
MVLEN;"_EL65V!+,F,MQP!S6U7"_#" 6MMXH@62218_$-VH:1RS$#9U)Y)]S7
M=4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !4<ZR/;R+$^R1E(1R,[3C@U)10!\Z_#3X?^.]&^
M**ZCJ<4T%O&TAO+IY@RW((/ YR^3@\],9X-?15%% !6'XRO;;3O!FL75Y)=Q
MVZ6KB1[,@3*",90G@-SP>U;E-DCCFB>*5%>-P59&&0P/4$=Q0!YEX5^S:?\
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MM/L\/V8J5,.P;"IZC;TQ4$.C:7;E3#IMG'MB,*[(%&(R<E!@?=R3QTH \?\
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MI\R7<8<*2"<X= % )!P'.>#7HOA"\M-6\&:7<6UH]O:RVP5;>8[BBCY=I/\
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M9/*<Q><>D?F8V[NV,]>.O%%]XHTC3FN!<W+*ELP6XE6%WC@) (#N 0O!!Y/
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MJRJ9#+&3"?O9.3A&SSQC'7BNW^)),WPYU:WAC9YKR);:"/&&>21@BC![Y84
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M0 4444 %%%% !1110 4444 %%%9^N:O;Z!H=[JMT&,-K$9&5>K8Z >Y.!^-
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M1C?*<G<<=A@=SDXQ2L_ ][:Z9X0M/MUNQ\/R[V?81YXV,F ,_+PV>_2NYHH
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MNFZ?JUDKM>23VLKVK,55Y2[!QNP3@D#&/6NPHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD#J =I(] >U8FOP_VQXBU:\T%TN;:?PW<PW<ELP=)93_ *E<C@O@OCN ?<4
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M!!*2!PC8XW8/%>=:YJ>C^)O#?B'5/!J2WFHRV$<=S-;HZ[HT<'RL,,%RADX
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M]D?B"\VHA&%4L", =!7&_$+4+*YL_'MM#Y=I=QK;&:*3+SW00(5=0>$C4'J
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M.HKFI?%9A\>1Z;)=6*Z,VD/?_:"<882HG+[MNWD]JY9;K6Y=9T3Q=:64D/\
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M3@22R!%S]37FWB36+72/B)>Q>)+^ZT_3-0TZ.&RN%A1XFP7\V(ED;!.0>,9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFL^'_!VD^);J%=:GCTJ=([TW,IGD9@BX*;FZ8*^E 'H.!G..M%<Y'XPAEE2
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MS%+C##=CDHV,$UOV&II>Z/'J4MM<V2,A=X;N/9)&!G.Y><=* +I (P1D>]!
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M-(% WD.><8' ]34VL:7XF\2Z/:7TUG;:?J.GW\%]:Z>;D2AO+W;E>0  %@Q
MP"!@<\G'=44 <3J^@ZAK>HW6LFRDMI%T:>P@M9)$+O)*02258J%& !SW/3 S
M4LO#FL0R_#UGL<#1+=XKW$J?*3 (ACGYN1GZ?E7H-% 'DS^%?%4'@;_A#X],
MAN$L[V.6VO\ [4JK-"MP)/F4_,' R#QCCJ3P?2=9BEN-%N84L8;UI$V-:S,
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M^W<2=W!^4?K67#\.I8;+2]-_X2&Z;3=*OH[NRA:!"Z!"2J,Y^\!G ..GKQ@
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M2=X<OM.",C)Y/TQBK.H> ;;5;OQ%)>WCM%K<<".D:;&@:'/ELC9/()SR.H%
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MC_7!HQ&2WS<':HZ=\_2J+_#US _E:RT5S_;;:U'*+<$+*P(*%2W*X/'((]:
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MFC&V,#VT;1"7[1PBL"S8PV 2#TYQ5Q=>\1PW%^LM@DEM'I[W,5VULT"K,O\
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M!Y"Y'09SSD [&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2 _*CD A/=L$$^@(]:NUYOX)O1:?"O5=4U"[DM)VN-0GNKA5W/$_FN"P'<C
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MD>,F61-KK\RO@9YQCC'.="3SU\:?#U;B_&HS+9WZM=JFP3D1QC?C)Z]?0]:
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***"< GTH
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M?(GBQ8VU^W2);!I'TPHF[AQ^_+YR  =N.G.:?:>*_#]](Z6NLV4K1P?:7VS
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M+?2;"UU&YU""UCCN[K'GS+]Z3' W'OCMZ5<KSQO&]Z/#EQXP\Q/['AU'[/\
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M!['!P>AQQ46H>(]%TF9H+_5+2VF6(S-')* P3(&['7&2![DT :04*H4 !0,
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MM TJXO)[R6RB>YN(?L\TISN>+^X3W7VZ5!_PE?AXVHN1K5@83(L6X7"GYV.
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M=6UL%D!;.SDD+GV! _"N'TO0[ZZ^!MY96>G2+JXDN&\F2,Q2./M)<KR ?F0
M>_%>N44 >7&;2M<T76=9M=(UNWO8=&N8)9M3,R^6"A)B =B&.1GC(&.HS4>F
M6R:WH'P[72[:07.F>3<SMY)C\J,0$.I) 'SL5 _O9ST&:])U6P&J:1>:>TAC
M6ZA>%G R5# @D>^#3=&TT:/HECIBRM,EI D"2,,%E4!1G'? % 'E&ERS3W_@
M>]_LZ^M8[:^N4GL8K"18K$O'( O*Y8DGELD=_E'%=!)HEYIGC^\TNSC!T3Q&
MOVVZ /\ J)(RHF&/24,BG_>/I7HM8N@>'O[$61IM3OM3N7^7[1?.&=4R2$&
M !D_4_@  #:KD?"X;_A,O&,C12I'-=P-$[QE1(%@125)'(!!'%==10!Y V@7
MI^&=Q\/Q;S#4)-1:$/Y;;/(-SYOG;L8V[/?[WR]>*V9+:;P[J7C:)K6XE75T
M%S8>5$S^=(T7EM'P.&# 'G'#9Z X]&IH="Y0,"X )7/(% ''6NA6^@^"=#LK
MC2[?4=4L[>*VMU>,-^_P"3NP=J!AN)[!<]0*JZWID^E?V3'+)=3V$CW,NJSP
MAP\TYB_=LP3D#.0HZ B,#H*[VB@#!\/)J\O@33H]0D=-7;3T$KR?>64IU;WS
MU]ZX>"UN]6^%VD^&OLES;>(+2:VB*R1,# \4JEIMV,;=JLP8'G.!R:]6I%8.
MH92"I&00>#0!Q>AAQ\5?%,K13+%+:V:1RM&P21D$FX*Q&#C<,XI?'RR)?>%+
MP03R06NL)).T,32%%,<BY(4$XR0.G>NS5E;.T@X.#@]Z6@#RB_MY+@?%21;*
MX)O;6-;;-NV9B+7;A>/FPW''>F-<3:+K^G7^K:?K4^FWVBVMLD]@)BT$T>XL
MDB1D-SO[CJ/KCUJD5E;.T@X.#@]Z ,OPUI]MI?AVSL[.RDLK6-3Y5O*Y=XU+
M$@$DDYYZ9..G:O,UTN:\^'OB'PPMC.-8N]6N&AC>!EVEI]R3%L8"A<'=GM@<
MX%>PT4 <%IDDFD:UXLL==@N)DOIA<VTHA:1;F(Q+&8UP#\R[,;>O.>E9'A_1
MK_2/$7@2UU&*22:QT>XBGEV%EA9MFU"^,9 !7KVKU2B@#QJ*UNH/!-C,;*[$
M5CXN^VRQBW?<EN+AFWA,9*X8'@=*U###J6O>.9KNTU:/3[U=-\F>"VD63*C[
MZ?+G*,5;&,X'2O4:* ./\#R:R9]6@U2X34((7C6UU3[-Y#W*[22&7H2G W#@
MY]0:Q[J[GTCQ3XPM]3M+QTU6WC;3YXK9Y4D582ABRH.TAMQP<?>)KTBB@#QB
MQ^VZ%8^"]4U'3-8?3(]%^P7"VBRI-:394[F1<-M;:!^ ]L[\^CV"Z+IS:4VK
M>')5FGN;*Y:)YBA;&[SD;=@/DG:V.@Z'BO2** /)K#6-:T/5]*\0>(-&N&M+
MK3I+.5K"U=C#+Y[.)#&!N42KM)XSD &M&[M8&\2^ 'M-%EL]/AFO'\C[.0(%
M>)MA< 80EB#@XP3ZBO2** .&%L4^+\C0VKI;+X>%NKK$1&'\XL$#8QG;SCTK
MF-&TF;4?AQX2T"*RGAU6POX)IQ) T9M/+D+.[$@8R,@?WMW&>:]@I&944LQ"
MJ.22< 4 >06$$7FZGX7\1:%KEU?/J,MQ T3S?9KI6E,D<A=6"I@XSGIM[GBI
M=4EN;/0?B%H6H6%[)?W\MU=63QVKRI<1/&!'AE!&5VA2#C&!7K=% &=H>4\.
MZ<)$>-EM8PRR(592%&00>17E-K:S_P#")>&H9+&ZW1^+C<2QM;/E(O-E.]AC
MA<,IR>.:]GHH XSPS'(GQ&\:R-#*D4[V;12-&0DFV':VTD8.#P<4R[+V7QBM
MKN:"X^S7&B&VCE2%G7S//#;20"%X.<G Q7;44 >,M9W ^'5ZBV-R+AO%!N50
M6[[RGVH-OQC.-@SGTKH]4@CG^(>OR7-G=SZ?+X:$$AAB;][\\A:-"!R^UAP.
M>:]#HH X7P;_ &O;Z_=V4][)JVE1VB&WU"YMC#/&=Q_<.<#>0.<XR._6H=9N
M[6R^,VDS7:G8-%G"OY981MYJ<G ^7C(S[X[UZ!6+-X?67QA;^(OM3K+!:/:"
M$(-K(S!B2>N<J* //;&TN-"N[!GTV>WM+_7+^[M[Q+1Y9+&-UVHJH =ADYQN
M4@ ],],^*TG/@BUL);"^:6'Q:)94EM7)\O[26+GY>1MY)Z<U[910!PGB&18?
M&D%LNG36\4VF2[-0M+1I'DD9P6@R%*IG 8DC)]1S7):;<G1_"GP\U":UU%+K
M3EFC>(V4K#!C*N&"J6!Y&& (X:O:*Q=7\/OJ.I6VI6FJW>GWMO$\(>$(ZLC%
M259'4CJJ\C!XZT >9WG]FW_@>>VTU[B_N9O$$-]>0?8I4,7F3AVQ&R[@@52,
M]#@_2NOUZ9+?QOIL(T^6"&:SF*ZE:VIED,C.N81A2%W ;BQ'..".375:?IYL
M@[RW4UW<R "2XF"AF S@84  #)X [FKM 'B&C.MCX?\ A@NH6T\)M;V=94FM
MW#*1'(<[2,X'!R.!CVJYXITFXN-(\=:A9V5P]IJMU8+:PI"Q:9HV3S9 F,X/
MKCG:3TP:])UCP\NKZQH^HM=/$VES--'&$!#LRE#N]L$]*VJ .*MT;_A<=Q<1
MPRBV?08XO.$9$;.)F;;NQ@D*<X]*3Q07M?B-X1U![>X>UCBO87DAA:3:[K'M
M!V@XSM/Y5VU% 'ET=M<+X&\5>%]0L[B;5YY[SR1Y+$79E8M%(K8Q@%E!.?EV
M\XQ7;WEE=KX(GL'9KF\&G-"6')ED\O&?Q/\ .MJB@#R6PW7-A\+U^Q79%@RI
M<B2UD7RF6V*Y.5X ? W=,]^*AOM/U6;3?&+6-C=3/'XBBOQ;*&C:[@01%A&W
M&>4.,=U^E>P4U'1P2C*P!()!SR.HH X_PA)I.JZI/K6G:7J\$LENL$USJ1E5
MFP<B,+(3G&6R1P,X!.3BMJ]G<Z#\3(/%8MI[C3+K3C879@C,CV[!]ZR%5!8J
M>AP#CJ:[NB@#%GU#^VM+NH=),I>2"1%N&C:-48J0N"P&3DCITP<XX!XB*VGU
MCX=>'- BM+BVUNPFLD=7A93:M R[Y"<8QM5L$'YMP SFO4 RL2 0<'!P>AI:
M /']4LI9?#GQ01+"X:2\NO\ 1U%NVZ?]V@!08^8;@>1]:Z*&)A\3= GCMY5@
M709(7E$3!%)>,JA., \$XKOJ1@Q4A2 V."1D"@#Q7P[:QZ]\(= T>Q@?^TUU
M!)E;R67RMER6:7=C&-@89SR3CKQ4VNR7%W%?JNFWMH]MXFAGDM+>R<JZ"5/]
M(9]IWE@,_*<8['&:]-\+>'X_"_AZVT:&X>XAM]VR210&(9BW...I-;% 'EM[
M!)->_%*06=P?MFGQ);DV[9F(M64JO'S$,0,#O4^JV5W9^$/"?BBPMW?5-&@@
M22W/R//"ZK'+"<_Q9P1GH1ZUZ76+/X>%SXA&J3ZG?O JIMTXR#[.'4Y5]N,Y
M!P>O4 ]A0 V&=?#NFZ=#=Q7$]Q>7(BE>VB,@$TA+,S8^ZF<\G@# K<HHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "CK110!YC>F+X:>.9M5>)CX=UW"2%$+-:72@E0H'.U^>!_%Z5T=FM
MKX6T74O$VL0K!=W3?:KI8U!9,X5(5]2/E'^TQ)[T[QWX?U'Q)I-G9Z>;57AO
MH;IVN)&48C;=@84\FK_BK0!XI\*WNCRS&W>X1=LJ?-Y<BL&4]L@,H]* (3XD
MFM==LM)U+3Q:R:A&[6<BS^8CN@W-&_RC:V.>,@X.#6;;^/XKCP]HFL#3G$6J
M:D-/\OS1NB8RM&&Z<C*D]JMKHNJ:MJNB7^MK9POI1>0+:RM()I60INY5=J@%
MCCDY(YXYYJ'P-XB@T72M&633/LNE:VNH13&63?-$)7DVLNW"M\V.K ^V.0#>
M^**(_P ,?$.]0V+1F&1G!'>G:9XL\O5HM'U'3WLE_LW[=#.\JL'C3"MN ^Z1
MD'&3Q^57_&>C77B'P?JFD6;0K<7D!B5IF*JN>YP"?TK*N_"E]J'B2QO;G[,+
M)-'FTZX1)6WYDVY*_+@@;>^.M "V7Q!LKR_TJ%8HFAU0'[.T%RLDD9V[E$J#
M[F1[G!X.*@L_B,)],GU>XT2ZMM)@,\<ETTT9Q)')L";<\ECP#TSQGO4OA32/
M&.D06^DZI?:5/I=B@C@N(%<7$Z*,(K@_*O;)&<XQWS56T\"7DOP[U#PU?W4,
M%Q<7,MQ%<6SEQ&QF\Y#R%Z-C/TH 35O%EKJ^F:]HDL-NTW]CS72/;7 N(F4*
M05+ ##@X./0Y!J'POXLGTS0O".G7FCS0VM_8P6]I>M,I5YA""$91DH&P<'GZ
M"M6RTSQ?J6C7MCXDN]*1I;.2V0V"N1(S+M\Q]V,8_NCU//057LO#&H'2_#5I
MK;64%IX>\N8O!,S^<\491&.Y5V* 2QZ\\=!D@%[2/&7]K:!=Z@-/,%W;7ALG
MLGF^=9@X0*2!QDL".V"#6UK.I_V/HMSJ)M+BZ:!-PM[9-[N>@"CZFN9TK3-.
MU'QY=>(-(U&*XL)8(WN$MW5XI+D!E1PPR-PC)!'NAK:\7:9J>K^&+RQT>\%I
M?2;=DC.R @,"REEY4, 5R.1F@#,'C<QMXBM[C3T6]T2U6[FCBN=Z2(59L!MH
M(8;2""/2K">+UDOO#ELEB?\ B>VCW,+&7'EE8U<JW'HP&1[\5C6_@S4WU379
M)HM,L[+5])2Q,5J[-Y# 2#@;%##Y\YXZ8QWHTSPMXC74_!]S?'3(X]!MYK:5
M899',H:-8PX)08)VYV]L=3G@ YSQ#K6H^(_A)K-_JEK;H8M35(O)D+E=EVJ8
M *CL,9[Y/ Z5WD'C!(]8U33M6L6T]K&S&H;VE$@>WRP+''0@J<CGV)KFYO V
MOOX*U;PVC:;LGU$W5O.T[@E#<";YAL^4@#'&<YZC'.QJ7A&[U?Q5JE[=- FG
MW^AG2F"2,95)9F+ ;<8^;'7M0!;/B\VYTBXOM.:WT_5W2*VG$H9D=QF-95Q\
MN[ID%AG@U7TOQE=:W=7<,/ARZ-I;7=S97$[3Q_(\0Z;<\ACQD9 R/?$<'AG5
MKW1M#TC639F#2IH)6G@E9FN/)_U?RE1LR0I/)Z$#KD6_"V@ZCHEEKJ77V5I;
M_4KF]A$4K$ 2G(5B5&"/8&@"KX9U>!? VDWNAZ/!::4]M)-LGNO+2V0'/+;6
M)SDG\#S4>G?$2WO=&L;^>S6R.HSO'8K<W 1)D09,I8@;4],C)R..:R3X%\1M
MX$T#PH\VGFQMCC4U2YD0W**V5C5O+X4_Q<9XP*T]<\-^([^73M3TM],T[4=(
MD(L;?>\D#PL@5T<[%(S@8P#C _  WO#?B2#Q';W;11B.6TN&MY0KB1"P (9'
M'WE((P<#OQ7/:-*OB_QMXD.I(L^GZ/,EE:VD@S'OV[I)&4\,Q. ">@''4UU6
MBQZNMHTFMRVIO)&SY=H&\J(8X +<L>I)..O3BL,^'-3T7Q7?ZYH!M)H=4"&]
ML;J1HAYB# DC=5;!(Z@CGKF@"U=Z-I^B6FNWZ6KR64]CB;3XVPA""0ML!("[
M@^#C'3/6JFD>)+--+\+Z?I6G+$^IV GM;5I=J00HBDAFP3QN4#CFM6\M-6U'
M1-1AF%K%<7-L\,4"2,T:%E(RS[03U_N\>]<1=:9JMG_PB.@V,FC-K6DZ<6;S
M[B6(D!5B!1U7<0<-E<8X&>@R ;0^(R'P_;:M_8MWB;4ETTQ>8FY93(8V[\@,
M#CUXZ5:7QL\9U^"YT6Z6^TA8G-M PF:=9<[-N.^001VQG)%8*Z'K&K:%:Z+%
MI^E64NE:K;W;F&]DEBD"OYC#<4W>83R=W]X'/-7-:\(^(KO4_$][IEY:6S:I
M#:1P'SG5OW).]6(7*APQ&5)(H Z#1/$O]J:YJNC7%JD%[IJQ/)Y4_FQL) 2,
M-@'(VD$$?G6\Q8(2H!;' )P"?K7"66@:[HFLZWK-K!H=JMWIT,<-OYKB*&6/
M?@$A!E/FSN&#[=ZZ_2)[VYTBUFU&&.&\>,&5(R=H;VR <'K@\C//- ''^'?&
MM])H5YJ.M6\7F-JTEA:PVTNXO)YOEK&,J..,[CVR<#I70V?B%G\1R:#J%H+6
M^^S_ &J$I+YD<T6[:2K$*=P.,@CN",URL?@36?[%NK$SV,<]OK3:OILX=V#/
MYI<+(NT;1@E3@MUSVP>FMM&N[OQ/!K^IQV\,UM:/;0P02F0 NP9V+%5_N@ 8
M]3WX *7B/7=7L/&7AK2K&WMGM[]KAI#),59O+B)V_=.!R#GDDC''?E=(\1MX
M2M_&VH+I3W%A;>()7N&CD5/+0I"/E7^(C.<<?6NQ\1Z'J5]XD\.ZQIQM6;3)
M)_,BN'9 RRQ[,@A3R.N.,^HK OO VLW?A?QCI2R6"RZY?M=6[F5\(K",8;Y.
MO[OMGK0!N:UXVM-+O;VSA%M-/8P+/.DUTL).X$A$!!W.0,XX'(YYK:LM8M+[
M0H-91FCLY;<7&95VE4*[OF'8@=:Y6[\/^*M/\5W&M^'KC2RFIQ1+?VE\TFU)
M(UVJ\;*,GCC!QG'Y=6^GM=:))I][.9FF@:&:55V[BRX8@=NIP.U '.V/Q LK
MZ]TR%(X3%J@/V5H[I9'1MNY1,@'[O(]VP>#BI-*\;?VI?3Z6NG-#K%M=F"YL
MI)>8H\9\[=MP4(Q@]\@=35?PKH_C'1[:WTG4K[2KC3+%!';SPJZW$Z*,(K@_
M*G09(W9 _&H+KPOX@_MC3?$ED]C'KJR/'J"O<R>3/;'I$/DS\N%(.!@Y)SDT
M /MO&5Y;Z[XM;5H;>'2]$\I2T<Q9@#'O! *C<S;@,9&.!SU-JW\>6[ZC)8R6
MT;R_8WO(C9W23J0OWD8C 5QP<<@\X)Q6=J'@?4=3OO%L$LUM'I^OI"XF21C+
M!)'&%'R[0"-R@YW#CC'.1?TRP\;3Z7/:Z_=:0[+;/%&UIY@-PY7:'D)'RCOA
M0>?3&" ,TSQ\=0E\.F31YK>UUV-C;3/,I*N$+[64=B <'U[=ZL>"]>U779=<
M;4+>WBCM-3FM$\J8MM\O:N,%1D=3G/4]!699>#=8MK'P/ SV)?0&/V@B5\2#
MRC'\GR=><\X]*U_"FAZGH5_KJ7!M'L;W49KZ"2.1C)^\*G:RE0!C!Y!.<CI0
M FI>++JV\43>'[#0YKZ\2Q%ZI\](T92Y7&3TY!_3C'(K6OQ$TR]TW39XA'!=
M7WG#R+V=8!"T1VR!VYQAB , DY'&,D4;I[Z/XURFQM[>=O\ A'8PRS3&,8^T
M/R"%;O[?X&!_ >MZ3'I>IZ!?67]MVLMS)<I=*P@N1<.'D7*Y90"!M/MS0!H'
MXC6QTW3[J'3;B9[K5/[*:.-U(2;GD-T92!D,."",XJ>/QEJ+:O;:/)X:GAU.
M>REN_)>ZCVKLD"8+#/!R#G'<<4S6/#_B#6+?09+B;3VN[+58M0N%5W2-5567
M9'\I)ZYR<9.>F<"[<:'J#_$2UU^/[,;.+39+-D:1A(69U?(&W&/EQU[T 9EE
M\1A=Z9HNI-HMQ#9ZC>BP=VF4F&8NR#@?>7<I&>/I1>ZS;V.O^+)M.T:/^V;#
M38II+B:7:MPF'*C@'&-I[9/3CK5"#P-K</@[1](+Z>;BPUI=19O.?8R"9I=H
M.S.[YL=,<5K3>%M1N/$?B>]:2U2UU?34LXB'8NC*KC+#;C'S]CVH R;;Q9XC
M-GX#0VMF\FLQJ\\C7!!DQ;&3G$?RY/)QG&,=\UJZG\1-/TXWDFV&6WL;@6]R
M%N5\_=D!BD6,N%)YY!X; ..:$7A3Q%%IG@T[=,-[X?(C:+[0_ERQ^1Y6X/Y>
M0W?&W';/>I['P[XMT37-2CTN_P!+?1=2NGO':X1_/M9)#F38!\K#.2,D8_F
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M*MG"(P[\;SU)]LDF@#G;'XC"ZT>36I]$N;;28A,)+IYHSB1)/+5 N1G<>AZ
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MT85U= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;@JCA<1_,W P ?S)K)6*Y/BSXC^9J-U+'%80;8GV%=K02L%^[D $G&".O.:
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MG@_=. ,\:4>M^(K:YTC0-4FCAO\ 4=0N(TNT\MG%M''Y@+  H)2"JXQCJ<4
M=98:Y9:EJFI:=;-(;C3G1+@/&5 +KN&,]>.<].:GN=,L+R[M[NYLK>:YMB3!
M+)&&:(GJ5)Y'X5Q_@J&6#Q[XZBFN7N7%S:?O9%4,1]G&,[0!P..G:N[H *K7
MVG6.J6XM]0L[>[@#!_+N(ED7<.AP1C(JS10 @ 4    < "EHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5\J4I\R^7@Y)SP<C&-P/) KJ001D'(I<T 9.J>'[75+ZROS+/;7]D6\BYMV
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MU ((R#D>M '+OX#TV;PU=:'<WVJ74-WM$]Q<W1EG=5.57<P. #V '?U-:/\
MPCMJ?$2:X\UP]VMF;(ABNQHBVXY&.N><UKAE*[@1M]<TC.JJS,P 498D]/K0
M!E>'/#MKX8TI--LI[J2VCXB6XDW^6N20HX' R??U)J"3PE9&]U"X@N+NU34N
M;V""0".<XVECD$JQ'!*E2?KS6IINHVNK:?%?64HEMILF.0=& )&1['%62P!
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M<L<\  >F*]'73;!)(I%LK8/"-L3")<H/13CC\*='I]E#>27D5I EU*,23+&
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M1@8H \IT70(O%7@WQ9HT-S:M=6NN7$NGM$ $A=0C(47)VH6)&.1AC6]%>?\
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MT5[<1V$CL69[59&$1R>HQT/IBN/TK2(I=/\ '>JV5L9=:T[5;\Z<RL=T,GD
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M: .D7Q%8O>BV1;AP;@VOG+"QC\T=4W=L8(STR,9SQ5V^O[;3;;S[J38A=47
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MZ; [_:].*"X1D(V[QN7!Z'(&>*X#4/"VJVVEC48+&6:5O%*:V]E&RF180=I
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.JG#':H)&TD Y'!('4XKSZ6U\365]H7B#6M#N-7$FG&ROK>QPLT+B0NLH0,
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MX%Q^O2L='6,7-A<:'XA;1UUN345-K8K<*2LI; E5\E"PW8V9&2N3UH ]9O\
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MS\S[0=HX/7L">U<1K^DWDL%O>V$&L:;X@M=+B2":V3S8KEL-_H\RC*D!N[8
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M=66OI<W,7DG,,0GE<L?;:R],]?K5K7/#FL:O?^/TLK61'O/[/DLFF4I'<-
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M2"50WW2$*[B#Z@$<'T-9GC?3K^[@T>^T^%KEM+U.*\EMD(W2Q@,K!<\%@&W
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M=\1W$EF'& .,]>,4[2M*U"+X/^(M+?3KE+^<:@L<)B(:0RLY0CUR&7GMWZ4
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M<&L:-=Z7.TB6UU"T$GE$ [&&"!D''!Q4MA9IIVG6UE$[O';QK$C/C<548&<
M=A6=J>N&UUNPT6U1'OKV.653(3LCCCQECCDG+* .._/%<AXK\47]UX'\960B
MCM-5TJ%H[G9(2ICDCRDD9QGD'H>A!Y[T =[:ZGI]]-+#:7UM<2PX\Q(I5<IG
MID \5;K(T*P2.SM;N:TM4O?LJ0>;"O/E 95<D9QGG%8%SXXN['6+&WO-/@AB
MO-4.G) TW^D*IW!)RO3:Q7IZ$')H ["[M(+^RGL[J,26]Q&T4J$\,K#!'Y&N
M=T32='BN#:6FO76H"TQ_H<NH><(?[NX#D@8XW$]/:G_$"XO+3P!KL]DZI*EC
M,=Y8@J-AY7'?TK(M=4BT>#P[ UA;'5[O3]D4\4+R>7;1JA(.U2Q^9E^7@=3G
MCD [:YO+:S5&NKB&!7<1H97"AF)P%&>I)[5(ZED90Q0D8#+C(]QFO,_%&L3Z
MYX5TR>[TV>QN(/$=I R2QLH?;,N'3< 2C @@X'<=JZ>7Q)?WG]M/HMG!<II,
MI@D$TA4W$JH'=%P#MP& R<Y.> !F@#4\/:%:^&M$M](L7F:UMP1'YS!F ))Q
MD 9Y)K3KBD\=3:EJ&@6^CV$,T.M6,EW%+/.4\O9MRK *?[W;/(_&JC?$*]C\
M*VVNRZ9 L,6HFPU/$Q(M@LOEF5>/F4'!P<'F@#O!!$)S/L'FE=N\]<>GL*DJ
MA!?27&L7-K&J&WMXD+2@\^8V3M_!=I_X&*IW&M33:_/HFF+ UW;VRW,[SD[4
M#L0BX'))VL<]ACKF@#;HK@W^(=R]AI3VVDHUW=:LVD7-O)<8^SSJ&SSM^9?E
MSGT(.#TKK;"XU Z,EQJ5FD5\$8R6]O)Y@R,X"L0,Y '7UH OT5Q>C^-;R[\2
M:=H]_96T,U]9O<F.*<M):,NW,4HQ][##TY!X[UO:OK)L+W3=.@C22]U&1TB#
MMA5"(79CCDX  P.I(Z=0 :U02WEK#=06LMS#'<7&[R8F<!Y-HRVT=3@=<=*Y
M+4_%^LZ-IL,MYH*BXDUB/3547&%E1V 65.#P0?NDC![T2:Q?1^*?#%EK6@Z>
MM_>->".YCF\TVX1,_(2@/SKMST]Q0!VE%>=W/Q$U6'1;[6!HML;33]7;3KA!
M=$R.!*L6Y/E /+ \X_K6G)XVETO5];L]<LHH(M.TY=262VE,FZ(E@5(*CYLK
MVX.: .QJ"ZO+6R2-[NYA@6218D,KA0SMP%&>I/85SFE^*=0NM<LK&YTB98+R
M!I//C@F"VSJ =DC.@!R#PPZD8QWJ3QMJ<6EV6ER3:7;:@DVJ6T $Y&(6=P!(
M 0<D'IT^M '345PNI>-M6MKGQ9':Z3:.GAV-)I&DNF'G(8O-.,)PVWC'3/<U
MH1^+I6\3:)8R6L<>GZS9-<6MP7.XR!0QB*XP#M.<Y[$8H ZJHKBX@M('GN9H
MX84&7DD8*JCU)/ KGF\33>?IEE'!"UYJDDYMLL0@@CY\UNYR"F /[XYX)K \
M4:\VJ>"O'.D7ULD.H:79/Y@1MR2(\9:.121D9P>.Q!Y- 'H:.DL:R1LKHP#*
MRG((/0@U%=7EK8QK)=W,-NCNL:M*X4,S' 4$]R>@KE;#Q%<6&L^'-#N+:);/
M4=.WV]UO.3*B*3&1C'W3N!SV(Q4>N>(?^)#IU]=Z19WMO=:O#;P+,<A4:;;'
M, 5.3CYATQD<T =K17$:EXSU>#4/%-K9:3:2#08(K@O+=,/-1D9R  G#87 '
M3WJZOBYKZ^T*RT^!$EU;3VU!7N"=L: (0N!U8EQWX )YZ4 =516#X0\03^)]
M!34YK)+3?))&(UF,G*.4;G:O=3C&>*P=4\<:Q:S>+$M-'M)%\.I'+(9;IAYT
M9B\TXPO#;>W3W- '>45Q]MXSN/[<TJVOK&&WL=6L9+RUF6<LZ"-59A(-H ^5
MP>">AZTR?QM<6_AZQ\3O8Q_V'=21AOG(FBBD<*DI&,'[RDKV!ZG% '9T5R-G
MXHUG4?%&I:5::/;&#3+R*"YG>Z()C= ^Y1MY89&0<?4YXKV/CB[D\0:-IE_8
M06\FJF<"W$V9[0QJ742KC'S*,]L>_6@#L(+RVNGF2WN(9FA?RY1&X8HV,X;'
M0X(X-35Q/@-0NN>-0H ']M'@?]<8ZECU;69?BE=Z0&MA80:9'<(F6S\\A4L?
M4_)] * .QHKA(/']S-X6T?63IT(:^U8:;)$)2=F9FBW@XY^[G&._6K4?BK7+
MSQ/J^E6&BVDD>E7,,<\LEX5W1R1[]R_(>1D9'MU.> #L:@BO+6>ZGM8KF&2X
MM]OG1(X+1[AE=PZC(Y&>M<#9?$759=$T/Q!=Z';PZ-J4Z6\C)=%YH6=BJN5V
M@%,X!YSSG':F>(/$UU8P>/Y-+TZQL]1TN& M>#YFG#1%E9L*,E0< '('TXH
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M9I])2+3KMX=1@:;[0J@QVX"A@)#G@G.!C/(K2FD\F"278S[%+;5QDX[#) H
MY.T\%#3-:\/7%A.BV6BV,EFD,@)>0.%^8L. ?E!Z<Y/2J$=KH_A'P_=:#XFU
M""1-:NKIXHUC;,OF'<T:CG+#=@>N1CFNK\/:W;^)- L]8M8Y(X+M/,190 P&
M2.<$CM6BT:.RLR*Q0Y4D9P?:@#%\'Z+)H'A:QL+B62:Z6)3/+(<LSX Y/?
M4>RBH+KP]=1>+O\ A(M+N(DFFM1:W=O.I*2JIRC@CD,N2.X(/;K71T4 <7/X
M%DVZ2;>[B$MKK#:O=2/&?](E;=N  /RCY\#K@*.O6NJU*U>^TN[LX[A[:2>%
MXEGC^]&64@,/<9S^%6J8\L<;QH[JK2-M0$_>."<#\ 3^% '$:1X)U:PU+PW>
M3:C8'^R+66T>.&U91*C!?F^_]X[<D],GI6MXL\-76N'3KW3-1&GZMILQEM9V
MC\Q#N7:Z.O=6%=)10!QNI>%-9U?2]/2]U>"74+?48+]Y! 5B_='(C1-V0#W)
M)/7V TM6T"YU'Q7H&LQW$21Z5Y^Z)E),OFILX/;&,]#GVKH** .!G\ 7TWA7
M6-&_M"W5]0U8ZDLWE,1'F99=F,\\KC.1UZ5H:EX+_MCQ#JE[?3QFRU'21IDL
M" [U 9FWANG\1XQV!]JW]5U>WTB&!Y]S/<SI;01IC=)(W11GCH"?H#1I.HR:
ME;RO-I]U8R13-"T5RH!)'\2D$AE.>"* ,3PQH'B32O)@UGQ%'J%I:+LMUCMO
M+DD&, RMD[L#L!UY)-6O%N@7'B*RL+>"XB@^S7\%XQD0MN\MMVT8/&2.OZ5T
M%% '&W/@Z]N)/&3_ &R!?^$CMUA4;#_H^(3%D\_-P<]O2IM3\&G5?"NCZ5)>
M&"[TQ[=XKN$$$&/"L1Z;DW#'OWQ727]XNGZ=<WLD;R);Q-*RQXW$*,G&2!GC
MUJ'1M4BUO1+'58$=(;RW2=%?&Y5900#COS0!F:WX;>]O]'U/39H[6^TEG$(=
M"8WB=0KQL 00" ,$="!P:I:CX.FU'2O$BM<PIJ.NPB"64(2D,:H550,Y.,L<
MG&2W8<5UU5[ZY:RT^XNDMYKEH8FD$$(!>0@9VJ#U)Z"@#G=>\(-KGAC3=.-X
M;6^L)()8;N$<HR8#$?5=PQ[]\5/XF\,OK.DZ=86,L-HEE>6]RFY"PQ$P(0 $
M=< 9[5LV]\DUM:22H]O+<QAUMYL"0';N*D>H[U3T#7[?Q#;W<UO!-"+6\ELW
M68+G?&<-T)&,^] &--X1O);_ ,6W(NX ->M8[=%V']QLC:/)Y^;.XG''3'O7
M,ZW:RZ?>^'-#&O:587>E:7A)=0B9$F)Q'F-PZL&PAW*"<!AUSD>JU'-;PW"A
M9X8Y5!R ZAAG\: ,#P9+>G2&M[D:6T-NPCMIM*5E@D3 ^Z"3T.02"1^.16?<
M^#;VXD\9M]MMQ_PD<*PK^[/^C@0^5D\_-P<]N:[,    8 HH Y#_ (0^XDU'
MPU<37$#PZ/8RV<L6P_OQ(BH3GMPF<<]:@MO UPOAF'PK=W\<^B03(R-L(G:)
M) ZQ,<XX( W#J!C /-=M10!SFD^'+G3];\1WTEVA35Y$D18U(:$K&$Z]^ #V
MQ6#I?@+6+'_A&/,U6Q?^PI92"EJP,ZNA4LWS_?.<Y]<GFO0:9%+'/"DL3J\;
MC<K*<@CU% &%X<T"XT74==N9KB*5=3O3=JJ*08_E5=ISUX4<\?2F2>'KQ/'G
M_"0VUY L$MBEG<021%FPKLX*D$ 9W$<@UOK/$\TD*2*TD>-Z@\KGIGTJ2@#S
MQ/A[JD>F6VDIK%JMA9:P-2MB;9C(1YIEV.=V#RQ&1C^E=#I.@7.F>(O$>K37
M$4D>JO%(L:J08O+C"<DGG(&>V/>M^26.%0TKJBE@H+'&23@#\20*RK/7;74O
M$&K:&+:59=.2%IFE"[)!*&(VX)SPO.0* .%^'NB7.O?#+PS;WMQ;MIL,BW6V
M-#YDACD+*AYP & )/<#&!UK=O_ ]QJ,GC+S+Z)(_$,$<:;8R3 4CV GGYL]>
MU=C#!#;Q^7!$D29SM10H_(5)0!R%[X7UBYD\.7Z:A9+J>CM(/FMV\F17CV,,
M;MP('(.>M9S?#N\.G7:KK,:Z@=<.MVDXM_ECEZ;77=\RD9'&.O>NH;Q% ^I7
M%A86MUJ$]J0+C[,$VPL1D*S.RC=C!V@DC(SC-6=*U>WU>.X:!)XVMYC!+'-&
M497 !(P?]X<C@]LCF@#E+CP%=:U>ZS<:[J%NZ:KI\=E)':0,GEE&9@ZLS'H2
M#R.U7M'T?Q5I]E*-6\207SV\#):LMH4RV,"2;#$N1Z#'?J<$=910!F>'FU1M
M"MCK+1O?C<)'CC,8<!B%;:>5RN#CMGMTK"/A&_CO/$:V^HPI9Z[('E;RCYL'
M[L1L%YP<@<$]">AKL** .,U[1(+\>'O#.GQ8M-.NH+F?'*PPPC*(3_>8A0!U
MQN/:MOQ%K6AZ59+#KMU##;WQ:W5)02)<@Y7@=QFMBFO&DFW>BMM.Y<C.#ZB@
M#B](\"VS_#:3PW?27!6\B(D>0_O8QP(Q]458U]/EK2@\/W]Y<:1-KEW;W+:4
MQDC,,97SI=A02-DG'#-\HSR<YXQ7244 >>?\*]U0:8NDIJ]JMC!JXU*W/V9C
M)_K3+L?YL'!)'&,^W0]'H^@7.F^*=?U>6XBD356@98T4@Q^6FSDYYSU[8]ZZ
M"JE_J4&FB)[K<D,CB,S8^1&) 7<>P).,],]<4 8_BWPU/K\-C<:?J!T_5=.N
M/M%I<^7O4'!5E9>ZL"0:IWOA+4]7T>'^T]91]9M[N*]MKF&WVPPR1YV@1[LE
M2"P.3D[NV !U]% '*WWA:ZU66_OKR>!=0N-,DTV$1J?+A1^6;GEB3CTX&/4U
M!;^#[R"Y\'2F\@(\/6[P.-A_?[HA%D<_+P,]_3WKL:* .!NO -]<>'M<TH:A
M;*=4U?\ M/S/*8^6/,1]F,\\Q@9XZ]*VCX>O/^$RO-?$\&)]-6Q$)!^4JS-N
MW=^6(QCM7244 <);^ [VW\->%-(%_;M_85Y'=-(8R//V;@% S\N=YYYZ5=U7
MPC<ZUJ=E<WLUF397ZW=O=) 5N(XU?<(=V>0>A/IVSS7744 <C/X0N+_Q#IFJ
MWTME]HT^Y>9+N" I/)&0P6%CG[H##)[[>@S5+_A7]Q+8ZHDFH1I=SZU_;5G/
M'$3]GE&W:K*3\PPN#R,ACTKNZ* .9F\.75_?SZK?36_V\Z?)8P+$K>7&'(+,
M<\DDA?3 &.<YK/M/!-Y:VG@Z#[= W_"/$[CY9_?CRS'QS\O!SWKMJS;W5Q;V
MUG<6EI<:A'<W"0AK0!PBL<>83G[@[F@"KXI\/?\ "1Z;!#'<FUN[2ZCO+2?;
MN$<R'*DKD9&"01GH:9'HEU+K#:W>/;-J"6AM+=(PWEQAF#,23R22%], 8[DU
MOT4 8/@S09_"_A2QT6>XCN&M%*"9%*[P6)Z'..OK7-ZS\/\ 5=3@\2VR:O:B
M'5[B*Y22:V9IHBA0B,MN \L;.!CC)KT*F)-')))&CJSQD!U!Y4D9&?P(- '-
M)X;OQXJO];>[MG:ZTU+$1B-E"LI9M_4\$L>/UKF]0TW2M-\!6_P\OK^.?639
M@6*1 J\CACY<B]=N&&3SP 3TS7IE-,:&02%%+@8#8Y ],T 5M,L5TS3+>S5V
MD\I &D;[TC=68^Y.2?<U;HHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \LGUK4HK_1=1L]5
MN;R"]\1&S>XW;;=X6,B^4D9)SMV8WX&2#@G-:VGW5WXHM-7OX]<ETV[T[5I8
M< DQPQ0O@J\>0&WH"23R-W' K6_X5]X;VJ@LIE1+O[;&BW<P6*;).Y &PF23
MD# .:DN? GAJ[U_^VYM,4WQ*EV61U20K]TN@.UB/<&@#%\+VBCXH>-7\ZY;R
MGL]JM.Y7YH22""<$9)P.W:M/5=3FF\>Z;X=:22&SGL)[MVB<H\KJR*$##!
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MR"$&["J<G*C@^E/O/ ?AR_>_:YL7=+^19KF(7$BQO("#OV!MH;Y1E@ 3^)H
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M!5" "A(;++A1PV>E1/X)T!]+N]-:TE-I=W7VR>/[3+\\VX-NSNR/F /!QD4
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M]O"T[O'"3D91"2%ZG&!QDXQ0!Q.DVVIZW9^*;J]\0ZH4T_4[^VCACE$:M&$
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MW3=+:!K>.9C;H8X/.G>7R5.,A-Y.. !QVXZ5JT %%%% !1110 4444 %%%%
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M"5C::;X7LK2P-V;.-6\@W?\ K-A8E<@@$#!X! P,"O)=3-A_PA/C2-6@V_\
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M,>U;D6HV,]W):PWEO)<Q_?A252Z_4 Y%<#KDTD_Q.B73;B/[8_ABZ6V8./\
M6-(A3^6?PK-\$WNAZTWAVW-YJIU[1P4?3WA6,VK[-LOF$1CY3SU;DD=Z /3S
MJ=@+HVQOK87"]8O-7>._3.>X_.DDU33X;Q+.6^M4NGQL@:90[9Z87.37C5OJ
M/A^=+?P_J.O:;"+/Q%)?F:[9DF<"5VVLK+@,Q)4DMC;S[!WB[4[";3O%:V[1
M64]MK5LTL#$O-(4>%1.2?N1XX&!CCKSB@#TI=<O?^%DR: WDFQ&DB]4A"'WF
M79@G.",#T'6MZYNK>R@,]U/%!$O625PJC\37%PW4$WQM)CE1@WAQ0,'J?M!;
M'Y<_2G>+=271_'/AJ^U1_*T-4N$,[_ZJ&Y8*$9ST7Y=Z@G^\: +OA3Q0^KKK
MLM]<V8@LM5>SMYHCM1XPD94Y+'))8]^:Z"+5=.GE2*&_M9)'+*B),I+%?O
M'G&#GTKQ*_ETZ;PMXJV-%Y#^+HID8?*"C-#EE/H0&.1]:[3Q1!I/AWQ;X+OD
MBM-.TU+RZ,TRJL<2O) 0"2.!N('/>@#NX]0LI;>6XCO+=X8B1)(LJE4(Z@G.
M!BB#4+*Y1GM[RWE1<[FCE5@,=<X->0236TG@_P :S&Y^SQKXH$ZF2-MK /"0
M' &0A(Y...>#TK2LKKPOXDOO%NI'7+$'4;!()([.3?+#$JE6E.5!S\X' (PH
MSG.  >FV>I6.HAC97MO<A,;C#*KXSTS@^U+>7]GI\0EO;N"VC)P'FD" GZFN
M/\%7^H2Z_J=GJ$FG:D\-O#MUBP&U9TR^V.102%D&6. <88>U*U['IOQ/U)M;
MDCAM+K3H4TZ:<A8\*S>=&">-Q)4D=2 /2@#L)+VTA2)Y;J%%E_U9:0 /QGCU
MXYI8[RVEM!=QW$+VQ7>)E<%"OKNZ8KQN.PCMU\'6]_&JV;>(KHV44W!6T(D\
MH8/.TY7 /&"!7L$-A;66F_8K&WBMX$0K'%$H55SG@ <#DT "ZE8MY&V]MS]H
M_P!3B5?WO^[SS^%"ZG8-?&Q6^MC=CK )5\P<9^[G/3FO&=$U*S;PQ\-;%9@;
MNRU58KJ( EH'"2@JX_A.>Q[<]!706%[/I_BBRM]/U"SUC3;S4;AH[>1<7>FS
M,)"[<?>C!+@EAD!A@GC(!Z.NHV37ILEO+<W8&3 )5\P#_=SFK#,J(7=@JJ,D
MDX %>.>$+S3-7M]$T?6+_5E\2Z5>B633S"JLLP8[Y"XCR48,Q)+<@XY.*[7X
MBO<PZ+IUS'&\EC;ZI;3:BB DFV5LL2!U .TD>@/:@#HH]7TR:UEN8M1M)+>(
MXDE292J'W(.!7.>$_$>H>+(+'6+2ZT_^SYO-^TV1R9H5RPB(8'[QVC(( P3C
MIS51K:Z^)7]LZ9/"^G?V.R7]S$X,3OYBF(%AP6 WGU ^HJ3X1RQR?"_1 CJS
M)$RN >5.]N#0!T7FWY\0SPK>V'V3[(&CM]I,ZR;CEVYY3&!]>]<9;>.-9F^'
MGAW7F6T%UJ.HQ6UPHB;:$><QG;\W!P.^:N0S6L/QLU%O,B3&@1>8<@<B9R<^
MX7!^F*XRRN(5^"W@[=*@VZU;ELL!C%TQ.?H.: /99]1LK:XBM[B\MXIY>(XY
M)55G^@)R:+G4+*R9%N[RW@9_NB655+<XXR>>2/SKR:[OM,DUSQ3X<\67^I6T
MM_>>;;10P*XO("J^4(V\MFW+MQ@$8/3G-3>*=2TW2/$6OV.H:E:HVJZ+#:XU
M)V7R3B11A@I#*=Q9L8Y ZYX /4;K5-/LHEEN[ZVMXW.%>694#'V)-8OB?7KO
M2KGPX+)K=X-2U..TE+*6.QD=LJ0<?P^AZUQJWFAVM[H&EZ?=VK%=!>*WU3.]
M+D95'CB0':96*9/4CI@YXS=-O;9_ 'PN G0F/5H%?+?=*QR@_D2!^- 'M!(5
M2S$  9)/:N3A\5M=?$.'1[6[L;C2VTN2[,D+;F619$7!8,1C#9QBD^)8NO\
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M)MV@@L&(&]<D XS]<16GBZ63Q?X@TRZL9+>PTF""1[EG3:H99&9V^;.TA5P
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M^C?9[EKNUL$O&P%VR(Q(&T[NN5/7% &]17/6/C&PU/3-*N[&"YFDU2)IK:V
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M.J8D0 $DX8XPK*V#S@^Q  .E(!&",BBN9\:^([OPY8Z?)9V37#W>H6]J6#*
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M0WS9!PPZ _6N+\(^,H/#WAQSJL&IRV9U:Y@DU%AYD4.9V5=[,V['09 ('<T
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MB@ HHHH **** "BBB@ HHHH X32_"=]<>'/&.D:A&;0:S?W<T$@=7Q', %)
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MP),OB6\U;2/$5_I4>H%6OK6!$996 QN4L#L8CJ1S5G6-$_MO6]"ME0IIVC7
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M>8A24J@)?"\DY)!!ST%2Z'XOU6;Q)H^E7_V&3^T+*::06L;!;:6/;E!)N99
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MM"(L*5W[]V<Y!R/R_.K>IV%Y=S0R6M\D*K')')!-!YL4H;;]Y<@\;3CG^(T
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!B>+?$/\
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MO%'M\MQ^\4,K 9.0=Q8YS7I6I:?_ &OHEQ8R321-<0E/.B)1T8CAEP<@@\T
M7ZHZI=7UI!"]AIWVZ1YTCD3SEC\N,G#/D]=HYQU->3PZ_>P:=H6LS+,K>&)/
ML6OKYC[7RWDEB.CE<"7)Z!AZUT?BMKBWT'0KQ);BWFO-?LY)%25D^224?NV
M." NT$=,@GJ: .QU+6H+"RU.6("YGT^W-Q+;HP#8PQ SV)"FG:%JG]M^'].U
M40^2+VVCN/+W;MF]0V,X&<9ZXKSVWL;:+Q!\3Y%0ATBC*G>>K6F6[\Y)-5_#
MD3:7=?#*6VN+D?VEISQ7:-.S)(JVH=1M)VC:1Q@"@#TS3[J^N9KU;S3OL:0S
MF.W?SED^T1X&),#[N22,'GBKU>,ZM=7L?A[QF4U&^5X?$T$44@N7W(C- "H.
M?NX8C!X]JZ_1$;3OBGK.F03W+6;Z9;W1CFG>4"4NZEAN)QD 9QZ4 =O1110
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M)BOGO(]/@2>23S795P&D_OD=-W^UU]ZKKXL\.O;0W":WI[0S2K#&RW"G<['
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MZ3* 0=Y ;G!)!(YKH/#LNI7O@RP>]M4T_4)+0!H54J(FQ@84\CL<'ITK;HH
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MRP#Z])O@;S7PG[M4.[Y./NYXSUJ?Q'96FL6VDZ3#JMO;^)M.N+=XA:S*\L/
M$AVG!VF/<>0,\4 ==IE\VH6K7!B$:&5TC(;=O56*A^@X.,CV(JY6;<0:A:_V
M;;Z2EFEG%($N5GW;EA"D 1X_BSCKQBM*@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH CG@ANH)(+B))89%*O&ZY5@>H(/44VTM+:
MPM8[6TMXK>WC&U(HD"JH] !P*FHH **** "BBB@ HHHH **** "BBB@ HHHH
M *;)&DT31RHKQN"K*PR"/0TZB@"O96-IIMJEK8VL-M;I]R*% B+] .!5BBB@
M JLFG64>H2WZ6=NM[*H22X6("1U'0%L9(]JLT4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\@YSC/-0:M'X=O)]$N],T7QMI%]HT2P6MQ:Z0Y/EC/RL&!!ZM]=QSG->X44
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN8+7_B1W4TEP8[C.Y&5U!7Y1S\^<>@Z]@ =%;^.;>;1]0O'TV]2ZL+X:?-9
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M,\J(ZEF'8$OGOTJI8>&/$5K#X:L[F"TN].LM+%G<6DEP5C6X7:!-C:?,&!@
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M0:NDWVF:&,E79("X:,[L!2><<_6@#J-2U*TTC3+G4;Z7RK6VC,DKA2VU1U.
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M((==M+J6SU!(#;2.BJRS1$[@KJ1V/((P1D]1Q5.^\$V5UI-K:0W5S;7%K?\
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M1PHGF(V'#J0PD![-N&ZKMKH6R_M[^_O);Z[MHFAADD14"!L;CA0/F;:,GVX
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M5]4@TZZG-Q-I22C[.TA.3VW!2>J@X/3IQ78T44 %%%% !1110 4444 %%%%
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M=:6<SVVEVFOVJO@,RV]O((C*  00O)R 1]XXQFNU\*6]I'KE[<Z=KMC>6US
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
C **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ederofferletter003.jpg
<TEXT>
begin 644 ederofferletter003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>1$+@S[!YI79O[XZXJ2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8O+>Y,(#12< X( 61.3@CKQR:X_PIKFLK\'?%WB"YO8[V?[=*7BNX%D21L1
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M!;V&[)]<5M:[XGO_  ?K$,=])_:%A=65U.A\L))'+!'YA7*\%64''&01U.:
M.WHKFM+E\03RZ5J#W=G-IUW:>;=1E=ABD90R>40.5Y(.XD]#[5S^F>*]:;Q#
MX=LKFZMYQJZW2S^1%F&%XT+KY,G&\8&#]X9[CI0!W&K:M9Z)I=SJ5_*8[6V7
M=*ZH7*CZ*"3U%7$8.BNIRK#(KR6PUS6]$^&?BK7(]1^U7MKJ-T$:YB# E9MF
M?EQVQQT&.E=FFKWNM>)=7T:QNA9#3((&>41!V>64,PX;C8% ]R3U&.0#J**\
MVM?&VN:FWA:&+[);3WU[=V-\#$7420*^63YA\I*YQU[9KHO!FL:AJB:U:ZE+
M'-/IFIR60G2/9YJ!58$KG /SXX]* .GSSCO17!+=WL/Q5UII]1E:RL])AN!
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M\NVC7<"!T+,"A&<X#'@XK%\0^,=:T+3/%MKYL4E_HT,%U:W)B&)HI3C#KTW
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M@@#(R#S0!WE!( R>!7G]KXB\0^(?$\]CI5W9V=I_9MGJ$1FMB[ 2$DH?F')
MZ]O3O5KXH27D7ANS-I>R6V[4K2.0( =ZM*HP<]N_'7ITR* .GBUFPFUN?1TF
M)OX(5GDB*,,(Q(!R1@Y(/0]JOUYO<1:E_P +1U=+*_2"X3P_ 6N'@#DD2R=%
MR!R?\]Q-IWC?4-7TSPK%%;N+[5[)[N=K8)E1&%#!!(P7)9L\YP >#U !Z%16
M+X9N-;N-.F&O6JP745P\<; IF:(?<<A68*Q!Y&>H]#6U0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:@FH3;?+RLBE2 OR\+\B\')XZU=N?!]A>ZSJ.HWDLUP-0L187%NVT1F($GC
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M%*TXTPW%I'(OSEO*W("/7IQ5QO#VB.D2-H^GLD*".)3;(0B@Y"CC@9)XK2H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP9XSUQV]3C:UOXD7VF>+M8\/VVAQ7+Z?IK:B)VO-@9%4$@C8<'DCC/..@)(
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MM;NUG)59 I)1PP!PPR1C!!![5E77@2X33K%]/O8?[3MM8;5Y'G0B*:5]V]<
MY48? ZD;1UKN:* .;\-^'K[1]8U[4+R\@G.J7"3A(HBNPK&J8R2>./\ Z]/\
M5>%8O$W]FL9WMY;*Y\SS$^\T3*4ECSV#*2/RK>EE2&)Y97"1HI9F8X  ZDUD
M:7XEMM6NXH(;.^CCGM1=V]Q+#B*:(D8(8$X/(.UL-@]* (=*\*P:3XIU;68)
M"$OU0BW PL3X =@/]H)'G_=K"F\#:C-X2\5:,;JU636[Z:Z23YB(A(5RI&.2
M-O7C.>U=[10!S#^'KZ3Q?HVM&6W6.QLI;62,%B6+[>0<=MH^N:G\6Z!<:_9Z
M>+2>**XL-0AOXQ*I*2&,GY3CD YZ\_2N@HH XS5_ I\1IJ]QJ5T(+^^MHK:%
M[;)%JL3^8A!."Q\SYB>.@''4ZGAVR\2P+N\1ZI9W<B+LC%G 8@WJ[Y)RW'0
M <]<\:.DZFNK61N4M;NV E>/R[J(QO\ *Q&<'L<9![BKU ')>)/#.L7/B*S\
M0^'=3M[/488#:317<1DAGA+;@" 000><BEU7PUJFI?\ "//)?02W&FZ@M]<2
M.I02D*RE449VC#<<GH,Y))K8DU^SC\30Z RS?;9K9KI3L^38K!3\WKDC@5J4
M >?Z[IEQH-MXWUNYN[6.#5XX4C+1F00D((07!X*G<"3T SUJ#PNNJ:;K%HBS
M>&-0@DC6WSI\TS3QPJ"5QO=P(P>V0.?7 /HS*&4JP!4C!!Z&H+6QM+%66TM8
M+<,<L(HPF3[XH X?_A M1;P]=61OK5;IM<.LPOL9DW>9Y@C8<'';(_*ML^';
MJYU+4-9NG@&HW%A]@@CC),<,>2QRQ&6)8Y)P. !CJ3TM% 'G<7@/7-+L/#UQ
MHNK6EOK&DV?V"0S1,\%U#D'# 88<@'BNYTVWN[>R5;^Z6YNV^:61$V)GT5<G
M"CH!D^^235NB@#A+CP!<7MGXJTR>_B6PUJ[^VQ2)&?-AEQ'C/." T8/O[5LI
MHE]J&J:5J&M-:F73 [1+;;B))6787.X#:-I;"\\GKQ714UY$B7=(ZHN0,L<#
M). /S(% '#?$#[1_PD/@K[*T2S_VJVWS<[3^Y?@XZ9Z9[9Z'I2ZOX(U'4X=5
MO$O;>'4M0N+:22(AF@:*#I"QX9E;+%C@9SC&.O9SV5K=21R7%M#*\1S&TD88
MH?4$]*GH X&?P1J]Q_PEP:]L OB"SB@"I$ZB!EB,?')R #^/M6EK7A>_U'0?
M#]O;W%M'>Z1=V]T#(&,<AC4J1QR,AB:ZRB@#CM1\&SZQXBOKW4)X3:7NB'2I
M4B!5P2Q8N,Y Y8X&3CU-3^&='\4Z<L-OK6LV=Y:V:;+?[/;M')-@8!E)8C@=
M@.O.>*ZJB@#R37]!O_#OAO1+-[FV:XE\6PW,<B@E 9)6< @X. 3CW]JZ/7?!
M>HZ\FJWK7L%IJEW;0VD0C+/$D,<AD*,?E+!R2&X'&!SSGL;FRM;P(+JVAG"'
M<HEC#;3ZC/0U/0!Q$/@W4VU76[FXN[&.'5M+2R>*WA8"%E5U&W)^Z _Z=!53
M_A"/$5O8>'KG3]7L;?6M%MOL2DPLT%Q!M52KC.[.4#9&/3WKT*B@"EI=O>V]
MD!J-TES>.=TKQH4C!]$4DD*,=R>Y[URFI^#-0OKGQE(ES:JGB"TBM8\[LP[$
M9-QXYSN)QQTQ[UW%-21)5W1NKKDKE3D9!P1^!!% '*Q^&+]?$/AO4FFMMFE6
M,EI*@+9D+J@W+QQC8.#ZU=\4^&4\1V]F\=RUGJ-A<+<V5TJ[O+D'8K_$I'!&
M1FM^B@#(M(]>E*+J,MC$JD%VM-Y,F.WS?<![_>X[CK7.:KIUQX>_X3;Q%<7,
M"PZE;1B/$1D,)2,Q@LIX8$L"<X  YXYKNJ" 001D'J#0!YCX:35M+U&P\FX\
M*ZG&8TMD%E/,TZ0_[!9W 0<$@8&!ZX%7+?P%J</A/1M'-W:-+I^L+J3R#<!(
M!,TNP#'!RV,\]*[JVL+.RW_9+2"#><MY487=]<=:L4 ><ZCX"UR\AU:$:E8-
M]JU2/489Y8G,N%=6$3'/W5 P,?D*['6+&\OK.&!$L;B,M_I5O=QDQSIM(*]]
MOS8/(/2M6B@#!\(>'1X7T1M/5U*-<2SI%&28X%=B1&F>=H_Q.!TK/M?#VLV/
MC;6O$$,EC)'J,4$2PNSJ8Q&",Y .<Y/:MK1=>L]>%^;19A]AO'LY?-3;^\0
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M0T2)9A=V,<<DQ9,+A\[=I[_=-:E !1110 4444 %%%% !1110 4444 %%%%
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MM,O9%T]-/5H&4*<RLGF%N0>BF,>F2V>E;FE:7;:-I%MI=KO^RVT0BB60[B$
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M>-41_*? *DD,P!'.<<UUMWX+TB\LX8'%PDL-W]N6ZCF*S>?T+EAU)!QCIC
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M;Z=916EJA2&(84%BQ]223R23DDGDDU8H **** "BBB@ HHHH **** "BBB@
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M9K-Y6T^/F^5_E(1IFR,'D#'6O;+#3;'2K(6=A:PVUJI9A%$@5 6)8X XY)-
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MK(0I_B.#PH]3]!DD ^:;X[OX8:_IU_C_ (2F.[N&,?2=KLREH&0=>1Y>TCC
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MP-8MM+;PO\4G\JU,D-\3$<+F,^7'@KZ'<#T[CVH ]K2Y@EFDACFC>6+'F(K
MLF>F1VI9[B"UA::XFCAB7[SR,%4?4FO/;-;&T^+&B_8_(B^TZ!*7\O \T^9&
M03C[Q^\<_6M3QQJ%A9ZKX9BO1'$TEZ[P7=S(5M[=UB;!<9&XD$A02.><\<@'
M6"[MC DXN(C"^ L@<;6R<#!Z')I8+F"Y#&":.4(Q1C&X;:PZ@X[UX69+"3P=
M):RS02&#QL%4'"[5-QV'\((W''IFM77A)8ZE\2;7P\@CF_LVR<06@ .<.)"J
MKT;9Z<]* .ZO/%$B>.=#T:SELY[.^CN3.Z-NDC>)5(&0<#[W<=JU+/5);K7M
M5@'EK8V"Q1ESU,Q4NXSG& C1_BQKS^]UWPQ)X_\ !^K:9>61M(=.O?,DA8?N
MXUC4JK ="/F^4\CFK>L1W>G>"]#OKR,B"XU>&_UI2,[(I&+D-_LHQC!]D]*
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M"&#$KS\H8KP2:]:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<4[A<(P)W?Q*"0I )ZU'IWBJYU'Q+XDTN?3+F&VTL1IYBLA8[D+EOE;/(*X
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M1-.>YDAC<+OD?.,DD#Y41R>IPXP"<4 =4L4:!@J*H8Y8 8R:%C1-VQ%7<<G
MQD^M<E'XZAM;#0O[1T^_%]JT)>&*&)7\QEBWG&UB!GH 3GGG YJ]8^,+*^N9
M[5+*_BN8+%+]H9X0C^6^<#!/#9!!!QTH FNM(U.\UY9Y=7']C!$)TX6RY:13
MD$R9SC./EQV],YVF574JP!4C!!'!KGK3QC8ZC9Z=<:?:W=VVH6S7<,,:HKB)
M2H+'<P'5@, D\U3'C&XG\9:3I%OI5S]EO=/:],K[%;!* ?*6R NX[N^<8!H
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MT 2[$Y^5>?:C8F0=HXZ<5@0^,-/N+W38%@NQ!JA=;*[*#RIBJEN"#N&0"02
M"!Q7)^%?%L>BVNJKJ8U*X@_X2*YM/MC9D2 &4)&K,S9QT' ..^.* /2A#$,8
MB08);A1U/4TOEI_<7\JYS5O&^F://J"3PW<D6FB(WT\2*4M_,^[G+!CP03M!
MP#1=^-M/M==N-'6SU*YN[<0M(+:V+@)(<!^OW1W/\^: .C,:,ZN44LOW6(Y'
MTI=J[MVT9]<5S5WXYTJT1YFBNY+1+[^SS<Q1AD\_.W;UW?>^7.,9[U-J/B^P
MTV*\FD@NY8+!5:]EB0$6V0&PP)!)"D,0H) (]: -U88D"A8T7;D+A0,9ZXIP
M55^Z /H*P[KQ5:023B"VNKU+>!+B=[4(PC1P2IP6!.0I/R@\4WQS))#X"U^:
M&66&6+3YY(Y(I"C*RH2"""".10!NF-&=79%++]UB.1]*'C20J716*G*Y&<'U
M%<;X?\:6?DZ+I-S:ZC'=75DK6TT\.U+MEC!948G[W?YL9[&M33/%]AJWAYM:
MM8+KR5F-OY+HJR^8'V;=N[@[CC!(H WG1)  Z*P!R PSS1Y:8QL7&2>G>L3Q
MAK\GACPEJ&LQ6;W+VT)<1AE ![%LD< ]<9/H*YG5M8NX?'?A*=H-147%E>%[
M%'#>:RK'M.T,4S\QY)&,\D4 >@[$SG:N?I0D:1@A$503DA1CFL&R\8Z9?Z)!
MJ<0N!YUP;1+9T F,X8J8\9QD;3WQ@$YQS5S2=>M-7N+ZTC66&\L9%CN;:8 /
M&67<I^4D$$<@@G]* -%8HT38B*J?W0,"EV)_<7CVKG=8\:Z;HT^H1S07<RZ;
M%'-?2P(I6W1R=I;+ G@$X4$XJQJ7BBSTX792"YO/L=N+FY^RJK>5&02"=S#)
M(5C@9.!TY&0#:\M/[B_E7-W.@:P-:O+NRU.Q:UNRA:WO[$S&':H7$;+(OR\9
MVD=23GFK<WBBR$,;VD5Q?L]H+WR[91N$)'RN=Q7&><#J<' X-$/BK3[RVT^6
MP$UY)J%N;FW@B4!VB&,L=Q 4 L!R1R<4 7],TZ'2[,6\(499I'*H%!9CDD <
M#D]*N8&<XYKF1XZTDV,%ULN@)-173)(S& \%PS!0K@GCDCD9&#FI;KQCIMG-
MKT4\5T&T2!+BZQ&&S&ZLP*X//"GKB@#H-JD8P,>F*0QH2I**=O*\=/I7.V?C
M2QOK^VLH[*_2:[M#=VGFQ*@N5 !8(2WWAN'WL#G()'-<\_B^TUWX6W6MZ[9Z
ME8V#R-EK.0"3:+@JH5D;((VJ&)P.3VH ]#\M/[B_E3L#&,<5SE_XQLK#5[O2
MELM1NKRTM5NGCMX=V8R2,@D@?PGJ?ID\5.GBS2YK#2+NV:2X&KX^Q11J \GR
MESP2 ,*"3D\8]<4 ;*Q1IMV1HNT87"@8'I3ZR-"\16GB!;LVD5Q&UI.UM.LT
M>TI*OWEZD$CCID<BJ.K^-],T:?4(YH;N6/34BDOIH44K;K)]W=E@3QS\H.!0
M!T4<4<0(CC1 3D[5 R:4QH9!(47>!@-CD#ZUS]_XQLK+6I=(2SU"[OH[,7OE
MVT&[?'NV\$D#.0?RQUP"^#QAI=WIFE7MEYUU_:H)LX(U DD &6X8@ *.I) [
M=2,@&[L4DG:,GVHV)_<7CVKB/AY?37U_XN:5[LK'K+HD=TY9H@(TRG). #GH
M<>G%22W3V_QBVR7<J68\//,\;RGRE83J"^TG ..IH T_#/AR70Y]8EN)8)VO
M]1EOD*(08O,"@ID]<;1SQGTK?:*-F+-&I8KM)(ZCT^E8EMXML)]1T^S>&ZMS
MJ2,]C+,@"7 4;CC!)4[><,%.*JMX\TH)93+!>O:7UTUI:7*1!DFE4D8&#NY*
MM@D ':?;(!TVQ/[B^G2L75](U34;ZW%MJZVFEE&2\M%ME9IP?23.4XR.!WJM
M<>.-+M[MXFANVMX[]--DNU1?+6X;&$/S;NK 9"XR>M4K::8?&._MOM$S6_\
M8<,HA:1BBN9G!(4G R%'2@#L0   !@#H!2,B,RLRJ2IRI(Z?2N.\>:Q>V%SX
M?L+:WN7BO]3CBG:%D7S$"NQC!+ @G:,]!C(SSBH;#^Q/#_B^Y@676C>KI<EZ
M;::9I(8H#(,J@R1N#9 QG R,XQ0!KZ[X<EU76-!O(988HM+N'G:)D)\T,A0K
MQTX8G/-/\8>'9/$GA6XT6VFBM?.:,B1DW! CJ_W1C^[CKWK*/Q-T9=!DUMK+
M5ETY+>.X%P;0['#MM"J<X+ X!]/6KI\;V?\ :MWI8TS53?P0"Y2W^SC=<1$D
M;T^;&,C'S;3G QGB@#HXXE2/'EHI;E@HX)[T\  8  'M6!:^,-.U#3]+N]/2
M>[.IQO);0QA5=E3[Y.]E VD@'GJ>];%E=K?6<5RD<D8D&=DJ[67V([&@":..
M.)=L:*B]<*,"E  )( R>M<]+XSTR&!+QX[G^S&N/LW]HA5\@/OV<\[@N_P"7
M=MVY[XYK#U6[GUGXD/X<NK2^.G#2?-Q#,L>'>;9YV0X/RA>/XASQ0!WGEIYG
MF;%WXQNQSCTS2-%&S[VC0MC&XJ,XZXK$U77+3PAIVFQWHOKB*26*R6Y.USO;
M"J9&)'4]6Z9JU?Z]9:6]U]L+Q0VML+F:8@%44D@#@Y+$J< #G% &H1D8--\M
M,8V+^58\/B2W;5H]+N+2[M+R>%IK>.<(//5<;MI5B,C(R"0><]*IP>.M*N-'
MT;5$BN_LNK78LX"47*R%F4!AG@95N1GI0!T@10<A0#]*/+3^XOY5SL/C6PN-
M<GTF"RU*6>WNEM9W2V)2)F7<&8YX4COC_&M?4-4@TYK>-UDEN+ERD$$0!>0@
M$G&2   "220/S% %O8H.=HS]*'1)  ZJP!R,C.#ZUYWXN\2Q:AHVDWEE)?6K
M6WB2VL[J'YD<%9!O1E4D..AXR#D8KI;3QEIDZZQ]I2XL'T@*UY'=( R(R[E8
M;2<@@'&.>,8S0!O^7&,_(O)R>.I]:4*H.0H!]<5CQ>)+8ZO!I=U:W5E=7,;2
M6PN%7$X7E@I5C\P!!*G!QVZUE>'M<T:WT::6Q?4)5EU.:W2*Y8M+)<;B61 Q
MX48;K@  DXY- '5"WA"E1#&%.<C:.<]?SJ0@$8/2L"#Q?ITMM>221W,$UI=B
MRDMI4'F&9L;%7!(;=N7!!Q@\D8-6M,U^UU/4+W3Q'-;W]GL,UM.%W!6&58%2
M00<'H>W.* -)8HTC$:1JJ#HH&!^5.  & ,#VI:S-0TE;VZ%S+=WB)'$56&"Y
MDA4DG.X[&&3P ,].?6@#1V)OW[5W8QNQSCTI%AB0 +&@VC:,*.!Z5Y_\-;6?
M6_ .@ZO>:IJ4E\^]YI'O96$HWNN"I;'3'('! -5_A[XOCM?"'AVVU,:A))?W
M$ULE_*-Z-,99"J,Y.XD@<'!';.: /2=B''RKQTXIU<_?^,-.TY9YYDN#8VTX
MM[B]55,4+D@8;G<0"P!(! )Y/!QJ:IJ=KHVE76IWLGEVMM&99& R0H'8#K0!
M<HKFF\;:? -3%Y:WMK-IUF+Z:"2-6<PG/SKL9@?ND=>,4_3_ !GI^H:E8V(M
MKV![^U-U:23P[5G4 %@O).0&'4#VR* .BHKD8_B+H\D4,_V;4%M9+\Z>URT&
M$BFW; &YS@MQD X[XK0D\6V,4^O0&"Z,FAQ)-=*%7YD92X*?-SPI]* -ZBN<
MD\::>(K)K:VO+N6\L#J20PHN];?"G<VY@/X@, DYK%U;68]3\2?#_4--NY_L
M6H33/M#LJR(;=F7<F<$@^HXH [VBBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /)])MK_5]!\>:'
M::>[F_UJ^MQ=,Z"*+?M4LP+;OE'. #GC\.GT/0;W3/'E]=&V?^S6TNVLX9V=
M#N:(MG(!ST8=NQJ[IEUX1T*6_AL=5L(9)KEI[I'U#>?-;[Q(9CM)QTXK3EU_
M1H;.&[EU>PCMISMBF:Y0)(?16S@]#T]* .!\-^&M<T.Z?1+CPOI5Y:)<N]OK
M;O'N6)G+?,A!=I!G [=.>,E-+%_=S_$33++3GN&O-0DA28R(L:,\"+\^3NP,
M@\ YYKT*TUG2[^X:WL]2L[F=4WF.&=78+G&< YQDCFLW1_\ A&;&^OFTN^MC
M<WL_F7 %Z9"\O"YP6.#P!QZ 4 <AJ?A?Q NFZEX>2R;4=-&AQV6F2"=(T258
MF1C(I(+,3M*G! _V>36CH^BZS%XJ\-WUSIKPV]GH;64[&:-MDI*<8#<_</(S
MU%=]3)IHK>%YIY$CB12SN[ *H'4DGI0!Y?K_ (?\4ZO'J:7.E/=W$6L17-C*
M+J-8S:K*A"HA8;9 H.XL!GGYCP*W]-TW5['QEXIO)-,9K75$MY(IDF3 *0[&
M3!(.[=C' &.<]JZ)?$&D/#83+J-L8]08+:'>/WY/3;ZUI4 >9:+X6U[2=(\#
MW9L2]WH4<UO=V0F3<Z2KM+(V[:2"%."1D9IWBKPEJVL:?XGO;6Q<7NK?8H8;
M5I8P52"0,6<[MN3EL $\ >IQZ710!RD>F:@?BB^M-9NM@VCK:>:73_6"4OC
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MVVD+#_:<UO<V2FX0B38(R5)SPV4;)/&>YZUZ=J&IV.E112W]U';QRRK"C2'
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M:OM2VB>6LOE["RYXR,GF@#/O/$5[8^/(=#N/LL5E>V$D]G<,C9,T9&]&^;!
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M[4-0(T\6PB6P$*A5D#9\S?UZ?+MZ5?H \_\ &MO#:>(? %O;QK'#%JFQ$7H
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MMI+\)>:K-#+<W0@R,1%2B*N[@#;W)/+>O&A_PCLX\8R>(A?1^:^G"P\GR#M
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MB[B2N=Y! X./6F>.WNM#O-)\5PSW1L=/FV:E:I*_EO;O\OF% <$H2&Z=,^E
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MJ;RUC1Y 3@;FW?*/4@+D^F15R'7-*N+U;.'4+9[AMVR-9 2^W[VWUQWQT[T
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M8@V-VTJ01G'/K6A:VEO8VL=K:PI#!$-J1H,!151]?TB."\F?4[58K)METYE
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M9]H;3/&&DR6MQ%?KIMNIDAMGD;4ML7WRQ! 526&!@YZGG%>E^'?#_P#PC_\
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M=JY7P1+%X'L+GPSK"RVWV>[F>TN6C8Q7,+L64AP,;AG!4\\5Z$2%&20![TM
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>LZP$MOLU[ID=I$OG'>'4N<D;< ?/ZGITH WM$U:WU[0[+5K0.(+R%9D#C#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(N&"LH(R.QYJOI.KKK*RW-K'FQ5VCBG)_P!<5.&91_=R" >^">F"0#2HHHH
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MB]&4]*R_&6O3>&/"6HZU!;)<R6D>_P IY"@/('4 ^M &[138VWQHQXW &G4
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M;;2PL[" P6=I!;PDDF.&,(N3U.!5>/0=&A29(M)L$69=LH6V0"09SAN.1]:
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M^S++RIVWRIY"[9&]6&.3[FN;U?PM>7.N/=)IN@:G8M#'%';:C"5-L%SD(0K
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M%G<7,5S/:02SP_ZJ5XPS)_ND\C\*C72=-2&>%-/M%BN"3.@A4+*3UW#'/XT
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M[O3]$C)DNY 5A)1W0VZCG>3C+YX(7@U>OW_L2Y\,^/$5KF&2TCL=5\M=[%9
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M'&#N%=39Z=8Z<KK96=O;*YRP@B5 Q]\#FGW5I;7T#07=O%<0MUCE0.I_ \4
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M;]P!]MPK*TC2M1L/%5C/H\>IVEA<32OJ>FW@W6\&58[X6/W27(^53T8Y"]*
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MYY-2U"R6= ('=IB$#.1M7!//W1Z]*VM&UFQU[3EOM/E,D)=HSN0HR.IPRLK
M$$$=#7&V^GWW_"1^ YS8W(BT_39X;IS&0(G:.-0#^*GI6GX LKNPL=92\M9;
M=IM8N[B,2+C=&[[E8?44 :-_XQT33+JX@NKEU^RO''<R+"[1P-)C8'8#"YR/
MID9QFG:]KMK86UY;"6X^U):M,WV:%I&A7!P[8! Y!QGK@XZ&N!\9Z?KNKZ?X
MLL3HEZ\SW$+V1M%589HE,?SN009)/E88;.,# &,UL;=6TOQ5XBFDT:^NK37(
M(GMI(0K&%TBV&*0;OE]0>G)[T :'@_Q$H\!^&[C4[F:YO[ZU5E 5I)9FQEC@
M<X'<]!QZU@:9X@2\\$^+[W5=>U.TLX-8GACOHE83V\2F/:H&W*^F,=S4.@Z9
MKGAR+P;JD^CWD\5KI3Z;>6L05I;=F9&$@4'D'8 <<@8XJ*]T/6KGX<^.K(:/
M=I=ZGJL\]I"P4M(CLF#P3C[IZ_K0!VT7BN,^-W\,BUN<PV2W#7#1,0Y9L#!
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M+(J;]DB[0%)&<8)Z8H [.H8+NVNC*+>XBF,,ABE$;AMCCJK8Z'D<'UKD-/\
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M3<F:POPAC"']TTV,22I]0(U)]5:NO95="CJ&5A@@C((I$1(HUCC5411A548
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M1A<*?G^;!)& ?4?2L'4]7TZ<0W%O-!9^1XQCDN+9WW3HWF[6ED8GY%('
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M([+N]@=I(/<<T_P_:167AVQM(C=/!%"J1F\.92@^[OX'.,<$9]:\FT:^6V\
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M.*C35=.DM6NH[^U:W5MK2K,I0'T)SC->6:I/IS:/?^(]!O=0UFPEO[.?5FV
M1RPQM\X151<D*%W\<@ 'O5WQ'=>'_$7@KQEJ7AA6O)KO3U^U3PJ^QRBG: #Q
MN"YS@9  SVH ](EU&R@+B:\MXS'&97#R@%4_O'G@>]8G_"1+KOAI=2\.:CIZ
MEI5Q+>$[ F_!R <@E0<9]17+6VJZ=J_Q)T*6QNH;J%_#\Z!XSN4MOC.W/3/!
MR.HKF?M.G2?L]Z1'YMN;BVN+1'&1NCD%P,@^C!=V1UQ0![9'?6DLTD,=U \L
M7^L19 63ZCM3)=2L(;5;J6]MH[=C@2O*H0GTSG%<5X@BN]"\?66L:7$7CUZ
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MYQ0!U)5202!D=#CI2X%85CXJM+W7I-&-K>6]T+;[7%Y\843Q;MI9<$G@D##
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPW3=:U73].^&NHVMW=SWNLW31:@LDS2"X1F&XL"2,J#D$8Q]*P=:U#5/[/\
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M("9"D$#YCZD$Y&!4,>I^(/%/B_QOIT.J1V.HZ?/&-/>>\>%+:%'.75%4APP
MW$]F':@#V^@YP<<FJ]M<+(B1O-"UR(U>18V]>X'7&<XJQ0!SOA[Q;%KVK:OI
MC64UE>:7(L<T4[*6.X95E )RI'0U>T?5WU9[PK9O%!;SO;K,7#+,RG#%<=@<
MCG'(-<7\2+*33M;\/Z_I5TUEJ5Y>QZ-/*B@[X9LC)'=D(W+[^M;/C2Y;PKX
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M5V;W2[>]6(@SPK*(]W3<H.,_C5#PIX@7Q1X;M=92V:V6X+XB9MQ7:[)U_P"
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M"S>:'IM_<Q7-S:J]Q$AC28$JX0]5W @E3Z'BB30]+DN+&=K*+S; $6C*-OD
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ML   6(Y],]*T;/6M/O[M[2"X!N402&%T9'V$X#!6 )7/\0XH OT444 %%%%
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M" 2 3T]Z 020"#C@^U 'D/A6UNA-\,A+IM^GV"SNX[EI;.11"QC4+N)7C)!
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M2;57F'D[L9C7>Q#Y(!X&,#G!P*EUJ"2'XL>&+U\_9Y;.[M5/82X5P/J55O\
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M%8&9;M9@3&0^-HQD*<D;=O.!4VAZ?=Z;\0;7[;#<2BU\+06DMWY#M&\R2$L
M^,$D<XZUZ+10!X[IUE?P_#7X>VLFG7ZW%IK-O)<1&TDWPHK299AMRH&1R>.:
MZ'Q%I&H:=XZMM0T;Y4\0Q?V=J 5L&-E4LDX]65%<?]\^M>@UBZ9X=33M5N]0
MDU+4+Z6:1VB6[FWK;*Y!*1C PO ZYX 'KD U8XXK2U6.- D,2!551]U0.  /
M:O);'1-4/P-LH+32KC^TK2Y^T263QM!+*BW7F,@R PRH!XZX&*]?HH X+1)=
M-U,W^M6>A:W:W!T]K>6?4A-YC<Y$2H[,6P=Q) Z\ G)QS:6VJV7PZ\#7HTK4
MYTTAQ_:%A"LD-R%,;QEE4;6)7=G Z@^F:]AHH \E\0V-GJ'@R_N])T#5U%]J
M-G)*MU%-)/<[)%W.8V+,%"C&3C.#VP3TGB>U,GCKP5-%93200W-S)-)';LRQ
M[H"JER!A<M@<_P!*[4D#&2!GCFEH \JN8(]-\4>(=)UO0=<O;'5I5DM)-.,I
MADC,21F%PC!5QMQ\W&.I Q5^T:X\->,-7BO]-O#9ZC86L=A);PR7"1^5&5:!
MF )!W,2"W!R3FO1J* .3^&4$]K\-]#M[JVGMIXK?8\4\91E.3U!YKCI;'5F\
M/>,M-M+"\-\/$#ZBL7D,JW$ EB?"N1M8LH/ .3C%>NT4 <=+'_;_ (W\.ZOI
M\=PD%A!<FYDE@>+<LBJ%B(8 D[ANQVV\XR,]C110!QOQ%BG^R^'[V*VGGBL-
M;MKJX$$32,D0#@MM4$G&X=!7(ZW!>WUK\3Y(=,U$C4(;46@-G)NGQ J_*,9/
M/;J.X'->O[E+%=PW 9(SSBEH X)()/\ A9>@78LK@6\6ARQ--]F<(CED(4G&
M <!N.M<Q:6%[%X(\-M+IMZ!8^*6N[B,VLF^.'S9B'V8SMPRG('>O9** /*/%
MVC7.H6OC?6+&QN3!?Z9#9PQ);L9+N9"Q,@0#=@!E4$CG!/3!.GXM@N+)/"^M
M6^F7]U86187MO8!X[A5>((KA5(8[<8(]":]$I%=74,C!E/0@Y!H \M\2Z?!<
M?#+7)=%T35(FU&Z@F\J9)I+B=A)&6D*$LR\+WQ]W/I6GK'VI?B3<W]OI=Q>1
M+X8FC13 PCFE\T.(BQ&,D#I7H%% 'DWA\SR>+?!U\;/41"-,GMI$.GR0PVCX
MCQ$JE?E48(W,3G'WCV]9I"0,9(&>!2T <AX^&HV\.BZM8V4]_'IFHK<75I;K
MND>+8Z$JO\17>"![>U8NMRSZWHW]M:'H%Y D.J6=]<QR6QAN+Y8FR^$/+8 0
MC/4J<=!GTFB@#CTM?[9^(%GK5I'*ME!IDMO<22PM&)B[J43# $[<,3Z9 [U2
M\#:1J.F7EWHUW"ZZ;H=S*NG2MTF27YDP?5%9D_X%[5WM% 'DOA2T4P67AO7?
M#^N2ZOIUV)!.\LWV1BKEEG5]^SH<XQDG(Q6KX>M[BVTOQY.-&DGN'U2[N+:W
MN+=D^T@Q*%VD@9#'<,CU/K7HM% 'E6@&:3QGX4O5M-16W&CS6SAK"2&*W?,>
M(E!4;57! ))Z?>-96@ZCI<%CX=T_4SJEG8Z->/=02SZ9,"Y)<())0-@ #G+#
M@X'0=?9KB".YMI;>4$QRH48 XR",'D5@Z=X5>PMX[*37=3N].B01I:3B';L
MP%++&'88XY;D=<T <+96:>?JOAC7_#NN7=Q-J,UQ!)'+-]DN%>4R([,K!$VD
MC/<8[GBNG\30O<_$CP:80S&R6]NI]@R5C\H(./=F KM:J0:=!!=W-W\[W-P
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MP&3N^8CMLYQD9[.B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3$$ DD"X(5N!C&/_ -5 &Q9>.(]7TW2;O2=.GF.HI,Y\\^4EMY7#B5\':=W
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MD+ [=ZL-@V^F3N]J .LHKS&'Q?X@NI=#LC<Q071UNYTF]D6 %9O*5R'4'IG
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MW$ \9QUZ5Q%]XSG/@V\U32-9N9)[?4+:!X;RU2.>WWR(CQR)L S\Q(('XG%
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MSU;S;=S)%&KP2HA=77:H^4@,"#G'!SUKGK+Q;KDW@CPIJDE]FZO==6QN6\I
M)8C<2)C&.#M4<C% 'I]9FM^(-,\.6L=UJL[0022+$KB)W&X] =H.,^]<SI-Y
MXAU;QGKUJ-92&QTF_A40BU1C+&T09D)ZCEN#UK<\9^'U\4>#]3T<XWW$)\IC
M_#(/F0_@P% %B3Q'I<6OP:')/(NHSQ&:*$P289!U.[;MX^M6DU.UDU673%:0
MW442S.OE-M",2%.[&WDJW&>QKQFX\47.J6'A3QKG:WA\QQ:L"OS?OG,,P/IM
MV!L?[8->C)K":7I%_P")9+*^OEO+@&**QA,TAA'R1E5'52 7_P"!F@#9UG7=
M.T"U2XU&<QJ[;(U2-I'D;&<*B@L3@$\"ET77=,\0Z>+[2KM;FWW%"0"I5AU5
ME(!4CT(!JIHVNV>N:<VL/IU]IX@+Q8U&V,,JCY22 >=IX^N*;X:TC[#-JVHO
M%Y,NJW?VHPXQY:A%1<C^\0NX^[$=J -&_P!4M].:".7>\]PS+!!&,O*0I8@#
MV )R<#\Q2Z5JEMK.FPW]IYODRYP)8VC8$$@@JP!!!!%<;XKM9I?BAX,":A<P
MATOMOEK&?+Q$N<;E/7OG/MBI?[;U76=$\1:KIE^;672[JX@M[<Q(T<A@ZB3(
MW?,0>A7 (].0#N:*\WBU_P 0^)O$=A9Z7JBZ5;7_ (=CU1 UJLK12-(HQSU&
M#CZ9[X(H:GXF\36_AWQCJT6L!7T+5&B@B%K'MDC B)1\@G'S'D8//7H  >KU
M5U#4;72K)KN\E\N%65<X))9F"JH Y))( 'J:YJRU/5;?XD'1+J^%U:7&DF^5
M3"J>3(LJH0I')4AOXB3QUJI\48I9-+T0I=S0C^VK)2L83!)E&#RIY';MZ@T
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M[D\?4U<HH \Z^'7A9SX'T:+6/[04VLS3_P!GW2!$202,RL05#'&0P!)&<''
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M*7A)YS -0E$RW@L6C-K*"LQ.,'Y>.>,]*OIX[\//.$%\1";LV*W1C80M<?\
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MY["9W2&;R6\J1DSN ;&/X3]<<9J74]:L])>UCN6<SW<ABMX8D+O*P4L0 /0
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M[=U&WB8,&^1A$047/H^TL?3S30!V-OXCT^XU!+#]_#=2Q&>&*>%HS,@QDIN
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*SM@_E1C@NY9B>I))Y)KF]5U.T\":3H^GH]O9VDLIM_M<\9\BW^4L,@$8!/
M&0!Z\8/1:7<3W>FQ3W(@\Q\G,#[XV7)VLI[@C!_&@"Y17$0^.;N\6UOK#3+B
M[L)[PVYCBLYBZQ[RGG>9MV$9&2OIWR,53U+Q[K-IIWB:_ATRQ,.@7GDRJ\S;
MIHPJ,=IQPV&[\=N>M 'H=%<K;>)=2/B_^Q+JRM5%QIS7]JT<K9&U@I1^.OS
MY'OUK!L?B%K4GA_1/$EYI-E'HU_.EO-Y<[--"7D**^",%<X!&<\Y]@ >@07]
MG<W-Q;074,L]O@31I(&:+.<;@.F<'K5BO-H];@\.>,?B'JL\;2+"-."QJ<&1
MVBVJN>V6(&>U=%<Z]J>F^(=/TF^BM&_M6.46D\08".9%W&-P3R",D,,=#P*
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MNN>XR.#Z$5GQ>(M5U*WCU+1["&[T\W[6C1%MLIC60QO,&)P &4G;C) SD9P
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M<I.> O#8' Z<')Z"B?QG>MX9N_%%C:03:5:2RAX"2)I8HG*/(K= ?E8A2#D
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7GVH*L)3ROE5=N=QSPHYXK?HH X;7/ =]JUYXE,>L11VNN6J0NLEL7D@*)M
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M".?<N3Y9SD[>AX'- '-^&?!^L>'6CL#XE>ZT&V.;6T:V42JH.51I<\J/H"<
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M"W-HC1Q7*W4@FVL<LK/NW,"><,3SSUH H>!=2O\ 4-*OX-1E,\VG:E<6"W+
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M8#"^OS@#CN* /76944LQ 4#))/ %4(->T>YNHK6#5K&6XF4O%%'<(SNHR"0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 V0.T;"-@KD':S#(!^F1F
ML;PCX?/A;PO9:(;H70M5*K+Y>S<"Q/(R?7UK;HH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !114-Y++!93S00&>:.-F2$-M,C
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MN@Q'[)9*WF?:^IWB0A>,$-C'3Z&F^*+CQ/XO-I_:OPRU4I:2>;"D.L1H%?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD%> -N,9/;)K6O/%^K:?9M+>>'1:R0V<EW<F>\ A3:Y58UE"$,[ ;@., C-
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M<^%K"[U.WAU#4+VVCN+JZN(P[R.ZACR>@&< #@ #% '5/-%$R+)(B&1MJ!F
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ME'D1-N&4$-_$"0"?3-FR\5_:?%]QH,MHD*"S6]M;GSMPN8B<$J-HQ@]>>XH
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M< Q&.G].SHH Y5_#NI-XQT?67N8)H[*SF@F+$J\CR%22!@@*"O ST/MSB_\
M""ZM_P (B='\ZR\[^V?[2W^8^W;Y_F[?NYSV_7VKT2B@#SO3#JI^)?CA-.CL
MRSQ6*LT\C+Y;>2V" %.X=>/E^M7H/ \VFW?@U-/EA:R\/K,)#*Q$DQDC*$@
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M^=OW9\GROG^7VSQ]/>NSHH Y_2=.UK2M,\.Z=')8&WL[=;>_+;V9PD853$>
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M:+]H+;9PQ8$9SP&).._?/% '-7OBS5O#/_"<Q37S7XTI;-[*6Y1 R-<97#;
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M]H?Y/I\H./KZFJ/CVXTVZUCQ):-]G2^@T!@6O2&#*WF,%@CX^8D#+YXPHP:
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M5\WQT^MS1V<EB=-2Q6V9,E2LC.&P1C^+&/\ ]5=/10!%+:V\^WSH(I-OW=Z
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M5!!SSTI]% $'V*UVQK]FAVQ-OC'EC"-ZCT-)]@L]K+]D@VL<L/+&"??BK%%
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M%%% !1110 4444 %%(2 "2< =2:K6&I66J6YN+"ZBN80[1F2)@R[E.",CT-
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M?E\?/\WR_3G\JFU#PG>:AHS:3)J5L]C)81V;Q3V7F %=P\U/G&UB".N<%0:
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M9B\U A .XYP * &Q>*;U]?\ "UDT,'DZS82W,A .Z-D1&P#G!!W^G:N"OO\
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MZ.<NKQ\*1GD 8 [=J ,#QAJUS96G@O5?$MO%83VVJN]TL3>8JJL4OS+C)P0
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MDIO&" /4YR?; !7U3QC<Z9<:7:7EUIFGRWED)5N;A'>VFG[Q+(& 7UR2<@C
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MGB"_FNF=H(C)%*$B<HV0_*E2#MSP>YQBNPU.QO+MX6M;V*%%5UEAFM_.CF#
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M/,:,(<R.6(P/<UNT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]JT;_7-*TIE6_P!1MK8LA<"60+\HX+>R\CGI4EWJMA80I-=7D$4;@LC,X^8
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M(],2[N951!$)))&. !C))]!4<6L:;/8PWT-_;R6DS!(ITD!1V)P #T.3Q]:
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M_K-GIBN;Z2R=(U1LLQQRH/<D9'XUR9U6PUKQEX"O-/M;E8[1+M)PUI(GV;,
M78Q*X&#QZ#CUKT^B@#RGP_I(NOA+XCAAL0VI2'4UC!BQ(3(7VXR,_,NWZ\4_
M2KU-1\3?#V6V@NFBMM,N8IG-LX6-_*B&UB1P001Z5ZG3)8Q+"\9+*'4J2IP1
MGT/8T >*Z-JVAK;>'])O]4DM(=(U62[CEN;*=)7^>0*CL4V+S)\S;B#CMGCO
M_BC;3W?PSUV&WA>:4V^0D:EF.&!. /8&K&F^%KRRLX]-G\075WI<48B6WD@B
M#-&!@(SA<D8XX )]:Z:@#S'Q!K$=EXQTO7KE-5.@7.FFU2ZLXI,PR^9N)90-
MVU@!SCG:*+C2K2PL-);0K^^\.W-O%<2V<EY&TD3QNZL\<RM]W<0K!<AAV&1@
M>G44 >8V-Y=GQ7X)U/4]-DL3-I$\+Q10N5CD)C(3 !*Y R >@^E>@:9JMOJR
M7+VRS*+>X>V?S8F3+H<'&1R/0C@U>HH X32[9O"?CWQ%<7P9-,UIH;F"[P3&
MDBJ5>-S_  GH03@$<9S3VLW\2_$G2M:MT<:9HMM.J7#*56XFE 4A,_>55&2P
MXR<#/..XHH \2T>21?!_@#2C:7GVW3->1;R+[,^82!/G/'N#D=N:[+P19VTG
MB+Q?-+;(TIUGS8I'CY*B)0&4D>N\9'O7=T4 <?XK-Q9^+?"^K2I(^DVLEPET
MRJ6$+R1A8Y& [#YE)[;ZY+Q9I-Y?Z1\0+[3K::>QOTLO(2)"WGR1D>:Z*.HQ
MM&1UVGKBO7:* .'6UM]7^(FB:QHR*;.RT^>*YN(TVHP?9Y<7N1AFQ_#WQD5P
MVCRSZ;X'\!ZP\%_+I5H]XMX;$$R0EW94DP.2!\P/LWO7L6I65Y=O:O9ZG+9&
M&3>ZK&KK,N,;6!&??((I=&TFTT+1[72[%2MM;)L3<<D]R3[DDG\: /.+T0:7
M9Z9XDT;3=4GTA-9:^ODD20RS!XF0SB-OFPK$'&!G&<=Z=XFN-.U#0(=;TC3+
MB*R.NV-Y<W+6SQM-MD >381NP %&<<\^F3ZG10!PUW,ES\6/#]S$LAA.E7(W
MM&R@%F0J#D<$@'@\\53\-:1>Z5XLU3PU]G<:'#=C5[:7'R;9,D0CTVR@L/\
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MPR>:(4="<S"0?(5()."?FSC!S75?%**27P+.8HI)/+NK65Q&I8A5G0L<#G@
MG\*[*B@#@(IK6[^+L]^4S:_\(ZL8EEB*C/G.2OS#KM(./0UQVBS76B>&? FI
MW]OJ9TRUL[FUO#:*WF6LCNI5G4?-C"D=.,^_/N%% &!X0M+"VTF:73+:[@M;
MNY>Y7[67#R%\%GVORH)R<$#UQS7'&*U@U7XAVFH63O-J+)]FA,!+72F!5 3C
MYOFR..AY.*]0HH \=NHKJPT^YT._MIH=2B\*QVWVJ&!IGO2$?=$&P5"JW7C<
M=V<@"K&DZW_PCMUX<U/5+2^;2+CPY;V(FCM))/(G4Y=64#< PV\XYVCTKUJB
M@#R7Q)IDMU>>#++P_')H8"7XMR8C_HX:(A-X(^3>>,'D;B.HJSK.NPZO\/;2
MYGMI].O=,U*U\ZVCMG=(Y8Y1CY5&6A.."N>W4C%>HUDZ[HKZS%:F'4+FPN;2
M?SX9H0K8;:RX96!###'C\L4 >:W&J:3K&C?$"[L[\2ZEJNG\6*P2H56.(QKM
M\Q%+L2PS@?W16QJ%K]@L? ^KVUG_ *#:2Q&_$,7S*I@:-'< 9(0M^&?K7:Z?
MIEQ;RBXO]0DO[E5*([1)&J XS@*.^!U)Z<8YK3H \K\6:3=:R?&>HZ/&\UG=
M:%'!B)21=7"L[93^\0FU<CN<=0<6['5(-1^(V@:A;1W+62Z'-&]PUNZHC;XS
MAB1Q]T]>_'6O2:* /%='@\CX=_#U/L[QS0Z^DDZ^45:,;I@688R!@KDGL14F
MLW<L'@[QYH&HVUT=8N;JXN( +=W%U$Y'E,A (("@+CMM KV:B@"KIY$FEVI*
M,NZ%<JZE2.!P0>1]#7%^#M*O=+UB_P##LT#C2=*NFN["4_=:.8$I&/783+GZ
M+7?44 >.Z/\ 991/X7\1Z?K<NL1:E)/%&@E$-R3,9$F#K\J@9&22.G?I73>$
M+2V?Q?XSFGMHV<ZE'+%))'U41* RDCL=PR.G-=Y10!XM<AC\&->MQ%*9Y=9D
M:.(1MO8&\5P0N,D;><^E=EXF=9/B%X'FC^>))+LM(HRJAH2JDD<#)X&>IKMZ
M* /+_"6I6[:?IWAC7-%O)O$.F7IDQ);.8]X=C]I$N-N,,3DG))( .16/J%W]
MJ^R2I9W-E]E\71S7%C%:N=@\TYFD<@DENHVD##8 .,U[110!YSI\JVWB'X@P
M7$4R-<E)HMT+;7C^S*,YQCJ"/KQUK,\.FYTNU^'VHWD4HTN#3)+2X)0XM)V5
M<,X_ASM*9/3/.,UZS10!XYXITZ1M)\87L,#MIVI:KI[VL8C)$I1HO.D5>X.#
MSCG:3TYKK; *OQAU%XUQ ^BVZ*ZCY&99'. >A(!''H:[:B@#A_$MVJ>.;"U:
MWEMFDTZ81ZC' TK,2ZY@08*@G:&)(/ P,=:X_P ,IOL/A9'-;RAK22Y6<2PL
M/*/E,!G(X^8@ ^ON*]HHH \;ECO(K#Q!<6]K/-;6WC%+^Y@BC+-+:J(RS*O\
M0W+NXZ[372Z+=V^I?%N]U&QCF>TFT2%1<?9W1'<2O_$0.<8_+VKOZ* .(\1W
MDFC_ !#T35;^*9M&^QSVOG)&76WG=D(9@ 2 RKMS7$74"S>"_$,7V*<)/XO$
M\<;VSKOB,T9+ $=,!L^G.:]NHH X+Q(EOI/C[PGJGV<Q6 6]CEE@@+*)9%3;
MNVCJVT\]\5RJ/]F\(W%]<1WML]MXPDO(@]I(RO\ O21O"J6V$$\@'#8KV>LG
M7-$DU?['+;ZC<6%U9RF6&6(*PR5*D,K AAAB/49X- '->!-3T?4=>\07EGJ"
MR7VHRQW$EH()8A"B(L8(\Q5+$XR3CJ0/K6\<K-;:M=ZCI.I/;:G'IZI)8W-N
M9;;4H]TA6(=]^2X^4Y^8<8-=GI^F36\HN+Z^>^N@A19&C6,(I()"JH[E5SG/
M05HT >8G6$TKQ-K5MXIT>]-GKMM;?9Q%:O<*1Y6Q[<[ <$,6./\ :)XS5J&Q
MMIOBI8QW&FI';#PUY @D0.D;>:/W1/3(3/'IGM7HE% 'CR+;+>:_X8\2Z?K<
MUS>:C+<6L=L)?)O8V<-&0Z<(5PH)) 4*.>*M7KVMMXG\2Z)XFM-:EAU><26C
M6D<CQ741B1/+^3HRE2.<=<Y'6O5Z* /+([5(?$'CM7MRN=#MH(B^7)*PR!D#
MG[Q!*@^IQ79^!=P\ >'D<,)$TZW1U88*L(U!!'8@@BN@H.<''7M0!XE9V]KK
M'PSUW1+2)6UFXUFX^SH$P_F?:?ED!QT4#EN@ (KK]#L8;CXE>,WF@CD=DL?(
MEEBR"R1G)4D8RK!<XZ$"ND\,>'_^$;TZ>S%T;A9;J6YW&/:09&+$=3QDG%;5
M 'D<%M<:A\(H?"[12Q>)H)4B\IE(DCG6<-YV?[N/GW]"#UR<5<M]1M+2_P#$
M7ACQ+H][>3W^IO=6J+:O)'>1MM,?S@84KM )8@+M'/%>H44 >47TEM:^*?$F
MC^)[367@UB57M6LTDDBN8S$B&+Y!PP*D<XZYXJ;Q)'<Z1/<W>AW<T=]%:0V]
MQHUY$9XM10+\J(W7S,,5)4GH,C'->HT4 >9:K)>:?XCFO=&N9)FN=1@%]H-W
M 6$CYC7SH'QD;0%8GE?E.<8Q72_$"Y6U\)R/)IPOH3<0"1&5F6)?,4^:53YF
M"X#8'7%=110!Y/:1VUWK_CF*^GU-[6_@L"EW':LCD!2-Z80#Y25QP<@=ZZ7P
M1<:N^H:M;ZE<V^IQ0B%8-7AA\HW(PQ*.!\I9/5>/F]:[.B@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* .3U/QW:Z=I%YK":?=76EVLYMWN8BGS.'\L[02"5#_*3Z@X!'-7V\40KK6K
M:5]DG-QIUHEVQRNV1&W8"G/7Y3UQ7G/B?2-;\-_"_6]$G@M9-*ANEEM;P3GS
M&22Z5]K1[?O L<G.*Z[4M"UJ/QGJ>IV%O;3VNIZ8EHS23;#!(A?!Q@[@0_8C
MD=NM "77B'1-8B\&ZG<:?>/_ &C=+)I[;]ODR-&Q_> -S\N[CD5IS>+X4*S0
M:?>7-A]M%B]U"H8+)NV$[<Y*!_E+>OJ.:YZV\):U!H/@6Q>&W:71+B.6[*39
M&U8V3Y<@9/S9_#K4^BZ/XN\.WEUHUDFGSZ)-=27$%[+,PEMDD8NR>7@AR"6P
M<@<\^E $>C7_ /9WC[QPJQS7,K7%DL%LCY9R8 2%W' '))Y %6->:1/BCX/<
M*^][2_+1"3@E4CP/3/S'GWK*U3P-K4_BK7/$NGB*WU7[1;SZ5*9.&5(Q')'*
M/[K@=L]!WXKH+W3-5OO&'AG6YK6*"#3[:Y6[7SPVUI54?+P,@;.O'!Z4 6=*
M\96^K^'IM6AL;F-H;HVCVDA43"4.$V$ D Y([]Q6OK&JP:)HUUJ=TDKQ6T9D
M9(4WNWLH[FN9TW1;=_']]JFG7L<FF3Q17-Q!&0R&[PR*X(XY3DCU"&MKQ;::
MQ?>%[ZVT&Y%OJ;J/)D+;?X@6&[!VDKD ]B<T 4E\:VD,NL0ZC9W%G/I5FM[.
MC%7S$0QRI4]?E((..?4<UJ:9JLNH321RV$MN%B25)3(CQR*V?NLI/(V\_48S
M7(6/AO6K/Q)JFIP:+ID4%[I4< MWN=R^:I<[9#L^;=N&3]>M:'A'PK)X?UK4
M)[2!].TB>) FF_:/-19LDO(@Z(I! P.OH, 4 7]3\6K8>(O[!@TF^O;]K,WD
M:P^6%=0P7&YF 7DG[V!QQDD"HM-\=:;JVG6,]K#<?:[R>2V2RD4+*LL8)D5N
M< *!DG/<=20*R=0FNH/C5;/:VOVG_BGW#H) K8^T#D9X/.."1QGZ&*+P/J6F
M76F:Y9M#+J=OJ-W>W-J7VQR)<_?16QU4!,$@ E3TS0!MGQSI\$&J?;8)K6[T
MR:&&XMI2N<RD+$P;.W8Q/WB1C!SC%6;GQ0MC;*U[8RV\\EVEG#&\B;979=P*
MOG&W&>3@Y!&"<9RYO#=Y/>ZYJTVGVES)JBVUN=.N7!3R(R=VYL$;SN8C&0,+
MSU-9]AX,N+/2K[3'TN*\T&YO%:+2;RY\PVT(C.[8QS@^9@A<X [@G@ T_$VJ
MZ?)H=K+KFCWVP:I!"L2R!2DWF (Y*L,ID@\9R.HK';4[G1_B?XHFMM,OM3/]
MGVDA@MW7*C]YN(WL!V'RCDGH.M))X,UM?!L.D1,91%K,5W;Q7%SO-O:I(K",
MN?O$;3CKC.,\9K;.E:Q8>.=4UJTM(;F#4+&&! TVPQ21EOOC'W3NZKD\=* ,
M?4M9L_$'B#X=ZSITTC6MW<W!4$D<>0^0R],@@C\ZV;CXA:/;RP,3NLYKS[$+
MA)4.)-Q3)3.[9N&-V/?&.:S+?P3>:2_@RWLREQ!H\\\]W,S!"[2JX)5?]YR<
M9X'K3?#>@>*_#LS:&L&EW&C)</);ZB[GSXXF<L4,>WYG&2 <X'OTH ]"HJC9
M2ZD][?K>VT$5JDBBT>.0LTB;1DL,<'.:O4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!3U32K'6K%[+4;=;BU<@M$Q.UL'
M(SCKR ?PJVJA$"C. ,#)R?S-+10 4444 %,EBCGA>*5%>-U*NC#(8'@@CTI]
M% %/2])T_1+%+'2[.&TM4)(BA0*N3U/UJY110 4444 4FTBP;6%U<VX-^L7D
MB?<<B/.=O7&,\X]:NT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNZHH \AU(P+9_%J!?+V.BM$@QAG-L 2H[DMQQWJQK-PUG8V>I:7K-K#?Q:%
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M@$^V<5A^#?$^FV_AK3-)U.X33]6LK:.UGLKD^7+O10OR*?O@XR"N0017:44
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M?^'=G"I&I:;JMK%>0&)A+;N(W$F\8R,L,\]>O->ST44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MC*'0JW((P:6B@#RNWUK4/!'BO4I;^>:X\)76H?9_-ED:1M.F*(026)/E,6QZ
M ^G?JX;ZRT?4?$NIWD[):6YB<L79E5?*4_*ON3T Y)JS9:2;N#7+35K!3:7]
MR[^7(RL'C*(O.#P?E/Z<URMO\-]0C\'^(O#;ZHTD=Q+&VF7,IRT:1A&C5_\
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M:7=S,R%7(5U-NQ&5]1[\CFM*QTO5M \1Z]<6MHM]9ZM*MU$1,$,,P0(ROG^
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M.@W>HBPT>UM-!CL;.$O:W<+W(8VJQKA-A&1("0!G(QWYS734 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% &-<^$M N]1>_FTNW:ZD(,C@$>9C^^!PWXYK81%
MC1410JJ,!0, #TI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** &R1I+&\<B*Z."K*PR"#U!J
MEI&BZ9H-@+'2;*&SM@Q;RX5P,GJ3ZFK]% !1110 4444 %%%% !1110 4444
M %4=4TBPUF".#4(/.BCD65%+,N'4Y5N".0>15ZB@  P **** "L>_P#"NA:E
MJ!O[O387NRH5IAE6<#H&((W#ZYK8HH 9##%;PI#!&D42 *B(N H] !TI]%%
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MHJ*I:3J(U;3(;T6\UOYF<PS !T()!# 9 /%7: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBH)KVWM[FVMI956:Y9EA0GER%+''T _S
MF@">BBB@ HHK#\0>(&T.\T6 6@F74[Y;/?YFWRR59MV,'/"GN* -RBBB@ HH
MHH **** "BBJPO[4ZD=/$RF[$7G-$.H0G )^I!_(T 6:*@N;VWLS +B54:>4
M0Q GEW.3@?@"?H#63I'B%]3\2:]I#V@A.DO"OF>9N\WS$W@XP,8&/6@#=HHJ
M":]MX+JWM9)56>X+"*//+;1DGZ ?S'K0!/1110 4444 %%%% !1110 4444
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MAUVH6 .Q6*\[03T'3G%)H=IJ"1/>ZR+0:I<*BRBTW&-%7.U5+<D99CSW8^E
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]C.L07E V?X@< G&,96^^(EG:&XFBABN+2UNS:3;+C_2,A]CLL04[E5L]P<
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M4@<XYP<UDZM<7LVL_#F^GM(I=0=YL!)<[\VI.2Q48YY/!QVS0!Z=17'6WCZ
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(4 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ederofferletter004.jpg
<TEXT>
begin 644 ederofferletter004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@##T'P\VB7^
MKW7VSS_[3NOM3KY6W8VT+@<GC"BLK7? 1UFXUMEUFXMH-8BB6>)8D?:T8PI!
M/(&!ROKSD9-=C10!YGJD5Z?%=W*^HZE:W"-&EOOT'[:L@51\\<BH0@+9.W<,
M')XSQL1^$=4N=0CUM-=NM*U"\MHHM3AMHD9)RHP" V[8X!QD$X_4]I10!!+9
M6T]J+6>".:  #RY5#@XZ9!ZUDZ9X3TW2?$6H:Q:P11R7D448C2%5$03=]W _
MBW<_05NT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 >5:=>Z;:>+?'(U9[R2WM+B(P1(9F$:F(,P7;PN2?:NGO(])TOQ#X3T
MNY@OKF[#7 T^Y,Q*Q[8F+!_FRQV\#(/UH\-:)J%AXK\57][;(MIJL\4D'[P,
M=JQ["&';/XU-K^D7]]XR\+ZE;0J]KILEP]P2X!Q)$4&T=^3D]./6@"DWQ)LD
MMKF\;2=26RM-1.G75PRQXAD#!,D;\E=S <9_I5S7/'-IH3:F\UA>2VNE"(WD
MZ!0$\S&-H)!? ()QZ]SQ7-W?@_7;CP5XETI;:(76IZVU_#F8;1$9DDY/]["$
M8]2.:3Q=X4\2^(H/$UI):VUREVB'3)IKG ME 7,8CP0')!RP/(/7@"@#9NLC
MXS:<H=]K:'.2NXXSYT8SCM6)X9\2Q>&/#M_<7EO=7%M)XDNK0S*P(@W3;4+E
MF!"]!GG%=(=*U6;X@Z=KLMK&EO%I<EK,%E!*R.ZOQTR!MQGCK5#2/#L5MX5U
MS1_$WV>"#5+Z[F :9>8Y&+C!_O*.?;&: .P6^#:L]@L3EHX5F>3(VKN) '7.
M3M;MVJQ*[1PNZ1M(RJ2$4@%CZ#/'YUR6C0ZSH7P_^U.T-_K1@61FNI/(5\*%
M7<3G;A "?]K/3-=+87C7.D6U[<Q?97D@666-V_U1*@D$\=/Z4 8^D^,;76?#
M4>M6UG<J'N/LWV63:)ED\SR]K#. <\]>G-%[XPMK6VU&]BL;JZL=-E:*\N(=
MI"%0"Y5206"9^;'H<9(K/T;0HH_'6J:C87:2:5,([LP1X*+>,K*S@CCF/!(]
M6!J"W\.ZSIFF^(M"MX89[34YKB:UNFE $ GSO61>IVDL1C.1@''6@#>@\4VE
MUKYTBWBEEE.GKJ,4RE?+EB9MHP<YSGU&/>K'AS7;;Q-X?M-9M(Y8H+I2R),
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M*Q@E4*A$VKRQR!U(SU%:WC/0+G7]&A33YD@U.SNHKNSF<95)$;G/J"I88]Z
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MR-N8;6R,<\9SSQ6/HFKE?'WB6]DM;M'ETZPDCL9/]=O993Y84G ;U&<#!)P
M34MEX*O])U+P>T"QS1:9->7%[('Q\]PK<(#U 9SZ< =ZK:_X&U/5/%FM:Y:_
MZ->"&W?2;I)!N2>(."&']Q@^TCGC/% 'HT;N\"N\31N1DQD@D>V1Q7F>GWEK
MJUQXHU7Q):7$46D:J6BNA* UJL4<9$:[&W<DG('#;CUKT739;V738'U&V2WO
M"@\Z*-]ZAN^T]QZ5PI\%:GJ7A[QGI5T$M&UF_>\M)0X<+Q'M# =#F,9QG@T
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M6;#0--DU'4IC#:QD!I C-@D@#A03R2!^-<6/%6O:I<^"HK*:SM!KVG2W,Y:
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M+'ILUC#9[TQM:XP/G(Z@,P/;@?C0!VVHZA:Z5IUQ?WLABM;=#)*X4MM4<DX
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M[#4-=TW6+B,M=Z<)! 0>/G !SZXP"/0\U%8>&K#2X]66Q#0'5)WN)F7!(=E
M.,CID$X]2:V:* .8_P"$)L_^$!_X0_[;=FQ\C[/YWR>;LSTSMQGMG%3_ /"*
M1KXAL=:CU&[2YMK,64@4)B>(,' ;*\'(ZKCK7044 <<?AQI<GAV\T.>\OI;*
M:X:Y@&]5:TD+E]T;!0<AF/+9]/7*S_#^&]\.7>D:AKNK7C77EB6[GD1I0J,&
M55^7:!D<\9/<],=A10!C)X=B7Q9_PD37<[77V(61C(7RR@;?GIG.[W_"N?\
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MY@,G\:=:V5K9(Z6EM# LDC2N(D"AG/5CCJ3W- $]%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!( ))P!U
M)HI" P((!!X(- ")(DB[D=6'JIS2+-$[%5D1F'4!@37DY:[\!>)=9\1649D\
M,RZ@8M3LHD_X]3L0BX11VRQW#TY^G4+K>EZ,WB;Q"=DMM_H\@D@ )FW1($"G
MODL /K0!V=%<U/XGGTK7;'3]:M(;>&_CD,%Q#,7571=[(X*C'R@D$=<$8%4+
M#QXU_<:0\6F.]CJC[8WBWM) ""4>0;-H4CKAOER.M '6&^M!'/(;J#9;DK,W
MF#$9P#ACV."#SZU."&4,I!!&01WKQR_AC'@#XIJ(T"KJEP5&T8!\J+D5VESX
MO^Q2-IMC;QSW-G913RB5W4$LIV1C:K<D*3D\#(ZYX .PICRQQ8\R14STW'&:
MJ:-J0UC1K/41;3VWVB(2&"=-KQD]58>HKC_C/%')\+M3+HK%9;8KD9P?/C'\
MB: .]5E=0RL&!Z$'-+33B*([4X4<*H_0"N.TWQO<W&OZ5I5]ID=K/J=O+/'#
M]HW2VY0!MDR;1M)4Y^H(YZT =G17GR?$74&TBSU=M"B^Q3:F=-D5;S,@;S3&
MK*"@!&0.I7K^-=!HGB*ZU#Q#J^B7]C%;76GK#*&AG,J21R!L<E5((*D$8H Z
M&BN?UGQ,FG:O!I,*QM=R0-<DRE@B(&"C[JL223QQV//0'(N/'T]KX=T_7[C1
M98-/>?R-1,KLLEG\VWS-NSYTSCGC@@XZX .WIDTT5O"\TTB1Q1J6=W8!5 ZD
MD]!6#/XF>UTR"]ELU_TV[2VL(Q(09MYPC/E?D!&6(Y( ]>*I:OK=[#H'B<ZQ
MX>CDM]/MC( TV8+Z(QEF )7((P5((]/7@ ZR.1)8UDC=71P&5E.00>A!IU<%
M'KFJ'QAX7TVR@M(-+N=*>Y^SJY7&!&,<+C"AL =^Y'&)X?B"+IK&YM-/>YT^
M[NQ;*T6]I50L5$Q79MV9&?O9 (/7( !V4]Q#:P//<31PQ(,M)(P55'N3TJ2O
M*_B/K<^N_#3Q!<6=E!)ID,_V<3/+^\8I*JLZKMQ@,"!SD@$^Q]'U2>XM=&N[
MBT6)KB*%GC$I(7(&><<XH NT5POA?Q7J%QX:\,I>1PSZKK$!DB/G$ JJ;W=_
MEXQD# SU'..1O:'X@;4M4U32;RV6VU'363S41]Z21N,HZD@'!P001P0>O6@#
M8^T0?:?LWG1^?MW^5N&[;G&<=<9[U)7G=^U[:_&2[DTFRM[B[?PXC%9I?*0D
M7#]2%)SP!T_*M2S\:S:IH&AZI9::J0ZE"\LT]S-LALPHY#N <DMP.!G!/;%
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MWL=4?;&\6]I( 02CR#9M"D8SAOE)'6D;QQ<V^L:;:WNEI;1ZA?R644;SXN%
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M[DS.WEQQ*54,3MR2S,!C'8\\<@'345B^'/$ UV.^BEM_LM]I]RUK=0;]X5P
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M^]R>>W;% '-:?XBU*_L-:MM,DU-=>M[>(_V5JB1QRQG<0[QOMVL&'"GE00.
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M<QS\JCD%@<@AN5&,@X[5/:>%]-L7THVHGA33$D2"-)VV-O'S%QGYSWR>Y)H
MV:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0R HP W D8)&#T/3..]6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV1-:R(21)&548;MSGB@#$U_Q'XMT+PGXFOY+9(OL*QR:?<W2QL\JM@.'2-R
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RHZC.NI?$#S_$-
MW9#2F0V+M<DK"3#O^ZV0P+=B#Z"K5GK.LW^I?#6YU%I[6YOX[EKRW5F1)"+=
MBI9,X_VL'IFM/PSH5U%XU\5:AJ6C[(+VZAELYIO+?(6/:2,,2O([XJYXBTW4
M+KQQX1OK:RDFM+"6Y:YE5T C#Q%%X+ GD]@: +\GBW3(I8=YE%I/<_8X[S9^
MY:;)79G.?O C.-N>,U%+XUTB*],#&<Q"_&FM="/,2W)QB,G.<\@9QMR<9KD?
M#/AW5=*E.@W_ (.TZ[BAN7>#6W,3*T9<L&92-^\9P!Z@<@<U#K&C^)]35_M6
MB7$]U:^((KJ*2*>)86M5E##8N\?/MZE@#U^;M0!W[^(K47TMM'!<S+#<):S3
MQ("D<K;<*><_QKD@$#/)J"Z\7:99N&F\X6?VD6;7H3,*3$[=I.<_>^4MC:#P
M2#7-:IH.I2^)%UC1M/OM,U5KR(3RQW"&UO( 5#&5-W4)D#"[L@8]10T3P]J^
MDWMUHEYX.T[4K=KR2:VUF0Q$"-Y"^9%8;RZYZ#KP.!S0!Z!XAFM;?PYJ4M[/
M<P6JVTAFFML^;&FTY9< D$#D'M6/;>+M(L8='TV(ZC=3W6GK<VP,+22RQA5Y
M9NA<Y&>?<XK3\56UQ>^$M8M+2!I[FXLIH8HU(!9F0J!EB .3W-<KI.BZQ;^(
MO"%S-IDR0:?H;6ERYDC.R4B,;<!LG[AY&1R* .CM?%^DWNB6FJVTDLD=Y*8(
M(?+(E>4$@Q[3T8%6SG@ $YQS7*:;K(GUWXBG4+O5+?3[6&WRA9C): PN9#&!
MG!SE@5R.AZ50L/#?B/3=/T;4DTB1[K3-:O+N2P,T>^6"<N-R'=MW /G!([UH
MG2=;NY_B!='1KB$:S8Q164<DL6YV$#(0<.0#EAWQ[T =-9:Y8VFC:9#:?;M0
M=[!)XDX>=X0H_>.20,G(ZG).<9I4\8Z5<6FESV)FO&U2-Y+2*%,.ZH,N<,0!
MC(!R>IQ7)VMAXH\-WFB:O::$^H(VB0:;?6*W$:2P21$D."3M899@<'WK6U%/
M$<^K:(UQI,C:<\,WVN"QG16BD8CRU9RRDH%SNVG!(Y!&!0!)J'C^W%GX>N]*
MM)[RWUF\%NDH0+LQNW*0Q!W?(PQTX//3.K?^+=-TY+B:<3_9;1UCN[E$S';,
M<<.<YXW#.T$#/.*X+3?#>OV/A#PG ^BS&XT?6WN)[=)8BS1,TWS)E@"/WB]2
M#UXJW!H6KZ=XAU>WN/!NGZS9ZI=M>0WTSQ?Z.7 W1RA@6(4CC:#GM[ 'H6J:
MG#I6E7&I3)++!;QF5_)7>VT#)('?CGBH+?7K2[L-+O8!))#J>W[/M R0R%P3
MSQ\JDUH1Q*D"Q$*5"A<!<#&,=/3VKB?!GAVXTN]U6Q></I6GSRP:4%/,:2A9
M'!]=I(4'M\PH W)/%VF1"&:03K833_9DOBG[DR;MH&<Y +<!B-I/?FB7Q;IT
M)UT.MQNT-%DO5$?*J4+@KS\WRC/K^-<C;^&-8G^&P\"WEBZRQLMM]O5T\IH5
ME#"4?-NW;1]W&=WMS3]8T;7(]4\=QVND2W46O6"+:SI+&J*RP-&5?+!@<XQ@
M$'/4<D '17OCS1K%K2,I?32W=D;Z"*"U=V>( '@ <G#9QVYSBM?4=:L=*T27
M5[V5HK.*,2,S(=P!Q@;>N22!CKDUR.E:+J\'BKPM=3:;*EO8Z&UG<2>9&1'*
M?+XP&R?N'D CI70^,EUAO"UXNA0K-J!V;4.W)7>-^W?\N[;G&>,XH 6U\5Z;
M/)J<5QYUC-ID2S7<=TH4QQLI8/D$@C"GH>,<TD?BW3?M\EE=>=8RK:&^'VI
M@: '#/G)QCC(;##/2N'G\(:MJ=[XLAATZYLK?6=*@CMY[NX61EE3?E9"'9LD
MD=,C'?M6M=1>*/&GA;4=(U+0UT2>2S>%IY+A)1)*1P$V9(3(!)/;@ ]0 =);
M>*=/GU-=/E2XM)Y+8W<7VF/8)(00"P.>,9&0V",]*;;^+-.GO;*V*W$7V^-Y
M+*22+"W*J-QV8R<XYPP!(Y -8ENWB?Q3H=YI&LZ$-'>6REMIKMKA)0[NA3,8
M4Y R=V3Z8YZBKX-T[589+"UU7P7IMA<Z>NR35$,3"7"[0T04;@6XSG&!GZ4
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M/;<%C_K26#%-N.!D9SD'C%_P!97NF>!-'T_4;1[6ZM;98I(W96.0.N5)'ZT
M32^+],AN;9'\_P"SW-W]ABNPF8FGR1LSG/52,XVY&,TM]XLTZPBN;B5;A[*T
ME\JZNXX]T<##&0W.X@9&2H('.2,''-^%(?%6@PIX8GT-)K6VG?R-7-PGEF$N
M6!*?>W@$C&,9[XYI+31=9L/#GB3PT^G/<_;I[MK2[#IY3)<$G,F3N!4L<\'.
M.,T ;^H>-=+L-5ETL0WUW>I;"Z\FTM6D+QDX!7'!'!YZ=LYXIEIX\T._NM&A
MM9)I!K*.UG*(\(Y3.]23T9<<@\US=C&_A_XH0V,-M=7PMO"]O;[HMNX[9G )
MW,.N/U_&H[[P9<6'PR<N\=OK5E=R:Q:E#N6&<R%Q$,=00=GN3]* /1+:^CNK
MJ[MT20-:R".1F VEBH; Y]&7\ZP;'Q:USXQUS1YK*6WM=+AA=KF0J%^82,6)
MW<+A5QWZYQ6QHMG+9:7$ER5-W)F:Y9>AE8[FQ[ G ]@!7&ZEX:U._P#$GC*V
M^RR)9Z]IL-O#?*Z;(F6.12&&=W5AT!R/2@#I8/%FG375A"Z7%NFHC-C--'M2
MXXW84YRI(Y 8*3V%6M?UZQ\-Z3)J6HM(MLC*A,<9<@LP4=.G)')XKESI>J^(
M--\,66H:9)8S:5>075U(SH4W0J0!&58D[FQV&%SGG@Z'Q&TR_P!9\%W6GZ9:
M/=74LT!6-75>%E1R<L0.BF@"8^-]-%]>V M-2-]:1"<VPM&\R6(YPZ#NN01S
MCGCJ:MP>*--O-/TZ\L6DO!J,9EM8H5^>10 6.&("@9&2Q&"0.I K)&GZB/B;
M=ZQ_9\QL7T5+59=\?,HE9RN-V>C#G&/>N.L?"GB'2- \(WC>'(=3FTNUFL[[
M2IY(BVV1PP>-B2F1M'?IQ0!ZEI&L66N6)N[*0LBR-%(CJ5>.13AD8'HP(J_7
M-Z<;[2]/M/LWA>"U^V7@\^UM9(T^RHPYD<C =OE&0OJ!DXR>DH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 0&5U(93@GD'O1INC6FE@F W,LA&#+=7,D[X]-SL2![#BM"B@ HHHH ****
M,U="L4\0OKH63[>]N+9G,AV^6"6"[>G4DYZU%=^&=(O]?MM;N;7S+^VC\N)S
M(VT '</DSM)!.02.#]!6O10 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>'K6.SGUC6KNP^URYE6,+&#MWN[>I.  #G!]*T3X_MI+2R%KI\\FIW4\UO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.T@-C@D9&:QO"GA\>%_#T&D)=&YC@:1ED9-I^=RYSSZL:VJ* "BBB@ HHHH
M**** "BBB@ K'U;3=8O;A'T[7WTZ,)AHUM8Y=QSURW(^GM6Q10!S']@^)_\
MH<Y?_!=#_A1_8/B?_H<Y?_!=#_A73T4 <Q_8/B?_ *'.7_P70_X4?V#XG_Z'
M.7_P70_X5T]% ',?V#XG_P"ASE_\%T/^%']@^)_^ASE_\%T/^%=/10!S']@^
M)_\ H<Y?_!=#_A1_8/B?_H<Y?_!=#_A73T4 <Q_8/B?_ *'.7_P70_X4?V#X
MG_Z'.7_P70_X5T]% ',?V#XG_P"ASE_\%T/^%']@^)_^ASE_\%T/^%=/10!S
M']@^)_\ H<Y?_!=#_A1_8/B?_H<Y?_!=#_A73T4 <Q_8/B?_ *'.7_P70_X4
M?V#XG_Z'.7_P70_X5T]% ',?V#XG_P"ASE_\%T/^%']@^)_^ASE_\%T/^%=/
M10!S']@^)_\ H<Y?_!=#_A1_8/B?_H<Y?_!=#_A73T4 <Q_8/B?_ *'.7_P7
M0_X4?V#XG_Z'.7_P70_X5T]% ',?V#XG_P"ASE_\%T/^%']@^)_^ASE_\%T/
M^%=/10!S']@^)_\ H<Y?_!=#_A1_8/B?_H<Y?_!=#_A73T4 <Q_8/B?_ *'.
M7_P70_X4?V#XG_Z'.7_P70_X5T]% ',?V#XG_P"ASE_\%T/^%']@^)_^ASE_
M\%T/^%=/10!S']@^)_\ H<Y?_!=#_A1_8/B?_H<Y?_!=#_A73T4 <Q_8/B?_
M *'.7_P70_X4?V#XG_Z'.7_P70_X5T]% ',?V#XG_P"ASE_\%T/^%']@^)_^
MASE_\%T/^%=/10!S']@^)_\ H<Y?_!=#_A1_8/B?_H<Y?_!=#_A73T4 <Q_8
M/B?_ *'.7_P70_X4?V#XG_Z'.7_P70_X5T]% ',IH?B99%9_&,KJ""5_LZ$9
M'ITKIJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BC/.** "BBC(_*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** .3T[Q3JFJZ[KFEVNCV8;294B=Y+]E\PLNX$ 1''%7_#_
M (HM]=N;^P>WELM3T]PEU9S8+)D95@1PRL.01^E<_P"#&4>/O'[%@ +RVR2>
MG[@5S>K7-K<:SXV\5M/=Q:$-/ATQ;NR8*UQ)O 8QL>, D)NZ<GGB@#U^66.&
M)Y975(T4LSL<!0.I)["HK&\@U&PMKZU??;W,2RQ-C&Y6&0?R->2M;V\6M^--
M-:+3X[>3P\DPLK8[H1(!)S@\,P !W8';BF1W]CIFC_#ZUEGT^RTB[T_-T\T
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M::4C?+*[%F8X ')/0# Z4 :5%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^/AS_P #9_\ XU1YWCO_ )\?#G_@;/\ _&JZ>B@#F/.\=_\ /CX<_P# V?\
M^-4>=X[_ .?'PY_X&S__ !JNGHH YCSO'?\ SX^'/_ V?_XU1YWCO_GQ\.?^
M!L__ ,:KIZ* .8\[QW_SX^'/_ V?_P"-4>=X[_Y\?#G_ (&S_P#QJNGHH YC
MSO'?_/CX<_\  V?_ .-4>=X[_P"?'PY_X&S_ /QJNGHH YCSO'?_ #X^'/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH Q)/"NF.MS&/M<<-V[R7$,=U(J2ER2V0#QDDYQC.>:DNO#&E75
M[IUVUNT4VG(8K8P2M$%C( *$*0"ORC@\<5KT4 <NGP]\/1Q0Q+!="*"[^VP1
MB\E"PR9).P;OE!+-D#UK5TW0-/TFXU">TCD#ZA+YUSOE9P[XQG!) X '&.E:
M=% &7H/A_3_#>GBQTQ)DME/R)).\@09SM7<3@<G@57;PEI3:U<ZP/MB7]RBQ
MS2QWDJ;E7H,!@ ![5N44 9,?AG1X],O=.6Q0VU\&%T'9F:?<,$NY.YCCN3FJ
MEEX*T6PO+*[B2Z>XLX&MXI);N5SY9(.PY;E1@8!X%=#10!RS_#SPU)X=&@RV
M4DFGHXDB22XD9H2"2/+8ME,9/0CJ?6K:^#M%3P])H:P3"SE=9)#]HD\R1P00
MS29W$Y5>_08Z5O44 %%%% !1110 5C:MKEUIMTL,'A[5=15D#&6T\G:#DC:=
M\BG/&>F.16S10!S'_"6:A_T)?B'_ ,E?_CU'_"6:A_T)?B'_ ,E?_CU=/10!
MS'_"6:A_T)?B'_R5_P#CU'_"6:A_T)?B'_R5_P#CU=/10!S'_"6:A_T)?B'_
M ,E?_CU'_"6:A_T)?B'_ ,E?_CU=/10!S'_"6:A_T)?B'_R5_P#CU'_"6:A_
MT)?B'_R5_P#CU=/10!S'_"6:A_T)?B'_ ,E?_CU'_"6:A_T)?B'_ ,E?_CU=
M/10!S'_"6:A_T)?B'_R5_P#CU'_"6:A_T)?B'_R5_P#CU=/10!S'_"6:A_T)
M?B'_ ,E?_CU'_"6:A_T)?B'_ ,E?_CU=/10!S'_"6:A_T)?B'_R5_P#CU'_"
M6:A_T)?B'_R5_P#CU=/10!S'_"6:A_T)?B'_ ,E?_CU'_"6:A_T)?B'_ ,E?
M_CU=/10!S'_"6:A_T)?B'_R5_P#CU'_"6:A_T)?B'_R5_P#CU=/10!S'_"6:
MA_T)?B'_ ,E?_CU'_"6:A_T)?B'_ ,E?_CU=/10!S'_"6:A_T)?B'_R5_P#C
MU'_"6:A_T)?B'_R5_P#CU=/10!S'_"6:A_T)?B'_ ,E?_CU'_"6:A_T)?B'_
M ,E?_CU=/10!S'_"6:A_T)?B'_R5_P#CU'_"6:A_T)?B'_R5_P#CU=/10!S'
M_"6:A_T)?B'_ ,E?_CU'_"6:A_T)?B'_ ,E?_CU=/10!S'_"6:A_T)?B'_R5
M_P#CU'_"6:A_T)?B'_R5_P#CU=/10!S'_"6:A_T)?B'_ ,E?_CU'_"6:A_T)
M?B'_ ,E?_CU=/10!S'_"6:A_T)?B'_R5_P#CU'_"6:A_T)?B'_R5_P#CU=/1
M0!S'_"6:A_T)?B'_ ,E?_CU'_"6:A_T)?B'_ ,E?_CU=/10!S'_"6:A_T)?B
M'_R5_P#CU'_"6:A_T)?B'_R5_P#CU=/10!S47BF_DF2-O!^OQAF +O\ 9L+G
MN<39Q72T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
7!1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
MB5!.1PT*&@H    -24A$4@  !:L   ,A" (   !I'GHO  "  $E$051X7NS=
M?W 4UYWW>T!5J=R$L%G'SL:[RW/79><ZUU6N];,NBEH_E&M3M_+\DZIL>:M2
MJ=03$F<Q5SB21?@=, 8%L, !@T%L;)4CQ?RP(X5%)(B-L+&>BQT+FS48R&('
M$8R%3;"$PR]CD(A NMUS9GIZSO=T3T]/:W[TO+M>Y3(S/=VGS[1FNC]S?HRI
M^DXU      ! O(V1#P$      ,0,"0@      (@_$A       !!_)"
M "#^2$       $#\D8       (#X(P$!      #Q1P("      #BCP0$
M  #$'PD(      "(/Q(0       0?R0@       @_DA       ! _)&
M  " ^",! 0      \4<" @      XH\$!       Q!\)"       B#\2$
M    $'\D(       (/Y(0       0/R1@       @/@C 0$      /%' @(
M     .*/! 0      ,0?"0@      (@_$A       !!_)"       "#^2$
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MQYYIMU.,\SOMAAXR^%"LIZQUW"LX@<BT:78CD43+D7'O/%^U<*Z^"Z!4D8
M    0$48U_VLG6M<[?3+/I0SV^W(P_FG"D2>7)A^1.4@B58DXUI7RWT!)8@$
M!     #BKK9.-?T8^_9F.[R0D8?;DPL-#4#.;-=7L\RI&6L]?F//N(//Z7L$
M2@\)"     #$6L,B-7C':*NJK=-W#902$A      B*^&1<YL+Z-M[)EV0A"4
M,A(0     (BIVKJQYSOL!*1^MMZ!Q3%MFLPR#-YMU9F"E7$]+^AE $H&"0@
M    Q%-RVA>?^,,QI\:>%E<D&DD^0X=83S4MM0,1)P3I?E:6!"@%)"
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M3C:WT'45HB29YT:^GQCF A3M"SWD1HQ_+PE3ERQYHS_8>3@R=.[H,RODW7L
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M,G\E6[+G?6V5BV_,S/@U,I*S)5R-R1-8;D?_\Q\_:U.7X7(G5/P1S;$;3J<
M2]8[O6I3;019@M1JL"6:\UD3U<=(UD][_<P)16XVR**=)W(CWF7+.0$)5Y_5
MIE(%67(YNWSNM&5?O^22]>\B]/%:MYU+'S]\P;Q;\W+C\K'V;Z3?Q]JO;3YZ
M25MEZ&3S0B> F/&5C6]JG]U>WT$FWC7IMY@_E!)"UU6XDKC.C7P_,;P*8*Y,
M^0D<\1=Z^(W(OQ?+_!^^\F%.7QG#GQQ=/<<KY_(P=<G2 W_RO+V?^N/51R\%
M_%L8OO+[#3\R[CVW S%O)\^2Y/GRC!!DZ.R!+;E?111(,B_(J<G&T$O.;6W:
MCC7I%>IGVPG(F>T9FWU[L[V:_URY34OM6US9><21"@C\UE$#NZK5%LYU8@O9
M%R/YN'JDMF[<P>?4([+!0CH=2-V99[15"5 J>0-O6SA7:[S@-.+(V)18S2CH
M+IS#=+=DR>S:HU>.Q\;5(^[5G ?3->9J(.->S=ZFV$OZJ0#U8+W<CIP2$8F[
M 4NTBIN S/C*NM?[39]#=F>\C_Z4ZN*H+5>.;FO(UAK"\V)1?.UEO28>&;IR
MP2J,2[++8N9*[FL:?T%V83SV*X=?6)KC=@(6-:HW0ICSJ[>-+[6^5HYLN5NN
MGQ3@T#Z^9BKOC4M'GO]'?6M>#'M)+D,?M*Z8J:TOSISL%TQZF8WZWGCL7Q-;
M^-?FW7W:LZG>YNGEV@7SRV?\]Q=Z,M<=_N3@SR<ZQ9/-.M++];.O-+K>QVR;
MBNQL"5)C04Y@N9V,/VJ/^.-R3]>SN5^X1'7LIM-)/W;I@]W/>/P@EB9K0VXY
M7*W*[9A$<SYGBNQC).NGO><71R[D9F75F=Z"D3_M7NO\WB@WXEVV7!.0D/59
M;2I5L$,+<':E%J\[;>]6;%D3D/#'6_N-;<<-AY,\ZM3H/_J2^?<^M>'I/VB9
M@NM[ZKOK6L_HGTY>S19,##49Z!W).-E<PM=5V)(XYT:^GQB& B27HGRA!]V(
M;YVDW/3XWC]Z?^]\>-[XQ9/3Y5"U?;;_XO=.V\;A<__YHXS?DXQ1W4CB'3'^
M(0Q?.=HJ]N[U!7ICX.-SIK?;6H8'_O!K5Z28?TGR?'E"34O7.:?*/S[\BQ59
MKH2+Q+ZS5;/ !/3;9YP;VK1K+^JKJ1!$#:HZ;9H]K8Q:TW^856M-=Y<6*4#6
MX%[-B4+D+#.&VV^GW8&KM4CRY:[V$:KE@GN=(*5*!S%R&!&7=-"0^\3 @791
M6Y<\QLS6'!I9.4Z?%/<QJD?<JSD/9M28$TAI_7W$7M)/!:F'AD5VZX_$QMVA
M5;2*FH 8O_NOO->Q>4VJ\_S,KS?^YO6/]'5&!MY>_8C[HUE^S7A>+(JOO1#7
MQ#63GMA]](KV0?GG4[O7!/L0#+(+>R2JAH-.&*\6[48TR':"%36R-T+C<\TZ
M,G+U=RNJO2[R@AQ:W5>?V-YU1N^O'&S,-J^]I!?9!UN<.5DOF&29<[6N_:/,
M*P+S+^0)HN&&>X"/\2OVGLE\UKW<Z.WXG^E-R>8DUWIVK$CO*+*S)4B-!3F!
M_;;C%7\8NC<'$=FQR]-)'GLX?K61DF^MAI7+^9PV>A\C65<()\AFC6^!NP](
MD(VDY): A*[/ZF"E,AY:UK/+6;PZPLB.?L[BGX#D<;R///_Z)_I+AS[Z77/C
MCV]7*TQ=\.#FUWKT@]4;;-ZT=/<)_0[U7-?&!=8]YS_O.*DW*/,>NL)$UF3
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M_]?AWOX+JN=+3M\[U_YKQ;^*U=QROH$W3BVDEJNG]K>)$>L<"U8<T<;9^.3
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MNW[YU"3SUZ3+U 75O_S/GH_]/EV'!_O?V/7T/YDW)3\?#=]8'K\G7^G9M2[
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M?>6<%HT[^)QU*S[VW=8Q7?]F)R#&(,-'TU+/-B/UL]5,,>&BAWP3D-(.%$A
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M%\R)5VKKG+1B7/>S]IJIUBC)%ZIXY62;-A.P[ 63/+K4/^WU74>$T48" @
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M]4+#B*VI?=E/.>%(XL&,C:N^/^Y]N;><VK7/.NXUDWUMM!7$3C':2$
M *4H.?6L%HL 89&       !*D1K-5#X.A$," @     H/0OG:MU,@#R1@
M    @/@C 0$      /%' @(      .*/! 0      ,0?"0@      (@_$A
M     !!_)"       "#^2$       $#\D8       (#X(P$!      #Q1P("
M      #BCP0$      #$'PD(      "(/Q(0       0?R0@       @_DA
M      ! _)&       " ^",! 0      \4<" @      XH\$!       Q!\)
M"       B#\2$       $'\D(       (/Y(0       0/R1@       @/@C
M 0$      /$WYOZ1O0       /%&&Q       !!_)"       "#^2$
M $#\D8       (#X(P$!      #Q1P("      #BCP0$      #$'PD(
M  "(/Q(0       0?R0@       @_DA       ! _)&       " ^",! 0
M    \4<" @      XH\$!       Q!\)"       B#\2$       $'\D(
M    (/Y(0       0/R1@       @/@C 0$      /%' @(      .*/! 0
M     ,0?"0@      (@_$A       !!_)"       "#^2$       $#\D8
M     (#X(P$!      #Q1P("      #BCP0$      #$'PD(      "(/Q(0
M       0?R0@  "@H&Y=N7ABXS+EYD7SY H   "C@00$  ",B@FU=1,;E]W5
MU73OL;9)O>WWC^SU<=_%3FN=>PYMO;.CT7J5W!H  $">2$   $"4;FM9=?>^
MEOLN=LJ8(R>3>MOOZFJZ=>5BN0L  ( 02$   $ $)C8NN^?0UBF#+\LL(T_W
M7>R\>U\+_64  $">2$   $!X$VKK[NQHS+_%1Q"3>MOO:%LKRP   ! $"0@
M  AC0FW=75U-H]'HP]]]%SO)00  0 @D(   (&=W=C06/OMPN^]BYVTMJV3!
M    O)"   " '$QL7%:8/B]!3.IM9WP0   0$ D(   (9$)MW=W[6F0,45Q3
M!E^^LZ-1EA8  $!# @(  +*[=>7BR7T[90!1(B;UMD^HK9/%!@  <)"   "
M+.YH6UO<43^"L$IXZ\K%LO     *"0@  /!3@CU?O$P9?)EI8@  @!<2$
MX.F>0UMET%#B"$$  ( 1"0@  # KQ_A#(00!   2"0@  #"(*OZX[V+GI-[M
M%OF4ORD#>VYK7C5QPS+'G3L;Y6I>"$$  ("&! 0  .@BB3^F#.RY<V?CYVKJ
M)FY8=O/">9;@L\E8K_U2PZ-W=[>H]$2YH_5)BUS9"R$(  !P(P$!   9[NIJ
MDFE""!,W+/M2PZ-3!O:H?][=W?*YFKJ (8BUFDQ,[GEKBWN#04QL7"8/$
M5"82$   D'9;RRJ9(X1PU\M-,JU0#\J5C2;W[?Q<39V[;'*#63%%+@  <)"
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M/\U   "H8"0@  !4M&@;@-SSUA;9/V7BAF7:R*8^$8;*4+Q&0LWZ\JQH!@(
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M^:C*(XF0"I. W)]X.0  J!PD(   5)R[NIID')"/JOR2"$W!$I")C<MDY0
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MRN2^G9^KJ;OG+?N-EL_ZF]C(R3"*)M?.L_X G6&&M:F43O?U6T]9*[A;8P$
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M"]K$+NU=>YG4-O9N7;GXOHN=,GTHNDF][0S\@:P:6K:H05+50H\8 *A )"
M@*#:N_:JMAYJL6XGY#J(MPFU=7=U-<D,HEBF#+Y\1QOWL<C! XN661]EVO@@
MW8>.T'X- "H!"0@ ("@UL8M:CO>>XFZA8MVZ<O&DWG:91Q38/8>VTO0#^9M<
M.\_Y9#O=UT_O& "(,1(0 ("9^J74W=##>D2-].$>! 05:V+CLF+E(/<<VGKS
M(KI<(1KS&YO<K=N.]YZ2ZP  XH$$! "@L^X'G"$#F=@%_@J<@Y!]8)1L;-NN
M1@G1YO.FNQ\ Q D)" ! Y_XYU%IH\8&L;EXT[^Y]+5,&7Y:9123NN]AY9T<C
M?5XPVK2/.]7UCPET 2 V2$   '8W>/<_50,0ZZ+?NOKGHA\YN:UEU=W[6J*:
M,F9RWTYK:[>N7"QW!!2 .PZV_I_I8P"@W)&  $!%>V#1,I5W:.-],!8@\G3S
MHGEWM*V]>U]+3GUDI@R^;*U_5U?3;2VK:/&!HIO?V'3X6(]*0+0IP $ Y8@$
M!  JU .+EJE.[VIA\#^,J@FU=1,;EUGN[&B\JZO)[8ZVM>HI^2J@%%B?EB_M
MV^_.A2?7SK,^,TF* :#LD(  0(6RKNF=^&-@<+"]:Z]<!P @;6S;KCX\Z2T(
M .6%! 0 *H5UC:[]8ME]Z(AU^6X]R.4[  3GS):EEDT=G7(= $ )(@$!@/B;
M7#NOO6NO&M)O?F.3^W&Y,@ @*V?6<.NCE<]2 "@7)"  $'-.:VVU'#[6(]<!
M (3PP*)E[F&D+><N7CK>>\J=-0, 2@<)" #$G#/>Q\#@8/>A(]8_Y3H @/PU
MM&QQXF9R$  H020@ ! WUC6WUBG]\+$>QNH#@-%F??R>NWC)"4&Z#QV1ZP
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MIU0"0IM$ " ! 8"\;.KH=.:XE<\"5:D1/6ZJ?Y013%$8UIEFG6]_,7\>HX=
MV=BV76L PJ3L "H3"0@ A'>ZK]]I73PP.,@%)1S6G:=U_TGW%A2=ZBQ#&@(W
M-5Y5]Z$C-%<$4&E(0  @/&?.EY?V[><Z$JJ'RTWUCY)ZH#21AD!Q^L4,# XR
M4PR BD(" @#AJ8EO&6"_DGWJP8?'SYQ%#Q>4'=53AG%#*M/&MNVJ_Z9:^!8#
M4#E(0  @*)5W6.13J#2?F?'(YQ<M8#13Q(,:177\S%GR5$=<J3&\1T9&^%(#
M4%%(0  @$&?$4WXNJUBJDPM#>R#>5#<9&H94".OKS#V"U>3:>7S! 8@W$A
MR.ZE??N=UL(#@X-<(%84FGN@,MVR9AD-0RJ-TRJ$D:T Q!4)" !DIX;-'V'$
MTTK"Z!Z HL9/G3!GSJ<>?%C^I2 VG&\ZE?5O;-LNUP& <D<" @!F6M+1WK67
MIA^Q9]W@J7XN\B80P%\E1@RACTR,N4=(/=W7+U< @')' @( !NU=>ZWKO^DK
MU\JG$#_6[9QU4W=SPQ)YOP? 2/6185;=^)E<.T]-]$[H#R"62$  (,/TE6M/
M]_6K7\".]YZ2*R V5/#! !] /E04\MG:F?)/#.7+/3RJI:%E"S\) (@'$A
M2+.N^5*=H.VEO6NO7 ?ECN #& U?7+?\IOI'&3DU?JQO1M4UAN]$ #%  @(
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M&$?HQ$28^_?O,Q<&@(P$!$!$E#J/*N3MB)"?_7+)B.6OC'QMI?"?;ZZ2F_@
M  -1' "BPXJY$?)LP=J.SLL,  $@(P$!$'YU;>?$ %2FO43'0TM?5K,/U9.;
M?JMOY0, )-$? **5Z"P9M6ZU_&!'>#$0%8!  @(@S-2ZI\I_I\]?E ] & U_
M_D4Q[47VZ.NOR0U] $ _0S< 1(N58B*JU'F4-@D @00$0#B)1H;XCUDP$37L
MN<4C7NZ;]F+HY^O>U+?U 0 :0SL 1(>58B+AV8*U:LN$RB  2$  A)D8 T+\
M$5$/+5DV<F6^''G(*(D* +Z,*5DGQQ!#:WS-EL<+7I,?^PB%]NN9ZS>^E@\
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M( $!H)>1EW_]QM=\WH>1J^AI%->[#1PE40%8G@T'@&BQ5FXHU!81C2+ ,DA
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M54,353\&9]ASBVU>]]0/2J)&P-N3.D]ZYU:<S;Y9-\>U>DCMW*]:-!,N!DI
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M(_X($"51,7B[=\_[=WO.M3WNDAE &#  Q"02G26$((%0FF>BG48( @PA$A#
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MCG7NGO67^LQ_M2V\?S;G]LGTC_=.WD/\81K;WI([JT DL#ZN2FF+,C 94)&
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M (%5C2ZV>PG\PLIJT1CNZ>UE+@RL@00$\$F-O5D"9MASBRG_ 1.B)"HPY!@
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M*A!F#  !)#:?"U/7=H[O$1%S2$!@:QEY^6)5\X[.R_)>^V#^"RR)DJA &#$
M!#!DY[DP2D/Z5O=WBE+G47DO8$XD(("K$JK-!^\]O&RYW'L$8ATE48&P80 (
MX,/8B@URR\H^E"8TE5 16TA  +L;_OR+<M<1L 9*H@)AP0 0P(]1ZU;+[2L
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MK9;?#=@-"0C"(, @65">62D=E=KD0GZN14U6=Y/R<%=O1ODYV"?IPJ&;",,
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M7$=>56#8+UZ86.GJ%\B[XH)LI>M$N7X?S(8$!*&2'RN&XMQ3740&G%"R5A1
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M2"#BI*@B+")T62&B"<CPYU^4.UT 3(*2J#"/<56;Y4X4@-CU>,%K<LMP<$A
M5/*; _L@ 4%('LU;)C]3PO)\D2\5.OE5 B%?QU!$$Y 1+S, !# U2J+"%!@
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M]JK'9'4W*<]$Y>&K_""?+K]*(.07E:5]XI1/#-WP17ER_PJ F5$2%4.  2"
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M%.<C=##<8KC+SV$#[O5UL.XL/Q?QLTN1W%8NOP\AH@8J8#&/ODY)5(09 T
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M(1D#DN (J7(*K(0$!.$75'6E6!2AE;2H@0I8&R51$3H&@ !0/;5AC=R>#%R
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MDD&.("<@?BZNO3W_!WB3'>_L'L/#]!N#RV[TMV2P74U O$&,*U_H:'!?4TU
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MW3=O>)UP93<^MQLD%W("$D#RLGKK'/%][ \U$PKZ7E%'?P/J6?^N3^W8ZQH
MHN6NWNHY]_4WXO>53N^H3OWT2/HM=2&;YM2#^@62[8:2J'")@0$@I0,D('YZ
MUQ$/$:1N?T#?_QM>2MJH]L#[QS?>^A'>P\+XBB[2FV.@[Y]#LP!*Z83Z&L];
M\6/=M#I?UY<V&J14VY/>;XAL A+(B];MG2M&&O[4E'K&.RBC87_ZCV>ROCV9
M_K>:9]R368P2$,W(H.]/S+ZX=^H?]O>5@/WQV'3E_Y-C[WA&)[GF<!V8WEXY
M_=(A;Y&L,_,,UM\QKTA,A-%2&NI#-2E&C-V6;PD("@D(S&MBY?K4SOUAF1VC
M/#'3/G$F.8N'<-"'UO!%>7+GQT8V;9_KJPQ>O^5(U-Z[MO.OV[AZ0F>C_B):
MWBQ WUT/)%Z1[[SO+,69^9=*QV_ZS5.[RE(]BYNX!H:(XB #7SS@[,;H4CZV
M!Y* !)2\>.NG_M0PL\P[/V55X;2/#Z6^MV?:B4UB35SI+5T[[>_NLSR+W7A_
MZ[J]LW]7.F&K&->SZLEM;T^L*YO>6NQ=':;@Z=^=T/\B-D9)5,3" )#2P2<@
M$0D1_'?[ _C^7[Y/PYOOZX$W>Y<+4;KW^^9YUG!5SPW?*_K<J*,>HYT05#KY
M4KVGD__- 7<E"\-+21N/5;NK/KD6<YGWX;[I?]B7\O$);W45Y1_NQ.P_[-:L
M>ANF!"2P%Y6"C -S_^'Y3B7GR_VB6H=1 J+8G7+#Z*NU>\UI?Q#WN7W*^]ZW
MJ[_<?SJ?<?V/%#,B-Q%&*\&Q]O]O[\Z?I"S/?H'_</+&!8GZNA!"1)!-")LB
M(VO^%.NM6*D$5 @&90E*9%.)H"S#)H(@^\ZPR3*,L30YE!ZU8BJ6)GKF32R.
M4?/&1*-Q/S/3,SW=??>,TST]S?3]?*H^O]C]/$\/D\K,=7_GNJ^[G/T@#<N!
M(4=6=9,RGDHG :$"7#WWGH&[EX_XS::Q]0<ZWAO2<''#C^:&'Y=E/N&E(Q*[
M!:;5DJ4WOGQH0N:FB2^>'OORNKY+,O;%Y(8=;;QXW^)!OSL\,?VH3X_>_.N5
M \ZE1L&W'JH2+->#Y[3Y8J:,,1:A?^T>V'PZ3-[G%)?=Y'U4&Z]W) 'I4/(R
MN]?) \U5YOL[!FUZX*H%B](S^7_XCZ?Z-G5S!-_2UE-F6NYZH&_-CG'-PUD/
M#5TQI^><AT<T'VIP\I9G'^VS9-XUU8_^H+[YSYMC3R[(_FXGD9&H25<9#2"K
MBT] NB1$^(9E?[!L#O[^'WZ=>;_XC#&NDS^J&?WBEJ&_;5V!9UQ6PD_,?/'L
M^/J=PU_8,KBF^5^:(>-;\?79"6_O&?[<D\->V=\R.S:]+ZGU41G;.L(/73NT
M/MBK^'7=Y)8\HJDC(^^CVOB(/ E(^B/2[14=^="&1STQ*L\)08V]AR.>;IDG
MDC\!:;#^QM\?'M_\/7GFAU^>&?_.OA&UF<T=:P;]=L_8#\ZT_)VC\63EJC]N
M&UPA1^&F=>E&F!P-)?JPVO4E^6ME6[I)[S8QD8!0D:Y;M2!EX.[E#3]Y&PPY
MLBK]8O=/B).[!2;' [_LLVGYP ,K;]BZ.'/$9ONN6+*@8=W>IWI1[R49XS,;
M'_5(_TT+6YXSYYKURP;N7][WD;9&BN1+$/*_F"E]0=V$-YX:U3K/HF[2NSL&
M53=_5AO/"5[L4'83W-76TV9U+ 'I8/)RWY(;FX.);%\<'[WGEZF/"[ZE]_:<
MO6#0G_+=]?69JE\_U-32,KM7S=Z)N>\V^=>N 0L;A\AB)&J254@#R.KB$Y N
M"1&>:7?9O[HC?__/LV[/\\4WK,"?#'L86\[BS?R'E^X3,S.=1CF'I^3<&&KX
M];2SI84A_%^M\<5!OZN9\.')"1\^7?5*.K/8./S-HQ,_3_V[ZB9]4#/ZMQN'
MO'1H0N,KJ4FW>1_5QD<<W#+F'R<;/^*=G1D#:U,?>GQ,>H/)-W]HZK+'?_!Z
M36N0\?FI<6_O&?9TQR>55M]PXO'!I]:U=\9MS?K!M1L'GZBDG2\YNGHC3*CW
M@_-&_&93":.0;M6[360D(%!N2=\"T[WECU=:Y>0.<ZZI_M4-!Q[K5WU_:L=*
M^_(__)NRFP+,_D6OU8L;/^*QYATT/5L_=&&O!UKRA0XE+TV79?7IU$UZ?\^P
MEF-Z&I\<)B"-=RT<\+_WM=:FC:N70Z-J%F=\?^;V/K#EE@\RUP9G)_SEJ8S\
M""-1DZIB&D!6YUOH=GA)7_H0(92Y[$]I_^__X3^G\<4\T4"#8YM'_OE$\RDA
M7YX>5[_]QA</CL]9S)?V$P]L'/E.Z\BD=A.0N@GUNT>?;SG$Y/-3M]9O[T0+
MP]J!9\H?!'3P0SL09"18>3;"Y)79N!W\'[,]D_Y]IN&68;7KKUNU('PLE) $
M!,KMTCM_%BYXJ!#Y.B\J5 >3EP=^^?VMCS6^OJ(U5?EF\^[OD[JK^I?_F?^$
MESG7//9@OSTK!^YXN,^O9!^YC$1-ILII %F=;P$?OM+X8OXE?<E#A(XN^TNW
M;#ZT;E#MA@'Y/R53R3ZQ_['U;7]<\,UO^/+.K&_GR%CB5LZ-,.V[>NX]UZU:
MT'_30ZF6[5"J?3N\$;J.! 3*[;*9,\,%#Q4BH@2$[LU(U,2II :0$NELB&#9
MGQ9\*TB\\F^$@4HA 8&R^O:/IH9+'2I'ZUB-,36M^T&@Y(Q$39J*:@#I)BS[
M6PUXY:AO!9DNX$88Z.8D(%!6ML!4NBN6+.R[8\7  X_U_57>02%0,D:B)D@"
M&T!*P;(_K>T#4$BH[K,1!KH;"0B4E2TP0,<9B9H0&D"*8]G?*G5\2>W&0<<Z
M?BH*,;M^]\JP"@7^EP0$RLD6&* @1J(F@@:0HEGV0]NNG#LKK$4!"0B4SR53
MIH4K'(!V&(D:O>]O618N70 ZJ?>JQ6$M"DA H'PNN_OGX?(&H!U&HD9NQ:)P
MW0+EU/_$AH'??"(/E<=&&,A+ @)E\A__-25<VU#9'EC8KV;#\)=WW?S&@;%_
MV7?S&[M&/;_NANIYN9>5TT.K1__?;8/7WY?[.I7,2-2(:0"A*ZT9<*IQE]#@
M$VN#MUH<V#CJ?VHG?W+LYO_S1"(/$HY<S^DSPHH4$DX" F5R\4_N"A<V5*K9
M]_>MW3WNT[JF8PARG)U0O[G_(VV?%%-$;K)DZ8TO'QCW\=FFY]=..+][^-Z%
M5X27S;J__ZLGFJXY-?;L0_DNH%(9B1HG#2#)LG;("WO&G#\^_L,S30-<ST[\
M\.EQ;^\;^9O'\T</)[:-.5]3U;[W#HT\59U[8Z,U@U\Z,.Z3]"^INDD?'![U
M[/K@LNJ!+QV9E+KFLR,CCN=]%!6LU_(%844*"2<!@3+I,?WN<%5#19H]O__+
M1YOJU[9]O._&ZE\$-Q:5FRQ8-O+]VN#ZD[<<7_2=["NOW+QU_%=-[WYU;.3F
M=B,5*HV1J%'2 )(<_6MWCOUG^),\I6[BNWN''LM-'_H_=[ YFVC/TS?5YM[8
M&'^\TI)K9/KRQ$W/9#>#'-HRYN/4KZ3:<;_?&#R'BM=W^Z-A10H))P&!,@F7
M-%2F65?MW34QK"Q#?]_:]_Z,&XO,3>9>=^YH[F4IGQ^X<=GLUBOG/#CLKZGR
MNF["JX]=E?ME4_&,1(V-!I#$Z%^[Z];\V7>&CPX.RPY!6L[Z;5^^!.3(MJK/
MTA><G?A)JG^PT>3W=@QLO7+-D->?;G[KH_U#C0*)5(\I=X5%*229! 3*X:(?
MWQFN9ZA(LY>T! TM/CX\^M=K!QY<.^S5P]G)R.DQ-;]LN;'8W&3N(Z,^:JF;
M/]L_Y.'[KCMWI.7BVK$G%[1<.:=W[:'F6OE?NP<^E)&,$ LC42.C 20I#CPQ
M^H/6#*(=D\YO&]!Z8_7@UU*[&MN7)P$9\-*1ENBD;L);3_8_].28].^1KXZ-
M3&]U.;EKW!>IRTZ//1=ND"$25R^>%]:ED&02$"B'2^_\6;B>H2+-6WES<\G8
MY/-#0U>FMZ[<U__5EK^G-9GTZO++4V\5F9O<VW/%QEM;WII<O^;JAF7PIJ<F
MI%]Y8V7SL(]'UM[R:?/MMQQ?F/LU$PLC4>.A 20YGMF7_J'=Y,RX/^T86K=Q
M<.WF$?4GLKH\,N.)_6MN?.M4QELGJ][8.^J5;<-?R+%E<$W.)V;>6%OUPKI^
M^]<.^_/I]*>//;>NZ;+U/WB[^<7)[^\:%'[9Q*+/QJ5A70I))@&!<KALYLQP
M,4-%NF]!OV./#W]Y]RWGCT_XM&[R7]9=F_'N?];LRRQG6Q.*XG*36?=><6!/
M^H'-3ZO>/"Y]\=\V]VF\;/Z /S0_8?+YQWO/";YF(F(D:APT@"1&]<#?'<OZ
M"9_5Z+'IIG]F[HY)QQ,-U@T_GY&;?WS@Q@/AP_/*O/'DS75K&MM)TKM=OJZ]
M]94-#9?U?W;_A.:Y44_?='9-\!"B<O'M4\/2%!)+ @)=SCFX\9IS]9*,L1VS
M%PZI3_^=K<'9\><>;AY66EQNDI6 U$UX\5>-3PL2D"NW;FO^ ^-71T8\'HQ?
M)2Y&HL9  TB2W%"[9?@KNV]ZZU#5>R<F?'*ZZJ7,_2:/C_Q;Y@:95,M&ZJV-
MH_^1$8[\8\_@0QMN?&GWS?6'J\[7C*W?-_IW6X<<RYM<9"8@J3TRF0E(W837
MGTB=@)OZSXGU6_KG/H'87#EW5EB=0F))0*#+73)E6KB,(1:SKMFZ=OCSFX<_
M_]1-?\V,/Y[YX1>'AU7G.]NEX[G)K'LOW[,K/<\_[ %IW!=SW](1[Z<*Z+H)
M+R^[,O>SB)"1J)5. PA-J@?\]F!S(T9*UBZ833>GAW<T^,>Q6UN/MFWQY>EQ
M;VX;G#O!-'//2RI2R>H!J7II@Q-PDZ;WJL5A=0J))0&!+N<<W*C-Z?-\>C1I
MIM-CSSZ8;N4(=#@W">: 9#2,U$U\^='OM0Y W35@X:PKEBSLNV/%P/W+^SZB
M&21:1J)6-@T@2;=A^%N-?1Q5?SN5?=1+W:2WGVK=('-H6]67F>^VI6[2N[N&
M9(4@U8-^?[SEW;/C7WNBW_[U(]Y)=X6<&O/\4QDGX#XQ\)EMH^L/5[UW?-Q[
M1\;6[QE>FWU<+E%P)BYDDH! EPL7,$0D?P(RZ8U5[9Y'F_^N/+G)G(='_+VE
M1_J+(Z-JJH?_)9V8G+SIU!.M U!/K1SRAZ/IAI'&$Q#/;Q^4>[8ND3 2M7)I
M $F\G)TO*763/]@_]$C&92=WC\ML#VE/TX$OF1]Q>L_X]+V?'AOS1LV$=)CR
MV>'1?TR?@'MP9-9OC29?GAK[TN/!UTS%ZSE]1EB@0C))0*!K.0<W=FUF&57/
M/MQV#TC^N_+E)K-[G3R0_7?"%G_?.^J_FP?^3SZ_??B;)W,O:/#QWD&/.!DW
M3D:B5J+OKEP<KDQ(F.P1I\UJQ[^Y-6-"ZNI^M7NS3Y"IF_3W@Z->VO:#<]M&
MOG9X_.?9.V*^.#+B:.9'M)[SDNWL^/I#Z1-PJ_YT.&L/3NO3CH\ZG7?""!7,
MF;B0)@&!KN4<W-BE]K,\.?+5?54?G,DJ(K\Z-G+SO.#ZE/P)2/[<9,ZB(7]Z
M.C<$^7C_#^IVMPQ /3KR-_M:_X[W\=&Q[Z9KW\;YJ>F398B)D:B5J._.Q\*5
M"0F3-P%I<';"6UMNR+BR_[''ASSWU,C?[QOS]M%Q[V1M=>G_S+[L\"+S$)DF
M1YZ\Z7^R?R4U/+]^YZC_U_SBY/?WCGH[?4'MN->WC_AS.D:OFYC35$+E<R8N
MI$E H&M==O?/PZ4+L9AUQ;R,#HMYBX=D-V),?G/UU;FW--]86&XR>UZ?_1M'
M_6'?V'>/5M7O&7UN;;^5CXYLWAUS=OR+*P:TGJ=[\J8]]_5<M'K,9RT/_&A[
MO[GA%T ,C$2M+!I :%(]\-FMPU_8-OR5/;?\[71VNGUJS',=',.Q8>1[F3%*
MTPDON=>L'7QNY^BW#HT]?WC,'W>/>';#@.<.3FS^1?/T375;Q_R[I9'DRYKA
MAU;W.[ZS==_-AWL'YSZ-BA?6J)!,$A#H0L[!C<Z<7IM6#*G=//+5/4WGVIZI
MJEV4><%W-CV5U;?\R8[^OP@?4G1NDC:GSZ\/-]?-_]S1?\%#P].[RK\Z/'19
MP\,?#%X)'T+%,Q*ULF@ 2;SJ&TYL&) UM73#B'>R0O!)?][:L>:+S.-=GFDC
M <EVX(G1'S0?'-9X F[-]M9)JZF\(W/V:BH3"1]")7,F+J1(0* +7?R3N\)%
M"Y5LSO?/'<NJ5K,G=^0F()_MNF%>XUVER$TR+%L_]O/4Q:?&U#S0\Q?+1W_2
M<N\7>P8V?F)& O+UD>'Y#^4E!D:B5@H-($E5/?"Y':/?.E3UWHD)G]:U'$_;
M>D'_%VJRVD RFR]J-K3L@CDT.K<W9/WP\YG1R3<F(-6#7CG:_$&I$W SYXRD
M/O3@D[E=(;D/H;+U6KX@K%0A@20@T(4NG38C7+%0R69=?7Q_5K7ZQ=%1>Q<T
M3^ZX;\F-]=GC2,]OZ-7X5G&Y21MF/S#H3RT#4/^ROM?L>WO.6WES\V0["4@2
M&8E:$32 )%7.U(^Z["Z/ZH&_R_KM\,._[Q[4^/K:87_.'&4:G/9R?'M5>JMC
MHV .2(XC6V_Y)'T"[L;&5S)[0#[:-Z3AE8-;;TD_4P(2H^NV+ LK54@@"0AT
MH<MFS@R7*U2VA];>TMQ_D79VXKL';G[ST+B/<PXX/#/VY,*FNXK+3?*:==7>
M7<T;N;\X/"P5;<SYU<A_IO]PMV_0 _?:!9,H1J)V?QI $JQZ\&LGLG["?W5J
M["N;FB:>KAGXW)Y;&QM#TN_63:I/)1W!75^>'/OJDP,;4XGJ&TX_==/[V0.D
M/JL9GGF2;JZU-[:>@+M_:"K:"/..S%TP_SXX]&#X'"K>Q;=/#8M52!H)"'05
M0T B]8OKGL]N6F[#Y+]NONZ^EKN*R4WRN7_9J.:PX^SX%Q^YLOGU!X;4IZOA
MXR,WS<V:A/J->VJH?$:B=G,:0!+MY*Z6 V@S?%D[*>=$VZ^;!I2>;3F&]LBV
M["Z/E+.3LA*3YA?'O];N%IC6+^#TV'/K6U[/G*5Z>NP+&P:^<#A]IMCD=[9G
M'<U++*Z:/S>L5R%I)"#052Z9,BU<J!"#V?/[OUC3>OIL'G63_KJU_X.9G1=%
MY2:Y?G'=N98S=!L'H,YJ>7W6M2</IA\^Z=T]H^I;)^1-^L-C+4$)T3(2M3O3
M ))X:X>\?J(#/__/CG]]<^8&F0'G#C5W_+6G;M*[60?E!EHGADQ^?U?3%IMF
M UYHZQ?9F:H7TD$)4>F]:G%8KT+22$"@J_28?G>X4"$6<WIM73?JOT\$Y6/=
MI \.C#KY2*]PD$<QN4F6[ZQ\O"IS &KFNZV](=D^/S1TI2$@B7#E@GGAVION
M0 ,(_?:O'_;'X^W]_/_R5-7O-P=M%VL&G3LP/FP5:75VPOF=[<8?J_MGGH";
M;C!).;!QY+O9NVD:U4UZ9T=F4$),^FY_-*Q7(6DD(-!5>MY[3[A*(3)7+%G8
M=\>*@0=6-GFL7_7]S=,]\BL\-TF;O7!(??-@O$GU:QL'H&9?<$7U^C'_S-Y0
M\VG-R)WS<Y]#O*Y]=&&X_.;"T@!"B^H;:K?=]/:QIA-A6G]03_[TZ:JW=@T[
ME9U-9#KRQ/#7#X_[L#:KB^3S4^/>WC?RN0W?='3NXR/?3VUU:3H!-_?=U?T.
M/?Z#UVO&-W])=9,_.3'VM:V#VHU4J'0]IMP5EJR0*!(0Z!+?_M'4<'T"*07F
M)BFSKJI>/?(O3T]NIZUCWB_['E@W[/G-PY_?-/38\CZMVV1(A,OG&8G:[6@
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M"'2*@V" R!B)FD4#")  CH,A.20@T"D.@@'B8R1JVG5;EX=+!8#(. Z&Y)"
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MKEFV0 ,(0/E)0(B2! 0*( $!*+/OS)G5:\6B?GM7A=4Y %U' D*4)"    !
M_"0@    0/PD(    $#\)"    ! _"0@    0/PD(    $#\)"    ! _"0@
M    0/PD(    $#\)"    ! _"0@    0/PD(    $#\)"    ! _"0@
M0/PD(    $#\)"    ! _"0@    0/PD(    $#\)"    ! _"0@    0/PD
M(    $#\)"    ! _"0@    0/PD(    $#\)"    ! _"0@    0/PD(
M $#\)"    ! _"0@    0/PD(    $#\)"    ! _"0@    0/PD(    $#\
M)"    ! _"0@    0/PD(    $#\)"    ! _"0@    0/PD(    $#\)"
M  ! _"0@    0/PD(    $#\)"    ! _"0@    0/PD(    $#\)"    !
M_"0@    0/PD(    $#\)"    ! _"0@    0/PD(    $#\)"    ! _"0@
M    0/PD(    $#\)"    ! _"0@    0/PD(    $#\)"    ! _"0@
M0/PD(    $#\)"    ! _"0@    0/PD(    $#\)"    ! _"0@    0/S^
5/^N))M-R.#;>     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980568176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">The Cigna Group<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-4991898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">900 Cottage Grove Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bloomfield<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">226-6000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,872,231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001739940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367975939904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 11,025<span></span>
</td>
<td colspan="2" class="nump">$ 10,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">277<span></span>
</td>
<td colspan="2" class="nump">414<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">TOTAL REVENUES</a></td>
<td class="nump">46,517<span></span>
</td>
<td colspan="2" class="nump">44,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpensesAbstract', window );"><strong>Benefits and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Pharmacy and other service costs</a></td>
<td class="nump">31,459<span></span>
</td>
<td colspan="2" class="nump">29,813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet', window );">Medical costs and other benefit expenses</a></td>
<td class="nump">9,046<span></span>
</td>
<td colspan="2" class="nump">8,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">3,538<span></span>
</td>
<td colspan="2" class="nump">3,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">459<span></span>
</td>
<td colspan="2" class="nump">458<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">TOTAL BENEFITS AND EXPENSES</a></td>
<td class="nump">44,502<span></span>
</td>
<td colspan="2" class="nump">41,818<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">2,015<span></span>
</td>
<td colspan="2" class="nump">2,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Interest expense and other</a></td>
<td class="num">(358)<span></span>
</td>
<td colspan="2" class="num">(299)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainLoss', window );">Net realized investment losses</a></td>
<td class="num">(56)<span></span>
</td>
<td colspan="2" class="num">(322)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">1,601<span></span>
</td>
<td colspan="2" class="nump">1,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">TOTAL INCOME TAXES</a></td>
<td class="nump">295<span></span>
</td>
<td colspan="2" class="nump">355<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,306<span></span>
</td>
<td colspan="2" class="nump">1,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">39<span></span>
</td>
<td colspan="2" class="nump">15<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">SHAREHOLDERS' NET INCOME</a></td>
<td class="nump">$ 1,267<span></span>
</td>
<td colspan="2" class="nump">$ 1,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Shareholders' net income per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 4.28<span></span>
</td>
<td colspan="2" class="nump">$ 3.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 4.24<span></span>
</td>
<td colspan="2" class="nump">$ 3.73<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Pharmacy revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 32,144<span></span>
</td>
<td colspan="2" class="nump">$ 30,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Fees and other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 3,071<span></span>
</td>
<td colspan="2" class="nump">$ 2,539<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_RealizedInvestmentGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net realized gains or (losses) on investments during the period, including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_RealizedInvestmentGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5,6,7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980448080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,306<span></span>
</td>
<td class="nump">$ 1,212<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax', window );">Net unrealized appreciation (depreciation) on securities and derivatives</a></td>
<td class="nump">194<span></span>
</td>
<td class="num">(843)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax', window );">Net long-duration insurance and contractholder liabilities measurement adjustments</a></td>
<td class="num">(331)<span></span>
</td>
<td class="nump">459<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity', window );">Net translation gains (losses) on foreign currencies</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Postretirement benefits liability adjustment</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(111)<span></span>
</td>
<td class="num">(434)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity', window );">Total comprehensive income</a></td>
<td class="nump">1,195<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income (loss) attributable to noncontrolling interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to redeemable noncontrolling interests</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to other noncontrolling interests</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TemporaryEquityOtherComprehensiveIncome', window );">Other comprehensive loss attributable to redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Total comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">SHAREHOLDERS' COMPREHENSIVE INCOME</a></td>
<td class="nump">$ 1,156<span></span>
</td>
<td class="nump">$ 765<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest, Including Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>OCI, Liability For Future Policy Benefit And Market Risk Benefit, Instrument-Specific Credit Risk, Gain (Loss), After Reclassification Adjustment And Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Available-For-Sale Securities And Derivatives Adjustment, Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Including Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Net of Tax, Including Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_TemporaryEquityOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of other comprehensive income or(loss) attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_TemporaryEquityOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of net income (loss) attributable to nonredeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367976062528">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 7,935<span></span>
</td>
<td class="nump">$ 5,924<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">914<span></span>
</td>
<td class="nump">905<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Accounts receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,704<span></span>
</td>
<td class="nump">17,218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,211<span></span>
</td>
<td class="nump">4,777<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,263<span></span>
</td>
<td class="nump">1,298<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">32,027<span></span>
</td>
<td class="nump">30,122<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,010<span></span>
</td>
<td class="nump">16,288<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ReinsuranceRecoverablesNonCurrent', window );">Reinsurance recoverables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,286<span></span>
</td>
<td class="nump">5,416<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,837<span></span>
</td>
<td class="nump">3,774<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">45,811<span></span>
</td>
<td class="nump">45,811<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">32,102<span></span>
</td>
<td class="nump">32,492<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,563<span></span>
</td>
<td class="nump">2,704<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate account assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,340<span></span>
</td>
<td class="nump">7,278<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">147,976<span></span>
</td>
<td class="nump">143,885<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesCurrent', window );">Current insurance and contractholder liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,166<span></span>
</td>
<td class="nump">5,409<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PharmacyAndServiceCostsPayable', window );">Pharmacy and other service costs payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,609<span></span>
</td>
<td class="nump">17,070<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,360<span></span>
</td>
<td class="nump">7,775<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_AccruedExpensesAndOtherLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,174<span></span>
</td>
<td class="nump">7,978<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,418<span></span>
</td>
<td class="nump">2,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">44,727<span></span>
</td>
<td class="nump">41,225<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesNoncurrent', window );">Non-current insurance and contractholder liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,790<span></span>
</td>
<td class="nump">11,976<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,707<span></span>
</td>
<td class="nump">7,786<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,692<span></span>
</td>
<td class="nump">2,766<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">29,124<span></span>
</td>
<td class="nump">28,100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate account liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,340<span></span>
</td>
<td class="nump">7,278<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">103,380<span></span>
</td>
<td class="nump">99,131<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies &#8212; Note 16</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">78<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,332<span></span>
</td>
<td class="nump">30,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,769)<span></span>
</td>
<td class="num">(1,658)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">38,841<span></span>
</td>
<td class="nump">37,940<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Less: Treasury stock, at cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,906)<span></span>
</td>
<td class="num">(21,844)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL SHAREHOLDERS' EQUITY</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">44,502<span></span>
</td>
<td class="nump">44,675<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Other noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">44,518<span></span>
</td>
<td class="nump">44,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 147,976<span></span>
</td>
<td class="nump">$ 143,885<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Par value per share, $0.01; shares issued, 399 million as of March&#160;31, 2023 and 398 million as of December&#160;31, 2022; authorized shares, 600 million.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements to the Consolidated Financial Statements for further information.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_AccruedExpensesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of other current liabilities and obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_AccruedExpensesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InsuranceAndContractholderLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amounts as of the balance sheet date of all current insurance and contractholder liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InsuranceAndContractholderLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InsuranceAndContractholderLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amounts as of the balance sheet date of all current insurance and contractholder liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InsuranceAndContractholderLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_PharmacyAndServiceCostsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects amounts due to pharmacies for prescriptions filled through our retail network of pharmacies. Also includes amounts due to clients for their portion of rebates that must be contractually shared.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_PharmacyAndServiceCostsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ReinsuranceRecoverablesNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable after one year under reinsurance contracts including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ReinsuranceRecoverablesNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367981051872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">399,000,000<span></span>
</td>
<td class="nump">398,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">600,000,000<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367974474880">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Total Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2"><div>Total</div></th>
<th class="th"><div>Shareholders' Equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss)</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Other Non- controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 46,976<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 46,958<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 29,574<span></span>
</td>
<td class="num">$ (1,068)<span></span>
</td>
<td class="nump">$ 32,623<span></span>
</td>
<td class="num">$ (14,175)<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in Total Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Effect of issuing stock for employee benefit plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">90<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(432)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(432)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(432)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,209<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Common dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(356)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(356)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(356)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,334)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NoncontrollingInterestOtherChanges', window );">Other transactions impacting noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,145<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">46,123<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">29,736<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="nump">33,464<span></span>
</td>
<td class="num">(15,581)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">54<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Change in Redeemable Noncontrolling Interests</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TemporaryEquityOtherComprehensiveIncome', window );">Other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityOtherChanges', window );">Other transactions impacting noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">55<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">44,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">44,675<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">30,233<span></span>
</td>
<td class="num">(1,658)<span></span>
</td>
<td class="nump">37,940<span></span>
</td>
<td class="num">(21,844)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in Total Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Effect of issuing stock for employee benefit plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(111)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(111)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(111)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,272<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Common dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(366)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(366)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(366)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(958)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(958)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(958)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NoncontrollingInterestOtherChanges', window );">Other transactions impacting noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Mar. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">44,518<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 44,502<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 30,332<span></span>
</td>
<td class="num">$ (1,769)<span></span>
</td>
<td class="nump">$ 38,841<span></span>
</td>
<td class="num">$ (22,906)<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">66<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Change in Redeemable Noncontrolling Interests</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TemporaryEquityOtherComprehensiveIncome', window );">Other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityOtherChanges', window );">Other transactions impacting noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance at Mar. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 78<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements to the Consolidated Financial Statements for further information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_NoncontrollingInterestOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other activity associated with noncontrolling interest that is not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_NoncontrollingInterestOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_TemporaryEquityOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of other comprehensive income or(loss) attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_TemporaryEquityOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in temporary equity from changes classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977083536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Total Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="5">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Common dividends declared (in dollars per share)</a></td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367971797760">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows from Operating Activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,306<span></span>
</td>
<td class="nump">$ 1,212<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">749<span></span>
</td>
<td class="nump">717<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainLoss', window );">Realized investment losses, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">56<span></span>
</td>
<td class="nump">322<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income tax benefit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(108)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Net changes in assets and liabilities, net of non-operating effects:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Accounts receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(479)<span></span>
</td>
<td class="num">(983)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">566<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReinsuranceRecoverable', window );">Reinsurance recoverable and Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72<span></span>
</td>
<td class="nump">584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Insurance liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,533<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable', window );">Pharmacy and other service costs payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">539<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities', window );">Accounts payable and Accrued expenses and other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">690<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">104<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH PROVIDED BY OPERATING ACTIVITIES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,028<span></span>
</td>
<td class="nump">2,030<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract', window );"><strong>Proceeds from investments sold:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ProceedsFromSaleOfDebtAndEquitySecurities', window );">Debt securities and equity securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">196<span></span>
</td>
<td class="nump">757<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract', window );"><strong>Investment maturities and repayments:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities', window );">Debt securities and equity securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">257<span></span>
</td>
<td class="nump">456<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfLoansReceivable', window );">Commercial mortgage loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments', window );">Other sales, maturities and repayments (primarily short-term and other long-term investments)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">160<span></span>
</td>
<td class="nump">479<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestmentsAbstract', window );"><strong>Investments purchased or originated:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PaymentsToAcquireDebtAndEquitySecurities', window );">Debt securities and equity securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,794)<span></span>
</td>
<td class="num">(1,246)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMortgageNotesReceivable', window );">Commercial mortgage loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Other (primarily short-term and other long-term investments)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(377)<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PaymentsForProceedsFromPropertyPlantAndEquipment', window );">Property and equipment purchases, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(408)<span></span>
</td>
<td class="num">(288)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Divestitures, net of cash sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED IN INVESTING ACTIVITIES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,983)<span></span>
</td>
<td class="num">(324)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows from Financing Activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionsToContractHoldersFunds', window );">Deposits and interest credited to contractholder deposit funds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">45<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WithdrawalFromContractHoldersFunds', window );">Withdrawals and benefit payments from contractholder deposit funds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ProceedsFromRepaymentsOfOtherShortTermDebt', window );">Net change in short-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(463)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(80)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Net proceeds on issuance of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,491<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(962)<span></span>
</td>
<td class="num">(1,368)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Common stock dividend paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(368)<span></span>
</td>
<td class="num">(357)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(136)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH USED IN FINANCING ACTIVITIES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(2,171)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of foreign currency rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,013<span></span>
</td>
<td class="num">(488)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash January 1, including held for sale assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,548<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash December 31, including held for sale assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,060<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations', window );">Cash and cash equivalents reclassified to Assets of businesses held for sale</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(591)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash and cash equivalents January 1,</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">5,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash and cash equivalents December 31,</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">4,469<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure of Cash Information:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid, net of refunds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">77<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 322<span></span>
</td>
<td class="nump">$ 308<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes $425 million reported in Assets of businesses held for sale as of January 1, 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Restricted cash and cash equivalents were reported in other long-term investments.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of accounts payable, accrued liabilities and other operating obligations not separately disclosed in the statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_PaymentsForProceedsFromPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For (Proceeds From) Property, Plant, And Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_PaymentsForProceedsFromPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_PaymentsToAcquireDebtAndEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Debt And Equity Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_PaymentsToAcquireDebtAndEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from maturities, repayments and calls of debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ProceedsFromRepaymentsOfOtherShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease and the net proceeds from (repayments of) short-term debt, defined as borrowing having initial term of repayment of one year or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ProceedsFromRepaymentsOfOtherShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ProceedsFromSaleOfDebtAndEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sales of debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ProceedsFromSaleOfDebtAndEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_RealizedInvestmentGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net realized gains or (losses) on investments during the period, including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_RealizedInvestmentGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionsToContractHoldersFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a segregated fund account during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionsToContractHoldersFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReinsuranceRecoverable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of benefits the ceding insurer expects to recover on insurance policies ceded to other insurance entities as of the balance sheet date for all guaranteed benefit types.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReinsuranceRecoverable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMortgageNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the purchase of receivables arising from the mortgage note on real estate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMortgageNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WithdrawalFromContractHoldersFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a segregated fund account during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WithdrawalFromContractHoldersFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367979135200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, reported in Assets of businesses held for sale</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="nump">$ 591<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977682256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of Business</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8211; Description of Business</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Cigna Group, together with its subsidiaries (either individually or collectively referred to as the "Company", "we," "us" or "our"), is a global health company with a mission of helping those we serve improve their health and vitality. Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental and related products and services. </span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The majority of these products are offered through employers and other groups such as governmental and non-governmental organizations, unions and associations. Cigna Healthcare also offers commercial health and dental insurance and Medicare products to individuals in the United States and selected international markets. In addition to these ongoing operations, The Cigna Group also has certain run-off operations.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A full description of our segments follows:</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Evernorth Health Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> includes a broad range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in Pharmacy Benefits, Home Delivery Pharmacy, Specialty Pharmacy, Distribution and Care Delivery and Management Solutions, which are provided to health plans, employers, government organizations and health care providers.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cigna Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> includes the U.S. Commercial, U.S. Government and International Health operating segments which provide comprehensive medical and coordinated solutions to clients and customers. U.S. Commercial products and services include medical, pharmacy, behavioral health, dental and other products and services for insured and self-insured clients. U.S. Government solutions include Medicare Advantage, Medicare Supplement and Medicare Part D plans for seniors and individual health insurance plans. International Health solutions include health care coverage in our international markets, as well as health care benefits for globally mobile individuals and employees of multinational organizations. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> comprises the remainder of our business operations, which includes ongoing businesses and exited businesses. Our ongoing businesses include continuing business (corporate-owned life insurance ("COLI")) and our run-off businesses. Our run-off businesses include (i) variable annuity reinsurance business (also referred to as "guaranteed minimum death benefit ("GMDB") and guaranteed minimum income benefit ("GMIB") business) that was effectively exited through reinsurance with Berkshire Hathaway Life Insurance Company of Nebraska ("Berkshire") in 2013, (ii) settlement annuity business, and (iii) individual life insurance and annuity and retirement benefits businesses comprised of deferred gains from the sales of these businesses. Our exited businesses include our interest in a joint venture in T&#252;rkiye, which was sold in December 2022 and the international life, accident and supplemental benefits businesses sold in July 2022 (the "Chubb transaction").</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">reflects amounts not allocated to operating segments, including net interest expense (defined as interest on corporate debt less net investment income on investments not supporting segment and other operations), certain litigation matters, expense associated with our frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs and intersegment eliminations for products and services sold between segments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977716608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8211; Summary of Significant Accounting Policies&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Basis of Presentation</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Consolidated Financial Statements include the accounts of The Cigna Group and its consolidated subsidiaries. Intercompany transactions and accounts have been eliminated in consolidation. These Consolidated Financial Statements were prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP"). Certain amounts in prior years have been reclassified to conform to the current year presentation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amounts recorded in the Consolidated Financial Statements necessarily reflect management's estimates and assumptions about medical costs, investment and receivable valuations, interest rates and other factors. Significant estimates are discussed throughout these Notes; however, actual results could differ from those estimates. The impact of a change in estimate is generally included in earnings in the period of adjustment.</span></div>These interim Consolidated Financial Statements are unaudited but include all adjustments (including normal recurring adjustments) necessary, in the opinion of management, for a fair statement of financial position and results of operations for the periods reported. The interim Consolidated Financial Statements and Notes should be read in conjunction with the Consolidated Financial Statements and Notes included in the 2022 Annual Report on Form 10-K ("2022 Form 10-K"). The preparation of interim Consolidated Financial Statements necessarily relies heavily on estimates. This and other factors, including the seasonal nature of portions of the health care and related benefits business, as well as competitive and other market conditions, call for caution in estimating full-year results based on interim results of operations.<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Recent Accounting Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's 2022 Form 10-K includes discussion of significant recent accounting pronouncements that either have impacted or may impact our financial statements in the future. The following information provides updates on recently adopted accounting pronouncements that have occurred since the Company filed its 2022 Form 10-K. There are no accounting pronouncements not yet adopted as of March&#160;31, 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Targeted Improvements to the Accounting for Long-Duration Contracts ("LDTI"), Accounting Standards Update ("ASU") 2018-12 and related amendments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Cigna Group adopted LDTI January 1, 2023, which includes the following key provisions:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Changes to the measurement of the future policy benefits liability for traditional and limited-pay insurance contracts:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Assumptions used to measure cash flows (such as mortality, morbidity and lapse assumptions) are updated at least annually with the effect of changes in those assumptions remeasured retrospectively and reflected in current period net income. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Discount rate assumptions are updated quarterly based on market-level yields for low credit risk fixed income instruments ("upper-medium grade fixed-income instrument"), with any changes reflected in other comprehensive income. The upper-medium grade fixed-income instrument yield is interpreted to mean A-rated.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Deferred policy acquisition costs ("DAC") related to long-duration insurance contracts are amortized on a constant-level basis over the expected term of the related contracts. Other related deferred or capitalized balances (such as unearned revenue liability and value of business acquired) may use this simplified amortization method. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Market risk benefits ("MRB"), defined as protecting the contractholder from other-than-nominal capital market risk and exposing the insurer to that risk, are measured at fair value, with changes in fair value recognized in net income each period, except for the effect of the Company's change in nonperformance risk (own credit risk), which is recognized in other comprehensive income. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Additional disclosures, including disaggregated roll forwards for the liability for future policy benefits, market risk benefits, separate account liabilities and DAC, as well as information about significant inputs, judgments, assumptions and methods used in measurement.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The transition methods applied at adoption were:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The liability for future policy benefits was remeasured using a modified retrospective approach applied to all outstanding contracts as of the beginning of the earliest period presented and was recognized in the opening balance of retained earnings. The impact of remeasuring the future policy benefits liability for the discount rate was recorded through accumulated other comprehensive income. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">DAC followed the transition method used for future policyholder benefits.</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Market risk benefits were remeasured at fair value at the beginning of the earliest period presented. The difference between this fair value and carrying value was recognized in the opening balance of retained earnings, excluding the effect of the Company's change in nonperformance risk (own credit risk), which is recognized in accumulated other comprehensive income. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effects of adoption:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The new guidance applies to our long-duration insurance products predominantly within the Cigna Healthcare segment and Other Operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The cumulative effects of adopting the new standard were immaterial. The impacts were a decrease to January 1, 2021 Shareholders' equity of $139 million and an increase to Shareholders' net income for the year ended December 31, 2022 and December 31, 2021 of $36 million and $5 million, respectively. The corresponding impact to diluted earnings per share was an increase of $0.11 and $0.02 for the year ended December 31, 2022 and December 31, 2021, respectively. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The prior periods within our Consolidated Statements of Income, Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets, Consolidated Statements of Changes in Total Equity and Consolidated Statements of Cash Flows were restated to conform to the current presentation. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Prior period balances in the Company's footnote disclosures have been updated to reflect adjustments resulting from the adoption of this standard. Refer to Note 9 to the Consolidated Financial Statements for the Company's updated accounting policies. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">It is possible that our income recognition pattern could change on a prospective basis for several reasons: </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Applying periodic assumption updates, versus the locked-in model, may change our timing of profit or loss recognition. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">DAC amortization is on a constant level basis over the expected term of the related contracts and no longer tied to the emergence of profit on such contracts. </span></div><div style="text-indent:45pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, in December 2022, the Financial Accounting Standards Board ("FASB") published ASU 2022-05, which simplified the retrospective adoption of LDTI by permitting companies to make an accounting policy election to exclude contracts that are sold and removed from the balance sheet prior to the effective date of the standard from the retrospective adoption of LDTI. The Cigna Group made this policy election for the contracts sold in the Chubb transaction and our divested interest in a joint venture in T&#252;rkiye.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977772768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Accounts Receivable, Net</a></td>
<td class="text">Note 3 &#8211; Accounts Receivable, Net<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts were included within Accounts receivable, net:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noninsurance customer receivables</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,899&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical manufacturers receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,128</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insurance customer receivables</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,467</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">264</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17,704</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,218&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div>These receivables are reported net of our allowances of $2.1 billion as of March&#160;31, 2023 and $1.9 billion as of December&#160;31, 2022. These allowances include contractual allowances for certain rebates receivable with pharmaceutical manufacturers and certain receivables from third-party payors, discounts and claims adjustments issued to customers in the form of client credits, an allowance for current expected credit losses and other non-credit adjustments.The Company's allowance for current expected credit losses was $87 million as of March&#160;31, 2023 and $86 million as of December&#160;31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977843136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplier Finance Program<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SupplierFinanceProgramTextBlock', window );">Supplier Finance Program</a></td>
<td class="text">Note 4 &#8211; Supplier Finance ProgramThe Company facilitates a voluntary supplier finance program (the "program") that provides suppliers the opportunity to sell their receivables due from us (i.e., our payment obligations to the suppliers) to a financial institution, on a non-recourse basis, in order to be paid earlier than our payment terms require. The Cigna Group is not a party to the program and agrees to commercial terms with its suppliers independently of their participation in the program. Amounts due to suppliers that participate in the program are generally paid within one month following the invoice date. A supplier's participation in the program has no impact on the Company's payment terms and the Company has no economic interest in a supplier's decision to participate in the program. The suppliers, at their sole discretion, determine which invoices, if any, to sell to the financial institution. No guarantees or pledged assets are provided by the Company or any of our subsidiaries under the program. As of March&#160;31, 2023 and December&#160;31, 2022, $1.5&#160;billion and $1.3&#160;billion, respectively, of the Company's outstanding payment obligations were confirmed as valid within the program by the financial institution and reflected in Accounts payable in the Consolidated Balance Sheets. The amounts confirmed as valid for both periods are predominately associated with one supplier. We have been informed by the financial institution that $324&#160;million as of March&#160;31, 2023 of the Company's outstanding payment obligations were voluntarily elected by suppliers to be sold to the financial institution under the program.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_SupplierFinanceProgramTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplier finance program</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_SupplierFinanceProgramTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367978958240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mergers, Acquisitions and Divestitures<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Mergers, Acquisitions and Divestitures</a></td>
<td class="text">Note 5 &#8211; Mergers, Acquisitions and Divestitures Divestiture of International BusinessesIn July 2022, the Company completed the sale of its life, accident and supplemental benefits businesses in six countries (Hong Kong, Indonesia, New Zealand, South Korea, Taiwan and Thailand) (the "Chubb transaction") for approximately $5.4 billion in cash. The Company recognized a gain of $1.7&#160;billion pre-tax ($1.4&#160;billion after-tax), which includes recognition of previously unrealized capital losses on investments sold and translation loss on foreign currencies. In December 2022, the Company also divested its ownership interest in a joint venture in T&#252;rkiye.Integration and Transaction-related CostsIn 2023 and 2022, the Company incurred net costs mainly related to the Chubb transaction. In the first three months of 2022, the Company also incurred net costs related to the sale of the Group Disability and Life business and acquisition of MDLIVE. These net costs were $1 million pre-tax ($1 million after-tax) for the three months ended March 31, 2023 and $52 million pre-tax ($37 million after-tax) for the three months ended March&#160;31, 2022. These costs consisted primarily of certain projects to separate or integrate the Company's systems, products and services, fees for legal, advisory and other professional services and certain employment-related costs.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977827776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Note 6 &#8211; Earnings Per ShareBasic and diluted earnings per share were computed as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.238%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Shares in thousands, dollars in millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of<br/>Dilution</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of<br/>Dilution</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shareholders' net income</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">295,706</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">295,706</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318,487&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318,487&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,293</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,293</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total shares</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">295,706</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,293</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">298,999</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318,487&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,795&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">321,282&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings per share</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.28</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.76&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.73&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amounts reflected above for the three months ended March 31, 2022 have been restated to reflect the impact of adopting amended accounting guidance for long-duration insurance contracts (discussed in Note 2 to the Consolidated Financial Statements).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect was anti-dilutive:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.955%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.152%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Anti-dilutive options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>The Company held approximately 102.7 million shares of common stock in treasury at March&#160;31, 2023, 99.1 million shares as of December&#160;31, 2022 and 77.3 million shares as of March&#160;31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977896176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8211; Debt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The outstanding amounts of debt, net of issuance costs, discounts or premiums, and finance leases were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term debt</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$17&#160;million, 8.300% Notes due January 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$63&#160;million, 7.650% Notes due March 2023</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$700 million, Floating Rate Notes due July 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,000 million, 3.000% Notes due July 2023</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">996</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,187 million, 3.750% Notes due July 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,187</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$500 million, 0.613% Notes due March 2024</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">499</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, including finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total short-term debt</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,418</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$500 million, 0.613% Notes due March 2024</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,000&#160;million, 3.500% Notes due June 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$900&#160;million, 3.250% Notes due April 2025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">878</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2,200&#160;million, 4.125% Notes due November 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,500&#160;million, 4.500% Notes due February 2026</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,503</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$800 million, 1.250% Notes due March 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">797</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$700 million, 5.685% Notes due March 2026</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">697</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,500&#160;million, 3.400% Notes due March 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,440</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$259&#160;million, 7.875% Debentures due May 2027</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">259</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$600&#160;million, 3.050% Notes due October 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">597</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,800&#160;million, 4.375% Notes due October 2028</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,785</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,785&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,500&#160;million, 2.400% Notes due March 2030</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,492</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,500 million, 2.375% Notes due March 2031 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,398</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$45&#160;million, 8.080% Step Down Notes due January 2033 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$800 million, 5.400% Notes due March 2033</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">794</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$190&#160;million, 6.150% Notes due November 2036</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">190</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2,200&#160;million, 4.800% Notes due August 2038 </span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,192&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$750&#160;million, 3.200% Notes due March 2040</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">743</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$121&#160;million, 5.875% Notes due March 2041</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$448&#160;million, 6.125% Notes due November 2041</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$317&#160;million, 5.375% Notes due February 2042</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">315</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,500&#160;million, 4.800% Notes due July 2046</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,466</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,000&#160;million, 3.875% Notes due October 2047</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">989</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,000&#160;million, 4.900% Notes due December 2048</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,969</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,250&#160;million, 3.400% Notes due March 2050</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,236</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,500 million, 3.400% Notes due March 2051</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,478</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, including finance leases</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">67</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29,124</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,100&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">The Company has entered into interest rate swap contracts hedging a portion of these fixed-rate debt instruments. See Note 11 in the Company's 2022 Form 10-K for further information about the Company's interest rate risk management and these derivative instruments.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Interest rate step down to 8.080% effective January 15, 2023.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Long-term debt</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Debt Issuance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 7, 2023, the Company issued $1.5&#160;billion of new senior notes. The proceeds of this issuance will be used for general corporate purposes, and may include repayment of outstanding debt securities. Interest on this debt is paid semi-annually.</span></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.777%"><tr><td style="width:1.0%"/><td style="width:23.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.456%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$700 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.685%</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$698 million</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$800 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 15, 2033</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.400%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$796 million</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"> Redeemable at any time discounted at the U.S. Treasury rate plus 20 basis points. Redeemable at par on or after March 15, 2024.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"> Redeemable at any time discounted at the U.S. Treasury rate plus 25 basis points. Redeemable at par on or after December 15, 2032. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Short-term and Credit Facilities Debt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revolving Credit Agreements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Our revolving credit agreements provide us with the ability to borrow amounts for general corporate purposes, including providing liquidity support if necessary under our commercial paper program discussed below.</span></div>As of March&#160;31, 2023, The Cigna Group had a $3.0 billion five-year revolving credit and letter of credit agreement maturing in April 2027; a $1.0 billion three-year revolving credit agreement maturing in April 2025; and a $1.0 billion 364-day revolving credit agreement maturing in April 2023. There were no outstanding balances under these revolving credit agreements as of March&#160;31, 2023.<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In April 2023, The Cigna Group entered into the following revolving credit agreements (the "Credit Agreements"), which replaced the agreements discussed above:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">a $4.0 billion five-year revolving credit and letter of credit agreement that will mature in April 2028 with an option to extend the maturity date for additional one-year periods, subject to consent of the banks. The Company can borrow up to $4.0 billion under the credit agreement for general corporate purposes, with up to $500 million available for issuance of letters of credit. </span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">a $1.0 billion 364-day revolving credit agreement that will mature in April 2024. The Company can borrow up to $1.0 billion under the credit agreement for general corporate purposes. This agreement includes the option to "term out" any revolving loans that are outstanding at maturity by converting them into a term loan maturing on the one-year anniversary of conversion.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Each of the Credit Agreements include an option to increase commitments in an aggregate amount of up to $1.5 billion across both facilities for a maximum total commitment of $6.5 billion. The Credit Agreements allow for borrowings at either a base rate or an adjusted term Secured Overnight Funding Rate ("SOFR") plus, in each case, an applicable margin based on the Company's senior unsecured credit ratings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Each of the two facilities is diversified among 21 large commercial banks, all of which had an A- equivalent or higher rating by at least one Nationally Recognized Statistical Rating Organization as of March 31, 2023. Each facility also contains customary covenants and restrictions, including a financial covenant that the Company's leverage ratio, as defined in the Credit Agreements, may not exceed 60% subject to certain exceptions upon the consummation of an acquisition. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Commercial Paper. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under our commercial paper program, we may issue short-term, unsecured commercial paper notes privately placed on a discounted basis through certain broker-dealers at any time not to exceed an aggregate amount of $5.0 billion. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The net proceeds of issuances have been and are expected to be used for general corporate purposes. There was no commercial paper outstanding balance as of March&#160;31, 2023.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Debt Covenants. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company was in compliance with its debt covenants as of March&#160;31, 2023.</span><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Interest Expense</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest expense on long-term and short-term debt was $345 million for the three months ended March&#160;31, 2023 and $314 million for the three months ended March&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977778880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common and Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock', window );">Common and Preferred Stock</a></td>
<td class="text">Note 8 &#8211; Common and Preferred Stock<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Dividends</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the first quarter of 2023, The Cigna Group declared quarterly cash dividends of $1.23 per share of the Company's common stock. In the first quarter of 2022, The Cigna Group declared quarterly cash dividends of $1.12 per share of the Company's common stock.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table provides details of the Company's dividend payments:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount per Share</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount Paid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"> (in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 8, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 23, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$1.23</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$368</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 9, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 24, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1.12</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$357</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April&#160;26, 2023, the Board of Directors declared the second quarter cash dividend of $1.23 per share of The Cigna Group common stock to be paid on June&#160;22, 2023 to shareholders of record on June&#160;7, 2023. The Company currently intends to pay regular quarterly </span></div>dividends, with future declarations subject to approval by its Board of Directors and the Board's determination that the declaration of dividends remains in the best interests of The Cigna Group and its shareholders. The decision of whether to pay future dividends and the amount of any such dividends will be based on the Company's financial position, results of operations, cash flows, capital requirements, the requirements of applicable law and any other factors the Board may deem relevant.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element may be used to capture the complete disclosure pertaining to an entity's common stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation. B Preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977722784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insurance and Contractholder Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceLossReservesAbstract', window );"><strong>Insurance Loss Reserves [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock', window );">Insurance and Contractholder Liabilities</a></td>
<td class="text">Insurance and Contractholder Liabilities<div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt;text-decoration:underline">Account Balances &#8211; Insurance and Contractholder Liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's insurance and contractholder liabilities were comprised of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.048%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unpaid claims and claim expenses</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,880</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,959</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">272</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Future policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">601</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">290</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,341</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,631</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractholder deposit funds</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">163</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">361</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,309</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,670</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,358&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,709&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,843&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market risk benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,172</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,220</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,419</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,440</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,509</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insurance and contractholder liabilities classified as Liabilities of businesses held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,562)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total insurance and contractholder liabilities</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,166</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,956</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,409&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,976&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,385&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,947&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.94pt">Amounts classified as Liabilities of businesses held for sale primarily include $3.7&#160;billion of Future policy benefits, $0.4&#160;billion of Unpaid claims and $0.4&#160;billion of Unearned premiums as of March&#160;31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Insurance and contractholder liabilities expected to be paid within one year are classified as current. The Company adopted amended accounting guidance for long-duration insurance contracts on January 1, 2023, discussed further in Note 2 to the Consolidated Financial Statements, which resulted in restatement of prior period amounts. Additionally, see below updated accounting policies and incremental disclosures associated with future policy benefits (Note 9C), contractholder deposit funds (Note 9D), and market risk benefits (Note 9E).</span></div>Unpaid Claims and Claim Expenses &#8211; Cigna HealthcareThis liability reflects estimates of the ultimate cost of claims that have been incurred but not reported, including expected development on reported claims, those that have been reported but not yet paid (reported claims in process) and other medical care expenses and services payable that are primarily comprised of accruals for incentives and other amounts payable to health care professionals and facilities. The total of incurred but not reported liabilities plus expected development on reported claims, including reported claims in process, was $4.6 billion at March&#160;31, 2023 and $4.2 billion at March&#160;31, 2022. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Activity, net of intercompany transactions, in the unpaid claims liability for the Cigna Healthcare segment was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,261&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Reinsurance and other amounts recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">221</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance, net</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,955</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred costs related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,041</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,024&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,897</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,748&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid costs related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,316</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,634&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,795</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,111</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,456&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,741</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Reinsurance and other amounts recoverable</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,959</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,491&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Reinsurance and other amounts recoverable reflect amounts due from reinsurers and policyholders to cover incurred but not reported and pending claims of certain business for which the Company administers the plan benefits without any right of offset. See Note 10 to the Consolidated Financial Statements for additional information on reinsurance.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Variances in incurred costs related to prior years' unpaid claims and claim expenses that resulted from the differences between actual experience and the Company's key assumptions were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.889%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Actual completion factors</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical cost trend</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">143</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total favorable variance</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">144</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Percentage of current year incurred costs as reported for the year ended December&#160;31, 2022.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Percentage of current year incurred costs as reported for the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Favorable prior year development in both years reflects lower than expected utilization of medical services as compared to our assumptions.</span></div>Future Policy Benefits<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting Policy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Future policy benefits represent the present value of estimated future obligations, estimated using actuarial methods, for long-term insurance policies and annuity products currently in force, consisting primarily of reserves for annuity contracts, life insurance benefits, and certain supplemental health products that are guaranteed renewable beyond one year.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contracts are grouped at a level no higher than issue year, based on the original contract issue date, and at lower levels of disaggregation within each issue year for certain businesses to reflect factors including product type, plan type and currency. Management estimates these obligations based on assumptions for premiums, interest rates, mortality or morbidity, future claim adjudication expenses and surrenders. Mortality, morbidity and surrender assumptions are based on the Company's own experience and published actuarial tables, and are updated at least annually, to the extent changes in circumstances require. Interest rate assumptions are based on</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">market-level yields for low credit risk fixed income instruments ("upper-medium grade fixed-income instrument"). For interest accretion purposes, interest rates are fixed at the year of the cohort's inception, however for purposes of liability measurement, are updated to the current rate quarterly, with all changes in the interest rate from inception to current period reported through Accumulated other comprehensive loss. For contracts issued domestically, we use observable inputs from a published spot rate curve for terms up to 30 years and extrapolate for longer terms using a constant forward rate approach. For contracts issued by foreign operating entities with functional currencies other than the U.S. dollar, we use observable inputs to approximate a risk free rate and add a credit spread adjustment to align with a low credit risk fixed income instrument. For terms beyond the last observable risk free rates, which vary by international market, we extrapolate to the ultimate forward rate assuming a constant credit spread.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the annuity business, the premium paying period is shorter than the benefit coverage period, and a deferred profit liability ("DPL") is reported in future policy benefits representing gross premium received in excess of net premiums. DPL is amortized based on expected future benefit payments.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cigna Healthcare</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average interest rates applied and duration for future policy benefits in the Cigna Healthcare segment, consisting primarily of supplemental health products including individual Medicare supplement, limited benefit health products and individual private medical insurance, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest accretion rate </span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.64&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current discount rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average duration </span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8.05 years</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.45 years</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The net liability for future policy benefits for the segment's supplemental health products represents the present value of benefits expected to be paid to policyholders, net of the present value of expected net premiums, which is the portion of expected future gross premium expected to be collected from policyholders that is required to provide for all expected future benefits and expenses. The present values of expected net premiums and expected future policy benefits for the Cigna Healthcare segment are as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"/><td style="width:73.368%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.240%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.525%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Present value of expected net premiums</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,557</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reversal of effect of beginning of period discount rate assumptions</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,537</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(367)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of assumption changes and actual variances from expected experience</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances and lapses </span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net premiums collected</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(326)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">56</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance at original discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of end of period discount rate assumptions</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,312)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(376)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,818</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Present value of expected policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,945</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,794&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reversal of effect of discount rate assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,611</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of assumption changes and actual variances from expected experience</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances and lapses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">307</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(326)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(385)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">58</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance at original discount rate</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,595</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,297&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of discount rate assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,217</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,905&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability for future policy benefits </span></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">399</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">202</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liability for future policy benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">601</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes the foreign exchange rate impact of translating from transactional and functional currency to United States dollar and the impact of flooring the liability at zero. The flooring impact is calculated at the cohort level after discounting the reserves at the current discount rate.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">As of March&#160;31, 2023 and March&#160;31, 2022, respectively, undiscounted expected future gross premiums were $17.6 billion and $13.5 billion. As of March&#160;31, 2023 and March&#160;31, 2022, respectively, discounted expected future gross premiums were $12.5 billion and $10.7 billion.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">As of March&#160;31, 2023 and March&#160;31, 2022, respectively, undiscounted expected future policy benefits were $12.8 billion and $11.2 billion.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">The liability for future policyholder benefits includes immaterial businesses shown as reconciling items above, most of which are in run-off. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">$154 million and $171 million of reinsurance recoverable asset reported in the Consolidated Balance Sheets as of March&#160;31, 2023 and March&#160;31, 2022, respectively, relate to the liability for future policy benefits.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average interest rates applied and duration for future policy benefits in Other Operations, consisting of annuity and life insurance products, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest accretion rate </span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.64&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current discount rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.95</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average duration </span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11.7 years</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.9 years</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Obligations for annuities represent discounted periodic benefits to be paid to an individual or groups of individuals over their remaining lives. Other Operations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">'</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> traditional insurance contracts, which are in run-off, have no premium remaining to be collected; therefore, future policy benefit reserves represent the present value of expected future policy benefits, discounted using the current discount rate and the remaining amortizable DPL.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Future policy benefits for Other Operations includes DPL of $392 million as of March&#160;31, 2023 and $384&#160;million as of March&#160;31, 2022. Future policy benefits excluding DPL, were $3.2&#160;billion as of both March&#160;31, 2023 and December&#160;31, 2022 and $3.9&#160;billion and $4.3&#160;billion as of March&#160;31, 2022 and December&#160;31, 2021, respectively. These balances exclude amounts classified as Liabilities of businesses held for sale of $3.7&#160;billion as of March&#160;31, 2022 and $3.8&#160;billion as of December&#160;31, 2021. The change in future policy benefits reserves year-to-date was primarily driven by changes in the current discount rate. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Undiscounted expected future policy benefits were $4.6&#160;billion as of March&#160;31, 2023 and $4.7&#160;billion as of March&#160;31, 2022. As of March&#160;31, 2023 and March&#160;31, 2022, $1.0&#160;billion and $1.2&#160;billion of the future policy benefit reserve was recoverable through treaties with external reinsurers.</span></div>Contractholder Deposit Funds<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting Policy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Liabilities for contractholder deposit funds primarily include deposits received from customers for investment-related and universal life products and investment earnings on their fund balances in Other Operations. These liabilities are adjusted to reflect administrative charges and, for universal life fund balances, mortality charges. Interest credited on these funds is accrued ratably over the contract period. </span>Contractholder deposit fund liabilities within Other Operations were $6.7 billion as of both March&#160;31, 2023 and December&#160;31, 2022 and $6.8 billion and $6.9 billion as of March&#160;31, 2022 and December&#160;31, 2021, respectively. Approximately 39% of the balance is reinsured externally. Activity in these liabilities is presented net of reinsurance in the Consolidated Statements of Cash Flows. The net year-to-date decrease in contractholder deposit fund liabilities generally relates to withdrawals and benefit payments from contractholder deposit funds, partially offset by deposits and interest credited to contractholder deposit funds.As of March&#160;31, 2023, the weighted average crediting rate, net amount at risk and cash surrender value for contractholder deposit fund liabilities not externally reinsured were 3.25%, $3.2 billion and $2.8 billion, respectively. The comparative amounts as of March&#160;31, 2022 were 3.18%, $3.5 billion and $2.9 billion, respectively. As of both March 31, 2023 and March 31, 2022, more than 99% of the $4.1 billion liability not reinsured externally is for contracts with guaranteed interest rates of 3% - 4%, and approximately $1.2 billion represented contracts with policies at the guarantee. At both of these same period ends, $1.2 billion was 50-150 bps above the guarantee and the remaining $1.7 billion represented contracts above the guarantee that pay the policyholder based on the greater of a guaranteed minimum cash value or the actual cash value. More than 90% of these contracts have actual cash values of at least 110% of the guaranteed cash value.Market Risk BenefitsLiabilities for market risk benefits consist of variable annuity reinsurance contracts (also referred to as GMDB and GMIB contracts) in Other Operations. These liabilities arise under annuities and riders to annuities written by ceding companies that guarantee the benefit received at death and, for a subset of policies, also provide contractholders the option, within 30 days of a policy anniversary after the appropriate waiting period, to elect minimum income payments. The Company's capital market risk exposure on variable annuity reinsurance contracts arises when the reinsured guaranteed minimum benefit exceeds the contractholder's account value in the related underlying mutual funds at the time the insurance benefit is payable under the respective contract. The Company receives and pays premium periodically based on the terms of the reinsurance agreements.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting Policy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Variable annuity reinsurance liabilities are measured as MRBs at fair value, net of nonperformance risk, with fluctuations in value gross of reinsurer nonperformance risk reported in benefits expense while fluctuations in the Company's own </span>nonperformance risk (own credit risk) are reported in Accumulated other comprehensive loss. Nonperformance risk reflects risk that a party might default and therefore not fulfill its obligations (i.e. nonpayment risk). The nonperformance risk adjustment reflects a market participant's view of nonpayment risk by adding an additional spread to the discount rate in the calculation of both (a) the variable annuity reinsurance liabilities to be paid by the Company and (b) the variable annuity reinsurance assets to be paid by the reinsurers, after considering collateral. The Company classifies variable annuity assets and liabilities in Level 3 of the fair value hierarchy described in Note 12 to the Consolidated Financial Statements because assumptions related to future annuitant behavior are largely unobservable. As discussed further in Note 10 to the Consolidated Financial Statements, due to the reinsurance agreements covering these liabilities, the liabilities do not generally impact net income except for the change in nonperformance risk on the reinsurance recoverable, which is reported in benefits expense and does not offset the nonperformance risk valuation on the liability. Variable annuity liabilities are established using capital market assumptions and assumptions related to future annuitant behavior (including mortality, lapse and annuity election rates). <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Market risk benefits activity was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:74.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.912%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">March 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, beginning of year</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,824&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, beginning of year, before the effect of nonperformance risk (own credit risk)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,379</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Changes due to expected run-off</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(6)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(19)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Changes due to capital markets versus expected</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Changes due to policyholder behavior versus expected</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(9)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Assumption changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, end of year, before the effect of changes in nonperformance risk (own credit risk)</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,305</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,689&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Nonperformance risk (own credit risk), end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, end of period</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,220</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,558&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Reinsured market risk benefit, end of period</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,301</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the net amount at risk and the average attained age of contractholders (weighted by exposure) for contracts assumed by the Company. The net amount at risk is the amount the Company would have to pay to contractholders if all deaths or annuitizations occurred as of the earliest possible date in accordance with the insurance contract. The Company should be reimbursed in full for these payments unless the Berkshire reinsurance limit is exceeded, as discussed further in Note 10 to the Consolidated Financial Statements.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions, excludes impact of reinsurance ceded)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net amount at risk</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,183</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average attained age of contractholders (weighted by exposure)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">75.4 years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76.4 years</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceLossReservesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceLossReservesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -URI https://asc.fasb.org/subtopic&amp;trid=2560295<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977608032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceDisclosuresAbstract', window );"><strong>Reinsurance Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceTextBlock', window );">Reinsurance</a></td>
<td class="text"><div style="margin-bottom:10pt"><span id="i66fd387b6c69448ebcef370cedc733d2_623"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 10 &#8211; Reinsurance</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's insurance subsidiaries enter into agreements with other insurance companies to limit losses from large exposures and to permit recovery of a portion of incurred losses. Reinsurance is ceded primarily in acquisition and disposition transactions when the underwriting company is not being acquired. Reinsurance does not relieve the originating insurer of liability. Therefore, reinsured liabilities must continue to be reported along with the related reinsurance recoverables. The Company regularly evaluates the financial condition of its reinsurers and monitors concentrations of its credit risk.</span></div>Reinsurance Recoverables<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The majority of the Company's reinsurance recoverables resulted from acquisition and disposition transactions in which the underwriting company was not acquired. The Company bears the risk of loss if its reinsurers and retrocessionaires do not meet or are unable to meet their reinsurance obligations to the Company. The Company reviews its reinsurance arrangements and establishes reserves against the recoverables.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's reinsurance recoverables as of March&#160;31, 2023 are presented at amount due by range of external credit rating and collateral level in the following table, with reinsurance recoverables that are market risk benefits separately presented at fair value:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.237%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Fair value of collateral contractually required to meet or exceed carrying value of recoverable</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Collateral provisions exist that may mitigate risk of credit loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">No collateral</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ongoing Operations</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">A- equivalent and higher current ratings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">BBB- to BBB+ equivalent current credit ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not rated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">210</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total recoverables related to ongoing operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">216</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">363</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquisition, disposition or run-off activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BBB+ equivalent and higher current ratings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lincoln National Life and Lincoln Life &amp; Annuity of New York</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Empower Annuity Insurance Company</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prudential Insurance Company of America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">380</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">380</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Life Insurance Company of North America</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">187</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">227</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not rated</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total recoverables related to acquisition, disposition or run-off activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">567</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,170</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total reinsurance recoverables before market risk benefits</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">709</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">367</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,251</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allowance for uncollectible reinsurance</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market risk benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,301</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total reinsurance recoverables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Certified by a Nationally Recognized Statistical Rating Organization ("NRSRO").</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes $231 million of current reinsurance recoverables that are reported in Other current assets.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes collateral provisions requiring the reinsurer to fully collateralize its obligation if its external credit rating is downgraded to a specified level.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Total Berkshire and certain Other recoverables reflected under acquisition, disposition or run-off activities in the Company's 2022 Form 10-K that relate to the Company&#8217;s variable annuity reinsurance products discussed in section B below are now reported at fair market value as MRBs, as further discussed in Note 9 to the Consolidated Financial Statements. At December&#160;31, 2022, we reported $711 million related to these recoverables related to the GMDB variable annuity reinsurance product. The restated December&#160;31, 2022 variable annuity reinsurance recoverable balance is $1.4 billion, which also includes the GMIB variable annuity reinsurance product that was classified in Other assets prior to the adoption of LDTI.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Collateral levels are defined internally based on the fair value of the collateral relative to the carrying amount of the reinsurance recoverable, the frequency at which collateral is required to be replenished and the potential for volatility in the collateral's fair value.</span></div>Effective Exit of Variable Annuity Reinsurance BusinessThe Company entered into an agreement with Berkshire to effectively exit the variable annuity reinsurance business via a reinsurance transaction in 2013. Variable annuity contracts are accounted for as assumed and ceded reinsurance and categorized as market risk benefits as discussed in Note 9 to the Consolidated Financial Statements. Berkshire reinsured 100% of the Company's future cash flows in this business, net of other reinsurance arrangements existing at that time. The reinsurance agreement is subject to an overall limit with approximately $3.1 billion remaining at March&#160;31, 2023. As a result of the reinsurance transaction, reserve increases are offset by a corresponding increase in the recorded reinsurance recoverable, provided the increased recoverable remains within the overall Berkshire limit.<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Collateral and Other Terms at March&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berkshire</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,043</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90% were secured by assets in a trust.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sun Life Assurance Company of Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liberty Re (Bermuda) Ltd.</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">128</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100% were secured by assets in a trust.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SCOR SE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70% were secured by a letter of credit.</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market risk benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,323</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">All reinsurers are rated A- equivalent and higher by an NRSRO.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes IBNR and outstanding claims of $25 million offset by premium due of $3 million. These amounts are excluded from market risk benefits at March&#160;31, 2023 in Note 9 and Note 10A to the Consolidated Financial Statements. At December&#160;31, 2022, IBNR and outstanding claims of $27 million offset by premium due of $3 million were excluded from the market risk benefits as restated due to the adoption of LDTI.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The impact of nonperformance risk (i.e. the risk that a counterparty might default) on the variable annuity reinsurance asset was immaterial for the three months ended March&#160;31, 2023 and March&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27830-158548<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI https://asc.fasb.org/topic&amp;trid=2303980<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6816-158387<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27758-158548<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977722784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Note 11 &#8211; InvestmentsThe Cigna Group's investment portfolio consists of a broad range of investments including debt securities, equity securities, commercial mortgage loans, policy loans, other long-term investments, short-term investments and derivative financial instruments. The sections below provide more detail regarding our investment balances and realized investment gains and losses. See Note 12 to the Consolidated Financial Statements for information about the valuation of the Company's investment portfolio. Further information about our accounting policies for investment assets can be found in Note 11 in the Company's 2022 Form 10-K.<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the Company's investments by category and current or long-term classification:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.212%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">616</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,293</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,218&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,872&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,069</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,501</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Policy loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,211</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,211</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term investments</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,936</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,936</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,728&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,728&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">914</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">19,010</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">19,924</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,288&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,193&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>Investment PortfolioDebt Securities<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting policy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Our accounting policy for debt securities (including bonds, mortgage and other asset-backed securities and preferred stocks redeemable by the investor) remains materially consistent with the policy disclosed in the Company's 2022 Form 10-K. However, with the adoption of amended accounting guidance for long-duration insurance contracts on January 1, 2023 (discussed in Note 2 to the Consolidated Financial Statements), net unrealized appreciation on debt securities supporting the Company's run-off settlement annuity business is no longer reported in Non-current insurance and contractholder liabilities but rather is reported in Accumulated other comprehensive loss. See Note 14 to the Consolidated Financial Statements for the impact to Accumulated other comprehensive loss.</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amortized cost and fair value by contractual maturity periods for debt securities were as follows as of March&#160;31, 2023:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">638</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">630</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,972</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,752</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,227</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,915</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed securities</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">381</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">344</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,668</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Actual maturities of these securities could differ from their contractual maturities used in the table above because issuers may have the right to call or prepay obligations, with or without penalties.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Gross unrealized appreciation (depreciation) on debt securities by type of issuer is shown below:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.046%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Appreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal government and agency</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">297</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign government</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,596</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(41)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(823)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,856</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">381</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">344</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,668</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(41)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">170</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(888)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal government and agency</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign government</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,742&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(981)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,806&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,842&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,059)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,872&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Review of declines in fair value. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management reviews impaired debt securities to determine whether a credit loss allowance is needed based on criteria that include:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">severity of decline;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">financial health and specific prospects of the issuer; and</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">changes in the regulatory, economic or general market environment of the issuer's industry or geographic region.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below summarizes debt securities with a decline in fair value from amortized cost for which an allowance for credit losses has not been recorded, by investment grade and the length of time these securities have been in an unrealized loss position. Unrealized depreciation on these debt securities is primarily due to declines in fair value resulting from increasing interest rates since these securities were purchased. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of Issues</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of Issues</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">One year or less</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment grade</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,362</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(594)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Below investment grade</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">353</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">936</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than one year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment grade</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,808</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(586)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,035</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,487&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(336)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Below investment grade</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">682</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">780</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">770</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,433</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(888)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,760</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,901&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,960&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,059)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,777&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table provides the values of the Company's equity security investments as of March&#160;31, 2023 and December&#160;31, 2022: </span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities with readily determinable fair values</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities with no readily determinable fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,926</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,029</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,606</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with our strategy to invest in targeted startup and growth-stage companies in the health care industry, approximately 95% of our investments in equity securities are in the health care sector.</span></div>Commercial Mortgage LoansMortgage loans held by the Company are made exclusively to commercial borrowers and are diversified by property type, location and borrower. Loans are generally issued at fixed rates of interest and are secured by high quality, primarily completed and substantially leased operating properties.The Company regularly evaluates and monitors credit risk from the initial mortgage loan underwriting and throughout the investment holding period. For more information on the Company's accounting policies and methodologies regarding these investments, see Note 11 in the Company's 2022 Form 10-K.<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the credit risk profile of the Company's commercial mortgage loan portfolio:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.890%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Loan-to-Value Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Debt Service Coverage Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Loan-to-Value Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Debt Service Coverage Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Loan-to-Value Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Below 60%</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">912</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.11</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.12</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60% to 79%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">504</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.73</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.73</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80% to 100%</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">191</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.32</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.17</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.89</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.89</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Long-Term Investments</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other long-term investments include investments in unconsolidated entities, including certain limited partnerships and limited liability companies holding real estate, securities or loans. These investments are carried at cost plus the Company's ownership percentage of reporting income or loss, based on the financial statements of the underlying investments that are generally reported at fair value. Income or loss from these investments is reported on a one quarter lag due to the timing of when financial information is received from the general partner or manager of the investments. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other long-term investments also include investment real estate carried at depreciated cost less any impairment write-downs to fair value when cash flows indicate that the carrying value may not be recoverable. Additionally, statutory and other restricted deposits and foreign currency swaps carried at fair value are reported in the table below as Other. The following table provides the carrying value information for these investments:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Real estate investments</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities partnerships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,259</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">243</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,936</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,728&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Derivative Financial InstrumentsThe Company uses derivative financial instruments to manage the characteristics of investment assets (such as duration, yield, currency and liquidity) to meet the varying demands of the related insurance and contractholder liabilities. The Company also uses derivative financial instruments to hedge the risk of changes in the net assets of certain of its foreign subsidiaries due to changes in foreign currency exchange rates and to hedge the interest rate risk of certain long-term debt.As of March&#160;31, 2023, there have been no material changes to the Company's derivative financial instruments. The effects of derivative financial instruments used in our individual hedging strategies were not material to the Consolidated Financial Statements as of March&#160;31, 2023 and December&#160;31, 2022. The gross fair values of our derivative financial instruments are presented in Note 12 to the Consolidated Financial Statements. Please refer to the Company's 2022 Form 10-K for further discussion of the types of derivative financial instruments and associated accounting policies. Realized Investment Gains and Losses<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting policy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Realized investment gains and losses are based on specifically identified assets and result from sales, investment asset write-downs, change in the fair value of certain derivatives and equity securities and changes in allowances for credit losses on debt securities and commercial mortgage loan investments. With the adoption of amended accounting guidance for long-duration insurance contracts on January 1, 2023 (discussed in Note 2 to the Consolidated Financial Statements), realized investment gains and losses no longer exclude amounts that were previously required to adjust future policy benefits for the run-off settlement annuity business. Prior period net realized investment losses have been updated to reflect the impact of adopting LDTI. </span><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following realized gains and losses on investments exclude realized gains and losses attributed to the Company's separate accounts because those gains and losses generally accrue directly to separate account policyholders:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.708%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment (losses), excluding credit loss expense and asset write-downs</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(51)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Credit loss recoveries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investment asset write-downs</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment (losses), before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(56)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>Net realized investment losses for the three months ended March&#160;31, 2023 and March&#160;31, 2022 were primarily due to mark-to-market losses on a strategic health care equity securities investment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977857472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12 &#8211; Fair Value Measurements</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company carries certain financial instruments at fair value in the financial statements including debt securities, certain equity securities, short-term investments and derivatives. Other financial instruments are measured at fair value only under certain conditions, such as when impaired or when there are observable price changes for equity securities with no readily determinable fair value.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fair value is defined as the price at which an asset could be exchanged in an orderly transaction between market participants at the balance sheet date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a market participant, not the amount that would be paid to settle the liability with the creditor.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's financial assets and liabilities carried at fair value have been classified based upon a hierarchy defined by GAAP. The hierarchy gives the highest ranking to fair values determined using unadjusted quoted prices in active markets for identical assets and liabilities (Level 1) and the lowest ranking to fair values determined using methodologies and models with unobservable inputs (Level 3). An asset's or a liability's classification is based on the lowest level of input that is significant to its measurement. For example, a financial asset or liability carried at fair value would be classified in Level 3 if unobservable inputs were significant to the instrument's fair value, even though the measurement may be derived using inputs that are both observable (Levels 1 and 2) and unobservable (Level 3).</span></div>For a description of the policies, methods and assumptions that are used to estimate fair value and determine the fair value hierarchy for each class of financial instruments, see Note 12 in the Company's 2022 Form 10-K.Financial Assets and Financial Liabilities Carried at Fair Value<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table provides information about the Company's financial assets and liabilities carried at fair value. Further information regarding insurance assets and liabilities carried at fair value is provided in Note 9E to the Consolidated Financial Statements. Separate account assets are also recorded at fair value on the Company's Consolidated Balance Sheets and are reported separately in the Separate Accounts section below as gains and losses related to these assets generally accrue directly to contractholders:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at fair value</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal government and agency</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">297</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local government</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,421</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">435</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,856</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">309</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">344</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,288</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">470</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,872&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">84</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Excludes certain equity securities that have no readily determinable fair value.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Level 3 Financial Assets and Financial Liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain inputs for instruments classified in Level 3 are unobservable (supported by little or no market activity) and significant to their resulting fair value measurement. Unobservable inputs reflect the Company's best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date. Additionally, as discussed in Note 9 to the Consolidated Financial Statements, the Company classifies variable annuity assets and liabilities in Level 3 of the fair value hierarchy.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Quantitative Information about Unobservable Inputs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The significant unobservable input used to value our corporate and government debt securities and mortgage and other asset-backed securities is an adjustment for liquidity. This adjustment is needed to reflect current market conditions and issuer circumstances when there is limited trading activity for the security. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the fair value and significant unobservable inputs that were developed directly by the Company and used in pricing these debt securities. The range and weighted average basis point ("bps") amounts for liquidity reflect the Company's best estimates of the unobservable adjustments a market participant would make to calculate these fair values. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.101%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Adjustment Range (Weighted Average by Quantity) as of</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Fair value in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable input March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate and government debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">433</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liquidity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">60 - 1060 (300)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">bps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60 - 1060 (270)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed securities</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liquidity</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">105 - 520 (310) </span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">bps</span></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110 - 520 (310)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Level 3 debt securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">470</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A significant increase in liquidity spread adjustments would result in a lower fair value measurement, while a decrease would result in a higher fair value measurement.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Changes in Level 3 Financial Assets and Financial Liabilities Carried at Fair Value</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the changes in financial assets and financial liabilities classified in Level 3. Gains and losses reported in the table may include net changes in fair value that are attributable to both observable and unobservable inputs.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt and Equity Securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains included in Shareholders' net income</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains (losses) included in Other comprehensive loss</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Losses required to adjust future policy benefits for settlement annuities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchases, sales and settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total purchases, sales and settlements</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transfers into/(out of) Level 3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transfers into Level 3</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total transfers into/(out of) Level 3</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total gains included in Shareholders' net income attributable to instruments held at the reporting date</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in unrealized gain or (loss) included in Other comprehensive loss for assets held at the end of the reporting period</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Amounts do not accrue to shareholders.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total gains and losses included in Shareholders' net income in the tables above are reflected in the Consolidated Statements of Income as Net realized investment losses and Net investment income.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Gains and losses included in Other comprehensive loss, net of tax in the tables above are reflected in Net unrealized appreciation (depreciation) on securities and derivatives in the Consolidated Statements of Comprehensive Income.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers into or out of the Level 3 category occur when unobservable inputs, such as the Company's best estimate of what a market participant would use to determine a current transaction price, become more or less significant to the fair value measurement. Market activity typically decreases during periods of economic uncertainty and this decrease in activity reduces the availability of market observable data. As a result, the level of unobservable judgment that must be applied to the pricing of certain instruments increases and is typically observed through the widening of liquidity spreads. Transfers between Level 2 and Level 3 during 2023 and 2022 primarily reflected changes in liquidity estimates for certain private placement issuers across several sectors. See discussion under Quantitative Information about Unobservable Inputs above for more information.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The investment income and fair value gains and losses of Separate account assets generally accrue directly to the contractholders and, together with their deposits and withdrawals, are excluded from the Company's Consolidated Statements of Income and Cash Flows. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fair values of Separate account assets were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level 3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Guaranteed separate accounts (See Note 16)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">349</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">562</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-guaranteed separate accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">221</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,586</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,935</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,904&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,582</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,521&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-guaranteed separate accounts priced at net asset value ("NAV") as a practical expedient </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,340</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,278&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Non-guaranteed separate accounts include $4.0 billion as of March&#160;31, 2023 and December&#160;31, 2022 in assets supporting the Company's pension plans, including $0.2 billion classified in Level 3 as of March&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Separate account assets classified in Level 3 primarily support the Company's pension plans and include certain newly-issued, privately-placed, complex or illiquid securities that are priced using methods discussed above, as well as commercial mortgage loans. Activity, including transfers into and out of Level 3, was not material for the three months ended March&#160;31, 2023 or 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Separate account investments in securities partnerships, real estate and hedge funds are generally valued based on the separate account's ownership share of the equity of the investee (NAV as a practical expedient), including changes in the fair values of its underlying investments. Substantially all of these assets support the Company's pension plans. The following table provides additional information on these investments:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.322%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unfunded Commitment as of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redemption Frequency<br/>(if currently eligible)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redemption Notice<br/>Period</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities partnerships</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">467</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">228</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not applicable</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not applicable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Real estate funds</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quarterly</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30 - 90 days</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedge funds</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Up to annually, varying by fund</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30 - 90 days</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">228</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2023, the Company does not have plans to sell any of these assets at less than fair value. These investments are structured to satisfy longer-term investment objectives. Securities partnerships are contractually non-redeemable and the underlying investment assets are expected to be liquidated by the fund managers within ten years after inception.</span></div>Assets and Liabilities Measured at Fair Value under Certain Conditions<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Some financial assets and liabilities are not carried at fair value, such as commercial mortgage loans that are carried at unpaid principal, investment real estate that is carried at depreciated cost and equity securities with no readily determinable fair value when there are no observable market transactions. However, these financial assets and liabilities may be measured using fair value under certain conditions, such as when investments become impaired and are written down to their fair value, or when there are observable price changes from orderly market transactions of equity securities that otherwise had no readily determinable fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three months ended March&#160;31, 2023 and 2022, impairments recognized requiring these assets to be measured at fair value were not material. Realized investment gains and losses from these observable price changes for the three months ended March&#160;31, 2023 and March&#160;31, 2022 were not material. </span></div>Fair Value Disclosures for Financial Instruments Not Carried at Fair Value<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table includes the Company's financial instruments not recorded at fair value but for which fair value disclosure is required. In addition to universal life products and finance leases, financial instruments that are carried in the Company's Consolidated Balance Sheets at amounts that approximate fair value are excluded from the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.045%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification in Fair Value Hierarchy</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,509</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, including current maturities, excluding finance leases</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">30,679</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">32,439</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,653&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,994&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977857472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_VariableInterestEntitiesAbstract', window );"><strong>Variable Interest Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities</a></td>
<td class="text">Note 13 &#8211; Variable Interest EntitiesWe perform ongoing qualitative analyses of our involvement with variable interest entities to determine if consolidation is required. The Company determined that it was not a primary beneficiary in any material variable interest entity as of March&#160;31, 2023 or December&#160;31, 2022. The Company's involvement with variable interest entities for which it is not the primary beneficiary has not changed materially from December&#160;31, 2022. For details of our accounting policy for variable interest entities and the composition of variable interest entities with which the Company is involved, refer to Note 13 in the Company's 2022 Form 10-K. The Company has not provided, and does not intend to provide, financial support to any of these variable interest entities in excess of its maximum exposure.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_VariableInterestEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_VariableInterestEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977713376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14 &#8211; Accumulated Other Comprehensive Income (Loss) ("AOCI")</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">AOCI includes net unrealized (depreciation) appreciation on securities and derivatives, change in discount rate and instrument specific credit risk for certain long-duration insurance contractholder liabilities (Note 9 to the Consolidated Financial Statements), foreign currency translation and the net postretirement benefits liability adjustment. AOCI includes the Company's share from unconsolidated entities reported on the equity method. Generally, tax effects in AOCI are established at the currently enacted tax rate and reclassified to Shareholders' net income in the same period that the related pre-tax AOCI reclassifications are recognized. Changes in the components of AOCI, including the impact of adopting amended accounting guidance for long-duration insurance contracts (discussed in Note 2 to the Consolidated Financial Statements), were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.316%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities and Derivatives</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance, as retrospectively restated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized appreciation (depreciation) on securities and derivatives</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">252</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,065)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax (expense) benefit</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net unrealized appreciation (depreciation) on securities and derivatives</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">198</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(834)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification adjustment for (gains) included in Shareholders' net income (Net realized investment losses)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification adjustment for tax expense included in Shareholders' net income</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (gains) reclassified from AOCI to Shareholders' net income</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(843)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net long-duration insurance and contractholder liabilities measurement adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(765)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current period change in discount rate for certain long duration liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(411)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax benefit (expense)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net current period change in discount rate for certain long duration liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(310)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current period change in instrument-specific credit risk for market risk benefits</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax benefit (expense)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net current period change in instrument-specific credit risk for market risk benefits</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(331)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(587)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Translation of foreign currencies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance, as retrospectively restated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Translation of foreign currencies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax benefit (expense)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net translation of foreign currencies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Net translation (loss) on foreign currencies attributable to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shareholders' other comprehensive income (loss), net of tax</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Postretirement benefits liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(916)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification adjustment for amortization of net prior actuarial losses and prior service costs (Interest expense and other)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification adjustment for tax (benefit) included in Shareholders' net income</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net adjustments reclassified from AOCI to Shareholders' net income</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(906)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,323)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance, as retrospectively restated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,658)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,068)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shareholders' other comprehensive (loss), net of tax</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,769)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.94pt">Established upon the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclousre of the changes in the componenets of other comprehensive income/loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977772768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Note 15 &#8211; Income Taxes<div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Income Tax Expense</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The 18.4% effective tax rate for the three months ended March&#160;31, 2023 was lower than the 22.7% rate for the three months ended March&#160;31, 2022. This decrease was driven largely by favorable results relative to the Company's foreign operations, partially offset by an increase pertaining to the year over year impact of remeasurement of deferred taxes. </span></div>As of March&#160;31, 2023, we had approximately $255&#160;million in deferred tax assets ("DTAs") associated with unrealized investment losses that are partially recorded in Accumulated other comprehensive loss. We have determined that a valuation allowance against the DTAs is not currently required based on the Company's ability to carryback losses and our ability and intent to hold certain securities until recovery. We continue to monitor and evaluate the need for any valuation allowance in the future.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977744064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies and Other Matters<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies and Other Matters</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 16 &#8211; Contingencies and Other Matters</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company, through its subsidiaries, is contingently liable for various guarantees provided in the ordinary course of business.</span></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline">Financial Guarantees: Retiree and Life Insurance Benefits</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company guarantees that separate account assets will be sufficient to pay certain life insurance or retiree benefits. For the majority of these benefits, the sponsoring employers are primarily responsible for ensuring that assets are sufficient to pay these benefits and are required to maintain assets that exceed a certain percentage of benefit obligations. If employers fail to do so, the Company or an affiliate of the buyer of the retirement benefits business has the right to redirect the management of the related assets to provide for benefit payments. As of March&#160;31, 2023, employers maintained assets that generally exceeded the benefit obligations under these arrangements of approximately $420 million. An additional liability is established if management believes that the Company will be required to make payments under the guarantees; there were no additional liabilities required for these guarantees, net of reinsurance, as of March&#160;31, 2023. Separate account assets supporting these guarantees are classified in Levels 1 and 2 of the GAAP fair value hierarchy.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company does not expect that these financial guarantees will have a material effect on the Company's consolidated results of operations, liquidity or financial condition.</span></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.84pt;text-decoration:underline">Certain Other Guarantees</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company had indemnification obligations as of March&#160;31, 2023 in connection with acquisition and disposition transactions. These indemnification obligations are triggered by the breach of representations or covenants provided by the Company, such as representations for the presentation of financial statements, filing of tax returns, compliance with law or identification of outstanding litigation. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential amount due is subject to contractual limitations based on a percentage of the transaction purchase price, while in other cases limitations are not specified or applicable. The Company does not believe that it is possible to determine the maximum potential amount due under these obligations because not all amounts due under these indemnification obligations are subject to limitation. There were no liabilities for these indemnification obligations as of March&#160;31, 2023.</span></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">C.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline">Guaranty Fund Assessments</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company operates in a regulatory environment that may require its participation in assessments under state insurance guaranty association laws. The Company's exposure to assessments for certain obligations of insolvent insurance companies to policyholders and claimants is based on its share of business written in the relevant jurisdictions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There were no material charges or credits resulting from existing or new guaranty fund assessments for the three months ended March&#160;31, 2023.</span></div>Legal and Regulatory Matters<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is routinely involved in numerous claims, lawsuits, regulatory inquiries and audits, government investigations, including under the federal False Claims Act and state false claims acts initiated by a government investigating body or by a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> relator's filing of a complaint under court seal, and other legal matters arising, for the most part, in the ordinary course of managing a global health services business. Additionally, the Company has received and is cooperating with subpoenas or similar processes from various governmental agencies requesting information, all arising in the normal course of its business. Disputed tax matters arising </span>from audits by the Internal Revenue Service or other state and foreign jurisdictions, including those resulting in litigation, are accounted for under GAAP guidance for uncertain tax positions.Pending litigation and legal or regulatory matters that the Company has identified with a reasonably possible material loss and certain other material litigation matters are described below. For those matters that the Company has identified with a reasonably possible material loss, the Company provides disclosure in the aggregate of accruals and range of loss, or a statement that such information cannot be estimated. The Company's accruals for the matters discussed below under "Litigation Matters" and "Regulatory Matters" are not material. Due to numerous uncertain factors presented in these cases, it is not possible to estimate an aggregate range of loss (if any) for these matters at this time. In light of the uncertainties involved in these matters, there is no assurance that their ultimate resolution will not exceed the amounts currently accrued by the Company. An adverse outcome in one or more of these matters could be material to the Company's results of operations, financial condition or liquidity for any particular period. The outcomes of lawsuits are inherently unpredictable and we may be unsuccessful in these ongoing litigation matters or any future claims or litigation.<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Litigation Matters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Express Scripts Litigation with Elevance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In March 2016, Elevance filed a lawsuit in the United States District Court for the Southern District of New York alleging various breach of contract claims against Express Scripts relating to the parties' rights and obligations under the periodic pricing review section of the pharmacy benefit management agreement between the parties including allegations that Express Scripts failed to negotiate new pricing concessions in good faith, as well as various alleged service issues. Elevance also requested that the court enter declaratory judgment that Express Scripts is required to provide Elevance competitive benchmark pricing, that Elevance can terminate the agreement and that Express Scripts is required to provide Elevance with post-termination services at competitive benchmark pricing for one year following any termination by Elevance. Elevance claimed it is entitled to $13 billion in additional pricing concessions over the remaining term of the agreement, as well as $1.8 billion for one year following any contract termination by Elevance and $150 million damages for service issues ("Elevance's Allegations"). On April 19, 2016, in response to Elevance's complaint, Express Scripts filed its answer denying Elevance's Allegations in their entirety and asserting affirmative defenses and counterclaims against Elevance. The court subsequently granted Elevance's motion to dismiss two of six counts of Express Scripts' amended counterclaims. Express Scripts filed its Motion for Summary Judgment on August 27, 2021. Elevance completed filing of its Response to Express Scripts' Motion for Summary Judgment on October 16, 2021. Express Scripts filed its Reply in Support of its Motion for Summary Judgment on November 19, 2021. On March 31, 2022, the court granted summary judgment in favor of Express Scripts on all of Elevance's pricing claims for damages totaling $14.8 billion and on most of Elevance's claims relating to service issues. Elevance's only remaining service claims relate to the review or processing of prior authorizations. On June 10, 2022, Express Scripts filed a Motion for Partial Summary Judgment seeking to limit Elevance's remaining prior authorization claims and a Motion to Exclude certain opinions offered by its experts. Elevance filed its opposition to both motions, and a cross-motion to submit a supplemental expert report, on July 9, 2022. Express Scripts' pending Motions were fully briefed at the end of July 2022. On March 8, 2023, the Court granted Express Scripts' Motion for Partial Summary Judgement, excluding in full the testimony of four of Elevance's experts and in part the testimony of two additional experts, and granted Elevance leave to submit a supplemental expert report. On April 5, 2023, the Court entered a scheduling order setting a trial on Elevance's remaining prior authorization claims to commence on December 4, 2023.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Medicare Advantage. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> action that was filed by a private individual on behalf of the government in the United States District Court for the Southern District of New York in 2017 was unsealed on August 6, 2020. The action asserts claims related to risk adjustment practices arising from certain health exams conducted as part of the Company's Medicare Advantage business. In September 2021, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> action was transferred to the United States District Court for the Middle District of Tennessee. On January 11, 2022, the U.S. Department of Justice ("DOJ") (U.S. Attorney's Offices for the Southern District of New York and the Middle District of Tennessee) filed a motion to partially intervene, which was granted on August 2, 2022. On October 14, 2022, the DOJ filed its complaint-in-intervention alleging that certain diagnoses made during in-home exams were invalid for risk adjustment purposes, seeking unspecified damages and penalties under the federal False Claims Act. The Company filed motions to dismiss the DOJ's complaint and the remainder of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> complaint on December 16, 2022. Briefing is complete and the matter is pending before the court.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Regulatory Matters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Civil Investigative Demand</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The DOJ is conducting industry-wide investigations of Medicare Advantage organizations' risk adjustment practices. For certain Medicare Advantage organizations, including The Cigna Group, those investigations have resulted in litigation (see "Litigation Matters&#8212;Medicare Advantage" above). The Company has responded to information requests (civil investigative demands) from the DOJ (U.S. Attorney's Office for the Eastern District of Pennsylvania) and is continuing to cooperate with the DOJ.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977744064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 17 &#8211; Segment Information</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See Note 1 to the Consolidated Financial Statements for a description of our segments. A description of our basis for reporting segment operating results is outlined below. Intersegment revenues primarily reflect pharmacy and care services transactions between the Evernorth Health Services and Cigna Healthcare segments.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company uses "pre-tax adjusted income (loss) from operations" and "adjusted revenues" as its principal financial measures of segment operating performance because management believes these metrics best reflect the underlying results of business operations and permit analysis of trends in underlying revenue, expenses and profitability. We define pre-tax adjusted income from operations as income before income taxes excluding pre-tax income (loss) attributable to noncontrolling interests, net realized investment results, amortization of acquired intangible assets, and special items. The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. Adjusted income (loss) from operations is measured on an after-tax basis for consolidated results and on a pre-tax basis for segment results. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company defines adjusted revenues as total revenues excluding the following adjustments: special items and The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. We exclude these items from this measure because management believes they are not indicative of past or future underlying performance of the business. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company does not report total assets by segment because this is not a metric used to allocate resources or evaluate segment performance.</span></div>Special items charges (benefits) recorded by the Company were $1 million both pre-tax and after-tax for the three months ended March&#160;31, 2023 and $52 million pre-tax ($37 million after-tax) for the three months ended March&#160;31, 2022. Effective January 1, 2023, we adopted amended accounting guidance for long-duration insurance contracts. See Note 2 to the Consolidated Financial Statements for further information. Prior period summarized segment information has been retrospectively adjusted to conform to this new basis of accounting. Summarized segment financial information was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Evernorth Health Services</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cigna Healthcare</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Operations</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate and Eliminations</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="33" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">34,511</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,650</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46,240</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,618</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">963</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,581)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net investment income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">143</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">78</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">277</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36,179</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,756</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,575)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net realized investment results from certain equity method investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36,179</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,718</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,575)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46,479</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(415)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,601</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-tax adjustments to reconcile to adjusted income from operations</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Income) attributable to noncontrolling interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment losses (gains) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">459</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Special items</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integration and transaction-related costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted income (loss) from operations</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,115</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(414)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,036</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Evernorth Health Services</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cigna Healthcare</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Operations</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate and Eliminations</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="33" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues from external customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net investment income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,586&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,290&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,006&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net realized investment results from certain equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,586&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,393&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,109&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-tax adjustments to reconcile to adjusted income from operations</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Income) attributable to noncontrolling interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment losses (gains) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Special items</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integration and transaction-related costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted income (loss) from operations</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenue from external customers includes Pharmacy revenues, Premiums and Fees and other revenues. Prior period amounts have been retrospectively adjusted to reflect adoption of amended accounting guidance for long-duration insurance contracts, as discussed in Note 2 to the Consolidated Financial Statements. The following table presents these revenues by product, premium and service type:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Products (Pharmacy revenues) (ASC 606)</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Network revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,748</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Home delivery and specialty revenues</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,699&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,867</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intercompany eliminations</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,496)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,245)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total pharmacy revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">32,144</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance premiums (ASC 944)</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Commercial</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insured</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,080</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stop loss</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,503</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,236</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">415</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1), (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-duration (Individual and family plans)</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,208</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-duration (Individual Medicare supplement and limited benefit health products)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">334</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">International Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-duration (Group medical insurance)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-duration (Individual private medical insurance)</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">86</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Cigna Healthcare</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,930</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,526&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Divested International businesses</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intercompany eliminations</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,356&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Services (Fees) (ASC 606)</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evernorth Health Services</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,499</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,606</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,496&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intercompany eliminations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fees and other revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46,240</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,592&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Other than supplemental benefits, all of U.S. Commercial and U.S. Government are short duration.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">U.S. Government and International Health recognize premium revenue on long-duration insurance contracts (coverage greater than one year or guaranteed to be renewed at the option of the policyholder beyond one year) related to certain medicare supplement, supplemental health and life products. All other premium revenue recognized as of March&#160;31, 2023 and March&#160;31, 2022 is primarily related to short-duration insurance contracts.</span></div>Evernorth Health Services may also provide certain financial and performance guarantees, including a minimum level of discounts a client may receive, generic utilization rates and various service levels. Clients may be entitled to receive compensation if we fail to meet the guarantees. Actual performance is compared to the contractual guarantee for each measure throughout the period and the Company defers revenue for any estimated payouts within Accrued expenses and other liabilities (current). These estimates are adjusted and paid following the end of the annual guarantee period. Historically, adjustments to original estimates have not been material. This guarantee liability was $1.5 billion as of March&#160;31, 2023 and $1.3 billion as of December&#160;31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367971561776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Basis of Presentation</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Consolidated Financial Statements include the accounts of The Cigna Group and its consolidated subsidiaries. Intercompany transactions and accounts have been eliminated in consolidation. These Consolidated Financial Statements were prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP"). Certain amounts in prior years have been reclassified to conform to the current year presentation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amounts recorded in the Consolidated Financial Statements necessarily reflect management's estimates and assumptions about medical costs, investment and receivable valuations, interest rates and other factors. Significant estimates are discussed throughout these Notes; however, actual results could differ from those estimates. The impact of a change in estimate is generally included in earnings in the period of adjustment.</span></div>These interim Consolidated Financial Statements are unaudited but include all adjustments (including normal recurring adjustments) necessary, in the opinion of management, for a fair statement of financial position and results of operations for the periods reported. The interim Consolidated Financial Statements and Notes should be read in conjunction with the Consolidated Financial Statements and Notes included in the 2022 Annual Report on Form 10-K ("2022 Form 10-K"). The preparation of interim Consolidated Financial Statements necessarily relies heavily on estimates. This and other factors, including the seasonal nature of portions of the health care and related benefits business, as well as competitive and other market conditions, call for caution in estimating full-year results based on interim results of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements, Recently Adopted Accounting Guidance and Accounting Guidance Not Yet Adopted</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Recent Accounting Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's 2022 Form 10-K includes discussion of significant recent accounting pronouncements that either have impacted or may impact our financial statements in the future. The following information provides updates on recently adopted accounting pronouncements that have occurred since the Company filed its 2022 Form 10-K. There are no accounting pronouncements not yet adopted as of March&#160;31, 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Targeted Improvements to the Accounting for Long-Duration Contracts ("LDTI"), Accounting Standards Update ("ASU") 2018-12 and related amendments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Cigna Group adopted LDTI January 1, 2023, which includes the following key provisions:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Changes to the measurement of the future policy benefits liability for traditional and limited-pay insurance contracts:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Assumptions used to measure cash flows (such as mortality, morbidity and lapse assumptions) are updated at least annually with the effect of changes in those assumptions remeasured retrospectively and reflected in current period net income. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Discount rate assumptions are updated quarterly based on market-level yields for low credit risk fixed income instruments ("upper-medium grade fixed-income instrument"), with any changes reflected in other comprehensive income. The upper-medium grade fixed-income instrument yield is interpreted to mean A-rated.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Deferred policy acquisition costs ("DAC") related to long-duration insurance contracts are amortized on a constant-level basis over the expected term of the related contracts. Other related deferred or capitalized balances (such as unearned revenue liability and value of business acquired) may use this simplified amortization method. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Market risk benefits ("MRB"), defined as protecting the contractholder from other-than-nominal capital market risk and exposing the insurer to that risk, are measured at fair value, with changes in fair value recognized in net income each period, except for the effect of the Company's change in nonperformance risk (own credit risk), which is recognized in other comprehensive income. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Additional disclosures, including disaggregated roll forwards for the liability for future policy benefits, market risk benefits, separate account liabilities and DAC, as well as information about significant inputs, judgments, assumptions and methods used in measurement.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The transition methods applied at adoption were:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The liability for future policy benefits was remeasured using a modified retrospective approach applied to all outstanding contracts as of the beginning of the earliest period presented and was recognized in the opening balance of retained earnings. The impact of remeasuring the future policy benefits liability for the discount rate was recorded through accumulated other comprehensive income. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">DAC followed the transition method used for future policyholder benefits.</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Market risk benefits were remeasured at fair value at the beginning of the earliest period presented. The difference between this fair value and carrying value was recognized in the opening balance of retained earnings, excluding the effect of the Company's change in nonperformance risk (own credit risk), which is recognized in accumulated other comprehensive income. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effects of adoption:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The new guidance applies to our long-duration insurance products predominantly within the Cigna Healthcare segment and Other Operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The cumulative effects of adopting the new standard were immaterial. The impacts were a decrease to January 1, 2021 Shareholders' equity of $139 million and an increase to Shareholders' net income for the year ended December 31, 2022 and December 31, 2021 of $36 million and $5 million, respectively. The corresponding impact to diluted earnings per share was an increase of $0.11 and $0.02 for the year ended December 31, 2022 and December 31, 2021, respectively. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The prior periods within our Consolidated Statements of Income, Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets, Consolidated Statements of Changes in Total Equity and Consolidated Statements of Cash Flows were restated to conform to the current presentation. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Prior period balances in the Company's footnote disclosures have been updated to reflect adjustments resulting from the adoption of this standard. Refer to Note 9 to the Consolidated Financial Statements for the Company's updated accounting policies. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">It is possible that our income recognition pattern could change on a prospective basis for several reasons: </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Applying periodic assumption updates, versus the locked-in model, may change our timing of profit or loss recognition. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">DAC amortization is on a constant level basis over the expected term of the related contracts and no longer tied to the emergence of profit on such contracts. </span></div><div style="text-indent:45pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, in December 2022, the Financial Accounting Standards Board ("FASB") published ASU 2022-05, which simplified the retrospective adoption of LDTI by permitting companies to make an accounting policy election to exclude contracts that are sold and removed from the balance sheet prior to the effective date of the standard from the retrospective adoption of LDTI. The Cigna Group made this policy election for the contracts sold in the Chubb transaction and our divested interest in a joint venture in T&#252;rkiye.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Evernorth Health Services may also provide certain financial and performance guarantees, including a minimum level of discounts a client may receive, generic utilization rates and various service levels. Clients may be entitled to receive compensation if we fail to meet the guarantees. Actual performance is compared to the contractual guarantee for each measure throughout the period and the Company defers revenue for any estimated payouts within Accrued expenses and other liabilities (current). These estimates are adjusted and paid following the end of the annual guarantee period.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy', window );">Unpaid Claims and Claims Expenses</a></td>
<td class="text">This liability reflects estimates of the ultimate cost of claims that have been incurred but not reported, including expected development on reported claims, those that have been reported but not yet paid (reported claims in process) and other medical care expenses and services payable that are primarily comprised of accruals for incentives and other amounts payable to health care professionals and facilities.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FuturePolicyBenefitsLiabilityPolicy', window );">Future Policy Benefits</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting Policy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Future policy benefits represent the present value of estimated future obligations, estimated using actuarial methods, for long-term insurance policies and annuity products currently in force, consisting primarily of reserves for annuity contracts, life insurance benefits, and certain supplemental health products that are guaranteed renewable beyond one year.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contracts are grouped at a level no higher than issue year, based on the original contract issue date, and at lower levels of disaggregation within each issue year for certain businesses to reflect factors including product type, plan type and currency. Management estimates these obligations based on assumptions for premiums, interest rates, mortality or morbidity, future claim adjudication expenses and surrenders. Mortality, morbidity and surrender assumptions are based on the Company's own experience and published actuarial tables, and are updated at least annually, to the extent changes in circumstances require. Interest rate assumptions are based on</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">market-level yields for low credit risk fixed income instruments ("upper-medium grade fixed-income instrument"). For interest accretion purposes, interest rates are fixed at the year of the cohort's inception, however for purposes of liability measurement, are updated to the current rate quarterly, with all changes in the interest rate from inception to current period reported through Accumulated other comprehensive loss. For contracts issued domestically, we use observable inputs from a published spot rate curve for terms up to 30 years and extrapolate for longer terms using a constant forward rate approach. For contracts issued by foreign operating entities with functional currencies other than the U.S. dollar, we use observable inputs to approximate a risk free rate and add a credit spread adjustment to align with a low credit risk fixed income instrument. For terms beyond the last observable risk free rates, which vary by international market, we extrapolate to the ultimate forward rate assuming a constant credit spread.</span></div>For the annuity business, the premium paying period is shorter than the benefit coverage period, and a deferred profit liability ("DPL") is reported in future policy benefits representing gross premium received in excess of net premiums. DPL is amortized based on expected future benefit payments.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ContractholderDepositFundsPolicyPolicyTextBlock', window );">Contractholder Deposit Funds</a></td>
<td class="text">Accounting Policy. Liabilities for contractholder deposit funds primarily include deposits received from customers for investment-related and universal life products and investment earnings on their fund balances in Other Operations. These liabilities are adjusted to reflect administrative charges and, for universal life fund balances, mortality charges. Interest credited on these funds is accrued ratably over the contract period.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitPolicyTextBlock', window );">Market Risk Benefits</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting Policy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Variable annuity reinsurance liabilities are measured as MRBs at fair value, net of nonperformance risk, with fluctuations in value gross of reinsurer nonperformance risk reported in benefits expense while fluctuations in the Company's own </span>nonperformance risk (own credit risk) are reported in Accumulated other comprehensive loss. Nonperformance risk reflects risk that a party might default and therefore not fulfill its obligations (i.e. nonpayment risk). The nonperformance risk adjustment reflects a market participant's view of nonpayment risk by adding an additional spread to the discount rate in the calculation of both (a) the variable annuity reinsurance liabilities to be paid by the Company and (b) the variable annuity reinsurance assets to be paid by the reinsurers, after considering collateral. The Company classifies variable annuity assets and liabilities in Level 3 of the fair value hierarchy described in Note 12 to the Consolidated Financial Statements because assumptions related to future annuitant behavior are largely unobservable. As discussed further in Note 10 to the Consolidated Financial Statements, due to the reinsurance agreements covering these liabilities, the liabilities do not generally impact net income except for the change in nonperformance risk on the reinsurance recoverable, which is reported in benefits expense and does not offset the nonperformance risk valuation on the liability. Variable annuity liabilities are established using capital market assumptions and assumptions related to future annuitant behavior (including mortality, lapse and annuity election rates).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceAccountingPolicy', window );">Reinsurance</a></td>
<td class="text">Reinsurance and other amounts recoverable reflect amounts due from reinsurers and policyholders to cover incurred but not reported and pending claims of certain business for which the Company administers the plan benefits without any right of offset. See Note 10 to the Consolidated Financial Statements for additional information on reinsuranceThe Company's insurance subsidiaries enter into agreements with other insurance companies to limit losses from large exposures and to permit recovery of a portion of incurred losses. Reinsurance is ceded primarily in acquisition and disposition transactions when the underwriting company is not being acquired. Reinsurance does not relieve the originating insurer of liability. Therefore, reinsured liabilities must continue to be reported along with the related reinsurance recoverables. The Company regularly evaluates the financial condition of its reinsurers and monitors concentrations of its credit risk.The Company reviews its reinsurance arrangements and establishes reserves against the recoverables.Collateral levels are defined internally based on the fair value of the collateral relative to the carrying amount of the reinsurance recoverable, the frequency at which collateral is required to be replenished and the potential for volatility in the collateral's fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text">Cigna Group's investment portfolio consists of a broad range of investments including debt securities, equity securities, commercial mortgage loans, policy loans, other long-term investments, short-term investments and derivative financial instruments.Further information about our accounting policies for investment assets can be found in Note 11 in the Company's 2022 Form 10-K.Accounting policy. Our accounting policy for debt securities (including bonds, mortgage and other asset-backed securities and preferred stocks redeemable by the investor) remains materially consistent with the policy disclosed in the Company's 2022 Form 10-K. However, with the adoption of amended accounting guidance for long-duration insurance contracts on January 1, 2023 (discussed in Note 2 to the Consolidated Financial Statements), net unrealized appreciation on debt securities supporting the Company's run-off settlement annuity business is no longer reported in Non-current insurance and contractholder liabilities but rather is reported in Accumulated other comprehensive loss.<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Review of declines in fair value. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management reviews impaired debt securities to determine whether a credit loss allowance is needed based on criteria that include:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">severity of decline;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">financial health and specific prospects of the issuer; and</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">changes in the regulatory, economic or general market environment of the issuer's industry or geographic region.</span></div>Mortgage loans held by the Company are made exclusively to commercial borrowers and are diversified by property type, location and borrower. Loans are generally issued at fixed rates of interest and are secured by high quality, primarily completed and substantially leased operating properties.The Company regularly evaluates and monitors credit risk from the initial mortgage loan underwriting and throughout the investment holding period. For more information on the Company's accounting policies and methodologies regarding these investments, see Note 11 in the Company's 2022 Form 10-K.Other long-term investments include investments in unconsolidated entities, including certain limited partnerships and limited liability companies holding real estate, securities or loans. These investments are carried at cost plus the Company's ownership percentage of reporting income or loss, based on the financial statements of the underlying investments that are generally reported at fair value. Income or loss from these investments is reported on a one quarter lag due to the timing of when financial information is received from the general partner or manager of the investments. Other long-term investments also include investment real estate carried at depreciated cost less any impairment write-downs to fair value when cash flows indicate that the carrying value may not be recoverable. Additionally, statutory and other restricted deposits and foreign currency swaps carried at fair value are reported in the table below as Other. Accounting policy. Realized investment gains and losses are based on specifically identified assets and result from sales, investment asset write-downs, change in the fair value of certain derivatives and equity securities and changes in allowances for credit losses on debt securities and commercial mortgage loan investments. With the adoption of amended accounting guidance for long-duration insurance contracts on January 1, 2023 (discussed in Note 2 to the Consolidated Financial Statements), realized investment gains and losses no longer exclude amounts that were previously required to adjust future policy benefits for the run-off settlement annuity business. Prior period net realized investment losses have been updated to reflect the impact of adopting LDTI.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">The Company uses derivative financial instruments to manage the characteristics of investment assets (such as duration, yield, currency and liquidity) to meet the varying demands of the related insurance and contractholder liabilities. The Company also uses derivative financial instruments to hedge the risk of changes in the net assets of certain of its foreign subsidiaries due to changes in foreign currency exchange rates and to hedge the interest rate risk of certain long-term debt.Please refer to the Company's 2022 Form 10-K for further discussion of the types of derivative financial instruments and associated accounting policies.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company carries certain financial instruments at fair value in the financial statements including debt securities, certain equity securities, short-term investments and derivatives. Other financial instruments are measured at fair value only under certain conditions, such as when impaired or when there are observable price changes for equity securities with no readily determinable fair value.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fair value is defined as the price at which an asset could be exchanged in an orderly transaction between market participants at the balance sheet date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a market participant, not the amount that would be paid to settle the liability with the creditor.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's financial assets and liabilities carried at fair value have been classified based upon a hierarchy defined by GAAP. The hierarchy gives the highest ranking to fair values determined using unadjusted quoted prices in active markets for identical assets and liabilities (Level 1) and the lowest ranking to fair values determined using methodologies and models with unobservable inputs (Level 3). An asset's or a liability's classification is based on the lowest level of input that is significant to its measurement. For example, a financial asset or liability carried at fair value would be classified in Level 3 if unobservable inputs were significant to the instrument's fair value, even though the measurement may be derived using inputs that are both observable (Levels 1 and 2) and unobservable (Level 3).</span></div>For a description of the policies, methods and assumptions that are used to estimate fair value and determine the fair value hierarchy for each class of financial instruments, see Note 12 in the Company's 2022 Form 10-K.<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Level 3 Financial Assets and Financial Liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain inputs for instruments classified in Level 3 are unobservable (supported by little or no market activity) and significant to their resulting fair value measurement. Unobservable inputs reflect the Company's best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date. Additionally, as discussed in Note 9 to the Consolidated Financial Statements, the Company classifies variable annuity assets and liabilities in Level 3 of the fair value hierarchy.</span></div>Quantitative Information about Unobservable InputsThe significant unobservable input used to value our corporate and government debt securities and mortgage and other asset-backed securities is an adjustment for liquidity. This adjustment is needed to reflect current market conditions and issuer circumstances when there is limited trading activity for the security.<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total gains and losses included in Shareholders' net income in the tables above are reflected in the Consolidated Statements of Income as Net realized investment losses and Net investment income.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Gains and losses included in Other comprehensive loss, net of tax in the tables above are reflected in Net unrealized appreciation (depreciation) on securities and derivatives in the Consolidated Statements of Comprehensive Income.</span></div>Transfers into or out of the Level 3 category occur when unobservable inputs, such as the Company's best estimate of what a market participant would use to determine a current transaction price, become more or less significant to the fair value measurement. Market activity typically decreases during periods of economic uncertainty and this decrease in activity reduces the availability of market observable data. As a result, the level of unobservable judgment that must be applied to the pricing of certain instruments increases and is typically observed through the widening of liquidity spreadsAssets and Liabilities Measured at Fair Value under Certain ConditionsSome financial assets and liabilities are not carried at fair value, such as commercial mortgage loans that are carried at unpaid principal, investment real estate that is carried at depreciated cost and equity securities with no readily determinable fair value when there are no observable market transactions. However, these financial assets and liabilities may be measured using fair value under certain conditions, such as when investments become impaired and are written down to their fair value, or when there are observable price changes from orderly market transactions of equity securities that otherwise had no readily determinable fair value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountsPolicy', window );">Separate Accounts</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The investment income and fair value gains and losses of Separate account assets generally accrue directly to the contractholders and, together with their deposits and withdrawals, are excluded from the Company's Consolidated Statements of Income and Cash Flows. </span></div>Separate account assets classified in Level 3 primarily support the Company's pension plans and include certain newly-issued, privately-placed, complex or illiquid securities that are priced using methods discussed above, as well as commercial mortgage loans. Separate account investments in securities partnerships, real estate and hedge funds are generally valued based on the separate account's ownership share of the equity of the investee (NAV as a practical expedient), including changes in the fair values of its underlying investments<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text">For details of our accounting policy for variable interest entities and the composition of variable interest entities with which the Company is involved, refer to Note 13 in the Company's 2022 Form 10-K.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies', window );">Guarantees</a></td>
<td class="text">Financial Guarantees: Retiree and Life Insurance BenefitsThe Company guarantees that separate account assets will be sufficient to pay certain life insurance or retiree benefits. For the majority of these benefits, the sponsoring employers are primarily responsible for ensuring that assets are sufficient to pay these benefits and are required to maintain assets that exceed a certain percentage of benefit obligations. If employers fail to do so, the Company or an affiliate of the buyer of the retirement benefits business has the right to redirect the management of the related assets to provide for benefit payments.An additional liability is established if management believes that the Company will be required to make payments under the guarantees;Separate account assets supporting these guarantees are classified in Levels 1 and 2 of the GAAP fair value hierarchy.Certain Other GuaranteesThe Company had indemnification obligations as of March&#160;31, 2023 in connection with acquisition and disposition transactions. These indemnification obligations are triggered by the breach of representations or covenants provided by the Company, such as representations for the presentation of financial statements, filing of tax returns, compliance with law or identification of outstanding litigation. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential amount due is subject to contractual limitations based on a percentage of the transaction purchase price, while in other cases limitations are not specified or applicable. The Company does not believe that it is possible to determine the maximum potential amount due under these obligations because not all amounts due under these indemnification obligations are subject to limitation.Guaranty Fund AssessmentsThe Company operates in a regulatory environment that may require its participation in assessments under state insurance guaranty association laws. The Company's exposure to assessments for certain obligations of insolvent insurance companies to policyholders and claimants is based on its share of business written in the relevant jurisdictions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text">Intersegment revenues primarily reflect pharmacy and care services transactions between the Evernorth Health Services and Cigna Healthcare segments.The Company uses "pre-tax adjusted income (loss) from operations" and "adjusted revenues" as its principal financial measures of segment operating performance because management believes these metrics best reflect the underlying results of business operations and permit analysis of trends in underlying revenue, expenses and profitability. We define pre-tax adjusted income from operations as income before income taxes excluding pre-tax income (loss) attributable to noncontrolling interests, net realized investment results, amortization of acquired intangible assets, and special items. The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. Adjusted income (loss) from operations is measured on an after-tax basis for consolidated results and on a pre-tax basis for segment results. The Company defines adjusted revenues as total revenues excluding the following adjustments: special items and The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. We exclude these items from this measure because management believes they are not indicative of past or future underlying performance of the business.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ContractholderDepositFundsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes an entity's accounting policy for contractholder deposit funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ContractholderDepositFundsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FuturePolicyBenefitsLiabilityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for liability for future benefit to be paid to or on behalf of policyholder. Includes, but is not limited to, input, judgment, assumption, and method used in measuring liability and change in input, judgment, and assumption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14937-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FuturePolicyBenefitsLiabilityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Includes, but is not limited to, input, judgment, assumption and method used in measuring market risk benefit, and change in input, judgment, and assumption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7C<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782774-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for contracts reported in separate accounts, including the extent and terms of minimum guarantees, basis of presentation for separate account assets and liabilities and related separate account activity, the liability valuation method and assumptions used in valuing each type of policyholder and contract holder account maintained by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27830-158548<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27758-158548<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI https://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14754-158437<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14784-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977772768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Accounts Receivable, Net</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts were included within Accounts receivable, net:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noninsurance customer receivables</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,899&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical manufacturers receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,128</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insurance customer receivables</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,467</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">264</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17,704</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,218&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980567424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Earnings Per Share</a></td>
<td class="text">Basic and diluted earnings per share were computed as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.238%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Shares in thousands, dollars in millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of<br/>Dilution</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of<br/>Dilution</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shareholders' net income</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">295,706</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">295,706</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318,487&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318,487&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,293</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,293</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total shares</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">295,706</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,293</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">298,999</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318,487&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,795&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">321,282&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings per share</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.28</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.76&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.73&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amounts reflected above for the three months ended March 31, 2022 have been restated to reflect the impact of adopting amended accounting guidance for long-duration insurance contracts (discussed in Note 2 to the Consolidated Financial Statements).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Outstanding Employee Stock Options Not Included in the Computation of Diluted Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect was anti-dilutive:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.955%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.152%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Anti-dilutive options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367978992912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock', window );">Outstanding Amounts of Debt and Finance Leases</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The outstanding amounts of debt, net of issuance costs, discounts or premiums, and finance leases were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term debt</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$17&#160;million, 8.300% Notes due January 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$63&#160;million, 7.650% Notes due March 2023</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$700 million, Floating Rate Notes due July 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,000 million, 3.000% Notes due July 2023</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">996</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,187 million, 3.750% Notes due July 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,187</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$500 million, 0.613% Notes due March 2024</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">499</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, including finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total short-term debt</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,418</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$500 million, 0.613% Notes due March 2024</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,000&#160;million, 3.500% Notes due June 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$900&#160;million, 3.250% Notes due April 2025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">878</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2,200&#160;million, 4.125% Notes due November 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,500&#160;million, 4.500% Notes due February 2026</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,503</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$800 million, 1.250% Notes due March 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">797</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$700 million, 5.685% Notes due March 2026</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">697</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,500&#160;million, 3.400% Notes due March 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,440</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$259&#160;million, 7.875% Debentures due May 2027</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">259</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$600&#160;million, 3.050% Notes due October 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">597</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,800&#160;million, 4.375% Notes due October 2028</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,785</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,785&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,500&#160;million, 2.400% Notes due March 2030</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,492</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,500 million, 2.375% Notes due March 2031 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,398</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$45&#160;million, 8.080% Step Down Notes due January 2033 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$800 million, 5.400% Notes due March 2033</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">794</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$190&#160;million, 6.150% Notes due November 2036</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">190</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2,200&#160;million, 4.800% Notes due August 2038 </span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,192&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$750&#160;million, 3.200% Notes due March 2040</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">743</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$121&#160;million, 5.875% Notes due March 2041</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$448&#160;million, 6.125% Notes due November 2041</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$317&#160;million, 5.375% Notes due February 2042</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">315</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,500&#160;million, 4.800% Notes due July 2046</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,466</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,000&#160;million, 3.875% Notes due October 2047</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">989</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,000&#160;million, 4.900% Notes due December 2048</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,969</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,250&#160;million, 3.400% Notes due March 2050</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,236</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,500 million, 3.400% Notes due March 2051</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,478</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, including finance leases</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">67</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29,124</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,100&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">The Company has entered into interest rate swap contracts hedging a portion of these fixed-rate debt instruments. See Note 11 in the Company's 2022 Form 10-K for further information about the Company's interest rate risk management and these derivative instruments.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Interest rate step down to 8.080% effective January 15, 2023.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock', window );">Summary of Debt Issuances</a></td>
<td class="text">On March 7, 2023, the Company issued $1.5&#160;billion of new senior notes. The proceeds of this issuance will be used for general corporate purposes, and may include repayment of outstanding debt securities. Interest on this debt is paid semi-annually.<div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.777%"><tr><td style="width:1.0%"/><td style="width:23.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.456%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$700 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.685%</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$698 million</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$800 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 15, 2033</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.400%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$796 million</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"> Redeemable at any time discounted at the U.S. Treasury rate plus 20 basis points. Redeemable at par on or after March 15, 2024.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span></div>(2) Redeemable at any time discounted at the U.S. Treasury rate plus 25 basis points. Redeemable at par on or after December 15, 2032.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Issuances Of Long-Term Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance-sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation. Also, Pertinent information about each long-term debt arrangement including the carrying amount as of the balance sheet date, by type of long-term debt. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977778880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common and Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsDeclaredTableTextBlock', window );">Dividend Payments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table provides details of the Company's dividend payments:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount per Share</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Amount Paid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"> (in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 8, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 23, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$1.23</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$368</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 9, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 24, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1.12</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$357</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsDeclaredTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsDeclaredTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977067216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insurance and Contractholder Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceLossReservesAbstract', window );"><strong>Insurance Loss Reserves [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Summary of Insurance and Contractholder Liabilities, Activity in the Unpaid Claims Liability and Liability Details for Unpaid Claims and Claim Expenses</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's insurance and contractholder liabilities were comprised of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.048%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unpaid claims and claim expenses</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,880</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,959</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">272</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Future policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">601</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">290</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,341</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,631</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractholder deposit funds</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">163</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">361</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,309</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,670</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,358&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,709&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,843&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market risk benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,172</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,220</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,419</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,440</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,509</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insurance and contractholder liabilities classified as Liabilities of businesses held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,562)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total insurance and contractholder liabilities</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,166</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,956</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,409&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,976&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,385&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,947&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.94pt">Amounts classified as Liabilities of businesses held for sale primarily include $3.7&#160;billion of Future policy benefits, $0.4&#160;billion of Unpaid claims and $0.4&#160;billion of Unearned premiums as of March&#160;31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Activity, net of intercompany transactions, in the unpaid claims liability for the Cigna Healthcare segment was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,261&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Reinsurance and other amounts recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">221</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance, net</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,955</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred costs related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,041</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,024&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,897</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,748&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid costs related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,316</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,634&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,795</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,111</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,456&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,741</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Reinsurance and other amounts recoverable</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,959</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,491&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock', window );">Variances in Incurred Costs Related to Prior Years' Unpaid Claims and Claims Expenses</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Variances in incurred costs related to prior years' unpaid claims and claim expenses that resulted from the differences between actual experience and the Company's key assumptions were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.889%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Actual completion factors</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical cost trend</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">143</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total favorable variance</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">144</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Percentage of current year incurred costs as reported for the year ended December&#160;31, 2022.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Percentage of current year incurred costs as reported for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock', window );">Future Policy Benefit Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average interest rates applied and duration for future policy benefits in the Cigna Healthcare segment, consisting primarily of supplemental health products including individual Medicare supplement, limited benefit health products and individual private medical insurance, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest accretion rate </span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.64&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current discount rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average duration </span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8.05 years</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.45 years</span></td></tr></table></div>The present values of expected net premiums and expected future policy benefits for the Cigna Healthcare segment are as follows: <div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"/><td style="width:73.368%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.240%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.525%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Present value of expected net premiums</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,557</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reversal of effect of beginning of period discount rate assumptions</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,537</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(367)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of assumption changes and actual variances from expected experience</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances and lapses </span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net premiums collected</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(326)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">56</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance at original discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of end of period discount rate assumptions</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,312)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(376)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,818</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Present value of expected policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,945</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,794&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reversal of effect of discount rate assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,611</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of assumption changes and actual variances from expected experience</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances and lapses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">307</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(326)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(385)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">58</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance at original discount rate</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,595</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,297&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of discount rate assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,217</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,905&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability for future policy benefits </span></td><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">399</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">202</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liability for future policy benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">601</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes the foreign exchange rate impact of translating from transactional and functional currency to United States dollar and the impact of flooring the liability at zero. The flooring impact is calculated at the cohort level after discounting the reserves at the current discount rate.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">As of March&#160;31, 2023 and March&#160;31, 2022, respectively, undiscounted expected future gross premiums were $17.6 billion and $13.5 billion. As of March&#160;31, 2023 and March&#160;31, 2022, respectively, discounted expected future gross premiums were $12.5 billion and $10.7 billion.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">As of March&#160;31, 2023 and March&#160;31, 2022, respectively, undiscounted expected future policy benefits were $12.8 billion and $11.2 billion.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">The liability for future policyholder benefits includes immaterial businesses shown as reconciling items above, most of which are in run-off. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">$154 million and $171 million of reinsurance recoverable asset reported in the Consolidated Balance Sheets as of March&#160;31, 2023 and March&#160;31, 2022, respectively, relate to the liability for future policy benefits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average interest rates applied and duration for future policy benefits in Other Operations, consisting of annuity and life insurance products, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest accretion rate </span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.64&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current discount rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.95</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average duration </span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11.7 years</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.9 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitActivityTableTextBlock', window );">Summary of Market Risk Benefit</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Market risk benefits activity was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:74.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.912%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">March 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, beginning of year</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,824&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, beginning of year, before the effect of nonperformance risk (own credit risk)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,379</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Changes due to expected run-off</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(6)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(19)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Changes due to capital markets versus expected</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Changes due to policyholder behavior versus expected</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(9)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Assumption changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, end of year, before the effect of changes in nonperformance risk (own credit risk)</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,305</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,689&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Nonperformance risk (own credit risk), end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, end of period</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,220</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,558&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Reinsured market risk benefit, end of period</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,301</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Collateral and Other Terms at March&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berkshire</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,043</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90% were secured by assets in a trust.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sun Life Assurance Company of Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liberty Re (Bermuda) Ltd.</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">128</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100% were secured by assets in a trust.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SCOR SE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70% were secured by a letter of credit.</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market risk benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,323</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">All reinsurers are rated A- equivalent and higher by an NRSRO.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes IBNR and outstanding claims of $25 million offset by premium due of $3 million. These amounts are excluded from market risk benefits at March&#160;31, 2023 in Note 9 and Note 10A to the Consolidated Financial Statements. At December&#160;31, 2022, IBNR and outstanding claims of $27 million offset by premium due of $3 million were excluded from the market risk benefits as restated due to the adoption of LDTI.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock', window );">Account Value, Net Amount at Risk and the Number of Contractholders for Guarantees Assumed in the Event of Death</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the net amount at risk and the average attained age of contractholders (weighted by exposure) for contracts assumed by the Company. The net amount at risk is the amount the Company would have to pay to contractholders if all deaths or annuitizations occurred as of the earliest possible date in accordance with the insurance contract. The Company should be reimbursed in full for these payments unless the Berkshire reinsurance limit is exceeded, as discussed further in Note 10 to the Consolidated Financial Statements.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions, excludes impact of reinsurance ceded)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net amount at risk</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,183</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average attained age of contractholders (weighted by exposure)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">75.4 years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76.4 years</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceLossReservesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceLossReservesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of beginning balance to ending balance for liability for future policy benefit, with separate presentation of expected future net premium and expected future benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of beginning balance to ending balance for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29G<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819547-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782768-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reasons for the change in incurred claims and claim adjustment expenses recognized in the income statement attributable to insured events of prior fiscal years. Also includes disclosures of additional premiums or return premiums accrued as a result of changes in incurred claims and claim adjustment expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.W)<br> -URI https://asc.fasb.org/extlink&amp;oid=27015833&amp;loc=d3e570705-122907<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the guaranteed benefits in excess of the current account balance, quantifies such excesses (the net amounts at risk) and includes other relevant, pertinent information as of the most recent balance sheet date by product type.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124504833&amp;loc=d3e7104-158389<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367978182976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceDisclosuresAbstract', window );"><strong>Reinsurance Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock', window );">Reinsurance Recoverables by Range of External Credit Rating and Collateral Level</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's reinsurance recoverables as of March&#160;31, 2023 are presented at amount due by range of external credit rating and collateral level in the following table, with reinsurance recoverables that are market risk benefits separately presented at fair value:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.237%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Fair value of collateral contractually required to meet or exceed carrying value of recoverable</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Collateral provisions exist that may mitigate risk of credit loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">No collateral</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ongoing Operations</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">A- equivalent and higher current ratings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">BBB- to BBB+ equivalent current credit ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not rated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">210</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total recoverables related to ongoing operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">216</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">363</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquisition, disposition or run-off activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BBB+ equivalent and higher current ratings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lincoln National Life and Lincoln Life &amp; Annuity of New York</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Empower Annuity Insurance Company</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prudential Insurance Company of America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">380</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">380</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Life Insurance Company of North America</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">187</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">227</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not rated</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total recoverables related to acquisition, disposition or run-off activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">567</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,170</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total reinsurance recoverables before market risk benefits</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">709</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">367</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,251</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allowance for uncollectible reinsurance</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market risk benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,301</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total reinsurance recoverables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Certified by a Nationally Recognized Statistical Rating Organization ("NRSRO").</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes $231 million of current reinsurance recoverables that are reported in Other current assets.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes collateral provisions requiring the reinsurer to fully collateralize its obligation if its external credit rating is downgraded to a specified level.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Total Berkshire and certain Other recoverables reflected under acquisition, disposition or run-off activities in the Company's 2022 Form 10-K that relate to the Company&#8217;s variable annuity reinsurance products discussed in section B below are now reported at fair market value as MRBs, as further discussed in Note 9 to the Consolidated Financial Statements. At December&#160;31, 2022, we reported $711 million related to these recoverables related to the GMDB variable annuity reinsurance product. The restated December&#160;31, 2022 variable annuity reinsurance recoverable balance is $1.4 billion, which also includes the GMIB variable annuity reinsurance product that was classified in Other assets prior to the adoption of LDTI.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitActivityTableTextBlock', window );">Reinsurance Recoverables for Variable Annuity Business</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Market risk benefits activity was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:74.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.912%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">March 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, beginning of year</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,824&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, beginning of year, before the effect of nonperformance risk (own credit risk)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,379</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Changes due to expected run-off</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(6)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(19)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Changes due to capital markets versus expected</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Changes due to policyholder behavior versus expected</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(9)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Assumption changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, end of year, before the effect of changes in nonperformance risk (own credit risk)</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,305</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,689&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Nonperformance risk (own credit risk), end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Balance, end of period</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,220</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,558&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Reinsured market risk benefit, end of period</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">1,301</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reinsurer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Collateral and Other Terms at March&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berkshire</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,043</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90% were secured by assets in a trust.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sun Life Assurance Company of Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liberty Re (Bermuda) Ltd.</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">128</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100% were secured by assets in a trust.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SCOR SE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70% were secured by a letter of credit.</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market risk benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,323</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">All reinsurers are rated A- equivalent and higher by an NRSRO.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes IBNR and outstanding claims of $25 million offset by premium due of $3 million. These amounts are excluded from market risk benefits at March&#160;31, 2023 in Note 9 and Note 10A to the Consolidated Financial Statements. At December&#160;31, 2022, IBNR and outstanding claims of $27 million offset by premium due of $3 million were excluded from the market risk benefits as restated due to the adoption of LDTI.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of beginning balance to ending balance for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29G<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819547-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782768-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123600520&amp;loc=SL75241803-196195<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367979509792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock', window );">Investments by category and current or long-term classification</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the Company's investments by category and current or long-term classification:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.212%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">616</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,293</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,218&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,872&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,069</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,501</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Policy loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,211</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,211</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term investments</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,936</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,936</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,728&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,728&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">914</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">19,010</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">19,924</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,288&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,193&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Debt Securities by Contractual Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amortized cost and fair value by contractual maturity periods for debt securities were as follows as of March&#160;31, 2023:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">638</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">630</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,972</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,752</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,227</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,915</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed securities</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">381</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">344</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,668</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">Gross Unrealized Appreciation (Depreciation) on Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Gross unrealized appreciation (depreciation) on debt securities by type of issuer is shown below:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.046%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Appreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal government and agency</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">297</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign government</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,596</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(41)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(823)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,856</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">381</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">344</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,668</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(41)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">170</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(888)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal government and agency</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign government</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,742&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(981)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,806&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,842&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,059)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,872&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Summary of Debt Securities with a Decline in Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below summarizes debt securities with a decline in fair value from amortized cost for which an allowance for credit losses has not been recorded, by investment grade and the length of time these securities have been in an unrealized loss position. Unrealized depreciation on these debt securities is primarily due to declines in fair value resulting from increasing interest rates since these securities were purchased. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of Issues</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of Issues</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">One year or less</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment grade</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,362</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(594)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Below investment grade</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">353</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">936</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than one year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment grade</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,808</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(586)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,035</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,487&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(336)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Below investment grade</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">682</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">780</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">770</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,433</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(888)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,760</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,901&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,960&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,059)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,777&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock', window );">Equity Security Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table provides the values of the Company's equity security investments as of March&#160;31, 2023 and December&#160;31, 2022: </span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities with readily determinable fair values</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities with no readily determinable fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,926</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,029</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,606</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock', window );">Summary of the Credit Risk Profile of the Commercial Mortgage Loan Portfolio</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the credit risk profile of the Company's commercial mortgage loan portfolio:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.890%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Loan-to-Value Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Debt Service Coverage Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Loan-to-Value Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Debt Service Coverage Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Loan-to-Value Ratio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Below 60%</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">912</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.11</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.12</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60% to 79%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">504</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.73</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.73</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80% to 100%</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">191</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.32</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.17</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.89</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.89</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock', window );">Carrying Value Information for Other Long-Term Investments</a></td>
<td class="text">The following table provides the carrying value information for these investments:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Real estate investments</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities partnerships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,259</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">243</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,936</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,728&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock', window );">Realized Gains and Losses on Investments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following realized gains and losses on investments exclude realized gains and losses attributed to the Company's separate accounts because those gains and losses generally accrue directly to separate account policyholders:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.708%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment (losses), excluding credit loss expense and asset write-downs</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(51)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Credit loss recoveries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investment asset write-downs</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment (losses), before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(56)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI And Equity Securities Without Readily Determinable Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Other Long-Term Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953659-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized gains and losses on investments reported in the statement of income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980476576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Financial Assets and Financial Liabilities Carried at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table provides information about the Company's financial assets and liabilities carried at fair value. Further information regarding insurance assets and liabilities carried at fair value is provided in Note 9E to the Consolidated Financial Statements. Separate account assets are also recorded at fair value on the Company's Consolidated Balance Sheets and are reported separately in the Separate Accounts section below as gains and losses related to these assets generally accrue directly to contractholders:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at fair value</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal government and agency</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">297</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local government</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign government</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,421</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">435</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,856</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">309</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">344</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,288</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">470</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,872&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">84</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Excludes certain equity securities that have no readily determinable fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value and Significant Unobservable Inputs Used in Pricing Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the fair value and significant unobservable inputs that were developed directly by the Company and used in pricing these debt securities. The range and weighted average basis point ("bps") amounts for liquidity reflect the Company's best estimates of the unobservable adjustments a market participant would make to calculate these fair values. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.101%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Adjustment Range (Weighted Average by Quantity) as of</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Fair value in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable input March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate and government debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">433</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liquidity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">60 - 1060 (300)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">bps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60 - 1060 (270)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage and other asset-backed securities</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liquidity</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">105 - 520 (310) </span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">bps</span></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110 - 520 (310)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Level 3 debt securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">470</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock', window );">Changes in Level 3 Financial Assets and Financial Liabilities Carried at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the changes in financial assets and financial liabilities classified in Level 3. Gains and losses reported in the table may include net changes in fair value that are attributable to both observable and unobservable inputs.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt and Equity Securities</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains included in Shareholders' net income</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains (losses) included in Other comprehensive loss</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Losses required to adjust future policy benefits for settlement annuities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchases, sales and settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total purchases, sales and settlements</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transfers into/(out of) Level 3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transfers into Level 3</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total transfers into/(out of) Level 3</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total gains included in Shareholders' net income attributable to instruments held at the reporting date</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in unrealized gain or (loss) included in Other comprehensive loss for assets held at the end of the reporting period</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Amounts do not accrue to shareholders.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FairValueOfSeparateAccountAssetsTableTextBlock', window );">Fair Values of Separate Account Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fair values of Separate account assets were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level 3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Guaranteed separate accounts (See Note 16)</span></div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">349</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">562</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-guaranteed separate accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">221</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,586</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,935</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,904&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,582</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,521&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-guaranteed separate accounts priced at net asset value ("NAV") as a practical expedient </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,340</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,278&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Non-guaranteed separate accounts include $4.0 billion as of March&#160;31, 2023 and December&#160;31, 2022 in assets supporting the Company's pension plans, including $0.2 billion classified in Level 3 as of March&#160;31, 2023 and December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock', window );">Additional Information on Separate Account Assets Priced at NAV</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Separate account investments in securities partnerships, real estate and hedge funds are generally valued based on the separate account's ownership share of the equity of the investee (NAV as a practical expedient), including changes in the fair values of its underlying investments. Substantially all of these assets support the Company's pension plans. The following table provides additional information on these investments:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.322%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unfunded Commitment as of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redemption Frequency<br/>(if currently eligible)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redemption Notice<br/>Period</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities partnerships</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">467</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">228</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not applicable</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not applicable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Real estate funds</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quarterly</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30 - 90 days</span></div></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedge funds</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Up to annually, varying by fund</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30 - 90 days</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">228</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value Disclosures for Financial Instruments Not Carried at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table includes the Company's financial instruments not recorded at fair value but for which fair value disclosure is required. In addition to universal life products and finance leases, financial instruments that are carried in the Company's Consolidated Balance Sheets at amounts that approximate fair value are excluded from the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.045%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification in Fair Value Hierarchy</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial mortgage loans</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,509</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, including current maturities, excluding finance leases</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">30,679</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">32,439</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,653&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,994&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets and liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3, by class of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_FairValueOfSeparateAccountAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclose the aggregate fair value of separate account assets, by fair value level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_FairValueOfSeparateAccountAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investments in certain entities that calculate net asset value per share or equivalent measured at fair value on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL6742756-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977827776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summarized Segment Financial Information</a></td>
<td class="text">Effective January 1, 2023, we adopted amended accounting guidance for long-duration insurance contracts. See Note 2 to the Consolidated Financial Statements for further information. Prior period summarized segment information has been retrospectively adjusted to conform to this new basis of accounting. Summarized segment financial information was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Evernorth Health Services</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cigna Healthcare</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Operations</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate and Eliminations</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="33" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">34,511</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,650</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46,240</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,618</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">963</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,581)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net investment income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">143</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">78</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">277</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36,179</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,756</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,575)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net realized investment results from certain equity method investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36,179</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,718</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,575)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46,479</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(415)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,601</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-tax adjustments to reconcile to adjusted income from operations</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Income) attributable to noncontrolling interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment losses (gains) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">459</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Special items</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integration and transaction-related costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted income (loss) from operations</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,115</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(414)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,036</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Evernorth Health Services</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cigna Healthcare</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Operations</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate and Eliminations</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="33" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues from external customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net investment income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,586&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,290&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,006&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net realized investment results from certain equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted revenues</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,586&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,393&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,109&#160;</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-tax adjustments to reconcile to adjusted income from operations</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Income) attributable to noncontrolling interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net realized investment losses (gains) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Special items</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Integration and transaction-related costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-tax adjusted income (loss) from operations</span></td><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt">Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977705248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of Business (Details)<br> $ in Billions</strong></div></th>
<th class="th">
<div>Jul. 01, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember', window );">International life, accident, supplemental benefits businesses sold to Chubb | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Sale price</a></td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367976087328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Decrease to shareholders' equity</a></td>
<td class="num">$ (44,518)<span></span>
</td>
<td class="num">$ (46,145)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (44,688)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="num">$ (46,976)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Increase to shareholders' net income</a></td>
<td class="nump">$ 1,267<span></span>
</td>
<td class="nump">$ 1,197<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Increase to diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 4.24<span></span>
</td>
<td class="nump">$ 3.73<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember', window );">Revision of Prior Period, Accounting Standards Update, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Increase to shareholders' net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Increase to diluted earnings per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Adjustment upon Adoption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Decrease to shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_PharmacyBenefitsManagementServicesMember', window );">Pharmacy Benefits Management Services | Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Performance guarantee liability</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements to the Consolidated Financial Statements for further information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_PharmacyBenefitsManagementServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_PharmacyBenefitsManagementServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_GuaranteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_GuaranteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367971710112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Receivable, Net - Summary of Accounts Receivable, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PharmaceuticalManufacturerReceivable', window );">Noninsurance customer receivables</a></td>
<td class="nump">$ 7,845<span></span>
</td>
<td class="nump">$ 6,899<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable', window );">Pharmaceutical manufacturers receivables</a></td>
<td class="nump">7,128<span></span>
</td>
<td class="nump">7,108<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceCustomerReceivables', window );">Insurance customer receivables</a></td>
<td class="nump">2,467<span></span>
</td>
<td class="nump">2,963<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 17,704<span></span>
</td>
<td class="nump">$ 17,218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InsuranceCustomerReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables due from customers under insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InsuranceCustomerReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables due from customers that are not under insurance contracts. These include pharmacy sales and fees due from employer clients.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_PharmaceuticalManufacturerReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables due from pharmaceutical manufacturers related to rebate contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_PharmaceuticalManufacturerReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140368184922400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Receivable, Net - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_AllowanceForReceivablesCurrent', window );">Allowance for receivables, current</a></td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for current expected credit losses on accounts receivable</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_AllowanceForReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for receivables, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_AllowanceForReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367978948544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplier Finance Program (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SupplierFinanceProgramPaymentTimingPeriod', window );">Payment term (in months)</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SupplierFinanceProgramObligationCurrent', window );">Outstanding payment obligations, current</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold', window );">Outstanding payment obligations, current, voluntarily elected by suppliers to be sold to the financial institution</a></td>
<td class="nump">$ 324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_SupplierFinanceProgramObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplier Finance Program, Obligation, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_SupplierFinanceProgramObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplier Finance Program, Outstanding Payment Obligation, Current, Voluntarily Elected To Be Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_SupplierFinanceProgramPaymentTimingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period when payment is expected to be made to finance provider or intermediary in supplier finance program, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_SupplierFinanceProgramPaymentTimingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367971563168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mergers, Acquisitions and Divestitures - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TransactionRelatedCosts', window );">Integration and transaction-related costs, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TransactionRelatedCostsAfterTax', window );">Integration and transaction-related costs, after-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember', window );">International life, accident, supplemental benefits businesses sold to Chubb | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Sale price</a></td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gain (loss) on sale of business, pre-tax</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax', window );">Gain (loss) on sale of business, after-tax</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_TransactionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-tax transaction-related costs primarily consisting of fees for legal, advisory and other professional services, as well as employee costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_TransactionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_TransactionRelatedCostsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>After-tax transaction-related costs including the impact of tax benefits realized from termination of merger agreement. Transaction-related costs consist primarily of fees for legal, advisory and other professional services as well as employee costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_TransactionRelatedCostsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980605392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Shareholders' net income</a></td>
<td class="nump">$ 1,267<span></span>
</td>
<td class="nump">$ 1,197<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted average (in shares)</a></td>
<td class="nump">295,706<span></span>
</td>
<td class="nump">318,487<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Common stock equivalents (in shares)</a></td>
<td class="nump">3,293<span></span>
</td>
<td class="nump">2,795<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total shares (in shares)</a></td>
<td class="nump">298,999<span></span>
</td>
<td class="nump">321,282<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">EPS, basic (in dollars per share)</a></td>
<td class="nump">$ 4.28<span></span>
</td>
<td class="nump">$ 3.76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_EarningsPerShareEffectOfDilution', window );">EPS, effect of dilution (in dollars per share)</a></td>
<td class="num">(0.04)<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">EPS, diluted (in dollars per share)</a></td>
<td class="nump">$ 4.24<span></span>
</td>
<td class="nump">$ 3.73<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_EarningsPerShareEffectOfDilution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in net income (loss) on a per share basis when the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period is assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_EarningsPerShareEffectOfDilution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980415120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Outstanding Employee Stock Options Not Included in the Computation of Diluted Earnings Per Share (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive options (in shares)</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977824496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Earnings Per Share - Shares of Common Stock Held in Treasury (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Shares of common stock held in treasury</a></td>
<td class="nump">102.7<span></span>
</td>
<td class="nump">99.1<span></span>
</td>
<td class="nump">77.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367970281072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Outstanding Amounts of Debt and Finance Leases (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jan. 15, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrentAbstract', window );"><strong>Short-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent', window );">Other, including finance leases</a></td>
<td class="nump">$ 36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Total short-term debt</a></td>
<td class="nump">3,418,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,993,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtNoncurrent', window );">Other, including finance leases</a></td>
<td class="nump">67,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">29,124,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,100,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue202383InterestMember', window );">$17&#160;million, 8.3% Notes due January 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrentAbstract', window );"><strong>Short-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">8.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2023765InterestMember', window );">$63&#160;million, 7.65% Notes due March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrentAbstract', window );"><strong>Short-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 63,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2023FloatingRateInterestMember', window );">$700&#160;million, Floating Rate Notes due July 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrentAbstract', window );"><strong>Short-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities</a></td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20233InterestMember', window );">$1,000&#160;million, 3% Notes due July 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrentAbstract', window );"><strong>Short-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities</a></td>
<td class="nump">996,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">994,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2023375InterestMember', window );">$1,187&#160;million, 3.75% Notes due July 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrentAbstract', window );"><strong>Short-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities</a></td>
<td class="nump">$ 1,187,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,186,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 1,187,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2024613InterestMember', window );">$500 million, 0.613% Notes due March 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrentAbstract', window );"><strong>Short-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities</a></td>
<td class="nump">$ 499,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">0.613%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue202435InterestMember', window );">$1,000&#160;million, 3.500% Notes due June 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 992,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">990,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2025325InterestMember', window );">$900&#160;million, 3.250% Notes due April 2025 (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 878,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">872,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20254125InterestMember', window );">$2,200&#160;million, 4.125% Notes due November 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 2,195,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,195,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 2,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue202645InterestMember', window );">$1,500&#160;million, 4.500% Notes due February 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 1,503,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,503,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2026125Member', window );">$800 million, 1.250% Notes due March 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 797,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">797,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20265685Member', window );">$700 million, 5.685% Notes due March 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 697,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">5.685%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue202734InterestMember', window );">$1,500&#160;million, 3.400% Notes due March 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 1,440,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,436,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_DebenturesDue20277875InterestMember', window );">$259&#160;million, 7.875% Debentures due May 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 259,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 259,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">7.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2027305Member', window );">$600&#160;million, 3.050% Notes due October 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 597,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">597,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20284375InterestMember', window );">$3,800&#160;million, 4.375% Notes due October 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 3,785,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,785,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 3,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue203024InterestMember', window );">$1,500&#160;million, 2.400% Notes due March 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 1,492,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,492,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20312375InterestMember', window );">$1,500 million, 2.375% Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 1,398,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,380,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_StepDownNotesDueJanuary2033Member', window );">$45&#160;million, 8.080% Step Down Notes due January 2033 (2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">8.08%<span></span>
</td>
<td class="nump">8.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20335400InterestMember', window );">$800 million, 5.400% Notes due March 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 794,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2036615InterestMember', window );">$190&#160;million, 6.150% Notes due November 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 190,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 190,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">6.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue203848InterestMember', window );">$2,200&#160;million, 4.800% Notes due August 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 2,192,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,192,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 2,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue204032InterestMember', window );">$750&#160;million, 3.200% Notes due March 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 743,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20415875InterestMember', window );">$121&#160;million, 5.875% Notes due March 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 119,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 121,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">5.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20416125InterestMember', window );">$448&#160;million, 6.125% Notes due November 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 488,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 448,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">6.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20425375InterestMember', window );">$317&#160;million, 5.375% Notes due February 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 315,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 317,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">5.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue204648InterestMember', window );">$1,500&#160;million, 4.800% Notes due July 2046</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 1,466,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,466,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20473875Member', window );">$1,000&#160;million, 3.875% Notes due October 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 989,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">989,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue204849InterestMember', window );">$3,000&#160;million, 4.900% Notes due December 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 2,969,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,968,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue205034InterestMember', window );">$1,250&#160;million, 3.400% Notes due March 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 1,236,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,236,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue205134InterestMember', window );">$1,500 million, 3.400% Notes due March 2051</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 1,478,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,478,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross value</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Short-Term Debt, Current Maturities Of Long-Term Debt, And Lease Obligations, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue202383InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue202383InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2023765InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue2023765InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2023FloatingRateInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue2023FloatingRateInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20233InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue20233InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2023375InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue2023375InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2024613InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue2024613InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue202435InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue202435InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2025325InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue2025325InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20254125InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue20254125InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue202645InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue202645InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2026125Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue2026125Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20265685Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue20265685Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue202734InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue202734InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_DebenturesDue20277875InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_DebenturesDue20277875InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2027305Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue2027305Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20284375InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue20284375InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue203024InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue203024InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20312375InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue20312375InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_StepDownNotesDueJanuary2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_StepDownNotesDueJanuary2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20335400InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue20335400InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue2036615InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue2036615InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue203848InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue203848InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue204032InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue204032InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20415875InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue20415875InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20416125InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue20416125InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20425375InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue20425375InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue204648InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue204648InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20473875Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue20473875Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue204849InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue204849InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue205034InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue205034InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue205134InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue205134InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367971732048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Debt Issuances and Redemptions (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 07, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20265685Member', window );">$700 million, 5.685% Notes due March 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.685%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20265685Member', window );">$700 million, 5.685% Notes due March 2026 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">5.685%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees', window );">Net proceeds</a></td>
<td class="nump">$ 698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20265685Member', window );">$700 million, 5.685% Notes due March 2026 | Senior Notes | Treasury rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate', window );">Redemption price discount, spread on variable rate</a></td>
<td class="nump">0.0020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20335400InterestMember', window );">$800 million, 5.400% Notes due March 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20335400InterestMember', window );">$800 million, 5.400% Notes due March 2033 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees', window );">Net proceeds</a></td>
<td class="nump">$ 796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20335400InterestMember', window );">$800 million, 5.400% Notes due March 2033 | Senior Notes | Treasury rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate', window );">Redemption price discount, spread on variable rate</a></td>
<td class="nump">0.0025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Price, Discount, Spread On Variable Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Long-term Debt, Net Of Discounts And Underwriting Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20265685Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue20265685Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_UsTreasuryUstInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_UsTreasuryUstInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_NotesDue20335400InterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_NotesDue20335400InterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980976944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($) </div>
<div>revolvingCreditFacility </div>
<div>position</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on long-term and short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,000,000<span></span>
</td>
<td class="nump">$ 314,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding balances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAgreementsApril2023Member', window );">Revolving credit agreements, April 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NumberOfRevolvingCreditFacility', window );">Number of revolving credit facilities | revolvingCreditFacility</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAgreementsApril2023Member', window );">Revolving credit agreements, April 2023 | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity', window );">Aggregate amount of options to increase commitments</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity', window );">Maximum total commitment</a></td>
<td class="nump">$ 6,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement', window );">Number of participating banks | position</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant', window );">Leverage ratio covenant</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member', window );">Five-year Revolving Credit Agreement, Maturing April 2028 | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Credit agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtInstrumentExtensionTerm', window );">Credit agreement extension term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member', window );">Five-year Revolving Credit Agreement, Maturing April 2028 | Letter of Credit | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_A364DayRevolvingCreditAgreementMaturingApril2024Member', window );">364-day Revolving Credit Agreement, Maturing April 2024 | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Credit agreement term</a></td>
<td class="text">364 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LineOfCreditFacilityConversionToTermLoanTerm', window );">Credit facility, conversion to term loan, term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member', window );">Revolving credit agreements, April 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding balances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member', window );">Revolving Credit And Letter Of Credit Facility Maturing April 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Credit agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_RevolvingCreditFacilityMaturingApril2025Member', window );">Revolving Credit Facility Maturing April 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Credit agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ci_A364DayRevolvingCreditAgreementMaturingApril2023Member', window );">364 Day Revolving Credit Agreement, Maturing April 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Credit agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">364 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_DebtInstrumentExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_DebtInstrumentExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Accordion Feature, Incremental Increase In Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LineOfCreditFacilityConversionToTermLoanTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Conversion To Term Loan, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LineOfCreditFacilityConversionToTermLoanTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The debt-to adjusted capital ratio which the Company must not exceed in accordance with the terms of the line of credit facility agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Maximum Borrowing Capacity And Accordion Feature, Incremental Increase In Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of banks participating in revolving credit and letter of credit agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_NumberOfRevolvingCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Revolving Credit Facility</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_NumberOfRevolvingCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAgreementsApril2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAgreementsApril2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_A364DayRevolvingCreditAgreementMaturingApril2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_A364DayRevolvingCreditAgreementMaturingApril2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_RevolvingCreditFacilityMaturingApril2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_RevolvingCreditFacilityMaturingApril2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ci_A364DayRevolvingCreditAgreementMaturingApril2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ci_A364DayRevolvingCreditAgreementMaturingApril2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367971321584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common and Preferred Stock - Dividends (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 26, 2023</div></th>
<th class="th"><div>Mar. 23, 2023</div></th>
<th class="th"><div>Mar. 24, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Common dividends declared (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Amount per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Total amount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 368<span></span>
</td>
<td class="nump">$ 357<span></span>
</td>
<td class="nump">$ 368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Common dividends declared (in dollars per share)</a></td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980673440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common and Preferred Stock - Accelerated Share Repurchase Agreements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Stock repurchased</a></td>
<td class="nump">$ 958<span></span>
</td>
<td class="nump">$ 1,334<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Stock repurchased</a></td>
<td class="nump">$ 958<span></span>
</td>
<td class="nump">1,334<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Stock repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367975026464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Insurance and Contractholder Liabilities - Account Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_MarketRiskBenefitLiabilityAmountCurrent', window );">Market risk benefits, current</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_UnearnedPremiumsCurrent', window );">Unearned Premiums, Current</a></td>
<td class="nump">1,419<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesCurrent', window );">Current insurance and contractholder liabilities</a></td>
<td class="nump">7,166<span></span>
</td>
<td class="nump">5,409<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_MarketRiskBenefitLiabilityAmountNoncurrent', window );">Market risk benefits, noncurrent</a></td>
<td class="nump">1,172<span></span>
</td>
<td class="nump">1,217<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_UnearnedPremiumsNoncurrent', window );">Unearned premiums, noncurrent</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesNoncurrent', window );">Non-current insurance and contractholder liabilities</a></td>
<td class="nump">11,790<span></span>
</td>
<td class="nump">11,976<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitLiabilityAmount', window );">Market risk benfits</a></td>
<td class="nump">1,220<span></span>
</td>
<td class="nump">1,268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnearnedPremiums', window );">Unearned premiums</a></td>
<td class="nump">1,440<span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_UnearnedPremiumsIncludingDisposalGroups', window );">Unearned premiums, including held for sale liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities', window );">Insurance and contractholder liabilities classified as held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,562)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilities', window );">Total insurance and contractholder liabilities</a></td>
<td class="nump">18,956<span></span>
</td>
<td class="nump">17,385<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups', window );">Unpaid claims classified as liabilities of business held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PolicyholderContractDepositsAttributableToDisposalGroups', window );">Contractholder deposit funds classified as liabilities of business held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember', window );">Cigna Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent', window );">Unpaid claims and claim expenses, current</a></td>
<td class="nump">4,880<span></span>
</td>
<td class="nump">4,117<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent', window );">Future policy benefits, current</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PolicyholderContractDepositCurrent', window );">Contractholder deposit funds, current</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent', window );">Unpaid claims and claim expenses, noncurrent</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent', window );">Future policy benefits, noncurrent</a></td>
<td class="nump">542<span></span>
</td>
<td class="nump">544<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PolicyholderContractDepositNoncurrent', window );">Contractholder deposit funds, noncurrent</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Unpaid claims and claim expenses</a></td>
<td class="nump">4,959<span></span>
</td>
<td class="nump">4,176<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,491<span></span>
</td>
<td class="nump">$ 4,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups', window );">Unpaid claims and claim expenses, including held for sale liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Future policy benefits</a></td>
<td class="nump">601<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups', window );">Future policy benefits, including held for sale liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderContractDeposits', window );">Contractholder deposit funds</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember', window );">Other Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent', window );">Unpaid claims and claim expenses, current</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent', window );">Future policy benefits, current</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PolicyholderContractDepositCurrent', window );">Contractholder deposit funds, current</a></td>
<td class="nump">361<span></span>
</td>
<td class="nump">351<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent', window );">Unpaid claims and claim expenses, noncurrent</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent', window );">Future policy benefits, noncurrent</a></td>
<td class="nump">3,341<span></span>
</td>
<td class="nump">3,442<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PolicyholderContractDepositNoncurrent', window );">Contractholder deposit funds, noncurrent</a></td>
<td class="nump">6,309<span></span>
</td>
<td class="nump">6,358<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Unpaid claims and claim expenses</a></td>
<td class="nump">272<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups', window );">Unpaid claims and claim expenses, including held for sale liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Future policy benefits</a></td>
<td class="nump">3,631<span></span>
</td>
<td class="nump">3,592<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups', window );">Future policy benefits, including held for sale liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderContractDeposits', window );">Contractholder deposit funds</a></td>
<td class="nump">$ 6,670<span></span>
</td>
<td class="nump">$ 6,709<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,843<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups', window );">Future policy benefits classified as liabilities of business held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group,Including Discontinued Operation, Insurance And Contractholder Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InsuranceAndContractholderLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance And Contractholder Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InsuranceAndContractholderLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InsuranceAndContractholderLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance And Contractholder Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InsuranceAndContractholderLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InsuranceAndContractholderLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amounts as of the balance sheet date of all current insurance and contractholder liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InsuranceAndContractholderLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InsuranceAndContractholderLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance And Contractholder Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InsuranceAndContractholderLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance And Contractholder Liabilities, Including Disposal Groups</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InsuranceAndContractholderLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amounts as of the balance sheet date of all current insurance and contractholder liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InsuranceAndContractholderLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance And Contractholder Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Claims And Claims Adjustment Expense Attributable To Disposal Groups</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Claims And Claims Adjustment Expense, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Claims And Claims Adjustment Expense Including Disposal Groups</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Claims And Claims Adjustment Expense, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Before Reinsurance, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Before Reinsurance, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefits Attributable To Disposal Groups</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefits Including Disposal Groups</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_MarketRiskBenefitLiabilityAmountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market Risk Benefit, Liability, Amount, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_MarketRiskBenefitLiabilityAmountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_MarketRiskBenefitLiabilityAmountNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market Risk Benefit, Liability, Amount, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_MarketRiskBenefitLiabilityAmountNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_PolicyholderContractDepositCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policyholder Contract Deposit, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_PolicyholderContractDepositCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_PolicyholderContractDepositNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policyholder Contract Deposit, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_PolicyholderContractDepositNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_PolicyholderContractDepositsAttributableToDisposalGroups">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policyholder Contract Deposits Attributable To Disposal Groups</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_PolicyholderContractDepositsAttributableToDisposalGroups</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_UnearnedPremiumsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unearned Premiums, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_UnearnedPremiumsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_UnearnedPremiumsIncludingDisposalGroups">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unearned Premiums Including Disposal Groups</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_UnearnedPremiumsIncludingDisposalGroups</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_UnearnedPremiumsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unearned Premiums, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_UnearnedPremiumsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitLiabilityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability position for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29G<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819547-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782768-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitLiabilityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderContractDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability due to policyholder for deposit held under long-duration contract issued by insurance entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 25<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124504495&amp;loc=d3e13193-158430<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderContractDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnearnedPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnearnedPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367971596832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insurance and Contractholder Liabilities - Unpaid Claims and Claim Expenses - Cigna Healthcare - Activity (Details) - Cigna Healthcare - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses', window );">Total of incurred but not reported liabilities plus expected claim development on reported claims, including reported claims in process</a></td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Beginning balance</a></td>
<td class="nump">4,176<span></span>
</td>
<td class="nump">4,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Less: Reinsurance and other amounts recoverable</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Beginning balance, net</a></td>
<td class="nump">3,955<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Incurred costs related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">9,041<span></span>
</td>
<td class="nump">8,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(144)<span></span>
</td>
<td class="num">(276)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred</a></td>
<td class="nump">8,897<span></span>
</td>
<td class="nump">7,748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Paid costs related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">5,316<span></span>
</td>
<td class="nump">4,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="nump">2,795<span></span>
</td>
<td class="nump">2,822<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total paid</a></td>
<td class="nump">8,111<span></span>
</td>
<td class="nump">7,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Ending balance, net</a></td>
<td class="nump">4,741<span></span>
</td>
<td class="nump">4,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Add: Reinsurance and other amounts recoverable</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Ending balance</a></td>
<td class="nump">$ 4,959<span></span>
</td>
<td class="nump">$ 4,491<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the total liability for incurred but not reported claims plus expected claim development on reported claims, including reported claims in process. Excludes amounts due for physician incentives and other medical care expenses and services payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367977040672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insurance and Contractholder Liabilities - Unpaid Claims and Claims Expenses - Cigna Healthcare - Variances in Incurred Costs Related to Prior Years' Unpaid Claims and Claims Expenses (Details) - Cigna Healthcare - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Favorable (unfavorable) variance, amount</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage', window );">Favorable (unfavorable) variance, percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember', window );">Actual completion factors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Favorable (unfavorable) variance, amount</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage', window );">Favorable (unfavorable) variance, percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember', window );">Medical cost trend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Favorable (unfavorable) variance, amount</a></td>
<td class="nump">$ 143<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage', window );">Favorable (unfavorable) variance, percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payments made in the reporting period to settle claims incurred in prior periods and related claims settlement costs as a percentage of incurred claims as reported in the prior year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncatastrophicEventAxis=ci_CompletionFactorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncatastrophicEventAxis=ci_CompletionFactorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncatastrophicEventAxis=ci_MedicalCostTrendMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncatastrophicEventAxis=ci_MedicalCostTrendMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367971323712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Insurance and Contractholder Liabilities - Future Policy Benefits - Interest Rates and Duration (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember', window );">Cigna Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesLineItems', window );"><strong>Insurance and Contractholder Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate', window );">Interest accretion rate</a></td>
<td class="nump">2.59%<span></span>
</td>
<td class="nump">2.64%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate', window );">Current discount rate</a></td>
<td class="nump">5.29%<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration', window );">Weighted average duration</a></td>
<td class="text">8 years 18 days<span></span>
</td>
<td class="text">7 years 5 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember', window );">Other Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesLineItems', window );"><strong>Insurance and Contractholder Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate', window );">Interest accretion rate</a></td>
<td class="nump">5.64%<span></span>
</td>
<td class="nump">5.64%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate', window );">Current discount rate</a></td>
<td class="nump">4.95%<span></span>
</td>
<td class="nump">3.59%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration', window );">Weighted average duration</a></td>
<td class="text">11 years 8 months 12 days<span></span>
</td>
<td class="text">13 years 10 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InsuranceAndContractholderLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InsuranceAndContractholderLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current weighted-average discount rate used to measure liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average duration of liability for future policy benefit, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Original weighted-average discount rate at contract issue date used to measure liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367979368416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insurance and Contractholder Liabilities - Future Policy Benefits - Present Value of Expected Premiums and Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm', window );">Observable inputs from published spot rate curve term (in years)</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember', window );">Cigna Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward', window );"><strong>Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange', window );">Beginning balance</a></td>
<td class="nump">$ 8,557<span></span>
</td>
<td class="nump">$ 9,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax', window );">Reversal of effect of beginning of period discount rate assumptions</a></td>
<td class="nump">1,537<span></span>
</td>
<td class="num">(367)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience', window );">Effect of assumption changes and actual variances from expected experience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition', window );">Issuances and lapses</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected', window );">Net premiums collected</a></td>
<td class="num">(326)<span></span>
</td>
<td class="num">(310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges', window );">Interest and other</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Ending balance at original discount rate</a></td>
<td class="nump">10,130<span></span>
</td>
<td class="nump">8,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax', window );">Effect of end of period discount rate assumptions</a></td>
<td class="num">(1,312)<span></span>
</td>
<td class="num">(376)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange', window );">Ending balance</a></td>
<td class="nump">8,818<span></span>
</td>
<td class="nump">8,450<span></span>
</td>
<td class="nump">8,557<span></span>
</td>
<td class="nump">9,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Beginning balance</a></td>
<td class="nump">8,945<span></span>
</td>
<td class="nump">9,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax', window );">Reversal of effect of discount rate assumptions</a></td>
<td class="nump">1,611<span></span>
</td>
<td class="num">(379)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience', window );">Effect of assumption changes and actual variances from expected experience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition', window );">Issuances and lapses</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits', window );">Benefit payments</a></td>
<td class="num">(326)<span></span>
</td>
<td class="num">(385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges', window );">Interest and other</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Ending balance at original discount rate</a></td>
<td class="nump">10,595<span></span>
</td>
<td class="nump">9,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax', window );">Effect of discount rate assumptions</a></td>
<td class="num">(1,378)<span></span>
</td>
<td class="num">(392)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Ending balance</a></td>
<td class="nump">9,217<span></span>
</td>
<td class="nump">8,905<span></span>
</td>
<td class="nump">8,945<span></span>
</td>
<td class="nump">9,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther', window );">Liability for future policy benefits</a></td>
<td class="nump">399<span></span>
</td>
<td class="nump">455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitOther', window );">Other</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Future policy benefits</a></td>
<td class="nump">601<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance', window );">Undiscounted expected future gross premiums</a></td>
<td class="nump">17,600<span></span>
</td>
<td class="nump">13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance', window );">Discounted expected future gross premiums</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">10,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance', window );">Undiscounted expected future policy benefits</a></td>
<td class="nump">12,800<span></span>
</td>
<td class="nump">11,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Future policy benefit reserve, reinsurance recoverable</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember', window );">Other Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Future policy benefits</a></td>
<td class="nump">3,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance', window );">Undiscounted expected future policy benefits</a></td>
<td class="nump">4,600<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Future policy benefit reserve, reinsurance recoverable</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability', window );">Future policy benefits, DPL</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability', window );">Future policy benefit, excluding DPL</a></td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="nump">4,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups', window );">Future policy benefits classified as liabilities of business held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future Policy Benefits, Domestic Contracts, Observable Inputs From Published Spot Rate Curve, Maximum Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Before Reinsurance And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Excluding Deferred Profit Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Expected Future Policy Benefit, Interest Expense And Other Changes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Expected Future Policy Benefit, Issuance And Derecognition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) From Cash Flow Change And Actual Variance From Expected Experience</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Expected Net Premium, Interest Income And Other Changes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Expected Net Premium, Issuance And Derecognition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefits Attributable To Disposal Groups</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefits, Deferred Profit Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in expected future policy benefit component of liability for future policy benefit from change in discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from increase (decrease) in expected net premium component of liability for future policy benefit from change in discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of discounted balance for expected future gross premium component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of undiscounted balance for expected future gross premium component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and current period update of cash flow assumption, of expected future policy benefit and expense component of liability for future policy benefit, discounted at original rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of undiscounted balance for expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected net premium component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of premium collected from policyholder to fund expected benefit payment for expected net premium component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and current period update of cash flow assumption, of expected net premium component of liability for future policy benefit, discounted at original rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, recoverable under reinsurance of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to policyholder from benefit payment for expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367979595056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Insurance and Contractholder Liabilities - Contractholder Deposit Funds (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesLineItems', window );"><strong>Insurance and Contractholder Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PolicyholderContractBalancePercentReinsuredExternally', window );">Contractholder deposit fund liabilities, approximate percent reinsured externally</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate', window );">Weighted average crediting rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk', window );">Net amount at risk</a></td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueDuePolicyholdersAmount', window );">Cash surrender value</a></td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage', window );">Minimum crediting rate</a></td>
<td class="nump">99.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue', window );">Percentage with cash values at more than 110% of guaranteed cash value</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis=us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member', window );">Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesLineItems', window );"><strong>Insurance and Contractholder Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderFunds', window );">Policyholder account balance</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis=ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember', window );">Policyholder Account Balance, Above Guaranteed Minimum Crediting Rate, Based On Greater Of Guaranteed Minimum Cash Value Or Actual Cash Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesLineItems', window );"><strong>Insurance and Contractholder Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderFunds', window );">Policyholder account balance</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis=ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member', window );">Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 To 0400</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesLineItems', window );"><strong>Insurance and Contractholder Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderFunds', window );">Policyholder account balance</a></td>
<td class="nump">4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis=us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember', window );">Policyholder Account Balance, at Guaranteed Minimum Crediting Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesLineItems', window );"><strong>Insurance and Contractholder Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderFunds', window );">Policyholder account balance</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 To 0400</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesLineItems', window );"><strong>Insurance and Contractholder Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating', window );">Guaranteed minimum credit rating</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 To 0400</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesLineItems', window );"><strong>Insurance and Contractholder Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating', window );">Guaranteed minimum credit rating</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember', window );">Cigna Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesLineItems', window );"><strong>Insurance and Contractholder Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderContractDeposits', window );">Contractholder deposit funds</a></td>
<td class="nump">$ 163<span></span>
</td>
<td class="nump">$ 171<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember', window );">Other Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InsuranceAndContractholderLiabilitiesLineItems', window );"><strong>Insurance and Contractholder Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderContractDeposits', window );">Contractholder deposit funds</a></td>
<td class="nump">$ 6,670<span></span>
</td>
<td class="nump">$ 6,709<span></span>
</td>
<td class="nump">$ 6,843<span></span>
</td>
<td class="nump">$ 6,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InsuranceAndContractholderLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InsuranceAndContractholderLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policyholder Account Balance, Percentage With Cash Values At More Than 110 Percent Of Guaranteed Cash Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_PolicyholderContractBalancePercentReinsuredExternally">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policyholder Contract Balance, Percent Reinsured Externally</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_PolicyholderContractBalancePercentReinsuredExternally</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueDuePolicyholdersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash to be paid to policyholder upon termination and surrender of long-duration contract issued by insurance entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueDuePolicyholdersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guaranteed minimum crediting rate on policyholder account balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of guaranteed benefit in excess of current account balance of policyholder account balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceNetAmountAtRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average crediting rate for liability for policyholder account balance, calculated at a point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderContractDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability due to policyholder for deposit held under long-duration contract issued by insurance entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 25<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124504495&amp;loc=d3e13193-158430<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderContractDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due to policyholder. Includes, but is not limited to, unpaid policy dividend, retrospective refund, and undistributed earnings on participating business. Excludes future policy benefit and claim expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis=us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis=us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis=ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis=ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis=ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis=ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis=us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis=us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367982255408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insurance and Contractholder Liabilities - Summary of Market Risk Benefit (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceLossReservesAbstract', window );"><strong>Insurance Loss Reserves [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_AnnuitizationElectionPeriod', window );">Annuitization election period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitRollForward', window );"><strong>Market Risk Benefit [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk', window );">Balance, beginning of year</a></td>
<td class="nump">$ 1,268<span></span>
</td>
<td class="nump">$ 1,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange', window );">Balance, beginning of year, before the effect of nonperformance risk (own credit risk)</a></td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">1,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff', window );">Changes due to expected run-off</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange', window );">Changes due to capital markets versus expected</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(271)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected', window );">Changes due to policyholder behavior versus expected</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption', window );">Assumption changes</a></td>
<td class="num">(33)<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange', window );">Balance, end of year, before the effect of changes in nonperformance risk (own credit risk)</a></td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">1,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax', window );">Nonperformance risk (own credit risk), end of period</a></td>
<td class="num">(85)<span></span>
</td>
<td class="num">(131)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk', window );">Balance, end of period</a></td>
<td class="nump">1,220<span></span>
</td>
<td class="nump">1,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance', window );">Reinsured market risk benefit, end of period</a></td>
<td class="nump">$ 1,301<span></span>
</td>
<td class="nump">$ 1,681<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_AnnuitizationElectionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time prior to a policy anniversary when an annuitization election must occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_AnnuitizationElectionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market Risk Benefit, Increase (Decrease) Due to Expected Run-Off</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market Risk Benefit, Increase (Decrease) From Interest Rate Change And Equity Market Change</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in instrument-specific credit risk on contract or contract feature in long-duration contract issued by insurance entity protecting contract holder from other-than-nominal capital market risk and exposing insurance entity to other-than-nominal capital market risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29G<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819547-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782768-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13K<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783743-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceLossReservesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceLossReservesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and after accumulated increase (decrease) in instrument-specific credit risk, of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29G<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819547-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782768-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124509262&amp;loc=SL117780254-158436<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and cumulative increase (decrease) in instrument-specific credit risk, of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29G<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819547-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782768-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk from change associated with actual policyholder behavior different from expected.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782768-158439<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29G<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819547-158441<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13K<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783743-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk from change in assumption, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13K<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783743-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782768-158439<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29G<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819547-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, recoverable under reinsurance for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29G<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819547-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782768-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367982126656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insurance and Contractholder Liabilities - Net Amount of Risk and Average Age of Contractholders (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems', window );"><strong>Net Amount at Risk by Product and Guarantee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax', window );">Net amount at risk</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember', window );">Variable Annuity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems', window );"><strong>Net Amount at Risk by Product and Guarantee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax', window );">Net amount at risk</a></td>
<td class="nump">$ 2,183<span></span>
</td>
<td class="nump">$ 1,892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1', window );">Average attained age of contractholders (weighted by exposure)</a></td>
<td class="text">75 years 4 months 24 days<span></span>
</td>
<td class="text">76 years 4 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in instrument-specific credit risk on contract or contract feature in long-duration contract issued by insurance entity protecting contract holder from other-than-nominal capital market risk and exposing insurance entity to other-than-nominal capital market risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29G<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819547-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782768-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13K<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783743-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average attained age of policyholders or contract holders in the specified guarantee type and subset of guarantee class, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph ((d)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124504833&amp;loc=d3e7104-158389<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367969934352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Reinsurance - Reinsurance Recoverables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">$ 4,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesAllowance', window );">Allowance for uncollectible reinsurance</a></td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance', window );">Market risk benefits</a></td>
<td class="nump">1,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,681<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverables', window );">Total reinsurance recoverables</a></td>
<td class="nump">5,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskCollateralizationAxis=ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember', window );">Fair value of collateral contractually required to meet or exceed carrying value of recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskCollateralizationAxis=ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember', window );">Collateral provisions exist that may mitigate risk of credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">3,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskCollateralizationAxis=us-gaap_CededCreditRiskUnsecuredMember', window );">No collateral</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | A- equivalent and higher current ratings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | BBB- to BBB+ equivalent current credit ratings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | Not rated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | Fair value of collateral contractually required to meet or exceed carrying value of recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | Fair value of collateral contractually required to meet or exceed carrying value of recoverable | A- equivalent and higher current ratings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | Fair value of collateral contractually required to meet or exceed carrying value of recoverable | BBB- to BBB+ equivalent current credit ratings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | Fair value of collateral contractually required to meet or exceed carrying value of recoverable | Not rated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | Collateral provisions exist that may mitigate risk of credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | Collateral provisions exist that may mitigate risk of credit loss | A- equivalent and higher current ratings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | Collateral provisions exist that may mitigate risk of credit loss | BBB- to BBB+ equivalent current credit ratings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | Collateral provisions exist that may mitigate risk of credit loss | Not rated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | No collateral</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | No collateral | A- equivalent and higher current ratings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | No collateral | BBB- to BBB+ equivalent current credit ratings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember', window );">Ongoing Operations | No collateral | Not rated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">3,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | BBB+ equivalent and higher current ratings | Lincoln National Life and Lincoln Life &amp; Annuity of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | BBB+ equivalent and higher current ratings | Empower Annuity Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | BBB+ equivalent and higher current ratings | Prudential Insurance Company of America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | BBB+ equivalent and higher current ratings | Life Insurance Company of North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | BBB+ equivalent and higher current ratings | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Not rated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Fair value of collateral contractually required to meet or exceed carrying value of recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Fair value of collateral contractually required to meet or exceed carrying value of recoverable | BBB+ equivalent and higher current ratings | Lincoln National Life and Lincoln Life &amp; Annuity of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Fair value of collateral contractually required to meet or exceed carrying value of recoverable | BBB+ equivalent and higher current ratings | Empower Annuity Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Fair value of collateral contractually required to meet or exceed carrying value of recoverable | BBB+ equivalent and higher current ratings | Prudential Insurance Company of America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Fair value of collateral contractually required to meet or exceed carrying value of recoverable | BBB+ equivalent and higher current ratings | Life Insurance Company of North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Fair value of collateral contractually required to meet or exceed carrying value of recoverable | BBB+ equivalent and higher current ratings | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Fair value of collateral contractually required to meet or exceed carrying value of recoverable | Not rated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Collateral provisions exist that may mitigate risk of credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">3,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Collateral provisions exist that may mitigate risk of credit loss | BBB+ equivalent and higher current ratings | Lincoln National Life and Lincoln Life &amp; Annuity of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Collateral provisions exist that may mitigate risk of credit loss | BBB+ equivalent and higher current ratings | Empower Annuity Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Collateral provisions exist that may mitigate risk of credit loss | BBB+ equivalent and higher current ratings | Prudential Insurance Company of America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Collateral provisions exist that may mitigate risk of credit loss | BBB+ equivalent and higher current ratings | Life Insurance Company of North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Collateral provisions exist that may mitigate risk of credit loss | BBB+ equivalent and higher current ratings | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | Collateral provisions exist that may mitigate risk of credit loss | Not rated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | No collateral</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | No collateral | BBB+ equivalent and higher current ratings | Lincoln National Life and Lincoln Life &amp; Annuity of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | No collateral | BBB+ equivalent and higher current ratings | Empower Annuity Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | No collateral | BBB+ equivalent and higher current ratings | Prudential Insurance Company of America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | No collateral | BBB+ equivalent and higher current ratings | Life Insurance Company of North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | No collateral | BBB+ equivalent and higher current ratings | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember', window );">Acquisition, disposition or run-off activities | No collateral | Not rated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesGross', window );">Reinsurance recoverables</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember', window );">Variable Annuity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance', window );">Market risk benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember', window );">Variable Annuity | GMDB</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance', window );">Market risk benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, recoverable under reinsurance for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29G<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819547-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782768-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21409-158489<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverablesAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on reinsurance recoverable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverablesAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverablesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation allowance recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverablesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskCollateralizationAxis=ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskCollateralizationAxis=ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskCollateralizationAxis=ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskCollateralizationAxis=ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskCollateralizationAxis=us-gaap_CededCreditRiskUnsecuredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskCollateralizationAxis=us-gaap_CededCreditRiskUnsecuredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_OngoingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_OngoingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis=ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis=ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis=ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis=ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis=ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis=ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_AcquisitionDispositionRunoffActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis=ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis=ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=ci_EmpowerAnnuityInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=ci_EmpowerAnnuityInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=ci_PrudentialInsuranceCompanyOfAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=ci_PrudentialInsuranceCompanyOfAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=ci_LifeInsuranceCompanyOfNorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=ci_LifeInsuranceCompanyOfNorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=us-gaap_OtherReinsurerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=us-gaap_OtherReinsurerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis=us-gaap_GuaranteedMinimumDeathBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis=us-gaap_GuaranteedMinimumDeathBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367976024960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance - Effective Exit of Variable Annuity Reinsurance Business (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance', window );">Market risk benefits</a></td>
<td class="nump">$ 1,301<span></span>
</td>
<td class="nump">$ 1,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis=us-gaap_VariableAnnuityMember', window );">Variable Annuity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FairValueMeasurementNonPerformanceRiskAdjustment', window );">Impact of non-performance risk</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember', window );">Berkshire | Secured | Market risk benefits reinsurance recoverable, including IBNR and outstanding claims, less premiums due | Collateralization risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=ci_LibertyMutualInsuranceMember', window );">Liberty Re (Bermuda) Ltd. | Secured | Market risk benefits reinsurance recoverable, including IBNR and outstanding claims, less premiums due | Collateralization risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=ci_SCORSEMember', window );">SCOR SE | Secured | Market risk benefits reinsurance recoverable, including IBNR and outstanding claims, less premiums due | Collateralization risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember', window );">Variable Annuity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances', window );">Market risk benefits reinsurance recoverable, including IBNR and outstanding claims, less premiums due</a></td>
<td class="nump">$ 1,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance', window );">Market risk benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims', window );">Incurred but not yet paid and outstanding claims</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAtCarryingValue', window );">Premiums due</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember', window );">Variable Annuity | Berkshire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_CededReinsuranceAgreementReinsuredRiskPercentage', window );">Percent of future claim payments reinsured</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining', window );">Remaining overall limit under reinsurance agreement</a></td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances', window );">Market risk benefits reinsurance recoverable, including IBNR and outstanding claims, less premiums due</a></td>
<td class="nump">1,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember', window );">Variable Annuity | Sun Life Assurance Company of Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances', window );">Market risk benefits reinsurance recoverable, including IBNR and outstanding claims, less premiums due</a></td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember', window );">Variable Annuity | Liberty Re (Bermuda) Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances', window );">Market risk benefits reinsurance recoverable, including IBNR and outstanding claims, less premiums due</a></td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember', window );">Variable Annuity | SCOR SE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances', window );">Market risk benefits reinsurance recoverable, including IBNR and outstanding claims, less premiums due</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_CededReinsuranceAgreementCoverageLimitAmountRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of overall limit to claims covered under ceded reinsurance agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_CededReinsuranceAgreementCoverageLimitAmountRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_CededReinsuranceAgreementReinsuredRiskPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of future claim payments reinsured under reinsurance agreement(s), net of existing retrocessional arrangements at the time agreement was made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_CededReinsuranceAgreementReinsuredRiskPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_FairValueMeasurementNonPerformanceRiskAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Measurement, Non-Performance Risk Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_FairValueMeasurementNonPerformanceRiskAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Includes incurred but not reported claims and outstanding claims,off-set by premiums due, related to market risk benefit contracts, as a well as reinsurance recoverable, defined as amount, after allowance for credit loss, recoverable under reinsurance for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, recoverable under reinsurance for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29G<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819547-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782768-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated amount after valuation allowance of reinsurance recoverables, due from reinsurers for incurred claims not yet reported, and claims settlement expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21409-158489<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis=us-gaap_VariableAnnuityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis=us-gaap_VariableAnnuityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskCollateralizationAxis=us-gaap_CededCreditRiskSecuredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskCollateralizationAxis=us-gaap_CededCreditRiskSecuredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=ci_CededCreditCollateralizationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=ci_CededCreditCollateralizationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=ci_LibertyMutualInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=ci_LibertyMutualInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=ci_SCORSEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=ci_SCORSEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_VariableAnnuityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=ci_SunLifeAssuranceCompanyOfCanadaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=ci_SunLifeAssuranceCompanyOfCanadaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980931488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Investments by Category (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestmentsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">$ 914<span></span>
</td>
<td class="nump">$ 905<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAbstract', window );"><strong>Long-term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">19,010<span></span>
</td>
<td class="nump">16,288<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ShortTermAndLongTermInvestmentsAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">19,924<span></span>
</td>
<td class="nump">17,193<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestmentsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">654<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAbstract', window );"><strong>Long-term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">9,293<span></span>
</td>
<td class="nump">9,218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ShortTermAndLongTermInvestmentsAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">9,909<span></span>
</td>
<td class="nump">9,872<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestmentsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAbstract', window );"><strong>Long-term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">3,069<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ShortTermAndLongTermInvestmentsAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">3,120<span></span>
</td>
<td class="nump">622<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_MortgagesMember', window );">Commercial mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestmentsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAbstract', window );"><strong>Long-term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">1,501<span></span>
</td>
<td class="nump">1,547<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ShortTermAndLongTermInvestmentsAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">1,607<span></span>
</td>
<td class="nump">1,614<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_PolicyLoansMember', window );">Policy loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestmentsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAbstract', window );"><strong>Long-term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">1,211<span></span>
</td>
<td class="nump">1,218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ShortTermAndLongTermInvestmentsAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">1,211<span></span>
</td>
<td class="nump">1,218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember', window );">Other long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestmentsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAbstract', window );"><strong>Long-term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">3,936<span></span>
</td>
<td class="nump">3,728<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ShortTermAndLongTermInvestmentsAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">3,936<span></span>
</td>
<td class="nump">3,728<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestmentsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAbstract', window );"><strong>Long-term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ShortTermAndLongTermInvestmentsAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments per Consolidated Balance Sheets</a></td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ShortTermAndLongTermInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-Term And Long-Term Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ShortTermAndLongTermInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MortgagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MortgagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_PolicyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_PolicyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980649040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities by Contractual Maturity Periods (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less</a></td>
<td class="nump">$ 638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years</a></td>
<td class="nump">3,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Due after five years through ten years</a></td>
<td class="nump">3,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Due after ten years</a></td>
<td class="nump">2,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Mortgage and other asset-backed securities</a></td>
<td class="nump">381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">10,668<span></span>
</td>
<td class="nump">$ 10,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less</a></td>
<td class="nump">630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">3,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through ten years</a></td>
<td class="nump">2,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Due after ten years</a></td>
<td class="nump">2,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Mortgage and other asset-backed securities</a></td>
<td class="nump">344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total</a></td>
<td class="nump">$ 9,909<span></span>
</td>
<td class="nump">$ 9,872<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, before allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367970127312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Gross Unrealized Appreciation (Depreciation) on Debt Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">$ 10,668<span></span>
</td>
<td class="nump">$ 10,842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Allowance for Credit Loss</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Appreciation</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Depreciation</a></td>
<td class="num">(888)<span></span>
</td>
<td class="num">(1,059)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">9,909<span></span>
</td>
<td class="nump">9,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">Federal government and agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Allowance for Credit Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Appreciation</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Depreciation</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and local government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Allowance for Credit Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Appreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Depreciation</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">Foreign government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Allowance for Credit Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Appreciation</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Depreciation</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">9,596<span></span>
</td>
<td class="nump">9,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Allowance for Credit Loss</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Appreciation</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Depreciation</a></td>
<td class="num">(823)<span></span>
</td>
<td class="num">(981)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">8,856<span></span>
</td>
<td class="nump">8,806<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Mortgage and other asset-backed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">381<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Allowance for Credit Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Appreciation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Depreciation</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">$ 344<span></span>
</td>
<td class="nump">$ 348<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, before allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367969900320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Summary of Debt Securities with a Decline in Fair Value (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>position</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>position</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">$ 7,433<span></span>
</td>
<td class="nump">$ 7,901<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost', window );">Total Amortized Cost</a></td>
<td class="nump">8,321<span></span>
</td>
<td class="nump">8,960<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Depreciation</a></td>
<td class="num">$ (888)<span></span>
</td>
<td class="num">$ (1,059)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Issues | position</a></td>
<td class="nump">3,760<span></span>
</td>
<td class="nump">3,777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InvestmentsCreditRatingAxis=ci_InvestmentGradeMember', window );">Investment grade | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract', window );"><strong>One year or less</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value</a></td>
<td class="nump">$ 3,176<span></span>
</td>
<td class="nump">$ 5,533<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">3,362<span></span>
</td>
<td class="nump">6,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Depreciation</a></td>
<td class="num">$ (186)<span></span>
</td>
<td class="num">$ (594)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Issues | position</a></td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">1,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract', window );"><strong>More than one year</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">$ 3,222<span></span>
</td>
<td class="nump">$ 1,151<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">3,808<span></span>
</td>
<td class="nump">1,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Depreciation</a></td>
<td class="num">$ (586)<span></span>
</td>
<td class="num">$ (336)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Issues | position</a></td>
<td class="nump">1,035<span></span>
</td>
<td class="nump">462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_InvestmentsCreditRatingAxis=ci_BelowInvestmentGradeMember', window );">Below investment grade | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract', window );"><strong>One year or less</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value</a></td>
<td class="nump">$ 353<span></span>
</td>
<td class="nump">$ 887<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Depreciation</a></td>
<td class="num">$ (18)<span></span>
</td>
<td class="num">$ (77)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Issues | position</a></td>
<td class="nump">936<span></span>
</td>
<td class="nump">1,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract', window );"><strong>More than one year</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">$ 682<span></span>
</td>
<td class="nump">$ 330<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">780<span></span>
</td>
<td class="nump">382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Depreciation</a></td>
<td class="num">$ (98)<span></span>
</td>
<td class="num">$ (52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Issues | position</a></td>
<td class="nump">770<span></span>
</td>
<td class="nump">369<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months Or Longer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, 12 Months Or Longer, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less Than 12 Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Less Than 12 Months, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InvestmentsCreditRatingAxis=ci_InvestmentGradeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InvestmentsCreditRatingAxis=ci_InvestmentGradeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_InvestmentsCreditRatingAxis=ci_BelowInvestmentGradeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_InvestmentsCreditRatingAxis=ci_BelowInvestmentGradeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367974958336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Equity Security Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract', window );"><strong>Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Equity securities with readily determinable fair values</a></td>
<td class="nump">$ 680<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost', window );">Equity securities with no readily determinable fair value</a></td>
<td class="nump">2,926<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">380<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost', window );">Total</a></td>
<td class="nump">3,606<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract', window );"><strong>Carrying Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities with readily determinable fair values</a></td>
<td class="nump">91<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities with no readily determinable fair value</a></td>
<td class="nump">3,029<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount', window );">Total</a></td>
<td class="nump">3,120<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PaymentsToAcquireDebtAndEquitySecurities', window );">Amount funded</a></td>
<td class="nump">$ 2,794<span></span>
</td>
<td colspan="2" class="nump">$ 1,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ci_EquitySecuritiesFVNIMember', window );">Equity Securities FV NI | Product Concentration Risk | Health Care Sector</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">95.00%<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount, Before Reclassification To Disposal Group, Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_PaymentsToAcquireDebtAndEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Debt And Equity Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_PaymentsToAcquireDebtAndEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ci_EquitySecuritiesFVNIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ci_EquitySecuritiesFVNIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_HealthcareSectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_HealthcareSectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367976026592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Summary of the Credit Risk Profile of the Commercial Mortgage Loan Portfolio (Details) - Real Estate Loan - Commercial Portfolio Segment<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Carrying value, after allowance for credit loss</a></td>
<td class="nump">$ 1,607<span></span>
</td>
<td class="nump">$ 1,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=us-gaap_RealEstateLoanMember', window );">Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio', window );">Average Debt Service Coverage Ratio</a></td>
<td class="nump">1.89<span></span>
</td>
<td class="nump">1.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FinancingReceivableCreditQualityLoanToValueRatio', window );">Average Loan-to-Value Ratio</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=us-gaap_RealEstateLoanMember', window );">Below 60%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Carrying value, after allowance for credit loss</a></td>
<td class="nump">$ 912<span></span>
</td>
<td class="nump">$ 901<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=us-gaap_RealEstateLoanMember', window );">Below 60% | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio', window );">Average Debt Service Coverage Ratio</a></td>
<td class="nump">2.11<span></span>
</td>
<td class="nump">2.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=us-gaap_RealEstateLoanMember', window );">60% to 79%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Carrying value, after allowance for credit loss</a></td>
<td class="nump">$ 504<span></span>
</td>
<td class="nump">$ 564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=us-gaap_RealEstateLoanMember', window );">60% to 79% | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio', window );">Average Debt Service Coverage Ratio</a></td>
<td class="nump">1.73<span></span>
</td>
<td class="nump">1.73<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=us-gaap_RealEstateLoanMember', window );">80% to 100%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Carrying value, after allowance for credit loss</a></td>
<td class="nump">$ 191<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=us-gaap_RealEstateLoanMember', window );">80% to 100% | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio', window );">Average Debt Service Coverage Ratio</a></td>
<td class="nump">1.32<span></span>
</td>
<td class="nump">1.17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Credit Quality Debt Service Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_FinancingReceivableCreditQualityLoanToValueRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable Credit Quality Loan To Value Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_FinancingReceivableCreditQualityLoanToValueRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=us-gaap_RealEstateLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=us-gaap_RealEstateLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablePortfolioSegmentAxis=us-gaap_CommercialPortfolioSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablePortfolioSegmentAxis=us-gaap_CommercialPortfolioSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoanToValueAxis=ci_LtvLessThan60PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoanToValueAxis=ci_LtvLessThan60PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoanToValueAxis=ci_Ltv60To79PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoanToValueAxis=ci_Ltv60To79PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoanToValueAxis=us-gaap_Ltv80To100PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoanToValueAxis=us-gaap_Ltv80To100PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367981902000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Carrying Values of Other Long-Term Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other long-term investments</a></td>
<td class="nump">$ 3,936<span></span>
</td>
<td class="nump">$ 3,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_RealEstateInvestmentMember', window );">Real estate investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other long-term investments</a></td>
<td class="nump">1,434<span></span>
</td>
<td class="nump">1,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=srt_PartnershipInterestMember', window );">Securities partnerships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other long-term investments</a></td>
<td class="nump">2,259<span></span>
</td>
<td class="nump">2,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other long-term investments</a></td>
<td class="nump">$ 243<span></span>
</td>
<td class="nump">$ 243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_RealEstateInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_RealEstateInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=srt_PartnershipInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=srt_PartnershipInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367975991888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Components of Net Investment Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Net Investment Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">$ 277<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367976135696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Realized Gains and Losses on Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainLossExcludingImpairments', window );">Net realized investment (losses), excluding credit loss expense and asset write-downs</a></td>
<td class="num">$ (51)<span></span>
</td>
<td class="num">$ (322)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal', window );">Credit loss recoveries</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_ImpairmentsOnInvestmentsTotal', window );">Other investment asset write-downs</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainLoss', window );">Net realized investment (losses), before income taxes</a></td>
<td class="num">$ (56)<span></span>
</td>
<td class="num">$ (322)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, And Commercial Mortgage Loans, Allowance For Credit Loss, Expense (Reversal)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_ImpairmentsOnInvestmentsTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total impairments recorded in pre-tax realized investment losses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_ImpairmentsOnInvestmentsTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_RealizedInvestmentGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net realized gains or (losses) on investments during the period, including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_RealizedInvestmentGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_RealizedInvestmentGainLossExcludingImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net realized gains or (losses) on investments during the period before impairments, including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_RealizedInvestmentGainLossExcludingImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367974265408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">9,909<span></span>
</td>
<td class="nump">9,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Forwards, swaps, options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets for Identical Assets (Level 1) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets for Identical Assets (Level 1) | Recurring | Forwards, swaps, options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">9,288<span></span>
</td>
<td class="nump">9,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2) | Recurring | Forwards, swaps, options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">447<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3) | Recurring | Forwards, swaps, options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">Federal government and agency | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">Federal government and agency | Quoted Prices in Active Markets for Identical Assets (Level 1) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">Federal government and agency | Significant Other Observable Inputs (Level 2) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">Federal government and agency | Significant Unobservable Inputs (Level 3) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and local government | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and local government | Quoted Prices in Active Markets for Identical Assets (Level 1) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and local government | Significant Other Observable Inputs (Level 2) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and local government | Significant Unobservable Inputs (Level 3) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">Foreign government | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">Foreign government | Quoted Prices in Active Markets for Identical Assets (Level 1) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">Foreign government | Significant Other Observable Inputs (Level 2) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">Foreign government | Significant Unobservable Inputs (Level 3) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">8,856<span></span>
</td>
<td class="nump">8,806<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate | Quoted Prices in Active Markets for Identical Assets (Level 1) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate | Significant Other Observable Inputs (Level 2) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">8,421<span></span>
</td>
<td class="nump">8,394<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate | Significant Unobservable Inputs (Level 3) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Mortgage and other asset-backed | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">344<span></span>
</td>
<td class="nump">348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Mortgage and other asset-backed | Quoted Prices in Active Markets for Identical Assets (Level 1) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Mortgage and other asset-backed | Significant Other Observable Inputs (Level 2) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">309<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Mortgage and other asset-backed | Significant Unobservable Inputs (Level 3) | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial assets at fair value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ci_ForwardsSwapsOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ci_ForwardsSwapsOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367978864336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - Separate Account Assets - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease', window );">Separate accounts assets classified in Level 3, period increase (decrease), including transfers in and out of Level 3</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=ci_SeparateAccountAssetsMember', window );">Recurring | Securities partnerships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception', window );">Expected liquidation period after inception</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected liquidation period after inception of the underlying assets measured at net asset value per share or unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=ci_SeparateAccountAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=ci_SeparateAccountAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=srt_PartnershipInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=srt_PartnershipInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980872048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Quantitative Information About Unobservable Inputs (Details) - Recurring - Significant Unobservable Inputs (Level 3)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Fair Value</a></td>
<td class="nump">$ 470<span></span>
</td>
<td class="nump">$ 447<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ci_CorporateAndGovernmentDebtSecuritiesMember', window );">Corporate and government debt securities | Securities Priced by the Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Fair Value</a></td>
<td class="nump">$ 433<span></span>
</td>
<td class="nump">$ 412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ci_CorporateAndGovernmentDebtSecuritiesMember', window );">Corporate and government debt securities | Securities Priced by the Company | Minimum | Liquidity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput', window );">Unobservable Adjustment</a></td>
<td class="nump">0.0060<span></span>
</td>
<td class="nump">0.0060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ci_CorporateAndGovernmentDebtSecuritiesMember', window );">Corporate and government debt securities | Securities Priced by the Company | Maximum | Liquidity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput', window );">Unobservable Adjustment</a></td>
<td class="nump">0.1060<span></span>
</td>
<td class="nump">0.1060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ci_CorporateAndGovernmentDebtSecuritiesMember', window );">Corporate and government debt securities | Securities Priced by the Company | Weighted Average | Liquidity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput', window );">Unobservable Adjustment</a></td>
<td class="nump">0.0300<span></span>
</td>
<td class="nump">0.0270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Mortgage and other asset-backed securities | Securities Priced by the Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Fair Value</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Mortgage and other asset-backed securities | Securities Priced by the Company | Minimum | Liquidity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput', window );">Unobservable Adjustment</a></td>
<td class="nump">0.0105<span></span>
</td>
<td class="nump">0.0110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Mortgage and other asset-backed securities | Securities Priced by the Company | Maximum | Liquidity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput', window );">Unobservable Adjustment</a></td>
<td class="nump">0.0520<span></span>
</td>
<td class="nump">0.0520<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Mortgage and other asset-backed securities | Securities Priced by the Company | Weighted Average | Liquidity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput', window );">Unobservable Adjustment</a></td>
<td class="nump">0.0310<span></span>
</td>
<td class="nump">0.0310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Fair Value</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ci_CorporateAndGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ci_CorporateAndGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=ci_UnobservableInputsDevelopedByCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=ci_UnobservableInputsDevelopedByCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=ci_MeasurementInputLiquidityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=ci_MeasurementInputLiquidityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367971672752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Changes in Level 3 Financial Assets and Financial Liabilities Carried at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract', window );"><strong>Transfers into/(out of) Level 3</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Change in unrealized gain or (loss) included in Other comprehensive loss for assets held at the end of the reporting period</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=ci_DebtAndEquitySecuritiesMember', window );">Debt and Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale', window );">Beginning balance, including held for sale assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Gains included in Shareholders' net income</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Gains (losses) included in Other comprehensive loss</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits', window );">Gains (losses) required to adjust future policy benefits for settlement annuities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract', window );"><strong>Purchases, sales and settlements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements', window );">Total purchases, sales and settlements</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract', window );"><strong>Transfers into/(out of) Level 3</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level 3</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level 3</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(164)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Total transfers into/(out of) Level 3</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale', window );">Ending balance, including held for sale assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings', window );">Total gains included in Shareholders' net income attributable to instruments held at the reporting date</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents total gains or losses for the period (realized and unrealized), arising from assets included in income attributable to instruments held at the reporting date, measured at fair value on a recurring basis using unobservable inputs (Level 3), which are included in earnings or resulted in a change in asset value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents total gains or losses for the period (realized and unrealized), arising from assets measured at fair value on a recurring basis using unobservable inputs (Level 3), which are included in gains or losses required to adjust future policy benefits for settlement annuities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included In Other Comprehensive Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Before Reclassification To Disposal Group Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=ci_DebtAndEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=ci_DebtAndEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367971838112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Values of Separate Account Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_GuaranteedSeparateAccountAssets', window );">Guaranteed separate accounts</a></td>
<td class="nump">$ 562<span></span>
</td>
<td class="nump">$ 585<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy', window );">Non-guaranteed separate accounts</a></td>
<td class="nump">6,020<span></span>
</td>
<td class="nump">5,936<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy', window );">Subtotal</a></td>
<td class="nump">6,582<span></span>
</td>
<td class="nump">6,521<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient', window );">Non-guaranteed separate accounts priced at NAV as a practical expedient</a></td>
<td class="nump">758<span></span>
</td>
<td class="nump">757<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate account assets</a></td>
<td class="nump">7,340<span></span>
</td>
<td class="nump">7,278<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy', window );">Non-guaranteed separate accounts</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_GuaranteedSeparateAccountAssets', window );">Guaranteed separate accounts</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy', window );">Non-guaranteed separate accounts</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy', window );">Subtotal</a></td>
<td class="nump">434<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_GuaranteedSeparateAccountAssets', window );">Guaranteed separate accounts</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy', window );">Non-guaranteed separate accounts</a></td>
<td class="nump">5,586<span></span>
</td>
<td class="nump">5,522<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy', window );">Subtotal</a></td>
<td class="nump">5,935<span></span>
</td>
<td class="nump">5,904<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_GuaranteedSeparateAccountAssets', window );">Guaranteed separate accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy', window );">Non-guaranteed separate accounts</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy', window );">Subtotal</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3) | Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy', window );">Non-guaranteed separate accounts</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_GuaranteedSeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guaranteed Separate Account Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_GuaranteedSeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of the assets held by the Entity for the benefit of separate account policyholders without guarantees classified in the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of the assets held by the Entity for the benefit of separate account policyholders without guarantees and priced at net asset value as a practical expedient.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_SeparateAccountAssetsClassifiedInFairValueHierarchy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of the assets held by the Entity for the benefit of separate account policyholders classified in the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_SeparateAccountAssetsClassifiedInFairValueHierarchy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367982151648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information on Separate Account Assets Priced at Net Asset Value (Details) - Separate Account Assets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments', window );">Unfunded Commitments</a></td>
<td class="nump">$ 228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=ci_SeparateAccountAssetsMember', window );">Recurring | NAV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AlternativeInvestment', window );">Fair Value</a></td>
<td class="nump">758<span></span>
</td>
<td class="nump">$ 757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=srt_PartnershipInterestMember', window );">Securities partnerships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments', window );">Unfunded Commitments</a></td>
<td class="nump">228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=srt_PartnershipInterestMember', window );">Securities partnerships | Recurring | NAV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AlternativeInvestment', window );">Fair Value</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_RealEstateFundsMember', window );">Real estate funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments', window );">Unfunded Commitments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_RealEstateFundsMember', window );">Real estate funds | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1', window );">Redemption Notice Period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_RealEstateFundsMember', window );">Real estate funds | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1', window );">Redemption Notice Period</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_RealEstateFundsMember', window );">Real estate funds | Recurring | NAV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AlternativeInvestment', window );">Fair Value</a></td>
<td class="nump">$ 287<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_HedgeFundsMember', window );">Hedge funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments', window );">Unfunded Commitments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_HedgeFundsMember', window );">Hedge funds | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1', window );">Redemption Notice Period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_HedgeFundsMember', window );">Hedge funds | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1', window );">Redemption Notice Period</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_HedgeFundsMember', window );">Hedge funds | Recurring | NAV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AlternativeInvestment', window );">Fair Value</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AlternativeInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL6742756-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 35<br> -Paragraph 54B<br> -URI https://asc.fasb.org/extlink&amp;oid=126972413&amp;loc=SL7495116-110257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AlternativeInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notice period the entity is required to deliver before it can redeem an investment calculated using net asset value per share, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, investments calculated by per unit, per membership interest, other equity or ownership interest and alternative investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL6742756-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of unfunded commitments for which the entity is obligated, to those certain investments for which net asset value per share is calculated (including by unit, membership interest, or other equity (ownership interest) unit measure) (alternative investments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL6742756-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=ci_SeparateAccountAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=ci_SeparateAccountAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=srt_PartnershipInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=srt_PartnershipInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_RealEstateFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_RealEstateFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367982042352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Assets and Liabilities Measured at Fair Value under Certain Conditions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue', window );">Realized investment losses on assets measured at fair value under certain conditions, after-tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount', window );">Realized investment gains on equity securities with no readily determinable fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Realized investment losses on impaired real estate, partnership entities, commercial mortgage loans and certain equity securities with no readily determinable fair value, after-tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367981897264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Disclosures for Financial Instruments Not Carried at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, including current maturities, excluding finance leases</a></td>
<td class="nump">$ 30,679<span></span>
</td>
<td class="nump">$ 28,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet', window );">Commercial mortgage loans</a></td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">1,491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet', window );">Commercial mortgage loans</a></td>
<td class="nump">1,607<span></span>
</td>
<td class="nump">1,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, including current maturities, excluding finance leases</a></td>
<td class="nump">$ 32,439<span></span>
</td>
<td class="nump">$ 30,994<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367979028784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities (Details) - entity<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_VariableInterestEntitiesNumberOfEntities', window );">Number of VIEs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_VariableInterestEntitiesNumberOfEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entities, Number Of Entities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_VariableInterestEntitiesNumberOfEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367976184928">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 44,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 46,976<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity', window );">Other comprehensive loss, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(111)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(434)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TemporaryEquityOtherComprehensiveIncome', window );">Less: Net translation (loss) on foreign currencies attributable to noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Shareholders other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(111)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(432)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">44,518<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">46,145<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive (Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(1,658)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,068)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Shareholders other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(111)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(432)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,769)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,500)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember', window );">Securities and Derivatives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(332)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,266<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive income (loss) before reclassifications, before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">252<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,065)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss), before reclassifications, tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(54)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, after-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(834)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification adjustment, tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Net amounts reclassified from AOCI to net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Shareholders other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">194<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(843)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(138)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">423<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember', window );">Reclassification adjustment for (gains) included in Shareholders' net income (Net realized investment losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification adjustment, before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember', window );">AOCI, Liability For Future Policy Benefit And Market Risk Benefit, Instrument-Specific Credit Risk, Parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(256)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(765)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Shareholders other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(331)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">459<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(587)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(306)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociLiabilityForFuturePolicyBenefitParentMember', window );">AOCI, Liability for Future Policy Benefit, Parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive income (loss) before reclassifications, before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(411)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">584<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss), before reclassifications, tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(130)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Shareholders other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(310)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">454<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember', window );">AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, Parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive income (loss) before reclassifications, before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(26)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss), before reclassifications, tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Shareholders other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(21)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Translation of foreign currencies attributable to parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(154)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(233)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Shareholders other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(61)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(138)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(294)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Translation of foreign currencies including portion attributable to noncontrolling interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity', window );">Other comprehensive income (loss) including temporary equity, before reclassifications, before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(60)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity', window );">Other comprehensive income (loss) including temporary equity, before reclassifications, tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity', window );">Other comprehensive income (loss) including temporary equity, before reclassifications, after-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(63)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember', window );">Translation of foreign currencies attributable to noncontrolling interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TemporaryEquityOtherComprehensiveIncome', window );">Less: Net translation (loss) on foreign currencies attributable to noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Postretirement benefits liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(916)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,336)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification adjustment, tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Net amounts reclassified from AOCI to net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Shareholders other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(906)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,323)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember', window );">Reclassification adjustment for amortization of net prior actuarial losses and prior service costs (Interest expense and other)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification adjustment, before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements to the Consolidated Financial Statements for further information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Before Reclassifications, After Tax, Including Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), before Reclassifications, before Tax, Including Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss) before Reclassifications, Tax, Including Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Net of Tax, Including Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_TemporaryEquityOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of other comprehensive income or(loss) attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_TemporaryEquityOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociLiabilityForFuturePolicyBenefitParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociLiabilityForFuturePolicyBenefitParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980512256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Consolidated effective tax rate</a></td>
<td class="nump">18.40%<span></span>
</td>
<td class="nump">22.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules', window );">Deferred tax assets associated with unrealized investment losses</a></td>
<td class="nump">$ 255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets relative to investments subject to Federal capital loss utilization rules. Capital losses can only be utilized to extent there are capital gains in a given year. If capital losses exceed capital gains, the taxpayer can utilize capital losses to the extent there are capital gains in the applicable carryback period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367975340176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies and Other Matters (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 19, 2016 </div>
<div>claim</div>
</th>
<th class="th">
<div>Mar. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 08, 2023 </div>
<div>expert</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ci_ExpressScriptsLitigationWithAnthemMember', window );">Express Scripts Litigation with Elevance | Judicial Ruling | Pricing Concessions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought by Elevance</a></td>
<td class="nump">$ 14,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ci_ExpressScriptsLitigationWithAnthemMember', window );">Express Scripts Litigation with Elevance | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_CommitmentsAndContingenciesNumberOfExpert', window );">Number of experts | expert</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert', window );">Number of additional experts | expert</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ci_ExpressScriptsLitigationWithAnthemMember', window );">Express Scripts Litigation with Elevance | Pending Litigation | Pricing Concessions Through Remaining Contract Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought by Elevance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ci_ExpressScriptsLitigationWithAnthemMember', window );">Express Scripts Litigation with Elevance | Pending Litigation | Pricing Concessions After Remaining Term of Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought by Elevance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ci_ExpressScriptsLitigationWithAnthemMember', window );">Express Scripts Litigation with Elevance | Pending Litigation | Damages for Service Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought by Elevance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ci_ExpressScriptsCounterclaimsAgainstElevanceMember', window );">Express Scripts counterclaims against Elevance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsDismissedNumber', window );">Number of counts dismissed | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of counts | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_IndemnificationGuaranteeMember', window );">Indemnification obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Liability for guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_RetirementAndLifeInsuranceContractsMember', window );">Retiree and Life Insurance Benefits | Financial Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Maximum guarantee exposure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLiquidationProceeds', window );">Assets maintained by employers (minimum)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Liability for guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments And Contingencies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_CommitmentsAndContingenciesNumberOfAdditionalExpert">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments And Contingencies, Number Of Additional Expert</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_CommitmentsAndContingenciesNumberOfAdditionalExpert</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_CommitmentsAndContingenciesNumberOfExpert">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments And Contingencies, Number Of Expert</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_CommitmentsAndContingenciesNumberOfExpert</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsLiquidationProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates, if estimable, the approximate extent to which the proceeds from liquidation of any assets held either as collateral or by third parties would be expected to cover the maximum potential amount of future payments under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsLiquidationProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsDismissedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of claims dismissed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsDismissedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ci_ExpressScriptsLitigationWithAnthemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ci_ExpressScriptsLitigationWithAnthemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=ci_PricingConcessionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=ci_PricingConcessionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=ci_PricingConcessionsThroughRemainingContractTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=ci_PricingConcessionsThroughRemainingContractTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=ci_PricingConcessionsAfterRemainingTermOfAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=ci_PricingConcessionsAfterRemainingTermOfAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=ci_DamagesForServiceIssuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=ci_DamagesForServiceIssuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ci_ExpressScriptsCounterclaimsAgainstElevanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ci_ExpressScriptsCounterclaimsAgainstElevanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_IndemnificationGuaranteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_IndemnificationGuaranteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_RetirementAndLifeInsuranceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_RetirementAndLifeInsuranceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_FinancialGuaranteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_FinancialGuaranteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367979551568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Summary of Special Items (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SpecialItemsBeforeTaxAbstract', window );"><strong>Pre-tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TransactionRelatedCosts', window );">Integration and transaction-related costs, pre-tax</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity', window );">Total impact from special items</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SpecialItemsAfterTaxAbstract', window );"><strong>After-tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TransactionRelatedCostsAfterTax', window );">Integration and transaction-related costs, after-tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity', window );">Total impact from special items</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of before-tax tax amounts classified as special items, attributable to the parent. Special items are excluded from the calculation of 'adjusted income (loss) from operations' because management believes they are not representative of the underlying results of operations. This is generally because the nature and size of these matters are not indicative of our ongoing business operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of after-tax amounts classified as special items, attributable to the parent. Special items are excluded from the calculation of 'adjusted income (loss) from operations' because management believes they are not representative of the underlying results of operations. This is generally because the nature and size of these matters are not indicative of our ongoing business operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_SpecialItemsAfterTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_SpecialItemsAfterTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_SpecialItemsBeforeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_SpecialItemsBeforeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_TransactionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-tax transaction-related costs primarily consisting of fees for legal, advisory and other professional services, as well as employee costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_TransactionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_TransactionRelatedCostsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>After-tax transaction-related costs including the impact of tax benefits realized from termination of merger agreement. Transaction-related costs consist primarily of fees for legal, advisory and other professional services as well as employee costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_TransactionRelatedCostsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367974366672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Summarized Segment Financial Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Revenues from customers</a></td>
<td class="nump">$ 46,240<span></span>
</td>
<td class="nump">$ 43,592<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">TOTAL REVENUES</a></td>
<td class="nump">46,517<span></span>
</td>
<td class="nump">44,006<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainsLossesEquityMethodInvestments', window );">Net realized investment results from certain equity method investments</a></td>
<td class="num">(38)<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SegmentRevenues', window );">Adjusted revenues</a></td>
<td class="nump">46,479<span></span>
</td>
<td class="nump">44,109<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">749<span></span>
</td>
<td class="nump">717<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">1,601<span></span>
</td>
<td class="nump">1,567<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract', window );"><strong>Pre-tax adjustments to reconcile to adjusted income from operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax', window );">(Income) loss attributable to noncontrolling interests</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries', window );">Net realized investment (gains) losses</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">459<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SpecialItemsBeforeTaxAbstract', window );"><strong>Special items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TransactionRelatedCosts', window );">Integration and transaction-related costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Pre-tax adjusted income (loss) from operations</a></td>
<td class="nump">2,036<span></span>
</td>
<td class="nump">2,485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_EvernorthMember', window );">Evernorth Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Revenues from customers</a></td>
<td class="nump">34,511<span></span>
</td>
<td class="nump">32,289<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember', window );">Cigna Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Revenues from customers</a></td>
<td class="nump">11,650<span></span>
</td>
<td class="nump">10,462<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember', window );">Other Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Revenues from customers</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">841<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Evernorth Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">TOTAL REVENUES</a></td>
<td class="nump">36,179<span></span>
</td>
<td class="nump">33,586<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainsLossesEquityMethodInvestments', window );">Net realized investment results from certain equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SegmentRevenues', window );">Adjusted revenues</a></td>
<td class="nump">36,179<span></span>
</td>
<td class="nump">33,586<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">918<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract', window );"><strong>Pre-tax adjustments to reconcile to adjusted income from operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax', window );">(Income) loss attributable to noncontrolling interests</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries', window );">Net realized investment (gains) losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">444<span></span>
</td>
<td class="nump">443<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SpecialItemsBeforeTaxAbstract', window );"><strong>Special items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TransactionRelatedCosts', window );">Integration and transaction-related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Pre-tax adjusted income (loss) from operations</a></td>
<td class="nump">1,320<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Cigna Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">TOTAL REVENUES</a></td>
<td class="nump">12,756<span></span>
</td>
<td class="nump">11,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainsLossesEquityMethodInvestments', window );">Net realized investment results from certain equity method investments</a></td>
<td class="num">(38)<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SegmentRevenues', window );">Adjusted revenues</a></td>
<td class="nump">12,718<span></span>
</td>
<td class="nump">11,393<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">877<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract', window );"><strong>Pre-tax adjustments to reconcile to adjusted income from operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax', window );">(Income) loss attributable to noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries', window );">Net realized investment (gains) losses</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">406<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SpecialItemsBeforeTaxAbstract', window );"><strong>Special items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TransactionRelatedCosts', window );">Integration and transaction-related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Pre-tax adjusted income (loss) from operations</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="nump">1,297<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">TOTAL REVENUES</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">979<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainsLossesEquityMethodInvestments', window );">Net realized investment results from certain equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SegmentRevenues', window );">Adjusted revenues</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">979<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract', window );"><strong>Pre-tax adjustments to reconcile to adjusted income from operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax', window );">(Income) loss attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries', window );">Net realized investment (gains) losses</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SpecialItemsBeforeTaxAbstract', window );"><strong>Special items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TransactionRelatedCosts', window );">Integration and transaction-related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Pre-tax adjusted income (loss) from operations</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=ci_CorporateAndEliminationsMember', window );">Corporate and Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">TOTAL REVENUES</a></td>
<td class="num">(2,575)<span></span>
</td>
<td class="num">(1,849)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainsLossesEquityMethodInvestments', window );">Net realized investment results from certain equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SegmentRevenues', window );">Adjusted revenues</a></td>
<td class="num">(2,575)<span></span>
</td>
<td class="num">(1,849)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="num">(415)<span></span>
</td>
<td class="num">(395)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SpecialItemsBeforeTaxAbstract', window );"><strong>Special items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Pre-tax adjusted income (loss) from operations</a></td>
<td class="num">(414)<span></span>
</td>
<td class="num">(343)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Revenues from customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract', window );"><strong>Pre-tax adjustments to reconcile to adjusted income from operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax', window );">(Income) loss attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries', window );">Net realized investment (gains) losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_SpecialItemsBeforeTaxAbstract', window );"><strong>Special items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_TransactionRelatedCosts', window );">Integration and transaction-related costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Revenues from customers</a></td>
<td class="num">(2,581)<span></span>
</td>
<td class="num">(1,849)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Evernorth Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Revenues from customers</a></td>
<td class="num">(1,618)<span></span>
</td>
<td class="num">(1,287)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Cigna Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Revenues from customers</a></td>
<td class="num">(963)<span></span>
</td>
<td class="num">(562)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Other Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Revenues from customers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of pre-tax income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_NonInvestmentRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue excluding net investment income and realized investment results.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_NonInvestmentRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net realized gains or (losses) on investments during the period, including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity. Includes gains (losses) on investments held by equity method subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_RealizedInvestmentGainsLossesEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to exclude net realized gains (losses) from equity method subsidiaries (recorded in Other revenues) from Operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_RealizedInvestmentGainsLossesEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_SegmentRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total revenues less realized investment gains from equity method subsidiaries, special items and other reconciling items determined by management.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_SegmentRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_SpecialItemsBeforeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_SpecialItemsBeforeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_TransactionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-tax transaction-related costs primarily consisting of fees for legal, advisory and other professional services, as well as employee costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_TransactionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_EvernorthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_EvernorthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=ci_CorporateAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=ci_CorporateAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367975930272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Revenue from External Customers (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 11,025<span></span>
</td>
<td class="nump">$ 10,356<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Total revenues from external customers</a></td>
<td class="nump">46,240<span></span>
</td>
<td class="nump">43,592<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Total revenues from external customers</a></td>
<td class="num">(2,581)<span></span>
</td>
<td class="num">(1,849)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Divested International businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_EvernorthMember', window );">Evernorth Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Total revenues from external customers</a></td>
<td class="nump">34,511<span></span>
</td>
<td class="nump">32,289<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_EvernorthMember', window );">Evernorth Health Services | Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Total revenues from external customers</a></td>
<td class="num">(1,618)<span></span>
</td>
<td class="num">(1,287)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember', window );">Cigna Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Total revenues from external customers</a></td>
<td class="nump">11,650<span></span>
</td>
<td class="nump">10,462<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember', window );">Cigna Healthcare | Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Total revenues from external customers</a></td>
<td class="num">(963)<span></span>
</td>
<td class="num">(562)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember', window );">Other Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Total revenues from external customers</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">841<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember', window );">Other Operations | Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ci_NonInvestmentRevenue', window );">Total revenues from external customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Pharmacy revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">32,144<span></span>
</td>
<td class="nump">30,697<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Pharmacy revenues | Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(1,496)<span></span>
</td>
<td class="num">(1,245)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_NetworkPharmacyMember', window );">Network revenues | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">15,748<span></span>
</td>
<td class="nump">15,531<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_HomeDeliveryAndSpecialtyMember', window );">Home delivery and specialty revenues | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">16,025<span></span>
</td>
<td class="nump">14,699<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OtherPharmacyMember', window );">Other revenues | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">1,867<span></span>
</td>
<td class="nump">1,712<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_USMedicalProductsMember', window );">Cigna Healthcare | Cigna Healthcare | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">10,930<span></span>
</td>
<td class="nump">9,526<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_MedicalRiskProductsMember', window );">Insured | Cigna Healthcare | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">4,080<span></span>
</td>
<td class="nump">3,720<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_StopLossMember', window );">Stop loss | Cigna Healthcare | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">1,503<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_OtherCommercialMedicalProductsMember', window );">Other Commercial Medical Products | Cigna Healthcare | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">368<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_MedicareAdvantageMember', window );">Medicare Advantage | Cigna Healthcare | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">2,236<span></span>
</td>
<td class="nump">2,078<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_MedicarePartDMember', window );">Medicare Part D | Cigna Healthcare | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">415<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_IndividualAndFamilyPlansShortDurationMember', window );">Short-duration (Individual and family plans) | Cigna Healthcare | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">1,208<span></span>
</td>
<td class="nump">611<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember', window );">Long-duration (Individual Medicare supplement and limited benefit health products) | Cigna Healthcare | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_GroupMedicalInsuranceShortDurationMember', window );">Short-duration (Group medical insurance) | Cigna Healthcare | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_IndividualPrivateMedicalInsuranceLongDurationMember', window );">Long-duration (Individual private medical insurance) | Cigna Healthcare | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">3,071<span></span>
</td>
<td class="nump">2,539<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(1,101)<span></span>
</td>
<td class="num">(602)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_ServiceFeesMember', window );">Fees | Evernorth Health Services | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,499<span></span>
</td>
<td class="nump">1,624<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_ServiceFeesMember', window );">Fees | Cigna Healthcare | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">1,606<span></span>
</td>
<td class="nump">1,496<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_ServiceFeesMember', window );">Fees | Other Operations | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember', window );">Other revenues | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ci_NonInvestmentRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue excluding net investment income and realized investment results.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ci_NonInvestmentRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=ci_OtherOperationsSegmentOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=ci_OtherOperationsSegmentOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_EvernorthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_EvernorthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_CignaHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ci_OtherOperationsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_NetworkPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_NetworkPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_HomeDeliveryAndSpecialtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_HomeDeliveryAndSpecialtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_OtherPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_OtherPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_USMedicalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_USMedicalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_MedicalRiskProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_MedicalRiskProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_StopLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_StopLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_OtherCommercialMedicalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_OtherCommercialMedicalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_MedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_MedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_MedicarePartDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_MedicarePartDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_IndividualAndFamilyPlansShortDurationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_IndividualAndFamilyPlansShortDurationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_GroupMedicalInsuranceShortDurationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_GroupMedicalInsuranceShortDurationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_IndividualPrivateMedicalInsuranceLongDurationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_IndividualPrivateMedicalInsuranceLongDurationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_ServiceFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_ServiceFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140367980512256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information - Financial and Performance Guarantees (Details) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ci_PharmacyBenefitsManagementServicesMember', window );">Pharmacy Benefits Management Services | Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Guarantee liability</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ci_PharmacyBenefitsManagementServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ci_PharmacyBenefitsManagementServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_GuaranteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_GuaranteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>ci-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ci="http://www.thecignagroup.com/20230331"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ci-20230331.xsd" xlink:type="simple"/>
    <context id="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifdeb9c39ab4c4ab3bc182291feaa44c7_I20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="i933d49a7caa5445f9359253b5b0b5023_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2699cfc415ab4727a3246be3ce9a03fb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1cf64ff3b0a2466f81f78f097b7c8d5d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i530643094c274242bf05d8df55f63659_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icfbd026f02e243f087fcef41ca300348_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id32446380c2041c8b63ae668e812de11_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia07eeeff84fa4f25a2dd79fdc9bc15dd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2b7588439a24468b996c973b3308b0f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if7d813880f744d49943f15dd7e540ba0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i90dec54128bd417fa982da7f2d7685f2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6d2cebed8b184349b833533515099744_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0206ebaad6534ebe9f01b32c7c8377aa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7909946bc91943678368051fb2668b17_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaf856e4d292f45ee82a219747b70690d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3c0abb6b8064491c945d2af1005f4e61_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i22ee4c2e55934757aa575a02b3920fb4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i05dd3918d78c4bf1a755567f7c64ddb8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia464d53888f74e16b5ba9e62ba445568_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i34d79544d8cb4787abb0f63293d81023_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6ca2b0796c79476594136b360600f553_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i99423769f3dd4edb99594b8b2aee677e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4e2dbc865d7444349a0f2776dabcbca6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i20a54758336f4568bce7df2f2f0da706_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7b841b999bc847b2a7d961377de9d3de_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i70ad8103265e4886a5533cccf894688b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i617514263e2a477ba7f3b8a9a6a9674a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2c898b920ca42a186661453324aadcd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30c711c00bcf422fafd828ded50e4f64_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i85fc8a53e3214c7c985953d9b3dc5a78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia71485e3f57d4b1e87922c63f04789e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie21827b448914783ad89a1e60a05565f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieb159500cff1416584b25f65dcff1e94_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd620fc2833e42f18e79f1190828960c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if9c54d8a0b0d4d1f9f08d455276b0990_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i29e9fa809dec40e4a4434d5f6b246b71_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i75919ae416364991a9685e11cb5779d9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i11d2197648684bb191b9dfd2c8308df3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i417f3083e801423e81a8d2f395260442_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia44468c92367407098fcf49709295d14_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i46e8477b53954f2eb5c8d27ecfddb379_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7677f2aaed8c4a29a27ff12fecd40d9e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic7fe65d9692f4e978e3eeb7d6c41aef0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1487aaff9d704b1b9f53a37e55ac7eea_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i677503e86b4241c6889f0c64707d9e13_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic71911f816574fdb881509b52a744fc9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i04417f56eeb14234a4bf022e54781719_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0168835d0324407988eb74d7d61484da_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3c7aed585f9d4d058090d2ff63838ee3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i51b230fe17da43ddb1e4f787e7e5b489_I20220701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ci:InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-01</instant>
        </period>
    </context>
    <context id="ia6534aa5174f46daae1011252bc79cfa_D20220701-20220701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ci:InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-01</endDate>
        </period>
    </context>
    <context id="i9b459f141c6c4b0da2923bbbd4e8c935_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9856273e9b994b9094b394811fc62689_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia476822164994b318ba1a7d0dfc61cc8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202383InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5453dc8934554e9faf7e6b1ef64dbf8b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202383InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic9fd170cd0b544f4947eb9267c3105ae_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2023765InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i75f10178c4e44f02b6fd42a4130fb189_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2023765InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3b1750dc39384c35b545131f314c0819_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2023FloatingRateInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0d639de145c64f1fb64c4f7629a3f64e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2023FloatingRateInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic135eb18221a4aa39a034dad9dff9585_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20233InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i414bed4bfa4b4862a19a234bbdaf714d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20233InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9658fcabcb764ce5972950cced53289b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2023375InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6aac5c43478c4cf5872ab0d87fb7cab3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2023375InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iacf9c0f395864206b0df7660a5342177_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2024613InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8f6de552f34d46ddaeb308e06fae469b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2024613InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib7f9f54a14524ef2ac66996f0eca9b9c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202435InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i44063dd30ab24985935f4de84ca1db87_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202435InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic8a730c53413415aaeb8a8df0ed50e7c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2025325InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i980904614f6544cc9a3e363b158e13cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2025325InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id66a58d38b054171873c7dc463a8d253_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20254125InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibd0a8f836e6446e7a62ab400a6266eb2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20254125InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i738c83b591a342bcb031de2dbdb544f9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202645InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9bd4adeaf8a34f6e935f49888c83341b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202645InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e91d995dc4d4716a67317f53051bfdd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2026125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5ceafda26d1e4338a268d433a918d78a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2026125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i895d782074b54523b13b795cfbfb9154_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20265685Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8b061b9ba35943ad9b01618d52b31bc0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20265685Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2ddccf40663440f6a73b0908b9484769_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202734InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i72bd03d2619c44c29af788238edb9b7a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue202734InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i93ed3d337efa49aeacbaf2137357b0ff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:DebenturesDue20277875InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3751913bfc0a45b7896c5c9cf5f54426_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:DebenturesDue20277875InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i43e32ecefdb440f3860ab5c831273423_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2027305Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9b5927dc1e2f4399b084401a0572efa8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2027305Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i07cc745a98c84df4bf6dc07b30708361_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20284375InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i15576a81e11a4a38ae45657dbce148c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20284375InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a285f2991c9444c9755852b3eabda27_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue203024InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2689f890bb1c42d68cefbbeb43a87908_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue203024InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i66e2ace24fe24d90b02d99ff1be0dd09_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20312375InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i482114586ed84365b9534d71073eda66_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20312375InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9d96d999b8824e5484e9bc064061c29a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:StepDownNotesDueJanuary2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1cdc895b7a2741f2ba68c6eb57fcd620_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:StepDownNotesDueJanuary2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64c8340c95104f9da98216f9c6c92918_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20335400InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i86cfeb71e3864eeca439c4353bb752e1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20335400InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3197f7cdd54b4088ae3c71e0ad16d93f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2036615InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7642ca01b359422c83d2c36109bbe311_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue2036615InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4bd52da1beae4ef3b43d1878bb83c53f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue203848InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i46c86b75d1b641a38501f46eab131bf7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue203848InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifc0d48e2aeb3466da82305ee7c4b7be0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue204032InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia12dcb2f4a5544df8a2c619e6c94a70b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue204032InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id71094b2f34d4d978a441ba8995647fa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20415875InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic5223523086642cba0dcbb8ed2b11004_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20415875InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e5d78ed27a4483e8828d091e08d011d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20416125InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i48fdb56eaaaa4b408d38131d70e82896_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20416125InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib12f851059264a8d8a5b7886c8931917_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20425375InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8300dd98b4ec4864a2dcf4b8241cfdfb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20425375InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib290912817514769b3acd20a811fc92b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue204648InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id3b44eaa966347caa1dcffe029cf7ae9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue204648InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib9bfe6abbbb94e408b73c2c728c561ae_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20473875Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1438a2bf41684eb7a1a30324f2a19a84_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20473875Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0a19a44748f045febddded935137ce5c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue204849InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i365a75f6100e40feb386d3c9e27ceb30_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue204849InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icd2e63c77f194ff6bc9c2d7d25ffca38_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue205034InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0e2dc1d6708c4916be653839738f0143_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue205034InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibdcc30e5c6a242ed85b05fc34479449c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue205134InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i87d06b6f0c7d4557ad2660d8e87b98f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue205134InterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i49ecf3f26ca94fe88ab72567822a17c1_I20230115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:StepDownNotesDueJanuary2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-15</instant>
        </period>
    </context>
    <context id="if31115610c334a439c3f11aa884c91ce_I20230307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-07</instant>
        </period>
    </context>
    <context id="i5019884ac20741cf8a16eed471340bcf_I20230307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20265685Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-07</instant>
        </period>
    </context>
    <context id="i93b7c27710884424a2eec7dcef7b23f9_D20230307-20230307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20265685Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-07</startDate>
            <endDate>2023-03-07</endDate>
        </period>
    </context>
    <context id="iffbc2955b58a40d8b0178672d5fb531f_I20230307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20335400InterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-07</instant>
        </period>
    </context>
    <context id="i809f71ecb14a46c19821cd0c10cf40d1_D20230307-20230307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20335400InterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-07</startDate>
            <endDate>2023-03-07</endDate>
        </period>
    </context>
    <context id="ifd4fe3f6c8b04276b496fb8ac4ef9399_D20230307-20230307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20265685Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-07</startDate>
            <endDate>2023-03-07</endDate>
        </period>
    </context>
    <context id="i11b7488d47bd4be38856523de2a8e659_D20230307-20230307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:NotesDue20335400InterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-07</startDate>
            <endDate>2023-03-07</endDate>
        </period>
    </context>
    <context id="if507247b2d15417b965fab339f79fe0a_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i37d8822645414b32a762b437086b9814_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i968eab3e6c6a464b8621cc1f22f13849_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditFacilityMaturingApril2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i2e9aa8daf53f4df3bad80c887b287e24_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditFacilityMaturingApril2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i2be2fccd54774ea28094ccdeb4da1bf1_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:A364DayRevolvingCreditAgreementMaturingApril2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i402359fab32e4e2e81a9d588165d9963_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:A364DayRevolvingCreditAgreementMaturingApril2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="iab20c9aeb2d14f4aaac0f23ac89dd20e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i542bd1f117ca43d18940ed6fff533658_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i37973f57d1cd47349579d1c948a6c36c_D20230401-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i6e7b2848129a456d9e6bd7711efd7860_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="idbd12673dfe8421ca4a56e0ea3593be9_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:A364DayRevolvingCreditAgreementMaturingApril2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i83622a269b3f44fba77ec17337d55e2d_D20230401-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:A364DayRevolvingCreditAgreementMaturingApril2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="iad29666a07fc46d68f52e52e2f6aaab4_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAgreementsApril2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ibc00f288660a48daae4fccef391cd358_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ci:RevolvingCreditAgreementsApril2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ia05553ebdf9b4a5b971cdfd702e8a711_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaa7f8f9afed94f2c8a4d8a3fadcba829_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i75204ef5bacc45e484f57be2c4af5158_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i67f0445844a9443db40d9291472caedc_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib9c3e4e75f4d46b58ea05c03cbcb7a51_D20230323-20230323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <startDate>2023-03-23</startDate>
            <endDate>2023-03-23</endDate>
        </period>
    </context>
    <context id="i194fae94da834e3e8279dc01c624343d_D20220324-20220324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <startDate>2022-03-24</startDate>
            <endDate>2022-03-24</endDate>
        </period>
    </context>
    <context id="i9df7da12ac1d49b3b2f3b1ad8b0cc70f_D20230426-20230426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-26</startDate>
            <endDate>2023-04-26</endDate>
        </period>
    </context>
    <context id="if460fb29b2ff45aba9a93619bbe01ff5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8ccb9215d3f94df49e58cec62ca66848_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i12abbe9e13194148aca94163b7fb2f0a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie62ccc5f564845298d35afec66862cec_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5db337d577d24323b93b59b505c32718_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i316a5e098c694bcebb1694c166dcab76_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if3314d3839844dbab40e20dd517db732_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i582bfa8cb42448fb904b42f8fd26b53c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NoncatastrophicEventAxis">ci:CompletionFactorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2cde04d0ebee47b58537b475418eccf3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NoncatastrophicEventAxis">ci:CompletionFactorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie8f7bc9e3c3445a6980b765bf65b3c78_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NoncatastrophicEventAxis">ci:MedicalCostTrendMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5a56d790203f47048913b46660f4d92c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NoncatastrophicEventAxis">ci:MedicalCostTrendMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie07ab2d445d1463d93902530db5e0775_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i473b5ac171fe47d1b52a690302b8557d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia0a2caf1b06d407cb66dd5cc1db191bc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id5e56cac561c4deaa30c887f1b7ca3b8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id78aeb82d8af4ed7bfd1cfe99bf87fa7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i06c863b5932f4981934aca0c04125d8c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4c0f09cba3a64073b1bafdd99ecce319_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icbf37f4fce204b8e884d185c87969b4b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if5e93c29f2c5415ea367dd5375f9e1f7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis">us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id7558e0f62de4d41b5896e38c58e6285_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis">us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i738906a5eed64e83ba37b8588bebd0dd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis">us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ieb0a38d6988945d98411fa2cfb859c04_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis">ci:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifef5e98d887a4bb79bae5426330ad2b3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis">ci:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib570f0c807bc458bb372ecd4c53d8d16_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2e6d884b55ec4e72892c2a763b882366_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifc70e358d2cd4b0ea0945ae4e8b52dff_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ica8c06a177734445979e540fbc4f756d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i28d661611097476d8854fab93897521d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7177e4ee9a5c4f679379c6951ad9f6f7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9a1939888a3f4aeba81ff8cbc1ac2f55_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i780ea719429c4f5cb4d6a43778d44e51_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia10fa22d1a0e4292823f2466bb3ac18a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i04eae3ae08ff4a07bf7a9b55fc3507d2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9388bcc230334c26b5f9322df9d8591c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i24318b9a944f4a469e7a3f8caa0b899c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6be26d0bc42043479ce8c2aef240151d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib8b0de1554c74c03ad99462fed6a95b3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i89103ff921074d9f97701ff931699e77_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i63373aa6dda746ada1c737d9b67a0111_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4b5560c0ea484a0f968eb97de6b00cf7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibfa79a53adb54371bdf95c80bb23094d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie8581a4b7b794c4faf53cae6809eec3d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7018a961b27d4b63814f4c220228acd0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OngoingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if29f75017f4f4bb0a8b89780edfbb7d9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6f1fb483551e4be28ea7d121f976ed2f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3b1a96c7936742f1ba643f3f3ec01c9a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i97b1549db8444e2797ebd89df1ce900e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2a5f607d270f47999ff876f8ac44a118_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:EmpowerAnnuityInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if34b462c128a4ea8b60fe20ba370c163_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:EmpowerAnnuityInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2e4431aa2e584220a1f57a7dccc10533_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:EmpowerAnnuityInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iedcac50b09424b1aa432ff4b96017412_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:EmpowerAnnuityInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0fd2fee2cdaf404fa42202dda7b39b0d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:PrudentialInsuranceCompanyOfAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic4941e338d0b4e0b8e6d69cfd7dde626_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:PrudentialInsuranceCompanyOfAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6c41111216894d92a04d6b36cddf134f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:PrudentialInsuranceCompanyOfAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i12710504ce2d46fcb5c81a1e9c69a306_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:PrudentialInsuranceCompanyOfAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i11dc2245009f49c584be01347c7fdde9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LifeInsuranceCompanyOfNorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7de558709bb64232bfbbe65efd501378_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LifeInsuranceCompanyOfNorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id3083d42461248ae9fa7521f47d83dcf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LifeInsuranceCompanyOfNorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8c45fc7e2545455c909e8f4c5d88874b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LifeInsuranceCompanyOfNorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i454476c483c445ca9cee416255427da7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">us-gaap:OtherReinsurerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icf1c5ed75d824327908e9fac5f4b684c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">us-gaap:OtherReinsurerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0c13b36393fe4c24a2b794f5f3cd158e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">us-gaap:OtherReinsurerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i14769193c2c44d64b974d678e97f5a09_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">us-gaap:OtherReinsurerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id01894bb31a3496e95680d18ead03b0a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1ee2dd01b1f0498e93bcd1ddbe776129_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i524a1762651448f19786403decb53347_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i81f3744507dd4c6dbd6080857f121446_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis">ci:NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7992aeade34b40958cdbbd41e22d97c6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ife4968b18fb541b9a5883c174de67fc1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4b71494c09c24a38b31d30590816b909_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2f9ecf64e8fc403ea59b7253fb207588_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:AcquisitionDispositionRunoffActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i412908e744344c22a44e310a933e677e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredContractuallyRequiredFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5eb4d443a88b4c8a801ccccb711a03ea_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">ci:CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie5fc53d0faf24ca488cf6251cc8e3cd9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskUnsecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ide82cffd58fc4bd9a6a046a625886af2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4f712834ae454cc19bd99506f5b35f37_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteedInsuranceContractTypeOfBenefitAxis">us-gaap:GuaranteedMinimumDeathBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iffb569d2047445a09609c8caab034843_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia933eb83cc3d4717aa4b14ae0603c0cc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i41bcd1ff54304762b1285aa37c402aca_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteedInsuranceContractTypeOfBenefitAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3bcfd173fa8c4857abc112fc0044dc2d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteedInsuranceContractTypeOfBenefitAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3e7f3a48f7c442e2a74854517e46d848_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1ab9b6688ad640f6bddb9c9f39e1b287_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ci:CededCreditCollateralizationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib58c428a8e7841c4b87ec82e8a298b2c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:SunLifeAssuranceCompanyOfCanadaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7e422e0176b14d37a373faa93a5ef72e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:SunLifeAssuranceCompanyOfCanadaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c53eb427a65420e90086c325382b3c6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LibertyMutualInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia4a0c523a4d649ed9576b306aa61bf9d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LibertyMutualInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d00cd3a880946819131992a6001d101_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:LibertyMutualInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ci:CededCreditCollateralizationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2ea827e8736f47cdac2e72202d163b29_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:SCORSEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6e712fcd6b0f49c58dd469be40702369_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:SCORSEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5d949019d7c44dcea3311dc5c763edbb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">ci:SCORSEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskCollateralizationAxis">us-gaap:CededCreditRiskSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ci:CededCreditCollateralizationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i112f3631ecd842d7934b73fe1e30c901_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id6833d4eac60499bac8b8e40d102c734_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifd51b7e314aa426795bbfa7b1914c75a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0d4227ad42c24dc39f4e62e2b85e81a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i56553614bb1d4575a81f8b42e1e9b673_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie585d9251acf4ffaa79b1ef027535117_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0ddaaa564876446e911564680d7ad205_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PolicyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8c539efc04b24f10bb5bd030d79f630c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PolicyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1141eeb8e3f34513b86f0ce1f1a4c72c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7a7d37bc4c9a46d6a3949bc3551de6de_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic5a5174826024b3b8526bf7dcd6066e5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie234bd06bf9543618cd63eb8ff57535e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1269c3f703d94ed6840f2e30642de9bc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0c306daec09546e08812586ae9f36ee0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic820b1328eff4b35a3d9cd660b0c2801_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7918ae8d451f4168bead8514e67d96dc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3942feca4c1d4b8b9e0695b4afd3cfd1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic28ad1e10f5a40aab28b4519e660c08a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i014e7b52c0f34c96a0a52bc15cdbbb2b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iab84ae88cd084601b0a81a723bc6f470_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib356a619fa9e420489d64c64c7002bfe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4d7923da0ee04654b571d67b56b68fcc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5ec5355a990d4c00b92ee9f78c5841da_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:InvestmentsCreditRatingAxis">ci:InvestmentGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i05eea674d36b42b9b7fd99b97319f904_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:InvestmentsCreditRatingAxis">ci:InvestmentGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iffb70a8f680e4c8290525b7e1fef6da3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:InvestmentsCreditRatingAxis">ci:BelowInvestmentGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i30b568ddad034fb38476af6dff0d5b42_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ci:InvestmentsCreditRatingAxis">ci:BelowInvestmentGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i52a0532147074a69a79d2bde730cc6b4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ci:EquitySecuritiesFVNIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquitySecuritiesByIndustryAxis">us-gaap:HealthcareSectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia91b63f759a34db984a3518b4db4eae5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:LtvLessThan60PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i53e6849ed22a418fbb6188f47afafa8f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:LtvLessThan60PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i227e56a283374d43b53193cb2ae5296a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:LtvLessThan60PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icb8ba53337fd497ab5e68995d0c88cd2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:LtvLessThan60PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idc795fae04a24e6bbfae9210f9e9def8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:Ltv60To79PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id71bd449e9c6454cacf21e30ce2c498b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:Ltv60To79PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia74150594d8b46d49cdade2e93655870_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:Ltv60To79PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ide32893117054ad98838d727032c109e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">ci:Ltv60To79PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia0150b47337d4406b098b239d61060d8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">us-gaap:Ltv80To100PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i37f1db0b0e904b5291a5862d25f76c60_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">us-gaap:Ltv80To100PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i57d71fb7be6245038f50e90a278d63e9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">us-gaap:Ltv80To100PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie9d56cac03234e309389948e70c6ec5b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LoanToValueAxis">us-gaap:Ltv80To100PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7e013bc327d64747b0fccc969e1f0449_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if4810804d0794cab810a5c6d840e43f8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6a727657552e4bba86a90d288d5a606b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib51509dfe7384c87a20dfce010e9054b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablePortfolioSegmentAxis">us-gaap:CommercialPortfolioSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibddf171f855d455eb0339d11c5a8b669_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i87598f99e83e4f8fad5b7954451b7bf8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i94d91ccb4d8945f2b31211b7f940aa8c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">srt:PartnershipInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6214eeb319f84edc87092fa100092fae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">srt:PartnershipInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idd9435629cbc409e80fce5ba86b95ec5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if1c8862dc33f41798f458e182a06dc81_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4c40a4ac7f2a434f87a71b9ba541fbed_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic52a72b46e934d71b88725042436b309_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if4088ab619834175a08deb5b39beb15b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2f13ab64129a4c8fb094e735383237e5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9f8a274704049218d1ef098ed77fc12_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9a01ce3605c34a9aa36f20dfda34e4fb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i77341c9a2ae245cc8c56080a14bfe2ae_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib0cce95292e14776a7278f0e33003cdf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia07ed9d3c52b404e94ba85d570434570_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i73b62bf7014e45babcc9a18ea1226d9e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i032a4c4c66d44f95966d06b499946c31_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i989ef71163ae4e9c8eaafced6a9b1a25_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i930d264a52e74abd92fd6023e6324ee9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i950a2d2b127a4b9581697e8ffc5a5f06_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5cf66280f27c4cdab8de0ed3b972cd3f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8d4d88313bd744c9b9bfe00dc4beadb1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6458608672034857ab59db70911f8c1c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie93c0af573094af9b33586116b3a5681_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic7c3e6ee73bb44aaaf1dc02c1f8d9b9e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i126d653bef214cb5a2293e321a3c6a1f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0c23114e19414957ab7bf2b512b8032d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i911bced2d64f49388c06235bcf671712_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i210b492f12ea4598b3c1eaa7fe5053a9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8b60856ce8d24fbba0e9bdc9e6c8e8c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9589c2b720554541a51b62fcbedfa89c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i98bf5cf8552e4f3f93ab9849ef07ea23_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0f40ed4344194d4fa94fd6bc5ff74a0f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0ade3d59c3b74f71a757f3ce93ec3fe0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic1d1efad88f74a06b2f78f6f4a608383_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7b20e60e442842d383d58e1005c97d30_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibe9c93b5d23348ed9f2d2524fee1a2f6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibabd51e3f7364ae0a5c3a97072265a04_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id300a0f63845475da13c0c4f8959c18c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iedcadbdbe30c4f6e8eb2478149ef29e7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i496ceb12f2c94b9b995de6a325274988_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0e6aa69b6ac14548852cbc0cb1dd129c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b18e9f370634eaca75f7ac03fc42ec6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i122d51c6af904c34830a2d18ee8b3883_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7ea52ae05bad4666b5128b751245b170_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i87b7744b55da48babac0660b53c793fc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i407a2545ce8c476abfbe4489ad433944_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i635a05614dc44dfaa59bf4c4b0677a6c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8480eea330a24711916d476ea14fc9ff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i362c06fa9cc443e7bd73051dc42cbaca_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ife2fcb28e086422c8dc4e953d482abc9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2522a8f54759495caa0225401ceef646_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i346d7b1c76574be19f46677e85e8c5b1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1008fa627a0f446c963b0e67d8dfd067_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0d801185130948b6b2dfb025cf2c9afe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2172b84fcfbb48169b1cf9a8c8d71a74_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib9534d4bd0db4a8cb06ac21b74224b43_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i173890bd1b474d3198c5dfb300324f59_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic61449fd99784439939f74a26e23b495_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i65136b8ff46f4dcdace35ad210e68997_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibf1f04ddb0f54df990cf80a00f7696af_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if04209b927ad49a5ba1f009ea469bf3a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForwardsSwapsOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2b42664d2d054b1cb8a6a20eb860282a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic382cb79965348f7b830702205a70233_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia299f05a1244456c8e2a637925cd98ee_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5d3981d68ffb4ab1bb2f4ebea953bca7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i220f8c95ac454213bbf6528472654e1f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i777f12cc915c480f8486fbf1ff5fb6c4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibe8a9caf5fe04d33a35af66b6ea9dad3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic24dc2bb53ce4ae88734117cb7dae442_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ci:CorporateAndGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i545e52d4ab804995a43a6de0a3f9451d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id68863ce55b24c80abd273a20e11d928_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id54e9025aabe47faba625607f255ae82_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i522b8ff4b68a4b3b83655840fe0d0999_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i603fe8aa57f54159aa3dd133fca86c4d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4564af3a4a1e4f07bd83540908642eeb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibc819642d63d44d7812cdbbde998e471_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iac58c114e37e4838bf9723da6c4ec12f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ci:MeasurementInputLiquidityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ci:UnobservableInputsDevelopedByCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie20fd12fb4e5463baaf5a977f3780fb8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i233fdf4af61947d7882a46454c266f5e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2a7a90ae1f548208c8ec8f1cbcbb9c3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i94d1343670dd4e47affa7005b7f60ff6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib6207da178a44fb3864bb680dfb0bea3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:DebtAndEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64364361359847419628a63147bdad2e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:DebtAndEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:DebtAndEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:DebtAndEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i22c741b1ef01438c9bc0c95b9bc802d8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:DebtAndEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2b4e0a32ed2947fcac341851c89b111c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:DebtAndEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib60c510aad1f4274b05705d4451bb34a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i58dc13e2e83f45fd86f4fa7e2de05b1f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if6b20b8ea802488fb1423cffdd53e8f6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ica72812ec3684d749901011e62b0851b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1f62a525c9374ed5aa1cf92ab9b8c5e1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i99d6d20ebb17402f979ebdb5a3daba9c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i14917100852d4b948ca51e874a6b0212_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i34c7bd2940204fe29e4f3ff5202d63eb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0e61a85231a745cf8f18edb83018a703_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i495afe57b9e945e19224d443146762a4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if62bb74d9f924edb9286be35b3c7f345_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">srt:PartnershipInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i364eea148f374c20a2f0c593046922d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">srt:PartnershipInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i94fa67011b4847c1abf1f21028ae49ec_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">srt:PartnershipInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icff956d5fbf6434c977eea973ab12ba8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i032c221bd5464f3fb6549e1bb245453c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i36aa4fc292e346ff9124e93f204c8bef_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie1e80cb53c7b4030ad4a2f2374f1b4a4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i54d622066b6642138a4374276ced4e96_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8cac1c831b434f6aa1415442992376c4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8cde07c70a8d4809a5d5efd16dd587e7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1c58cb565aea4436b757679a195e2465_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic830eb3995b34b459ed632cf6d7d18c9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i40c865978ae54de8924e8ce3f15cd96f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i77f80db721434c238adc7b810844e85e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7922415e72f84dc0925918d4db42294a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05431ad3c0184457a9136c2f15684621_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib508898f275f4a768acf67c63c4a4668_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">srt:PartnershipInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5800d762bbc4479e8c8005dfaec6b354_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia35e6eb5dace45a085e40ef481f10932_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if429d97f6f9945029dfcdc1fc970e03f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5868b67b67224406aa46fb0e8471fa5e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i30053fba320b4d05beed1c1e1964b4b6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i49c2e14e07b54fc488c910392b015f3e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51f0ae43a8284805b5e99637347441a3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3d8b2a4b61444ca69c5e9a155af379a2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:SeparateAccountAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i18bbba0896f543cb9afd321606482dda_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i699bc3f219a0454d9541076c3ff72173_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i74213a55ce4840b39cb8ba80e171a3c6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia1e2a8ecd49b468db83c7246a6233f79_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i27a2c2fd471047389035115e103c4803_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7ec41b20522442a78d304f69275d1f6f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib47e378add8046febeed46402863f4f0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1eedce94285e450ea3c9ec311118b0dc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaf6aec08fb614f1f9373704db9a45990_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3574069d949f4ff58e5ed013efd6e44e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie315d35584a941c298193aa052832950_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9da4771b623549e5a758939e8718e0c6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociLiabilityForFuturePolicyBenefitParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1f0e583ccd0840039ba45ea866313d48_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociLiabilityForFuturePolicyBenefitParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3b0fa25db54c4cd5b97bf60ce65ce025_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5bc43d6d65d948eabf0c43a48194633f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6f5efb187a364a69a0332046f8b9dc86_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9dfb7b298e8348bebbdbb2ffbb195fc5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id43a85e5eb1645de94bf7c939c4071e2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6f42f5791c2144cbba874ff9a5058d6e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ci:AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic32d3eff65f84a3d9776350854ae8231_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id05c2da7d3ae4ceeb35fccff9cd109a3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i12523f50e770418e8cf76bec13c9b6f9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i57486b0895474a619153155e196783bb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i70d4659b2e374fa3b6fa858f21168b54_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5f152f9fd42e4e7bb1d7e7e7177095a5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie0fe44d65b564dfb91c260cbd59420f9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i32dd55f2fefd4ac7af712ac3651d80a0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iae231709f2154539b08738af3e5159cc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5730b56e2aba4bf0b30069589628b932_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i49e8b987a931474faf2d5c0788c6dd63_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i947635db683b4b3daa054f199155a2d0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i382b1889e4f048a797548743cf8e44d8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i500856a7a2f34b819a1cf711b4cbedd5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0deee6eee2ee46eeafe6188d0a931786_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9329656f7a714f9e906a28f984a13e6d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie7bdac56a5c747909f091b44b4679bf5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ida787829236f4e5b915c9415a14edb54_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i854c62090cb94df2a90a243d3b2a0448_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:RetirementAndLifeInsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:FinancialGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i003bcebd887e4bdcb34dc4edd5766fda_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:RetirementAndLifeInsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:FinancialGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6ffe330f5d2e42feb4023beb365c915f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie05d40387e70450eb97782a7626bd016_D20160301-20160331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsLitigationWithAnthemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">ci:PricingConcessionsThroughRemainingContractTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-01</startDate>
            <endDate>2016-03-31</endDate>
        </period>
    </context>
    <context id="i2602421334c748649e7b6a705dad545e_D20160301-20160331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsLitigationWithAnthemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">ci:PricingConcessionsAfterRemainingTermOfAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-01</startDate>
            <endDate>2016-03-31</endDate>
        </period>
    </context>
    <context id="i3e3b74c468ff4912bbea80db07b86240_D20160301-20160331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsLitigationWithAnthemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">ci:DamagesForServiceIssuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-01</startDate>
            <endDate>2016-03-31</endDate>
        </period>
    </context>
    <context id="i41708a20f5d543b49694e126b9d63ab6_D20160419-20160419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsCounterclaimsAgainstElevanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-19</startDate>
            <endDate>2016-04-19</endDate>
        </period>
    </context>
    <context id="i4776d8e52c934378b5373425506ecca3_I20160419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsCounterclaimsAgainstElevanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-04-19</instant>
        </period>
    </context>
    <context id="i6bd9f07d9d3a43dab2134f8b473b3aa9_D20220331-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsLitigationWithAnthemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">ci:PricingConcessionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ife782ca69c664ec9a42a195307da9dad_I20230308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ci:ExpressScriptsLitigationWithAnthemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-08</instant>
        </period>
    </context>
    <context id="i3ea40c1add1f432fa8308f993c435e87_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i69df325bba59494fa467077df69372c4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i477f7b8fc897444eb3eebca010f1c1a0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0aa4b4d327cd427280e23f867e7643d7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i070491a32c554309b0445a4d7d37f76a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2b088ac82fa046b686f50cf0918542f7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i06b3a5cafe1847468ebadf3df7edea80_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2cfd792e023147cea75b506ff355c317_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ci:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i21521b1995554ec8b02652d45c45d285_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i95c34c40cb7248e783ae13fc742a640d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic95354c853bf4761a405bfd3190f1ed6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4127249d3cc243de9f905eb276897d65_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i569d8e14804541b9a5e8a0e5a286a5bc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i724c42af69b6448fb2e4a5b6e6c155f7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i098db1bf768848acb5c35d20817215a9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ci:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8d60420098854826bb75b05e15a8dd62_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:NetworkPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ieeb14631940d478e80234443fdde93c4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:NetworkPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8b73e14198fb493797caa14157f4db48_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:HomeDeliveryAndSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if1d9f3a8c7e244afaeef48f7c0e28797_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:HomeDeliveryAndSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6dc2e436d3a3436ca9bb0c3657718683_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OtherPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib360b82d50b24f408baf926cbd36d43a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OtherPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie39a13614111404c93bbc50726bc2979_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i46b371195fbd4772a749aa7a8dd2fd45_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i08e34d7cd37940d9be3d86d7521f5686_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:MedicalRiskProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie1dd8e92561043ffbfbeda8cee9c928f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:MedicalRiskProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie3e9e00387384de780ea3b39d4254134_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:StopLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i33cfaac4439f45c89db679459cae7478_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:StopLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i834a123ddeb74d1eaa0c05c2490b66b9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OtherCommercialMedicalProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3733229295b04395a86ff23f3d3e14d6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:OtherCommercialMedicalProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idd3caeb6fdf54d798d5192a6b8874b10_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:MedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic5f66cd5ef874b81984fce532b63f71b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:MedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic24d316520f741b8aeeb8ece569a197f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:MedicarePartDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i300f527e494a4843be09f505c8e493ff_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:MedicarePartDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i700e68e0f51a4716a2d3851471d18417_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:IndividualAndFamilyPlansShortDurationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib8ae8fc97f3b4994bbaf95a5fe2b78d5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:IndividualAndFamilyPlansShortDurationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i36971d451ade4af1a50bd70e7bb2a491_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib2336928c4ea49a6bc4d4b5d15ee8bb8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ieaf7a109b0e34a0b924d846bbfe77c7a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:GroupMedicalInsuranceShortDurationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i19b8b552cfe8495aa3582c0783a57614_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:GroupMedicalInsuranceShortDurationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9c721be6f0264a54b1ef23c9b0206b6e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:IndividualPrivateMedicalInsuranceLongDurationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib9dbc603d392490aa593c0ee390a23ae_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:IndividualPrivateMedicalInsuranceLongDurationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib2847aa537584cefa3f2f5652bedb86f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:USMedicalProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib92eee19a6c741c3adc4a9c5ace7b113_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:USMedicalProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia11f9b58557a432b96d0a2ff40cf82c3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">ci:OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idccd94a3f926401c88f9bd7436ab16f5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">ci:OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0bccbb16e5d84306923a81662d3ea9ab_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">ci:OtherOperationsSegmentOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i79d10ac7a0e94fe7b6f88281dfc04939_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">ci:OtherOperationsSegmentOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic7d6a700163d4c319d21beade0fbcc04_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:ServiceFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1627e82149974da486e8f3cc3f75d2ab_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:ServiceFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:EvernorthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4a92f9eb139e45b58b6841d00343544b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:ServiceFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idffd5dd03d124226bb773704874daf86_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:ServiceFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:CignaHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1b6cacd9b87c4887ab34f6e65fe9d106_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:ServiceFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3577cdfec471463b8b1da0e53a0c050c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:ServiceFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i22cd581f72e445d8916b2124487b2977_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1e8cce4152f1403bace3946d48f2b9f5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i10032a6591314de5846c1184b289a4b8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if9e80ce4c0d14006b2d6a845fa506e93_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9556a32ddbb54ebeb4e7256d387ed702_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:PharmacyBenefitsManagementServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:GuaranteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i63fb1e4d8af94facb895426daf4d4db1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ci:PharmacyBenefitsManagementServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:GuaranteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="revolvingcreditfacility">
        <measure>ci:revolvingCreditFacility</measure>
    </unit>
    <unit id="position">
        <measure>ci:position</measure>
    </unit>
    <unit id="entity">
        <measure>ci:entity</measure>
    </unit>
    <unit id="claim">
        <measure>ci:claim</measure>
    </unit>
    <unit id="expert">
        <measure>ci:expert</measure>
    </unit>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xL2ZyYWc6MmJjZmM1ZWVlMGU3NDgxZmFmN2Q3ZjczZjhlNjcxOTkvdGFibGU6YTIyNTNiYTRlNjNlNDM4Y2E2MmVkNzI2YjY0NGUzYTAvdGFibGVyYW5nZTphMjI1M2JhNGU2M2U0MzhjYTYyZWQ3MjZiNjQ0ZTNhMF8zLTItMS0xLTU0NzA5OA_c55f8419-2789-43c1-ae2b-9329352bb7c0">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xL2ZyYWc6MmJjZmM1ZWVlMGU3NDgxZmFmN2Q3ZjczZjhlNjcxOTkvdGFibGU6YTIyNTNiYTRlNjNlNDM4Y2E2MmVkNzI2YjY0NGUzYTAvdGFibGVyYW5nZTphMjI1M2JhNGU2M2U0MzhjYTYyZWQ3MjZiNjQ0ZTNhMF80LTItMS0xLTU0NzA5OA_3be8c4ed-a9c3-4a7d-b8ca-f9b1982870bf">2023</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xL2ZyYWc6MmJjZmM1ZWVlMGU3NDgxZmFmN2Q3ZjczZjhlNjcxOTkvdGFibGU6YTIyNTNiYTRlNjNlNDM4Y2E2MmVkNzI2YjY0NGUzYTAvdGFibGVyYW5nZTphMjI1M2JhNGU2M2U0MzhjYTYyZWQ3MjZiNjQ0ZTNhMF81LTItMS0xLTU0NzA5OA_9325a0e8-92ab-4efa-a45a-a43de0cb53ef">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xL2ZyYWc6MmJjZmM1ZWVlMGU3NDgxZmFmN2Q3ZjczZjhlNjcxOTkvdGFibGU6YTIyNTNiYTRlNjNlNDM4Y2E2MmVkNzI2YjY0NGUzYTAvdGFibGVyYW5nZTphMjI1M2JhNGU2M2U0MzhjYTYyZWQ3MjZiNjQ0ZTNhMF82LTItMS0xLTU0NzA5OA_c987e69b-171e-4370-970f-9485c0dee199">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xL2ZyYWc6MmJjZmM1ZWVlMGU3NDgxZmFmN2Q3ZjczZjhlNjcxOTkvdGFibGU6YTIyNTNiYTRlNjNlNDM4Y2E2MmVkNzI2YjY0NGUzYTAvdGFibGVyYW5nZTphMjI1M2JhNGU2M2U0MzhjYTYyZWQ3MjZiNjQ0ZTNhMF83LTItMS0xLTU0NzA5OA_74959c11-1477-4342-963c-7ebfdf4dcabe">0001739940</dei:EntityCentralIndexKey>
    <ci:FairValueMeasurementNonPerformanceRiskAdjustment
      contextRef="i41bcd1ff54304762b1285aa37c402aca_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MDcvZnJhZzpjYWUwOTVmYmVmM2I0NThlYTA1MTlkNDBlNmE0NTZjZC90YWJsZTowN2I1ZTg0ZThkMzI0ZGE0YjQ2NWQ0ODg0OGUzNzhhZS90YWJsZXJhbmdlOjA3YjVlODRlOGQzMjRkYTRiNDY1ZDQ4ODQ4ZTM3OGFlXzItNC0xLTEtNTQ3MDk4_81f12584-882b-44a3-a343-0c1442b82cce"
      unitRef="usd"
      xsi:nil="true"/>
    <ci:FairValueMeasurementNonPerformanceRiskAdjustment
      contextRef="i3bcfd173fa8c4857abc112fc0044dc2d_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MDcvZnJhZzpjYWUwOTVmYmVmM2I0NThlYTA1MTlkNDBlNmE0NTZjZC90YWJsZTowN2I1ZTg0ZThkMzI0ZGE0YjQ2NWQ0ODg0OGUzNzhhZS90YWJsZXJhbmdlOjA3YjVlODRlOGQzMjRkYTRiNDY1ZDQ4ODQ4ZTM3OGFlXzItNS0xLTEtNTQ3MDk4_b3d5e9d4-5d0d-4c6b-9d33-516c7e17b3b7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="i51f0ae43a8284805b5e99637347441a3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTAvZnJhZzplYTM0YzRjYTY3Nzk0MTExOTA2MWJjNGY4ZWMzOWUwOC90YWJsZToyMmE2Yzg4N2I3MGM0MTNkOGRkMGU2YmRhODdhNzY5YS90YWJsZXJhbmdlOjIyYTZjODg3YjcwYzQxM2Q4ZGQwZTZiZGE4N2E3NjlhXzQtNC0xLTEtNTQ3MDk4_507cef23-fa02-4ce5-9aaa-99955a3aeebf"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="i3d8b2a4b61444ca69c5e9a155af379a2_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTAvZnJhZzplYTM0YzRjYTY3Nzk0MTExOTA2MWJjNGY4ZWMzOWUwOC90YWJsZToyMmE2Yzg4N2I3MGM0MTNkOGRkMGU2YmRhODdhNzY5YS90YWJsZXJhbmdlOjIyYTZjODg3YjcwYzQxM2Q4ZGQwZTZiZGE4N2E3NjlhXzQtNS0xLTEtNTQ3MDk4_7fdc730a-0b22-4eda-8650-b87fc12831a2"
      unitRef="usd"
      xsi:nil="true"/>
    <ci:RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTAvZnJhZzplYTM0YzRjYTY3Nzk0MTExOTA2MWJjNGY4ZWMzOWUwOC90YWJsZToyMmE2Yzg4N2I3MGM0MTNkOGRkMGU2YmRhODdhNzY5YS90YWJsZXJhbmdlOjIyYTZjODg3YjcwYzQxM2Q4ZGQwZTZiZGE4N2E3NjlhXzYtNC0xLTEtNTQ3MDk4_87c9b64b-6167-4ee9-ae3d-9b3e966b7feb"
      unitRef="usd"
      xsi:nil="true"/>
    <ci:RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTAvZnJhZzplYTM0YzRjYTY3Nzk0MTExOTA2MWJjNGY4ZWMzOWUwOC90YWJsZToyMmE2Yzg4N2I3MGM0MTNkOGRkMGU2YmRhODdhNzY5YS90YWJsZXJhbmdlOjIyYTZjODg3YjcwYzQxM2Q4ZGQwZTZiZGE4N2E3NjlhXzYtNS0xLTEtNTQ3MDk4_c99fe177-e013-44fe-a8fb-5379a6f16f74"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTAvZnJhZzplYTM0YzRjYTY3Nzk0MTExOTA2MWJjNGY4ZWMzOWUwOC90YWJsZToyMmE2Yzg4N2I3MGM0MTNkOGRkMGU2YmRhODdhNzY5YS90YWJsZXJhbmdlOjIyYTZjODg3YjcwYzQxM2Q4ZGQwZTZiZGE4N2E3NjlhXzctNC0xLTEtNTQ3MDk4_cd3fda68-9b4f-4a26-9f06-d6ffc8371988"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTAvZnJhZzplYTM0YzRjYTY3Nzk0MTExOTA2MWJjNGY4ZWMzOWUwOC90YWJsZToyMmE2Yzg4N2I3MGM0MTNkOGRkMGU2YmRhODdhNzY5YS90YWJsZXJhbmdlOjIyYTZjODg3YjcwYzQxM2Q4ZGQwZTZiZGE4N2E3NjlhXzctNS0xLTEtNTQ3MDk4_d83ec1ba-2e13-4d37-9d94-9b56587a3ad1"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTkx_d9cf79b6-2490-441b-8176-72c7b5822219">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl84OQ_d2e074b8-b3ca-47a4-a046-8fc30c4e8dc5">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTE_536396f0-42a7-4530-a9b9-9d788e8a68cd">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTc_6fbb033d-da2b-4a95-be64-b6c86f8ba39a">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTky_9fa3a692-6231-419f-abd8-d4f8b4220e37">001-38769</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8zODk_c3521966-0528-4b00-b910-c6f36222c01f">The Cigna Group</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6YjFmNDdjZWE1ODQ1NGExYjg4YTMwYTJlYzgwOWZjNWIvdGFibGVyYW5nZTpiMWY0N2NlYTU4NDU0YTFiODhhMzBhMmVjODA5ZmM1Yl8wLTAtMS0xLTU0NzA5OA_548ad97c-92b9-498d-b00b-62fa90c318e2">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6YjFmNDdjZWE1ODQ1NGExYjg4YTMwYTJlYzgwOWZjNWIvdGFibGVyYW5nZTpiMWY0N2NlYTU4NDU0YTFiODhhMzBhMmVjODA5ZmM1Yl8wLTEtMS0xLTU0NzA5OA_c5e0c5fc-a1d6-4bd3-8382-1da0f33bd57d">82-4991898</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl80NDk_c806883d-9c02-4f92-a44e-dfc929979b73">900 Cottage Grove Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl80NTM_bcb914f3-d892-4e4e-9e53-c0119dfbf585">Bloomfield</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTkz_57564d37-0ec5-477c-87a1-d4d6b2ef86eb">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl80Njk_e5fe5642-5982-4bc0-bbce-2a556b36259d">06002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl81MjY_41a393b6-9963-4089-b3f1-8a5d17bb187e">860</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl81MzA_90d78b84-0a6e-4d4c-bf2e-5920be8a33f8">226-6000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6Y2I4ODg0NjU1MDAxNGZjYTlmYTgzZDFiYjU4YmZmOGIvdGFibGVyYW5nZTpjYjg4ODQ2NTUwMDE0ZmNhOWZhODNkMWJiNThiZmY4Yl8xLTAtMS0xLTU0NzA5OA_1ad8176a-bfd7-41f8-b118-ec5c50f251a6">Common Stock, Par Value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6Y2I4ODg0NjU1MDAxNGZjYTlmYTgzZDFiYjU4YmZmOGIvdGFibGVyYW5nZTpjYjg4ODQ2NTUwMDE0ZmNhOWZhODNkMWJiNThiZmY4Yl8xLTEtMS0xLTU0NzA5OA_3602fcec-f473-401e-a3e6-549cbdd97534">CI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6Y2I4ODg0NjU1MDAxNGZjYTlmYTgzZDFiYjU4YmZmOGIvdGFibGVyYW5nZTpjYjg4ODQ2NTUwMDE0ZmNhOWZhODNkMWJiNThiZmY4Yl8xLTItMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjE1ZTBiMmY5NDQ1NDQxYzBhMTRkMTRjNzg2NjQzYjkzXzQ_7c3034a0-6cbf-4406-b2e3-1f4640c9b329">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8xMDk0_d0e18b38-b942-4668-9a06-b3b98204fa8b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8xMzg4_0cb88475-81eb-4f23-a245-317ab519cd40">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6OTJhNzRkNWQ1OGMwNDYxOWI4NjM5YzRmYTMzNGEyN2YvdGFibGVyYW5nZTo5MmE3NGQ1ZDU4YzA0NjE5Yjg2MzljNGZhMzM0YTI3Zl8wLTAtMS0xLTU0NzA5OA_c7411039-b502-42b5-86dc-8bc4281b6f3a">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6OTJhNzRkNWQ1OGMwNDYxOWI4NjM5YzRmYTMzNGEyN2YvdGFibGVyYW5nZTo5MmE3NGQ1ZDU4YzA0NjE5Yjg2MzljNGZhMzM0YTI3Zl8xLTMtMS0xLTU0NzA5OA_96211037-197b-45ef-b168-bb8e87983b3a">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGFibGU6OTJhNzRkNWQ1OGMwNDYxOWI4NjM5YzRmYTMzNGEyN2YvdGFibGVyYW5nZTo5MmE3NGQ1ZDU4YzA0NjE5Yjg2MzljNGZhMzM0YTI3Zl8yLTMtMS0xLTU0NzA5OA_5b1be86d-9c70-4a90-9abd-00be0c769b3d">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTkw_01af121c-5cca-4799-8ec2-d6025b66fedb">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ifdeb9c39ab4c4ab3bc182291feaa44c7_I20230428"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8xMDE1L2ZyYWc6YTVmMmU2MGIxYmE3NDdkZjk5MmU2MjFlZDI3NDI5ZmIvdGV4dHJlZ2lvbjphNWYyZTYwYjFiYTc0N2RmOTkyZTYyMWVkMjc0MjlmYl8yMTM1_e76ae1c1-4518-4d6a-bebd-c8fab9a66aff"
      unitRef="shares">295872231</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i933d49a7caa5445f9359253b5b0b5023_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzctNS0xLTEtNTQ3MDk4_6e356be0-72f3-46bb-b2ec-d6cdaced9880"
      unitRef="usd">32144000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2699cfc415ab4727a3246be3ce9a03fb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzctNy0xLTEtNTQ3MDk4_b608a220-43b4-414e-bb6d-c0d3e771d842"
      unitRef="usd">30697000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzgtNS0xLTEtNTQ3MDk4_0426fc01-519a-4958-adfe-82c54a97504d"
      unitRef="usd">11025000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzgtNy0xLTEtNTQ3MDk4_82bd1d0d-3d97-4d39-b707-03d5f4ea8e2f"
      unitRef="usd">10356000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1cf64ff3b0a2466f81f78f097b7c8d5d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzktNS0xLTEtNTQ3MDk4_83b59999-c3a8-4739-8c25-4ba6307c28eb"
      unitRef="usd">3071000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i530643094c274242bf05d8df55f63659_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzktNy0xLTEtNTQ3MDk4_924c3d8b-87cf-4a58-aeee-db86200494dc"
      unitRef="usd">2539000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEwLTUtMS0xLTU0NzA5OA_0bd806e6-8bc2-45cd-9d98-d8fa5ef6363e"
      unitRef="usd">277000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEwLTctMS0xLTU0NzA5OA_36cf6d52-c0ac-4ef6-9830-7348e5cae671"
      unitRef="usd">414000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzExLTUtMS0xLTU0NzA5OA_0ac468c7-3646-477e-b021-17aca69f01c6"
      unitRef="usd">46517000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzExLTctMS0xLTU0NzA5OA_b9e95365-24e8-46b2-a0f0-ac7626b5a698"
      unitRef="usd">44006000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEzLTUtMS0xLTU0NzA5OA_c3c745e0-faab-4ee8-8cde-d370e47072c2"
      unitRef="usd">31459000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEzLTctMS0xLTU0NzA5OA_2fc001d2-249f-4ef4-b606-4b3956446652"
      unitRef="usd">29813000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE0LTUtMS0xLTU0NzA5OA_7debbd55-0a05-499d-85f8-24e2c1dc9b25"
      unitRef="usd">9046000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE0LTctMS0xLTU0NzA5OA_3fd58480-6fc6-4346-a85f-569666fd106e"
      unitRef="usd">8272000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE1LTUtMS0xLTU0NzA5OA_8ef06699-9103-4116-a1ac-5f12a5850f10"
      unitRef="usd">3538000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE1LTctMS0xLTU0NzA5OA_aa2ba26f-2635-4ed1-9fe2-749bf50cc82a"
      unitRef="usd">3275000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE2LTUtMS0xLTU0NzA5OA_b75edf90-41d6-4615-be11-f855076cc6ea"
      unitRef="usd">459000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE2LTctMS0xLTU0NzA5OA_01ad8e17-2c25-4100-9031-1579a895ff34"
      unitRef="usd">458000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE3LTUtMS0xLTU0NzA5OA_a4296909-1b07-4580-a873-be3c6ca28ba8"
      unitRef="usd">44502000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE3LTctMS0xLTU0NzA5OA_2c887ebd-2fb1-4159-b27e-a29d03ae639e"
      unitRef="usd">41818000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE4LTUtMS0xLTU0NzA5OA_bddbf9b0-ac12-4b2d-99c8-52a4c706dcae"
      unitRef="usd">2015000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE4LTctMS0xLTU0NzA5OA_56970ec1-46d1-42da-a19c-a4deb639cfd2"
      unitRef="usd">2188000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE5LTUtMS0xLTU0NzA5OA_0417fc0c-d9d1-4020-8536-9fb60abef367"
      unitRef="usd">-358000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE5LTctMS0xLTU0NzA5OA_3dea0a2f-db00-4c45-bc82-390112e51307"
      unitRef="usd">-299000000</us-gaap:OtherNonoperatingIncomeExpense>
    <ci:RealizedInvestmentGainLoss
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIyLTUtMS0xLTU0NzA5OA_dea2bf33-feea-4208-9d1c-304c2192f354"
      unitRef="usd">-56000000</ci:RealizedInvestmentGainLoss>
    <ci:RealizedInvestmentGainLoss
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIyLTctMS0xLTU0NzA5OA_12493226-c472-47e5-99ea-a9c4706db302"
      unitRef="usd">-322000000</ci:RealizedInvestmentGainLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIzLTUtMS0xLTU0NzA5OA_0118b9fd-629d-466b-8f3f-c42b8544fc63"
      unitRef="usd">1601000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIzLTctMS0xLTU0NzA5OA_1556d15b-48f1-4191-86f8-73377cfb6937"
      unitRef="usd">1567000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI0LTUtMS0xLTU0NzA5OA_acdde8f0-b78f-47ac-ab80-838071023113"
      unitRef="usd">295000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI0LTctMS0xLTU0NzA5OA_8c91905f-ebae-4e12-89d6-f1a4630a6fc5"
      unitRef="usd">355000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI1LTUtMS0xLTU0NzA5OA_57915525-1cff-455e-b188-41e347a02700"
      unitRef="usd">1306000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI1LTctMS0xLTU0NzA5OA_102a37c5-08ac-4a1e-9332-52a57043267b"
      unitRef="usd">1212000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI2LTUtMS0xLTU0NzA5OA_91475474-3f2d-48b5-bf8e-b8c29b92e368"
      unitRef="usd">39000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI2LTctMS0xLTU0NzA5OA_e5fba830-b7e9-4d2a-9d4e-e9ecb3440398"
      unitRef="usd">15000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI3LTUtMS0xLTU0NzA5OA_f9fafe56-8ed2-4d6f-85bd-a235e72de841"
      unitRef="usd">1267000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI3LTctMS0xLTU0NzA5OA_b71d309d-9ca3-4c0b-aa5c-2b67275d02db"
      unitRef="usd">1197000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI5LTUtMS0xLTU0NzA5OA_f4aca24b-ae68-440a-b82e-8c23a078cd0f"
      unitRef="usdPerShare">4.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI5LTctMS0xLTU0NzA5OA_7e94545c-5dd5-40ad-8402-14ded75dd02b"
      unitRef="usdPerShare">3.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzMwLTUtMS0xLTU0NzA5OA_43717eef-eeda-4033-8829-51818dafe390"
      unitRef="usdPerShare">4.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzMwLTctMS0xLTU0NzA5OA_fbc1a597-6d69-4d17-8314-e2aeec6dfd6f"
      unitRef="usdPerShare">3.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzQtNS0xLTEtNTQ3MDk4_90abbf5c-7b6f-4d51-a697-b841700bba8e"
      unitRef="usd">1306000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzQtNy0xLTEtNTQ3MDk4_8ab5a675-2a99-441f-a3fb-56dc1264a26a"
      unitRef="usd">1212000000</us-gaap:ProfitLoss>
    <ci:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzYtNS0xLTEtNTQ3MDk4_f276bbbb-bd88-440b-a0ac-8eef469af0a7"
      unitRef="usd">194000000</ci:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax>
    <ci:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzYtNy0xLTEtNTQ3MDk4_35c93aec-9e7e-4334-bc7f-e8ec9b9a4686"
      unitRef="usd">-843000000</ci:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax>
    <ci:OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNS0xLTEtNTk3NDcx_0bd12898-7e42-4129-9e81-236baab51a8d"
      unitRef="usd">-331000000</ci:OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax>
    <ci:OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNy0xLTEtNTk3NDcx_1c048248-06d6-4527-9699-9259b5dbd011"
      unitRef="usd">459000000</ci:OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax>
    <ci:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNS0xLTEtNTQ3MDk4_ead6c906-7a6c-4fb7-9789-df781e279724"
      unitRef="usd">16000000</ci:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity>
    <ci:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNy0xLTEtNTQ3MDk4_35bee086-c8e3-40db-b944-6b19988ccfe7"
      unitRef="usd">-63000000</ci:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzExLTUtMS0xLTU0NzA5OA_124e425c-a9a7-4f6c-8bc2-6e1caf5929b8"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzExLTctMS0xLTU0NzA5OA_3dfd2d59-cc65-4740-803c-0b1b5451cba2"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <ci:OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEyLTUtMS0xLTU0NzA5OA_fd5acbb8-bf0b-474e-bfb9-b76bf7f9dabd"
      unitRef="usd">-111000000</ci:OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity>
    <ci:OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEyLTctMS0xLTU0NzA5OA_e5bd59b8-acff-40a9-84f0-57e953521a33"
      unitRef="usd">-434000000</ci:OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity>
    <ci:ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEzLTUtMS0xLTU0NzA5OA_6452969d-1612-49e0-bccf-da70eb8edb52"
      unitRef="usd">1195000000</ci:ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity>
    <ci:ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEzLTctMS0xLTU0NzA5OA_4c603a81-46c3-4370-942a-6aff72d75ecd"
      unitRef="usd">778000000</ci:ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE2LTUtMS0xLTU0NzA5OA_ff61b6b8-d30d-4d80-b1db-ff4e37fe7953"
      unitRef="usd">34000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE2LTctMS0xLTU0NzA5OA_659b721e-341f-4097-bf9b-a992c9a31cc2"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE3LTUtMS0xLTU0NzA5OA_219d76bb-1cfd-4a30-81fa-4f24f0619c8e"
      unitRef="usd">5000000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE3LTctMS0xLTU0NzA5OA_bdb6324f-b7ae-484d-a5d1-a9cbaf53feaa"
      unitRef="usd">12000000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <ci:TemporaryEquityOtherComprehensiveIncome
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE4LTUtMS0xLTU0NzA5OA_63d67157-cbdb-4538-b2fe-eafb5c25c089"
      unitRef="usd">0</ci:TemporaryEquityOtherComprehensiveIncome>
    <ci:TemporaryEquityOtherComprehensiveIncome
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE4LTctMS0xLTU0NzA5OA_8ead8ea9-7460-4be6-aa76-7648b71546a0"
      unitRef="usd">-2000000</ci:TemporaryEquityOtherComprehensiveIncome>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE5LTUtMS0xLTU0NzA5OA_96cc84e3-5f58-47a6-a5c4-3a404b9cade2"
      unitRef="usd">39000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE5LTctMS0xLTU0NzA5OA_3a6c2d42-a5ed-4b47-8f76-2d52bf842af8"
      unitRef="usd">13000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzIwLTUtMS0xLTU0NzA5OA_4741fbbc-64f4-4c52-9dbb-a934e1607170"
      unitRef="usd">1156000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzIwLTctMS0xLTU0NzA5OA_c602d313-2305-4b2e-ac6d-814d71a51d5d"
      unitRef="usd">765000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzYtMS0xLTEtNTQ3MDk4_c621c55d-67d7-47e3-b168-0052f146dfd0"
      unitRef="usd">7935000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzYtMy0xLTEtNTQ3MDk4_e483f4e2-0134-4faf-8374-b9e8c431fc37"
      unitRef="usd">5924000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzctMS0xLTEtNTQ3MDk4_6e58cd50-6ceb-4b37-8d1e-c2cfab519842"
      unitRef="usd">914000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzctMy0xLTEtNTQ3MDk4_b136721f-f061-4fe3-af15-6ae5cb0c5c55"
      unitRef="usd">905000000</us-gaap:ShortTermInvestments>
    <us-gaap:ReceivablesNetCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzgtMS0xLTEtNTQ3MDk4_b4d406ff-5343-4643-ac40-11099267e6c1"
      unitRef="usd">17704000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzgtMy0xLTEtNTQ3MDk4_51d694db-a877-47da-b5f9-5123c07b3070"
      unitRef="usd">17218000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzktMS0xLTEtNTQ3MDk4_d59cf30e-f796-4b3a-bb6b-273cef19a621"
      unitRef="usd">4211000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzktMy0xLTEtNTQ3MDk4_46f8e2ec-fd55-44cd-a088-ab4007ad34df"
      unitRef="usd">4777000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEwLTEtMS0xLTU0NzA5OA_c986094d-b6d4-47ba-9f14-f6b999e97223"
      unitRef="usd">1263000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEwLTMtMS0xLTU0NzA5OA_e184b990-0d77-4d55-ad49-e7ed65c4679c"
      unitRef="usd">1298000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEyLTEtMS0xLTU0NzA5OA_9aa0ecb2-439c-4277-89fe-46bea7f792cd"
      unitRef="usd">32027000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEyLTMtMS0xLTU0NzA5OA_5bbe8a6d-2253-45d5-8f58-a6331a9768ea"
      unitRef="usd">30122000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEzLTEtMS0xLTU0NzA5OA_ea1db71c-8e69-41b8-a9ba-5d0040b2e4eb"
      unitRef="usd">19010000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEzLTMtMS0xLTU0NzA5OA_e72c918c-a597-474e-a170-f2142e110cde"
      unitRef="usd">16288000000</us-gaap:LongTermInvestments>
    <ci:ReinsuranceRecoverablesNonCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE0LTEtMS0xLTU0NzA5OA_5aa64ebd-3245-41fa-b2f9-6098ad15f8b8"
      unitRef="usd">5286000000</ci:ReinsuranceRecoverablesNonCurrent>
    <ci:ReinsuranceRecoverablesNonCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE0LTMtMS0xLTU0NzA5OA_e8dbe745-b137-4a8a-83e0-1f7061ec6fcc"
      unitRef="usd">5416000000</ci:ReinsuranceRecoverablesNonCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE2LTEtMS0xLTU0NzA5OA_3488d113-25f8-4aa1-89ac-45d540354775"
      unitRef="usd">3837000000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE2LTMtMS0xLTU0NzA5OA_0c15b4f5-83d2-4988-a69a-4a901dd62c36"
      unitRef="usd">3774000000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:Goodwill
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE3LTEtMS0xLTU0NzA5OA_22f3dc03-b2bf-49bc-8bb6-b280ed1a5cc1"
      unitRef="usd">45811000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE3LTMtMS0xLTU0NzA5OA_0579eb36-c167-4f6e-ac4f-8d839aa63d39"
      unitRef="usd">45811000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE4LTEtMS0xLTU0NzA5OA_7569facc-91d2-4d21-92bd-8be7564fc737"
      unitRef="usd">32102000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE4LTMtMS0xLTU0NzA5OA_606c6e00-9244-4d69-aba4-00e335e87c0c"
      unitRef="usd">32492000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE5LTEtMS0xLTU0NzA5OA_2c2493a2-3ce3-4378-99ae-832990eaaeec"
      unitRef="usd">2563000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE5LTMtMS0xLTU0NzA5OA_57070670-5068-4a3b-9b4b-84eb01a3e79c"
      unitRef="usd">2704000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:SeparateAccountAssets
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIwLTEtMS0xLTU0NzA5OA_73bd6393-42e4-4c26-bd35-1e8639ec8172"
      unitRef="usd">7340000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIwLTMtMS0xLTU0NzA5OA_6c111ea2-82cb-4b26-a946-7f22aaa08789"
      unitRef="usd">7278000000</us-gaap:SeparateAccountAssets>
    <us-gaap:Assets
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIxLTEtMS0xLTU0NzA5OA_f02ed902-0ce0-4c35-9002-03d3b852b2fe"
      unitRef="usd">147976000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIxLTMtMS0xLTU0NzA5OA_f7fff571-48ef-4940-a349-e127170daa6d"
      unitRef="usd">143885000000</us-gaap:Assets>
    <ci:InsuranceAndContractholderLiabilitiesCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIzLTEtMS0xLTU0NzA5OA_16b33893-917f-4017-91d2-5ed04b0af8be"
      unitRef="usd">7166000000</ci:InsuranceAndContractholderLiabilitiesCurrent>
    <ci:InsuranceAndContractholderLiabilitiesCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIzLTMtMS0xLTU0NzA5OA_20ec4532-c297-4eb0-9e39-01131f073d2c"
      unitRef="usd">5409000000</ci:InsuranceAndContractholderLiabilitiesCurrent>
    <ci:PharmacyAndServiceCostsPayable
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI0LTEtMS0xLTU0NzA5OA_fe804b71-1e9a-4c19-a1b6-4401dfc4cd2c"
      unitRef="usd">17609000000</ci:PharmacyAndServiceCostsPayable>
    <ci:PharmacyAndServiceCostsPayable
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI0LTMtMS0xLTU0NzA5OA_acf1354a-c049-49fb-8776-a986bbb3b160"
      unitRef="usd">17070000000</ci:PharmacyAndServiceCostsPayable>
    <us-gaap:AccountsPayableCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI1LTEtMS0xLTU0NzA5OA_41022e96-79cf-4ae2-b967-2c90bf775832"
      unitRef="usd">7360000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI1LTMtMS0xLTU0NzA5OA_18ac489a-f37c-4ec1-a714-d74297b28e87"
      unitRef="usd">7775000000</us-gaap:AccountsPayableCurrent>
    <ci:AccruedExpensesAndOtherLiabilities
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI2LTEtMS0xLTU0NzA5OA_36e0b0c3-6a81-41fd-947c-c799fd45fc5e"
      unitRef="usd">9174000000</ci:AccruedExpensesAndOtherLiabilities>
    <ci:AccruedExpensesAndOtherLiabilities
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI2LTMtMS0xLTU0NzA5OA_b0aeb6ff-21f1-4e80-b147-de6a735a696d"
      unitRef="usd">7978000000</ci:AccruedExpensesAndOtherLiabilities>
    <us-gaap:DebtCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI3LTEtMS0xLTU0NzA5OA_af932630-72d2-4203-875c-3422bc72559b"
      unitRef="usd">3418000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI3LTMtMS0xLTU0NzA5OA_de2112bc-0175-4727-adc0-cb5da30eceb7"
      unitRef="usd">2993000000</us-gaap:DebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI5LTEtMS0xLTU0NzA5OA_4bd306e6-839c-4c2c-b81f-894b16d96e37"
      unitRef="usd">44727000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI5LTMtMS0xLTU0NzA5OA_7ffe16a4-d89f-49d6-9763-76e5f24f322c"
      unitRef="usd">41225000000</us-gaap:LiabilitiesCurrent>
    <ci:InsuranceAndContractholderLiabilitiesNoncurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMwLTEtMS0xLTU0NzA5OA_9338ff28-17c3-49d4-936e-a69df5160a76"
      unitRef="usd">11790000000</ci:InsuranceAndContractholderLiabilitiesNoncurrent>
    <ci:InsuranceAndContractholderLiabilitiesNoncurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMwLTMtMS0xLTU0NzA5OA_a44adfa6-6eae-4b0f-b1d1-3eed36def226"
      unitRef="usd">11976000000</ci:InsuranceAndContractholderLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMxLTEtMS0xLTU0NzA5OA_a72ff1c4-b417-405a-9c9b-515020a6cbaa"
      unitRef="usd">7707000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMxLTMtMS0xLTU0NzA5OA_01113199-5d06-4601-8809-daf773980ca9"
      unitRef="usd">7786000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMyLTEtMS0xLTU0NzA5OA_c0f8cb04-d992-459f-9791-c1cfd7642a3d"
      unitRef="usd">2692000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMyLTMtMS0xLTU0NzA5OA_4809f36f-6a2f-4048-8673-5a1061b6d99c"
      unitRef="usd">2766000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMzLTEtMS0xLTU0NzA5OA_a441e383-0c72-4d47-8ae9-41916e7dff83"
      unitRef="usd">29124000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMzLTMtMS0xLTU0NzA5OA_031c2ccf-4ee1-437f-9758-c51d899420bd"
      unitRef="usd">28100000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:SeparateAccountsLiability
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM0LTEtMS0xLTU0NzA5OA_5e011b86-a445-4574-a876-e058c3178a9e"
      unitRef="usd">7340000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM0LTMtMS0xLTU0NzA5OA_917de155-e4db-434c-8967-b1ec380a671b"
      unitRef="usd">7278000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:Liabilities
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM1LTEtMS0xLTU0NzA5OA_82f48fc6-4b1e-4072-9c12-7f8af979830f"
      unitRef="usd">103380000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM1LTMtMS0xLTU0NzA5OA_1910bc6f-591d-4929-a6ae-39b31a5bd6fd"
      unitRef="usd">99131000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM2LTEtMS0xLTU0NzA5OA_410c945c-c96b-491a-aab5-2707b7dffd8e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM2LTMtMS0xLTU0NzA5OA_8eeedf58-d0e2-40f8-8b86-077a5ed635f8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM3LTEtMS0xLTU0NzA5OA_139a7533-451c-41dc-8ff0-569767ca17ec"
      unitRef="usd">78000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM3LTMtMS0xLTU0NzA5OA_a4ce84c7-19ab-464f-b99d-4d830b9eedf0"
      unitRef="usd">66000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockValue
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTEtMS0xLTU0NzA5OA_8d2482df-cd75-47ae-976b-bacf4ba05ab7"
      unitRef="usd">4000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTMtMS0xLTU0NzA5OA_20560a86-6865-406c-95e4-b3ce23b74169"
      unitRef="usd">4000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQwLTEtMS0xLTU0NzA5OA_749f47b6-7e8a-4561-9acb-d82b9dd137b2"
      unitRef="usd">30332000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQwLTMtMS0xLTU0NzA5OA_99927523-d0b4-4bf2-bbf5-8db7be5836c2"
      unitRef="usd">30233000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQxLTEtMS0xLTU0NzA5OA_31dd39bd-e7bc-411b-a63d-52b3f6de38c4"
      unitRef="usd">-1769000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQxLTMtMS0xLTU0NzA5OA_731c83fa-4eea-409a-86d1-8ef2c67b0e56"
      unitRef="usd">-1658000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQyLTEtMS0xLTU0NzA5OA_197c57a2-bd47-44dd-ab83-2284e16d8de2"
      unitRef="usd">38841000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQyLTMtMS0xLTU0NzA5OA_36c37ec6-ca45-43f2-999c-6357a46584de"
      unitRef="usd">37940000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQzLTEtMS0xLTU0NzA5OA_b9475012-22a7-4ae9-892e-77643aa0f42f"
      unitRef="usd">22906000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQzLTMtMS0xLTU0NzA5OA_f720eea4-20f9-40aa-9c2e-55cf9814c9cf"
      unitRef="usd">21844000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ0LTEtMS0xLTU0NzA5OA_1d1f7e3a-db3d-4cac-83ed-611def49fc83"
      unitRef="usd">44502000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ0LTMtMS0xLTU0NzA5OA_864afb31-0910-42a1-b5b6-717fed9ea74f"
      unitRef="usd">44675000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ1LTEtMS0xLTU0NzA5OA_27b904c3-684c-4f48-9492-f5d20d449ec0"
      unitRef="usd">16000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ1LTMtMS0xLTU0NzA5OA_ccc13179-2a66-4ae0-a061-19c1ea7c9991"
      unitRef="usd">13000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ2LTEtMS0xLTU0NzA5OA_5b43daf5-7f14-40c1-9f9e-61a4a640ca5f"
      unitRef="usd">44518000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ2LTMtMS0xLTU0NzA5OA_3652dd29-c6f7-4939-a019-d0a25976ad42"
      unitRef="usd">44688000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ3LTEtMS0xLTU0NzA5OA_ccd73141-40ba-4156-bf25-d59af259b96b"
      unitRef="usd">147976000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ3LTMtMS0xLTU0NzA5OA_97090691-b4c3-43b5-b77b-061701c2fa9e"
      unitRef="usd">143885000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzM2_9d52a65c-ab4b-4b2c-9f9f-46cb2ad62472"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzM2_ed619e9c-b002-40d3-a381-4d57cd3798be"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzU1_4aae0c51-0138-475b-b5bf-de6d9a74ac64"
      unitRef="shares">399000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzcx_7e34226c-205b-48d0-af19-97bea63e04f5"
      unitRef="shares">398000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzEwMw_a5cea792-bbb4-494e-8ce0-566675b6131a"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzEwMw_a685b8f1-7c80-4df2-b418-9462b66f3001"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id32446380c2041c8b63ae668e812de11_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMS0xLTEtNTQ3MDk4_b11e4b39-97be-4030-992e-f4b750eaa8de"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia07eeeff84fa4f25a2dd79fdc9bc15dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMy0xLTEtNTQ3MDk4_c47cdd19-3043-4ddc-8472-3fb8251772c5"
      unitRef="usd">30233000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib2b7588439a24468b996c973b3308b0f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtNS0xLTEtNTQ3MDk4_7268058b-daf3-4f83-b55f-ca21c3179757"
      unitRef="usd">-1658000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7d813880f744d49943f15dd7e540ba0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtNy0xLTEtNTQ3MDk4_2d1ad352-3fd3-4c93-8d68-6014b98ef8cb"
      unitRef="usd">37940000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90dec54128bd417fa982da7f2d7685f2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtOS0xLTEtNTQ3MDk4_80c452f7-d6bd-4b5b-a0ba-20e188f66261"
      unitRef="usd">-21844000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d2cebed8b184349b833533515099744_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTEtMS0xLTU0NzA5OA_9356d6da-3934-4e59-b329-f57e0dfa69e3"
      unitRef="usd">44675000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0206ebaad6534ebe9f01b32c7c8377aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTMtMS0xLTU0NzA5OA_2557cd11-338d-4aa3-86ba-661f15475ab4"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTUtMS0xLTU0NzA5OA_e205003c-80c6-4204-b42d-5e25a7ea436c"
      unitRef="usd">44688000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTctMS0xLTU0NzA5OA_90433d9f-2558-4927-afa9-7a1032a8b39a"
      unitRef="usd">66000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7909946bc91943678368051fb2668b17_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzctMy0xLTEtNTQ3MDk4_6d00cfc8-0223-4448-80f7-4fbcadf65647"
      unitRef="usd">99000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iaf856e4d292f45ee82a219747b70690d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzctOS0xLTEtNTQ3MDk4_4d856e91-c15f-4906-920e-caed86139078"
      unitRef="usd">-104000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzctMTEtMS0xLTU0NzA5OA_4a05ae94-38c4-4422-bd33-018f22bb3a0f"
      unitRef="usd">-5000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzctMTUtMS0xLTU0NzA5OA_45b0779e-7fc8-4215-b26d-149f25866e19"
      unitRef="usd">-5000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3c0abb6b8064491c945d2af1005f4e61_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzgtNS0xLTEtNTQ3MDk4_9f7f0761-168a-4143-8751-1b6e70602d3e"
      unitRef="usd">-111000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzgtMTEtMS0xLTU0NzA5OA_ada1d0a2-27d5-41bd-8a61-a81867fb1fc0"
      unitRef="usd">-111000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzgtMTUtMS0xLTU0NzA5OA_1a3a396b-f4f2-49eb-9b27-c5887fc98e80"
      unitRef="usd">-111000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i22ee4c2e55934757aa575a02b3920fb4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzktNy0xLTEtNTQ3MDk4_9322eacc-4ac3-4f72-b023-ab9b97e1c447"
      unitRef="usd">1267000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzktMTEtMS0xLTU0NzA5OA_ed450034-cb02-4600-85b0-6be0b24371ec"
      unitRef="usd">1267000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i05dd3918d78c4bf1a755567f7c64ddb8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzktMTMtMS0xLTU0NzA5OA_ffaa1eeb-3c56-4a8c-9797-638020385245"
      unitRef="usd">5000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzktMTUtMS0xLTU0NzA5OA_751bce05-f144-4c38-b496-13c786334bd4"
      unitRef="usd">1272000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzktMTctMS0xLTU0NzA5OA_67a91ea2-19d3-409a-acb2-c0ee2d14b8d3"
      unitRef="usd">34000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjg4YjViZjdkNDM0MDQxNjJiMDYwZGEwM2JmNWUxOTIyXzU0OTc1NTgxMzk0MQ_46f2df2d-c6cc-4fac-86d3-47034aa0fc58"
      unitRef="usdPerShare">1.23</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i22ee4c2e55934757aa575a02b3920fb4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEwLTctMS0xLTU0NzA5OA_9a813110-264d-4d1f-abe7-329797f92bfa"
      unitRef="usd">366000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEwLTExLTEtMS01NDcwOTg_0cd1c19d-bbad-4ac2-981c-89caf1d96a67"
      unitRef="usd">366000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEwLTE1LTEtMS01NDcwOTg_ed6444c1-3031-4f8d-8fcf-609bda5ba755"
      unitRef="usd">366000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iaf856e4d292f45ee82a219747b70690d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzExLTktMS0xLTU0NzA5OA_2326caaf-c9ab-4e1c-abdf-b838c848c5f8"
      unitRef="usd">958000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzExLTExLTEtMS01NDcwOTg_86b34cca-cac0-47a9-85de-d617bb80ebff"
      unitRef="usd">958000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzExLTE1LTEtMS01NDcwOTg_cc26bb71-1de2-4683-9cfc-58aa1d667808"
      unitRef="usd">958000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <ci:NoncontrollingInterestOtherChanges
      contextRef="i9713eec14c284c5094eb258ae84ae2c8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEyLTExLTEtMS01NDcwOTg_6187d803-3e26-4edf-b90b-75910aa3a2a9"
      unitRef="usd">0</ci:NoncontrollingInterestOtherChanges>
    <ci:NoncontrollingInterestOtherChanges
      contextRef="i05dd3918d78c4bf1a755567f7c64ddb8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEyLTEzLTEtMS01NDcwOTg_8a6ed664-dc95-4bbf-926b-fc35b33dfb4e"
      unitRef="usd">-2000000</ci:NoncontrollingInterestOtherChanges>
    <ci:NoncontrollingInterestOtherChanges
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEyLTE1LTEtMS01NDcwOTg_8797416f-afe7-4852-83e0-f46671a9b04f"
      unitRef="usd">-2000000</ci:NoncontrollingInterestOtherChanges>
    <us-gaap:TemporaryEquityOtherChanges
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEyLTE3LTEtMS01NDcwOTg_dfaa5478-3447-4800-8522-b48ad7c74bf9"
      unitRef="usd">-22000000</us-gaap:TemporaryEquityOtherChanges>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia464d53888f74e16b5ba9e62ba445568_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTEtMS0xLTU0NzA5OA_0177b6de-4b7a-4eaa-b504-3f34767c35f0"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i34d79544d8cb4787abb0f63293d81023_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTMtMS0xLTU0NzA5OA_03db70c1-def6-43ad-84aa-af3e229b4525"
      unitRef="usd">30332000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ca2b0796c79476594136b360600f553_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTUtMS0xLTU0NzA5OA_2d4c9807-3947-433b-af43-6f26299eefff"
      unitRef="usd">-1769000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99423769f3dd4edb99594b8b2aee677e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTctMS0xLTU0NzA5OA_ae1c0d33-979f-4468-ad09-a30911f5ddb2"
      unitRef="usd">38841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4e2dbc865d7444349a0f2776dabcbca6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTktMS0xLTU0NzA5OA_ccff80b3-017d-49ef-b312-38d4238603f0"
      unitRef="usd">-22906000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i20a54758336f4568bce7df2f2f0da706_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTExLTEtMS01NDcwOTg_16da37cf-5f2f-4582-aade-bfe11dcbaccf"
      unitRef="usd">44502000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b841b999bc847b2a7d961377de9d3de_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTEzLTEtMS01NDcwOTg_550fa676-19a0-4547-aef2-ed987230c5cf"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTE1LTEtMS01NDcwOTg_56ffa54d-dba1-4758-be51-9502a99a6e99"
      unitRef="usd">44518000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzEzLTE3LTEtMS01NDcwOTg_5f1c233a-6d93-40fe-b23d-d5b7991d3dbb"
      unitRef="usd">78000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i70ad8103265e4886a5533cccf894688b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTEtMS0xLTU4NTgyMA_a5c7dd7b-fc0d-48e3-86ba-a2f614e48cef"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i617514263e2a477ba7f3b8a9a6a9674a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTMtMS0xLTU4NTgyMA_a7849b11-b004-4f86-8107-ca09bbf49e09"
      unitRef="usd">29574000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2c898b920ca42a186661453324aadcd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTUtMS0xLTU4NTgyMA_9e956362-a4b5-4535-a069-df21dc860b72"
      unitRef="usd">-1068000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i30c711c00bcf422fafd828ded50e4f64_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTctMS0xLTU4NTgyMA_024f2260-cfee-444f-bac6-dcb6062dcf0c"
      unitRef="usd">32623000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85fc8a53e3214c7c985953d9b3dc5a78_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTktMS0xLTU4NTgyMA_353edb31-5e7d-4833-baa6-84be8085eb18"
      unitRef="usd">-14175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia71485e3f57d4b1e87922c63f04789e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTExLTEtMS01ODU4MjA_98bb3c29-d795-4c01-b373-aa494ce0b2d1"
      unitRef="usd">46958000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie21827b448914783ad89a1e60a05565f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTEzLTEtMS01ODU4MjA_c2bc670e-180e-4a86-b5f3-3963b956f308"
      unitRef="usd">18000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb159500cff1416584b25f65dcff1e94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE1LTEtMS01ODU4MjA_32e6079e-6d8c-452a-9487-2b21fb789b79"
      unitRef="usd">46976000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ieb159500cff1416584b25f65dcff1e94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE3LTEtMS01ODU4MjA_edaf8827-9b73-4399-bc97-527cd8e302e2"
      unitRef="usd">54000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifd620fc2833e42f18e79f1190828960c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTMtMS0xLTU0NzA5OA_e66eb9e9-b5ff-4bea-9267-9691b5528320"
      unitRef="usd">162000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if9c54d8a0b0d4d1f9f08d455276b0990_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTktMS0xLTU0NzA5OA_f2e52c45-7c4c-4cd1-b5fc-d70ba4132bcb"
      unitRef="usd">-72000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTExLTEtMS01NDcwOTg_de3fbf9f-6c73-4f79-b986-ea91e2ae4d0e"
      unitRef="usd">90000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE1LTEtMS01NDcwOTg_ce501d47-0f65-4c33-b6e4-4922ea8a529f"
      unitRef="usd">90000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i29e9fa809dec40e4a4434d5f6b246b71_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIwLTUtMS0xLTU0NzA5OA_8c4362bd-d6c5-4b38-a16a-0b22e8e25e98"
      unitRef="usd">-432000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIwLTExLTEtMS01NDcwOTg_3892c3db-305a-43d9-9dd1-9fdd436e567d"
      unitRef="usd">-432000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIwLTE1LTEtMS01NDcwOTg_e2f7e909-98e7-467c-a1a1-a1189b362298"
      unitRef="usd">-432000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <ci:TemporaryEquityOtherComprehensiveIncome
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIwLTE3LTEtMS01NDcwOTg_b955c582-e45d-4b4a-8a3f-80e139d5d626"
      unitRef="usd">-2000000</ci:TemporaryEquityOtherComprehensiveIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i75919ae416364991a9685e11cb5779d9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIxLTctMS0xLTU0NzA5OA_29a9ea18-123f-4e60-8ede-afc93f3e61b7"
      unitRef="usd">1197000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIxLTExLTEtMS01NDcwOTg_ce207828-e761-4822-a1e3-87f5760126fa"
      unitRef="usd">1197000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i11d2197648684bb191b9dfd2c8308df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIxLTEzLTEtMS01NDcwOTg_198fc92d-dc43-4bfa-8550-621b6199c137"
      unitRef="usd">12000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIxLTE1LTEtMS01NDcwOTg_1fdb090f-2262-4ef9-9148-c79d3b5513ed"
      unitRef="usd">1209000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIxLTE3LTEtMS01NDcwOTg_f3b9566a-0e7f-45c7-b5c1-9078e2b64e5c"
      unitRef="usd">3000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIyLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmEwOTVhNTg4MWM2ZTRlOTFiNDhlYjJjYzY1ZDFlYTBhXzQy_43e2c3cb-4403-4fd4-b583-7604908d607e"
      unitRef="usdPerShare">1.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i75919ae416364991a9685e11cb5779d9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIyLTctMS0xLTU0NzA5OA_749be484-9632-4a66-93e8-1d9e71fdaed6"
      unitRef="usd">356000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIyLTExLTEtMS01NDcwOTg_b8b8e2b2-3ba3-447e-bdc6-ba13280e45ce"
      unitRef="usd">356000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIyLTE1LTEtMS01NDcwOTg_90726f2b-ca8e-4f69-933a-bf6720e36968"
      unitRef="usd">356000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ifd620fc2833e42f18e79f1190828960c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIzLTMtMS0xLTU0NzA5OA_7d9c8e01-4e33-4460-b979-fa4e117b8496"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if9c54d8a0b0d4d1f9f08d455276b0990_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIzLTktMS0xLTU0NzA5OA_5bad0200-7e49-44cd-9be9-ea9d56240585"
      unitRef="usd">1334000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIzLTExLTEtMS01NDcwOTg_f60477f2-976f-4715-b028-eda73b45b2a6"
      unitRef="usd">1334000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzIzLTE1LTEtMS01NDcwOTg_671f01ec-9701-46c0-bdc9-c52fd55a36a2"
      unitRef="usd">1334000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <ci:NoncontrollingInterestOtherChanges
      contextRef="ifd620fc2833e42f18e79f1190828960c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI0LTMtMS0xLTU0NzA5OA_4fe56696-7ea2-4fc3-8479-09b8f1fc097d"
      unitRef="usd">0</ci:NoncontrollingInterestOtherChanges>
    <ci:NoncontrollingInterestOtherChanges
      contextRef="i2d9465aaeea94d7a8cface714b7e07dc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI0LTExLTEtMS01NDcwOTg_9d4e9c33-349e-4334-8c04-1eab000c25ab"
      unitRef="usd">0</ci:NoncontrollingInterestOtherChanges>
    <ci:NoncontrollingInterestOtherChanges
      contextRef="i11d2197648684bb191b9dfd2c8308df3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI0LTEzLTEtMS01NDcwOTg_64fc28a9-ff2f-4de7-9af7-6ace3944866a"
      unitRef="usd">-8000000</ci:NoncontrollingInterestOtherChanges>
    <ci:NoncontrollingInterestOtherChanges
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI0LTE1LTEtMS01NDcwOTg_81413a06-329a-4923-b321-4953765ba090"
      unitRef="usd">-8000000</ci:NoncontrollingInterestOtherChanges>
    <us-gaap:TemporaryEquityOtherChanges
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI0LTE3LTEtMS01NDcwOTg_b0e3440c-76d8-43eb-be3f-3f4af4187c76"
      unitRef="usd">0</us-gaap:TemporaryEquityOtherChanges>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i417f3083e801423e81a8d2f395260442_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTEtMS0xLTU0NzA5OA_ecdff555-0469-47c4-84a1-c5b20f4723ff"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia44468c92367407098fcf49709295d14_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTMtMS0xLTU0NzA5OA_c602da25-7ce7-4963-bf5d-aeaea461d450"
      unitRef="usd">29736000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46e8477b53954f2eb5c8d27ecfddb379_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTUtMS0xLTU0NzA5OA_c6f01889-f311-4569-9d8b-17b549a10a04"
      unitRef="usd">-1500000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7677f2aaed8c4a29a27ff12fecd40d9e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTctMS0xLTU0NzA5OA_cbfdf355-c992-49a1-ad55-af2e0bdd8e6f"
      unitRef="usd">33464000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7fe65d9692f4e978e3eeb7d6c41aef0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTktMS0xLTU0NzA5OA_d149c7ed-455f-47e2-96b5-619ca8a0a49a"
      unitRef="usd">-15581000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1487aaff9d704b1b9f53a37e55ac7eea_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTExLTEtMS01NDcwOTg_2dd97d86-31f8-4224-bd5f-37b90ae84672"
      unitRef="usd">46123000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i677503e86b4241c6889f0c64707d9e13_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTEzLTEtMS01NDcwOTg_51686e55-76db-4f21-a077-29b43cc1a1f1"
      unitRef="usd">22000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTE1LTEtMS01NDcwOTg_90a25ab5-2ea0-4c13-b677-547f35e2e1ed"
      unitRef="usd">46145000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzI1LTE3LTEtMS01NDcwOTg_efb68e77-e9cc-41d9-83dd-f6de8f9edf4f"
      unitRef="usd">55000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:ProfitLoss
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUtMi0xLTEtNTQ3MDk4_2ea5f69c-d416-448e-bb36-09910a2b4819"
      unitRef="usd">1306000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUtNC0xLTEtNTQ3MDk4_75d0f478-a637-4d65-9d55-db1b304a5c7d"
      unitRef="usd">1212000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzctMi0xLTEtNTQ3MDk4_432b92bc-159e-475e-be2a-44a4e68a74a0"
      unitRef="usd">749000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzctNC0xLTEtNTQ3MDk4_07359145-9265-4897-becc-719305fd869b"
      unitRef="usd">717000000</us-gaap:DepreciationDepletionAndAmortization>
    <ci:RealizedInvestmentGainLoss
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzgtMi0xLTEtNTQ3MDk4_66fb6307-ef47-4615-ba70-e0f1bcf066e9"
      unitRef="usd">-56000000</ci:RealizedInvestmentGainLoss>
    <ci:RealizedInvestmentGainLoss
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzgtNC0xLTEtNTQ3MDk4_8e1d38cf-145b-41b9-934d-9ce973338066"
      unitRef="usd">-322000000</ci:RealizedInvestmentGainLoss>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzktMi0xLTEtNTQ3MDk4_f8e3061f-66d6-40a5-95a3-74ce0a42482d"
      unitRef="usd">108000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzktNC0xLTEtNTQ3MDk4_7d5e6dba-3610-4bc5-b89a-22e31afef865"
      unitRef="usd">134000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzEzLTItMS0xLTU0NzA5OA_59400853-b280-48e5-b6b6-d25c3e63b991"
      unitRef="usd">479000000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzEzLTQtMS0xLTU0NzA5OA_e4485689-2c24-432d-a1a5-de5296efaf00"
      unitRef="usd">983000000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE0LTItMS0xLTU0NzA5OA_afccda8d-f738-43d6-83e3-a62dd4b053a1"
      unitRef="usd">-566000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE0LTQtMS0xLTU0NzA5OA_dc5978fe-0471-42d8-a6b8-729286e3dc3c"
      unitRef="usd">-222000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInReinsuranceRecoverable
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE1LTItMS0xLTU0NzA5OA_ac1f642b-424b-4750-8cf8-a0ad4836e55d"
      unitRef="usd">-72000000</us-gaap:IncreaseDecreaseInReinsuranceRecoverable>
    <us-gaap:IncreaseDecreaseInReinsuranceRecoverable
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE1LTQtMS0xLTU0NzA5OA_08201fda-a8c1-48b1-a456-652c75763d3d"
      unitRef="usd">-584000000</us-gaap:IncreaseDecreaseInReinsuranceRecoverable>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE2LTItMS0xLTU0NzA5OA_adeea012-5ec7-4275-b45b-751fc16cfb7c"
      unitRef="usd">1533000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE2LTQtMS0xLTU0NzA5OA_ee545fb6-5653-452f-a623-cf1d3704df43"
      unitRef="usd">142000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <ci:IncreaseDecreaseInPharmacyAndServiceCostsPayable
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE3LTItMS0xLTU0NzA5OA_c83f5d69-b6ba-440e-b609-5dc7f75655e1"
      unitRef="usd">539000000</ci:IncreaseDecreaseInPharmacyAndServiceCostsPayable>
    <ci:IncreaseDecreaseInPharmacyAndServiceCostsPayable
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE3LTQtMS0xLTU0NzA5OA_c98a3aef-75fc-4145-9646-9dc96c93bd53"
      unitRef="usd">-74000000</ci:IncreaseDecreaseInPharmacyAndServiceCostsPayable>
    <ci:IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE4LTItMS0xLTU0NzA5OA_64fcb767-ea9b-4cd6-bd78-28b6cdf701ab"
      unitRef="usd">690000000</ci:IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities>
    <ci:IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE4LTQtMS0xLTU0NzA5OA_5be68d15-7aaf-4b97-9dc1-2546e2482032"
      unitRef="usd">85000000</ci:IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE5LTItMS0xLTU0NzA5OA_6957f021-fd3a-4027-85b0-e8e5c3cbd997"
      unitRef="usd">-104000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE5LTQtMS0xLTU0NzA5OA_819649f3-b4f0-463e-a6e6-f6842fedb49a"
      unitRef="usd">63000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIwLTItMS0xLTU0NzA5OA_c9f6e341-8fd6-4de6-8745-3e39e7e9e4eb"
      unitRef="usd">5028000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIwLTQtMS0xLTU0NzA5OA_5d85ce0f-1d51-41c7-9500-4a00e6cd94eb"
      unitRef="usd">2030000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <ci:ProceedsFromSaleOfDebtAndEquitySecurities
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIzLTItMS0xLTU0NzA5OA_bd7dc2bb-115d-4dc5-9051-23f6caab80d8"
      unitRef="usd">196000000</ci:ProceedsFromSaleOfDebtAndEquitySecurities>
    <ci:ProceedsFromSaleOfDebtAndEquitySecurities
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIzLTQtMS0xLTU0NzA5OA_eb3b95b7-35b8-4ef7-b06f-c37bf28c7a72"
      unitRef="usd">757000000</ci:ProceedsFromSaleOfDebtAndEquitySecurities>
    <ci:ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI1LTItMS0xLTU0NzA5OA_b982d66d-0bf7-4283-aa1e-173848a0f44a"
      unitRef="usd">257000000</ci:ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities>
    <ci:ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI1LTQtMS0xLTU0NzA5OA_d181c0e4-9505-4b4c-9ded-757953e6fa5e"
      unitRef="usd">456000000</ci:ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities>
    <us-gaap:ProceedsFromCollectionOfLoansReceivable
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI2LTItMS0xLTU0NzA5OA_c67a0cae-4032-4def-8beb-2e4e31d07de6"
      unitRef="usd">4000000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
    <us-gaap:ProceedsFromCollectionOfLoansReceivable
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI2LTQtMS0xLTU0NzA5OA_d5873846-d3a3-41c1-86e3-23f911b4d30b"
      unitRef="usd">65000000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI3LTItMS0xLTU0NzA5OA_91707dc4-a1fa-4db4-b860-3490747dd97e"
      unitRef="usd">160000000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI3LTQtMS0xLTU0NzA5OA_8f14592e-f58f-4106-a62a-d3eae03b38bb"
      unitRef="usd">479000000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <ci:PaymentsToAcquireDebtAndEquitySecurities
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI5LTItMS0xLTU0NzA5OA_d5dcfe2f-537d-4dbe-a509-b71a27e5649c"
      unitRef="usd">2794000000</ci:PaymentsToAcquireDebtAndEquitySecurities>
    <ci:PaymentsToAcquireDebtAndEquitySecurities
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI5LTQtMS0xLTU0NzA5OA_63be975e-a5ef-47ac-b600-86d8cda714e6"
      unitRef="usd">1246000000</ci:PaymentsToAcquireDebtAndEquitySecurities>
    <us-gaap:PaymentsToAcquireMortgageNotesReceivable
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMwLTItMS0xLTU0NzA5OA_7af09f4f-d640-4683-8418-e3242c2967d0"
      unitRef="usd">0</us-gaap:PaymentsToAcquireMortgageNotesReceivable>
    <us-gaap:PaymentsToAcquireMortgageNotesReceivable
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMwLTQtMS0xLTU0NzA5OA_4b1b73d9-48a8-4977-9879-b16785f9f348"
      unitRef="usd">59000000</us-gaap:PaymentsToAcquireMortgageNotesReceivable>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMxLTItMS0xLTU0NzA5OA_97918b9c-1038-481e-aa39-eecba17269e2"
      unitRef="usd">377000000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMxLTQtMS0xLTU0NzA5OA_5cc64e46-1759-4e32-825a-339e5c70c6a9"
      unitRef="usd">425000000</us-gaap:PaymentsToAcquireOtherInvestments>
    <ci:PaymentsForProceedsFromPropertyPlantAndEquipment
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMyLTItMS0xLTU0NzA5OA_a11165fc-1df2-42f3-8090-95e1fdf71aa4"
      unitRef="usd">408000000</ci:PaymentsForProceedsFromPropertyPlantAndEquipment>
    <ci:PaymentsForProceedsFromPropertyPlantAndEquipment
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMyLTQtMS0xLTU0NzA5OA_2aa57fe0-3a8a-43b1-bcd4-775311586a6c"
      unitRef="usd">288000000</ci:PaymentsForProceedsFromPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM0LTItMS0xLTU0NzA5OA_e63647ad-9477-44e1-9699-8d92326ee87e"
      unitRef="usd">22000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM0LTQtMS0xLTU0NzA5OA_c8b5a649-4307-44a0-8705-f02d8e5553a0"
      unitRef="usd">-57000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM1LTItMS0xLTU0NzA5OA_27ed17fc-4b0b-4198-aa7f-08c4fbc656f9"
      unitRef="usd">43000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM1LTQtMS0xLTU0NzA5OA_47e7f790-a8a5-4142-8bc4-161a595b03e0"
      unitRef="usd">6000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM2LTItMS0xLTU0NzA5OA_70345755-cf0c-4988-a295-e637114d5c5f"
      unitRef="usd">-2983000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM2LTQtMS0xLTU0NzA5OA_de053d13-eae1-4d0c-914d-d26c4f8b03ef"
      unitRef="usd">-324000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:AdditionsToContractHoldersFunds
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM4LTItMS0xLTU0NzA5OA_5a829602-6405-4026-a01b-8f74f0fa2203"
      unitRef="usd">45000000</us-gaap:AdditionsToContractHoldersFunds>
    <us-gaap:AdditionsToContractHoldersFunds
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM4LTQtMS0xLTU0NzA5OA_0a46c049-4e5a-4a2c-9b85-91fe5e21e7b5"
      unitRef="usd">43000000</us-gaap:AdditionsToContractHoldersFunds>
    <us-gaap:WithdrawalFromContractHoldersFunds
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM5LTItMS0xLTU0NzA5OA_8f71d9ae-eb58-44d9-8a4b-3d4a46ffee5e"
      unitRef="usd">48000000</us-gaap:WithdrawalFromContractHoldersFunds>
    <us-gaap:WithdrawalFromContractHoldersFunds
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM5LTQtMS0xLTU0NzA5OA_b2a52d56-ac5d-462c-9f34-5d79bdbc9058"
      unitRef="usd">49000000</us-gaap:WithdrawalFromContractHoldersFunds>
    <ci:ProceedsFromRepaymentsOfOtherShortTermDebt
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQwLTItMS0xLTU0NzA5OA_f51533f3-ef10-41aa-a536-35710f37d854"
      unitRef="usd">-9000000</ci:ProceedsFromRepaymentsOfOtherShortTermDebt>
    <ci:ProceedsFromRepaymentsOfOtherShortTermDebt
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQwLTQtMS0xLTU0NzA5OA_5b3debd5-a815-40c2-a5f3-15cb4eb1276e"
      unitRef="usd">-463000000</ci:ProceedsFromRepaymentsOfOtherShortTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ0LTItMS0xLTU0NzA5OA_d9983382-31cc-4f97-bac8-232ec3e3ea79"
      unitRef="usd">80000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ0LTQtMS0xLTU0NzA5OA_63c16f86-df27-450f-8108-101e7edd1461"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ1LTItMS0xLTU0NzA5OA_378dd899-4718-48c8-b1e1-3b05400db02d"
      unitRef="usd">1491000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ1LTQtMS0xLTU0NzA5OA_f74a5de7-af04-4de7-8e81-e0c1c1b37162"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ2LTItMS0xLTU0NzA5OA_aee5ff7d-85ff-44f7-9d66-420ec660f3a8"
      unitRef="usd">962000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ2LTQtMS0xLTU0NzA5OA_734b41b3-f6ac-4705-bf15-debe8f54f256"
      unitRef="usd">1368000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ3LTItMS0xLTU0NzA5OA_cdb7a7b7-2f27-4e7c-b256-98b5f44bcf16"
      unitRef="usd">30000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ3LTQtMS0xLTU0NzA5OA_61721542-f2fa-4d6d-9c5c-be545c576895"
      unitRef="usd">93000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ4LTItMS0xLTU0NzA5OA_d847ff3c-0b5e-4914-830c-24f8c7743237"
      unitRef="usd">368000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ4LTQtMS0xLTU0NzA5OA_2f7b09c1-467e-4f4f-8d6b-ccfcaf6d6078"
      unitRef="usd">357000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ5LTItMS0xLTU0NzA5OA_43209fba-e332-4bec-9f42-e031fa1f1196"
      unitRef="usd">-136000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ5LTQtMS0xLTU0NzA5OA_5fa23537-0afa-4035-be93-f7dd6e860b28"
      unitRef="usd">-70000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUwLTItMS0xLTU0NzA5OA_159fac32-9301-4dd8-a831-931f6808a70a"
      unitRef="usd">-37000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUwLTQtMS0xLTU0NzA5OA_1affbf90-4413-432e-a4d7-521bcd13abd1"
      unitRef="usd">-2171000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUxLTItMS0xLTU0NzA5OA_0f510e80-73b4-43de-ae6d-32f4b8ca0136"
      unitRef="usd">5000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUxLTQtMS0xLTU0NzA5OA_203e5dfe-669d-43c4-b19d-ee961dcd4bb6"
      unitRef="usd">-23000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUyLTItMS0xLTU0NzA5OA_cd9bbdef-bbbe-40e2-925e-1a8b95601eed"
      unitRef="usd">2013000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUyLTQtMS0xLTU0NzA5OA_56327850-ce35-456e-8228-496dbf146b1f"
      unitRef="usd">-488000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTItMS0xLTU0NzA5OA_40db761f-a266-4f65-b6bb-86c4a203c722"
      unitRef="usd">5976000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="ieb159500cff1416584b25f65dcff1e94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTQtMS0xLTU0NzA5OA_79aa366d-893d-4698-8351-155de9b73318"
      unitRef="usd">5548000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU0LTItMS0xLTU0NzA5OA_cab9c01b-bba2-4a36-a9fe-361fe56e5dd6"
      unitRef="usd">7989000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU0LTQtMS0xLTU0NzA5OA_68007cd1-77bc-4f06-9fe8-d027ebcdfddb"
      unitRef="usd">5060000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU1LTItMS0xLTU0NzA5OA_115e8e3b-10ab-4648-a8b2-a80b2bcb8c21"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU1LTQtMS0xLTU0NzA5OA_320766a2-bc6b-4671-b705-848e1fb2e4c4"
      unitRef="usd">591000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTItMS0xLTU0NzA5OA_8eee97e6-4411-4def-985b-4e731dff18d0"
      unitRef="usd">7989000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTQtMS0xLTU0NzA5OA_5e85d59a-d8a5-45a7-8a41-a74c2856ca74"
      unitRef="usd">4469000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU4LTItMS0xLTU0NzA5OA_ab0c4445-b790-47d0-92cb-6e4eb3c7f7ce"
      unitRef="usd">77000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU4LTQtMS0xLTU0NzA5OA_d3399559-aa7f-4d23-8b23-b043ad991fd6"
      unitRef="usd">43000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU5LTItMS0xLTU0NzA5OA_720fb73b-5148-4904-b702-04500e9623df"
      unitRef="usd">322000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU5LTQtMS0xLTU0NzA5OA_124c1341-e99b-4b0c-900b-2319a9a1cc23"
      unitRef="usd">308000000</us-gaap:InterestPaidNet>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzI1ODM4NTIzMjUzMTA2_4df9f1d4-3d6c-46bf-9b9c-e4feff6e7297"
      unitRef="usd">425000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:NatureOfOperations
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMzEvZnJhZzpiYjUzZDdmNTBjOTU0MmQ3YjMwOTE1YjRkMDQwZDBmYy90ZXh0cmVnaW9uOmJiNTNkN2Y1MGM5NTQyZDdiMzA5MTViNGQwNDBkMGZjXzQxNDY_87e6250d-e64a-4d48-a001-84a70e2da569">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 1 &#x2013; Description of Business&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Cigna Group, together with its subsidiaries (either individually or collectively referred to as the "Company", "we," "us" or "our"), is a global health company with a mission of helping those we serve improve their health and vitality. Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental and related products and services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The majority of these products are offered through employers and other groups such as governmental and non-governmental organizations, unions and associations. Cigna Healthcare also offers commercial health and dental insurance and Medicare products to individuals in the United States and selected international markets. In addition to these ongoing operations, The Cigna Group also has certain run-off operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A full description of our segments follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Evernorth Health Services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; includes a broad range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in Pharmacy Benefits, Home Delivery Pharmacy, Specialty Pharmacy, Distribution and Care Delivery and Management Solutions, which are provided to health plans, employers, government organizations and health care providers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Cigna Healthcare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; includes the U.S. Commercial, U.S. Government and International Health operating segments which provide comprehensive medical and coordinated solutions to clients and customers. U.S. Commercial products and services include medical, pharmacy, behavioral health, dental and other products and services for insured and self-insured clients. U.S. Government solutions include Medicare Advantage, Medicare Supplement and Medicare Part D plans for seniors and individual health insurance plans. International Health solutions include health care coverage in our international markets, as well as health care benefits for globally mobile individuals and employees of multinational organizations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Other Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; comprises the remainder of our business operations, which includes ongoing businesses and exited businesses. Our ongoing businesses include continuing business (corporate-owned life insurance ("COLI")) and our run-off businesses. Our run-off businesses include (i) variable annuity reinsurance business (also referred to as "guaranteed minimum death benefit ("GMDB") and guaranteed minimum income benefit ("GMIB") business) that was effectively exited through reinsurance with Berkshire Hathaway Life Insurance Company of Nebraska ("Berkshire") in 2013, (ii) settlement annuity business, and (iii) individual life insurance and annuity and retirement benefits businesses comprised of deferred gains from the sales of these businesses. Our exited businesses include our interest in a joint venture in T&#xfc;rkiye, which was sold in December 2022 and the international life, accident and supplemental benefits businesses sold in July 2022 (the "Chubb transaction").&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;reflects amounts not allocated to operating segments, including net interest expense (defined as interest on corporate debt less net investment income on investments not supporting segment and other operations), certain litigation matters, expense associated with our frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs and intersegment eliminations for products and services sold between segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMzQvZnJhZzo3YjM0NjI3ZDcxYjQ0MjhkOTBkMTY0Nzk3ODIwNjFhMS90ZXh0cmVnaW9uOjdiMzQ2MjdkNzFiNDQyOGQ5MGQxNjQ3OTc4MjA2MWExXzkwOA_9647b300-85a2-49d0-95d0-2d0ed780e7bb">&lt;div style="margin-bottom:10pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 2 &#x2013; Summary of Significant Accounting Policies&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Consolidated Financial Statements include the accounts of The Cigna Group and its consolidated subsidiaries. Intercompany transactions and accounts have been eliminated in consolidation. These Consolidated Financial Statements were prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP"). Certain amounts in prior years have been reclassified to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Amounts recorded in the Consolidated Financial Statements necessarily reflect management's estimates and assumptions about medical costs, investment and receivable valuations, interest rates and other factors. Significant estimates are discussed throughout these Notes; however, actual results could differ from those estimates. The impact of a change in estimate is generally included in earnings in the period of adjustment.&lt;/span&gt;&lt;/div&gt;These interim Consolidated Financial Statements are unaudited but include all adjustments (including normal recurring adjustments) necessary, in the opinion of management, for a fair statement of financial position and results of operations for the periods reported. The interim Consolidated Financial Statements and Notes should be read in conjunction with the Consolidated Financial Statements and Notes included in the 2022 Annual Report on Form 10-K ("2022 Form 10-K"). The preparation of interim Consolidated Financial Statements necessarily relies heavily on estimates. This and other factors, including the seasonal nature of portions of the health care and related benefits business, as well as competitive and other market conditions, call for caution in estimating full-year results based on interim results of operations.&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's 2022 Form 10-K includes discussion of significant recent accounting pronouncements that either have impacted or may impact our financial statements in the future. The following information provides updates on recently adopted accounting pronouncements that have occurred since the Company filed its 2022 Form 10-K. There are no accounting pronouncements not yet adopted as of March&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts ("LDTI"), Accounting Standards Update ("ASU") 2018-12 and related amendments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Cigna Group adopted LDTI January 1, 2023, which includes the following key provisions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Changes to the measurement of the future policy benefits liability for traditional and limited-pay insurance contracts:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Assumptions used to measure cash flows (such as mortality, morbidity and lapse assumptions) are updated at least annually with the effect of changes in those assumptions remeasured retrospectively and reflected in current period net income. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Discount rate assumptions are updated quarterly based on market-level yields for low credit risk fixed income instruments ("upper-medium grade fixed-income instrument"), with any changes reflected in other comprehensive income. The upper-medium grade fixed-income instrument yield is interpreted to mean A-rated.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Deferred policy acquisition costs ("DAC") related to long-duration insurance contracts are amortized on a constant-level basis over the expected term of the related contracts. Other related deferred or capitalized balances (such as unearned revenue liability and value of business acquired) may use this simplified amortization method. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Market risk benefits ("MRB"), defined as protecting the contractholder from other-than-nominal capital market risk and exposing the insurer to that risk, are measured at fair value, with changes in fair value recognized in net income each period, except for the effect of the Company's change in nonperformance risk (own credit risk), which is recognized in other comprehensive income. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Additional disclosures, including disaggregated roll forwards for the liability for future policy benefits, market risk benefits, separate account liabilities and DAC, as well as information about significant inputs, judgments, assumptions and methods used in measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;The transition methods applied at adoption were:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;The liability for future policy benefits was remeasured using a modified retrospective approach applied to all outstanding contracts as of the beginning of the earliest period presented and was recognized in the opening balance of retained earnings. The impact of remeasuring the future policy benefits liability for the discount rate was recorded through accumulated other comprehensive income. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;DAC followed the transition method used for future policyholder benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Market risk benefits were remeasured at fair value at the beginning of the earliest period presented. The difference between this fair value and carrying value was recognized in the opening balance of retained earnings, excluding the effect of the Company's change in nonperformance risk (own credit risk), which is recognized in accumulated other comprehensive income. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Effects of adoption:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;The new guidance applies to our long-duration insurance products predominantly within the Cigna Healthcare segment and Other Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;The cumulative effects of adopting the new standard were immaterial. The impacts were a decrease to January 1, 2021 Shareholders' equity of $139 million and an increase to Shareholders' net income for the year ended December 31, 2022 and December 31, 2021 of $36 million and $5 million, respectively. The corresponding impact to diluted earnings per share was an increase of $0.11 and $0.02 for the year ended December 31, 2022 and December 31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;The prior periods within our Consolidated Statements of Income, Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets, Consolidated Statements of Changes in Total Equity and Consolidated Statements of Cash Flows were restated to conform to the current presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Prior period balances in the Company's footnote disclosures have been updated to reflect adjustments resulting from the adoption of this standard. Refer to Note 9 to the Consolidated Financial Statements for the Company's updated accounting policies. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;It is possible that our income recognition pattern could change on a prospective basis for several reasons: &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Applying periodic assumption updates, versus the locked-in model, may change our timing of profit or loss recognition. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;DAC amortization is on a constant level basis over the expected term of the related contracts and no longer tied to the emergence of profit on such contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:45pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Additionally, in December 2022, the Financial Accounting Standards Board ("FASB") published ASU 2022-05, which simplified the retrospective adoption of LDTI by permitting companies to make an accounting policy election to exclude contracts that are sold and removed from the balance sheet prior to the effective date of the standard from the retrospective adoption of LDTI. The Cigna Group made this policy election for the contracts sold in the Chubb transaction and our divested interest in a joint venture in T&#xfc;rkiye.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMzQvZnJhZzo3YjM0NjI3ZDcxYjQ0MjhkOTBkMTY0Nzk3ODIwNjFhMS90ZXh0cmVnaW9uOjdiMzQ2MjdkNzFiNDQyOGQ5MGQxNjQ3OTc4MjA2MWExXzkxMQ_6eddb992-a01d-42a4-a465-ef652cab63f2">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Consolidated Financial Statements include the accounts of The Cigna Group and its consolidated subsidiaries. Intercompany transactions and accounts have been eliminated in consolidation. These Consolidated Financial Statements were prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP"). Certain amounts in prior years have been reclassified to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Amounts recorded in the Consolidated Financial Statements necessarily reflect management's estimates and assumptions about medical costs, investment and receivable valuations, interest rates and other factors. Significant estimates are discussed throughout these Notes; however, actual results could differ from those estimates. The impact of a change in estimate is generally included in earnings in the period of adjustment.&lt;/span&gt;&lt;/div&gt;These interim Consolidated Financial Statements are unaudited but include all adjustments (including normal recurring adjustments) necessary, in the opinion of management, for a fair statement of financial position and results of operations for the periods reported. The interim Consolidated Financial Statements and Notes should be read in conjunction with the Consolidated Financial Statements and Notes included in the 2022 Annual Report on Form 10-K ("2022 Form 10-K"). The preparation of interim Consolidated Financial Statements necessarily relies heavily on estimates. This and other factors, including the seasonal nature of portions of the health care and related benefits business, as well as competitive and other market conditions, call for caution in estimating full-year results based on interim results of operations.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNDMvZnJhZzplNzdkNTIyYWY0Nzk0MmJmYWE1ZDY1MmU1ZWRmYmU1Zi90ZXh0cmVnaW9uOmU3N2Q1MjJhZjQ3OTQyYmZhYTVkNjUyZTVlZGZiZTVmXzUwNjY_e454230b-e920-4641-a7da-2d29bd2011c3">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's 2022 Form 10-K includes discussion of significant recent accounting pronouncements that either have impacted or may impact our financial statements in the future. The following information provides updates on recently adopted accounting pronouncements that have occurred since the Company filed its 2022 Form 10-K. There are no accounting pronouncements not yet adopted as of March&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts ("LDTI"), Accounting Standards Update ("ASU") 2018-12 and related amendments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Cigna Group adopted LDTI January 1, 2023, which includes the following key provisions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Changes to the measurement of the future policy benefits liability for traditional and limited-pay insurance contracts:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Assumptions used to measure cash flows (such as mortality, morbidity and lapse assumptions) are updated at least annually with the effect of changes in those assumptions remeasured retrospectively and reflected in current period net income. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Discount rate assumptions are updated quarterly based on market-level yields for low credit risk fixed income instruments ("upper-medium grade fixed-income instrument"), with any changes reflected in other comprehensive income. The upper-medium grade fixed-income instrument yield is interpreted to mean A-rated.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Deferred policy acquisition costs ("DAC") related to long-duration insurance contracts are amortized on a constant-level basis over the expected term of the related contracts. Other related deferred or capitalized balances (such as unearned revenue liability and value of business acquired) may use this simplified amortization method. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Market risk benefits ("MRB"), defined as protecting the contractholder from other-than-nominal capital market risk and exposing the insurer to that risk, are measured at fair value, with changes in fair value recognized in net income each period, except for the effect of the Company's change in nonperformance risk (own credit risk), which is recognized in other comprehensive income. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Additional disclosures, including disaggregated roll forwards for the liability for future policy benefits, market risk benefits, separate account liabilities and DAC, as well as information about significant inputs, judgments, assumptions and methods used in measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;The transition methods applied at adoption were:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;The liability for future policy benefits was remeasured using a modified retrospective approach applied to all outstanding contracts as of the beginning of the earliest period presented and was recognized in the opening balance of retained earnings. The impact of remeasuring the future policy benefits liability for the discount rate was recorded through accumulated other comprehensive income. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;DAC followed the transition method used for future policyholder benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Market risk benefits were remeasured at fair value at the beginning of the earliest period presented. The difference between this fair value and carrying value was recognized in the opening balance of retained earnings, excluding the effect of the Company's change in nonperformance risk (own credit risk), which is recognized in accumulated other comprehensive income. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Effects of adoption:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;The new guidance applies to our long-duration insurance products predominantly within the Cigna Healthcare segment and Other Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;The cumulative effects of adopting the new standard were immaterial. The impacts were a decrease to January 1, 2021 Shareholders' equity of $139 million and an increase to Shareholders' net income for the year ended December 31, 2022 and December 31, 2021 of $36 million and $5 million, respectively. The corresponding impact to diluted earnings per share was an increase of $0.11 and $0.02 for the year ended December 31, 2022 and December 31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;The prior periods within our Consolidated Statements of Income, Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets, Consolidated Statements of Changes in Total Equity and Consolidated Statements of Cash Flows were restated to conform to the current presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Prior period balances in the Company's footnote disclosures have been updated to reflect adjustments resulting from the adoption of this standard. Refer to Note 9 to the Consolidated Financial Statements for the Company's updated accounting policies. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;It is possible that our income recognition pattern could change on a prospective basis for several reasons: &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Applying periodic assumption updates, versus the locked-in model, may change our timing of profit or loss recognition. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;DAC amortization is on a constant level basis over the expected term of the related contracts and no longer tied to the emergence of profit on such contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:45pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Additionally, in December 2022, the Financial Accounting Standards Board ("FASB") published ASU 2022-05, which simplified the retrospective adoption of LDTI by permitting companies to make an accounting policy election to exclude contracts that are sold and removed from the balance sheet prior to the effective date of the standard from the retrospective adoption of LDTI. The Cigna Group made this policy election for the contracts sold in the Chubb transaction and our divested interest in a joint venture in T&#xfc;rkiye.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04417f56eeb14234a4bf022e54781719_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNDMvZnJhZzplNzdkNTIyYWY0Nzk0MmJmYWE1ZDY1MmU1ZWRmYmU1Zi90ZXh0cmVnaW9uOmU3N2Q1MjJhZjQ3OTQyYmZhYTVkNjUyZTVlZGZiZTVmXzU0OTc1NTgxNTAxNTg_8e592cd3-14d9-49bc-b122-702440c3ca10"
      unitRef="usd">-139000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i0168835d0324407988eb74d7d61484da_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNDMvZnJhZzplNzdkNTIyYWY0Nzk0MmJmYWE1ZDY1MmU1ZWRmYmU1Zi90ZXh0cmVnaW9uOmU3N2Q1MjJhZjQ3OTQyYmZhYTVkNjUyZTVlZGZiZTVmXzU0OTc1NTgxNTAxOTg_3e478653-f5d2-459c-924f-87ac8f613430"
      unitRef="usd">36000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i3c7aed585f9d4d058090d2ff63838ee3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNDMvZnJhZzplNzdkNTIyYWY0Nzk0MmJmYWE1ZDY1MmU1ZWRmYmU1Zi90ZXh0cmVnaW9uOmU3N2Q1MjJhZjQ3OTQyYmZhYTVkNjUyZTVlZGZiZTVmXzU0OTc1NTgxNTAxODQ_c31d1402-edbf-4b0e-bfcd-c5bed269632e"
      unitRef="usd">5000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0168835d0324407988eb74d7d61484da_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNDMvZnJhZzplNzdkNTIyYWY0Nzk0MmJmYWE1ZDY1MmU1ZWRmYmU1Zi90ZXh0cmVnaW9uOmU3N2Q1MjJhZjQ3OTQyYmZhYTVkNjUyZTVlZGZiZTVmXzU0OTc1NTgxNTAyMTI_22a9a366-8fdc-4316-b699-3de6d1b3d7a9"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3c7aed585f9d4d058090d2ff63838ee3_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNDMvZnJhZzplNzdkNTIyYWY0Nzk0MmJmYWE1ZDY1MmU1ZWRmYmU1Zi90ZXh0cmVnaW9uOmU3N2Q1MjJhZjQ3OTQyYmZhYTVkNjUyZTVlZGZiZTVmXzU0OTc1NTgxNTAyMjE_74afdefe-5447-4944-9c21-a6b573d3881c"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNjQvZnJhZzozZTEyZjczNTljZGM0NzdmOGQxMmQ4ZWZhMGVlYTU0ZS90ZXh0cmVnaW9uOjNlMTJmNzM1OWNkYzQ3N2Y4ZDEyZDhlZmEwZWVhNTRlXzEy_afb972f0-1dd4-48b5-8b8c-e7c0120b4690">Note 3 &#x2013; Accounts Receivable, Net&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following amounts were included within Accounts receivable, net:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noninsurance customer receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,845&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical manufacturers receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,128&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Insurance customer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;264&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;17,704&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;These receivables are reported net of our allowances of $2.1 billion as of March&#160;31, 2023 and $1.9 billion as of December&#160;31, 2022. These allowances include contractual allowances for certain rebates receivable with pharmaceutical manufacturers and certain receivables from third-party payors, discounts and claims adjustments issued to customers in the form of client credits, an allowance for current expected credit losses and other non-credit adjustments.The Company's allowance for current expected credit losses was $87 million as of March&#160;31, 2023 and $86 million as of December&#160;31, 2022.</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90ZXh0cmVnaW9uOjRmYzQ3OTRiNWM2OTQ3Mjg4NjExODljZmRmZmU4NDAzXzU0_418d5290-1ba7-4b36-9984-d249fc9e3f03">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following amounts were included within Accounts receivable, net:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noninsurance customer receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,845&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical manufacturers receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,128&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Insurance customer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;264&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;17,704&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <ci:PharmaceuticalManufacturerReceivable
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzEtMS0xLTEtNTQ3MDk4_3789cfb3-6536-4b13-8385-ec38881c735b"
      unitRef="usd">7845000000</ci:PharmaceuticalManufacturerReceivable>
    <ci:PharmaceuticalManufacturerReceivable
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzEtMy0xLTEtNTQ3MDk4_6f57fd82-c8db-43ba-9698-826c801e7b86"
      unitRef="usd">6899000000</ci:PharmaceuticalManufacturerReceivable>
    <ci:NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzItMS0xLTEtNTQ3MDk4_ca1ec2b8-3c9a-4cc5-b00e-4806011e978b"
      unitRef="usd">7128000000</ci:NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable>
    <ci:NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzItMy0xLTEtNTQ3MDk4_160cb97b-c22f-49c5-b0a9-deec01f4ad61"
      unitRef="usd">7108000000</ci:NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable>
    <ci:InsuranceCustomerReceivables
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzMtMS0xLTEtNTQ3MDk4_02dc2513-6a50-4c5f-a5e2-98a7adbd08cb"
      unitRef="usd">2467000000</ci:InsuranceCustomerReceivables>
    <ci:InsuranceCustomerReceivables
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzMtMy0xLTEtNTQ3MDk4_d92d5c33-5ec5-4f61-91ac-3a541bb4eaa7"
      unitRef="usd">2963000000</ci:InsuranceCustomerReceivables>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzQtMS0xLTEtNTQ3MDk4_c4e18d79-850a-428f-9ae9-d53923867bf8"
      unitRef="usd">264000000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzQtMy0xLTEtNTQ3MDk4_93af2b82-7262-47f3-9fa4-8eec6e149764"
      unitRef="usd">248000000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzctMS0xLTEtNTQ3MDk4_f7641ff5-910b-4341-8d5d-5e43a78f303c"
      unitRef="usd">17704000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzAvZnJhZzo0ZmM0Nzk0YjVjNjk0NzI4ODYxMTg5Y2ZkZmZlODQwMy90YWJsZToyNGFlMDc2MTFiYjI0ODE1YmQ1ZjJjZmRhMjlhYzBjMC90YWJsZXJhbmdlOjI0YWUwNzYxMWJiMjQ4MTViZDVmMmNmZGEyOWFjMGMwXzctMy0xLTEtNTQ3MDk4_c968669a-f9a8-4a0a-9509-31030e69f737"
      unitRef="usd">17218000000</us-gaap:ReceivablesNetCurrent>
    <ci:AllowanceForReceivablesCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzMvZnJhZzo1MjZjNTQwNzAzNTc0M2JlODA0NDY5NGJkODg2ZTk1ZS90ZXh0cmVnaW9uOjUyNmM1NDA3MDM1NzQzYmU4MDQ0Njk0YmQ4ODZlOTVlXzYx_d41bf9cc-2a34-4dea-bb24-319cf32433c0"
      unitRef="usd">2100000000</ci:AllowanceForReceivablesCurrent>
    <ci:AllowanceForReceivablesCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzMvZnJhZzo1MjZjNTQwNzAzNTc0M2JlODA0NDY5NGJkODg2ZTk1ZS90ZXh0cmVnaW9uOjUyNmM1NDA3MDM1NzQzYmU4MDQ0Njk0YmQ4ODZlOTVlXzc3_0b697ce0-dbfa-44c0-8445-7d3a43acad4b"
      unitRef="usd">1900000000</ci:AllowanceForReceivablesCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzkvZnJhZzpjYThhMDE1ZDcyYzA0OWQ3YmRhNjI3NmNmYWRmNzQ3Mi90ZXh0cmVnaW9uOmNhOGEwMTVkNzJjMDQ5ZDdiZGE2Mjc2Y2ZhZGY3NDcyXzY4_c3ff9742-a8d0-4cab-8db7-47179fd40c77"
      unitRef="usd">87000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zNzkvZnJhZzpjYThhMDE1ZDcyYzA0OWQ3YmRhNjI3NmNmYWRmNzQ3Mi90ZXh0cmVnaW9uOmNhOGEwMTVkNzJjMDQ5ZDdiZGE2Mjc2Y2ZhZGY3NDcyXzg0_60fbcb27-6cf8-44e9-b68c-8e98c04a9b8b"
      unitRef="usd">86000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <ci:SupplierFinanceProgramTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yMjAvZnJhZzo3YmVhN2QxZjg2MTA0NzkwYTQ5ZjRjZTU5OGE4ZmViYy90ZXh0cmVnaW9uOjdiZWE3ZDFmODYxMDQ3OTBhNDlmNGNlNTk4YThmZWJjXzQxNzgxNDQxODU4Mzk5_13abbc0f-1209-49ef-9bb7-427a8d27b679">Note 4 &#x2013; Supplier Finance ProgramThe Company facilitates a voluntary supplier finance program (the "program") that provides suppliers the opportunity to sell their receivables due from us (i.e., our payment obligations to the suppliers) to a financial institution, on a non-recourse basis, in order to be paid earlier than our payment terms require. The Cigna Group is not a party to the program and agrees to commercial terms with its suppliers independently of their participation in the program. Amounts due to suppliers that participate in the program are generally paid within one month following the invoice date. A supplier's participation in the program has no impact on the Company's payment terms and the Company has no economic interest in a supplier's decision to participate in the program. The suppliers, at their sole discretion, determine which invoices, if any, to sell to the financial institution. No guarantees or pledged assets are provided by the Company or any of our subsidiaries under the program. As of March&#160;31, 2023 and December&#160;31, 2022, $1.5&#160;billion and $1.3&#160;billion, respectively, of the Company's outstanding payment obligations were confirmed as valid within the program by the financial institution and reflected in Accounts payable in the Consolidated Balance Sheets. The amounts confirmed as valid for both periods are predominately associated with one supplier. We have been informed by the financial institution that $324&#160;million as of March&#160;31, 2023 of the Company's outstanding payment obligations were voluntarily elected by suppliers to be sold to the financial institution under the program.</ci:SupplierFinanceProgramTextBlock>
    <ci:SupplierFinanceProgramPaymentTimingPeriod
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yMjAvZnJhZzo3YmVhN2QxZjg2MTA0NzkwYTQ5ZjRjZTU5OGE4ZmViYy90ZXh0cmVnaW9uOjdiZWE3ZDFmODYxMDQ3OTBhNDlmNGNlNTk4YThmZWJjXzQxNzgxNDQxODU4NDEy_b234839a-7c66-49ac-a93e-84386a6206e1">P1M</ci:SupplierFinanceProgramPaymentTimingPeriod>
    <ci:SupplierFinanceProgramObligationCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yMjAvZnJhZzo3YmVhN2QxZjg2MTA0NzkwYTQ5ZjRjZTU5OGE4ZmViYy90ZXh0cmVnaW9uOjdiZWE3ZDFmODYxMDQ3OTBhNDlmNGNlNTk4YThmZWJjXzE4MTQxOTQxODYwODA4_5f45b071-6339-4b27-b070-7c7e54cd66f7"
      unitRef="usd">1500000000</ci:SupplierFinanceProgramObligationCurrent>
    <ci:SupplierFinanceProgramObligationCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yMjAvZnJhZzo3YmVhN2QxZjg2MTA0NzkwYTQ5ZjRjZTU5OGE4ZmViYy90ZXh0cmVnaW9uOjdiZWE3ZDFmODYxMDQ3OTBhNDlmNGNlNTk4YThmZWJjXzE4MTQxOTQxODYwNzg1_f30b59da-87f9-4642-bb07-310f727cc534"
      unitRef="usd">1300000000</ci:SupplierFinanceProgramObligationCurrent>
    <ci:SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yMjAvZnJhZzo3YmVhN2QxZjg2MTA0NzkwYTQ5ZjRjZTU5OGE4ZmViYy90ZXh0cmVnaW9uOjdiZWE3ZDFmODYxMDQ3OTBhNDlmNGNlNTk4YThmZWJjXzE2NDkyNjc0NDMwMjA_9a3a1f23-fd02-40e9-8bca-9c811f865849"
      unitRef="usd">324000000</ci:SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zODUvZnJhZzpiNWY3MmYyOGM1YWY0ZDk0YmZmNzU5NGQ0OTU3MTcwMS90ZXh0cmVnaW9uOmI1ZjcyZjI4YzVhZjRkOTRiZmY3NTk0ZDQ5NTcxNzAxXzEz_44dac6b4-f27e-4075-a758-769180b94157">Note 5 &#x2013; Mergers, Acquisitions and Divestitures Divestiture of International BusinessesIn July 2022, the Company completed the sale of its life, accident and supplemental benefits businesses in six countries (Hong Kong, Indonesia, New Zealand, South Korea, Taiwan and Thailand) (the "Chubb transaction") for approximately $5.4 billion in cash. The Company recognized a gain of $1.7&#160;billion pre-tax ($1.4&#160;billion after-tax), which includes recognition of previously unrealized capital losses on investments sold and translation loss on foreign currencies. In December 2022, the Company also divested its ownership interest in a joint venture in T&#xfc;rkiye.Integration and Transaction-related CostsIn 2023 and 2022, the Company incurred net costs mainly related to the Chubb transaction. In the first three months of 2022, the Company also incurred net costs related to the sale of the Group Disability and Life business and acquisition of MDLIVE. These net costs were $1 million pre-tax ($1 million after-tax) for the three months ended March 31, 2023 and $52 million pre-tax ($37 million after-tax) for the three months ended March&#160;31, 2022. These costs consisted primarily of certain projects to separate or integrate the Company's systems, products and services, fees for legal, advisory and other professional services and certain employment-related costs.</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i51b230fe17da43ddb1e4f787e7e5b489_I20220701"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zODgvZnJhZzo3YmU0MTVlZjg2Mzg0NGM5OGM3YjI0ZjI1ZjhmNzRiMi90ZXh0cmVnaW9uOjdiZTQxNWVmODYzODQ0Yzk4YzdiMjRmMjVmOGY3NGIyXzI2Nw_9855449e-3fbe-4b8e-8de8-e2ae60d00953"
      unitRef="usd">5400000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ia6534aa5174f46daae1011252bc79cfa_D20220701-20220701"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zODgvZnJhZzo3YmU0MTVlZjg2Mzg0NGM5OGM3YjI0ZjI1ZjhmNzRiMi90ZXh0cmVnaW9uOjdiZTQxNWVmODYzODQ0Yzk4YzdiMjRmMjVmOGY3NGIyXzMwNQ_38f4370f-3aac-48aa-8c28-51171b314cc1"
      unitRef="usd">1700000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <ci:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax
      contextRef="ia6534aa5174f46daae1011252bc79cfa_D20220701-20220701"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zODgvZnJhZzo3YmU0MTVlZjg2Mzg0NGM5OGM3YjI0ZjI1ZjhmNzRiMi90ZXh0cmVnaW9uOjdiZTQxNWVmODYzODQ0Yzk4YzdiMjRmMjVmOGY3NGIyXzMxNw_f584a412-728e-4c02-a305-c21a8640e0fb"
      unitRef="usd">1400000000</ci:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax>
    <ci:TransactionRelatedCosts
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80MDYvZnJhZzo5ZWEwNjdkNzZiMmQ0ZWY3YjNlZjRjZGFjYmQyM2Y1MC90ZXh0cmVnaW9uOjllYTA2N2Q3NmIyZDRlZjdiM2VmNGNkYWNiZDIzZjUwXzQ2MQ_d0015958-f379-4ca0-94cf-542ec2cfb56a"
      unitRef="usd">1000000</ci:TransactionRelatedCosts>
    <ci:TransactionRelatedCostsAfterTax
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80MDYvZnJhZzo5ZWEwNjdkNzZiMmQ0ZWY3YjNlZjRjZGFjYmQyM2Y1MC90ZXh0cmVnaW9uOjllYTA2N2Q3NmIyZDRlZjdiM2VmNGNkYWNiZDIzZjUwXzQ3Mw_5fb79ec6-3849-4b41-9aca-3f1fbb848af9"
      unitRef="usd">1000000</ci:TransactionRelatedCostsAfterTax>
    <ci:TransactionRelatedCosts
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80MDYvZnJhZzo5ZWEwNjdkNzZiMmQ0ZWY3YjNlZjRjZGFjYmQyM2Y1MC90ZXh0cmVnaW9uOjllYTA2N2Q3NmIyZDRlZjdiM2VmNGNkYWNiZDIzZjUwXzQ5OA_5928028c-b476-41fc-be8b-3ff0457ebabc"
      unitRef="usd">52000000</ci:TransactionRelatedCosts>
    <ci:TransactionRelatedCostsAfterTax
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80MDYvZnJhZzo5ZWEwNjdkNzZiMmQ0ZWY3YjNlZjRjZGFjYmQyM2Y1MC90ZXh0cmVnaW9uOjllYTA2N2Q3NmIyZDRlZjdiM2VmNGNkYWNiZDIzZjUwXzUxOA_4b2eb7af-0439-4c98-8e76-f981753d2d66"
      unitRef="usd">37000000</ci:TransactionRelatedCostsAfterTax>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80MzAvZnJhZzoxMzVhOTA4MjcxZmQ0MWUzOTdkZDcwOWJhNjljNWM1NC90ZXh0cmVnaW9uOjEzNWE5MDgyNzFmZDQxZTM5N2RkNzA5YmE2OWM1YzU0XzEy_0dd57210-0ff2-4c28-b8df-4ae1336dec7e">Note 6 &#x2013; Earnings Per ShareBasic and diluted earnings per share were computed as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Shares in thousands, dollars in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of&lt;br/&gt;Dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of&lt;br/&gt;Dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shareholders' net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;295,706&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;295,706&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;295,706&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;298,999&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;321,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4.28&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4.24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Amounts reflected above for the three months ended March 31, 2022 have been restated to reflect the impact of adopting amended accounting guidance for long-duration insurance contracts (discussed in Note 2 to the Consolidated Financial Statements).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect was anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Anti-dilutive options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;0.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The Company held approximately 102.7 million shares of common stock in treasury at March&#160;31, 2023, 99.1 million shares as of December&#160;31, 2022 and 77.3 million shares as of March&#160;31, 2022.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80MzYvZnJhZzozNGU2N2NiZDkyOTc0YjgwYjBmMGNmZGZhZDIwNTNiYS90ZXh0cmVnaW9uOjM0ZTY3Y2JkOTI5NzRiODBiMGYwY2ZkZmFkMjA1M2JhXzY4_356e26ce-2f86-4b21-a20f-de31d0255aee">Basic and diluted earnings per share were computed as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Shares in thousands, dollars in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of&lt;br/&gt;Dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of&lt;br/&gt;Dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shareholders' net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;295,706&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;295,706&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;295,706&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;298,999&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;321,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4.28&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4.24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Amounts reflected above for the three months ended March 31, 2022 have been restated to reflect the impact of adopting amended accounting guidance for long-duration insurance contracts (discussed in Note 2 to the Consolidated Financial Statements).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzUtMS0xLTEtNTQ3MDk4_26798cb3-528a-4633-94be-0789f44a397f"
      unitRef="usd">1267000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzUtNS0xLTEtNTQ3MDk4_ea2c9391-cd50-499a-8df1-06f1872bc683"
      unitRef="usd">1267000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzUtNy0xLTEtNTQ3MDk4_825c1c1a-68d3-4aa6-97b1-1226133cfbcd"
      unitRef="usd">1197000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzUtMTEtMS0xLTU0NzA5OA_b6a031ca-0ff8-4005-b37f-9df64ffe2b31"
      unitRef="usd">1197000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzctMS0xLTEtNTQ3MDk4_55ecce30-3580-4edd-a891-be08a57255a2"
      unitRef="shares">295706000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzctNS0xLTEtNTQ3MDk4_ecb68f28-048c-4f42-89f8-a7f550e22658"
      unitRef="shares">295706000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzctNy0xLTEtNTQ3MDk4_6be72884-cf54-4d3d-9c9d-ec0f7f44da16"
      unitRef="shares">318487000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzctMTEtMS0xLTU0NzA5OA_97cfcc6f-1b09-4908-816c-cf65020f969c"
      unitRef="shares">318487000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzgtMy0xLTEtNTQ3MDk4_043d66a2-9b65-4c8d-bba7-4f56be02b504"
      unitRef="shares">3293000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzgtNS0xLTEtNTQ3MDk4_40d55dfe-e1f1-4fac-accb-75e7f44d8bda"
      unitRef="shares">3293000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzgtOS0xLTEtNTQ3MDk4_455c5a46-6351-4d84-9c3c-71ae4f356e8e"
      unitRef="shares">2795000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzgtMTEtMS0xLTU0NzA5OA_10bc6f3e-cf1a-4278-bf37-d7ba6d3622b6"
      unitRef="shares">2795000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzktMS0xLTEtNTQ3MDk4_de6ba747-de34-4165-9820-a68b1c9157de"
      unitRef="shares">295706000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzktMy0xLTEtNTQ3MDk4_c407aa71-99a5-4b2c-a67a-87cc8b0fa8c5"
      unitRef="shares">3293000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzktNS0xLTEtNTQ3MDk4_d88f874f-b103-4789-a623-4adc4164fc0a"
      unitRef="shares">298999000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzktNy0xLTEtNTQ3MDk4_c6683929-73b3-4009-b747-14a65085a0de"
      unitRef="shares">318487000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzktOS0xLTEtNTQ3MDk4_3526c446-bacd-4aca-a325-30c33447b89d"
      unitRef="shares">2795000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzktMTEtMS0xLTU0NzA5OA_85c7d57a-a10d-4fbb-821b-4018e02aba58"
      unitRef="shares">321282000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzEwLTEtMS0xLTU0NzA5OA_7adbeb62-6194-42ad-a82b-8aa25eea5abf"
      unitRef="usdPerShare">4.28</us-gaap:EarningsPerShareBasic>
    <ci:EarningsPerShareEffectOfDilution
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzEwLTMtMS0xLTU0NzA5OA_9f834017-d3e1-455c-a9a9-b860a5a38ddc"
      unitRef="usdPerShare">-0.04</ci:EarningsPerShareEffectOfDilution>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzEwLTUtMS0xLTU0NzA5OA_d93553ec-c83a-4933-9686-2879d491cd7f"
      unitRef="usdPerShare">4.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzEwLTctMS0xLTU0NzA5OA_06f31ab4-74fa-4596-9b89-8ffcdea853c8"
      unitRef="usdPerShare">3.76</us-gaap:EarningsPerShareBasic>
    <ci:EarningsPerShareEffectOfDilution
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzEwLTktMS0xLTU0NzA5OA_bd55a729-ff6f-4722-8ab8-9025972f3536"
      unitRef="usdPerShare">-0.03</ci:EarningsPerShareEffectOfDilution>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDIvZnJhZzo0YTc1ZGQyNDExZDY0OTc4YTM2Mjc2N2IxNTU1ZTJkZS90YWJsZTpiOWZkNDU5MTVlODI0OThjOGQxNWZkNjc0ZTk0OGMxYS90YWJsZXJhbmdlOmI5ZmQ0NTkxNWU4MjQ5OGM4ZDE1ZmQ2NzRlOTQ4YzFhXzEwLTExLTEtMS01NDcwOTg_3ac78294-948c-4e15-af9e-5a431bda66a7"
      unitRef="usdPerShare">3.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDUvZnJhZzo2NjA5MmZhZjZjYjM0NmQ5OGU2NjI3OGY5YzE3MDNiZS90ZXh0cmVnaW9uOjY2MDkyZmFmNmNiMzQ2ZDk4ZTY2Mjc4ZjljMTcwM2JlXzE2Mg_baf142df-e646-4be9-94a1-bb75779c6080">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect was anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Anti-dilutive options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;0.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9b459f141c6c4b0da2923bbbd4e8c935_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDUvZnJhZzo2NjA5MmZhZjZjYjM0NmQ5OGU2NjI3OGY5YzE3MDNiZS90YWJsZToyMTZkMzk2ZmZlM2Y0MTAwYjY3MDU5ODAzYTU3NjJiMi90YWJsZXJhbmdlOjIxNmQzOTZmZmUzZjQxMDBiNjcwNTk4MDNhNTc2MmIyXzMtNS0xLTEtNTQ3MDk4_7608c3e0-dcc1-4b98-a2e1-5c132ddff20a"
      unitRef="shares">900000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9856273e9b994b9094b394811fc62689_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDUvZnJhZzo2NjA5MmZhZjZjYjM0NmQ5OGU2NjI3OGY5YzE3MDNiZS90YWJsZToyMTZkMzk2ZmZlM2Y0MTAwYjY3MDU5ODAzYTU3NjJiMi90YWJsZXJhbmdlOjIxNmQzOTZmZmUzZjQxMDBiNjcwNTk4MDNhNTc2MmIyXzMtNy0xLTEtNTQ3MDk4_600b3afb-a962-43e7-aa06-0c84c7e865aa"
      unitRef="shares">2800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:TreasuryStockCommonShares
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDgvZnJhZzpmOWI1NDU1NWZjNzc0ZTkwYmY5NTExNTQ3YzYwNGUxMC90ZXh0cmVnaW9uOmY5YjU0NTU1ZmM3NzRlOTBiZjk1MTE1NDdjNjA0ZTEwXzM2_cff52d07-47a6-4109-a404-2a9734798741"
      unitRef="shares">102700000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDgvZnJhZzpmOWI1NDU1NWZjNzc0ZTkwYmY5NTExNTQ3YzYwNGUxMC90ZXh0cmVnaW9uOmY5YjU0NTU1ZmM3NzRlOTBiZjk1MTE1NDdjNjA0ZTEwXzgx_65f98705-dc94-4d70-a9c7-867d189249f9"
      unitRef="shares">99100000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NDgvZnJhZzpmOWI1NDU1NWZjNzc0ZTkwYmY5NTExNTQ3YzYwNGUxMC90ZXh0cmVnaW9uOmY5YjU0NTU1ZmM3NzRlOTBiZjk1MTE1NDdjNjA0ZTEwXzEwNA_5f82f94f-09f0-49c0-b527-c0c6693f2375"
      unitRef="shares">77300000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90ZXh0cmVnaW9uOmI0ZDg5Y2M4OWRmMzQ5OWJhOGY3NDdmZDUxNGIxZDZjXzQyNA_fc62fadf-63a4-4625-a302-f01ec121a8e4">&lt;div style="margin-bottom:10pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 7 &#x2013; Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The outstanding amounts of debt, net of issuance costs, discounts or premiums, and finance leases were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$17&#160;million, 8.300% Notes due January 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$63&#160;million, 7.650% Notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$700 million, Floating Rate Notes due July 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,000 million, 3.000% Notes due July 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;996&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,187 million, 3.750% Notes due July 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,187&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$500 million, 0.613% Notes due March 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;499&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other, including finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,418&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$500 million, 0.613% Notes due March 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,000&#160;million, 3.500% Notes due June 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$900&#160;million, 3.250% Notes due April 2025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;878&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$2,200&#160;million, 4.125% Notes due November 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,500&#160;million, 4.500% Notes due February 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,503&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$800 million, 1.250% Notes due March 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;797&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$700 million, 5.685% Notes due March 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,500&#160;million, 3.400% Notes due March 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,440&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$259&#160;million, 7.875% Debentures due May 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;259&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 3.050% Notes due October 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;597&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,800&#160;million, 4.375% Notes due October 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,785&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,500&#160;million, 2.400% Notes due March 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,492&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,500 million, 2.375% Notes due March 2031 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,398&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$45&#160;million, 8.080% Step Down Notes due January 2033 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$800 million, 5.400% Notes due March 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;794&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$190&#160;million, 6.150% Notes due November 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;190&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$2,200&#160;million, 4.800% Notes due August 2038 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 3.200% Notes due March 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;743&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$121&#160;million, 5.875% Notes due March 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$448&#160;million, 6.125% Notes due November 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$317&#160;million, 5.375% Notes due February 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;315&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,500&#160;million, 4.800% Notes due July 2046&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,466&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,000&#160;million, 3.875% Notes due October 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,000&#160;million, 4.900% Notes due December 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,969&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,250&#160;million, 3.400% Notes due March 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,236&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,500 million, 3.400% Notes due March 2051&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,478&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other, including finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;67&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;29,124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;The Company has entered into interest rate swap contracts hedging a portion of these fixed-rate debt instruments. See Note 11 in the Company's 2022 Form 10-K for further information about the Company's interest rate risk management and these derivative instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Interest rate step down to 8.080% effective January 15, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Debt Issuance. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On March 7, 2023, the Company issued $1.5&#160;billion of new senior notes. The proceeds of this issuance will be used for general corporate purposes, and may include repayment of outstanding debt securities. Interest on this debt is paid semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.777%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$700 million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 15, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.685%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$698 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$800 million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 15, 2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.400%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$796 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt; Redeemable at any time discounted at the U.S. Treasury rate plus 20 basis points. Redeemable at par on or after March 15, 2024.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt; Redeemable at any time discounted at the U.S. Treasury rate plus 25 basis points. Redeemable at par on or after December 15, 2032. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Short-term and Credit Facilities Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Revolving Credit Agreements.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Our revolving credit agreements provide us with the ability to borrow amounts for general corporate purposes, including providing liquidity support if necessary under our commercial paper program discussed below.&lt;/span&gt;&lt;/div&gt;As of March&#160;31, 2023, The Cigna Group had a $3.0 billion five-year revolving credit and letter of credit agreement maturing in April 2027; a $1.0 billion three-year revolving credit agreement maturing in April 2025; and a $1.0 billion 364-day revolving credit agreement maturing in April 2023. There were no outstanding balances under these revolving credit agreements as of March&#160;31, 2023.&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In April 2023, The Cigna Group entered into the following revolving credit agreements (the "Credit Agreements"), which replaced the agreements discussed above:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;a $4.0 billion five-year revolving credit and letter of credit agreement that will mature in April 2028 with an option to extend the maturity date for additional one-year periods, subject to consent of the banks. The Company can borrow up to $4.0 billion under the credit agreement for general corporate purposes, with up to $500 million available for issuance of letters of credit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;a $1.0 billion 364-day revolving credit agreement that will mature in April 2024. The Company can borrow up to $1.0 billion under the credit agreement for general corporate purposes. This agreement includes the option to "term out" any revolving loans that are outstanding at maturity by converting them into a term loan maturing on the one-year anniversary of conversion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Each of the Credit Agreements include an option to increase commitments in an aggregate amount of up to $1.5 billion across both facilities for a maximum total commitment of $6.5 billion. The Credit Agreements allow for borrowings at either a base rate or an adjusted term Secured Overnight Funding Rate ("SOFR") plus, in each case, an applicable margin based on the Company's senior unsecured credit ratings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Each of the two facilities is diversified among 21 large commercial banks, all of which had an A- equivalent or higher rating by at least one Nationally Recognized Statistical Rating Organization as of March 31, 2023. Each facility also contains customary covenants and restrictions, including a financial covenant that the Company's leverage ratio, as defined in the Credit Agreements, may not exceed 60% subject to certain exceptions upon the consummation of an acquisition. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Commercial Paper. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Under our commercial paper program, we may issue short-term, unsecured commercial paper notes privately placed on a discounted basis through certain broker-dealers at any time not to exceed an aggregate amount of $5.0 billion. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The net proceeds of issuances have been and are expected to be used for general corporate purposes. There was no commercial paper outstanding balance as of March&#160;31, 2023.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Debt Covenants. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company was in compliance with its debt covenants as of March&#160;31, 2023.&lt;/span&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"&gt;Interest Expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Interest expense on long-term and short-term debt was $345 million for the three months ended March&#160;31, 2023 and $314 million for the three months ended March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <ci:ScheduleOfShortTermDebtLongTermDebtTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90ZXh0cmVnaW9uOmI0ZDg5Y2M4OWRmMzQ5OWJhOGY3NDdmZDUxNGIxZDZjXzQyNw_80147c39-2c7b-477d-846b-00f7bfe5610f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The outstanding amounts of debt, net of issuance costs, discounts or premiums, and finance leases were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$17&#160;million, 8.300% Notes due January 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$63&#160;million, 7.650% Notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$700 million, Floating Rate Notes due July 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,000 million, 3.000% Notes due July 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;996&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,187 million, 3.750% Notes due July 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,187&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$500 million, 0.613% Notes due March 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;499&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other, including finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,418&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$500 million, 0.613% Notes due March 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,000&#160;million, 3.500% Notes due June 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$900&#160;million, 3.250% Notes due April 2025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;878&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$2,200&#160;million, 4.125% Notes due November 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,500&#160;million, 4.500% Notes due February 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,503&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$800 million, 1.250% Notes due March 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;797&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$700 million, 5.685% Notes due March 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,500&#160;million, 3.400% Notes due March 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,440&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$259&#160;million, 7.875% Debentures due May 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;259&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 3.050% Notes due October 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;597&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,800&#160;million, 4.375% Notes due October 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,785&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,500&#160;million, 2.400% Notes due March 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,492&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,500 million, 2.375% Notes due March 2031 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,398&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$45&#160;million, 8.080% Step Down Notes due January 2033 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$800 million, 5.400% Notes due March 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;794&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$190&#160;million, 6.150% Notes due November 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;190&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$2,200&#160;million, 4.800% Notes due August 2038 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 3.200% Notes due March 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;743&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$121&#160;million, 5.875% Notes due March 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$448&#160;million, 6.125% Notes due November 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$317&#160;million, 5.375% Notes due February 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;315&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,500&#160;million, 4.800% Notes due July 2046&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,466&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,000&#160;million, 3.875% Notes due October 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,000&#160;million, 4.900% Notes due December 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,969&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,250&#160;million, 3.400% Notes due March 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,236&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,500 million, 3.400% Notes due March 2051&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,478&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other, including finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;67&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;29,124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;The Company has entered into interest rate swap contracts hedging a portion of these fixed-rate debt instruments. See Note 11 in the Company's 2022 Form 10-K for further information about the Company's interest rate risk management and these derivative instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Interest rate step down to 8.080% effective January 15, 2023.&lt;/span&gt;&lt;/div&gt;</ci:ScheduleOfShortTermDebtLongTermDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia476822164994b318ba1a7d0dfc61cc8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZDc2NzkwZTU2ZDc4NDI3NTk5ODM4YjBmNzI4NmRjMDNfNA_f6cbf7d9-f6e8-4a1d-9976-17f1362aa461"
      unitRef="usd">17000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia476822164994b318ba1a7d0dfc61cc8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZDc2NzkwZTU2ZDc4NDI3NTk5ODM4YjBmNzI4NmRjMDNfOA_2782fbfd-3486-4c13-ad33-b3278b18cd59"
      unitRef="number">0.08300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia476822164994b318ba1a7d0dfc61cc8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQtMi0xLTEtNTQ3MDk4_1897c4b2-77af-432b-920b-abcefcc7a93d"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i5453dc8934554e9faf7e6b1ef64dbf8b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQtNC0xLTEtNTQ3MDk4_060447dc-88d9-41c3-9435-c588e4c8a241"
      unitRef="usd">17000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic9fd170cd0b544f4947eb9267c3105ae_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzUtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246NWQ2ZTUzYjE4Yjk5NDI3N2JlODI5NDJmZjM2M2I3ZGJfNA_80a8bc88-2cd6-4c45-ba12-691a002f27ee"
      unitRef="usd">63000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic9fd170cd0b544f4947eb9267c3105ae_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzUtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246NWQ2ZTUzYjE4Yjk5NDI3N2JlODI5NDJmZjM2M2I3ZGJfOA_87740afd-8f61-4b36-908e-aebf6e033498"
      unitRef="number">0.07650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="ic9fd170cd0b544f4947eb9267c3105ae_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzUtMi0xLTEtNTQ3MDk4_a5bec557-194f-4d61-a10b-db4e1ec99d60"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i75f10178c4e44f02b6fd42a4130fb189_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzUtNC0xLTEtNTQ3MDk4_72df14db-631d-4c65-b013-9bbdb524560b"
      unitRef="usd">63000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3b1750dc39384c35b545131f314c0819_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzYtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZWE4NGIwOGY5M2I1NDM3YTkwYWM5MGM4NjE5YzBiNWVfNA_f5835481-a2a6-4811-b735-6336e52321e4"
      unitRef="usd">700000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent
      contextRef="i3b1750dc39384c35b545131f314c0819_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzYtMi0xLTEtNTQ3MDk4_694ce160-0f0f-49a4-a4dd-8368ab538795"
      unitRef="usd">700000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0d639de145c64f1fb64c4f7629a3f64e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzYtNC0xLTEtNTQ3MDk4_43181fdf-c775-4ae9-a479-a4161fe5e327"
      unitRef="usd">700000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic135eb18221a4aa39a034dad9dff9585_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzctMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZDEzZDRkNmY3Y2ViNDczNWI5NzZmZTljY2M4OWMyMDBfNA_39977f94-f9da-4f3e-b718-7cb2115fe8d2"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic135eb18221a4aa39a034dad9dff9585_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzctMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZDEzZDRkNmY3Y2ViNDczNWI5NzZmZTljY2M4OWMyMDBfOA_161dd9ac-109c-4af5-8c7a-85b956b3831d"
      unitRef="number">0.03000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="ic135eb18221a4aa39a034dad9dff9585_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzctMi0xLTEtNTQ3MDk4_43de2ccb-2839-4c17-bf43-2843357662a3"
      unitRef="usd">996000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i414bed4bfa4b4862a19a234bbdaf714d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzctNC0xLTEtNTQ3MDk4_7059dba2-7a39-42e8-a2ad-4ec91eaa6d52"
      unitRef="usd">994000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9658fcabcb764ce5972950cced53289b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzgtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZDUyNTNjYmE4YjY5NGNjODljMDQ2NjJjNjA2ZmNiZDFfNA_35a1db67-ce59-4d03-b58b-9e96aed0424c"
      unitRef="usd">1187000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9658fcabcb764ce5972950cced53289b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzgtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZDUyNTNjYmE4YjY5NGNjODljMDQ2NjJjNjA2ZmNiZDFfOA_2131f811-92a3-4dd8-9c06-d8515e637c8e"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="i9658fcabcb764ce5972950cced53289b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzgtMi0xLTEtNTQ3MDk4_a13450e8-bea3-4dfd-830a-64678a03a877"
      unitRef="usd">1187000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6aac5c43478c4cf5872ab0d87fb7cab3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzgtNC0xLTEtNTQ3MDk4_c911e2f6-4bb4-4e4f-bc68-135aab33c3e9"
      unitRef="usd">1186000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iacf9c0f395864206b0df7660a5342177_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzktMC0xLTEtNTgwMDkxL3RleHRyZWdpb246MTA5ZGMyYzM3MmQxNGI3Mjg1ZDYxZWIwMGVmY2ZiMzZfNA_aea1f4c8-c9b7-4f08-a77f-e61d4f8516b9"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iacf9c0f395864206b0df7660a5342177_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzktMC0xLTEtNTgwMDkxL3RleHRyZWdpb246MTA5ZGMyYzM3MmQxNGI3Mjg1ZDYxZWIwMGVmY2ZiMzZfOA_f9082ba0-fd5a-42f8-ba9f-b4c7a616e687"
      unitRef="number">0.00613</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="iacf9c0f395864206b0df7660a5342177_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzktMi0xLTEtNjEwMjIw_6b09fa3b-823b-4722-a59b-8a0329e0a52f"
      unitRef="usd">499000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i8f6de552f34d46ddaeb308e06fae469b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzktNC0xLTEtNTg1Mzg3_29183070-be5a-4a92-bfb1-29a41ede1cdc"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <ci:OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzktMi0xLTEtNTQ3MDk4_67175fb5-e76d-498d-939b-d65ddecea006"
      unitRef="usd">36000000</ci:OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent>
    <ci:OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzktNC0xLTEtNTQ3MDk4_3388a1b0-ce87-496a-b643-3f6b7a7d8c3b"
      unitRef="usd">33000000</ci:OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent>
    <us-gaap:DebtCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzEwLTItMS0xLTU0NzA5OA_3c92c3d2-8d79-4e94-a7ea-145ae30fc406"
      unitRef="usd">3418000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzEwLTQtMS0xLTU0NzA5OA_50c8f6ac-7895-4a7a-8831-a78e6f5a6d52"
      unitRef="usd">2993000000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iacf9c0f395864206b0df7660a5342177_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE3LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmVlNDE3N2ZkMTY4YzQ5M2E4OGFmMzIyOGU2ZjFiNGZiXzQ_aea1f4c8-c9b7-4f08-a77f-e61d4f8516b9"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iacf9c0f395864206b0df7660a5342177_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE3LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmVlNDE3N2ZkMTY4YzQ5M2E4OGFmMzIyOGU2ZjFiNGZiXzg_f9082ba0-fd5a-42f8-ba9f-b4c7a616e687"
      unitRef="number">0.00613</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iacf9c0f395864206b0df7660a5342177_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE3LTItMS0xLTU0NzA5OA_610a1965-361a-42c7-bef1-441da615bf58"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8f6de552f34d46ddaeb308e06fae469b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE3LTQtMS0xLTU0NzA5OA_7f788b15-db12-46a7-a3f7-fe9160054708"
      unitRef="usd">499000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib7f9f54a14524ef2ac66996f0eca9b9c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE4LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjM4NWMxODdmODBiZjQ1MjliOGQ1NGZkNTQ1MDA3ZmIwXzQ_ce9a7ed0-01ed-45fe-b62a-1509405128b1"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib7f9f54a14524ef2ac66996f0eca9b9c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE4LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjM4NWMxODdmODBiZjQ1MjliOGQ1NGZkNTQ1MDA3ZmIwXzg_fe9da043-cf08-436b-868f-a4badc089486"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib7f9f54a14524ef2ac66996f0eca9b9c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE4LTItMS0xLTU0NzA5OA_4e5a1276-d97a-41f4-bc53-34a84af12804"
      unitRef="usd">992000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i44063dd30ab24985935f4de84ca1db87_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE4LTQtMS0xLTU0NzA5OA_2af9c558-4a56-4677-ba91-5422a7fc1600"
      unitRef="usd">990000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic8a730c53413415aaeb8a8df0ed50e7c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE5LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmNiYmI3MmM1OTFjYjRmNDU5ZDdjNTM5NmQ0MTllN2ZiXzQ_8d734c44-88f5-44af-8c7d-e02b174eb7d8"
      unitRef="usd">900000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic8a730c53413415aaeb8a8df0ed50e7c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE5LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmNiYmI3MmM1OTFjYjRmNDU5ZDdjNTM5NmQ0MTllN2ZiXzg_ba53e804-be01-482b-b73a-bb0e436f31a1"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic8a730c53413415aaeb8a8df0ed50e7c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE5LTItMS0xLTU0NzA5OA_718b5596-847c-43ed-a796-ebc15d97cb9f"
      unitRef="usd">878000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i980904614f6544cc9a3e363b158e13cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzE5LTQtMS0xLTU0NzA5OA_c6ab676d-e586-4388-9b7b-88e2caf31c4d"
      unitRef="usd">872000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id66a58d38b054171873c7dc463a8d253_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmZmNDIxYTAyZGZjNjRiNzdiZTBhYTA1YmNhNmQ1ZDI1XzQ_4d2593bb-660b-438e-8b96-cc125326256b"
      unitRef="usd">2200000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id66a58d38b054171873c7dc463a8d253_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmZmNDIxYTAyZGZjNjRiNzdiZTBhYTA1YmNhNmQ1ZDI1Xzg_eb1c0c44-c4a6-4999-80ef-26987e0b0d6f"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id66a58d38b054171873c7dc463a8d253_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIwLTItMS0xLTU0NzA5OA_e2d5e8bd-8974-46c7-9e2c-53a74ccf599f"
      unitRef="usd">2195000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibd0a8f836e6446e7a62ab400a6266eb2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIwLTQtMS0xLTU0NzA5OA_877bf60f-b365-4f44-a033-878ee4d56b96"
      unitRef="usd">2195000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i738c83b591a342bcb031de2dbdb544f9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIxLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjk0NzkyMDE0Y2FhNTQ4YzBiN2JkYzAwYjkyYjAwMmM5XzQ_b3031e99-93e1-48e8-9cb4-2ccca7aca68d"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i738c83b591a342bcb031de2dbdb544f9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIxLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjk0NzkyMDE0Y2FhNTQ4YzBiN2JkYzAwYjkyYjAwMmM5Xzg_cd9abd22-8d16-462c-933e-11ee9662bbf5"
      unitRef="number">0.04500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i738c83b591a342bcb031de2dbdb544f9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIxLTItMS0xLTU0NzA5OA_34afe7e5-7c12-46ad-b14c-bac51d7c0299"
      unitRef="usd">1503000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9bd4adeaf8a34f6e935f49888c83341b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIxLTQtMS0xLTU0NzA5OA_d3bec110-3610-41cc-bb70-bc3c9220cb57"
      unitRef="usd">1503000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9e91d995dc4d4716a67317f53051bfdd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIyLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjY4YjFkMmZiOWQ4NDQ4ODQ5ZTM4ZTdiMGU2Y2JlZDljXzQ_1f6d99be-e2f9-4706-b3d0-ec928f33d33b"
      unitRef="usd">800000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9e91d995dc4d4716a67317f53051bfdd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIyLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjY4YjFkMmZiOWQ4NDQ4ODQ5ZTM4ZTdiMGU2Y2JlZDljXzg_808eb465-fcff-4ebd-90f6-b8cc701c536f"
      unitRef="number">0.01250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9e91d995dc4d4716a67317f53051bfdd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIyLTItMS0xLTU0NzA5OA_e1c01252-dfaf-4d1a-989f-6fd0927b3d4e"
      unitRef="usd">797000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5ceafda26d1e4338a268d433a918d78a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIyLTQtMS0xLTU0NzA5OA_a6e2c488-074e-476f-84f3-ee5eeaf49998"
      unitRef="usd">797000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i895d782074b54523b13b795cfbfb9154_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTAtMS0xLTU2NTcyMi90ZXh0cmVnaW9uOjMxNWY1YmFhZDIwYTQ1OWRhMTY4ZWI3MjJkYjE2MzE1XzE2NDkyNjc0NDE2OTY_e67eeea2-296a-4e6a-9689-ccad5724bab4"
      unitRef="usd">700000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i895d782074b54523b13b795cfbfb9154_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTAtMS0xLTU2NTcyMi90ZXh0cmVnaW9uOjMxNWY1YmFhZDIwYTQ1OWRhMTY4ZWI3MjJkYjE2MzE1XzE2NDkyNjc0NDE3MDQ_475b6eba-cc1f-4031-a21a-0aa9fe8b7cde"
      unitRef="number">0.05685</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i895d782074b54523b13b795cfbfb9154_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTItMS0xLTU2NTg5Mg_a8bf47a9-3ef8-41bb-86da-ff11e4492eb8"
      unitRef="usd">697000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8b061b9ba35943ad9b01618d52b31bc0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTQtMS0xLTU2NjI5NQ_5d68a223-ced9-40a9-8788-2b6f8310eb47"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2ddccf40663440f6a73b0908b9484769_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmQwMWU1MDYxMGExNDQ5NzNhNTBmYTQ0Y2E2NWFiNzcxXzQ_15b7b4df-3e20-4cc8-a0d4-60e39dcd52cc"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2ddccf40663440f6a73b0908b9484769_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmQwMWU1MDYxMGExNDQ5NzNhNTBmYTQ0Y2E2NWFiNzcxXzg_24754482-0878-4113-9f81-3c5b65cff137"
      unitRef="number">0.03400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2ddccf40663440f6a73b0908b9484769_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTItMS0xLTU0NzA5OA_4b740c91-5667-48c9-a815-a2fdf2b24fb1"
      unitRef="usd">1440000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i72bd03d2619c44c29af788238edb9b7a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzIzLTQtMS0xLTU0NzA5OA_21d370da-7480-43ca-9b9c-4cf4d90e3950"
      unitRef="usd">1436000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i93ed3d337efa49aeacbaf2137357b0ff_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI0LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjZhZmU2N2E2ZDlmZDRmZWNhZTUzMGEwOTc2MzBhYmQ5XzQ_7e80fd10-d32c-4ee0-bb75-d49a6a6849d1"
      unitRef="usd">259000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i93ed3d337efa49aeacbaf2137357b0ff_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI0LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjZhZmU2N2E2ZDlmZDRmZWNhZTUzMGEwOTc2MzBhYmQ5Xzg_e1449750-c611-40bb-a96a-f6d3e27b0514"
      unitRef="number">0.07875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i93ed3d337efa49aeacbaf2137357b0ff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI0LTItMS0xLTU0NzA5OA_66e64fca-7763-4e2c-8dd8-f321ec653e7b"
      unitRef="usd">259000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3751913bfc0a45b7896c5c9cf5f54426_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI0LTQtMS0xLTU0NzA5OA_d6cd2f83-32b2-4a37-b819-322fb56eea49"
      unitRef="usd">259000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i43e32ecefdb440f3860ab5c831273423_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI1LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjc5ODBkOTk5NTYxZDRkNTU4NTRiNmNiMTU3MDBkNDY2XzQ_a1392108-f2f1-4a45-8d7b-3b5fdceb5a2c"
      unitRef="usd">600000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i43e32ecefdb440f3860ab5c831273423_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI1LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjc5ODBkOTk5NTYxZDRkNTU4NTRiNmNiMTU3MDBkNDY2Xzg_e2e00902-27b6-4c9d-aaa1-1c011b686689"
      unitRef="number">0.03050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i43e32ecefdb440f3860ab5c831273423_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI1LTItMS0xLTU0NzA5OA_c405c44b-a786-48a1-9b84-ad439e4d46ae"
      unitRef="usd">597000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9b5927dc1e2f4399b084401a0572efa8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI1LTQtMS0xLTU0NzA5OA_d61be6f3-cd6c-4d92-8a47-3fc2e20525fb"
      unitRef="usd">597000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i07cc745a98c84df4bf6dc07b30708361_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI2LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmU5ZjRjZGFmZDAxODQ3YTVhNDZhYzI1NjcwNjBlZDMwXzQ_c1eafcbe-317e-40fe-92e6-d81e352117b2"
      unitRef="usd">3800000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i07cc745a98c84df4bf6dc07b30708361_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI2LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmU5ZjRjZGFmZDAxODQ3YTVhNDZhYzI1NjcwNjBlZDMwXzg_03ab16ac-c8a3-4f62-af88-018df67cda5e"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i07cc745a98c84df4bf6dc07b30708361_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI2LTItMS0xLTU0NzA5OA_3df2e2a8-bfe2-48ef-acde-21d091377780"
      unitRef="usd">3785000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i15576a81e11a4a38ae45657dbce148c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI2LTQtMS0xLTU0NzA5OA_08f176c5-0442-471d-9b30-53945c5110e4"
      unitRef="usd">3785000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7a285f2991c9444c9755852b3eabda27_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI3LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdjYTMzMzFiMTAyOTQxY2ZiZDEwOTk3ZmU4M2E2ZTVlXzQ_4696891d-4f30-438a-a4f2-76d0fa7cebad"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7a285f2991c9444c9755852b3eabda27_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI3LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdjYTMzMzFiMTAyOTQxY2ZiZDEwOTk3ZmU4M2E2ZTVlXzg_231f0c04-87b1-4c5f-9bcb-087d5a22f300"
      unitRef="number">0.02400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7a285f2991c9444c9755852b3eabda27_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI3LTItMS0xLTU0NzA5OA_cc5cff24-4c16-4ab7-b884-4fe0782c35dd"
      unitRef="usd">1492000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2689f890bb1c42d68cefbbeb43a87908_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI3LTQtMS0xLTU0NzA5OA_e9a1a211-73f4-42dd-993c-2a24dcdac2c3"
      unitRef="usd">1492000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i66e2ace24fe24d90b02d99ff1be0dd09_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI4LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmIwNzgyMzM0MjAwOTQzMzE5NTUwMzAxNmY4NGQ2YjJhXzQ_835c2234-d9cd-4a69-9b47-c76f8e8f7efe"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i66e2ace24fe24d90b02d99ff1be0dd09_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI4LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmIwNzgyMzM0MjAwOTQzMzE5NTUwMzAxNmY4NGQ2YjJhXzg_83f25c93-3520-4b72-8e60-46815ff79652"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i66e2ace24fe24d90b02d99ff1be0dd09_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI4LTItMS0xLTU0NzA5OA_390f6cdf-d9dc-4491-b73f-b019ae662f59"
      unitRef="usd">1398000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i482114586ed84365b9534d71073eda66_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI4LTQtMS0xLTU0NzA5OA_c8b39b97-d540-49b5-a819-d87df2897396"
      unitRef="usd">1380000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9d96d999b8824e5484e9bc064061c29a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI5LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjUxOWQ1NmExNGE1MTQ3ODk5MzlmNmVlZTZlYThkNWMzXzQ_7bb118bc-92e1-4c77-aad8-901522f4db03"
      unitRef="usd">45000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9d96d999b8824e5484e9bc064061c29a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI5LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjUxOWQ1NmExNGE1MTQ3ODk5MzlmNmVlZTZlYThkNWMzXzg_f278f887-9622-4317-b5d2-6e7d217151ba"
      unitRef="number">0.08080</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9d96d999b8824e5484e9bc064061c29a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI5LTItMS0xLTU0NzA5OA_e24e6123-217b-48a6-8589-4b1449c71d80"
      unitRef="usd">45000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1cdc895b7a2741f2ba68c6eb57fcd620_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzI5LTQtMS0xLTU0NzA5OA_99927a45-1653-4156-94eb-cc133cf5ba38"
      unitRef="usd">45000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i64c8340c95104f9da98216f9c6c92918_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTAtMS0xLTU2NTgzOC90ZXh0cmVnaW9uOjFiOTk3Y2JlNjk1NzQ3NzJiNzliNDBkNTBhNjc1YTFlXzE2NDkyNjc0NDE2OTk_da3dbbf2-38a1-4663-b0f8-1a4aa5b903f2"
      unitRef="usd">800000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i64c8340c95104f9da98216f9c6c92918_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTAtMS0xLTU2NTgzOC90ZXh0cmVnaW9uOjFiOTk3Y2JlNjk1NzQ3NzJiNzliNDBkNTBhNjc1YTFlXzE2NDkyNjc0NDE3MDU_8263f4ce-e389-4ebb-b0a7-b692507a2ec6"
      unitRef="number">0.05400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i64c8340c95104f9da98216f9c6c92918_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTItMS0xLTU2NTg4Mg_e7a14495-6aa4-443d-902a-13fb4b17fed5"
      unitRef="usd">794000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i86cfeb71e3864eeca439c4353bb752e1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTQtMS0xLTU2NjMwNA_3be35600-7386-4e14-9792-2ff8ca331df4"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3197f7cdd54b4088ae3c71e0ad16d93f_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjhjMTdmNjMyMDc5NzRjNzJiYzkzYzA0M2M1MjVjZTc5XzQ_e928520f-b918-4cba-b9c1-e4ae8bfc114d"
      unitRef="usd">190000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3197f7cdd54b4088ae3c71e0ad16d93f_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjhjMTdmNjMyMDc5NzRjNzJiYzkzYzA0M2M1MjVjZTc5Xzg_8d618112-cd14-4bb9-b228-864b6d016b6b"
      unitRef="number">0.06150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3197f7cdd54b4088ae3c71e0ad16d93f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMwLTItMS0xLTU0NzA5OA_75b3885d-4fdf-4e75-87a5-e698ace60262"
      unitRef="usd">190000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7642ca01b359422c83d2c36109bbe311_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMwLTQtMS0xLTU0NzA5OA_d0481fc3-bee8-4266-9029-26c532dde6c5"
      unitRef="usd">190000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4bd52da1beae4ef3b43d1878bb83c53f_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjZjMGZmNjQwZjYxMzRiY2U4MDJlNmIxYjJkNzIyMDEyXzQ_4d3c76dd-3a59-4d62-84f8-f90d5ec15461"
      unitRef="usd">2200000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4bd52da1beae4ef3b43d1878bb83c53f_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjZjMGZmNjQwZjYxMzRiY2U4MDJlNmIxYjJkNzIyMDEyXzg_58f2c0bc-44af-49ce-9e33-387287570436"
      unitRef="number">0.04800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4bd52da1beae4ef3b43d1878bb83c53f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTItMS0xLTU0NzA5OA_76157e22-f8c3-406a-9d0f-3a8ddbc500aa"
      unitRef="usd">2192000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i46c86b75d1b641a38501f46eab131bf7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMxLTQtMS0xLTU0NzA5OA_508ef3a1-eedc-4517-b654-921bf1ae57c7"
      unitRef="usd">2192000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifc0d48e2aeb3466da82305ee7c4b7be0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMyLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmNmZjE1ZDE3MWJmNTRjMTJhMjMzNTllYmNlZWIyYzI5XzQ_a370499b-063a-4491-bb7e-e6e71fa88fe4"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifc0d48e2aeb3466da82305ee7c4b7be0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMyLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmNmZjE1ZDE3MWJmNTRjMTJhMjMzNTllYmNlZWIyYzI5Xzg_4bea3736-e44e-45cb-a762-a4dd0b9d0f3d"
      unitRef="number">0.03200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ifc0d48e2aeb3466da82305ee7c4b7be0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMyLTItMS0xLTU0NzA5OA_54e7b365-9a33-4c08-98f9-2eb4b5c4d172"
      unitRef="usd">743000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia12dcb2f4a5544df8a2c619e6c94a70b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMyLTQtMS0xLTU0NzA5OA_7b90b627-65ef-4caa-821b-dcf720094c8e"
      unitRef="usd">743000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id71094b2f34d4d978a441ba8995647fa_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMzLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmViMWIxMTFmOTE0YTRiYTBiNTI4ZTIwMDgwNjliYmVhXzQ_c2131434-faf4-4bd2-91a4-ff179f5b8c24"
      unitRef="usd">121000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id71094b2f34d4d978a441ba8995647fa_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMzLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmViMWIxMTFmOTE0YTRiYTBiNTI4ZTIwMDgwNjliYmVhXzg_0b531cba-19f7-453f-aeb8-8cdfcdeeb566"
      unitRef="number">0.05875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id71094b2f34d4d978a441ba8995647fa_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMzLTItMS0xLTU0NzA5OA_5315c6e2-66ae-4beb-a83a-9948380391be"
      unitRef="usd">119000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic5223523086642cba0dcbb8ed2b11004_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzMzLTQtMS0xLTU0NzA5OA_50cf4e5f-872d-4119-a1c8-df41a6f933a2"
      unitRef="usd">119000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4e5d78ed27a4483e8828d091e08d011d_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM0LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjJiZDY0Y2FkOTM2OTQwYTViOGVmYzc5ZjBlOThiYTJhXzQ_bab427d1-960a-4ee8-84d5-616d873ec097"
      unitRef="usd">448000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4e5d78ed27a4483e8828d091e08d011d_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM0LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjJiZDY0Y2FkOTM2OTQwYTViOGVmYzc5ZjBlOThiYTJhXzg_477cce6b-b561-41ad-90ec-de079f17bc50"
      unitRef="number">0.06125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4e5d78ed27a4483e8828d091e08d011d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM0LTItMS0xLTU0NzA5OA_833c0524-0d10-4cdf-9592-53a7d983164b"
      unitRef="usd">488000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i48fdb56eaaaa4b408d38131d70e82896_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM0LTQtMS0xLTU0NzA5OA_7c56b647-9665-473e-a339-f7c6da92b289"
      unitRef="usd">488000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib12f851059264a8d8a5b7886c8931917_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM1LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmFkZWQ5ODk2NWYwMDQ4ZjFhOTZjODM5ODQ5MmMyNTFjXzQ_ed370d3e-ab08-4ba4-a042-357d56c37284"
      unitRef="usd">317000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib12f851059264a8d8a5b7886c8931917_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM1LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmFkZWQ5ODk2NWYwMDQ4ZjFhOTZjODM5ODQ5MmMyNTFjXzg_3939e5bc-25bc-44f2-af5a-3bdc1c97333d"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib12f851059264a8d8a5b7886c8931917_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM1LTItMS0xLTU0NzA5OA_4c58c30f-c42a-4509-8cae-eaa4d9faad4d"
      unitRef="usd">315000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8300dd98b4ec4864a2dcf4b8241cfdfb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM1LTQtMS0xLTU0NzA5OA_ed0c3215-6422-431c-b7c0-8698d10fd936"
      unitRef="usd">315000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib290912817514769b3acd20a811fc92b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM2LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjkxOTdlYjkyMTVmYzQ0ZDY4NWQzY2ExMjAwMDE4OTdlXzQ_217d02fb-b800-468a-804a-af81ccda474a"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib290912817514769b3acd20a811fc92b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM2LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjkxOTdlYjkyMTVmYzQ0ZDY4NWQzY2ExMjAwMDE4OTdlXzg_8f16737e-1aab-4937-90ca-49de0712756c"
      unitRef="number">0.04800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib290912817514769b3acd20a811fc92b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM2LTItMS0xLTU0NzA5OA_bc400bd3-1641-4de8-b776-b8bab438b756"
      unitRef="usd">1466000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id3b44eaa966347caa1dcffe029cf7ae9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM2LTQtMS0xLTU0NzA5OA_6271d714-5ce4-4b89-a68c-b8af07b553f8"
      unitRef="usd">1466000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib9bfe6abbbb94e408b73c2c728c561ae_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM3LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjZmN2Y2OWE0OWIyODRiMDJhOGM2MjkwM2NjMzdiMzBmXzQ_d88de763-7c7a-4219-bba9-29f41994ce44"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib9bfe6abbbb94e408b73c2c728c561ae_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM3LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjZmN2Y2OWE0OWIyODRiMDJhOGM2MjkwM2NjMzdiMzBmXzg_4f902388-2825-4429-b872-ac4e6f7ad605"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib9bfe6abbbb94e408b73c2c728c561ae_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM3LTItMS0xLTU0NzA5OA_a8e3375b-24b7-473d-9b6e-b9a9707da51d"
      unitRef="usd">989000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1438a2bf41684eb7a1a30324f2a19a84_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM3LTQtMS0xLTU0NzA5OA_cd2a2c26-6389-4a1f-97ac-343bfcadfddd"
      unitRef="usd">989000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0a19a44748f045febddded935137ce5c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM4LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmZmMmE5MTU0ZGIzNzRmZDI5YmNhYTJiNDRiZDU2YmJhXzQ_2b344549-6edc-4a28-8ea2-00d8af0978bf"
      unitRef="usd">3000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0a19a44748f045febddded935137ce5c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM4LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmZmMmE5MTU0ZGIzNzRmZDI5YmNhYTJiNDRiZDU2YmJhXzg_7ddd843b-c31e-44c3-9731-79e14cb84e5a"
      unitRef="number">0.04900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0a19a44748f045febddded935137ce5c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM4LTItMS0xLTU0NzA5OA_574bd9e9-0e51-43d9-8a40-dd93a31f55cc"
      unitRef="usd">2969000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i365a75f6100e40feb386d3c9e27ceb30_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM4LTQtMS0xLTU0NzA5OA_f2fb098f-37cf-455f-ace2-3be711392a7e"
      unitRef="usd">2968000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icd2e63c77f194ff6bc9c2d7d25ffca38_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM5LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjA3Zjg0NzE3N2MzMTQ0NWJhNTE0NGVhNTgwMThlZGYwXzQ_f2204554-1ac7-4fee-aa99-764851f4f294"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icd2e63c77f194ff6bc9c2d7d25ffca38_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM5LTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjA3Zjg0NzE3N2MzMTQ0NWJhNTE0NGVhNTgwMThlZGYwXzg_96452555-e071-4471-be1b-aa33d3b54993"
      unitRef="number">0.03400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="icd2e63c77f194ff6bc9c2d7d25ffca38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM5LTItMS0xLTU0NzA5OA_66b2c3bf-eb3f-438d-9612-241965f5ee59"
      unitRef="usd">1236000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0e2dc1d6708c4916be653839738f0143_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzM5LTQtMS0xLTU0NzA5OA_a32a097f-1b74-4d31-aef8-13b39a9e7664"
      unitRef="usd">1236000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibdcc30e5c6a242ed85b05fc34479449c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjI1YmRhNjU4NTk5MjRmM2Q4MGNmNDM2ZGE3NjkwNWE4XzQ_33cc3112-5d56-4cbe-bc30-e736e9448d03"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibdcc30e5c6a242ed85b05fc34479449c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQwLTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjI1YmRhNjU4NTk5MjRmM2Q4MGNmNDM2ZGE3NjkwNWE4Xzg_5084396a-197c-48f1-a158-bcaaf5c29fdd"
      unitRef="number">0.03400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibdcc30e5c6a242ed85b05fc34479449c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQwLTItMS0xLTU0NzA5OA_5bd49c5c-ca76-4ae3-b39b-5c321a67209b"
      unitRef="usd">1478000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i87d06b6f0c7d4557ad2660d8e87b98f5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQwLTQtMS0xLTU0NzA5OA_42b7b4db-bbdc-4fd3-bc46-5466d20d03df"
      unitRef="usd">1478000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQxLTItMS0xLTU0NzA5OA_4cbf4426-54d6-400c-9f37-9ff0e95c367b"
      unitRef="usd">67000000</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQxLTQtMS0xLTU0NzA5OA_2628dcb5-e743-4290-94d2-a5e4ecda300d"
      unitRef="usd">66000000</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQyLTItMS0xLTU0NzA5OA_f3c87ec4-abb7-46ad-b9c1-b46a88d28da7"
      unitRef="usd">29124000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90YWJsZTo0NDc1YmM4ODU0ZGM0MmVmOGFkOGJiMmZiNzVkZmVjZS90YWJsZXJhbmdlOjQ0NzViYzg4NTRkYzQyZWY4YWQ4YmIyZmI3NWRmZWNlXzQyLTQtMS0xLTU0NzA5OA_7a09aa32-0159-4090-a281-09f84ed13df8"
      unitRef="usd">28100000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i49ecf3f26ca94fe88ab72567822a17c1_I20230115"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NTEvZnJhZzpiNGQ4OWNjODlkZjM0OTliYThmNzQ3ZmQ1MTRiMWQ2Yy90ZXh0cmVnaW9uOmI0ZDg5Y2M4OWRmMzQ5OWJhOGY3NDdmZDUxNGIxZDZjXzM5NA_517ef796-7a5f-47ea-baca-b9c933344193"
      unitRef="number">0.08080</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <ci:ScheduleOfIssuancesOfLongTermDebtTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90ZXh0cmVnaW9uOjFlYmNmMWZmZmVmNjQ4ZGRiMzlkYjdmZWU0NTIyMGE3XzEzMDg_86ec3d75-a0bc-4db0-8466-047631f38b01">On March 7, 2023, the Company issued $1.5&#160;billion of new senior notes. The proceeds of this issuance will be used for general corporate purposes, and may include repayment of outstanding debt securities. Interest on this debt is paid semi-annually.&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.777%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$700 million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 15, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.685%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$698 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$800 million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 15, 2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.400%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$796 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt; Redeemable at any time discounted at the U.S. Treasury rate plus 20 basis points. Redeemable at par on or after March 15, 2024.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;(2) Redeemable at any time discounted at the U.S. Treasury rate plus 25 basis points. Redeemable at par on or after December 15, 2032.</ci:ScheduleOfIssuancesOfLongTermDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if31115610c334a439c3f11aa884c91ce_I20230307"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90ZXh0cmVnaW9uOjFlYmNmMWZmZmVmNjQ4ZGRiMzlkYjdmZWU0NTIyMGE3XzI4MA_4ca2ae9b-5a1f-48ed-b8ab-464d380109ec"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5019884ac20741cf8a16eed471340bcf_I20230307"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90YWJsZTphMDU5MDc1MmYxM2Y0MjU0YWExYzQ1MjQ5MGEwNDc4ZS90YWJsZXJhbmdlOmEwNTkwNzUyZjEzZjQyNTRhYTFjNDUyNDkwYTA0NzhlXzEtMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246MGE3NGNjMDMyNzE3NDc5ZDg1ZmQwYTg0YTlkMTU5MzVfNA_52860a62-756a-4099-9ee2-184b88cbcdd6"
      unitRef="usd">700000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5019884ac20741cf8a16eed471340bcf_I20230307"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90YWJsZTphMDU5MDc1MmYxM2Y0MjU0YWExYzQ1MjQ5MGEwNDc4ZS90YWJsZXJhbmdlOmEwNTkwNzUyZjEzZjQyNTRhYTFjNDUyNDkwYTA0NzhlXzEtNC0xLTEtNTQ3MDk4_a61a1b1a-b036-4c67-a2d1-319be244f5f6"
      unitRef="number">0.05685</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <ci:ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees
      contextRef="i93b7c27710884424a2eec7dcef7b23f9_D20230307-20230307"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90YWJsZTphMDU5MDc1MmYxM2Y0MjU0YWExYzQ1MjQ5MGEwNDc4ZS90YWJsZXJhbmdlOmEwNTkwNzUyZjEzZjQyNTRhYTFjNDUyNDkwYTA0NzhlXzEtNi0xLTEtNTQ3MDk4_e96c7294-5982-4afe-bc7a-e09fdf4ca2cb"
      unitRef="usd">698000000</ci:ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iffbc2955b58a40d8b0178672d5fb531f_I20230307"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90YWJsZTphMDU5MDc1MmYxM2Y0MjU0YWExYzQ1MjQ5MGEwNDc4ZS90YWJsZXJhbmdlOmEwNTkwNzUyZjEzZjQyNTRhYTFjNDUyNDkwYTA0NzhlXzItMC0xLTEtNTQ3MDk4L3RleHRyZWdpb246ZmFkNGNhOTBlNTZiNDIzZGJhYzYyZWExYzcwZTI0ZDBfNA_a2b44b1c-37b1-44b4-834f-30105f0f76e9"
      unitRef="usd">800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iffbc2955b58a40d8b0178672d5fb531f_I20230307"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90YWJsZTphMDU5MDc1MmYxM2Y0MjU0YWExYzQ1MjQ5MGEwNDc4ZS90YWJsZXJhbmdlOmEwNTkwNzUyZjEzZjQyNTRhYTFjNDUyNDkwYTA0NzhlXzItNC0xLTEtNTQ3MDk4_fc44350a-da80-4f1d-ae87-81d84f6a0fef"
      unitRef="number">0.05400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <ci:ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees
      contextRef="i809f71ecb14a46c19821cd0c10cf40d1_D20230307-20230307"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90YWJsZTphMDU5MDc1MmYxM2Y0MjU0YWExYzQ1MjQ5MGEwNDc4ZS90YWJsZXJhbmdlOmEwNTkwNzUyZjEzZjQyNTRhYTFjNDUyNDkwYTA0NzhlXzItNi0xLTEtNTQ3MDk4_61cb7457-fa12-43c6-8fcc-31eb333a8955"
      unitRef="usd">796000000</ci:ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees>
    <ci:DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate
      contextRef="ifd4fe3f6c8b04276b496fb8ac4ef9399_D20230307-20230307"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90ZXh0cmVnaW9uOjFlYmNmMWZmZmVmNjQ4ZGRiMzlkYjdmZWU0NTIyMGE3XzU3NQ_7b78f33e-2674-4ce5-921b-84c31e6e45ea"
      unitRef="number">0.0020</ci:DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate>
    <ci:DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate
      contextRef="i11b7488d47bd4be38856523de2a8e659_D20230307-20230307"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjAvZnJhZzoxZWJjZjFmZmZlZjY0OGRkYjM5ZGI3ZmVlNDUyMjBhNy90ZXh0cmVnaW9uOjFlYmNmMWZmZmVmNjQ4ZGRiMzlkYjdmZWU0NTIyMGE3XzcwOA_3668e3c7-dc4e-4689-8763-33d51c143e9b"
      unitRef="number">0.0025</ci:DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if507247b2d15417b965fab339f79fe0a_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8zNw_e9a76249-49fe-4fe0-9b4e-12299702e5c2"
      unitRef="usd">3000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i37d8822645414b32a762b437086b9814_D20220401-20220430"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8xODYw_30145194-a9df-41a0-bf59-4d071142c4a3">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i968eab3e6c6a464b8621cc1f22f13849_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8xMTU_6f1ffec4-9331-481c-ba40-c624cb9113f3"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i2e9aa8daf53f4df3bad80c887b287e24_D20220401-20220430"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8xODU5_97d6d05f-0c35-4bcd-b3b5-794234820196">P3Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2be2fccd54774ea28094ccdeb4da1bf1_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8xNzM_fd0083cd-44e4-4d8a-a10c-c82308c0e374"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i402359fab32e4e2e81a9d588165d9963_D20220401-20220430"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8xODY0_c5c3a924-0db7-4032-b98c-c3a506c5a855">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCredit
      contextRef="iab20c9aeb2d14f4aaac0f23ac89dd20e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODk4L2ZyYWc6MWFiOThjYWZjYmEzNDU3NWJiMmU3MTRjNDlmMGEwNDYvdGV4dHJlZ2lvbjoxYWI5OGNhZmNiYTM0NTc1YmIyZTcxNGM0OWYwYTA0Nl8yMzc_fc27790f-7b37-40b2-a5e4-b6d17e256136"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i542bd1f117ca43d18940ed6fff533658_I20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xNTk_a84ef919-62bc-4936-9c83-ef860cae259a"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i37973f57d1cd47349579d1c948a6c36c_D20230401-20230430"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xNTUy_b26252ed-c34c-431d-85b9-a8e5f4ee396e">P5Y</us-gaap:DebtInstrumentTerm>
    <ci:DebtInstrumentExtensionTerm
      contextRef="i37973f57d1cd47349579d1c948a6c36c_D20230401-20230430"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xNTU0_8c2e9253-9785-4712-b802-45be394ac738">P1Y</ci:DebtInstrumentExtensionTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i542bd1f117ca43d18940ed6fff533658_I20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8zNzg_a84ef919-62bc-4936-9c83-ef860cae259a"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6e7b2848129a456d9e6bd7711efd7860_I20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV80NTE_6764b0dc-b915-4803-8591-a175092b6355"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="idbd12673dfe8421ca4a56e0ea3593be9_I20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV81MDI_63360fe6-3a4f-460c-82f7-5e78a05d7c33"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i83622a269b3f44fba77ec17337d55e2d_D20230401-20230430"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV81NDk3NTU4MTU0NjQ_ec238a25-b530-454f-96c8-894fa3ea727f">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="idbd12673dfe8421ca4a56e0ea3593be9_I20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV81OTI_63360fe6-3a4f-460c-82f7-5e78a05d7c33"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <ci:LineOfCreditFacilityConversionToTermLoanTerm
      contextRef="i83622a269b3f44fba77ec17337d55e2d_D20230401-20230430"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xNTUz_2a3fe312-6ee6-4190-9216-17e05d6ec4a5">P1Y</ci:LineOfCreditFacilityConversionToTermLoanTerm>
    <ci:LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity
      contextRef="iad29666a07fc46d68f52e52e2f6aaab4_I20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV85NDc_e38fdf3b-54fc-4254-a92e-22b031e792cc"
      unitRef="usd">1500000000</ci:LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity>
    <ci:LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity
      contextRef="iad29666a07fc46d68f52e52e2f6aaab4_I20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xMDEw_02443b8e-edd8-4691-9953-ecc086df691e"
      unitRef="usd">6500000000</ci:LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity>
    <ci:NumberOfRevolvingCreditFacility
      contextRef="ibc00f288660a48daae4fccef391cd358_I20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xMjQ5_16d66da8-6b7d-4f9d-a32c-156206233a1c"
      unitRef="revolvingcreditfacility">2</ci:NumberOfRevolvingCreditFacility>
    <ci:NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement
      contextRef="iad29666a07fc46d68f52e52e2f6aaab4_I20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xMjg0_fc38cb34-642c-462c-8b17-d3401b6a8e27"
      unitRef="position">21</ci:NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement>
    <ci:LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant
      contextRef="iad29666a07fc46d68f52e52e2f6aaab4_I20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81OTI5L2ZyYWc6ZGQxMmVkZWQ1ZTRmNDIxZGE3Y2ZmY2FlNDkzNGRlNjEvdGV4dHJlZ2lvbjpkZDEyZWRlZDVlNGY0MjFkYTdjZmZjYWU0OTM0ZGU2MV8xNDc4_beb0e07c-78ce-4717-99b5-dd9ea8ee3f2c"
      unitRef="number">0.60</ci:LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia05553ebdf9b4a5b971cdfd702e8a711_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODY1L2ZyYWc6YWRiMGY3NGU1NDg4NGFjNTkzZTUyMjhjMWJiMjE4MWQvdGV4dHJlZ2lvbjphZGIwZjc0ZTU0ODg0YWM1OTNlNTIyOGMxYmIyMTgxZF8yMzY_2e557b81-d977-42f8-a558-a6d89e721ff6"
      unitRef="usd">5000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="ia05553ebdf9b4a5b971cdfd702e8a711_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODY1L2ZyYWc6YWRiMGY3NGU1NDg4NGFjNTkzZTUyMjhjMWJiMjE4MWQvdGV4dHJlZ2lvbjphZGIwZjc0ZTU0ODg0YWM1OTNlNTIyOGMxYmIyMTgxZF80NDU_51b0aa4f-be92-4231-bd72-ca5523ceaf88"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:InterestExpenseDebt
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjkvZnJhZzo1ZjQzODQ2YWJlNzE0MDVhYmUwNDZhODY1NzU0ZTJjYS90ZXh0cmVnaW9uOjVmNDM4NDZhYmU3MTQwNWFiZTA0NmE4NjU3NTRlMmNhXzExMQ_9acef062-60f5-4e7f-ab48-e3d5de60a079"
      unitRef="usd">345000000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NjkvZnJhZzo1ZjQzODQ2YWJlNzE0MDVhYmUwNDZhODY1NzU0ZTJjYS90ZXh0cmVnaW9uOjVmNDM4NDZhYmU3MTQwNWFiZTA0NmE4NjU3NTRlMmNhXzE3Nw_a0de348a-45fe-41f0-af90-23b2ca54b7fb"
      unitRef="usd">314000000</us-gaap:InterestExpenseDebt>
    <ci:ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzIvZnJhZzplYWZkYmYzNWNiZDE0YjE4YjEwNmVmYmM2ODUxYjYwNy90ZXh0cmVnaW9uOmVhZmRiZjM1Y2JkMTRiMThiMTA2ZWZiYzY4NTFiNjA3XzEy_9d02c753-1293-4cbe-84fa-e771720010ed">Note 8 &#x2013; Common and Preferred Stock&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In the first quarter of 2023, The Cigna Group declared quarterly cash dividends of $1.23 per share of the Company's common stock. In the first quarter of 2022, The Cigna Group declared quarterly cash dividends of $1.12 per share of the Company's common stock.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table provides details of the Company's dividend payments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Record Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Amount Paid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt; (in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 23, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$1.23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$368&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 9, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$357&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April&#160;26, 2023, the Board of Directors declared the second quarter cash dividend of $1.23 per share of The Cigna Group common stock to be paid on June&#160;22, 2023 to shareholders of record on June&#160;7, 2023. The Company currently intends to pay regular quarterly &lt;/span&gt;&lt;/div&gt;dividends, with future declarations subject to approval by its Board of Directors and the Board's determination that the declaration of dividends remains in the best interests of The Cigna Group and its shareholders. The decision of whether to pay future dividends and the amount of any such dividends will be based on the Company's financial position, results of operations, cash flows, capital requirements, the requirements of applicable law and any other factors the Board may deem relevant.</ci:ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzc3_d569d0e5-36ac-420e-bbcc-2164f968a01a"
      unitRef="usdPerShare">1.23</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iaa7f8f9afed94f2c8a4d8a3fadcba829_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzE5Nw_6fe552b2-6b0c-49d8-8ae3-3c471b9ee6b8"
      unitRef="usdPerShare">1.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i75204ef5bacc45e484f57be2c4af5158_D20221001-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzE5Nw_9361f3f4-f93f-4209-98b5-7a00e29671a2"
      unitRef="usdPerShare">1.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i67f0445844a9443db40d9291472caedc_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzE5Nw_a969759e-0c5c-4bfe-b5c5-0a501e3916ba"
      unitRef="usdPerShare">1.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzE5Nw_d9900ec1-8b3e-4e97-99d3-c997a74f22dd"
      unitRef="usdPerShare">1.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsDeclaredTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzEwMzM_98595cc5-46c9-4521-87b7-47aeec8e29ac">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table provides details of the Company's dividend payments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Record Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Amount Paid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt; (in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 23, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$1.23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$368&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 9, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$357&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DividendsDeclaredTableTextBlock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="ib9c3e4e75f4d46b58ea05c03cbcb7a51_D20230323-20230323"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90YWJsZToyNDEyNTFmYjk2ZjU0ZjE5ODFiOGY3Yjc2Y2MzNjkxYi90YWJsZXJhbmdlOjI0MTI1MWZiOTZmNTRmMTk4MWI4ZjdiNzZjYzM2OTFiXzItMi0xLTEtNTQ3MDk4_1b458679-c41c-4b8c-8247-87b0d881e380"
      unitRef="usdPerShare">1.23</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ib9c3e4e75f4d46b58ea05c03cbcb7a51_D20230323-20230323"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90YWJsZToyNDEyNTFmYjk2ZjU0ZjE5ODFiOGY3Yjc2Y2MzNjkxYi90YWJsZXJhbmdlOjI0MTI1MWZiOTZmNTRmMTk4MWI4ZjdiNzZjYzM2OTFiXzItMy0xLTEtNTQ3MDk4_88c81aa6-5077-40e3-bc1b-4aa830718841"
      unitRef="usd">368000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i194fae94da834e3e8279dc01c624343d_D20220324-20220324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90YWJsZToyNDEyNTFmYjk2ZjU0ZjE5ODFiOGY3Yjc2Y2MzNjkxYi90YWJsZXJhbmdlOjI0MTI1MWZiOTZmNTRmMTk4MWI4ZjdiNzZjYzM2OTFiXzctMi0xLTEtNTQ3MDk4_0bf12113-505f-4a37-b5e2-0053a4a89eb9"
      unitRef="usdPerShare">1.12</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i194fae94da834e3e8279dc01c624343d_D20220324-20220324"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90YWJsZToyNDEyNTFmYjk2ZjU0ZjE5ODFiOGY3Yjc2Y2MzNjkxYi90YWJsZXJhbmdlOjI0MTI1MWZiOTZmNTRmMTk4MWI4ZjdiNzZjYzM2OTFiXzctMy0xLTEtNTQ3MDk4_8749013a-b42d-4a36-bb30-a8f6141aa086"
      unitRef="usd">357000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i9df7da12ac1d49b3b2f3b1ad8b0cc70f_D20230426-20230426"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80NzgvZnJhZzo3YjczMTg3NjYyMDY0MmQ4OWJkYTkxMTE0MGFmNjQ2MS90ZXh0cmVnaW9uOjdiNzMxODc2NjIwNjQyZDg5YmRhOTExMTQwYWY2NDYxXzM4Nw_7b37fbf9-5878-4d56-a6c8-f4af5d1d3b55"
      unitRef="usdPerShare">1.23</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90ZXh0cmVnaW9uOjIwZjgzYjA5Mjk3NDQ5MDQ4YWFkOGUxMWVhODc3YTAwXzk1MTA3NzU1ODAzNDYx_8c781003-ed5b-464f-a045-58afacbbcccc">Insurance and Contractholder Liabilities&lt;div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;A.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt;text-decoration:underline"&gt;Account Balances &#x2013; Insurance and Contractholder Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's insurance and contractholder liabilities were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unpaid claims and claim expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,880&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,959&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;272&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;542&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;601&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;290&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,631&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contractholder deposit funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;361&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,309&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,670&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Market risk benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;48&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,172&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,220&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unearned premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,419&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,440&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,509&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Insurance and contractholder liabilities classified as Liabilities of businesses held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total insurance and contractholder liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,166&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11,790&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;18,956&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.94pt"&gt;Amounts classified as Liabilities of businesses held for sale primarily include $3.7&#160;billion of Future policy benefits, $0.4&#160;billion of Unpaid claims and $0.4&#160;billion of Unearned premiums as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Insurance and contractholder liabilities expected to be paid within one year are classified as current. The Company adopted amended accounting guidance for long-duration insurance contracts on January 1, 2023, discussed further in Note 2 to the Consolidated Financial Statements, which resulted in restatement of prior period amounts. Additionally, see below updated accounting policies and incremental disclosures associated with future policy benefits (Note 9C), contractholder deposit funds (Note 9D), and market risk benefits (Note 9E).&lt;/span&gt;&lt;/div&gt;Unpaid Claims and Claim Expenses &#x2013; Cigna HealthcareThis liability reflects estimates of the ultimate cost of claims that have been incurred but not reported, including expected development on reported claims, those that have been reported but not yet paid (reported claims in process) and other medical care expenses and services payable that are primarily comprised of accruals for incentives and other amounts payable to health care professionals and facilities. The total of incurred but not reported liabilities plus expected development on reported claims, including reported claims in process, was $4.6 billion at March&#160;31, 2023 and $4.2 billion at March&#160;31, 2022. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Activity, net of intercompany transactions, in the unpaid claims liability for the Cigna Healthcare segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance and other amounts recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;221&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,955&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Incurred costs related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,041&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,897&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Paid costs related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,316&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,795&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,111&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,741&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance and other amounts recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,959&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Reinsurance and other amounts recoverable reflect amounts due from reinsurers and policyholders to cover incurred but not reported and pending claims of certain business for which the Company administers the plan benefits without any right of offset. See Note 10 to the Consolidated Financial Statements for additional information on reinsurance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Variances in incurred costs related to prior years' unpaid claims and claim expenses that resulted from the differences between actual experience and the Company's key assumptions were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Actual completion factors&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical cost trend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;143&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total favorable variance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;144&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Percentage of current year incurred costs as reported for the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Percentage of current year incurred costs as reported for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Favorable prior year development in both years reflects lower than expected utilization of medical services as compared to our assumptions.&lt;/span&gt;&lt;/div&gt;Future Policy Benefits&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accounting Policy.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Future policy benefits represent the present value of estimated future obligations, estimated using actuarial methods, for long-term insurance policies and annuity products currently in force, consisting primarily of reserves for annuity contracts, life insurance benefits, and certain supplemental health products that are guaranteed renewable beyond one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Contracts are grouped at a level no higher than issue year, based on the original contract issue date, and at lower levels of disaggregation within each issue year for certain businesses to reflect factors including product type, plan type and currency. Management estimates these obligations based on assumptions for premiums, interest rates, mortality or morbidity, future claim adjudication expenses and surrenders. Mortality, morbidity and surrender assumptions are based on the Company's own experience and published actuarial tables, and are updated at least annually, to the extent changes in circumstances require. Interest rate assumptions are based on&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;market-level yields for low credit risk fixed income instruments ("upper-medium grade fixed-income instrument"). For interest accretion purposes, interest rates are fixed at the year of the cohort's inception, however for purposes of liability measurement, are updated to the current rate quarterly, with all changes in the interest rate from inception to current period reported through Accumulated other comprehensive loss. For contracts issued domestically, we use observable inputs from a published spot rate curve for terms up to 30 years and extrapolate for longer terms using a constant forward rate approach. For contracts issued by foreign operating entities with functional currencies other than the U.S. dollar, we use observable inputs to approximate a risk free rate and add a credit spread adjustment to align with a low credit risk fixed income instrument. For terms beyond the last observable risk free rates, which vary by international market, we extrapolate to the ultimate forward rate assuming a constant credit spread.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the annuity business, the premium paying period is shorter than the benefit coverage period, and a deferred profit liability ("DPL") is reported in future policy benefits representing gross premium received in excess of net premiums. DPL is amortized based on expected future benefit payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The weighted average interest rates applied and duration for future policy benefits in the Cigna Healthcare segment, consisting primarily of supplemental health products including individual Medicare supplement, limited benefit health products and individual private medical insurance, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest accretion rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current discount rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5.29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average duration &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8.05 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.45 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The net liability for future policy benefits for the segment's supplemental health products represents the present value of benefits expected to be paid to policyholders, net of the present value of expected net premiums, which is the portion of expected future gross premium expected to be collected from policyholders that is required to provide for all expected future benefits and expenses. The present values of expected net premiums and expected future policy benefits for the Cigna Healthcare segment are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Present value of expected net premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,557&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Reversal of effect of beginning of period discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,537&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Effect of assumption changes and actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Issuances and lapses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net premiums collected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;56&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance at original discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Effect of end of period discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,818&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Present value of expected policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Reversal of effect of discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,611&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Effect of assumption changes and actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Issuances and lapses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;307&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance at original discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Effect of discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,217&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;399&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liability for future policy benefits &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;601&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Includes the foreign exchange rate impact of translating from transactional and functional currency to United States dollar and the impact of flooring the liability at zero. The flooring impact is calculated at the cohort level after discounting the reserves at the current discount rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;As of March&#160;31, 2023 and March&#160;31, 2022, respectively, undiscounted expected future gross premiums were $17.6 billion and $13.5 billion. As of March&#160;31, 2023 and March&#160;31, 2022, respectively, discounted expected future gross premiums were $12.5 billion and $10.7 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;As of March&#160;31, 2023 and March&#160;31, 2022, respectively, undiscounted expected future policy benefits were $12.8 billion and $11.2 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;The liability for future policyholder benefits includes immaterial businesses shown as reconciling items above, most of which are in run-off. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;$154 million and $171 million of reinsurance recoverable asset reported in the Consolidated Balance Sheets as of March&#160;31, 2023 and March&#160;31, 2022, respectively, relate to the liability for future policy benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Other Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The weighted average interest rates applied and duration for future policy benefits in Other Operations, consisting of annuity and life insurance products, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest accretion rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5.64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current discount rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4.95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average duration &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11.7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Obligations for annuities represent discounted periodic benefits to be paid to an individual or groups of individuals over their remaining lives. Other Operations&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; traditional insurance contracts, which are in run-off, have no premium remaining to be collected; therefore, future policy benefit reserves represent the present value of expected future policy benefits, discounted using the current discount rate and the remaining amortizable DPL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Future policy benefits for Other Operations includes DPL of $392 million as of March&#160;31, 2023 and $384&#160;million as of March&#160;31, 2022. Future policy benefits excluding DPL, were $3.2&#160;billion as of both March&#160;31, 2023 and December&#160;31, 2022 and $3.9&#160;billion and $4.3&#160;billion as of March&#160;31, 2022 and December&#160;31, 2021, respectively. These balances exclude amounts classified as Liabilities of businesses held for sale of $3.7&#160;billion as of March&#160;31, 2022 and $3.8&#160;billion as of December&#160;31, 2021. The change in future policy benefits reserves year-to-date was primarily driven by changes in the current discount rate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Undiscounted expected future policy benefits were $4.6&#160;billion as of March&#160;31, 2023 and $4.7&#160;billion as of March&#160;31, 2022. As of March&#160;31, 2023 and March&#160;31, 2022, $1.0&#160;billion and $1.2&#160;billion of the future policy benefit reserve was recoverable through treaties with external reinsurers.&lt;/span&gt;&lt;/div&gt;Contractholder Deposit Funds&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accounting Policy. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Liabilities for contractholder deposit funds primarily include deposits received from customers for investment-related and universal life products and investment earnings on their fund balances in Other Operations. These liabilities are adjusted to reflect administrative charges and, for universal life fund balances, mortality charges. Interest credited on these funds is accrued ratably over the contract period. &lt;/span&gt;Contractholder deposit fund liabilities within Other Operations were $6.7 billion as of both March&#160;31, 2023 and December&#160;31, 2022 and $6.8 billion and $6.9 billion as of March&#160;31, 2022 and December&#160;31, 2021, respectively. Approximately 39% of the balance is reinsured externally. Activity in these liabilities is presented net of reinsurance in the Consolidated Statements of Cash Flows. The net year-to-date decrease in contractholder deposit fund liabilities generally relates to withdrawals and benefit payments from contractholder deposit funds, partially offset by deposits and interest credited to contractholder deposit funds.As of March&#160;31, 2023, the weighted average crediting rate, net amount at risk and cash surrender value for contractholder deposit fund liabilities not externally reinsured were 3.25%, $3.2 billion and $2.8 billion, respectively. The comparative amounts as of March&#160;31, 2022 were 3.18%, $3.5 billion and $2.9 billion, respectively. As of both March 31, 2023 and March 31, 2022, more than 99% of the $4.1 billion liability not reinsured externally is for contracts with guaranteed interest rates of 3% - 4%, and approximately $1.2 billion represented contracts with policies at the guarantee. At both of these same period ends, $1.2 billion was 50-150 bps above the guarantee and the remaining $1.7 billion represented contracts above the guarantee that pay the policyholder based on the greater of a guaranteed minimum cash value or the actual cash value. More than 90% of these contracts have actual cash values of at least 110% of the guaranteed cash value.Market Risk BenefitsLiabilities for market risk benefits consist of variable annuity reinsurance contracts (also referred to as GMDB and GMIB contracts) in Other Operations. These liabilities arise under annuities and riders to annuities written by ceding companies that guarantee the benefit received at death and, for a subset of policies, also provide contractholders the option, within 30 days of a policy anniversary after the appropriate waiting period, to elect minimum income payments. The Company's capital market risk exposure on variable annuity reinsurance contracts arises when the reinsured guaranteed minimum benefit exceeds the contractholder's account value in the related underlying mutual funds at the time the insurance benefit is payable under the respective contract. The Company receives and pays premium periodically based on the terms of the reinsurance agreements.&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accounting Policy.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Variable annuity reinsurance liabilities are measured as MRBs at fair value, net of nonperformance risk, with fluctuations in value gross of reinsurer nonperformance risk reported in benefits expense while fluctuations in the Company's own &lt;/span&gt;nonperformance risk (own credit risk) are reported in Accumulated other comprehensive loss. Nonperformance risk reflects risk that a party might default and therefore not fulfill its obligations (i.e. nonpayment risk). The nonperformance risk adjustment reflects a market participant's view of nonpayment risk by adding an additional spread to the discount rate in the calculation of both (a) the variable annuity reinsurance liabilities to be paid by the Company and (b) the variable annuity reinsurance assets to be paid by the reinsurers, after considering collateral. The Company classifies variable annuity assets and liabilities in Level 3 of the fair value hierarchy described in Note 12 to the Consolidated Financial Statements because assumptions related to future annuitant behavior are largely unobservable. As discussed further in Note 10 to the Consolidated Financial Statements, due to the reinsurance agreements covering these liabilities, the liabilities do not generally impact net income except for the change in nonperformance risk on the reinsurance recoverable, which is reported in benefits expense and does not offset the nonperformance risk valuation on the liability. Variable annuity liabilities are established using capital market assumptions and assumptions related to future annuitant behavior (including mortality, lapse and annuity election rates). &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Market risk benefits activity was as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.877%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;1,268&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Balance, beginning of year, before the effect of nonperformance risk (own credit risk)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;1,379&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;1,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Changes due to expected run-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Changes due to capital markets versus expected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Changes due to policyholder behavior versus expected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Assumption changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Balance, end of year, before the effect of changes in nonperformance risk (own credit risk)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;1,305&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;1,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Nonperformance risk (own credit risk), end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;1,220&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Reinsured market risk benefit, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;1,301&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;1,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table presents the net amount at risk and the average attained age of contractholders (weighted by exposure) for contracts assumed by the Company. The net amount at risk is the amount the Company would have to pay to contractholders if all deaths or annuitizations occurred as of the earliest possible date in accordance with the insurance contract. The Company should be reimbursed in full for these payments unless the Berkshire reinsurance limit is exceeded, as discussed further in Note 10 to the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions, excludes impact of reinsurance ceded)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net amount at risk&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Average attained age of contractholders (weighted by exposure)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;75.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90ZXh0cmVnaW9uOjIwZjgzYjA5Mjk3NDQ5MDQ4YWFkOGUxMWVhODc3YTAwXzU0OTc1NTgxNTgzNg_25e61b7a-db46-4bcb-a789-93509735493b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's insurance and contractholder liabilities were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unpaid claims and claim expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,880&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,959&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;272&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;542&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;601&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;290&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,631&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contractholder deposit funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;361&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,309&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,670&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Market risk benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;48&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,172&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,220&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unearned premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,419&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,440&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,509&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Insurance and contractholder liabilities classified as Liabilities of businesses held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total insurance and contractholder liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,166&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11,790&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;18,956&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.94pt"&gt;Amounts classified as Liabilities of businesses held for sale primarily include $3.7&#160;billion of Future policy benefits, $0.4&#160;billion of Unpaid claims and $0.4&#160;billion of Unearned premiums as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Activity, net of intercompany transactions, in the unpaid claims liability for the Cigna Healthcare segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance and other amounts recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;221&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,955&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Incurred costs related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,041&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,897&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Paid costs related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,316&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,795&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,111&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,741&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance and other amounts recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,959&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtMS0xLTEtNjIzNTMy_5bb9bd06-0531-43e0-bae0-bb492ef64ba2"
      unitRef="usd">4880000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtMy0xLTEtNjIzNTMy_d039058b-cb36-45a5-8684-e7987ba2973b"
      unitRef="usd">79000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtNS0xLTEtNjIzNTMy_8c694165-b0d1-4726-b0e5-cf8941a95da1"
      unitRef="usd">4959000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtNy0xLTEtNjIzNTMy_4c44fbbb-e5a4-4fa8-98b7-4a4dde711823"
      unitRef="usd">4117000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtOS0xLTEtNjIzNTMy_6089e291-d1a0-4987-b8a9-7329dc4c68eb"
      unitRef="usd">59000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtMTEtMS0xLTYyMzUzMg_7544aebc-5d38-4135-a50e-c79b2ce0b3a9"
      unitRef="usd">4176000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzMtMTMtMS0xLTYyMzUzMg_e98654a2-5a55-48f2-8561-4f6d4d5f38ce"
      unitRef="usd">4491000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtMS0xLTEtNjIzNTMy_b48791db-8674-439b-b1bd-184808c3b26b"
      unitRef="usd">97000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtMy0xLTEtNjIzNTMy_b5ce1245-4d80-418d-801a-fb9822f8152f"
      unitRef="usd">175000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtNS0xLTEtNjIzNTMy_d89f447e-62f7-4f41-8742-378647c8ea7f"
      unitRef="usd">272000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent
      contextRef="i5db337d577d24323b93b59b505c32718_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtNy0xLTEtNjIzNTMy_34456350-60df-4907-a577-79cfe3f8c5f8"
      unitRef="usd">107000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent
      contextRef="i5db337d577d24323b93b59b505c32718_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtOS0xLTEtNjIzNTMy_e13cf29d-f43e-4d12-ae9b-ebedf265eeea"
      unitRef="usd">177000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i5db337d577d24323b93b59b505c32718_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtMTEtMS0xLTYyMzUzMg_254f5c12-7546-41b2-bc77-422ebd9c9d5b"
      unitRef="usd">284000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzQtMTMtMS0xLTYyMzUzMg_9f8286bb-2c77-480e-82e6-e9870100533c"
      unitRef="usd">744000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups>
    <ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtMS0xLTEtNTQ3MDk4_035e9247-46f0-40dd-bc7a-c6f0cc6c41ea"
      unitRef="usd">59000000</ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent>
    <ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtMy0xLTEtNTQ3MDk4_7b3d3e84-e8c6-40ed-83fa-270e11548141"
      unitRef="usd">542000000</ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtNS0xLTEtNTQ3MDk4_9d43d7e6-9085-4a0b-b951-af88c8d5edb2"
      unitRef="usd">601000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtNy0xLTEtNTQ3MDk4_babea748-b5e5-4f7e-b68e-cabbfa4ac365"
      unitRef="usd">43000000</ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent>
    <ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtOS0xLTEtNTQ3MDk4_be064ed0-fee4-4ea4-9a98-c6da6f08f3bc"
      unitRef="usd">544000000</ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtMTEtMS0xLTU0NzA5OA_7a32d953-673a-40bc-a91b-812bc54c83a5"
      unitRef="usd">587000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <ci:LiabilityForFuturePolicyBenefitsIncludingDisposalGroups
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzYtMTMtMS0xLTU0NzA5OA_d5c670d2-918d-4aa4-9c9b-8d0345646b6a"
      unitRef="usd">681000000</ci:LiabilityForFuturePolicyBenefitsIncludingDisposalGroups>
    <ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctMS0xLTEtNTQ3MDk4_b411b74b-3aa8-4bbc-b190-91ed4aafcfd0"
      unitRef="usd">290000000</ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent>
    <ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctMy0xLTEtNTQ3MDk4_3fd7fedc-fd04-49d2-be84-5190f105d6de"
      unitRef="usd">3341000000</ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctNS0xLTEtNTQ3MDk4_f119c422-c7b2-4ad5-86c4-12975c59aa9c"
      unitRef="usd">3631000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent
      contextRef="i5db337d577d24323b93b59b505c32718_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctNy0xLTEtNTQ3MDk4_8db5654a-c548-41c1-8ece-19b166c7caff"
      unitRef="usd">150000000</ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent>
    <ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent
      contextRef="i5db337d577d24323b93b59b505c32718_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctOS0xLTEtNTQ3MDk4_d5ba6cf8-a2f8-4c1a-b38d-87b3f4d82970"
      unitRef="usd">3442000000</ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i5db337d577d24323b93b59b505c32718_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctMTEtMS0xLTU0NzA5OA_7725153c-3d8b-49b9-99f2-44b586137289"
      unitRef="usd">3592000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <ci:LiabilityForFuturePolicyBenefitsIncludingDisposalGroups
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzctMTMtMS0xLTU0NzA5OA_504416fa-0564-44d2-a16b-861c194487bd"
      unitRef="usd">7981000000</ci:LiabilityForFuturePolicyBenefitsIncludingDisposalGroups>
    <ci:PolicyholderContractDepositCurrent
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTEtMS0xLTYyMzU1Mg_95be5efb-149f-4fa5-8faa-db3a584d0be8"
      unitRef="usd">12000000</ci:PolicyholderContractDepositCurrent>
    <ci:PolicyholderContractDepositNoncurrent
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTMtMS0xLTYyMzU1Mg_99bb151d-857b-4e1c-a5a9-c3af33ba81c5"
      unitRef="usd">151000000</ci:PolicyholderContractDepositNoncurrent>
    <us-gaap:PolicyholderContractDeposits
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTUtMS0xLTYyMzU1Mg_d9950d5d-7a30-44bf-b7ac-f6e3e4506683"
      unitRef="usd">163000000</us-gaap:PolicyholderContractDeposits>
    <ci:PolicyholderContractDepositCurrent
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTctMS0xLTYyMzU1Mg_11d3dbe2-ea69-4d06-9210-1ce22fa21e6e"
      unitRef="usd">14000000</ci:PolicyholderContractDepositCurrent>
    <ci:PolicyholderContractDepositNoncurrent
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTktMS0xLTYyMzU1Mg_6b2bab4b-f6b7-4396-8383-b293b9cd80ba"
      unitRef="usd">157000000</ci:PolicyholderContractDepositNoncurrent>
    <us-gaap:PolicyholderContractDeposits
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTExLTEtMS02MjM1NTI_f1c7dd2e-a304-4793-91c9-ea501c557b75"
      unitRef="usd">171000000</us-gaap:PolicyholderContractDeposits>
    <us-gaap:PolicyholderContractDeposits
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEyLTEzLTEtMS02MjM1NTI_f5feb7c6-7780-4d6a-ba0e-3dbf68114105"
      unitRef="usd">181000000</us-gaap:PolicyholderContractDeposits>
    <ci:PolicyholderContractDepositCurrent
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTEtMS0xLTYyMzU1Mg_3219af24-84a2-4b6b-815e-cd44d819d021"
      unitRef="usd">361000000</ci:PolicyholderContractDepositCurrent>
    <ci:PolicyholderContractDepositNoncurrent
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTMtMS0xLTYyMzU1Mg_660f50bf-6b79-4adc-9a84-a6407518e18b"
      unitRef="usd">6309000000</ci:PolicyholderContractDepositNoncurrent>
    <us-gaap:PolicyholderContractDeposits
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTUtMS0xLTYyMzU1Mg_a3378675-db62-4e7b-b8d0-f98ed2416fe9"
      unitRef="usd">6670000000</us-gaap:PolicyholderContractDeposits>
    <ci:PolicyholderContractDepositCurrent
      contextRef="i5db337d577d24323b93b59b505c32718_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTctMS0xLTYyMzU1Mg_20f264d2-3cb3-4268-a167-a36d13bb43ae"
      unitRef="usd">351000000</ci:PolicyholderContractDepositCurrent>
    <ci:PolicyholderContractDepositNoncurrent
      contextRef="i5db337d577d24323b93b59b505c32718_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTktMS0xLTYyMzU1Mg_14408c21-7081-4e52-a302-c01e8c56d292"
      unitRef="usd">6358000000</ci:PolicyholderContractDepositNoncurrent>
    <us-gaap:PolicyholderContractDeposits
      contextRef="i5db337d577d24323b93b59b505c32718_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTExLTEtMS02MjM1NTI_04afc309-9d6b-41b3-bd1f-ad498916883d"
      unitRef="usd">6709000000</us-gaap:PolicyholderContractDeposits>
    <us-gaap:PolicyholderContractDeposits
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTEzLTEtMS02MjM1NTI_7ed97f41-c95c-46e2-800b-bcf44eb9b2f1"
      unitRef="usd">6843000000</us-gaap:PolicyholderContractDeposits>
    <ci:MarketRiskBenefitLiabilityAmountCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtMS0xLTEtNTQ3MDk4_04a8d8f3-b922-426f-9ba1-cd12f5abeb98"
      unitRef="usd">48000000</ci:MarketRiskBenefitLiabilityAmountCurrent>
    <ci:MarketRiskBenefitLiabilityAmountNoncurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtMy0xLTEtNTQ3MDk4_40b06e5b-69c1-4615-a9d9-044d928942f0"
      unitRef="usd">1172000000</ci:MarketRiskBenefitLiabilityAmountNoncurrent>
    <us-gaap:MarketRiskBenefitLiabilityAmount
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtNS0xLTEtNTQ3MDk4_c02862dd-8be9-442c-882b-9ab64955402a"
      unitRef="usd">1220000000</us-gaap:MarketRiskBenefitLiabilityAmount>
    <ci:MarketRiskBenefitLiabilityAmountCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtNy0xLTEtNTQ3MDk4_bc61b84a-8295-4d22-986f-9c9e5909fbeb"
      unitRef="usd">51000000</ci:MarketRiskBenefitLiabilityAmountCurrent>
    <ci:MarketRiskBenefitLiabilityAmountNoncurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtOS0xLTEtNTQ3MDk4_f6f5ed5e-0f7e-40fe-aa9a-e21015488d80"
      unitRef="usd">1217000000</ci:MarketRiskBenefitLiabilityAmountNoncurrent>
    <us-gaap:MarketRiskBenefitLiabilityAmount
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtMTEtMS0xLTU0NzA5OA_19b911eb-d7fa-43db-83e5-268c6cf1a09f"
      unitRef="usd">1268000000</us-gaap:MarketRiskBenefitLiabilityAmount>
    <us-gaap:MarketRiskBenefitLiabilityAmount
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzgtMTMtMS0xLTU0NzA5OA_352e30a0-e941-4515-8167-5413f32df080"
      unitRef="usd">1558000000</us-gaap:MarketRiskBenefitLiabilityAmount>
    <ci:UnearnedPremiumsCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktMS0xLTEtNTQ3MDk4_d98b4b2d-fffe-4330-88e5-4c919e9a563a"
      unitRef="usd">1419000000</ci:UnearnedPremiumsCurrent>
    <ci:UnearnedPremiumsNoncurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktMy0xLTEtNTQ3MDk4_2fc03291-267b-4bee-ade1-e31d94b8d8d4"
      unitRef="usd">21000000</ci:UnearnedPremiumsNoncurrent>
    <us-gaap:UnearnedPremiums
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktNS0xLTEtNTQ3MDk4_45dc1738-89b0-4759-b1c3-45ae960172e8"
      unitRef="usd">1440000000</us-gaap:UnearnedPremiums>
    <ci:UnearnedPremiumsCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktNy0xLTEtNTQ3MDk4_23ce4b85-c174-4cbe-9223-585021cf7b11"
      unitRef="usd">576000000</ci:UnearnedPremiumsCurrent>
    <ci:UnearnedPremiumsNoncurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktOS0xLTEtNTQ3MDk4_3e6dd27d-70c4-4840-9f76-5ee1c59047af"
      unitRef="usd">22000000</ci:UnearnedPremiumsNoncurrent>
    <us-gaap:UnearnedPremiums
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktMTEtMS0xLTU0NzA5OA_49f3e92f-560e-414e-bbc1-a00f2f905be3"
      unitRef="usd">598000000</us-gaap:UnearnedPremiums>
    <ci:UnearnedPremiumsIncludingDisposalGroups
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzktMTMtMS0xLTU0NzA5OA_c0cb0070-6ab9-45df-a6cb-db36e8dfcca2"
      unitRef="usd">1030000000</ci:UnearnedPremiumsIncludingDisposalGroups>
    <ci:InsuranceAndContractholderLiabilitiesIncludingDisposalGroups
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzEzLTEzLTEtMS01NjczNDk_770f401d-4348-41b9-9aab-6aa92adefae2"
      unitRef="usd">23509000000</ci:InsuranceAndContractholderLiabilitiesIncludingDisposalGroups>
    <ci:DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE0LTEzLTEtMS01NjczNTY_df938b7c-5b34-4839-b218-dab8222ffaa6"
      unitRef="usd">4562000000</ci:DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities>
    <ci:InsuranceAndContractholderLiabilitiesCurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTEtMS0xLTU0NzA5OA_0d683982-5b12-45ba-b851-5595eae77c35"
      unitRef="usd">7166000000</ci:InsuranceAndContractholderLiabilitiesCurrent>
    <ci:InsuranceAndContractholderLiabilitiesNoncurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTMtMS0xLTU0NzA5OA_ab522b81-b527-400f-aa77-a9f2dac5bbb2"
      unitRef="usd">11790000000</ci:InsuranceAndContractholderLiabilitiesNoncurrent>
    <ci:InsuranceAndContractholderLiabilities
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTUtMS0xLTU0NzA5OA_94f2633e-1aec-401a-b8a8-68831c039d1b"
      unitRef="usd">18956000000</ci:InsuranceAndContractholderLiabilities>
    <ci:InsuranceAndContractholderLiabilitiesCurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTctMS0xLTU0NzA5OA_e15d746b-4598-452c-9627-e90e59194624"
      unitRef="usd">5409000000</ci:InsuranceAndContractholderLiabilitiesCurrent>
    <ci:InsuranceAndContractholderLiabilitiesNoncurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTktMS0xLTU0NzA5OA_2444524a-50e0-41ca-92e4-b864d2ff3cbc"
      unitRef="usd">11976000000</ci:InsuranceAndContractholderLiabilitiesNoncurrent>
    <ci:InsuranceAndContractholderLiabilities
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTExLTEtMS01NDcwOTg_cb1666c9-e127-45d2-b6f0-1bcddded3484"
      unitRef="usd">17385000000</ci:InsuranceAndContractholderLiabilities>
    <ci:InsuranceAndContractholderLiabilities
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90YWJsZTo1NGU3YWUzZTU0Y2U0NTliOWNhNGIwNTg3MDk2YWRjZS90YWJsZXJhbmdlOjU0ZTdhZTNlNTRjZTQ1OWI5Y2E0YjA1ODcwOTZhZGNlXzE1LTEzLTEtMS01NDcwOTg_a932c0d6-0003-4d8f-ad4b-18aa628e80b1"
      unitRef="usd">18947000000</ci:InsuranceAndContractholderLiabilities>
    <ci:LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90ZXh0cmVnaW9uOjIwZjgzYjA5Mjk3NDQ5MDQ4YWFkOGUxMWVhODc3YTAwXzIxMA_83bd8e0f-1ce1-422e-a4a4-48fd3e509b64"
      unitRef="usd">3700000000</ci:LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90ZXh0cmVnaW9uOjIwZjgzYjA5Mjk3NDQ5MDQ4YWFkOGUxMWVhODc3YTAwXzI0MA_35cf57da-e861-4523-acd9-b15aaa2d20fe"
      unitRef="usd">400000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups>
    <ci:PolicyholderContractDepositsAttributableToDisposalGroups
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF80OTAvZnJhZzoyMGY4M2IwOTI5NzQ0OTA0OGFhZDhlMTFlYTg3N2EwMC90ZXh0cmVnaW9uOjIwZjgzYjA5Mjk3NDQ5MDQ4YWFkOGUxMWVhODc3YTAwXzI2NA_8c890b92-a141-4625-ba46-af45e554e13e"
      unitRef="usd">400000000</ci:PolicyholderContractDepositsAttributableToDisposalGroups>
    <us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDIvZnJhZzozZDNhNWZiNTM4MzI0MWU5OTA5N2JlNTViOTIxYTkwOS90ZXh0cmVnaW9uOjNkM2E1ZmI1MzgzMjQxZTk5MDk3YmU1NWI5MjFhOTA5XzQ1OA_2da03472-dd86-4ac5-9995-45507a2caa38">This liability reflects estimates of the ultimate cost of claims that have been incurred but not reported, including expected development on reported claims, those that have been reported but not yet paid (reported claims in process) and other medical care expenses and services payable that are primarily comprised of accruals for incentives and other amounts payable to health care professionals and facilities.</us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90ZXh0cmVnaW9uOmE5MjIwYTE0NzM5ODQ3M2ZhYmI2ZmMxNzBkNWNjOGRiXzE0NA_770c4739-98d6-4ae4-acb3-a3d206e3492d"
      unitRef="usd">4600000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses>
    <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90ZXh0cmVnaW9uOmE5MjIwYTE0NzM5ODQ3M2ZhYmI2ZmMxNzBkNWNjOGRiXzE1Nw_885d0b59-78b0-4b9d-be92-016d0c3c4fbc"
      unitRef="usd">4200000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzQtMS0xLTEtNTQ3MDk4_79c6af41-5e6f-4b3b-93ce-7829475a10a0"
      unitRef="usd">4176000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="if3314d3839844dbab40e20dd517db732_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzQtMy0xLTEtNTQ3MDk4_cab736f5-5323-4dc3-8248-3b3b1ce1795b"
      unitRef="usd">4261000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzUtMS0xLTEtNTQ3MDk4_81176d85-60f3-468a-9ee6-fc23886cb95a"
      unitRef="usd">221000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="if3314d3839844dbab40e20dd517db732_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzUtMy0xLTEtNTQ3MDk4_c1f7e22c-1e5d-496a-b374-0e7b8b793ebf"
      unitRef="usd">261000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzYtMS0xLTEtNTQ3MDk4_c4be79fc-e967-4269-b62e-de25dbfc346d"
      unitRef="usd">3955000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="if3314d3839844dbab40e20dd517db732_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzYtMy0xLTEtNTQ3MDk4_5f2301e6-39c0-472e-b8bf-64f5863df2b1"
      unitRef="usd">4000000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzktMS0xLTEtNTQ3MDk4_0749bb2d-d90a-426e-aae3-8594bb50ed73"
      unitRef="usd">9041000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzktMy0xLTEtNTQ3MDk4_77f3497f-f4f8-4e94-8732-63bcab42db4c"
      unitRef="usd">8024000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzEwLTEtMS0xLTU0NzA5OA_ee0da9f3-ba2e-4a01-9a5a-ca604a889fe2"
      unitRef="usd">-144000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzEwLTMtMS0xLTU0NzA5OA_6f019744-36a3-4720-8175-15740e0b92f8"
      unitRef="usd">-276000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzExLTEtMS0xLTU0NzA5OA_e921668e-2990-4119-888a-6a5885ccc4ed"
      unitRef="usd">8897000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzExLTMtMS0xLTU0NzA5OA_9900d7e6-905f-4c7e-927e-d5794339d26e"
      unitRef="usd">7748000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzEzLTEtMS0xLTU0NzA5OA_817f7a56-cd6c-4150-9d55-d88ee2f79dc3"
      unitRef="usd">5316000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzEzLTMtMS0xLTU0NzA5OA_febcc9ed-7f20-4192-84e1-65719ac350c1"
      unitRef="usd">4634000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE0LTEtMS0xLTU0NzA5OA_793d074b-876a-4848-9c76-22cd058da01d"
      unitRef="usd">2795000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE0LTMtMS0xLTU0NzA5OA_07005c17-4cb0-4514-bf57-afd0b64d9226"
      unitRef="usd">2822000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE1LTEtMS0xLTU0NzA5OA_16dc2b7d-0e17-4ffb-8fc8-2ce1e2c18584"
      unitRef="usd">8111000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE1LTMtMS0xLTU0NzA5OA_4115c93f-640f-47d3-999a-c282a7cf5062"
      unitRef="usd">7456000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE3LTEtMS0xLTU0NzA5OA_637365fe-d988-43b8-83b2-4d72d78a0a74"
      unitRef="usd">4741000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE3LTMtMS0xLTU0NzA5OA_ec4a5693-f658-4663-ad34-3f6b10014458"
      unitRef="usd">4292000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE4LTEtMS0xLTU0NzA5OA_0d723937-c916-4228-a994-fd895e674fa4"
      unitRef="usd">218000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE4LTMtMS0xLTU0NzA5OA_70df34c1-d1d5-45cd-bd83-eaf64d427558"
      unitRef="usd">199000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE5LTEtMS0xLTU0NzA5OA_f9a1807d-2155-41f3-ae94-ef26810bb621"
      unitRef="usd">4959000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTo1ZmZlOWFkZjUxZjg0NWEzYTEyZDljNTViNjUzMmMwNC90YWJsZXJhbmdlOjVmZmU5YWRmNTFmODQ1YTNhMTJkOWM1NWI2NTMyYzA0XzE5LTMtMS0xLTU0NzA5OA_20861f38-def8-4fbd-af26-7488d4de1769"
      unitRef="usd">4491000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceAccountingPolicy
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90ZXh0cmVnaW9uOmE5MjIwYTE0NzM5ODQ3M2ZhYmI2ZmMxNzBkNWNjOGRiXzEwODQ_dce0273b-93b5-45b4-8395-c1b450030ff3">Reinsurance and other amounts recoverable reflect amounts due from reinsurers and policyholders to cover incurred but not reported and pending claims of certain business for which the Company administers the plan benefits without any right of offset. See Note 10 to the Consolidated Financial Statements for additional information on reinsuranceThe Company's insurance subsidiaries enter into agreements with other insurance companies to limit losses from large exposures and to permit recovery of a portion of incurred losses. Reinsurance is ceded primarily in acquisition and disposition transactions when the underwriting company is not being acquired. Reinsurance does not relieve the originating insurer of liability. Therefore, reinsured liabilities must continue to be reported along with the related reinsurance recoverables. The Company regularly evaluates the financial condition of its reinsurers and monitors concentrations of its credit risk.The Company reviews its reinsurance arrangements and establishes reserves against the recoverables.Collateral levels are defined internally based on the fair value of the collateral relative to the carrying amount of the reinsurance recoverable, the frequency at which collateral is required to be replenished and the potential for volatility in the collateral's fair value.</us-gaap:ReinsuranceAccountingPolicy>
    <us-gaap:ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90ZXh0cmVnaW9uOmE5MjIwYTE0NzM5ODQ3M2ZhYmI2ZmMxNzBkNWNjOGRiXzEwODM_68fac909-f80d-433e-83fd-6a6bbfea0408">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Variances in incurred costs related to prior years' unpaid claims and claim expenses that resulted from the differences between actual experience and the Company's key assumptions were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Actual completion factors&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical cost trend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;143&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total favorable variance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;144&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Percentage of current year incurred costs as reported for the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Percentage of current year incurred costs as reported for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i582bfa8cb42448fb904b42f8fd26b53c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzUtMS0xLTEtNTQ3MDk4_80a9a333-b095-499e-8110-00b6a8451fe9"
      unitRef="usd">-1000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage
      contextRef="i582bfa8cb42448fb904b42f8fd26b53c_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzUtMy0xLTEtNTQ3MDk4_1cd41644-bbcb-4368-a13b-40307748018c"
      unitRef="number">0</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i2cde04d0ebee47b58537b475418eccf3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzUtNS0xLTEtNTQ3MDk4_29438b3b-dee6-4fce-b27f-66f0af7d918c"
      unitRef="usd">-99000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage
      contextRef="i2cde04d0ebee47b58537b475418eccf3_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzUtNy0xLTEtNTQ3MDk4_050d358b-6ad8-4478-9c3f-975ca01094ba"
      unitRef="number">0.003</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ie8f7bc9e3c3445a6980b765bf65b3c78_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzYtMS0xLTEtNTQ3MDk4_83a3d29d-6f6c-4971-ae92-c9eede9165e4"
      unitRef="usd">-143000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage
      contextRef="ie8f7bc9e3c3445a6980b765bf65b3c78_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzYtMy0xLTEtNTQ3MDk4_b2415a94-c74b-4b24-8558-24677e5c3ad7"
      unitRef="number">0.005</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i5a56d790203f47048913b46660f4d92c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzYtNS0xLTEtNTQ3MDk4_6ee848f7-78eb-46ff-9255-e192073bbe67"
      unitRef="usd">-177000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage
      contextRef="i5a56d790203f47048913b46660f4d92c_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzYtNy0xLTEtNTQ3MDk4_eac720bf-1319-4a92-b748-5e2c73db1941"
      unitRef="number">0.006</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzgtMS0xLTEtNTQ3MDk4_95592f1b-8229-4e8b-8cb2-7c48c91b37b6"
      unitRef="usd">-144000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzgtMy0xLTEtNTQ3MDk4_38a1df85-d0a4-4c78-8f10-49b68a8b9491"
      unitRef="number">0.005</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzgtNS0xLTEtNTQ3MDk4_6709686a-2322-4ed3-988e-d85946510484"
      unitRef="usd">-276000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MDgvZnJhZzphOTIyMGExNDczOTg0NzNmYWJiNmZjMTcwZDVjYzhkYi90YWJsZTphMDMxNTYyMGU1MTM0MDc3OGQ1MjJiNDA2MGM2OGJkOS90YWJsZXJhbmdlOmEwMzE1NjIwZTUxMzQwNzc4ZDUyMmI0MDYwYzY4YmQ5XzgtNy0xLTEtNTQ3MDk4_6fa08a57-4da4-4da1-81cf-c25687434074"
      unitRef="number">0.009</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage>
    <us-gaap:FuturePolicyBenefitsLiabilityPolicy
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzU0OTc1NTgzMTQxOA_4bf3fab3-235d-4b30-9756-a339ba61010a">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accounting Policy.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Future policy benefits represent the present value of estimated future obligations, estimated using actuarial methods, for long-term insurance policies and annuity products currently in force, consisting primarily of reserves for annuity contracts, life insurance benefits, and certain supplemental health products that are guaranteed renewable beyond one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Contracts are grouped at a level no higher than issue year, based on the original contract issue date, and at lower levels of disaggregation within each issue year for certain businesses to reflect factors including product type, plan type and currency. Management estimates these obligations based on assumptions for premiums, interest rates, mortality or morbidity, future claim adjudication expenses and surrenders. Mortality, morbidity and surrender assumptions are based on the Company's own experience and published actuarial tables, and are updated at least annually, to the extent changes in circumstances require. Interest rate assumptions are based on&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;market-level yields for low credit risk fixed income instruments ("upper-medium grade fixed-income instrument"). For interest accretion purposes, interest rates are fixed at the year of the cohort's inception, however for purposes of liability measurement, are updated to the current rate quarterly, with all changes in the interest rate from inception to current period reported through Accumulated other comprehensive loss. For contracts issued domestically, we use observable inputs from a published spot rate curve for terms up to 30 years and extrapolate for longer terms using a constant forward rate approach. For contracts issued by foreign operating entities with functional currencies other than the U.S. dollar, we use observable inputs to approximate a risk free rate and add a credit spread adjustment to align with a low credit risk fixed income instrument. For terms beyond the last observable risk free rates, which vary by international market, we extrapolate to the ultimate forward rate assuming a constant credit spread.&lt;/span&gt;&lt;/div&gt;For the annuity business, the premium paying period is shorter than the benefit coverage period, and a deferred profit liability ("DPL") is reported in future policy benefits representing gross premium received in excess of net premiums. DPL is amortized based on expected future benefit payments.</us-gaap:FuturePolicyBenefitsLiabilityPolicy>
    <ci:FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzQxNzgxNDQxODczMDAw_78425758-2fd4-43cb-ad7d-b1e12e771cd3">P30Y</ci:FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm>
    <us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3Xzk1MTA3NzU1ODIwMTUy_6a03a391-4b57-4a64-b822-45ac6a740690">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The weighted average interest rates applied and duration for future policy benefits in the Cigna Healthcare segment, consisting primarily of supplemental health products including individual Medicare supplement, limited benefit health products and individual private medical insurance, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest accretion rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current discount rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5.29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average duration &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8.05 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.45 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The present values of expected net premiums and expected future policy benefits for the Cigna Healthcare segment are as follows: &lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Present value of expected net premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,557&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Reversal of effect of beginning of period discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,537&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Effect of assumption changes and actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Issuances and lapses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net premiums collected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;56&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance at original discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Effect of end of period discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,818&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Present value of expected policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Reversal of effect of discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,611&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Effect of assumption changes and actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Issuances and lapses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;307&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance at original discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,595&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Effect of discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,217&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;399&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liability for future policy benefits &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;601&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Includes the foreign exchange rate impact of translating from transactional and functional currency to United States dollar and the impact of flooring the liability at zero. The flooring impact is calculated at the cohort level after discounting the reserves at the current discount rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;As of March&#160;31, 2023 and March&#160;31, 2022, respectively, undiscounted expected future gross premiums were $17.6 billion and $13.5 billion. As of March&#160;31, 2023 and March&#160;31, 2022, respectively, discounted expected future gross premiums were $12.5 billion and $10.7 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;As of March&#160;31, 2023 and March&#160;31, 2022, respectively, undiscounted expected future policy benefits were $12.8 billion and $11.2 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;The liability for future policyholder benefits includes immaterial businesses shown as reconciling items above, most of which are in run-off. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;$154 million and $171 million of reinsurance recoverable asset reported in the Consolidated Balance Sheets as of March&#160;31, 2023 and March&#160;31, 2022, respectively, relate to the liability for future policy benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The weighted average interest rates applied and duration for future policy benefits in Other Operations, consisting of annuity and life insurance products, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest accretion rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5.64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current discount rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4.95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average duration &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11.7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTowNDBkMGJjYTAwNWY0YjE2YWUyYzcwMmRlNmE5OTc5Yy90YWJsZXJhbmdlOjA0MGQwYmNhMDA1ZjRiMTZhZTJjNzAyZGU2YTk5NzljXzItMS0xLTEtNTQ3MDk4_89f7c3de-e649-4a29-bdf9-85806c5ffa1b"
      unitRef="number">0.0259</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTowNDBkMGJjYTAwNWY0YjE2YWUyYzcwMmRlNmE5OTc5Yy90YWJsZXJhbmdlOjA0MGQwYmNhMDA1ZjRiMTZhZTJjNzAyZGU2YTk5NzljXzItMy0xLTEtNTQ3MDk4_9669dcb9-af07-46db-a156-31d6bf306a3f"
      unitRef="number">0.0264</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate>
    <us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTowNDBkMGJjYTAwNWY0YjE2YWUyYzcwMmRlNmE5OTc5Yy90YWJsZXJhbmdlOjA0MGQwYmNhMDA1ZjRiMTZhZTJjNzAyZGU2YTk5NzljXzMtMS0xLTEtNTQ3MDk4_a1d2a83e-3ea4-4240-9f1d-256f45dd8a9f"
      unitRef="number">0.0529</us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate>
    <us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTowNDBkMGJjYTAwNWY0YjE2YWUyYzcwMmRlNmE5OTc5Yy90YWJsZXJhbmdlOjA0MGQwYmNhMDA1ZjRiMTZhZTJjNzAyZGU2YTk5NzljXzMtMy0xLTEtNTQ3MDk4_a10a12b7-f50d-48b6-bb19-37674b2265d5"
      unitRef="number">0.0490</us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTowNDBkMGJjYTAwNWY0YjE2YWUyYzcwMmRlNmE5OTc5Yy90YWJsZXJhbmdlOjA0MGQwYmNhMDA1ZjRiMTZhZTJjNzAyZGU2YTk5NzljXzQtMS0xLTEtNTQ3MDk4_ecfc70f3-fd69-4d61-afe8-e44965f6a498">P8Y18D</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTowNDBkMGJjYTAwNWY0YjE2YWUyYzcwMmRlNmE5OTc5Yy90YWJsZXJhbmdlOjA0MGQwYmNhMDA1ZjRiMTZhZTJjNzAyZGU2YTk5NzljXzQtMy0xLTEtNTQ3MDk4_fa30ad4b-7f1c-4ea9-903b-939547fb915f">P7Y5M12D</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzQtMS0xLTEtNTQ3MDk4_b8e58a1a-8817-41c6-a5ff-e7ba727288b8"
      unitRef="usd">8557000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange
      contextRef="if3314d3839844dbab40e20dd517db732_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzQtMy0xLTEtNTQ3MDk4_b75ec6ca-d92c-4903-8827-5a47066e9aa7"
      unitRef="usd">9314000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzUtMS0xLTEtNTQ3MDk4_326dc799-9416-40ce-b39f-9088be41635b"
      unitRef="usd">-1537000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax
      contextRef="if3314d3839844dbab40e20dd517db732_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzUtMy0xLTEtNTQ3MDk4_10e5e7c0-4829-456d-800a-d090b8887d60"
      unitRef="usd">367000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax>
    <ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzYtMS0xLTEtNTQ3MDk4_66801276-6a4d-40e0-ab19-25a44f4b9787"
      unitRef="usd">0</ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience>
    <ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience
      contextRef="if3314d3839844dbab40e20dd517db732_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzYtMy0xLTEtNTQ3MDk4_b5dd06dc-9d21-404e-827d-9de1f65dd98e"
      unitRef="usd">0</ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience>
    <ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzctMS0xLTEtNTQ3MDk4_7229fe62-667b-4713-801e-f6cfa500b654"
      unitRef="usd">306000000</ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition>
    <ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzctMy0xLTEtNTQ3MDk4_7ccb69e5-3904-4800-b0b0-26b47f2e619b"
      unitRef="usd">143000000</ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzgtMS0xLTEtNTQ3MDk4_b08999bf-3c5c-4901-b665-34146445a260"
      unitRef="usd">326000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzgtMy0xLTEtNTQ3MDk4_cf04cb45-6c4f-4ccf-8ea5-258509f01f2e"
      unitRef="usd">310000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected>
    <ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzktMS0xLTEtNTQ3MDk4_d8a185fb-24bd-4769-813b-ccf327a742db"
      unitRef="usd">56000000</ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges>
    <ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzktMy0xLTEtNTQ3MDk4_1b36d62f-d0f3-4e83-bc1d-90ce397ede0a"
      unitRef="usd">46000000</ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzEwLTEtMS0xLTU0NzA5OA_4e14fb6a-f69a-41f4-b085-3d97c4beee07"
      unitRef="usd">10130000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzEwLTMtMS0xLTU0NzA5OA_00fa4e77-4c8e-4d49-9f1a-8f674264e396"
      unitRef="usd">8826000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzExLTEtMS0xLTU0NzA5OA_a8f81ec5-c301-4a92-9b86-4049b8e888ed"
      unitRef="usd">-1312000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzExLTMtMS0xLTU0NzA5OA_4d98ae9f-d133-4cdc-917a-9ee0bbffb387"
      unitRef="usd">-376000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzEyLTEtMS0xLTU0NzA5OA_b3df9be4-f9ce-4a3b-aeeb-208d7bcf56bf"
      unitRef="usd">8818000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzEyLTMtMS0xLTU0NzA5OA_cb59a5d2-821f-4e78-af11-48fdea90d25c"
      unitRef="usd">8450000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE1LTEtMS0xLTU0NzA5OA_d1d26687-a97f-4fcc-a7d6-fd93ca51fdf6"
      unitRef="usd">8945000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="if3314d3839844dbab40e20dd517db732_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE1LTMtMS0xLTU0NzA5OA_ddfabffc-b877-40f9-8ab2-8eb482791635"
      unitRef="usd">9794000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE2LTEtMS0xLTU0NzA5OA_2fe112d5-a8f3-4edc-9aa8-56ad17b73aef"
      unitRef="usd">1611000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="if3314d3839844dbab40e20dd517db732_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE2LTMtMS0xLTU0NzA5OA_73bda4f9-3c97-4b40-bd7a-56df83f4ee88"
      unitRef="usd">-379000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience
      contextRef="i8ccb9215d3f94df49e58cec62ca66848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE3LTEtMS0xLTU0NzA5OA_8ac22905-3420-4870-9d3f-fb2ae56bb80b"
      unitRef="usd">0</ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience>
    <ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience
      contextRef="if3314d3839844dbab40e20dd517db732_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE3LTMtMS0xLTU0NzA5OA_47ec7a3e-8dc5-4fa7-b739-9a02a2889427"
      unitRef="usd">0</ci:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience>
    <ci:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE4LTEtMS0xLTU0NzA5OA_2256e121-255b-4fef-b238-833f68ac9c35"
      unitRef="usd">307000000</ci:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition>
    <ci:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE4LTMtMS0xLTU0NzA5OA_e6ef9865-3db4-41ee-8918-fd1c32c94855"
      unitRef="usd">215000000</ci:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition>
    <us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE5LTEtMS0xLTU0NzA5OA_764fafbd-5f00-4b31-a584-48f75fe2926f"
      unitRef="usd">326000000</us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzE5LTMtMS0xLTU0NzA5OA_bdb2b8d2-f416-4bbd-aa32-7bf85c7b401f"
      unitRef="usd">385000000</us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits>
    <ci:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIwLTEtMS0xLTU0NzA5OA_feab1ae2-f98e-414b-8b6d-1c2c1adc91c9"
      unitRef="usd">58000000</ci:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges>
    <ci:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIwLTMtMS0xLTU0NzA5OA_e0415c52-d9cc-45b7-9849-bfb3758adf0b"
      unitRef="usd">52000000</ci:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIxLTEtMS0xLTU0NzA5OA_76da9bc7-de18-48a6-991e-825791dfc2ee"
      unitRef="usd">10595000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIxLTMtMS0xLTU0NzA5OA_d7bc6ab2-1574-49b5-81a8-661551497228"
      unitRef="usd">9297000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIyLTEtMS0xLTU0NzA5OA_ceb533c7-96d6-4abb-83f8-9d3819e62406"
      unitRef="usd">1378000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIyLTMtMS0xLTU0NzA5OA_b4c4bd7a-5dd4-4d9a-9357-8696321d9563"
      unitRef="usd">392000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIzLTEtMS0xLTU0NzA5OA_8aba3050-d1ad-4ba6-a470-8291e539fe68"
      unitRef="usd">9217000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzIzLTMtMS0xLTU0NzA5OA_85020a96-5194-4406-812f-0cb07193b471"
      unitRef="usd">8905000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzI1LTEtMS0xLTU0NzA5OA_e30c23d1-a808-420e-843a-877a849d1ef5"
      unitRef="usd">399000000</ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther>
    <ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzI1LTMtMS0xLTU0NzA5OA_3b658f49-7cf7-4084-a229-4d00445f39cd"
      unitRef="usd">455000000</ci:LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther>
    <ci:LiabilityForFuturePolicyBenefitOther
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzI2LTEtMS0xLTU0NzA5OA_277455a7-bb87-43d1-8614-5bf8327c1d43"
      unitRef="usd">202000000</ci:LiabilityForFuturePolicyBenefitOther>
    <ci:LiabilityForFuturePolicyBenefitOther
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzI2LTMtMS0xLTU0NzA5OA_6a239376-84d5-4237-bb2a-c87e66b3b52c"
      unitRef="usd">226000000</ci:LiabilityForFuturePolicyBenefitOther>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzI3LTEtMS0xLTU0NzA5OA_89500049-82cc-48e2-afe2-28585d5eeb3d"
      unitRef="usd">601000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90YWJsZTozOTgwMWE2ZDk0YmI0N2EyOTgyMDVkMjkxOGNmOWVmZC90YWJsZXJhbmdlOjM5ODAxYTZkOTRiYjQ3YTI5ODIwNWQyOTE4Y2Y5ZWZkXzI3LTMtMS0xLTU0NzA5OA_c9c4047c-3257-4d63-a9ec-12bab4fb29dc"
      unitRef="usd">681000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzI3NDg3NzkwNzUzODg_fd09624f-afe6-4a7a-afce-d255cf321ab4"
      unitRef="usd">17600000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzI3NDg3NzkwNzUzOTY_ad61f0e6-c19a-4e72-98f4-e282fad76772"
      unitRef="usd">13500000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzI3NDg3NzkwNzU0ODE_559c16d5-ba3d-4ad8-afdc-6cbe70fd7ffc"
      unitRef="usd">12500000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzI3NDg3NzkwNzU0ODk_b539c711-fd43-42bc-8d92-9a59b9d03b8e"
      unitRef="usd">10700000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzI3NDg3NzkwNzU2NzQ_76985a8c-30e0-463c-bc3a-1cb32cc3ac50"
      unitRef="usd">12800000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzI3NDg3NzkwNzU2ODI_58aacbbb-3eea-4869-86ab-a3d1eca0d547"
      unitRef="usd">11200000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="if460fb29b2ff45aba9a93619bbe01ff5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzM5MDc_ef59845c-3a88-498d-ae0c-6a38c8c809b4"
      unitRef="usd">154000000</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i12abbe9e13194148aca94163b7fb2f0a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjYvZnJhZzo4OGY2ZjE3NTViZTY0Y2MzOGJlNjk4YjIwOGRlYzNmNy90ZXh0cmVnaW9uOjg4ZjZmMTc1NWJlNjRjYzM4YmU2OThiMjA4ZGVjM2Y3XzM5MTQ_5e6e3557-41da-4043-b16b-7dbdf4b30639"
      unitRef="usd">171000000</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjkvZnJhZzphYmI3ZmI1Y2JmYmU0MDFmOTYxNTcyMDFiZjNmNjJhOC90YWJsZToyMzZhZTBjMTAyMTk0ZTZmOWJlYTA5ZWQyODE5ZDQyNS90YWJsZXJhbmdlOjIzNmFlMGMxMDIxOTRlNmY5YmVhMDllZDI4MTlkNDI1XzItMS0xLTEtNTQ3MDk4_eaaba99b-6add-43c7-9d62-96a7df12c814"
      unitRef="number">0.0564</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjkvZnJhZzphYmI3ZmI1Y2JmYmU0MDFmOTYxNTcyMDFiZjNmNjJhOC90YWJsZToyMzZhZTBjMTAyMTk0ZTZmOWJlYTA5ZWQyODE5ZDQyNS90YWJsZXJhbmdlOjIzNmFlMGMxMDIxOTRlNmY5YmVhMDllZDI4MTlkNDI1XzItMy0xLTEtNTQ3MDk4_e70f8788-c401-420a-b33e-2dee3062617d"
      unitRef="number">0.0564</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate>
    <us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjkvZnJhZzphYmI3ZmI1Y2JmYmU0MDFmOTYxNTcyMDFiZjNmNjJhOC90YWJsZToyMzZhZTBjMTAyMTk0ZTZmOWJlYTA5ZWQyODE5ZDQyNS90YWJsZXJhbmdlOjIzNmFlMGMxMDIxOTRlNmY5YmVhMDllZDI4MTlkNDI1XzMtMS0xLTEtNTQ3MDk4_c94dd6f4-adf9-47e0-b74e-907d69f90070"
      unitRef="number">0.0495</us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate>
    <us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjkvZnJhZzphYmI3ZmI1Y2JmYmU0MDFmOTYxNTcyMDFiZjNmNjJhOC90YWJsZToyMzZhZTBjMTAyMTk0ZTZmOWJlYTA5ZWQyODE5ZDQyNS90YWJsZXJhbmdlOjIzNmFlMGMxMDIxOTRlNmY5YmVhMDllZDI4MTlkNDI1XzMtMy0xLTEtNTQ3MDk4_a8e5e2f0-7964-4219-afd4-21a28eab6c64"
      unitRef="number">0.0359</us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjkvZnJhZzphYmI3ZmI1Y2JmYmU0MDFmOTYxNTcyMDFiZjNmNjJhOC90YWJsZToyMzZhZTBjMTAyMTk0ZTZmOWJlYTA5ZWQyODE5ZDQyNS90YWJsZXJhbmdlOjIzNmFlMGMxMDIxOTRlNmY5YmVhMDllZDI4MTlkNDI1XzQtMS0xLTEtNTQ3MDk4_102f1565-eefc-44ad-8c1c-f5f75ba0645e">P11Y8M12D</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MjkvZnJhZzphYmI3ZmI1Y2JmYmU0MDFmOTYxNTcyMDFiZjNmNjJhOC90YWJsZToyMzZhZTBjMTAyMTk0ZTZmOWJlYTA5ZWQyODE5ZDQyNS90YWJsZXJhbmdlOjIzNmFlMGMxMDIxOTRlNmY5YmVhMDllZDI4MTlkNDI1XzQtMy0xLTEtNTQ3MDk4_dabb9b57-3484-48f7-b8e4-d76f2f543267">P13Y10M24D</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration>
    <ci:LiabilityForFuturePolicyBenefitsDeferredProfitLiability
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUwOTk0_5277f800-aa85-43a7-98e7-73a8c276647b"
      unitRef="usd">392000000</ci:LiabilityForFuturePolicyBenefitsDeferredProfitLiability>
    <ci:LiabilityForFuturePolicyBenefitsDeferredProfitLiability
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUxMDAy_dd298733-eb55-4d9d-9ea5-bea58713287a"
      unitRef="usd">384000000</ci:LiabilityForFuturePolicyBenefitsDeferredProfitLiability>
    <ci:LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability
      contextRef="i5db337d577d24323b93b59b505c32718_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUxMjA2_8765fdea-5ae3-4ac6-b5d7-527b551944d6"
      unitRef="usd">3200000000</ci:LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability>
    <ci:LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUxMjA2_cb2b32a2-e143-4e4e-94cf-739d955064d5"
      unitRef="usd">3200000000</ci:LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability>
    <ci:LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzM4NDgyOTA3MDA3MjE_5b1699d5-6635-4d84-836a-17eaa7b6d7b7"
      unitRef="usd">3900000000</ci:LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability>
    <ci:LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability
      contextRef="ie07ab2d445d1463d93902530db5e0775_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzM4NDgyOTA3MDA3Mzg_363db60a-4c86-4f6f-a123-ea45a6da5422"
      unitRef="usd">4300000000</ci:LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability>
    <ci:LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUyMDI4_83bd8e0f-1ce1-422e-a4a4-48fd3e509b64"
      unitRef="usd">3700000000</ci:LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups>
    <ci:LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups
      contextRef="ie07ab2d445d1463d93902530db5e0775_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUzMzEw_37cb1063-84b7-4d85-b960-e13b33908a7e"
      unitRef="usd">3800000000</ci:LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUxNjc0_b8f47e94-ebf8-43f2-a0e1-1ae486d6d148"
      unitRef="usd">4600000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUxNjgy_b68cf143-5062-4811-b8d6-1998e58fb15f"
      unitRef="usd">4700000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUyMzgz_b0a3dc69-22bb-452b-a4e8-9647267a485f"
      unitRef="usd">1000000000</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzUvZnJhZzo5ZjBmZDliMTQ4MGI0MWE1ODcwMDkxMWE4MmIyZmE4MS90ZXh0cmVnaW9uOjlmMGZkOWIxNDgwYjQxYTU4NzAwOTExYTgyYjJmYTgxXzI5Njg2ODEzOTUyMzkx_56472dbe-0bd5-4d9a-be94-3513a29efa59"
      unitRef="usd">1200000000</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <ci:ContractholderDepositFundsPolicyPolicyTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81MzgvZnJhZzowZWRhNDQyNDMzMWE0NjQxOGE2ODFmNWFmOTNkZjcxZC90ZXh0cmVnaW9uOjBlZGE0NDI0MzMxYTQ2NDE4YTY4MWY1YWY5M2RmNzFkXzU0OTc1NTgxNTI5NQ_70641201-485d-452e-9852-da4111bebd1e">Accounting Policy. Liabilities for contractholder deposit funds primarily include deposits received from customers for investment-related and universal life products and investment earnings on their fund balances in Other Operations. These liabilities are adjusted to reflect administrative charges and, for universal life fund balances, mortality charges. Interest credited on these funds is accrued ratably over the contract period.</ci:ContractholderDepositFundsPolicyPolicyTextBlock>
    <us-gaap:PolicyholderContractDeposits
      contextRef="i5db337d577d24323b93b59b505c32718_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDQvZnJhZzo3OTkwM2Y4NjI4MzE0NGNlODcxYTkyZGQ5OTQwNTA2My90ZXh0cmVnaW9uOjc5OTAzZjg2MjgzMTQ0Y2U4NzFhOTJkZDk5NDA1MDYzXzYw_44a221d0-8028-4ded-98e2-7e784de2dcfd"
      unitRef="usd">6700000000</us-gaap:PolicyholderContractDeposits>
    <us-gaap:PolicyholderContractDeposits
      contextRef="ie62ccc5f564845298d35afec66862cec_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDQvZnJhZzo3OTkwM2Y4NjI4MzE0NGNlODcxYTkyZGQ5OTQwNTA2My90ZXh0cmVnaW9uOjc5OTAzZjg2MjgzMTQ0Y2U4NzFhOTJkZDk5NDA1MDYzXzYw_9aa6249c-acb0-4810-bfe7-866c1f3c9dd8"
      unitRef="usd">6700000000</us-gaap:PolicyholderContractDeposits>
    <us-gaap:PolicyholderContractDeposits
      contextRef="i316a5e098c694bcebb1694c166dcab76_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDQvZnJhZzo3OTkwM2Y4NjI4MzE0NGNlODcxYTkyZGQ5OTQwNTA2My90ZXh0cmVnaW9uOjc5OTAzZjg2MjgzMTQ0Y2U4NzFhOTJkZDk5NDA1MDYzXzg3OTYwOTMwMjI5MDY_8df9100f-ba43-4459-b4d9-f9f3382b27ae"
      unitRef="usd">6800000000</us-gaap:PolicyholderContractDeposits>
    <us-gaap:PolicyholderContractDeposits
      contextRef="ie07ab2d445d1463d93902530db5e0775_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDQvZnJhZzo3OTkwM2Y4NjI4MzE0NGNlODcxYTkyZGQ5OTQwNTA2My90ZXh0cmVnaW9uOjc5OTAzZjg2MjgzMTQ0Y2U4NzFhOTJkZDk5NDA1MDYzXzg3OTYwOTMwMjI5NDU_5d349bc8-6a4f-4fc7-bb36-c146f61f101b"
      unitRef="usd">6900000000</us-gaap:PolicyholderContractDeposits>
    <ci:PolicyholderContractBalancePercentReinsuredExternally
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDQvZnJhZzo3OTkwM2Y4NjI4MzE0NGNlODcxYTkyZGQ5OTQwNTA2My90ZXh0cmVnaW9uOjc5OTAzZjg2MjgzMTQ0Y2U4NzFhOTJkZDk5NDA1MDYzXzU0OTc1NTgxMzk1MzQ_7ae1bf11-d1ad-48db-94b8-37f122d384a2"
      unitRef="number">0.39</ci:PolicyholderContractBalancePercentReinsuredExternally>
    <us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzE3MA_8f9ec00b-9cdb-4d53-b199-c4043ea47e30"
      unitRef="number">0.0325</us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate>
    <us-gaap:PolicyholderAccountBalanceNetAmountAtRisk
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzE3NA_8da4a7a3-120d-4541-8cf1-f0d0b4dec688"
      unitRef="usd">3200000000</us-gaap:PolicyholderAccountBalanceNetAmountAtRisk>
    <us-gaap:CashSurrenderValueDuePolicyholdersAmount
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzE4MQ_815057b2-5c64-4fd7-b9b4-0422625dc6eb"
      unitRef="usd">2800000000</us-gaap:CashSurrenderValueDuePolicyholdersAmount>
    <us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzIzNw_119f3425-0905-402b-9147-bc65f1e285e0"
      unitRef="number">0.0318</us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate>
    <us-gaap:PolicyholderAccountBalanceNetAmountAtRisk
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzI0MQ_86779f80-d528-420b-b7b1-f7714c2399a3"
      unitRef="usd">3500000000</us-gaap:PolicyholderAccountBalanceNetAmountAtRisk>
    <us-gaap:CashSurrenderValueDuePolicyholdersAmount
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzI0OA_54ead027-6e20-4632-b426-02c5e14b65d0"
      unitRef="usd">2900000000</us-gaap:CashSurrenderValueDuePolicyholdersAmount>
    <ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzI3Ng_32693699-e74e-404b-98f1-e84699682b31"
      unitRef="number">0.99</ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage>
    <ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzI3Ng_d8743bd4-9b52-462f-b98a-b1e8cae8d844"
      unitRef="number">0.99</ci:PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage>
    <us-gaap:PolicyholderFunds
      contextRef="i473b5ac171fe47d1b52a690302b8557d_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzI4Mg_ad14ef04-f1b0-4ed9-a558-8f240246b4f9"
      unitRef="usd">4100000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderFunds
      contextRef="ia0a2caf1b06d407cb66dd5cc1db191bc_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzI4Mg_b1094706-b8c3-41c3-bc40-6bb2d3eef604"
      unitRef="usd">4100000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditRating
      contextRef="id5e56cac561c4deaa30c887f1b7ca3b8_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzM3OA_52a949fe-286b-4abe-a1f2-317a63cc9b79"
      unitRef="number">0.03</us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditRating>
    <us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditRating
      contextRef="id78aeb82d8af4ed7bfd1cfe99bf87fa7_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzM3OA_97db19b1-36e9-4c95-ac84-80f25a54b0f4"
      unitRef="number">0.03</us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditRating>
    <us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditRating
      contextRef="i06c863b5932f4981934aca0c04125d8c_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzM4Mw_35ec5978-e1e4-4daa-b4c9-415ee0b9e3fb"
      unitRef="number">0.04</us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditRating>
    <us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditRating
      contextRef="i4c0f09cba3a64073b1bafdd99ecce319_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzM4Mw_606e8b25-fc5d-44b4-b393-4b27371c2358"
      unitRef="number">0.04</us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditRating>
    <us-gaap:PolicyholderFunds
      contextRef="icbf37f4fce204b8e884d185c87969b4b_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzQwNQ_4d8c956a-ccbc-471e-b251-b555fd71ac0b"
      unitRef="usd">1200000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderFunds
      contextRef="if5e93c29f2c5415ea367dd5375f9e1f7_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzQwNQ_f6a662ac-7866-4449-aec1-80d4f5cb5f9f"
      unitRef="usd">1200000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderFunds
      contextRef="id7558e0f62de4d41b5896e38c58e6285_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzQ2OA_8e52ef93-5789-4252-ae8c-a38622008dc1"
      unitRef="usd">1200000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderFunds
      contextRef="i738906a5eed64e83ba37b8588bebd0dd_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzQ2OA_d520f7bf-2a4f-4cf1-94c7-9c134ba72afe"
      unitRef="usd">1200000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderFunds
      contextRef="ieb0a38d6988945d98411fa2cfb859c04_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzUyNw_31c519fd-c0cc-46ff-89ac-195dd63a5499"
      unitRef="usd">1700000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderFunds
      contextRef="ifef5e98d887a4bb79bae5426330ad2b3_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzUyNw_e98ab20f-911d-466f-98af-766e8cad7778"
      unitRef="usd">1700000000</us-gaap:PolicyholderFunds>
    <ci:PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzY5Ng_7f96b53c-0a17-49cd-b6fb-809b2c5e7ed1"
      unitRef="number">0.90</ci:PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue>
    <ci:PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDcvZnJhZzphOGVkNzVhNzliNjE0NGQzYWIwMjhiMTdjODIyMTA5Mi90ZXh0cmVnaW9uOmE4ZWQ3NWE3OWI2MTQ0ZDNhYjAyOGIxN2M4MjIxMDkyXzY5Ng_8c8cc0c4-2d72-4f83-a120-2b2c86855ca0"
      unitRef="number">0.90</ci:PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue>
    <ci:AnnuitizationElectionPeriod
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTAvZnJhZzplNDk1Nzc3NGE3ZmE0MDY2OTAxZjBmZGNhMDI2NmQxNC90ZXh0cmVnaW9uOmU0OTU3Nzc0YTdmYTQwNjY5MDFmMGZkY2EwMjY2ZDE0XzQxNzgxNDQxODYyMTEz_d89424b4-100d-481c-93cd-ea143fd7a0ae">P30D</ci:AnnuitizationElectionPeriod>
    <us-gaap:MarketRiskBenefitPolicyTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzQ1L2ZyYWc6Mzk4ZTNiNTBiODk1NGM2OTg4Y2YxNDQ2NDA2OTE4OWYvdGV4dHJlZ2lvbjozOThlM2I1MGI4OTU0YzY5ODhjZjE0NDY0MDY5MTg5Zl81NDk3NTU4MTc1MjE_280083a7-b7d3-4ecb-b6fe-6c301b66d1b7">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accounting Policy.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Variable annuity reinsurance liabilities are measured as MRBs at fair value, net of nonperformance risk, with fluctuations in value gross of reinsurer nonperformance risk reported in benefits expense while fluctuations in the Company's own &lt;/span&gt;nonperformance risk (own credit risk) are reported in Accumulated other comprehensive loss. Nonperformance risk reflects risk that a party might default and therefore not fulfill its obligations (i.e. nonpayment risk). The nonperformance risk adjustment reflects a market participant's view of nonpayment risk by adding an additional spread to the discount rate in the calculation of both (a) the variable annuity reinsurance liabilities to be paid by the Company and (b) the variable annuity reinsurance assets to be paid by the reinsurers, after considering collateral. The Company classifies variable annuity assets and liabilities in Level 3 of the fair value hierarchy described in Note 12 to the Consolidated Financial Statements because assumptions related to future annuitant behavior are largely unobservable. As discussed further in Note 10 to the Consolidated Financial Statements, due to the reinsurance agreements covering these liabilities, the liabilities do not generally impact net income except for the change in nonperformance risk on the reinsurance recoverable, which is reported in benefits expense and does not offset the nonperformance risk valuation on the liability. Variable annuity liabilities are established using capital market assumptions and assumptions related to future annuitant behavior (including mortality, lapse and annuity election rates).</us-gaap:MarketRiskBenefitPolicyTextBlock>
    <us-gaap:MarketRiskBenefitActivityTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90ZXh0cmVnaW9uOmE0MGNhMjViNzMwOTQyMDQ4ZjY5NDAwOTgwNmFjMWM4Xzk2MjA3MjY3NDMyMzIw_0cc75045-b3a0-4b01-96fc-e249633a2723">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Market risk benefits activity was as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.877%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;1,268&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Balance, beginning of year, before the effect of nonperformance risk (own credit risk)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;1,379&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;1,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Changes due to expected run-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Changes due to capital markets versus expected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Changes due to policyholder behavior versus expected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Assumption changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Balance, end of year, before the effect of changes in nonperformance risk (own credit risk)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;1,305&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;1,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Nonperformance risk (own credit risk), end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;1,220&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;Reinsured market risk benefit, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;1,301&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;1,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reinsurer &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Collateral and Other Terms at March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Berkshire&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,043&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90% were secured by assets in a trust.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sun Life Assurance Company of Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liberty Re (Bermuda) Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;128&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100% were secured by assets in a trust.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SCOR SE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70% were secured by a letter of credit.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Market risk benefits &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,323&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;All reinsurers are rated A- equivalent and higher by an NRSRO.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Includes IBNR and outstanding claims of $25 million offset by premium due of $3 million. These amounts are excluded from market risk benefits at March&#160;31, 2023 in Note 9 and Note 10A to the Consolidated Financial Statements. At December&#160;31, 2022, IBNR and outstanding claims of $27 million offset by premium due of $3 million were excluded from the market risk benefits as restated due to the adoption of LDTI.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketRiskBenefitActivityTableTextBlock>
    <us-gaap:MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzItMS0xLTEtNTc2NTE4_9bbd06b1-431d-4185-9da2-ec6b0b5b63ed"
      unitRef="usd">1268000000</us-gaap:MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk>
    <us-gaap:MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
      contextRef="ieb159500cff1416584b25f65dcff1e94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzItMi0xLTEtNTc2NDcx_b7c5d17b-85b0-4b34-aea7-580ce7cb1202"
      unitRef="usd">1824000000</us-gaap:MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk>
    <us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzMtMS0xLTEtNTc2NTE4_edc29f1d-01c3-4cce-a8de-584d3bf05643"
      unitRef="usd">1379000000</us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange>
    <us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange
      contextRef="ieb159500cff1416584b25f65dcff1e94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzMtMi0xLTEtNTc2NDcx_57f117d7-a26e-45bf-bfda-5802f3b29efd"
      unitRef="usd">1949000000</us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange>
    <ci:MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzQtMS0xLTEtNTc2NTE4_0516c645-7fae-4090-af63-4c666a82a399"
      unitRef="usd">-6000000</ci:MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff>
    <ci:MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzQtMi0xLTEtNTc2NDcx_f5f31507-3ad7-48e9-b1e6-4633d80727fa"
      unitRef="usd">-19000000</ci:MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff>
    <ci:MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzUtMS0xLTEtNTc2NTE4_000f96b2-425a-4122-9136-093b3071f328"
      unitRef="usd">-41000000</ci:MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange>
    <ci:MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzUtMi0xLTEtNTc2NDcx_818b681c-b083-4d88-a262-41be0339c327"
      unitRef="usd">-271000000</ci:MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange>
    <us-gaap:MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzYtMS0xLTEtNTc2NTE4_8d843920-d1c7-4e4f-99a7-ee18c6360067"
      unitRef="usd">6000000</us-gaap:MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected>
    <us-gaap:MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzYtMi0xLTEtNTc2NDcx_2b37aad3-f4ec-449a-8ca2-b394a98adc85"
      unitRef="usd">-9000000</us-gaap:MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected>
    <us-gaap:MarketRiskBenefitIncreaseDecreaseFromOtherAssumption
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzctMS0xLTEtNTc2NTE4_17297b5a-9e93-42d3-9b34-d028a1f5592d"
      unitRef="usd">-33000000</us-gaap:MarketRiskBenefitIncreaseDecreaseFromOtherAssumption>
    <us-gaap:MarketRiskBenefitIncreaseDecreaseFromOtherAssumption
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzctMi0xLTEtNTc2NDcx_240c8809-20dc-48b6-aa97-f12037cf42e4"
      unitRef="usd">39000000</us-gaap:MarketRiskBenefitIncreaseDecreaseFromOtherAssumption>
    <us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzgtMS0xLTEtNTc2NDcx_4dcfecc9-7edc-40df-8757-96ff2f74fbcf"
      unitRef="usd">1305000000</us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange>
    <us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzgtMi0xLTEtNTc2NDcx_edd2e794-0a2f-4a40-9413-9b2880ac2f12"
      unitRef="usd">1689000000</us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange>
    <us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzktMS0xLTEtNTc2NTE4_1bac2e81-139c-4afd-a394-3e1834260d50"
      unitRef="usd">85000000</us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax>
    <us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzktMi0xLTEtNTc2NDcx_9660f6eb-da11-452c-9e5c-2f07191e5c6c"
      unitRef="usd">131000000</us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax>
    <us-gaap:MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzEwLTEtMS0xLTU3NjQ3MQ_dc9aaebf-5737-4ff9-93d7-931206cd302a"
      unitRef="usd">1220000000</us-gaap:MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk>
    <us-gaap:MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzEwLTItMS0xLTU3NjQ3MQ_2a65a498-c42f-4467-be66-2f8d3363cbe7"
      unitRef="usd">1558000000</us-gaap:MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk>
    <us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzExLTEtMS0xLTU3NjUxOA_055d44c9-54d9-4da1-82f7-f167d6d2da4b"
      unitRef="usd">1301000000</us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance
      contextRef="ic71911f816574fdb881509b52a744fc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTYvZnJhZzphNDBjYTI1YjczMDk0MjA0OGY2OTQwMDk4MDZhYzFjOC90YWJsZTo4YWMxZWJiOGFjYTk0N2U5OTk1NjQ5MzZmMmRmZTU3Yi90YWJsZXJhbmdlOjhhYzFlYmI4YWNhOTQ3ZTk5OTU2NDkzNmYyZGZlNTdiXzExLTItMS0xLTU3NjQ3MQ_3ec60296-2204-4030-8dd6-a09bdf29db68"
      unitRef="usd">1681000000</us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTkvZnJhZzoyYjM0YzE2MWM0NTc0ZGZmYjRmNDg5NWFhMTFlOWI1OS90ZXh0cmVnaW9uOjJiMzRjMTYxYzQ1NzRkZmZiNGY0ODk1YWExMWU5YjU5Xzk2MjA3MjY3NDMzNDQ2_962b08e3-0216-45d4-8ca9-d853dfc83543">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table presents the net amount at risk and the average attained age of contractholders (weighted by exposure) for contracts assumed by the Company. The net amount at risk is the amount the Company would have to pay to contractholders if all deaths or annuitizations occurred as of the earliest possible date in accordance with the insurance contract. The Company should be reimbursed in full for these payments unless the Berkshire reinsurance limit is exceeded, as discussed further in Note 10 to the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions, excludes impact of reinsurance ceded)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net amount at risk&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Average attained age of contractholders (weighted by exposure)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;75.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock>
    <us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax
      contextRef="ib570f0c807bc458bb372ecd4c53d8d16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTkvZnJhZzoyYjM0YzE2MWM0NTc0ZGZmYjRmNDg5NWFhMTFlOWI1OS90YWJsZTpmMjQ4MTk2OGFjZmI0MTdiYTQzN2MyMzZkMDUwODM0Zi90YWJsZXJhbmdlOmYyNDgxOTY4YWNmYjQxN2JhNDM3YzIzNmQwNTA4MzRmXzItMS0xLTEtNTQ3MDk4_9bbfed7f-4f0c-4837-a975-c9b5ad209b6b"
      unitRef="usd">2183000000</us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax>
    <us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax
      contextRef="i2e6d884b55ec4e72892c2a763b882366_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTkvZnJhZzoyYjM0YzE2MWM0NTc0ZGZmYjRmNDg5NWFhMTFlOWI1OS90YWJsZTpmMjQ4MTk2OGFjZmI0MTdiYTQzN2MyMzZkMDUwODM0Zi90YWJsZXJhbmdlOmYyNDgxOTY4YWNmYjQxN2JhNDM3YzIzNmQwNTA4MzRmXzItMy0xLTEtNTQ3MDk4_c882c238-5cf0-4ee6-a6df-119e1b5c7b91"
      unitRef="usd">1892000000</us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax>
    <us-gaap:NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1
      contextRef="ifc70e358d2cd4b0ea0945ae4e8b52dff_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTkvZnJhZzoyYjM0YzE2MWM0NTc0ZGZmYjRmNDg5NWFhMTFlOWI1OS90YWJsZTpmMjQ4MTk2OGFjZmI0MTdiYTQzN2MyMzZkMDUwODM0Zi90YWJsZXJhbmdlOmYyNDgxOTY4YWNmYjQxN2JhNDM3YzIzNmQwNTA4MzRmXzMtMS0xLTEtNTQ3MDk4_48ddde58-b643-4812-8c43-6311d96cb329">P75Y4M24D</us-gaap:NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1>
    <us-gaap:NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1
      contextRef="ica8c06a177734445979e540fbc4f756d_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTkvZnJhZzoyYjM0YzE2MWM0NTc0ZGZmYjRmNDg5NWFhMTFlOWI1OS90YWJsZTpmMjQ4MTk2OGFjZmI0MTdiYTQzN2MyMzZkMDUwODM0Zi90YWJsZXJhbmdlOmYyNDgxOTY4YWNmYjQxN2JhNDM3YzIzNmQwNTA4MzRmXzMtMy0xLTEtNTQ3MDk4_6f62d4e5-6da7-4d7f-869b-8615ac93261d">P76Y4M24D</us-gaap:NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1>
    <us-gaap:ReinsuranceTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NjIvZnJhZzo2NmZkMzg3YjZjNjk0NDhlYmNlZjM3MGNlZGM3MzNkMi90ZXh0cmVnaW9uOjY2ZmQzODdiNmM2OTQ0OGViY2VmMzcwY2VkYzczM2QyXzYyNg_6f790e66-0863-4ba3-9172-0afa9c87c910">&lt;div style="margin-bottom:10pt"&gt;&lt;span id="i66fd387b6c69448ebcef370cedc733d2_623"/&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 10 &#x2013; Reinsurance&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's insurance subsidiaries enter into agreements with other insurance companies to limit losses from large exposures and to permit recovery of a portion of incurred losses. Reinsurance is ceded primarily in acquisition and disposition transactions when the underwriting company is not being acquired. Reinsurance does not relieve the originating insurer of liability. Therefore, reinsured liabilities must continue to be reported along with the related reinsurance recoverables. The Company regularly evaluates the financial condition of its reinsurers and monitors concentrations of its credit risk.&lt;/span&gt;&lt;/div&gt;Reinsurance Recoverables&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The majority of the Company's reinsurance recoverables resulted from acquisition and disposition transactions in which the underwriting company was not acquired. The Company bears the risk of loss if its reinsurers and retrocessionaires do not meet or are unable to meet their reinsurance obligations to the Company. The Company reviews its reinsurance arrangements and establishes reserves against the recoverables.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's reinsurance recoverables as of March&#160;31, 2023 are presented at amount due by range of external credit rating and collateral level in the following table, with reinsurance recoverables that are market risk benefits separately presented at fair value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.237%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Fair value of collateral contractually required to meet or exceed carrying value of recoverable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Collateral provisions exist that may mitigate risk of credit loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;No collateral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ongoing Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;A- equivalent and higher current ratings &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;BBB- to BBB+ equivalent current credit ratings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Not rated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;63&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total recoverables related to ongoing operations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;363&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquisition, disposition or run-off activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;BBB+ equivalent and higher current ratings &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Lincoln National Life and Lincoln Life &amp;amp; Annuity of New York&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Empower Annuity Insurance Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prudential Insurance Company of America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;380&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;380&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Life Insurance Company of North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;187&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;227&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Not rated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total recoverables related to acquisition, disposition or run-off activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;567&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,170&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total reinsurance recoverables before market risk benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;709&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;367&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,251&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Allowance for uncollectible reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Market risk benefits &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,301&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total reinsurance recoverables &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Certified by a Nationally Recognized Statistical Rating Organization ("NRSRO").&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Includes $231 million of current reinsurance recoverables that are reported in Other current assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Includes collateral provisions requiring the reinsurer to fully collateralize its obligation if its external credit rating is downgraded to a specified level.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Total Berkshire and certain Other recoverables reflected under acquisition, disposition or run-off activities in the Company's 2022 Form 10-K that relate to the Company&#x2019;s variable annuity reinsurance products discussed in section B below are now reported at fair market value as MRBs, as further discussed in Note 9 to the Consolidated Financial Statements. At December&#160;31, 2022, we reported $711 million related to these recoverables related to the GMDB variable annuity reinsurance product. The restated December&#160;31, 2022 variable annuity reinsurance recoverable balance is $1.4 billion, which also includes the GMIB variable annuity reinsurance product that was classified in Other assets prior to the adoption of LDTI.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Collateral levels are defined internally based on the fair value of the collateral relative to the carrying amount of the reinsurance recoverable, the frequency at which collateral is required to be replenished and the potential for volatility in the collateral's fair value.&lt;/span&gt;&lt;/div&gt;Effective Exit of Variable Annuity Reinsurance BusinessThe Company entered into an agreement with Berkshire to effectively exit the variable annuity reinsurance business via a reinsurance transaction in 2013. Variable annuity contracts are accounted for as assumed and ceded reinsurance and categorized as market risk benefits as discussed in Note 9 to the Consolidated Financial Statements. Berkshire reinsured 100% of the Company's future cash flows in this business, net of other reinsurance arrangements existing at that time. The reinsurance agreement is subject to an overall limit with approximately $3.1 billion remaining at March&#160;31, 2023. As a result of the reinsurance transaction, reserve increases are offset by a corresponding increase in the recorded reinsurance recoverable, provided the increased recoverable remains within the overall Berkshire limit.&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reinsurer &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Collateral and Other Terms at March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Berkshire&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,043&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90% were secured by assets in a trust.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sun Life Assurance Company of Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liberty Re (Bermuda) Ltd.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;128&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100% were secured by assets in a trust.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SCOR SE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70% were secured by a letter of credit.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Market risk benefits &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,323&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;All reinsurers are rated A- equivalent and higher by an NRSRO.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Includes IBNR and outstanding claims of $25 million offset by premium due of $3 million. These amounts are excluded from market risk benefits at March&#160;31, 2023 in Note 9 and Note 10A to the Consolidated Financial Statements. At December&#160;31, 2022, IBNR and outstanding claims of $27 million offset by premium due of $3 million were excluded from the market risk benefits as restated due to the adoption of LDTI.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The impact of nonperformance risk (i.e. the risk that a counterparty might default) on the variable annuity reinsurance asset was immaterial for the three months ended March&#160;31, 2023 and March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReinsuranceTextBlock>
    <us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90ZXh0cmVnaW9uOmUyYjFjMDY3NTFlODQ3ZTc5OWJjZDJhZjNlMjI2OTViXzc1MA_6a5e0dfb-37d8-4830-a8b7-7df1597ea309">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's reinsurance recoverables as of March&#160;31, 2023 are presented at amount due by range of external credit rating and collateral level in the following table, with reinsurance recoverables that are market risk benefits separately presented at fair value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.237%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Fair value of collateral contractually required to meet or exceed carrying value of recoverable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Collateral provisions exist that may mitigate risk of credit loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;No collateral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ongoing Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;A- equivalent and higher current ratings &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;BBB- to BBB+ equivalent current credit ratings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Not rated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;63&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total recoverables related to ongoing operations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;363&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquisition, disposition or run-off activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;BBB+ equivalent and higher current ratings &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Lincoln National Life and Lincoln Life &amp;amp; Annuity of New York&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Empower Annuity Insurance Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prudential Insurance Company of America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;380&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;380&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Life Insurance Company of North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;187&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;227&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Not rated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total recoverables related to acquisition, disposition or run-off activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;567&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,170&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,888&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total reinsurance recoverables before market risk benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;709&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;367&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,251&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Allowance for uncollectible reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Market risk benefits &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,301&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total reinsurance recoverables &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Certified by a Nationally Recognized Statistical Rating Organization ("NRSRO").&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Includes $231 million of current reinsurance recoverables that are reported in Other current assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Includes collateral provisions requiring the reinsurer to fully collateralize its obligation if its external credit rating is downgraded to a specified level.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Total Berkshire and certain Other recoverables reflected under acquisition, disposition or run-off activities in the Company's 2022 Form 10-K that relate to the Company&#x2019;s variable annuity reinsurance products discussed in section B below are now reported at fair market value as MRBs, as further discussed in Note 9 to the Consolidated Financial Statements. At December&#160;31, 2022, we reported $711 million related to these recoverables related to the GMDB variable annuity reinsurance product. The restated December&#160;31, 2022 variable annuity reinsurance recoverable balance is $1.4 billion, which also includes the GMIB variable annuity reinsurance product that was classified in Other assets prior to the adoption of LDTI.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i28d661611097476d8854fab93897521d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzItMi0xLTEtNTQ3MDk4_504f63ae-d473-48b1-9620-0f0cefa7aad5"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i7177e4ee9a5c4f679379c6951ad9f6f7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzItNC0xLTEtNTQ3MDk4_2d6a6239-2f17-479c-8482-79a13b843145"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i9a1939888a3f4aeba81ff8cbc1ac2f55_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzItNi0xLTEtNTQ3MDk4_449a54fe-b367-4e71-8170-e56c1eef405a"
      unitRef="usd">94000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i780ea719429c4f5cb4d6a43778d44e51_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzItOC0xLTEtNTQ3MDk4_ef41c16b-28a2-44ee-9899-adac5549a901"
      unitRef="usd">94000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="ia10fa22d1a0e4292823f2466bb3ac18a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzMtMi0xLTEtNTQ3MDk4_830d7d30-d5dc-482b-bed8-25c847604514"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i04eae3ae08ff4a07bf7a9b55fc3507d2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzMtNC0xLTEtNTQ3MDk4_74f877af-b449-4ef6-8b2a-f935448f82c0"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i9388bcc230334c26b5f9322df9d8591c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzMtNi0xLTEtNTQ3MDk4_eada4234-ce26-4733-9cda-6c41808b71b7"
      unitRef="usd">59000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i24318b9a944f4a469e7a3f8caa0b899c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzMtOC0xLTEtNTQ3MDk4_383d396d-0a43-47c6-a52c-7665655a6839"
      unitRef="usd">59000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i6be26d0bc42043479ce8c2aef240151d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzQtMi0xLTEtNTQ3MDk4_128d4ecf-fe7a-4f69-bfce-4cb6f3e3c8ee"
      unitRef="usd">142000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="ib8b0de1554c74c03ad99462fed6a95b3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzQtNC0xLTEtNTQ3MDk4_40a9d135-43b2-4420-96a9-af73433ee74a"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i89103ff921074d9f97701ff931699e77_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzQtNi0xLTEtNTQ3MDk4_1a5ccf07-9d8a-4150-baf1-e78a668d8be8"
      unitRef="usd">63000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i63373aa6dda746ada1c737d9b67a0111_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzQtOC0xLTEtNTQ3MDk4_5e4f8221-632a-41cc-acc9-4e3b5c9d3ef4"
      unitRef="usd">210000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i4b5560c0ea484a0f968eb97de6b00cf7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzUtMi0xLTEtNTQ3MDk4_2e0524f5-b6e9-49ae-a660-213c548e6330"
      unitRef="usd">142000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="ibfa79a53adb54371bdf95c80bb23094d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzUtNC0xLTEtNTQ3MDk4_197c518e-53c9-4c98-b52b-d83c3422f8c7"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="ie8581a4b7b794c4faf53cae6809eec3d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzUtNi0xLTEtNTQ3MDk4_d36b2dfd-b03a-4ae1-a2b5-232cfb6ae1a0"
      unitRef="usd">216000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i7018a961b27d4b63814f4c220228acd0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzUtOC0xLTEtNTQ3MDk4_22e690ba-f66b-461e-b282-99f9a40f4920"
      unitRef="usd">363000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="if29f75017f4f4bb0a8b89780edfbb7d9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzgtMi0xLTEtNTQ3MDk4_fbf094c9-0e09-490f-aeb4-abc8abbaea01"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i6f1fb483551e4be28ea7d121f976ed2f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzgtNC0xLTEtNTQ3MDk4_ea344f53-3835-4550-be68-11e1e219f376"
      unitRef="usd">2750000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i3b1a96c7936742f1ba643f3f3ec01c9a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzgtNi0xLTEtNTQ3MDk4_4b36713d-9838-4525-8483-cc8b9f64dc9f"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i97b1549db8444e2797ebd89df1ce900e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzgtOC0xLTEtNTQ3MDk4_7dd6b4ed-62f5-4069-bc22-76dcacd655a3"
      unitRef="usd">2750000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i2a5f607d270f47999ff876f8ac44a118_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEwLTItMS0xLTU0NzA5OA_5a098f10-b5fd-4e16-9013-2cc51dbd1412"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="if34b462c128a4ea8b60fe20ba370c163_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEwLTQtMS0xLTU0NzA5OA_45df7e4d-e847-4377-8478-86fd9baa6a16"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i2e4431aa2e584220a1f57a7dccc10533_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEwLTYtMS0xLTU0NzA5OA_be6f64a4-2df1-4e6a-bd3a-150c810ab65a"
      unitRef="usd">133000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="iedcac50b09424b1aa432ff4b96017412_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEwLTgtMS0xLTU0NzA5OA_2210cc89-c6a8-49e4-a90f-91ed5545640a"
      unitRef="usd">133000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i0fd2fee2cdaf404fa42202dda7b39b0d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzExLTItMS0xLTU0NzA5OA_dd42c205-d5fd-4064-b825-6e68c6602e0f"
      unitRef="usd">380000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="ic4941e338d0b4e0b8e6d69cfd7dde626_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzExLTQtMS0xLTU0NzA5OA_0ac99748-a8be-40df-8f26-2f6b0eec81d3"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i6c41111216894d92a04d6b36cddf134f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzExLTYtMS0xLTU0NzA5OA_3c8dbec0-ec62-4ace-b2b4-c98102cda92a"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i12710504ce2d46fcb5c81a1e9c69a306_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzExLTgtMS0xLTU0NzA5OA_1f8b7ef5-8e1b-402b-8d6c-c8bd2843086e"
      unitRef="usd">380000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i11dc2245009f49c584be01347c7fdde9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEyLTItMS0xLTU0NzA5OA_190f15ad-77d1-4803-a7c5-6556478c79d6"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i7de558709bb64232bfbbe65efd501378_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEyLTQtMS0xLTU0NzA5OA_9d529333-b348-4698-be48-b6adaaa1a796"
      unitRef="usd">386000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="id3083d42461248ae9fa7521f47d83dcf_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEyLTYtMS0xLTU0NzA5OA_634ce9d4-31f9-4c86-84b1-b478ccd4ced3"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i8c45fc7e2545455c909e8f4c5d88874b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEyLTgtMS0xLTU0NzA5OA_e179582f-a1e0-4cd9-8aba-358260090bde"
      unitRef="usd">386000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i454476c483c445ca9cee416255427da7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEzLTItMS0xLTU0NzA5OA_f1c61255-be00-4843-90e7-741ca2d5a4ea"
      unitRef="usd">187000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="icf1c5ed75d824327908e9fac5f4b684c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEzLTQtMS0xLTU0NzA5OA_13fd995d-d107-47b4-8830-c7d8a8ae6cdc"
      unitRef="usd">25000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i0c13b36393fe4c24a2b794f5f3cd158e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEzLTYtMS0xLTU0NzA5OA_9a326da5-3a4d-4134-9765-02fb699781cb"
      unitRef="usd">15000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i14769193c2c44d64b974d678e97f5a09_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzEzLTgtMS0xLTU0NzA5OA_a5448f77-f0d7-421a-8b8c-f28f634f0e28"
      unitRef="usd">227000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="id01894bb31a3496e95680d18ead03b0a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE1LTItMS0xLTU0NzA5OA_b18088f2-e07c-4884-934f-2075567fa845"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i1ee2dd01b1f0498e93bcd1ddbe776129_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE1LTQtMS0xLTU0NzA5OA_7710f68f-0e81-4d9f-a56e-92b93c423ad8"
      unitRef="usd">9000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i524a1762651448f19786403decb53347_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE1LTYtMS0xLTU0NzA5OA_3a62b783-ebe3-4be7-89d2-17e5b4d87207"
      unitRef="usd">3000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i81f3744507dd4c6dbd6080857f121446_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE1LTgtMS0xLTU0NzA5OA_5af190d6-c6b5-4e29-aa18-f23b00147859"
      unitRef="usd">12000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i7992aeade34b40958cdbbd41e22d97c6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE2LTItMS0xLTU0NzA5OA_73a92c9a-ec49-4974-abff-937fdbf417bc"
      unitRef="usd">567000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="ife4968b18fb541b9a5883c174de67fc1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE2LTQtMS0xLTU0NzA5OA_256d68f0-53f7-4d94-a2bd-8f71552bc4f5"
      unitRef="usd">3170000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i4b71494c09c24a38b31d30590816b909_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE2LTYtMS0xLTU0NzA5OA_fc27d909-d667-4b06-abcd-b888ae91feaf"
      unitRef="usd">151000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i2f9ecf64e8fc403ea59b7253fb207588_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE2LTgtMS0xLTU0NzA5OA_ca958eab-5488-4d94-a12e-55f7434397cb"
      unitRef="usd">3888000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i412908e744344c22a44e310a933e677e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE3LTItMS0xLTU0NzA5OA_3a91e77f-de7f-4f56-8a51-45c3033f5548"
      unitRef="usd">709000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="i5eb4d443a88b4c8a801ccccb711a03ea_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE3LTQtMS0xLTU0NzA5OA_36a94361-2c2a-441d-afc3-680a0fdc319e"
      unitRef="usd">3175000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="ie5fc53d0faf24ca488cf6251cc8e3cd9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE3LTYtMS0xLTU0NzA5OA_9602062e-6e9b-4088-a9df-c13a6596c81c"
      unitRef="usd">367000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE3LTgtMS0xLTU0NzA5OA_6cfefbac-8dbd-40e7-b0e5-f1c10f6916f7"
      unitRef="usd">4251000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:ReinsuranceRecoverablesAllowance
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE4LTgtMS0xLTU0NzA5OA_a66aafe7-4582-4b61-b354-f9b87f30ec66"
      unitRef="usd">35000000</us-gaap:ReinsuranceRecoverablesAllowance>
    <us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE5LTgtMS0xLTU4NzQyOQ_aabdb55e-ee88-4eb8-8e6c-2855e91e91aa"
      unitRef="usd">1301000000</us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:ReinsuranceRecoverables
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90YWJsZTpmNGQ1MzMxNDA4MjA0ZTVkYjI4NTY0ODA3ZTJkNGMzOC90YWJsZXJhbmdlOmY0ZDUzMzE0MDgyMDRlNWRiMjg1NjQ4MDdlMmQ0YzM4XzE5LTgtMS0xLTU0NzA5OA_038e267e-c717-4493-84dd-65b069fbfee8"
      unitRef="usd">5517000000</us-gaap:ReinsuranceRecoverables>
    <us-gaap:ReinsuranceRecoverablesGross
      contextRef="ide82cffd58fc4bd9a6a046a625886af2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90ZXh0cmVnaW9uOmUyYjFjMDY3NTFlODQ3ZTc5OWJjZDJhZjNlMjI2OTViXzI0Ng_9a7d2d2e-6adc-4976-8055-b80e4700d091"
      unitRef="usd">231000000</us-gaap:ReinsuranceRecoverablesGross>
    <us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i4f712834ae454cc19bd99506f5b35f37_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90ZXh0cmVnaW9uOmUyYjFjMDY3NTFlODQ3ZTc5OWJjZDJhZjNlMjI2OTViXzU0OTc1NTgxOTM5NQ_91dc5104-9cb8-403d-a263-90fbef802bc6"
      unitRef="usd">711000000</us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance
      contextRef="iffb569d2047445a09609c8caab034843_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NzcvZnJhZzplMmIxYzA2NzUxZTg0N2U3OTliY2QyYWYzZTIyNjk1Yi90ZXh0cmVnaW9uOmUyYjFjMDY3NTFlODQ3ZTc5OWJjZDJhZjNlMjI2OTViXzU0OTc1NTgxOTQwMQ_e520424e-b16c-4e7d-ac44-3dcefa012972"
      unitRef="usd">1400000000</us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance>
    <ci:CededReinsuranceAgreementReinsuredRiskPercentage
      contextRef="ia933eb83cc3d4717aa4b14ae0603c0cc_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODMvZnJhZzo2NTI4ZTdiZTU5NTI0ZmZhYjQ0MjhkZjc3MDk1ZGUwYS90ZXh0cmVnaW9uOjY1MjhlN2JlNTk1MjRmZmFiNDQyOGRmNzcwOTVkZTBhXzIwNg_6c63f176-5298-412b-8a81-001ea5032d21"
      unitRef="number">1</ci:CededReinsuranceAgreementReinsuredRiskPercentage>
    <ci:CededReinsuranceAgreementCoverageLimitAmountRemaining
      contextRef="ia933eb83cc3d4717aa4b14ae0603c0cc_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81ODMvZnJhZzo2NTI4ZTdiZTU5NTI0ZmZhYjQ0MjhkZjc3MDk1ZGUwYS90ZXh0cmVnaW9uOjY1MjhlN2JlNTk1MjRmZmFiNDQyOGRmNzcwOTVkZTBhXzQwMw_acf7f17d-e983-4bee-bdd7-a18041e9eb5d"
      unitRef="usd">3100000000</ci:CededReinsuranceAgreementCoverageLimitAmountRemaining>
    <ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances
      contextRef="ia933eb83cc3d4717aa4b14ae0603c0cc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzItNC0xLTEtNTQ3MDk4_67dc1566-a866-4965-b4b5-14c18b1cfb7a"
      unitRef="usd">1043000000</ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances>
    <ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances
      contextRef="i3e7f3a48f7c442e2a74854517e46d848_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzItNi0xLTEtNTQ3MDk4_c0776355-32bc-4d8f-a43e-9ec1cce089d8"
      unitRef="usd">1116000000</ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1ab9b6688ad640f6bddb9c9f39e1b287_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzItOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246OTFiZDNhYzNiN2E2NDhjNDg4MjM3NGM5ZTUzYWIzYTVfNA_b08f653d-e628-4ac7-a723-05ff9fba48d2"
      unitRef="number">0.90</us-gaap:ConcentrationRiskPercentage1>
    <ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances
      contextRef="ib58c428a8e7841c4b87ec82e8a298b2c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzMtNC0xLTEtNTQ3MDk4_356da99a-ae8f-4463-adbb-456f16e63774"
      unitRef="usd">117000000</ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances>
    <ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances
      contextRef="i7e422e0176b14d37a373faa93a5ef72e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzMtNi0xLTEtNTQ3MDk4_2672545d-aeae-44ee-896c-a3f7880b2933"
      unitRef="usd">115000000</ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances>
    <ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances
      contextRef="i5c53eb427a65420e90086c325382b3c6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzQtNC0xLTEtNTQ3MDk4_4ca101c3-57f2-40f3-a8c9-3a47859005ae"
      unitRef="usd">128000000</ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances>
    <ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances
      contextRef="ia4a0c523a4d649ed9576b306aa61bf9d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzQtNi0xLTEtNTQ3MDk4_74e7abf6-4073-425b-abe8-2ea261524bc4"
      unitRef="usd">128000000</ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2d00cd3a880946819131992a6001d101_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzQtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246YWVmZDI2ZTNmN2Q2NDA1MmE1YWYzYTEwMGY5NTcwM2NfNA_4598d0fe-ebf3-4f4b-a33f-c44d45e8a7bf"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances
      contextRef="i2ea827e8736f47cdac2e72202d163b29_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzUtMi0xLTEtNjE0NjEz_ff9f6f98-c76a-4267-837f-63a0a51dc230"
      unitRef="usd">35000000</ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances>
    <ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances
      contextRef="i6e712fcd6b0f49c58dd469be40702369_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzUtNC0xLTEtNjE0NjEz_7c051682-c39e-417e-b2c0-a5789cf49f36"
      unitRef="usd">39000000</ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5d949019d7c44dcea3311dc5c763edbb_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzUtNi0xLTEtNjIyMzcxL3RleHRyZWdpb246MTk2MDIxODAwYjM1NGMyY2I4YTlmMzY0ZjJhY2E2M2ZfNTQ5NzU1ODEzODky_2e00e8c4-7e89-4ebf-bb8f-0217b94204c7"
      unitRef="number">0.70</us-gaap:ConcentrationRiskPercentage1>
    <ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances
      contextRef="ib570f0c807bc458bb372ecd4c53d8d16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzUtNC0xLTEtNTQ3MDk4_d2bc1209-a05a-48f0-b7c6-abe80121e66d"
      unitRef="usd">1323000000</ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances>
    <ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances
      contextRef="iffb569d2047445a09609c8caab034843_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90YWJsZTo5MzQ2MWU4ODQ5YTE0Nzg0YmJiYmFiNzlmZjc5NGQ1ZC90YWJsZXJhbmdlOjkzNDYxZTg4NDlhMTQ3ODRiYmJiYWI3OWZmNzk0ZDVkXzUtNi0xLTEtNTQ3MDk4_b3b63f95-3764-4c59-843f-f1ca6eb28017"
      unitRef="usd">1398000000</ci:MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances>
    <us-gaap:ReinsuranceReceivablesIncurredButNotReportedClaims
      contextRef="ib570f0c807bc458bb372ecd4c53d8d16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90ZXh0cmVnaW9uOjA3ZTQ5MWJmY2Y0YTQ4YWM4YjJkM2RmYzI3ZmM3YTcyXzU0OTc1NTgxMzk4NTE_70c24c80-044c-40d6-989c-b8a5918e8557"
      unitRef="usd">25000000</us-gaap:ReinsuranceReceivablesIncurredButNotReportedClaims>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="ib570f0c807bc458bb372ecd4c53d8d16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90ZXh0cmVnaW9uOjA3ZTQ5MWJmY2Y0YTQ4YWM4YjJkM2RmYzI3ZmM3YTcyXzU0OTc1NTgxMzk4Njc_66c12bcc-9c81-44fa-92e0-226b671283bd"
      unitRef="usd">3000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:ReinsuranceReceivablesIncurredButNotReportedClaims
      contextRef="iffb569d2047445a09609c8caab034843_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90ZXh0cmVnaW9uOjA3ZTQ5MWJmY2Y0YTQ4YWM4YjJkM2RmYzI3ZmM3YTcyXzU0OTc1NTgxMzk5MTk_8a1fc47c-6b22-4915-96b6-7716995a14dd"
      unitRef="usd">27000000</us-gaap:ReinsuranceReceivablesIncurredButNotReportedClaims>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="iffb569d2047445a09609c8caab034843_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MTYvZnJhZzowN2U0OTFiZmNmNGE0OGFjOGIyZDNkZmMyN2ZjN2E3Mi90ZXh0cmVnaW9uOjA3ZTQ5MWJmY2Y0YTQ4YWM4YjJkM2RmYzI3ZmM3YTcyXzU0OTc1NTgxMzk5MzY_29b5409c-6d05-4bde-8bf6-a3d4fa1bbcb5"
      unitRef="usd">3000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MjIvZnJhZzplMGUwMzY0MDhmYWM0NGI0OWY4ZjhjYTcyNmQ5ZGJiYS90ZXh0cmVnaW9uOmUwZTAzNjQwOGZhYzQ0YjQ5ZjhmOGNhNzI2ZDlkYmJhXzE0_c3a01010-ff34-4856-9f4b-a32016cefb3a">Note 11 &#x2013; InvestmentsThe Cigna Group's investment portfolio consists of a broad range of investments including debt securities, equity securities, commercial mortgage loans, policy loans, other long-term investments, short-term investments and derivative financial instruments. The sections below provide more detail regarding our investment balances and realized investment gains and losses. See Note 12 to the Consolidated Financial Statements for information about the valuation of the Company's investment portfolio. Further information about our accounting policies for investment assets can be found in Note 11 in the Company's 2022 Form 10-K.&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the Company's investments by category and current or long-term classification:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;616&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,909&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,069&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commercial mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,501&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Policy loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,211&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,211&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,936&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,936&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;914&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;19,010&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;19,924&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Investment PortfolioDebt Securities&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accounting policy.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Our accounting policy for debt securities (including bonds, mortgage and other asset-backed securities and preferred stocks redeemable by the investor) remains materially consistent with the policy disclosed in the Company's 2022 Form 10-K. However, with the adoption of amended accounting guidance for long-duration insurance contracts on January 1, 2023 (discussed in Note 2 to the Consolidated Financial Statements), net unrealized appreciation on debt securities supporting the Company's run-off settlement annuity business is no longer reported in Non-current insurance and contractholder liabilities but rather is reported in Accumulated other comprehensive loss. See Note 14 to the Consolidated Financial Statements for the impact to Accumulated other comprehensive loss.&lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The amortized cost and fair value by contractual maturity periods for debt securities were as follows as of March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;630&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,972&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,752&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,227&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,915&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,268&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Mortgage and other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;381&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;344&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,668&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,909&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Actual maturities of these securities could differ from their contractual maturities used in the table above because issuers may have the right to call or prepay obligations, with or without penalties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Gross unrealized appreciation (depreciation) on debt securities by type of issuer is shown below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Appreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal government and agency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;276&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;297&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;373&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,596&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,856&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Mortgage and other asset-backed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;381&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;344&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,668&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;170&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,909&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal government and agency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Mortgage and other asset-backed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Review of declines in fair value. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Management reviews impaired debt securities to determine whether a credit loss allowance is needed based on criteria that include:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;severity of decline;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;financial health and specific prospects of the issuer; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;changes in the regulatory, economic or general market environment of the issuer's industry or geographic region.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The table below summarizes debt securities with a decline in fair value from amortized cost for which an allowance for credit losses has not been recorded, by investment grade and the length of time these securities have been in an unrealized loss position. Unrealized depreciation on these debt securities is primarily due to declines in fair value resulting from increasing interest rates since these securities were purchased. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of Issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of Issues&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;One year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment grade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,362&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(594)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Below investment grade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;353&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;936&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;More than one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment grade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,808&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Below investment grade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;682&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;780&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;770&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,433&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,760&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table provides the values of the Company's equity security investments as of March&#160;31, 2023 and December&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.044%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity securities with readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity securities with no readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,926&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,029&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,606&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consistent with our strategy to invest in targeted startup and growth-stage companies in the health care industry, approximately 95% of our investments in equity securities are in the health care sector.&lt;/span&gt;&lt;/div&gt;Commercial Mortgage LoansMortgage loans held by the Company are made exclusively to commercial borrowers and are diversified by property type, location and borrower. Loans are generally issued at fixed rates of interest and are secured by high quality, primarily completed and substantially leased operating properties.The Company regularly evaluates and monitors credit risk from the initial mortgage loan underwriting and throughout the investment holding period. For more information on the Company's accounting policies and methodologies regarding these investments, see Note 11 in the Company's 2022 Form 10-K.&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the credit risk profile of the Company's commercial mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.890%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Loan-to-Value Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Debt Service Coverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Loan-to-Value Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Debt Service Coverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Loan-to-Value Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Below 60%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;912&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60% to 79%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;504&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80% to 100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;191&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;60&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Other Long-Term Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other long-term investments include investments in unconsolidated entities, including certain limited partnerships and limited liability companies holding real estate, securities or loans. These investments are carried at cost plus the Company's ownership percentage of reporting income or loss, based on the financial statements of the underlying investments that are generally reported at fair value. Income or loss from these investments is reported on a one quarter lag due to the timing of when financial information is received from the general partner or manager of the investments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other long-term investments also include investment real estate carried at depreciated cost less any impairment write-downs to fair value when cash flows indicate that the carrying value may not be recoverable. Additionally, statutory and other restricted deposits and foreign currency swaps carried at fair value are reported in the table below as Other. The following table provides the carrying value information for these investments:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,434&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Securities partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,259&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,936&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Derivative Financial InstrumentsThe Company uses derivative financial instruments to manage the characteristics of investment assets (such as duration, yield, currency and liquidity) to meet the varying demands of the related insurance and contractholder liabilities. The Company also uses derivative financial instruments to hedge the risk of changes in the net assets of certain of its foreign subsidiaries due to changes in foreign currency exchange rates and to hedge the interest rate risk of certain long-term debt.As of March&#160;31, 2023, there have been no material changes to the Company's derivative financial instruments. The effects of derivative financial instruments used in our individual hedging strategies were not material to the Consolidated Financial Statements as of March&#160;31, 2023 and December&#160;31, 2022. The gross fair values of our derivative financial instruments are presented in Note 12 to the Consolidated Financial Statements. Please refer to the Company's 2022 Form 10-K for further discussion of the types of derivative financial instruments and associated accounting policies. Realized Investment Gains and Losses&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accounting policy. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Realized investment gains and losses are based on specifically identified assets and result from sales, investment asset write-downs, change in the fair value of certain derivatives and equity securities and changes in allowances for credit losses on debt securities and commercial mortgage loan investments. With the adoption of amended accounting guidance for long-duration insurance contracts on January 1, 2023 (discussed in Note 2 to the Consolidated Financial Statements), realized investment gains and losses no longer exclude amounts that were previously required to adjust future policy benefits for the run-off settlement annuity business. Prior period net realized investment losses have been updated to reflect the impact of adopting LDTI. &lt;/span&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following realized gains and losses on investments exclude realized gains and losses attributed to the Company's separate accounts because those gains and losses generally accrue directly to separate account policyholders:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net realized investment (losses), excluding credit loss expense and asset write-downs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Credit loss recoveries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investment asset write-downs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net realized investment (losses), before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Net realized investment losses for the three months ended March&#160;31, 2023 and March&#160;31, 2022 were primarily due to mark-to-market losses on a strategic health care equity securities investment.</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MjUvZnJhZzpjNTNhMzY2YzY4OGE0NzA5YmQ5N2RjNDNlZTZlZmU3Yi90ZXh0cmVnaW9uOmM1M2EzNjZjNjg4YTQ3MDliZDk3ZGM0M2VlNmVmZTdiXzU1Ng_92035247-adc7-4939-9994-50e98377f773">Cigna Group's investment portfolio consists of a broad range of investments including debt securities, equity securities, commercial mortgage loans, policy loans, other long-term investments, short-term investments and derivative financial instruments.Further information about our accounting policies for investment assets can be found in Note 11 in the Company's 2022 Form 10-K.Accounting policy. Our accounting policy for debt securities (including bonds, mortgage and other asset-backed securities and preferred stocks redeemable by the investor) remains materially consistent with the policy disclosed in the Company's 2022 Form 10-K. However, with the adoption of amended accounting guidance for long-duration insurance contracts on January 1, 2023 (discussed in Note 2 to the Consolidated Financial Statements), net unrealized appreciation on debt securities supporting the Company's run-off settlement annuity business is no longer reported in Non-current insurance and contractholder liabilities but rather is reported in Accumulated other comprehensive loss.&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Review of declines in fair value. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Management reviews impaired debt securities to determine whether a credit loss allowance is needed based on criteria that include:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;severity of decline;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;financial health and specific prospects of the issuer; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;changes in the regulatory, economic or general market environment of the issuer's industry or geographic region.&lt;/span&gt;&lt;/div&gt;Mortgage loans held by the Company are made exclusively to commercial borrowers and are diversified by property type, location and borrower. Loans are generally issued at fixed rates of interest and are secured by high quality, primarily completed and substantially leased operating properties.The Company regularly evaluates and monitors credit risk from the initial mortgage loan underwriting and throughout the investment holding period. For more information on the Company's accounting policies and methodologies regarding these investments, see Note 11 in the Company's 2022 Form 10-K.Other long-term investments include investments in unconsolidated entities, including certain limited partnerships and limited liability companies holding real estate, securities or loans. These investments are carried at cost plus the Company's ownership percentage of reporting income or loss, based on the financial statements of the underlying investments that are generally reported at fair value. Income or loss from these investments is reported on a one quarter lag due to the timing of when financial information is received from the general partner or manager of the investments. Other long-term investments also include investment real estate carried at depreciated cost less any impairment write-downs to fair value when cash flows indicate that the carrying value may not be recoverable. Additionally, statutory and other restricted deposits and foreign currency swaps carried at fair value are reported in the table below as Other. Accounting policy. Realized investment gains and losses are based on specifically identified assets and result from sales, investment asset write-downs, change in the fair value of certain derivatives and equity securities and changes in allowances for credit losses on debt securities and commercial mortgage loan investments. With the adoption of amended accounting guidance for long-duration insurance contracts on January 1, 2023 (discussed in Note 2 to the Consolidated Financial Statements), realized investment gains and losses no longer exclude amounts that were previously required to adjust future policy benefits for the run-off settlement annuity business. Prior period net realized investment losses have been updated to reflect the impact of adopting LDTI.</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90ZXh0cmVnaW9uOjIzOWU5NDhlNmIzOTQ3NzhiMjk3NTZmOTY5ODJjNzZiXzQwNQ_99074310-4662-4299-995d-645986798245">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the Company's investments by category and current or long-term classification:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;616&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,909&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,069&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commercial mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,501&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Policy loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,211&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,211&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,936&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,936&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;914&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;19,010&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;19,924&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="i112f3631ecd842d7934b73fe1e30c901_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzItMi0xLTEtNTQ3MDk4_0e18b5be-1baf-4349-adfd-f15107afcd1a"
      unitRef="usd">616000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i112f3631ecd842d7934b73fe1e30c901_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzItNC0xLTEtNTQ3MDk4_70c3f1ef-7abe-47b1-9dcd-b188c0c0f1d3"
      unitRef="usd">9293000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i112f3631ecd842d7934b73fe1e30c901_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzItNi0xLTEtNTQ3MDk4_bf062b8b-7526-49a1-9e07-29bd00c55077"
      unitRef="usd">9909000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="id6833d4eac60499bac8b8e40d102c734_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzItOC0xLTEtNTQ3MDk4_eedf26cb-472c-4c95-b9ea-41627ba4fa6f"
      unitRef="usd">654000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="id6833d4eac60499bac8b8e40d102c734_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzItMTAtMS0xLTU0NzA5OA_92acb6b8-66be-4f5a-ac59-7360a2d03247"
      unitRef="usd">9218000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="id6833d4eac60499bac8b8e40d102c734_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzItMTItMS0xLTU0NzA5OA_c0880b39-39b0-4f30-8895-7dd1ebc1322d"
      unitRef="usd">9872000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ifd51b7e314aa426795bbfa7b1914c75a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzMtMi0xLTEtNTQ3MDk4_7fa0a6dc-0118-45ea-9836-ea36f959c3d3"
      unitRef="usd">51000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ifd51b7e314aa426795bbfa7b1914c75a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzMtNC0xLTEtNTQ3MDk4_44fe50fa-5f43-4296-9bed-08ef679b3046"
      unitRef="usd">3069000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ifd51b7e314aa426795bbfa7b1914c75a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzMtNi0xLTEtNTQ3MDk4_2058fb4b-9519-4eb8-b508-e19065a3b2af"
      unitRef="usd">3120000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i0d4227ad42c24dc39f4e62e2b85e81a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzMtOC0xLTEtNTQ3MDk4_b8ee6d9a-e6ab-499f-8c1c-746f687f6d19"
      unitRef="usd">45000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i0d4227ad42c24dc39f4e62e2b85e81a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzMtMTAtMS0xLTU0NzA5OA_c8d8f54b-338e-4e00-aa07-5f468d1dda34"
      unitRef="usd">577000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i0d4227ad42c24dc39f4e62e2b85e81a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzMtMTItMS0xLTU0NzA5OA_ba94b3e9-d532-4ed1-bbf0-9f57f05c9705"
      unitRef="usd">622000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i56553614bb1d4575a81f8b42e1e9b673_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzQtMi0xLTEtNTQ3MDk4_bcfec0e8-8693-4575-a122-49bf90095074"
      unitRef="usd">106000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i56553614bb1d4575a81f8b42e1e9b673_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzQtNC0xLTEtNTQ3MDk4_e40f3143-def0-4c0c-9f13-88d104bdb675"
      unitRef="usd">1501000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i56553614bb1d4575a81f8b42e1e9b673_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzQtNi0xLTEtNTQ3MDk4_436a6828-a095-4c74-bca1-b581c349d76a"
      unitRef="usd">1607000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ie585d9251acf4ffaa79b1ef027535117_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzQtOC0xLTEtNTQ3MDk4_90376607-ac33-4e77-ba75-66d3c58f9b3d"
      unitRef="usd">67000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ie585d9251acf4ffaa79b1ef027535117_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzQtMTAtMS0xLTU0NzA5OA_87f598ca-95b9-4eb9-987a-3b3e7b34748c"
      unitRef="usd">1547000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ie585d9251acf4ffaa79b1ef027535117_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzQtMTItMS0xLTU0NzA5OA_a9e7b0c7-65b6-465f-87ec-c7835302c618"
      unitRef="usd">1614000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i0ddaaa564876446e911564680d7ad205_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzUtMi0xLTEtNTQ3MDk4_d0def798-c89c-40b4-aafe-c1c393658ce5"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i0ddaaa564876446e911564680d7ad205_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzUtNC0xLTEtNTQ3MDk4_0e41f626-3c0d-4de8-b0ab-017b0cafb801"
      unitRef="usd">1211000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i0ddaaa564876446e911564680d7ad205_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzUtNi0xLTEtNTQ3MDk4_074e186b-b25a-46fb-a65a-d6ae3d2e4ef9"
      unitRef="usd">1211000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i8c539efc04b24f10bb5bd030d79f630c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzUtOC0xLTEtNTQ3MDk4_bcc25ab6-0f3b-4db6-b36f-98a329acaaa2"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i8c539efc04b24f10bb5bd030d79f630c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzUtMTAtMS0xLTU0NzA5OA_ba35f1a6-7a20-4c46-aa46-989845cb089c"
      unitRef="usd">1218000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i8c539efc04b24f10bb5bd030d79f630c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzUtMTItMS0xLTU0NzA5OA_61b280f5-7553-4344-906c-d2abedbb7696"
      unitRef="usd">1218000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i1141eeb8e3f34513b86f0ce1f1a4c72c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzYtMi0xLTEtNTQ3MDk4_754e454a-e4ea-4dd3-9a7b-2c25c4a4ad89"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i1141eeb8e3f34513b86f0ce1f1a4c72c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzYtNC0xLTEtNTQ3MDk4_c0cde90c-0549-4485-aa7e-3f157291ee02"
      unitRef="usd">3936000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i1141eeb8e3f34513b86f0ce1f1a4c72c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzYtNi0xLTEtNTQ3MDk4_f4016007-9c30-4c52-a7e6-155c6ece4394"
      unitRef="usd">3936000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i7a7d37bc4c9a46d6a3949bc3551de6de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzYtOC0xLTEtNTQ3MDk4_236c5ce6-7c0e-4a96-980f-55d3f562f1e1"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i7a7d37bc4c9a46d6a3949bc3551de6de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzYtMTAtMS0xLTU0NzA5OA_6b6d90a5-a005-4b7e-b98a-e77b70dea7b0"
      unitRef="usd">3728000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i7a7d37bc4c9a46d6a3949bc3551de6de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzYtMTItMS0xLTU0NzA5OA_da8968b1-9c0f-4ed1-9e9a-28f6e7d05d53"
      unitRef="usd">3728000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ic5a5174826024b3b8526bf7dcd6066e5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzctMi0xLTEtNTQ3MDk4_c1e12387-33f4-47fb-a78e-e77b556ae0f0"
      unitRef="usd">141000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ic5a5174826024b3b8526bf7dcd6066e5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzctNC0xLTEtNTQ3MDk4_2c89d064-4582-46a1-9ddb-6a99ca85bd94"
      unitRef="usd">0</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ic5a5174826024b3b8526bf7dcd6066e5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzctNi0xLTEtNTQ3MDk4_2e059c7a-4855-452e-8872-93ef7fa312a8"
      unitRef="usd">141000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ie234bd06bf9543618cd63eb8ff57535e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzctOC0xLTEtNTQ3MDk4_e63ea2e2-6fc6-4304-b68d-a5987657b21e"
      unitRef="usd">139000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ie234bd06bf9543618cd63eb8ff57535e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzctMTAtMS0xLTU0NzA5OA_1e653023-2e7f-4e91-957b-720145278ad8"
      unitRef="usd">0</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ie234bd06bf9543618cd63eb8ff57535e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzctMTItMS0xLTU0NzA5OA_6fa37e79-c7fb-4f31-96a4-6a3cae785e8f"
      unitRef="usd">139000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzgtMi0xLTEtNTY3OTE4_75e743f7-309b-450b-a80c-13b96543a971"
      unitRef="usd">914000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzgtNC0xLTEtNTY3OTMw_d52e9acd-c0a5-4e5a-a4c0-00335fdb67b0"
      unitRef="usd">19010000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzgtNi0xLTEtNTY3OTM1_80f464e8-e37c-4bf5-a175-3765347e496c"
      unitRef="usd">19924000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzgtOC0xLTEtNTQ3MDk4_2a84f41f-1dcd-4ee6-9e67-bcf3e7a02512"
      unitRef="usd">905000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzgtMTAtMS0xLTU0NzA5OA_a85dbfe7-7ab3-42ac-9563-98c899590d8b"
      unitRef="usd">16288000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82MzEvZnJhZzoyMzllOTQ4ZTZiMzk0Nzc4YjI5NzU2Zjk2OTgyYzc2Yi90YWJsZTpkMGY0OWY5ZDc2N2U0NDIxOGFhYzVhZTc0NmQyYzQ3YS90YWJsZXJhbmdlOmQwZjQ5ZjlkNzY3ZTQ0MjE4YWFjNWFlNzQ2ZDJjNDdhXzgtMTItMS0xLTU0NzA5OA_01f64b85-a45b-470f-806b-92ab88f4b6f5"
      unitRef="usd">17193000000</us-gaap:Investments>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90ZXh0cmVnaW9uOjJlNDM0NjA3NzIwMzRmNzBiOTNmYmY0YWEzYzJjM2RhXzYwNg_3240bf0c-ce02-4d22-84f7-44527bf6740d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The amortized cost and fair value by contractual maturity periods for debt securities were as follows as of March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;630&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,972&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,752&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,227&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,915&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,268&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Mortgage and other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;381&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;344&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,668&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,909&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzItMi0xLTEtNTQ3MDk4_f282aacf-f0c9-4158-970f-f25657c5c575"
      unitRef="usd">638000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzItNC0xLTEtNTQ3MDk4_628ef374-ec47-4e18-8c0c-fa35c5222158"
      unitRef="usd">630000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzMtMi0xLTEtNTQ3MDk4_3f0ad67a-4413-49c1-8d4d-38ceadff5ab0"
      unitRef="usd">3972000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzMtNC0xLTEtNTQ3MDk4_0c5c3767-54d6-4825-ae41-3ca1690ccd7a"
      unitRef="usd">3752000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzQtMi0xLTEtNTQ3MDk4_12988439-5173-45eb-919f-ff1b1f36a472"
      unitRef="usd">3227000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzQtNC0xLTEtNTQ3MDk4_dd9de19c-08b8-496f-91b9-7d3346c9cc55"
      unitRef="usd">2915000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzUtMi0xLTEtNTQ3MDk4_f5d37f72-2146-4128-9a74-dd42ab511918"
      unitRef="usd">2450000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzUtNC0xLTEtNTQ3MDk4_a89adb6f-fe84-4c16-8e79-708aa2f5dac7"
      unitRef="usd">2268000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzYtMi0xLTEtNTQ3MDk4_242ce549-571b-4eee-87c8-37478d9cf22b"
      unitRef="usd">381000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzYtNC0xLTEtNTQ3MDk4_15adeac2-0a56-4cb8-9f64-0cbe324d1787"
      unitRef="usd">344000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzctMi0xLTEtNTQ3MDk4_d73c2656-867e-4182-96a7-4c8440b0c10c"
      unitRef="usd">10668000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZToyMmFlNmI2NThlMGM0OTU2YmZkOGRkNTI5OGNkZWM1YS90YWJsZXJhbmdlOjIyYWU2YjY1OGUwYzQ5NTZiZmQ4ZGQ1Mjk4Y2RlYzVhXzctNC0xLTEtNTQ3MDk4_5d424130-1d61-4a44-ba5d-b8e093e2ec67"
      unitRef="usd">9909000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90ZXh0cmVnaW9uOjJlNDM0NjA3NzIwMzRmNzBiOTNmYmY0YWEzYzJjM2RhXzYwOQ_5cf65c3c-b98a-44f3-93fe-dfe03d42b1fd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Gross unrealized appreciation (depreciation) on debt securities by type of issuer is shown below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Appreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal government and agency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;276&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;297&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;373&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,596&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,856&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Mortgage and other asset-backed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;381&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;344&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,668&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;170&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,909&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal government and agency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Mortgage and other asset-backed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i1269c3f703d94ed6840f2e30642de9bc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzItMi0xLTEtNTQ3MDk4_0f5de470-ffb4-41c5-807f-7fd1110c3e8a"
      unitRef="usd">276000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i1269c3f703d94ed6840f2e30642de9bc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzItNC0xLTEtNTQ3MDk4_370e3b5f-d8c5-46d0-8ed6-f3755235901b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1269c3f703d94ed6840f2e30642de9bc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzItNi0xLTEtNTQ3MDk4_d591a249-aa61-482f-9c37-17a9b3951017"
      unitRef="usd">29000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1269c3f703d94ed6840f2e30642de9bc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzItOC0xLTEtNTQ3MDk4_b0b6ec69-0586-43c8-a26f-3cdf8c403ff5"
      unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i1269c3f703d94ed6840f2e30642de9bc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzItMTAtMS0xLTU0NzA5OA_9140a3fb-cb84-4ec0-a923-04695084728a"
      unitRef="usd">297000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i0c306daec09546e08812586ae9f36ee0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzMtMi0xLTEtNTQ3MDk4_261d88ad-e8db-40ab-95f8-83fcbbc19e56"
      unitRef="usd">42000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i0c306daec09546e08812586ae9f36ee0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzMtNC0xLTEtNTQ3MDk4_19472a03-06aa-475e-abb0-e62eb80c6a68"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0c306daec09546e08812586ae9f36ee0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzMtNi0xLTEtNTQ3MDk4_0dfc2dc7-44c3-4382-b8da-25d8f49fd4a2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0c306daec09546e08812586ae9f36ee0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzMtOC0xLTEtNTQ3MDk4_4a3df0f7-cb4d-4d46-8c20-02144707c175"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0c306daec09546e08812586ae9f36ee0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzMtMTAtMS0xLTU0NzA5OA_ab128420-1a76-437e-9ab1-e9ab57a329c1"
      unitRef="usd">41000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ic820b1328eff4b35a3d9cd660b0c2801_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzQtMi0xLTEtNTQ3MDk4_4ac80666-0f95-4054-b3b7-78642a9d8f07"
      unitRef="usd">373000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="ic820b1328eff4b35a3d9cd660b0c2801_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzQtNC0xLTEtNTQ3MDk4_5adc6655-fe57-48a0-a4b1-e7538017d7e4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic820b1328eff4b35a3d9cd660b0c2801_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzQtNi0xLTEtNTQ3MDk4_18f1e381-9588-4ab9-bd57-82057ee2bd32"
      unitRef="usd">16000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic820b1328eff4b35a3d9cd660b0c2801_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzQtOC0xLTEtNTQ3MDk4_26e440be-447e-4bf2-90cd-a3b440a2f3e3"
      unitRef="usd">18000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic820b1328eff4b35a3d9cd660b0c2801_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzQtMTAtMS0xLTU0NzA5OA_bbb74ec0-6151-41d2-9f87-048ff9937453"
      unitRef="usd">371000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i7918ae8d451f4168bead8514e67d96dc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzUtMi0xLTEtNTQ3MDk4_77a86c89-d7ab-438e-9875-49dc33cae3cd"
      unitRef="usd">9596000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i7918ae8d451f4168bead8514e67d96dc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzUtNC0xLTEtNTQ3MDk4_013ffda2-7407-42b9-95c7-acc18d15b56a"
      unitRef="usd">41000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7918ae8d451f4168bead8514e67d96dc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzUtNi0xLTEtNTQ3MDk4_5cb3a81f-e3fd-4683-b05e-8e8291a59911"
      unitRef="usd">124000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7918ae8d451f4168bead8514e67d96dc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzUtOC0xLTEtNTQ3MDk4_3bcec229-755a-42b1-b5ef-bf1cd9b23775"
      unitRef="usd">823000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i7918ae8d451f4168bead8514e67d96dc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzUtMTAtMS0xLTU0NzA5OA_20fb097f-4842-4296-bf84-fd65c5ee68c5"
      unitRef="usd">8856000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i3942feca4c1d4b8b9e0695b4afd3cfd1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzYtMi0xLTEtNTQ3MDk4_56d90427-a19d-40b4-8f25-e2fd3ea3420b"
      unitRef="usd">381000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i3942feca4c1d4b8b9e0695b4afd3cfd1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzYtNC0xLTEtNTQ3MDk4_a8dd91a2-cd9e-4705-8908-622b16e38afb"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3942feca4c1d4b8b9e0695b4afd3cfd1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzYtNi0xLTEtNTQ3MDk4_e182ea78-b7c8-4d72-80c9-7b3d9988e99c"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3942feca4c1d4b8b9e0695b4afd3cfd1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzYtOC0xLTEtNTQ3MDk4_dcefe469-084a-4b63-8df8-1d7552b92eef"
      unitRef="usd">38000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3942feca4c1d4b8b9e0695b4afd3cfd1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzYtMTAtMS0xLTU0NzA5OA_d1b7d709-9872-48e2-b35d-1fbfbde240d2"
      unitRef="usd">344000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzctMi0xLTEtNTQ3MDk4_c1d28837-7ea2-4717-b457-5fffac033612"
      unitRef="usd">10668000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzctNC0xLTEtNTQ3MDk4_db0a060b-4177-4600-8dc5-33aaa629c6f3"
      unitRef="usd">41000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzctNi0xLTEtNTQ3MDk4_a8df212a-b13b-45a1-bc56-2ffb777e3e1f"
      unitRef="usd">170000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzctOC0xLTEtNTQ3MDk4_ef48f7a4-cbb9-40df-9d1e-aabc7fa04ff9"
      unitRef="usd">888000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzctMTAtMS0xLTU0NzA5OA_353212f8-4682-47a3-8578-e9b5ae920d37"
      unitRef="usd">9909000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ic28ad1e10f5a40aab28b4519e660c08a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzExLTItMS0xLTU0NzA5OA_ab7cbc38-454a-4615-be43-38b057446929"
      unitRef="usd">292000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="ic28ad1e10f5a40aab28b4519e660c08a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzExLTQtMS0xLTU0NzA5OA_22370eb3-5726-422a-afdb-5f58ab3a33aa"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic28ad1e10f5a40aab28b4519e660c08a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzExLTYtMS0xLTU0NzA5OA_b003222a-18b8-4a81-8591-8a473875d23b"
      unitRef="usd">32000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic28ad1e10f5a40aab28b4519e660c08a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzExLTgtMS0xLTU0NzA5OA_2622c498-31aa-4264-9322-ce7758e8db46"
      unitRef="usd">12000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic28ad1e10f5a40aab28b4519e660c08a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzExLTEwLTEtMS01NDcwOTg_578ce64a-b359-480b-9e35-3dd0ae0155ff"
      unitRef="usd">312000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i014e7b52c0f34c96a0a52bc15cdbbb2b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEyLTItMS0xLTU0NzA5OA_cd12edef-9bb3-4860-9925-7e5df2ae8bc1"
      unitRef="usd">43000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i014e7b52c0f34c96a0a52bc15cdbbb2b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEyLTQtMS0xLTU0NzA5OA_9383a15e-3134-4ce3-8ef6-a4c894e0633d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i014e7b52c0f34c96a0a52bc15cdbbb2b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEyLTYtMS0xLTU0NzA5OA_d34fb8a5-74b8-4d1b-b534-036d57d611c1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i014e7b52c0f34c96a0a52bc15cdbbb2b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEyLTgtMS0xLTU0NzA5OA_f3e3b48f-cf89-4d6b-81dd-48ff4d235371"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i014e7b52c0f34c96a0a52bc15cdbbb2b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEyLTEwLTEtMS01NDcwOTg_a6814670-0ff6-4f29-9227-4a42d470c1e3"
      unitRef="usd">41000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="iab84ae88cd084601b0a81a723bc6f470_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEzLTItMS0xLTU0NzA5OA_c4609fd1-6a2c-4ce5-b327-7e955e6cc7d1"
      unitRef="usd">375000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="iab84ae88cd084601b0a81a723bc6f470_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEzLTQtMS0xLTU0NzA5OA_fde6fc32-95ab-4f9c-8a1a-10f983b452fb"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iab84ae88cd084601b0a81a723bc6f470_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEzLTYtMS0xLTU0NzA5OA_105f4dae-ab30-4e1a-9897-7a9e75fdc10b"
      unitRef="usd">11000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iab84ae88cd084601b0a81a723bc6f470_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEzLTgtMS0xLTU0NzA5OA_761fd036-3eae-4b2b-bf55-aa503027d2b7"
      unitRef="usd">21000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iab84ae88cd084601b0a81a723bc6f470_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzEzLTEwLTEtMS01NDcwOTg_e7540e84-319a-4888-9ce8-393896fbc2d1"
      unitRef="usd">365000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ib356a619fa9e420489d64c64c7002bfe_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE0LTItMS0xLTU0NzA5OA_4ff3a1ce-514c-446f-b99b-72e488330160"
      unitRef="usd">9742000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="ib356a619fa9e420489d64c64c7002bfe_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE0LTQtMS0xLTU0NzA5OA_3bb4adc2-1dc5-43b1-9976-c36a1eceab0e"
      unitRef="usd">44000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib356a619fa9e420489d64c64c7002bfe_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE0LTYtMS0xLTU0NzA5OA_dcff203b-f5a5-455e-af75-e28ba9f783f7"
      unitRef="usd">89000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib356a619fa9e420489d64c64c7002bfe_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE0LTgtMS0xLTU0NzA5OA_25880ed4-06e8-4803-a02d-6817239d8c23"
      unitRef="usd">981000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib356a619fa9e420489d64c64c7002bfe_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE0LTEwLTEtMS01NDcwOTg_f478d0e7-ae60-4347-ac1d-99a0ec9a38cc"
      unitRef="usd">8806000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i4d7923da0ee04654b571d67b56b68fcc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE1LTItMS0xLTU0NzA5OA_05e7dc6e-4cd1-425a-b183-86aae6a498e5"
      unitRef="usd">390000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i4d7923da0ee04654b571d67b56b68fcc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE1LTQtMS0xLTU0NzA5OA_e722fac9-ae82-49c2-939d-88ef31b80353"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4d7923da0ee04654b571d67b56b68fcc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE1LTYtMS0xLTU0NzA5OA_5b90f535-e014-49eb-870d-9f6a07519e3f"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4d7923da0ee04654b571d67b56b68fcc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE1LTgtMS0xLTU0NzA5OA_68e49e40-f16c-4ae4-b5c0-4f0acb8c5913"
      unitRef="usd">43000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4d7923da0ee04654b571d67b56b68fcc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE1LTEwLTEtMS01NDcwOTg_64ad2578-0410-4803-a32a-238a2a2f3285"
      unitRef="usd">348000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE2LTItMS0xLTU0NzA5OA_d4334e99-1aa1-436d-a545-d7b01c4de098"
      unitRef="usd">10842000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE2LTQtMS0xLTU0NzA5OA_8fd18c9a-9a22-4a8b-8c80-ec2d5fc530d3"
      unitRef="usd">44000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE2LTYtMS0xLTU0NzA5OA_fdf6ce8a-e273-4b90-94b6-4d1bcbba9e95"
      unitRef="usd">133000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE2LTgtMS0xLTU0NzA5OA_ba99bca8-a062-41ce-8aab-7b0c2f82e926"
      unitRef="usd">1059000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDMvZnJhZzoyZTQzNDYwNzcyMDM0ZjcwYjkzZmJmNGFhM2MyYzNkYS90YWJsZTplNTI5NGYzMWI3Y2M0NzgzODhkZjNhNjdhOTEwMTE0Zi90YWJsZXJhbmdlOmU1Mjk0ZjMxYjdjYzQ3ODM4OGRmM2E2N2E5MTAxMTRmXzE2LTEwLTEtMS01NDcwOTg_c4303e95-f935-44d6-8c3a-63f1b72e0ed9"
      unitRef="usd">9872000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90ZXh0cmVnaW9uOjg0OGJiOGJhYmY5OTRhZTViZDJiMmIzODQ0NTkyMzZjXzc5Nw_5b755e5d-c4bc-4d6c-8044-a9eba1890453">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The table below summarizes debt securities with a decline in fair value from amortized cost for which an allowance for credit losses has not been recorded, by investment grade and the length of time these securities have been in an unrealized loss position. Unrealized depreciation on these debt securities is primarily due to declines in fair value resulting from increasing interest rates since these securities were purchased. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of Issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of Issues&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;One year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment grade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,362&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(594)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Below investment grade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;353&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;936&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;More than one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment grade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,808&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Below investment grade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;682&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;780&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;770&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,433&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,760&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtMi0xLTEtNTQ3MDk4_fd14793b-c8ea-4a5a-b2d0-353ed36bbdef"
      unitRef="usd">3176000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost
      contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtNC0xLTEtNTQ3MDk4_192acec9-4d83-4281-8529-d339c56ed333"
      unitRef="usd">3362000000</ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtNi0xLTEtNTQ3MDk4_e918aed9-e691-4872-bf06-3702f2c1251d"
      unitRef="usd">186000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtOC0xLTEtNTQ3MDk4_6972f8c2-c9b2-4fe8-b870-e2c1d07a3224"
      unitRef="position">1019</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtMTAtMS0xLTU0NzA5OA_39fc375d-b87c-4612-9c91-3112786c17e5"
      unitRef="usd">5533000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost
      contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtMTItMS0xLTU0NzA5OA_339a4ec6-4adc-4659-9672-23b59604eb27"
      unitRef="usd">6127000000</ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtMTQtMS0xLTU0NzA5OA_bd0791cd-f4e1-4439-af07-1b3a837fb04d"
      unitRef="usd">594000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzMtMTYtMS0xLTU0NzA5OA_e694a324-3ab6-46d5-9d29-7034a149278c"
      unitRef="position">1659</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtMi0xLTEtNTQ3MDk4_858c4ec8-8f06-4d3e-8e30-abdb8ae6679c"
      unitRef="usd">353000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost
      contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtNC0xLTEtNTQ3MDk4_773254b7-3f72-4a17-a697-4e34b1c4e4da"
      unitRef="usd">371000000</ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtNi0xLTEtNTQ3MDk4_dd61debd-f5df-4976-b2a4-91a49978e3b1"
      unitRef="usd">18000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtOC0xLTEtNTQ3MDk4_1a22c55f-5cf4-4fd8-b943-dbcac7a45bb9"
      unitRef="position">936</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtMTAtMS0xLTU0NzA5OA_aaeccd08-1202-45db-b389-c3e8adf617a2"
      unitRef="usd">887000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost
      contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtMTItMS0xLTU0NzA5OA_b3f1c971-272f-46fc-a504-1ce1d6f33c5d"
      unitRef="usd">964000000</ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtMTQtMS0xLTU0NzA5OA_4837ec8c-6b43-4abd-a4cc-a8764cf7275f"
      unitRef="usd">77000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzQtMTYtMS0xLTU0NzA5OA_a2185f6a-cce6-4d59-be8c-eeaba6a55263"
      unitRef="position">1287</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtMi0xLTEtNTQ3MDk4_e977a85c-1716-4d7b-9915-6e355ac9a919"
      unitRef="usd">3222000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost
      contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtNC0xLTEtNTQ3MDk4_e2629255-49ce-44da-ac94-9339b2003275"
      unitRef="usd">3808000000</ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtNi0xLTEtNTQ3MDk4_743a79d5-41ac-4af3-be42-6489babcb388"
      unitRef="usd">586000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i5ec5355a990d4c00b92ee9f78c5841da_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtOC0xLTEtNTQ3MDk4_e9ebc401-cdbe-4264-986a-1cabd1d41296"
      unitRef="position">1035</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtMTAtMS0xLTU0NzA5OA_415274d3-18a0-44c2-840c-39221c1773cf"
      unitRef="usd">1151000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost
      contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtMTItMS0xLTU0NzA5OA_ec49ec42-6b95-4c9c-a292-8a420a941c7e"
      unitRef="usd">1487000000</ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtMTQtMS0xLTU0NzA5OA_e4cf7459-982f-4479-b3f5-41d5108a0b9c"
      unitRef="usd">336000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i05eea674d36b42b9b7fd99b97319f904_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzYtMTYtMS0xLTU0NzA5OA_6c877ff0-764e-4472-a008-59c90a7b2970"
      unitRef="position">462</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctMi0xLTEtNTQ3MDk4_c4cb2076-971d-4b63-be86-b6de7300bc3a"
      unitRef="usd">682000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost
      contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctNC0xLTEtNTQ3MDk4_05f2c0cd-da57-4b5d-a2cc-239d9b8bdc3a"
      unitRef="usd">780000000</ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctNi0xLTEtNTQ3MDk4_f75ca82c-abe2-4d2a-89f5-0db490d99240"
      unitRef="usd">98000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="iffb70a8f680e4c8290525b7e1fef6da3_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctOC0xLTEtNTQ3MDk4_e8f0edbc-0034-4a31-9e0e-969ed0c8b16e"
      unitRef="position">770</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctMTAtMS0xLTU0NzA5OA_d6b466eb-f094-4432-90e0-d07b01c96a79"
      unitRef="usd">330000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost
      contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctMTItMS0xLTU0NzA5OA_109af9fd-3364-44ff-bbd0-c9f87619e45d"
      unitRef="usd">382000000</ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctMTQtMS0xLTU0NzA5OA_f69d449a-a1b8-4abc-8e75-a05436ed09f2"
      unitRef="usd">52000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i30b568ddad034fb38476af6dff0d5b42_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzctMTYtMS0xLTU0NzA5OA_1a79021c-7aa9-4eb1-bb07-a3558ae8baad"
      unitRef="position">369</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtMi0xLTEtNTQ3MDk4_9732935a-214f-4e24-842c-fd5646eed6e2"
      unitRef="usd">7433000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtNC0xLTEtNTQ3MDk4_1fca1e92-70a1-4129-9f79-7c7b2538fc46"
      unitRef="usd">8321000000</ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtNi0xLTEtNTQ3MDk4_e057d6db-4acb-4dd7-b049-fd3967370097"
      unitRef="usd">888000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtOC0xLTEtNTQ3MDk4_2144f462-f929-4ad3-9220-6a3d462630d4"
      unitRef="position">3760</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtMTAtMS0xLTU0NzA5OA_76860ae3-a28c-4f1c-8557-e4001dc19666"
      unitRef="usd">7901000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtMTItMS0xLTU0NzA5OA_d21c6dd2-819a-485f-b769-fc527fd15862"
      unitRef="usd">8960000000</ci:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtMTQtMS0xLTU0NzA5OA_a316717b-4822-4be3-98d8-ea84b3e842d7"
      unitRef="usd">1059000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NDYvZnJhZzo4NDhiYjhiYWJmOTk0YWU1YmQyYjJiMzg0NDU5MjM2Yy90YWJsZTphMWRhOGZhNTdhOWM0ZTM4Yjg5N2UyOWIxZDc5OTM4NS90YWJsZXJhbmdlOmExZGE4ZmE1N2E5YzRlMzhiODk3ZTI5YjFkNzk5Mzg1XzgtMTYtMS0xLTU0NzA5OA_5bfe996a-57a8-4e4f-8ee7-3e352587929e"
      unitRef="position">3777</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <ci:EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90ZXh0cmVnaW9uOjdkNWU4NDQzZWM1MzQ0N2I4ZDRmODNhMmY4MTAzNTRiXzMzMQ_3e8bb31e-3b50-4f47-af75-d1decbaa7c15">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table provides the values of the Company's equity security investments as of March&#160;31, 2023 and December&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.044%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity securities with readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity securities with no readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,926&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,029&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,606&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzItMi0xLTEtNTQ3MDk4_087363fd-811a-4dea-8acf-06ade3e7f19f"
      unitRef="usd">680000000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzItNC0xLTEtNTQ3MDk4_0c148caa-7e7d-4502-b5c5-6291b3586154"
      unitRef="usd">91000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzItNi0xLTEtNTQ3MDk4_0c5b66a6-30d3-4643-8842-5c948a4b78d6"
      unitRef="usd">673000000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzItOC0xLTEtNTQ3MDk4_be0c566d-e24b-4e37-94d7-9a50f3fb6094"
      unitRef="usd">138000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <ci:EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzMtMi0xLTEtNTQ3MDk4_61b8c3ef-7dee-4d04-a8c2-220d8580d163"
      unitRef="usd">2926000000</ci:EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzMtNC0xLTEtNTQ3MDk4_a1bde2c2-1afe-441f-927c-064f3e8ae4e8"
      unitRef="usd">3029000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <ci:EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzMtNi0xLTEtNTQ3MDk4_0b3eda7f-8e80-4777-85f6-8c4730adb9ce"
      unitRef="usd">380000000</ci:EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzMtOC0xLTEtNTQ3MDk4_784132b0-1ccc-42cd-a999-f1e83859caf4"
      unitRef="usd">484000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <ci:EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzQtMi0xLTEtNTQ3MDk4_5e3b2e6b-d1fd-49e6-9e54-ab117070e5a5"
      unitRef="usd">3606000000</ci:EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost>
    <ci:EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzQtNC0xLTEtNTQ3MDk4_3907894f-9506-4854-910d-278c9d826048"
      unitRef="usd">3120000000</ci:EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount>
    <ci:EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzQtNi0xLTEtNTQ3MDk4_74e7ae05-378c-4b8a-ac6c-7e76f18606e7"
      unitRef="usd">1053000000</ci:EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost>
    <ci:EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90YWJsZTpiOWZkZmI2Yjk4NTI0ZGI5OWEyMWY2ZDk0MDI0NmZhOC90YWJsZXJhbmdlOmI5ZmRmYjZiOTg1MjRkYjk5YTIxZjZkOTQwMjQ2ZmE4XzQtOC0xLTEtNTQ3MDk4_ff47bfe2-d927-4958-8eb3-2da7c58c436f"
      unitRef="usd">622000000</ci:EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i52a0532147074a69a79d2bde730cc6b4_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NTUvZnJhZzo3ZDVlODQ0M2VjNTM0NDdiOGQ0ZjgzYTJmODEwMzU0Yi90ZXh0cmVnaW9uOjdkNWU4NDQzZWM1MzQ0N2I4ZDRmODNhMmY4MTAzNTRiXzE0Mg_6902c8dc-32e0-40b9-8c2b-3c0d94045ba7"
      unitRef="number">0.95</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90ZXh0cmVnaW9uOjc4MDcxODFmMjU2OTRiOWJiNjY2YTRiMmVlNDE1OWM1XzExNQ_9a783164-6bd9-4a8b-ba6b-43577219da60">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the credit risk profile of the Company's commercial mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.890%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Loan-to-Value Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Debt Service Coverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Loan-to-Value Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Debt Service Coverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Loan-to-Value Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Below 60%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;912&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60% to 79%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;504&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80% to 100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;191&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;60&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ia91b63f759a34db984a3518b4db4eae5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzItMi0xLTEtNTQ3MDk4_9637dd9f-71b0-4f46-9cc5-ceb42f32f0bf"
      unitRef="usd">912000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio
      contextRef="i53e6849ed22a418fbb6188f47afafa8f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzItNC0xLTEtNTQ3MDk4_40b166d6-56de-4f5e-99df-313834e06b41"
      unitRef="number">2.11</ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i227e56a283374d43b53193cb2ae5296a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzItOC0xLTEtNTQ3MDk4_d2f00ff2-c469-4c23-8d98-c34209d135f3"
      unitRef="usd">901000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio
      contextRef="icb8ba53337fd497ab5e68995d0c88cd2_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzItMTAtMS0xLTU0NzA5OA_a389f378-16bb-419c-9ad5-84e54443cad6"
      unitRef="number">2.12</ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="idc795fae04a24e6bbfae9210f9e9def8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzMtMi0xLTEtNTQ3MDk4_39142ab9-8d66-459b-8a05-5d1749a07dc5"
      unitRef="usd">504000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio
      contextRef="id71bd449e9c6454cacf21e30ce2c498b_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzMtNC0xLTEtNTQ3MDk4_3f9751f0-0bdb-44e7-bfc9-8e60460d2bf2"
      unitRef="number">1.73</ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ia74150594d8b46d49cdade2e93655870_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzMtOC0xLTEtNTQ3MDk4_88e1ce69-49c7-4769-95f3-a062ade2648b"
      unitRef="usd">564000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio
      contextRef="ide32893117054ad98838d727032c109e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzMtMTAtMS0xLTU0NzA5OA_c2f6bcb1-5578-47ba-bb6f-5c4874994b79"
      unitRef="number">1.73</ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ia0150b47337d4406b098b239d61060d8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzQtMi0xLTEtNTQ3MDk4_0a7a3c55-cd1b-480e-a448-0eded2bb7caf"
      unitRef="usd">191000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio
      contextRef="i37f1db0b0e904b5291a5862d25f76c60_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzQtNC0xLTEtNTQ3MDk4_9533a3a5-f6a5-4bc8-8fba-d9d36af5a9c1"
      unitRef="number">1.32</ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i57d71fb7be6245038f50e90a278d63e9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzQtOC0xLTEtNTQ3MDk4_5a05a205-c3dd-43c5-bfe6-e55e1a9ade7f"
      unitRef="usd">149000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio
      contextRef="ie9d56cac03234e309389948e70c6ec5b_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzQtMTAtMS0xLTU0NzA5OA_65102682-cffa-4481-a89d-a94f1ecea39e"
      unitRef="number">1.17</ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i7e013bc327d64747b0fccc969e1f0449_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzgtMi0xLTEtNTQ3MDk4_a904e99c-1364-4b04-a161-e144ebef80db"
      unitRef="usd">1607000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio
      contextRef="if4810804d0794cab810a5c6d840e43f8_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzgtNC0xLTEtNTQ3MDk4_58fced72-4a00-43bb-aa15-fa1e50f495d4"
      unitRef="number">1.89</ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio>
    <ci:FinancingReceivableCreditQualityLoanToValueRatio
      contextRef="if4810804d0794cab810a5c6d840e43f8_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzgtNi0xLTEtNTQ3MDk4_7c89d175-2cca-4d21-ac9b-cf757ce40bfb"
      unitRef="number">0.60</ci:FinancingReceivableCreditQualityLoanToValueRatio>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i6a727657552e4bba86a90d288d5a606b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzgtOC0xLTEtNTQ3MDk4_c2aee398-9da2-4a8a-987e-e8fe31cfc040"
      unitRef="usd">1614000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio
      contextRef="ib51509dfe7384c87a20dfce010e9054b_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzgtMTAtMS0xLTU0NzA5OA_55f59e23-92c0-4aff-9de8-b202c4d74997"
      unitRef="number">1.89</ci:FinancingReceivableCreditQualityDebtServiceCoverageRatio>
    <ci:FinancingReceivableCreditQualityLoanToValueRatio
      contextRef="ib51509dfe7384c87a20dfce010e9054b_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82NzkvZnJhZzo3ODA3MTgxZjI1Njk0YjliYjY2NmE0YjJlZTQxNTljNS90YWJsZTo1MWU1NTEwYmNjNmQ0ZDM3OGIwNzFkNGRkMjE2ZjJkMS90YWJsZXJhbmdlOjUxZTU1MTBiY2M2ZDRkMzc4YjA3MWQ0ZGQyMTZmMmQxXzgtMTItMS0xLTU0NzA5OA_7c2293a0-1d1a-4223-8687-e405e0342b93"
      unitRef="number">0.60</ci:FinancingReceivableCreditQualityLoanToValueRatio>
    <ci:ScheduleOfOtherLongTermInvestmentsTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90ZXh0cmVnaW9uOmFmMDYzNTAzZTNlZDQ0MWFiNjg3ZjI4OWI5ZDAwYWU3XzEwMTc_d55ca17f-2295-4de3-88e0-2212b15b9f3d">The following table provides the carrying value information for these investments:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,434&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Securities partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,259&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,936&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</ci:ScheduleOfOtherLongTermInvestmentsTableTextBlock>
    <us-gaap:OtherLongTermInvestments
      contextRef="ibddf171f855d455eb0339d11c5a8b669_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzItMi0xLTEtNTQ3MDk4_88159f42-dbed-4314-bef9-cf9aca1e6267"
      unitRef="usd">1434000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i87598f99e83e4f8fad5b7954451b7bf8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzItNC0xLTEtNTQ3MDk4_b9bd40c7-3a7f-47d9-8070-3f0594531e7e"
      unitRef="usd">1319000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i94d91ccb4d8945f2b31211b7f940aa8c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzMtMi0xLTEtNTQ3MDk4_2978ef8b-f8c3-4d67-91d3-7a7ef2703067"
      unitRef="usd">2259000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i6214eeb319f84edc87092fa100092fae_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzMtNC0xLTEtNTQ3MDk4_a5893ee8-d341-47e8-b092-cad47f4a97c6"
      unitRef="usd">2166000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="idd9435629cbc409e80fce5ba86b95ec5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzQtMi0xLTEtNTQ3MDk4_ac590c81-ab19-42d3-bc02-495c0601b30a"
      unitRef="usd">243000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="if1c8862dc33f41798f458e182a06dc81_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzQtNC0xLTEtNTQ3MDk4_918438c8-2c2c-465b-af3a-3453b8cae74c"
      unitRef="usd">243000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzUtMi0xLTEtNTQ3MDk4_879d04b1-8647-4fb7-99c5-a08a9992a266"
      unitRef="usd">3936000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF82ODUvZnJhZzphZjA2MzUwM2UzZWQ0NDFhYjY4N2YyODliOWQwMGFlNy90YWJsZToyN2ZkMmZmNDEyZWQ0NTQ1YjE5MzZmNmJmMmU1MjhlMy90YWJsZXJhbmdlOjI3ZmQyZmY0MTJlZDQ1NDViMTkzNmY2YmYyZTUyOGUzXzUtNC0xLTEtNTQ3MDk4_ce5c2814-30a6-4d05-8cbf-8c63b935fa7e"
      unitRef="usd">3728000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MDAvZnJhZzpiMGJiYjkxYzAwN2I0OTMxOWJjNTIxODY4MDQ1ODhkZi90ZXh0cmVnaW9uOmIwYmJiOTFjMDA3YjQ5MzE5YmM1MjE4NjgwNDU4OGRmXzg3Ng_4e314892-d55b-49ed-8848-a5bfc46f0a71">The Company uses derivative financial instruments to manage the characteristics of investment assets (such as duration, yield, currency and liquidity) to meet the varying demands of the related insurance and contractholder liabilities. The Company also uses derivative financial instruments to hedge the risk of changes in the net assets of certain of its foreign subsidiaries due to changes in foreign currency exchange rates and to hedge the interest rate risk of certain long-term debt.Please refer to the Company's 2022 Form 10-K for further discussion of the types of derivative financial instruments and associated accounting policies.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:RealizedGainLossOnInvestmentsTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90ZXh0cmVnaW9uOmZmMGJhYTgxNjFhNzRkYWNhNDNjZjdjYzZhNDg0NDEwXzUxMg_e5864175-dbf1-4537-8810-4fbb930a4bd9">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following realized gains and losses on investments exclude realized gains and losses attributed to the Company's separate accounts because those gains and losses generally accrue directly to separate account policyholders:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net realized investment (losses), excluding credit loss expense and asset write-downs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Credit loss recoveries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investment asset write-downs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net realized investment (losses), before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RealizedGainLossOnInvestmentsTableTextBlock>
    <ci:RealizedInvestmentGainLossExcludingImpairments
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzMtNi0xLTEtNTQ3MDk4_a6dd7d19-acc3-48ff-85c0-c18087ca51d1"
      unitRef="usd">-51000000</ci:RealizedInvestmentGainLossExcludingImpairments>
    <ci:RealizedInvestmentGainLossExcludingImpairments
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzMtOC0xLTEtNTQ3MDk4_5ca15e5e-63e3-48e3-b6da-1ceb8c5818c0"
      unitRef="usd">-322000000</ci:RealizedInvestmentGainLossExcludingImpairments>
    <ci:DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzQtNi0xLTEtNTQ3MDk4_a433c245-32e8-4c73-ac3d-8c84ee26175b"
      unitRef="usd">-3000000</ci:DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal>
    <ci:DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzQtOC0xLTEtNTQ3MDk4_58a5f95f-c969-4a7e-afd6-dd7466e8c7cc"
      unitRef="usd">0</ci:DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal>
    <ci:ImpairmentsOnInvestmentsTotal
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzUtNi0xLTEtNTQ3MDk4_6b6cff3d-33f7-4b9d-9879-dadcf9c31589"
      unitRef="usd">8000000</ci:ImpairmentsOnInvestmentsTotal>
    <ci:ImpairmentsOnInvestmentsTotal
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzUtOC0xLTEtNTQ3MDk4_864850e6-a81b-4f69-a50d-f19477a524fe"
      unitRef="usd">0</ci:ImpairmentsOnInvestmentsTotal>
    <ci:RealizedInvestmentGainLoss
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzYtNi0xLTEtNTQ3MDk4_e979d9de-a5ca-4c65-a4d0-679a16951dd2"
      unitRef="usd">-56000000</ci:RealizedInvestmentGainLoss>
    <ci:RealizedInvestmentGainLoss
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MjcvZnJhZzpmZjBiYWE4MTYxYTc0ZGFjYTQzY2Y3Y2M2YTQ4NDQxMC90YWJsZTo2ODExYWRmOTZkM2I0NDM5OTZlOWQ0ZDM2MWU4YTVjNC90YWJsZXJhbmdlOjY4MTFhZGY5NmQzYjQ0Mzk5NmU5ZDRkMzYxZThhNWM0XzYtOC0xLTEtNTQ3MDk4_49c40b0b-4470-4304-980e-17655f545dc7"
      unitRef="usd">-322000000</ci:RealizedInvestmentGainLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MzYvZnJhZzpjZmY5NWFlZWY4N2M0NDcxYjA0YjRjMWFiMDU2ZWNkMS90ZXh0cmVnaW9uOmNmZjk1YWVlZjg3YzQ0NzFiMDRiNGMxYWIwNTZlY2QxXzE1OTA_dd4a39e3-5a6a-47fe-a09f-938fff209499">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 12 &#x2013; Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company carries certain financial instruments at fair value in the financial statements including debt securities, certain equity securities, short-term investments and derivatives. Other financial instruments are measured at fair value only under certain conditions, such as when impaired or when there are observable price changes for equity securities with no readily determinable fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Fair value is defined as the price at which an asset could be exchanged in an orderly transaction between market participants at the balance sheet date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a market participant, not the amount that would be paid to settle the liability with the creditor.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's financial assets and liabilities carried at fair value have been classified based upon a hierarchy defined by GAAP. The hierarchy gives the highest ranking to fair values determined using unadjusted quoted prices in active markets for identical assets and liabilities (Level 1) and the lowest ranking to fair values determined using methodologies and models with unobservable inputs (Level 3). An asset's or a liability's classification is based on the lowest level of input that is significant to its measurement. For example, a financial asset or liability carried at fair value would be classified in Level 3 if unobservable inputs were significant to the instrument's fair value, even though the measurement may be derived using inputs that are both observable (Levels 1 and 2) and unobservable (Level 3).&lt;/span&gt;&lt;/div&gt;For a description of the policies, methods and assumptions that are used to estimate fair value and determine the fair value hierarchy for each class of financial instruments, see Note 12 in the Company's 2022 Form 10-K.Financial Assets and Financial Liabilities Carried at Fair Value&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table provides information about the Company's financial assets and liabilities carried at fair value. Further information regarding insurance assets and liabilities carried at fair value is provided in Note 9E to the Consolidated Financial Statements. Separate account assets are also recorded at fair value on the Company's Consolidated Balance Sheets and are reported separately in the Separate Accounts section below as gains and losses related to these assets generally accrue directly to contractholders:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal government and agency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;297&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,421&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;435&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,856&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Mortgage and other asset-backed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;309&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;344&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,288&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;470&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,909&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;84&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Excludes certain equity securities that have no readily determinable fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Level 3 Financial Assets and Financial Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Certain inputs for instruments classified in Level 3 are unobservable (supported by little or no market activity) and significant to their resulting fair value measurement. Unobservable inputs reflect the Company's best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date. Additionally, as discussed in Note 9 to the Consolidated Financial Statements, the Company classifies variable annuity assets and liabilities in Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"&gt;Quantitative Information about Unobservable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The significant unobservable input used to value our corporate and government debt securities and mortgage and other asset-backed securities is an adjustment for liquidity. This adjustment is needed to reflect current market conditions and issuer circumstances when there is limited trading activity for the security. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the fair value and significant unobservable inputs that were developed directly by the Company and used in pricing these debt securities. The range and weighted average basis point ("bps") amounts for liquidity reflect the Company's best estimates of the unobservable adjustments a market participant would make to calculate these fair values. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable Adjustment Range (Weighted Average by Quantity) as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Fair value in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable input March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate and government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;433&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liquidity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;60 - 1060 (300)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;bps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60 - 1060 (270)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;bps&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Mortgage and other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liquidity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;105 - 520 (310) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;bps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;110 - 520 (310)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;bps&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Level 3 debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;470&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A significant increase in liquidity spread adjustments would result in a lower fair value measurement, while a decrease would result in a higher fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Changes in Level 3 Financial Assets and Financial Liabilities Carried at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the changes in financial assets and financial liabilities classified in Level 3. Gains and losses reported in the table may include net changes in fair value that are attributable to both observable and unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt and Equity Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gains included in Shareholders' net income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gains (losses) included in Other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Losses required to adjust future policy benefits for settlement annuities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transfers into/(out of) Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total transfers into/(out of) Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total gains included in Shareholders' net income attributable to instruments held at the reporting date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in unrealized gain or (loss) included in Other comprehensive loss for assets held at the end of the reporting period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Amounts do not accrue to shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total gains and losses included in Shareholders' net income in the tables above are reflected in the Consolidated Statements of Income as Net realized investment losses and Net investment income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Gains and losses included in Other comprehensive loss, net of tax in the tables above are reflected in Net unrealized appreciation (depreciation) on securities and derivatives in the Consolidated Statements of Comprehensive Income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transfers into or out of the Level 3 category occur when unobservable inputs, such as the Company's best estimate of what a market participant would use to determine a current transaction price, become more or less significant to the fair value measurement. Market activity typically decreases during periods of economic uncertainty and this decrease in activity reduces the availability of market observable data. As a result, the level of unobservable judgment that must be applied to the pricing of certain instruments increases and is typically observed through the widening of liquidity spreads. Transfers between Level 2 and Level 3 during 2023 and 2022 primarily reflected changes in liquidity estimates for certain private placement issuers across several sectors. See discussion under Quantitative Information about Unobservable Inputs above for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The investment income and fair value gains and losses of Separate account assets generally accrue directly to the contractholders and, together with their deposits and withdrawals, are excluded from the Company's Consolidated Statements of Income and Cash Flows. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Fair values of Separate account assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Guaranteed separate accounts (See Note 16)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;562&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-guaranteed separate accounts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;221&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,586&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;434&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,935&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,582&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-guaranteed separate accounts priced at net asset value ("NAV") as a practical expedient &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;758&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,340&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Non-guaranteed separate accounts include $4.0 billion as of March&#160;31, 2023 and December&#160;31, 2022 in assets supporting the Company's pension plans, including $0.2 billion classified in Level 3 as of March&#160;31, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Separate account assets classified in Level 3 primarily support the Company's pension plans and include certain newly-issued, privately-placed, complex or illiquid securities that are priced using methods discussed above, as well as commercial mortgage loans. Activity, including transfers into and out of Level 3, was not material for the three months ended March&#160;31, 2023 or 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Separate account investments in securities partnerships, real estate and hedge funds are generally valued based on the separate account's ownership share of the equity of the investee (NAV as a practical expedient), including changes in the fair values of its underlying investments. Substantially all of these assets support the Company's pension plans. The following table provides additional information on these investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unfunded Commitment as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Redemption Frequency&lt;br/&gt;(if currently eligible)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Redemption Notice&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Securities partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;228&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Not applicable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Not applicable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Real estate funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quarterly&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30 - 90 days&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedge funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Up to annually, varying by fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30 - 90 days&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;758&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;228&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of March&#160;31, 2023, the Company does not have plans to sell any of these assets at less than fair value. These investments are structured to satisfy longer-term investment objectives. Securities partnerships are contractually non-redeemable and the underlying investment assets are expected to be liquidated by the fund managers within ten years after inception.&lt;/span&gt;&lt;/div&gt;Assets and Liabilities Measured at Fair Value under Certain Conditions&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Some financial assets and liabilities are not carried at fair value, such as commercial mortgage loans that are carried at unpaid principal, investment real estate that is carried at depreciated cost and equity securities with no readily determinable fair value when there are no observable market transactions. However, these financial assets and liabilities may be measured using fair value under certain conditions, such as when investments become impaired and are written down to their fair value, or when there are observable price changes from orderly market transactions of equity securities that otherwise had no readily determinable fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the three months ended March&#160;31, 2023 and 2022, impairments recognized requiring these assets to be measured at fair value were not material. Realized investment gains and losses from these observable price changes for the three months ended March&#160;31, 2023 and March&#160;31, 2022 were not material. &lt;/span&gt;&lt;/div&gt;Fair Value Disclosures for Financial Instruments Not Carried at Fair Value&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table includes the Company's financial instruments not recorded at fair value but for which fair value disclosure is required. In addition to universal life products and finance leases, financial instruments that are carried in the Company's Consolidated Balance Sheets at amounts that approximate fair value are excluded from the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification in Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commercial mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,509&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities, excluding finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;30,679&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;32,439&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83MzYvZnJhZzpjZmY5NWFlZWY4N2M0NDcxYjA0YjRjMWFiMDU2ZWNkMS90ZXh0cmVnaW9uOmNmZjk1YWVlZjg3YzQ0NzFiMDRiNGMxYWIwNTZlY2QxXzE1ODg_a2d201de-0f01-4a8a-9068-fbd8db44b1e5">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company carries certain financial instruments at fair value in the financial statements including debt securities, certain equity securities, short-term investments and derivatives. Other financial instruments are measured at fair value only under certain conditions, such as when impaired or when there are observable price changes for equity securities with no readily determinable fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Fair value is defined as the price at which an asset could be exchanged in an orderly transaction between market participants at the balance sheet date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a market participant, not the amount that would be paid to settle the liability with the creditor.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's financial assets and liabilities carried at fair value have been classified based upon a hierarchy defined by GAAP. The hierarchy gives the highest ranking to fair values determined using unadjusted quoted prices in active markets for identical assets and liabilities (Level 1) and the lowest ranking to fair values determined using methodologies and models with unobservable inputs (Level 3). An asset's or a liability's classification is based on the lowest level of input that is significant to its measurement. For example, a financial asset or liability carried at fair value would be classified in Level 3 if unobservable inputs were significant to the instrument's fair value, even though the measurement may be derived using inputs that are both observable (Levels 1 and 2) and unobservable (Level 3).&lt;/span&gt;&lt;/div&gt;For a description of the policies, methods and assumptions that are used to estimate fair value and determine the fair value hierarchy for each class of financial instruments, see Note 12 in the Company's 2022 Form 10-K.&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Level 3 Financial Assets and Financial Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Certain inputs for instruments classified in Level 3 are unobservable (supported by little or no market activity) and significant to their resulting fair value measurement. Unobservable inputs reflect the Company's best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date. Additionally, as discussed in Note 9 to the Consolidated Financial Statements, the Company classifies variable annuity assets and liabilities in Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;Quantitative Information about Unobservable InputsThe significant unobservable input used to value our corporate and government debt securities and mortgage and other asset-backed securities is an adjustment for liquidity. This adjustment is needed to reflect current market conditions and issuer circumstances when there is limited trading activity for the security.&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total gains and losses included in Shareholders' net income in the tables above are reflected in the Consolidated Statements of Income as Net realized investment losses and Net investment income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Gains and losses included in Other comprehensive loss, net of tax in the tables above are reflected in Net unrealized appreciation (depreciation) on securities and derivatives in the Consolidated Statements of Comprehensive Income.&lt;/span&gt;&lt;/div&gt;Transfers into or out of the Level 3 category occur when unobservable inputs, such as the Company's best estimate of what a market participant would use to determine a current transaction price, become more or less significant to the fair value measurement. Market activity typically decreases during periods of economic uncertainty and this decrease in activity reduces the availability of market observable data. As a result, the level of unobservable judgment that must be applied to the pricing of certain instruments increases and is typically observed through the widening of liquidity spreadsAssets and Liabilities Measured at Fair Value under Certain ConditionsSome financial assets and liabilities are not carried at fair value, such as commercial mortgage loans that are carried at unpaid principal, investment real estate that is carried at depreciated cost and equity securities with no readily determinable fair value when there are no observable market transactions. However, these financial assets and liabilities may be measured using fair value under certain conditions, such as when investments become impaired and are written down to their fair value, or when there are observable price changes from orderly market transactions of equity securities that otherwise had no readily determinable fair value.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90ZXh0cmVnaW9uOmJkYmUyM2JhYzU0YzQzOWRhYmE1ZmZkNDQzZjQ0NmY5XzUxMw_4e319d47-67c5-4c0c-b47b-93ef57198842">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table provides information about the Company's financial assets and liabilities carried at fair value. Further information regarding insurance assets and liabilities carried at fair value is provided in Note 9E to the Consolidated Financial Statements. Separate account assets are also recorded at fair value on the Company's Consolidated Balance Sheets and are reported separately in the Separate Accounts section below as gains and losses related to these assets generally accrue directly to contractholders:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal government and agency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;297&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,421&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;435&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,856&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Mortgage and other asset-backed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;309&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;344&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,288&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;470&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9,909&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;84&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Excludes certain equity securities that have no readily determinable fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4c40a4ac7f2a434f87a71b9ba541fbed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtMi0xLTEtNTQ3MDk4_720567ef-8d69-433c-8e04-ce04abdf2004"
      unitRef="usd">151000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic52a72b46e934d71b88725042436b309_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtNC0xLTEtNTQ3MDk4_e91a24ad-c6de-4802-895c-bb891c96895d"
      unitRef="usd">147000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if4088ab619834175a08deb5b39beb15b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtNi0xLTEtNTQ3MDk4_be7e1c47-b4c0-47bf-a811-33d68128c853"
      unitRef="usd">146000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2f13ab64129a4c8fb094e735383237e5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtOC0xLTEtNTQ3MDk4_00111b66-cb63-4804-8d58-a40f0f5e2eb0"
      unitRef="usd">165000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id9f8a274704049218d1ef098ed77fc12_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtMTAtMS0xLTU0NzA5OA_d292ea63-8fa0-4105-a952-cb2479b246eb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9a01ce3605c34a9aa36f20dfda34e4fb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtMTItMS0xLTU0NzA5OA_844e6820-b9d1-4509-9ac4-c34f1430ce3a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i77341c9a2ae245cc8c56080a14bfe2ae_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtMTQtMS0xLTU0NzA5OA_805ac004-3350-42af-bb68-af5e751ebd3b"
      unitRef="usd">297000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib0cce95292e14776a7278f0e33003cdf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzQtMTYtMS0xLTU0NzA5OA_bcf9c68e-b0b8-43f0-b2b4-6008de5f78f3"
      unitRef="usd">312000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia07ed9d3c52b404e94ba85d570434570_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtMi0xLTEtNTQ3MDk4_eb88192d-d5df-4984-9930-149561837bc8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i73b62bf7014e45babcc9a18ea1226d9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtNC0xLTEtNTQ3MDk4_c3888377-e998-4cde-b8bd-bf5bf9f0488a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i032a4c4c66d44f95966d06b499946c31_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtNi0xLTEtNTQ3MDk4_1ce80063-9513-4210-aae5-0c7c6d160bb0"
      unitRef="usd">41000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i989ef71163ae4e9c8eaafced6a9b1a25_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtOC0xLTEtNTQ3MDk4_b7e9bd09-53be-4b35-a4c0-86cf9c6ae1ae"
      unitRef="usd">41000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i930d264a52e74abd92fd6023e6324ee9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtMTAtMS0xLTU0NzA5OA_63cc2628-73ec-45a3-bb90-ae1f32ef63e7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i950a2d2b127a4b9581697e8ffc5a5f06_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtMTItMS0xLTU0NzA5OA_2ae5e9e0-10c8-4cd4-9b01-44e15a51ce8e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5cf66280f27c4cdab8de0ed3b972cd3f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtMTQtMS0xLTU0NzA5OA_f7959288-a2fe-44d6-800e-60f25384982e"
      unitRef="usd">41000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8d4d88313bd744c9b9bfe00dc4beadb1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzUtMTYtMS0xLTU0NzA5OA_abbeed49-fc30-4543-b2c9-e69f7ac2e4d6"
      unitRef="usd">41000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6458608672034857ab59db70911f8c1c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtMi0xLTEtNTQ3MDk4_4891a336-d365-40f7-99bc-bb64077b1207"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie93c0af573094af9b33586116b3a5681_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtNC0xLTEtNTQ3MDk4_8107ee8e-e7f1-440a-a42e-f04846353516"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic7c3e6ee73bb44aaaf1dc02c1f8d9b9e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtNi0xLTEtNTQ3MDk4_7fed1ac3-206e-48d2-85e8-242d62eddfa5"
      unitRef="usd">371000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i126d653bef214cb5a2293e321a3c6a1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtOC0xLTEtNTQ3MDk4_4076e15e-65e3-452b-85a5-2ee126bcf40e"
      unitRef="usd">365000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0c23114e19414957ab7bf2b512b8032d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtMTAtMS0xLTU0NzA5OA_e5c7ed87-41d0-4831-b981-2b345fa4df0d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i911bced2d64f49388c06235bcf671712_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtMTItMS0xLTU0NzA5OA_358ca9a6-6230-4051-98e9-c7955cedd96c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i210b492f12ea4598b3c1eaa7fe5053a9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtMTQtMS0xLTU0NzA5OA_90ccbc6a-508e-47f3-a99a-75f8222e3638"
      unitRef="usd">371000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8b60856ce8d24fbba0e9bdc9e6c8e8c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzYtMTYtMS0xLTU0NzA5OA_298a1443-0436-422b-ab0f-b3ace1cec580"
      unitRef="usd">365000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9589c2b720554541a51b62fcbedfa89c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctMi0xLTEtNTQ3MDk4_a5f725f0-3fbe-4ce5-9394-61dd02b6cd3c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i98bf5cf8552e4f3f93ab9849ef07ea23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctNC0xLTEtNTQ3MDk4_6ea4a1b0-0a56-497f-8aa5-3479edeb825a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0f40ed4344194d4fa94fd6bc5ff74a0f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctNi0xLTEtNTQ3MDk4_3cfa783e-1e4d-4cfb-9208-f0d87c4feedd"
      unitRef="usd">8421000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ade3d59c3b74f71a757f3ce93ec3fe0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctOC0xLTEtNTQ3MDk4_44e2b644-4aa9-466e-a31c-3f93ec1070ac"
      unitRef="usd">8394000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic1d1efad88f74a06b2f78f6f4a608383_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctMTAtMS0xLTU0NzA5OA_d320b76e-5cb8-48c6-b13e-82a59c7eb780"
      unitRef="usd">435000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7b20e60e442842d383d58e1005c97d30_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctMTItMS0xLTU0NzA5OA_8f6a2645-89a3-45aa-a5a2-b66993bd384f"
      unitRef="usd">412000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibe9c93b5d23348ed9f2d2524fee1a2f6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctMTQtMS0xLTU0NzA5OA_bbefb5d1-848d-4bd6-82db-76d96dfa1c3b"
      unitRef="usd">8856000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibabd51e3f7364ae0a5c3a97072265a04_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzctMTYtMS0xLTU0NzA5OA_8e389d14-046c-4daa-8891-141af7994484"
      unitRef="usd">8806000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id300a0f63845475da13c0c4f8959c18c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtMi0xLTEtNTQ3MDk4_efb3de96-368a-4c7b-8ca8-0dcf012a1a62"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iedcadbdbe30c4f6e8eb2478149ef29e7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtNC0xLTEtNTQ3MDk4_3c2b54f9-459e-412a-a844-27160d216f49"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i496ceb12f2c94b9b995de6a325274988_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtNi0xLTEtNTQ3MDk4_8ad91c71-b90b-4b38-a663-e985a5df68d4"
      unitRef="usd">309000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0e6aa69b6ac14548852cbc0cb1dd129c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtOC0xLTEtNTQ3MDk4_4b247109-ad77-48bc-b912-7b33063ec394"
      unitRef="usd">313000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1b18e9f370634eaca75f7ac03fc42ec6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtMTAtMS0xLTU0NzA5OA_49da9ead-e5fa-4ff3-ae58-fd571b598c98"
      unitRef="usd">35000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i122d51c6af904c34830a2d18ee8b3883_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtMTItMS0xLTU0NzA5OA_7771a70d-b86b-4051-801b-e043de0d2190"
      unitRef="usd">35000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7ea52ae05bad4666b5128b751245b170_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtMTQtMS0xLTU0NzA5OA_6ba109b5-d9eb-4c63-9e2a-315e7a81f799"
      unitRef="usd">344000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i87b7744b55da48babac0660b53c793fc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzgtMTYtMS0xLTU0NzA5OA_e18fcd42-9ef9-46b4-aaa4-e5b97bd955d1"
      unitRef="usd">348000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i407a2545ce8c476abfbe4489ad433944_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktMi0xLTEtNTQ3MDk4_fbd7089d-3dfb-41f2-a14e-bde6945ed30c"
      unitRef="usd">151000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i635a05614dc44dfaa59bf4c4b0677a6c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktNC0xLTEtNTQ3MDk4_f8053c8c-0b3b-44b0-86f7-430beb833ee9"
      unitRef="usd">147000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8480eea330a24711916d476ea14fc9ff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktNi0xLTEtNTQ3MDk4_60cba6fb-f96d-45ba-8905-f555d1bf6023"
      unitRef="usd">9288000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i362c06fa9cc443e7bd73051dc42cbaca_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktOC0xLTEtNTQ3MDk4_bd6dedba-42a9-4354-918c-1b8872be4c08"
      unitRef="usd">9278000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ife2fcb28e086422c8dc4e953d482abc9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktMTAtMS0xLTU0NzA5OA_30daa583-cc3c-414f-8449-98cf7332b3c0"
      unitRef="usd">470000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2522a8f54759495caa0225401ceef646_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktMTItMS0xLTU0NzA5OA_e34445b3-1e19-468c-81d7-e4c81a2d2395"
      unitRef="usd">447000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i346d7b1c76574be19f46677e85e8c5b1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktMTQtMS0xLTU0NzA5OA_130bbc4a-3dac-4200-8e46-d9fa72d86997"
      unitRef="usd">9909000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1008fa627a0f446c963b0e67d8dfd067_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzktMTYtMS0xLTU0NzA5OA_1097e69d-442d-47fe-902f-95da2117de17"
      unitRef="usd">9872000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i407a2545ce8c476abfbe4489ad433944_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTItMS0xLTU0NzA5OA_c5b470b4-0fa4-4aa5-bc2f-89e5883a6cab"
      unitRef="usd">6000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i635a05614dc44dfaa59bf4c4b0677a6c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTQtMS0xLTU0NzA5OA_fc0de268-ebeb-4cb8-aa6a-fb5c40aed005"
      unitRef="usd">6000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i8480eea330a24711916d476ea14fc9ff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTYtMS0xLTU0NzA5OA_af465a58-cbed-4ea1-b107-40a1db0e2083"
      unitRef="usd">84000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i362c06fa9cc443e7bd73051dc42cbaca_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTgtMS0xLTU0NzA5OA_7b2fe36b-4751-4709-aa92-07262a47aebd"
      unitRef="usd">132000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="ife2fcb28e086422c8dc4e953d482abc9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTEwLTEtMS01NDcwOTg_407e1720-7ea0-4b5a-bfdd-0fe45021ae7d"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i2522a8f54759495caa0225401ceef646_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTEyLTEtMS01NDcwOTg_88e5d2fd-2463-4e43-b8d7-2ced63323c39"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i346d7b1c76574be19f46677e85e8c5b1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTE0LTEtMS01NDcwOTg_67b7b726-3862-4913-9ab2-fd4a7de079ae"
      unitRef="usd">91000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i1008fa627a0f446c963b0e67d8dfd067_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEwLTE2LTEtMS01NDcwOTg_526cc767-0c3e-4fa3-ab99-48c59bc4378d"
      unitRef="usd">138000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:OtherShortTermInvestments
      contextRef="i407a2545ce8c476abfbe4489ad433944_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTItMS0xLTU0NzA5OA_a6278a64-52f7-4867-b202-895d3d7d019f"
      unitRef="usd">0</us-gaap:OtherShortTermInvestments>
    <us-gaap:OtherShortTermInvestments
      contextRef="i635a05614dc44dfaa59bf4c4b0677a6c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTQtMS0xLTU0NzA5OA_7eea4608-61a2-4b55-a211-36a8d90c9886"
      unitRef="usd">0</us-gaap:OtherShortTermInvestments>
    <us-gaap:OtherShortTermInvestments
      contextRef="i8480eea330a24711916d476ea14fc9ff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTYtMS0xLTU0NzA5OA_69c8c56c-c40c-4216-bec5-f6525ef429ee"
      unitRef="usd">141000000</us-gaap:OtherShortTermInvestments>
    <us-gaap:OtherShortTermInvestments
      contextRef="i362c06fa9cc443e7bd73051dc42cbaca_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTgtMS0xLTU0NzA5OA_1e5338c4-8a6c-44d1-8352-c2245a14a499"
      unitRef="usd">139000000</us-gaap:OtherShortTermInvestments>
    <us-gaap:OtherShortTermInvestments
      contextRef="ife2fcb28e086422c8dc4e953d482abc9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTEwLTEtMS01NDcwOTg_e3921493-53f7-47c1-a2fd-5e161b2531cc"
      unitRef="usd">0</us-gaap:OtherShortTermInvestments>
    <us-gaap:OtherShortTermInvestments
      contextRef="i2522a8f54759495caa0225401ceef646_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTEyLTEtMS01NDcwOTg_11d5af50-4b21-47f8-9915-6ba1ba9f4a2f"
      unitRef="usd">0</us-gaap:OtherShortTermInvestments>
    <us-gaap:OtherShortTermInvestments
      contextRef="i346d7b1c76574be19f46677e85e8c5b1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTE0LTEtMS01NDcwOTg_1a2882b8-7740-40cf-9bce-14572cda6be0"
      unitRef="usd">141000000</us-gaap:OtherShortTermInvestments>
    <us-gaap:OtherShortTermInvestments
      contextRef="i1008fa627a0f446c963b0e67d8dfd067_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzExLTE2LTEtMS01NDcwOTg_1a1d1dbd-84db-4fd7-9fc2-8c2538849e1a"
      unitRef="usd">139000000</us-gaap:OtherShortTermInvestments>
    <us-gaap:DerivativeAssets
      contextRef="i0d801185130948b6b2dfb025cf2c9afe_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTItMS0xLTU0NzA5OA_5b814c43-166d-4d81-bf7b-35dc8c9a9ee5"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i2172b84fcfbb48169b1cf9a8c8d71a74_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTQtMS0xLTU0NzA5OA_75d7cc04-56b9-493a-a27b-f5507a3294cc"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib9534d4bd0db4a8cb06ac21b74224b43_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTYtMS0xLTU0NzA5OA_8d2b7f24-50cc-4347-851c-01aa36cfe34c"
      unitRef="usd">206000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i173890bd1b474d3198c5dfb300324f59_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTgtMS0xLTU0NzA5OA_4ac88ab9-a76d-4c64-b937-d1368cc71083"
      unitRef="usd">230000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ic61449fd99784439939f74a26e23b495_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTEwLTEtMS01NDcwOTg_cbe0412c-4931-43e0-9cbf-d97914478e94"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i65136b8ff46f4dcdace35ad210e68997_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTEyLTEtMS01NDcwOTg_3465660e-e3c7-4941-9b63-92959fa69356"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ibf1f04ddb0f54df990cf80a00f7696af_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTE0LTEtMS01NDcwOTg_bff0cfb3-1b3a-46d5-89c8-fdc34d874d16"
      unitRef="usd">207000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="if04209b927ad49a5ba1f009ea469bf3a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NDUvZnJhZzpiZGJlMjNiYWM1NGM0MzlkYWJhNWZmZDQ0M2Y0NDZmOS90YWJsZTo5YzhhOTc1OTA3NzY0NWEyOWU3N2Q1ZDVmY2RkZTVkZS90YWJsZXJhbmdlOjljOGE5NzU5MDc3NjQ1YTI5ZTc3ZDVkNWZjZGRlNWRlXzEyLTE2LTEtMS01NDcwOTg_44e9c5ef-538f-4403-b4ac-ea84a5483e35"
      unitRef="usd">231000000</us-gaap:DerivativeAssets>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90ZXh0cmVnaW9uOjBjNjM1MmIzZjQxZDQ5Yzc5ZjQ3YjNhMGI4MGJmOTkwXzkyNQ_5da13032-859f-40ef-88bf-36716db071ed">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the fair value and significant unobservable inputs that were developed directly by the Company and used in pricing these debt securities. The range and weighted average basis point ("bps") amounts for liquidity reflect the Company's best estimates of the unobservable adjustments a market participant would make to calculate these fair values. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable Adjustment Range (Weighted Average by Quantity) as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Fair value in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable input March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate and government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;433&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liquidity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;60 - 1060 (300)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;bps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60 - 1060 (270)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;bps&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Mortgage and other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liquidity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;105 - 520 (310) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;bps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;110 - 520 (310)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;bps&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Level 3 debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;470&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:MarketableSecurities
      contextRef="i2b42664d2d054b1cb8a6a20eb860282a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtMi0xLTEtNTQ3MDk4_5f7f25d4-5d10-427b-8e8e-1a8ef5dce2ca"
      unitRef="usd">433000000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="ic382cb79965348f7b830702205a70233_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtNC0xLTEtNTQ3MDk4_088c1e20-dcd9-42dd-90ac-58259b59d752"
      unitRef="usd">412000000</us-gaap:MarketableSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput
      contextRef="ia299f05a1244456c8e2a637925cd98ee_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246NDliZGI5MGY1NGZhNDgxYzlmNmMyYTZmOTgwMmEwYTdfNA_2062f6d7-7c75-47b4-a3f1-7779f775c6f9"
      unitRef="number">0.0060</us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput>
    <us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput
      contextRef="i5d3981d68ffb4ab1bb2f4ebea953bca7_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246NDliZGI5MGY1NGZhNDgxYzlmNmMyYTZmOTgwMmEwYTdfOQ_54d78ebb-3001-4b99-9fc2-3cbb76224448"
      unitRef="number">0.1060</us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput>
    <us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput
      contextRef="i220f8c95ac454213bbf6528472654e1f_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246NDliZGI5MGY1NGZhNDgxYzlmNmMyYTZmOTgwMmEwYTdfMTM_d84ff22c-76db-4b5e-9baa-0e503af650ae"
      unitRef="number">0.0300</us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput>
    <us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput
      contextRef="i777f12cc915c480f8486fbf1ff5fb6c4_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdmMzRlZjAzMjllZDRjMzRiYjI0ZDAxMGViZWRjMWJjXzQ_845a6f11-2b07-43b8-bdf5-f8b00c8f9363"
      unitRef="number">0.0060</us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput>
    <us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput
      contextRef="ibe8a9caf5fe04d33a35af66b6ea9dad3_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdmMzRlZjAzMjllZDRjMzRiYjI0ZDAxMGViZWRjMWJjXzk_3cfac65f-cd88-4d0d-8250-d36bae7c112b"
      unitRef="number">0.1060</us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput>
    <us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput
      contextRef="ic24dc2bb53ce4ae88734117cb7dae442_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzMtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdmMzRlZjAzMjllZDRjMzRiYjI0ZDAxMGViZWRjMWJjXzEz_5f8f05b9-ef3d-477d-b39a-0b2f96fdfb01"
      unitRef="number">0.0270</us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput>
    <us-gaap:MarketableSecurities
      contextRef="i545e52d4ab804995a43a6de0a3f9451d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtMi0xLTEtNTQ3MDk4_418066e8-7bf7-44fa-be18-424f8fbaa62c"
      unitRef="usd">35000000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="id68863ce55b24c80abd273a20e11d928_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtNC0xLTEtNTQ3MDk4_cb9c862a-0447-4423-b887-b6d31a612144"
      unitRef="usd">35000000</us-gaap:MarketableSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput
      contextRef="id54e9025aabe47faba625607f255ae82_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246MmVhM2E2MTk2MGZmNDAyMzhmOTRjNDM1NGQyMGZkMmRfNA_d5994148-7766-40c7-9a7e-d26dd15324aa"
      unitRef="number">0.0105</us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput>
    <us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput
      contextRef="i522b8ff4b68a4b3b83655840fe0d0999_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246MmVhM2E2MTk2MGZmNDAyMzhmOTRjNDM1NGQyMGZkMmRfOQ_8796ca2e-0184-41e0-b58f-f36ef70317f2"
      unitRef="number">0.0520</us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput>
    <us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput
      contextRef="i603fe8aa57f54159aa3dd133fca86c4d_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtOC0xLTEtNTQ3MDk4L3RleHRyZWdpb246MmVhM2E2MTk2MGZmNDAyMzhmOTRjNDM1NGQyMGZkMmRfMTM_e28fdc1f-bd0d-41b9-a87f-8155b1240e10"
      unitRef="number">0.0310</us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput>
    <us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput
      contextRef="i4564af3a4a1e4f07bd83540908642eeb_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjU1ZTgwOGE4NTEzYTRjOWI5ZTgyMTQ0NmY3MWYyNDI3XzQ_8d170cb2-6244-4946-9a8e-26c6e29021d3"
      unitRef="number">0.0110</us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput>
    <us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput
      contextRef="ibc819642d63d44d7812cdbbde998e471_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjU1ZTgwOGE4NTEzYTRjOWI5ZTgyMTQ0NmY3MWYyNDI3Xzk_8be7d993-b33f-44fa-bce1-da41c5a731bb"
      unitRef="number">0.0520</us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput>
    <us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput
      contextRef="iac58c114e37e4838bf9723da6c4ec12f_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzQtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjU1ZTgwOGE4NTEzYTRjOWI5ZTgyMTQ0NmY3MWYyNDI3XzEz_4eaa639d-2235-4b6f-9aac-12281562c878"
      unitRef="number">0.0310</us-gaap:DebtSecuritiesAvailableForSaleMeasurementInput>
    <us-gaap:MarketableSecurities
      contextRef="ie20fd12fb4e5463baaf5a977f3780fb8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzUtMi0xLTEtNTQ3MDk4_e73f209b-571c-4d23-9b3a-0b05c973f54b"
      unitRef="usd">2000000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i233fdf4af61947d7882a46454c266f5e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzUtNC0xLTEtNTQ3MDk4_614ab2f3-327d-4998-b767-9c6ba76b628a"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="ib2a7a90ae1f548208c8ec8f1cbcbb9c3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzYtMi0xLTEtNTQ3MDk4_981c3841-4d3a-4484-8931-b4c747ad4568"
      unitRef="usd">470000000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i94d1343670dd4e47affa7005b7f60ff6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NTcvZnJhZzowYzYzNTJiM2Y0MWQ0OWM3OWY0N2IzYTBiODBiZjk5MC90YWJsZTo3NjRjMTYxNTdmODA0OTdiOTIzZGFkYzViOTU2NjViNy90YWJsZXJhbmdlOjc2NGMxNjE1N2Y4MDQ5N2I5MjNkYWRjNWI5NTY2NWI3XzYtNC0xLTEtNTQ3MDk4_d342004a-cebd-4963-beee-06343bf36108"
      unitRef="usd">447000000</us-gaap:MarketableSecurities>
    <ci:FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90ZXh0cmVnaW9uOmZmMGY1M2JmZTc3MDQyMWM5NjY0ODc1OTdiYmNmMDY5XzE1MTM_fd594dd6-74e1-4ddf-aa8b-358a46525104">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the changes in financial assets and financial liabilities classified in Level 3. Gains and losses reported in the table may include net changes in fair value that are attributable to both observable and unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt and Equity Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gains included in Shareholders' net income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gains (losses) included in Other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Losses required to adjust future policy benefits for settlement annuities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transfers into/(out of) Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total transfers into/(out of) Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total gains included in Shareholders' net income attributable to instruments held at the reporting date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in unrealized gain or (loss) included in Other comprehensive loss for assets held at the end of the reporting period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Amounts do not accrue to shareholders.&lt;/span&gt;&lt;/div&gt;</ci:FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ib6207da178a44fb3864bb680dfb0bea3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzQtNi0xLTEtNTQ3MDk4_c00062e1-eba0-4b1a-b569-a3999f8015c5"
      unitRef="usd">447000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale
      contextRef="i64364361359847419628a63147bdad2e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzQtOC0xLTEtNTQ3MDk4_1bf0ab73-2f3c-49b9-a529-3a933a6c024c"
      unitRef="usd">796000000</ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzUtNi0xLTEtNTQ3MDk4_99afbcf7-de5d-4e02-955f-fa18555c91c1"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzUtOC0xLTEtNTQ3MDk4_08f767a0-878c-46af-913e-9c13a5a706e0"
      unitRef="usd">12000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzYtNi0xLTEtNTQ3MDk4_d67aae4a-8996-4eab-b30e-13028877d2fb"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzYtOC0xLTEtNTQ3MDk4_2f08495c-129d-41cb-baaf-4b1208330c70"
      unitRef="usd">-15000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits
      contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzctNi0xLTEtNTQ3MDk4_7268fcd5-722c-45ca-9afd-a619f013325b"
      unitRef="usd">0</ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits>
    <ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits
      contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzctOC0xLTEtNTQ3MDk4_e295daa8-df03-4036-8829-6b3d7b2a1032"
      unitRef="usd">-12000000</ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzktNi0xLTEtNTQ3MDk4_6d639c39-e694-4a17-97c8-781e7fb7dbca"
      unitRef="usd">4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzktOC0xLTEtNTQ3MDk4_f105af1a-004d-41d3-b31c-28fb0b35fdc3"
      unitRef="usd">49000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzExLTYtMS0xLTU0NzA5OA_e9e45fa9-96a5-4831-a403-74c97477461b"
      unitRef="usd">9000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzExLTgtMS0xLTU0NzA5OA_8ba87b2d-7738-420d-ae8b-7f4afd644051"
      unitRef="usd">81000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements
      contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzEyLTYtMS0xLTU0NzA5OA_ecb8236a-6a33-4d9a-8c36-e633880b6dfd"
      unitRef="usd">-5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements
      contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzEyLTgtMS0xLTU0NzA5OA_2b8bdc83-d1ba-4d89-863a-cb36c653e7e4"
      unitRef="usd">-32000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE0LTYtMS0xLTU0NzA5OA_fa49dfbe-7ed2-49c8-8244-38ce4d6cc2a5"
      unitRef="usd">39000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE0LTgtMS0xLTU0NzA5OA_ec260379-07d4-4267-8aa6-4b9453b4639c"
      unitRef="usd">101000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE1LTYtMS0xLTU0NzA5OA_d0eeecac-bfd5-46e3-b1c0-2ecd1421723d"
      unitRef="usd">16000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE1LTgtMS0xLTU0NzA5OA_495bcfd8-bc46-4eb8-8ce3-4bbb92535b26"
      unitRef="usd">164000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE2LTYtMS0xLTU0NzA5OA_5ac2f7dd-1b16-4701-89ee-6cfce9f6649b"
      unitRef="usd">23000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE2LTgtMS0xLTU0NzA5OA_0c06bede-006e-47a6-a2e2-9045c765892a"
      unitRef="usd">-63000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i22c741b1ef01438c9bc0c95b9bc802d8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE3LTYtMS0xLTU0NzA5OA_e2cb9756-2254-4d25-8e53-cf6e86eedd8a"
      unitRef="usd">471000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale
      contextRef="i2b4e0a32ed2947fcac341851c89b111c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE3LTgtMS0xLTU0NzA5OA_e17cf2fb-7ad0-4559-a13a-51b2ad7e3c38"
      unitRef="usd">686000000</ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale>
    <ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings
      contextRef="i82014af0ad374636b93c8f5e7e8cd7c0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE4LTYtMS0xLTU0NzA5OA_f485e901-b808-42a0-b220-908f3822c007"
      unitRef="usd">1000000</ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings>
    <ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings
      contextRef="i1e0baf3f11044e2b92a5268fd1d22ca8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE4LTgtMS0xLTU0NzA5OA_d32b6f71-ab55-48a4-93ec-8f78a00739a4"
      unitRef="usd">0</ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings>
    <ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE5LTYtMS0xLTU0NzA5OA_ce9b89ed-f202-4772-9c80-09669593cb84"
      unitRef="usd">5000000</ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss>
    <ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjAvZnJhZzpmZjBmNTNiZmU3NzA0MjFjOTY2NDg3NTk3YmJjZjA2OS90YWJsZTo5ZDMyNTdkN2RkM2Q0ZDE3YTI1OTFjN2I2MTlhYjNmOS90YWJsZXJhbmdlOjlkMzI1N2Q3ZGQzZDRkMTdhMjU5MWM3YjYxOWFiM2Y5XzE5LTgtMS0xLTU0NzA5OA_07e05165-d88b-4abe-87e6-c71d2cb02a30"
      unitRef="usd">-13000000</ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:PolicyholderAccountsPolicy
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjMvZnJhZzowZDAyNjI3Y2YxYzY0YzUxYmQ5MWM0ZmUyMjE0MmEwMS90ZXh0cmVnaW9uOjBkMDI2MjdjZjFjNjRjNTFiZDkxYzRmZTIyMTQyYTAxXzI2NQ_d0de532e-a47d-4fca-8948-1b0095e8857c">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The investment income and fair value gains and losses of Separate account assets generally accrue directly to the contractholders and, together with their deposits and withdrawals, are excluded from the Company's Consolidated Statements of Income and Cash Flows. &lt;/span&gt;&lt;/div&gt;Separate account assets classified in Level 3 primarily support the Company's pension plans and include certain newly-issued, privately-placed, complex or illiquid securities that are priced using methods discussed above, as well as commercial mortgage loans. Separate account investments in securities partnerships, real estate and hedge funds are generally valued based on the separate account's ownership share of the equity of the investee (NAV as a practical expedient), including changes in the fair values of its underlying investments</us-gaap:PolicyholderAccountsPolicy>
    <ci:FairValueOfSeparateAccountAssetsTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90ZXh0cmVnaW9uOjlkY2FiM2I0MDg5OTQwYWFhNGI4NjdmYmEyMzRhNDczXzM3NQ_bd9f3775-a10e-49df-bea2-a1f739144ceb">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Fair values of Separate account assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Guaranteed separate accounts (See Note 16)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;562&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-guaranteed separate accounts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;221&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,586&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;434&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,935&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6,582&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-guaranteed separate accounts priced at net asset value ("NAV") as a practical expedient &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;758&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,340&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Non-guaranteed separate accounts include $4.0 billion as of March&#160;31, 2023 and December&#160;31, 2022 in assets supporting the Company's pension plans, including $0.2 billion classified in Level 3 as of March&#160;31, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</ci:FairValueOfSeparateAccountAssetsTableTextBlock>
    <ci:GuaranteedSeparateAccountAssets
      contextRef="ib60c510aad1f4274b05705d4451bb34a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItMi0xLTEtNTQ3MDk4_fefd9e7e-946b-4d2a-99d1-bb6dad5a660c"
      unitRef="usd">213000000</ci:GuaranteedSeparateAccountAssets>
    <ci:GuaranteedSeparateAccountAssets
      contextRef="i58dc13e2e83f45fd86f4fa7e2de05b1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItNC0xLTEtNTQ3MDk4_83eb9ad3-12e6-41ae-ad35-08532755ff61"
      unitRef="usd">203000000</ci:GuaranteedSeparateAccountAssets>
    <ci:GuaranteedSeparateAccountAssets
      contextRef="if6b20b8ea802488fb1423cffdd53e8f6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItNi0xLTEtNTQ3MDk4_3e1d2466-e594-42d2-b96d-750c3f4e1977"
      unitRef="usd">349000000</ci:GuaranteedSeparateAccountAssets>
    <ci:GuaranteedSeparateAccountAssets
      contextRef="ica72812ec3684d749901011e62b0851b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItOC0xLTEtNTQ3MDk4_d8976336-c890-456a-bf47-50040b114047"
      unitRef="usd">382000000</ci:GuaranteedSeparateAccountAssets>
    <ci:GuaranteedSeparateAccountAssets
      contextRef="i1f62a525c9374ed5aa1cf92ab9b8c5e1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItMTAtMS0xLTU0NzA5OA_497e4bee-39fb-416c-9d8f-d15a1217710e"
      unitRef="usd">0</ci:GuaranteedSeparateAccountAssets>
    <ci:GuaranteedSeparateAccountAssets
      contextRef="i99d6d20ebb17402f979ebdb5a3daba9c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItMTItMS0xLTU0NzA5OA_67bf52fe-36e5-4992-99d7-c7772dd7af4a"
      unitRef="usd">0</ci:GuaranteedSeparateAccountAssets>
    <ci:GuaranteedSeparateAccountAssets
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItMTQtMS0xLTU0NzA5OA_e07a7ce9-a68b-4c4e-ae0c-c1c7611044fe"
      unitRef="usd">562000000</ci:GuaranteedSeparateAccountAssets>
    <ci:GuaranteedSeparateAccountAssets
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzItMTYtMS0xLTU0NzA5OA_1552a73b-9a75-4250-9002-7afc6a74db95"
      unitRef="usd">585000000</ci:GuaranteedSeparateAccountAssets>
    <ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="ib60c510aad1f4274b05705d4451bb34a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtMi0xLTEtNTQ3MDk4_699e3d4d-f376-4264-af92-9ab9ac829b72"
      unitRef="usd">221000000</ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="i58dc13e2e83f45fd86f4fa7e2de05b1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtNC0xLTEtNTQ3MDk4_1b57f86f-dc7a-4f90-869b-d38db1c5301e"
      unitRef="usd">211000000</ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="if6b20b8ea802488fb1423cffdd53e8f6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtNi0xLTEtNTQ3MDk4_c3975889-9786-4c21-971b-f59549a5a820"
      unitRef="usd">5586000000</ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="ica72812ec3684d749901011e62b0851b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtOC0xLTEtNTQ3MDk4_291a6fec-1419-4fea-b585-a33987ce1beb"
      unitRef="usd">5522000000</ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="i1f62a525c9374ed5aa1cf92ab9b8c5e1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtMTAtMS0xLTU0NzA5OA_ab16422f-f094-473e-9040-087cac3149d5"
      unitRef="usd">213000000</ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="i99d6d20ebb17402f979ebdb5a3daba9c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtMTItMS0xLTU0NzA5OA_005b669d-7a64-4b7b-a0ff-9fb303d09699"
      unitRef="usd">203000000</ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtMTQtMS0xLTU0NzA5OA_2492bbea-86ee-4f7b-84ab-1a08b4724c97"
      unitRef="usd">6020000000</ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzMtMTYtMS0xLTU0NzA5OA_06a6e91e-e600-476d-994f-ea73d358dc44"
      unitRef="usd">5936000000</ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:SeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="ib60c510aad1f4274b05705d4451bb34a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtMi0xLTEtNTQ3MDk4_5cbf063a-4da9-4f57-b79f-ac6c39ca31b4"
      unitRef="usd">434000000</ci:SeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:SeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="i58dc13e2e83f45fd86f4fa7e2de05b1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtNC0xLTEtNTQ3MDk4_ac54e08c-9386-45a4-a45f-0da43d1236f5"
      unitRef="usd">414000000</ci:SeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:SeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="if6b20b8ea802488fb1423cffdd53e8f6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtNi0xLTEtNTQ3MDk4_14a0b87e-5c16-42c4-b0e7-7b15a8853902"
      unitRef="usd">5935000000</ci:SeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:SeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="ica72812ec3684d749901011e62b0851b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtOC0xLTEtNTQ3MDk4_9ffdf85d-ac9a-4586-acc7-6a1a56826504"
      unitRef="usd">5904000000</ci:SeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:SeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="i1f62a525c9374ed5aa1cf92ab9b8c5e1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtMTAtMS0xLTU0NzA5OA_00ebda4a-af61-48b5-8eb8-e2f1c8765dac"
      unitRef="usd">213000000</ci:SeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:SeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="i99d6d20ebb17402f979ebdb5a3daba9c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtMTItMS0xLTU0NzA5OA_102d6718-6325-4645-b2ba-dfca652a0cdc"
      unitRef="usd">203000000</ci:SeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:SeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtMTQtMS0xLTU0NzA5OA_45fbcc3e-c8c3-4862-a177-35a833ce4be7"
      unitRef="usd">6582000000</ci:SeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:SeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzQtMTYtMS0xLTU0NzA5OA_300f9058-d5ac-4f44-890e-8ea16dec6382"
      unitRef="usd">6521000000</ci:SeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzUtMTQtMS0xLTU0NzA5OA_5434c142-fb5f-444c-b9be-83ab9cff554c"
      unitRef="usd">758000000</ci:NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient>
    <ci:NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzUtMTYtMS0xLTU0NzA5OA_6dafc12d-97ef-40b4-ab44-8a40a1b3d831"
      unitRef="usd">757000000</ci:NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient>
    <us-gaap:SeparateAccountAssets
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzYtMTQtMS0xLTYxODMxNg_4ebe8533-685c-484e-9b12-30dfa74d6e7f"
      unitRef="usd">7340000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia5c9a21a47954ed3bf7ede8a2133682a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90YWJsZTpjMmZjOTQwNzM1ZWE0OTYwYjAzYzkwOGQzODRkMGIzOC90YWJsZXJhbmdlOmMyZmM5NDA3MzVlYTQ5NjBiMDNjOTA4ZDM4NGQwYjM4XzYtMTYtMS0xLTU0NzA5OA_29825374-4dbd-4494-be07-1dab449077eb"
      unitRef="usd">7278000000</us-gaap:SeparateAccountAssets>
    <ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="i14917100852d4b948ca51e874a6b0212_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90ZXh0cmVnaW9uOjlkY2FiM2I0MDg5OTQwYWFhNGI4NjdmYmEyMzRhNDczXzg3_9511c22c-c5dc-42c4-a945-1b53db533586"
      unitRef="usd">4000000000</ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="i34c7bd2940204fe29e4f3ff5202d63eb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90ZXh0cmVnaW9uOjlkY2FiM2I0MDg5OTQwYWFhNGI4NjdmYmEyMzRhNDczXzg3_e2ed9c5a-d0cc-47b2-91f8-9615573413ed"
      unitRef="usd">4000000000</ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="i0e61a85231a745cf8f18edb83018a703_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90ZXh0cmVnaW9uOjlkY2FiM2I0MDg5OTQwYWFhNGI4NjdmYmEyMzRhNDczXzE3NQ_34a2dde7-cd1c-410f-8dc0-78be9d929a7e"
      unitRef="usd">200000000</ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy>
    <ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
      contextRef="i495afe57b9e945e19224d443146762a4_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NjkvZnJhZzo5ZGNhYjNiNDA4OTk0MGFhYTRiODY3ZmJhMjM0YTQ3My90ZXh0cmVnaW9uOjlkY2FiM2I0MDg5OTQwYWFhNGI4NjdmYmEyMzRhNDczXzE3NQ_ee67379b-f07d-40c9-8199-6564d412dbc5"
      unitRef="usd">200000000</ci:NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy>
    <us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90ZXh0cmVnaW9uOjUxMTBhNGFiODQyYzQ2YmFhY2ZmYjgxMjkwNDliM2Q1XzEwNjg_2bca64a9-d6dd-4d29-a17f-f2051d39e98d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Separate account investments in securities partnerships, real estate and hedge funds are generally valued based on the separate account's ownership share of the equity of the investee (NAV as a practical expedient), including changes in the fair values of its underlying investments. Substantially all of these assets support the Company's pension plans. The following table provides additional information on these investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unfunded Commitment as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Redemption Frequency&lt;br/&gt;(if currently eligible)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Redemption Notice&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Securities partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;228&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Not applicable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Not applicable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Real estate funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quarterly&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30 - 90 days&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedge funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Up to annually, varying by fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30 - 90 days&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;758&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;228&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock>
    <us-gaap:AlternativeInvestment
      contextRef="if62bb74d9f924edb9286be35b3c7f345_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzItMi0xLTEtNTQ3MDk4_b23848d9-78ef-474e-a893-a40754356cc1"
      unitRef="usd">467000000</us-gaap:AlternativeInvestment>
    <us-gaap:AlternativeInvestment
      contextRef="i364eea148f374c20a2f0c593046922d6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzItNC0xLTEtNTQ3MDk4_25a289da-dd02-4163-8b1a-79bd84682b78"
      unitRef="usd">451000000</us-gaap:AlternativeInvestment>
    <us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments
      contextRef="i94fa67011b4847c1abf1f21028ae49ec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzItNi0xLTEtNTQ3MDk4_db973636-4ef5-46be-974e-530c729295fb"
      unitRef="usd">228000000</us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments>
    <us-gaap:AlternativeInvestment
      contextRef="icff956d5fbf6434c977eea973ab12ba8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzMtMi0xLTEtNTQ3MDk4_75629eca-1f1c-4ebc-b03c-f97a61018d83"
      unitRef="usd">287000000</us-gaap:AlternativeInvestment>
    <us-gaap:AlternativeInvestment
      contextRef="i032c221bd5464f3fb6549e1bb245453c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzMtNC0xLTEtNTQ3MDk4_d315c56d-ad6b-46c7-a442-c71c7dade110"
      unitRef="usd">302000000</us-gaap:AlternativeInvestment>
    <us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments
      contextRef="i36aa4fc292e346ff9124e93f204c8bef_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzMtNi0xLTEtNTQ3MDk4_25d10118-3967-400e-98c4-42fbf16377ca"
      unitRef="usd">0</us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments>
    <us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1
      contextRef="ie1e80cb53c7b4030ad4a2f2374f1b4a4_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzMtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdkNGQxZmY3NmNkMDQwZjQ4NWZlNTkwYjlkODk1MjJkXzQ_0a04712d-7b32-4e90-9e9a-e6a920a33bea">P30D</us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1>
    <us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1
      contextRef="i54d622066b6642138a4374276ced4e96_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzMtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOjdkNGQxZmY3NmNkMDQwZjQ4NWZlNTkwYjlkODk1MjJkXzk_cf0dd07c-e09f-429e-8987-7a90a1406ea8">P90D</us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1>
    <us-gaap:AlternativeInvestment
      contextRef="i8cac1c831b434f6aa1415442992376c4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzQtMi0xLTEtNTQ3MDk4_54c32a27-70ac-4f74-8de3-afb99be30d46"
      unitRef="usd">4000000</us-gaap:AlternativeInvestment>
    <us-gaap:AlternativeInvestment
      contextRef="i8cde07c70a8d4809a5d5efd16dd587e7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzQtNC0xLTEtNTQ3MDk4_78b36e37-8aba-4017-8800-7dcebabbfb6b"
      unitRef="usd">4000000</us-gaap:AlternativeInvestment>
    <us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments
      contextRef="i1c58cb565aea4436b757679a195e2465_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzQtNi0xLTEtNTQ3MDk4_6f4c0d1c-8e0e-4e3c-a623-dbae502167a1"
      unitRef="usd">0</us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments>
    <us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1
      contextRef="ic830eb3995b34b459ed632cf6d7d18c9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzQtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmFlYzM3Njk4ZDMwOTQyZTFiYTc2MTU2NTgyNDMwYjYwXzQ_3cae52c7-6089-42ea-ba6c-cfc9782cc064">P30D</us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1>
    <us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1
      contextRef="i40c865978ae54de8924e8ce3f15cd96f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzQtMTAtMS0xLTU0NzA5OC90ZXh0cmVnaW9uOmFlYzM3Njk4ZDMwOTQyZTFiYTc2MTU2NTgyNDMwYjYwXzk_516fdf15-d21a-46b3-898b-6cda535af266">P90D</us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1>
    <us-gaap:AlternativeInvestment
      contextRef="i77f80db721434c238adc7b810844e85e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzUtMi0xLTEtNTQ3MDk4_cb456af3-67ba-4dc7-b712-ce2d54cf01af"
      unitRef="usd">758000000</us-gaap:AlternativeInvestment>
    <us-gaap:AlternativeInvestment
      contextRef="i7922415e72f84dc0925918d4db42294a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzUtNC0xLTEtNTQ3MDk4_b6c63e8c-d6c9-4aa4-bc62-6b75e81dba52"
      unitRef="usd">757000000</us-gaap:AlternativeInvestment>
    <us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments
      contextRef="i05431ad3c0184457a9136c2f15684621_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90YWJsZTo5NjVjN2IzMGNjNjk0MzNhODFkMTQ5NGJkNmE4YmE4MS90YWJsZXJhbmdlOjk2NWM3YjMwY2M2OTQzM2E4MWQxNDk0YmQ2YThiYTgxXzUtNi0xLTEtNTQ3MDk4_88934901-03f9-477f-9a35-f69994f9de8f"
      unitRef="usd">228000000</us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments>
    <ci:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception
      contextRef="ib508898f275f4a768acf67c63c4a4668_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83NzUvZnJhZzo1MTEwYTRhYjg0MmM0NmJhYWNmZmI4MTI5MDQ5YjNkNS90ZXh0cmVnaW9uOjUxMTBhNGFiODQyYzQ2YmFhY2ZmYjgxMjkwNDliM2Q1XzEwNDk_d3d81ae7-4092-4394-93c3-d7b24f5b95aa">P10Y</ci:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90ZXh0cmVnaW9uOmU0NWMxZGVjOGQxMDRjOTQ5MTk3M2JmOWNiYTFlM2ExXzQyMA_7a715e41-4391-479b-9ac2-106473486e38">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table includes the Company's financial instruments not recorded at fair value but for which fair value disclosure is required. In addition to universal life products and finance leases, financial instruments that are carried in the Company's Consolidated Balance Sheets at amounts that approximate fair value are excluded from the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification in Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commercial mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,509&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities, excluding finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;30,679&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;32,439&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet
      contextRef="i5800d762bbc4479e8c8005dfaec6b354_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzItNC0xLTEtNTQ3MDk4_1e4169fc-deef-47de-a037-d955c39f7e16"
      unitRef="usd">1509000000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet
      contextRef="ia35e6eb5dace45a085e40ef481f10932_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzItNi0xLTEtNTQ3MDk4_b5130e97-1e24-4b0e-af31-c18f0a04efa3"
      unitRef="usd">1607000000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet
      contextRef="if429d97f6f9945029dfcdc1fc970e03f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzItOC0xLTEtNTQ3MDk4_1b1665f8-9798-44a2-b59e-4ea48426e85d"
      unitRef="usd">1491000000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet
      contextRef="i5868b67b67224406aa46fb0e8471fa5e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzItMTAtMS0xLTU0NzA5OA_ac4471e5-9bcc-4515-9e5a-962040bda723"
      unitRef="usd">1614000000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:LongTermDebtFairValue
      contextRef="i30053fba320b4d05beed1c1e1964b4b6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzMtNC0xLTEtNTQ3MDk4_9f9e35d4-58bd-4a86-a2d6-e884965c77f0"
      unitRef="usd">30679000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia35e6eb5dace45a085e40ef481f10932_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzMtNi0xLTEtNTQ3MDk4_96832169-022e-4012-a5da-219c81ee004a"
      unitRef="usd">32439000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i49c2e14e07b54fc488c910392b015f3e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzMtOC0xLTEtNTQ3MDk4_36a6aa11-faf8-4d23-9bb0-95464fa15efb"
      unitRef="usd">28653000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i5868b67b67224406aa46fb0e8471fa5e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83ODEvZnJhZzplNDVjMWRlYzhkMTA0Yzk0OTE5NzNiZjljYmExZTNhMS90YWJsZTo2Y2QyZmZlZmMzMGU0NmUwYjdkMjc0YWM2MjllMWMyYi90YWJsZXJhbmdlOjZjZDJmZmVmYzMwZTQ2ZTBiN2QyNzRhYzYyOWUxYzJiXzMtMTAtMS0xLTU0NzA5OA_b51a3ab2-a314-4699-8b0c-97745a06e73b"
      unitRef="usd">30994000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTMvZnJhZzpjMTE2YThmMzVlZDA0ZDExYWJlZWNlM2JjMzEyYWMzMC90ZXh0cmVnaW9uOmMxMTZhOGYzNWVkMDRkMTFhYmVlY2UzYmMzMTJhYzMwXzEy_0ed8d348-885e-4719-9c33-4ba263acc07c">Note 13 &#x2013; Variable Interest EntitiesWe perform ongoing qualitative analyses of our involvement with variable interest entities to determine if consolidation is required. The Company determined that it was not a primary beneficiary in any material variable interest entity as of March&#160;31, 2023 or December&#160;31, 2022. The Company's involvement with variable interest entities for which it is not the primary beneficiary has not changed materially from December&#160;31, 2022. For details of our accounting policy for variable interest entities and the composition of variable interest entities with which the Company is involved, refer to Note 13 in the Company's 2022 Form 10-K. The Company has not provided, and does not intend to provide, financial support to any of these variable interest entities in excess of its maximum exposure.</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <ci:VariableInterestEntitiesNumberOfEntities
      contextRef="i18bbba0896f543cb9afd321606482dda_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTYvZnJhZzo1ZmY1NTUyYmRiOWU0OTdiOGNmZWFmMTQ5NGU2OTRkMy90ZXh0cmVnaW9uOjVmZjU1NTJiZGI5ZTQ5N2I4Y2ZlYWYxNDk0ZTY5NGQzXzE3NA_3cb9330d-e186-4726-8789-3f70f0b2caa9"
      unitRef="entity">0</ci:VariableInterestEntitiesNumberOfEntities>
    <ci:VariableInterestEntitiesNumberOfEntities
      contextRef="i699bc3f219a0454d9541076c3ff72173_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTYvZnJhZzo1ZmY1NTUyYmRiOWU0OTdiOGNmZWFmMTQ5NGU2OTRkMy90ZXh0cmVnaW9uOjVmZjU1NTJiZGI5ZTQ5N2I4Y2ZlYWYxNDk0ZTY5NGQzXzE3NA_6eeafa07-3506-4854-ba3a-56c100e0ea15"
      unitRef="entity">0</ci:VariableInterestEntitiesNumberOfEntities>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF83OTYvZnJhZzo1ZmY1NTUyYmRiOWU0OTdiOGNmZWFmMTQ5NGU2OTRkMy90ZXh0cmVnaW9uOjVmZjU1NTJiZGI5ZTQ5N2I4Y2ZlYWYxNDk0ZTY5NGQzXzc1MA_f44e5c8d-0f48-40ff-9fc9-bb319552385a">For details of our accounting policy for variable interest entities and the composition of variable interest entities with which the Company is involved, refer to Note 13 in the Company's 2022 Form 10-K.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <ci:AccumulatedOtherComprehensiveIncomeDisclosureTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90ZXh0cmVnaW9uOmQ2ZGIzNThhY2JiZTQ1ZGRiNjY2ZmFhZmM5YzU1ODc1XzU0OTc1NTgxNTM5OQ_b05b6bd8-3358-41f0-8b3e-5a3f4e056adc">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 14 &#x2013; Accumulated Other Comprehensive Income (Loss) ("AOCI")&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;AOCI includes net unrealized (depreciation) appreciation on securities and derivatives, change in discount rate and instrument specific credit risk for certain long-duration insurance contractholder liabilities (Note 9 to the Consolidated Financial Statements), foreign currency translation and the net postretirement benefits liability adjustment. AOCI includes the Company's share from unconsolidated entities reported on the equity method. Generally, tax effects in AOCI are established at the currently enacted tax rate and reclassified to Shareholders' net income in the same period that the related pre-tax AOCI reclassifications are recognized. Changes in the components of AOCI, including the impact of adopting amended accounting guidance for long-duration insurance contracts (discussed in Note 2 to the Consolidated Financial Statements), were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities and Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance, as retrospectively restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unrealized appreciation (depreciation) on securities and derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Tax (expense) benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net unrealized appreciation (depreciation) on securities and derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;198&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Reclassification adjustment for (gains) included in Shareholders' net income (Net realized investment losses)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Reclassification adjustment for tax expense included in Shareholders' net income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net (gains) reclassified from AOCI to Shareholders' net income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net long-duration insurance and contractholder liabilities measurement adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current period change in discount rate for certain long duration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Tax benefit (expense)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net current period change in discount rate for certain long duration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current period change in instrument-specific credit risk for market risk benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Tax benefit (expense)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net current period change in instrument-specific credit risk for market risk benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Translation of foreign currencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance, as retrospectively restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(233)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Translation of foreign currencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Tax benefit (expense)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net translation of foreign currencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Net translation (loss) on foreign currencies attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shareholders' other comprehensive income (loss), net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Postretirement benefits liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Reclassification adjustment for amortization of net prior actuarial losses and prior service costs (Interest expense and other)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Reclassification adjustment for tax (benefit) included in Shareholders' net income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net adjustments reclassified from AOCI to Shareholders' net income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(906)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning balance, as retrospectively restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shareholders' other comprehensive (loss), net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(432)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2.94pt"&gt;Established upon the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.&lt;/span&gt;&lt;/div&gt;</ci:AccumulatedOtherComprehensiveIncomeDisclosureTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i74213a55ce4840b39cb8ba80e171a3c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzMtNi0xLTEtNTQ3MDk4_ebfecc33-3df1-432c-85c3-fb2064b30ad0"
      unitRef="usd">-332000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1e2a8ecd49b468db83c7246a6233f79_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzMtOC0xLTEtNTQ3MDk4_810f5856-6cae-4caf-a64a-216e8b9b801e"
      unitRef="usd">1266000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQtNi0xLTEtNTQ3MDk4_65d450cf-605f-4991-b459-4ad3a884e893"
      unitRef="usd">252000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i27a2c2fd471047389035115e103c4803_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQtOC0xLTEtNTQ3MDk4_0156a8f0-75ae-4403-b188-2a20370b9ac3"
      unitRef="usd">-1065000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzUtNi0xLTEtNTQ3MDk4_f73a5ed5-405a-4200-bf40-528136ccf0ae"
      unitRef="usd">54000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i27a2c2fd471047389035115e103c4803_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzUtOC0xLTEtNTQ3MDk4_ccdfc641-265e-4b62-a56c-5d3d8416cf13"
      unitRef="usd">-231000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzYtNi0xLTEtNTQ3MDk4_e03d2721-aa17-457b-b00d-6fdf3fe72160"
      unitRef="usd">198000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i27a2c2fd471047389035115e103c4803_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzYtOC0xLTEtNTQ3MDk4_3a100373-eb99-412c-b238-8c12069431e7"
      unitRef="usd">-834000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i7ec41b20522442a78d304f69275d1f6f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzgtNi0xLTEtNTQ3MDk4_8a1c8d08-1749-4d04-8462-d8144c893526"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ib47e378add8046febeed46402863f4f0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzgtOC0xLTEtNTQ3MDk4_1a7861d1-035c-40f7-9734-4d4c1ed0f1b3"
      unitRef="usd">11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzEwLTYtMS0xLTU0NzA5OA_e8033f1c-6b4b-40cc-9712-b05d460da0ce"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i27a2c2fd471047389035115e103c4803_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzEwLTgtMS0xLTU0NzA5OA_64dca594-cc3c-46f1-9b03-1792c394e67f"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzExLTYtMS0xLTU0NzA5OA_fcddc4b3-1b0e-4e55-9e96-2591ebd35efe"
      unitRef="usd">4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i27a2c2fd471047389035115e103c4803_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzExLTgtMS0xLTU0NzA5OA_f2c3c503-7f50-4337-8f30-41067ab822c0"
      unitRef="usd">9000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8e2d1e147e7d420589e26b226a17b7a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzEyLTYtMS0xLTU0NzA5OA_52677bfe-2d34-4719-879a-95df7751ea8a"
      unitRef="usd">194000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i27a2c2fd471047389035115e103c4803_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzEyLTgtMS0xLTU0NzA5OA_06da0bef-bc0e-494c-acf3-c3955e461e84"
      unitRef="usd">-843000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1eedce94285e450ea3c9ec311118b0dc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzEzLTYtMS0xLTU0NzA5OA_f1dd272e-e3ff-4558-8a8c-78cb6c040e8d"
      unitRef="usd">-138000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaf6aec08fb614f1f9373704db9a45990_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzEzLTgtMS0xLTU0NzA5OA_b8ed6c3e-3800-47d9-aabc-8b4ccaf4bf50"
      unitRef="usd">423000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3574069d949f4ff58e5ed013efd6e44e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE1LTYtMS0xLTU0NzA5OA_1f73f14c-d84e-47e9-a0be-97fc7c2f0bc2"
      unitRef="usd">-256000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie315d35584a941c298193aa052832950_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE1LTgtMS0xLTU0NzA5OA_158ba139-5daf-4536-b0f3-0f7af99e7961"
      unitRef="usd">-765000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i9da4771b623549e5a758939e8718e0c6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE2LTYtMS0xLTU0NzA5OA_f6045a23-cecd-4250-8f3f-e843ad44a9e6"
      unitRef="usd">-411000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i1f0e583ccd0840039ba45ea866313d48_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE2LTgtMS0xLTU0NzA5OA_63cf78c0-4ea0-4b74-a359-4f967b091f61"
      unitRef="usd">584000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i9da4771b623549e5a758939e8718e0c6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE3LTYtMS0xLTU0NzA5OA_a8dbea50-3b67-4f53-9c06-f12e4cf23e0e"
      unitRef="usd">-101000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i1f0e583ccd0840039ba45ea866313d48_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE3LTgtMS0xLTU0NzA5OA_a271efb8-bfd0-4bf3-befa-bc78a45c537a"
      unitRef="usd">130000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9da4771b623549e5a758939e8718e0c6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE4LTYtMS0xLTU0NzA5OA_01e4b535-d103-4be4-98ab-487218ac462f"
      unitRef="usd">-310000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1f0e583ccd0840039ba45ea866313d48_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE4LTgtMS0xLTU0NzA5OA_1d37fff2-c336-43dc-9cab-559d1e9a612d"
      unitRef="usd">454000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i3b0fa25db54c4cd5b97bf60ce65ce025_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE5LTYtMS0xLTU0NzA5OA_6ecb2946-6e78-46a0-bb35-e8882b841902"
      unitRef="usd">-26000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i5bc43d6d65d948eabf0c43a48194633f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzE5LTgtMS0xLTU0NzA5OA_9b68be17-a827-4e5e-a395-b2c9c114e263"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i3b0fa25db54c4cd5b97bf60ce65ce025_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIwLTYtMS0xLTU0NzA5OA_86c2dbef-067a-4ec6-a40f-6fed72afefce"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i5bc43d6d65d948eabf0c43a48194633f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIwLTgtMS0xLTU0NzA5OA_2502a562-475b-46ca-87dc-7503f77ab041"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3b0fa25db54c4cd5b97bf60ce65ce025_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIxLTYtMS0xLTU0NzA5OA_cdfb67f5-0ad2-4468-8076-5b0c493f20fb"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5bc43d6d65d948eabf0c43a48194633f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIxLTgtMS0xLTU0NzA5OA_99a512ed-f058-4bbf-9f1c-8512d22acec4"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f5efb187a364a69a0332046f8b9dc86_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIyLTYtMS0xLTU0NzA5OA_9402019f-9999-4238-99c2-07a2020f65aa"
      unitRef="usd">-331000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9dfb7b298e8348bebbdbb2ffbb195fc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIyLTgtMS0xLTU0NzA5OA_0057d70f-8570-462c-9364-a3360991b501"
      unitRef="usd">459000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id43a85e5eb1645de94bf7c939c4071e2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIzLTYtMS0xLTU0NzA5OA_c05a83c1-70f3-4599-95b6-0d7705fae3e0"
      unitRef="usd">-587000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f42f5791c2144cbba874ff9a5058d6e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzIzLTgtMS0xLTU0NzA5OA_80eb6535-7429-483c-b9dc-fbf623d2ad01"
      unitRef="usd">-306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic32d3eff65f84a3d9776350854ae8231_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI1LTYtMS0xLTU0NzA5OA_eb167783-6f84-4332-8fe1-7e92b5b7d5ff"
      unitRef="usd">-154000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id05c2da7d3ae4ceeb35fccff9cd109a3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI1LTgtMS0xLTU0NzA5OA_fa396256-f070-4a03-99be-6d20efac530b"
      unitRef="usd">-233000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <ci:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity
      contextRef="i12523f50e770418e8cf76bec13c9b6f9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI2LTYtMS0xLTU0NzA5OA_6ad32ff3-f5fc-46a3-ab52-30b86fc97878"
      unitRef="usd">15000000</ci:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity>
    <ci:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity
      contextRef="i57486b0895474a619153155e196783bb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI2LTgtMS0xLTU0NzA5OA_013831e0-246d-4f3f-80c6-54f93ee63d66"
      unitRef="usd">-60000000</ci:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity>
    <ci:OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity
      contextRef="i12523f50e770418e8cf76bec13c9b6f9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI3LTYtMS0xLTU0NzA5OA_261daacc-5a6f-4be9-aa78-ac5d6ee14492"
      unitRef="usd">-1000000</ci:OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity>
    <ci:OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity
      contextRef="i57486b0895474a619153155e196783bb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI3LTgtMS0xLTU0NzA5OA_5b5dca32-fdc3-4e5a-a65a-898b68c6199a"
      unitRef="usd">3000000</ci:OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity>
    <ci:OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity
      contextRef="i12523f50e770418e8cf76bec13c9b6f9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI4LTYtMS0xLTU0NzA5OA_dc6be23e-703e-4927-9278-0230cc9f332b"
      unitRef="usd">16000000</ci:OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity>
    <ci:OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity
      contextRef="i57486b0895474a619153155e196783bb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzI4LTgtMS0xLTU0NzA5OA_3a43b1aa-e3cb-416f-9427-89a6ba764a20"
      unitRef="usd">-63000000</ci:OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity>
    <ci:TemporaryEquityOtherComprehensiveIncome
      contextRef="i70d4659b2e374fa3b6fa858f21168b54_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM1LTYtMS0xLTU0NzA5OA_c40d1fac-51a4-4d3a-81e2-55d774dcff15"
      unitRef="usd">0</ci:TemporaryEquityOtherComprehensiveIncome>
    <ci:TemporaryEquityOtherComprehensiveIncome
      contextRef="i5f152f9fd42e4e7bb1d7e7e7177095a5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM1LTgtMS0xLTU0NzA5OA_3e743bb5-f27c-49d2-82ac-1ffe7b16a2ae"
      unitRef="usd">-2000000</ci:TemporaryEquityOtherComprehensiveIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie0fe44d65b564dfb91c260cbd59420f9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM2LTYtMS0xLTU0NzA5OA_592e09fd-6f40-40b8-8a61-9d6e5e4d09e5"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i32dd55f2fefd4ac7af712ac3651d80a0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM2LTgtMS0xLTU0NzA5OA_b8145114-1c4d-4e53-8725-eb47d024be08"
      unitRef="usd">-61000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae231709f2154539b08738af3e5159cc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM3LTYtMS0xLTU0NzA5OA_0af8c856-fd16-4abe-a44e-15c060deb9d6"
      unitRef="usd">-138000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5730b56e2aba4bf0b30069589628b932_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM3LTgtMS0xLTU0NzA5OA_6591b52d-b375-4d2d-b269-14117b717fcb"
      unitRef="usd">-294000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i49e8b987a931474faf2d5c0788c6dd63_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM5LTYtMS0xLTU0NzA5OA_49750946-63a4-40dc-9a0e-5a9a3fc9b3e0"
      unitRef="usd">-916000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i947635db683b4b3daa054f199155a2d0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzM5LTgtMS0xLTU0NzA5OA_826a5c34-fd75-4655-9873-cad177a8aaaf"
      unitRef="usd">-1336000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i382b1889e4f048a797548743cf8e44d8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQwLTYtMS0xLTU0NzA5OA_f71c507e-0b46-4da9-be89-7a20871b11c4"
      unitRef="usd">-13000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i500856a7a2f34b819a1cf711b4cbedd5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQwLTgtMS0xLTU0NzA5OA_0af37a25-76b9-464a-937f-14c1e4507c38"
      unitRef="usd">-16000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i0deee6eee2ee46eeafe6188d0a931786_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQzLTYtMS0xLTU0NzA5OA_0fe1c5d7-5d72-4e1b-bdc2-6ba76ffaf85f"
      unitRef="usd">-3000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i9329656f7a714f9e906a28f984a13e6d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQzLTgtMS0xLTU0NzA5OA_be2d7c36-58fa-46b8-a39f-1603dce0eeda"
      unitRef="usd">-3000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0deee6eee2ee46eeafe6188d0a931786_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQ0LTYtMS0xLTU0NzA5OA_88eff44f-1df4-4bb1-8f34-779f206be328"
      unitRef="usd">-10000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9329656f7a714f9e906a28f984a13e6d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQ0LTgtMS0xLTU0NzA5OA_50455c5b-6556-4084-a54e-ec6ae5d8fa63"
      unitRef="usd">-13000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0deee6eee2ee46eeafe6188d0a931786_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQ4LTYtMS0xLTU0NzA5OA_39600754-0848-449f-bd7e-f241ec0c0eb3"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9329656f7a714f9e906a28f984a13e6d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQ4LTgtMS0xLTU0NzA5OA_75e407d6-9d50-4e04-acf7-91ca5d284b44"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie7bdac56a5c747909f091b44b4679bf5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQ5LTYtMS0xLTU0NzA5OA_025d8295-b251-4e23-868a-480b0834b19c"
      unitRef="usd">-906000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida787829236f4e5b915c9415a14edb54_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzQ5LTgtMS0xLTU0NzA5OA_205491b1-694a-4f5f-ae01-b96b4286686b"
      unitRef="usd">-1323000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib2b7588439a24468b996c973b3308b0f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzU3LTYtMS0xLTU4NjYwMw_7cc07ddf-8c5e-42e7-b1c3-c98c26233a43"
      unitRef="usd">-1658000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2c898b920ca42a186661453324aadcd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzU3LTgtMS0xLTU4NjYwMw_72b136a2-703e-49df-9a1d-576393840f9f"
      unitRef="usd">-1068000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3c0abb6b8064491c945d2af1005f4e61_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzU4LTYtMS0xLTU4NjYwMw_c24bed45-b527-4642-bc67-be0321735abd"
      unitRef="usd">-111000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i29e9fa809dec40e4a4434d5f6b246b71_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzU4LTgtMS0xLTU4NjYwMw_8d969008-8021-4aaa-974d-e80fa672ce97"
      unitRef="usd">-432000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ca2b0796c79476594136b360600f553_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzU5LTYtMS0xLTU4NjYwMw_10fae0ef-b3bd-4e06-a2b0-67c1dea3223b"
      unitRef="usd">-1769000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46e8477b53954f2eb5c8d27ecfddb379_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84MTEvZnJhZzpkNmRiMzU4YWNiYmU0NWRkYjY2NmZhYWZjOWM1NTg3NS90YWJsZTpmN2JhNzA0MTNjZDU0Mzc3YTI0MDkyNDhkZmViYmExYy90YWJsZXJhbmdlOmY3YmE3MDQxM2NkNTQzNzdhMjQwOTI0OGRmZWJiYTFjXzU5LTgtMS0xLTU4NjYwMw_f2293a62-108d-498f-8bb7-ede60597ab4b"
      unitRef="usd">-1500000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NTkvZnJhZzpjNzgxN2FmY2FlNzM0NDVmYjU1OTJiYjA0Zjc0Y2E2NC90ZXh0cmVnaW9uOmM3ODE3YWZjYWU3MzQ0NWZiNTU5MmJiMDRmNzRjYTY0XzEx_b644f664-09bd-4e6f-a875-fa0c21bf28c4">Note 15 &#x2013; Income Taxes&lt;div style="margin-bottom:10pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Income Tax Expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The 18.4% effective tax rate for the three months ended March&#160;31, 2023 was lower than the 22.7% rate for the three months ended March&#160;31, 2022. This decrease was driven largely by favorable results relative to the Company's foreign operations, partially offset by an increase pertaining to the year over year impact of remeasurement of deferred taxes. &lt;/span&gt;&lt;/div&gt;As of March&#160;31, 2023, we had approximately $255&#160;million in deferred tax assets ("DTAs") associated with unrealized investment losses that are partially recorded in Accumulated other comprehensive loss. We have determined that a valuation allowance against the DTAs is not currently required based on the Company's ability to carryback losses and our ability and intent to hold certain securities until recovery. We continue to monitor and evaluate the need for any valuation allowance in the future.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NjIvZnJhZzo3YWZiYzE3NDQ3MDg0OTA1YjQ0MjY1M2UzYzE1NTUxYy90ZXh0cmVnaW9uOjdhZmJjMTc0NDcwODQ5MDViNDQyNjUzZTNjMTU1NTFjXzg4_6d251a54-555a-4eae-b220-4b72f4028fe9"
      unitRef="number">0.184</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NjIvZnJhZzo3YWZiYzE3NDQ3MDg0OTA1YjQ0MjY1M2UzYzE1NTUxYy90ZXh0cmVnaW9uOjdhZmJjMTc0NDcwODQ5MDViNDQyNjUzZTNjMTU1NTFjXzE5NQ_51312052-7c7d-4859-b982-37bc2bb8a8fd"
      unitRef="number">0.227</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <ci:DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules
      contextRef="icfbd026f02e243f087fcef41ca300348_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NTczL2ZyYWc6ODkzMDJiZjk1OTAyNDk0OTlhYjA5ODRlMmMxOTdmZWYvdGV4dHJlZ2lvbjo4OTMwMmJmOTU5MDI0OTQ5OWFiMDk4NGUyYzE5N2ZlZl8zNg_2c512830-96bd-40cc-8ee2-33a522794fc2"
      unitRef="usd">255000000</ci:DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NzEvZnJhZzo1NjJlNTVkMTdkMDY0Mzg3ODYxZjEyNGFiYzgzMTFmNC90ZXh0cmVnaW9uOjU2MmU1NWQxN2QwNjQzODc4NjFmMTI0YWJjODMxMWY0XzI5MTA_8e2d96e8-48d0-47bb-a1c1-810c0ca03da8">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 16 &#x2013; Contingencies and Other Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company, through its subsidiaries, is contingently liable for various guarantees provided in the ordinary course of business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;A.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline"&gt;Financial Guarantees: Retiree and Life Insurance Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company guarantees that separate account assets will be sufficient to pay certain life insurance or retiree benefits. For the majority of these benefits, the sponsoring employers are primarily responsible for ensuring that assets are sufficient to pay these benefits and are required to maintain assets that exceed a certain percentage of benefit obligations. If employers fail to do so, the Company or an affiliate of the buyer of the retirement benefits business has the right to redirect the management of the related assets to provide for benefit payments. As of March&#160;31, 2023, employers maintained assets that generally exceeded the benefit obligations under these arrangements of approximately $420 million. An additional liability is established if management believes that the Company will be required to make payments under the guarantees; there were no additional liabilities required for these guarantees, net of reinsurance, as of March&#160;31, 2023. Separate account assets supporting these guarantees are classified in Levels 1 and 2 of the GAAP fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company does not expect that these financial guarantees will have a material effect on the Company's consolidated results of operations, liquidity or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;B.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.84pt;text-decoration:underline"&gt;Certain Other Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company had indemnification obligations as of March&#160;31, 2023 in connection with acquisition and disposition transactions. These indemnification obligations are triggered by the breach of representations or covenants provided by the Company, such as representations for the presentation of financial statements, filing of tax returns, compliance with law or identification of outstanding litigation. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential amount due is subject to contractual limitations based on a percentage of the transaction purchase price, while in other cases limitations are not specified or applicable. The Company does not believe that it is possible to determine the maximum potential amount due under these obligations because not all amounts due under these indemnification obligations are subject to limitation. There were no liabilities for these indemnification obligations as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;C.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline"&gt;Guaranty Fund Assessments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company operates in a regulatory environment that may require its participation in assessments under state insurance guaranty association laws. The Company's exposure to assessments for certain obligations of insolvent insurance companies to policyholders and claimants is based on its share of business written in the relevant jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;There were no material charges or credits resulting from existing or new guaranty fund assessments for the three months ended March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;Legal and Regulatory Matters&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company is routinely involved in numerous claims, lawsuits, regulatory inquiries and audits, government investigations, including under the federal False Claims Act and state false claims acts initiated by a government investigating body or by a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; relator's filing of a complaint under court seal, and other legal matters arising, for the most part, in the ordinary course of managing a global health services business. Additionally, the Company has received and is cooperating with subpoenas or similar processes from various governmental agencies requesting information, all arising in the normal course of its business. Disputed tax matters arising &lt;/span&gt;from audits by the Internal Revenue Service or other state and foreign jurisdictions, including those resulting in litigation, are accounted for under GAAP guidance for uncertain tax positions.Pending litigation and legal or regulatory matters that the Company has identified with a reasonably possible material loss and certain other material litigation matters are described below. For those matters that the Company has identified with a reasonably possible material loss, the Company provides disclosure in the aggregate of accruals and range of loss, or a statement that such information cannot be estimated. The Company's accruals for the matters discussed below under "Litigation Matters" and "Regulatory Matters" are not material. Due to numerous uncertain factors presented in these cases, it is not possible to estimate an aggregate range of loss (if any) for these matters at this time. In light of the uncertainties involved in these matters, there is no assurance that their ultimate resolution will not exceed the amounts currently accrued by the Company. An adverse outcome in one or more of these matters could be material to the Company's results of operations, financial condition or liquidity for any particular period. The outcomes of lawsuits are inherently unpredictable and we may be unsuccessful in these ongoing litigation matters or any future claims or litigation.&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Litigation Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Express Scripts Litigation with Elevance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. In March 2016, Elevance filed a lawsuit in the United States District Court for the Southern District of New York alleging various breach of contract claims against Express Scripts relating to the parties' rights and obligations under the periodic pricing review section of the pharmacy benefit management agreement between the parties including allegations that Express Scripts failed to negotiate new pricing concessions in good faith, as well as various alleged service issues. Elevance also requested that the court enter declaratory judgment that Express Scripts is required to provide Elevance competitive benchmark pricing, that Elevance can terminate the agreement and that Express Scripts is required to provide Elevance with post-termination services at competitive benchmark pricing for one year following any termination by Elevance. Elevance claimed it is entitled to $13 billion in additional pricing concessions over the remaining term of the agreement, as well as $1.8 billion for one year following any contract termination by Elevance and $150 million damages for service issues ("Elevance's Allegations"). On April 19, 2016, in response to Elevance's complaint, Express Scripts filed its answer denying Elevance's Allegations in their entirety and asserting affirmative defenses and counterclaims against Elevance. The court subsequently granted Elevance's motion to dismiss two of six counts of Express Scripts' amended counterclaims. Express Scripts filed its Motion for Summary Judgment on August 27, 2021. Elevance completed filing of its Response to Express Scripts' Motion for Summary Judgment on October 16, 2021. Express Scripts filed its Reply in Support of its Motion for Summary Judgment on November 19, 2021. On March 31, 2022, the court granted summary judgment in favor of Express Scripts on all of Elevance's pricing claims for damages totaling $14.8 billion and on most of Elevance's claims relating to service issues. Elevance's only remaining service claims relate to the review or processing of prior authorizations. On June 10, 2022, Express Scripts filed a Motion for Partial Summary Judgment seeking to limit Elevance's remaining prior authorization claims and a Motion to Exclude certain opinions offered by its experts. Elevance filed its opposition to both motions, and a cross-motion to submit a supplemental expert report, on July 9, 2022. Express Scripts' pending Motions were fully briefed at the end of July 2022. On March 8, 2023, the Court granted Express Scripts' Motion for Partial Summary Judgement, excluding in full the testimony of four of Elevance's experts and in part the testimony of two additional experts, and granted Elevance leave to submit a supplemental expert report. On April 5, 2023, the Court entered a scheduling order setting a trial on Elevance's remaining prior authorization claims to commence on December 4, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Medicare Advantage. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; action that was filed by a private individual on behalf of the government in the United States District Court for the Southern District of New York in 2017 was unsealed on August 6, 2020. The action asserts claims related to risk adjustment practices arising from certain health exams conducted as part of the Company's Medicare Advantage business. In September 2021, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; action was transferred to the United States District Court for the Middle District of Tennessee. On January 11, 2022, the U.S. Department of Justice ("DOJ") (U.S. Attorney's Offices for the Southern District of New York and the Middle District of Tennessee) filed a motion to partially intervene, which was granted on August 2, 2022. On October 14, 2022, the DOJ filed its complaint-in-intervention alleging that certain diagnoses made during in-home exams were invalid for risk adjustment purposes, seeking unspecified damages and penalties under the federal False Claims Act. The Company filed motions to dismiss the DOJ's complaint and the remainder of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; complaint on December 16, 2022. Briefing is complete and the matter is pending before the court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Regulatory Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Civil Investigative Demand&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. The DOJ is conducting industry-wide investigations of Medicare Advantage organizations' risk adjustment practices. For certain Medicare Advantage organizations, including The Cigna Group, those investigations have resulted in litigation (see "Litigation Matters&#x2014;Medicare Advantage" above). The Company has responded to information requests (civil investigative demands) from the DOJ (U.S. Attorney's Office for the Eastern District of Pennsylvania) and is continuing to cooperate with the DOJ.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NzEvZnJhZzo1NjJlNTVkMTdkMDY0Mzg3ODYxZjEyNGFiYzgzMTFmNC90ZXh0cmVnaW9uOjU2MmU1NWQxN2QwNjQzODc4NjFmMTI0YWJjODMxMWY0XzI5MDI_80c9654f-2985-4e6f-9dfe-e899dd45db34">Financial Guarantees: Retiree and Life Insurance BenefitsThe Company guarantees that separate account assets will be sufficient to pay certain life insurance or retiree benefits. For the majority of these benefits, the sponsoring employers are primarily responsible for ensuring that assets are sufficient to pay these benefits and are required to maintain assets that exceed a certain percentage of benefit obligations. If employers fail to do so, the Company or an affiliate of the buyer of the retirement benefits business has the right to redirect the management of the related assets to provide for benefit payments.An additional liability is established if management believes that the Company will be required to make payments under the guarantees;Separate account assets supporting these guarantees are classified in Levels 1 and 2 of the GAAP fair value hierarchy.Certain Other GuaranteesThe Company had indemnification obligations as of March&#160;31, 2023 in connection with acquisition and disposition transactions. These indemnification obligations are triggered by the breach of representations or covenants provided by the Company, such as representations for the presentation of financial statements, filing of tax returns, compliance with law or identification of outstanding litigation. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential amount due is subject to contractual limitations based on a percentage of the transaction purchase price, while in other cases limitations are not specified or applicable. The Company does not believe that it is possible to determine the maximum potential amount due under these obligations because not all amounts due under these indemnification obligations are subject to limitation.Guaranty Fund AssessmentsThe Company operates in a regulatory environment that may require its participation in assessments under state insurance guaranty association laws. The Company's exposure to assessments for certain obligations of insolvent insurance companies to policyholders and claimants is based on its share of business written in the relevant jurisdictions.</us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i854c62090cb94df2a90a243d3b2a0448_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NzEvZnJhZzo1NjJlNTVkMTdkMDY0Mzg3ODYxZjEyNGFiYzgzMTFmNC90ZXh0cmVnaW9uOjU2MmU1NWQxN2QwNjQzODc4NjFmMTI0YWJjODMxMWY0Xzg5NQ_eb9361f8-5555-43d7-a4ba-0377392cb863"
      unitRef="usd">420000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:GuaranteeObligationsLiquidationProceeds
      contextRef="i003bcebd887e4bdcb34dc4edd5766fda_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NzEvZnJhZzo1NjJlNTVkMTdkMDY0Mzg3ODYxZjEyNGFiYzgzMTFmNC90ZXh0cmVnaW9uOjU2MmU1NWQxN2QwNjQzODc4NjFmMTI0YWJjODMxMWY0Xzg5NQ_f95ff50a-fb76-434f-bd09-57de323008be"
      unitRef="usd">420000000</us-gaap:GuaranteeObligationsLiquidationProceeds>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i854c62090cb94df2a90a243d3b2a0448_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NzEvZnJhZzo1NjJlNTVkMTdkMDY0Mzg3ODYxZjEyNGFiYzgzMTFmNC90ZXh0cmVnaW9uOjU2MmU1NWQxN2QwNjQzODc4NjFmMTI0YWJjODMxMWY0XzEwNDU_bf786559-90b4-4004-bb93-597d0b13ca4c"
      unitRef="usd">0</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i6ffe330f5d2e42feb4023beb365c915f_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84NzEvZnJhZzo1NjJlNTVkMTdkMDY0Mzg3ODYxZjEyNGFiYzgzMTFmNC90ZXh0cmVnaW9uOjU2MmU1NWQxN2QwNjQzODc4NjFmMTI0YWJjODMxMWY0XzI0MjU_dca831f8-0886-49b3-9c06-2b059818581a"
      unitRef="usd">0</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="ie05d40387e70450eb97782a7626bd016_D20160301-20160331"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1Xzk0Nw_588bb41a-5001-4f07-8e37-ad53965c6141"
      unitRef="usd">13000000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i2602421334c748649e7b6a705dad545e_D20160301-20160331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzEwMzc_5efa5e24-6801-4a67-87af-fbcd8a154d68"
      unitRef="usd">1800000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i3e3b74c468ff4912bbea80db07b86240_D20160301-20160331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzExMDQ_2dc714cf-814e-4882-8a17-63e28868de6d"
      unitRef="usd">150000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyClaimsDismissedNumber
      contextRef="i41708a20f5d543b49694e126b9d63ab6_D20160419-20160419"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzE0MzE_5eae7fe8-4a6d-4c5d-a7d8-7265c851abc6"
      unitRef="claim">2</us-gaap:LossContingencyClaimsDismissedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i4776d8e52c934378b5373425506ecca3_I20160419"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzE0Mzc_61c7eac7-e8bd-42ef-a7fe-7e2a083010d8"
      unitRef="claim">6</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i6bd9f07d9d3a43dab2134f8b473b3aa9_D20220331-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzE5MTQ_ee342915-b87a-45cb-b01b-5c1acd9135cc"
      unitRef="usd">14800000000</us-gaap:LossContingencyDamagesSoughtValue>
    <ci:CommitmentsAndContingenciesNumberOfExpert
      contextRef="ife782ca69c664ec9a42a195307da9dad_I20230308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzQxNzgxNDQxODYwMzY2_e3bae527-5800-4bcf-a3a1-8e4bd570cf71"
      unitRef="expert">4</ci:CommitmentsAndContingenciesNumberOfExpert>
    <ci:CommitmentsAndContingenciesNumberOfAdditionalExpert
      contextRef="ife782ca69c664ec9a42a195307da9dad_I20230308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODMvZnJhZzpiMDViY2FiYjhkYjQ0ZTU0OGIyMDMxYTViNTc2NTE4NS90ZXh0cmVnaW9uOmIwNWJjYWJiOGRiNDRlNTQ4YjIwMzFhNWI1NzY1MTg1XzQxNzgxNDQxODYwMzY3_8596592f-6340-4a18-ac98-e05e51cd2054"
      unitRef="expert">2</ci:CommitmentsAndContingenciesNumberOfAdditionalExpert>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODkvZnJhZzozY2IwZmQzMjY5N2M0YWM5OWM1YjQ0NGU1NzNkZWZiYi90ZXh0cmVnaW9uOjNjYjBmZDMyNjk3YzRhYzk5YzViNDQ0ZTU3M2RlZmJiXzU5Nw_ba23af6b-8910-41f9-b919-687bf464495a">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 17 &#x2013; Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;See Note 1 to the Consolidated Financial Statements for a description of our segments. A description of our basis for reporting segment operating results is outlined below. Intersegment revenues primarily reflect pharmacy and care services transactions between the Evernorth Health Services and Cigna Healthcare segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company uses "pre-tax adjusted income (loss) from operations" and "adjusted revenues" as its principal financial measures of segment operating performance because management believes these metrics best reflect the underlying results of business operations and permit analysis of trends in underlying revenue, expenses and profitability. We define pre-tax adjusted income from operations as income before income taxes excluding pre-tax income (loss) attributable to noncontrolling interests, net realized investment results, amortization of acquired intangible assets, and special items. The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. Adjusted income (loss) from operations is measured on an after-tax basis for consolidated results and on a pre-tax basis for segment results. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company defines adjusted revenues as total revenues excluding the following adjustments: special items and The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. We exclude these items from this measure because management believes they are not indicative of past or future underlying performance of the business. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company does not report total assets by segment because this is not a metric used to allocate resources or evaluate segment performance.&lt;/span&gt;&lt;/div&gt;Special items charges (benefits) recorded by the Company were $1 million both pre-tax and after-tax for the three months ended March&#160;31, 2023 and $52 million pre-tax ($37 million after-tax) for the three months ended March&#160;31, 2022. Effective January 1, 2023, we adopted amended accounting guidance for long-duration insurance contracts. See Note 2 to the Consolidated Financial Statements for further information. Prior period summarized segment information has been retrospectively adjusted to conform to this new basis of accounting. Summarized segment financial information was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Evernorth Health Services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate and Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;34,511&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11,650&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46,240&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,618&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;963&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;143&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;277&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;36,179&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12,756&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;157&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46,517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Net realized investment results from certain equity method investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;36,179&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12,718&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;157&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46,479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,601&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-tax adjustments to reconcile to adjusted income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(Income) attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net realized investment losses (gains) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;459&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Special items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Integration and transaction-related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pre-tax adjusted income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,320&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,115&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,036&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Evernorth Health Services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate and Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Net realized investment results from certain equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-tax adjustments to reconcile to adjusted income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(Income) attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net realized investment losses (gains) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Special items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Integration and transaction-related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pre-tax adjusted income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Revenue from external customers includes Pharmacy revenues, Premiums and Fees and other revenues. Prior period amounts have been retrospectively adjusted to reflect adoption of amended accounting guidance for long-duration insurance contracts, as discussed in Note 2 to the Consolidated Financial Statements. The following table presents these revenues by product, premium and service type:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Products (Pharmacy revenues) (ASC 606)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Network revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15,748&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Home delivery and specialty revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16,025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,867&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intercompany eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total pharmacy revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;32,144&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance premiums (ASC 944)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;U.S. Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Insured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,080&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stop loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,503&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;368&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;U.S. Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,236&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medicare Part D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;415&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1), (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-duration (Individual and family plans)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,208&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-duration (Individual Medicare supplement and limited benefit health products)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;334&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;International Health&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-duration (Group medical insurance)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-duration (Individual private medical insurance)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;86&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Cigna Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,930&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Divested International businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intercompany eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11,025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Services (Fees) (ASC 606)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Evernorth Health Services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,499&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,606&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other Operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intercompany eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total fees and other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46,240&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Other than supplemental benefits, all of U.S. Commercial and U.S. Government are short duration.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;U.S. Government and International Health recognize premium revenue on long-duration insurance contracts (coverage greater than one year or guaranteed to be renewed at the option of the policyholder beyond one year) related to certain medicare supplement, supplemental health and life products. All other premium revenue recognized as of March&#160;31, 2023 and March&#160;31, 2022 is primarily related to short-duration insurance contracts.&lt;/span&gt;&lt;/div&gt;Evernorth Health Services may also provide certain financial and performance guarantees, including a minimum level of discounts a client may receive, generic utilization rates and various service levels. Clients may be entitled to receive compensation if we fail to meet the guarantees. Actual performance is compared to the contractual guarantee for each measure throughout the period and the Company defers revenue for any estimated payouts within Accrued expenses and other liabilities (current). These estimates are adjusted and paid following the end of the annual guarantee period. Historically, adjustments to original estimates have not been material. This guarantee liability was $1.5 billion as of March&#160;31, 2023 and $1.3 billion as of December&#160;31, 2022.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84ODkvZnJhZzozY2IwZmQzMjY5N2M0YWM5OWM1YjQ0NGU1NzNkZWZiYi90ZXh0cmVnaW9uOjNjYjBmZDMyNjk3YzRhYzk5YzViNDQ0ZTU3M2RlZmJiXzYwMA_2971c4aa-58fc-40f5-89c0-06c378b69539">Intersegment revenues primarily reflect pharmacy and care services transactions between the Evernorth Health Services and Cigna Healthcare segments.The Company uses "pre-tax adjusted income (loss) from operations" and "adjusted revenues" as its principal financial measures of segment operating performance because management believes these metrics best reflect the underlying results of business operations and permit analysis of trends in underlying revenue, expenses and profitability. We define pre-tax adjusted income from operations as income before income taxes excluding pre-tax income (loss) attributable to noncontrolling interests, net realized investment results, amortization of acquired intangible assets, and special items. The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. Adjusted income (loss) from operations is measured on an after-tax basis for consolidated results and on a pre-tax basis for segment results. The Company defines adjusted revenues as total revenues excluding the following adjustments: special items and The Cigna Group's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. Special items are matters that management believes are not representative of the underlying results of operations due to their nature or size. We exclude these items from this measure because management believes they are not indicative of past or future underlying performance of the business.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <ci:SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDk3NTU4MTk5NDIvZnJhZzpiYTU5MzQzZWMwODY0NThhYjNjYWRmODc4NGZkMjA5Ny90ZXh0cmVnaW9uOmJhNTkzNDNlYzA4NjQ1OGFiM2NhZGY4Nzg0ZmQyMDk3XzU0OTc1NTgxNDA5Ng_4855afe8-d852-4748-95a4-0ddbde0d0a8a"
      unitRef="usd">-1000000</ci:SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity>
    <ci:SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDk3NTU4MTk5NDIvZnJhZzpiYTU5MzQzZWMwODY0NThhYjNjYWRmODc4NGZkMjA5Ny90ZXh0cmVnaW9uOmJhNTkzNDNlYzA4NjQ1OGFiM2NhZGY4Nzg0ZmQyMDk3XzU0OTc1NTgxNDA5Ng_c8ee9758-1611-44e0-812f-74f04482cb28"
      unitRef="usd">-1000000</ci:SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity>
    <ci:SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDk3NTU4MTk5NDIvZnJhZzpiYTU5MzQzZWMwODY0NThhYjNjYWRmODc4NGZkMjA5Ny90ZXh0cmVnaW9uOmJhNTkzNDNlYzA4NjQ1OGFiM2NhZGY4Nzg0ZmQyMDk3XzU0OTc1NTgxNDE3Ng_91a83145-5e09-4c44-97eb-b28c40d6b8bb"
      unitRef="usd">-52000000</ci:SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity>
    <ci:SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF81NDk3NTU4MTk5NDIvZnJhZzpiYTU5MzQzZWMwODY0NThhYjNjYWRmODc4NGZkMjA5Ny90ZXh0cmVnaW9uOmJhNTkzNDNlYzA4NjQ1OGFiM2NhZGY4Nzg0ZmQyMDk3XzU0OTc1NTgxNDE5Mg_49be9318-5f4f-4089-bffb-73f784a3423f"
      unitRef="usd">-37000000</ci:SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF84OTUvZnJhZzpjNGJkNmYzNjlhZTA0NGI3ODQwM2ZhYzg3OGYxOTk4NS90ZXh0cmVnaW9uOmM0YmQ2ZjM2OWFlMDQ0Yjc4NDAzZmFjODc4ZjE5OTg1XzYw_1fcdd39a-ff6a-4e51-82d7-e5a3dcb10263">Effective January 1, 2023, we adopted amended accounting guidance for long-duration insurance contracts. See Note 2 to the Consolidated Financial Statements for further information. Prior period summarized segment information has been retrospectively adjusted to conform to this new basis of accounting. Summarized segment financial information was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Evernorth Health Services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate and Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;34,511&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11,650&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46,240&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,618&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;963&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;143&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;277&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;36,179&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12,756&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;157&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46,517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Net realized investment results from certain equity method investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;36,179&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12,718&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;157&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46,479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,601&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-tax adjustments to reconcile to adjusted income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(Income) attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net realized investment losses (gains) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;459&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Special items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Integration and transaction-related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pre-tax adjusted income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,320&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,115&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,036&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Evernorth Health Services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cigna Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate and Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Net realized investment results from certain equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-tax adjustments to reconcile to adjusted income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(Income) attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net realized investment losses (gains) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Special items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Integration and transaction-related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pre-tax adjusted income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%;padding-left:2.94pt"&gt;Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.&lt;/span&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <ci:NonInvestmentRevenue
      contextRef="i3ea40c1add1f432fa8308f993c435e87_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzItMi0xLTEtNTQ3MDk4_a649ce32-548e-4d40-94ae-6264bfe5ce4d"
      unitRef="usd">34511000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzItNC0xLTEtNTQ3MDk4_3263963b-cc42-4d21-9b97-a1527e1c20b5"
      unitRef="usd">11650000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i69df325bba59494fa467077df69372c4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzItNi0xLTEtNTQ3MDk4_6b17051a-cef8-40e9-ad5e-907820f46c3a"
      unitRef="usd">79000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i477f7b8fc897444eb3eebca010f1c1a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzItOC0xLTEtNTQ3MDk4_a8956a44-463c-4174-961a-0ab698e5f521"
      unitRef="usd">0</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzItMTAtMS0xLTU0NzA5OA_3cf2cf9a-f5e8-4d6b-b9e5-d697ab990397"
      unitRef="usd">46240000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i0aa4b4d327cd427280e23f867e7643d7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMtMi0xLTEtNTQ3MDk4_74f2ea28-20e9-4a01-ba6b-c63ccfe96637"
      unitRef="usd">-1618000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i070491a32c554309b0445a4d7d37f76a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMtNC0xLTEtNTQ3MDk4_218caaa9-bcea-4e13-af02-a3c53f76ee58"
      unitRef="usd">-963000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i2b088ac82fa046b686f50cf0918542f7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMtNi0xLTEtNTQ3MDk4_c31d0006-412a-47e9-83a7-b8da65774554"
      unitRef="usd">0</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i06b3a5cafe1847468ebadf3df7edea80_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMtOC0xLTEtNTQ3MDk4_83851408-73e0-4cc3-a19d-d69f686c82a3"
      unitRef="usd">-2581000000</ci:NonInvestmentRevenue>
    <us-gaap:NetInvestmentIncome
      contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQtMi0xLTEtNTQ3MDk4_e014c3bc-a2ce-4159-84be-397f4ff1d68d"
      unitRef="usd">50000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQtNC0xLTEtNTQ3MDk4_2fd613d4-6194-4a30-9fc2-b989ca3d105e"
      unitRef="usd">143000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQtNi0xLTEtNTQ3MDk4_68a69127-9d0f-4010-a565-4151ae2d5dd2"
      unitRef="usd">78000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQtOC0xLTEtNTQ3MDk4_88410f9f-244a-426e-b584-42d99a58f187"
      unitRef="usd">6000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQtMTAtMS0xLTU0NzA5OA_f2c2aa6d-0e4b-483c-b35e-4b6b5c05444e"
      unitRef="usd">277000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUtMi0xLTEtNTQ3MDk4_77cf4103-606f-476b-b9bc-e0c6385effb2"
      unitRef="usd">36179000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUtNC0xLTEtNTQ3MDk4_3915a51d-a360-4174-9382-b21563d1f4b5"
      unitRef="usd">12756000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUtNi0xLTEtNTQ3MDk4_26701e7e-d24b-4296-b3e1-690204c40fcb"
      unitRef="usd">157000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUtOC0xLTEtNTQ3MDk4_3a71a27e-8172-4a2f-a3f9-a72af5bddc99"
      unitRef="usd">-2575000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUtMTAtMS0xLTU0NzA5OA_b1fa3dea-7f5e-48e2-b2f2-265498154538"
      unitRef="usd">46517000000</us-gaap:Revenues>
    <ci:RealizedInvestmentGainsLossesEquityMethodInvestments
      contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzYtMi0xLTEtNTQ3MDk4_9e6a75e3-59f8-4a24-bca6-c259c750ac6e"
      unitRef="usd">0</ci:RealizedInvestmentGainsLossesEquityMethodInvestments>
    <ci:RealizedInvestmentGainsLossesEquityMethodInvestments
      contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzYtNC0xLTEtNTQ3MDk4_904268d4-0d9c-40a8-aada-1f3178d56f12"
      unitRef="usd">38000000</ci:RealizedInvestmentGainsLossesEquityMethodInvestments>
    <ci:RealizedInvestmentGainsLossesEquityMethodInvestments
      contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzYtNi0xLTEtNTQ3MDk4_0bfdfb6d-1315-49c7-b546-6b7cc17eec6a"
      unitRef="usd">0</ci:RealizedInvestmentGainsLossesEquityMethodInvestments>
    <ci:RealizedInvestmentGainsLossesEquityMethodInvestments
      contextRef="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzYtOC0xLTEtNTQ3MDk4_29143155-3ae7-484a-9692-19a6c9420ae8"
      unitRef="usd">0</ci:RealizedInvestmentGainsLossesEquityMethodInvestments>
    <ci:RealizedInvestmentGainsLossesEquityMethodInvestments
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzYtMTAtMS0xLTU0NzA5OA_c6b551de-87ec-4c31-b694-34fcbeba6513"
      unitRef="usd">38000000</ci:RealizedInvestmentGainsLossesEquityMethodInvestments>
    <ci:SegmentRevenues
      contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzgtMi0xLTEtNTQ3MDk4_00fa4f40-0b55-405a-8dbb-a458d8a7cbf4"
      unitRef="usd">36179000000</ci:SegmentRevenues>
    <ci:SegmentRevenues
      contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzgtNC0xLTEtNTQ3MDk4_f5afbe6b-c245-4858-b085-d45438d014ae"
      unitRef="usd">12718000000</ci:SegmentRevenues>
    <ci:SegmentRevenues
      contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzgtNi0xLTEtNTQ3MDk4_86647f5e-380f-42d0-b31e-9882b6ca3f3d"
      unitRef="usd">157000000</ci:SegmentRevenues>
    <ci:SegmentRevenues
      contextRef="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzgtOC0xLTEtNTQ3MDk4_d1b27e4e-7227-41f2-a2da-7bfae49fc1bb"
      unitRef="usd">-2575000000</ci:SegmentRevenues>
    <ci:SegmentRevenues
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzgtMTAtMS0xLTU0NzA5OA_296d3757-0b98-4e06-b535-3e0b6166cf5f"
      unitRef="usd">46479000000</ci:SegmentRevenues>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEwLTItMS0xLTU0NzA5OA_8dda3df1-7395-4496-9b1a-77adc33844de"
      unitRef="usd">918000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEwLTQtMS0xLTU0NzA5OA_9fca3e26-3c33-477e-988a-e14d71a391b2"
      unitRef="usd">1077000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEwLTYtMS0xLTU0NzA5OA_29e2a362-6289-4a45-8bc9-4c2274e74676"
      unitRef="usd">21000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEwLTgtMS0xLTU0NzA5OA_38dadec9-7cf5-4ca9-948e-88c9f7566670"
      unitRef="usd">-415000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEwLTEwLTEtMS01NDcwOTg_f25abd6e-c73a-4be9-bc8d-0359417f7b88"
      unitRef="usd">1601000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax
      contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEyLTItMS0xLTU0NzA5OA_8e9d4205-0b96-4cc2-af93-24536ffd0e56"
      unitRef="usd">42000000</ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax>
    <ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax
      contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEyLTQtMS0xLTU0NzA5OA_7a31bc9c-10ad-4d52-a850-1e8fc206bf7d"
      unitRef="usd">1000000</ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax>
    <ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax
      contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEyLTYtMS0xLTU0NzA5OA_d0e0bd50-5f0f-4e67-af19-ede7308f37c5"
      unitRef="usd">0</ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax>
    <ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax
      contextRef="i477f7b8fc897444eb3eebca010f1c1a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEyLTgtMS0xLTU0NzA5OA_b6528e38-f29e-499c-80d5-4a40028ec761"
      unitRef="usd">0</ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax>
    <ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEyLTEwLTEtMS01NDcwOTg_be51d583-2e19-4824-a393-39ffab511d60"
      unitRef="usd">43000000</ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax>
    <ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
      contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEzLTItMS0xLTU0NzA5OA_47088b60-d3b8-4664-b00c-f2d632fcc90c"
      unitRef="usd">0</ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries>
    <ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
      contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEzLTQtMS0xLTU0NzA5OA_20344983-f4ea-4d23-9a4e-583c1c675679"
      unitRef="usd">-24000000</ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries>
    <ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
      contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEzLTYtMS0xLTU0NzA5OA_3b5c09cd-013f-42c7-9fe0-19e41e09f044"
      unitRef="usd">6000000</ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries>
    <ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
      contextRef="i477f7b8fc897444eb3eebca010f1c1a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEzLTgtMS0xLTU0NzA5OA_6f2ac3a6-65aa-4700-88cb-6c8a60115827"
      unitRef="usd">0</ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries>
    <ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzEzLTEwLTEtMS01NDcwOTg_b24b9efd-7734-4620-ad28-af771f595d49"
      unitRef="usd">-18000000</ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE0LTItMS0xLTU0NzA5OA_ebdd075e-ba0a-4d2f-a11b-b1e4d2c8f16f"
      unitRef="usd">444000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE0LTQtMS0xLTU0NzA5OA_290838fb-13dc-428f-a34a-5154f42c771e"
      unitRef="usd">15000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE0LTYtMS0xLTU0NzA5OA_43e5c31a-3ed3-4a34-8feb-252678e6d1f3"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i477f7b8fc897444eb3eebca010f1c1a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE0LTgtMS0xLTU0NzA5OA_8e45632b-9ced-4e13-92b7-a433572565e1"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE0LTEwLTEtMS01NDcwOTg_ae32cc59-b395-4cc0-a6d1-6c57776ba05a"
      unitRef="usd">459000000</us-gaap:AmortizationOfIntangibleAssets>
    <ci:TransactionRelatedCosts
      contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE2LTItMS0xLTU0NzA5OA_01ab55cd-0d66-4d2c-915b-1c4cb33599d4"
      unitRef="usd">0</ci:TransactionRelatedCosts>
    <ci:TransactionRelatedCosts
      contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE2LTQtMS0xLTU0NzA5OA_d117ac11-bf13-4a9e-9954-bbe1476ef253"
      unitRef="usd">0</ci:TransactionRelatedCosts>
    <ci:TransactionRelatedCosts
      contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE2LTYtMS0xLTU0NzA5OA_86548429-8dc2-4533-9c00-497f4df22f84"
      unitRef="usd">0</ci:TransactionRelatedCosts>
    <ci:TransactionRelatedCosts
      contextRef="i477f7b8fc897444eb3eebca010f1c1a0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE2LTgtMS0xLTU0NzA5OA_f33b77d0-6ccf-4060-8f95-13107dc816ae"
      unitRef="usd">1000000</ci:TransactionRelatedCosts>
    <ci:TransactionRelatedCosts
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzE2LTEwLTEtMS01NDcwOTg_4fe784a1-6e42-4ada-bb5d-f989fa748a9b"
      unitRef="usd">1000000</ci:TransactionRelatedCosts>
    <ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i52975741f5b743d397d1c230ee0efabd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI0LTItMS0xLTU0NzA5OA_fdb0f6cb-8835-4187-a9db-05372d14c8fb"
      unitRef="usd">1320000000</ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib237d7386fc0472b9a506110cb61f44b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI0LTQtMS0xLTU0NzA5OA_e3eb771a-5c53-45cb-80d6-fd3d1ffaf958"
      unitRef="usd">1115000000</ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2cfd792e023147cea75b506ff355c317_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI0LTYtMS0xLTU0NzA5OA_6186b18d-90d0-4d7a-afc0-06f656a59051"
      unitRef="usd">15000000</ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8e5ea39eca164e8e8a90cedba5af3ece_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI0LTgtMS0xLTU0NzA5OA_e1561ae1-2bdf-47ab-ab2d-c0559e899bad"
      unitRef="usd">-414000000</ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI0LTEwLTEtMS01NDcwOTg_15391f32-081a-4ecf-9a29-5d32dc5924e4"
      unitRef="usd">2036000000</ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <ci:NonInvestmentRevenue
      contextRef="i21521b1995554ec8b02652d45c45d285_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI4LTItMS0xLTU0NzA5OA_bdca7244-feed-44c4-b684-2d3b69fa3580"
      unitRef="usd">32289000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i0c17511bddf043d19b3f9f2ec6405f99_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI4LTQtMS0xLTU0NzA5OA_83ef90b5-2e29-4848-91fa-9c12bcf1c60e"
      unitRef="usd">10462000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i95c34c40cb7248e783ae13fc742a640d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI4LTYtMS0xLTU0NzA5OA_952c1a1d-e104-4462-b4a3-666a8f6d7e39"
      unitRef="usd">841000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="ic95354c853bf4761a405bfd3190f1ed6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI4LTgtMS0xLTU0NzA5OA_f3204551-baaa-473b-be25-ad6a7f8e76ea"
      unitRef="usd">0</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI4LTEwLTEtMS01NDcwOTg_c8b71c6f-c04b-450c-938c-b0f8a4b03c07"
      unitRef="usd">43592000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i4127249d3cc243de9f905eb276897d65_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI5LTItMS0xLTU0NzA5OA_dc3df917-6a3e-4a78-9c3e-2b7bb82a06ab"
      unitRef="usd">-1287000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i569d8e14804541b9a5e8a0e5a286a5bc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI5LTQtMS0xLTU0NzA5OA_890a540b-a528-4281-aa28-ff99cff572f9"
      unitRef="usd">-562000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i724c42af69b6448fb2e4a5b6e6c155f7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI5LTYtMS0xLTU0NzA5OA_5c434ee1-88cb-4d33-8933-5fd54738b232"
      unitRef="usd">0</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i098db1bf768848acb5c35d20817215a9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzI5LTgtMS0xLTU0NzA5OA_54a6a52a-fa77-4fdc-9469-637e67a58024"
      unitRef="usd">-1849000000</ci:NonInvestmentRevenue>
    <us-gaap:NetInvestmentIncome
      contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMwLTItMS0xLTU0NzA5OA_0fd5bb88-68a7-4aba-8e3c-290ebc52ddb9"
      unitRef="usd">10000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMwLTQtMS0xLTU0NzA5OA_00fa5f5b-79d2-4024-bf6f-6489c641375d"
      unitRef="usd">266000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMwLTYtMS0xLTU0NzA5OA_952b5c75-79c3-47cb-9728-1d483e934a94"
      unitRef="usd">138000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMwLTgtMS0xLTU0NzA5OA_5b1b8b90-3573-4ad3-a275-5549c3834d87"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMwLTEwLTEtMS01NDcwOTg_9a03e151-a664-4f9e-9390-e148c0df0368"
      unitRef="usd">414000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMxLTItMS0xLTU0NzA5OA_c6d58d90-2d70-4231-8d3a-803d230bfaf1"
      unitRef="usd">33586000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMxLTQtMS0xLTU0NzA5OA_2a73b2ac-d30c-4a69-b586-52bd4d63fb05"
      unitRef="usd">11290000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMxLTYtMS0xLTU0NzA5OA_c64b9727-ee95-461c-8139-c27c28081840"
      unitRef="usd">979000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMxLTgtMS0xLTU0NzA5OA_8a04ada7-3c51-463c-b8ad-77e6dabb945e"
      unitRef="usd">-1849000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMxLTEwLTEtMS01NDcwOTg_e135917b-3c0f-4ffe-90a1-07a8cccf6a62"
      unitRef="usd">44006000000</us-gaap:Revenues>
    <ci:RealizedInvestmentGainsLossesEquityMethodInvestments
      contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMzLTItMS0xLTU0NzA5OA_d479ef98-7e45-4de2-b9f1-64bd10ea9a7b"
      unitRef="usd">0</ci:RealizedInvestmentGainsLossesEquityMethodInvestments>
    <ci:RealizedInvestmentGainsLossesEquityMethodInvestments
      contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMzLTQtMS0xLTU0NzA5OA_3d1e1ed8-dad1-4982-a276-7099063ae4a2"
      unitRef="usd">-103000000</ci:RealizedInvestmentGainsLossesEquityMethodInvestments>
    <ci:RealizedInvestmentGainsLossesEquityMethodInvestments
      contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMzLTYtMS0xLTU0NzA5OA_bac537bb-91b5-4f27-9aa9-4ea9a46933ea"
      unitRef="usd">0</ci:RealizedInvestmentGainsLossesEquityMethodInvestments>
    <ci:RealizedInvestmentGainsLossesEquityMethodInvestments
      contextRef="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMzLTgtMS0xLTU0NzA5OA_3f417c00-2490-410a-a51d-e33a3aa8e5c6"
      unitRef="usd">0</ci:RealizedInvestmentGainsLossesEquityMethodInvestments>
    <ci:RealizedInvestmentGainsLossesEquityMethodInvestments
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzMzLTEwLTEtMS01NDcwOTg_22d200c4-6566-492d-a9b4-df7e5ae5a08d"
      unitRef="usd">-103000000</ci:RealizedInvestmentGainsLossesEquityMethodInvestments>
    <ci:SegmentRevenues
      contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM1LTItMS0xLTU0NzA5OA_43c8d5ef-6ae2-46d3-ae00-1c9ba6bbad0c"
      unitRef="usd">33586000000</ci:SegmentRevenues>
    <ci:SegmentRevenues
      contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM1LTQtMS0xLTU0NzA5OA_fd782bab-3c9a-4fb4-9b42-5b41fc50e9f3"
      unitRef="usd">11393000000</ci:SegmentRevenues>
    <ci:SegmentRevenues
      contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM1LTYtMS0xLTU0NzA5OA_c61921e5-992e-4626-99db-4ed8e49697a1"
      unitRef="usd">979000000</ci:SegmentRevenues>
    <ci:SegmentRevenues
      contextRef="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM1LTgtMS0xLTU0NzA5OA_d44b7b18-358d-44f0-92ed-823a7d170cbb"
      unitRef="usd">-1849000000</ci:SegmentRevenues>
    <ci:SegmentRevenues
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM1LTEwLTEtMS01NDcwOTg_1f85ba07-8b7e-4443-b19c-6a68e740b4c3"
      unitRef="usd">44109000000</ci:SegmentRevenues>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM3LTItMS0xLTU0NzA5OA_d9e85f97-782a-40ec-ab0b-8184326d76ee"
      unitRef="usd">870000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM3LTQtMS0xLTU0NzA5OA_c61bf8d8-56b9-413d-8e4e-3409be4f9c04"
      unitRef="usd">877000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM3LTYtMS0xLTU0NzA5OA_51c929a9-220a-42f4-a7c5-01d22302dd4b"
      unitRef="usd">215000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM3LTgtMS0xLTU0NzA5OA_539af87c-c276-412f-a227-5ed75c6faea0"
      unitRef="usd">-395000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM3LTEwLTEtMS01NDcwOTg_ebe48a11-10df-4be9-9b9e-f8b680c40851"
      unitRef="usd">1567000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax
      contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM5LTItMS0xLTU0NzA5OA_30ce66bd-d798-402b-bc2f-118d757b4790"
      unitRef="usd">11000000</ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax>
    <ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax
      contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM5LTQtMS0xLTU0NzA5OA_2b87a580-757b-44aa-b41f-a6479f8955af"
      unitRef="usd">1000000</ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax>
    <ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax
      contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM5LTYtMS0xLTU0NzA5OA_b160ff20-ae7b-44da-b970-3376ef99ea8a"
      unitRef="usd">5000000</ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax>
    <ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax
      contextRef="ic95354c853bf4761a405bfd3190f1ed6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM5LTgtMS0xLTU0NzA5OA_b84414d8-b048-481d-9331-10b6e7917753"
      unitRef="usd">0</ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax>
    <ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzM5LTEwLTEtMS01NDcwOTg_1ea7cfb9-d849-456d-849e-58b76c0abfbc"
      unitRef="usd">17000000</ci:IncomeLossAttributableToNoncontrollingInterestBeforeTax>
    <ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
      contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQwLTItMS0xLTU0NzA5OA_3efe93d9-7ac2-41a1-b848-643f867f9738"
      unitRef="usd">0</ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries>
    <ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
      contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQwLTQtMS0xLTU0NzA5OA_2f48cf94-8521-473c-90cb-7437557be277"
      unitRef="usd">-406000000</ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries>
    <ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
      contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQwLTYtMS0xLTU0NzA5OA_54a55416-a2e2-4345-ac01-23ba97c0a759"
      unitRef="usd">-19000000</ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries>
    <ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
      contextRef="ic95354c853bf4761a405bfd3190f1ed6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQwLTgtMS0xLTU0NzA5OA_c8a1fede-9b0f-4585-805c-9031a1f5f6d5"
      unitRef="usd">0</ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries>
    <ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQwLTEwLTEtMS01NDcwOTg_56cc7f5f-b5d4-45ba-9155-36a97e3335ee"
      unitRef="usd">-425000000</ci:RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQxLTItMS0xLTU0NzA5OA_924b49db-e142-4230-8b01-810cbeda3f0c"
      unitRef="usd">443000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQxLTQtMS0xLTU0NzA5OA_0882db20-9a3a-4e02-a7f0-6a507a6b440a"
      unitRef="usd">15000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQxLTYtMS0xLTU0NzA5OA_3b24d079-35e5-4c65-b8cb-328828360f41"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic95354c853bf4761a405bfd3190f1ed6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQxLTgtMS0xLTU0NzA5OA_114022a2-14cb-4f1f-9f2f-bd7025e7ec10"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQxLTEwLTEtMS01NDcwOTg_10f0a0d8-89d7-45de-9262-6c5808694169"
      unitRef="usd">458000000</us-gaap:AmortizationOfIntangibleAssets>
    <ci:TransactionRelatedCosts
      contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQzLTItMS0xLTU0NzA5OA_cfbb4865-f2c3-4d4a-8184-b00c4746ae9a"
      unitRef="usd">0</ci:TransactionRelatedCosts>
    <ci:TransactionRelatedCosts
      contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQzLTQtMS0xLTU0NzA5OA_e7bb06ab-e061-40ef-a88e-16b55b18cf25"
      unitRef="usd">0</ci:TransactionRelatedCosts>
    <ci:TransactionRelatedCosts
      contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQzLTYtMS0xLTU0NzA5OA_2cdea456-c691-4669-a0ab-e0fd26413bf6"
      unitRef="usd">0</ci:TransactionRelatedCosts>
    <ci:TransactionRelatedCosts
      contextRef="ic95354c853bf4761a405bfd3190f1ed6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQzLTgtMS0xLTU0NzA5OA_e3a2e65a-96d1-453e-993d-ffb8537abdb8"
      unitRef="usd">52000000</ci:TransactionRelatedCosts>
    <ci:TransactionRelatedCosts
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzQzLTEwLTEtMS01NDcwOTg_b2e38d57-f232-47e7-b152-a00cb1c5f8e8"
      unitRef="usd">52000000</ci:TransactionRelatedCosts>
    <ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icd49f43776dd4735b953f9d403d03b94_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUxLTItMS0xLTU0NzA5OA_047e5e41-947b-47ca-8f9d-b217f91f2954"
      unitRef="usd">1302000000</ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8c82b42922ac446cace99ca0e53e3f4f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUxLTQtMS0xLTU0NzA5OA_8e07f05d-3153-4f3b-9d77-f1f2005495e8"
      unitRef="usd">1297000000</ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i48937205bb2a466ca4f1d04f3313e053_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUxLTYtMS0xLTU0NzA5OA_143feff4-55f7-48bb-b19c-852496243635"
      unitRef="usd">229000000</ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9beda9005ff246f689493b48e7c6ead5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUxLTgtMS0xLTU0NzA5OA_95a5fe98-58db-4bf0-89da-a529dc049f79"
      unitRef="usd">-343000000</ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MDEvZnJhZzphMTY5NGMyYWJhNDY0YzQ0YjkyZTY1NDdjMzRhMDYwYi90YWJsZToyYTg3NTU3MTkwZWE0M2M5YjBjMjA5MzI5M2I0NDM1ZC90YWJsZXJhbmdlOjJhODc1NTcxOTBlYTQzYzliMGMyMDkzMjkzYjQ0MzVkXzUxLTEwLTEtMS01NDcwOTg_fe87b11f-d52c-4c0f-b656-cb673da34641"
      unitRef="usd">2485000000</ci:AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d60420098854826bb75b05e15a8dd62_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzQtNi0xLTEtNTQ3MDk4_ba00f80b-dfda-455b-8513-6b30d3ebb392"
      unitRef="usd">15748000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieeb14631940d478e80234443fdde93c4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzQtOC0xLTEtNTQ3MDk4_3c9521a7-e3a3-4317-870d-7d8ba805dae7"
      unitRef="usd">15531000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b73e14198fb493797caa14157f4db48_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzUtNi0xLTEtNTQ3MDk4_921bd8c3-eb6f-4191-a98a-4c19db6e3f6c"
      unitRef="usd">16025000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1d9f3a8c7e244afaeef48f7c0e28797_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzUtOC0xLTEtNTQ3MDk4_26194a18-221d-4a42-8249-57c720f3fb4d"
      unitRef="usd">14699000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6dc2e436d3a3436ca9bb0c3657718683_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzYtNi0xLTEtNTQ3MDk4_e9b514b0-8d94-41cd-8ef0-3ec9877d8f4d"
      unitRef="usd">1867000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib360b82d50b24f408baf926cbd36d43a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzYtOC0xLTEtNTQ3MDk4_3331403e-6302-4a4f-af1b-8ce135a0b738"
      unitRef="usd">1712000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie39a13614111404c93bbc50726bc2979_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzctNi0xLTEtNTQ3MDk4_f0b39aee-f7e9-48e1-9c5b-73d5f310d3a0"
      unitRef="usd">-1496000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46b371195fbd4772a749aa7a8dd2fd45_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzctOC0xLTEtNTQ3MDk4_f07d30f9-3b55-406c-9776-3f610bbba1cb"
      unitRef="usd">-1245000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i933d49a7caa5445f9359253b5b0b5023_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzgtNi0xLTEtNTQ3MDk4_907b1c32-cdcc-42b0-9f8c-2c8193eb68d9"
      unitRef="usd">32144000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2699cfc415ab4727a3246be3ce9a03fb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzgtOC0xLTEtNTQ3MDk4_3b5fe53f-f511-47b3-96a7-5b79c5833cfb"
      unitRef="usd">30697000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:PremiumsEarnedNet
      contextRef="i08e34d7cd37940d9be3d86d7521f5686_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzEyLTYtMS0xLTU0NzA5OA_e779c04c-de0f-4fbd-bc0e-bc33be20c06a"
      unitRef="usd">4080000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie1dd8e92561043ffbfbeda8cee9c928f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzEyLTgtMS0xLTU0NzA5OA_23f7e682-2a84-4a60-a472-dfda512699b3"
      unitRef="usd">3720000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie3e9e00387384de780ea3b39d4254134_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzEzLTYtMS0xLTU0NzA5OA_ac3b0663-895f-4238-a44a-430348593271"
      unitRef="usd">1503000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i33cfaac4439f45c89db679459cae7478_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzEzLTgtMS0xLTU0NzA5OA_437dbe8d-bddc-4454-91bd-5afa79114f57"
      unitRef="usd">1325000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i834a123ddeb74d1eaa0c05c2490b66b9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE0LTYtMS0xLTU0NzA5OA_f7d47d7c-61a2-4ead-ad97-43dfc3c571bb"
      unitRef="usd">368000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i3733229295b04395a86ff23f3d3e14d6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE0LTgtMS0xLTU0NzA5OA_3a3b255f-ff84-4b46-b036-a1defa67af20"
      unitRef="usd">360000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="idd3caeb6fdf54d798d5192a6b8874b10_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE2LTYtMS0xLTU0NzA5OA_b950d83e-dbe6-47d8-ade9-47a1cdbd9ccb"
      unitRef="usd">2236000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic5f66cd5ef874b81984fce532b63f71b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE2LTgtMS0xLTU0NzA5OA_9739a9a3-a05f-4cdf-8280-fe1cd82ba17e"
      unitRef="usd">2078000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic24d316520f741b8aeeb8ece569a197f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE3LTYtMS0xLTU0NzA5OA_04609c9c-4a14-47bf-9d5c-6fbca7b483a6"
      unitRef="usd">415000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i300f527e494a4843be09f505c8e493ff_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE3LTgtMS0xLTU0NzA5OA_f11995cd-b4f2-4f37-86ce-a6050777b736"
      unitRef="usd">401000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i700e68e0f51a4716a2d3851471d18417_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE5LTYtMS0xLTU0NzA5OA_eacedf20-a8a9-4a86-8c5c-7d7040e98324"
      unitRef="usd">1208000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ib8ae8fc97f3b4994bbaf95a5fe2b78d5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzE5LTgtMS0xLTU0NzA5OA_e5387150-f006-4ca1-9e8b-fbe006cfa721"
      unitRef="usd">611000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i36971d451ade4af1a50bd70e7bb2a491_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzIwLTYtMS0xLTU0NzA5OA_63e30f91-c63c-44de-bf18-1f521f459790"
      unitRef="usd">334000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ib2336928c4ea49a6bc4d4b5d15ee8bb8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzIwLTgtMS0xLTU0NzA5OA_c279e9fb-b2f1-4e4b-9182-0fa0cba40842"
      unitRef="usd">329000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ieaf7a109b0e34a0b924d846bbfe77c7a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzIyLTYtMS0xLTU0NzA5OA_75bde9e6-a14b-45f7-bff2-28f18fd128ee"
      unitRef="usd">700000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i19b8b552cfe8495aa3582c0783a57614_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzIyLTgtMS0xLTU0NzA5OA_32b14a90-8026-421d-a3cf-561a97a357ee"
      unitRef="usd">620000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i9c721be6f0264a54b1ef23c9b0206b6e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzIzLTYtMS0xLTU0NzA5OA_f9cfe49e-e410-47fa-a62b-b1fb777fbb1f"
      unitRef="usd">86000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ib9dbc603d392490aa593c0ee390a23ae_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzIzLTgtMS0xLTU0NzA5OA_1c941c06-26a5-4c4c-a3eb-38a0e0ae199f"
      unitRef="usd">82000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ib2847aa537584cefa3f2f5652bedb86f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI0LTYtMS0xLTU0NzA5OA_5a714504-31b1-4391-b41f-840968eb4d12"
      unitRef="usd">10930000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ib92eee19a6c741c3adc4a9c5ace7b113_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI0LTgtMS0xLTU0NzA5OA_73777da8-02f0-43a2-ac41-4382254b1c45"
      unitRef="usd">9526000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ia11f9b58557a432b96d0a2ff40cf82c3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI1LTYtMS0xLTU0NzA5OA_018d01fd-022a-4113-809a-6dfd05f01b84"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="idccd94a3f926401c88f9bd7436ab16f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI1LTgtMS0xLTU0NzA5OA_72e36c55-f606-467f-a0d4-6b08c100b0ec"
      unitRef="usd">763000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i0bccbb16e5d84306923a81662d3ea9ab_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI3LTYtMS0xLTYxOTkyMA_2a5850c2-fc22-471e-90c1-2d2b66619700"
      unitRef="usd">79000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i79d10ac7a0e94fe7b6f88281dfc04939_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI3LTgtMS0xLTYxOTkyMA_bb3128a4-387e-407b-a4ba-48356bd0e1ce"
      unitRef="usd">69000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i06b3a5cafe1847468ebadf3df7edea80_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI4LTYtMS0xLTU0NzA5OA_271dced2-1c40-44f4-b87a-194a4eccae20"
      unitRef="usd">16000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i098db1bf768848acb5c35d20817215a9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI4LTgtMS0xLTU0NzA5OA_da9be9a8-1c9c-4846-b37e-6a0919e65120"
      unitRef="usd">-2000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI5LTYtMS0xLTU0NzA5OA_97df2651-0fed-44f3-8d98-93f7fc6a9151"
      unitRef="usd">11025000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzI5LTgtMS0xLTU0NzA5OA_f649c7ff-cd76-47fd-be7b-b46bfcb64699"
      unitRef="usd">10356000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7d6a700163d4c319d21beade0fbcc04_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzMyLTYtMS0xLTU0NzA5OA_4282095d-1ab2-4ce9-a475-f3a5c67c5436"
      unitRef="usd">2499000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1627e82149974da486e8f3cc3f75d2ab_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzMyLTgtMS0xLTU0NzA5OA_5e1df0fa-fb2b-4caf-879a-d64c6d98046c"
      unitRef="usd">1624000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a92f9eb139e45b58b6841d00343544b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzMzLTYtMS0xLTU0NzA5OA_1faf4a13-a0aa-47a0-9776-c20adea10792"
      unitRef="usd">1606000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idffd5dd03d124226bb773704874daf86_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzMzLTgtMS0xLTU0NzA5OA_72e6d793-7a30-411e-83d7-f3216b0d31e6"
      unitRef="usd">1496000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b6cacd9b87c4887ab34f6e65fe9d106_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM0LTYtMS0xLTU0NzA5OA_2ba73519-e3ec-4988-9db0-66bcb94d54f7"
      unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3577cdfec471463b8b1da0e53a0c050c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM0LTgtMS0xLTU0NzA5OA_0221901f-4df7-4578-9d61-2b99a31abb11"
      unitRef="usd">5000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22cd581f72e445d8916b2124487b2977_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM1LTYtMS0xLTU0NzA5OA_5fcd1344-2984-47b0-94de-b14e875260ae"
      unitRef="usd">66000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e8cce4152f1403bace3946d48f2b9f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM1LTgtMS0xLTU0NzA5OA_9ff3f121-134e-4ed6-ab45-19ed11af7750"
      unitRef="usd">16000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10032a6591314de5846c1184b289a4b8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM2LTYtMS0xLTU0NzA5OA_f320d87f-69bd-4806-aa77-6bf9b7dea9ba"
      unitRef="usd">-1101000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9e80ce4c0d14006b2d6a845fa506e93_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM2LTgtMS0xLTU0NzA5OA_57505bb3-8115-4775-88f5-ae91ae9e6dd2"
      unitRef="usd">-602000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1cf64ff3b0a2466f81f78f097b7c8d5d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM3LTYtMS0xLTU0NzA5OA_a037a379-ee93-4ddc-ac73-bd2c6a573826"
      unitRef="usd">3071000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i530643094c274242bf05d8df55f63659_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM3LTgtMS0xLTU0NzA5OA_054c4657-58d7-44bf-b47c-e151feee5702"
      unitRef="usd">2539000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ci:NonInvestmentRevenue
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM4LTYtMS0xLTU0NzA5OA_f608adf4-c48a-4a94-bfc1-b5c13df7d8ba"
      unitRef="usd">46240000000</ci:NonInvestmentRevenue>
    <ci:NonInvestmentRevenue
      contextRef="i044bb95efb8c4a0bbb942e2001a161da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTAvZnJhZzphMWE4NGI0NzFjOWY0ZWZkYmM1ZGRmNDc5Yjk3YmQzZi90YWJsZTo0YjkzZTdiZjJhMDU0ZjJlOTkxMzEwYzY4MzFhZDE5OC90YWJsZXJhbmdlOjRiOTNlN2JmMmEwNTRmMmU5OTEzMTBjNjgzMWFkMTk4XzM4LTgtMS0xLTU0NzA5OA_312d3fa0-e101-47b2-8cda-7d380e0421c9"
      unitRef="usd">43592000000</ci:NonInvestmentRevenue>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i6773af2402ee4977b48366d53115a5cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTMvZnJhZzphYzhiMzU0NDMyZjE0MDA2OWZjMTA2ZDI5MmM5OTg0NC90ZXh0cmVnaW9uOmFjOGIzNTQ0MzJmMTQwMDY5ZmMxMDZkMjkyYzk5ODQ0XzY1Mw_f4d4a11f-adc5-42ac-934e-ae32f8ff690c">Evernorth Health Services may also provide certain financial and performance guarantees, including a minimum level of discounts a client may receive, generic utilization rates and various service levels. Clients may be entitled to receive compensation if we fail to meet the guarantees. Actual performance is compared to the contractual guarantee for each measure throughout the period and the Company defers revenue for any estimated payouts within Accrued expenses and other liabilities (current). These estimates are adjusted and paid following the end of the annual guarantee period.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i9556a32ddbb54ebeb4e7256d387ed702_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTMvZnJhZzphYzhiMzU0NDMyZjE0MDA2OWZjMTA2ZDI5MmM5OTg0NC90ZXh0cmVnaW9uOmFjOGIzNTQ0MzJmMTQwMDY5ZmMxMDZkMjkyYzk5ODQ0XzYzNQ_81858e51-d1e0-4512-9985-e4951ecdba14"
      unitRef="usd">1500000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i63fb1e4d8af94facb895426daf4d4db1_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF85MTMvZnJhZzphYzhiMzU0NDMyZjE0MDA2OWZjMTA2ZDI5MmM5OTg0NC90ZXh0cmVnaW9uOmFjOGIzNTQ0MzJmMTQwMDY5ZmMxMDZkMjkyYzk5ODQ0XzE2NDkyNjc0NDIzMjA_833272c8-1772-4a06-8ef1-040a5d2ad77a"
      unitRef="usd">1300000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTMtMS0xLTU0NzA5OA_20560a86-6865-406c-95e4-b3ce23b74169"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTMtMS0xLTU0NzA5OA_20560a86-6865-406c-95e4-b3ce23b74169"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTMtMS0xLTU0NzA5OA_20560a86-6865-406c-95e4-b3ce23b74169"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzE4Mg_c38bd102-2a43-40c9-954e-9ee16d667456" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzE4Mg_c38bd102-2a43-40c9-954e-9ee16d667456" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Par value per share, $0.01; shares issued, 399 million as of March&#160;31, 2023 and 398 million as of December&#160;31, 2022; authorized shares, 600 million.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTMtMS0xLTU0NzA5OA_20560a86-6865-406c-95e4-b3ce23b74169"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzE4Mg_c38bd102-2a43-40c9-954e-9ee16d667456"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTQtMS0xLTU0NzA5OA_5e85d59a-d8a5-45a7-8a41-a74c2856ca74"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTQtMS0xLTU0NzA5OA_5e85d59a-d8a5-45a7-8a41-a74c2856ca74"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTQtMS0xLTU0NzA5OA_5e85d59a-d8a5-45a7-8a41-a74c2856ca74"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzI1Mg_621034ee-a185-4141-b59a-278aa5be2095" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzI1Mg_621034ee-a185-4141-b59a-278aa5be2095" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Restricted cash and cash equivalents were reported in other long-term investments.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTQtMS0xLTU0NzA5OA_5e85d59a-d8a5-45a7-8a41-a74c2856ca74"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzI1Mg_621034ee-a185-4141-b59a-278aa5be2095"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTQtMS0xLTU0NzA5OA_79aa366d-893d-4698-8351-155de9b73318"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTQtMS0xLTU0NzA5OA_79aa366d-893d-4698-8351-155de9b73318"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTQtMS0xLTU0NzA5OA_79aa366d-893d-4698-8351-155de9b73318"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzU0OTc1NTgxNDQ3OQ_1dc42f8b-c807-4376-a384-691001e0ef4e" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzU0OTc1NTgxNDQ3OQ_1dc42f8b-c807-4376-a384-691001e0ef4e" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes $425 million reported in Assets of businesses held for sale as of January 1, 2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTQtMS0xLTU0NzA5OA_79aa366d-893d-4698-8351-155de9b73318"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzU0OTc1NTgxNDQ3OQ_1dc42f8b-c807-4376-a384-691001e0ef4e"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI2LTctMS0xLTU0NzA5OA_e5fba830-b7e9-4d2a-9d4e-e9ecb3440398"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI2LTctMS0xLTU0NzA5OA_e5fba830-b7e9-4d2a-9d4e-e9ecb3440398"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE5LTctMS0xLTU0NzA5OA_3dea0a2f-db00-4c45-bc82-390112e51307"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE5LTctMS0xLTU0NzA5OA_3dea0a2f-db00-4c45-bc82-390112e51307"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzctNy0xLTEtNTQ3MDk4_b608a220-43b4-414e-bb6d-c0d3e771d842"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzctNy0xLTEtNTQ3MDk4_b608a220-43b4-414e-bb6d-c0d3e771d842"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE0LTctMS0xLTU0NzA5OA_3fd58480-6fc6-4346-a85f-569666fd106e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE0LTctMS0xLTU0NzA5OA_3fd58480-6fc6-4346-a85f-569666fd106e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI3LTctMS0xLTU0NzA5OA_b71d309d-9ca3-4c0b-aa5c-2b67275d02db"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI3LTctMS0xLTU0NzA5OA_b71d309d-9ca3-4c0b-aa5c-2b67275d02db"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzMwLTctMS0xLTU0NzA5OA_fbc1a597-6d69-4d17-8314-e2aeec6dfd6f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzMwLTctMS0xLTU0NzA5OA_fbc1a597-6d69-4d17-8314-e2aeec6dfd6f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE1LTctMS0xLTU0NzA5OA_aa2ba26f-2635-4ed1-9fe2-749bf50cc82a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE1LTctMS0xLTU0NzA5OA_aa2ba26f-2635-4ed1-9fe2-749bf50cc82a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE4LTctMS0xLTU0NzA5OA_56970ec1-46d1-42da-a19c-a4deb639cfd2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE4LTctMS0xLTU0NzA5OA_56970ec1-46d1-42da-a19c-a4deb639cfd2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzgtNy0xLTEtNTQ3MDk4_82bd1d0d-3d97-4d39-b707-03d5f4ea8e2f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzgtNy0xLTEtNTQ3MDk4_82bd1d0d-3d97-4d39-b707-03d5f4ea8e2f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE3LTctMS0xLTU0NzA5OA_2c887ebd-2fb1-4159-b27e-a29d03ae639e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE3LTctMS0xLTU0NzA5OA_2c887ebd-2fb1-4159-b27e-a29d03ae639e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIyLTctMS0xLTU0NzA5OA_12493226-c472-47e5-99ea-a9c4706db302"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIyLTctMS0xLTU0NzA5OA_12493226-c472-47e5-99ea-a9c4706db302"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI1LTctMS0xLTU0NzA5OA_102a37c5-08ac-4a1e-9332-52a57043267b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI1LTctMS0xLTU0NzA5OA_102a37c5-08ac-4a1e-9332-52a57043267b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI5LTctMS0xLTU0NzA5OA_7e94545c-5dd5-40ad-8402-14ded75dd02b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI5LTctMS0xLTU0NzA5OA_7e94545c-5dd5-40ad-8402-14ded75dd02b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEwLTctMS0xLTU0NzA5OA_36cf6d52-c0ac-4ef6-9830-7348e5cae671"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEwLTctMS0xLTU0NzA5OA_36cf6d52-c0ac-4ef6-9830-7348e5cae671"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE2LTctMS0xLTU0NzA5OA_01ad8e17-2c25-4100-9031-1579a895ff34"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE2LTctMS0xLTU0NzA5OA_01ad8e17-2c25-4100-9031-1579a895ff34"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzExLTctMS0xLTU0NzA5OA_b9e95365-24e8-46b2-a0f0-ac7626b5a698"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzExLTctMS0xLTU0NzA5OA_b9e95365-24e8-46b2-a0f0-ac7626b5a698"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEzLTctMS0xLTU0NzA5OA_2fc001d2-249f-4ef4-b606-4b3956446652"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEzLTctMS0xLTU0NzA5OA_2fc001d2-249f-4ef4-b606-4b3956446652"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIzLTctMS0xLTU0NzA5OA_1556d15b-48f1-4191-86f8-73377cfb6937"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIzLTctMS0xLTU0NzA5OA_1556d15b-48f1-4191-86f8-73377cfb6937"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI0LTctMS0xLTU0NzA5OA_8c91905f-ebae-4e12-89d6-f1a4630a6fc5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI0LTctMS0xLTU0NzA5OA_8c91905f-ebae-4e12-89d6-f1a4630a6fc5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzktNy0xLTEtNTQ3MDk4_924c3d8b-87cf-4a58-aeee-db86200494dc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzktNy0xLTEtNTQ3MDk4_924c3d8b-87cf-4a58-aeee-db86200494dc"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI2LTctMS0xLTU0NzA5OA_e5fba830-b7e9-4d2a-9d4e-e9ecb3440398"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE5LTctMS0xLTU0NzA5OA_3dea0a2f-db00-4c45-bc82-390112e51307"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzctNy0xLTEtNTQ3MDk4_b608a220-43b4-414e-bb6d-c0d3e771d842"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE0LTctMS0xLTU0NzA5OA_3fd58480-6fc6-4346-a85f-569666fd106e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI3LTctMS0xLTU0NzA5OA_b71d309d-9ca3-4c0b-aa5c-2b67275d02db"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzMwLTctMS0xLTU0NzA5OA_fbc1a597-6d69-4d17-8314-e2aeec6dfd6f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE1LTctMS0xLTU0NzA5OA_aa2ba26f-2635-4ed1-9fe2-749bf50cc82a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE4LTctMS0xLTU0NzA5OA_56970ec1-46d1-42da-a19c-a4deb639cfd2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzgtNy0xLTEtNTQ3MDk4_82bd1d0d-3d97-4d39-b707-03d5f4ea8e2f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE3LTctMS0xLTU0NzA5OA_2c887ebd-2fb1-4159-b27e-a29d03ae639e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIyLTctMS0xLTU0NzA5OA_12493226-c472-47e5-99ea-a9c4706db302"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI1LTctMS0xLTU0NzA5OA_102a37c5-08ac-4a1e-9332-52a57043267b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI5LTctMS0xLTU0NzA5OA_7e94545c-5dd5-40ad-8402-14ded75dd02b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEwLTctMS0xLTU0NzA5OA_36cf6d52-c0ac-4ef6-9830-7348e5cae671"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzE2LTctMS0xLTU0NzA5OA_01ad8e17-2c25-4100-9031-1579a895ff34"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzExLTctMS0xLTU0NzA5OA_b9e95365-24e8-46b2-a0f0-ac7626b5a698"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzEzLTctMS0xLTU0NzA5OA_2fc001d2-249f-4ef4-b606-4b3956446652"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzIzLTctMS0xLTU0NzA5OA_1556d15b-48f1-4191-86f8-73377cfb6937"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzI0LTctMS0xLTU0NzA5OA_8c91905f-ebae-4e12-89d6-f1a4630a6fc5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90YWJsZTpiODJmMzcwNGM5MmE0MGM5YjFkOGNlMGI2ODEzNmQzYi90YWJsZXJhbmdlOmI4MmYzNzA0YzkyYTQwYzliMWQ4Y2UwYjY4MTM2ZDNiXzktNy0xLTEtNTQ3MDk4_924c3d8b-87cf-4a58-aeee-db86200494dc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTIvZnJhZzpiNjZkZTgyY2E4OWQ0MTljYTI5NDcwMzFlOTA4ZGVkMy90ZXh0cmVnaW9uOmI2NmRlODJjYTg5ZDQxOWNhMjk0NzAzMWU5MDhkZWQzXzU0OTc1NTgxNDczMA_8ffa81d8-bed0-4b63-9401-79dfcfad62ef"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTItMS0xLTU0NzA5OA_40db761f-a266-4f65-b6bb-86c4a203c722"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTItMS0xLTU0NzA5OA_40db761f-a266-4f65-b6bb-86c4a203c722"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUzLTItMS0xLTU0NzA5OA_40db761f-a266-4f65-b6bb-86c4a203c722"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzU0OTc1NTgxNDQ3OQ_1dc42f8b-c807-4376-a384-691001e0ef4e"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ0LTQtMS0xLTU0NzA5OA_63c16f86-df27-450f-8108-101e7edd1461"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ0LTQtMS0xLTU0NzA5OA_63c16f86-df27-450f-8108-101e7edd1461"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMxLTQtMS0xLTU0NzA5OA_5cc64e46-1759-4e32-825a-339e5c70c6a9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMxLTQtMS0xLTU0NzA5OA_5cc64e46-1759-4e32-825a-339e5c70c6a9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIzLTQtMS0xLTU0NzA5OA_eb3b95b7-35b8-4ef7-b06f-c37bf28c7a72"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIzLTQtMS0xLTU0NzA5OA_eb3b95b7-35b8-4ef7-b06f-c37bf28c7a72"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI5LTQtMS0xLTU0NzA5OA_63be975e-a5ef-47ac-b600-86d8cda714e6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI5LTQtMS0xLTU0NzA5OA_63be975e-a5ef-47ac-b600-86d8cda714e6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM5LTQtMS0xLTU0NzA5OA_b2a52d56-ac5d-462c-9f34-5d79bdbc9058"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM5LTQtMS0xLTU0NzA5OA_b2a52d56-ac5d-462c-9f34-5d79bdbc9058"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE4LTQtMS0xLTU0NzA5OA_5be68d15-7aaf-4b97-9dc1-2546e2482032"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE4LTQtMS0xLTU0NzA5OA_5be68d15-7aaf-4b97-9dc1-2546e2482032"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ3LTQtMS0xLTU0NzA5OA_61721542-f2fa-4d6d-9c5c-be545c576895"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ3LTQtMS0xLTU0NzA5OA_61721542-f2fa-4d6d-9c5c-be545c576895"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM1LTQtMS0xLTU0NzA5OA_47e7f790-a8a5-4142-8bc4-161a595b03e0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM1LTQtMS0xLTU0NzA5OA_47e7f790-a8a5-4142-8bc4-161a595b03e0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzgtNC0xLTEtNTQ3MDk4_8e1d38cf-145b-41b9-934d-9ce973338066"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzgtNC0xLTEtNTQ3MDk4_8e1d38cf-145b-41b9-934d-9ce973338066"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU0LTQtMS0xLTU0NzA5OA_68007cd1-77bc-4f06-9fe8-d027ebcdfddb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU0LTQtMS0xLTU0NzA5OA_68007cd1-77bc-4f06-9fe8-d027ebcdfddb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE2LTQtMS0xLTU0NzA5OA_ee545fb6-5653-452f-a623-cf1d3704df43"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE2LTQtMS0xLTU0NzA5OA_ee545fb6-5653-452f-a623-cf1d3704df43"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM4LTQtMS0xLTU0NzA5OA_0a46c049-4e5a-4a2c-9b85-91fe5e21e7b5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM4LTQtMS0xLTU0NzA5OA_0a46c049-4e5a-4a2c-9b85-91fe5e21e7b5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU5LTQtMS0xLTU0NzA5OA_124c1341-e99b-4b0c-900b-2319a9a1cc23"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU5LTQtMS0xLTU0NzA5OA_124c1341-e99b-4b0c-900b-2319a9a1cc23"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUxLTQtMS0xLTU0NzA5OA_203e5dfe-669d-43c4-b19d-ee961dcd4bb6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUxLTQtMS0xLTU0NzA5OA_203e5dfe-669d-43c4-b19d-ee961dcd4bb6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ4LTQtMS0xLTU0NzA5OA_2f7b09c1-467e-4f4f-8d6b-ccfcaf6d6078"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ4LTQtMS0xLTU0NzA5OA_2f7b09c1-467e-4f4f-8d6b-ccfcaf6d6078"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE5LTQtMS0xLTU0NzA5OA_819649f3-b4f0-463e-a6e6-f6842fedb49a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE5LTQtMS0xLTU0NzA5OA_819649f3-b4f0-463e-a6e6-f6842fedb49a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI3LTQtMS0xLTU0NzA5OA_8f14592e-f58f-4106-a62a-d3eae03b38bb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI3LTQtMS0xLTU0NzA5OA_8f14592e-f58f-4106-a62a-d3eae03b38bb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUtNC0xLTEtNTQ3MDk4_75d0f478-a637-4d65-9d55-db1b304a5c7d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUtNC0xLTEtNTQ3MDk4_75d0f478-a637-4d65-9d55-db1b304a5c7d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzctNC0xLTEtNTQ3MDk4_07359145-9265-4897-becc-719305fd869b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzctNC0xLTEtNTQ3MDk4_07359145-9265-4897-becc-719305fd869b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE0LTQtMS0xLTU0NzA5OA_dc5978fe-0471-42d8-a6b8-729286e3dc3c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE0LTQtMS0xLTU0NzA5OA_dc5978fe-0471-42d8-a6b8-729286e3dc3c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM2LTQtMS0xLTU0NzA5OA_de053d13-eae1-4d0c-914d-d26c4f8b03ef"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM2LTQtMS0xLTU0NzA5OA_de053d13-eae1-4d0c-914d-d26c4f8b03ef"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ1LTQtMS0xLTU0NzA5OA_f74a5de7-af04-4de7-8e81-e0c1c1b37162"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ1LTQtMS0xLTU0NzA5OA_f74a5de7-af04-4de7-8e81-e0c1c1b37162"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIwLTQtMS0xLTU0NzA5OA_5d85ce0f-1d51-41c7-9500-4a00e6cd94eb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIwLTQtMS0xLTU0NzA5OA_5d85ce0f-1d51-41c7-9500-4a00e6cd94eb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzEzLTQtMS0xLTU0NzA5OA_e4485689-2c24-432d-a1a5-de5296efaf00"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzEzLTQtMS0xLTU0NzA5OA_e4485689-2c24-432d-a1a5-de5296efaf00"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUyLTQtMS0xLTU0NzA5OA_56327850-ce35-456e-8228-496dbf146b1f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUyLTQtMS0xLTU0NzA5OA_56327850-ce35-456e-8228-496dbf146b1f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzktNC0xLTEtNTQ3MDk4_7d5e6dba-3610-4bc5-b89a-22e31afef865"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzktNC0xLTEtNTQ3MDk4_7d5e6dba-3610-4bc5-b89a-22e31afef865"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQwLTQtMS0xLTU0NzA5OA_5b3debd5-a815-40c2-a5f3-15cb4eb1276e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQwLTQtMS0xLTU0NzA5OA_5b3debd5-a815-40c2-a5f3-15cb4eb1276e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM0LTQtMS0xLTU0NzA5OA_c8b5a649-4307-44a0-8705-f02d8e5553a0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM0LTQtMS0xLTU0NzA5OA_c8b5a649-4307-44a0-8705-f02d8e5553a0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ5LTQtMS0xLTU0NzA5OA_5fa23537-0afa-4035-be93-f7dd6e860b28"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ5LTQtMS0xLTU0NzA5OA_5fa23537-0afa-4035-be93-f7dd6e860b28"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUwLTQtMS0xLTU0NzA5OA_1affbf90-4413-432e-a4d7-521bcd13abd1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUwLTQtMS0xLTU0NzA5OA_1affbf90-4413-432e-a4d7-521bcd13abd1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ2LTQtMS0xLTU0NzA5OA_734b41b3-f6ac-4705-bf15-debe8f54f256"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ2LTQtMS0xLTU0NzA5OA_734b41b3-f6ac-4705-bf15-debe8f54f256"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMyLTQtMS0xLTU0NzA5OA_2aa57fe0-3a8a-43b1-bcd4-775311586a6c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMyLTQtMS0xLTU0NzA5OA_2aa57fe0-3a8a-43b1-bcd4-775311586a6c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMwLTQtMS0xLTU0NzA5OA_4b1b73d9-48a8-4977-9879-b16785f9f348"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMwLTQtMS0xLTU0NzA5OA_4b1b73d9-48a8-4977-9879-b16785f9f348"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU4LTQtMS0xLTU0NzA5OA_d3399559-aa7f-4d23-8b23-b043ad991fd6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU4LTQtMS0xLTU0NzA5OA_d3399559-aa7f-4d23-8b23-b043ad991fd6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU1LTQtMS0xLTU0NzA5OA_320766a2-bc6b-4671-b705-848e1fb2e4c4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU1LTQtMS0xLTU0NzA5OA_320766a2-bc6b-4671-b705-848e1fb2e4c4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI2LTQtMS0xLTU0NzA5OA_d5873846-d3a3-41c1-86e3-23f911b4d30b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI2LTQtMS0xLTU0NzA5OA_d5873846-d3a3-41c1-86e3-23f911b4d30b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI1LTQtMS0xLTU0NzA5OA_d181c0e4-9505-4b4c-9ded-757953e6fa5e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI1LTQtMS0xLTU0NzA5OA_d181c0e4-9505-4b4c-9ded-757953e6fa5e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE3LTQtMS0xLTU0NzA5OA_c98a3aef-75fc-4145-9646-9dc96c93bd53"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE3LTQtMS0xLTU0NzA5OA_c98a3aef-75fc-4145-9646-9dc96c93bd53"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE1LTQtMS0xLTU0NzA5OA_08201fda-a8c1-48b1-a456-652c75763d3d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE1LTQtMS0xLTU0NzA5OA_08201fda-a8c1-48b1-a456-652c75763d3d"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ0LTQtMS0xLTU0NzA5OA_63c16f86-df27-450f-8108-101e7edd1461"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMxLTQtMS0xLTU0NzA5OA_5cc64e46-1759-4e32-825a-339e5c70c6a9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIzLTQtMS0xLTU0NzA5OA_eb3b95b7-35b8-4ef7-b06f-c37bf28c7a72"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI5LTQtMS0xLTU0NzA5OA_63be975e-a5ef-47ac-b600-86d8cda714e6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM5LTQtMS0xLTU0NzA5OA_b2a52d56-ac5d-462c-9f34-5d79bdbc9058"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE4LTQtMS0xLTU0NzA5OA_5be68d15-7aaf-4b97-9dc1-2546e2482032"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ3LTQtMS0xLTU0NzA5OA_61721542-f2fa-4d6d-9c5c-be545c576895"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM1LTQtMS0xLTU0NzA5OA_47e7f790-a8a5-4142-8bc4-161a595b03e0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzgtNC0xLTEtNTQ3MDk4_8e1d38cf-145b-41b9-934d-9ce973338066"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU0LTQtMS0xLTU0NzA5OA_68007cd1-77bc-4f06-9fe8-d027ebcdfddb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE2LTQtMS0xLTU0NzA5OA_ee545fb6-5653-452f-a623-cf1d3704df43"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM4LTQtMS0xLTU0NzA5OA_0a46c049-4e5a-4a2c-9b85-91fe5e21e7b5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU5LTQtMS0xLTU0NzA5OA_124c1341-e99b-4b0c-900b-2319a9a1cc23"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUxLTQtMS0xLTU0NzA5OA_203e5dfe-669d-43c4-b19d-ee961dcd4bb6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ4LTQtMS0xLTU0NzA5OA_2f7b09c1-467e-4f4f-8d6b-ccfcaf6d6078"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE5LTQtMS0xLTU0NzA5OA_819649f3-b4f0-463e-a6e6-f6842fedb49a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI3LTQtMS0xLTU0NzA5OA_8f14592e-f58f-4106-a62a-d3eae03b38bb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUtNC0xLTEtNTQ3MDk4_75d0f478-a637-4d65-9d55-db1b304a5c7d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzctNC0xLTEtNTQ3MDk4_07359145-9265-4897-becc-719305fd869b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE0LTQtMS0xLTU0NzA5OA_dc5978fe-0471-42d8-a6b8-729286e3dc3c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM2LTQtMS0xLTU0NzA5OA_de053d13-eae1-4d0c-914d-d26c4f8b03ef"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ1LTQtMS0xLTU0NzA5OA_f74a5de7-af04-4de7-8e81-e0c1c1b37162"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzIwLTQtMS0xLTU0NzA5OA_5d85ce0f-1d51-41c7-9500-4a00e6cd94eb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzEzLTQtMS0xLTU0NzA5OA_e4485689-2c24-432d-a1a5-de5296efaf00"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUyLTQtMS0xLTU0NzA5OA_56327850-ce35-456e-8228-496dbf146b1f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzktNC0xLTEtNTQ3MDk4_7d5e6dba-3610-4bc5-b89a-22e31afef865"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQwLTQtMS0xLTU0NzA5OA_5b3debd5-a815-40c2-a5f3-15cb4eb1276e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzM0LTQtMS0xLTU0NzA5OA_c8b5a649-4307-44a0-8705-f02d8e5553a0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ5LTQtMS0xLTU0NzA5OA_5fa23537-0afa-4035-be93-f7dd6e860b28"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzUwLTQtMS0xLTU0NzA5OA_1affbf90-4413-432e-a4d7-521bcd13abd1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzQ2LTQtMS0xLTU0NzA5OA_734b41b3-f6ac-4705-bf15-debe8f54f256"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMyLTQtMS0xLTU0NzA5OA_2aa57fe0-3a8a-43b1-bcd4-775311586a6c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzMwLTQtMS0xLTU0NzA5OA_4b1b73d9-48a8-4977-9879-b16785f9f348"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU4LTQtMS0xLTU0NzA5OA_d3399559-aa7f-4d23-8b23-b043ad991fd6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU1LTQtMS0xLTU0NzA5OA_320766a2-bc6b-4671-b705-848e1fb2e4c4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI2LTQtMS0xLTU0NzA5OA_d5873846-d3a3-41c1-86e3-23f911b4d30b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzI1LTQtMS0xLTU0NzA5OA_d181c0e4-9505-4b4c-9ded-757953e6fa5e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE3LTQtMS0xLTU0NzA5OA_c98a3aef-75fc-4145-9646-9dc96c93bd53"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzE1LTQtMS0xLTU0NzA5OA_08201fda-a8c1-48b1-a456-652c75763d3d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzQxNzgxNDQxODU2MDgx_e87389d9-99f8-434e-8d0f-c0f8975f29dc"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ3LTMtMS0xLTU0NzA5OA_97090691-b4c3-43b5-b77b-061701c2fa9e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ3LTMtMS0xLTU0NzA5OA_97090691-b4c3-43b5-b77b-061701c2fa9e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQxLTMtMS0xLTU0NzA5OA_731c83fa-4eea-409a-86d1-8ef2c67b0e56"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQxLTMtMS0xLTU0NzA5OA_731c83fa-4eea-409a-86d1-8ef2c67b0e56"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE3LTMtMS0xLTU0NzA5OA_0579eb36-c167-4f6e-ac4f-8d839aa63d39"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE3LTMtMS0xLTU0NzA5OA_0579eb36-c167-4f6e-ac4f-8d839aa63d39"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMwLTMtMS0xLTU0NzA5OA_a44adfa6-6eae-4b0f-b1d1-3eed36def226"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMwLTMtMS0xLTU0NzA5OA_a44adfa6-6eae-4b0f-b1d1-3eed36def226"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMxLTMtMS0xLTU0NzA5OA_01113199-5d06-4601-8809-daf773980ca9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMxLTMtMS0xLTU0NzA5OA_01113199-5d06-4601-8809-daf773980ca9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEwLTMtMS0xLTU0NzA5OA_e184b990-0d77-4d55-ad49-e7ed65c4679c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEwLTMtMS0xLTU0NzA5OA_e184b990-0d77-4d55-ad49-e7ed65c4679c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEyLTMtMS0xLTU0NzA5OA_5bbe8a6d-2253-45d5-8f58-a6331a9768ea"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEyLTMtMS0xLTU0NzA5OA_5bbe8a6d-2253-45d5-8f58-a6331a9768ea"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI1LTMtMS0xLTU0NzA5OA_18ac489a-f37c-4ec1-a714-d74297b28e87"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI1LTMtMS0xLTU0NzA5OA_18ac489a-f37c-4ec1-a714-d74297b28e87"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEzLTMtMS0xLTU0NzA5OA_e72c918c-a597-474e-a170-f2142e110cde"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEzLTMtMS0xLTU0NzA5OA_e72c918c-a597-474e-a170-f2142e110cde"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQzLTMtMS0xLTU0NzA5OA_f720eea4-20f9-40aa-9c2e-55cf9814c9cf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQzLTMtMS0xLTU0NzA5OA_f720eea4-20f9-40aa-9c2e-55cf9814c9cf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzctMy0xLTEtNTQ3MDk4_b136721f-f061-4fe3-af15-6ae5cb0c5c55"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzctMy0xLTEtNTQ3MDk4_b136721f-f061-4fe3-af15-6ae5cb0c5c55"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIwLTMtMS0xLTU0NzA5OA_6c111ea2-82cb-4b26-a946-7f22aaa08789"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIwLTMtMS0xLTU0NzA5OA_6c111ea2-82cb-4b26-a946-7f22aaa08789"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE0LTMtMS0xLTU0NzA5OA_e8dbe745-b137-4a8a-83e0-1f7061ec6fcc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE0LTMtMS0xLTU0NzA5OA_e8dbe745-b137-4a8a-83e0-1f7061ec6fcc"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQyLTMtMS0xLTU0NzA5OA_36c37ec6-ca45-43f2-999c-6357a46584de"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQyLTMtMS0xLTU0NzA5OA_36c37ec6-ca45-43f2-999c-6357a46584de"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ1LTMtMS0xLTU0NzA5OA_ccc13179-2a66-4ae0-a061-19c1ea7c9991"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ1LTMtMS0xLTU0NzA5OA_ccc13179-2a66-4ae0-a061-19c1ea7c9991"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE5LTMtMS0xLTU0NzA5OA_57070670-5068-4a3b-9b4b-84eb01a3e79c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE5LTMtMS0xLTU0NzA5OA_57070670-5068-4a3b-9b4b-84eb01a3e79c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIzLTMtMS0xLTU0NzA5OA_20ec4532-c297-4eb0-9e39-01131f073d2c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIzLTMtMS0xLTU0NzA5OA_20ec4532-c297-4eb0-9e39-01131f073d2c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ2LTMtMS0xLTU0NzA5OA_3652dd29-c6f7-4939-a019-d0a25976ad42"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ2LTMtMS0xLTU0NzA5OA_3652dd29-c6f7-4939-a019-d0a25976ad42"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIxLTMtMS0xLTU0NzA5OA_f7fff571-48ef-4940-a349-e127170daa6d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIxLTMtMS0xLTU0NzA5OA_f7fff571-48ef-4940-a349-e127170daa6d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzYtMy0xLTEtNTQ3MDk4_e483f4e2-0134-4faf-8374-b9e8c431fc37"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzYtMy0xLTEtNTQ3MDk4_e483f4e2-0134-4faf-8374-b9e8c431fc37"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM0LTMtMS0xLTU0NzA5OA_917de155-e4db-434c-8967-b1ec380a671b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM0LTMtMS0xLTU0NzA5OA_917de155-e4db-434c-8967-b1ec380a671b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM1LTMtMS0xLTU0NzA5OA_1910bc6f-591d-4929-a6ae-39b31a5bd6fd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM1LTMtMS0xLTU0NzA5OA_1910bc6f-591d-4929-a6ae-39b31a5bd6fd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI0LTMtMS0xLTU0NzA5OA_acf1354a-c049-49fb-8776-a986bbb3b160"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI0LTMtMS0xLTU0NzA5OA_acf1354a-c049-49fb-8776-a986bbb3b160"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzktMy0xLTEtNTQ3MDk4_46f8e2ec-fd55-44cd-a088-ab4007ad34df"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzktMy0xLTEtNTQ3MDk4_46f8e2ec-fd55-44cd-a088-ab4007ad34df"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzgtMy0xLTEtNTQ3MDk4_51d694db-a877-47da-b5f9-5123c07b3070"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzgtMy0xLTEtNTQ3MDk4_51d694db-a877-47da-b5f9-5123c07b3070"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM3LTMtMS0xLTU0NzA5OA_a4ce84c7-19ab-464f-b99d-4d830b9eedf0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM3LTMtMS0xLTU0NzA5OA_a4ce84c7-19ab-464f-b99d-4d830b9eedf0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM2LTMtMS0xLTU0NzA5OA_8eeedf58-d0e2-40f8-8b86-077a5ed635f8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM2LTMtMS0xLTU0NzA5OA_8eeedf58-d0e2-40f8-8b86-077a5ed635f8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI5LTMtMS0xLTU0NzA5OA_7ffe16a4-d89f-49d6-9763-76e5f24f322c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI5LTMtMS0xLTU0NzA5OA_7ffe16a4-d89f-49d6-9763-76e5f24f322c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI2LTMtMS0xLTU0NzA5OA_b0aeb6ff-21f1-4e80-b147-de6a735a696d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI2LTMtMS0xLTU0NzA5OA_b0aeb6ff-21f1-4e80-b147-de6a735a696d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE2LTMtMS0xLTU0NzA5OA_0c15b4f5-83d2-4988-a69a-4a901dd62c36"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE2LTMtMS0xLTU0NzA5OA_0c15b4f5-83d2-4988-a69a-4a901dd62c36"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMyLTMtMS0xLTU0NzA5OA_4809f36f-6a2f-4048-8673-5a1061b6d99c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMyLTMtMS0xLTU0NzA5OA_4809f36f-6a2f-4048-8673-5a1061b6d99c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE4LTMtMS0xLTU0NzA5OA_606c6e00-9244-4d69-aba4-00e335e87c0c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE4LTMtMS0xLTU0NzA5OA_606c6e00-9244-4d69-aba4-00e335e87c0c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ0LTMtMS0xLTU0NzA5OA_864afb31-0910-42a1-b5b6-717fed9ea74f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ0LTMtMS0xLTU0NzA5OA_864afb31-0910-42a1-b5b6-717fed9ea74f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMzLTMtMS0xLTU0NzA5OA_031c2ccf-4ee1-437f-9758-c51d899420bd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMzLTMtMS0xLTU0NzA5OA_031c2ccf-4ee1-437f-9758-c51d899420bd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI3LTMtMS0xLTU0NzA5OA_de2112bc-0175-4727-adc0-cb5da30eceb7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI3LTMtMS0xLTU0NzA5OA_de2112bc-0175-4727-adc0-cb5da30eceb7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQwLTMtMS0xLTU0NzA5OA_99927523-d0b4-4bf2-bbf5-8db7be5836c2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQwLTMtMS0xLTU0NzA5OA_99927523-d0b4-4bf2-bbf5-8db7be5836c2"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ3LTMtMS0xLTU0NzA5OA_97090691-b4c3-43b5-b77b-061701c2fa9e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQxLTMtMS0xLTU0NzA5OA_731c83fa-4eea-409a-86d1-8ef2c67b0e56"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE3LTMtMS0xLTU0NzA5OA_0579eb36-c167-4f6e-ac4f-8d839aa63d39"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMwLTMtMS0xLTU0NzA5OA_a44adfa6-6eae-4b0f-b1d1-3eed36def226"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMxLTMtMS0xLTU0NzA5OA_01113199-5d06-4601-8809-daf773980ca9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEwLTMtMS0xLTU0NzA5OA_e184b990-0d77-4d55-ad49-e7ed65c4679c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEyLTMtMS0xLTU0NzA5OA_5bbe8a6d-2253-45d5-8f58-a6331a9768ea"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI1LTMtMS0xLTU0NzA5OA_18ac489a-f37c-4ec1-a714-d74297b28e87"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzEzLTMtMS0xLTU0NzA5OA_e72c918c-a597-474e-a170-f2142e110cde"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQzLTMtMS0xLTU0NzA5OA_f720eea4-20f9-40aa-9c2e-55cf9814c9cf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzctMy0xLTEtNTQ3MDk4_b136721f-f061-4fe3-af15-6ae5cb0c5c55"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIwLTMtMS0xLTU0NzA5OA_6c111ea2-82cb-4b26-a946-7f22aaa08789"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE0LTMtMS0xLTU0NzA5OA_e8dbe745-b137-4a8a-83e0-1f7061ec6fcc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQyLTMtMS0xLTU0NzA5OA_36c37ec6-ca45-43f2-999c-6357a46584de"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ1LTMtMS0xLTU0NzA5OA_ccc13179-2a66-4ae0-a061-19c1ea7c9991"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE5LTMtMS0xLTU0NzA5OA_57070670-5068-4a3b-9b4b-84eb01a3e79c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIzLTMtMS0xLTU0NzA5OA_20ec4532-c297-4eb0-9e39-01131f073d2c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ2LTMtMS0xLTU0NzA5OA_3652dd29-c6f7-4939-a019-d0a25976ad42"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzIxLTMtMS0xLTU0NzA5OA_f7fff571-48ef-4940-a349-e127170daa6d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzYtMy0xLTEtNTQ3MDk4_e483f4e2-0134-4faf-8374-b9e8c431fc37"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM0LTMtMS0xLTU0NzA5OA_917de155-e4db-434c-8967-b1ec380a671b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM1LTMtMS0xLTU0NzA5OA_1910bc6f-591d-4929-a6ae-39b31a5bd6fd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI0LTMtMS0xLTU0NzA5OA_acf1354a-c049-49fb-8776-a986bbb3b160"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzktMy0xLTEtNTQ3MDk4_46f8e2ec-fd55-44cd-a088-ab4007ad34df"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzgtMy0xLTEtNTQ3MDk4_51d694db-a877-47da-b5f9-5123c07b3070"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM3LTMtMS0xLTU0NzA5OA_a4ce84c7-19ab-464f-b99d-4d830b9eedf0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM2LTMtMS0xLTU0NzA5OA_8eeedf58-d0e2-40f8-8b86-077a5ed635f8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI5LTMtMS0xLTU0NzA5OA_7ffe16a4-d89f-49d6-9763-76e5f24f322c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI2LTMtMS0xLTU0NzA5OA_b0aeb6ff-21f1-4e80-b147-de6a735a696d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE2LTMtMS0xLTU0NzA5OA_0c15b4f5-83d2-4988-a69a-4a901dd62c36"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMyLTMtMS0xLTU0NzA5OA_4809f36f-6a2f-4048-8673-5a1061b6d99c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzE4LTMtMS0xLTU0NzA5OA_606c6e00-9244-4d69-aba4-00e335e87c0c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQ0LTMtMS0xLTU0NzA5OA_864afb31-0910-42a1-b5b6-717fed9ea74f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzMzLTMtMS0xLTU0NzA5OA_031c2ccf-4ee1-437f-9758-c51d899420bd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzI3LTMtMS0xLTU0NzA5OA_de2112bc-0175-4727-adc0-cb5da30eceb7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzQwLTMtMS0xLTU0NzA5OA_99927523-d0b4-4bf2-bbf5-8db7be5836c2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzQxNzgxNDQxODU2Mzc0_9560dbb7-050d-41b1-9eba-b1e0f4c9e1f6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMS0xLTEtNTQ3MDk4_b11e4b39-97be-4030-992e-f4b750eaa8de"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMS0xLTEtNTQ3MDk4_b11e4b39-97be-4030-992e-f4b750eaa8de"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTctMS0xLTU4NTgyMA_024f2260-cfee-444f-bac6-dcb6062dcf0c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTctMS0xLTU4NTgyMA_024f2260-cfee-444f-bac6-dcb6062dcf0c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTEtMS0xLTU0NzA5OA_9356d6da-3934-4e59-b329-f57e0dfa69e3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTEtMS0xLTU0NzA5OA_9356d6da-3934-4e59-b329-f57e0dfa69e3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTUtMS0xLTU0NzA5OA_e205003c-80c6-4204-b42d-5e25a7ea436c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTUtMS0xLTU0NzA5OA_e205003c-80c6-4204-b42d-5e25a7ea436c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTktMS0xLTU4NTgyMA_353edb31-5e7d-4833-baa6-84be8085eb18"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTktMS0xLTU4NTgyMA_353edb31-5e7d-4833-baa6-84be8085eb18"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE1LTEtMS01ODU4MjA_32e6079e-6d8c-452a-9487-2b21fb789b79"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE1LTEtMS01ODU4MjA_32e6079e-6d8c-452a-9487-2b21fb789b79"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTEzLTEtMS01ODU4MjA_c2bc670e-180e-4a86-b5f3-3963b956f308"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTEzLTEtMS01ODU4MjA_c2bc670e-180e-4a86-b5f3-3963b956f308"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE3LTEtMS01ODU4MjA_edaf8827-9b73-4399-bc97-527cd8e302e2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE3LTEtMS01ODU4MjA_edaf8827-9b73-4399-bc97-527cd8e302e2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTctMS0xLTU0NzA5OA_90433d9f-2558-4927-afa9-7a1032a8b39a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTctMS0xLTU0NzA5OA_90433d9f-2558-4927-afa9-7a1032a8b39a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtOS0xLTEtNTQ3MDk4_80c452f7-d6bd-4b5b-a0ba-20e188f66261"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtOS0xLTEtNTQ3MDk4_80c452f7-d6bd-4b5b-a0ba-20e188f66261"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTMtMS0xLTU0NzA5OA_2557cd11-338d-4aa3-86ba-661f15475ab4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTMtMS0xLTU0NzA5OA_2557cd11-338d-4aa3-86ba-661f15475ab4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMy0xLTEtNTQ3MDk4_c47cdd19-3043-4ddc-8472-3fb8251772c5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMy0xLTEtNTQ3MDk4_c47cdd19-3043-4ddc-8472-3fb8251772c5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTMtMS0xLTU4NTgyMA_a7849b11-b004-4f86-8107-ca09bbf49e09"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTMtMS0xLTU4NTgyMA_a7849b11-b004-4f86-8107-ca09bbf49e09"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtNS0xLTEtNTQ3MDk4_7268058b-daf3-4f83-b55f-ca21c3179757"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtNS0xLTEtNTQ3MDk4_7268058b-daf3-4f83-b55f-ca21c3179757"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTExLTEtMS01ODU4MjA_98bb3c29-d795-4c01-b373-aa494ce0b2d1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTExLTEtMS01ODU4MjA_98bb3c29-d795-4c01-b373-aa494ce0b2d1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtNy0xLTEtNTQ3MDk4_2d1ad352-3fd3-4c93-8d68-6014b98ef8cb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtNy0xLTEtNTQ3MDk4_2d1ad352-3fd3-4c93-8d68-6014b98ef8cb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTEtMS0xLTU4NTgyMA_a5c7dd7b-fc0d-48e3-86ba-a2f614e48cef"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTEtMS0xLTU4NTgyMA_a5c7dd7b-fc0d-48e3-86ba-a2f614e48cef"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTUtMS0xLTU4NTgyMA_9e956362-a4b5-4535-a069-df21dc860b72"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTUtMS0xLTU4NTgyMA_9e956362-a4b5-4535-a069-df21dc860b72"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements to the Consolidated Financial Statements for further information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMS0xLTEtNTQ3MDk4_b11e4b39-97be-4030-992e-f4b750eaa8de"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTctMS0xLTU4NTgyMA_024f2260-cfee-444f-bac6-dcb6062dcf0c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTEtMS0xLTU0NzA5OA_9356d6da-3934-4e59-b329-f57e0dfa69e3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTUtMS0xLTU0NzA5OA_e205003c-80c6-4204-b42d-5e25a7ea436c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTktMS0xLTU4NTgyMA_353edb31-5e7d-4833-baa6-84be8085eb18"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE1LTEtMS01ODU4MjA_32e6079e-6d8c-452a-9487-2b21fb789b79"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTEzLTEtMS01ODU4MjA_c2bc670e-180e-4a86-b5f3-3963b956f308"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTE3LTEtMS01ODU4MjA_edaf8827-9b73-4399-bc97-527cd8e302e2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTctMS0xLTU0NzA5OA_90433d9f-2558-4927-afa9-7a1032a8b39a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtOS0xLTEtNTQ3MDk4_80c452f7-d6bd-4b5b-a0ba-20e188f66261"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMTMtMS0xLTU0NzA5OA_2557cd11-338d-4aa3-86ba-661f15475ab4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtMy0xLTEtNTQ3MDk4_c47cdd19-3043-4ddc-8472-3fb8251772c5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTMtMS0xLTU4NTgyMA_a7849b11-b004-4f86-8107-ca09bbf49e09"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtNS0xLTEtNTQ3MDk4_7268058b-daf3-4f83-b55f-ca21c3179757"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTExLTEtMS01ODU4MjA_98bb3c29-d795-4c01-b373-aa494ce0b2d1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzUtNy0xLTEtNTQ3MDk4_2d1ad352-3fd3-4c93-8d68-6014b98ef8cb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTEtMS0xLTU4NTgyMA_a5c7dd7b-fc0d-48e3-86ba-a2f614e48cef"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90YWJsZTpkYjYzZDY2OTkyZTM0NmQ2YmQ1OGFkNzJkMTZhMzYxOS90YWJsZXJhbmdlOmRiNjNkNjY5OTJlMzQ2ZDZiZDU4YWQ3MmQxNmEzNjE5XzE5LTUtMS0xLTU4NTgyMA_9e956362-a4b5-4535-a069-df21dc860b72"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDcvZnJhZzpjYzM2MjA5MmE5ZDQ0ZGZkODQ1NmU0OTI4NmFlYmI1OC90ZXh0cmVnaW9uOmNjMzYyMDkyYTlkNDRkZmQ4NDU2ZTQ5Mjg2YWViYjU4XzQxNzgxNDQxODU2MjQ3_823234bf-f8db-4046-beea-1aeb71cc400b"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzExLTctMS0xLTU0NzA5OA_3dfd2d59-cc65-4740-803c-0b1b5451cba2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzExLTctMS0xLTU0NzA5OA_3dfd2d59-cc65-4740-803c-0b1b5451cba2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzIwLTctMS0xLTU0NzA5OA_c602d313-2305-4b2e-ac6d-814d71a51d5d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzIwLTctMS0xLTU0NzA5OA_c602d313-2305-4b2e-ac6d-814d71a51d5d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNy0xLTEtNTQ3MDk4_35bee086-c8e3-40db-b944-6b19988ccfe7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNy0xLTEtNTQ3MDk4_35bee086-c8e3-40db-b944-6b19988ccfe7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE3LTctMS0xLTU0NzA5OA_bdb6324f-b7ae-484d-a5d1-a9cbaf53feaa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE3LTctMS0xLTU0NzA5OA_bdb6324f-b7ae-484d-a5d1-a9cbaf53feaa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE2LTctMS0xLTU0NzA5OA_659b721e-341f-4097-bf9b-a992c9a31cc2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE2LTctMS0xLTU0NzA5OA_659b721e-341f-4097-bf9b-a992c9a31cc2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzQtNy0xLTEtNTQ3MDk4_8ab5a675-2a99-441f-a3fb-56dc1264a26a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzQtNy0xLTEtNTQ3MDk4_8ab5a675-2a99-441f-a3fb-56dc1264a26a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE4LTctMS0xLTU0NzA5OA_8ead8ea9-7460-4be6-aa76-7648b71546a0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE4LTctMS0xLTU0NzA5OA_8ead8ea9-7460-4be6-aa76-7648b71546a0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzYtNy0xLTEtNTQ3MDk4_35c93aec-9e7e-4334-bc7f-e8ec9b9a4686"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzYtNy0xLTEtNTQ3MDk4_35c93aec-9e7e-4334-bc7f-e8ec9b9a4686"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE5LTctMS0xLTU0NzA5OA_3a6c2d42-a5ed-4b47-8f76-2d52bf842af8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE5LTctMS0xLTU0NzA5OA_3a6c2d42-a5ed-4b47-8f76-2d52bf842af8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEzLTctMS0xLTU0NzA5OA_4c603a81-46c3-4370-942a-6aff72d75ecd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEzLTctMS0xLTU0NzA5OA_4c603a81-46c3-4370-942a-6aff72d75ecd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNy0xLTEtNTk3NDcx_1c048248-06d6-4527-9699-9259b5dbd011"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNy0xLTEtNTk3NDcx_1c048248-06d6-4527-9699-9259b5dbd011"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEyLTctMS0xLTU0NzA5OA_e5bd59b8-acff-40a9-84f0-57e953521a33"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEyLTctMS0xLTU0NzA5OA_e5bd59b8-acff-40a9-84f0-57e953521a33"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzExLTctMS0xLTU0NzA5OA_3dfd2d59-cc65-4740-803c-0b1b5451cba2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzIwLTctMS0xLTU0NzA5OA_c602d313-2305-4b2e-ac6d-814d71a51d5d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNy0xLTEtNTQ3MDk4_35bee086-c8e3-40db-b944-6b19988ccfe7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE3LTctMS0xLTU0NzA5OA_bdb6324f-b7ae-484d-a5d1-a9cbaf53feaa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE2LTctMS0xLTU0NzA5OA_659b721e-341f-4097-bf9b-a992c9a31cc2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzQtNy0xLTEtNTQ3MDk4_8ab5a675-2a99-441f-a3fb-56dc1264a26a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE4LTctMS0xLTU0NzA5OA_8ead8ea9-7460-4be6-aa76-7648b71546a0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzYtNy0xLTEtNTQ3MDk4_35c93aec-9e7e-4334-bc7f-e8ec9b9a4686"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzE5LTctMS0xLTU0NzA5OA_3a6c2d42-a5ed-4b47-8f76-2d52bf842af8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEzLTctMS0xLTU0NzA5OA_4c603a81-46c3-4370-942a-6aff72d75ecd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzctNy0xLTEtNTk3NDcx_1c048248-06d6-4527-9699-9259b5dbd011"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90YWJsZTo2ZjdmNDYxMDM1NmQ0YjkwOTUzMjY0MjgxZWY3YzNlYS90YWJsZXJhbmdlOjZmN2Y0NjEwMzU2ZDRiOTA5NTMyNjQyODFlZjdjM2VhXzEyLTctMS0xLTU0NzA5OA_e5bd59b8-acff-40a9-84f0-57e953521a33"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8yOTgvZnJhZzo4YTM3NDZmNzg1NWM0YTg2YWFkYzMwZGUyZWFhZjU1Ny90ZXh0cmVnaW9uOjhhMzc0NmY3ODU1YzRhODZhYWRjMzBkZTJlYWFmNTU3XzU0OTc1NTgxNDM0MA_a4060eac-ef5e-4f46-a5bd-c355e306eb30"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTItMS0xLTU0NzA5OA_8eee97e6-4411-4def-985b-4e731dff18d0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTItMS0xLTU0NzA5OA_8eee97e6-4411-4def-985b-4e731dff18d0"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90YWJsZTpmNjM1YmQyMWFmZTc0NWEyYjdlY2Y0OTNkNWY1N2I4Yi90YWJsZXJhbmdlOmY2MzViZDIxYWZlNzQ1YTJiN2VjZjQ5M2Q1ZjU3YjhiXzU2LTItMS0xLTU0NzA5OA_8eee97e6-4411-4def-985b-4e731dff18d0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMTMvZnJhZzo5OTgyZTE5MzJjOGQ0YWJiYjkxOWE2ZGJiYTgyMThlZC90ZXh0cmVnaW9uOjk5ODJlMTkzMmM4ZDRhYmJiOTE5YTZkYmJhODIxOGVkXzI1Mg_621034ee-a185-4141-b59a-278aa5be2095"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTEtMS0xLTU0NzA5OA_8d2482df-cd75-47ae-976b-bacf4ba05ab7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTEtMS0xLTU0NzA5OA_8d2482df-cd75-47ae-976b-bacf4ba05ab7"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90YWJsZTo0YzJiYTVmNmQ0ZGI0NzhjOGVhZTkxZTIwYTNmYzQ4ZS90YWJsZXJhbmdlOjRjMmJhNWY2ZDRkYjQ3OGM4ZWFlOTFlMjBhM2ZjNDhlXzM5LTEtMS0xLTU0NzA5OA_8d2482df-cd75-47ae-976b-bacf4ba05ab7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQxODAwNDEzNzIyYzRlMzBiNTNhZDVkNDY0Y2FiNGU4L3NlYzpkMTgwMDQxMzcyMmM0ZTMwYjUzYWQ1ZDQ2NGNhYjRlOF8zMDEvZnJhZzpkMTkxMDFmMmIzNzU0N2MxYmY5YjI2ZmNhNTI4MmUxZS90ZXh0cmVnaW9uOmQxOTEwMWYyYjM3NTQ3YzFiZjliMjZmY2E1MjgyZTFlXzE4Mg_c38bd102-2a43-40c9-954e-9ee16d667456"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>106
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M;, N%>Z@>5-(G**94TB=HKE32)ZBV5-(GZ+Y4R" H@Q0H("B'##@@*$<,."
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MPMUF[#'+,^40/^R5J/^UD'NKT?;7VLD5]NO5Y5:INF1;%W:B5!)ZLZ7(Y_#
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MJCZ-[W/%I2$"ED@9=*ZQ^NNJ]U6"5459JQ?*8N4OIQG^+H!V"KB_5,KN!'=
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MS:+P^U*B$4^U-Q&,05Z_ R.>I%-6R;/3SZ  SE'B=H=<Q8LGQWR"OG[..O#
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MPL9O$_&'-VWX'K R'D-$>&0_D.4->+\VN &F'ZQ@^$!T]3]02P,$%     @
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MIT#O*T4%T K.03?])W\!4$L#!!0    ( $E6I5:8("WLK 0  "0+   9
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M9,*3H4;8Z"8S[*/%)2A*BQBX9Z:NT0:B$74O?072C^,FJ:MH$N=D6AW %%W
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MA,*"Z8P; C_WM]U9T23P9U=X]:97/<=O.U[4"8AF(ASWX0@8MC71<./>U/$
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MDR75.P?=C4F .BA8=K*QS9XS4ND%^2<+:!I1PV6QI#O?C\]P1BVG"?5#)EZ
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M/"I#@%JU!B'X,HR(C0O%P%?D!JJ\RW7E[GN'.%<&68U*;NNV54LM-RL0 67
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MN2Z5%[6_)\G7)95GYF<$FJB>MK,:K"\V*K@NT# 0/QV7-0XSN-+(LD!5L>U
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M0S*C ;B_TBBAW1>:H/H5SYM_ 5!+ P04    " !)5J56T/7$2$D#  #Y!P
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MHX'L5R1A/DSB >-KO_H?4$L#!!0    ( $E6I5:&]S4]CP8  *(2   9
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M.$(M475Y1#\@N!55==LCCTF0\SDTUC'D(2Z[E\Z+6:4@3"4)'YS$$GUUBSC
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MYCJ>S3:'N+.[HR$W_"UO<6\V&G[1G@/1<3Z.'>$H)I][# R.YXT-""@=O]K
M_=%#?U?VM[X;U!*)\]<11R')^ FA?=I^@#F+WQWNEL>O-SA7HH$83#F'Z>#H
MY:@#"0]?1.*--ZOP%6)FO#=UN%Q*@7[Q KR?&Q2ZON$ [6>ITW\!4$L#!!0
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M82@S=)LB+*P5V\MW0K"6&C[LGVQ02QZ9 XSRP?C?S#7\\W(;/T:M_P,(?7.
M >$X,#M6M'H9P.CE!B=?X]-UKV51Y476:UASD"M6F[=FW8&R0[)VIG04NX,<
MB26<_0B% XNE$G:W[@/0:6C4+NP4[EB>*E1.7N# $K03Y"O49JIST$[<\[*E
MIYVL@7)C=OJA0O<)1H0WSYXHF'O0^!E&->SG32C>R 8FT$*$U[=E@:;6O?IB
MK/JR;-"8K&Q#*:BA9&@'LV7?#Z*+<TEB0B0> 1U4'M<M$XQ.6!1[21#@(@B\
M-/%Q,9GACVF'PE>XBE,OC/TC;07F!%,V2Z-^PFGH)=/@C'T2>I@WCF*P0!!'
M;#)E*0LG$V=(+RY*O0#+!Z$W25(6)!,C;I*<D18)NK1/3Q<6:V>7O]NIM1FM
M-LI&T[/^9NOA]1[SG'3:G1C]8/:)T?"DU]'X*L:(#UM\>JC4GK"9%>#Y$Q(1
M4@1.X\!(@5/]@-ULU72K-S#9"#!M5M@*_+5Z?VHU>7[IA@[A&3L-#G@ECLZ.
MNI\,A56G"[A=;<\/8W::;FYA]?6S:S^+XQ@^WM,E3F8[U$CH7%BK3;8,.M@7
MC2A-4<JD&H1^]S=@NR[_:F&D2$6A;WX#J$EXL&&,*8RAYT?IM\0'X;/X(/3"
MJ0&Y[\5IB(MI'&P30N0EL_ H(833"4LPL0=.X$WCV3%""'P6IDCU:+J);A#O
M\0*6G*9$4>',9S.D6"<UCCW?3_]N7@C\:!\@>':0%:QNAD"C642I;4BBT_"$
M= S\Y['"=.*;OY83#)JBF2.%))W\KT@A"&Q2GR9G@[A._A(AQ A7,-O<ALE_
MQPC184:8_NV,D(3T[Z]P@A^:WW!FPA@:-$3$GT0*\30Q_D 4J)-2[CS!M"_?
M9A?J6.,H:12=)3?=D4*7'AZY;U6TKN=^)]Q&5AINZT:-,:I 8P4O%E@=>\.6
M<+WD]]1)"G(!0$DM/#6*Y7H3"P-]NQ?GN>S/4?C*LM]@-[9HL36A[I'V'J6L
M%B_RUJ$#",4EO3/H!T9HTXE6N%"P45D_FN.?\-G'/[8IW6Q&;(ZYCKP[4^A)
M!'TIMO9YFVF/QI##[*[7%@>FU[5XZ>A]>'XXH/?M,F.:/\/X-U8N4G$O.$C+
MZ]LW+/53D\=T)CSDM2#Q)K%M<KPD"MA[0GV.+AXE;#W<E.OU@/Y3ST="![&7
MSF:NA UJPQ04%J!W<M4C<TV[&-8R\&8\2XDST'>";VPIJ'>UIT(5H#V(?"PU
M@;PNB'6'.&/=+$8MWDN 7\:W8\HYP-<$SLR&/U%,ICZ+O FJ^JV6M>$QHEYP
M/]7ZQ)E$^1NE4_SWK:P?)15VDU0?!6UIL,AU?L_!7PO@Q@O1": ?0-_;O[[A
MV)[\@&J7@!*#C6#$$BW8[1(IO,$HPIL7]T7>TF8&KI_S%9WEU26G<,-3/CIJ
MM/$_;2%[.*M?5[5U7=H]&4DBUVMS>EAATZW9TO8E#H\0'D5P<CBS$;-!@CC7
MOAQ2U>RG026T7KG)KC,V\7V6PK/'E:R;XIX:G .346*GH0/#7CS1J\PB- 9>
M$J;LAX)X$B9M:]SM%\6&\2?8MUB_HV*GLR= &:3&5(?%#F&H^ ;MOA=AN]*W
M<J?$<\/L.M[UH1P@3]#PHTW>MPK[ -1*2H?];C!@R6Y^41^5/IU9@4]5//5[
M6^:'*1DYX$\"J)=$L]UF['COZ+:*?8M(:6)UU$M>#9!'X;!X(ZHM2R+MW9PD
MI79SR^"7X,8Z^(Q-7/;&5;O1=XZG1FE1H9SV/.O,HF.JKY8%=IK1&I32"Y1E
MW1DF*\'6@C=T.K!H.69I8:O3';%\)1ZH&-GSXDV5HKL:521;+V690]:=6$MS
M8&:EG;&N3X&@KAM8[:>QM^U8E\ VM^>BS^0QNR9'FW#L&M^[):?"!]UVSA%(
MV,Y6HMC^IM KJK;9X( 7QX<^_9P//LP! 0OS^5$Q4[_M-[K^:?^%\]I^V-L,
MMY]'H>@"R[)2S#'5'T^2$6OL)T=[ V(WG_GNI 9TS26<A@C0 +R?2Q1[=T,+
M]-]]K_X#4$L#!!0    ( $E6I5:D ;;/0AT  'Q=   9    >&PO=V]R:W-H
M965T<R]S:&5E=#(W+GAM;-5<;6_<1I+^*X1VD5C 2);D=5[LQ(!LQXGOXL2P
MXET<#O>AA^R98<PA)VQ2\NROOWJJJM]&%*7=!19W7VS-#+N[NKI>GGII?G?3
M]9_<QMJA^+QM6O?]T688=L\>/W;EQFZ-.^UVMJ5?5EV_-0-][->/W:ZWIN)!
MV^;QQ=G95X^WIFZ/7GS'W[WO7WS7C4-3M_9]7[AQNS7]_J5MNIOOC\Z/_!<?
MZO5FP!>/7WRW,VM[98>/N_<]?7H<9JGJK6U=W;5%;U??'UV>/WMY_@T&\!-_
MK>V-2_XNL)5EUWW"A[?5]T=GH,@VMAPPA:'_KNTKVS28B>CX0R<]"FMB8/JW
MG_T-;YXVLS3.ONJ:O]75L/G^Z)NCHK(K,S;#A^[F)ZL;>HKYRJYQ_&]QH\^>
M'17EZ(9NJX.)@FW=RO_FLS+B(0,N=, %TRT+,96OS6!>?-=W-T6/IVDV_,%;
MY=%$7-WB5*Z&GGZM:=SPXDI.H^A6Q56];NM579IV*"[+LAO;H6[7Q?NNJ<O:
MNN*1_^OXN\<#+8T)'I>ZS$M9YN*.99X4[[IVV+CBA[:R53[^,9$<Z+[P=+^\
MF)WPG>E/BR?GB^+B[.+)S'Q/ A^>\'Q/[IAO:L/_?;ET0T]R\S]3&Y;Y_C(]
M'Y3IF=N9TGY_1-KB;']MCUY\\:?SK\Z>SU#[ET#M7^9F?_'2N-KAS-YC[G8P
MD/ I(O^):8K?-K9XU;6.V%"9P5;%F[HU;5F;IKBB1RSIY."*NBV;L;+%0$\;
M81Y/Q:-)DDSQ8]^-N\*T55'33V4ZHQN7KJYJTQ.;3XNW[6#[LMON3+LOB.&M
M,ZRRC@>'R3?FVA9+:]O"-C6I L]4M\G,-.84!+B';.#&]K:@L]F9/LP#*U</
M>]+!8>,7ADCL>MINO6M(*-:VM;UIFCU^MSNE 5SXV-;XQ$LP*RZWMB=U*AX=
M_7AY^?[H^+1X9?N!+&5AMK(E^I.F[OIB;TV?[K"W96.<(W6D&8?.TX8_L50Y
M]CUM@H<5N^3P3FE1F9IFZ/HJ4G<_0UI;6N?H3&AO9!IA-\G2M&2;\?N7KK!N
MJ+>\.3X71Y9\I^>T)(-?;&U%VVV(6#>X!2U\32,PEI\G@FQ];9:-+:Y-,S*Y
M_!0=/CU7]&'FCNCMBQ4)0=>3>*1V*2&!3J^J'9E(!Q9M2-C6&U Q\/G_TM%#
MSXM-=V.O;;^ ]1^)-%J)S#6D<6PJ&K]:8:6^(\YN.AH6YF<Y*FJ22>("G:4I
MRHUIUQ;L] \5=2H.JA#,<#J6EN3&>>;O2!"ZBN>I?A^%*:<S=N!IL -/9Q7X
M _'TP%KW74M_EW*FBT*>(/(NJXZ%-7GVQY'$@1YEID]]3TPL_HN0@8Z=,C#_
M&GUJ:UCS2<#(EE\4<+;%^=G)?WJ..G_.,$[$0I?(0R\+9*J:+3!L#$E-S1+%
MZB5'2HP@K=N:?3CBD>0@:(5+[1R?X&H<QMZ*5*RZAL ,%JM;P46@C!:^KD'M
MN*O$ K1*'FR%<O\>0IG"KF3U)BM9XQ"&R"*BL+%B3G-6,5VD$%"*MIM9I>U@
M-(9(#QLJ<J;E)GA3FLST:XN?WVZQ*T^AV)[D,&GSQ<]=NSYY/?;"!+(R[#$)
M+1S]_/JWMT?'BW0 69NV,GWEBH_,)'KJ\NKCT3&M>_[-R?F%&HJ&C92A9:M$
M3%*GHN1CB>(_3#L"PBCYB^)F4]-V@O0,V9%]LGLY*HB3>U9\\:=O+BZ^>EZ\
M8O4.N]Q:X^C V7H1AZ((%#O @SV9Z=:N<!)-;99U Z\!=M#NJQJL("G"9N"I
MB-*3'42MI2E9L4K/IKC^96).1R=67XDH2N,VQ8HV0&QU(^V-CFW;D2O!L@O\
MN21O2A3PBF9'ABRQSL<L%B*5Q-6A:&A:V&1B&PP7.SMLT)(U%&M7*C-8^+M\
MN@)<8;IP5$/?N9UE:-WL]?C8=:A/54>E!K ET:-SZ;:D27[CKTFY(1_L '*O
MDI#]!QTQ.0I: QB\@G(1;OUDAY.&#'Q3[&O;D%CA"(A/14G4U31E[3Z1TGQF
M8K LSF#H1Y&J1T?CC@@[@=\:M\6:CL[*TR>WGH8@"RH@-?3LR;8J7@LPIK<;
MA"TP-KI7R._#UY+-P+NP<Z3YAB /;7%Y D95"0,M.3&<ADJF*?\82;I9']D5
MTT9?7[XB+?.:15,U4-O*J^V$9#+W#:2L_KOPVS#2(@WV/%\*?"3_*N+S>2?,
M()JW7FG\DF'>T^)79I3_H?+4T\F59E=#J+'@TC0@*)'XL85;9:F[MNUH$\V#
MW %46"R[',EP$I(11M#4QVSH2:F((B+8D<EO!%GI_H0)6TNRGO#U'<N7R%#0
M]D='[SZ\A# 0W74K%I3,R0 5(.O"X$RWNNF:RJ,+%HX3LO'M2=L!NS9^LRK&
ML@SV06SLG)^+#P;\[<1!X*D%'TW00?IV9>I>]J]"FNAO_(TA(;G.OXN\1ETD
MN$(<%A5=T/J M6+,,J,P9+XZPJ&V:VDL.T)($&_D47?3IDIX'*RR.R!C3FV"
M;:R"3044:#KLG+$C3#QX15^;];JW:Y:IGJP]-G##KL;O)#?4T]9\D1U'_-8A
M3&#[),XL3%8K9B4%6T 6;BPM;5R&# 0=I["E;G<CIOU]K-8*U#+#1Q.*-*HO
MJ-O4(47&P*YPP%0G$DSC=R3@(AKL*?$;PIUGV<"'\*.X,9G!'UDR#;F<2C0H
M\P!8N.\@3)X"DEOR,82N!A@./JK$PC@O5DN[KEL@9O\%:3J-=\%Q:(R#/1%O
MA*A4BC &F2I,H98#4Q%UAK74 _)#6.^WYO7M83Y^(Z%']%J>( ZX-!:!J(S;
M4:S<0Z2<1$AQ"D\R<;(B#+=.2PV-I_8>"\9Q;W*DF?W IW_L0(2C$DE9L'UI
MAQN$L&QKTYGIX$K3]WO,*E_]\^?(9DIU_]]AI1YZEC\P'4XB/=&\7.E:>U.L
M0]S%6L*8$_''73Z9=*H:,2LM6+'WX)@"EMX']XR-?[*F&38EO(.SZQ!XB[_]
ME78O,7=N/G1?V(0])%Z9"YJ=(G<1GWJ+^+>G4"E5*)4M0[Z1F&K@;[L#='Y>
M7&V(/I%8]V5AR4,/G'W\\_F3;XMMW31L,9%?  OB//FXQ'EYC>1<B$5ZD1 1
MQ3M+VK2&-!)7''Y[SLL^^2I;]<]/_<<%D@4!VLH^2</Q92>63,T($5?5S3@D
MX@DM*1PH9AE/MX(UST[/SV6UL].SBW]A!X<TI@<KB2515^>%!6*698*2_ ]1
M]I99NIA[Y%4F]Y,#7JKB7B$K[>9GBT#EMPYHZ <1".QV;A@"HC<<$*DYXXA]
M+E669\D\H]XG3(J0,Z3,O!E9==U H;--X4>2K?-!"BWI$V<QS^,TZ<0!LV2:
M;'3+;+$ 2E6_3HL/ ,28"BFLXEN_C_OS=UZ,(MDAYDOR 9K<CBQX.\#<$>9T
M-7)S##,A)JI>:@<EQ6$&TOI6LV=J6SDRV"4@0,("4..0>^.LFW%9L'U)AH_]
M@'"^+A/XX_,GBX(&NU'B]Z8K/W&H!.1AFP4C>D\ $3L@(<S.BB@A-U=P'.A<
M2G[N:3/H7[L\P"G^A0"'9;>5" L#%0;Q!%O;KZWZ-$]H6W" DP1($>XV>X#<
MJ/>P! N>*DK 9'KE90=;_>CHS>4512O%;EPVM=L@_7?UD6<Y.7OJG5T2#\F&
M,D27""IG6Y9['-JV'@8!<Y U]6%;\PEN_I:X[8M0A*.GQ'&GD2:+''LM,N^:
M0]@2UZNH+QX+2*523)MG*GLMT,H9)3V6X*_"%//[.KV58]J:2@/&PTUX18L[
M8,*]U=B,RV5:QI"<-@EI52,ASH!"<]Y %L7O'7TF86\9TL$2?O&GBZ<7S_M/
M]=[.98F_"EGBK^[)PDJ\_"'JPE0J=WZ2'T@+6E*9C<*,XLKVUS6L)531-*[S
M&="BU"I'S*>" RGZ6A,D(#6S>1!G4."LM^-6U8^.QL-L!^4DK-0.O)S4$LCO
M</J=S,<X$#Q798Z%A&M#@D(6Q FI,BTIV"N>22A?D@21K Z-M]\\,PLV^3@U
M#RMR,\"RC61AK(#DN O26:DOI)NLG:A''PV EQ@\&D:S/'$([O-]>37#NR?L
M*$T&<^;$A6P(9L'7OCI!'#=[!%[>]Y.AZ$?+"0;:659K2:/91^HQCWTI+:^Y
MB&/30&QGZBK)K;(ZMI770<DP)AN5C<R)]-=!I+^>E<:/+2_]JC'U5C:B?_Z@
MFYL2\/DI?X.JQT!/'7E:]=)MP9=S^0?)-<Z6RM(Q@\^@@.1:TOA+.D;DW7N[
M(_VQ52KRP:54$,UN)_GF-CRK<R\T#7NP1'C*+X'4/C/FT<$$4FGL4. [3LX]
M5.QPLIE<.*_=)$0FX +#)5/:/1<).02J.1N[@M'OZ;3%\:-PT<+.ID+FBYYA
MQJ[8B"DI9=YN9;G(@UDP;&5*%<HYD?DFB,PWL^?[1D+F]V+,7VHX/"4G\_,<
M=@H0['XSG36@,Q#0*5JL?X<\9514C>8[<M)K7Q>-OVK.!58#$9?/\BPTV4TQ
M(^.1)%[T#0P21K6,J$,0J>K-%4M,49(9!>ZIG2]UZ_%RW,V="TZ-B\P4W-Z"
MU&5EDX5COHR#?74#;B2TQQB5B-<3#]0$L0I6 MZ?(DX6D:7==Y"?5H*CTZ2^
MQ&/@J#7/I3Z#@->F7F\8L2'L(E@I8Q>Q<,!)AKY>2QI69]1'@2&$?!1*NAL8
M1_8:ZHU\EI%3:F)7V73'A9A7?N\^%RT R0<'6MI.[(#RHQCV.UI^1V"'_Q0^
M\H%!SMZ%:GQBE:3>G<A.W&B:4P15)(+;>MS>JKHO8C6)RZ*^GK3PDLE&A$T_
M[ 5O/K<63")"<R+RKL)4>.A6D2<[F1B^(#N#9?K:^BIU!+)1'P:(BLK<;*5K
M$2#CYP$\3++D9=V7Q)A!XK_><N% .U,\F^XF^]]<B3I%X3<>(2ROE?AL["F.
MLQ-=%;U.Y_-[+*CJS\IN0T?V)8NCY>TM?-^$2(W.BN>C?TSRT8N,[0=Q-W,N
M5.]\$:UI\AJCS2D6U![HX; ^KR0&_^:SK9?W9.@0#0KC(FQGI27?2PPF=2I%
M1@CIC:Q0,'ULA21;+S291 3=KE-RB;AKS421*4;@#9*?G&E?CY1U:%&RS+P[
M-=PV/*]I]1!_:O%"Y4ZSZG>0O^2LM*70!:E3)/D +(!IX0.8WZNQ+;6 HM8$
M/PF;V$YR_]+IU2GQHFE@+._D C+ZH.>S8""CDMT3O!-BH855A<V(Y$NW:)(0
MD:( R!59>*B:R/:%8>H8.#4 %4_HS.EQ/LJ]1A)RN1<Y:XUR0S27MYL>D,IP
M0'KY<< ,')Q7MM<YM/)M0"O?SJ*,5WD1\;5%47 @I-%6DYAE?K8)S/)S OE7
MB5CI@I4NN,*""2CP;7_ZN_,!DP;:TK&*L$1@H.\ .PE-'71J8ULCM4/L9_P0
ML "W"L:FL9!,%<=0]TQ,EJ6[G=J6D"6KSJ5!2Y:A0[2)!D].") YZM?BS@19
M'5"9K9TZ3!V8. L1AN#1G%4NUDY0LF5!(F'=Q]Q2@"'WQTCG9[&W]VSVV+7^
M\P$:,0=XYZ>9[F6=$*F_PA]#!3U2)*,4L.'AD<3ZDRO>?7CI#NO8R/"3PYDH
MVZ@/634C(("X8Y(%P=4$"9T3Z.IKYU.5G^ ^@-$\7E=( X-!FSB<_S8VF3NC
MI/_Z_)[D3.#1Y-$\>/1$I(7D)S*P;!:]V.MOU:A>-C!*%# M*3K)IT-&[XQF
M-;>CM5T)-A$3'P!@5BFQQ&D.PRLAKX4@"<@WEBKIG)$$P9,]VNLQ<[=:.4O.
MX,I*EV=Q?O:/Y<A-["9(J_0<=0=NYHV)D<EIYS*<++,&#HW" M]8#.F4@TC[
M:I)$*3>%,2*Q"BL:V!!I_>#: N=Z.LVT^G/<2R,J^*Z9RW J,A>*!W%)Y)\L
MBDFI]<ZZ@[ *Q31LR1EFI;W7-QLK0C\"L]_T=9+PW6-R2,'22FPJC3;Y^E5G
MG8I*4Q.:3..N0;HG14%37*F=C  TBR":568]MB-L; ?;,[*K7MI$&H&K8DN;
M=SNI)4JT0OL!O#129$<($DUF5EJ4??=@$*42I;_ ?5:Q3'NV75MS:$</(@6B
M?LD_G:"<TWSA:UPW26<4E>Y[@&21*T:1#GX#\-/%X-RL#5"2;CC9W"N N8%+
M,!K$<M>T=BXI$FK2GCK>;:S9AP@AS,,,A;_T,-]7],6NQ*K()+^E=K%"?(6(
M%C9?;$*R0AWBKRH>;F-;#?L4]1'T!L0UW.=37 .V25RBECI.^&7:A3#K5R^B
MS;Z8M;IO TB9=J?SHY,B YN6 '@@PBNR7YW/QT@IOE@2^@=DX&+7*AF19A J
MNR3\:<D>L)8L?&D]_8J4E[ 9"S+PR]JL$1<9I)LT=Z6?-"N<Y);"DHO"(5R\
M];T8$P(OUR(?46>20/?TS=BK83QLCT*!9*).>8 C ;XM%(G=!/TX,F941W!^
MVT\?]$E?'I:F3HM?)Q:6/I\#EA:/(K>79 <4!3(7$]\+ D^6!O7*=#"[R=XW
M.Q)*+C]!T"OR&I+JVFL8C*UV/9HU<:D.10KIM."$*XL%^! LG-*KA>GTOL<=
M+"A^\G<BPAQI,8R[KO.:<>A7"0G'V<91^OJ@);MX%&]J^,.Z>+#3/A8P.+84
M6TEO* )02T]YOWUX4,@XPDEJ22*RHA_;$\(/].PP2$HR8-4 5-BS^? \Q8F_
M=.V)ST+DJ.L@=DJ=%> 2\8IEWF73/2QA\8$] R<?;0E+<M#4F24%@QNA_;+]
M/&0,6E4L-)<F@H,7B?5NB0OF!L4<CQ]:RP BN(>2YH$P2MI68\%8UN=ZO_;S
M*+G/PX_1(&@.F'.".SK'55V&!H)09>'D1O^<G_)3'*2,Q%V3LNS)VM$9=%N:
MB$14[^3X5D[;7M=]UZ:M_#(Y6]^*T$2_EV'=NC<[\D>8&0T#<\XB7BP\G[T)
M^.)UM(E1NM]&FSCI0>:G3*'#" QYG]V5ZCSD1)PCA:RX!-,CYU^ZW*EX$QOZ
MKKVR+R2UN0@):;W@0'X&.=[CK#:*=(NX)5JW<A$7-'IM[V'ZD^,SKC(_>,,$
M%W2_'/(=7FNP;%5TLTG$HE#-I]0RP%\)X$S;J_6QP!/[6=M28ADZHR7/<P;*
M=/'H<J&ZI^\;[AGK?4O0G&'7OE#QK_F-*6XFW>\DA7LOZ_1R7P<#>T?ST)QB
MQ#NLY_.W3]_ B/V5<>:[F$R>UH?YF5(9 2#%4=UN0LCVF#6]^CM>T_>_[D18
M?HD)I/4@C!3N0MQ!XYU=_F2*"0UP7!:(")$)5E?-Y1 N. ,.P"6FTZMB2=:4
M8L32!L'FCH3#70E>:)%!,Q6B2>]*>(+4);U)6.O2FQ)2!\5* ?F;5G10F\K0
MCJ$:)(VW),!]Q1=_TI8:WV2L)GYGR-N7-0F G.WMEB' B]/B,@::65@P0:;&
M,^SH;CQI7%N''H*4E3V\5X \P 1)"XZ"[YU40,G!E &CB8_N^M.#.Y-)DXV8
M,C'*$8&(0AQ*4&PB2"X:BY\?=]P+MZG)B?;E9A\X0Q 5%YF%@OCSFNO\ W^W
MWHAI:S\Q^.J2)5V$'KZF/;8A,?O'V V2JM#4KKRN0;FI84"%D*^\>ZN/?N8*
MW/EQ"!-1P?T'")+2>M=T:P_9N=U017]L;Y=#=,DGQR1<*LG(#@)5I:+FF5R&
M?L,LY%8R0]L33ZX@RV4W1V@'\$[9;1"41>QGL]TAP#:'$L&MD$&>IJ4AR&(B
M#'0&NC?T/TWMG5MO#X@3%^>-6*9D!-*NV?QPO6XXN&2IO5AL'<-Y^)J3;Q)8
M=DBM14*$^ZZ0;NJ+8RTOW'J"S\?O)FF=C&(4OTP+(_Z^OJ\ <BP:+?0TM[@8
MFM&@\8BH$$T-->^0F/;&@H6=,12#XELLK?NTB3B>6R8&'R>.R&=]<^"PA+"%
M6^PD;S?<5[3?(0X1#9LRK"(EH_3CQSC"9)99S+MOD9R00.,353Y$4].<-;T:
M5]P.&1_>"[W(DLSAF!QW!&8EBCLL27*<_O9O8CN]Z3O5IG7.O\D<DM--WP5P
MY\4%11W2OH LR+5XY>Q6Z:WM3C7L@UV_X**/#Y 3-*\4@;A?>.WPB[^S\N,<
M];_>$9F& LU@/C]L)[_,Q/"/*AL_'7-/=)XY24#3 [@R=4=A%K/&]RV<S[_0
MX,K? ]1$TC1:G9UCNIQV:V*Y5W-X6MH7%T3QEN3A/3Z'=Q55QK,WE_3H=2)8
M6*(1[* [U1=_N!0Z=&M)$W@D4O>Q^,N7\>C[JC<W%)Q)(X@V>">MU]'R/$"4
MT<L9KG><SA;98@/T^7SS<JA,AAKM#]H?,7E^\Y.]X=0@^05I"IM*7$K^,!B;
M$/.%K@R/3Z!8OOI"<\V,8/;?+J#Q)?'KKKE&7VF?71TY?W)O+G".N;$5]WR^
M<?;'T 8]R<SYP=%ZQVF>%1_("Z&# VSZ&=7WMR%?X.O8:<P7&[$%*MRZK:L:
M<%,W#4"&&U<K!++B7_%JAA!_YPV-'?RND!)O5[Y1W[8UOW<^VR5E_MC_R%<0
M=A!VOEIJ"9MU>]:IK(-6+I/)Q1N.N=IP%]4$JOEFQ"V*\Q5#\UM:.D'^6%XW
M)!/)NU ^E^BQ-&'+.]NC4F6DN* 3IOV$I\7;5;(#WP9?4<32Y8Z6FT0+0Z0V
M=7(78SGN;1\S0. GF[1 ?,B];C3XDF(O-VN(D5*&ATSG03K);S#>00 W_5Z(
M75)] $*/Q=\(26J7%-8JP-UDJ:54+Y5]Z7:]..4\_V3#@AJB#]E=@>=WV><\
M:^W2,7RT$V@S(%_/$,1GTU#%0UEQZ%'94CW:&$Q=V6T;0Y6TL31Y6XR\RLR_
M,J:0!$2K%V3T]5D/*S3[GIW9A7$I@H1B;7L!T2Q6/7?><J]'>KN/PR^4'%M&
MK2H189AN-F9)#D=[[)I^BU6FTD,+O)+'7Y,F)$32/?:ME-IV)& P(LR-QMP4
M(82->UQE5^,!/M?9:\QN,6&_DSY%Y"5_MW+[U%]S(3QOI;? -Y$GD7O69 3E
MV/MN0:&#"(PLP0;'P;=\^@G1XD0ZO^47TEBU<EOSF:_LQ(*L)CDJ2:LD=*:W
M7Q(RDW[E V/$H#*-+4:2/"1$.<A8:*-.?(D$J,IFEO<A#;[,($DPOG5=PLWF
MV>70K[ ,_0J(OP^N1Z:1S[W[#_I_V*%M2X,X"JNA%S9MRDG'W*<3"7.38U+E
MWG.W( >YSK&TIKN5P]=<2U)*R<HES &Y<,4FCG,/(2;4"B#;+UU!J6<%2?SH
MVE/D\\H821+G#K-9O@.&4VG)M&E/?<H$SI4XP)^L*)=UV^0=35QO0)L2&X<T
M$8.]R9WM]"4R:'P9^#J/]SCV&H'Y[^2H756K#9L#4O&"ROG\S9(KO;3_-A;'
M)Q'5_"P,<?W]?[T<YC+,(2F!'6UU:[2*HR\-T#L_61]0?)^#+>Z^!,BP_8ZW
M$+BLUX7K-XA\3F P0P)0XYM'B&..]:4YH:_SB.<_"@_[;1WQJU;8R/,+&M$.
M$JRT)D=82#P_8H-TVA+HU7':ZT,1MY;<3ZF9DS2IPO(N=YG]NP53Z8E;\'<@
MT<]%RS1[??7F@#L1K(795+R_17[+0FX,AT:IO_E6GN(N9AYP4=Y+P[\LN</*
M?Z*QZ&;['&^CR'SYF9B!>+ <!W]YJ^U:MNA=TTBN3D(630U,Y2*40XO\\C5?
M'E,$!<#:KMG2"BI:Q#(QRB/D=MVMJ[I?)GKKC<3,\K["E]V[S6OS0UA@XIT:
M8W@[DY9(].4L<@G.QX'<=HQZI0^'3XNK=!=2WN$+]<[;V=O2YQU8BE&N@V^<
M%K[DP+5>*5%[:^26&9EGX@PR;@]1/9C(4(5B*$< ?\#+K$A XE7_[/6NGACN
MBI'7 ]B#YZ.!XD<//#&+M2MNZ3L79SCE%K[)WP,3[Z(F+V!XELL/D_7_0(3^
MSPG,WT)NQ\,3IDO3/%%.[K.G^T EX1N&-D+ACF]RA)<;)<2FQCH$E6)B)UWO
MX^2%V/S.!;SVF]_ZV@[R;NSP;>%?+7XI+]2.C\M[R2G:62/'UM@5#3T[_?KI
MD82G_L/0[?CUVLMN&+HM_[FQADC' _0[WAWB/V"!\,+U%_\+4$L#!!0    (
M $E6I59(%P.2GP(  .H%   9    >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM
M;'U4;6_:,!#^*Z>LFEHI:EZ!E $2M)O6#^U0VVT?IGTPX2!6'9O93M/]^YT3
M2.D$?+'/]MUSS_E>1K72SZ9 M/!:"FG&7F'M9A@$)B^P9.92;5#2RTKIDEDZ
MZG5@-AK9LC$J11"'83\H&9?>9-3<S?5DI"HKN,2Y!E.5)=-_9RA4/?8B;W?Q
MP->%=1?!9+1A:WQ$^WTSUW0*.I0E+U$:KB1H7(V]:32<I4Z_4?C!L39[,KA(
M%DH]N\/M<NR%CA *S*U#8+2]X#4*X8"(QI\MIM>Y=(;[\@[]2Q,[Q;)@!J^5
M^,F7MAA[F0=+7+%*V =5?\5M/#V'ERMAFA7J5C=)/<@K8U6Y-28&)9?MSEZW
M_[!GD(5'#.*M0=SP;ATU+&^899.15C5HITUH3FA";:R)')<N*8]6TRLG.SN9
MYKFJI#7P@#GR%[80Z,,]%</YDY/-Q2BPY,8I!_D6<M9"QD<@$[A3TA8&/LLE
M+M_;!T2OXQCO.,[BDX!W3%]"$OD0AW%R B_I8DX:O.0(WENH!GY-%\9JJHW?
MAP)M<=+#.*Y?AF;#<AQ[U! &]0MZDX\?HG[XZ03+M&.9GD(_FIE#/$\B'>;Y
M5""LE*"FY'(-K&Q]U:@1N,Q%1:FC4K0%E] QT7M,)-HAG-]**DHAJ+_,!5">
M\J)+%-R0=KE O;N)X5Y)+DVEF<QQ6]STK/?2<08#/TM[M/?][.H*Y@6CULNQ
MLCQG@@I?5BM*5J51FW>& S^*,[>&&=R>]A'[:7] ZU4_@6^V^/^UGT*<9O"D
M+#D\@VC@#\*T%>(H@T.9#?;ZC[RMFRECH/FUMA6[VVZ03=O^?5-OIR#]X9K^
M" 2NR#2\'/0\T.UD:0]6;9IN7BA+H35B0<,8M5.@]Y52=G=P#KKQ/OD'4$L#
M!!0    ( $E6I58@=PV _ ,  (P)   9    >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;)56VW+;-A#]E1TVTUHSBDB1NKJ29FS'F?@AC2=VFX=.'R!R)6(,
M @P 6L[?=P%0E#1QU/2!Q(6[9\]B+^!BI_23*1$MO%1"FF546EM?QK')2ZR8
M&:@:)7W9*%TQ2TN]C4VMD15>J1)QFB23N&)<1JN%W[O7JX5JK. 2[S68IJJ8
M_G:-0NV6T3#:;WSFV]*ZC7BUJ-D6']#^6=]K6L4=2L$KE(8K"1HWR^AJ>'D]
M=O)>X"^..W,T!^?)6JDGM[@KEE'B"*' W#H$1L,SWJ 0#HAH?&TQH\ZD4SR>
M[]'?>]_)ES4S>*/$%U[8<AG-(BAPPQIA/ZO=!VS]\01S)8Q_PZZ532+(&V-5
MU2H3@XK+,+*7]AQ^1B%M%5+/.QCR+-\QRU8+K7:@G32AN8EWU6L3.2Y=4!ZL
MIJ^<].SJEFG)Y=; /6IX*)E&N'AD:X&FMX@M&7!B<=Z"70>P] =@&7Q4TI8&
M;F6!Q:E^3,0Z=NF>W75Z%O CTP/(AGU(DS0[@Y=UWF8>+_MY;_^^6ANK*3G^
M><W? #=Z'<X5S*6I68[+B"K"H'[&:/7K+\-)\OL9LJ..[.@<^NI&575CF4]>
MM8%K9G@.3!;PCHO&8@'?>_.:"^>-'%"+%A7WJ#6A&G]&.Z17[NF0 #.P48*J
MV5S"8ZD13Z(.%+.\[()VNDSAPO,TP"784C6&+)L^%(3'M-^MN!#D,6WB2XZU
M/:+!*M5(:WKM4=QN-E3:[FCV!_*C?6^S5*) ;7X#2:V.2W('X0T,^^ED>C(.
MYX<QD+V$+[ZXG>_/J*E703H?]Z?)I!NSX:P_FDV[D6)74=BH?/,GP*\-?V8"
MB3MD_72>M>^T/YV/V_>CLDP$/\T!-8C-9_WY?-YA!X4L)<JS]) $AW-Z Z-!
M.J/A(ADDHUY8CVC(!M-)NYWUPCJ#JW"JKL.Z5NF<7*MGI!AK"A'2XT)<A1#C
M]R%.H:13@36BZ]*&$I8DK-KC>0Q>497XD+!"U9;X4C #%LMS9]]M;1M>,)D'
MTT+)[=NBT2'_N30T==]R(N+*U<!%P0UU2$,@E#=_*$MA<8:=P1O*("4(SI%Y
MSR6I<CK?!\>N<H'H#<Y4Z+BKT/'9XOG46/)7%H[\;54+]8U.ZL''_%/M>!M'
M"^YD+IHBT SD3@K[_Y7S64:O=Z3'$MN*=435$6G<DPZ)JEK2OMZE\F5RPCP_
M97ZF9:PQ9XUQV8-< X:2W%'K8!3KMUZ1;N/_:" 7=X=^T OMQ"?<U3%&QSH9
MS"$=S."UP,9'-V2%>NO_ PSXU N79;?;_6I<A1OV(![^4XC>EM(1!&Y(-1E,
M*2(ZW/UA857M[]NULG1[^VE)OTNHG0!]WRA*U7;A#'0_8*M_ 5!+ P04
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M171BV,ILH?T6HZIRL \0]C#ZCI8!-N9D0-2Q\RS[*OMQ%(0DV6*[4=&I>!]
M!.& ",*#B. 7Y!'QIGZY]L6E-M3-8"AKCG^1.;Y[KIVK@_W\*\3(GPL)2OS>
M*]]MI<^>]M@N!:JV5 #:(%\T=:G3*LL7"[1\O=M<MH]2:I#?P:]$VN2R=U"[
M 2@^2V <A2ED99J'Q@U?2,/#B3=Y"U**L'R<K,?L&UTC]2=J\[F1C4I)(?5(
MLH"X=4-EF+-O_Q%[W/L!:X\9(L:=^KC\669YJFE4B]HCH0M'(W.GH6[H[G1F
M WDA'FH3<@_6 \04'9N6$DOD%:X3*](U*AK2!5,75;ATG#Q;3A/DMU7=:,O;
M>J;726V7'0PUU:K^;?SY]$"NS(9<F1T,4MM4KDU3N3!-92C\^X+^,#_"JX]Z
M_*/V1[D/O77;D' ;, H"5*Q6A>Z.<&'6&=RB%5[L!V.VM3S7.ASJZBI7+965
M=1N%L56'G22M05@L-2$6U%F7:J[49HDF1T5ZR#,*2!-DQ'L@==#%RIS4L0+M
M<"(]1CP@P@/T9*4-V*% .KOI=;[;=W<RZJJWGDC3QB0+V9%YTY!BV)O. GST
M53_+54K%UZP)IQZM":; ,]^P7[<=,U@_GKJA[0S1-.@O_V(/OJ8I!I(\B*+3
MP4^E**7]J94,V&-?JXZ!-0G=)VA? 8HVY 5*TCQ0Z%(-1N8#'6ZHQM79EO;C
MR@;TZ@.G^;/HA+T;>*Q7L'0IJGMIO&E+Y\-0P76A'<0?E=2^5/6?5V!H2(A/
M(594M'UWIFO5A[':*6+ L)OX'AK]Q.?NR<C90S.E(H5V'&QW9(9.4#<YC !1
M-Q7GKL.!O $6O-E(6ZJ9+['5A,/L'HE$"&1K5ZIIY* 8_9P^ XPWSWMZ.Y?W
M.SL)0NWL*'G.V8<<.P-D@:C)_\.QF"1Y.-3-E7BBDJ$&E\;A\RZ-6>A]E4M#
M(+8$T"L:Z7G8B5%,0B3>KA/]$VUP3\_0< #2__T&6'^F%A\S/]%@#6#7C)X3
M0%6D._!QWX"+ES":A"0!S=/'>HPFDUR9R4?9PXH&Y:J"3XP#C88YD(O17(\?
M0%&DEL%!ZWD$0I"Q,4SWMZ;O0@ @KD^5+N>WK>Y&F<8K S9:;[ H:O@"W.GQ
M6B>XZ _9U%-&K6Y88\ERY+4HTLZ@.RPEVK1>HJFS H$-N18MC?O6;3W[IC]G
MZTGV57.#)_:V#))^L_HZQ)/".L>NF."ZJN=EXUP'O'7.?4.'?4-ITFWJF$>
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MUKJUP^.*0QB<L@AL)C%@&4G;'99(LU+^@7RCR^*]2E/?); *]KN:O&*>+[*
MR0MVX^13VLE4.*)ZQRV\X_GJ(YL412GM$[GN!IWKG^A<C1G"SG#0VWGZE*_4
M(P37=-=-L%<9^LR8012Y_V^Z3 !5 M!S(HB?Y$++F+-HU'O&@]8<Z+V4-THC
M\6KZ-<WIUOVM)8,%HR$+!RR ,\+AAHOKDV,&M.$K3N8_Y[_!Z9!%G6#8@]@
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ME1LVP=ZMVAK%'%@%9D:M14FILX^LL._<T+.L$(>P-48H!B5*LLS1+EST7:Y
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MAT8R+YP)$+S&$5UQR2N4;D3_F-8"Z>=Q=%B@Q)H["T7O#BU8)2IP"FZV;5'
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MQB%<UE1N$,"W4!O]_)/3:?YJTM4FF6^3;&J3++!$5HB'5AX/K2IV'5\J20M
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M7/=O/**J@5(91I:N)Q?28(>[Y1IG,"CK@.=+*<W!L&W>3/7T#U!+ P04
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M:5-Q.J3,L"16\D"4]48V.W%B.C2FSVM[[2NC<)<CSB1?F*IYO=%D"8JL2J:
M?&Q'361!%K*J\'961F9;<@,B)[PFW["^]$X]DG<I&,:%?H\8W6*Z ;WNN!!X
MLSKV#,9I3_.R+J;K-J;PF9CNF!J1*/A 0C^,!N"+E^$I9#T\'("GYY_^']Q#
M<7N%PU[AT/%%YRO\ZVJMC<*2_STD3DLW'J:S;6"F&Y;!G.([UZ#V0).W;X)+
M__.05*])EKX2V1,9HU[&Z"7VY%]-9FU-:E>395>3IJO)(4%;XL!WS+8/[I/
M#T>3V-N?2C7@-IV._.GI[RDD'8!,)J.H]VHS]4Z>I^VE6&$;7FLBH$"8/YI<
M4*+:_M0:1C;NQ:ZEP??OIB6V=%#6 ?<+*<W1L$V@_T@D?P%02P,$%     @
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M:  *C=W.>:=$Y4JM:[[A+F0'KY?_IYSB5*6&T,&_WK ?'U&#2L@*)*^?SJ\
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MS*J/#X(OA"IW,+_?2ZFW7\H*=N\2FOX'4$L#!!0    ( $E6I5;U<=NUA@0
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MD\TL)C-,($@),9EK$=V14S*.(LRWI-JL)50"N89\):,$\T;&2PF &ZH5.;X
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M"HW]DATFV-*"- 'X?"&$WD[,"ZHF.?P'4$L#!!0    ( $E6I5:>M5<N PD
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M$"1(AV'8!UHZ6UPI4B,I._WW/5*R8CFRUZ(.T'R(2>KNN;N'=R1OM);JB\X
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M9MAS@K("^'TAI=E,K(&FBYU\ U!+ P04    " !)5J561W/M;2@#   :#
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MF<#V[\3M3WA>U"]]+7+.\[0^W%*RHJP*$-^O\YP?3JH*VC<39_\"4$L#!!0
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M'\8W1ENQ(52'\5%RM4J4GHR_4+'AF": ,$W1@E')E6=S5J3 T5>"5Z0@DH!
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MZP;+= E[,W5WIMXDJLH)5$"F3'K78P6,UPU//9"L,CW#BDG5@9C/7#6)P+6
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MV_VM/_)FFZ:MEKN#Q2M8EJN'_XM/.R>4 X+XD0/"W0'AYQX0[0Z(/O> >'=
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MSL:-M=M=85MVH-!,>@Z2>L])SPU?L21/UM%K%3.B+*!OT(T,SG[TN.'VJ^V
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M:?%Q2Z,5Y2I _KYF<G+* W6":C?V]#]02P,$%     @ 25:E5EPBD@!\ P
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MV857<DE2&#EZFTD0*W"2]^]PY'WJ@GNE8'NH08,:V*(GDQ+,TO$"T",0@;A
M#&3G$FX"154@8Q2K) KBH;O:1;$F.Q&EUZ#T_HM"Y@K$ED9E@I>+#,VU:U1W
M.L$V8<,=L&#0]UMDUMPGDH4-6?A,LBU(PZ:@.(X6'J+Y?K^%9DU^(EK4H$7/
M1+-R1 <<?B_T6AS63"=R]!N.OI7C5CO&0G\"$2EFB*M, Q$I05U,2?J@C40V
M_MJ%US]<IABWZ*SY3Z2+&[K82O>=*\*Z"H\/"L=>%+5=(3YP#NS%O>T.VZMI
MT-0TL)KT#:$"_22LA*["!J]IT*\4; \3>]N/M?=:%EU'"O<\NKU-[.E.Q=GI
M/?#;V'0==V^7],.V3]NSGTJW[1RP]6O] JNN ^]YW "';;RW:!;PMEO _V\7
MGF'7=90]%O_ %NRY3F79M@O8WB^\S+)Q1]?0Z[4)WZ)KP-NV =O[AJ.V7>MV
M'7DP\ ;MZCO>BOMMVW9WSB'F$*A[^04MI/:HN99YEWT=16S.59N!XLOJ:#+E
M2A]TJLM,GT5!F!?T\SGGZFE@3CO-Z3;Y!U!+ P04    " !)5J56HV015JP%
M  "@(0  &0   'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6RU6M%NHS@4_14K
M.UK-2),&VR2!;AJIDZJ[(TVET52=?5CM@TO<!!5PUG;3F?WZ-81BP,84+7UI
M0W+NY=P;<XXO9/7,^*/84RK!CS3)Q,5D+^7A?#83T9ZF1)RQ \W4)P^,IT2J
M0[Z;B0.G9%L$I<D,>=YBEI(XFZQ7Q7M?^7K%GF029_0K!^(I30G_^8DF[/EB
M B<O;WR+=WN9OS%;KPYD1V^IO#M\Y>IH5F79QBG-1,PRP.G#Q>02GF]\E <4
MB.\Q?1:UUR OY9ZQQ_S@\_9BXN6,:$(CF:<@ZM^1;FB2Y)D4CW_*I)/JG'E@
M_?5+]NNB>%7,/1%TPY(_XZW<7TR""=C2!_*4R&_L^0]:%C3/\T4L$<5?\%QB
MO0F(GH1D:1FL&*1Q=OI/?I2-J 5 OR, E0'HM0&X#,!%H2=F15E71)+UBK-G
MP'.TRI:_*'I31*MJXBS_&F\E5Y_&*DZN/V='*J3Z7J0 4_ [9T* NTPMB"3^
MEV[!Y4$MCB@F1<O?7U%]] &H=Z[HO02W-'KBL8RIR!&2Q(GXH'+=W5Z!]^\^
M@'<@SL!-G"0J2*QF4I'.3SV+2H*?3@11!\$;PL\ AA\!\A"VA&_<X5<TJL)1
M,WRF6E7U"U7]0D4^W)FO4?%'<'E4!9/[A$[5-345)*'@KR\J"'R6-!5_VPH^
MG<&WGR&_;L_%@43T8J*Z+2@_TLGZUU_@POO-5OY(R1K-P%4SL"O[^C)E7!;K
M9,.$M)5ZBE\4\;FB'-?06RR"U>Q8K\&&"GQ4H1KD_(J<[R:7*(DB642!^F+
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MU?8?*-0T$9;$*CY?E#Y?G$KQ7MB,F26Q2LP\U\"(:V69+F0ZX#H-/^M07[;
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M[I<Y*8O:':#O<Z7L>N,N:,=W\AM02P,$%     @ 25:E5@M^N:-P P  10T
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M1U<5=)>\)5<C,9-@^"1[6ZW"?GOZAK7^+WRABZ=<N''S1/WX:56VF06CT=/
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M!(./%JS:5=,F1M9^6E?2V-GW86FW,RA78.\+*<TA<0N@W_?9/U!+ P04
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MPJ?1,I&?LY=?>.40T_K&69(7?]%+)=OOH/$RE]F\*JPLF,=I^3_Z7@5BK4!
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M2A/N.K;>+O&DK1Z1M7VDO6XD^=U)^HBM)&)0C;A1[>.6NU7%=;QOO0T#I-C
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MIF%*F^@P, U")LQ2@M*8T:$PI$T,!? 5@O.5,5FJ("B.[_7+ RHQF_H:3"#
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MXG@_CC)3U8X&:3N+0BH,- N6% ">X@ _$6>F1FF!*6UBC( 64)P6F./,5"8
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MP58EY48:SA0 E@<'8GE@%,M-:1.][9QZG/I80J XWR@=2KU02;FZM?P 8#W
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M4><;WJBSVJDZ@Y'7EZGS@:!\G*#Z5_1-'N^B4E+'-VDBBTI-=][1F0'C'AI
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MTIX1X&$^@=.3,S@!H6 DI"0>FT6.,O3G1$6;S:C))CF2S1TW/4C[GR")D_0
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M',$<@ <,"</Z/;CW/O(V[RFO^Q_L^ ]02P,$%     @ 25:E5I>*NQS
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M$OIIA_-"$*KV_1D'DVT#?N+.=_8 $[-#0FR'N5B%,_PCN/VZ/P[1,%DDQ+)
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M_TZJQ\NY]7;YZ_)KY^2&NN(<[BN&Y[]02P,$%     @ 25:E5HENS'XK @
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !)5J56U+3A<.\    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !)
M5J56F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( $E6I58_,,%QP04  +\>   8
M  " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !)
M5J56V/BK),8&  !7'   &               @($%#@  >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ 25:E5M)=?XM$!0  4!4  !@
M         ("! 14  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0
M   ( $E6I58ATDA*(@@   TC   8              " @7L:  !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !)5J56;O5G$H,"  "G!@
M&               @('3(@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!
M A0#%     @ 25:E5N-T<7Z."0  KE(  !@              ("!C"4  'AL
M+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( $E6I59V3KGDQ0(
M (P(   8              " @5 O  !X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"% ,4    " !)5J56W;YCJ<L*  ",-P  &               @(%+
M,@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ 25:E5IUK
MUVH; P  - @  !@              ("!3#T  'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+ 0(4 Q0    ( $E6I5;A]-X9C@<  "P2   9
M  " @9U   !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @
M25:E5@+ Y1<4"P  O!T  !D              ("!8D@  'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6Q02P$"% ,4    " !)5J56.TC*T*<"   )!@  &0
M            @(&M4P  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4
M Q0    ( $E6I5:8("WLK 0  "0+   9              " @8M6  !X;"]W
M;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ 25:E5A+5I:B-!
M-0H  !D              ("!;EL  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6Q02P$"% ,4    " !)5J56!Q_6S](#  "O"   &0              @($R
M8   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( $E6I5;;
M#G+RI H   H<   9              " @3MD  !X;"]W;W)K<VAE971S+W-H
M965T,38N>&UL4$L! A0#%     @ 25:E5A-HGS1$ P  T@<  !D
M     ("!%F\  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $E6I5;0]<1(20,  /D'   9              "
M@0NM  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ 25:E
M5H;W-3V/!@  HA(  !D              ("!B[   'AL+W=O<FMS:&5E=',O
M<VAE970R,RYX;6Q02P$"% ,4    " !)5J56"GCJ5<$"   K!@  &0
M        @(%1MP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0
M   ( $E6I5;7.?D*#@X  +@E   9              " @4FZ  !X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ 25:E5M+1G:<Q"@   QX
M !D              ("!CL@  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"% ,4    " !)5J56I &VST(=  !\70  &0              @('VT@
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( $E6I59(%P.2
MGP(  .H%   9              " @6_P  !X;"]W;W)K<VAE971S+W-H965T
M,C@N>&UL4$L! A0#%     @ 25:E5B!W#8#\ P  C D  !D
M ("!1?,  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " !)
M5J56;QPQZ7T&  #>$   &0              @(%X]P  >&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( $E6I5;'5<-]AP(  '\%   9
M          " @2S^  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#
M%     @ 25:E5CTEW:O^#   3"8  !D              ("!Z@ ! 'AL+W=O
M<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !)5J56?D)#8QX(  "'
M%0  &0              @($?#@$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM
M;%!+ 0(4 Q0    ( $E6I5;$]Y$%1@D  .X:   9              " @706
M 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ 25:E5A]T
M7XFK"@  X!\  !D              ("!\1\! 'AL+W=O<FMS:&5E=',O<VAE
M970S-2YX;6Q02P$"% ,4    " !)5J56BS<F69X%  #I#@  &0
M    @('3*@$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (
M $E6I59M94C-@0(  &0%   9              " @:@P 0!X;"]W;W)K<VAE
M971S+W-H965T,S<N>&UL4$L! A0#%     @ 25:E5E97+LSB!0  *"0  !D
M             ("!8#,! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M% ,4    " !)5J56FGK*Q6T#  #("0  &0              @(%Y.0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( $E6I5:P\BGY8P(
M .$%   9              " @1T] 0!X;"]W;W)K<VAE971S+W-H965T-# N
M>&UL4$L! A0#%     @ 25:E5@V[9SO, @  K <  !D              ("!
MMS\! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " !)5J56
M5 _@P,4#  #G#@  &0              @(&Z0@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;%!+ 0(4 Q0    ( $E6I590^(*/- 0  %D-   9
M      " @;9& 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%
M  @ 25:E5CTE_CNQ @  /0<  !D              ("!(4L! 'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " !)5J56.*X* U4"   P!@
M&0              @($)3@$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+
M 0(4 Q0    ( $E6I58--@0Z/1(  %+'   9              " @950 0!X
M;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ 25:E5@12I=M&
M!   CAH  !D              ("!"6,! 'AL+W=O<FMS:&5E=',O<VAE970T
M-RYX;6Q02P$"% ,4    " !)5J56*28Y:;T'  !72   &0
M@(&&9P$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( $E6
MI5;U<=NUA@0  %<:   9              " @7IO 0!X;"]W;W)K<VAE971S
M+W-H965T-#DN>&UL4$L! A0#%     @ 25:E5NAS2M;U @  , L  !D
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M=#4T+GAM;%!+ 0(4 Q0    ( $E6I585<[KM& @  *4X   9
M  " @:N, 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @
M25:E5J0B&SAT!@  Y#,  !D              ("!^I0! 'AL+W=O<FMS:&5E
M=',O<VAE970U-BYX;6Q02P$"% ,4    " !)5J56K/_1?1<$  ""#@  &0
M            @(&EFP$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4
M Q0    ( $E6I58F?>8.%0,  +P)   9              " @?.? 0!X;"]W
M;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ 25:E5E#U'!_(#P
MM]4  !D              ("!/Z,! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX
M;6Q02P$"% ,4    " !)5J56.EX/:V8&   +,   &0              @($^
MLP$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( $E6I5;G
M.[ D< 8  )DM   9              " @=NY 0!X;"]W;W)K<VAE971S+W-H
M965T-C$N>&UL4$L! A0#%     @ 25:E5EPBD@!\ P  Z0X  !D
M     ("!@L ! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $E6I58>P*Q.!P,   0-   9              "
M@>+8 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ 25:E
M5JD!Q^'[ @  EP<  !D              ("!(-P! 'AL+W=O<FMS:&5E=',O
M<VAE970V."YX;6Q02P$"% ,4    " !)5J5650%E_H<#  #9"0  &0
M        @(%2WP$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0
M   ( $E6I59HP[/Y;0D  )Y7   9              " @1#C 0!X;"]W;W)K
M<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ 25:E5M$ B'H7 P  LPD
M !D              ("!M.P! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q0
M2P$"% ,4    " !)5J56=0)=$>,$  !L(0  &0              @($"\ $
M>&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( $E6I5:D:N*&
M.P4  !P5   9              " @1SU 0!X;"]W;W)K<VAE971S+W-H965T
M-S,N>&UL4$L! A0#%     @ 25:E5L?H&ZV3!0  P1P  !D
M ("!COH! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " !)
M5J56)CLYQDD%  "U)@  &0              @(%8  ( >&PO=V]R:W-H965T
M<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( $E6I5:0?Y^CW (  ,H'   9
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M970X,"YX;6Q02P$"% ,4    " !)5J56G/32RX8&  #!.@  &0
M    @(&;&P( >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    (
M $E6I58$+P]AP (  *\(   9              " @5@B @!X;"]W;W)K<VAE
M971S+W-H965T.#(N>&UL4$L! A0#%     @ 25:E5AX7%*2$"P  -U8  !D
M             ("!3R4" 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q02P$"
M% ,4    " !)5J56(Z_OR>$*  !-6P  &0              @($*,0( >&PO
M=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( $E6I5;_-!4_:@(
M #(&   9              " @2(\ @!X;"]W;W)K<VAE971S+W-H965T.#4N
M>&UL4$L! A0#%     @ 25:E5E@9,2]. P  D!4   T              ( !
MPSX" 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !)5J56EXJ[',     3 @
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8;6Q02P4&     %T 70""&0  RDX"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>522</ContextCount>
  <ElementCount>435</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>181</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Changes in Total Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity</Role>
      <ShortName>Consolidated Statements of Changes in Total Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Changes in Total Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Changes in Total Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements of Cash Flows (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlowsParenthetical</Role>
      <ShortName>Consolidated Statements of Cash Flows (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/DescriptionofBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Accounts Receivable, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/AccountsReceivableNet</Role>
      <ShortName>Accounts Receivable, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Supplier Finance Program</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/SupplierFinanceProgram</Role>
      <ShortName>Supplier Finance Program</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Mergers, Acquisitions and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/MergersAcquisitionsandDivestitures</Role>
      <ShortName>Mergers, Acquisitions and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Common and Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/CommonandPreferredStock</Role>
      <ShortName>Common and Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Insurance and Contractholder Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InsuranceandContractholderLiabilities</Role>
      <ShortName>Insurance and Contractholder Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Reinsurance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/Reinsurance</Role>
      <ShortName>Reinsurance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/VariableInterestEntities</Role>
      <ShortName>Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Contingencies and Other Matters</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ContingenciesandOtherMatters</Role>
      <ShortName>Contingencies and Other Matters</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Accounts Receivable, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/AccountsReceivableNetTables</Role>
      <ShortName>Accounts Receivable, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/AccountsReceivableNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/EarningsPerShare</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/Debt</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Common and Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/CommonandPreferredStockTables</Role>
      <ShortName>Common and Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/CommonandPreferredStock</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Insurance and Contractholder Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesTables</Role>
      <ShortName>Insurance and Contractholder Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/InsuranceandContractholderLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Reinsurance (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ReinsuranceTables</Role>
      <ShortName>Reinsurance (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/Reinsurance</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/Investments</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/FairValueMeasurements</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/SegmentInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Description of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/DescriptionofBusinessDetails</Role>
      <ShortName>Description of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/DescriptionofBusiness</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Accounts Receivable, Net - Summary of Accounts Receivable, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails</Role>
      <ShortName>Accounts Receivable, Net - Summary of Accounts Receivable, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Accounts Receivable, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/AccountsReceivableNetNarrativeDetails</Role>
      <ShortName>Accounts Receivable, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Supplier Finance Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/SupplierFinanceProgramDetails</Role>
      <ShortName>Supplier Finance Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/SupplierFinanceProgram</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Mergers, Acquisitions and Divestitures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails</Role>
      <ShortName>Mergers, Acquisitions and Divestitures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Earnings Per Share - Outstanding Employee Stock Options Not Included in the Computation of Diluted Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share - Outstanding Employee Stock Options Not Included in the Computation of Diluted Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Earnings Per Share - Shares of Common Stock Held in Treasury (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/EarningsPerShareSharesofCommonStockHeldinTreasuryDetails</Role>
      <ShortName>Earnings Per Share - Shares of Common Stock Held in Treasury (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Debt - Outstanding Amounts of Debt and Finance Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails</Role>
      <ShortName>Debt - Outstanding Amounts of Debt and Finance Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Debt - Debt Issuances and Redemptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails</Role>
      <ShortName>Debt - Debt Issuances and Redemptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Common and Preferred Stock - Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails</Role>
      <ShortName>Common and Preferred Stock - Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Common and Preferred Stock - Accelerated Share Repurchase Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails</Role>
      <ShortName>Common and Preferred Stock - Accelerated Share Repurchase Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Insurance and Contractholder Liabilities - Account Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails</Role>
      <ShortName>Insurance and Contractholder Liabilities - Account Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Insurance and Contractholder Liabilities - Unpaid Claims and Claim Expenses - Cigna Healthcare - Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails</Role>
      <ShortName>Insurance and Contractholder Liabilities - Unpaid Claims and Claim Expenses - Cigna Healthcare - Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Insurance and Contractholder Liabilities - Unpaid Claims and Claims Expenses - Cigna Healthcare - Variances in Incurred Costs Related to Prior Years' Unpaid Claims and Claims Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails</Role>
      <ShortName>Insurance and Contractholder Liabilities - Unpaid Claims and Claims Expenses - Cigna Healthcare - Variances in Incurred Costs Related to Prior Years' Unpaid Claims and Claims Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Insurance and Contractholder Liabilities - Future Policy Benefits - Interest Rates and Duration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails</Role>
      <ShortName>Insurance and Contractholder Liabilities - Future Policy Benefits - Interest Rates and Duration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Insurance and Contractholder Liabilities - Future Policy Benefits - Present Value of Expected Premiums and Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails</Role>
      <ShortName>Insurance and Contractholder Liabilities - Future Policy Benefits - Present Value of Expected Premiums and Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Insurance and Contractholder Liabilities - Contractholder Deposit Funds (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails</Role>
      <ShortName>Insurance and Contractholder Liabilities - Contractholder Deposit Funds (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Insurance and Contractholder Liabilities - Summary of Market Risk Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails</Role>
      <ShortName>Insurance and Contractholder Liabilities - Summary of Market Risk Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Insurance and Contractholder Liabilities - Net Amount of Risk and Average Age of Contractholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails</Role>
      <ShortName>Insurance and Contractholder Liabilities - Net Amount of Risk and Average Age of Contractholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Reinsurance - Reinsurance Recoverables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails</Role>
      <ShortName>Reinsurance - Reinsurance Recoverables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Reinsurance - Effective Exit of Variable Annuity Reinsurance Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails</Role>
      <ShortName>Reinsurance - Effective Exit of Variable Annuity Reinsurance Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Investments - Investments by Category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails</Role>
      <ShortName>Investments - Investments by Category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Investments - Debt Securities by Contractual Maturity Periods (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails</Role>
      <ShortName>Investments - Debt Securities by Contractual Maturity Periods (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Investments - Gross Unrealized Appreciation (Depreciation) on Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails</Role>
      <ShortName>Investments - Gross Unrealized Appreciation (Depreciation) on Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Investments - Summary of Debt Securities with a Decline in Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails</Role>
      <ShortName>Investments - Summary of Debt Securities with a Decline in Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Investments - Equity Security Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails</Role>
      <ShortName>Investments - Equity Security Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Investments - Summary of the Credit Risk Profile of the Commercial Mortgage Loan Portfolio (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails</Role>
      <ShortName>Investments - Summary of the Credit Risk Profile of the Commercial Mortgage Loan Portfolio (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Investments - Carrying Values of Other Long-Term Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails</Role>
      <ShortName>Investments - Carrying Values of Other Long-Term Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Investments - Components of Net Investment Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails</Role>
      <ShortName>Investments - Components of Net Investment Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Investments - Realized Gains and Losses on Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails</Role>
      <ShortName>Investments - Realized Gains and Losses on Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Fair Value Measurements - Quantitative Information About Unobservable Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails</Role>
      <ShortName>Fair Value Measurements - Quantitative Information About Unobservable Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Fair Value Measurements - Changes in Level 3 Financial Assets and Financial Liabilities Carried at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Changes in Level 3 Financial Assets and Financial Liabilities Carried at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Fair Value Measurements - Fair Values of Separate Account Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails</Role>
      <ShortName>Fair Value Measurements - Fair Values of Separate Account Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Fair Value Measurements - Additional Information on Separate Account Assets Priced at Net Asset Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information on Separate Account Assets Priced at Net Asset Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value under Certain Conditions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails</Role>
      <ShortName>Fair Value Measurements - Assets and Liabilities Measured at Fair Value under Certain Conditions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Fair Value Measurements - Fair Value Disclosures for Financial Instruments Not Carried at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value Disclosures for Financial Instruments Not Carried at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/VariableInterestEntitiesDetails</Role>
      <ShortName>Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/VariableInterestEntities</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLoss</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Contingencies and Other Matters (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails</Role>
      <ShortName>Contingencies and Other Matters (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thecignagroup.com/role/ContingenciesandOtherMatters</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Segment Information - Summary of Special Items (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails</Role>
      <ShortName>Segment Information - Summary of Special Items (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Segment Information - Summarized Segment Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails</Role>
      <ShortName>Segment Information - Summarized Segment Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Segment Information - Revenue from External Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails</Role>
      <ShortName>Segment Information - Revenue from External Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="ci-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Segment Information - Financial and Performance Guarantees (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails</Role>
      <ShortName>Segment Information - Financial and Performance Guarantees (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 8 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. ci-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Not-Referenced] WARN: 8 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: ci:FairValueMeasurementNonPerformanceRiskAdjustment, ci:RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue, us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount, us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease -  ci-20230331.htm 4</Log>
    <Log type="Warning">[dqc-0001-Axis-With-Inappropriate-Members] The fact us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax with a value of -411000000 is dimensionally qualified with the us-gaap:StatementEquityComponentsAxis and the unallowable member us-gaap:AociLiabilityForFuturePolicyBenefitParentMember. Base taxonomy member is not allowed by rule.  The properties of this us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax fact are Context: i9da4771b623549e5a758939e8718e0c6_D20230101-20230331, Unit: usd, Rule Element Id: 75. ci-20230331.htm 4</Log>
    <Log type="Warning">[dqc-0001-Axis-With-Inappropriate-Members] The fact us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax with a value of 584000000 is dimensionally qualified with the us-gaap:StatementEquityComponentsAxis and the unallowable member us-gaap:AociLiabilityForFuturePolicyBenefitParentMember. Base taxonomy member is not allowed by rule.  The properties of this us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax fact are Context: i1f0e583ccd0840039ba45ea866313d48_D20220101-20220331, Unit: usd, Rule Element Id: 75. ci-20230331.htm 4</Log>
    <Log type="Warning">[dqc-0001-Axis-With-Inappropriate-Members] The fact us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax with a value of -26000000 is dimensionally qualified with the us-gaap:StatementEquityComponentsAxis and the unallowable member us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember. Base taxonomy member is not allowed by rule.  The properties of this us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax fact are Context: i3b0fa25db54c4cd5b97bf60ce65ce025_D20230101-20230331, Unit: usd, Rule Element Id: 75. ci-20230331.htm 4</Log>
    <Log type="Warning">[dqc-0001-Axis-With-Inappropriate-Members] The fact us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax with a value of 6000000 is dimensionally qualified with the us-gaap:StatementEquityComponentsAxis and the unallowable member us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember. Base taxonomy member is not allowed by rule.  The properties of this us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax fact are Context: i5bc43d6d65d948eabf0c43a48194633f_D20220101-20220331, Unit: usd, Rule Element Id: 75. ci-20230331.htm 4</Log>
    <Log type="Warning">[dqc-0001-Axis-With-Inappropriate-Members] The fact us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax with a value of -101000000 is dimensionally qualified with the us-gaap:StatementEquityComponentsAxis and the unallowable member us-gaap:AociLiabilityForFuturePolicyBenefitParentMember. Base taxonomy member is not allowed by rule.  The properties of this us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax fact are Context: i9da4771b623549e5a758939e8718e0c6_D20230101-20230331, Unit: usd, Rule Element Id: 75. ci-20230331.htm 4</Log>
    <Log type="Warning">[dqc-0001-Axis-With-Inappropriate-Members] The fact us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax with a value of 130000000 is dimensionally qualified with the us-gaap:StatementEquityComponentsAxis and the unallowable member us-gaap:AociLiabilityForFuturePolicyBenefitParentMember. Base taxonomy member is not allowed by rule.  The properties of this us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax fact are Context: i1f0e583ccd0840039ba45ea866313d48_D20220101-20220331, Unit: usd, Rule Element Id: 75. ci-20230331.htm 4</Log>
    <Log type="Warning">[dqc-0001-Axis-With-Inappropriate-Members] The fact us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax with a value of -5000000 is dimensionally qualified with the us-gaap:StatementEquityComponentsAxis and the unallowable member us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember. Base taxonomy member is not allowed by rule.  The properties of this us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax fact are Context: i3b0fa25db54c4cd5b97bf60ce65ce025_D20230101-20230331, Unit: usd, Rule Element Id: 75. ci-20230331.htm 4</Log>
    <Log type="Warning">[dqc-0001-Axis-With-Inappropriate-Members] The fact us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax with a value of 1000000 is dimensionally qualified with the us-gaap:StatementEquityComponentsAxis and the unallowable member us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember. Base taxonomy member is not allowed by rule.  The properties of this us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax fact are Context: i5bc43d6d65d948eabf0c43a48194633f_D20220101-20220331, Unit: usd, Rule Element Id: 75. ci-20230331.htm 4</Log>
    <Log type="Warning">[dqc-0001-Axis-With-Inappropriate-Members] The fact us-gaap:OtherComprehensiveIncomeLossNetOfTax with a value of -310000000 is dimensionally qualified with the us-gaap:StatementEquityComponentsAxis and the unallowable member us-gaap:AociLiabilityForFuturePolicyBenefitParentMember. Base taxonomy member is not allowed by rule.  The properties of this us-gaap:OtherComprehensiveIncomeLossNetOfTax fact are Context: i9da4771b623549e5a758939e8718e0c6_D20230101-20230331, Unit: usd, Rule Element Id: 75. ci-20230331.htm 4</Log>
    <Log type="Warning">[dqc-0001-Axis-With-Inappropriate-Members] The fact us-gaap:OtherComprehensiveIncomeLossNetOfTax with a value of 454000000 is dimensionally qualified with the us-gaap:StatementEquityComponentsAxis and the unallowable member us-gaap:AociLiabilityForFuturePolicyBenefitParentMember. Base taxonomy member is not allowed by rule.  The properties of this us-gaap:OtherComprehensiveIncomeLossNetOfTax fact are Context: i1f0e583ccd0840039ba45ea866313d48_D20220101-20220331, Unit: usd, Rule Element Id: 75. ci-20230331.htm 4</Log>
    <Log type="Warning">[dqc-0001-Axis-With-Inappropriate-Members] The fact us-gaap:OtherComprehensiveIncomeLossNetOfTax with a value of -21000000 is dimensionally qualified with the us-gaap:StatementEquityComponentsAxis and the unallowable member us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember. Base taxonomy member is not allowed by rule.  The properties of this us-gaap:OtherComprehensiveIncomeLossNetOfTax fact are Context: i3b0fa25db54c4cd5b97bf60ce65ce025_D20230101-20230331, Unit: usd, Rule Element Id: 75. ci-20230331.htm 4</Log>
    <Log type="Warning">[dqc-0001-Axis-With-Inappropriate-Members] The fact us-gaap:OtherComprehensiveIncomeLossNetOfTax with a value of 5000000 is dimensionally qualified with the us-gaap:StatementEquityComponentsAxis and the unallowable member us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember. Base taxonomy member is not allowed by rule.  The properties of this us-gaap:OtherComprehensiveIncomeLossNetOfTax fact are Context: i5bc43d6d65d948eabf0c43a48194633f_D20220101-20220331, Unit: usd, Rule Element Id: 75. ci-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="ci-20230331.htm">ci-20230331.htm</File>
    <File>ci-20230331.xsd</File>
    <File>ci-20230331_cal.xml</File>
    <File>ci-20230331_def.xml</File>
    <File>ci-20230331_lab.xml</File>
    <File>ci-20230331_pre.xml</File>
    <File>ederofferletter.htm</File>
    <File>exhibit201-supplementalpbm.htm</File>
    <File>exhibit31-thecignagroupxre.htm</File>
    <File>exhibit311-2023_q1.htm</File>
    <File>exhibit312-2023_q1.htm</File>
    <File>exhibit321-2023_q1.htm</File>
    <File>exhibit322-2023_q1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ci-20230331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1193">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>112
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ci-20230331.htm": {
   "axisCustom": 2,
   "axisStandard": 44,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1193,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 522,
   "dts": {
    "calculationLink": {
     "local": [
      "ci-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ci-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ci-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ci-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ci-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ci-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 1038,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 4,
    "http://www.thecignagroup.com/20230331": 4,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 13
   },
   "keyCustom": 128,
   "keyStandard": 307,
   "memberCustom": 103,
   "memberStandard": 76,
   "nsprefix": "ci",
   "nsuri": "http://www.thecignagroup.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.thecignagroup.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Description of Business",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.thecignagroup.com/role/DescriptionofBusiness",
     "shortName": "Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Accounts Receivable, Net",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.thecignagroup.com/role/AccountsReceivableNet",
     "shortName": "Accounts Receivable, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:SupplierFinanceProgramTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Supplier Finance Program",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.thecignagroup.com/role/SupplierFinanceProgram",
     "shortName": "Supplier Finance Program",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:SupplierFinanceProgramTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Mergers, Acquisitions and Divestitures",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestitures",
     "shortName": "Mergers, Acquisitions and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Earnings Per Share",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.thecignagroup.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.thecignagroup.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Common and Preferred Stock",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.thecignagroup.com/role/CommonandPreferredStock",
     "shortName": "Common and Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Insurance and Contractholder Liabilities",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilities",
     "shortName": "Insurance and Contractholder Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Reinsurance",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.thecignagroup.com/role/Reinsurance",
     "shortName": "Reinsurance",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Consolidated Statements of Income",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.thecignagroup.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.thecignagroup.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Variable Interest Entities",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.thecignagroup.com/role/VariableInterestEntities",
     "shortName": "Variable Interest Entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:AccumulatedOtherComprehensiveIncomeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Accumulated Other Comprehensive Income (Loss)",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLoss",
     "shortName": "Accumulated Other Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:AccumulatedOtherComprehensiveIncomeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.thecignagroup.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Contingencies and Other Matters",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.thecignagroup.com/role/ContingenciesandOtherMatters",
     "shortName": "Contingencies and Other Matters",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Segment Information",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.thecignagroup.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "27",
     "role": "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Accounts Receivable, Net (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.thecignagroup.com/role/AccountsReceivableNetTables",
     "shortName": "Accounts Receivable, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Earnings Per Share (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.thecignagroup.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Statements of Comprehensive Income",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ci:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:ScheduleOfShortTermDebtLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Debt (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.thecignagroup.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:ScheduleOfShortTermDebtLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsDeclaredTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Common and Preferred Stock (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.thecignagroup.com/role/CommonandPreferredStockTables",
     "shortName": "Common and Preferred Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsDeclaredTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Insurance and Contractholder Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesTables",
     "shortName": "Insurance and Contractholder Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Reinsurance (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.thecignagroup.com/role/ReinsuranceTables",
     "shortName": "Reinsurance (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.thecignagroup.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.thecignagroup.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Segment Information (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.thecignagroup.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i51b230fe17da43ddb1e4f787e7e5b489_I20220701",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Description of Business (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
     "shortName": "Description of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i0168835d0324407988eb74d7d61484da_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:PharmaceuticalManufacturerReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Accounts Receivable, Net - Summary of Accounts Receivable, Net (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails",
     "shortName": "Accounts Receivable, Net - Summary of Accounts Receivable, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:PharmaceuticalManufacturerReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "ci:AllowanceForReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Accounts Receivable, Net - Narrative (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.thecignagroup.com/role/AccountsReceivableNetNarrativeDetails",
     "shortName": "Accounts Receivable, Net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "ci:AllowanceForReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:SupplierFinanceProgramPaymentTimingPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Supplier Finance Program (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.thecignagroup.com/role/SupplierFinanceProgramDetails",
     "shortName": "Supplier Finance Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:SupplierFinanceProgramPaymentTimingPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:TransactionRelatedCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Mergers, Acquisitions and Divestitures - Narrative (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails",
     "shortName": "Mergers, Acquisitions and Divestitures - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "ia6534aa5174f46daae1011252bc79cfa_D20220701-20220701",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails",
     "shortName": "Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i9b459f141c6c4b0da2923bbbd4e8c935_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Earnings Per Share - Outstanding Employee Stock Options Not Included in the Computation of Diluted Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails",
     "shortName": "Earnings Per Share - Outstanding Employee Stock Options Not Included in the Computation of Diluted Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i9b459f141c6c4b0da2923bbbd4e8c935_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Earnings Per Share - Shares of Common Stock Held in Treasury (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.thecignagroup.com/role/EarningsPerShareSharesofCommonStockHeldinTreasuryDetails",
     "shortName": "Earnings Per Share - Shares of Common Stock Held in Treasury (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ci:ScheduleOfShortTermDebtLongTermDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Debt - Outstanding Amounts of Debt and Finance Leases (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails",
     "shortName": "Debt - Outstanding Amounts of Debt and Finance Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ci:ScheduleOfShortTermDebtLongTermDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ci:ScheduleOfIssuancesOfLongTermDebtTableTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "if31115610c334a439c3f11aa884c91ce_I20230307",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Debt - Debt Issuances and Redemptions (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails",
     "shortName": "Debt - Debt Issuances and Redemptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ci:ScheduleOfIssuancesOfLongTermDebtTableTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "if31115610c334a439c3f11aa884c91ce_I20230307",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Debt - Narrative (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.thecignagroup.com/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Common and Preferred Stock - Dividends (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails",
     "shortName": "Common and Preferred Stock - Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "ib9c3e4e75f4d46b58ea05c03cbcb7a51_D20230323-20230323",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.thecignagroup.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Common and Preferred Stock - Accelerated Share Repurchase Agreements (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails",
     "shortName": "Common and Preferred Stock - Accelerated Share Repurchase Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:MarketRiskBenefitLiabilityAmountCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Insurance and Contractholder Liabilities - Account Balances (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails",
     "shortName": "Insurance and Contractholder Liabilities - Account Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:MarketRiskBenefitLiabilityAmountCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "if460fb29b2ff45aba9a93619bbe01ff5_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "ci:LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Insurance and Contractholder Liabilities - Unpaid Claims and Claim Expenses - Cigna Healthcare - Activity (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails",
     "shortName": "Insurance and Contractholder Liabilities - Unpaid Claims and Claim Expenses - Cigna Healthcare - Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "if460fb29b2ff45aba9a93619bbe01ff5_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "ci:LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Insurance and Contractholder Liabilities - Unpaid Claims and Claims Expenses - Cigna Healthcare - Variances in Incurred Costs Related to Prior Years' Unpaid Claims and Claims Expenses (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails",
     "shortName": "Insurance and Contractholder Liabilities - Unpaid Claims and Claims Expenses - Cigna Healthcare - Variances in Incurred Costs Related to Prior Years' Unpaid Claims and Claims Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i87820e99b64949afb0c81b4dcb08b38e_D20230101-20230331",
      "decimals": "3",
      "lang": "en-US",
      "name": "ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "if460fb29b2ff45aba9a93619bbe01ff5_I20230331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Insurance and Contractholder Liabilities - Future Policy Benefits - Interest Rates and Duration (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails",
     "shortName": "Insurance and Contractholder Liabilities - Future Policy Benefits - Interest Rates and Duration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "if460fb29b2ff45aba9a93619bbe01ff5_I20230331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FuturePolicyBenefitsLiabilityPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Insurance and Contractholder Liabilities - Future Policy Benefits - Present Value of Expected Premiums and Benefits (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails",
     "shortName": "Insurance and Contractholder Liabilities - Future Policy Benefits - Present Value of Expected Premiums and Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FuturePolicyBenefitsLiabilityPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "ci:PolicyholderContractBalancePercentReinsuredExternally",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Insurance and Contractholder Liabilities - Contractholder Deposit Funds (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails",
     "shortName": "Insurance and Contractholder Liabilities - Contractholder Deposit Funds (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "ci:PolicyholderContractBalancePercentReinsuredExternally",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:AnnuitizationElectionPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Insurance and Contractholder Liabilities - Summary of Market Risk Benefit (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails",
     "shortName": "Insurance and Contractholder Liabilities - Summary of Market Risk Benefit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:AnnuitizationElectionPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MarketRiskBenefitActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Insurance and Contractholder Liabilities - Net Amount of Risk and Average Age of Contractholders (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails",
     "shortName": "Insurance and Contractholder Liabilities - Net Amount of Risk and Average Age of Contractholders (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "ib570f0c807bc458bb372ecd4c53d8d16_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceRecoverablesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Reinsurance - Reinsurance Recoverables (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails",
     "shortName": "Reinsurance - Reinsurance Recoverables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceRecoverablesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "ieb159500cff1416584b25f65dcff1e94_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Changes in Total Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity",
     "shortName": "Consolidated Statements of Changes in Total Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "ia71485e3f57d4b1e87922c63f04789e4_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketRiskBenefitReinsuranceRecoverableAfterAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Reinsurance - Effective Exit of Variable Annuity Reinsurance Business (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
     "shortName": "Reinsurance - Effective Exit of Variable Annuity Reinsurance Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i1ab9b6688ad640f6bddb9c9f39e1b287_D20230101-20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Investments - Investments by Category (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails",
     "shortName": "Investments - Investments by Category (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Investments - Debt Securities by Contractual Maturity Periods (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails",
     "shortName": "Investments - Debt Securities by Contractual Maturity Periods (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Investments - Gross Unrealized Appreciation (Depreciation) on Debt Securities (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails",
     "shortName": "Investments - Gross Unrealized Appreciation (Depreciation) on Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Investments - Summary of Debt Securities with a Decline in Fair Value (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails",
     "shortName": "Investments - Summary of Debt Securities with a Decline in Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ci:EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Investments - Equity Security Investments (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails",
     "shortName": "Investments - Equity Security Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ci:EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i7e013bc327d64747b0fccc969e1f0449_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Investments - Summary of the Credit Risk Profile of the Commercial Mortgage Loan Portfolio (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails",
     "shortName": "Investments - Summary of the Credit Risk Profile of the Commercial Mortgage Loan Portfolio (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i7e013bc327d64747b0fccc969e1f0449_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLongTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Investments - Carrying Values of Other Long-Term Investments (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails",
     "shortName": "Investments - Carrying Values of Other Long-Term Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLongTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetInvestmentIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Investments - Components of Net Investment Income (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails",
     "shortName": "Investments - Components of Net Investment Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:RealizedInvestmentGainLossExcludingImpairments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Investments - Realized Gains and Losses on Investments (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails",
     "shortName": "Investments - Realized Gains and Losses on Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:RealizedInvestmentGainLossExcludingImpairments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Changes in Total Equity (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquityParenthetical",
     "shortName": "Consolidated Statements of Changes in Total Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ci:EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
     "shortName": "Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i346d7b1c76574be19f46677e85e8c5b1_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "ib508898f275f4a768acf67c63c4a4668_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "ib508898f275f4a768acf67c63c4a4668_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ci:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "ib2a7a90ae1f548208c8ec8f1cbcbb9c3_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Fair Value Measurements - Quantitative Information About Unobservable Inputs (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails",
     "shortName": "Fair Value Measurements - Quantitative Information About Unobservable Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "ib2a7a90ae1f548208c8ec8f1cbcbb9c3_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ci:FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Fair Value Measurements - Changes in Level 3 Financial Assets and Financial Liabilities Carried at Fair Value (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails",
     "shortName": "Fair Value Measurements - Changes in Level 3 Financial Assets and Financial Liabilities Carried at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ci:FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ci:FairValueOfSeparateAccountAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:GuaranteedSeparateAccountAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Fair Value Measurements - Fair Values of Separate Account Assets (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails",
     "shortName": "Fair Value Measurements - Fair Values of Separate Account Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ci:FairValueOfSeparateAccountAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:GuaranteedSeparateAccountAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i05431ad3c0184457a9136c2f15684621_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Fair Value Measurements - Additional Information on Separate Account Assets Priced at Net Asset Value (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
     "shortName": "Fair Value Measurements - Additional Information on Separate Account Assets Priced at Net Asset Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i05431ad3c0184457a9136c2f15684621_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value under Certain Conditions (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails",
     "shortName": "Fair Value Measurements - Assets and Liabilities Measured at Fair Value under Certain Conditions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i30053fba320b4d05beed1c1e1964b4b6_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Fair Value Measurements - Fair Value Disclosures for Financial Instruments Not Carried at Fair Value (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails",
     "shortName": "Fair Value Measurements - Fair Value Disclosures for Financial Instruments Not Carried at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i30053fba320b4d05beed1c1e1964b4b6_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i18bbba0896f543cb9afd321606482dda_I20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "ci:VariableInterestEntitiesNumberOfEntities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "entity",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Variable Interest Entities (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails",
     "shortName": "Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i18bbba0896f543cb9afd321606482dda_I20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "ci:VariableInterestEntitiesNumberOfEntities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "entity",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "ia5c9a21a47954ed3bf7ede8a2133682a_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ci:AccumulatedOtherComprehensiveIncomeDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i74213a55ce4840b39cb8ba80e171a3c6_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncreaseDecreaseInDeferredIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.thecignagroup.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6bd9f07d9d3a43dab2134f8b473b3aa9_D20220331-20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Contingencies and Other Matters (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails",
     "shortName": "Contingencies and Other Matters (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6bd9f07d9d3a43dab2134f8b473b3aa9_D20220331-20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:TransactionRelatedCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Segment Information - Summary of Special Items (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails",
     "shortName": "Segment Information - Summary of Special Items (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ci:SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ci:SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ci:NonInvestmentRevenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Segment Information - Summarized Segment Financial Information (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails",
     "shortName": "Segment Information - Summarized Segment Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ci:RealizedInvestmentGainsLossesEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i6773af2402ee4977b48366d53115a5cc_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Segment Information - Revenue from External Customers (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
     "shortName": "Segment Information - Revenue from External Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i06b3a5cafe1847468ebadf3df7edea80_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "i9556a32ddbb54ebeb4e7256d387ed702_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Segment Information - Financial and Performance Guarantees (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails",
     "shortName": "Segment Information - Financial and Performance Guarantees (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ci-20230331.htm",
      "contextRef": "icfbd026f02e243f087fcef41ca300348_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Consolidated Statements of Cash Flows (Parenthetical)",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlowsParenthetical",
     "shortName": "Consolidated Statements of Cash Flows (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 181,
   "tag": {
    "ci_A364DayRevolvingCreditAgreementMaturingApril2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "364 Day Revolving Credit Agreement, Maturing April 2023",
        "label": "364 Day Revolving Credit Agreement, Maturing April 2023 [Member]",
        "terseLabel": "364 Day Revolving Credit Agreement, Maturing April 2023"
       }
      }
     },
     "localname": "A364DayRevolvingCreditAgreementMaturingApril2023Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_A364DayRevolvingCreditAgreementMaturingApril2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "364 Day Revolving Credit Agreement, Maturing April 2024",
        "label": "364 Day Revolving Credit Agreement, Maturing April 2024 [Member]",
        "terseLabel": "364-day Revolving Credit Agreement, Maturing April 2024"
       }
      }
     },
     "localname": "A364DayRevolvingCreditAgreementMaturingApril2024Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-For-Sale And Derivatives, Parent",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-For-Sale And Derivatives, Parent [Member]",
        "terseLabel": "Securities and Derivatives"
       }
      }
     },
     "localname": "AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesParentMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-For-Sale And Derivatives, Realized Investment (Gains) Losses, Parent",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-For-Sale And Derivatives, Realized Investment (Gains) Losses, Parent [Member]",
        "terseLabel": "Reclassification adjustment for (gains) included in Shareholders' net income (Net realized investment losses)"
       }
      }
     },
     "localname": "AOCIAccumulatedGainLossDebtSecuritiesAvailableForSaleAndDerivativesRealizedInvestmentGainsLossesParentMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI, Liability For Future Policy Benefit And Market Risk Benefit, Instrument-Specific Credit Risk, Parent",
        "label": "AOCI, Liability For Future Policy Benefit And Market Risk Benefit, Instrument-Specific Credit Risk, Parent [Member]",
        "terseLabel": "AOCI, Liability For Future Policy Benefit And Market Risk Benefit, Instrument-Specific Credit Risk, Parent"
       }
      }
     },
     "localname": "AOCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskParentMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Volume Weighted Average Share Price, Less Discount",
        "label": "Accelerated Share Repurchases, Volume Weighted Average Share Price, Less Discount",
        "terseLabel": "Accelerated stock repurchase, volume weighted average share price (in dollars per share)"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ci_AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes an entity's accounting policy for accounts payable, accrued expenses and other liabilities.",
        "label": "Accounts Payable Accrued Expenses Other Liabilities Policy [Policy Text Block]",
        "terseLabel": "Accrued Expenses and Other Current and Non-Current Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAccruedExpensesOtherLiabilitiesPolicyPolicyTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_AccruedExpensesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of other current liabilities and obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Expenses And Other Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherLiabilities",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AccumulatedOtherComprehensiveIncomeDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclousre of the changes in the componenets of other comprehensive income/loss.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeDisclosureTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_AcquisitionDispositionRunoffActivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products related to acquisition, disposition or runoff activities.",
        "label": "Acquisition Disposition Runoff Activities [Member]",
        "terseLabel": "Acquisition, disposition or run-off activities"
       }
      }
     },
     "localname": "AcquisitionDispositionRunoffActivitiesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
        "terseLabel": "Pre-tax adjusted income (loss) from operations"
       }
      }
     },
     "localname": "AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AdministrativeServicesOnlyHealthCareServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Administrative Services Only Health Care Services",
        "label": "Administrative Services Only Health Care Services [Member]",
        "terseLabel": "Administrative Services Only Health Care Services"
       }
      }
     },
     "localname": "AdministrativeServicesOnlyHealthCareServicesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_AllowanceForReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for receivables, classified as current.",
        "label": "Allowance For Receivables Current",
        "terseLabel": "Allowance for receivables, current"
       }
      }
     },
     "localname": "AllowanceForReceivablesCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AllowanceForReceivablesOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other allowances classified as current, including allowances, discounts and claims adjustments issued to customers in the form of client credits, allowance for current expected credit losses and other non-credit adjustments.",
        "label": "Allowance For Receivables, Other",
        "terseLabel": "Remaining allowances"
       }
      }
     },
     "localname": "AllowanceForReceivablesOther",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alternative Investment, Before Reclassification To Disposal Group, Assets Held For Sale",
        "label": "Alternative Investment, Before Reclassification To Disposal Group, Assets Held For Sale",
        "terseLabel": "Fair Value, including held for sale assets"
       }
      }
     },
     "localname": "AlternativeInvestmentBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AnnuitizationElectionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time prior to a policy anniversary when an annuitization election must occur.",
        "label": "Annuitization Election Period",
        "terseLabel": "Annuitization election period"
       }
      }
     },
     "localname": "AnnuitizationElectionPeriod",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ci_AssetBackedAndCorporateSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Backed And Corporate Securities",
        "label": "Asset Backed And Corporate Securities [Member]",
        "terseLabel": "Asset-backed and corporate securities"
       }
      }
     },
     "localname": "AssetBackedAndCorporateSecuritiesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Debt Securities Amortized Cost Basis Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Available For Sale Debt Securities Amortized Cost Basis Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Amortized cost, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Unrealized Appreciation, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Before Reclassification To Disposal Group Assets Held For Sale",
        "negatedLabel": "Unrealized Depreciation, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 1.0,
       "parentTag": "ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale",
        "negatedLabel": "Unrealized Depreciation, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 2.0,
       "parentTag": "ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale",
        "negatedLabel": "Unrealized Depreciation, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails_1": {
       "order": 2.0,
       "parentTag": "ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale",
        "totalLabel": "Amortized Cost, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 2.0,
       "parentTag": "ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Fair Value, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails_1": {
       "order": 1.0,
       "parentTag": "ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale",
        "totalLabel": "Amortized Cost, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 2.0,
       "parentTag": "ci_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Fair Value, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities Debt Securities Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Available For Sale Securities Debt Securities Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Fair Value, including held for sale assets",
        "verboseLabel": "Debt Securities, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 2.0,
       "parentTag": "ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities In Unrealized Loss Positions, Qualitative Disclosure, Less Than 12 Months, Number Of Positions, Before Reclassification To Disposal Group, Assets Held For Sale",
        "label": "Available For Sale Securities In Unrealized Loss Positions, Qualitative Disclosure, Less Than 12 Months, Number Of Positions, Before Reclassification To Disposal Group, Assets Held For Sale",
        "terseLabel": "Number of Issues, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureLessThan12MonthsNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities In Unrealized Loss Positions, Qualitative Disclosure, Number Of Positions, Before Reclassification To Disposal Group, Assets Held For Sale",
        "label": "Available For Sale Securities In Unrealized Loss Positions, Qualitative Disclosure, Number Of Positions, Before Reclassification To Disposal Group, Assets Held For Sale",
        "totalLabel": "Total Number of Issues, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 1.0,
       "parentTag": "ci_AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities In Unrealized Loss Positions, Qualitative Disclosure, Twelve Months Or Longer, Number Of Positions, Before Reclassification To Disposal Group, Assets Held For Sale",
        "label": "Available For Sale Securities In Unrealized Loss Positions, Qualitative Disclosure, Twelve Months Or Longer, Number Of Positions, Before Reclassification To Disposal Group, Assets Held For Sale",
        "terseLabel": "Number of Issues, including held for sale assets"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureTwelveMonthsOrLongerNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ci_BelowInvestmentGradeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External credit-ratings or internal groupings that could be used to describe the current status of the payment and performance risk of debt and securities investments that connote non-investment grade.",
        "label": "Below Investment Grade [Member]",
        "terseLabel": "Below investment grade"
       }
      }
     },
     "localname": "BelowInvestmentGradeMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Berkshire Hathway Life Insurance Company Of Nebraska And Other Recoverables",
        "label": "Berkshire Hathway Life Insurance Company Of Nebraska And Other Recoverables [Member]",
        "terseLabel": "Berkshire Hathway Life Insurance Company Of Nebraska and Other Recoverables"
       }
      }
     },
     "localname": "BerkshireHathwayLifeInsuranceCompanyOfNebraskaAndOtherRecoverablesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Berkshire Hathway Life Insurance Company Of Nebraska",
        "label": "Berkshire Hathway Life Insurance Company Of Nebraska [Member]",
        "terseLabel": "Berkshire Hathaway Life Insurance Company of Nebraska",
        "verboseLabel": "Berkshire"
       }
      }
     },
     "localname": "BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes an insurance entity's accounting policy for deferred policy acquisition costs, including the nature and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.",
        "label": "Capitalization Of Deferred Policy Acquisition Costs Policy [Policy Text Block]",
        "terseLabel": "Deferred Policy Acquisition Costs"
       }
      }
     },
     "localname": "CapitalizationOfDeferredPolicyAcquisitionCostsPolicyPolicyTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_CashCashEquivalentsAndShortTermInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate of cash, cash equivalents and short-term investments.",
        "label": "Cash Cash Equivalents And Short Term Investments [Member]",
        "verboseLabel": "Short-term investments and cash"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestmentsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_CededCreditCollateralizationRiskMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration risk related to collateralization of a specified benchmark, such as reinsurance recoverables.",
        "label": "Ceded Credit Collateralization Risk [Member]",
        "terseLabel": "Collateralization risk"
       }
      }
     },
     "localname": "CededCreditCollateralizationRiskMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ceded Credit Risk, Secured, Collateral Provisions Exist That May Mitigate Risk",
        "label": "Ceded Credit Risk, Secured, Collateral Provisions Exist That May Mitigate Risk [Member]",
        "terseLabel": "Collateral provisions exist that may mitigate risk of credit loss"
       }
      }
     },
     "localname": "CededCreditRiskSecuredCollateralProvisionsExistThatMayMitigateRiskMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_CededCreditRiskSecuredContractuallyRequiredFairValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ceded Credit Risk, Secured, Contractually Required Fair Value",
        "label": "Ceded Credit Risk, Secured, Contractually Required Fair Value [Member]",
        "terseLabel": "Fair value of collateral contractually required to meet or exceed carrying value of recoverable"
       }
      }
     },
     "localname": "CededCreditRiskSecuredContractuallyRequiredFairValueMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_CededReinsuranceAgreementCoverageLimitAmountRemaining": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of overall limit to claims covered under ceded reinsurance agreement.",
        "label": "Ceded Reinsurance Agreement, Coverage Limit, Amount Remaining",
        "terseLabel": "Remaining overall limit under reinsurance agreement"
       }
      }
     },
     "localname": "CededReinsuranceAgreementCoverageLimitAmountRemaining",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_CededReinsuranceAgreementReinsuredRiskPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of future claim payments reinsured under reinsurance agreement(s), net of existing retrocessional arrangements at the time agreement was made.",
        "label": "Ceded Reinsurance Agreement Reinsured Risk Percentage",
        "terseLabel": "Percent of future claim payments reinsured"
       }
      }
     },
     "localname": "CededReinsuranceAgreementReinsuredRiskPercentage",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ci_CignaHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cigna Healthcare",
        "label": "Cigna Healthcare [Member]",
        "terseLabel": "Cigna Healthcare"
       }
      }
     },
     "localname": "CignaHealthcareMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails",
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_CommitmentToFundPartnershipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitment To Fund Partnership",
        "label": "Commitment To Fund Partnership [Member]",
        "terseLabel": "Commitment to fund partnership"
       }
      }
     },
     "localname": "CommitmentToFundPartnershipMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_CommitmentToPurchaseEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitment To Purchase Equity Securities",
        "label": "Commitment To Purchase Equity Securities [Member]",
        "terseLabel": "Commitment to purchase equity securities"
       }
      }
     },
     "localname": "CommitmentToPurchaseEquitySecuritiesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments And Contingencies",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_CommitmentsAndContingenciesNumberOfAdditionalExpert": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments And Contingencies, Number Of Additional Expert",
        "label": "Commitments And Contingencies, Number Of Additional Expert",
        "terseLabel": "Number of additional experts"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesNumberOfAdditionalExpert",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ci_CommitmentsAndContingenciesNumberOfExpert": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments And Contingencies, Number Of Expert",
        "label": "Commitments And Contingencies, Number Of Expert",
        "terseLabel": "Number of experts"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesNumberOfExpert",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ci_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments And Contingencies [Table]",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_CommitmentsToContributeAdditionalEquityAndCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment commitments of estimated payments required under contractual arrangements diversified by issuer, property type and geographic regions.",
        "label": "Commitments To Contribute Additional Equity And Capital",
        "terseLabel": "Unfunded commitments"
       }
      }
     },
     "localname": "CommitmentsToContributeAdditionalEquityAndCapital",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_CompletionFactorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts relating to actual claims emerging differently from assumptions about claim payment speed used to set reserves.",
        "label": "Completion Factors [Member]",
        "terseLabel": "Actual completion factors"
       }
      }
     },
     "localname": "CompletionFactorsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest, Including Temporary Equity",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest, Including Temporary Equity",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_ContractholderDepositFundsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes an entity's accounting policy for contractholder deposit funds.",
        "label": "Contractholder Deposit Funds, Policy [Policy Text Block]",
        "terseLabel": "Contractholder Deposit Funds"
       }
      }
     },
     "localname": "ContractholderDepositFundsPolicyPolicyTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_ContractualAllowanceNoninsuranceCustomerReceivables": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual allowances from third-party payors based upon the contractual payment terms.",
        "label": "Contractual Allowance, Noninsurance Customer Receivables",
        "terseLabel": "Noninsurance customer receivables allowance"
       }
      }
     },
     "localname": "ContractualAllowanceNoninsuranceCustomerReceivables",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_ContractualAllowancePharmaceuticalManufacturersReceivables": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual allowances for certain rebates receivables with pharmaceutical manufacturers, classified as current.",
        "label": "Contractual Allowance, Pharmaceutical Manufacturers Receivables",
        "terseLabel": "Pharmaceutical manufacturers receivables allowance"
       }
      }
     },
     "localname": "ContractualAllowancePharmaceuticalManufacturersReceivables",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_CorporateAndEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects amounts not allocated to other segments, such as net interest expense (defined as interest on corporate debt less net investment income on investments not supporting segment operations), interest on uncertain tax positions, certain litigation matters, intersegment eliminations, compensation cost for stock options, expense associated with its frozen pension plans, certain corporate project and overhead costs.",
        "label": "Corporate And Eliminations [Member]",
        "terseLabel": "Corporate and Eliminations"
       }
      }
     },
     "localname": "CorporateAndEliminationsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_CorporateAndGovernmentDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities that are issued by either a domestic or foreign corporate business entity with a promise of repayment.",
        "label": "Corporate And Government Debt Securities [Member]",
        "terseLabel": "Corporate and government debt securities"
       }
      }
     },
     "localname": "CorporateAndGovernmentDebtSecuritiesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Rating, Nationally Recognized Statistical Rating Organization (NRSRO)",
        "label": "Credit Rating, Nationally Recognized Statistical Rating Organization (NRSRO) [Axis]",
        "terseLabel": "Credit Rating, Nationally Recognized Statistical Rating Organization (NRSRO) [Axis]"
       }
      }
     },
     "localname": "CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSROAxis",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Rating, Nationally Recognized Statistical Rating Organization (NRSRO)",
        "label": "Credit Rating, Nationally Recognized Statistical Rating Organization (NRSRO) [Domain]",
        "terseLabel": "Credit Rating, Nationally Recognized Statistical Rating Organization (NRSRO) [Domain]"
       }
      }
     },
     "localname": "CreditRatingNationallyRecognizedStatisticalRatingOrganizationNRSRODomain",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_DamagesForServiceIssuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Damages sought in litigation for service issues.",
        "label": "Damages For Service Issues [Member]",
        "terseLabel": "Damages for Service Issues"
       }
      }
     },
     "localname": "DamagesForServiceIssuesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_DebenturesDue20277875InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures bearing interest at 7.875% due in 2027.",
        "label": "Debentures due 2027 7.875% Interest [Member]",
        "terseLabel": "$259\u00a0million, 7.875% Debentures due May 2027"
       }
      }
     },
     "localname": "DebenturesDue20277875InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt And Equity Securities Classified In Level2 Percentage Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Debt And Equity Securities Classified In Level2 Percentage Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Percent of debt and equity securities classified in Level 2"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ci_DebtAndEquitySecuritiesClassifiedInLevel3Percentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of debt and equity securities classified in Level 3",
        "label": "Debt And Equity Securities Classified In Level 3 Percentage",
        "terseLabel": "Percent of debt and equity securities classified in Level 3"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesClassifiedInLevel3Percentage",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ci_DebtAndEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subtotal of debt and equity securities carried at fair value on the balance sheet.",
        "label": "Debt and Equity Securities [Member]",
        "terseLabel": "Debt and Equity Securities"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_DebtInstrumentExtensionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Extension Term",
        "label": "Debt Instrument, Extension Term",
        "terseLabel": "Credit agreement extension term"
       }
      }
     },
     "localname": "DebtInstrumentExtensionTerm",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ci_DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redemption Price, Discount, Spread On Variable Rate",
        "label": "Debt Instrument, Redemption Price, Discount, Spread On Variable Rate",
        "terseLabel": "Redemption price discount, spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPriceDiscountSpreadOnVariableRate",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ci_DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available For Sale, Allowance For Credit Loss, Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Debt Securities, Available For Sale, Allowance For Credit Loss, Before Reclassification To Disposal Group Assets Held For Sale",
        "negatedTerseLabel": "Allowance for Credit Loss, including held for sale assets"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "ci_RealizedInvestmentGainLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, And Commercial Mortgage Loans, Allowance For Credit Loss, Expense (Reversal)",
        "label": "Debt Securities, Available-For-Sale, And Commercial Mortgage Loans, Allowance For Credit Loss, Expense (Reversal)",
        "negatedLabel": "Credit loss recoveries"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months Or Longer",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months Or Longer [Abstract]",
        "terseLabel": "More than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 1.0,
       "parentTag": "ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, 12 Months Or Longer, Amortized Cost",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, 12 Months Or Longer, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAmortizedCost",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Amortized Cost",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Amortized Cost",
        "totalLabel": "Total Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less Than 12 Months",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less Than 12 Months [Abstract]",
        "terseLabel": "One year or less"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 2.0,
       "parentTag": "ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Less Than 12 Months, Amortized Cost",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Less Than 12 Months, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Total",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Total [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionTotalAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Including Disposal Group, Measurement Input",
        "label": "Debt Securities, Available-For-Sale, Including Disposal Group, Measurement Input",
        "terseLabel": "Unobservable Adjustment, including held for sale assets"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleIncludingDisposalGroupMeasurementInput",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 1.0,
       "parentTag": "ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Accumulated Loss, Before Reclassification To Disposal Group, Assets Held-For-Sale",
        "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Accumulated Loss, Before Reclassification To Disposal Group, Assets Held-For-Sale",
        "negatedTotalLabel": "Total Unrealized Depreciation, including held for sale assets"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Amortized Cost, Before Reclassification To Disposal Group, Assets Held-For-Sale",
        "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Amortized Cost, Before Reclassification To Disposal Group, Assets Held-For-Sale",
        "totalLabel": "Total Amortized Cost, including held for sale assets"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 2.0,
       "parentTag": "ci_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Before Reclassification To Disposal Group, Assets Held For Sale",
        "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Before Reclassification To Disposal Group, Assets Held For Sale",
        "totalLabel": "Total Fair Value, including held for sale assets"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets relative to investments subject to Federal capital loss utilization rules. Capital losses can only be utilized to extent there are capital gains in a given year. If capital losses exceed capital gains, the taxpayer can utilize capital losses to the extent there are capital gains in the applicable carryback period.",
        "label": "Deferred Tax Assets, Investments Subject To Federal Capital Loss Utilization Rules",
        "terseLabel": "Deferred tax assets associated with unrealized investment losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Assets Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Derivative Assets Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Derivative assets, including held for sale assets"
       }
      }
     },
     "localname": "DerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Credit Risk Valuation Adjustment, Derivative Assets, Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Derivative Credit Risk Valuation Adjustment, Derivative Assets, Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Adjustment for credit risk on derivatives assets"
       }
      }
     },
     "localname": "DerivativeCreditRiskValuationAdjustmentDerivativeAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Credit Risk Valuation Adjustment, Derivative Liabilities, Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Derivative Credit Risk Valuation Adjustment, Derivative Liabilities, Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Adjustment for credit risk on derivatives liabilities"
       }
      }
     },
     "localname": "DerivativeCreditRiskValuationAdjustmentDerivativeLiabilitiesBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Liabilities Before Reclassification To Disposal Group Liabilities Held For Sale",
        "label": "Derivative Liabilities Before Reclassification To Disposal Group Liabilities Held For Sale",
        "terseLabel": "Derivative liabilities, including held for sale liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesBeforeReclassificationToDisposalGroupLiabilitiesHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Notional Amount Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Derivative Notional Amount Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Notional Value, including held for sale assets"
       }
      }
     },
     "localname": "DerivativeNotionalAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Current Insurance And Contractholder Liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Current Insurance And Contractholder Liabilities",
        "negatedLabel": "Insurance and contractholder liabilities classified as held for sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails": {
       "order": 2.0,
       "parentTag": "ci_DisposalGroupIncludingDiscontinuedOperationInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Current Investments, Current",
        "label": "Disposal Group Including Discontinued Operation, Current Investments, Current",
        "negatedLabel": "Investments classified as assets of business held for sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 1.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group,Including Discontinued Operation, Insurance And Contractholder Liabilities",
        "label": "Disposal Group,Including Discontinued Operation, Insurance And Contractholder Liabilities",
        "negatedTerseLabel": "Insurance and contractholder liabilities classified as held for sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DisposalGroupIncludingDiscontinuedOperationInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails_1": {
       "order": 2.0,
       "parentTag": "ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Investments",
        "label": "Disposal Group, Including Discontinued Operation, Investments",
        "negatedTotalLabel": "Investments classified as assets of business held for sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInvestments",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Noncurrent Insurance And Contractholder Liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Noncurrent Insurance And Contractholder Liabilities",
        "negatedLabel": "Insurance and contractholder liabilities classified as held for sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails": {
       "order": 1.0,
       "parentTag": "ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Noncurrent Investments",
        "label": "Disposal Group Including Discontinued Operation Noncurrent Investments Current",
        "negatedLabel": "Investments classified as assets of business held for sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails": {
       "order": 1.0,
       "parentTag": "ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Separate Account Assets, Current",
        "label": "Disposal Group Including Discontinued Operation, Separate Account Assets, Current",
        "negatedLabel": "Separate account assets of business classified as held for sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Net Of Tax",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Net Of Tax",
        "terseLabel": "Gain (loss) on sale of business, after-tax"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag",
        "label": "Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag",
        "terseLabel": "Gain (loss) on sale of business, location not disclosed"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_EarningsPerShareEffectOfDilution": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The decrease in net income (loss) on a per share basis when the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period is assumed.",
        "label": "Earnings Per Share Effect Of Dilution",
        "terseLabel": "EPS, effect of dilution (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareEffectOfDilution",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ci_EmpowerAnnuityInsuranceCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Empower Annuity Insurance Company",
        "label": "Empower Annuity Insurance Company [Member]",
        "terseLabel": "Empower Annuity Insurance Company"
       }
      }
     },
     "localname": "EmpowerAnnuityInsuranceCompanyMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI And Equity Securities Without Readily Determinable Fair Value",
        "label": "Equity Securities, FV-NI And Equity Securities Without Readily Determinable Fair Value [Table Text Block]",
        "terseLabel": "Equity Security Investments"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAndEquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost",
        "label": "Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost",
        "label": "Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost [Abstract]",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost, Before Reclassification To Disposal Group, Assets Held For Sale",
        "label": "Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Amortized Cost, Before Reclassification To Disposal Group, Assets Held For Sale",
        "totalLabel": "Total, including held for sale assets"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount",
        "label": "Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount, Before Reclassification To Disposal Group, Assets Held For Sale",
        "label": "Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount, Before Reclassification To Disposal Group, Assets Held For Sale",
        "totalLabel": "Total, including held for sale assets"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount, Before Reclassification To Disposal Group, Assets Held For Sale",
        "label": "Equity Securities, FV-NI And Without Readily Determinable Fair Value, And Hybrid Instruments, Carrying Amount, Before Reclassification To Disposal Group, Assets Held For Sale [Abstract]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSaleAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_EquitySecuritiesFVNIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities FV NI",
        "label": "Equity Securities FV NI [Member]",
        "terseLabel": "Equity Securities FV NI"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Fv Ni Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Equity Securities Fv Ni Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Equity securities with readily determinable fair values, including held for sale assets",
        "verboseLabel": "Equity securities, including held for sale assets"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Fv Ni Cost Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Equity Securities Fv Ni Cost Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Equity securities with readily determinable fair values, including held for sale assets"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Amortized Cost",
        "label": "Equity Securities Without Readily Determinable Fair Value, Amortized Cost",
        "terseLabel": "Equity securities with no readily determinable fair value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Amortized Cost, Before Reclassification To Disposal Group, Assets Held For Sale",
        "label": "Equity Securities Without Readily Determinable Fair Value, Amortized Cost, Before Reclassification To Disposal Group, Assets Held For Sale",
        "terseLabel": "Equity securities with no readily determinable fair values including held for sale assets"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value Amount Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Equity Securities Without Readily Determinable Fair Value Amount Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Equity securities with no readily determinable fair value, including held for sale assets"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_EvernorthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Services includes pharmacy benefits management (PBM), pharmacy home delivery, and certain medical management services. This segment includes Express Scripts business from the date of acquisition with the exception of Express Scripts Medicare Part D business that is reported in the Government operating segment.",
        "label": "Evernorth [Member]",
        "terseLabel": "Evernorth Health Services"
       }
      }
     },
     "localname": "EvernorthMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_ExpressScriptsCounterclaimsAgainstElevanceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Express Scripts Counterclaims Against Elevance",
        "label": "Express Scripts Counterclaims Against Elevance [Member]",
        "terseLabel": "Express Scripts counterclaims against Elevance"
       }
      }
     },
     "localname": "ExpressScriptsCounterclaimsAgainstElevanceMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_ExpressScriptsLitigationWithAnthemMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Express Scripts Litigation With Anthem [Member]",
        "terseLabel": "Express Scripts Litigation with Elevance"
       }
      }
     },
     "localname": "ExpressScriptsLitigationWithAnthemMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets and liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3, by class of assets and liabilities.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Changes in Level 3 Financial Assets and Financial Liabilities Carried at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected liquidation period after inception of the underlying assets measured at net asset value per share or unit.",
        "label": "Fair Value Investments Entities That Calculate Net Asset Value Per Share Liquidating Investment Period From Inception",
        "terseLabel": "Expected liquidation period after inception"
       }
      }
     },
     "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLiquidatingInvestmentPeriodFromInception",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ci_FairValueMeasurementNonPerformanceRiskAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Measurement, Non-Performance Risk Adjustment",
        "label": "Fair Value Measurement, Non-Performance Risk Adjustment",
        "terseLabel": "Impact of non-performance risk"
       }
      }
     },
     "localname": "FairValueMeasurementNonPerformanceRiskAdjustment",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents total gains or losses for the period (realized and unrealized), arising from assets included in income attributable to instruments held at the reporting date, measured at fair value on a recurring basis using unobservable inputs (Level 3), which are included in earnings or resulted in a change in asset value.",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Attributed To Instruments Held Included In Earnings",
        "terseLabel": "Total gains included in Shareholders' net income attributable to instruments held at the reporting date"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAttributedToInstrumentsHeldIncludedInEarnings",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents total gains or losses for the period (realized and unrealized), arising from assets measured at fair value on a recurring basis using unobservable inputs (Level 3), which are included in gains or losses required to adjust future policy benefits for settlement annuities.",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Required To Adjust Future Policy Benefits",
        "terseLabel": "Gains (losses) required to adjust future policy benefits for settlement annuities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossRequiredToAdjustFuturePolicyBenefits",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease), Including Disposal Groups",
        "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease), Including Disposal Groups",
        "terseLabel": "Separate accounts assets classified in Level 3, including disposal groups, period increase (decrease), including transfers in and out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecreaseIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included In Other Comprehensive Income (Loss)",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included In Other Comprehensive Income (Loss)",
        "terseLabel": "Change in unrealized gain or (loss) included in Other comprehensive loss for assets held at the end of the reporting period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Before Reclassification To Disposal Group Assets Held For Sale",
        "periodEndLabel": "Ending balance, including held for sale assets",
        "periodStartLabel": "Beginning balance, including held for sale assets"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValueBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_FairValueOfSeparateAccountAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclose the aggregate fair value of separate account assets, by fair value level.",
        "label": "Fair Value Of Separate Account Assets [Table Text Block]",
        "terseLabel": "Fair Values of Separate Account Assets"
       }
      }
     },
     "localname": "FairValueOfSeparateAccountAssetsTableTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_FinancingReceivableCreditQualityDebtServiceCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Credit Quality Debt Service Coverage Ratio",
        "label": "Financing Receivable, Credit Quality Debt Service Coverage Ratio",
        "terseLabel": "Average Debt Service Coverage Ratio"
       }
      }
     },
     "localname": "FinancingReceivableCreditQualityDebtServiceCoverageRatio",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ci_FinancingReceivableCreditQualityLoanToValueRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable Credit Quality Loan To Value Ratio",
        "label": "Financing Receivable Credit Quality Loan To Value Ratio",
        "terseLabel": "Average Loan-to-Value Ratio"
       }
      }
     },
     "localname": "FinancingReceivableCreditQualityLoanToValueRatio",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ci_ForwardsSwapsOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forwards Swaps Options",
        "label": "Forwards Swaps Options [Member]",
        "terseLabel": "Forwards, swaps, options"
       }
      }
     },
     "localname": "ForwardsSwapsOptionsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future Policy Benefits, Domestic Contracts, Observable Inputs From Published Spot Rate Curve, Maximum Term",
        "label": "Future Policy Benefits, Domestic Contracts, Observable Inputs From Published Spot Rate Curve, Maximum Term",
        "terseLabel": "Observable inputs from published spot rate curve term (in years)"
       }
      }
     },
     "localname": "FuturePolicyBenefitsDomesticContractsObservableInputsFromPublishedSpotRateCurveMaximumTerm",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ci_GainLossOnExtinguishmentOfDebtNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Extinguishment Of Debt, Net Of Tax",
        "label": "Gain (Loss) On Extinguishment Of Debt, Net Of Tax",
        "negatedTerseLabel": "Loss on repurchase of debt, after-tax"
       }
      }
     },
     "localname": "GainLossOnExtinguishmentOfDebtNetOfTax",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_GroupDisabilityAndLifeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Group Disability And Life [Member]",
        "terseLabel": "Group Disability and Life"
       }
      }
     },
     "localname": "GroupDisabilityAndLifeMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_GroupMedicalInsuranceShortDurationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Group Medical Insurance, Short-Duration",
        "label": "Group Medical Insurance, Short-Duration [Member]",
        "terseLabel": "Short-duration (Group medical insurance)"
       }
      }
     },
     "localname": "GroupMedicalInsuranceShortDurationMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_GuaranteedMinimumDeathBenefitsTotalContractholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of underlying contractholders for the Guaranteed Minimum Death Benefit business.",
        "label": "Guaranteed Minimum Death Benefits Total Contractholders",
        "terseLabel": "Number of contractholders (estimated)"
       }
      }
     },
     "localname": "GuaranteedMinimumDeathBenefitsTotalContractholders",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ci_GuaranteedSeparateAccountAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails": {
       "order": 2.0,
       "parentTag": "ci_SeparateAccountAssetsClassifiedInFairValueHierarchy",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guaranteed Separate Account Assets",
        "label": "Guaranteed Separate Account Assets",
        "terseLabel": "Guaranteed separate accounts"
       }
      }
     },
     "localname": "GuaranteedSeparateAccountAssets",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails": {
       "order": 1.0,
       "parentTag": "ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of the assets held by the Entity for the benefit of separate account policyholders with guarantees.",
        "label": "Guaranteed Separate Account Assets Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Guaranteed separate accounts, including held for sale assets"
       }
      }
     },
     "localname": "GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_HomeDeliveryAndSpecialtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Home Delivery And Specialty [Member]",
        "terseLabel": "Home delivery and specialty revenues"
       }
      }
     },
     "localname": "HomeDeliveryAndSpecialtyMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_ImpairmentsOnInvestmentsTotal": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "ci_RealizedInvestmentGainLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total impairments recorded in pre-tax realized investment losses",
        "label": "Impairments On Investments Total",
        "negatedLabel": "Other investment asset write-downs"
       }
      }
     },
     "localname": "ImpairmentsOnInvestmentsTotal",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_IncomeLossAttributableToNoncontrollingInterestBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of pre-tax income (loss) attributable to noncontrolling interest.",
        "label": "Income Loss Attributable To Noncontrolling Interest Before Tax",
        "negatedLabel": "(Income) loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "IncomeLossAttributableToNoncontrollingInterestBeforeTax",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of accounts payable, accrued liabilities and other operating obligations not separately disclosed in the statement of cash flows.",
        "label": "Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities",
        "terseLabel": "Accounts payable and Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_IncreaseDecreaseInPharmacyAndServiceCostsPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Pharmacy And Service Costs Payable",
        "terseLabel": "Pharmacy and other service costs payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInPharmacyAndServiceCostsPayable",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_IndividualAndFamilyPlansShortDurationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual And Family Plans, Short-Duration",
        "label": "Individual And Family Plans, Short-Duration [Member]",
        "terseLabel": "Short-duration (Individual and family plans)"
       }
      }
     },
     "localname": "IndividualAndFamilyPlansShortDurationMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Medicare Supplement And Limited Benefit Health Products, Long-Duration",
        "label": "Individual Medicare Supplement And Limited Benefit Health Products, Long-Duration [Member]",
        "terseLabel": "Long-duration (Individual Medicare supplement and limited benefit health products)"
       }
      }
     },
     "localname": "IndividualMedicareSupplementAndLimitedBenefitHealthProductsLongDurationMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_IndividualPrivateMedicalInsuranceLongDurationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Private Medical Insurance, Long-Duration",
        "label": "Individual Private Medical Insurance, Long-Duration [Member]",
        "terseLabel": "Long-duration (Individual private medical insurance)"
       }
      }
     },
     "localname": "IndividualPrivateMedicalInsuranceLongDurationMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_InsuranceAndContractholderLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 2.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance And Contractholder Liabilities",
        "label": "Insurance And Contractholder Liabilities",
        "totalLabel": "Total insurance and contractholder liabilities"
       }
      }
     },
     "localname": "InsuranceAndContractholderLiabilities",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_InsuranceAndContractholderLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance And Contractholder Liabilities",
        "label": "Insurance And Contractholder Liabilities [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "InsuranceAndContractholderLiabilitiesAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_InsuranceAndContractholderLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1": {
       "order": 2.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amounts as of the balance sheet date of all current insurance and contractholder liabilities.",
        "label": "Insurance And Contractholder Liabilities Current",
        "terseLabel": "Current insurance and contractholder liabilities",
        "totalLabel": "Current insurance and contractholder liabilities"
       }
      }
     },
     "localname": "InsuranceAndContractholderLiabilitiesCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_InsuranceAndContractholderLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance And Contractholder Liabilities, Current",
        "label": "Insurance And Contractholder Liabilities, Current [Abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "InsuranceAndContractholderLiabilitiesCurrentAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance And Contractholder Liabilities, Current, Including Disposal Groups",
        "label": "Insurance And Contractholder Liabilities, Current, Including Disposal Groups",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance And Contractholder Liabilities, Including Disposal Groups",
        "label": "Insurance And Contractholder Liabilities, Including Disposal Groups",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "InsuranceAndContractholderLiabilitiesIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_InsuranceAndContractholderLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance and Contractholder Liabilities [Line Items]",
        "terseLabel": "Insurance and Contractholder Liabilities [Line Items]"
       }
      }
     },
     "localname": "InsuranceAndContractholderLiabilitiesLineItems",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_InsuranceAndContractholderLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1": {
       "order": 1.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amounts as of the balance sheet date of all current insurance and contractholder liabilities.",
        "label": "Insurance And Contractholder Liabilities Noncurrent",
        "terseLabel": "Non-current insurance and contractholder liabilities",
        "totalLabel": "Non-current insurance and contractholder liabilities"
       }
      }
     },
     "localname": "InsuranceAndContractholderLiabilitiesNoncurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_InsuranceAndContractholderLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance And Contractholder Liabilities, Noncurrent",
        "label": "Insurance And Contractholder Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Non-current"
       }
      }
     },
     "localname": "InsuranceAndContractholderLiabilitiesNoncurrentAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance And Contractholder Liabilities, Noncurrent, Including Disposal Groups",
        "label": "Insurance And Contractholder Liabilities, Noncurrent, Including Disposal Groups",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_InsuranceAndContractholderLiabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance And Contractholder Liabilities [Table]",
        "terseLabel": "Insurance And Contractholder Liabilities [Table]"
       }
      }
     },
     "localname": "InsuranceAndContractholderLiabilitiesTable",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_InsuranceCustomerReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables due from customers under insurance contracts.",
        "label": "Insurance Customer Receivables",
        "terseLabel": "Insurance customer receivables"
       }
      }
     },
     "localname": "InsuranceCustomerReceivables",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_InsuranceUnearnedPremiumsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance, Unearned Premiums",
        "label": "Insurance, Unearned Premiums [Policy Text Block]",
        "terseLabel": "Unearned Premium"
       }
      }
     },
     "localname": "InsuranceUnearnedPremiumsPolicyTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetInvestmentIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein. Also includes the total amount of revenue recognized for the period from operating leases, including minimum lease revenue, contingent revenue, percentage revenue and sublease revenue.",
        "label": "Interest And Dividend Income Operating And Operating Leases Income Statement Lease Revenue",
        "terseLabel": "Investment income"
       }
      }
     },
     "localname": "InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_InterestInJointVentureInTurkeyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest In Joint Venture In Turkey",
        "label": "Interest In Joint Venture In Turkey [Member]",
        "terseLabel": "Interest in Turkiye Joint Venture"
       }
      }
     },
     "localname": "InterestInJointVentureInTurkeyMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Businesses to be Sold and Group Disability And Life subsegments of Other Operations segment.",
        "label": "International Businesses To Be Sold Group Disability And Life [Member]",
        "terseLabel": "International businesses to be sold and Group Disability and Life business"
       }
      }
     },
     "localname": "InternationalBusinessesToBeSoldGroupDisabilityAndLifeMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_InternationalHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Health",
        "label": "International Health [Member]",
        "terseLabel": "International Health"
       }
      }
     },
     "localname": "InternationalHealthMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sold life, accident and supplemental benefits businesses in Hong Kong, Indonesia, New Zealand, South Korea, Taiwan and Thailand.",
        "label": "International Life Accident Supplemental Benefits Businesses Excluding Turkey Joint Venture [Member]",
        "terseLabel": "International life, accident, supplemental benefits businesses sold to Chubb"
       }
      }
     },
     "localname": "InternationalLifeAccidentSupplementalBenefitsBusinessesExcludingTurkeyJointVentureMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_InternationalLifeAccidentSupplementalBenefitsBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Life, accident and supplemental benefits businesses in Hong Kong, Indonesia, New Zealand, South Korea, Taiwan, Thailand and interest in a joint venture in Turkey.",
        "label": "International Life Accident Supplemental Benefits Businesses [Member]",
        "terseLabel": "International life, accident and supplemental benefits businesses"
       }
      }
     },
     "localname": "InternationalLifeAccidentSupplementalBenefitsBusinessesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_InvestmentGradeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External credit-ratings or internal groupings that could be used to describe the current status of the payment and performance risk of debt and securities investments that connote investment grade.",
        "label": "Investment Grade [Member]",
        "terseLabel": "Investment grade"
       }
      }
     },
     "localname": "InvestmentGradeMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_InvestmentIncomeAndGainsAndLossesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Income And Gains And Losses [Abstract]"
       }
      }
     },
     "localname": "InvestmentIncomeAndGainsAndLossesAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "xbrltype": "stringItemType"
    },
    "ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Investments Before Reclassification To Disposal Group Assets Held For Sale",
        "totalLabel": "Investments including held for sale assets"
       }
      }
     },
     "localname": "InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_InvestmentsCreditRatingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by credit rating of debt and securities investments.",
        "label": "Investments Credit Rating [Axis]",
        "terseLabel": "Investments Credit Rating [Axis]"
       }
      }
     },
     "localname": "InvestmentsCreditRatingAxis",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_InvestmentsCreditRatingDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External credit-ratings or internal groupings that could be used to describe the current status of the payment and performance risk of debt and securities investments.",
        "label": "Investments Credit Rating [Domain]",
        "terseLabel": "Investments Credit Rating [Domain]"
       }
      }
     },
     "localname": "InvestmentsCreditRatingDomain",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Claims And Claims Adjustment Expense Attributable To Disposal Groups",
        "label": "Liability For Claims And Claims Adjustment Expense Attributable To Disposal Groups",
        "terseLabel": "Unpaid claims classified as liabilities of business held for sale"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 4.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Claims And Claims Adjustment Expense, Current",
        "label": "Liability For Claims And Claims Adjustment Expense, Current",
        "terseLabel": "Unpaid claims and claim expenses, current"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount (expected to be paid within one year) needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability For Claims And Claims Adjustment Expense Current Including Disposal Groups",
        "terseLabel": "Unpaid claims and claim expenses, including held for sale liabilities"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseCurrentIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total liability for incurred but not reported claims plus expected claim development on reported claims, including reported claims in process. Excludes amounts due for physician incentives and other medical care expenses and services payable.",
        "label": "Liability For Claims And Claims Adjustment Expense Excluding Physician Incentives And Other Expenses",
        "verboseLabel": "Total of incurred but not reported liabilities plus expected claim development on reported claims, including reported claims in process"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseExcludingPhysicianIncentivesAndOtherExpenses",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1": {
       "order": 4.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Claims And Claims Adjustment Expense Including Disposal Groups",
        "label": "Liability For Claims And Claims Adjustment Expense Including Disposal Groups",
        "terseLabel": "Unpaid claims and claim expenses, including held for sale liabilities"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 4.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Claims And Claims Adjustment Expense, Noncurrent",
        "label": "Liability For Claims And Claims Adjustment Expense, Noncurrent",
        "terseLabel": "Unpaid claims and claim expenses, noncurrent"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount (expected to be paid after one year) needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability For Claims And Claims Adjustment Expense Noncurrent Including Disposal Groups",
        "terseLabel": "Unpaid claims and claim expenses, including held for sale liabilities"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseNoncurrentIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefits",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Before Reinsurance And Other",
        "label": "Liability For Future Policy Benefit, Before Reinsurance And Other",
        "terseLabel": "Liability for future policy benefits"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitBeforeReinsuranceAndOther",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 3.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Before Reinsurance, Current",
        "label": "Liability For Future Policy Benefit, Before Reinsurance, Current",
        "terseLabel": "Future policy benefits, current"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitBeforeReinsuranceCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 3.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Before Reinsurance, Noncurrent",
        "label": "Liability For Future Policy Benefit, Before Reinsurance, Noncurrent",
        "terseLabel": "Future policy benefits, noncurrent"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitBeforeReinsuranceNoncurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Excluding Deferred Profit Liability",
        "label": "Liability For Future Policy Benefit, Excluding Deferred Profit Liability",
        "terseLabel": "Future policy benefit, excluding DPL"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExcludingDeferredProfitLiability",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Interest Expense And Other Changes",
        "label": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Interest Expense And Other Changes",
        "terseLabel": "Interest and other"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpenseAndOtherChanges",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Issuance And Derecognition",
        "label": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Issuance And Derecognition",
        "terseLabel": "Issuances and lapses"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuanceAndDerecognition",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) From Cash Flow Change And Actual Variance From Expected Experience",
        "label": "Liability For Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) From Cash Flow Change And Actual Variance From Expected Experience",
        "terseLabel": "Effect of assumption changes and actual variances from expected experience"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChangeAndActualVarianceFromExpectedExperience",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Expected Net Premium, Interest Income And Other Changes",
        "label": "Liability For Future Policy Benefit, Expected Net Premium, Interest Income And Other Changes",
        "terseLabel": "Interest and other"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncomeAndOtherChanges",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Expected Net Premium, Issuance And Derecognition",
        "label": "Liability For Future Policy Benefit, Expected Net Premium, Issuance And Derecognition",
        "terseLabel": "Issuances and lapses"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuanceAndDerecognition",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefits",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Other",
        "label": "Liability For Future Policy Benefit, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitOther",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefits Attributable To Disposal Groups",
        "label": "Liability For Future Policy Benefits Attributable To Disposal Groups",
        "terseLabel": "Future policy benefits classified as liabilities of business held for sale"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued obligation to policyholders that relates to insured events for long-duration contracts, expected to be paid within one year.",
        "label": "Liability For Future Policy Benefits Current Including Disposal Groups",
        "terseLabel": "Future policy benefits, including held for sale liabilities"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitsDeferredProfitLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefits, Deferred Profit Liability",
        "label": "Liability For Future Policy Benefits, Deferred Profit Liability",
        "terseLabel": "Future policy benefits, DPL"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsDeferredProfitLiability",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitsIncludingDisposalGroups": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1": {
       "order": 1.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefits Including Disposal Groups",
        "label": "Liability For Future Policy Benefits Including Disposal Groups",
        "terseLabel": "Future policy benefits, including held for sale liabilities"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued obligation to policyholders that relates to insured events for long-duration contracts, expected to be paid after one year.",
        "label": "Liability For Future Policy Benefits Noncurrent Including Disposal Groups",
        "terseLabel": "Future policy benefits, including held for sale liabilities"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payments made in the reporting period to settle claims incurred in prior periods and related claims settlement costs as a percentage of incurred claims as reported in the prior year.",
        "label": "Liability For Unpaid Medical Claims And Claims Adjustment Expense Incurred Claims Prior Years Percentage",
        "terseLabel": "Favorable (unfavorable) variance, percentage"
       }
      }
     },
     "localname": "LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYearsPercentage",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ci_LibertyMutualInsuranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liberty Mutual Insurance",
        "label": "Liberty Mutual Insurance [Member]",
        "verboseLabel": "Liberty Re (Bermuda) Ltd."
       }
      }
     },
     "localname": "LibertyMutualInsuranceMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_LifeInsuranceCompanyOfNorthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Life Insurance Company Of North America",
        "label": "Life Insurance Company Of North America [Member]",
        "terseLabel": "Life Insurance Company of North America"
       }
      }
     },
     "localname": "LifeInsuranceCompanyOfNorthAmericaMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reinsurance recoverables resulting from the 1998 sale of the Companys individual life insurance and annuity business.",
        "label": "The Lincoln National Life Insurance Company And Lincoln Life And Annuity Of New York [Member]",
        "terseLabel": "Lincoln National Life and Lincoln Life &amp; Annuity of New York"
       }
      }
     },
     "localname": "LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Accordion Feature, Incremental Increase In Maximum Borrowing Capacity",
        "label": "Line Of Credit Facility, Accordion Feature, Incremental Increase In Maximum Borrowing Capacity",
        "terseLabel": "Aggregate amount of options to increase commitments"
       }
      }
     },
     "localname": "LineOfCreditFacilityAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LineOfCreditFacilityConversionToTermLoanTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Conversion To Term Loan, Term",
        "label": "Line Of Credit Facility, Conversion To Term Loan, Term",
        "terseLabel": "Credit facility, conversion to term loan, term"
       }
      }
     },
     "localname": "LineOfCreditFacilityConversionToTermLoanTerm",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ci_LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The debt-to adjusted capital ratio which the Company must not exceed in accordance with the terms of the line of credit facility agreement.",
        "label": "Line Of Credit Facility Debt To Adjusted Capital Ratio Covenant",
        "terseLabel": "Leverage ratio covenant"
       }
      }
     },
     "localname": "LineOfCreditFacilityDebtToAdjustedCapitalRatioCovenant",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ci_LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity And Accordion Feature, Incremental Increase In Maximum Borrowing Capacity",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity And Accordion Feature, Incremental Increase In Maximum Borrowing Capacity",
        "terseLabel": "Maximum total commitment"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityAndAccordionFeatureIncrementalIncreaseInMaximumBorrowingCapacity",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_LitigationMattersAndRegulatoryMattersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Matters And Regulatory Matters",
        "label": "Litigation Matters And Regulatory Matters [Member]",
        "terseLabel": "Litigation Matters and Regulatory Matters"
       }
      }
     },
     "localname": "LitigationMattersAndRegulatoryMattersMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails": {
       "order": 2.0,
       "parentTag": "ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale",
        "totalLabel": "Investments including held for sale assets"
       }
      }
     },
     "localname": "LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_Ltv60To79PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LTV 60 to 79 Percent [Member]",
        "terseLabel": "60% to 79%"
       }
      }
     },
     "localname": "Ltv60To79PercentMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_LtvGreaterThan100PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt-to-value ratio greater than 100 percent. Element name an standard label in DTV [numeric lower end] to [numeric higher end] Percent [Member] format.",
        "label": "Ltv Greater Than 100 Percent [Member]",
        "terseLabel": "Greater than 100%"
       }
      }
     },
     "localname": "LtvGreaterThan100PercentMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_LtvLessThan60PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LTV Less Than 60 Percent [Member]",
        "terseLabel": "Below 60%"
       }
      }
     },
     "localname": "LtvLessThan60PercentMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Risk Benefit, Increase (Decrease) Due to Expected Run-Off",
        "label": "Market Risk Benefit, Increase (Decrease) Due to Expected Run-Off",
        "terseLabel": "Changes due to expected run-off"
       }
      }
     },
     "localname": "MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Risk Benefit, Increase (Decrease) From Interest Rate Change And Equity Market Change",
        "label": "Market Risk Benefit, Increase (Decrease) From Interest Rate Change And Equity Market Change",
        "terseLabel": "Changes due to capital markets versus expected"
       }
      }
     },
     "localname": "MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_MarketRiskBenefitLiabilityAmountCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 2.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Risk Benefit, Liability, Amount, Current",
        "label": "Market Risk Benefit, Liability, Amount, Current",
        "terseLabel": "Market risk benefits, current"
       }
      }
     },
     "localname": "MarketRiskBenefitLiabilityAmountCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_MarketRiskBenefitLiabilityAmountNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 1.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Risk Benefit, Liability, Amount, Noncurrent",
        "label": "Market Risk Benefit, Liability, Amount, Noncurrent",
        "terseLabel": "Market risk benefits, noncurrent"
       }
      }
     },
     "localname": "MarketRiskBenefitLiabilityAmountNoncurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Includes incurred but not reported claims and outstanding claims,off-set by premiums due, related to market risk benefit contracts, as a well as reinsurance recoverable, defined as amount, after allowance for credit loss, recoverable under reinsurance for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.",
        "label": "Market Risk Benefit Reinsurance Recoverable After Allowance And Related Balances",
        "terseLabel": "Market risk benefits reinsurance recoverable, including IBNR and outstanding claims, less premiums due"
       }
      }
     },
     "localname": "MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalances",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market risk benefit reinsurance recoverable, including IBNR and outstanding claims, less premiums due.",
        "label": "Market Risk Benefit Reinsurance Recoverable After Allowance And Related Balances [Member]",
        "terseLabel": "Market risk benefits reinsurance recoverable, including IBNR and outstanding claims, less premiums due"
       }
      }
     },
     "localname": "MarketRiskBenefitReinsuranceRecoverableAfterAllowanceAndRelatedBalancesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Marketable Securities Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Fair Value, including held for sale assets"
       }
      }
     },
     "localname": "MarketableSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Percent Level2 Investments Foreign Bonds Broker Quote Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Maximum Percent Level2 Investments Foreign Bonds Broker Quote Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Maximum percentage of investments classified in Level 2 representing foreign bonds priced using unadjusted broker quotes"
       }
      }
     },
     "localname": "MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ci_MeasurementInputLiquidityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Liquidity",
        "label": "Measurement Input, Liquidity [Member]",
        "terseLabel": "Liquidity"
       }
      }
     },
     "localname": "MeasurementInputLiquidityMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_MedicalCostTrendMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts relating to actual claims emerging differently from assumptions about the level of claims per member used to set reserves.",
        "label": "Medical Cost Trend [Member]",
        "terseLabel": "Medical cost trend"
       }
      }
     },
     "localname": "MedicalCostTrendMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_MedicalRiskProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical Risk Products [Member]",
        "terseLabel": "Insured"
       }
      }
     },
     "localname": "MedicalRiskProductsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_MedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicare Advantage [Member]",
        "terseLabel": "Medicare Advantage"
       }
      }
     },
     "localname": "MedicareAdvantageMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_MedicarePartDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A government health plan for prescription drugs.",
        "label": "Medicare Part D [Member]",
        "terseLabel": "Medicare Part D"
       }
      }
     },
     "localname": "MedicarePartDMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nationally Recognized Statisical Rating Organizations (NRSRO), A- Or Higher",
        "label": "Nationally Recognized Statisical Rating Organizations (NRSRO), A- Or Higher [Member]",
        "terseLabel": "A- equivalent and higher current ratings"
       }
      }
     },
     "localname": "NationallyRecognizedStatisicalRatingOrganizationsNRSROAOrHigherMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nationally Recognized Statisical Rating Organizations (NRSRO), BBB- To BBB+ Rating",
        "label": "Nationally Recognized Statisical Rating Organizations (NRSRO), BBB- To BBB+ Rating [Member]",
        "terseLabel": "BBB- to BBB+ equivalent current credit ratings"
       }
      }
     },
     "localname": "NationallyRecognizedStatisicalRatingOrganizationsNRSROBBBToBBBRatingMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nationally Recognized Statisical Rating Organizations (NRSRO), Not Rated",
        "label": "Nationally Recognized Statisical Rating Organizations (NRSRO), Not Rated [Member]",
        "terseLabel": "Not rated"
       }
      }
     },
     "localname": "NationallyRecognizedStatisicalRatingOrganizationsNRSRONotRatedMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nationally Recognized Statistical Rating Organizations (NRSRO), BBB+ Or Higher",
        "label": "Nationally Recognized Statistical Rating Organizations (NRSRO), BBB+ Or Higher [Member]",
        "terseLabel": "BBB+ equivalent and higher current ratings"
       }
      }
     },
     "localname": "NationallyRecognizedStatisticalRatingOrganizationsNRSROBBBOrHigherMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NetworkPharmacyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Network Pharmacy [Member]",
        "terseLabel": "Network revenues"
       }
      }
     },
     "localname": "NetworkPharmacyMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails": {
       "order": 1.0,
       "parentTag": "ci_SeparateAccountAssetsClassifiedInFairValueHierarchy",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of the assets held by the Entity for the benefit of separate account policyholders without guarantees classified in the fair value hierarchy.",
        "label": "Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy",
        "terseLabel": "Non-guaranteed separate accounts"
       }
      }
     },
     "localname": "NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails": {
       "order": 2.0,
       "parentTag": "ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Non-guaranteed separate accounts, including held for sale assets"
       }
      }
     },
     "localname": "NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_SeparateAccountAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of the assets held by the Entity for the benefit of separate account policyholders without guarantees and priced at net asset value as a practical expedient.",
        "label": "Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient",
        "terseLabel": "Non-guaranteed separate accounts priced at NAV as a practical expedient"
       }
      }
     },
     "localname": "NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails_1": {
       "order": 1.0,
       "parentTag": "ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of the assets held by the Entity for the benefit of separate account policyholders without guarantees and priced at net asset value as a practical expedient.",
        "label": "Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Non-guaranteed separate accounts priced at NAV as a practical expedient, including held for sale assets"
       }
      }
     },
     "localname": "NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_NonInvestmentRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue excluding net investment income and realized investment results.",
        "label": "Non Investment Revenue",
        "totalLabel": "Total revenues from external customers",
        "verboseLabel": "Revenues from customers"
       }
      }
     },
     "localname": "NonInvestmentRevenue",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_NoncontrollingInterestOtherChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other activity associated with noncontrolling interest that is not separately disclosed.",
        "label": "Noncontrolling Interest Other Changes",
        "verboseLabel": "Other transactions impacting noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestOtherChanges",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables due from customers that are not under insurance contracts. These include pharmacy sales and fees due from employer clients.",
        "label": "Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable",
        "terseLabel": "Pharmaceutical manufacturers receivables"
       }
      }
     },
     "localname": "NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails": {
       "order": 2.0,
       "parentTag": "ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Noninsurance customer receivables, including held for sale assets"
       }
      }
     },
     "localname": "NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_NotesDue2022305InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable bearing interest at 3.05% due in 2022. Debt assumed acquisition from Express Scripts.",
        "label": "Notes Due 2022, 3.05% Interest [Member]",
        "terseLabel": "Notes Due 2022, 3.05% Interest"
       }
      }
     },
     "localname": "NotesDue2022305InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue2023375InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable bearing interest at 3.75% due in 2023. Debt issued to finance acquisition.",
        "label": "Notes Due 2023, 3.75% Interest [Member]",
        "terseLabel": "$1,187\u00a0million, 3.75% Notes due July 2023"
       }
      }
     },
     "localname": "NotesDue2023375InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue20233InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable bearing interest at 3% due in 2023. Debt assumed acquisition from Express Scripts.",
        "label": "Notes Due 2023, 3% Interest [Member]",
        "terseLabel": "$1,000\u00a0million, 3% Notes due July 2023"
       }
      }
     },
     "localname": "NotesDue20233InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue2023765InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes payable bearing interest at 7.65% due in 2023.",
        "label": "Notes due 2023 7.65% Interest [Member]",
        "terseLabel": "$63\u00a0million, 7.65% Notes due March 2023"
       }
      }
     },
     "localname": "NotesDue2023765InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue202383InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes payable bearing interest at 8.3% due in 2023.",
        "label": "Notes Due 2023, 8.3% Interest [Member]",
        "terseLabel": "$17\u00a0million, 8.3% Notes due January 2023"
       }
      }
     },
     "localname": "NotesDue202383InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue2023FloatingRateInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable with floating interest due in 2023. Debt issued to finance acquisition.",
        "label": "Notes Due 2023 Floating Rate Interest [Member]",
        "terseLabel": "$700\u00a0million, Floating Rate Notes due July 2023"
       }
      }
     },
     "localname": "NotesDue2023FloatingRateInterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue202435InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable bearing interest at 3.5% due in 2024. Debt assumed acquisition from Express Scripts.",
        "label": "Notes Due 2024 3.5% Interest [Member]",
        "terseLabel": "$1,000\u00a0million, 3.500% Notes due June 2024"
       }
      }
     },
     "localname": "NotesDue202435InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue2024613InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes payable bearing .613% interest due in 2024.",
        "label": "Notes Due 2024 .613% Interest [Member]",
        "terseLabel": "$500 million, 0.613% Notes due March 2024"
       }
      }
     },
     "localname": "NotesDue2024613InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue2025325InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes payable bearing interest at 3.25% due in 2025.",
        "label": "Notes Due 2025 3.25% Interest [Member]",
        "terseLabel": "$900\u00a0million, 3.250% Notes due April 2025 (1)"
       }
      }
     },
     "localname": "NotesDue2025325InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue20254125InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable bearing interest at 4.125% due in 2025. Debt issued to finance acquisition.",
        "label": "Notes Due 2025, 4.125% Interest [Member]",
        "terseLabel": "$2,200\u00a0million, 4.125% Notes due November 2025"
       }
      }
     },
     "localname": "NotesDue20254125InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue2026125Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes payable bearing interest at 1.25% due in 2026.",
        "label": "Notes due 2026, 1.25% [Member]",
        "terseLabel": "$800 million, 1.250% Notes due March 2026"
       }
      }
     },
     "localname": "NotesDue2026125Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue202645InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable bearing interest at 4.5% due in 2026. Debt assumed acquisition from Express Scripts.",
        "label": "Notes Due 2026, 4.5% Interest [Member]",
        "terseLabel": "$1,500\u00a0million, 4.500% Notes due February 2026"
       }
      }
     },
     "localname": "NotesDue202645InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue20265685Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes due 2026, 5.685%",
        "label": "Notes due 2026, 5.685% [Member]",
        "terseLabel": "$700 million, 5.685% Notes due March 2026"
       }
      }
     },
     "localname": "NotesDue20265685Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails",
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue2027305Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes payable bearing interest at 3.05% due October 15, 2027.",
        "label": "Notes Due 2027, 3.05% [Member]",
        "terseLabel": "$600\u00a0million, 3.050% Notes due October 2027"
       }
      }
     },
     "localname": "NotesDue2027305Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue202734InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable bearing interest at 3.4% due in 2027. Debt assumed acquisition from Express Scripts.",
        "label": "Notes Due 2027, 3.4% Interest [Member]",
        "terseLabel": "$1,500\u00a0million, 3.400% Notes due March 2027"
       }
      }
     },
     "localname": "NotesDue202734InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue20284375InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable bearing interest at 4.375% due in 2028. Debt issued to finance acquisition.",
        "label": "Notes Due 2028, 4.375% Interest [Member]",
        "terseLabel": "$3,800\u00a0million, 4.375% Notes due October 2028"
       }
      }
     },
     "localname": "NotesDue20284375InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue203024InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Due 2030, 2.4% Interest",
        "label": "Notes Due 2030, 2.4% Interest [Member]",
        "terseLabel": "$1,500\u00a0million, 2.400% Notes due March 2030"
       }
      }
     },
     "localname": "NotesDue203024InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue20312375InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes payable bearing interest at 2.375% due in 2031.",
        "label": "Notes Due 2031, 2.375% Interest [Member]",
        "terseLabel": "$1,500 million, 2.375% Notes due 2031"
       }
      }
     },
     "localname": "NotesDue20312375InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue20335400InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Due 2033, 5.400% Interest",
        "label": "Notes Due 2033, 5.400% Interest [Member]",
        "terseLabel": "$800 million, 5.400% Notes due March 2033"
       }
      }
     },
     "localname": "NotesDue20335400InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails",
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue2036615InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes payable bearing interest at 6.15% due in 2036.",
        "label": "Notes due 2036 6.15% Interest [Member]",
        "terseLabel": "$190\u00a0million, 6.150% Notes due November 2036"
       }
      }
     },
     "localname": "NotesDue2036615InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue203848InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable bearing interest at 4.8% due in 2038. Debt issued to finance acquisition.",
        "label": "Notes Due 2038, 4.8% Interest [Member]",
        "terseLabel": "$2,200\u00a0million, 4.800% Notes due August 2038"
       }
      }
     },
     "localname": "NotesDue203848InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue204032InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Due 2040, 3.2% Interest",
        "label": "Notes Due 2040, 3.2% Interest [Member]",
        "terseLabel": "$750\u00a0million, 3.200% Notes due March 2040"
       }
      }
     },
     "localname": "NotesDue204032InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue20415875InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes payable bearing interest at 5.875% due in 2041.",
        "label": "Notes Due 2041, 5.875% Interest [Member]",
        "terseLabel": "$121\u00a0million, 5.875% Notes due March 2041"
       }
      }
     },
     "localname": "NotesDue20415875InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue20416125InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable bearing interest at 6.125% due in 2041. Debt assumed acquisition from Express Scripts.",
        "label": "Notes Due 2041, 6.125% Interest [Member]",
        "terseLabel": "$448\u00a0million, 6.125% Notes due November 2041"
       }
      }
     },
     "localname": "NotesDue20416125InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue20425375InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes payable bearing interest at 5.375% due in 2042.",
        "label": "Notes Due 2042, 5.375% Interest [Member]",
        "terseLabel": "$317\u00a0million, 5.375% Notes due February 2042"
       }
      }
     },
     "localname": "NotesDue20425375InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue204648InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable bearing interest at 4.8% due in 2046. Debt assumed acquisition from Express Scripts.",
        "label": "Notes Due 2046, 4.8% Interest [Member]",
        "terseLabel": "$1,500\u00a0million, 4.800% Notes due July 2046"
       }
      }
     },
     "localname": "NotesDue204648InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue20473875Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes payable bearing interest at 3.875% due October 15, 2047.",
        "label": "Notes Due 2047, 3.875% [Member]",
        "terseLabel": "$1,000\u00a0million, 3.875% Notes due October 2047"
       }
      }
     },
     "localname": "NotesDue20473875Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue204849InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes payable bearing interest at 4.9% due in 2048. Debt issued to finance acquisition.",
        "label": "Notes Due 2048, 4.9% Interest [Member]",
        "terseLabel": "$3,000\u00a0million, 4.900% Notes due December 2048"
       }
      }
     },
     "localname": "NotesDue204849InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue205034InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Due 2050, 3.4% Interest",
        "label": "Notes Due 2050, 3.4% Interest [Member]",
        "terseLabel": "$1,250\u00a0million, 3.400% Notes due March 2050"
       }
      }
     },
     "localname": "NotesDue205034InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NotesDue205134InterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes payable bearing interest at 3.4% due 2051.",
        "label": "Notes Due 2051, 3.4% Interest [Member]",
        "terseLabel": "$1,500 million, 3.400% Notes due March 2051"
       }
      }
     },
     "localname": "NotesDue205134InterestMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of banks participating in revolving credit and letter of credit agreement",
        "label": "Number Of Banks Participating In Revolving Credit And Letter Of Credit Agreement",
        "terseLabel": "Number of participating banks"
       }
      }
     },
     "localname": "NumberOfBanksParticipatingInRevolvingCreditAndLetterOfCreditAgreement",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ci_NumberOfRevolvingCreditFacility": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Revolving Credit Facility",
        "label": "Number Of Revolving Credit Facility",
        "terseLabel": "Number of revolving credit facilities"
       }
      }
     },
     "localname": "NumberOfRevolvingCreditFacility",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ci_OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OCI, Liability For Future Policy Benefit And Market Risk Benefit, Instrument-Specific Credit Risk, Gain (Loss), After Reclassification Adjustment And Tax",
        "label": "OCI, Liability For Future Policy Benefit And Market Risk Benefit, Instrument-Specific Credit Risk, Gain (Loss), After Reclassification Adjustment And Tax",
        "terseLabel": "Net long-duration insurance and contractholder liabilities measurement adjustments"
       }
      }
     },
     "localname": "OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTax",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OngoingOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ongoing Operations [Member]",
        "terseLabel": "Ongoing Operations"
       }
      }
     },
     "localname": "OngoingOperationsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_OrganizationalEfficiencyPlanCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organizational Efficiency Plan Charges",
        "label": "Organizational Efficiency Plan Charges",
        "terseLabel": "Charge for organizational efficiency plan, 2020 (Selling, general and administrative expenses)",
        "verboseLabel": "Charge for organizational efficiency plan, 2020"
       }
      }
     },
     "localname": "OrganizationalEfficiencyPlanCharges",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OrganizationalEfficiencyPlanChargesNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organizational Efficiency Plan Charges, Net Of Tax",
        "label": "Organizational Efficiency Plan Charges, Net Of Tax",
        "terseLabel": "Charge for organizational efficiency plan, 2020 (Selling, general and administrative expenses)"
       }
      }
     },
     "localname": "OrganizationalEfficiencyPlanChargesNetOfTax",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting policies related to Other Assets, Current and Noncurrent and the items included therein.",
        "label": "Other Assets Current And Noncurrent Policy [Policy Text Block]",
        "terseLabel": "Other Assets (Current and Non-Current)"
       }
      }
     },
     "localname": "OtherAssetsCurrentAndNoncurrentPolicyPolicyTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_OtherCommercialMedicalProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commercial Medical Products [Member]",
        "terseLabel": "Other Commercial Medical Products"
       }
      }
     },
     "localname": "OtherCommercialMedicalProductsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Available-For-Sale Securities And Derivatives Adjustment, Net Of Tax",
        "label": "Other Comprehensive Income (Loss), Available-For-Sale Securities And Derivatives Adjustment, Net Of Tax",
        "verboseLabel": "Net unrealized appreciation (depreciation) on securities and derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Before Reclassifications, After Tax, Including Temporary Equity",
        "label": "Other Comprehensive Income (Loss), Before Reclassifications, After Tax, Including Temporary Equity",
        "totalLabel": "Other comprehensive income (loss) including temporary equity, before reclassifications, after-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), before Reclassifications, before Tax, Including Temporary Equity",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax, Including Temporary Equity",
        "terseLabel": "Other comprehensive income (loss) including temporary equity, before reclassifications, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTaxIncludingTemporaryEquity",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "ci_OtherComprehensiveIncomeLossBeforeReclassificationsAfterTaxIncludingTemporaryEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss) before Reclassifications, Tax, Including Temporary Equity",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax, Including Temporary Equity",
        "negatedTerseLabel": "Other comprehensive income (loss) including temporary equity, before reclassifications, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTaxIncludingTemporaryEquity",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Before Tax, Including Temporary Equity",
        "label": "Other Comprehensive Income (Loss), Before Tax, Including Temporary Equity",
        "terseLabel": "Translation of foreign currencies, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxIncludingTemporaryEquity",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Including Temporary Equity",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Including Temporary Equity",
        "terseLabel": "Net translation gains (losses) on foreign currencies"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Net of Tax, Including Temporary Equity",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Including Temporary Equity",
        "totalLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Tax, Including Temporary Equity",
        "label": "Other Comprehensive Income (Loss), Tax, Including Temporary Equity",
        "terseLabel": "Translation of foreign currencies, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxIncludingTemporaryEquity",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OtherGovernmentProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Government Products [Member]",
        "terseLabel": "Other Government Products"
       }
      }
     },
     "localname": "OtherGovernmentProductsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Other Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Other long term investments, including held for sale assets"
       }
      }
     },
     "localname": "OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Operations, International Businesses To Be Sold And Interest In Joint Venture In Turkey",
        "label": "Other Operations, International Businesses To Be Sold And Interest In Joint Venture In Turkey [Member]",
        "terseLabel": "Divested International businesses"
       }
      }
     },
     "localname": "OtherOperationsInternationalBusinessesToBeSoldAndInterestInJointVentureInTurkeyMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_OtherOperationsInternationalBusinessesToBeSoldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International businesses to be sold to Chubb (excludes interest in Turkiye joint venture).",
        "label": "Other Operations, International Businesses To Be Sold [Member]",
        "terseLabel": "International businesses [to be] sold to Chubb"
       }
      }
     },
     "localname": "OtherOperationsInternationalBusinessesToBeSoldMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_OtherOperationsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Operations Segment",
        "label": "Other Operations Segment [Member]",
        "terseLabel": "Other Operations"
       }
      }
     },
     "localname": "OtherOperationsSegmentMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails",
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_OtherOperationsSegmentOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Operations Segment, Other",
        "label": "Other Operations Segment, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperationsSegmentOtherMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_OtherPharmacyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Pharmacy [Member]",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "OtherPharmacyMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Short-Term Debt, Current Maturities Of Long-Term Debt, And Lease Obligations, Current",
        "label": "Other Short-Term Debt, Current Maturities Of Long-Term Debt, And Lease Obligations, Current",
        "verboseLabel": "Other, including finance leases"
       }
      }
     },
     "localname": "OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Other Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Short-term investments, including held for sale assets"
       }
      }
     },
     "localname": "OtherShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_OtherVariableInterestEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Variable Interest Entities",
        "label": "Other Variable Interest Entities [Member]",
        "terseLabel": "Other Variable Interest Entities"
       }
      }
     },
     "localname": "OtherVariableInterestEntitiesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_PaymentsForProceedsFromPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For (Proceeds From) Property, Plant, And Equipment",
        "label": "Payments For (Proceeds From) Property, Plant, And Equipment",
        "negatedLabel": "Property and equipment purchases, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromPropertyPlantAndEquipment",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_PaymentsToAcquireDebtAndEquitySecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Acquire Debt And Equity Securities",
        "label": "Payments To Acquire Debt And Equity Securities",
        "negatedLabel": "Debt securities and equity securities",
        "terseLabel": "Amount funded"
       }
      }
     },
     "localname": "PaymentsToAcquireDebtAndEquitySecurities",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_PharmaceuticalManufacturerReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables due from pharmaceutical manufacturers related to rebate contracts.",
        "label": "Pharmaceutical Manufacturer Receivable",
        "terseLabel": "Noninsurance customer receivables"
       }
      }
     },
     "localname": "PharmaceuticalManufacturerReceivable",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails": {
       "order": 4.0,
       "parentTag": "ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Pharmaceutical manufacturers receivable, including held for sale assets"
       }
      }
     },
     "localname": "PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_PharmacyAndServiceCostsPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects amounts due to pharmacies for prescriptions filled through our retail network of pharmacies. Also includes amounts due to clients for their portion of rebates that must be contractually shared.",
        "label": "Pharmacy And Service Costs Payable",
        "terseLabel": "Pharmacy and other service costs payable"
       }
      }
     },
     "localname": "PharmacyAndServiceCostsPayable",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_PharmacyBenefitsManagementServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy benefit management services provided to corporate client, other employer groups and their employees. These services include pharmacy home delivery, retail network administration and specialty pharmacy",
        "label": "Pharmacy Benefits Management Services [Member]",
        "terseLabel": "Pharmacy Benefits Management Services"
       }
      }
     },
     "localname": "PharmacyBenefitsManagementServicesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policyholder Account Balance, Above Guaranteed Minimum Crediting Rate, Based On Greater Of Guaranteed Minimum Cash Value Or Actual Cash Value",
        "label": "Policyholder Account Balance, Above Guaranteed Minimum Crediting Rate, Based On Greater Of Guaranteed Minimum Cash Value Or Actual Cash Value [Member]",
        "terseLabel": "Policyholder Account Balance, Above Guaranteed Minimum Crediting Rate, Based On Greater Of Guaranteed Minimum Cash Value Or Actual Cash Value"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateBasedOnGreaterOfGuaranteedMinimumCashValueOrActualCashValueMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Percentage",
        "label": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Percentage",
        "terseLabel": "Minimum crediting rate"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceGuaranteedMinimumCreditingRatePercentage",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ci_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 To 0400",
        "label": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 To 0400 [Member]",
        "terseLabel": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 To 0400"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0400Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policyholder Account Balance, Percentage With Cash Values At More Than 110 Percent Of Guaranteed Cash Value",
        "label": "Policyholder Account Balance, Percentage With Cash Values At More Than 110 Percent Of Guaranteed Cash Value",
        "terseLabel": "Percentage with cash values at more than 110% of guaranteed cash value"
       }
      }
     },
     "localname": "PolicyholderAccountBalancePercentageWithCashValuesAtMoreThan110PercentOfGuaranteedCashValue",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ci_PolicyholderContractBalancePercentReinsuredExternally": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policyholder Contract Balance, Percent Reinsured Externally",
        "label": "Policyholder Contract Balance, Percent Reinsured Externally",
        "terseLabel": "Contractholder deposit fund liabilities, approximate percent reinsured externally"
       }
      }
     },
     "localname": "PolicyholderContractBalancePercentReinsuredExternally",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ci_PolicyholderContractDepositCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PolicyholderContractDeposits",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policyholder Contract Deposit, Current",
        "label": "Policyholder Contract Deposit, Current",
        "terseLabel": "Contractholder deposit funds, current"
       }
      }
     },
     "localname": "PolicyholderContractDepositCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_PolicyholderContractDepositNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 2.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policyholder Contract Deposit, Noncurrent",
        "label": "Policyholder Contract Deposit, Noncurrent",
        "terseLabel": "Contractholder deposit funds, noncurrent"
       }
      }
     },
     "localname": "PolicyholderContractDepositNoncurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_PolicyholderContractDepositsAttributableToDisposalGroups": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policyholder Contract Deposits Attributable To Disposal Groups",
        "label": "Policyholder Contract Deposits Attributable To Disposal Groups",
        "terseLabel": "Contractholder deposit funds classified as liabilities of business held for sale"
       }
      }
     },
     "localname": "PolicyholderContractDepositsAttributableToDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pretax Adjustments To Reconcile Adjusted Income From Operations [Abstract]",
        "terseLabel": "Pre-tax adjustments to reconcile to adjusted income from operations"
       }
      }
     },
     "localname": "PretaxAdjustmentsToReconcileAdjustedIncomeFromOperationsAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_PricingConcessionsAfterRemainingTermOfAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing concessions sought in litigation for one year arfter contract termination.",
        "label": "Pricing Concessions After Remaining Term Of Agreement [Member]",
        "terseLabel": "Pricing Concessions After Remaining Term of Agreement"
       }
      }
     },
     "localname": "PricingConcessionsAfterRemainingTermOfAgreementMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_PricingConcessionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Concessions",
        "label": "Pricing Concessions [Member]",
        "terseLabel": "Pricing Concessions"
       }
      }
     },
     "localname": "PricingConcessionsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_PricingConcessionsThroughRemainingContractTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing concessions sought in litigation for remainder of contract term.",
        "label": "Pricing Concessions Through Remaining Contract Term [Member]",
        "terseLabel": "Pricing Concessions Through Remaining Contract Term"
       }
      }
     },
     "localname": "PricingConcessionsThroughRemainingContractTermMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Issuance Of Long-term Debt, Net Of Discounts And Underwriting Fees",
        "label": "Proceeds From Issuance Of Long-term Debt, Net Of Discounts And Underwriting Fees",
        "terseLabel": "Net proceeds"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebtNetOfDiscountsAndUnderwritingFees",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from maturities, repayments and calls of debt and equity securities.",
        "label": "Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities",
        "terseLabel": "Debt securities and equity securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_ProceedsFromRepaymentsOfOtherShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease and the net proceeds from (repayments of) short-term debt, defined as borrowing having initial term of repayment of one year or less.",
        "label": "Proceeds From (Repayments Of) Other Short-Term Debt",
        "terseLabel": "Net change in short-term debt"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfOtherShortTermDebt",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_ProceedsFromSaleOfDebtAndEquitySecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sales of debt and equity securities.",
        "label": "Proceeds From Sale Of Debt And Equity Securities",
        "terseLabel": "Debt securities and equity securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfDebtAndEquitySecurities",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_PrudentialInsuranceCompanyOfAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prudential Insurance Company Of America",
        "label": "Prudential Insurance Company Of America [Member]",
        "terseLabel": "Prudential Insurance Company of America"
       }
      }
     },
     "localname": "PrudentialInsuranceCompanyOfAmericaMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_RealEstateJointVenturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Joint Ventures",
        "label": "Real Estate Joint Ventures [Member]",
        "terseLabel": "Real estate joint ventures"
       }
      }
     },
     "localname": "RealEstateJointVenturesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_RealizedInvestmentGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gains or (losses) on investments during the period, including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity.",
        "label": "Realized Investment Gain Loss",
        "negatedLabel": "Realized investment losses, net",
        "terseLabel": "Net realized investment losses",
        "totalLabel": "Net realized investment (losses), before income taxes"
       }
      }
     },
     "localname": "RealizedInvestmentGainLoss",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_RealizedInvestmentGainLossExcludingImpairments": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "ci_RealizedInvestmentGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gains or (losses) on investments during the period before impairments, including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity.",
        "label": "Realized Investment Gain Loss Excluding Impairments",
        "verboseLabel": "Net realized investment (losses), excluding credit loss expense and asset write-downs"
       }
      }
     },
     "localname": "RealizedInvestmentGainLossExcludingImpairments",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsRealizedGainsandLossesonInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gains or (losses) on investments during the period, including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity. Includes gains (losses) on investments held by equity method subsidiaries.",
        "label": "Realized Investment Gain Loss Including Equity Method Subsidiaries",
        "negatedLabel": "Net realized investment (gains) losses"
       }
      }
     },
     "localname": "RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_RealizedInvestmentGainsLossesEquityMethodInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails": {
       "order": 2.0,
       "parentTag": "ci_SegmentRevenues",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to exclude net realized gains (losses) from equity method subsidiaries (recorded in Other revenues) from Operating revenues.",
        "label": "Realized Investment Gains Losses Equity Method Investments",
        "negatedLabel": "Net realized investment results from certain equity method investments"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLossesEquityMethodInvestments",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Realized investment losses on impaired real estate, partnership entities, commercial mortgage loans and certain equity securities with no readily determinable fair value, after-tax.",
        "label": "Realized Investment Losses Commercial Mortgage Loans And Real Estate Entities With No Readily Determinable Fair Value",
        "terseLabel": "Realized investment losses on assets measured at fair value under certain conditions, after-tax"
       }
      }
     },
     "localname": "RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables, Net, Current Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Receivables, Net, Current Before Reclassification To Disposal Group Assets Held For Sale",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_RedeemableNoncontrollingInterestsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for noncontrolling shareholders' preferred and common stock interests of consolidated, less than fully owned subsidiaries.",
        "label": "Redeemable Noncontrolling Interests Policy [Policy Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestsPolicyPolicyTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_ReinsuranceRecoverablesIncludingDisposalGroups": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reinsurance Recoverables Including Disposal Groups",
        "label": "Reinsurance Recoverables Including Disposal Groups",
        "terseLabel": "Reinsurance recoverables, including held for sale assets"
       }
      }
     },
     "localname": "ReinsuranceRecoverablesIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_ReinsuranceRecoverablesNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable after one year under reinsurance contracts including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.",
        "label": "Reinsurance Recoverables, Noncurrent",
        "terseLabel": "Reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverablesNonCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_RestructuringChargesNetOfTaxExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges, Net Of Tax Expense",
        "label": "Restructuring Charges, Net Of Tax Expense",
        "terseLabel": "Charge for organizational efficiency plan (Selling, general and administrative expenses)"
       }
      }
     },
     "localname": "RestructuringChargesNetOfTaxExpense",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_RetirementAndLifeInsuranceContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement And Life Insurance Contracts [Member]",
        "terseLabel": "Retiree and Life Insurance Benefits"
       }
      }
     },
     "localname": "RetirementAndLifeInsuranceContractsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_RevolvingCreditAgreementsApril2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving credit agreements entered into in April 2023",
        "label": "Revolving Credit Agreements April 2023 [Member]",
        "terseLabel": "Revolving credit agreements, April 2023"
       }
      }
     },
     "localname": "RevolvingCreditAgreementsApril2023Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit And Letter Of Credit Facility Maturing April 2027",
        "label": "Revolving Credit And Letter Of Credit Facility Maturing April 2027 [Member]",
        "terseLabel": "Revolving Credit And Letter Of Credit Facility Maturing April 2027"
       }
      }
     },
     "localname": "RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit And Letter Of Credit Facility Maturing April 2027, Revolving Credit Facility Maturing April 2025, And 364 Day Revolving Credit Agreement, Maturing April 2023",
        "label": "Revolving Credit And Letter Of Credit Facility Maturing April 2027, Revolving Credit Facility Maturing April 2025, And 364 Day Revolving Credit Agreement, Maturing April 2023 [Member]",
        "terseLabel": "Revolving credit agreements, April 2022"
       }
      }
     },
     "localname": "RevolvingCreditAndLetterOfCreditFacilityMaturingApril2027RevolvingCreditFacilityMaturingApril2025And364DayRevolvingCreditAgreementMaturingApril2023Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit And Letter Of Credit Facility Maturing April 2028",
        "label": "Revolving Credit And Letter Of Credit Facility Maturing April 2028 [Member]",
        "terseLabel": "Five-year Revolving Credit Agreement, Maturing April 2028"
       }
      }
     },
     "localname": "RevolvingCreditAndLetterOfCreditFacilityMaturingApril2028Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_RevolvingCreditFacilityMaturingApril2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility Maturing April 2025",
        "label": "Revolving Credit Facility Maturing April 2025 [Member]",
        "terseLabel": "Revolving Credit Facility Maturing April 2025"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMaturingApril2025Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_SCORSEMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SCOR SE",
        "label": "SCOR SE [Member]",
        "terseLabel": "SCOR SE"
       }
      }
     },
     "localname": "SCORSEMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element may be used to capture the complete disclosure pertaining to an entity's common stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation. B Preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued and outstanding.",
        "label": "Schedule Of Common Stock By Class Schedule Of Preferred Stock By Class [Text Block]",
        "terseLabel": "Common and Preferred Stock"
       }
      }
     },
     "localname": "ScheduleOfCommonStockByClassScheduleOfPreferredStockByClassTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_ScheduleOfIssuancesOfLongTermDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Issuances Of Long-Term Debt",
        "label": "Schedule Of Issuances Of Long-Term Debt [Table Text Block]",
        "terseLabel": "Summary of Debt Issuances"
       }
      }
     },
     "localname": "ScheduleOfIssuancesOfLongTermDebtTableTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_ScheduleOfOtherLongTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Other Long-Term Investments",
        "label": "Schedule Of Other Long-Term Investments [Table Text Block]",
        "terseLabel": "Carrying Value Information for Other Long-Term Investments"
       }
      }
     },
     "localname": "ScheduleOfOtherLongTermInvestmentsTableTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_ScheduleOfShortTermDebtLongTermDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance-sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation. Also, Pertinent information about each long-term debt arrangement including the carrying amount as of the balance sheet date, by type of long-term debt. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule Of Short Term Debt Long Term Debt [Table Text Block]",
        "terseLabel": "Outstanding Amounts of Debt and Finance Leases"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtLongTermDebtTableTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_ScheduleOfSpecialItemsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of pre- and after-tax amounts reported as special items, attributable to the parent. Special items are amounts that management does not believe are representative of underlying results of operations.",
        "label": "Schedule Of Special Items [Table Text Block]",
        "terseLabel": "Summary of Special Items"
       }
      }
     },
     "localname": "ScheduleOfSpecialItemsTableTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities Limited Partnerships And Real Estate Limited Partnerships",
        "label": "Securities Limited Partnerships And Real Estate Limited Partnerships [Member]",
        "terseLabel": "Securities limited partnerships and real estate limited partnerships"
       }
      }
     },
     "localname": "SecuritiesLimitedPartnershipsAndRealEstateLimitedPartnershipsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_SegmentRevenues": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total revenues less realized investment gains from equity method subsidiaries, special items and other reconciling items determined by management.",
        "label": "Segment Revenues",
        "totalLabel": "Adjusted revenues"
       }
      }
     },
     "localname": "SegmentRevenues",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separate Account Assets Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Separate Account Assets Before Reclassification To Disposal Group Assets Held For Sale",
        "totalLabel": "Total, including held for sale assets"
       }
      }
     },
     "localname": "SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SeparateAccountAssetsClassifiedInFairValueHierarchy": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_SeparateAccountAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of the assets held by the Entity for the benefit of separate account policyholders classified in the fair value hierarchy.",
        "label": "Separate Account Assets Classified In Fair Value Hierarchy",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "SeparateAccountAssetsClassifiedInFairValueHierarchy",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails_1": {
       "order": 2.0,
       "parentTag": "ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of the assets held by the Entity for the benefit of separate account policyholders classified in the fair value hierarchy.",
        "label": "Separate Account Assets Classified In Fair Value Hierarchy Before Reclassification To Disposal Group Assets Held For Sale",
        "totalLabel": "Subtotal, including held for sale assets"
       }
      }
     },
     "localname": "SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SeparateAccountAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A separate investment account established and maintained by an insurance entity under relevant state insurance law to which funds have been allocated for certain contracts of the insurance entity. Funds in a separate account are not commingled with other assets of the insurance entity for investment purposes.",
        "label": "Separate Account Assets [Member]",
        "terseLabel": "Separate Account Assets"
       }
      }
     },
     "localname": "SeparateAccountAssetsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_ServiceFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service, Fees",
        "label": "Service, Fees [Member]",
        "terseLabel": "Fees"
       }
      }
     },
     "localname": "ServiceFeesMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_ShortTermAndLongTermInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-Term And Long-Term Investments",
        "label": "Short-Term And Long-Term Investments [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "ShortTermAndLongTermInvestmentsAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails": {
       "order": 1.0,
       "parentTag": "ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale",
        "label": "Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale",
        "totalLabel": "Investments including held for sale assets"
       }
      }
     },
     "localname": "ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemChargeBenefitAfterTaxLitigation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "After-tax charges associated with litigation matters that are classified as special items, attributable to the parent. Special items reflect amounts that management does not believe are representative of underlying results of operations.",
        "label": "Special Item Charge (Benefit) After Tax Litigation",
        "verboseLabel": "(Benefits) charges associated with litigation matters (Selling, general and administrative expenses)"
       }
      }
     },
     "localname": "SpecialItemChargeBenefitAfterTaxLitigation",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemChargeBenefitBeforeTaxLitigation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "After-tax charges associated with litigation matters that are classified as special items, attributable to the parent. Special items reflect amounts that management does not believe are representative of underlying results of operations.",
        "label": "Special Item Charge (Benefit) Before Tax Litigation",
        "terseLabel": "(Benefits) charges associated with litigation matters",
        "verboseLabel": "(Benefits) charges associated with litigation matters (Selling, general and administrative expenses)"
       }
      }
     },
     "localname": "SpecialItemChargeBenefitBeforeTaxLitigation",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemChargesDebtExtinguishmentCostsBeforeTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Item Charges Debt Extinguishment Costs Before Tax",
        "label": "Special Item Charges Debt Extinguishment Costs Before Tax",
        "terseLabel": "Debt extinguishment costs"
       }
      }
     },
     "localname": "SpecialItemChargesDebtExtinguishmentCostsBeforeTax",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemChargesDebtExtinguishmentCostsNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Item Charges Debt Extinguishment Costs Net Of Tax",
        "label": "Special Item Charges Debt Extinguishment Costs Net Of Tax",
        "terseLabel": "Debt extinguishment costs"
       }
      }
     },
     "localname": "SpecialItemChargesDebtExtinguishmentCostsNetOfTax",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemGainLossFromContractAdjustmentBeforeTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Item, Gain (Loss) From Contract Adjustment, Before Taxes",
        "label": "Special Item, Gain (Loss) From Contract Adjustment, Before Taxes",
        "negatedLabel": "Contractual adjustment for a former client (Pharmacy revenues)",
        "negatedTerseLabel": "Contractual adjustment for a former client"
       }
      }
     },
     "localname": "SpecialItemGainLossFromContractAdjustmentBeforeTaxes",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemGainLossFromContractAdjustmentNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Item, Gain (Loss) From Contract Adjustment, Net Of Tax",
        "label": "Special Item, Gain (Loss) From Contract Adjustment, Net Of Tax",
        "negatedLabel": "Contractual adjustment for a former client (Pharmacy revenues)"
       }
      }
     },
     "localname": "SpecialItemGainLossFromContractAdjustmentNetOfTax",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Item, Gain (Loss) On Risk Corridor Allowance Adjustment, Before Taxes",
        "label": "Special Item, Gain (Loss) On Risk Corridor Allowance Adjustment, Before Taxes",
        "negatedLabel": "Risk corridors recovery (Selling, general and administrative expenses)",
        "negatedTerseLabel": "Risk corridors recovery"
       }
      }
     },
     "localname": "SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Item, Gain (Loss) On Risk Corridor Allowance Adjustment, Net Of Tax",
        "label": "Special Item, Gain (Loss) On Risk Corridor Allowance Adjustment, Net Of Tax",
        "negatedTerseLabel": "Risk corridors recovery (Selling, general and administrative expenses)"
       }
      }
     },
     "localname": "SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemGainLossOnSaleOfBusinessBeforeTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Item, Gain (Loss) On Sale Of Business, Before Taxes",
        "label": "Special Item, Gain (Loss) On Sale Of Business, Before Taxes",
        "negatedLabel": "(Gain) on sale of business"
       }
      }
     },
     "localname": "SpecialItemGainLossOnSaleOfBusinessBeforeTaxes",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemGainLossOnSaleOfBusinessNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Item, Gain (Loss) On Sale Of Business, Net Of Tax",
        "label": "Special Item, Gain (Loss) On Sale Of Business, Net Of Tax",
        "negatedLabel": "(Gain) on sale of business"
       }
      }
     },
     "localname": "SpecialItemGainLossOnSaleOfBusinessNetOfTax",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of before-tax tax amounts classified as special items, attributable to the parent. Special items are excluded from the calculation of 'adjusted income (loss) from operations' because management believes they are not representative of the underlying results of operations. This is generally because the nature and size of these matters are not indicative of our ongoing business operations.",
        "label": "Special Item Gain Or Loss Before Tax Attributable To Reportng Entity",
        "negatedTotalLabel": "Total impact from special items"
       }
      }
     },
     "localname": "SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of after-tax amounts classified as special items, attributable to the parent. Special items are excluded from the calculation of 'adjusted income (loss) from operations' because management believes they are not representative of the underlying results of operations. This is generally because the nature and size of these matters are not indicative of our ongoing business operations.",
        "label": "Special Item Gain Or Loss Net Of Tax Attributable To Reportng Entity",
        "negatedTotalLabel": "Total impact from special items"
       }
      }
     },
     "localname": "SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SpecialItemsAfterTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Special Items After Tax [Abstract]",
        "terseLabel": "After-tax"
       }
      }
     },
     "localname": "SpecialItemsAfterTaxAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_SpecialItemsBeforeTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Special Items Before Tax [Abstract]",
        "terseLabel": "Special items",
        "verboseLabel": "Pre-tax"
       }
      }
     },
     "localname": "SpecialItemsBeforeTaxAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ci_StepDownNotesDueJanuary2033Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Step-down debt due in January 2033.",
        "label": "Step Down Notes Due January 2033 [Member]",
        "terseLabel": "$45\u00a0million, 8.080% Step Down Notes due January 2033 (2)"
       }
      }
     },
     "localname": "StepDownNotesDueJanuary2033Member",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_StopLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An insurance product that provides additional coverage on Administrative Services Only plans that provides reimbursement for claims in excess of a predetermined amount.",
        "label": "Stop Loss [Member]",
        "terseLabel": "Stop loss"
       }
      }
     },
     "localname": "StopLossMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_SunLifeAssuranceCompanyOfCanadaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sun Life Assurance Company of Canada",
        "label": "Sun Life Assurance Company Of Canada [Member]",
        "verboseLabel": "Sun Life Assurance Company of Canada"
       }
      }
     },
     "localname": "SunLifeAssuranceCompanyOfCanadaMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_SupplierFinanceProgramObligationCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Finance Program, Obligation, Current",
        "label": "Supplier Finance Program, Obligation, Current",
        "terseLabel": "Outstanding payment obligations, current"
       }
      }
     },
     "localname": "SupplierFinanceProgramObligationCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SupplierFinanceProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Finance Program, Outstanding Payment Obligation, Current, Voluntarily Elected To Be Sold",
        "label": "Supplier Finance Program, Outstanding Payment Obligation, Current, Voluntarily Elected To Be Sold",
        "terseLabel": "Outstanding payment obligations, current, voluntarily elected by suppliers to be sold to the financial institution"
       }
      }
     },
     "localname": "SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SupplierFinanceProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_SupplierFinanceProgramPaymentTimingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period when payment is expected to be made to finance provider or intermediary in supplier finance program, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Supplier Finance Program, Payment Timing, Period",
        "terseLabel": "Payment term (in months)"
       }
      }
     },
     "localname": "SupplierFinanceProgramPaymentTimingPeriod",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SupplierFinanceProgramDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ci_SupplierFinanceProgramTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplier finance program",
        "label": "Supplier Finance Program [Text Block]",
        "terseLabel": "Supplier Finance Program"
       }
      }
     },
     "localname": "SupplierFinanceProgramTextBlock",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SupplierFinanceProgram"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ci_TemporaryEquityOtherComprehensiveIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      },
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of other comprehensive income or(loss) attributable to temporary equity interest.",
        "label": "Temporary Equity Other Comprehensive Income",
        "netLabel": "Other comprehensive loss",
        "terseLabel": "Less: Net translation (loss) on foreign currencies attributable to noncontrolling interests",
        "verboseLabel": "Other comprehensive loss attributable to redeemable noncontrolling interests"
       }
      }
     },
     "localname": "TemporaryEquityOtherComprehensiveIncome",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_TransactionRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails": {
       "order": 1.0,
       "parentTag": "ci_SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-tax transaction-related costs primarily consisting of fees for legal, advisory and other professional services, as well as employee costs.",
        "label": "Transaction Related Costs",
        "terseLabel": "Integration and transaction-related costs",
        "verboseLabel": "Integration and transaction-related costs, pre-tax"
       }
      }
     },
     "localname": "TransactionRelatedCosts",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_TransactionRelatedCostsAfterTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails": {
       "order": 1.0,
       "parentTag": "ci_SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "After-tax transaction-related costs including the impact of tax benefits realized from termination of merger agreement. Transaction-related costs consist primarily of fees for legal, advisory and other professional services as well as employee costs.",
        "label": "Transaction Related Costs After Tax",
        "terseLabel": "Integration and transaction-related costs, after-tax",
        "verboseLabel": "Integration and transaction-related costs, after-tax"
       }
      }
     },
     "localname": "TransactionRelatedCostsAfterTax",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_USGroupDisabilityAndLifeInsuranceBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S Group Disability And Life Insurance Business",
        "label": "U.S Group Disability And Life Insurance Business [Member]",
        "terseLabel": "U.S Group Disability and Life Insurance"
       }
      }
     },
     "localname": "USGroupDisabilityAndLifeInsuranceBusinessMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_USMedicalProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U.S. Medical Products [Member]",
        "terseLabel": "Cigna Healthcare"
       }
      }
     },
     "localname": "USMedicalProductsMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_UnearnedPremiumsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 5.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unearned Premiums, Current",
        "label": "Unearned Premiums, Current",
        "terseLabel": "Unearned Premiums, Current"
       }
      }
     },
     "localname": "UnearnedPremiumsCurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_UnearnedPremiumsCurrentIncludingDisposalGroups": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date, expected to be paid in one year.",
        "label": "Unearned Premiums Current Including Disposal Groups",
        "terseLabel": "Unearned premiums, current, including held for sale liabilities"
       }
      }
     },
     "localname": "UnearnedPremiumsCurrentIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_UnearnedPremiumsIncludingDisposalGroups": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1": {
       "order": 3.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unearned Premiums Including Disposal Groups",
        "label": "Unearned Premiums Including Disposal Groups",
        "terseLabel": "Unearned premiums, including held for sale liabilities"
       }
      }
     },
     "localname": "UnearnedPremiumsIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_UnearnedPremiumsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 5.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unearned Premiums, Noncurrent",
        "label": "Unearned Premiums, Noncurrent",
        "terseLabel": "Unearned premiums, noncurrent"
       }
      }
     },
     "localname": "UnearnedPremiumsNoncurrent",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_UnearnedPremiumsNoncurrentIncludingDisposalGroups": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date, expected to be paid after one year.",
        "label": "Unearned Premiums Noncurrent Including Disposal Groups",
        "terseLabel": "Unearned premiums, including held for sale liabilities"
       }
      }
     },
     "localname": "UnearnedPremiumsNoncurrentIncludingDisposalGroups",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ci_UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unfunded Commitments, Percentage Expected To Fund In Next Fiscal Year",
        "label": "Unfunded Commitments, Percentage Expected To Fund In Next Fiscal Year",
        "terseLabel": "Unfunded commitments, percentage expected to fund in next fiscal year"
       }
      }
     },
     "localname": "UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ci_UnobservableInputsDevelopedByCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant unobservable inputs used in pricing Level 3 securities that were developed directly by the Company.",
        "label": "Unobservable Inputs Developed By Company [Member]",
        "terseLabel": "Securities Priced by the Company"
       }
      }
     },
     "localname": "UnobservableInputsDevelopedByCompanyMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_UnobservableInputsNotDevelopedByCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant unobservable inputs used in pricing Level 3 securities that were not developed directly by the Company",
        "label": "Unobservable Inputs Not Developed By Company [Member]",
        "terseLabel": "Securities Not Priced by the Company"
       }
      }
     },
     "localname": "UnobservableInputsNotDevelopedByCompanyMember",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ci_VariableInterestEntitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entities [Abstract]",
        "terseLabel": "Variable Interest Entities [Abstract]"
       }
      }
     },
     "localname": "VariableInterestEntitiesAbstract",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "xbrltype": "stringItemType"
    },
    "ci_VariableInterestEntitiesNumberOfEntities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities, Number Of Entities",
        "label": "Variable Interest Entities, Number Of Entities",
        "terseLabel": "Number of VIEs"
       }
      }
     },
     "localname": "VariableInterestEntitiesNumberOfEntities",
     "nsuri": "http://www.thecignagroup.com/20230331",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r962"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r963"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r964"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r959"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "verboseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r961"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CommercialPaperAverageRatePaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial Paper, Average Rate Paid",
        "terseLabel": "Commercial paper average interest rate"
       }
      }
     },
     "localname": "CommercialPaperAverageRatePaid",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r368",
      "r679",
      "r680",
      "r684",
      "r685",
      "r749",
      "r890",
      "r1019",
      "r1022",
      "r1023"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r368",
      "r679",
      "r680",
      "r684",
      "r685",
      "r749",
      "r890",
      "r1019",
      "r1022",
      "r1023"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r368",
      "r412",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r440",
      "r527",
      "r528",
      "r529",
      "r530",
      "r532",
      "r533",
      "r535",
      "r537",
      "r538",
      "r1020",
      "r1021"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r368",
      "r412",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r440",
      "r527",
      "r528",
      "r529",
      "r530",
      "r532",
      "r533",
      "r535",
      "r537",
      "r538",
      "r1020",
      "r1021"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Maturities of Outstanding Long-Term Debt"
       }
      }
     },
     "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r311",
      "r372",
      "r380",
      "r387",
      "r478",
      "r647",
      "r648",
      "r649",
      "r666",
      "r667",
      "r692",
      "r695",
      "r697",
      "r698",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adjustment upon Adoption"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r311",
      "r372",
      "r380",
      "r387",
      "r478",
      "r647",
      "r648",
      "r649",
      "r666",
      "r667",
      "r692",
      "r695",
      "r697",
      "r698",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period Of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r311",
      "r372",
      "r380",
      "r387",
      "r478",
      "r647",
      "r648",
      "r649",
      "r666",
      "r667",
      "r692",
      "r695",
      "r697",
      "r698",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period Of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r523",
      "r524",
      "r525",
      "r526",
      "r635",
      "r784",
      "r845",
      "r891",
      "r892",
      "r922",
      "r934",
      "r949",
      "r1024",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails",
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r523",
      "r524",
      "r525",
      "r526",
      "r635",
      "r784",
      "r845",
      "r891",
      "r892",
      "r922",
      "r934",
      "r949",
      "r1024",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_PartnershipInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Partnership Interest [Member]",
        "terseLabel": "Securities partnerships",
        "verboseLabel": "Securities partnerships"
       }
      }
     },
     "localname": "PartnershipInterestMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r442",
      "r789",
      "r923",
      "r941",
      "r1016",
      "r1017",
      "r1025",
      "r1056"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails",
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails",
      "http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails",
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r442",
      "r789",
      "r923",
      "r941",
      "r1016",
      "r1017",
      "r1025",
      "r1056"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails",
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails",
      "http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails",
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r523",
      "r524",
      "r525",
      "r526",
      "r595",
      "r635",
      "r643",
      "r644",
      "r645",
      "r757",
      "r784",
      "r845",
      "r891",
      "r892",
      "r922",
      "r934",
      "r949",
      "r1011",
      "r1024",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails",
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r523",
      "r524",
      "r525",
      "r526",
      "r595",
      "r635",
      "r643",
      "r644",
      "r645",
      "r757",
      "r784",
      "r845",
      "r891",
      "r892",
      "r922",
      "r934",
      "r949",
      "r1011",
      "r1024",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails",
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r312",
      "r369",
      "r370",
      "r371",
      "r373",
      "r374",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r402",
      "r479",
      "r480",
      "r667",
      "r693",
      "r697",
      "r698",
      "r699",
      "r741",
      "r747",
      "r748",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r312",
      "r369",
      "r370",
      "r371",
      "r373",
      "r374",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r402",
      "r479",
      "r480",
      "r667",
      "r693",
      "r697",
      "r698",
      "r699",
      "r741",
      "r747",
      "r748",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember": {
     "auth_ref": [
      "r312",
      "r373",
      "r374",
      "r380",
      "r387",
      "r479",
      "r480",
      "r667",
      "r693",
      "r699",
      "r741",
      "r747",
      "r748",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Accounting Standards Update, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Accounting Standards Update, Adjustment"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r636",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r312",
      "r369",
      "r371",
      "r373",
      "r374",
      "r377",
      "r378",
      "r386",
      "r402",
      "r667",
      "r693",
      "r697",
      "r698",
      "r741",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r984",
      "r985",
      "r987",
      "r988",
      "r989",
      "r999",
      "r1000",
      "r1034",
      "r1041",
      "r1042"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r387",
      "r636",
      "r965",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r387",
      "r636",
      "r965",
      "r966",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r891",
      "r892",
      "r1045",
      "r1047",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": {
     "auth_ref": [
      "r168"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.",
        "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt",
        "negatedTerseLabel": "Accelerated stock repurchase, amount remitted"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r373",
      "r374",
      "r375",
      "r453",
      "r454",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r647",
      "r648",
      "r649",
      "r666",
      "r667",
      "r675",
      "r676",
      "r677",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r735",
      "r736",
      "r738",
      "r739",
      "r740",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r983"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.",
        "label": "Accounts and Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r26",
      "r938"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r42",
      "r48",
      "r186",
      "r969",
      "r970",
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Postretirement benefits liability"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": {
     "auth_ref": [
      "r41",
      "r48",
      "r186",
      "r350",
      "r351",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]",
        "terseLabel": "Reclassification adjustment for amortization of net prior actuarial losses and prior service costs (Interest expense and other)"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r40",
      "r48",
      "r186",
      "r726",
      "r732",
      "r969",
      "r970",
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Translation of foreign currencies attributable to noncontrolling interest"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r40",
      "r48",
      "r186",
      "r349",
      "r970",
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Translation of foreign currencies including portion attributable to noncontrolling interest"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r45",
      "r47",
      "r48",
      "r328",
      "r815",
      "r856",
      "r860"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r349",
      "r350",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r44",
      "r48",
      "r186",
      "r748",
      "r851",
      "r852",
      "r969",
      "r970",
      "r971",
      "r980",
      "r981",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r40",
      "r48",
      "r186",
      "r350",
      "r351",
      "r727",
      "r728",
      "r729",
      "r730",
      "r732",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Translation of foreign currencies attributable to parent"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r647",
      "r648",
      "r649",
      "r980",
      "r981",
      "r982",
      "r1033"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionsToContractHoldersFunds": {
     "auth_ref": [
      "r974"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a segregated fund account during the period.",
        "label": "Additions to Contract Holders Funds",
        "terseLabel": "Deposits and interest credited to contractholder deposit funds"
       }
      }
     },
     "localname": "AdditionsToContractHoldersFunds",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r329",
      "r450",
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for current expected credit losses on accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AlternativeInvestment": {
     "auth_ref": [
      "r701",
      "r712"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund.",
        "label": "Alternative Investment",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AlternativeInvestment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r75",
      "r119",
      "r122"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets",
        "verboseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive options (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax": {
     "auth_ref": [
      "r944",
      "r948",
      "r1057",
      "r1062"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in expected future policy benefit component of liability for future policy benefit from change in discount rate.",
        "label": "AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax",
        "negatedPeriodEndLabel": "Effect of discount rate assumptions",
        "periodStartLabel": "Reversal of effect of discount rate assumptions"
       }
      }
     },
     "localname": "AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax": {
     "auth_ref": [
      "r944",
      "r948",
      "r1057",
      "r1062"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from increase (decrease) in expected net premium component of liability for future policy benefit from change in discount rate.",
        "label": "AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax",
        "negatedPeriodStartLabel": "Reversal of effect of beginning of period discount rate assumptions",
        "periodEndLabel": "Effect of end of period discount rate assumptions"
       }
      }
     },
     "localname": "AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AociLiabilityForFuturePolicyBenefitParentMember": {
     "auth_ref": [
      "r337",
      "r340",
      "r350",
      "r351",
      "r683",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in liability for future policy benefit from change in discount rate, attributable to parent.",
        "label": "AOCI, Liability for Future Policy Benefit, Parent [Member]",
        "terseLabel": "AOCI, Liability for Future Policy Benefit, Parent"
       }
      }
     },
     "localname": "AociLiabilityForFuturePolicyBenefitParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax": {
     "auth_ref": [
      "r947",
      "r950",
      "r1059",
      "r1063"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in instrument-specific credit risk on contract or contract feature in long-duration contract issued by insurance entity protecting contract holder from other-than-nominal capital market risk and exposing insurance entity to other-than-nominal capital market risk.",
        "label": "AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, before Tax",
        "negatedTerseLabel": "Nonperformance risk (own credit risk), end of period",
        "terseLabel": "Net amount at risk"
       }
      }
     },
     "localname": "AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember": {
     "auth_ref": [
      "r338",
      "r340",
      "r350",
      "r351",
      "r683",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in instrument-specific credit risk on contract or contract feature in long-duration contract issued by insurance entity protecting contract holder from other-than-nominal capital market risk and exposing insurance entity to other-than-nominal capital market risk, attributable to parent.",
        "label": "AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, Parent [Member]",
        "terseLabel": "AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, Parent"
       }
      }
     },
     "localname": "AociMarketRiskBenefitInstrumentSpecificCreditRiskParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r924",
      "r993"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "terseLabel": "Mortgage and other asset-backed",
        "verboseLabel": "Mortgage and other asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails",
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r246",
      "r270",
      "r324",
      "r364",
      "r420",
      "r432",
      "r438",
      "r474",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r534",
      "r536",
      "r538",
      "r539",
      "r679",
      "r684",
      "r717",
      "r938",
      "r1020",
      "r1021",
      "r1043"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r317",
      "r333",
      "r364",
      "r474",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r534",
      "r536",
      "r538",
      "r539",
      "r679",
      "r684",
      "r717",
      "r938",
      "r1020",
      "r1021",
      "r1043"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Financial assets at fair value:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Appreciation"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Unrealized Depreciation"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r103",
      "r458",
      "r805"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r103",
      "r457",
      "r804"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r103",
      "r459",
      "r806"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r103",
      "r456",
      "r803"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Mortgage and other asset-backed securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r109",
      "r807"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Mortgage and other asset-backed securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r100",
      "r455",
      "r491",
      "r795"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Debt Securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r210",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BenefitsLossesAndExpenses": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.",
        "label": "Benefits, Losses and Expenses",
        "totalLabel": "TOTAL BENEFITS AND EXPENSES"
       }
      }
     },
     "localname": "BenefitsLossesAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BenefitsLossesAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Benefits, Losses and Expenses [Abstract]",
        "terseLabel": "Benefits and expenses"
       }
      }
     },
     "localname": "BenefitsLossesAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r77",
      "r320",
      "r898"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r71",
      "r77",
      "r80"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodStartLabel": "Cash, cash equivalents and restricted cash and cash equivalents January 1,",
        "terseLabel": "Cash, cash equivalents and restricted cash and cash equivalents December 31,"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations": {
     "auth_ref": [
      "r71",
      "r77",
      "r80"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations",
        "negatedTerseLabel": "Cash and cash equivalents reclassified to Assets of businesses held for sale",
        "terseLabel": "Cash, cash equivalents and restricted cash, reported in Assets of businesses held for sale"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r71",
      "r77",
      "r80"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents and restricted cash December 31, including held for sale assets",
        "periodStartLabel": "Cash, cash equivalents and restricted cash January 1, including held for sale assets"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r71",
      "r240"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashSurrenderValueDuePolicyholdersAmount": {
     "auth_ref": [
      "r843",
      "r949"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash to be paid to policyholder upon termination and surrender of long-duration contract issued by insurance entity.",
        "label": "Policyholder Account Balance, Cash Surrender Value",
        "terseLabel": "Cash surrender value"
       }
      }
     },
     "localname": "CashSurrenderValueDuePolicyholdersAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Abstract]",
        "terseLabel": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Abstract]"
       }
      }
     },
     "localname": "CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededCreditRiskAxis": {
     "auth_ref": [
      "r1051",
      "r1066"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of reinsurer or group of reinsurers in reinsurance contract.",
        "label": "Reinsurer, Name [Axis]",
        "terseLabel": "Ceded Credit Risk, Reinsurer [Axis]"
       }
      }
     },
     "localname": "CededCreditRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededCreditRiskCollateralizationAxis": {
     "auth_ref": [
      "r1066"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information as to collaterization of reinsurance recoverables.",
        "label": "Ceded Credit Risk, Collateralization [Axis]",
        "terseLabel": "Ceded Credit Risk, Collateralization [Axis]"
       }
      }
     },
     "localname": "CededCreditRiskCollateralizationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededCreditRiskCollateralizationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralization of ceded credit risk.",
        "label": "Ceded Credit Risk, Collateralization [Domain]",
        "terseLabel": "Ceded Credit Risk, Collateralization [Domain]"
       }
      }
     },
     "localname": "CededCreditRiskCollateralizationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CededCreditRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Ceded Credit Risk [Line Items]",
        "terseLabel": "Ceded Credit Risk [Line Items]"
       }
      }
     },
     "localname": "CededCreditRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededCreditRiskReinsurerDomain": {
     "auth_ref": [
      "r1051"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of reinsurer or group of reinsurers in reinsurance contract.",
        "label": "Reinsurer, Name [Domain]",
        "terseLabel": "Ceded Credit Risk, Reinsurer [Domain]"
       }
      }
     },
     "localname": "CededCreditRiskReinsurerDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CededCreditRiskSecuredMember": {
     "auth_ref": [
      "r1066"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reinsurance recoverable that is secured by collateral.",
        "label": "Ceded Credit Risk, Secured [Member]",
        "terseLabel": "Secured"
       }
      }
     },
     "localname": "CededCreditRiskSecuredMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CededCreditRiskTable": {
     "auth_ref": [
      "r868"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.",
        "label": "Ceded Credit Risk [Table]",
        "terseLabel": "Ceded Credit Risk [Table]"
       }
      }
     },
     "localname": "CededCreditRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededCreditRiskUnsecuredMember": {
     "auth_ref": [
      "r1066"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reinsurance recoverable that is not secured by collateral.",
        "label": "Ceded Credit Risk, Unsecured [Member]",
        "terseLabel": "No collateral"
       }
      }
     },
     "localname": "CededCreditRiskUnsecuredMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r14",
      "r247",
      "r271"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPortfolioSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portfolio segment of the company's total financing receivables related to commercial receivables.",
        "label": "Commercial Portfolio Segment [Member]",
        "terseLabel": "Commercial Portfolio Segment"
       }
      }
     },
     "localname": "CommercialPortfolioSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsNarrativeDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r34",
      "r255",
      "r276"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Contingencies \u2014 Note 16"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r132",
      "r520",
      "r521",
      "r886",
      "r1018"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies and Other Matters"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMatters"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r144",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Commitment and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Amount per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Common dividends declared (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r980",
      "r981",
      "r1033"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20",
      "r938"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r49",
      "r345",
      "r347",
      "r355",
      "r799",
      "r821"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "SHAREHOLDERS' COMPREHENSIVE INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r182",
      "r183",
      "r199",
      "r345",
      "r347",
      "r354",
      "r798",
      "r820"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Comprehensive income (loss) attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r88",
      "r89",
      "r237",
      "r238",
      "r445",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails",
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r88",
      "r89",
      "r237",
      "r238",
      "r445",
      "r868",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails",
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r88",
      "r89",
      "r237",
      "r238",
      "r445",
      "r885",
      "r1066"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails",
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r88",
      "r89",
      "r237",
      "r238",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails",
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r88",
      "r89",
      "r237",
      "r238",
      "r445",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails",
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r187",
      "r189",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r924",
      "r926",
      "r1064"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "verboseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r93",
      "r431",
      "r432",
      "r433",
      "r434",
      "r440",
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r55",
      "r789"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Pharmacy and other service costs"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Goods and Service"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Foreign currency swap contracts"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r326"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Short-term debt",
        "totalLabel": "Total short-term debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets",
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt, Current [Abstract]",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "DebtCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r150",
      "r363",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r556",
      "r563",
      "r564",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r15",
      "r16",
      "r17",
      "r248",
      "r249",
      "r267",
      "r368",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r552",
      "r553",
      "r554",
      "r555",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r737",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails",
      "http://www.thecignagroup.com/role/DebtNarrativeDetails",
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r17",
      "r249",
      "r267",
      "r567"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Gross value"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r242",
      "r243",
      "r540",
      "r737",
      "r918",
      "r919"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Principal"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r31",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest Rate",
        "verboseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails",
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails",
      "http://www.thecignagroup.com/role/DebtNarrativeDetails",
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r32",
      "r368",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r552",
      "r553",
      "r554",
      "r555",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r737",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails",
      "http://www.thecignagroup.com/role/DebtNarrativeDetails",
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Aggregate principal amount of outstanding debt securities redeemed"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r32",
      "r161",
      "r164",
      "r165",
      "r166",
      "r241",
      "r242",
      "r243",
      "r262",
      "r368",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r552",
      "r553",
      "r554",
      "r555",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r565",
      "r737",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails",
      "http://www.thecignagroup.com/role/DebtNarrativeDetails",
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Credit agreement term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest",
        "negatedTerseLabel": "Allowance for Credit Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss": {
     "auth_ref": [
      "r491"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, before allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss",
        "terseLabel": "Amortized Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails",
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r467",
      "r496",
      "r915"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r467",
      "r496"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedTerseLabel": "Unrealized Depreciation"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": {
     "auth_ref": [
      "r1005"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions",
        "terseLabel": "Number of Issues"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r467",
      "r496",
      "r915"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 1.0,
       "parentTag": "ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r467",
      "r496"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 2.0,
       "parentTag": "ci_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedTerseLabel": "Unrealized Depreciation"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "auth_ref": [
      "r1005"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Number of Issues"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": {
     "auth_ref": [
      "r1003"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest",
        "terseLabel": "Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsDebtSecuritiesbyContractualMaturityPeriodsDetails",
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleMeasurementInput": {
     "auth_ref": [
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Measurement Input",
        "terseLabel": "Unobservable Adjustment"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r464",
      "r492",
      "r915"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r465",
      "r493"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Unrealized Depreciation"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r463",
      "r915",
      "r1006"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Summary of Debt Securities with a Decline in Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r466",
      "r494"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "totalLabel": "Number of Issues"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails",
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails",
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r654",
      "r655"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense": {
     "auth_ref": [
      "r808",
      "r823",
      "r826",
      "r827",
      "r854",
      "r940",
      "r977"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.",
        "label": "Deferred Policy Acquisition Costs, Amortization Expense",
        "terseLabel": "Amortization of deferred policy acquisition costs"
       }
      }
     },
     "localname": "DeferredPolicyAcquisitionCostAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Assets, Investments",
        "terseLabel": "Unrealized depreciation on investments and foreign currency translation"
       }
      }
     },
     "localname": "DeferredTaxAssetsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r75",
      "r415"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes derivative asset.",
        "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r334",
      "r335",
      "r716",
      "r900"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of credit risk valuation adjustment to derivative assets to properly reflect the credit quality of the counterparties.",
        "label": "Derivative Credit Risk Valuation Adjustment, Derivative Assets",
        "terseLabel": "Adjustment for credit risk on derivatives assets"
       }
      }
     },
     "localname": "DerivativeCreditRiskValuationAdjustmentDerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of credit risk valuation adjustment to derivative liabilities to properly reflect the credit quality of the entity.",
        "label": "Derivative Credit Risk Valuation Adjustment, Derivative Liabilities",
        "terseLabel": "Adjustment for credit risk on derivatives liabilities"
       }
      }
     },
     "localname": "DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r1031"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Derivative gain (loss) recognized in the income statement"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r211",
      "r212",
      "r215",
      "r216",
      "r900"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r208",
      "r211",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r334",
      "r335",
      "r716",
      "r900"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r1029",
      "r1030"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional Value"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r208",
      "r209",
      "r214",
      "r215",
      "r217",
      "r219",
      "r221",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r202",
      "r203",
      "r208",
      "r209",
      "r218",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r125",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by Sale"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r124",
      "r128",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Held-for-Sale"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "negatedTerseLabel": "Accounts receivable, net classified as Assets of businesses held for sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Sale price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r514",
      "r977",
      "r1009"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "terseLabel": "Gain (loss) on sale of business, pre-tax"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r928",
      "r931"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r167"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Common dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsDeclaredTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.",
        "label": "Dividends Declared [Table Text Block]",
        "terseLabel": "Dividend Payments"
       }
      }
     },
     "localname": "DividendsDeclaredTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Shareholders' net income per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r356",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r388",
      "r391",
      "r396",
      "r397",
      "r398",
      "r402",
      "r698",
      "r699",
      "r800",
      "r822",
      "r905"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "EPS, basic (in dollars per share)",
        "verboseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r356",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r391",
      "r396",
      "r397",
      "r398",
      "r402",
      "r698",
      "r699",
      "r800",
      "r822",
      "r905"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "totalLabel": "EPS, diluted (in dollars per share)",
        "verboseLabel": "Increase to diluted earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r85",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r399",
      "r400",
      "r401",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r1037"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of foreign currency rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Consolidated effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectsOfReinsuranceTableTextBlock": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effects of reinsurance, for example, but not limited to, disclosure of direct, assumed, and ceded insurance.",
        "label": "Effects of Reinsurance [Table Text Block]",
        "terseLabel": "Effects of Reinsurance"
       }
      }
     },
     "localname": "EffectsOfReinsuranceTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r160",
      "r311",
      "r349",
      "r350",
      "r351",
      "r369",
      "r370",
      "r371",
      "r374",
      "r383",
      "r386",
      "r405",
      "r478",
      "r570",
      "r647",
      "r648",
      "r649",
      "r666",
      "r667",
      "r697",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r732",
      "r748",
      "r851",
      "r852",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r52",
      "r70",
      "r75",
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Income distributions"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership percentage, less than"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r70",
      "r116",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Operating Joint Ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesByIndustryAxis": {
     "auth_ref": [
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.",
        "label": "Industry Sector [Axis]",
        "terseLabel": "Industry Sector [Axis]"
       }
      }
     },
     "localname": "EquitySecuritiesByIndustryAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.",
        "label": "Equity Securities, FV-NI, Cost",
        "terseLabel": "Equity securities with readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": {
     "auth_ref": [
      "r325",
      "r714"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity securities",
        "verboseLabel": "Equity securities with readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesIndustryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.",
        "label": "Industry Sector [Domain]",
        "terseLabel": "Industry Sector [Domain]"
       }
      }
     },
     "localname": "EquitySecuritiesIndustryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r114",
      "r268",
      "r956",
      "r957",
      "r958"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails",
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r469"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "ci_EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities with no readily determinable fair value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": {
     "auth_ref": [
      "r470"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount",
        "terseLabel": "Amount of impairments or value changes resulting from observable price changes on equity securities with no readily available fair value still held"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount",
        "terseLabel": "Realized investment gains on equity securities with no readily determinable fair value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r554",
      "r716",
      "r918",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r702",
      "r703",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r228",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Financial Assets and Financial Liabilities Carried at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value and Significant Unobservable Inputs Used in Pricing Debt Securities"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r226",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r222",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r222",
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r222",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair Value Disclosures for Financial Instruments Not Carried at Fair Value"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r554",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r703",
      "r754",
      "r755",
      "r756",
      "r918",
      "r919",
      "r924",
      "r925",
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r222",
      "r230",
      "r554",
      "r918",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r702",
      "r703",
      "r705",
      "r706",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r554",
      "r918",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r554",
      "r597",
      "r602",
      "r703",
      "r754",
      "r924",
      "r925",
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r554",
      "r597",
      "r602",
      "r703",
      "r755",
      "r918",
      "r919",
      "r924",
      "r925",
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r554",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r703",
      "r756",
      "r918",
      "r919",
      "r924",
      "r925",
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notice period the entity is required to deliver before it can redeem an investment calculated using net asset value per share, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, investments calculated by per unit, per membership interest, other equity or ownership interest and alternative investments.",
        "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Investment Redemption, Notice Period",
        "terseLabel": "Redemption Notice Period"
       }
      }
     },
     "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]",
        "terseLabel": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]"
       }
      }
     },
     "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investments in certain entities that calculate net asset value per share or equivalent measured at fair value on a recurring or nonrecurring basis.",
        "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table]",
        "terseLabel": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table]"
       }
      }
     },
     "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investments in certain entities that calculate net asset value per share or equivalent measured at fair value on a recurring or nonrecurring basis.",
        "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table Text Block]",
        "terseLabel": "Additional Information on Separate Account Assets Priced at NAV"
       }
      }
     },
     "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of unfunded commitments for which the entity is obligated, to those certain investments for which net asset value per share is calculated (including by unit, membership interest, or other equity (ownership interest) unit measure) (alternative investments).",
        "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments",
        "verboseLabel": "Unfunded Commitments"
       }
      }
     },
     "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "auth_ref": [
      "r597",
      "r701",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "terseLabel": "NAV"
       }
      }
     },
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r707"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "verboseLabel": "Gains included in Shareholders' net income"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r708"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Gains (losses) included in Other comprehensive loss"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)",
        "terseLabel": "Separate accounts assets classified in Level 3, period increase (decrease), including transfers in and out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueunderCertainConditionsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements)",
        "totalLabel": "Total purchases, sales and settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements) [Abstract]",
        "terseLabel": "Purchases, sales and settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "negatedLabel": "Sales"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "auth_ref": [
      "r709"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "terseLabel": "Transfers into Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net",
        "totalLabel": "Total transfers into/(out of) Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract]",
        "terseLabel": "Transfers into/(out of) Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r709"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "negatedLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r554",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r754",
      "r755",
      "r756",
      "r918",
      "r919",
      "r924",
      "r925",
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsChangesinLevel3FinancialAssetsandFinancialLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r710",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r233",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialGuaranteeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An agreement (contract) that requires the guarantor to make payments to the guaranteed party based on another entity's failure to pay specified obligations, such as debt, to a lender.",
        "label": "Financial Guarantee [Member]",
        "terseLabel": "Financial Guarantees"
       }
      }
     },
     "localname": "FinancialGuaranteeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r461",
      "r462",
      "r482",
      "r485",
      "r486",
      "r487",
      "r490",
      "r495",
      "r497",
      "r498",
      "r565",
      "r569",
      "r688",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r915",
      "r995",
      "r996",
      "r997",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails",
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest": {
     "auth_ref": [
      "r1001"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.",
        "label": "Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest",
        "negatedTerseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock": {
     "auth_ref": [
      "r96",
      "r1002"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics.",
        "label": "Financing Receivable Credit Quality Indicators [Table Text Block]",
        "terseLabel": "Summary of the Credit Risk Profile of the Commercial Mortgage Loan Portfolio"
       }
      }
     },
     "localname": "FinancingReceivableCreditQualityIndicatorsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r1001"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.",
        "label": "Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss",
        "terseLabel": "Carrying value, after allowance for credit loss"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss": {
     "auth_ref": [
      "r488",
      "r489",
      "r1001"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, before allowance for credit loss, of financing receivable. Excludes net investment in lease.",
        "label": "Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss",
        "terseLabel": "Carrying value, before allowance for credit loss"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivablePortfolioSegmentAxis": {
     "auth_ref": [
      "r482",
      "r485",
      "r894",
      "r895",
      "r896",
      "r897",
      "r908",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses.",
        "label": "Financing Receivable Portfolio Segment [Axis]",
        "terseLabel": "Financing Receivable Portfolio Segment [Axis]"
       }
      }
     },
     "localname": "FinancingReceivablePortfolioSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsNarrativeDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivablePortfolioSegmentDomain": {
     "auth_ref": [
      "r894",
      "r895",
      "r896",
      "r897",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses.",
        "label": "Financing Receivable Portfolio Segment [Domain]",
        "terseLabel": "Financing Receivable Portfolio Segment [Domain]"
       }
      }
     },
     "localname": "FinancingReceivablePortfolioSegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsNarrativeDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": {
     "auth_ref": [
      "r97",
      "r98",
      "r449",
      "r486",
      "r487",
      "r490",
      "r894",
      "r895",
      "r896",
      "r897",
      "r909",
      "r910",
      "r913",
      "r914",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Class of Financing Receivable [Axis]",
        "terseLabel": "Class of Financing Receivable [Axis]"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsNarrativeDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": {
     "auth_ref": [
      "r894",
      "r895",
      "r896",
      "r897",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Class of Financing Receivable [Domain]",
        "terseLabel": "Class of Financing Receivable [Domain]"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsNarrativeDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Translation of Foreign Currencies"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r1028",
      "r1064"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by government not domiciled in United States of America (US).",
        "label": "Debt Security, Government, Non-US [Member]",
        "terseLabel": "Foreign government"
       }
      }
     },
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FuturePolicyBenefitsLiabilityPolicy": {
     "auth_ref": [
      "r836",
      "r838",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for liability for future benefit to be paid to or on behalf of policyholder. Includes, but is not limited to, input, judgment, assumption, and method used in measuring liability and change in input, judgment, and assumption.",
        "label": "Liability for Future Policy Benefit [Policy Text Block]",
        "terseLabel": "Future Policy Benefits"
       }
      }
     },
     "localname": "FuturePolicyBenefitsLiabilityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r75",
      "r148",
      "r149"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss on repurchase of debt, pre-tax"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r322",
      "r502",
      "r794",
      "r916",
      "r938",
      "r1007",
      "r1008"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r512",
      "r513",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GuaranteeObligationsByNatureAxis": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of guarantee.",
        "label": "Guarantor Obligations, Nature [Axis]",
        "terseLabel": "Guarantor Obligations, Nature [Axis]"
       }
      }
     },
     "localname": "GuaranteeObligationsByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteeObligationsCurrentCarryingValue": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Current Carrying Value",
        "terseLabel": "Liability for guarantees"
       }
      }
     },
     "localname": "GuaranteeObligationsCurrentCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsLiquidationProceeds": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates, if estimable, the approximate extent to which the proceeds from liquidation of any assets held either as collateral or by third parties would be expected to cover the maximum potential amount of future payments under the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Liquidation Proceeds, Monetary Amount",
        "terseLabel": "Assets maintained by employers (minimum)"
       }
      }
     },
     "localname": "GuaranteeObligationsLiquidationProceeds",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Maximum guarantee exposure"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails",
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsNatureDomain": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Nature [Domain]",
        "terseLabel": "Guarantor Obligations, Nature [Domain]"
       }
      }
     },
     "localname": "GuaranteeObligationsNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GuaranteedInsuranceContractTypeOfBenefitAxis": {
     "auth_ref": [
      "r265",
      "r301",
      "r1061"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benefit for guaranteed benefit obligations in traditional and nontraditional long-duration contracts with policy and contract holders.",
        "label": "Guaranteed Insurance Contract, Type of Benefit [Axis]",
        "terseLabel": "Guaranteed Insurance Contract, Type of Benefit [Axis]"
       }
      }
     },
     "localname": "GuaranteedInsuranceContractTypeOfBenefitAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteedInsuranceContractTypeOfBenefitDomain": {
     "auth_ref": [
      "r864",
      "r939",
      "r1061"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Benefit for guaranteed benefit obligations in traditional and nontraditional long-duration contracts with policy and contract holders.",
        "label": "Guaranteed Insurance Contract, Type of Benefit [Domain]",
        "terseLabel": "Guaranteed Insurance Contract, Type of Benefit [Domain]"
       }
      }
     },
     "localname": "GuaranteedInsuranceContractTypeOfBenefitDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GuaranteedMinimumDeathBenefitMember": {
     "auth_ref": [
      "r265",
      "r302",
      "r1061"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Feature in an insurance contract that guarantees a minimum amount that will be payable upon the death of the insured.",
        "label": "Guaranteed Minimum Death Benefit [Member]",
        "terseLabel": "GMDB"
       }
      }
     },
     "localname": "GuaranteedMinimumDeathBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.",
        "label": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]",
        "terseLabel": "Guarantees"
       }
      }
     },
     "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GuaranteesMember": {
     "auth_ref": [
      "r1026"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A guaranty by which one person assumes responsibility for paying another's debts or fulfilling another's responsibilities; or a promise, pledge, assurance, especially one given in writing, that attests: (a) to the quality or durability of a product or service; (b) that something will be performed in a specified manner; or (c) that execution, completion, or existence of something is as represented or stipulated by agreement.",
        "label": "Guarantees [Member]",
        "terseLabel": "Guarantees"
       }
      }
     },
     "localname": "GuaranteesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GuarantyLiabilities": {
     "auth_ref": [
      "r135",
      "r136",
      "r254",
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.",
        "label": "Guaranty Liabilities",
        "terseLabel": "Guaranty liability"
       }
      }
     },
     "localname": "GuarantyLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthcareSectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sector of the economy consisting of companies engaged in healthcare-related business activities.",
        "label": "Healthcare Sector [Member]",
        "terseLabel": "Health Care Sector"
       }
      }
     },
     "localname": "HealthcareSectorMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgeFundsMember": {
     "auth_ref": [
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in registered hedge funds.",
        "label": "Hedge Funds [Member]",
        "terseLabel": "Hedge funds"
       }
      }
     },
     "localname": "HedgeFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r208",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r123",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Assets and Liabilities of Businesses Held for Sale"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r51",
      "r244",
      "r258",
      "r284",
      "r420",
      "r431",
      "r437",
      "r440",
      "r801",
      "r907"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r928",
      "r931"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r9",
      "r10",
      "r11",
      "r12",
      "r128",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r365",
      "r658",
      "r659",
      "r662",
      "r668",
      "r670",
      "r672",
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r366",
      "r385",
      "r386",
      "r418",
      "r656",
      "r669",
      "r671",
      "r824"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "TOTAL INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r348",
      "r652",
      "r653",
      "r659",
      "r660",
      "r661",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.",
        "label": "Increase (Decrease) in Accounts and Other Receivables",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsAndOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInsuranceLiabilities": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in insurance liability balances during the period.",
        "label": "Increase (Decrease) in Insurance Liabilities",
        "terseLabel": "Insurance liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Net changes in assets and liabilities, net of non-operating effects:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReinsuranceRecoverable": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of benefits the ceding insurer expects to recover on insurance policies ceded to other insurance entities as of the balance sheet date for all guaranteed benefit types.",
        "label": "Increase (Decrease) in Reinsurance Recoverable",
        "negatedLabel": "Reinsurance recoverable and Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInReinsuranceRecoverable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Changes in Total Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Change in Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r398",
      "r638"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Common stock equivalents (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndemnificationGuaranteeMember": {
     "auth_ref": [
      "r134",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor.",
        "label": "Indemnification Agreement [Member]",
        "terseLabel": "Indemnification obligations"
       }
      }
     },
     "localname": "IndemnificationGuaranteeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InsuranceLossReservesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance Loss Reserves [Abstract]",
        "terseLabel": "Insurance Loss Reserves [Abstract]"
       }
      }
     },
     "localname": "InsuranceLossReservesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InsuranceRelatedAssessmentsMember": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Any funding mandated by statute or regulatory authority that is related directly or indirectly to underwriting activities, including pools for self-insurance and excluding premium taxes and income taxes. The funds derived from the assessments generally enable a government guarantor to pay insurance claims in the event that the underwriting insurer is insolvent or otherwise unable to meet its payment obligations.",
        "label": "Insurance-related Assessments [Member]",
        "terseLabel": "Guaranty Fund Assessments"
       }
      }
     },
     "localname": "InsuranceRelatedAssessmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r121",
      "r786",
      "r787",
      "r788",
      "r790",
      "r901"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Other Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r118",
      "r120"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r58",
      "r560",
      "r568",
      "r920",
      "r921"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense on long-term and short-term debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r357",
      "r360",
      "r361"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swap contracts"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r412",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r331",
      "r899",
      "r938"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r319",
      "r330",
      "r404",
      "r499",
      "r500",
      "r501",
      "r785",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.",
        "label": "Investment Holdings, Schedule of Investments [Table Text Block]",
        "terseLabel": "Investments by category and current or long-term classification"
       }
      }
     },
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentIncomeInvestmentExpense": {
     "auth_ref": [
      "r59",
      "r285"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetInvestmentIncome",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to the generation of investment income.",
        "label": "Investment Income, Investment Expense",
        "terseLabel": "Less investment expenses"
       }
      }
     },
     "localname": "InvestmentIncomeInvestmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeTextBlock": {
     "auth_ref": [
      "r57",
      "r58",
      "r59",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table Text Block]",
        "terseLabel": "Components of Net Investment Income"
       }
      }
     },
     "localname": "InvestmentIncomeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r473",
      "r1053"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails",
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails",
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails",
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails",
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails",
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails",
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails_1": {
       "order": 1.0,
       "parentTag": "ci_InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Investments per Consolidated Balance Sheets"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Debt Securities by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r114",
      "r245",
      "r261",
      "r305",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_JudicialRulingMember": {
     "auth_ref": [
      "r1013"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation outcome that occurs as a result of judicial intervention, supervision, or approval.",
        "label": "Judicial Ruling [Member]",
        "terseLabel": "Judicial Ruling"
       }
      }
     },
     "localname": "JudicialRulingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r29",
      "r364",
      "r474",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r534",
      "r536",
      "r538",
      "r539",
      "r680",
      "r684",
      "r685",
      "r717",
      "r906",
      "r1020",
      "r1043",
      "r1044"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r25",
      "r251",
      "r274",
      "r938",
      "r979",
      "r998",
      "r1036"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r30",
      "r318",
      "r364",
      "r474",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r534",
      "r536",
      "r538",
      "r539",
      "r680",
      "r684",
      "r685",
      "r717",
      "r938",
      "r1020",
      "r1043",
      "r1044"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r290",
      "r293"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 2.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilities",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Unpaid claims and claim expenses"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.",
        "label": "Liability for Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock": {
     "auth_ref": [
      "r832",
      "r854",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of beginning balance to ending balance for liability for future policy benefit, with separate presentation of expected future net premium and expected future benefit.",
        "label": "Liability for Future Policy Benefit, Activity [Table Text Block]",
        "terseLabel": "Future Policy Benefit Activity"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate": {
     "auth_ref": [
      "r836",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current weighted-average discount rate used to measure liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Current Weighted-Average Discount Rate",
        "terseLabel": "Current discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance": {
     "auth_ref": [
      "r833"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of discounted balance for expected future gross premium component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Gross Premium, Discounted, before Reinsurance",
        "terseLabel": "Discounted expected future gross premiums"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance": {
     "auth_ref": [
      "r833",
      "r948"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of undiscounted balance for expected future gross premium component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Gross Premium, Undiscounted, before Reinsurance",
        "terseLabel": "Undiscounted expected future gross premiums"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange": {
     "auth_ref": [
      "r832",
      "r833",
      "r854",
      "r948"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected future policy benefit and expense component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change",
        "periodStartLabel": "Beginning balance",
        "verboseLabel": "Ending balance"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance": {
     "auth_ref": [
      "r948",
      "r1057",
      "r1062"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and current period update of cash flow assumption, of expected future policy benefit and expense component of liability for future policy benefit, discounted at original rate.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance",
        "totalLabel": "Ending balance at original discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]",
        "terseLabel": "Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance": {
     "auth_ref": [
      "r833",
      "r948"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of undiscounted balance for expected future policy benefit and expense component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance",
        "terseLabel": "Undiscounted expected future policy benefits"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange": {
     "auth_ref": [
      "r832",
      "r833",
      "r854",
      "r948"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected net premium component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Ending balance"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected": {
     "auth_ref": [
      "r942",
      "r948",
      "r1057",
      "r1062"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of premium collected from policyholder to fund expected benefit payment for expected net premium component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected",
        "negatedTerseLabel": "Net premiums collected"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance": {
     "auth_ref": [
      "r948",
      "r1057",
      "r1062"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and current period update of cash flow assumption, of expected net premium component of liability for future policy benefit, discounted at original rate.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance",
        "totalLabel": "Ending balance at original discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]",
        "terseLabel": "Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance": {
     "auth_ref": [
      "r832",
      "r834",
      "r854",
      "r948"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, recoverable under reinsurance of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance",
        "terseLabel": "Future policy benefit reserve, reinsurance recoverable"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration": {
     "auth_ref": [
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average duration of liability for future policy benefit, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Liability for Future Policy Benefit, Weighted-Average Duration",
        "terseLabel": "Weighted average duration"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitWeightedAverageDuration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate": {
     "auth_ref": [
      "r836",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Original weighted-average discount rate at contract issue date used to measure liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate",
        "terseLabel": "Interest accretion rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefits": {
     "auth_ref": [
      "r811",
      "r832",
      "r837",
      "r854",
      "r948"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 3.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilities",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.",
        "label": "Liability for Future Policy Benefit, before Reinsurance",
        "totalLabel": "Future policy benefits"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": {
     "auth_ref": [
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.",
        "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]",
        "terseLabel": "Insurance and Contractholder Liabilities"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits": {
     "auth_ref": [
      "r943",
      "r948",
      "r976",
      "r1057",
      "r1062"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to policyholder from benefit payment for expected future policy benefit and expense component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment",
        "negatedTerseLabel": "Benefit payments"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsPaymentForBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Paid costs related to:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Incurred costs related to:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": {
     "auth_ref": [
      "r266",
      "r290",
      "r293"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "periodEndLabel": "Ending balance, net",
        "periodStartLabel": "Beginning balance, net"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r17",
      "r249",
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Outstanding balances"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r27"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r1013"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r1013"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoanToValueAxis": {
     "auth_ref": [
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by debt-to-value ratio, for example, but not limited to, 80 percent to 100 percent. Element name and standard label in Debt-to-Value [numeric lower end] to [numeric higher end] Percent [Member] or Debt-to-Value Greater Than [low end numeric value] Percent [Member] or Debt-to-Value Less Than [high end numeric value] Percent [Member] formats.",
        "label": "Debt-to-Value [Axis]",
        "terseLabel": "Debt-to-Value [Axis]"
       }
      }
     },
     "localname": "LoanToValueAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoanToValueDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt-to-value (DTV) ratio, for example, but not limited to, 80 percent to 100 percent. Element name and standard label in DTV [numeric lower end] to [numeric higher end] Percent [Member] or DTV Greater Than [low end numeric value] Percent [Member] or DTV Less Than [high end numeric value] Percent [Member] formats.",
        "label": "Debt-to-Value [Domain]",
        "terseLabel": "Debt-to-Value [Domain]"
       }
      }
     },
     "localname": "LoanToValueDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r992"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Accounts Receivable, Net"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets",
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt and Lease Obligation [Abstract]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current maturities"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Long-term debt, including current maturities, excluding finance leases"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r321"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-Term Investments",
        "terseLabel": "Investments per Consolidated Balance Sheets",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets",
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Investments [Abstract]",
        "terseLabel": "Long-term"
       }
      }
     },
     "localname": "LongTermInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r32",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r137",
      "r138",
      "r522",
      "r523",
      "r524",
      "r1014",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r137",
      "r138",
      "r522",
      "r523",
      "r524",
      "r1014",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r522",
      "r965"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "netLabel": "Guarantee liability",
        "terseLabel": "Performance guarantee liability",
        "verboseLabel": "Reserves for litigation matters, pre-tax"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "auth_ref": [
      "r1013"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow reducing loss contingency liability.",
        "label": "Loss Contingency Accrual, Payments",
        "terseLabel": "Amounts paid for loss contigency"
       }
      }
     },
     "localname": "LossContingencyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r1013"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Loss contingency accrual provision"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyClaimsDismissedNumber": {
     "auth_ref": [
      "r1014",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims dismissed.",
        "label": "Loss Contingency, Claims Dismissed, Number",
        "terseLabel": "Number of counts dismissed"
       }
      }
     },
     "localname": "LossContingencyClaimsDismissedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r1013",
      "r1014",
      "r1015"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Damages sought by Elevance"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r137",
      "r138",
      "r522",
      "r523",
      "r524",
      "r1014",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationFinancialandPerformanceGuaranteesDetails",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r1014",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of counts"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_Ltv80To100PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt-to-value (DTV) ratio from 80 percent to 100 percent. Element name and standard label in DTV [numeric lower end] to [numeric higher end] Percent [Member] format.",
        "label": "Debt-to-Value Ratio, 80 to 100 Percent [Member]",
        "terseLabel": "80% to 100%"
       }
      }
     },
     "localname": "Ltv80To100PercentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketRiskBenefitActivityTableTextBlock": {
     "auth_ref": [
      "r846",
      "r950"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of beginning balance to ending balance for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.",
        "label": "Market Risk Benefit, Activity [Table Text Block]",
        "terseLabel": "Summary of Market Risk Benefit",
        "verboseLabel": "Reinsurance Recoverables for Variable Annuity Business"
       }
      }
     },
     "localname": "MarketRiskBenefitActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesTables",
      "http://www.thecignagroup.com/role/ReinsuranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk": {
     "auth_ref": [
      "r828",
      "r846",
      "r859",
      "r950"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and after accumulated increase (decrease) in instrument-specific credit risk, of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.",
        "label": "Market Risk Benefit, after Increase (Decrease) from Instrument-Specific Credit Risk",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of year"
       }
      }
     },
     "localname": "MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange": {
     "auth_ref": [
      "r846",
      "r859",
      "r950"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and cumulative increase (decrease) in instrument-specific credit risk, of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.",
        "label": "Market Risk Benefit, before Reinsurance and Cumulative Increase (Decrease) from Instrument-Specific Credit Risk Change",
        "periodEndLabel": "Balance, end of year, before the effect of changes in nonperformance risk (own credit risk)",
        "periodStartLabel": "Balance, beginning of year, before the effect of nonperformance risk (own credit risk)"
       }
      }
     },
     "localname": "MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected": {
     "auth_ref": [
      "r945",
      "r950",
      "r1059",
      "r1063"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk from change associated with actual policyholder behavior different from expected.",
        "label": "Market Risk Benefit, Increase (Decrease) from Actual Policyholder Behavior Different from Expected",
        "terseLabel": "Changes due to policyholder behavior versus expected"
       }
      }
     },
     "localname": "MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption": {
     "auth_ref": [
      "r946",
      "r950",
      "r1059",
      "r1063"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk from change in assumption, classified as other.",
        "label": "Market Risk Benefit, Increase (Decrease) from Other Assumption",
        "terseLabel": "Assumption changes"
       }
      }
     },
     "localname": "MarketRiskBenefitIncreaseDecreaseFromOtherAssumption",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketRiskBenefitLiabilityAmount": {
     "auth_ref": [
      "r847",
      "r950"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 4.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilities",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1": {
       "order": 5.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability position for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.",
        "label": "Market Risk Benefit, Liability, Amount",
        "totalLabel": "Market risk benfits"
       }
      }
     },
     "localname": "MarketRiskBenefitLiabilityAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketRiskBenefitPolicyTextBlock": {
     "auth_ref": [
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Includes, but is not limited to, input, judgment, assumption and method used in measuring market risk benefit, and change in input, judgment, and assumption.",
        "label": "Market Risk Benefit [Policy Text Block]",
        "terseLabel": "Market Risk Benefits"
       }
      }
     },
     "localname": "MarketRiskBenefitPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketRiskBenefitReinsuranceRecoverableAfterAllowance": {
     "auth_ref": [
      "r950",
      "r1060"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ReinsuranceRecoverables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, recoverable under reinsurance for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.",
        "label": "Market Risk Benefit, Reinsurance Recoverable, after Allowance",
        "terseLabel": "Market risk benefits",
        "verboseLabel": "Reinsured market risk benefit, end of period"
       }
      }
     },
     "localname": "MarketRiskBenefitReinsuranceRecoverableAfterAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails",
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketRiskBenefitRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Market Risk Benefit [Roll Forward]",
        "terseLabel": "Market Risk Benefit [Roll Forward]"
       }
      }
     },
     "localname": "MarketRiskBenefitRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesSummaryofMarketRiskBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r13",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Mergers, Acquisitions and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r39",
      "r250",
      "r273",
      "r364",
      "r474",
      "r527",
      "r530",
      "r531",
      "r532",
      "r538",
      "r539",
      "r717"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Other noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": {
     "auth_ref": [
      "r278"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.",
        "label": "Mortgage Loans on Real Estate, Commercial and Consumer, Net",
        "terseLabel": "Commercial mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgagesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan.",
        "label": "Mortgages [Member]",
        "verboseLabel": "Commercial mortgage loans"
       }
      }
     },
     "localname": "MortgagesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails",
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r406",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Description of Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DescriptionofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue": {
     "auth_ref": [
      "r300"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the general accounts corresponding to the specified product, guarantee type and subset of the guarantee.",
        "label": "Net Amount at Risk by Product and Guarantee, General Account Value",
        "terseLabel": "Account value"
       }
      }
     },
     "localname": "NetAmountAtRiskByProductAndGuaranteeGeneralAccountValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetAmountAtRiskByProductAndGuaranteeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Net Amount at Risk by Product and Guarantee [Line Items]",
        "terseLabel": "Net Amount at Risk by Product and Guarantee [Line Items]"
       }
      }
     },
     "localname": "NetAmountAtRiskByProductAndGuaranteeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetAmountAtRiskByProductAndGuaranteeTable": {
     "auth_ref": [
      "r265",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contracts with guaranteed benefits in excess of the current account balance, sets forth the amounts of such excesses (the net amounts at risk) and other pertinent information by type of guarantee by type of insurance product), as of the most recent balance sheet date.",
        "label": "Net Amount at Risk, by Product and Guarantee [Table]",
        "terseLabel": "Net Amount at Risk, by Product and Guarantee [Table]"
       }
      }
     },
     "localname": "NetAmountAtRiskByProductAndGuaranteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1": {
     "auth_ref": [
      "r265",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average attained age of policyholders or contract holders in the specified guarantee type and subset of guarantee class, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Net Amount at Risk by Product and Guarantee, Weighted Average Attained Age",
        "terseLabel": "Average attained age of contractholders (weighted by exposure)"
       }
      }
     },
     "localname": "NetAmountAtRiskByProductAndGuaranteeWeightedAverageAttainedAge1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r359"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "NET CASH USED IN FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash Flows from Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r359"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows from Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r71",
      "r73",
      "r76"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "NET CASH PROVIDED BY OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash Flows from Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r184",
      "r198",
      "r343",
      "r346",
      "r385",
      "r386",
      "r971"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of net income (loss) attributable to nonredeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net income attributable to other noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "terseLabel": "Net income attributable to redeemable noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r377",
      "r378",
      "r380",
      "r381",
      "r388",
      "r389",
      "r395",
      "r398",
      "r420",
      "r431",
      "r437",
      "r440",
      "r907"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Increase to shareholders' net income",
        "totalLabel": "SHAREHOLDERS' NET INCOME",
        "verboseLabel": "Shareholders' net income"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r154",
      "r184",
      "r185"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetInvestmentIncome": {
     "auth_ref": [
      "r819"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.",
        "label": "Net Investment Income",
        "terseLabel": "Net investment income",
        "totalLabel": "Net investment income",
        "verboseLabel": "Net investment income (loss)"
       }
      }
     },
     "localname": "NetInvestmentIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r82",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r380",
      "r387",
      "r402",
      "r453",
      "r454",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r647",
      "r648",
      "r649",
      "r664",
      "r665",
      "r666",
      "r667",
      "r675",
      "r676",
      "r677",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r735",
      "r736",
      "r738",
      "r739",
      "r740",
      "r741",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r791",
      "r792",
      "r793",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements, Recently Adopted Accounting Guidance and Accounting Guidance Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncatastrophicEventAxis": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of noncatastrophic event causing change in the insurer's provision.",
        "label": "Noncatastrophic Event [Axis]",
        "terseLabel": "Noncatastrophic Event [Axis]"
       }
      }
     },
     "localname": "NoncatastrophicEventAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncatastrophicEventDomain": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncatastrophic event causing change in the insurer's provision.",
        "label": "Noncatastrophic Event [Domain]",
        "terseLabel": "Noncatastrophic Event [Domain]"
       }
      }
     },
     "localname": "NoncatastrophicEventDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestInVariableInterestEntity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity (net assets) in a variable interest entity (VIE) not attributable, directly or indirectly, to the parent entity. That is, this is the portion of equity in a VIE that is attributable to the noncontrolling interest (previously referred to as minority interest).",
        "label": "Noncontrolling Interest in Variable Interest Entity",
        "terseLabel": "VIEs, Carrying value"
       }
      }
     },
     "localname": "NoncontrollingInterestInVariableInterestEntity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r180",
      "r570",
      "r980",
      "r981",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Other Non- controlling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotDesignatedAsHedgingInstrumentEconomicHedgeMember": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument, not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP), used as economic hedge for exposure to risk.",
        "label": "Not Designated as Hedging Instrument, Economic Hedge [Member]",
        "terseLabel": "Not Designated as Hedging Instrument, Economic Hedge"
       }
      }
     },
     "localname": "NotDesignatedAsHedgingInstrumentEconomicHedgeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r420",
      "r431",
      "r437",
      "r440",
      "r907"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r332",
      "r938"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r323"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Other Commitment",
        "terseLabel": "Additional commitments",
        "verboseLabel": "Commitment"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails",
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of other commitment.",
        "label": "Other Commitments [Axis]",
        "terseLabel": "Other Commitments [Axis]"
       }
      }
     },
     "localname": "OtherCommitmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails",
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation.",
        "label": "Other Commitments [Domain]",
        "terseLabel": "Other Commitments [Domain]"
       }
      }
     },
     "localname": "OtherCommitmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails",
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r48",
      "r350",
      "r726",
      "r728",
      "r732",
      "r969"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r48",
      "r50",
      "r350",
      "r726",
      "r728",
      "r732",
      "r969"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "totalLabel": "Other comprehensive income (loss) before reclassifications, after-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r46",
      "r349"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedLabel": "Other comprehensive income (loss), before reclassifications, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r336",
      "r339"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Derivative gain (loss) recognized in other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r339",
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "terseLabel": "Derivative gain (loss) reclassified from other comprehensive income into shareholders' net income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r50",
      "r160",
      "r344",
      "r347",
      "r353",
      "r726",
      "r731",
      "r732",
      "r797",
      "r818",
      "r969",
      "r970"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Shareholders other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r43",
      "r45"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Postretirement benefits liability adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r210",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r994",
      "r1004",
      "r1028",
      "r1035"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other debt securities"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebtNoncurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.",
        "label": "Other Long-Term Debt, Noncurrent",
        "terseLabel": "Other, including finance leases"
       }
      }
     },
     "localname": "OtherLongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtOutstandingAmountsofDebtandFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermInvestments": {
     "auth_ref": [
      "r279",
      "r967"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term investments classified as other.",
        "label": "Other Long-Term Investments",
        "terseLabel": "Other long-term investments"
       }
      }
     },
     "localname": "OtherLongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermInvestmentsMember": {
     "auth_ref": [
      "r1064"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term investments classified as other.",
        "label": "Other Long-Term Investments [Member]",
        "terseLabel": "Other long-term investments",
        "verboseLabel": "Other long-term investments"
       }
      }
     },
     "localname": "OtherLongTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails",
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Interest expense and other"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReinsurerMember": {
     "auth_ref": [
      "r1051"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reinsurer classified as other.",
        "label": "Reinsurer, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherReinsurerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherShortTermInvestments": {
     "auth_ref": [
      "r257",
      "r280",
      "r968"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term investments classified as other.",
        "label": "Other Short-Term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "OtherShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r72",
      "r292"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r972",
      "r973"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedTerseLabel": "Common stock dividend paid",
        "terseLabel": "Total amount paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Investments [Abstract]",
        "terseLabel": "Investments purchased or originated:"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsToAcquireMortgageNotesReceivable": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the purchase of receivables arising from the mortgage note on real estate.",
        "label": "Payments to Acquire Mortgage Notes Receivable",
        "negatedLabel": "Commercial mortgage loans"
       }
      }
     },
     "localname": "PaymentsToAcquireMortgageNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investments classified as other.",
        "label": "Payments to Acquire Other Investments",
        "negatedLabel": "Other (primarily short-term and other long-term investments)"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r1013"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ContingenciesandOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy": {
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension plans. This accounting policy may address (1) the types of plans sponsored by the entity (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]",
        "terseLabel": "Pension Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPensionsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r171",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r637",
      "r926",
      "r927",
      "r931",
      "r932",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plans"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceGuaranteeMember": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An agreement (contract) that requires the guarantor to make payments to a guaranteed party based on another entity's failure to perform under an obligating agreement. This may include the issuance of a performance standby letter of credit which requires the guarantor to make payments if a specified party fails to perform under a nonfinancial contractual obligation.",
        "label": "Performance Guarantee [Member]",
        "terseLabel": "Performance Guarantee"
       }
      }
     },
     "localname": "PerformanceGuaranteeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyLoansMember": {
     "auth_ref": [
      "r1064"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan issued by an insurance company, collateralized by the cash value of the borrower's life insurance policy.",
        "label": "Policy Loans [Member]",
        "terseLabel": "Policy loans",
        "verboseLabel": "Policy loans"
       }
      }
     },
     "localname": "PolicyLoansMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails",
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis": {
     "auth_ref": [
      "r845",
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range above guaranteed minimum crediting rate on policyholder account balance.",
        "label": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate [Axis]",
        "terseLabel": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate [Axis]"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain": {
     "auth_ref": [
      "r845",
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range above guaranteed minimum crediting rate on policyholder account balance.",
        "label": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate [Domain]",
        "terseLabel": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate [Domain]"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member": {
     "auth_ref": [
      "r949",
      "r1058"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range from 51 basis points to 150 basis points above guaranteed minimum crediting rate on policyholder account balance.",
        "label": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 [Member]",
        "terseLabel": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember": {
     "auth_ref": [
      "r949",
      "r1058"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range at zero basis point above guaranteed minimum crediting rate on policyholder account balance.",
        "label": "Policyholder Account Balance, at Guaranteed Minimum Crediting Rate [Member]",
        "terseLabel": "Policyholder Account Balance, at Guaranteed Minimum Crediting Rate"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating": {
     "auth_ref": [
      "r845",
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guaranteed minimum crediting rate on policyholder account balance.",
        "label": "Policyholder Account Balance, Guaranteed Minimum Credit Rating",
        "terseLabel": "Guaranteed minimum credit rating"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceGuaranteedMinimumCreditRating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis": {
     "auth_ref": [
      "r845",
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of guaranteed minimum crediting rate on policyholder account balance.",
        "label": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate Range [Axis]",
        "terseLabel": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate Range [Axis]"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain": {
     "auth_ref": [
      "r845",
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range of guaranteed minimum crediting rate on policyholder account balance.",
        "label": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate Range [Domain]",
        "terseLabel": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate Range [Domain]"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderAccountBalanceNetAmountAtRisk": {
     "auth_ref": [
      "r842",
      "r949"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of guaranteed benefit in excess of current account balance of policyholder account balance.",
        "label": "Policyholder Account Balance, Net Amount at Risk",
        "terseLabel": "Net amount at risk"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceNetAmountAtRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate": {
     "auth_ref": [
      "r841",
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average crediting rate for liability for policyholder account balance, calculated at a point in time.",
        "label": "Policyholder Account Balance, Weighted Average Crediting Rate",
        "terseLabel": "Weighted average crediting rate"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceWeightedAverageCreditingRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PolicyholderAccountsPolicy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for contracts reported in separate accounts, including the extent and terms of minimum guarantees, basis of presentation for separate account assets and liabilities and related separate account activity, the liability valuation method and assumptions used in valuing each type of policyholder and contract holder account maintained by the entity.",
        "label": "Policyholder Accounts, Policy [Policy Text Block]",
        "terseLabel": "Separate Accounts"
       }
      }
     },
     "localname": "PolicyholderAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet": {
     "auth_ref": [
      "r263",
      "r286"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.",
        "label": "Policyholder Benefits and Claims Incurred, Net",
        "terseLabel": "Medical costs and other benefit expenses"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderContractDeposits": {
     "auth_ref": [
      "r1055"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 5.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilities",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails_1": {
       "order": 2.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilitiesIncludingDisposalGroups",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability due to policyholder for deposit held under long-duration contract issued by insurance entity.",
        "label": "Policyholder Contract Deposit",
        "terseLabel": "Contractholder deposit funds",
        "totalLabel": "Contractholder deposit funds"
       }
      }
     },
     "localname": "PolicyholderContractDeposits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderFunds": {
     "auth_ref": [
      "r840",
      "r844",
      "r845",
      "r949"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due to policyholder. Includes, but is not limited to, unpaid policy dividend, retrospective refund, and undistributed earnings on participating business. Excludes future policy benefit and claim expense.",
        "label": "Policyholder Account Balance",
        "terseLabel": "Policyholder account balance"
       }
      }
     },
     "localname": "PolicyholderFunds",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValueDisclosuresforFinancialInstrumentsNotCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r796",
      "r817",
      "r825",
      "r862"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails": {
       "order": 1.0,
       "parentTag": "ci_NonInvestmentRevenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAtCarryingValue": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.",
        "label": "Premiums Receivable, Net",
        "terseLabel": "Premiums due"
       }
      }
     },
     "localname": "PremiumsReceivableAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollectionOfLoansReceivable": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.",
        "label": "Proceeds from Collection of Loans Receivable",
        "terseLabel": "Commercial mortgage loans"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfLoansReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Cash proceeds from sale of business"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/MergersAcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Divestitures, net of cash sold"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Net proceeds on issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r974",
      "r975"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale [Abstract]",
        "terseLabel": "Proceeds from investments sold:"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Sale and Maturity of Held-to-Maturity Securities [Abstract]",
        "terseLabel": "Investment maturities and repayments:"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.",
        "label": "Proceeds from Sale and Maturity of Other Investments",
        "verboseLabel": "Other sales, maturities and repayments (primarily short-term and other long-term investments)"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "verboseLabel": "Pharmacy revenues"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r316",
      "r343",
      "r346",
      "r358",
      "r364",
      "r373",
      "r385",
      "r386",
      "r420",
      "r431",
      "r437",
      "r440",
      "r474",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r534",
      "r536",
      "r538",
      "r539",
      "r678",
      "r681",
      "r682",
      "r699",
      "r717",
      "r801",
      "r907",
      "r935",
      "r936",
      "r971",
      "r1020"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "ci_ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r1010",
      "r1040"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r126",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RealEstateFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in funds that invest in commercial or residential real estate.",
        "label": "Real Estate Funds [Member]",
        "terseLabel": "Real estate funds"
       }
      }
     },
     "localname": "RealEstateFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsAdditionalInformationonSeparateAccountAssetsPricedatNetAssetValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RealEstateInvestmentMember": {
     "auth_ref": [
      "r882",
      "r883",
      "r884",
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents direct equity investments in real estate projects (Land, buildings and improvements owned for income production and capital accretion potential) and certain loans accounted for as real estate investments. For loans accounted for as real estate investments, the entity (lender) has virtually the same risks and rewards as those of owners or joint venture participants. Such arrangements are treated as if the entity actually has an ownership interest in the property. In such arrangements, the entity (lender) participates in expected residual profits, which may be in the form of an equity kicker or a higher than usual effective interest rate. At the outset and during the construction and development of the property, the borrower generally has little or no equity in the property and the entity's (lender's) only source of repayment is the property. The entity (lender) generally (a) agrees to provide substantially all funds to acquire, develop, and construct the property, (b) funds the commitment or origination fees or both, and (c) funds interest during the development and construction of the property.",
        "label": "Real Estate Investment [Member]",
        "terseLabel": "Real estate investments"
       }
      }
     },
     "localname": "RealEstateInvestmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RealEstateLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan to finance the purchase of real estate, including but not limited to, land or building.",
        "label": "Real Estate Loan [Member]",
        "terseLabel": "Real Estate Loan"
       }
      }
     },
     "localname": "RealEstateLoanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsNarrativeDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RealizedGainLossOnInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of realized gains and losses on investments reported in the statement of income.",
        "label": "Realized Gain (Loss) on Investments [Table Text Block]",
        "terseLabel": "Realized Gains and Losses on Investments"
       }
      }
     },
     "localname": "RealizedGainLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]",
        "terseLabel": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r275",
      "r303",
      "r938"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Accounts receivable, net",
        "totalLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetSummaryofAccountsReceivableNetDetails",
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r48",
      "r350",
      "r726",
      "r730",
      "r732",
      "r969"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "negatedLabel": "Reclassification adjustment, before tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r48",
      "r50",
      "r350",
      "r726",
      "r730",
      "r732",
      "r969"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "ci_OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity",
       "weight": -1.0
      },
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTotalLabel": "Net amounts reclassified from AOCI to net income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r46",
      "r342",
      "r349"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Reclassification adjustment, tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r152",
      "r153",
      "r155",
      "r156"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "verboseLabel": "Redeemable noncontrolling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceAccountingPolicy": {
     "auth_ref": [
      "r869",
      "r951",
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.",
        "label": "Reinsurance Accounting Policy [Policy Text Block]",
        "terseLabel": "Reinsurance"
       }
      }
     },
     "localname": "ReinsuranceAccountingPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReinsuranceDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reinsurance Disclosures [Abstract]",
        "terseLabel": "Reinsurance Disclosures [Abstract]"
       }
      }
     },
     "localname": "ReinsuranceDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims": {
     "auth_ref": [
      "r288",
      "r289"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated amount after valuation allowance of reinsurance recoverables, due from reinsurers for incurred claims not yet reported, and claims settlement expenses.",
        "label": "Reinsurance Recoverables, Incurred but Not Reported Claims",
        "terseLabel": "Incurred but not yet paid and outstanding claims"
       }
      }
     },
     "localname": "ReinsuranceReceivablesIncurredButNotReportedClaims",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r290",
      "r293",
      "r1052",
      "r1054"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "periodEndLabel": "Add: Reinsurance and other amounts recoverable",
        "periodStartLabel": "Less: Reinsurance and other amounts recoverable"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceRecoverables": {
     "auth_ref": [
      "r264",
      "r288",
      "r816"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.",
        "label": "Reinsurance Recoverables, Including Reinsurance Premium Paid",
        "totalLabel": "Total reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceRecoverablesAllowance": {
     "auth_ref": [
      "r481",
      "r483",
      "r484"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReinsuranceRecoverables",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on reinsurance recoverable.",
        "label": "Reinsurance Recoverable, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for uncollectible reinsurance"
       }
      }
     },
     "localname": "ReinsuranceRecoverablesAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceRecoverablesGross": {
     "auth_ref": [
      "r451",
      "r486"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReinsuranceRecoverables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation allowance recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.",
        "label": "Reinsurance Recoverables, Gross",
        "terseLabel": "Reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverablesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceTextBlock": {
     "auth_ref": [
      "r809",
      "r810",
      "r869",
      "r951",
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.",
        "label": "Reinsurance [Text Block]",
        "terseLabel": "Reinsurance"
       }
      }
     },
     "localname": "ReinsuranceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/Reinsurance"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r75",
      "r517",
      "r518",
      "r1012"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charge for organizational efficiency plan (Selling, general and administrative expenses)",
        "verboseLabel": "Charge for organizational efficiency plan"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummaryofSpecialItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r22",
      "r167",
      "r272",
      "r855",
      "r860",
      "r938"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r311",
      "r369",
      "r370",
      "r371",
      "r374",
      "r383",
      "r386",
      "r478",
      "r647",
      "r648",
      "r649",
      "r666",
      "r667",
      "r697",
      "r851",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r171",
      "r172",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r637",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r171",
      "r172",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r637",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r411",
      "r412",
      "r430",
      "r435",
      "r436",
      "r442",
      "r443",
      "r445",
      "r571",
      "r572",
      "r789"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails": {
       "order": 2.0,
       "parentTag": "ci_NonInvestmentRevenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r903",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r352",
      "r364",
      "r411",
      "r412",
      "r430",
      "r435",
      "r436",
      "r442",
      "r443",
      "r445",
      "r474",
      "r527",
      "r528",
      "r530",
      "r531",
      "r532",
      "r534",
      "r536",
      "r538",
      "r539",
      "r717",
      "r801",
      "r1020"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails": {
       "order": 1.0,
       "parentTag": "ci_SegmentRevenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "TOTAL REVENUES"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Accounts Receivable, Net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccountsReceivableNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r48",
      "r1038",
      "r1039"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Changes in the Components of AOCI"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareOutstandingEmployeeStockOptionsNotIncludedintheComputationofDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Outstanding Employee Stock Options Not Included in the Computation of Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r104",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r259",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock": {
     "auth_ref": [
      "r294",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reasons for the change in incurred claims and claim adjustment expenses recognized in the income statement attributable to insured events of prior fiscal years. Also includes disclosures of additional premiums or return premiums accrued as a result of changes in incurred claims and claim adjustment expenses.",
        "label": "Schedule of Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Variances in Incurred Costs Related to Prior Years' Unpaid Claims and Claims Expenses"
       }
      }
     },
     "localname": "ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock": {
     "auth_ref": [
      "r1066"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.",
        "label": "Ceded Credit Risk [Table Text Block]",
        "terseLabel": "Reinsurance Recoverables by Range of External Credit Rating and Collateral Level"
       }
      }
     },
     "localname": "ScheduleOfCededCreditRiskByReinsurerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ReinsuranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r208",
      "r209",
      "r214",
      "r215",
      "r217",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Summary of Derivative Instruments Held"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r990"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Revenue from External Customers"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable": {
     "auth_ref": [
      "r913",
      "r1002"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about credit quality indicator for financing receivable.",
        "label": "Financing Receivable, Credit Quality Indicator [Table]",
        "terseLabel": "Financing Receivable, Credit Quality Indicator [Table]"
       }
      }
     },
     "localname": "ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Net Investment Income [Line Items]",
        "terseLabel": "Net Investment Income [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "auth_ref": [
      "r57",
      "r58",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table]",
        "terseLabel": "Investment Income [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsComponentsofNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails",
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails",
      "http://www.thecignagroup.com/role/InvestmentsNarrativeDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryoftheCreditRiskProfileoftheCommercialMortgageLoanPortfolioDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsCarryingValuesofOtherLongTermInvestmentsDetails",
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails",
      "http://www.thecignagroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "verboseLabel": "Summary of Insurance and Contractholder Liabilities, Activity in the Unpaid Claims Liability and Liability Details for Unpaid Claims and Claim Expenses"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock": {
     "auth_ref": [
      "r265",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the guaranteed benefits in excess of the current account balance, quantifies such excesses (the net amounts at risk) and includes other relevant, pertinent information as of the most recent balance sheet date by product type.",
        "label": "Schedule of Net Amount of Risk by Product and Guarantee [Table Text Block]",
        "terseLabel": "Account Value, Net Amount at Risk and the Number of Contractholders for Guarantees Assumed in the Event of Death"
       }
      }
     },
     "localname": "ScheduleOfNetAmountOfRiskByProductAndGuaranteeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r53",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Foreign and U.S. Revenues from External Customers"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r90",
      "r91",
      "r92",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r90",
      "r91",
      "r92",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summarized Segment Financial Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r151",
      "r157",
      "r159",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "terseLabel": "Share Activity"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r188",
      "r191",
      "r193",
      "r195",
      "r196",
      "r679",
      "r680",
      "r684",
      "r685",
      "r765",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r408",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r440",
      "r445",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r516",
      "r519",
      "r916",
      "r1056"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails",
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r408",
      "r409",
      "r410",
      "r420",
      "r423",
      "r434",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountAssets": {
     "auth_ref": [
      "r812",
      "r863",
      "r865",
      "r953"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails": {
       "order": 2.0,
       "parentTag": "ci_SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset at fair value held for benefit of separate account policyholder.",
        "label": "Separate Account Asset",
        "terseLabel": "Separate account assets",
        "totalLabel": "Separate account assets"
       }
      }
     },
     "localname": "SeparateAccountAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets",
      "http://www.thecignagroup.com/role/FairValueMeasurementsFairValuesofSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountsLiability": {
     "auth_ref": [
      "r814",
      "r863",
      "r866",
      "r867",
      "r954"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.",
        "label": "Separate Account, Liability",
        "terseLabel": "Separate account liabilities"
       }
      }
     },
     "localname": "SeparateAccountsLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Fees and other revenues",
        "verboseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome",
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceOtherMember": {
     "auth_ref": [
      "r1026"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, financial service, and other financial service, classified as other.",
        "label": "Service, Other [Member]",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "ServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r646",
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Employee Incentive Plans"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r252",
      "r253",
      "r269",
      "r968"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails": {
       "order": 2.0,
       "parentTag": "ci_ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Investments per Consolidated Balance Sheets",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets",
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Investments [Abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "ShortTermInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r882",
      "r883",
      "r884",
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-Term Investments [Member]",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsInvestmentsbyCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contracts, Claims Development [Table Text Block]",
        "terseLabel": "Summary of Incurred and Paid Claims Development, Claims Frequency Metrics and Incurred but Not Yet Reported Liabilities"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r81",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r314",
      "r408",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r440",
      "r445",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r515",
      "r516",
      "r519",
      "r916",
      "r1056"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesContractholderDepositFundsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsInterestRatesandDurationDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesFuturePolicyBenefitsPresentValueofExpectedPremiumsandBenefitsDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails",
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails",
      "http://www.thecignagroup.com/role/SegmentInformationSummarizedSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r37",
      "r160",
      "r311",
      "r349",
      "r350",
      "r351",
      "r369",
      "r370",
      "r371",
      "r374",
      "r383",
      "r386",
      "r405",
      "r478",
      "r570",
      "r647",
      "r648",
      "r649",
      "r666",
      "r667",
      "r697",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r732",
      "r748",
      "r851",
      "r852",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r369",
      "r370",
      "r371",
      "r405",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r19",
      "r20",
      "r167",
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Effect of issuing stock for employee benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Accelerated stock repurchase, amount authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r23",
      "r24",
      "r99",
      "r938",
      "r979",
      "r998",
      "r1036"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "TOTAL SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r180",
      "r181",
      "r197",
      "r311",
      "r312",
      "r350",
      "r369",
      "r370",
      "r371",
      "r374",
      "r383",
      "r478",
      "r570",
      "r647",
      "r648",
      "r649",
      "r666",
      "r667",
      "r697",
      "r726",
      "r727",
      "r732",
      "r748",
      "r852",
      "r853",
      "r979",
      "r998",
      "r1036"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Decrease to shareholders' equity",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity",
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "terseLabel": "AOCI"
       }
      }
     },
     "localname": "StockholdersEquityPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SegmentInformationRevenuefromExternalCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r733",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails",
      "http://www.thecignagroup.com/role/DebtNarrativeDetails",
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r733",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r733",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails",
      "http://www.thecignagroup.com/role/DebtNarrativeDetails",
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r733",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockDividendsDetails",
      "http://www.thecignagroup.com/role/DebtNarrativeDetails",
      "http://www.thecignagroup.com/role/DescriptionofBusinessDetails",
      "http://www.thecignagroup.com/role/InvestmentsEquitySecurityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Disclosure of Cash Information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r830"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r830"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "negatedTerseLabel": "Favorable (unfavorable) variance, amount",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimExpensesCignaHealthcareActivityDetails",
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesUnpaidClaimsandClaimsExpensesCignaHealthcareVariancesinIncurredCostsRelatedtoPriorYearsUnpaidClaimsandClaimsExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SwapMember": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A forward-based contract in which two parties agree to swap streams of payments over a specified period. The payment streams are based on an agreed-upon (or notional) principal amount. The term notional is used because swap contracts generally involve no exchange of principal at either inception or maturity. Rather, the notional amount serves as a basis for calculation of the payment streams to be exchanged.",
        "label": "Swap [Member]",
        "terseLabel": "Swaps"
       }
      }
     },
     "localname": "SwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r35",
      "r364",
      "r474",
      "r717"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityOtherChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in temporary equity from changes classified as other.",
        "label": "Temporary Equity, Other Changes",
        "terseLabel": "Other transactions impacting noncontrolling interests"
       }
      }
     },
     "localname": "TemporaryEquityOtherChanges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r447",
      "r448",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r461",
      "r462",
      "r565",
      "r569",
      "r688",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r995",
      "r996",
      "r997",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails",
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails",
      "http://www.thecignagroup.com/role/InvestmentsSummaryofDebtSecuritieswithaDeclineinFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Shares of common stock held in treasury"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareSharesofCommonStockHeldinTreasuryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r36",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r20",
      "r160",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Stock repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails",
      "http://www.thecignagroup.com/role/EarningsPerShareSharesofCommonStockHeldinTreasuryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r36",
      "r169",
      "r170"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Less: Treasury stock, at cost"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r160",
      "r167",
      "r169"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Repurchase of common stock",
        "terseLabel": "Stock repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/CommonandPreferredStockAcceleratedShareRepurchaseAgreementsDetails",
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofChangesinTotalEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r924",
      "r1064"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "State and local government"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r802",
      "r924",
      "r1064"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "Federal government and agency"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.thecignagroup.com/role/InvestmentsGrossUnrealizedAppreciationDepreciationonDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnearnedPremiums": {
     "auth_ref": [
      "r813"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails": {
       "order": 1.0,
       "parentTag": "ci_InsuranceAndContractholderLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.",
        "label": "Unearned Premiums",
        "totalLabel": "Unearned premiums"
       }
      }
     },
     "localname": "UnearnedPremiums",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesAccountBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy": {
     "auth_ref": [
      "r829",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]",
        "terseLabel": "Unpaid Claims and Claims Expenses"
       }
      }
     },
     "localname": "UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrealized gains and losses on investments.",
        "label": "Unrealized Gain (Loss) on Investments [Table Text Block]",
        "terseLabel": "Gross Unrealized Appreciation (Depreciation) on Debt Securities"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UsTreasuryUstInterestRateMember": {
     "auth_ref": [
      "r1032"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate on direct treasury obligation of U.S. government (UST).",
        "label": "US Treasury (UST) Interest Rate [Member]",
        "terseLabel": "Treasury rate"
       }
      }
     },
     "localname": "UsTreasuryUstInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/FairValueMeasurementsQuantitativeInformationAboutUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableAnnuityMember": {
     "auth_ref": [
      "r950",
      "r954",
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract providing periodic payment that varies according to investment experience of separate account in which amount paid to provide for annuity is allocated.",
        "label": "Variable Annuity [Member]",
        "terseLabel": "Variable Annuity"
       }
      }
     },
     "localname": "VariableAnnuityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/InsuranceandContractholderLiabilitiesNetAmountofRiskandAverageAgeofContractholdersDetails",
      "http://www.thecignagroup.com/role/ReinsuranceEffectiveExitofVariableAnnuityReinsuranceBusinessDetails",
      "http://www.thecignagroup.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "auth_ref": [
      "r190",
      "r194"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "terseLabel": "Maximum exposure to loss, variable interest entities"
       }
      }
     },
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r188",
      "r679",
      "r680",
      "r684",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/DebtDebtIssuancesandRedemptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r390",
      "r398"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Total shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "auth_ref": [
      "r83",
      "r84"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).",
        "label": "Weighted Average Number of Shares Issued, Basic",
        "terseLabel": "Weighted average (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Shares:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/EarningsPerShareComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WithdrawalFromContractHoldersFunds": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a segregated fund account during the period.",
        "label": "Withdrawal from Contract Holders Funds",
        "negatedLabel": "Withdrawals and benefit payments from contractholder deposit funds"
       }
      }
     },
     "localname": "WithdrawalFromContractHoldersFunds",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.thecignagroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1031": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1033": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1034": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1035": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1036": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1037": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1038": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1039": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1040": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1041": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1042": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1043": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1044": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1045": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1046": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1047": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1048": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1049": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1050": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1051": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1052": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1053": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1054": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1055": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504495&loc=d3e13193-158430",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1056": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1057": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1058": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1059": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782768-158439",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1060": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782768-158439",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1061": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782768-158439",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1062": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1063": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1064": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1065": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1066": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1067": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1068": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1069": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1070": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1071": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1072": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1073": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1074": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1075": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1076": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "30",
   "Topic": "405",
   "URI": "https://asc.fasb.org/extlink&oid=99384745&loc=d3e23169-109297",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907419&loc=d3e10037-110241",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907419&loc=d3e10037-110241",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=123422226&loc=d3e11019-110243",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=123422226&loc=d3e11049-110243",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e13051-110250",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21459-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "83",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126929950&loc=d3e34841-113949",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.5)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5,6,7)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21409-158489",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB Topic 5.W)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "((d)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)(1)(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(m)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(n)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5066-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL120267963-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6480726&loc=d3e6691-158385",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6816-158387",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(6))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(7)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124509262&loc=SL117780254-158436",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14754-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14784-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(6)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14937-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782768-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782768-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782774-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/subtopic&trid=2560295",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6484091&loc=d3e19268-158472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "https://asc.fasb.org/topic&trid=2303980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r893": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r894": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1404",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r895": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1404",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r896": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r897": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1405",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921830-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921833-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921842-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "80",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504731&loc=d3e11522-158419",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(h)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(h)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783743-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(j)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783743-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(k)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783743-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819541-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29G",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819547-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99379264&loc=d3e27758-158548",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99379264&loc=d3e27830-158548",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505678&loc=SL117422397-158474",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505678&loc=SL117422401-158474",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r959": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r961": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r962": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r963": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r964": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5111-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>113
<FILENAME>0001739940-23-000016-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001739940-23-000016-xbrl.zip
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M!F<;O.@:#Q5"JTE< /T3:C%%<H,:..><SOHR3LD&9];/K'\OZY7KD&*%["M
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MQ&G-;^XS>\?B[I0MSA0J+B%#P4"H!#)%$#3C;WY:\YDS82ZA#BB!BQ'8L0E
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M#UKE:ELMR8CQGTCEB$_2_@=L0YUCIICTK^9C8/I*J]C(2(9D&TZW\O!H[7_
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MKDI;%I/=R90B8SB)0".G*3H.5W?1,0G^@X@23!F_^XIN]D/L]7-17_&NLJ%
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M-Y$DN5(;#$,<_N]*QKT_KIE$92.5C2S>>OR\C6SP^OXGS[0+!%-$+6<@2V]
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M=-9N;7UIGT/4^'&+M^DNW&^;@[9 Q-X "]D\>]_RURV$4&X8I1)YKBCB*@I
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MC$:2X -WKM+8VY(PLP*$X(51&@2+N2IJU?,6C=-(44.UC"QX5J4-;V,%LZ"
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MN:YQ2K#>>\*(,HC:W#7$1@P<%M"6&$^B51XT>I[E=Z40; Z?IP3KL(U.IH3
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M-*\V$V_5V%D! O9$.)YW#UF@X+QR99$TN0VPP20$23VKTH:WL8)94&"("I$
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MVA^W#^%>C_9:[[IPG5ZCM<OR8-]FRY-&*Z=\ZC@7-'(L<;0>Q22*B?2@L$#
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MFQO;_0P.XZS<*W>RA'N\M1SPL#$[&JW X=[@<"G)MX4@7U]&]15(_#)(G,T
M">&(BQ _(.,5SMTO,3+6!82QB]@K:1P+]P")>VP^SBM3GWZ0NLJ%_3,S;ITT
M*X=?9.Z!RO4'1>+]9!2+=X$]3%HBS^CM.!@6W]4]RU_^I0-?#5];Z\.S#3*W
M^-P9%=2P;_L^6RT0QMRA*+]Y-+;]8(=A5,O'=SOAIAIM]IO]?6;6ZVM^\QEL
ML12YT-%!['8OU[;V&ZQ8D96<-"3[<8[P]V_$U8:'F.\VQN,SLBRI65C[,G5.
M8X#'ZH[*6\'X2X?%OWS"Q"9"B4<@S=QNWQBDHZ<H2$R%DS+%X!:SW?Z==U/G
M=_IDK=@>6#L>=KJ3/N143_J0O[C<.'M3[&T!M)WT.Q.='QW8883 X3L[2"$Z
MXQEX+^ZY=<QYHBDU),]!Y=RK3YN%^G.J5P &? =BD-'_KFPVWLS8U2]*28LB
MG)WBJYHGXP)^ 8>_MX[^20^%07$:*E\02!WP-+@6?I:V4B>?HI(V$D\@WB :
M\9"K=F.>1:F3=<;*/.MSY14UXH56] 5E5Y6YEZO\JC99W4M0[HQ&)W'XKU&&
M\5S?.RI*H[[$8:P-OJ[*]);.I1Y_.T;L>##QQA<#S3['J<%B7[=R"K/ 7S]B
MW6C0/1G?_)$;&<[-8\I^8ER:OAJ7=C#\&D'L1^2&T1XAFR!@>&F[7^S9* ]E
MFCU33=%?FZGV8YHPK_/KM#B*\I^-VNO-MXVUVMOMYNZ'GV0Z\WV$M;_>;^3.
MYJ^;C=9&HW4UO^UI-QL-6158_LQF(^&KA#W\9J-2JTSH![^L6*7X;C>[:&F0
MHJQZ3EF06<TM5UY]L/OQ@3+XM]5XW_B *3WB _[;/NTW3IVU!D\)//Q@F"G/
M?]W%8U "R[*VW:IM_OL/>QW8?TKM[EI]?W&)R=D RE>5^!')K)9M:MG>;#;6
M&J\WU][7@*4VM^MKK6(2YD^LXG<X<V&3UPG29'7F 6VS[NYQD7/>X')#:O41
MM736-_ZJEE(M5UYMCF.O1E9K;ZYR5D4/NDE=^F^[?7L2.N.89\\\+?I<]Y./
MCCQ+M*;LAL5:"-N<Z5[8#X^O5"O\[0H;6G0V+$[;%94(WQ@L!-VY27XO5N9:
MGL6LS'6I5UC_T%QSTGX8#V)_E(^*5,9;MJ7EE?$N[PHS3*X9[U^V:W.'L)V#
M&,>CRE#+LXRB,M1E7F'U8R];% :,<MU :S"&('?C_TXZX[/*?LNSNK*RWR5>
M8<)^;+]V=%![TQU\J5QNB19452:[Q"M,1=$O&.YG/"A*/;ZSWUGYY,IVR[.R
M^L>V6^T^5;M/OZ9E1EUL/M'56MWV[7Z!$876E?!)_E76&Q_5UCLC?S(:Y0K-
MW)AAK6^[9Z-.0;N^@CA@>YA4PN?W;,?127?"S)K'<?+E%;J79]'9+<F0"MTK
M=/_E"AA^@>]LM;:53[ETQD7-;@$@\(ONY=\S_G0'HY-<-+SF!B=C< ?#HSBN
M;7=&1Q6HE&BY!:Y@I8*51W5>.30I4(6O9DXR'L(B%(CR83CP,600J2"C/$LI
MR#(CQ@+"P-+4UZK+LNBJ+KILZ]9L_6=CNZJ)K@C& GHE@AG^6A3]/N[;[H1:
M%+UV*VY1IE44=)G)1846"Z%G[!(MUE:+A$7MC?7CP;!"BC*M8(44%5(\KIYI
M^G6W:[?_S9S6'=N=-$N85*1].](DIS5V1\7TP L*4J%*>5:[PI0*4Q[==UT>
MX!2KM6;11FNS/VEO Y>KL*)$JUBA1846CZYGY@(MY&IMX_2@XSI525ZI%D_<
MZZ2HK&SKZ9:' ^/;R7VK6KO;&Y51E6C5Q ]/<"Y^0]RU46Y<&VK _F*G_Z*H
MQ%ZY:@4*LHC#HD(;9)-[U/8&PR*B;.6";= 86WL[')P<%\$F^(/<D_%K$??H
MQ(TZH6.'$([>VJ*OZ$I7_A9]N7//K[?H$_SG6O3-IV7=!SL<US97'[O7:7'%
MEYTQ0)6_PUW=T#_INA;>;6&+QBASE/.D!_+%OM+"R+FXJZ]RWFFMM3;JW_8L
MO+>8<T.+.Z+ET_9#!#-<Q1-3O&]#1$56C1!W[5PXP\=?/D/AH!;EG7=^?$)7
ML>$_U;CQQZ^QNPOU?C=[Y^:5#R[7F4R<T)5K:GYI",?C6N%M:]GN_WQ8*OA4
M[=YGEZ9<XQ=//I!S]EW=H6_2?4\K7JQHGL%^PW+>(?OQ<&9O[G%C<Q[-HN^T
M9%<MZ!YII,U"8O.,Y2S5HK4@"(NU^J 82[U1#-.HVZ$_J#'RXBD:S#[.(]_(
MJV;'P[]M]FOP/=U\..I%+9[Z"&9X'(>3#NDUV\NC04:_WV'&T&+KZ'VPL!3:
MFP<-W&%5'@3Y?TID/\$&'J<E^IWE21\GYA&K]"YEJ]-9B2QO1%?U=.3@["CF
M"X#]DM_OG,5[!-:X*$:]%#?\G-]Y&X&U_F@?.'H_H M[C#+BZ/^\$9I^!9WF
M #_;\7/LG^2#0<OC:']IS>[BEDK_!4]L,ZGX9S'-8C8]_0 LM&?]61Y;5VK[
MN,^:X-I"K<QLP/KOZRMQKR><TXB1NSW:C3/!3D;AVD PPUC@QBIOK>!<),.$
MH8(YX; 3P-!G#L;[.AD,R<O!8"<CM&_M\<L+/_!F..@51T?A%CYVQ@>O3T8@
MCCC<./7=DRS&M=$HPO]#RY[>;5J8G.^TL+-F:_/S7O_=P=[Y<:=QN'>TU]H_
M:],-WORXA>NM[F&[M2D:Z_Y+_?Q-M]E:XWMO_SZJGQG<_OANM-<Z[C37W_7@
M>[XTWM;S/%)<AS_;AV^.FF\;W?K;3=K,]]W;.F]W+C[SS[L#UPO=9F^3UWMM
M>*8UW#X_.FNWMKZTS[N=^L<MWJ:[<+]M7F_5Z=YZH_//N1\WBMFE&^-&:XO5
MUX_X)QF9D"YBI&ABB$OGD*/1HR!]L#X&HS5>><7H"\+YU*"Q1PDH[@:=DTEW
MOV*EV;7=TUKOY4RO?>5U?UEBR)R](DL!F3^<V'P7R*32&)\\)\(ZKJBRC()1
M1>:CL9@E5T FO81,6D'FXD/FV37(=!)K"TN'.',<<<(C<DZ"=N/ HE(DZ%S4
MPO +:=049"X:;LTGKBT31Q_&7N>D5UIJ?O5.>K]EF>ESRDQF?VK*\X^0^5(S
M-NRP'T,CCBO<?3C<W9^FJIA3F3PLCR#&(FZ$1C:DB#3U@ENC!.9AY14A+S 5
M)::JLR'R4:GJM:^\,;53<@CY97*'.7?.B)B<]MQB!W_A-%*,B262!'MO<E=!
MR.-"R'7JIJD+)." 6# *\< ,<@HKA%D0B4>K(TT (?@%!,6_2MT>W8ZK].HM
MEOTF7ASA'10'\\J>9+T3#-\U>U!F)D=\DCPEYK"%X%HF39+2"1OEE-=!A"HM
M62Z@/IKF>IHY8> ?Y)G5B"L :NVI0-Q9R;#R5$<',?8+K$B)J=[B9267!6-^
MF>H)AB5GV'!/%:><NH1%T"$)D223PE1YO-)AS'4R:"CW+&B'M/()<9OCR1@C
M"DY+X/3<\.!77M$7@IDJC5?V-![$5K5._W,<C7.Y.?SX7:GY8O&[*J<WMYP>
MJ,GFE99,SB-40'LOH-WX\KZU.ZX7A&X7PV=$<^T3=D%C&272SE/$A0_(!*-1
MT,F*F#TJ _VF:GJ_I#QDKLK;+2R9>_"\7043#P$3_CI,, F1?1 4>6P]X@ ,
MR&B&D6)<1^%ME(JLO.)DNA)ET6QU/KFY92D7;H%>OJ]M;_R]T=C=V%EJEG;?
ME5LT;%X\"G=9:UY%SP^(UJ>S2)WU7&JO$)-<(JY41 Y3@HBRWDJ3,/$2T%J^
M$*3,O.XGL/4I,GB_5J2_S)"T>'2Q@J3'@:0I NE,-())@2B/.E<S4V1QPLAZ
M):ET F!) R3Q%QC_\O[N?'&A.H_V*_SDK]B/*??:RKO#\?0X]D=+L"^\3&?'
MJL-I\W:85X?3OE90P(4^=WR$)QZ-RV\N)=_B7+S(ZS6H13.]'0S":*T?=B;*
M,MH9=$-%?!Z0^)S/B,4\\XJ+B$&GK$,\ OO1/D04F,*1*ZRHSV<2R LNIC<S
M2Q>+5043SR!HJM#DJ=!D*HRBR<.Z!0IAE$DY#\^1DU@B[I@1DG,I!: )-2\T
M855I1-E+(^HQY#N9L+IOV)Z;!$G+$Q^5?!MT\0C?!PB^_-D!0'(<7H;4@-6O
MN[;3&VWV_<EP6)UJ>&C QC/HGPK1N2 $PA8+Q(T)2(ND<QJ,>A*\<7G4LWF!
M^73:JSSLKZJP>#[LKX*6^4#+=$U&"D)SC9%,'A@@XQ)9P!8DI)%2ID"P!&>K
M7U!%JZJ,LN?\=F(7?KG_HK8/)C<$3IC9H V]3K\S&@^+OHW/@PZ6(&)?/#IX
MH3UO)[H#:+WVG>9L3!2G0NP'1&PR@PSJF+"4QB!#,$.<$$!L8CT2B5 KM,")
MY)9.+P33)2:#52KP^9#!"ECF 2Q35-!:ZBR5"5')(,J,@2"3(D6*&Y<$]EY3
MFX&%JNG^&XMFW556\!9[7^L-X%[.B[%N>3B']?]WTLGCLCO]L>WO=_+@(#L:
MQ27?""Y!\+YX1/!;W6FFS2N%62OTI8+B^T$QG<'QG!(Q)(.!W@6(RB41R$5"
M4-)"8"6]EQ&@N-R;O56Z[_DPO HQ'A@QIL@;+$W0D2A$BSX:L.3(8$80$<I8
M;41*C&?$F(X)%\ULJ[-5OWZVZJ^-QL:;S=9.;:VQ7MOXY\-&8Z<Z:+70F+UX
M+.]R6^;](+<L@:C\(@ZOCCD\)):S&>S/<FJDP081AQ4"S,;(:L50[C,MO:7:
MV<DQ!X&G-V7*0P"KDU<EPZC%XY451CT11DW7$'JM570!T>0(\$UAD*,J(DM-
MP,Q&R4S,9_E?:/++E+,ZBO404POG0%\FK3-J:3CHU0;'<5C$?\\BH7BWY5LT
M@%\\$MJ<:$U_?Z)*&><K:'] :.>SDH\AN&1</E9+*.*.!F2,UTA0R[W",GB;
MNSF]P&0)^K#?&6>?(C'Y"_-NEQ:3%H]T5ICTZ)@T13>%- IT&)BF#/ ?&BRR
MQ'AD>8@.N*9/(1]9>4'T0R4XYP$,50'C+6:_F4=LQ]'5H96OQUF6FE26H*IH
M-G7\[6FYXPB>%WZ: NRL((U!?_ ]<%_5%57P?!]X%K-Z17&BDL<>!9/A&5.,
MM& 2F>0DMBXF)M7**S9C]^GWQ:D9JBH"?]IV'X!C5;;[-+8[?0(D1(LM32@X
MC!'W7"#G-47,8$)H%(1AE4\#3]>:+)#M/BIS6FSB\-S>62U6B=[YU)6TH?-Y
M;O,'AA%NYKPHH;T:1- M-J:N<+*XO058EJJ0=D%"%-]YN7VA-E\[CK^UG?XD
MJU2QFWNPF\VS&9$)D!OJ$F,HQ6@1IU@C"%$\8IA[2@Q-3/"55S/& =Z=W%2%
MK,\I,*DL]F$M=BH>(90;1JE$GBN*N(H"&0.V:PW\ LO@&,Z]SNATZ=,"F6Q5
MQ/H =0,NIL$P7@QSJHWMZ?,XE5[:^K#%*Q_XND-W.9BOTS\!\36OBE'^*G1L
M\KY6UK"-T_'0P@IT^G9XMCF.O5%CT,]W.1P4IU0OMR"J+;\'] .S>EYB0K0S
M*2!)34!<2H=T8@G< G5:<)Z\9"NOR N)EV!&:%4$6Q:06[QZA KD2@-RTV17
M"!F(<(CKE,MH#4%:)HT48TKYY*1A*H.<D-,S5DJ%-.5*(\[MX-9FXW6SOE%K
MK?VSY.>U2I!]6%0Z"PA^L?UY<?RA N+[ ?&L%IO6AQ!UPL@IG1!7UB/K-$::
M::P(K XA+.^"+D'):Y6H?#:DL(**7X>**<ZFO2$&BX2BLQ'Q2"C2)DB4B.62
M82N3%[G8Z9>[)%59RH5F;).9\TL_:+[L ?OBT;@/PP% <75NX(&Q>E:S3*$,
MA-A4(.(3T#HA(G)$:XBT(P.2AREH1XZOV8R!@>4A=E42L628M'A\L<*DQ\*D
MZ9P?II8I+Q#6$&5R2R(RC-%\OE(HS!F5RF5,HN276ZY7.;\%89"S#?Y]'(U>
MUK[RR)H=CX<==S*VN?WF>%#K?Y>5S[TYB[3\<F^#ER#>7SQ."4KT=1]H[1LU
M:@UNVMJID/P^2#ZK3:<A7 FN.&*)!L2U$\@E#113>VJ<H9%)O?**55TZJYQA
M&3A@A2&/CR%3;#"*Y*QF>>,A&L0#M<@$'E$TT3O&.69YIOV,5AN+9LA5,O%7
MN,/.?]:V-_[3?+^^L;WSKUICHW6Q%5Q6IO>XH?NBK=Y_/UI$=@_;?-:,][/M
M=">NZO6@UQOT=\8#?S29+S?ZRXXZODIK/* CF]6U-)ED4Q02Z1@H.#*9D!8N
M($N9B(J&J#DITAHS2IG*PX>7*=6ZK!@]>Z&7'Z,7/:*H,/J),7HJV'"*!(9-
M0,9;AKC'#EEPOH@ZJ:@2 =-0I)Z)J<I-'[)I:]F"D0,[C!>&^:]:_VM^^C@.
M:Z/\8EG#D@=?S1NS4\OT!55?NEM\;.&]RFH3]UF'!6-Z#Q2-+R*9NW_ _2$.
M"^!^V,";7N=T&W;8!V&-+K_N@KE=D#-<D;.[D+-93?02M]Y2#I0L2HTXQQ8Y
M32/2GC*+E?8!IY57?)56<WT?LHM?B>'O@0+=182_^\>R-\#?+\:T%?P]$OQ-
MQ:8J&BXX!*,B!($ _0+2X+00X2$&B$TA.(78E*VJZ4K-1<.@N4:?DQLL2P Z
MV\[7.]V3<0Q+QZA_8J46S.7\*N/^&0DLB$LJ#2._L)[**=W+*=6_S.#DG"FB
M8DPHQF#!*3&&M*8&":*)#C9%9G#!R7F).?G/^8\G'(ARZRW=F=.7'X!_E?.7
M&(!+$Q-4 /RS #P5%23GB15&(1ED+H\C"FE&.(K4QNAE2$&F(BI@#SOW90XH
M^ !1PQ]%N>8#FZ%8I9>&6%SR96<,#^5_;)I$_,^?QX-1)Z_$RV'LVG'G<_PS
M[T0@NIH-^[J ["CF"ZR\^HW\_KBN\UX/L?*JE@$F#0;C_F <RVG'>_\<_'_V
MWK6IK5S;]_XJ+LX^9_>J0D3W2WH_5+$"Z4U7 [F03I,W*5V&P(FQ6;9)0C[]
M(TUC DR38+!AVJCVVC3!]K2F-/73?PP-C8']\=]=^]Z<ICE)=X_3]3;_3.\_
M%.D[ONV]WSW:^?0YS[GO.^_?B9W-H\\?WK_^_L_W=WAOWY/=_<-OZ;K?=S8^
MZABM)D$C!P$C[B1#AB=.*A.BCS9("C%OXX^ZZTTO#]W1<'CR_-FSKU^_KGUS
M_<Y:KW_X+,&6/>NGEY^-W[NROG&<YN-PT#JR7W+R1^BV<I"Q323-9V'Z$#O@
MAZWA$;1LZ)U4L._%UK[M'T)^S_;Q2;_W!7(^UD'^0'[CAO?YFOGP3.SU6W_U
MNH=H\W24%JN54V5E6 Q:[6XK*^VUUEN UFX>9SJ^0GI3!8"J&2_;7=OU;=MI
MO<WM&GU5OG \[>="%>E"HPB&=/FU"DCCN[N0@Z,<X'/,4S[EX[V?NS/UTG%J
MS%GNIWS[@]O?_6^G77L:VNGU?[72TM=*MY2/*1WVT]M.;'^8ARA=:0"MP<6'
MUFJ=,>Z&\Z8)GNZFCH^O[3 \&B_[ESYU#FO\XR/6I6:G-?C&CQRGIZ;=O< \
MOBKO/.0(]UGKF>I;?CTB[%JZ^$L_\PV,"$0TQIPP1:GGP+ 3S 81N.3>.@[Z
M(\U1X^>?.NJ/;^'$'@)R?;"?D8WI#I_;SE=[-EAY=K5O4L=<'HCK?3CJEO7_
M<?UGZY/:^M-NGGFGWJI/6^-VCH[673PWU5J?VM"Q)P-X/O[E]_$"V^Y6EZH^
M]/O5>Q'U-:QZ@$8O_^BS-3SJMW.'WODWG[^\5KUT39J,7E-T36E]X\MXC?S?
MQOB[IO:,_?KV"5F32MWV]J=XC0EQIT_^JK'ZYI?G/583'<;DTO&HGTC:9GB%
M:V2\(4=>7I%2*VSKCR3=3RH 75FA+JU+:=EYD1:U/AQ!=Y 6C];VPZ1J^97W
M_NXE7N<Q8<T4#9OPA(S6R2:Y8]^-U<AC#_0C#^="#=K^43_I[IWTOJ-!:ZL;
MTDS>L7U_U&)D]<HXWK+/F^&PN[T0'Y6UV.ZVTO=T<L+>6B6#15G?[T2\6S^C
MQ^T0.O XSVBV#V\Q*C/A^YVZ[%=UL<87G[N9<^O^I*VY.'HN^:M^TH+[>Z?F
M7,WKJ0>A+WYZO3N/5)/WGV8; /"K>V_(SE/S3K\N7KZNPW/7=8\?[.^PW<T/
MQ[O?#\GN^QU\L'](#]Z__'SP?>?KAS_>G7UX__+HPZ=W9/=B"ZI'/WP*QZD-
MWW8V=\CN\6M\\.GSU[W]=]]W/AW@G4^'WSZ\/V 'WU.[WE[;@OJ4OH<>X-U/
M6U]WOK^C'S;?M/?V-\3N_L[9[J?79WN;+SOIVI]VZ-]'_WQ_/=RMMI^VAKO[
MK]G.YF?^T6#K7!0>*2<CXD$09*51R&E.TF/AG-6P^!D$IYJ5#[OY/X64FMG2
MV##FSG;/OQQH?4II$A<$NV?7L*NM$U8J@:@U!G%.(K(L.B1D\(1*;JFT,TJ2
M> ?=W*Q=_R><-F>OVG7U5QR]YV=5?\NUE_^U6AU?S7N0]MNBVA$S']@[G2E=
MM"\HV4=O4;/\M'M1M=R>I#GDVZ/0B-\"_/C7OUKI+P/PI_WVL)V^WG9#6B3[
M[2^5VZ0D(RW&Z8_:R!60KVR\34@ \K+7?YODT=N+1VJC&S9_/% ;X=/IJ*YR
M>D3WXK[]5O345'KJH&[&1JIDDK\.N:"KPZ4.66P]T@"12V,CMKG0G%F"./:2
MJ_2!AN?1"[$7V#0#-M>--R:\818\,J  <<8X<EY%!!J\<<9RJ>7*NN;UF.TG
M7\)]P?1C)P?4AG% ;;L[2+]V/502T9^'UXX2";4Z;>O:G9&"/ :;WEE%ZK3L
MQ01<;B5YVW0"C5.2TV!^!E)R N9?;/]U_O"<)9J_/!VF9^=5L@O]V7E9NX3T
M'=O_#,,W[<'G\[]M=P?#_FE^KMZ>I"^(;?^B#Z%=O>4/V^Y6BT0.@GT#OF,'
M@_R.ZC'^L2*DRY;U8-KUP%\2GY]3&_VWC]@%0K712 &GB!-JTLJ@TR/ I+/6
M"6)U6%E/S\(]UH/F)199%BHTQPM?6+!X+#B[Q@+B,=>4:X1ED(@+JI"1)@&!
M"N-$< $3LK+.1;UH1LGRL8 .QJ0 NX/.2!X>IIDV&/GE85 Y%6.OGS[0;273
MK ]=WR[.Q,>&_<(X$U^.'IT7HR?G;#\_9Z/695+_>.KJ]GVZ1N<T#\ ^')_T
M^K9_MO6?T[2<%+;?6>>=V_U@@_0&2Z2L](A'E]BNM$$A*DV *J,H7UDG2Q H
M4WR,Q<=8&-0$!M5]CPX :XF\!H8X#@ZEQX CZ8@Q6GL?0:VLR^)Z7&37XZM>
MLN=@V#YW(;J1E3>X\#&>7?(J+K6B7 #W01,4Y36LCZ/Y?L;V5_D/%<BK=UU]
MXL[="J\ZJ0/*!M(](;[U;4+B-4(Y<"H\LL:J)"63GM3.4R2!>!N%H<;ELGAX
M@:5D\5@NL\>R(*?AR*FE&F,A!AJ$0=Y+@;CB&&G,/,*..,$%\<[2A)Q[)QI;
M4L?DXH443\;$I)#B[+)<JDCB6_@*[G=8IG&"\_%WL7]"_N(6F"W>SR:5UPC"
M>N<T<A&[C'=(OSF#G)(NJFB"=2'AG=QG$_IQCY+,J0[4,K-B 9V.A14S9\6$
MHNPN"<'$"NMCS+4H#-(\8B04&,$$)9:QE77.ZM'2B\**<NSL/H#8[PUM9^*Q
MLZ56AC.I"]PX9?A(F]NWQ?NK7K_:0QH.^VUW.AP5T-WM=:OPVEXGW<_A=D[C
M X/AS4M".:L\L_7B^P1M*;F@1IJ TI)/$3> D?,^HF 5!J<A.$%'=77%XCLL
M&Z-N9W)@=)EYUP0_Z./PKB!M2J35)##W$C.K">+2,\29PBB-O472QJAH4 )\
M,I>5JA>C7"BJS$0'C]\RGF:T0LW<T]TT1#$^3-'M^1;$;L[5BV%V'RW_XN9,
M("U[:47)]0VZ5]:4JFI!7E06/P1YF;)XE#0ACRT7?^3AK,V@/@2 X^I?2SN9
M%CRJMCDNCW$$1'J>+IW2OZ+RWUP\3Y/U?M'UT^EZ.FD;+$KBI-,H,!P0#QHC
M1X)#,7)@*H(R@JVL3_!L+XZ?HL3H+[]#H=#D,6A2\Q)(89RB!!#+&1HYSHEQ
MHW'(&D.]L8QX3ZN*5C-)T=AP-\ R1]S_1 7VJH"I)RD %R 6=J$$8 )UOU![
MIM1F$S0@)2;D='"(^)@TH&48:1(MXFF8(Y;$^)S3? FVJDIL_=.6@(4G\^!)
M306ZX"1+Z$!.64!<\X"L""2I0.]L%"R"S<FZ[YVI>TDCYQ=(!MX4'%]<@XMG
MS#='&?KV\VL[^#<%P%Z-9(KM;Q#0=^CW"L6GHSB?%,3$@E1$*.03SQ$73"-'
M(R"PT0E/A<?:9"&F*:&_+[ V+.[!)Q9-?VNV%(9,R9":$M1@0_I_@Q27&'$'
M$EFK)%*2:Y?@PJ7%*^MU(?CDDV\L7@#&M)'Q3R?^8IE#2ILC&L?F_P22CV-*
M;Q-#6J@_'?7%!.5HI/>: T,B"HVXLHGZPG/$+,?<&6\#Y%V@>DK/Q1&-)?9]
MP4#5/#]E =5#@ZJ>XL-*3P.G"4\0DCSE"NF8Y"D-@KJH.;51SS#%QR+'M-\U
M^GG4P.L!T(LG;R<+G;?_N_%FZW_W_MK<>O/VOULO]G9>I7]N[;[=_GNKM;V;
M_KVUJ.KU88:W885U9UO,_+Y]TY"5<Z$D?CG:.KLE<_OK!&W/%2?1.8\DCQQQ
M+R@RP>4(+\8A+8J**%P=;15+D-9Y9FO8 V9UN4=C[U@_?;G6@-D65U^2-6"A
MK*>"^:DQ7[.,O,0T,,)06H]%LHPH(.ME0)KPH(@5)(A\W%?6@\*6A[0SL)N>
M52;\C">G6*/CZ5E=\GE[F&[*_WS"$O%_?S_I#=IYC)[WH5-5N_P]=RFB:WFZ
M7^\@.X!\@97UW\B_YKMP3W43*^NMC)W8ZPV[O2$LY@3_\,\1]L=_=^U[<[KW
MZ>@H?1?>/3Y@>YOO2&KCT=[FAZ.#]V\^I;9^_K#_9R==YWAW_QW[Y_L[O+?O
MR>[^X;?=S1V\L_'1<BPQ6(\@"D!)DV5?JTO3BPD!#$MP#&=1/.JN-[WJ7/IP
M>/+\V;.O7[^N?7/]SEJO?_@LH9@]ZZ>7GXW?N[*^<9QFZG#0.K)?H.4 NJWL
M>+)#"*.0GM@!/VP-CZ!E0^^D6@)ZL;5O^X>0W[.="-W[4F6K'>0/Y#=N>)^O
MF3=XDE!O_97K16Z.ZT6^Z(TJ1 Y:[6XKFP)KK;< K=T\SG1\A?2F"@!5,UZV
MN[;KV[;3>IO;-?JJ?.%XVJ]"D]K=D3V0+K]6H6I\=Q=B]%EH?UG_G_1C_& ?
MI_:WNQ<HPI4D>NPGGU:;:;FG?=Y,L]VSW(6Y9P:W[YC?3KOV-+33Z_]JV7ZN
MREGMLAWVT]M.;'^4S?0(!M :7'QH[<9^.F^:X.ENZF3YV@[#H[%.N/2I\V[%
M/SYB76KVZ?#FC]0'Y#+>/62'Z*R'J/J67[.(7^V=RS_S#8S@1#3&G#!%J>=I
M2CK!;%H]N>3>.@[Z8S)]5\:?.KI('G%B#P&Y/MC/R.92=,]MYZL]&ZP\N]HW
MJ6,N#\3U/AQUR_K_N/ZS]4EM_>E;JA^C_=F+T:M6XM2]'7LR@.?C7WX?KX#M
M;M5)U8=^OSIPHK[(5,,X>OE'R]?PJ/7G/L?S;SY_>:UZZ9JJ&+VFY!JA],:7
M\1JY\;6?79:D!I&;/_JSR_[\M03H^33V=GTPT:]+?FP!-<(+6YN&DYU1&8PO
M4BMLZX\D+D^J1_D*#O]M.U4=XK=' -<B"G[AWYZO\_SN&4+,%!>9,(0C:C;)
MH?ANO#9-,SK39(Y8CF[:&.15NGK"=VS?'[486;W%'L-L,MTL71=N@H=CEW3B
M]5Y\3"HT@KQWT*BCZ,[M;BM]3R<INT$MBF^ZFVW>DY-MDBGNZ193ZJYC?4D"
MSET+W[IO:&LNCH)+_HZ?M.#^WHUS73R#3>^%W]?>& RNZZ0'S3'?Z"^8?/4G
M<.C_A1T<M6PWW5_^!?YSVOYB.]E)<)\3>PW;_KEO","D.VS()LZ]-_)]= %3
M&3$%REG$6D4/D1-O&<:,ZX_;M]R_3X_/1C?D_VS]>(@VAB]LOY_]6G_;SBDL
MQ$[^]YW-K7,/</[<YV\[FR^/=XZWTW>]P[MTY]O!\8$X^+1-/QSO'NWN;_.=
MXW??/KR]V.+!!]__;!_L_WV<MW<^_+&-=[\??=K[X^^C#^E:'_:WOQ[L[QX?
M?'_-/]2V>-Y\VCG^\VCW_4'>WOE\\.DUV_MCAW]X_[*SM_^RL_/IWT<[],.G
MW<VCSC_?#\ZW=R[51?62$B]$0%(%A;@"AAR1&F$L:"1<AACPRKI:-:R<^Y_E
MN?\%1N-]=\8;C,9[[V];X8VEQ')E!(? 7%000*<_,28UM14:*:$%C<U#X_62
MT< UBQPHPH1QQ*.-2#/%D3.@/6<D>J96UL6JH?6L>(_'IR>0;6"[^P5&=2YO
M-DT6_,AL8S3:VZ->?[@/_>-+G5[0,A5:?%UU21#:!X&1]. 0=TPA'0@@3WVT
M3A"C.5U9-Z2DVRSGZ1NL4@H<9@&'Z[K#$285)1'EG&M)=R23S$8BD+0@O,->
M)'LMP0'/*N;N453'XGF]SD.6!JT^>$B*W'6@JOU[)PFR !G=&B-!WEST=ZX*
M].*TWT^<*;;/[!AT6!<HC@>.98Q(,,X0E^F']1PC0K Q5"J0GJRL$[6J\")K
ME.;YA9:%'HW1*(4>\Z?'=04C2)"&!X>L5MFI'"QR(AHDTG!YK!S#U>$PM4K)
MK.J$%=?)K5TGW6&OWX;B.IFW;AGW]5GB3@'.[(#SN2Y7@C ^,@PH*B.S/R4!
MQTF'J&)IZ(BQDB:YPA-OR *KE>)167JU4I@Q-V9<%RE<1@T4/(I!",2Y#\AB
MK9%UZ6E0-C >8F:&4JHX6AYRVITGDQXI]9;]>0C:@IM)C1$K5:>/POV*C31S
M_&Q]S>BY?K;::(F3F82<##Q92<XB$PE'43IC#!A%*<LI-*BL)YY:'-%27"Q+
M+UH*.^;-CIWK[ "B>:($1CAD#TM6,#9P@R"-H!2>2V5\Q0ZS0 Z6YB5 FWG\
M_\1N5&M*-%N2G:=OOK\DFZI_F@;<QHBUPMIYL?9L@DXSUJ9GUE'$F?&(TP1<
M;2(@+AU8%96A/JRL,[J*:=U27!RA=B=T/4PNL[L<5UU:"C5&]A4*S9%"-<4G
MG$MC) .B5##$11!(Y[3J5J;EPAHE-=A$(;Q*Z+T+JCT("IZ )ZM*:S2$_G&K
M?<^0Y04P1QNCCG*OUX(2"YUF1J?O$S026!*<(AYID 9QXA*8C+-(!(PY=A0X
MN&2/FE5,\ )KI.+,6GI54^@Q=WK4O5F*>D.T1U:8'"_$ 5FB,(J4< J$8!\@
MT4.N4KU [JQEB!=Z ^WNX+1?)<WJ@^^EIE6A="5X:$XBQK>?7^KS-Y>Z?+?7
M+;;6['F$)Z@98:U,@B4@1KE(:B;:7/+4((F-MH&(J)W.)S^I7H+D]B6<:/G$
M3*'(PU.DKFIT<* 20!QA2=58;9%F@!&)"DL"7D;O,T4XJ5.DL0%&2[!'MWA^
MI%?]WDEJS5F5="GG6SK)=DEQ),W9D33N]E<=VQUN=,/6N.?3[Z/$VO 7V &\
MR<W<B^\&4+G$-W*:Y@WO3X]/.SGK[":<).G<KI*/IT]N'/=2IWZO_ED8/$,&
MTPE*+HVV#B37KTBB+3'8$J2-]97_G&,FN%)B99VM:K;(6W?%+;6T2JZP:%%9
M5-.#V!/A>!1)!0:*N,FQYM+81"6#20B2>B8SBY0J^80>=#K_T>N%K^U.ISBU
MYBRHQAU=4#-#U+ )LH?2R(+'##GJ8D*-\T@[)],_-89 <K7-?!Y.K.IR(*YX
ML)JL>PHRYH.,NCH1RH!C$GDB%>)1YDI_/"(=-#/62A:8N1$9C757+8/W9^^\
M@MG0=@_;N0A3.1+W0.?WQST^BG3<A>'6-]\YS3U7L#0'+/$)2D8)::+U'AF2
MC:9 "3+4A21G(+W$HU<Y"2NCJP37PQX71\D4#\[2*YF"DX?'24WE2"Q]$A\X
M083SA!-ID'66(XR!,0%:>>PKG'!S[RCJXH297N7<_VA9DUG4&&ESZ<3N;J_K
M2T# S.$C)GEE/.6&68J8!X8X4QH98P%I1HW!8"U @@]=%0M]X+\X999>RA1\
M/  ^ZB? %%98*HP$EGDOFSED''=(<W"86 ;5F7\Z,25K<=#,<0:^A1/;M\-1
M4?;3DK/HP6I3G/?[>6;N$9 *AF:'H>U):8L4<T$RDP0,A61">2J1"TP@ CK]
M&;PFBN:*88R7DU[%(=-@%5/P\0#XJ'M@/"$$DA&DJ<^E;Q(^K.$2J4BIM38M
M!MID?%"U#$>]EJ40\/[>_L9?K8VW;[?VW\XLC<#U/FA8G</[EH"=^O8; NC&
MZ+M"Y)D3^=L$09?'*1A,$?: DZ!+6L[@_$^6UE8MJ*,QG[[E:M6H)3CO-@V2
M'S7'T>7VW+I\[((S][ZU91>5N8T1Q86Y\V!N305'E92I4 1Q#3E DV-D6<[?
M2:@B"@=K9<C,9:M:SZK.V]S!=U=7W[*(Y+_:UK4[[>'/BJO,JCMN] XLYA<\
M@0WN\V/7K1\)-?)IS@SQ/*V/>IW49:W.S8_0O7>NFC9=IE[5F[AP/[JQY-O/
MM\=/5*X8?^5YND2D<NI_]BO[I$QH1#K&M&'($)56=DS4*'110,#<81NU@^S?
M(G();*D&;?(O,!YG9/0T$8^/;M<4/#XJ'FN&#TU/*A>,(D]SJC=P&!E@!F%"
M&(E8L4!'25&P*4$,#YICY,BF!]^/<HSTJF#,=*$O[:13?6\P'+1.[%G.(%2B
M&N8GY,9CD$#U=M3W+W+7OQKU?&'3#-DT*>U;!)TDFB*(0#Z6[XE!ECB)>%)Q
M(7KN*S81M2HGP&EQM%L);5AFM5,8\I ,J>D;ZR-A@EOD,3>(F^B05BK'.&CI
MG&,N3=6*(5C5PZ,6+[YA@03.>9C/_83, D2)/[J0N=A*.N_P<_04"VOV!"(3
M5 PG:8D (Y$R/B)N@2)GI$+4&YS6$R4T&\5GRD6.SVR> VI9^/'H(J;PXR'Y
M45,P1%O/=3* (E,><? $644X"HI3HQS5H%7F1R))\= \L(#IGT)HP;<3Z [2
M97]X:GZR;;@LMM6CRYID6YV/P-;Y "03JSH)=\F-7.@T0SI-3.B:D.&P9TA:
M37)J_H ,3YSRRI@8N(A>P,JZ6243DB@NCKHI+IJE53<%(X^ D9K(<=B"DS$B
M2F+""&B,'.$J=;&TB@DK38Z_RQ'/RW *98%$SMNC7G\XJID8P-TMQ_T"&%F/
MKF;&1M9FZN1B6<T>.I.RLMIH&)4,(T5S+C.*&=)*>,0XI<XK*H1Q.0$T)W7H
M+(YV*9Z9I=4N!1ISAT9-J02@A"0\($R40%Q1A6SP&'DG0F(]>' J9_TPIIXT
MJ+'NF.6I(C1=C6RUID2S]==^;V@[K?.4/K/R*]VNDYJ&V\9HM!*F.%?J3DK5
MQEU@6()$FAF?DYQXY#2)2!ONB Q&0DX[R_EJXO$":[4[06S.'JA?-^8^OJG%
M1%%CE%]!T;Q15!. *D8@TG(4M,E'18-$1DF&E 01*8^,YJA$3E8IO?>&W(/P
MX EXL79[7>3O>=YO6:S61Y=1MST"4E)9SH-I.Y-RR!G&=(Q4(Z(\RTSCR+!<
M<42:$$5"EE5R99V0565*D%)QA350$!6H/#94ZJ'7G-L0K402+"#N<$2.!((8
MI/&5 2*E(ZA,2F/46%?9,D0N;4*$- =":VB_798\JZTNE#+6\]_B&_7^=M?W
MCF'??KN,)RA<FB67)N57LXK&2#Q'CA.%.!86&6\<$D1@BJWTSMHJH!(O@2NI
MA"PMG]8I('D4D-1+-))\2-X8) *6B$M,D-;8H&"C4LQH[&V5.E?I>^N;$K0T
M?>VB[B6G3_'K/' QHV)RS9M(9Q.DC<=1>X<Y"L90Q(6)R"A#D"<^!B4YM2SD
MX 0YH9K:XDB;XL99>FE3&/)0#*FI&IXD3&0R(FEI3IC&-=)2,20LP9(XF= R
M*FLT(6%:\=K,<1K^U>L>WC,2>P&LJ\;(F-S=^ZFW<W!E]BC;D_;0=OX".X ]
MESK$YH:4DR&SQ-&D_(V6<P),,X2]R@6GN4+:@D&<&")!A1@U2S@RJX26$V;%
M7=-@35. \AA J7MM&/'4YU0< "17?<TVDM#("Q*T,9QBEVTDO9H>E.*V>="S
M9M?K-A:OS:,5;QR,C:^S J09 FE2FD,!F!"G)4I21R N%$=6*XD "^T94=H:
M6/P"CL5IL_0"IR#D@1!2TS2&J !$" 0\N*1IN$<ZYQAS!#S3V$I%W(R*.#;
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M3I+F=19Q(B1RD0H4A+'IO\89Z9)QS]5J6CT66/G.>DUXP!(;]VCL=<W\)%>
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M"]OG>G84P]+X6^\1MSYGD5(4N33*R#KCC +B.:^R2%&I2HA.<S%64#@+%,[
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M96VB@7NCL4+,9+<)8R[1FS,D(Y74&("8XR')JI+U<MI31S,5?A9^+A _IPD
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M(:V?@Q/PV>'7.6OE!;0RE>?BB>1K6MVBW3>[(B6=WA<Y9:;0VPU_\W*(3GX
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M"%B7'CA/A75/ ;9+.JFG,8=G<&*UGEKI-M.[3.-IIW'M)*KD6?I:@V*D$?$
M"AD;%9*)R\SP-*32KJS72^4N12A'F;OS28M6YNX\YF[-7Z4))\QBB1@U-I<$
M8,@Q2M)O@BDIG,4&E[F[6'.W0<=&BY2>SSRN9S;$P#C''BD9=)+2X) #%A&+
MW$9.M/)J=F$Z#4AR>%ZW=G2Q:Z5K\_2ZL:XMKI>V;8K/6$V<S?^V'=OUT++#
MUH[M^Z,6(ZNM/!FGW2V869=-Y&#SG.W_]7@=M#P+!"<J)@N,@<:$T_0?8G6@
MD1E!95H\:%5M_+:UGXYZG=2!@]'2<)<2XV6IF&ZI&,N]*R5Q?8A1"($PEP9Q
MY3G2W!+DA:,X<D59C"OK]ZXO/@=./\3^YDS:>UUP%C(7,L^<S)9S+K5/%IM4
M'"N<TX%%;M(OU(A ^$.3N426S!+;M8U)+S$-EN82O[GZ@)')4(\B( OI_WBR
MU;A(ACHUJXK5#TT5=A=V%W8WR&7*)6BNE!-)2/-(P0F?9+4"'T-P3)F;X?VS
MNNN%X@VC>*W*GI<1$ZT-BHP0Q$4^]QJT0R0]"MQ8@BWF.3Q0X'HYUJG# PN_
M"[\+O^=2^$'F8P360LAN<VHL53$2&I-MS7$P4+3W(E.[EAW)NQ@B$P)Y8RC*
MG$8VI'_:M')C%X(&&5?6&5OELOA-"KL+NQNMO;V*($4PTM#(P2@-#,"I(#TG
M%B(NVGLI*%X[V!L(-UY!2+);Y--_0)&13B!)C+?:8IO GK2W6!6:%/%= %X
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MUN6U&HN7?N8;&'&,:(PY88I2SX%A)Y@-(G#)O74<]$=&V,KX4T?]\2V<V$-
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M,$7@EADDF$Y01+!4&E,A-79M7W R>[)C&:!CV7;?"J*Z8L1N/ECL6&N4+Q$
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M?WOKBO?>G@=7 ='708,?A/W_P.MV]&XA:]N%I TMPKB5R2U/%2]9H&FXF'N
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M:2Y<BK)($!<,(UAD17@4*_C+VB9;9_$L)J\(,%9E*^Y-X;X/SLZ:QA7^$\W
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M+1,5IM,=RE<K;>;MHA7'>4K&R/DI!^034<HS!F*L2O?#+54EU;?P![8^%'%
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M^;8/3LLBP"<'C>/CVK8K^JO@.5OAWL^O] !(;?UDE]:!I![\_-8"%**UF2+
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MA0&,'?YEG9.9:H% -4$88D:0!&EP6X,V(8E2$65.&*XZYB'G-5U;G^V8/-Y
M?A[M]#5 71.<K-ORR.YZ.8^HTK@U+!!^KK$HJG+[7BQYB^5A'5%XJH\<#YN\
M7-G[)S=Q9772.8-R@43PM8^'?8IR"U0TV.W###C3U('!]8N"IH&C"*71W A^
MFK$N,IGO_#,R7?-?S-/,IPQ-7JUNHZ4L&.6, OXHG!RP=3OY4C0Z[\WW3E.O
M1/#J.523U+=/+^HG*JQOU\[A^;]2006VA"(+RXA8:%+$I1(H51QCR^.(LW1M
MDY+9S*Q<,V^.=MY/27^/UC8O-9]+[IA#Y#T^7VK^.EXWAW_-TJ^K.I\_<'>#
M1R^^9'S-]9_H]K84.-5Y_Q=W)F$[ZY7M8,9*QO>6)(IV"7Y7&33.ZC_AR:V#
MB[U/->PZ"QYNNVW+PU;]<C^J?_H:[C7V::VASFO36Y^M77QXHBX.3W;9P>6/
M8]#34U=.^[!U0$'GX#Y?HWI#@:^W]0?T[O(78UJH6#)D26) T9((B23B*(E3
M$"29,APETQ$@(F.M9!H*;C432O#81#16:9A&6&/%YD;-HF'4K%B<]6!\>7+6
M[7LO9'W?:>QI2LAS/B^D/-E-A3]+IYGYBK.U\2BII[=Z^F23&;Y!AA,#)JS3
M]:#US@.;N_(JU^QFZ9F4-J93&TI#;*(Y,TH* ;^5+%*1EDHKM;8Y)C9Y1T37
M;4SDS5F"]X,>#,;M;[XD__;&29F:1&DL-<[OT58!L)(4$!7'::JY40FAL2L4
M$GP>@%4;=:\IHPBN?4S3](O.,SW@*&Z6752QF5FS[CK)9$XOO I[2^A[\\'<
M2],VUOU0#A?!,=!>]B?PO-1'(M[\JP,6]__!'^NP=!JX8B\3ZW[Z#HVCIGH]
M^ [&^1A^TS7P34-DYR(GNXUCUWJZK=\68>.9MBYK;SU?%6=@9?\ R_+T]"Y$
M,L(23(QUD7#!J-82&V83GAAP%\$PI;G?!A[D%7Y;:9%RVR.:/JB[VRY*%SDK
M5*[3'O#IG$8"',*$YO]8"6\.3-?1&&7<#VNN>:VCC)='8?U3#6ABC;JD3S!+
M8)Z.P8Q]RV;V.QUE!.^L_O.'HXQPSZ_AP270Q$N=U4Z^M6HG\+G;[_RT>_'O
MRUU2/_^5\BAB+#6(6@G&2W*#.#C5R!!AXE"' "ET;3/:F&6)P[P=$$<E>L=%
MW+V0^*)WW:5S>X(CET-SQ\0]$8/G*$2$$V99K(4PP%8PB8A42:ILV?@Z*1I?
MWU%\P)[.%9Q/,%+7D'VO7?Z\DI[YTE,[KW\%VV\934*+** G8EP(Q!7A*,(X
MP9)BIA1VWO]L,L5D* A\7]07?X(WSR(AX*G>4SCJIK]G&^)/)217",D?@!@+
MGJ9@V)VU!71A"KQ10<,(*8*!N8!C&EJ?&GB5(SJ,%[J.C$Y,WJX/-P1\"N!$
MI\R\7Y[YG74&/3!4@S88O*;'(>#3KK]&F:KED<NQGCPY;]B3S9N^9DX4?!O.
MO!,:$(IVD?V5]\'=G=NOKL0_$+'.6",TU\#YO V4_3@[NV-;M)M31F['TUD8
MWR[UH^QIX]/KW;^7DLI[9O?^N:C\3+](OL'9?:C\C:QRBH4:JB/ ,F589)FQ
M+"4LX8"V+%:4ZU X%MHW1_GC<X(WHG*H[$#YH=/KWX;,/V-^T%VH_(V3,C6)
MD0PQ!ZXCW0'&E!A.)1,V!,MEX :I]%1^N)$UJ]R .PX(\B,*RLUET +;T+P8
MMO@LFV]/DVD/&WE(J]MS&Y]=4VS]^BC;%3@RYWE3#RI="O?W/.D!3)20+F\D
M;RO_!?R,H0^1YSR,0@<^P+?]9??'3IEG[1YT!_FH.@R# </+TV%X=53W9E7,
MY=V'CN_"#N\5 KUB'V,,0K_E>N<!="7V(L+:]D')^J+#GSOG]1-]6K\\S&JM
MK^'ASP-@?/6FWXOX]/'DH/7UHD8.L#M!.,GZFLV#QA:IDZ^TWMJ].-S^!M<
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MS-K+X(H\CZNL9V$!"S,5,;!C9YU>YN[UKFN:PO'.T2[C?ZU-7%70DW!TB9!
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M"K6B*>5,T0BL=X0IMA0S%7*<5H[=DJGIP<W;*#]W6/W3[KD[V@>T&M>W:_3
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MJ$D>E"0YY$P@^4@LS2AK)@1-69"B. 79K7&IYZ5D'L,!?Y(3_<?W:'^0IM8
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M=@,L=30R&FE:*X$HCE!N8C0D"\Y24%(D[>>C^,LA>]7IM[1D3VC)+!,^!^I
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M8L-)VWT;['[=_:T1592XW]T!OG-T\B(2TMAZ\?3R_DEO(ZCVQOO!>G=[V-M
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M#]]!>^/352S<[G]8.^X/ ]X+<6]UB_8VVHBSG5&IV;#^H?VM!!OCN+[UWY<
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MQG#>^#@>)OMW>[_]5>Q]^[/=V/W4WMG\0O;@F>J[_SG9^5;/IS>TL5N'Y]W
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M9)&O_LK2>8^77RV*+$[7\+]', LZ.4?$V=9,G88>>^JW:+OO\17"ISWA@O@
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M85(X;9Q/#< 1SPO >8Y4+)CK8K[1.<^:F 71DF_.IQ];)*A2D[.IR:G5[(T
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MCB+5--F@I%(49(>M308]C&1GK?9LF'O/(+=9B>FSQ!3O;&X="&$\D4$@9UD
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M7ISN3D10TAR^M;GV.C$:T^Y^>UKT&KV:&-AOW?)(_,,9S%&OK HX/8K@P:B
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M+6OI7F)5G^:%M:/B2#G>PV9W;:YVW_\PVC]%SZ9KMMT#I88*C09;^,/HQ6^
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MP3FA&NO<*L=9A@Q1%&&;K/%:>4/PT$0%,07@S7"KF(]8!IAQ%[D4\#F8?9?
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M0@IAI6:FH,,\<PZK&ZNE<+'?4M"]6WF;XE3GR[FFLO\(&^\;F5A9;)0.=''
MSG.*.<LQ_Z@]M3$?DB9B7GEK!1L?@(V[TWX90G7@T2>40'4AGJ1!+OF(N'<R
ML<B\CG%M@_#I^KBK XY+%JPL\%#U1] .ATB$X%YQCYD-QG!)4PS2&N%8@8<7
M@(<IWPO'U@3"!.+,Y0@?Q<C ^B";%..,Q:BX!>I4P*& PSS!01N"64J&$JQX
M,,DHA4G*M9FD 1MK3MF>!1P>!@Y3W"$7MDE8(1,T< <B,'(V$125ME+JH%W4
M:QMRE=N?%'180G20C"EFK0S!*BYML,0KIH)Q4EE,2$D.>@ETF/*ZB,B3II0@
MR6A&!^^1]3X'<)@3W@06$U_; (0O\##_$^&KGS=T=79^LECAL(+JH%OKCLZ1
M=R_/D;_88= GE*.@<\@<NGL?/,5_?[]=]KIT3&X*);''T7+-+4Y&ZNB,"E$Z
MC/V\SAL5'?, '?-IVGM%(Q:4)X&<C*!9C(T(F"=&E# ON([ %/"J>Z\>"O4+
M#PD6L)F[+RQ996RN<.H$9XJXD(SP&CL'$&-X<96_!-A,^<*(45X0'9%@F<9Z
MHU&N*8N"9IYQ2I/V:K5]805J7CW41"TTL=PIIPSW/-D$N]E&J;&)T;,"-2\"
M-9.\)C#I:$@!.<S =K:1($N=0)11GYR$ORW.MK,L8%/ 9GG!1F&BK9'$416X
MDTP3GKBGN4>=MC[@ C8O #93CCI*HS38692D=(A+$I&CFB)CDK$<)VXH@ U;
M:3_^XL'FB7UYY^7">P% V+QJ&/+F1K>0;J_6.^V@;DJUO&&^5>V2YM!-]#$(
M7:Y>KO[R5U^.4\#K2KR40W_R / 2UG5\@BO_60X!EVN\KFO,,^6:L*7@";-E
M_Z]F!^[4J36J6)UMU?YJIE@AP/B=ZH7_8]M??Z]M=CJGHRYF^>[[W=Y)2=5>
ME)V6J$E*8*(2V&?.8:N=-KD$2TC.J6#*^=BEL=\.IX-@R25LN#<(1YR#8#@A
M&QU'UGEMG;/1YBHLJW\^]J?+Q7K)&OT/2<=*).5V=T*0R%VD.EH5""7)*!D#
M3?-'C\YI&X5NU=DT7ZU R ,A9"JT%2WC/ F&F,ZYWB)G<D:I$2&11$I,8DJN
M;= WH"1^5@"Y%,:"(0O $.:(-=(KPZ3B-!%G)6<)_A<])MZ4XCY+!1]3!2]S
MH4O" C*::8 /*G)Y7X:\U\XDR8,WZ:=G( 5 %EJG0SDBN E.<\XC549%%[0)
MB?AH,(Z%A"P;BDS%H50(TG$ 94D3D!"<CZ)Z2I&2P5L?\DE]5DC(-0RYPW,T
M[IP+\Q1_##OEDX_]Y)P<^B/G7>687UK_W;OVU^Y9[%VZYK8O6T6/FEP_I8M;
MJ3/SPSHS5B29*]4IG+@RQJ2DE4S:>LXM(;K0XZ51;._._MK;'M3_SLKM$VY<
M;(J=S2_"8J,3 :M:I(!X)!(93!BBW@L27""<T-= D$N1JB4$C\2XXY)Z0K7E
MT6HG<8H4.\L4]D3.J=)" 8\Y@<?N)'AP$9**/*"HN4*Y"#Y8UTHC+5,PSEII
MB2S@4<!C,<PC<LZ(M30*S2G%EB2AK K>>X(%*V5:7@8D]B=!PD69)+<<T9 (
M, QID0O,(B*PUP1;)W//&<)>01)G 8AE HB8G3,".VPXY0Z0@C.:$G=&8J*
MUA: >!& .)P$"$H)]EX;Y*75B)O(D<VI H;$( 07DN,"$ M)R5INK\Z_>Z<A
M=@9-VYIVZ.3LJ\TV7-;;DGRUL.8$*= 4(_7!)HYYLIEFT5S;QC'C<#F1]P(
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M"10Z%YHB[B1!C@F.DG&P; P4HLQE[:?=5K_.+;B\-"UW[J<Z0_/;B^C/^HS
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MB^VSQN$7Z25+1$DDJ %KEU"'M-4$84RB%9C10 D8"GBZ;N[_'E/$*P=1.AW
M% ,6]H]J"4RVD0\)B. 8H-_4.K'2H-V1N^H:BO;@W\/A=LJPWZ]<EG9D10Q
MNL8&\+7O7&H1N$?_U!W';'54"J9BJBW@R\UV<Z1D[%<P3+[#OAEDS?(0H_=Q
M6_/*Z/W1SGQ;C?0P_I4'NEF1[X^Q;9L=>/RE,6F??W>"&7OVQ?JD8'<&%(VN
M^@D!YH>@D 4JSDDTT8FPML'69_ABW*4O9C27>2O5;<\?W7"8 !G8[%>4H7_:
MFFGU7",0;_+'8@^((!C$H'OZ<<@7NBF!+3N,SP)1A0]][79"Y7$??6YLS603
MJC?)'V[8554HH'+/'UW=)MSPW P?J5]MZM%UQ[O]"H6K?7^GE72G!7T_RT<2
M>6GYS-1<=VNBV=^CPOC(5(+UYSQ&:J7VEB:AO?8>[-^Q&J\2&*[X4)4N45F.
M7_OQM_$OOX^;X#8[E<:MOO3[32HDIF,$%3$:OGU%(-;QD$2,,H!'=QZ]O5Z]
M-9'Z,7Q/X'5.U:UOXW7RR/>8$(_ZYH\&:]8QTV6L<Q\K%>N<T7M=]HXT\P>F
MA2^X\/#]0US#(YG;G;'+O#]U&N\'#WN/%-65_^A=QPOF=5#@<D<L_JS [(3.
MCY<1[F<Z%C!K&$]/'[O[6,!<,J\?L^Q#:WZ9:I!7-*PV9F#W*9A0)N]R\L9Q
MO_'\T:6>O[LP9WSQA7N?[C>YUP(MV:LWC%3MQ5Z[?XOY,$/^YUXC?&4JI%Q:
M'PNI]SW_:EVO]BC(PQ[\59SV>*2+1EYST3PJ)6&S$SX.$SK^&"94K$:N+*WO
M[8\].F<-FA,(WC</VHUVX\,[O//A_?'.A^WS@ZW&R4&[?MZ@!\<-^H[5+P^&
M=$7]8I?6/W_B.UN[8G_O'6Y<'.+]]I_-_>S1N6BU#XZ]R(='#B8/AAR?7,#8
M<S($;VRUCNI[NVQGZV.S^N[G;;;S&49Q<8+S,_[G8GO0>)L/A;P;-.!S]:T3
M_D6JX(F0$ED-/[B1 CGN!"+<$^V(3TY5QY0Q?P5]IA=X\J/ \IQ6]C7#\NPG
M?@ LLZ@2LUPGY3FGD5K%M>""J,AET*-#>#_(>2RPO*2PW)R 98^5DDP(Q*CS
MB >=D.4L(A,]\3YB;8+.L$R(G(+EGP\;7] N>*FB$ \+!A/KC)-2:QLDQTFZ
M$)SQ)C$3B:-:?=FJZ!S!!-T1%1XGG+[M=K)E.4PCNAD%)DL3!EX9^=^9H&5_
ML8^M^-\?SP\^AZ^.<EF->PN>ZZ+1A#'2QM;1<6/KD->/ZZSQH2X.]O+S;U_L
M[_V3&IM?'-9)"A90E%0C;KU"5E&&L$C)) <*)-"U#3,K"GT6>S&?&J@R#G((
M;IA7VNS4;&W0.^T/)I-(GU*]9;G\[3^4M[]/.[6_FBG6-OOC0.,X&:N;:F]M
MQP;[E%JE\Z@N^:K;)SJA/:?:ZJ@T)YX[K:+7-&I+C7;T62W2PFX>@&[U::.3
M"1FL,1;9",2&<\F0#<XA+F0B,DJF% =V\QHJ$;Q #]?7#B5/MJ+ 6J(T8J*D
M(SPP99EBR5K#K(A)T?B<5E2!DH=!R:2A1*6B8 $'@!(;4<YJ0=I(CRQ+2FOL
MJ&$L0\ETQ=K7(\^/O<:SULE] 4CXJPF64'6<H/;+'['7/@WVU]I?@[#^E(!*
MJ6GZP_9U7K#H.%56"DYQ-!AKZ1D53%/'O"PL;4FA=7>:I7%O"2:>(:$211PG
M8&G:&\0L5UK R@H; 5KI*G>ZGE?]T@(B<^1GEEOL!85]%B0W,1@!3(UA::TD
M+IE0^-GR@L@D/U,\*NN2!/Q0#.43A,BZJ!&-EDHB*'>>SP:15R+)KZWOP,,<
MSS1@[$/N9HL-EYH8PH@QU$J,20#M4AS/+RNO=SF>]S__TS[8VJ8'>S!V"L^X
MM4GJ[7<D%UN <9W5/^R+QIX_J]-&=CQS873 *:+H@"WPQ$':&4O(<QZXB-HJ
MEVX[_[3,GN<7TYI_O]WY6/O[W6IZEE?!8 $]I*F*6C&9N/+!>AH5!2P*1#)'
M[VSX6KC&"V'7IT%]S#6.X1['[RZ^Y."63$8CKZ0%KB$5TDPE))G%5I#@82%G
M-B]:'7OE25ZH1["<GP%#GFROR*@(33Y(AQ,W7N@0N#0N N4%[)"FV"M+BR&7
M3H\QABB/!9&:(L],1)RHB!SU&%FAM/&PO(GE!FCF1=W)"Q3D17&GU3!71##<
M8&)"SJ\+/@)Y);F '2@4%H-SQ5QY87&]5/G;Y_!<WR?-E?K>":UO;5=SM7]<
M)XT/]?-]NLWW]UKM^L4^/CC^\VB?OJ-U>I# Y!&-BT]D!^9T9^OD_ N-&$?M
M.0(Z:'+'IH2<TPEA2I0SG&+NU=J&NI?M4FO% 4!U58FX*AH[%^/E9@K;@IL>
M/>-9QM?=X?!)W8[FL^2/3"9_EEXP+YE_]-AD\\6V@UF9C"R%$_8:*^>YT,XQ
M1:,/W L6-)C/Y8S0BBK9R4!@H,X3B@VR6(!=K1-&3GE9.?(QH21*&:I6AO3U
MG!%ZGM8QC\L+*3IA&0\@O0:=\&17R"/K61>=L.PZ83*NZYB3+!F!F)(<@<XW
M")8WH42\E=%14 RJT@EF7I'=GQ:87^K6I9G9LG<P ?B[ZFDS+)[7JXJ*;J):
MKA7^#3 N]S'JA-H17"KV*M]$IU9U+_N)F].L4N^R[3\:'ZL5[)X.^@,[+(3H
M6[;9[F?OTD/J;C[58)O=VBS"-LN=.&#$N6]6^.-TT.C"'8<M7=Y6(WW=ROAF
M6<[<Q7-7U#__V=ZG,)Z]7;[_N<[WC_\\J=./[?V+;0;?9_M[_OQZIXGZQ0EO
M[+W[HK"G')8(8<X]XCA(9+3QR&DK#-%1"P%ZE4[',*\U/QN7S_S:B^WF:;L6
MABT+7F*K_'LXA/[5/MD<O!WU1O@G=QXH.^->.^/8?Y$2C'#G/0)"31#GR2)#
M(T:42B>K5D@N5V^]=6-4]7[[<=218J@MXO<*94(M];KM&V76KTI9SRS4=*VH
M=<:FZE>"-^?3$6J.D/=4>Z1 WD(WMJCOG7S1EB3/E4?248JX(0(9V-)(*2*-
M$9;P !N;3A\&G"_DS6NK%,B;S\ZXV/]"C1,<5@')@ 7B+D2D<RZQ90'@CSCG
MG?@1Y WC<C=!+L/3;*#K7W4#R]OG_DV4IAKC_+ (],NT0,BUWIOMKS!!^4%@
MLK[&7K4-JY+9>2)^::[']6%9[?SGL#]J;=BZH_?5YH-4[7S!W"C)GK8&OXX;
M(_VPETB5Q5EUK6JV<ZGXWK@W4?[FX*@7835@\$?]6NSD-9JE:[(JF'Z=/GDE
M[EN.F]*UZ?6KO@LV-V:28YUR/S#'3=()($-1&4QPSGXA50^C!=@:=[< HMEU
M-VX:,6KR-9&WI!2SB7),8^1&*<<UDS((!EO&"N]G9CO<!+OMSC>0F4JE;W>V
MHAML=L+0@9=WQ+O_R?OA[QP7KYI@PIMOAPTV]WHV:_7-*L=WJ]GWK6XV8O=@
M;'^TNO[DI<'O>/NJY]R'3V<Y=Z"^==0&\,*-#]MXY_,^/S@^.L[ U6COBH,/
M?S:G"O2W/YT=[&U>-(YWSW8^'!SM7^SB_6/X[/%1>P?N!>.F!UNMD_WVGT?_
MN7B'OWAF\UQCE!+CB&L!U'^804TQD3XFQ^QD3Q++N/,A2F9IXBQ&8PAG@LN(
M%?&:T;5:!'WR-9<$[8'FV1@2-5*K>HJ2WVO7UF^J']Q"2MM3,4.6GAD+9Q?'
MOWLJ;TX]YPK,(["'&-A% 0.+P=1C8"_$8!*#&6+NL\G?OX%O^_/E$:!/8P$Z
MSM<$ :+[%_M\YT/V46^*?1":!OUXW-AJM [V#EH'[4]LNFECG=0IC.\8V,7Q
M(=^O?,^MYL'6"3OX4,=U^D^KT?ZGG;MG 'L@N7<XQ4Q0KI -7@&59 898S@2
M.+>\4"K!C$^N(S:1Y1(Y3H3(<YB3P?>" CJH.2>$3(K0V^9AQ]8^]+JG7_\K
M'T\8+T ML_\$J]#--^@W^X/*6K$UU^O:4*O:L>07KK[1'W6"S.9- .P<9A!5
M2/FF\M^!+KW^DN^V81=5EE0;[G5HX8*M+@C"&[AW7OWQ7\-V,*UNYQ"!QFU?
MO^6;6O\(OCOU>J5D ^S1;\,^ANG2: -=#@\^M-HF,:)J(3/J,=P?M1@>M=S(
M0\Q-%0'MLY/RT/:JY^R>]J[/V:AMZO#VO5AUX0[7/W!8]>;([X*&Z$<P'/\&
MRC"$,7IO<[-B',W.D'=GB;<.;,L1>VF-4&"J <^LM5VOS4:/NW?1S5UG(N?>
MIZ2U9SP*YI@C4A)-.3$B2* -[T>-EZ>'G>=PU%0M3VFU]KG%]/ A+\<\.D#C
M 6 =+&B.%ER:[: "[FA(/;/9R?.T/P&8^V'[DSN1=V*NM>+)4^PBI9P;;?/Y
M,TOA=EQZ&0*_C' N'J7_N]O*8M#_VQ_%<-J*.^F:!M[+G&EI$/SBW=C^.Z]?
MM%H[8+L!4C?!-@,$]V##;>?T2;#\3NC.WB'<W],I!#_>OMCY_$DTMHX J>%W
M0/#&Q5&S?GS"&GL'[9V]?;&S]>=QX^*@F7L4Y7[1!BO.8 -R*2GBU&0$%P')
M?+1,*@,"(B81^66M*H %@+TLB*.V.:=@Z.36A?U;X:2?716C'H?GPX:'V8^4
M^\1>A^UQGU\_[-4Y0]A6IE$/,^N*L15I**/7*7[<5<M8RUC+6.\8*YEKKZ9Y
M= \BXCXMH):O><F#.[^\VIGX<1N7TO;K47)S:[[0':=)EF][O!W2JZ?T]GEH
MAM:KF;N_QGRTS-XC9F^O"X)<9J[(;)'9E9F]:9F=>Q.R.^9DV<Y$;-WT3B^D
M(=F/MMO<YGG)3J LNC/9U.,OR3F3)Y\])(0F)AF)/FA.@S*,.\52))%A;S"Y
M;W[BWSD8DCL27G/#+D\*SB-=L,/#(7"O#_LY4BT.MCS-*3R-?#+^P_NC_8M_
MC@[V/&ZT=^$[NRQ'KF\<#FGOGAU4D>K62>-B/Z?PX/KQ.[[_^?UQX_/[5N-B
MEQYDM^U6.,K=*^J3AT-P)-H)%Q%Q-B'.N$$VI( 2$00KFWP@=FU#SNA=LZK'
M!>^%\,]X]J3 :X'7)8#7S$.GT'4ELA]7!'JGSFHK[%DB,2%E 7^Y<@29X -R
M1&N//4XDL+4-\X::UW-6NX!O =\"OE/@6T!W4: [=1@Z84F==D@)FIOH6@#=
MB!6BQN7ZQT)@I3+H&CQ=-ZZ ;@'=12_TZP?=)Q>N"%(S%GBT7F)N#,R,=CIR
M'')NF6+\OJ=_BD-A#@ [697\2XPA4>D=$%KJ$?=&(&>B19Q(JISER<JTMB$%
M7W0SW()Q!>-^>HPK5OVB':I[FX/ZWQD#/U6G)78VOQAJO9-.(RFS79^$1387
MW5%,8DL#9I17%).2.=?;*1A8,+!@8#&NGP_[MB>QS^/<R9,9Q(S#@'T,(ZV!
M JH02'2>,$I#QCZMZ*I@WT_0,?W=Y &VU6QBLR).PQ0$<2HRPJW-G4^,<"Y9
MY8@AW"MA2T#\V3"L/AT05\EB*X-'F!"-N #3U6@F4;1,)B.,9SDJ(\@*>P>7
MN#]RP8;Y8$.Q^Q:,&],M>'F* B>+1.*Y>Z:1R+@8$-8QP3HZAGGN1O,&RU4.
M+!3H>/7042!C49 Q234H%CHY[I 1I.IBHY$36*-(#);",D=MRI!!Z'0CFP(9
M!3*>[&'!@5.J+/STE ?/3.)1TDB=%E$3*TLD[1GA82J2YG2,,AB+HK0.<6,2
MTIYXI+A,4JLD S%K&WRZOFP1T"*@]S 'BGP^S%,P'>GQ.N@D0($SIB,H<(R1
MM5AE$T#J0$*PC*]M"#5=#[6(:!'1']#N(IH/%,VI0(2SACL6#0J"41#-0!"8
M0QB9)%3"PAN%Q=J&I$\.0\Q1-!][='&%(@UO;ZN+]Y1SBD_"J!ESN&P8]637
M@)!",$FX<R1PH835)&G':231.*E8B3@\&UCM3D<<G$_1XZB1EH:AO#[(DJJ\
MNDL&8R.P A9!\"LX@O<"N2@%')X)'$K(8<' ,15RB!PG1CB#&05FPSWV0&\(
M0QIL#\Q=@-43N;&;P*L<K2S0\>JAHT#&HB!CDFMP)JW45",+O (@0W'DO 7;
M2&CB&3=!29LA0^)IGT6!C (93W:71*%%,%00ZQ-/R5IE' 'U195@@A!50@[/
M" ]3(0>#F9(@^\AZ!J9(5 HY"_:(E(%YH9-Q+*QMR"?[,XN OGH!+>; HOT(
MT_$(K9(PVEMDA*L2"@PR6EG$'(O*,:ZX]I5!P(L$%PDNK/S%)'<J7&$-""CV
M"DGA).)2)*15],@KS03#U$NB*UY.YG5NMAR-N)?<_?M:MYYR*F*!O@0<@K56
M2*Z5Y%Q&0PC\(34.R@:*Q=-B%-?A*S6_QX N8J];D.M!R/5I.G81<(A)&8U\
M[GS-L>/(VA21)YX9)H7V463S78.^^7V%/0HE >/5 T<Q6!8,'E/Q"QPY29)*
MQ#P.B(>HD</6(4PR%[+):4PRZ:%DE>,7!3I>/704R%@49$R5*U8\$BT=<E18
ML).20U;";T':R *-/"93(*- QL*<*]H+9F+RF#O*$\'."1<P \0P23+LGQ:_
M*&;*7&!C^BB%]X 73B*<F .F ;\Y)A,RVC)JK <M0&\W4XKT%NDMML+S.AJF
M@QO.,I&(E4A9FK.=N$36P@^CC>;".ZR-'ZK^)Y?5*A+\ZB6X2.[")'<JN"&)
MHQHG@900+/<8X<A@Z5&@UL7@G))&+I_D_@2G,7:JKO577:ROM;TNYS$66C:>
MDQB=CBPQ+@AS6B;L(P'UQKVBOL0Z7AS(]F=4AA(\<L$MBCS7,PZ!(6.50Q1L
M"\\MMT&;UQ#K**D=KQXXBOVR8/"8BG5X[$,TV",LN$&<:P'6BXJ()2(4-;"J
MF.9:+X:58UX%.I88.@ID+ HR)OE&XAB$#RMD/,L.#T$1((9$1 @OHX^<&5X@
MHT#&PGPMRJK E//<&\MED!8VG'&>"4%"E"&66,<2P,94K(,RZ84'G% >1\1M
M+D2I<4)"!):$I(E$,K=81Y'>5R^]Q598M*-A.M8AG0P&6[ 1,!:(.S 4G-$6
M1:6<PB%:Y7!6_8K.JX5(D>#7*\%%<A<FN5.QCF"UD3JW\O6@<ZNZ4R8:BZA.
M,JJ 11!L^23W)SC(49'0^80Y?I)8[9-=#EY801375&+*'7-:4.F2"CY(+&5\
MXI&.@E4/P"H_'<[P8 =0IA5B+''$54ZE5#I6'$,(:2-.P#$(+XF4!1R6&!SN
M-$^*;^'1F#$5Q:!>FX EP(70%'&9NV>'X)"TQGBKA0O9);GZ(=""&Z\>-PJ7
M> (N3'6RB%@8KRSB6@@ !QJ1UHHBPV)2R3)"K2Y<HF#"HBI>4,8=Z"67C.!,
M$@U@P*+3*8E<\^*)@8H"#@\"A^F.\+ 6ED:*9/(2<88Y<E('9(712@KE*(D
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M:U_AAMW0GTD+SF(/+IO?:[6Z9_W\*^C1NNWYHZ&GD(W4X&^W@N!,\*PLZRO
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MKGC\A&W6>H:U"D!NG6'ATIFL'9#@O25 8R8VLD2<\T%G1R%G^^RE,8L<8E5
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M$Z.+24FKK:>1"\'1N+D/".RG.,$ E/U/12H1"X[WTFA:<GV<+@&@O#GA<2@
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M,3D3(P,E)7_5Z. DB^S92\E:2=PM\V[E5&"5$;$R(B[GN1^"@K0Y1I4I>Q/
M48]_ $^<4N:88M'-=+NK*-@!%&RURBUM/F22B2B1"@KB#Z^B(RPD7%9IF GT
MV4M1[/LUA<'O['4LR+*X*L?BEVO.PJ1;4#\MXAG<ER^MX\;_4^%U6[A6_5%L
MWG%7XFG:P:O/KG]8CH[>#H9_(*R_.HZ_7"8A;$QR$$KCT]'\KNIOQD[N[PEG
M>-2=4L<U40[OYYC(($3@((G@R1 (6J"Q+"(QP4!*7#$M/2J']2]NKT22W2N3
M7H)Y^;UPYGJ]=>[_G2*Y2,-!Q9\'XD_;.#5.9BLS"599 DXGXG)4!!UW4"J9
MH$,H(F\XXS]WB(ZR$X;HFE)<?C4]\E'Y+Y^");H&-'R="+]>:H9KP82;&7V%
M>*PB^(,0_$/;@E1>A9S19!0B:P+>1F*-MB2Z&+(-@LG2?[Q-E/'@X$+ERWS:
M%MP=<EHML*7(;\L",PJ,I$D19Y@GD-$,<Y)&DID%K9WDD-/2++!'%^75A *_
MVIEU^2R=W4U-\*D4DI>.Z8.CT@O\[V4$&!><W76U!K_#INO80=UWH"!=,R:Z
M3EC2#SG"J_KX0?IXIVU/)ZMMM#&A%@Z.0%"2.(B4*&W1IK*2Q5+9+MM\H_<W
MJ)>JM59-]OF=F3[7$UF_ \WGFB'KVB5'5&1](+*V/!VP :BGZ.2 I@0$!6(-
M381I)666(&/0BR9"=!5:E^ 771*$7M*!?IW,K6/L,G>7%]_FWDPJ,J?UW:=-
M/=+1N!XI7=4CS2$;:K_.IP7FB )#?/0I%1?^]0EW!"G_INMU^ZXW944*O7T<
MW.E^+Q2&@C8AP-6(OUKXO516&'%%K_6XM=EO77_X9R%)>-T?!9R=LV$:=:8:
M^V)G"H@'NT<(3A_?'NY^+-S&&PANX>^=@U<4/WNP\?%M?^/U![[[<?/3QA^S
MU=B;"*:?V,['/P]W#_;$SL5[NGE1/O\[CFL# ?/=ETT$R1W^_N__7+QA6]NO
M_HH1G+!)$.D46HHZH\U(;296&,0@3BW8%CFKBKB((6K@6H#E'-?3!I0"P4%;
MT/P>Y=MMOI?'$_#YW#Y3<JTF*,5^[I7-T6MV1V\CN;(W)C2RUW?U=]J?6_F2
MG.(:H^V89O5'W*>O]_YR/*(9A!X-S3B#X(PCEBI#LH\F>K2B6&IS\@!5J(]=
M5-ZCW@XF,PX(V\Q$J?%'Q_;I[4P#4QY4!.V&>G%*\'(+!]CI=3Z8*4/,Y4='
M5RQW_>-I$= ,L\OSRUNT5,3SWFA_,#P=$S->YS8HNNH:X\R+WOB<]G:NNZ.Q
MF,69 0^.4:,UQ%:7@\!EC0WY:KG[A)WVRWXZ;DA+&F(55*O-"V..PG+U@<<)
M_]S0$J"B#.F2YZ:HX+;B^U((:HX+)8J+C4I-Y0%Q[.4"5Z-[\7 BJ^^]8=Y>
M6_O"OX@+T' --=M@/!6%HF:_7^;Q>')X'@9GA['GTR5E9\.>@V\W9F8AC!CB
MD";^C$^G7PJ3S,3.*#VW^Z&/CSK>?.4^WATV5#VC_4(,7 AG7O1>71+\%C*+
M_+5ACMET)F0ZTZ'A4H]),<I0&E(]_.3E)1MNG3E#>MXP0-YYT3'1SLPEOTQ9
MB\8U<H-A>_E7#@IE*B]%[!JCU#4RY0ENS K:%250.,0OCCFIQJ159R>-U;C?
M3\-B?9Y?KH\_[_WZZM6_QU275V_O-1Q3I\UK>_MC1M?C3P58<&JO<V%.Q:K<
M8U3>/SL>$R+A"_][-BC_-%MT3$<5&J;#\9J.!7?,GA5N?]3__E?ZG Y[['_&
M;+-E.0=?'C*@HW2Z/XBXCGM3AJNC04R'$X0X.[Z&*_WCD[/3RUN*_\$M/I$G
M7!0<K+NQX:>3'";^Q.B*(.S:, ^;:S7$W'CQ\6;%CQ8GO_ENV<"#AI3WZ,I*
M>5&8)%%TW=')87J.]YW9$64P5[MZ_FZXE(AKFP'78/)LO7Z>^^R-(S(SN#&S
M[Q3K;XCZ\QY>KCSOX&QO+%G7G@(7NC!AC97(Y7I,;M1,1,.J-L!EN#:0\>R/
M>JQ9*SY>]QM#O5J?F6.D.=[G];^7Y=] 9\E2[S;D9YH.,&ET-@I=-@$,C$]1
M&NZ\,>@2&Q9OO<^=AMC-^\C"BUT2AZUQ ,R[0N>JF:5&@PG4H))KQ"NB_3;L
M7_+)-0IN0G/Z?"+(EY2H9T?-YZ[MI(9(&/<KBEV_, 1?EX:Q,3.!AEF*O2O<
M:VP)AXJT$9HRAKGF#EHMZ.U//8Z)178;%^RW$5W?:8;<MHDGWZOL^*7AY^WL
M^ ^1=WDI[RO@U/_*/'>2:+>9^5<=:G#S;42[=T+C+,0%$2.ZL@D]5X@6/Q8$
ME"^SJ)PO_-%7_)2OKDR=JQ?_=<WH^>5*HU^%,>X"C;F/<>>P6MT)3-914B&Y
M!>Z"MY:6T)'4/D>MX='Y%B]C)N-)>G4<KTW,)) 3MXY_+Y[>$%<9/[ Y.!Y.
M__RG&_6[1<NX>=7PK+_[ZV^'&P>;_9V/&VSSUPVZ<7'X:>?C;_N;'W>/\'MT
M@^_0S=>[1UNM ,MOGW:./IQO\-_V=RX^T)V+]Q=;'W_?WSEZP_";.,;W%[L'
M[^GFT8YL:!F_-.UK; 1-E Z20*"!>-">6)%P,5$1&Y@;U^L"_>+IQ,L??$;W
MH'@.XS2_LJF='YR=SJC;;W.7T,:>\+-?O_XP[;EA'-NIEYUM'N*$H6T_&?@5
M7ZU]\P#*_S]F:1RGMR]QD-(WIY1I#N.<,,O,M-RXUS\G_OL?Q7^?V%##PEMY
M,AB6]Z?DD870>'RARW&\FI)3CM(T7(#K5#S[%C_EM"O0^&E'EU/W5=[*FTV#
MYA!5KA$;)9,OI%)K0IQH7FCUK>.I8ZUCK6.M8UW%6._']EM9)Q_ .KFF++#O
MQQ'F?U]&F%^-(\P;UR+,[RXCS&./HO&U+Z/*/_#D_7$MRCL^VMNZBK&^:Z*T
MU^>*U[D:S]6'Z['H]CR)'WF>FK*L&\]_5_7,]Z%3_7$X62]9L'N5T/;!DS?M
M SB=O_NPV];YJYNO;KX.S%_=?'7SU<VWCI/W]<VW= +XAY98'_5C/$RKF9JW
MK;.-ZT'_17AQEK,!Z]7KU>O5Z]7KU1_]ZM^)DGB5VN[US:J%;U)O#R<@KM>H
MUZC7>.K76!*1YIC"@;_@LBM0.O^(\&V*)>6FMU<HW8\G#:=CS^VEXW#^&'R:
M#YG'>Q-AK%(9/;@7R,,8+5;Y: \@M(  U($+.G,' K+13C-OO9/ LD_QKW=?
MY]J<YG7.DB]?T3+?)&GN#*/%M^9M3A@MY,[%_O[6=BA%V6+S M__^.9\Z^,'
ML<G+O?X\VN&_?]K=_O/3[A^SC!:'!UN_OI&;%Q_DQNL@-@_>LYWM=W)W.XCF
MN3[N'NS^^OOAYL??#PM[\L8L5Y#F5"J=,C&QL"<+$8A)%$C '\['S"F%9R_9
MG Y'Z\/?OA!EX*7D5?A;9BND+L+?PERF07*GN0>5K("(R&>,YI("!Z&\H+:!
M/\YXA;\5P=_F+*%/LLQQ<+@[54P$#.7$6!F(]\:R8!7^$1'^0*^4MK1B4#7!
M[HM!&:@QSI?J20%,2T=-3%YZ87WR3/IJ@JT:@V9-,)]T8@$T\1 H >US(5)F
M1(BH#.,F&"D*!K7Y&JL)]D/"7S7!;H<_GIE ] /&K8-@LJ<6DA92&,&%3K*:
M8"N&OQ:G(J6,,:\4"5Z5YI+H?)HH#7% ,\TR\>0IPI^2U03K$ 95$^QV#(HV
M&\<U: H4+&<FLI2I-2EJG0/CRS?!.M[98EVP:6/[U>G&'P6?/M#-BU=RZ]5?
MD5N>' *3R0Z-,T8E<59R!*O"DH(_5/*W][:H!MH/"8[50+L='*VC+"2AJ P"
MG'5.J,QIS-$)2)#]\@VT"HY+ L=WL^!H )(RG!)O(R,@J276!2"XLIF!H+C.
MKAN-?RI"5?/MO@BEM0 6K.,N<9 AF" 5-=0Q\#GABS6"MG(D>M]"(BI=H.@Z
M"B'13.,N$^\5.I'H0&K)DH\"S31NVW'\:J+]D !83;3; =#3$!(Z.>CY,-!:
M.<VUR30)0:D(,=<8VLH!<&<6 'WIE*I,(IYZ0T!D-,JX!Z)H.?^1&1=0/'LI
M6+LSR>I0:$DYRNN29-?P=DT(L,*-9+M'35W^6H/9.1-Z_P:S:V+..:I3M%$$
MB?) (5GPSL@H-04!^+-&XSJ)<A_:N6K)&\,LCR3*F E8 \1:00D#*Q4S0OM@
MGD(L[BLP]UB&W@\")@N;1EIXQ7W6E$$"Z9T/Z"@RDQSC7$6;:O2JHV#2ROP*
MPAB$#$V2M6@PA8BFD_&1^"Q]MIF",<N+756)[JQY0 5W$" H%0&RE19_H<J#
MM194$*Q&>U8MN;-F  O)4*H$L9() IQ1XER2A 8=5$2Y]"5A -8Y8[WB16<M
M &MLRIHQ)5Q"9R*@[G<YI*B<]<SQFF"T:KQH)1AYG:R/U!(I?"+@16F''2@Q
MJHF9N,1<FHL756@[(K0+*WGT$B-7X"1/NI0U69ZC0K6>E."0DJTQ@(X*\YR,
M'"5"X(H;HD4*!*03Q'N+-D!B6?"4E4BZ1@$JG#RF#2!IZ4CJ&=<.O)6&*:N3
MR3E()S-5-0K063AIY;!P=!V2390P&IHX !#K2Y-92*4-37$V4HT#=%ZF%S81
M9,@*M0K-7 ?<!<Z;F&B*PEO-0Q2YQ@%6+KNMK(^LK;3<&.)X1LL>HB*&TD04
MKJ(4!JSA\RW[:@54Q%C8"C 1HC&""1\U0+#>^IPHC0%\<M&S&@E8.6*TTB2<
M]RE%L"0'0=%Y '0>>+ D*9NU"SPAAG0L%O"C41$-AOCG\:+9$7=DKMT+Q.Z;
MQ;;.9H\":10U2G,JP$CMO+31:VH9RR:P4",CG02WG79V!!C+G!"*1*$D 9HU
ML=87*@L%5&MT5NF3B(MT+PWVJ8#)PA91LB)0EZ46U(++U@N!Z,*8\L))91[!
M(JI@LA0P:65'&$9U2B:1I'.)A5!''/!$2EX$*"&%9.H)5_8\%8E>V#P(.@A\
MSJ2%]P#.N<QBH#R@<1#1X:FU,"N7W!:A7TZ1N2 (IZHP6D5.C$R&<.!1\11C
M=O+92Z'7.2A2 :.S)@#C*JIRT)XY@^"EX]R*)#B:ID$Y5FM'5@T8K?0(= Y4
M8C(1)9,@(+E'P'"2\)1P,7W(0'';B:?(O_)4I';Q),B  LD@,0LEF5X[KWWF
M7C+N#17\$7A[J^&^G"A .S\BR:!3-)H BQ0- ,&(MX81[@7(["!F&FL<H,+)
M8^9',.9#BFAP0@8KC E4<2%1ERC-](0 J<8!N@@GK?P((4UPUBF"*XAP0B4C
MUB1+@K92XB)'JT*-!'1>IA<V$3BC'BS/C"<'TAHO DO.H;LIJ13N$5(HJ^P^
M4'9;^1&6AN#1[2*2FD1 9T&<M8YHF0WG/ DE3(T%5,AXK 0)KZB1*B03.63O
M'2V)^,$F%4PR0=18P,HAHY4@P:UQ#$ 0"D(1X-P3YVDF7KB06$A!&MJU:,#W
M[G47^Y^GUYY<@I3/_\18DUVQ&KG\93 \&0S=Z56;5QQFS?QZG'(2:6S@OO3.
MD2"!.<F\XCGX%+/#MVJXI). %]I)$TYFS66F1.12&Q:2)%98((K%2+E7(8JO
M>#?K8R75--+.6DGH2F49LI&2)\@B6^&\-6!3ICHY_@A64@63I8!)*VE"H6?L
MF*>$.HFVD]69&.<D$:!MBLD;+BNE1/<E>O'3E')D%D$ , L1LK.0H_)!YJS!
MT4<H);DNT<=G1R0.3LGDRE6L'RK6LS:""-EI(Q)A"2+:"-D3RZDAF4:C ^24
M8GSVTCP'OLYQE(HGG;40J(M)1&F#\!JR9DY+G45(5J0@<J*/:R%4/%D,3]H)
M%Y#0LP @X)PEH%0B3K! BNF7 J.:NE#P!/V0:B1T5:@7SZQDI2N,B\8T1H'R
MO'"TJ@Q.42.,J.<IJXX5S&D&(SCU&N55AD*R:X(BGJ%A8+A#=-;)ZQ(<!=$.
MCE8[H$+&XN23GM.D: +@!GA$D(C2)+R,#%9'\0AV0(6,!T)&NT5*5HXKD,18
M5[(KG2-..DZ\4M8*CXL(N12<+LS+7>6VLZK>)QMPK67D0H!)T68>N>3%<V2.
M9U7C =T6ZE9>A?<IXW(R8L!$ K[P3O#HB5;1JI@="Z7;B'ENY#KW[*V(TEE+
MP#L?)4LB:Z' )>ID$,YJJCE7TE&H$8%N(THK[<(D86QD0"BH0""BF6",980!
M<UE;"V"@013:1I1*3?&=!'1C,#S=<WOC'AZ#T_TT[+G1*)V2\J I5IZ*1[2A
MT+VACF:%]K($+:-C(M  V5CTO)FI*1?=!+N].5T\LA<Q646$,HY T)Z8X RA
M,63*N&-.\:>0<E$34SMK/J487/31)U$@1"632C=GPTK2!;=)UY2+CH))*^5"
M!.XE9$M VD0 X8,X T"X1EF-G*D,ME:G=%ZB%S8/P*J0/..9!PO>>FME3,H)
M+KD&:TP]35FUY,Z: <9%RX(NQ:G4%U9^0YQ2@B1;JL]C5B:BQR.HK29 !8Q'
MR*E ='#*>N4"0X_"&,F#1X_"LQ@9GZ1PU[.4U0%&.VVBV&B,6N*BU@1,H;:S
MC!/MA:"JI,+8 AA,5#7?5:E=6,TSSTRR66A<<$@N."T+;2L5.0!/X1%.4JK4
M/LS;;R=-@(W.)A=)DAG]_5R*4),T)$>IF9?6!%N*4-<Y9Z(B1F?U/.,\2A:4
MRY9"$&!$:=V!*)(,FIRFUJ"N'C%:.1-:EQQ7&HDWRH\I)PQEGB0*(J;BUELZ
M%S&JV'9$;!=6]#HYR5VBTKL(2JE"166\QI\@/7N,IMU5;!\HMJVL".4=FN=>
MDF@3BFTH'3H3=T0PF;0SK)QCHMA".ZNY:OH*&8NS36BO-8"7,CKT#AW. E6*
M>BF"MN@@5$V_<LAHI3TD9G*(P!$H2@Q?>2#..4!7P5OMH\6U9 4R3(=4_;>R
M3?C!,*8A.1V<_%1N/1H<]F-O*D#?2D6Q I'<'IRZ0Y0@C\]P*0S?E/OPD(E9
M)!7LWC/?-4Q<_%B$:L<ER)!, *V<SSX!&(M&E1 6H)I1*\7$3^WLB.RCIL9&
M(F)&(XIE3AR#1'Q,RH),4=#P["633Z#4]"& ^#VR3BL./9IMIH1T5"H&,0#$
M[)RT/D, 3Y763E7;;-4XU$JLR(:BX6P"H5X@#N%*$:.R)B"H3]X(D1(Z<PST
MDM)1*QBL"Q@L;)08,#0E)THD%C1CEJF(QDE"/9>#S94>H]M(,6NQ*!J\4VBL
M9*LB >D=,99*DF7QWGQ6N)C/7MKGW+2]N&JS5)CJJLTB% ]496<#VBPB:33,
M!94,+1B.&SZX6F/399AJI8_XJ&**"$[ "^N&D$ L0_N&>6,T1[<X4-/ E%XX
MV%2Q8LVP8F&3)J?"_LE-HD8!Y\$@2B0K103#_W_VWK6IC21I&_XK"N)Y8F<B
M7&R=#YXGB&",[?6\([%X\'C@BZ..(-"!U<$8?OV;U9) 2.(@)$#"?=\[,[:D
M[JZNRKSRRJRL3.M\61S]I>%@1EX*PP'\4,V0]\PC#N03:<X-,MHGQ1AUS.=B
M'@J7K*5$HK5A+510:G7*9^0,-\);"R1%<$Q\C$ER649:7AR)IO)=(N,<_":&
M2"1Y%PQ8B29!(> DFE@:*#,"D*B,M?QT<+ P,6%<!N6(5U(H[D"\$I=2J9A;
M@GKA2!EK66VLF$JR(0P[Y[E%+%A@+11CI".7*)AD%0U:&J.R&V/6^N!,"51K
M!E2+Y^EBK).55%F<.)?>2.9PE"KHD *63WPDMP2J18%J*K6'8*.B- %Q3D/N
M/161P30A(X*EA*@020%46BVK]-F3H\62RIW<E]SCVKU>NSGH,_,B:OO^?_UZ
M[V(LNZ?R))9#;-('#.>WLW:WGJ7B;2<V;*_^/?Z65QC1S?PRDU-GNS'?8&/K
M%_+K HUP?I*<RY7)+QI(W#4Z?_A>J[_K=SJQU=MNA5J[Y0=_*8%Y+F!^?_[G
MM+<)M)\K[#C"R18UJ 5R'H!9FRBT9E9ZZS:VUKEP79FDO;(T;UF)0"5@/!E@
M3+F<R>,0J=0HNN)<A]/(6FE1<L)S;&/ 6,P"C%)K5T1K5R9CI]3:)]/:*?_+
M)BZ%%1KEKH2(PUHA1[!"H+$D@&M-L68;6[H\C%4BQ@HGSY2(\62(<31U[-K1
M%%D^<:T$@7_E4BO64(05E=1R9:,+&UN$+1RO*?5V92W]LA)92KU],KTM_LFZ
M2VH[_GQW_^@;QRH213%2T6+$G;#(I1# P8]<8$IL5%EQ2TM?(L;J)IP\'#'*
M6JK+0I*+2231.HI 4T"42P9. V?(Z: 0]3%(QBCSK"RGNOI*O3)I(R4->#KE
MQ9/**Y6#_Z<2,2TIXH8P9*RC* 5N58A8&0N29TH>4$+&"B=PE)#Q=)!!)R%#
M4.D!Y!7"GD7$DV7(.F-R:TMAG.=,Z<+E?PWU5]:HQ,I?Q^U.#_5BIUFIM[['
M;J\) K]0C977WE%K93(9=G-;H&+]]F'Y/EVO7NFW+ ?'?LQ(:<AF1UO)D:"Y
M1($&0'.P7$@;$5A0 0.!?0TM9<J.?"M+?Y:5V%#BQ]/CQU2&@XK1<HDUDL32
M'$ 5*.>H(B:M#@9[H[5<6MBC5.*5)0'+RG.X0XE+99U36:<2&Z3QX)U(CSS'
M^00,D<A%+U"2@HJ8.#4QYLI$ZQSG*#%B90W]LC(;2HQ8'D9,I3*0*!@#1PZ!
M5P 8P7.K;B8H\I1R 6AN>2Y%3=CT&;E245=$45<FE:%DY$^OP-,Y#9$92KAA
M2+#LTBM/@)*G@$0DDC@J&/&^=.E+ %F#S(820)X!0*92&0@)PB:1\Z%HSF9,
M&AE#!,I=*IPUB0.<E#[]RFOQRJ0RE'Q]B=HZE;M +-6:.HV4XJ"RV"=DG(^(
M<*&H#U:ZB$NGO@2)%4]>*$%BB2 QE:U + DDN( T#P[Q%!0RR5.D/?@#6G,3
MB5TUK_ZQ-2.&Q2P&M2 FZEFL4RK##ESUO2C;4+'=;GQD%L,\D[)(AM:#9WW5
M$'!AFH2#QH1H01@V7#OI:$@.4^$3]<:F^%":=+W>V\5RES[.<@#Q8D;:@W":
M<,\9(C)77@^:()>40TP$KV'53(SB-<1('@&)SY$26J+1TX5>B )G@">?G..:
M2 ,.7#)6>QUR:UC^4#Y6HM&3H=%T$H4(RGO,D9#.(&Z8198"&B4AL+*,&GY7
MQ+:$A-<-"0L3%&<$XX&[@(/C@ 0.2^LI<8I3RAUGCR<HI>K/J?I3*1DZ4*<2
M!=7'WB/.N$+ )#W"Q%HF?8J,@^I3_ J*2I6(LRZ(LWA02#%ML O$<<4#(T9[
M 4X1PYA1GH1Y/ DI$6=.Q)E*\.#6:VV!9UB571\O.7*&*10(D]I[18KJ-F /
M2J+QDZG]PD3#2\*Y2<$8I3EGQC"3%+=41LH<-Z(D&L^F]M-I(=Y%S GUV;\@
MP#0B1L:[A()1!I9-Z6CXJRAU40+.N@#.XD='!!@MIU/B,O'@@_61"1LHP5%J
M0*&29SP?X$RED3 NA90XHLB\ M3A!!DG&3+4").L-$S(68!3:OWKUOK%XQF)
M),Q#<#@)'I(QV">-+<9)22/M@\^:E%J_N-9/I:.XE& Y<D<FQRSB,@BDC=<H
M!<]XT. .$ID#&M,=F4JB44+.JA(-P!N*C3-4V<"-%<X"!&&3SSX:E]B#CZZ4
MD+,XY$PEMW >C1<Q(<%T0IQCAARW'D6KN15<,R"%.:*Q-E3CGLR74.^>->Q%
M?I-[H*+\9?G+U?AE*=+E+U_9+PN1_G<O=TP;=4J"?XVN&-H!E+,*WYH1$ZJW
M0FSUWB)3<+"E<IZQGE#%+=_6>V!;_-T\B(@E=(EZ&NHVYTN,3S?=-#Q/\/L?
MOM$/\% /;V'KK4J<:L_5.[:]RK']'BNM=J43;8"A H/+!:3JK;RTE63KG<IW
MV^C'S8FV6 ,R4>LWX17\X.^9--9;?3MP:,;$H6D[1_76%6? \)8WADS8II@4
MDL%G0SG9^G^N\^^MFR/(]Q^P1J(QYH0I2CV/##O!;!"!2^ZMXU%_4X)LC*Z:
M&.;@#DSHI(+ 3%##J?4.O&H#=$HHEX)2?,"'X9H8MG,.D-7,AZ2#DI0 !X[.
M"Z>%\4#$K$R.;-SR'*&$TI%*8K3EG#B+-6.*& R>H?983SXG*B&#L38ZSGBR
MRHC@*'8F"8\5</*->V9YV5I6K-S=\CD5WP#YW-CZ,WZ/C0JK? "Q:OFZ;50&
M'D#%ML+8AW_6K:LW"MF<6NLG>Y4[%&MCZ]U0=^JMLSX,-[4[\,=NK],OLO,K
MOF&[W7JJQP ?5T9O:3L1W*FV@V=^+[3HEV[_[*S=Z<'/W$4%7K ''\*M0.M@
MT4YCKY(I^7?0SE^+&>D"VL!=O6WU*KTVJ&D$+>S$;K\!PG$TII259K3=?B?F
MT6Q6OHP_<SCB3DR-Z'OY'I5W[29,X<6_NA47N[T*_ .N6@]&DBKG!1)<G+7A
M=P7DC09V9C,$UN$ZN-EYN]\(E7XWYE&-<")6;*77@3D>.I)G@ >QF*G\S")Y
M.[]K8[BV%Q4[&$TGYBG)[Q-@$)N5;0"$? /;:%R\@>LJ8'9\'RXOYK;6AH&:
MX6S F[0*K\/F*;V6G[]Z\$&Q,F_&7_AZF;HP;9UZ,3^VU2K@T%X+8N-:_,:7
M$Z8GWVQLUH_KL6,[_OAB!BC>!,&9L+@<3%-W8]J]&#6!-<F)8(77-@4'&!B-
M%E8P:K$0T5AO7@YK[K)\A<D(T;<[Q:N_!7\U=@8V>O:TW NI$]-BI)4PA0X3
M);DC*A\ =9IH%2D+S,!S]OJ@&X"$Q5F%3ZU!HFA^GG7M?N^F4GXJE'*6G*P$
MVLV>LGNG8&+*5.*&F(B-C9I[J@Q-BIF$H[1@'2)(TCZHTSC&]:> *X-,R-H^
M4+AVOP,/Z9SE98Z%KAZU@9RULJX#$+G>.*O)7S<!6H[LT>"W&=0Z T5'.:X!
M=Q[[>3U?4;'AI#\X<U5 5Z,.9 GPZ&*SLG^<?W']-?RM%6,8#&\$K\/BLB/4
MA D9@-E@-/5NMP\C\/6.[S>[/4 K>.[Y<6QE8 %C ;=LU)OU#&: I)D771F$
M*R =CCA#SJ3T5&X1GUD(<X.V3>PG*L5LHAS3&+E1RG'-I R"@7  ,OAO.\7.
M L$$76\QW(SP?0",_#NOV,"\;[?"F$FO#FQ5V&U]SN_2@=<<5.;MC/[ZN^W6
MN_GZXKWVHS]NP3K$[GX6C'T8Z.^-MC]]Z6#AOA\&"]OG!Y<'E[7]/^HY*%C]
MNH=WOU;9[M<#7*.?+@_V?Z_O[OQ>/SPY%=5W!A_^<XQ]\^^6_6KZNR>_G]1.
MJJ3:_'1Y>++W YXA#BZ]@#^S@Y/:<?7C)U[]^$=S=__T_)_+TXO:WC= 9P)S
M3A& >$(<QX2T=@DQJ8@,#BL2PP;8=&_/8$& H<2-%T22K.&IW6BTS[,P%VYB
MI=MO@GK 3;J3]G22\TSCP=!7.<_:$K)=;I^!LH0ZB$X/?!9@5>/V/M^O/R0.
MF8X48SB.W3B)%5F[@8G8UA I!N\$%X)/U,GPX;)$5L[:=1C5+QONK+L!#*W9
M[K>&9/ *)QY"M+HC*G'C_:ZA!<!B!NT:LJZF/2UH%W SWV]D&!R\T?4TPMO,
M (+AW ^CNH/@+4A!PYYUX]O1'WX;N?CU5K&6Q46_W33R8MHA+JSOX.O?SNNA
M=YSW%C;Q8']A&.\:/GGX]6;QU42L>? =(YN"Z5N_QIODD=\Q(1YUY5V#-9NX
M'.L3C)6(34[5F@S6;&I%EWY7NHD-7YNQ AMXT%WO"8'?NT$[QT_-U$]G[,=Z
MP-O8F8KP%5CV,CD@F3M5_A[8PVPI'G#@>9FS]OHG^(8GMGU-Z#\7YO^7KR/;
MOSVR_1>5H6^7PS*++,D#A?^!Q_*?> X?'GHN9O67#]<\#N@6/+*1_9Y?ERN^
M0^*28_,WMYSO*6NP>E)8S8&C"B-O*MF)>DA5@X>\^D\UA3O1QZ8#AWHXB_1I
MH'(MYF(ZYEN96\)^2B$J]?!%]'#^65RP$L[<\_QRE7!NF^4;(8LEU,%97(3+
M!Y0/*!^P5@_X"=J?O7O@#M%3-$2;9QIG)HBOFMGY/XM4O9LCYW>U3]M0QZF4
M/-" !7?$.VVEI3@Z+3'5U#[TM$VU".MGDG[=H7)UTM\?N:,U3']GM9//)]7]
M@Q^U_="$<>+=_5#?W?]T>?CQP^G!Y=_PYR^T=O)WO78QF?[N81S5'[63]Z1&
M#SB,5\!S1/6D=GKP]?-)[>LG4=L_H/!?]L]EM5>MY[/\[WNU_3U6W3GEWT12
MB8K D0@$(YZK!NFH(R)6QR2"C]3;C2W.V!H?MUF]ZJ]K#'6S5^150-W"IWP\
MT]0[98P4C.NDG&98@5.'A87_,/;04SXEU"T!ZFKO)J .:^U)I!@%'PQ 70C(
M8.N1T%08)TQ0@@+4$;I"-6R7A#=+8JNSXR<OR4/^'"4//&F'WB?D^&,)@9.2
ML6+,KM7/@:H)Q+/4F 3P1BCG7$BO([62*4,%Z)B.M]2N9=/'&EWO&NJVO]MZ
M(Z/?AW;G+\"\ZG6&;I']=P6%B)=8^" LW)W PC_9YT;\S^>+PZ_AS%$N:SN-
M^N%'N/[C :E]/#RN[1S].+AL-&O-ZL7!_F%S-\])\_WYP7Y(M>UO%$N:9%!(
M>2405XXCRQ)!2BF3E!)>)K.Q):<K0%5093[Y$H$938+4*3EN'7&.)AY=M$8P
MYZTJY>O5R=?NWC?!@]+1.<0P)H@[8P;5YIEW3DF:L49O;!$\2\)^F4_ @)PE
M[8VPG@M."7,N-[/47%$I>"2WU(+@I8"MKX!5]ZO?@N8I4>J1DKF?@1,1&6<M
MPE%@9D$$L 7K#.(W)6"_3IQ7>$:N\ )LP)TM)=2W1JQH3B=P)JB '4R$>F^(
M\%P#P' M4ZXZDT1RTM]20[NT6L\=#-O?OEG<<BK%/#2K,#>')]N7U9-&XW '
MQG7YN7YP\@D?[FS_J'[\NWX(]ZU^_>/DG\N];YKG<T&$(.JP0IPYC5Q( B7M
M,/8Z&2;9<FB1B]H:;T&<(N:!,<L$@)9T$HA1L.&60$,I8&LM8*??F$_62Y&0
M#UHC'G! F@J, I/.1N4)H6Y)O,A3'CQU3C ?N8U:*\8)4=ZI8"/GM)2P5RAA
M[R^_B:3!GW<&Q<0"N'8J(,<,$"-PO(Q,N3,-V=BBZN<A1K,)P20Q>FR*S1J]
M<O7!!P(72;!91IVQ52XEMO!^JN B"AKR 5+,#7BNG%D9(K8L&2Y(*/=3GPU_
M]Z;W4SG16,JHD7*Y>39/%KE(P%A3#L@*+J:D'AQ+L<;;J;.1ZSD*%+YV;%AX
M S)(K24P-B$<Y5YCZP)5+&=;$!(,U>4&Y#-BP]0&I'?&:TF!3'&>L8$RY(!8
M(R<#(U822CB?B0VO1T$78T2O;?_Q>6;MS@-0:[[_& 2/!E-AK8M<)>O O@J)
M<TZ3 *^5EN'[E8#"^\+WU>;?QU7ZGE;W3VGUXV&SMK-]4;T\;N[NP[UV<A79
MO0OX_+3:_)SW'X,PAA.>6Y9+F5N6*V2LBBA0&0(1C'*;NQ'C:22=?P.2TJ(_
M@)/:<L><9E((S7&*.&!C3+D!^>H$;'?OFU9&>DLCPD1SQ$G$R F=4&(R)H49
M 8#9V!)T\3B;Q"Q%;:U027 BC+4,1)BQY*V6GM_BS97RM<;RE?<?(]4I>))0
M;JH( I;;:6F5D"9 W0GE0-@Q4$$R(\Q662#.MB!96*,-R/6E1<O8@.1"<IN8
MY99$GK!R03/!L<%:<AJC*Z/W*X$J]T?OOY!#>._=C^]Y;?\]C/?SR>[77-S^
MZ**ZOX=K39C5KP<7M9WB?M]T( I[1Y&DG.>..1)XD8Z(2B\C!9Y, @->- -5
MYM^!])H8$*8@6> Y78=0'YP+T1@-3)R4$O8*)>STFW91!6,8<D!1AN%-'PD*
MEA,OK&+$N>40(^N%]H3PR%3DFFF7C*(L6"!%T1.:2@%[A0+V_O(;C]9*9@*B
ME D$?E<"#+,>$4J!'$GJM=*W,*-72HR>: /R<7NN+_G*N\6>XS.<1'W0?L)#
MCVJM\UYCI#@% %O'H^"2.6N3L$:IQ)3&R>ERK_'9H/;+]%YC5"SEKE)(*.(1
M#Y0ADYNF88>%-_"EX&",IX\SK<]6XPJ?I%IS:%AXJY$" 0P)O$Q)#%?@ &AJ
MN>2">RIE$G&QK<9!"7!XS(_>VU3_$0.ZC)UV"1ES0L;4%J0DW#J:&&)4!? 0
MC49.286,E\XJZ235-FNIAI7[K3P'6=[C&>ZQ8'6JV6WT;JWNLDX9=_OM7F[I
M,FRBL0SBNYRI>W Y@^6MU(I505BTX,L2)V9%",7B79FI5=9@&PGP5DVQ]CIZ
MG8AWWCGC6>EK/!MQ.)CV-8PFGFE.P,W(;9FYYD@;1I#C7O'<U%9(O;'%9^2%
MKX^WL52[\N(-FTL8?_IB-J\/QA?V"PT/A'$F%0Z!1X"&E'+/(N%4DC@E6::@
M/B.,3_E_@7&*,;?(1Y?]/\F0BS$B+&'-7&*2X SC7#U'J^O7C*7EH\M'O^)'
MS^A=/-G.]KXNC2_356O[1I>L>LMWHNT6;1>N^U!USW(CWQM=I08-I ;]0_./
M;:71/H^=6_J(OJF<']=S7ZILX08/F+[!,8SJUCO<VQ7SWAZ8PWD=OKS@N6'P
M5*/FJXY3__=FSM-01O#U)=:!2/1[MU\RHT'Q5.;^LLG+ ]><BHG9'/OW'.U"
M96X6/+CJN'-=^/\H(@=K?(IL@E=\:QOG]J*[\>^;DP,S,[X2DY-X^U+>T9[T
MWG:C$TTEF?*2:0'O*//!0>.4H=$Z0J3CF,07;$]:W/'AK9#?'>=V,S<:S#Z\
M*W+EG>UT<K=AVZM<]PMZC@Z/OCYW<\>BF^-X?XHB2P6^;L-[->J#'H\KU=GQ
M9'M(C,^:AR>_-^&^]</F%U:[W,;5DP\GNYF<[AP!@3YE!\T_3@Y/MNGN7Q,I
M(\W#9J[C4Z5_- _W/1#7O8OJUZJHG1S@W1U/,ED^R)5]=@[$/Y?O2<ZG34&
MXQ$D4CSF&$5(R%KM$!/:<BFH()BO56M'?RWCZ4J,QQHM7W\XWG)Y9C/MS<I'
M6Q^V46VTX1;=8>/HP:_RTP9#:-J+;!%SR_M**[=@'1O#M94JNDCF_MRVU^O4
M77]P;:]= :@XKHQW9<PM)*?;4&[.8 )KTV%1J4U!'MM ;TG-]69POM', &K=
MX_\\XR\?/*GKU%T1QLI7KEW?4RSOFG:H^S#L];Q_W(FQ4H7?'W<K[ULAAH)<
M7;4LFB=W;B6UZP5_^:I[\7UZL@9\J[>0<_:76J_66HOV)%M*0[*UFS*ZE*I&
M2\N^>-G>;*Y7D-CW_^OGL-!?3]M ;!YY6QLH>=)96(^[_P2)^;]'<,%:V9=U
MM@%N:7S2I/Q5$>Z[W9[E]G9Y21Q\XMXN+_EJ\Z0G28I5L$1IRWER3$ONG-0X
M5T1TT3ZXM\M5"'#L[-G7>N]X*LK7O1GFNQD3+.*'Q6U69T_\D:&_X9ZX.-RI
M7M3VPVF-?CZMTCU\N/.>'>Q_(KO['TYJ]!.M[C?@6;7FU357>^*-T^KE)U*C
M>^SPX][EX0Y<OQ^.JR=?1/5KE1V<'/S8_?HA[\^+HBS39&J3!Q&3-!(4G<6(
M.V*1$](@RXPQ26,BO)B])[X^J4T+I6)?:>@RX7R-8?)%6F"]Y*O- 9.2L_P_
MPH317'%B\HD"R0A7+MA !\="R.TP.;Y)LB2$_#VF=B?"M\/@N!]LF[1WP'ZW
MN[;Q$1;G;+ A\Y_8",.CP26NSHFKDR52OA&7L'6*(9J81]SD&B>"&L2L8<Q*
MCRGW&UO*R!<]9W(3W)ZIC.]XG9$7T>C!CM!PLZ?8!OKKV';B<;L!KDWW7\7V
M#WS;;L;E':I>5T)_]<LGJRZZ)A184TRX!:4.3'')I#/,ZR2BBMH'Y?',O>]G
MXL)9H/]L=[N?AB+]J?7>=K)+VB4EDL^%Y%^F&;(Q-CF?% I1!,0CIL@(D4 >
MB19">$,\V=@B:\R/%RJ9^CA^_.(UC=>$49*(G4TL$8(YC]09"BQ"ZA1(H-1;
M7: .':$.+5%G35%GBC]BG914X))KI8$_2IN0(2PBXPFSN:,N"#^@SL+M6I>H
M^\\=ZWU9^OC+()OHUQL\<E"D!9CC&=#)V.K6O\<BZVAYW4%>-8]<J'1$R2.?
M -$+@7XW+L^?"L<H_ZH$^;E _F":6@9 >!NY1=H8"=32.N08CH@P3+56*M"4
M"\JM,;5<O=#K:P&B6S)XGI=;YN,D\*<2DM85DJ9X)TU8<R-RR4&3:S-[@"0+
MY),[0K%F#'N5>><T)DWEBY41R^6I]9^CS/7_]>L=H)J]]O" 5B7U>Z!@E;-V
MH^XO*BZV8JKWNKF$5 6TI]<H=*]B6ZW^($G^24R'V*0/>(T91[!R&@FBFWHZ
M<=W9;LPW $@C2ZQM^:KI\QH$1%:'/B]WKVUDICX/-72_O5WHYX="/?];:.?O
M0^5<_0)O:V&\_#2?5IF^^"!0/L>(N/ 6&9L"LI*8A EC5+C;"[RM#ZLN [8_
M$ZM^2:0J$6DN1)JBTY$:$:S5*"3,$,=,(JVI0=*QH!RU!#,Z,XS[<#J]QA'<
M%Z :_^UW_#%PR^Z;2A=$>W P])HI/VU%[74AF3]K4<U9.J1619YGFZ8K>7ZF
M'HRK+;AKSCY6QSMZ@DC>E:26K&(N5G$Z[>?(()GQS* H#4?<$H6,\AHI3:)*
M3@7G[<86+SV<TL/YN5)22HQY+,9,>2Z)8&$3L0ACGC<"0FY[13RB.I_Y82(%
MSP!CS/HDH*PV=7D=OUR2![D.S/NOTFE\3?OIL[GW/)&_52;?8\):FL:Y3.-[
M,(L'-[O\;7^+)G*1K$%&6H&X9@19CAE2W!O%%2P_<1M;T[;Q13;)R\29U0OQ
MEXJ^DHI^-*GHVEFM' U(*:81IS@@&[5#*C?_"I)S+,C&EIX^_;%6Z3!K5K'F
MKGY!9T\1W_]YJM<\(+BQ0*^+GYW>/7VZY%4 ))_B[G[J=ONY(DVWM J/M@H7
ML^B?=YHR:9&TC"$>C$7:,XFB9$QK[&1(85;>]MR;NLMN$K%09'0!^'NUL+(2
M9+*$E;6$E2FR29UVP6N& G$68$4;I"6SR#LFO10,3 W?V&)+2!9Y6ESY"=)(
M]CMP;8J=7$:BU_[W+^U^K]).OXZJCI<!P3*+9)UBV3?%>2$I+E-*5HJ@O.J4
MDBNQ_0126P@M*WG(?#P$SW!ODN4F)!>1BH$B;KQ&FG*.F/:1!^D]4%3@(=/A
M[3*_I,PO>=7Y)27@+ -PIAR?Z*G$3!F$5>"(4ZF0ME8B[@P7S/&<[;:Q!2N^
M/LDFKRG3X9H=#MR<TLMY/;NA*Q$7?WJ\WNWW=E,)V(\!;#*#(08<8_36(Y>"
M0%Q&AASQ&-'H ^&4*,H" /9T<=,R >+E57XE8M:ERJ^VRD]Q-&Z$\REHY#S/
MM8H<.(4>])X[!^LOF'!49I6?/G50ID*\3"I$[PEBU&4FQ-IO6?X<$<%:[)6H
M/Q_JTQE$3UA/DPH!$4< ]16LJ38Q(NF3CR9)R8W;V,J]YM8]%%BF6JPX;JT$
M;7WZ5(L2P19"L"G>BCV6+H:(,)81$,Q*9&FDR& NO))"@Q1L;,EI!'LE216O
M@M"^;X4E-=A[O<QU.8*P8MVFEM24[X'OOB*6;F&&#M9,<6!L,0%39]H;Y[$'
M_QW^JS$-NNA#];S$O&S7]PA[QF;E'E/OC!(242HXXH$*I*-@R"<9M8PQ!)UK
M/ZAU;D@RK^EZCJCP_(;C50+RDMK_K1<@+YS30!V/V#(: S5<)6\]XT0+XK5Q
MA! _Z)_Z7,5*R\: SXG@T]D.1/E$DT/*!HRX$ 99PBP2Q%$;5&2>:?!(]+):
M ZZ87_)D@?:7*LX]B+8?/;BI8,7V>IVZZ_>RRN92WG!AK],OCE%4CD'7X >5
MWG&L=.)9&UX5')]@>TOH1?@3^CZ+1[S6U_>9[]U7Q-2NSN[$TY3=W1[J?BZ\
M^^E:[[.)G>ZC5EK;^:PMGY7,S+6(!E;;:9Q/\%N,'% M9+!.3(.GC+%Z%>T;
M5\-;>K2I>940OJBWM)80OCH9X"L!X66SAR5!^Y0C%1AU,BF"K!.Y"I/ER+#H
MD4Y*6X!U9BR_O=W#*J+L@IL\@YNMNS_U[MBVCF+VH/JM3H1!78(_E=VK2KLS
M:+OYL*:;11,D6T0P;KA5L15R$OM-#^L,AMH.B_?I?-!*O#HW:UXQ7#$SO=Q=
MI@>\_HI8ZH6=+:D4LXER3&/D1BG'-9,R"$:(L,+[%W*VOESA1MD^\"F-LICA
M;_EHG#; <A*L..)*462\Q@@;*8T 9]QI_BIZFLYC<Y]Q@VH^R_-:$7VYVU3K
M@^B+)\F!R^6<$3$Y[;G%.;N?TT@Q)I9($NQ+]Z\JL?W9L'TZETY%+(@4*&CM
M$+<N(JVB1%Z!9^X=II;EYK"+Y-(]%[@6GM:_BRV8$=V'?XW&U;2=HWKKZO$8
MM&SX4)0Q[:T9X5R]%4"4WR)3H.I257NLJ6IQR[?U'KR(OUO=B5A"F]6G0:@Y
M7V)\NNFFX7F"MYL@*N#-A7:EU>Y5K/>=?K&#UAW;:MN<<.(&HECK-V%@OB"W
M&>_JK7Z!, ,L4(D;8B(V-FKNJ3(T*682CM("1XYF@)%P30S;.91CN); 9:11
M3G+AB),"L\A)2DKRD#LDWRU-RY:50D+OF].;.Y6Y+FICT%;X09N6\%WVF N-
M@:M=&[QL^"FXT*D1?6]P=?[%NW:KT%6;/_NK!_\9[&R"R_UIN/^97ZA7N?+M
MZZWOL=LK&A4/1Y0'5RN>??7-8!@3B[N*D_SQKNF]+5;QIICJ')6P/QXVU7EZ
MQN(C]@SNZ =6L_)+B-=_^[4"GW2S(1UT@,XC@]6M?R^PH?N 9;MA48>+.$/+
MQM7J*:)']\\_';FOTQI^K\9.:+B(UH A8I[JP).0QF#C@[(L!"J"XE,UL]J=
M476$/)O#,W85#_-XU.Y<5-H>%J!R#I,(JW9->N#:S'K>5+I]?YP58[ 439BW
MBW]U*PZDOP+_ +GJQ7SO\V,+N%<!83^%]3^S&<SK\.->Y;S=;X1*OUO@88B]
MV&G"U,!O,X/*"E0<!QSROS. PO@&;E_H8[,-P@7C!VGK%N2M2 ?*E[2+\21@
M;Y7OF;Y5FM?\;;-2'8PBW_-[O7=1Z5V<9=/2N,A\$"0S"W_H=Z[#:X4T98+7
M;M8]S(,'8P3: I=FH>P=U[M75V:QO+IQ)X:^CX/)L=]MO6$=,$3X FXWG(JQ
M*041MIN5;9!TN+#;;_3>%!<VBB6!*V[,_TD_'!7XTLLSV\PMU5W,VM2H#_JL
MYTOS=.6W@(N'0[Z1LP$*/GS;_!KP$M<3,7A2OM,QT)RCX^)VYW4@#</[->K_
MZ]=#?I<NZ)@-W6E5VJQ<BYJ+O?,(,C20+UH\<"1KPZG.@9;B\TS/\]!AAD#+
MQM##%P'60O.O'S^2LD'8=/2:9P5.P PTK!^TDJ]WN_T\$NL[.<;:A8=WP*@
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M[+QZ^TR'$4N@6F4?M@2J%P6J*?]5!IL\H0$9%0&HL./(NNS$6HXM<2QH6$P
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MV^H==RL17+DP4QWAUS-T[X;JW<1XJ12SB0+%!($P2CF0#RF#8"!$5GC_;:?
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MG35@.*X1GSVL4D[ZQ*3?$^];H\C=Y[&4FR+19AF!U=F[/*M6+G )=3V2$3*
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MGH('*C67E)0GD-<'/2>9J]:&<8,)PBP!>H*?@8QE B5IC.')A*C3FIU _HF
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MH"(H/OD<:JW5V%,J:>)**ZN,D=Q():SF!C!I:WN(DH!_?]:MJS<&0%R-MEM
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MHVM-S-+*H?NUUY^S#:VZOT_UFREJ3^AVK0#R XY5W["7O3KPNT6H$-A@!FR
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MVO:PV\N.ZQ,+QE2HN]GEA.&<@U5+3&6<M+M?;1X_EM>G(7YG_=->E=8VMO)
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M4/F?\N1"/Z[S/NO[NF?:9.;A^%HSJ_8X#<X$B+,0FAC#Z:HVI+C9<K[2Q5&
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MY8X'1I4/G"JJ<:0L::FBDIR%VX17FJ51!5 ?%E!WFW$6Q1.-EFJ4O<.(@TV
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MZXT,3^DH+WCP(,Z:INO<D619B!:IE!WF.F;#*%%$I>!&$\$%TU4AO""%K#R
M:WW-TJ/I.#WZ1U/DJ[;+XW'SER?!3S\]>)##(U[16[S"G EC^4@@^DHWQR0Y
M.XCY EM7!["7D.LJN_U]&Y1(?4:G(=<\*G60)Z7&P=OJ7.Y6QW+Z@4$IWUN*
MKOG8# R8**T2D2%A<BL^2SERWDKDJ3!>"6R]C)M0OE?R.5;7@%V:#__.Z%)0
M9"$4:7CS#>94ZL 1#L8CCJU&U@:+2&)$Z2!D(CF\V,P9O;WY6@1X9=G!TES>
MA1T\L5Q?90?8I9"<#(@P(A '1H"<X!))I[PG*D8O;6$'!5S6(2&\@,O3@DO#
M[4T-X0 K C$;%>*:6V2DH8@8*[WA%-NH"[@4<'E(TV.9+6.+Z?$8#HRFL]Q+
M)P0)$6D5P?@ QHF<-!PQGKR+SDI!V.H8'S?XHL=#X^$YXX^EOGQRE3[YW+/W
M7X?CL\$PAJ=+X'_8./#Z=GQ?^/576KD_4=#B0]U_N@3 EZ_3#YM!"8R3Y8EC
MA$&S(XZ%13HXARP7.FBKO$N\5"NL5$9.0=^"O@\6U"GH^X#HVPCF)&&3B[E/
M/.6 OEIHY+ 6*'#!F0Z8<!OKTHQ-Z!M?T+>@[^:A[S)#<@WT+0"[&,!>I;=:
M2EXE=C*=.RS1@)%C)"*C-7726Y98*'4H!5T+NJYJV&#Y)3>%Y3XL"#>BCX$X
MJB*/2%&J$">)(DN#1<HE&[E)GCA7BFX*##XW&'RBX&D!OX=TL#:#IM3(P)10
M"#NC$8]8(B>80"QB)XF4/HE451CQXF(M4=WG^LF[%HY=>][N'-)]^*JR^>J@
M;H?8>M'I#08O6RX"+,?1Z(W6T'Z?B?/>N?KJYL5:='[W[99_PVC(8N^^*1QD
MZ0WIZ@.?D[9^[?=.?H%[M;MGL&S[I[%O\],,_ED)0?VY@RP";[\/^Q:6O=VU
M_?-WPW@RV.MU\U/V>QUXN<-J@G$<# MO68BWO/WVKX-W5WF+#L&RD A2S C$
MN9'(. )FF[+!,Z8Y#X#>9JTC$XLJD<=()2T@74#ZZ6/!CP+2Q?)<)H*_OXK@
M)GG+(I6( 5XCKE05^+ H$AX4L<R0W(J4;.--: Q=,+Q@^&9@^-+[&A:BO4HP
M_;'I((S4,DF1I-H@;KE VGGXR5.J>%1<*KFU0YN#6 M&%XPN&+TI<>F"UJN(
MUH=7T9KI8&$?#5(^"<!H:Y#A.B*MO4E*2"D5WMKAY#ZQ[ *7!2Y7'RZ?LC]F
M<4NL#8)6_V04A6?QW_8/#C\G*JP+,B(/IP)Q%PUR7@>$F3"<J*2<UMDO(7'A
MO \TRFHEZUWGP\P?_8B&]GO+5G6O52U_:]AK]2/(KF]W8OZ#'=?$CN*E50?.
MW@0+[E,A>V-GAW*-<HV'N,8CM=)]Q+R'^;#ZHM;1+UMV..RWW=G0NEJHNY?4
M,XAVK9^7D =1NK4\9D7WE*N]GMGA@]Y\^E7S-F!LA6HM1K7.Y\7PHPF<8I%S
M#R48JYXBFPQ#E LF4PHX"@G&*EV-ABU%BE>XW6N1XL>2XD8<5UE&G#<>$6P#
MXD& %&N!$8DZ>8JE2RI7L14A7ALA?J+ZTCO+<&G,N"39;@3_0 5C%T"81<H5
MJE$JT-#$H!BB8E@GIKPHK1D+PCP@PG!5N=R2UT;E2?&.Q>B\!4A)Q!.+"\*L
M$\(T E9."JHCTRA1$Q$WP",T#B(G&F ,O_%*DH(P!6'6I?EK,40>"TJ:D1L7
M!0E",T0C<!2N*4>6&8:82<DZ04B0.?C-5L,4>>S@R%-Y4*^;1]:I^B&W7ASF
MYL@O6P\"Y;<8.(;O/'#L!7EY#V?O;1WTMYALN7[HO%(CQS)8 VQWSO(BSO;G
M_G#F!NW0MOWVU4+TP@'O"MP7<_S 7&&MG<0H,*<1EY(CA[$'2A@DH\E[@_TF
M<,#Y /X8?3X*RCR\+[K9R.=><%-@94%8:3BF*6:<&Z"#B4>+>* ,&<LC H;H
MB9=*2)7':?."* 51'L"J?/AI: 5)'@9)&FYPYH3'Q@>$"<N-&KU")D6,B(F<
M1&P2YGQK1]Z_/U@1Y-6C!LMT0!<#9!7DN^&$EHE:SZQ$4EA@"G!D<L&$0])K
M*S$A0E-5#)"",JM=@U ,D*>%E3D.:<J=B2D@V%R.N*08V4 ULDDIDH01@8,%
MLM8]:I8(*8^=4OP$B_OZI ?/<E'E_;=ZJ64]B%^_\HL/;?>PG7.+[6 0AW<K
M"GC6$;^G;!8VNZ_[Z=UD,U]7>UFP=#$LQ7-\Q-&%@)6(R%E<.7,2LH0XY$B$
M/WB=B,Q]2ODZ>W-*CL#*(L;2.U<5Q%@R8C3=OP9KII-#A 6/.-6 &(Q;)(C@
M*?MP%,GCBYJ5\ 4P"F"L3F+T;0&C>(>6!"0-[R]G,6^912P&ACB "-(I.D0%
ME4I'&4ABF^ =*FBRLFBR-!]T09-'1I.&KUE'+B2C#AD/J\HC8<A0IY#EC E%
MA12Q)#P7-%EQ7W,Q9AX4-9JN9!L9]5X8Y*I^Y]YC9(%Y(.F%4DHZBX7=VN%B
MG8>TK'%R]1,(_(=3D$C;:;5SLZC20Z9<8^VNL:2 3P40:E6$=3X2YH*?P[K?
M4\MV0VO8AVO5 (VJHH.8EV!0XC[K$??Q[9\.ICOX9[V!O^3]*Z;3<D@0G1,#
MPL0Z(7(:7I RQX \,D0X1#SW#JPG8P(OIE,QG=8A#E00Y!$0I!$3"H0HZPE!
M+I'LRC41&2,X<BX2KF1,5!17;D&0M0@,%01Y! 1I!(.T%%QS:I .GB(N&$/&
M8XRX48F'1&G2A8,4!%F+8-"/$*0@Q8)(T0CT),:<4@$CZ7U"'$N,=#("$4:P
M"EX3:>.\OG@%(PI&K$Z(IV#$$C&B&=;A*2K-+4$R<J 3-EBP141 R6B3K.+:
M&E= XG;^XM4;&U\^>9M/EFW=R$^6;=W(3Y9MW<A/EFW=R$^6;=W(3Y9MW<A/
MWC5K[=93W%8Y1>;R)+7IM+07N5'HRV4.35OBL-"%-F##AH4N]NZ;XEE;9@[1
MZ]%1+_-"U\*%]VY>87H*#B?I'=*:"<2)5LB:X! 63-% N-<I>_"V&<5K[,5;
M5-$\1D^A N,%QE<BD:O ^-K!>",S+++HE"(6"2\8XB(#.@X2I< "2<DF(ZJI
MSV2M&P84&"\POE$POLQLND>!\8+4"R)U(P-/$BT=T0$9'##B05ED08DCV'4I
MI!4&"[+F?5T*3!>87GV87J09NHXB6F:BMT3RJ*.V!OL8G!4VL>CCG=J;%L!>
M1<!N)$)&(B2Q$7;6A82XL@Y91T$BL! F:F.<#5L[G#1;]RW</[T@9D',%4;,
M)TK@+/Z)M0/19J8H$<R0Q"C"FEC$HT_(6&J0"(P&+PSED6_MT&W,FG,H"O.=
MET<Z?HKQ\](*BZ\!^86QO%RD7&2-+K(9S=>K"_[4'L+-_"W Z<6[;@ONT\FJ
MK\$U%UF%T6+7;W>?3;O7#>XP$79\XYFO^)AU^M,0I+?PJ-U>?WC4^I]H._!_
M'V+_:]O':;K'XH-6RQ8M=8M^@0>PH^WQMA_+SJS*SNP/CV*_M=],D2H[\]0R
MT^N?]F!78M7[Z6VG?0+VU*;O4;W@JV1^'_2 &%Q2\_-9S^9E7%ZS'D?]&%LG
M\+FC02MV0PRM7=OW1RU&MEL44WJ+M7HXAOA4\^K_C%]C]PPN5V6<PL,");&=
MEC\;P'/%_N!!C.D''53?NC_*+.RQO&V1]:IE(=_>+SGO#5?$^SC_U18)JQ-!
MB2/&""%X]-IA*@4-7'@N M6B\C[2L?>1_M#[N-?K3N?/C82KN N7Z"[D<[)2
M7?!64<Y1BKG+./<<.:DYHH$Y:9)E0N.M'4:WJ6YV#%[[-A %E382E; G2A#B
M0DB8LT",8\DD&KWD6"1C"BJM%BHUDBPUB\E@)Q"-U""NN4:&)(N,)]3Y1+S$
MN24.WN:2%E0JJ+06J&2$9Z!?L7>@<'54FME(6/**4PO %.Z/2@5X%@2>1LZ@
M$=032P**!'.@0Y(BQRU#4DJKDPPJ,K.UHWFST4Y!G8(ZJX@ZW@@FN->"N<25
M)!8HD$N!$8,3B4$NEPN5'J+W0*,YG0$IYD(0Y*RUB"OFD(M4(!ND50E4B(SV
M^AZB!9$*(JTB(F'.G3,B)J<]M]C!'SCP?(Q!\4H2;+'.5@N6FBEF7CL%-EA"
M'G.'N, >&:8]<CAIRQUF'JNM'<ZVA5DE\VRC9CU=/SZF/XB'61Q:_5& XD%G
M/OVH@>J<]5NU!JKW1C-.*)AS)C#O*6<AFF2PB(XJJ8T*\C8>\&;!0H&U!X8U
M,<<5'CP+R1"%I&41<:LT,AY^HDXYIZG%TE8-&JA6]P6U^<#R&+4&19YO:MLB
M3="1< W,FY-<[A^UQ5%8JJ45SB]1GHO(+BBR33^QP59P[) 55"-.-4$6-@JE
M9(Q/22B:S-:.N+^3N CLR@HL:%_/J4W2.,FY3HY&#H(JH_1$B*2*@V-EY+?A
M;A6>,QXC05I[,"0"8T@;^)=(07#%M*.,+LW!463X<65XD;)?;'1PQ"5@S9IK
MZYWP3 2*-5&4"'N;B&UAT4\AT@V?I> 6>!*U<*240CP%CPR7!DFFHE16:$QY
M9M&:-_-)%B[C7459ONLU'BEM<M@[?<*<R;TX;+4G,CGJW/EP68>W MC;>I-7
M#F 7B0(%;A)G2LD00+$*9P1+)G#, F;.\%N3I+,!.K3V]"?8R"FVUG7 !3T7
M0L_=;_,FUP+Q<4YK)+4%]+3.(AV91]3@Z+R@(3B3$U]6R*M:1'6YHJJ]IHY3
M0ZGUG$MO?01C-KL@6&2)IR*J3R*J#=\#QLF*)!Q2)E#$@=8@EV1"DFOC)2=,
MB;"U0V6SRK[(ZJ;(*FPU4Q0#9%/+)<@J3R1@GD F6<2"%5E]$EF=E]8%%J42
M(*N>(:Z\0T91C4C@FD7#N#79*&&ZR.K&RJIQ,5B#L4B)<IFD-MPPEQ,QO8PV
MW+Y4Y8>R6GR%2Y+AIF/!$:>=P8@)E4>R!X8L!9$6@H-0:\:#5AN<#%7D>-GI
M0T7G+E->FUE"QF(6B2#(2LD13R8BPT!^<W#5XY PDWI^.[_U2Q&ZMLQ[92N]
MY\MA5?F^E,2A6ZW(?0(BMU[RC4/ I3OSQI7L)3BR1$S\/L>]YV40.@ &TJ P
MXI01I .S2,/6489=LHEL[3"V+?2]W09W0*8G;79:<&'E/(<%%QX&%QJ^1&H5
M<[!K*##LP;:1!CF  "2H"SQ(EAP66SN$;%-S;]=_P87GA@M+]U).<:&(_H*B
MWW!->LF=452A&(U 7!*/-&$&>:H\U5@3S?'6CE'W[KY1Y'XCY'Z1K*HEN#RO
M9%459O"P\-#P>FJ+N0U6(>8% 7A@'CEM U(JRF"S[TO$I:53%6Q8;VQX2B]J
M082'082F7S42)@Q1#B !)\13BLA@2Q!65GOOD[22;NUPOHWQVC@1RISZC?SD
M9C2+OPYSZ3BCM1_A.2ZJ2?23U-9^')QUAJ/FH!Z>U[:[K?C_SMK#\]9)'![U
M9C]]-T][B1@^LK_<MT'-U5L]C1C^!AL[R+-RXN!MM;V[U>Y./S H60'+T887
M\XIVN3(Q&8U4Y& ^ATB1,XD@L*H#P=$:JUS)"MA\&5^"[[M90'0W82]"O:!0
M-]SA+)!(8M HV !&K]$TI_I(I+ Q6#(;N:4Y"YX5@=Y8@5Z:T[HH[:>6[X;/
M&TZT8,HY9(@#I9VH0L9:@WC6UUP:QC:ZKUF1\66GY!89?VH9;SBN@701Y3%&
ME!N,.,$669$;JS)FF;4Z"B^+C&^^C"_!T5R(^1,)==/W3&F K?,<22$E,',:
MD#6.HY!4%!;^AW58-69>?,L;^<FEIVJOB=>Y N#QI.Z'3=5^7O/G[]NS=RWG
MSZ^4<_U#W;BTA)(?0)V3.<YSSKP.0,V0M)$B+G-)703*3KQQ5CIG _:/E8Z^
M4ODE!?@*\#U:MGT!OH<&OD: (04%FV=S"HVQB">P8,"*H4@X3I(7.)K$JGQ[
M9NYMR13@*\"W4<"WS,A, _@*MBV(;7,*"HBA) ID#(U ZJB$GX)#/ 8=N9%&
M6?(H!04%V JP/?U+/VV]1.%V#XU_C<!3X-PI1S1B0N>)Q@DC ,* -&56!:*P
M=^[A*R8*^!7P>_J7?J*I7 7R'A3RFF$YDK1P%BNDG0+.QSE#CAB/I)6@O#AV
MW+.J)(3@]:!])6:WD9^\:SW(\F-V#]\ 75TSH"WW%VN]Z/0&@Y<M%P$9XZ@-
M>FMHO\\$\N[<#'V)-&"AY=\P&K#8NV\*#5AZ;ZGZP.?,G%_[O9-?X%[M[ADL
MV_YI[-O\-(-_5D)0?^X@B\#;[\.^A65O=VW__-TPG@SV>MW\E/U>!U[NL!IR
M& ?#0AT6HPYL7OV,B5HDHY#2U"(.FAU9AQW*?2<8E4')".BMU;(ZSJ^&P520
MLB#ERL3_"E*N(E(V8H9>$I=TT$A(9Q G+" =>42,8^,B3\9CGI'RWL-!"U(6
MI-PHI%QZ_[&"E*N$E,VICL0;:JQ!L)? *6GBR"HO$":!4H8I6!9N:X<249"R
M(.7F(^5J=&PKF+E*F-F<;L&,35KYW/=1 KND"5E*%1(Q*.%ELM'BK1UFFIAY
M^YAE@<L"EZL/ET_9Q.Y!0;($09>)H'/ZXH$5KBTAB."0$'?1(.-,1$D[J;'G
M6 N2$S^$7 \3_:X%;BM9QC8_&O9'/Z*A_=ZR53E;5:;;&O9:_0@"Y-N=F/]@
MQZ5NHRA9U5"M-Q'(^Q2^/=@LYW*-<HT5F/7]B-'N:TR?6E&^;-GAL-]V9T/K
M:J'N7M*1(-JUDEQ"]/MY-F18Q,9<9L7FE#"]GMGA@]Y\#E23)Z!-A>\LQG?$
MG,@MPSY*Z0(*RN@\?]@AY\%L)$2#R:@<5P;G&J;[&XREK<H*2O$RRP^+%#^6
M%#<G_SBMK- 899%%G%N+<@TBLA+D-VDCA$T@Q46(-U*(EUE*5X3XL82XV<^0
M2)P2Q<C&2H@#"+%1&#&F9$S&1*OMULX27+=%B%?/">F!/@ONM6 N<26)Y2#/
M*3!B<"(QR$>1X=+'<$FRW0C,.,TYX4$CASG0;$T",K"%B& GHS)$*<%*'\,U
M%?-%=/4R"Z2*KGXL>9Y3*Q6M\LD9%#0WB L9$/P0D=!.28^M2\X#XV[&")Y$
M6S]V$."I/(77C5'I5"T]6R\.<W_/EZWQ%BSU"<4K>HMG_/FT-VCG@_!3/W;L
ML/TU_IP#/XB^RF]X=3WM(.8+ ,20E_=P:M[6$7V+66?KA\XK->(E@S7 =N<L
M+^)LB]D/9V[0#FW;;U^M="U$[([ _?[;/']G3-&P8)"RGB(.6A<!-]-(<I:T
M5,DHII=&Q.:CZ&,4\1=17YU)+[>4^2+;"\IVTPN:N/;)<*0%)0@ W".#O4,*
M(%T(Y2)5:FN'+VV>89'KU9/K)?A"BUP_K5PW*P&X%8(3B2S-#689%\CZO(',
M6:/ V%+"@*VUK)X41:Q73ZR7Z1XMS'P5I+SA(O7_/WM?VMPVDJ3]5Q#:GFT[
M@F#C*%SVOH[0^NCQ;LONL=W3V_UEH@ 41+1)@ . DN5?_V96 2!(@A)/$:!J
M(J8E"X5"'9E/96;EX5(]8B%3/1\+$ENNI;J:A4>X"5)Z9$5V:$G)_/Q9_1%+
MO<@3_#B\O6HNM>P@<("'5=\*"3"W3U5/MRS5M.$$9Z9I6I@@@AA[!_,=D+'/
MN^RT*  R26$LW[D/M))&"@V "3)N.RUH<AVCGR7-<R9+2_?#[EA%H#3W]6/T
MOM[,2[Z7$M&V0[1O+79$SR ^P83(3">@DQBFIKH^[(^K:P%&7YH1%KT@I$LE
MK"3;=LZ&*-GVJ&R[8B+47-<(?4-3/6I2E3#-4*D3::I-+<VAMD^(1B]>'2RG
M@.3:[G'MP?.(/,2UTF1P(&Y>,0R:OD%"S?%44!\LE02VI8+2Z*NF 6SNFK86
M$5UZ59T_2Q_,.BA9^I%9>L4*J.L$=H@:JDZ D0&:(]6+C$CU0T<S+.:P0-<D
M2Y\_2Q\\*8.4K0_,NBT^D5JD42UT5=<+'958:,LW;$.U \O57-LCNNV!3FRY
M'>+;)Y >X?,4V(*.E1C3BLA$![*/WO5Q($L\!PBG*\S:?D2BM_ZU2$JBT"14
MB@SZ$BBI<H]AADN02X/\]CAX(D?@+_,=_"0V\#7NGU0B#B.)?&\QS@>1[Q/7
MMM3("$R5A(3R3/2JKVD!<8A-F4?7*Q%'B0[8C/NE_G(N"'+(Q H208Z-("OW
M!,SQ?<VFOLHT6\>"%I%*79>INNU;EJ^[063<XXPD$40BR-X(<LBL#A)!CHT@
M*W<31A R2BQ;#6P/$,2V/95J'%"BT+");OJ1+1%$(D@?KD7N0Q")%%LBQ<J5
M!S.IP6R+JIX= E* @*AZGAFJ4>3#UCG4#WWWXI5E=,AJ*CFUH[<=DE,/R*FK
M-QR^P4PWM!PU,DQ#)0YS5%^W##C9M<#7 RMR6==85=; /<N6<EO/LJ7<UK-L
M*;?U+%O*;3W+EG);S[*EW-:S;+FK!U=9=D=H2\N5=S:NR=-E7Y+%NCCSVC?/
M,!W>\T.6P-ES+3<NSG:XK3NSRFT'7)ASL:D=TH?GLN0@6=FM%\:[W]HB=C7B
M,(L17?4(IE=W JJZ0 ^J;^A.Y.F1X5D$"[N9VM[FNX.>,(^1E$3BM\3OKN'W
M(3VH)'[W#K]77+)<ICF19H6JJ5NF2B+35[W0<=0(H%O3+.)9>/>B#PQO[\*<
M$K\E?DO\[I#_VJ/@MX3H+2%ZQ>=-)V;$HHBHEA4Y*G%]7_5U+\!\O,2S#6+:
MIG7QRC .E:E3 K0$: G0.]>B\3!1E0>R4Q09Q(YLUR.>Z1.7.8'-:&CME&E1
M0G47H7K%Z="SJ!4QSU4M-_15XD<:1FU3E5J&%P8:\2+'NWAEMN0OV[R C41I
MB=(2I3OD&BK-(+T#[E4?U(BYCJ_KD1I:1J"20(M4W\8X$]]VS)":Q,:D5\:
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MXMDDYWE;WC$F?DF!I[.ZU1!:Q6FF@* 5 W?3"7)VKHSH#5-\QA!B0*+*IRQ
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ME0:.J?JA$=C4<DS7L"]>F0/-Z?.]\K9@_QAVQB/ET>@U9NUMF[1,S2:FYI'
M<(A!##_2K- -(\N*;!,T7.GUV#_,6KW"MDA ;,M1+3=T5$+\2/6)$ZA,MW00
M@ICE: 8&\UGFWCE^3P@<)\T3)P:X/-DS$I8KZ5B)@+,5&"T6<QLK0<G7AT@N
MM^L:]E6D?@32:CVONI;FY8<=T_CLM3 =.<"[DYLOB%]\2)/W"99KG+"D* ]R
M>3@?\'!NR^<<V9I+PXBH 7&I2JA'5#\*=-6W AUS;X<NFI>)/8 ][K%&<=#C
M\A'3]AWJ4'IZ8-].-D\9[+N3]5""_:. _8HF9NI&:$94 ]4+]H@XOJ&Z04A5
M)S1=C6G$T ,/P-X<6-[JW<.9(.X!]+2?"NJ/616KM2ZTS*N0,$Y"H/$7JG?X
M6#-K:%1,SKM\$8.R% ?WL[UN_>WE-,UCW-47&1O3(KYA+W$35&.(H+&\JC1G
MV,'%JV?Z\^,>^5M.HKG<QM CN,#"C[H8X?!FT^F8(<!@R6^6L"@N\H%"QV,E
MC93?AI^'RNMT NIC$$,#O(KA?_LYQ31D^)I",Z;DHS0KE' F O6&BX%Z3VGS
MC>YO_LK^)<N5W\O$<AD+TNL$/E^EIZ\L# H<@>,4^JTV7(F3''Y- L8/0T3#
M7'D6X#?H-5.N,T:+BN  *)0[1C,ES93K&86W"L9"I4B!^N #";N%?]$"&L-W
MIKQW($3\UQ2@+[@;I6/ 0VA\E^*]8-G;<X7OD^@H@.VA<:),6!@'G#QK(A\L
M$OQ(S!278!Q'.-$TG,'@A\HE,@!GD^7)U\L"P\QQ;%<T"T8"^4U]H* .QWM<
M_;NAQ#GT!T=U!IO?'#)GH'O7<XFI\.3!9W$RHT+/:+ 9]'\=)_6!HM5\]>J_
M_.RG5ZOL*80%W=4THIN.802$F9IOF32T0F*3@/J$N?_R=/.B\=:!:1R'^2!)
M"UFL.7$Q=IN2B&$^ )]&Q+("JI. Z<3P(L,CH1_4,MR'&6!9'!Q 0V\UJG\2
MQ($#^Y63ZQ?XR'^/T^#KR26RJUHB^^/[*+[Z#A+/FZN[/_]ZJUV]N30^_O[G
M7R"U&7^^>6]!7R Q76L?0+KZ\_]&6C#Y9T)_]V8?)R#!_?S^^X<O_]"NOH.$
M]>4?\/T_K#\G5]^NWOSY]>JOKS#NK];'-__0_N_['_K5[;\B$A*JZY%*P\!2
MB4$#U4/77,I,(W*CR/:TX$)A(+9.83&+# 3<]1DNE0F]@Y,I3Y%/;^*0U9P>
MQ0EP2W5"35G&A63DGQIBX%"+D_)F0Z'*)$[B"7#U&/:-'W4@R00@FP%P4248
MQXB,^#G@=@;H/U"N 9J0<&9%/(Z_"](#;BW]$VZ H]-9KN1BJ*);@)'7O"<Q
M<L W^#TNQH+ERYX5=&)E25X2<Z3<,B6B\1B;3!@30#B?!2!34,RP9$ACDH J
MW!4V$SWC&Q5N8-/Z;=0=%$:#$?1, 6$8- 6!]'J4SL1WH-,X#?F,\)^O2__:
MD$4LRVL$Q%ZXVVU> )0A@DWI'721*[=Q,8+MN P"V,E08=]P9@LN'..8^K"
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M%T  ?W@8&Z<@<3QP0:9Y E6#X:H:M*\I;MZ^6LRRZ7!13MT0>*&O QP_M'$
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M 50)9RA]4Q2,QF/\2941= C[58NRV+82E=Z#0 0B]0PFC#LK)@^'SV5X0X&
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MJ1D_KU8,A:5Z!T 5!_&49SL2NL@=3FI2 7F:%W"(@=3[ *FN]+\SA8+X!0K
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MJ$\SY+\$>10/L@EC_+"+L\:AOW 8^G?RB#L8X502%K^6F8)^ P +ND0I7_'
M0I!&!B(V!7?A!E6Q\@S,1VE6J*"73)IV<WD&'FQW1,1E,RZHX2V-.X:V.'Z
MR44_($L4P4@$_]5&['!6:=/<O)>"7 */X@E7NZ,Z=DK<5?$;36X7J*Z)T!-)
M1$0 J-7W0G+/#K9GN;CX7( A*70<>=']-,O26QXFB+!$HP@(&\U6 SS;_^+V
MK!1/E3'H3L+V?CT#%DE1?XTG<5<NN793QMN,"U(A?SPQ5RIK!S1TE&9R?AL5
MC"G>1G%/&Y:$P@^B$=,GCZV#K3O>:I1WA@O:$,UY3#L+Y2%V=-(OG2ZF8QA/
M-./[T8-CZ<OJ";2@0N<\TXO4H+NB07-5X :X.YT!H-Y-N;MPZ5LBG,NE GV$
MS8%O5UY9\_.,2ZO('DW,E8M^8*L%<$* >5G*Y<[S&=\%E."$6CR9I#C<-/@J
M3[E'5M66B7\/A>TTR_QFD9F%8V5I=1E4+K97B,PLX9:8C]DU3>+OXAKHV<7?
MKSZ6L?-5Y%;E];4HAPFWP6IE&LN!CIU9')2)&&K_/V,+_[_2I[TE4AMW$'M&
M;X_65#L%]PZ6T27W4 C1.A5=<II%6*32JS2OG<37^Z-7^7 :'D2T3"[U,"LT
M:'1^WI;N&!E#'JMRABDYD$@< =# M^;IS:(Q^Q:7P9KPF2]U/L*?LW0V[46.
MK]_+A#_3<JG6)4;#K%UU@ 'NR5Q:YPG-JE""><(']#J%X='K*EE:99;F*1AY
MH"&/=&"5]0F_5V9Z6VS<L$)S+S3>*RL3L%6)V["K%%Y.IP6 _W=6QTZ6<>G!
M+.,*2)W.JY&;CF\ZO\L365$69G8<5S0 TL=T1;O'7+A9#C?%U(5?(<W+7%-Y
MK98)G: &9IZ+%F59.LW9B^J7EU5RUSCA ^$OO5S$9&LU[RE':/%XCF1#3:!9
M60*A_'+Y>,@?+:76%<\<,B26M?:Q-M1W?&;NV.M]@]6UH67;?1JLMVFWCUT0
M8XM\X0\V]5::MN3C%L)$E]+9WY<F;X.2&,>M5]*3LB-K0U#:\WT_>Y\H\)TQ
MBAK/-UCCP^2[WV4MNT>NZ'(NEVS;)3-.SLE;5V/J'I??R],?6[Q9CE+H]#X:
MWKG3+A>2D/4^ZTE; \UP^U-[1A9W["Q3R>*.\^-QH)E:?RC[- 4">W02BZQ5
M!SB)EZ:^;56G#G/_@:J]=9''VZ?VS!AXKKFB:VU)]8]1^^P,J>U E<"Z2&UK
M]'O3(!VBM9,J=FM+D_7H1"GO/0^MVSVX-#M*HALM><<PXK!*WF8KT!$,67-B
MF<[F$+(;RSVBNB5)_5BJ5Z](?<UQ:0QT1^\1M1^C;F4'/0#0:T'<Z I'B"JW
M%V9Y&=,XR;DG*/HEU7?IE6MH@'D(4^Y\5'F.[E(1K"I:%,ZO_W,ZX7FJXK0N
M*[*3.\6^E_0G+Z6U]LZI+9?* _;ISOJ'O]X@9K2.49IF<8()^T5^,T%U6 @N
MGI:!OD#"_BS+&XGKIBME-H139RZ2-(A\^0,LA<)3,"SE"A^(O "#.G_&<EZ-
M*MUG#SSQY_2Q!;?.:ZZ)HHMEMJNZ+%"=88K1C*>1XIN!FW,)FS6>9[^J2Q/P
M-UY??18I7ZL<E/B'NFV9$XLF"2;0S5E1B+)$(O45=%1ZL==9[; \U3R'7IW6
MLHIN;3@1P8;&$WP71CAM9@&O$^[SJ@]3>L<=6^9%BY T$NY&-IW!NM#.[/F6
M*'&O[:RSM/MEGOBP9%(@Q!^,H:7XXI8=3XI_PJ_TFEV]*8\-+#<YBH.JJ)VH
MSMA,AHCU$) 59B*]<]GSXMKT<I/O56?[L<EYC@F+$^@9/?$'RHA6G%BE,.+8
MQ6LG9MPC<TJG6(NNYEA1<3IC<WZMJZOPLIV+9%&GZ%RABJAE,2L*:Z&.#<4+
M7=],O*C<Y/@-1!<3M;VF4Z1+Y1/+4UCI/A#:1Y'WF@\[JX;=%#+*S$WW)Q5I
M9N"N8JLPQW91^1QCM:*FDWX9VA:BORI?P-LL+ECCG.*%:0<;I=$8E$D5EZA_
M*C)+0A_P'1!7Z#4<ZXN%0I"S:%D6<)PFUR(M2AWNTI(T^..B;Z\('2\6':/K
M,2_721R SC;A'Q-8'.>;>6<O)KVE$RPW*.90G]^5X_8<$<K6B_&&0V4I"..W
MX>?ANCWB?JX_&)9;N6]MJ\_@$'\@CK7;^\90^9 FZIK!\3+46RS_$L74&U#<
M35$?QN+;-S0>ES5C,'4<]"L*C;8D#L")5.GZ 0BF*1\%H.LTY>#:?;[_G5=3
M39&NOS/.0(#Q@LN7P:!(9>3I 5.L(5**@U4L-%>; *"P9/=B<GI!]DB!\Q1X
MC?H&<9*D-P(:>,@/1PND3 Z'O-A6OE!_G7<O CEX*$ Y@ 04E3S'!)4\<WJ9
MO3/-JMRY2\7L<ZS;<8WA$IRMN,UCD3634. 98-$<3#%,N\Z6G_KC^+I*=1O-
M1R #.@^9'D*F@WB4:&4@:4P210,0%_)X7H)QH2P)%B?GD8E5U1)QYJ"444;B
MB#]4B;'3V0/)D.1&;;E1(A"J1KTECD"9))U=CUI4)1FR>5_(IMZID,TU*V8\
MIO*XE8'B/G7RW0RA^[*22SLA5&X^.6'2GFMEOW*MK,SW_SC@T#ZFX>F0Z>+5
M<G1L+7!AD?%U.JP(S*2E*:B1PG, RC-73UFX^G*28C4"$"AOA"HS'=- 5#6@
M_'Z+JY&B^$H%?E5@O9^E7UD&9 DZ?L:SIZ'6 ^JFB"D&[&3?,%$$FA#I]34&
M$!>U9@KRX _64*O,D<)2C?58Z^P26,6X5+US42O!9TSD@$;P%745A.CK,V%\
MZH7&M25S?&(WZ?@&5=/7PD1Q69LHAB>M](96CJP>W*K]I-(B9OG\JI+. \!%
MXHJ2'/('MFY0WJ;P/!>E?:!\QB\F^*=X*=@Z'KE6@!J:@[ BW6L)JBYUD6Q]
MT&LZ0C3W[L1E/K\_$F;\)?SX,;]WI\J;JA? \C^0.4^".G?#5%[D:/5MM!JS
MHL#5C%:Z%)(L<&B<"=-O/3;W97F-]8/>^)!I$S6D=_<,<GV/I#\[U&+^XJD"
MT%3?!$-L"Y2:T=N$TVE<(,YAX<$ *7M.Q/=M*E\P#IMYC-9+#IX@L0I\KSGR
MOBY"E@=9[%>LP$OLY*QF65[PI[:';<[ ]W%K;9E8PY[/!RLK-;_>;%FA>P_+
M']RAWKP/J]-YM:>_'H@L8-]X<F X*H&$]>9 A+D0KU9';!Q6)1R7C()X!5.>
MG\E:PV4?2+K.C./L5ABOF?^F*GG4:H-?MX5]6"0\(]&X!0J%6NJ45:HB+LES
M:B'&T/@;BD_KS.,$LPE@@S=PD$U\EBV9P+N_#K\S85A'MIFD25R4;,X-?TT[
M'[=U)->8L@3OE^NK%\2ZD$VFH@S(_%JQSJ?)[R0# )Z0O\#Q+6U<6XD\*/PH
M*:TK=]U8MRW%P<_S2D'_7:7^.K$@^#ZI\UI54%#="O"$-!7&+TE6@S9X#&#X
ME628---E_6 ,W;E@TI;JC.]Y.BMJA.%H?4/'G$K:C]^NUN2\3^'_3<B\#U\C
MW^_5UWU2?]UR]_%T30)MJR$<]C*\O2SN!OPJ>EKG:$*6FJ& GJ=1<8O"FKBK
MU8:D*?1LYLQ6>YT"@T,/YJ8]+%_6?AG%^=R?J"RMG%<%#\NJVVU%N_F'YC=<
M0I+ 12@+=_-D5U6MQ10.%JP?M2JPS:<.C=HNUVI'%>42AH.^DZ7LO=KR%GI"
MTP->6F&1YWD!J\4KY?JNN9<'3NT+\'19[WU2WFYF>:'\>T:S4NUMU;7G>=8I
M][2(P^H5K!V I#"_<$,CF#X$]IK6[E=H]2KRA22J@T7N ZW#:+S ':Z: Q.,
M5HOG[L'$\Q7WD:'RL53$!9L;=J74XO?^.Z59B/-Y SJ[<""KEX;+"'BG52_.
MXM*L69GEI6ZN4FD'Y L.?_N?6<+*41DEABU?YG#=$27&Q?9.*1JL?DUDQ<,2
MXYA]5%R83KG9 I6XK+'/]18/A"1:0I68?RGJ+B9FY9(*ZHRX^RU+5WDC\4<_
MXE*B>@J[*,2N45F[HO&%IL=/7FK)=52"+_P+1!W[O,H=63D3\HM)%*\:RR76
M _J/\UK?99Q4RE6HYKB<';)A\<6^\UG09($*1/VJF.Y2R>Z:3JN+L$%[,=RF
M%]B@X9_2+#$H[!V-=.DXI'E.W#&]%<8I5-/YS"K'QSDY3[BW IOP^K]X"[LQ
MIAO=P'3N[OIY^?KR1-C.!W,J;.<?5YJU:.G*O>[<7#0#W2*#CKE=!]%PE4<'
MI=VIM ,Q3BR-OGCG=?+/!>P240%X<X)@#3\%MY6N>YPH@P)]^Y,9ZO_<FT;T
M-N\_%+P$D@\'4)P.QAZQ@OME5J3<-,/%F%*YLME5#HOE-1*FKT>1+&SX*M Q
MX$6"9KU97H4Q<3X3HUV[>+@.P.(LBLH;F_(B";@WJ3Y5DR(WQ '_C^.Y(O]I
M!NRI:[ZJN^4:(T=^KETNE;??X.7DFBF7 0<:W3/) -4^.A'"J*@.WFQV\;QI
MDZR&5'W)4G4%I%"Q4&,@,(5+VM4M6<*NTR(6GE<9/*55)EY>O6%QVODLGXI!
MI)FX4JODW,:-68LQZ]$90G.$I:9)4N;0$*=BY9U9DAU/9KTL7,_-LB%L3)G)
M=C,WT$49QQK.W4GO^Z"Y\P=!0GJ'/->07O2Y\")HX8K>B2>D8:MO+HXVM#89
MINE5K4 L6^:1$EB 2=$4N!"A45DM%D?1E4S)V]JM6G2ZT]NM_H<F,S2EU=OK
MLP"C*2GL6"*V);U-N#C<B);QJY@:)+GU03534&]9AB0M?,2'J$@T;^F:(E<=
MI+-L]M*T!<]H"OQ1\/3QM6:,LK(Q=.97Z<TA\#M8O)'@N<!YM%@=N87]Q0F7
MQ6;<3%9:VV=):5P-LC07TL]O\"<8'%<6*J%6*+Q80QO$L5C%M-@@J!5"?)QE
MU]RN1^>)P;-<?!HA%82V*E4^A]ERN@'L$I (1K"A71,1NF[[HS)*)Z7G:,KS
M(B.GI7!V"UJ2'ECW>6 9G?+ .DC L>Z</BOX)XQ J7+!STW=G)-6?.3363%.
MTZ_5?;O06( Y4 T4)4A1C4.Q ?UG?#PG\+ZH-"4(]6["W:2YHH[J4Y#.QF'M
M9U-?QO*>8R%HILEUBCS7B$A!,Q9(ABA?@=I;.=+P6\^(CL><+1G-$N&YG2$P
M-E[!@RU#E8R&-\#4E6!7!=\D_+IF@A4!>'P._FN6E)>>'%?F]\J\530;<YV:
MS_ "5U1Y)Z35"S025+KL:DD-%+?X2<V!>QRS&R:NT^$G#0%T>=1'RU7$8"$6
M!&2R;"9NEF"H-RD" _=2J;+AEQO)-U5<40JA]?^W]^7-;2-)OE\%H6UOVQ$4
M3("WO=L1:EGV:*9M>2QY9M]?$R!9)-$& 0X.R9Q/_S*SJG"0 ,53+)!XL:]'
M)HM 56565MX_N?T6K9\FF$IPL0:8=2(P9>4/%D! 8O06VJ78+TI%T]N7RIGM
M$RF5^P27,U"(":E_[7' 732$[I*@X?$UYSC&Z3/AQAYS1Q$64HO<B+@/1&H1
MBY'/Q-N1%,R/DSV@"X1"G<!>@CD]Q.1 %098T>>1(7G04TY H[V9%S#5V0(>
M**>>3*707%&N6T?LTAIZ,U*OA$&(L>*(* 7+LGG0&%=.%7XQH$92:BC)%@AI
MAP4U4GM,<GEXP1B\4=BY2;(,*(,!TF\HO:D90OQN.?26^PDB_.D:(HW8.>/R
M" ;"+ 8I$BIB$$U1,^-N/3M(+U88P,A?])->WD_2-9:I7@!K3!V-EB?F. 1]
MP1V"\?V2U-REG,M\K7RKD$02\V1G,O%,@@E^2FTN!HX7X'2>^-:*Q:][*L@X
M(/^*Z]'+*0^%2/H\J%/^9HJ)$('$-;<I?(IJ:1Z8[K)0(IL6<;!ACRA(,,V8
MFP3# JRL)-TWFG&BI$+X251R&,4%K^DJW5\Z*:/)3B<?Q_U04DYI?'U+;W=;
MKX ,KNW)G&A\.'\?O*LM$L8V?S#LU(H'-QHI*;UA)I6U(*:Y@@A[+O>BV"2J
MZH(VK MZ(*,[&$S8,')8JH(:MGZQ*!R#[,UNRBN0.)0XT5M&?%4(2R!YL(S)
M)&_@_MA0NCJ7JM!7Y,%59-Z0S$D.P2\-O9=.[EP@<DR=UXD/>041WZ2CDS*!
MG8?DADDL>5.M2CGY_X!8<"GA#7<E5V)CDY&K']QB7HHS)SH2R-9Q5O<O4IL#
M1DG#X23_)E'!K\Z3"+:VYAKF>M;<4:RWB]^NO]T^W%Y?_:%=75_???_R</OE
MDW9S_W#[^>KAYKX4+(M\-TL%S=<"^%S,-?UT=?55!I>#=+8IE<O_ +D2A!02
M$*$TN*)Y-JLL^^4^!)@),#/9*2+)'@;+(O]$BXWC^,_.58=;)YZ++$,.R,N<
MJ-9R;A)C$*^: :JSHZJIP_Z:.H0)?V3(3WL^M:CA G "9>G%#C--)';PX/ D
MX2.*%^&O*HSE@U?OBTM+G+F8 N0H@7/+L3+C\TU4Y)[!Y"H,F".LX.0+*[D7
MF7 ANC(5,CG5N>DN^.[$6Q3'Z55!<4[)G FV&HPSOR=@_<?B)4<"\:JB(7MD
M#BQV*#H-BJV+BY:N(G3"7HO2*":-K15I4XN_P%FA-<J>A)\F+5LS>DB>3O%/
M":"-N5[LT7+(TVR#R$WY\+D;:/5J#X27VF@=/S*"OH IMH9<N0&UM,.(#I<X
M""-M,I^ABLA_FSJ"2?@A)42I_)?R?HES-&:!=27?4A-,):,.!51=4:1'(,=<
M,H-.FVDDE2BT%"M8R=L4('DB(4_\)^[Z_/ELKCOMR#7-IM**YOW-I\\W7QZT
M;S=?[[ZAFED.Y3)I%YV*99'3[_.'_[:FL_=7L7@,A%D8RWOB8B'<!'IWN6H#
MC>V2C_E1G:4C?_'RU5_]K1M#K2<..NY!EB[C"VOX9Q3PVYUW6;Z@J^H"!ER&
MUD\M_IZW5=9>P]T4O%GJ%7@!6S7B712#A:%]#LHN/J2NS!@GCI/_^'NRO['"
M$"1DQ#&J@7*NYY+=#2S,_=@B7[A&G1KBZ'0J%T4P;PWM%S^4M8[HT!^(7HZ8
M:^F.;6H6S('-Z8[GR2/\#EU*O?XU2'+ I5Z\XNTRB?Y/3 XI/BY57LC%;\V&
M4GDARIUE[&$=B3S;^+(.8^[\"Z55B:PJ?N0Q^,H3$45GT"D+)]Z0GX%8)Z#:
M>>Q.R8\D&^K:??H(T !0&D+>=8I4REBE%KD.?!"FBL#DN&#AC?Y$+( 'TN?X
MNGP;(@F?V+[F6A2M RF,^Z-KWW#0@BXL8E6+LDTN(D$C$&L(M"4YQZMB-I)R
MZ3CVIB&2)#2W%"O!K R&'52%1X:*0> ICAT+K5L^K3Q1BD4/!:M8:NB:4G'S
MWL)C"_$&8>K(XJ[IFR]?<)> I2 6DI2+7R7##W#.0%O^2=G=3I94@>7 7WT6
M/G$K=KS0J@Y8D:I0.(-<R\8/Y;BF.1<47=:T@_&-O41MOI#L%;P98XLR&"HI
M6";YUGI\JWXBZ3\WC\"0Y-OG<A;D@,A<O><D4Y_)BI<@SAZ*A+[O64!X2LQ
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MQG8_(G;H1P&\)LC1>TM!I.=P>Q6A5LO,DFL >J8;HLG[%$Y0JR!BH1;Y(2V
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M(*J-W??&9H.;GTEB@HRZPCN:/HUE(DK!F0.OUQA8RW;?8212,$\#70!]SXW
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M7I&4Z8<)8K(ZP$:8\,N3:V? EI2?S!DR3F+F7(;9RO +&YE IDL';&91 K3
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M>MD'@?'CTAK!9-]9SI,U#R[>9I<):TSOZ>)V%!-%R9O=,%?>[%3U<+^<K:G
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M@V\?3"RL$0,R!2%6?%&)$)80R2(AA\:X8RPCL#%QGRK'L+")\+EX718ODAH
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MM\;QV@3(GN:RL1?:O(=N!J+J8;(TWR *9KQ)C<<!T3T)N&4A_,^<TYOC4K.
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MHY#O[C<:P)X_,*XU?!V"UCH/HJ2<BH:LEG+$>#*U$5K?!-7@F#R;@QQU*PD
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MH>W<WTZ!5:I?4$/PP&BHN,>:6IM'8W':X&Q=D+D?\/*9L49),2T0-JRX@VD
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M?[ /^Y;7C"F%.4*UW27:<][7.UJL/K3^"RTV:EN/[VYZY/PXG35RUW'2;TW
M+^K?EM=S.=<-=CXI0WBWH#S%F_ONFS,].0PG660[W*BE<!AN6RO)+$ K+SA
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M]H >KPG^J(L)YC9#G#(O\G:53F2$I&P"&55K"ZJ5O=_]J=LHTR\2-H;&B",
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M1@K.J%Q2/EO<<19?X$NVZ$P FTUF$Z+:R'6%D! Y4\_"F!WN=7Q=ON \:!O
M/>RCVWY5JY]+;V*SHZ2P@JU!@['. .K*>8K4$C&DY-R]%MC'ES=^3L9([/UY
MX=5+3=WPLDD !:VSLA*J38E]6F36 D:FQU.2OD@JO3=A.T3F=_V='DCL)UG4
M%(K/H$-H4X,1(2+RWUS223H9E>]]E?TA.L9@6H_5^&?]M(Z5]Z V+Y&RWJL$
M@>,T,(HM<++" D='MLWL*"1[=[0=J<WKK?=CI=TC(NVXB:>E5<'G!%[:PEZZ
M#?!PM4"V11HR;:CK]I!TJ.W9<Z2'4@B* D0D7K8A279JD9%AA.#4(BNC=,^
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M@#.TQG;T0#>?MS\2+ND__N7_!U!+ P04    " !*5J56P<9)X4+9   KY@D
M$P   &-I+3(P,C,P,S,Q7V1E9BYX;6SLO6MS6T>2)OQ]?H77^W5S7/=+Q_1L
MR)+=HPVWI;#LGGT_(>J2)6&;!#0 *$OSZ]\LD) H$"1P<.H (*B9#ELB89RG
M\LE3E9F5EW_[WQ\O+[[[@+/Y>#KYZ_?\7]GWW^$D3?-X\O:OW__Q^\_@OO_?
M__XO__)O_P/@__[XVR_?O9BFJTN<++Y[/L.PP/S=G^/%N^_^,^/\G]^5V?3R
MN_^<SOXY_A  _GWY'SV?OO\T&[]]M_A.,"'7?SO[2XA!9XX<9-(9E,\)7/0:
M I;,BBV26?>_WOXE*A3),@G&!P%*,X1@3 ',R2@M$T^.+[_T8CSYYU_J/V*8
MXW>TN,E\^=>_?O]NL7C_EQ]^^////__U8YQ=_.MT]O8'P9C\8?7I[V\^_O'.
MY_^4RT]S[_T/R]]^_NA\O.F#]+7\A__[]U_>I'=X&6 \F2_")'UY #T^+S[_
MA[?1Z!^N?TD?G8__,E_^][],4U@LZ=FZA._N_43]&ZP^!O5'P 5(_J\?Y_G[
M?_^7[[Z[EER8I=GT G_#\MW-'__X[>5=I./)XH<\OOSAYC,_A(L+0KS\AL6G
M]_C7[^?CR_<7N/K9NQF6>]&OEEQ!Z0KG?]9O^Z$WIG<$9):N(@+]%"=5P1MB
MW/3M_3%__B[(6,+5Q:(AXKO?W13O]#*,6PKXSE<W0+O\(KC$RXBSEE"_^MY;
M.%<@UQ'6KUR\PS1^.PEO9].K]_^:II<_+#$^GT[FTXMQKGOKFP7]LVZV\VEY
M29OR)6X'G<90-UHFKU_M_[GE^VZ!):T83\9UH_F%_GKSI153:]CX<8&3C/G[
M[\;YK]^/(S.1L:P5>JL24S$A9I&,S]:KH/UHRW?7%:S6<#%-7SWJHFZ=T\]<
M7X2(%\N?CJ[F\#:$]Z//7TB+QI?TQ_E(H?&8;01&YPJHS"5X*VF_Q)!DX:AM
MT7<U9;[2O!+F<:DK-X\@G1'B![Q8S%<_J0R))3OWH[AF9O]U_88?<'*%\V=Q
MOIB%M!C%&)VRS$-07H*2,H(K 8'9Y%EV)6;M&J]J'</7:_JB;\]FJ]7=O*E[
MOLK5_FC*[F+:4*C7S-$"OO]N.LLX^^OWK!')/].ZZ2590OI/,L>>7\T7]&;,
M?OJ8+JZJ)?=L/D?Z7_X]?!Q%E2SG@FP BPR48)H@JP(\2*_0QHA>#*,'76 >
M7E7Z<;M9408CYJXN\;ZZ]'J&E^.KR_E/83;!_"LN1MX;XV/AX'S0H"*/$$-@
M0&9Y% YIJ[:^L:;< ?'(]:"?4.^R+/JR3!!>3C[@?%$WQ>L#="1X02V"A&(E
M[8A%<8C*.3 Y$#[/DV*R,<\;8#QRIOL*]B[7LI4),%(A.1F<!M3,$H["@/QL
MVEZ<=)Z+$(0L QW]CYS5O41XETK5E\H?<4*B6\Q_F=8#X]DD__3Q/7E'MU;I
ML&1$KTG#I /%3($HM0#'8V0HBQ>N-<=;03UZ>Z^MV <XM)]/YXM7Y6_3::[H
MWN#LPSCA_,WT(H^<+CXJ'4CC%9D3J"2XE.F@,<DX3>JJO&JL$/>C.;PF-*9N
M.HC<AS#CR%-.G]X1$IRM9$ 0GU^$\>6<SJ6KV>S:$'$%K<0<P.5H"&="B%PR
M*-%DQYCV.K<^]7?%=F[:,@@G QB';_""?O7V;P1Q%BX(X;-\2:*O$EB,/^"-
M3$8V2Y&$-6"\H+,0<X)@(@<K,F,DC\!MZZ-F-V3GIC<#\#& F?GL<CI;C/][
M>47QJKR<+,+D[3A>8/5M%W,2@',JD^6%H:0J $7GKS80C6!1!YFUMHVUY6%$
MYZ8E#>5_2,MUE%1!#-G>')26/&%?H@"TGK%"WI)4YE 6Z[GI1!NIWU4'W5<=
M7KW'NGE-WEZ[R!7?J"1EI,JTT%R0]B]RL(+7"KAE/)&K3,<@:ZP(&V \>F>E
MKV@',"A>+=[A[-?I9/HUM-7!Y;/!J$R$+!SIHD'"Z8N'8@5BLHD[WMJ0>!C1
MX]>!=@)O:"FD\>@W#!?C_\;\)4;V-Q+/4D=CB2EZST%*0>NUP8*32@&MF4R7
M% -3:Q<2ZW><#W[_H^6TG=0&.-:_[#&K.X[QY(KT[683FD[F/V*9SO#Z<[^'
MCSC_Z2.=:_3\\23,/BW%0HJ:ZNW(=&GFDN6",UKF2$L1>$8&O,A"!Q\=5KYH
M!,^#M,EJSDIHO"T,N)Q'JW^G1O4 ULAGR#<;Y(W9-"*[6+L4$5+@!,N3_>5D
MB.26LX"*\>Q]ZPR >Z"<B?;T$_%=YDW_V\XIH5CNI'0,&AV$!J>= ,5])A.;
M&>"&!1ZLC:2;S:\Y5T]_]/SN*<B[E-HF5YNKK>K98C$;QZM%($?X]^D]NP_S
MF H/I(..;"*%*A%T%L%R38>KTP'=AI2P_A>?74 ^>@49EI:[>N3:ZM&',+ZX
M1OM\>GDYG;Q93-,_KT.Y\Q_#?)Q&&4DH(3H2CC9DB56U#T( ]S%++;,QOK6Y
MTA'BF>E06TKN:I#OJT$UVX,4>OX:9V_>A1E^#ND(C]P$X2$:8T&1?D.0.8--
M:*TO3.O4>L.Y#\NCUXDF0MYP =<[*6\=V+5*<N8">=CDH(E"2R6[%J(LN8;A
M9)8^"]4\[6XCD,/SWH:H+>QW%_( =Z_KH%Z,+ZX6F$?2R^ $(PO7DH6K: \"
MIYBGA;I86+">?*"!N;^!<J;L[R/H(>Y/5SO<[_5X&FGR9&W*U80QI(TN!?"9
MW%S'"JMY (RSUG'MKQ$T9/M6@<_@.WL/,6YZJ;^[+M?X2[J8SC'_]?O%[ J_
M_)#L3_RX^.EB^<"_?C_'M_4/^VK"?+:H'E&^2HM7LYNTD&<?Q_-1TDZ9P!B(
MF%.-O&:(,13PP1O2^,QXC+OH CW@EA[0W[[HP'W/;J@%#Y14/: 5>] X;2C.
MAAO]+3RW\WY>++?"G4"-UNJZ^G-]%TC+3?Z^>K0O=+?AZ"[AC01\,/9-X*XH
MY2$@$Z "[7C!60-6D\<1LK6H=LJ6/RW6OZKJ.PKI7>0Z2%G$$MC?EV;.R(J4
ME2.SHD2R,I3E=7E.0TE,&ZL$8[&U)?<5@,/9;PU)N1LQW%.B U10W:SK!HP3
M5N8H'-!958O1781@D$$R3D1M1#"Y>>7?;0#G0._^$KWW[?VW'];D07;F/P>I
MLGW^+DS>XGP\^7VZ"!<__=?5>/'I:WA]:FXW?OO0%;C;E[16C^NS*<(GE"4*
M<J%YQ!REX3K&8H51^MYZW(U/:EZ=&[+*RB1#RE3(F!2!O#TA+;F1Q:F@6<FI
M]1;<OCKWY23-,,SQ!5[_^^570<QKT?TVO;CX>3K[,\SR2+E"SJL6D%*D%]+3
M+NF,#1"Y+T)QVB-S:G\AV07B2<03N^C&AHO*P2@9XN"Z XX6<%U4^KKF@Y+D
M=[EK"3*PC-8!7TK,D(M.+WL JXK/07$?FU]>M$%^>'T;5$'NA$ .SNX MO-R
M%2_G\RO,+ZYF%3O.QM/\CW!QA:NH+>;GT\N:&;!,)1D99YEC(4"VK*8%! 7>
M2T,VH0@!%4_!MDX*[H[R">C><*P-E69: <WP775</^"7V\)?<?&JU/)ZJQ&9
M]Q9$+B02H6K"G(P@BPM*(==)M[Y[VP77>>M2<V8&J%_YZG)YZS8[PXQX6?]Z
MSY[+N=3<:01%YC,H5>J[$#A(+H672:$1K>W3MBLX;XT\(ML#I.&^&'\89W+>
MYK<R(9Z'^;L1D\H*[Q&D$ 0N2 8Q% \JRY1J&CC#UEIX'Y;SUJ<F# R0VOI[
M7?G5[-,2T/+L?I9HX;-Z<L\7?\?%NVD>&<;(%.0>2LRUWE0K"#X+R-[PHHUD
M>;=;J0Y:L@NN\]:8YLPT3(]-X]'FC>[Z(+\.\(R*H6TM!@1N,=#.%SQ$%1G8
MI&1&Q@LYWELK-K8_YSS5H+V(!\BE;>5_\JR*X!)*R+QV;15T.AH)V:A .R+G
MO'G2TQ#1A1;QO=_Q\OUT%F:?[FJ152)QK%?A1I'W%)@$GXL!%WDJO-0^-:T[
M=73!=X:1O49D#! R64/V/,QFGVJ?N,OIU;*M5&=-GH^D=\(P5_WR7&ML&(+C
M=)ZHZ%6RD47GFA_RS5=Q"F=!*ZU9MP>.2WE#)::C;6TQ]_G_HT0'IQ"<;&)>
M_28DF,X5#0ZMMME%=&S+)=ON#SM#W1E(T@/$YM9@?G:_1\D:K7CR0&NWY!55
M'=6B0-097132,=$Z'G<?EC-4D*;B'R#HME%[;VQ?AE:IO.QG0Q:O*II0)5J^
MR)P+:Q&Y'_C .C4OY##*L3<) P2V!C@4D\K)<W*DM(QD0N9H(;#B0":I=63.
M2]>ZSG-H.ZB[7)^E5)]-7TE&]B23!LW_>%\S.7ZJ22#SVC?HEW&-:S*F,;("
M+"(9W2[3^6&< ,Q!&B>MQN;=PG>$]NC=D2$H&+Z8007/];)U3):!7/DL(#(K
M0>O,I.8A^-#ZN#Z98H8^;/<0X[&+&>XLX687(R-S.JDI7\N,7QY,X9HI6H+V
MI*:1#B!F,IC / J,M.<.EH^U"=")E#MT(OH^G>DM\"&*W+[&=),QN@NH+K4/
M74K=-@$Z; W$ ,2M5[PUD_K!5")K1ZK/&)1@9'T#R,-PV@+WQNID."%LG;-X
M0%6XIS#B6)K01=A#5$F$&6'YG-+O3##)08SU[H*\"(@^$):LHU Q!QM;VXZW
MGW^$&M?^E*S72.PKSP$R36]=;-\ ,FBDE72L26[)-ZR!QI!#75Y042%';EL[
MZ'= ')[E_3FYTSR\CT '>'N?Y;R47;AX'<;YY>1Y>#]>A(L;<"F*%(Q.X$5M
M&VJ8!Q=U!&.X-9D7QE/KZZD' 3UBYML)>@"'C_S2J\NKBUK5<5\P^09HY *5
M]QG0BP(J1@N."4<\>L%TJ'/;FK=TWA7<8]:.00@89+#,@@2#>=6&X085+YII
MX03(A!653^!4K?Y'*R,Z@;)Y7_C-2!ZQ#C00[1#1V-LI2ZM5)FM#B!JDK[,*
M)!H(T1GPB@6#2902^9"Y8X^>ZKY"'2!I<'/0^09;YD:8$#0879NK)$^;CB*C
MU@:GB2D=43;O<_8 GG,P\YO)NW&7@]\(Q8W_NO17G9*.;)(":)4&5:R"P(TG
MRR3DY+P*N%OYX9;>!FN/?<21O+Y";&C>K4&YT=I=P#3L57('P.%[E/2B8S.M
M/60YW O[N5>*QN1+!HFUKP)'"9$S"3;Y.A#$>29;-!PZ$+$/M"$9CM<N(FS,
MYYN$DS ;3U_/\,-X>C6_^/0;OI_.R#-8>0"RB)RS!*\SK=*Z!+0P<AB9ME9:
M:\B0:$#O-AR';5C1DZ+I0/)M&'.[7N6'\7PYR^<U(9Q=5U_>>VG\+/^_J^O1
M #?(M8MH'-9Z 9O)56 (WGH!J#"3K2J%VJW'Z-87OP_*QZHW!^3F@-U07N \
MS<;OZW=-RX]7<W) Y_,7U1.]F'\-9Y?N)P]^6ZMN)[M#7NMN8FT=PH@Y\BB5
MX"[:G*VU&'AM>Q)P]. WMQ@W\-F\_#%<A$G"-^\0%\OA;JO@X(OQO-[O7Y$S
M\.,G^LO[Z3Q<_*T*X$O%8OW,]2@&S%\F,?SR.6=!>!VMMPY$\(R\!U5G (D"
MV4M9;!(BZ &*"@ZUO/YUD[>>^O!#:[>;<;[YRRAFTA_.,Y 8%2A'?E\4@H.Q
MJ(I22C#7ND/4OEB/DKAXDOI]MV;S .P/<!,WO'RO/=X:1C;9"4BV7D]+9<CX
M\8'.*F=K7W4FFH]L/-#2#I5$]EC>A%/4J%-)>QM>-DM_523OT)(YJ'VM]*VC
M.;U@')+/4@N4)HO6E^F'6=FQPG<GJ=,'?^\ZZ]8 >06= /\:+O'&.]L%]D#)
MA'M"/DZZX2EJT4.FUL J<$(:[*(R6@D)F0"#,M'4#L@!HO%>IL285JWORDY*
M<[=D1YZQXG9AOFWI[?+Z<!*N)??+N."SE&IKFL6;J_?OKVVC<+$:#+T*;. J
MP\!I8;-$30=9PNL>_=$J!L@4V9$A92:V]_3H!>'P_NI!.)X>@:"&ON?^N'_Z
M>"//WZ]F_\1/_V=*+/V#/DMO\RKM,:<:#\U@(K/D3GL+04@!.B7+C/%1.C64
MSFU%=SAU/*QJ]-;'MKP.?6@_OPCS^;B,TW*=RV.!6>\+LQQR\9P<YHP0<L[@
MLLK616NC;5V8L 72-U?I?E>I)9L#9,T^ ._FM-@%X"&\F4W@CN.W-*5T=W7I
MP<=A=ZE5=9<VDK9UA.@QT3:J"@1?%%@OT$D;5?8'W*>.Z"X<5U^ZT#"TGOP'
M7N0RG=%?\=?I8O.6NTH9YEJH8!@($^LA;#+$4B)PH6A%GI;$6_=>VQ/JD0W_
M_J0_I%(#,3; [=)7L*__0B#+CY_>[(!=:4]V7DJ@BXV@@O(0HZ0_E3IR-SCM
M;>M9AWWPGK7*#<G=$%,"KN(<_^NJULI^J$FW])\M=W7+)9F,M>=E\.3:>*D@
ME&1 VB(]=S*']LTC-T/Y9I[?;YZW8&^ $J4-L&Y>LUV #62.WPOJ2-T*6E"W
M71UZR/TPN\T-P(A&,P( V0IZ"S@9D#$) HA9>!^LU*[Y*)S#*L2VG@4'U8<N
MXAY>#VZ.0LF-5M8B^,S)!.,VTY\P@U5>>,)(@)MW.=H$Y A-KMH0]3#]>TCY
M7D.W?1KLFZO+RS#[-"UOZ)=+ZVRR^)+;^WIZ,4YCW#\OMMO7MTJ4[;&HM<Q9
MJ;S+69@2=5(>8ZAE%LX%GTQA]-=1MT?U'=KRYZVOGDTG],=T/8CPU4T/PY>3
MVY\83]+X?>VLMDJ;TC5JH**!Z*PB)2P,7) 26%0I!<.QR-8)LKU!GTA;=QFU
MX$(6\!X%J.SH_:U=\#E+2@JI@C6M.RD^UJ%QA]73@<;(=>%[@,#$5R-[GGV@
MW>,:[:T^*C=K_#',QVF$6%122@(J0?:*)K%%3!E,2B()E9D-K6?(=83XU/1P
M2 :'Z&=VTWSA-<Z6 ^]>C"^N%IA',1M3K&. 1M3>"R%#B%J#3X79DD6*?J<1
M[QT4ZQXH3TV!6C RQ.4?%IS-,"]MFT_+,3[S\779P'SQ[+)NL?^]#+3\]+$.
M2\01[9@AV;J3"F7J8&T.P04&(@KE#&>*I]9;4U>,3TVU!N5P@,A6W4*?+R-Y
M;W%2 :?95;AXME@UEUY.E!I9S4T0M:^@J).)=$T),=*26*SS2@>OFD_)W@G8
M4].N]FP-T-YG,TB2U76QZRBR:(K/"GSAJHYQ(HV/&<%D[[V-1L78^MS; NF;
M&NW/T !]@^Z!%SXMY3,JQ0H510#C>&UW:@6X&!-PM.B=C\GDPVQ&*T3?U&=O
M?AH.&^PKF^O+*ZEL=%F1-ZIUG<''''C#$A@ILS-HJR%X(G&<@Y8@'MOC.Q2G
MQRX7K&TA:('Y*BU>S=[@[,,X75^;^)"4BRR#8YS56U4)CJQ#<$71"J0KVN_4
M(&]+(XY-SS[6A?4!69\VE'[CYCTW>.;/)OD&T?SF*F474 V[;MT+Y/#=M_IS
M=)?P1@(^&/O):!Y4B)"8#J ,';-1TC&K?$;+70Q6--P0#L7Z ZVY#D1Z%[FV
M+;EZ_2[,+D/ZM"J2^'N8A+?+_6X%<=7X1]/FEAP']+23*AD(HD&$%$0(07CA
M]9H'M:'29=>G';:Y4B->IL,*M6U%U+-\23*=+VH6U0=<P7HUN?CT'Q@N%N_(
MN\<UL,YSX:U(8)DG&[L$#9Z;"$'6WD_.1*ZW#[SL_MQ'K@L#"WJ NX.O7:UQ
MS<C[-=3:J%?EM@>VG +B-=DUA@/S=2>L2)UV2.:V\LKZ0,Y7Z\X/NZ-[.B;D
MP,P-<.VPYLY?HUQE$>\ ;:#TQ@=@'2?!<2A&'XZN]*9C\%WI:X@I6_+F+0-C
MEV,G4H#(0B"<RI.IQG)*K0,H!]>4+9F/)Z H75@88H 3SLJ4S"[::_]V%69A
MLL!5-2\/P29!9S5&Z4#5<<$.D3!:(WF0Z+-OW0WL?C2'C]PV(VU]Q%,;B0^0
M;_,9SLJD$AR-8%$"%[43/9G6A(<[8.2X2:T2&=VMBWO6,9P/[[VDVSA6\?QZ
MW@R9UC^5@FEQW<_V57F6I^^_5%=F80*3&:2JTT]C4N!5R2"2%K)@R=;L5(>S
M)6RQ"Y:G8Y0.PD[#;(1=\*WJK7= V##HN1NJPT= V[/9055Z4''@+6<5R.5.
M&^<*)&LY*)4\^&P#O3TB.A8X<W*G(^>$E>6!P.DIZ$H7!@Y]+*WW58\YHD)=
M((>806F5P>N$X.AH1NT"(Y$<XH@Z:I?[(7CM<AKU(:7Y"(6O9X*H2,8:0P3D
M=8I[B70")U&@Y,"YT)F5W2;2/H[Y1<>Q5OK(O&%.V^9Y#[N .>]Q1YWH>' L
MSCZR''S<D6*2%%<R$!8E**$M!)<BN65,T__0V-)FZLFIC3MJR&L'$3;GL]=8
ME2*=$,$HL+$VP2N.CC27!!TW-FN3HY)BIZSZLQYYTXG>=B-ONG!SP%K?O^/L
M+<[FM]+]Y[2.%V3=S!?C&NF9_QIFU[>.>Q?\[O&,5E6_?9>W5OKKHRC<.H&<
M"#,R.C+@M"Y>2H,&O1CM\;Q3;\[_R^<\2..*DMP)L'8Y<I>TUQF7("J,(N1Z
MJ]RZ*<!3&*53A$:9R37(]7I>U5"WLQ)!5RVKDTZU:5U5\&V43E_];C9*IPO[
M ]QQD%N4$//\9Y+\K6WJ5?G2YW9D"V>&:0[,: 7*L@"1UU+4:+UV10:;6^=G
M[ #KFR[>>Z/6F-.VN8)?">2^EFQ_(S[JQ=.KR>KCG\7^JESS\%,]FN?C6#/U
MYXN;+UKFN?]\$=Z.+ _%9>G)'Y"B"C""1RP@HM5>*)8P\(?-EH-A_:;)&S+>
M3E!-ANZ:O/LJ1T$(;HWR=$Q84]N=2W"19S">A&J45&23#FDS[ [UFW+O9#(,
MQ'W#F\[]W\E?D=[&W\/'4491@K0:@O8.5,@*G'<&:,]U/#J-<7T6=[L]>07B
MFSZVVVSW(G: NNU#]0>-RB7GO 1&2P25A(0HDX&LO4R::</*XYLE>[;S(/OL
MS:>H4<<N\#R<;)8!?1.C2YP\8<=*KBUM!/BB*I&ED&OL612/;_CJ4^BBW$FG
MCS,/LHMNG= TO5U@?YL'>9I:U&BLWCXJ<$H:S"P7/$30TD=0+"?PP0HP7 M?
M"HLVMKY"."G-/8UYD$=1W [,MPTX_O%F-0TBQ/'%>/&)1%FGO+V<D "K?%=A
MT9N;6L9""5%'8+F.@:C)Z%'5J8:HC10\!K_#!,B.#WT\,Q\[\3@]" DG,>5Q
M-4.$B^1TRF"Y#*!B%8_E"$;9*+5SN12[57F>R/C0/57I< 2=Q%S:[6,F0R(Q
M^NQH-64Y]I)!M!@ R<\5)A>G91E*Y\YI?&@GU3C ^- NO!YA?&A)*H=D$N2@
M"1[G$9RC/Q4,W"GEF$S?QH>>C&?=DLVCC _=!>"W\:%[4]IY'.0^?!QE?&@)
MPJ/&#,'4*>6"27#!(%@=R="(DI-=>1X*TW-\Z,#ZTH&&H?6DZV1 :=$BRX38
MUE;7LC (FKSF8D.2-LB@1.L,J#YX3W&J8R?Z6TYU[,+= 1.OUSOYO[I:S&L*
M.?WLI\OW%]-/B,MY$*_>7[M-T\6UB8#T"?K*Y]/+]U>+Y4*GY68*P)WA /LF
M;!\06ZM$[V.)<RU!7*#+,@>6R(=56>C("G/9)Q.TE%:Z.P,<!L39;[]\1N]3
MK@]8]AM+5S-B9N6T8*ZIA;>PO"KK(+Y<PTI6K_]]JBI&7I6+]/X)),NUJ,1)
M++HT'Q;2"GO?,Z<GCF>7M;9D1'ZH"-%F0%Z'P"1R")TFTU^A#]'3YFG6LV:.
M+<!KX(<_A8ZBL^N'U>%)'R M_$UZA_GJ E^5GLNY=EPQV!CI' :7T(/2F8'S
MEH%2BEM3>%&\=>/[MBLX5'[,26CP$<D_E1R7G@O_\=/F+UBZ65H:R8D;L-%8
M4,P6\(PQ2"D6[NCM5KYUW&S Y1PKYG9,)6V[XS=3E@&\YLW(;MWA[()OH*C<
M-FS'"<J=C#+LI*0]F3R&QB69K"8/'F(4IK;[$82SGG$J<U/0.1=:ESX<1].V
M1/,>K:)U(7"(H99WW>R;2)'/PF3D$5@]"!0Z A:] \ST?](4PWEK1^M>,*?B
M/.W+V_K<RB9"/V!X[@7&Q:W8S+57-I^6^G/ZT<_C2;WB^P7#O,<D]'T>TBI@
MUGN!:Y&O+*T0NK#(K%:"K"F%%D,2,2H>':;1/@_L.Y4T+EY.YN0O5)?@BV\D
M0DDF, 2O':F<)K?(L9!!!RE<*#()T?SB>C.4_G-7X^+YU6Q6F^#$.AT@+4;*
M!ZVD\N!*3J!2,>"3IA=*2:N%*8G #;"Z-1A'N()HP/;=F:C]Y#M 9*:.BB8O
M:5S'UI&[-++DG13I-&3I).W%M#][GRW((BPW:(I<GZC2F^XU",>ANA<MTW8R
M':1)_>3M[SB[O+7,D>:)82D%!-:[640!P68-&I,NT4LDO[4QS1M@/'ZJ^\JV
M8>I+&H]>T>%,YOATMEC#]/?:97MI@+TJMR'7K-EZ0KZ*%^.WU]><JU4PSLAX
M\AFR];3/%5,@,I7!:6OI;(XIY>U9@ T!/5Y=.2(Q \S)OJWIGO/@"UGO7.I,
M)CQ!"4+7J+!(@3L?N&T=AS^KW6-?60XRJ_HKY7L>WH\7X6)=!S^O6OHD,1'&
MZ]1!E D() .NI4[*F\!]:ZNP&\+S,!@'9&5@0^/7Z23=:';A@INL(^FS(?<^
MD5\>I1(@I>(J6^VDV:E+\)ZZ\@7),89=#,?? ZJRI_ '4(GEP7</-"N*R-DB
M9*-MW?'(+"Z:-L!L7.3:&Z=:MS]X ,Y9*T<K&@89NK:+%&CUEGMK!$3AZWA#
ML6R?[4$:G8L0Z-I7>NZ&[*SU9@!R!C))OYR\S\-L]NES1'"D=*ULX1Z$K-Y8
M9AJ\LQDL2\EEY"G&UGT?'L)S'G9),XD/4?KQ%;9E-17.%[^%Q75%37Z-LU1K
MJ-[BJ%AET;((S'@!2F8.T:,&&Y643-/.6/2@NO$0NG/4E&9L#+Z+7*=Q>)MU
MDB$1!A?K>%VLXW4=!,9LK!NHY<W["]R%<:ALL>'Y[R[54\G@^GH=RUMM:9TF
M,=2J%CI3E4@, E:QZ*QR#*P@;^W7W$5QK'RIWKP^J">=Y3M$A<]7B&Y=7.^"
M:ZC*P7LP':E@L"=G#ZI 3X$?4B&\\5KEH&A##!Q4D)8L;&,(*;E.43-;5/-R
MKH,JPK9"P /I01<YM^VU\.MT@?,75UAY(%-D9<:LYLIR$[&02^533?',O"9'
M!PE9!JM55,&JM6#HAJN2!Q]Q;%MP7Q*F TBP;7N66[BDDVNPM%>"Q\)(BPMI
M<5$.8HF>=D89,FI5W/J(UH>)O?.$L^*UG_P&>V&E->OJEE1PC'8A2.AIA2XE
MVIV*!%TP)N>CB6%[5YT''W%>Q/:38-L[[MNX?KZ8ACHLJ;J3:P"-#5EGD<%P
MINI\I'J3%C-(SF5D,OF@MF33[?RL\^*ZD4S;=@J_#7!]DXE.1FU-!O2UK0UC
M B(Z#DZ26A*=GFG=B>FSWJ/[2*_AM?,Z*KN^P0C& QT=''*N2V7*@I>8@"MI
MI"R>:[^]M_N#CS@S7GM)\"ZSN@VSRO!UC0O>1Y6E ^X]V7K:2O"<3I*B@G:%
M6Q.]ZL+LW4><%;,])7B76=.(6;FN<.BR0%<G_QCK2>%*A)"0L,EDZ< 0FNE.
M5M6=)YP7K[WD=Y=6VX96+<4Z+BE"=B9$2**65'"MP.5LP%L7'7U/UIYUX?7N
M(\Z*V)X2O,NL:\2LXG> ">-01++HDHRREG4GH&4&D#HE9G4206V?:O7P,\Z+
MVYXRO$NN;T.N47=@E<*8\A[0"/*]C:#C'RVK4V*C2R$K;3KMQG>><%;$]I/?
MAMA%HYB4(7U;>5_9UU(H!2%S\KXP&@C,TAE!KI<(T5F6.KVK7[[ZO)C<3V(;
M*&P4?S+:N!4B98+Q(A@0QI.W%3TI%?<.!+>>M@]-QT$W#K]\]WF1N*?,-K#8
M*-9DI5K;(++**1,&.LIKBX=H)$1N!#@GD@E"EJ*W%T@\](2S8K2?_#;PVFOP
M',;KSL@K<-;=<9]M3BDPR<%F+4!YA4!.%P,IT7 NR=&R.PR7V_Z@Q\]R:VEN
M(+M1G,E*MMI5,HLQJ<@AT:+()'<.8DH14+J0LXXZ=KNS^_+5CY_0_A+;0&&C
M@))3=R-=W",7BM&1($FE5 H:8M$<"M<Q1YL\>=9=N-SPC+,BM:\,-[#;)J@D
MF5@_):05-?// #*RQ96,9(%;YFD?<5A$-FAUZ,#MW2><$[,]Y;>!US91)<G%
M78WS49B$#D$6J0F9S! E,K!>"Q1!\^RZ.*B;GG%6W/:5X09V^T26WBSP_8OI
MGY,5PO\3)E=A]HF RM69GX(O2EF(6I5:]BX(G* SWTLA++,BY^V#C[8^YO%S
MW%:2&VAN$V.24BO&[F1X",63B[7Y-BD@$K)@H@,NLD]*T^;".VW/&Y[Q^ EN
M*,,-N11M(DW2&+Z^NS OG?<,08M -D'Q"5PTA+,H'H5,7N<N-O*&1YP5MSTE
MN(':-A$HZ91;#VXZ9EUFB7!EVE"<Y>"$4&3R25*Z$J7.7:YT[C[AK(CM)[\-
MO+:)22DFQ?H58I*))5? 2EJP<JY&/+,"9I3D*664W'?@]>X3SHG7GO+;P&N;
M%"?%]=T 2DI%.T,F@,W5TDO10Z"M!'R6V7J92O)=(L>;GG%6W/:5X09VVP2A
M%#=W[Q#I-.".]A*P5M(J U<0,-+.XGT)4A'L+#NQ>_<9Y\5N3QEN8+=-?$H)
M?==+0U^GC/)0QQ^)6C\7()3$2?FXDRE[R7"[(_3P,\Z*W;XRW,!NF_B4,G<L
M@62"9U$Z$,I5XSW5^XR,D(32WGH;H^Z2IWCW"6?%;#_Y;>"U37Q*64FGQ<IF
MEV2_H1#@T-11P<) Y*GZ9$)&2R>%$UU<VMO??59<[BNS#2RVR7!23OEUUUI(
MS.1G@51UV$E,KC:>3N U*K3:Z[(^J^]A+N\\X:P8[2>_#;RV"3QI=N?N.'IM
M.&<.R'\.Y%=K)%R)E Y]DD)$\LZZ6,-WGW!.O/:4WX9*CC8A)\WOX"J2<1Y4
M@6)JIU16B\>=2[2/**5\,C)W*KB[^X2SXK6?_#;PRH=L?[X4Q'Q^5=MRS\,D
M_X89+Z_'TO7J>+[#][9L<MYU&6M]S8,KOM"1Z%-0BF$@X]6YG+*UQ'<V9K3C
M,X9I92X=3\8K TGS6M87:F]1)D#8*+,KEI?UB.\IMS+_\K4_A[2:A.9%3+3)
M!>#!.GI%9 '':[NS5 HYE?2[];ZVC9?X!<NQ-Z/]>'^X7']/20_0V;Q#YR%Z
M[[).*@!R1\>A"0C1A-HNT7%$BX*,GD%UXG'T@6JG)<W8:%LU_GHV38AY7J?=
MK/;?K_LR_XJ+5V4Y'[A.FW@VR7_0WC[[L[9PGKS]&7$^0N]EJ#W/4-:$"Z$0
MG H)<F)1YYA*-MO+41L >=QJ<P0R!F]%]QN^OYJE=V&.^=8N27YS+F2= 3>\
M=HLO&H(5!;AR3KIZN\];=T'= =;CUIZAY#] U[F_D6SFOTSG<YR_FOSTL6KN
MU7C^KN)]M9QE,[(RY>P=>=Z!UJZ,XN!M]""="RD4@2JT-EBV@CH/]6@K^[;5
M\15;A;89V'+G^SU\'$EA5(F>08Q<U'%7$;RQM;Q0"\5TEMIO+T+8[5F/F_-A
M1-JV;GY]NUHY?:]GXX2K<^[-^QF&_&KRCS ;UZY[U80:A:B5X'2P!8N\=N9@
MX#.9VE8(F27+O*P/1-Y<K+#?XQ^]9AQ&\ U+\1_JPJB+"$A6#G!68_'1)J#%
M!R@Y6N%3P5*&&,IQ8CU+VYD-W:5ZPCU+N9%6:HF0E]>H5@?:URQ9.U8K1%T;
M2PP;_3BUGJ6=>-W>L[2+? _9HG(77$^U9VDGSG;M5;F/P _:LU1P;G3MR*E4
M;;8MR-[AL?;KQ-H$BDLCAVU>?'H]2P?1@RYR'JP%XNURZGK+H)6-@+9>$04F
MP8F8( ER9[)/7'9*ZC[5$O0N8M]:@MY%9D.U)]U8.A D,EJ.IGV/%J<("D1%
MZ#BCXZS4+IN\2][@J9=?]"6UMPP'&IJUN EH_D[_S7(K8E:9F#""%*)VY?.Y
MNI\&6(RF")62M*V#@IMPG(NAUEO& \T]NHWI1L=W0360H;89T7',M/Z,;5&!
M'N(^P"9P@XX0Z,AYO013=:Z2K8.#K84L?<A9JH*\]>RB0RK!%A/M4#K01<H#
M</\&)^/I;'E(K6JVC=31, /<:P*D3(#((@>NK0@Y2L:C;$S['1#'&6O6EYUI
M2]$.D)-P.W:X5&>CG!-%UYQ9)'6V3( K.H,UJI10O([6-*9Z'<.Y'/*]9#O
MS=YM/#>ZO NB@0[WNVB.<[#W8^D!RGN(>(!-?0.RJ!DOQ1N03#A0)0J(H785
M%*)D9DLJJ762T:%(WW*0#\UY%\D.P/4?\]]G&.97LT]_S+_*;%HE6RLNA2$'
M,_!,J^7,@V.YMB&4PD>FG7>MG;DMD Y_N/=E;3J<R.\]YH=)@_XUS&9A,?Z
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MJSF):CY_<_V]UP.-,G.J8!90+;K:7H8<2A$"2.F=+1J37&\)W6XLW"9 AYX
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MEL1YQ/@[Z4*G&'\73@8/].X"YJG&^#L1]6#$=Q\I#W^]DY4/*M1>F<:#<CJ
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MN\F]HI-B>HFKB=C79\-\E+*/6'M:1\<CO7-&0$BU-Z;4#K6UF./V)/.VF)Z
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M)>!9PJV"I*>E]5TCXNV5OHM<VU;]OQ]_FHS&G^X;+-X$:UTR,MC (,F@0?E
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M59+Y(VHY>N;1FL)=6!Y9<K"M<8Y<.%2T'>(D*V_819Y18>10\>P@:58GS&,
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M>VW)&O2,W%B#/K1VVAM!/^9<F(,YMJ9+PJ#J[.  KEC&:J#K%G=1"+@I0D!
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M8#0]B'S/-PA31286))A20YVH(K@4/3C'DW>).XNMG;LE"*_<"#I$(1T*U!_
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M%G.8WWUE6Y+#QJ!Z93_L4X ;M(C>1"F+#<44I6*.GFM;<D#+O%+<N.TIX\8
MSV%P\:L[*A LF(M6!F3@LKIR&;Q6&9SQC@67,+I.+.V'7!*T6<)YC()^$6[2
M[<WBQW>3FYM?)M-_A6F^]E9D&R0#Y8( Y15"*$F!JQNGM]P4V]N\PQ[6<W+N
MIT'MO9\IT@TLI<^RFP<[WW^/YA^_+:C^>C5?+WTAF,777'MFHW V0; R5N?/
M@J\MG2E@"LYP)71OW$^-UG"IUM["PCI<B@]F'FV=^-9+.9 ;TQ5:HD0+4JI
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M_\_MTDM9HQ2HDS<.)$]U-'/AX)VP8$+BCI>036P]U[0;LN=V7O>HEQXFKS]
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MY9(,V>U4^R-?/JC"&PI^TE1JO:3O:5FW:7X[K=54'\/T QU(SBC)BC)06T!
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M'/.*QF]9CKH6SZO)^,/&.C#I'"U*L,%2Y.P]!<V!&^!2^>JP![5Y'_VDE32
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MA   %(0@T(O@#;(#0TZ!-XIMF'RE0JAW\  %>-O]'089(1S?8? .X0*HMF$
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M6K$KG0G-]^=#+L>TKAOWV4S<G9PI)$H[D8#D 2\&[DS\GGMGKQ79)1\O8BJ
M8VV28>*/GX8.6/2O^Q[.+O4)"U_')Y. 8_<U'@X@W4\J<UKWJ@3LH=;,:HPH
MP%:BJL?#$@^-=SZ#I4RLW\A=6R<!^NOJ42:X_5YIVC"X3<3'C#BC)"=2V[)E
M8F.V2.94QO_E@]1#FN4P_168R$I( 4I'#8TI*;<7OM(\$'L RKU?GX<<(@
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MTM0@?6:T!=?F3J;F)L<,3^AM;ZLP&IQ (%$4NP# !XE!DQ?KMG;V C3O 0J
M#J F?V=UAOG[&EL<L]S^\*ZG(T!>T0-_2"M=.Y^NV\4-3 4$@/^[Q KS16,
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M\ '"P$% ') !% %50 O0 XP $\ 2L -. S#  _ !T$ @<!8X#UP&K@$W@=M
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MW>Q79.!]_)K@WS\W$H&Z(+-@\$5,Z&"NK/0SP#6^[70,?E.V<-$<#-W#-HO
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MWGYO%"^7,N6CSQ49/7GC^&RA6-KZ/;"Q_1-<S$+ O;Y(E 3[I*Z<*$+A_)W
MB>.PS.S%(H,OSZU$HU*,4W,D_/K$O2("8!H>A-R#\VIE%X_"![+I#/24PS&!
MA?B'U_N^R*!1AM/%]ESI/4RQ 9EU''Y3&TN-DMV4NGGFWWCY%9C[RQ$?O>YC
M)&T2RCOO%^#>.*<&1':>25MAH)=\T-'6P\WU[0Z<\4+*Z;EC<^WTL*)PL<%
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M8'Y:^8DGHE-<!(#PZ'EGZ9:KUB1\),KF$DVT(\W.J&P)@+/%RULI.G@F.DL
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M92K6@QU^.+P)X8KQ5NE8S(77IZPFS"[YLEKLH ]LV*)FQ\]T<8K_/KCOWTD
M_Y<F<W@&_AG 41JUIK*+SU[)U]7:*8V),HQ$H![Q%$./A 69BA X]W?5-E[>
MT>2^CBF+ADTN58L.,8OJ<,]]3N),7Q/81:V+,PNQ)^QZ 5YDJ?OX-'\@*[VS
MA N'ND"P8ZNCEY"GAD/ NC2:IL2M[PZ-,.E1@\GKS<\39VJOJN\%P=4'&K+5
MKH\=J*AHD-0<">\KWI"3VAA6N;X'C-2WB7Q>I<#KDFN@3W1=_P!#FTQAHUO
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M:;W/\X!XDU4_P!@C&L'#3891"-H7S:5?6'#*T[%Q73S&1K.OU3/%ZC1+]:=
ME?4,&/@29!(K&?F,SLN[R!;OCNC4J&V 6'BN\9=F%:+YVC12YY3)F[IK1275
MQ]MDM2CC?-PET]CD) 3?>G4^J5SY7(Q0&9I%>QEIOR*J"U#K7(@,R4RC *+5
MC"?P^U'N-E,!]:MFSL>X#W&NDQ$B[;?Z2Q-#[E=<^PA[^I)1I!O&PMSL: 61
M(@"BUN-.5PX&Z^X%9%[2=UMIMQ=UN9!Q?/DNJ'/^K-PDZB08?X11* V;I#-U
MW3?9"4NE&Y\.N!%78AD^L/RP\CA7:N0^A8SK0S9*6D^MD1\76FN"(MH>]]NS
M.RKQL&3I H0)/XPN4>%"C)Y;[R2I]B=.^P<!X*"6::*%W\9XL-4BZY$S1KA8
M)Y>%BU6[G..2H?@/FUKCN5\6/?:AEF\R2M76O3LW913.W\V#A2B4N+T3;UG,
MXVYX$J>:C,*8"V($WQE_8)_3#TMM<J=3*F8S;'Q0I%!/^PWZ$NXDYE69ZS)Z
MQ'(TD?*= '@CPC$CBY)N.9H? C;3]WJ(\:%WB=? SP6<!'7%=+=^OZIK,WXQ
M,ANL?DVIY%VS??=B4O?"GN+:OH__E4>]:^/?VY<6C[[P-SB#]]HOE@82KY<*
M;0!_3?8C0SD^6PYU6'B.I(\O*FE%@)\OFZ5LG/G[X8TAK+B=L@]0DV*="5K*
MG)=2N-$*NZ*]JX9< 8ZBUYS[:D[1O_A>4=G1,8>$*=\%"8803PU:KJC@_*PL
M'9Q+^LF^,/($GW/M"1X*WP[P/^L5L,6OXH_!M6[V( &![DKW[$V;ICD6.]F7
MOTK1R;?6>>M?4# Y.:1SDQG1G1N<.(X!R45Q(T[?P&O>B9HQ7%B@I>W;_#CW
MM9""M<2PZ(X\7E*DB$9Q[@VQG WY#,556:[T4X\$KQ:CCZ4YUCO)&JL.#J[1
M^:VU"]FK!;$\DW;2(3@H&+1--#!Q7FGG4I_HTSJW(U24EE+WX//S',JS(.:;
M_:3Q3VM&!#ZK1%,2  %'QVPHQH;5/Z4L_P:$^O\N ?R_&PFB7D7].) [K)@M
MH2R[8[G@AU_87,B+/!IN;B5/JEB_U(:DR)M,<F>-3S0N L81+)K[S[2OYL0"
M&.REV1N;:F;1^<WPAL@[S^*KNUFXF3F7^OI>%-!;11-GOLJL!":OM[7 "A.#
MF69/F@?C0E[2JCN1!&KYY;9__+A6X1F'CK:LNV%8 Y3BJJQ0(@ RQ<U<+6EW
MOK(&]SP9">S0R,8+2W3PN^/6+^;$N6UK&K&4=U"KP!L?W>?#S4=\*$H;56_N
M'3$PVOGQUT(&')>:A3N>>87ZKCQ4@LT-HU5BHV.1VG?,I@YU:&+G$'P7MXY?
MS6_M+\7>R%TF4X]9/^XAV]^BK</O#[YEC.]DX#_0[I:=2TR4]5A%UF5;#D(S
MTGE%!P\\3L 9J9Q5*::MTU^Y?P]JU'N)Z!BK4YFHQI8-E"$\$H-VYX5!'(>)
MCW$ZKCNN/'W:BJQ[#'KAJ9 F*N#B1?I-*!!S#U?O,O(J"3O;,?.(SW"M/?EV
M6+1<&J)6[_U(R:T3!Z'A,1193/K#N1FM$K"9%>8V@H_E[=YTCSZ67*,H<7_,
MN6$R=W"TS7S"ERM!-;&RH?93FM=%M<O/P)VY'PE1BR0B@79V;0=T5D@6\"!:
MK5[;5!Y[S7'.Q4XM^/$&/X!Z;&+$KDX''R=/=+.,[*6&U)\<H=GFZ;&#7US@
M/-TU$_@>+J_QX%ZRRRQJCFCO0X8X2^>DKBP;/_A!];W]<-&5CEZ%C-\E95=
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M/QZB^,_W>G^;%!N AS4?77XU)_%_F+".=^(PNV=_II-N79X/@OTK*45A=.C
M91>8/S\H3\K\0U:/\4<:J,F&'?R%QI\+/_I?=HZC__PZBB(O)9A_D/PY]O\&
M=M'Y4^2*<&R[7!0^<_DO5=$$  4!P'",-/MS\/DBZ3^S/+8B1?YVO_^E5<#_
MV:0+S\#0"^RYUI_*YW2(4%DO^CRSA[0/I;+8['TWL'.F7HH5IV!W,:J!3GVL
M:^3\]F#J[/,>.1^]!)RQ,,':H7O",.MG]K/1'V[E<SP7(Z86<[S\97/3'=H=
MW^X1R;U]_P%<EPKK>X=:QV!Z!_!+2#!J4"JFSW_85X#'^>#G1.*G'B,%<FC%
M(.W-[!SWU]=SJ'/(!$4TEU)U8:X$  T!  9JJDU.D95PE]X@-@$C#5&5G>>N
M%WO8;$.+!)1EE,%"84%.QNTBQ=7<HKQ4[C"'5%^K$#_[!5 L]4+JTZJ7PD\Y
MK4%,"8G+&0%3#W(HVDB"M3K'_.YWYK_-4/:UJ/L@K[ALWM.C5%45+7O]'6.0
M+/7UJYP>X['G;G@[.%.#I@,)^V&WXAR.B(LETDGUH*P@S<MRXR@0L\NWC??/
M3]#LB;&2?Y%^WU.^TDR=WLET$9.F^-IE#C$=O%LO\1,?GN+:'4RF!$K%]P7@
MFA>/6Y5-JE-<HX3<4Z-I>#HMO6E.+Z0WQ_F>_S1Z+V5^E_-+9^G70''_@DT"
M()[6#-<V 0[NCOX10CF7)L8?,^2"*)7Z>>,K3[B!C6)A^B_]K4VK@NQXA*[F
M5D]U7GL?6._);$H)1TGQ'LO;D9;LT:$/LD>'V_!JF0NP&Z;LMW>DPKR(Z:OB
M(TJ/*W2(8K'X2NT/.>="KT9>='P7-^_)DUC R6S9H.!_SP=-8$_KL4DV%C*R
MBWX8^V/*_5DCK8<3DE[E7##H&JK_[9[!8[R>>+TC6[>UX,E,D81?T>"B1>2S
MOE8M&@40BQ'G^^8!!.PFK,[)&6.M; W3U#&)I[1Q5P0$J0B'?W#KC#(VQ.\2
M "!QI"LVV'%EWFR=KJ<SJ?28QR9Q?G[++BMVR6#'N)?Y55?9DL -/=.JHEI-
MD?OC8J*N3\>+8YPZWJP\ -[6H]G*UH\QB.](D#%[RJ3'_*NT&]^R-$AC$L@1
M-L]1J@)QAKCX^-+3>=CM-,89EZ)<A-)^YMPBB2@A61 !78E;7_.C@9+U1,4T
MFVG=D._8*6MO4U#)[HR(\[!RQP744 QQS!K4/Y4,S'_^/+M7Z=BHH(+UH1&_
M!=)K/V\0E$[NZ\@+Q_#I ),OTA7GLC'(IO.OPD+NL/K9_BHVKOL-B8[^$(J:
M#F7O7,$BH>?V/S-*6;[#OT%WVL?4S?%R3CUT@U_8G[$CC1ZD2LFLY"D7U=KH
M.?5++'B0W&+#]^_]8*%/3O^4*C\=,-X0D<AW/*9(1?9 ,+=E)$67 '#,&0WB
MH+.%U$#FM?I$'QHZF^Z[]^G-^C*I'(5]=E$W=TP<__S!TC!NH;:6:C$BC>A8
MHAC6,-LHFD!_NG6!^(+ N<.&L3Z;)@YV#IX\+4#!\,+73WV,O[W>,DTM>V2C
M8S[C614GZ-R8'HEV@J4%]/1>\XUD) !N$7,K_ "<[J**'W_:X6 #9_9.S UW
M?6MWK=NN"GS6?9=6,T\\R[SJ)6?I&_>L9]=%.&6957X=PW^4F\I<;J>QSM,2
MR+3#L<!%@<3!F1E>*ISA$ ^EWRN>@YP:7;[I(W($@.YD>280CL2S(L67\<S.
M!,!Q,/$I<+RM:/7X!HKD[PTB/Y*6T[3+NV2^. @]*S%=03U4L@__D*,=@?[X
MA,:#:N?+;^AP_GC1Q/IT7H>^*UC0[.O68O[LDH"F7C61-39X)@3*RT_\%)WJ
M.:E;7AJLFFI3F\N5>M1TKY8 0#)@,X_I]S'EA21'O?^3B9\O7I]L6!KX7++3
M\SG, /%96^?J:DI$/.?5%3QQ<Y BX';<9$.Q6IS90..IJ;]R$E,X.C-9VLB@
M8:]O5\?)M+2L=,=Y4]DT%1W6^U8"&@5JF>IZIKS9VR*M8V PK3.48I9P$8G5
M^W;=W>D\Q0L:$<.[Q9?%<I*P+AC*<*!F8F=WETR;_^OO(T7I;@+@#NV)2>T6
M#^<9<%F@RP61&E_C9N6=\=+"$S_?_9JN,_5#41+7=.,GNU0^-L-\"A61;B*F
M'"%5L,!<=?K.!YF+/IQSZK<1)KZV\JX/%6P!GHVDU-U;(:!]XJ(])'"W.BI:
M9W]<S/"<>;,__Z'1=IS_<>+1-I<] = 37%&4=B4(15%"%+87<>M&;LVW<C0X
M9EMFI:F9I@ AOG5F\>Q$7>[FLWW2 RWQ;I%'OP9UA,X$GNL:X2D%SSO6B@6"
M3RYV,^EDEY_7U)O$S=>G5G(2=_4;*>S?N79'OO.P?/8#/'9^<!&7!':J?._6
M9[3<O:9KI,-0,0,\]SDJ?TP W-Q<)KM</OWIZ5UAQSH9D7.9[O$OR;TRM'<0
MS[AM@ZH2(B4,YY?FGK8__<Y8G_)+E$FNQ"!MQP!]("YZ/MR4$RB;.CV(INP"
M)IGN#>Y&A@>V$P"?OA_?Y7ME/YUY!>KE%;,ZRB??CIF;'RW,>;^62^^S<7!A
MTLQ<GIB:;G,1)_VT;SNX^YXN/S4<%^.\DX,.7.BGO=)J)!?]\&58R9X]19[=
M&,6O3M.]"[WB^YOP$WVJ_9-Y=TUU+P) Y3QNTW!SF":;2^W#='I*=4&FND%V
M$D<00K]T49 FF"D*L!CDN,FDLQR VK'=$?EL+VJR[M02_DYS1);I])/=##"F
M)+LG88F?0]-.ELX$WN&Z-GL.:S'37G8SN;5/ .3#1-=[A34LO>B7!E0FFB.B
M"V+NT#C9FGE9TP_-4_N^'7H5$AOFJ659K,SUQ$P8++MCRW&+;8U4I3EL^.E(
MUJW%:V/]5V)%B'NUKOJ]D\@@+J:JP])J@UR:(>!RTO\9;0TKG/XX "^77YYX
MZ[;IT2FP\6F:4&D1-I'VK6S2;V>3SJ:B@;4Y<O%OB?SA2Z)02:Y8_?R<G^."
MR9U+X=^O?VA=VGF]HFJ-)?-S#DYP&@GH>SZ28/] \,?M$(D<:V,J8]V\N@/4
MFU]RBITZ*@2 ["L"@'T0U\6')0"R[M03 #@2+#\!\+,08W8AE'AI)/0N+861
M7_Y7ACT0YNPVQZDH9%[6%7YQSV20 )BRA4/^JR;V?T>3 /@OJOD8C<XC=R2^
M!PU'V9KN6>(%=H]\$0HSDF)-$ODEX.(R]X>K#5C8&=;Z./)WS[@E2E!$7#H-
M?CPOYN7L_TE5@.VNJ *MM,M#ONM1:E)N_7<$%73,G[\7"\C#OD5@5:+</[,O
MVWJP/B@P_V7UJ<\=T*-40?)1^P'9O=>#JFZ#+QBJ\/\OJ!CD=@%!,N3C('X%
M* 0[-O!@^@("0V%-SQ%ICE;.3MH6QAFKB.DYT]F?EI:6N5;E?38.!95CG_6G
MJ%G5U6IUO?0:$_J\P*!O,*I(L&4$-:)%5IN28YO.KV9YG,O_SX C>@* $QEY
MH&?)>LI'Y;6C1&D^"UYNF>KS"A=Y#G'Y&C"J\'4KM4+MFNH"QX&CQ\Z[57BC
M0I-Q5V5/4^6A:/\)AE6?"Y_*4K00^.[H)3,IW[C$\>0Y[W*N8*QNVS#P)E@-
M_*)?BQ+(-FM26M, ?3W6T1K;4$U<#5U_5])7;?]4,T_V&B>3PQ6)CX,U =W>
MFSI&D/7BU[041CZLF>@K.6!(U\;IYF;ULWW3+W\ZWCXEGL.*2_>=D)_-'N\^
MPK"NH[U%5[;[$49+MEIO0N 4R=-/?)F40UVA-1_GN*]82-7@XMT_,%(U+==W
M'5*_^B!XP?NT)[!O>>S([-( D<G20EI_$P I[VV&AR$WQF])4#1,P@T27)2*
M)<Y3P@4US%6CR2;:-K<7 GHO*@!Z@<C:48Z.&D!F]4;4B=]D)+)5XMXE[MFM
M<DU[HJTI"EF"M9<DT,C+>3[R!=L2:V@(O!\WC2V"!;K<+(AQ"*O7"W&WO"%R
M]66A$P'@7J9@#<E;:YY^M#M^N$-<^OS3K<X?=$ZJ_I-TU.F?+JVB7%?VB)87
M9/\BJR B\499W[9 C)"&\)N**UIL_#-STD!3#H.M]U8*O0I+X9M\3#2?30F
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MZ.B3=Q@.X#D\@XHW=AFY\-&F/2WZ3Z&#-F]T F9'3/;B'^FTW<7+<NC>+'0
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MJ.]1SY#05+F@3P?*>=W8>:5QH78BTGZ3Z_[]KWHR0AHW-WCQ@)Z>.\+F*[Y
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MV%\;]+I_H6'R*M8P&<UPQ!(UOJH/1BD;B!XA%+6*5GG3^5N<[XL8O7K@RO3
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M G1.0%>G_/@OQZR!Z+0/9SO1&:TMM'TH=,@'L>3(7\H-!VWG_303';<1&3C
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MD?-L7V B'T/D:$ZC*49J#@<(/!'5/WQZ'BE>>[WL7ZU])7O%-5NLCP_6_,?
M'FFC2JT_J<UGHC2Z1R@*Y%-\;]\O62OQ-'U(':.#_Z/MFQ(]9WKPHG9:+HN'
MLC+L%<G(UY,.Y.^F$96$NS2% ]TWUGK V6A:'.#.%7ITFB<>#8I(GQ[+9&!B
M:BY(=5C79AR]^A9_(ZV-\[RL3[NQ\8+?E:8"V%@<3_WYP<HNP[ >9MV99OVE
MU& 3-7*63KV\T3['6*\2/W%WW%YNR,KS=UO'\XFSLLP^X^!%)E'J?1Q@GZ,/
M'K(;$3_/-:!-QLE?OE"2\VN?-,LUHKS$:K_HEM847&?'/5X":%)BRUS>@2+L
M:4Y;]W==%W6MOL!J+98YE'TF/4Q[*G](+&U-;X8#/ @M%1$T*^%X/&J/9)IX
M.TUM"_$YDY(]^<,J^[**$0M4' %0@J9I]#??'[-0RL;[#GUQ\ZE?NC5<[063
MTNPR:F9X>*MYFA(K/.)M*AG(X#!$U'=KPLVRTI1[@N8)X(([::0CE^B?/BX#
MVLU#@_POV'/WP@EZA#N)H[J%%[9<#L%!T=^E3-C !K_=SBJQ1ID 04:T@Z_#
M')1&4.@)I90$E8!_Q^Z].29FE/$G]P>G<:?HH;-&\_!-\XR&I<>CHW?-"KM^
MTVO^C(F^;2_F$[Y/^\8G>1#EVP<=2-@+>B07 7\DIY-+0DY:PGLC>H#;*4L/
M3*+JZN7W1;#N+S+Q?QT9K7]0=$7WS]AR%>CXVNO765Q[<NBEFLIW' "S)(A9
M?"(R=<UX<_=5KCA01!B%U-P;;7[I-) /-'7_QDZV?M<<E1+K''99W_@^-J^1
M0T#2WP0UA??B:J(D2-ZFH5$#0A]CH*506TGR\)5&)J0XPINZX@%B*?;%+2G]
M$-.>%EYI^:MYOSC1#0=(Z\'ONC-N![>CV^\:4U(2YOD/;^07/I]XH:E'P<NJ
MWAHMWGEV? R!0 :TI]:=XVN\V#+DRPN@=-&0XI3*QM;&2LNBDK*RDB(O%A;P
M#IC>,D;&PL.=K3/V 'PD&97GU$6N$_\.\('I#\T!/  P$43E"\K$QGB'[,'_
M'GWX(U4CKY1>Q1]L8N_[JA=Q5=S /WPZ/SEJ@H2/SIZS%6S,8P(910;)=U_A
MW5?0C^^?'B39"KJ3%UW6AHRYN!BPK\[ .#:'POL9)H[E^Z-S(AC2^\%?=F3Q
MRCXK T;TR7WEKF\M!,2M$NUY:;&U)VQL?"D_VW!#13UL?K:Q--AL8M6&CHW%
MJK''3'VSY,AM5):G3ZK>UOU*72<FLU"+]R08/C"WKQ=C*Y)CF[YR)D>[TH__
M/))..)\T^'19-W&\4/*!YVI)*X+C7%JEI]2.C78[=J/0Q4%^D9R7L;1QT\PM
MG"FN#X_DLWU:I+WB:,^=F#=#)KO]%YK,X5GIXP<5@S%-_NMK/N3$]4<;"2[H
M<Y/%R&/RD4=+GS78,X+[1\YE5(YG8V*R.:_.3H(2&G+<\HI*=VF^0?("_.BE
M&*1(Q*@XQR8EPTW4+$.2G$K]_(+'#S+W'1V-$Y%/J)WQ^3^,KREM9Z.C_(=;
MECB.:,(6/UP;1$[OIW3XJ^!6!^3^[^+*9Y:[-,6SZ9$W*_.\IUQAJ9$E]$YT
M)=8L ]DZCNMR'VD64#,;=Y)!/L[4<0.;2_-R-]"^UD[8AZ*F9>0$L<_.-&CI
M<(!E.NB@ ]B:]<2/LEE09@W)DMAO_=,'Y QT\S#5DJ'P( 8!=CVM^(0_9M\W
M4QIER^]3#6I/,5R'M#ZM;6H.(<,!3$$UBO.Z42IW,#34ZIG#MV@\C[._?&Z'
MZ&VA4-VTT;2DJ+ATT+%0O@]K?ITS.B/SR8R/"D>=6)C&>RQC[][%SHY9][ZB
MPMM*+54E#05&I!D=7/[X@-=YD6\VO">A;D ?(<87).7W=FGG89Z-D_:]CL&'
M*2P#G:ZW?!YITMQNN39:R.R_8B)./4:(+6H<X&XA5MIZDMPO_[*KU7#W'%;-
M_XHO3.S(!XPB??"$I@ZF*Z^A)C4/RZ55K\)?A,4$%0CPG7&#Y0*R3;6?\YZ]
M^>$@B#UIO?)'I9S C)2:Z:S#0Q<-7M!UN_'P]4J)21%*EG*R$N*=3C8#U:24
M-U:GMM^!6J&7&I$]S2_Q1@HO#O[>+U4@<\DVCNU+70[&,AI>X0#-^#0GEOM*
M. "KBA .,-;*<='L;0+ZY@]O]6F]X!PS^I_5HG)!1T^7Q 9P@'18I5_FD48V
M"FH'7 4S6Z-N^SR5N\UH8L=78HX!'8 ^[-_[H3P XQ"6[",!QH^J"%MM,*V-
MM>$)#,R_5ERC9&C9&,+>Y_T@3T=L'I/F^U:5IUPX!/C\F6;HF;FT[XVI,3%J
ML>5G"POU5D5<.  SUO#L0*<?*QC:DCB&H>6=2Z;##P%5%,/U(8Q3,VE\\B\7
MZW^;.I^VQX&%0R4#201B#\HJ](5_.B<R&BQPW& ?++&O.7LL7<7-?%S2/;$J
M$9%!MDEJ7QIK=WV*WT(3)]G)E1:/A3:D/5ZLY&N!83Z1>;7Y%.DO7]:J2<1M
MBZR_"<TQ!=-CPGYE)%BKE,Q;NJ%&4:1K[)8#^BPR1@\3N9YYF=OGDJYJ%(H&
M#L-OX@"/MSE;H,O/<(#[K,LE1@UHW>-@FPF1UE^&"*5)2BR+PS%C>.L^%5DO
M0KN\5;(T5S(.^9F\P>05D$_,3]3S1^&!J.J<A;'8G?GWRKYA [Q"3BF;PIS3
MS;>P=)/:ETG71LC+MQ,Q:.[OL/JT]W4^^@4I"9#T;G6=!>V+4<H#>J!N5L]2
MMPQO*Y+4T"P/_]B,>^;[:S<R55GB$=:K$R]NIX2W H6)KY'=IE=YGUZO&*O/
M:3&_PP'D2(+!//AX>6<EH%ZB\):S(XT*9Q&E8^[B.J@RDN8U;U&JG8,O@_*K
MG/( F1@FKG.];NWN?2I2@^BW :T!WBG,I[1490Y>^@-I(P/SL[5=S<Y3![<V
MYM=0G>V?Z0[K.^A")TH^M_G*"YH%$-[9(D:"U*;^H26VLRH6+38"'EE'779<
M!/M;.*]2CQM6&<J-IA^0 F4#295^>NP;4RK)-"-2M \U<(!<N]G;8@+TR\]
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MOW*8?_+E2'>MPUP"0M8RQ%%IKNC%%$$-SZ22Y0]Q#R<>L7U\HQ+'ZL?XH)"
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MEEEHW-:WAO90,9=Z%Y*O_3#V-H^?5\9%5 +-B*;F>0-+ Z.(EN<W58&&G/9
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MQPEK.SV+H[OQ/([G],+LTDVL&HHEL_MXC <8[4DK7WAJ@B</?U_#%RPO>/"
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MM?RJ4Q!U%'=.LLV^<LDMLFL21L1Y1D,G#>^_JN_\,ZUI4,$#PDFN,"-9ZO+
M47.(Y)YL;-J/3Y7??>--W+*6F\WJ?"V\O(V4DSN1Q?L3T3$Y][^*#'G71\1>
M.NQP4VUITX(&W5OC:Z72D96#0ZD7PZR[(XX^M(Z_5&MB>>CSBX7<]2PE8KR'
M:BD^TP9.)^%"-W!.X*.1($T\8%3Q*QZ =<;VDYW>N?R"!WS,6L,-,.$!C2$9
M!SD;T[!M7LO-(CQ "M.%NJ0P&[EZ P8#=_@A1"\*4 QH':K+NA/4(YPYZ%^-
MB;D@"AD'#VA>T6F[>^!Y68O_'XZ(!UP-.?A[R#:&YN7Z"3S $PK&<L3C9L\Q
M,9>NS7C 'RB<'8P)EK[5D[V+@$&$S-T56GR) OJGQ3C.QUTV?'LX]_^H%O'=
M(+,$IBR 4IQBWA_0[JWUU?:T2W/G_:KI7/YJU' !1;P2<LE4?M+67]]<?5\V
M#L[L?& ;]Z:4]<9=Z_?"(UI=&U-%\48(%(/$?]5IU>-/38HNDT0[R2XT6[%7
M*Y)8>G-D(1-GF.V'!Q0&69[X'U_=^JW+MB!,\+%-0=O?+6<,Z8Z+ 3U946#F
M[;C8W%ZK\W%KZ^W'CO2&<?$,#37Z'XL/^TR!)HSA2E]8(+QNP?OO02E 3,62
M([@>5&*<_8BW:VV0_;T2X9MM=;3)U/E_YNFKHH?1N(%7ZT8X=HN%*X*.![P.
M#FG'Y@[D')8=3E_LF^$L\[(8W2/;E]Y46=.7_:6AR0SNQW"JN'PQM)P#.[4.
M"K[Z:%BC]"_HLA<.:'$URHCBUH7OG9RP:!^8<GN0=]'??7LT=$ V&0]@"'GH
M<Q/<)J.*=EO:139UF'[:$/2J3R=!VYLZ993R5-4_I7"4<?=##GVB\!(6$:6[
MH?BBIILEX[J.RC;SAH7.)J_?DBOZCO%<8>M"P067I(X3 4192&5-5ZG(DX+\
MAI.<A/TM+DV)LP.P(/A4?V3 /2DY,ZQ<A@),>YHSRB>L2+QTG"P$/^0+7DNG
M9Y9VV_E<7):WV\(5^CQ2 UHH;FPB;1+ G/C9(@IKAM':D#$T%M4,&&U%S<C<
M(]I>=9=[1RA.(>SX/D*1DUC(.GG31KN)SJDY97"C[DP]SDLZJ<^^SB1P[E.*
M&7]*14G?AD Z]6QV7MWCQ*KR%*?2N;GF]5<I)N8%B3-UY!J7&Q_O*KI2&.X_
MB[QVBZOX5NE-P"V.JP0E!SCSG@2NC8.AY]/_KO=T_;?:VVYZQ6^+*VC%/SLX
MGX3A >_&P/-)(91XP$8/'K!OZM?;KAB\A0?LG!WU7LKC 8OMXX4U8'O8[M'N
M25M'L/A?O@;\[SP,S>E_ZQWT3*WC >U;YZ#)&\Y;TS"9MI/S>SB&G),S64O0
MT8C%(:,'? %LB6;0V@W K&U,5P<Z#+G1WEP,=X+>=+\7^L75U,GK$=<36U+[
M.)'ZR3IY&E-@HK_4 YTS^KD4AY>Z1T/%[>5R#/7'YDU(K.;(W1S?11[$2]DH
M1UU6<<+H!+$$L;-XG7$Z=KN3[B"XA@(,K>&J%L&I!6RI-A"L5N3MMHIH6W]9
M6I!Y!X >6)Z1O*$VH\; N*MU&L@9EG4FL*D8,9_9V,PFG%<Q0:(AX' ]N:/_
MS+NA"=<^><P.GR:Z_.W]A5F5#CP)Y 2SMS\Z'AGX).7A7J[?E+42_\7A*5TX
M]#E%:\Z#SW6]ROJ'SX]GAYXF1PHEJ^YFI'W_V;>D995MM6%>E;9Z#2%DSI$W
MD$,^W7<F<!%?DJOKY(%9UFK5:LS&(<H8A%TWE],?:XA@P]N3FS]X$'>%UBE:
M\*N6WS#NL?$JJPAH19V]#,K<*2V=6X1"+9M]7137BQ;H0$!A"S<QA;MA/#5#
M24@NIT9%WM5(3Z&:^ K%4PP12F;)':M7-R]_8IBM<;>,+(G5AW KUF9KFJYM
M#AL-6D.48XS,> >N\*P-MP>T3.J7?:@9/3P\T/:4:965UJY2HNI)G"#KA\J2
M'KN:DZ:A9(J*&_:RS&K2E#XL_>=Y)04E<5P?6,P.RS_'OXR\M^H;I\_-*'Y=
M.[Z>-JX:>?@=X]:2W?NZ'G)[)E.ME^FCMU67P%.2HG4YZ6<UN!Q4!1A3Y7-V
MG/+^YPDJD$(FV(7D$ZVWFX3@+U2_98*PD.?>4DO_JN^D6E[[Z9*'OJMK_G42
M%:<T[K+/V(5UG<17+^RD74I56@CZ[KO2YL)0=J0583S-LG/ F1Q736-P >F4
M M8(8XJI6]SY'&*V/HM B[HL+44TUAM(F5C(5[X6N^=*._0'I3:74N<R&1Z0
M:F1X82D$ZN01\!5U_T!CN-\WRB/"YPK4N1=7FFFWDK5%<;T'<=](<\Q0/;P^
M[2H2W(_G]N2='VSA+921V;FPM?+((=5PW"G&Z(7?4#:/QC8'#P<0S51]V93N
MD6\#Q1:)0AB-*Z)O"<Q^5_/W+TU?S'AU/<':B/_V7<#R)>88#["<V3KL-8G%
MW6G^5X%Y.Q4/$" 91\ V5H[&/90U&SQ?ACP,RA]FY5:Q,DWI/@XYJS2F-C#B
M?])#ROJ&Q0*-%D&/$7@A9:'H[F*6I3W#]HS*/$I<L,.^["M+*AT4]#;Z.*SR
M<KGBSX JXQWU/GS1%8X'$"\6O6WWN_A4ZO#8J3B$97J\4]M&04I;'\-@"-0C
MT4VP$'-B*8C,DB<8<M(XCK:J6E:'GMQ.GBK20KUQW+#\TC0L9A0K=1@4K\IS
M"K54T@J:W='ZG^[-_Z_7]QVU\(#;DL-2= S[EFZGE$G<<XN]&4[YCTEOO_2-
M&,Y5]8E6(S(M7+ ;=+JASAQ6%K."A2B4A6S-9^ES.KK4GTRS%.&"_FP&<!4W
MMM__G1M !:D$YK<Z_JD&W0UIJD/]4V<6H>.$X82D=>%@V_J\M 9;U&%2*^=*
M<5E*6G5&I52PT-TL%]O8Q\:9FK',B98!6SRH>(G0(9V0!![GM\<B7T*_W@"*
M?2MQESANY'OC [+XI?GIG]/Z5O.?VQLR?K<W?& '@U$=8<N*N*OG/RSW@EY@
MNO$ PQ8-64JX>DY PUC(?RCD'_M?Y9A1+]P]*!Y@*WCX'@]X\!U\>4SGC,ID
M")8]LQ0WPB4SH.MD55^>:LU/+;?OSQ?]"7/4]UUAY@SPK&#04SR@"PZ#8=Z$
M+;E<]L,V'+? YT97-V 4KZZU7S4_/>*WK"2A]O?' CR0%7A NMVTY:FU*\/E
MU@'N5+H5W&_DA0=D1\JN;>43='BWHBW_'Z";^#^C&[<_HQL0\CT7>*!JT/+H
MF_O5'.@5D!Z(RAG5D/UY4[.-GJCBI#7^@@F%LW<?6;[@EY'! U#R\_3[9JBK
M.66I<@=OY1WA)(FTOG6W+.<ORTCH_>7&[Z(V>2XZ VG.'"\\%A@8L3WMICWW
M10@KSK?(=+3H$0AS/$ '**W)YX"8S+*-@_#12>K;"@CDZZUQV$!>F3!T7^_$
M US;FC;)O,Y2YE-]B3LNO-0[3E\_(R9E'H^G9B)I3<@++><:HM _.8S#6<&&
MP.N]1[S(\Q_K9[=;3+8]$&:*4VTF;XJKBN A7^9]W F!X;--JJ6E;Y+3"8"W
MUP^]T@4> 7.5LA5H]0\4IE!NTK4;.<YH#K2%>7U!K(+0'D'V2C>HX/4-N9*?
MH9$/V54G:FS=]K:D[\:CE[4\B:_?B_'1;$->_N-,FZ;&_O8K^"7_VZ(0=HWL
MZCW,O]D<:J\&[V=H83W=O\,NFI9QMS5/,7U55S#_4E;&'P\HEL5"Y[P;^?:F
M+RV"+:!-9$5_;4K[=TYC?Y+6%;>+XEA/,2$7RU."F+#XJ*S%/3594K8N_1#%
M"V0D0#V/HM[?K=RAENQ;T9%G29(#K *E $<RYOJ8_IS-[O%%10/+^O.XT#N;
M2]ZQ.FH&2;G]&;SMWZ<4_:?[LR-NI4.?)ZHJ/#S8Y2R0,T+=:T^L>@I*:G"-
M0<^;!IOW?6,<8Y7="?=)W&[")0=N8=IEEX@0O5 CJB 88B/O2%2@Q\14/ZES
M?L4JY@=A)H0F:CZ>-%RNV7 W&>1U%G%1BWQ4JL<Y%^":'EYL/]IX/EHX^[")
MR56^Q+252MN/5RDY[&Z_F:7^P]?!7=@<*2^1;;.N!5,.X"E3N0TZK#@^T1Z>
MAENY/ C9MUCKET#2GLG,-S0+-<X[VY&7K+:LRNHQ98PEO5 E7AL5[+,M.YQ,
MLA5(/FF6.$_ETS-/*,UNK,WM9^F7-E ;E*IT/['6.LVQ,O)-G%VW_A'47R+K
M* ZG1O%5B3Y:;UW@W<A&#)NLV_M9^Z?8L]3(%!5?L1@&..YJ2;4Q>&,5 ]4+
MPL)^0J>ESQ:EE?5(E4W1*6>S>51*0F+!W8G1I#IKS<\KOP&%FE[$$ .9Q'?6
MY300E^I[?EGS+B^G:#Z.!B7W60Y[%NTQ9:F\2$<N-[<O:5 L)(]D5LY1A*UT
M>C"&-V6?WGYH>ZV)C(8O2W"R/L@/YTG32FD4/[_,XMLFLMLI;LRV1Y>JH!:Y
M,)$1WH[A;T@L0>/LGVYA9'I/O93OLEJG=QA"&F6]*_,=$!BL%8N4E'''':(R
M]N_+"&_MUR3^Q\RS,!3K)LVC/30X$/T0A5Y]UKAB&TTY8!0]['1K?JCA]"M9
M$5<R-VV,4.8F/&1XQKRMOJ9UJP*JQ.Z'>%&:TS!H72I5G,34,ZX]K:=2,V7C
MZ=TNQUY8HE+ZV.:5HLRF\VVL](\YR4&:9,CBZ3W<-;$(^I=1\9HMO?U!1P,6
MJX<GJ<*>AECWICU1PD;CC,_"!+:)&O2<NI^E=+E4WI-\/FZEO90M.@57XZY
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M"IJ8BU=@T_&3[8(EM@;4) )9=->-A,?G>ZDG^ =)$H8IDJV+>A[1/5)[<3<
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M=<EN>KX8M]<\5'IP;?2SA3,/QWN_RTZP^IG,[N\NMZWROB?5?RG ;,R0];M
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M8"IAYZJ_ZBCEGMR4W]^U'BYK!-Q+ .>I7X]1>, =]>@V]*A73_-#- +<Q[D
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M-E_==+_/.:RCIO>;8.M1NFGQI<(*+W-N3EVAP1ZF1CE)]W9R](X-,9O\RGA
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MN\VSW$O %<P6&HF<D0"AAL:/J006:XRTN09L+:*Z;XN&_LHA.6JA&'FOK2P
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M% Z7ONRK<%C<'6#OW+<KFD__HFNZ*A"NO_@C ^Y2+KUE6YT3&$&^:[YN%<B
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M^H%Y?%9RXY5/8?/SS?WEL94WC+T'+NF-QU,;#>1&S7(9^@;3*OQ>)/QU'6=
M( $I$S6_&_^)/)%HF1FJRT6LM=GT4'1KG;1ZX9XCV)!2J10=.,CX0%//]J4.
MD93HO>)/-<7F)T(8:?3]2R<+>_1V)R760C<_2HXP-Y-7F<2/NF"B);J*KR]Q
MX<9%6R.C7C3GI;*H]I8/S9=L^Z^3FIPZ+MK<,JDTUT&K*%I/)&WJ.193#4/O
M&=[1H/?W6>NT^TLOZ%[\*@-,;G!>O7-<_\*LWC<W #"^V;[96%GFGS[W.OS;
M\MW_N5/!_\&11ICMAH*RND]$]]2W$F 5\]2!:,_*+EMG3NG">=-4\R>-F:#:
MVJ1BQ?P]M?E,2GE#<\U/KQ6VR9,5V#D^-+2R)FHK"O"G/]XW[T+G-%%^-7#E
M8((QF8C;?-3HX'9?_U'ZD?;FDEK7!J 3@?NCE8&@)\Z<!X.Y0,-7R$2MO/^
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M6%7<7GCZ;D2P0$3^T<8$6=P"?O'GG&^LA($NW;NOGV<='R:8W[GZJ^# XUN
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MW-AFR@@8:_3.=S3AC^2R,4G=4U@4WT096V%Y(X,1V!8:G(G\NP43C!AZK-\
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M1*<$64RXFV<EV,+\B4(8'?%8BK/A1-+UD7Z^.;7< 'LPZU7*_U*=/KIA"\=
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MV9&J6+G(,FE\'A%0/G!^+H\>'$OY5S8.".K.#L-WCN\4$U@<FPF[+MG8EP=
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MKG9CM] YM>B5<L+W8AX_O'0QOD!ZEI$P"9G=FI]]\0>[N2Q;K2B"7+E$FS"
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M%0N9%H2X+& @^FOCR!K9X&RG<EF247QOKV=9V:$CO,\X+QD(>PT+\B+;LEG
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M0W<^QBX.CA("YNY_H.ZUMVMY0IN@WO,*E1RO"W+C9-MK-%[E<!L*V,M9?(2
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MUFE5=X]4_KWF.>.-MMQY-,C8O_]%_+2DV?(Z?^)5+;>]GTO,^"_\@?!R&?"
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M-V)?6_'-G\%[\9=%*W+)/0A "P=P'8O-OFW+Q%:[;VMT3=OPVS:<+UI^6U_
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MDS2,G"@,@G#X5-IC2\]-R6XT@B3VG"&UQ_'V"!$>))7^(H7(2QVQ@]$4)GZ
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MVG1#.00R2[LOD#"/>A0YT(\1%P8>QC".> R91TB04,8\KN40GD?&W+3E#BN
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MHO36H&CG7,*TOL#=PM';"?:.#1/];E^KXJBC/I+D]"S[:00Q49%-QPO8,K,
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M]D^GBJ.FIQ563(&GEJNVZI*WC*D?&LZT->0<Q'!: \^!RAEI^ T<0. !&D!
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M=[EQ8!UY)]LB*L-+6[+!7C-L\^(1DW=;=S<:!^+)IH%D%1"ZG]\5Y7/;IE\
MF^5I43XT[<HPD<,\]E[F9O"HW';:'C#"V>.9.NC$POI[D X E94FXCE"7>6
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M5OK)D37F9F7V2-0QB;2AU#,GSP1H9)UMB,V 6N*#W%LK&7ZYPL25P0=9?%D
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MYI:#\<#6-IO'!'TB2]HV^"9F\5#X#EK*Q@^<RG@>RFG/GA[\B($FMLQ[D>/
M7PO$1=R-24(2F4V$(/)\ I/ 3: 3X#!&$8L<HA7KT%EL;CM .YG>T X^AJ:F
MG6L)H['/I%2^E*03C!WJU$'$EIEZ;*EIS5 -IE^8F3KW7+Q/67<\<]UT(6;7
M^0=<YN*2RETB#V%.$@;#A"7" I6S>#T>P#!(TM /PC"*?;-$QFD(-_DPI\F
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MN=ITR3(C8+237#/&\\U/DIO1*=7-'_BQ^O(HOZ%N?EK,PX!&D0]=C".(PH#
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MY.A3!!'R'8B)%\ H=-)0SF9./&S23?L,6HP4_036<],#A_9YZ3SO-RO!S@^
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MC(J$QTG&!8L#,^;-Z2G7(^+C>=T\T52IFQ3U(.5OFI])#=IZ.V,3/K$)N+Q
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MY5$ <T20HFZ3OKS<<:>%4?GX^6&FMB(<[QS2[1KRG^OY"U":].B(<8CRQ87
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M^"MY 54"FWLCUOA?=MA\HNK;JVMD!TIXT$K?Y)&\EE^73]1 K30WXBSW\'#
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MP'+1U#$;.V^>IO"B2_WV$^/9E%XH7JYU\?).3[!3%&@NH8VJ5R",0*,MN*E
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M+^6SW"GJTLM&[IVC'S->9*E 4,0,JYZK$2RRH("<Y23#B=J_6>4.]A%B:IY
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M3:YOWG^^VCN9.MJ>^0IL%%(4$J!5Z4I^C4HIQ3/ASJUP@ZXC_V"@,*,N]&Z
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MPS#"0G$/<EB$F$DD:43C$$E7R:I0= !PHVRR&-.4U7@.Z%9(2T.X#Z&9&1P
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MZ7LE<F< :98J_RM%$+-8P)0B$2?R<1@A0__+N7!3,RQ=!<&&_ZU5\6I'$L9
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M;@VIW9FHGK HC9H-N>!=7K0_-?233/ V4UF.4!Q90;4 MB>G#:%@2ZD[160
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M>,<0(LHCZ=50#A,2IA$AC*2146F"]<IST^0=K=MV:9_:L32VF8.FT)LIY5$
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MTXZ;IV_AM)^#G2V<#EP^[.3E.V></RCI*26N-'8I]4AQURW2Y"!V]5SM08+
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MZ-PT>1-FRS>4 ZQ)MRU^,$#;3$^[QG!DO;LEMU&8JC\#7X%W&YI!1_3^>.6
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MP=;'M=_Y4[E\DH[L!_FT?/494TW(KZJ9N IC/5;Y4LJM2SNE"14I\7T8,)Q
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M3C,1&-6F#"=A;M&H?0-D:4.NJPFF>R5R=*^9 .>1-QN#B:4+\'['R* /$\G
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M5DZW9A0TC&F&I1D18M4S5>5Q^ +#!*<\BST:Q=RJH9O)HG-3.9KFKDQ*4;T
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MNN;5XR=5&H>8V_WZ#UXW[#/6S:1Z#<&4SFA&T<8\\U,A!$SC2"47!"',PCB
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M\#.&!?C:C)1GN55]W*PW;7><=[4E5C5NO?QK^YM;N9,DC$4Q# 2-(:*^#[/
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M/CYTWU1J]P3=/>UZZLIA1V;7])ZSS9)_%;N#)=Z1*J>J9U^^W*C#)MWMI1N
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MAF>@F0:::[@24/)=AXH7]7 "T.,=])G7#^FS[S S8C)1N<J2&)_@:3,F)A/
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M WKVH/S7UA8\_NQ)5( 1>^W';W;Q.>6=28AVZN<HIUG $@J9'_H0,8XA%E$
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M(G.S<E_063<0&9 )?!#2X_N+*Z#&]HF'8&25!WP*A#/2@ \^>K(LX%/,]9.
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M!\8UZ#UGFR7_*J2EOWG8Z-*,NF'5ZN&QY/>\J"0;=0]"Q:1N";EM?XDH3T5
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MZ+Y+!_:+7*_H;]_YHWP=[J6IT&2876S6]ZM25<=>/*AV\?YMAKT@\GRI4U&
MFI)1D?@PQC[R&)..56CE/AFN.S?U<$$I7_)2:X-*L0#*CH<%( _UO(>."\MN
MD(:R,%,;(R \LBK1%(,MR=M,V2W5H";;8?-&.YA<-6DT7'7:9HQV4+QJNFAY
MNW7P_3,I?^,ZUO^.%USDZZN"ELK!><^;_]WPF]6'/QYUPNOW3?%5B-N(QT&*
M&85>D*72;60<9D&621O&2Y'/ QXES# D/V3]N2FPMH&MBGFN5])CK(D%Y::
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M:.)5<HXB']3TJZA"A[QN2-#PH*O'W&]^U@ ZWA[-UW^3#=0:GD-;K/V#!@X
MI'3SL%G^_]R]>W/DMI(O^%40L3-[VA&"AP_P=><O]<ONN>U6;TOVQ%W'1@5>
ME#@ND1JR2MTZGWX!D*QB/0FP0(J>B!D?M40R,W\@$YF)?,CRA#NA4JOE7F[)
M9A:@\/EC'$+JL12B%'M0YFS ),6NE[@1CGW':!:@%MFY*;D.J[(40%:Y9/<Y
MH.NRY#F5![QXM2HSLEZI ]U5 9ZP^,OIS_"2)=%3?/:!'EG;=1@&'QN W]4
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MDR':>BIJ/ Q'5E2=.:LMZ[+,5\YT4MPW?Q/\U\;1",[6,.PL*2Y#XI.JKV'
M["NQ@4\9.$"IK?R](<OLOJZA_)S]]SICZN>O94$Y9]6"A21)*'=@BC&%2,[
MQL)=@QXC$<,A2@*]\=>&=.>FO)KCNT><Y2LL'6898N6/3\OB15 ';Q[K\NF?
M#(<K:2Z"GFH; =J1=5K#<5&"#LM7H,,T:+F^ K\5.5]AX0I>/\H:=HL#E<QP
MLS5.29/JM,.4S* X&*5D>/LPU;5S7/ANQ^ZK2^60%R:44AB&<N);0#R(44I@
M&L:A1X,@3+!1?+J'WMQ4U6[F =AE>%#E7!_@>NK)(HPCJZ6+$#16/YJX6%([
M?=0F53>:HN^K&=W;AJF7/W"9R6.T-M^_;F$E:-)E(<VRS;CR!4\=1(0O!P//
MXQ!1E\ 8(P]RRF/J4<_W?*.:7&W*<U,Y+>.;$A2@6#<>[ZL/O9[*&070D97/
M"2Q?P)9M\.<H@R6-T;*DDO3I3JJ<C.'85U/F#S!.W[]^QME2)6'5N5+;M*UF
M]FZQKG[/2XZ7,@?K<U%5;>G W7>^?.;"IEX]5#?EYR*_Y^7& 1V8R4IPZ/H1
MX1 GOC"\8A=#[ C-Z'//)T&$HC31,KSF)MC<U&TW5=52[OZL\.[/VY\5NS/:
M/#:X;'*,.ZG08(L-V((#)#K;&K :'U #)/ONUQ!UTJ/ULYXOR]2?U1KK9^G/
MBFV35W.B#/V_\RMJDI<_R_?@9$[^O+B=*A]_7E(?YN+/D[^!9Z=U\6I^+^CR
M[%E*]>%'8[M<4UJN.6L-Y9J_Z^6R^"[;E KZ=5M2*>"".*X;JM&UG,H^&4X"
MD\1+84H2&CHIIC0V:MULB:^YV8CO<%F^2+/PN;832:T1<<N\LA2I8A\(=\30
M4;>UF)IGMM,OT=B'N:U$8"O2%=@(!1JI-C& S?I=[ZQ?+9O:'BV>\MI%V];Q
MKR6NICT7M@OEP8&QY<>;AQ_\$+W'+]_X<[%\ECT1U3.O[TNN.A;\AE=K.2/E
M^JG,EF)%43N/*(Z8Y_,8NLR5LSAH! E- QAX"0G\R,$TT9I#/IB#N2EK(01D
M^ 5LQ&B_[(T@5Z 5!2A9Y'09I.]*#5NG?C=\=/1'UL."?_#>''CS]K(#5T#?
MZQQ])29R#P>NB!V7[2(03_M6PQX[F1-TD=1=;^6R!PUS*U0;N7?%XU/)'V19
MRS/_E-/BD<N-[0M?W:1W^,=763!7Y-WV:7=%/7I[VW'+3_V88 01XUS\)Y#M
M]V@($X>1P&.^&\=&[?<L\36WG:KNVD>[<LD0M! ,O)%NQ$]7(.>JOY1Q+KJM
ME=3S*5YA?4;>R^JEV1$)?&J6YG.]-%_JI1&B78%&N),CZ4?H!689<TN>A2VN
M)O4L+$.Y[UG8?OR P0]UJIA,Y*\W#AGU^EKR)_Q2-Y;(V3N\7%8WZ7M.5N)?
M^WTK%K'#(Q1C OV44J'1'0_&%+DP2GWD1VG*A<K7'A%Q*3=ST^.235!MX^XX
M9X#7O7.VOS48GG#Q:O7Z&M.NP<BZNA4&2&G 5AS0D4=U(5(2R?G8:L'D;PXZ
M'$VY2@;#,*9<K<G&9C2KIFK$'C=B78'.JLDOB:I5$SLMDZMV]-NR,QG6'LQG
M1G-<3&*Z(1ZVT-@9]V'MH4-+9)]YOI8;FA?$"#,7XHB%$ 5A#+'O^5 X+!YQ
M(Y\RQ'4Z8^X_V&AOFJ(KY<W=]6?P[<,?'[[\_N'6M*"U 4O/"Q@"P<A;0\N2
MS4K372&M59(VCYVX4G17F,-*T+V_VP\KO,/5P\=E\?U7SN[Y+SC+Y2^O4V&V
M[1^I"F4@BZ<]DJ8!BF+H>T1\N'$B/EP/A=!#?DH")V&Q8]1.S"9S\S-,R^Q9
M\"><UWO!?1-5$!LL+>YSE0PB?EF<C$+8"SD8K_+E<8<QU^[U@P]2.B#% TJ^
M*_"+6M_FKUB*>9BP(VTGJV7W8^ _02#"F+791".&@FH2DAA,8V !FK#SMN;=
M?I).7VJ.Z^VFY7Q9RS#X3=K^O5HX,4[<*$E@F 9R1#E/Y?FH VG(@L@E@3 "
MM88W3<3OW+:0FD'I?GVJJG.6U*LLKMXV,:,E&WGG4(&-;K_FC; P+4HHQ;W2
M20N] J[7YH06;4[H%=B^#!OA+9;N3;-*MDK_1N9VVM+!:: _*#V<B.S06>O/
MO.X%57W*FVC$;[C\BZOH_'Y<0@8N>"G;&=R56.4,J93/8^5VB4=C+TJ1\%M8
M"E'HQ9 @$D!$B>,%<4BB@)F-:1^'T;EM11TY36>ZC[22>MO/'-9GY'VG(Z)T
M*=^WD=JMF(>A=O!&7M'("AIAFQ*"G\8OT!Q[5:S-LA^)S4DWF+'!WM]91J<W
MX QV?]#UW4-9K.\?OG'9!Z?^DSKGO>/E8Y.QYGAQY*9."E-'UH"ZS(/8P0ED
M. BC-/!0RO5/7<WISVT#.#:;OI$";,0 K1Q "G+!R'J-]=$X9QT7]=%/5HT!
M-\_F'(2\P=GIN"LPV6EIO1*TLQ*5%&,E]]NE4&/W3<=-X:Z52C16>VJT71TY
M9,360>EP3,\<C0YXZ'2'H<,EWCG^O. Q<PBO+2(?.31U ^B&6.Q(#DM@$KH)
MC%&(7#_TTC R.GVQR][<-JQM$>UKALU>)4HVHUULU*#87.-?LPYW_9VC6],$
MLRYP-(IE1E_J:>?7E,KNCF_Q4M:I;1H*LM_J!IMU38$L><,KV1"52COFGB\2
MSA,'A0P&*?&%DO=<F/ P@5BX(\B-6<20I^MV7,S-W'1ZPVU3[BMMLE+PJV_M
M7KX\_5['I*"/[8-TA &--* 1YPIL!0+MPFQ$ E*F*["5:LI%TG=0)EVLJ=R5
M"1;-R&.Q!O)I_^5R$I-Y,];0Z/HV]AXZS--IIF.J-_LF_20>F=]G8@>N@WD+
M)':T,(G$?N;'*41>@&'LQS$,PX#$@8]H@K5B:7KDYK9K=;F540%,_WN=E2H!
MK&7<J,N9)NC$9X[KX1#ZX@>(6.)!85DD, K2)'!"G/ H7#SSDA33P]XE^S\.
M>#V7SQZ8(QL!^RAN66T.C.RY87J86'*K>HA-ZB;I";[O]FC>-?0(OFZX\15G
M[ M?+>+4BQT/<YC$,8(H#L5/'@U@ZO$T9EZ08&945[SW_+DI[4W3VB?!G^F1
M]RYRNB?5@_$8_8"Y@4*RUFWN\PX_9:LF6K-M\'/SQ(575C?_667/YTN[!AP=
M'X7)VHGO[M,G/J@]*MKA^>KQRP9.%>?E<T:Y2DIMSG=2% <(IR%T62!,-NH1
MF'!A/41^C/TH\.,DT.IJ<YK$W#[V.NF[["M8T050[X._#):1O_F&.?$U*VCL
MCV Z+;VMV=J'!*8=G7U2P(/)V*>O'.B-4;I^7"^%@\=VI^*J0;G7FSF+S>L:
M!\(3X#2$H9,@.0:;08)1"B-$B' ;N'32C+PS(_)STP5?BVI5\I7P$]34>5*S
M7H%EADFVS%:&LVT-UT+3=Q@-X;%]B2WCH.$<-*S74\C!EOF3#3VLZZ)A<-IR
M0\R(3^N6# +FP$T9]A3CTY?/[1<JFP(N<?:HDLOJ'S9$/OQXXGG%OP@ ZI&:
M"Q90UW6]5)ZX,(C2A,.8<.'88-\A",5Q&KJ:)R[#.)B;!OP]ESX/H(KON@V
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MBQX4MZ"9*0;J0>CZ,54[R]8;P)A\,4;>([;R@*U 8"L1J$4".S*!-TJJGZZ
M6,:;$M2RF1][VEDS[6#)Y&LW433%XAI:";=8Q?ED/,8.E:D"-E8QZ41T[#[7
M;+.LRM7BFW@1^?6/K%KXV/<CST]A&KJQ<-5<!F.$*22$)@%)D$/TJFQWGCJW
M;:N&=J6^JJY-_:=D5E/Q[<)V?L<9#,;(V\9 '+2UR%&YS]GSXH:.+2_^M;7C
M=Y\UR0=_E/WVJSW^1PM3SVX?L%CC:RKL*F%!+UP7.W["$TA]UX4H#5(8,^9
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M?^AKU&O_SH//&5G+$A"@1 $=2(#$!'1! 34J^]'>#2Y  0.4J,WSFKS&?7#
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M%U!:6,[S^FSZ11I9X776IV$7=/E5;1*E1* 6Z?A%YI6N%A9*OQ9VV@6;JD+
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M%#*71C'R$D1\W0#)&3)STP [K +>\&K4;:,'UU[CT1):(ZN"7:!:-ILNKE:
MTA]P;P>PB6RWNP?>O$YJNKH<!2\\FZ*473AQ&WW#>2XG*E:R!_;W!R[[],G?
M'7LU']?5"A24KDM+4]7[T3P]3OW,O9/-4>_GOSM 7>-J8[5ZT.7C>(,/H<]X
MM9)6W+L'\8;P9C+=ZJ6^O_[E@F :1K&'(&:A Y'+.$R\%$,_P4X:\"3R8]T1
M!C;YFIOBKKFJAQF(+XDV<S\>%<L5D!_3N@+\QY-8XC-](T9=RE[5_UH+-$FF
MP%[GI&,]DS[6/9-J^927"FIA5&)34XW9/*W^P^LLI/;6]%H+.M%>]AH+:[*7
MC0'_R<W/*K&I=LLQ$.ILKZ,\WG@_OED]R#J4HES=\?)1QEJ:JN#?9-L(=8)Y
MDWXN\OOVSX+^9\G=#5EF]^H;JIH[%G% 4R\5;A$B#I5!>BK<(B>"CAS0*'[R
M:,#TNC[89<Q$.TS3$T()UST^3K-<%5DLI03Z)Y8V5Z]W!WZE%1D[;B.E DHL
M*!D'DO,KT# *MK*!FQ1(Z;I720VM1 0=&3<WO\HR:N^_K[2<$VV_K[&L)MOO
M".B?W'UMTIIJ\QT!G\[>.\;3AYTR?"T+MJ:K=Q*0?%6J1TN;H(F.DQA%?N!Q
MZ/M$>+@D\"!&80*Y'\4H9@&*'&9RV'">W-P<UX9;L,/N^>ZP0T#6.X*P!]W(
M.]IIU$8XD=!#Q=+!1 ^Q2<\G] 3?/Z;0O&N8+OEEC4LL' ;.-M6AL@^<K B]
M$T^\2=O&NC^R:H%#'@8\)I#Q((*(.P@F;DADOCIC+@THBU,3S6)"?&YZ9LL[
MV-8[M]Q? <F_#$BWX]7_E#(8UHP;K8V>0AH+\9'5DUVPC176$-0LJ2\CTI,J
MLR&@[*NV0<\8INB^<!DL*1Y5\?OU:E5F9*VJ?^X*V<E,4BV6XO[[-GRRB EE
MU.<(4C4OG::)[#3&8!CX,?%32H- *W]P, =S4WF?>57]+R#$D$$((0? '2'D
M*4&^(X:XJI;#,.O#?*7T=-^H^(^L "7H-?/@C63_)W"]A_VN")O@L#TE.!@^
M2YK0G/ZDZG P//LZ<?B#!@P>;92N<%5;O?M0+,6]G[?%**<J&"CV.!7O+?29
M[/J=< ;CT ^A@Q(4ARY'KJ?5JNQ"/N:F)-4X X-YD!>L0&_T=2I<1U9^6Y-/
M!MEV!0$=2:XLU/-<M" &0SBG69B) J=C+I#9K,S+83TS#_."AT\W\_)R!';F
M6EIXW/!VF=E*I64VQ.O>](+@MMKUCO]8O16B_[40UCDGW.'0#X,0HA1'$'NQ
M!],PC)@?NS0V:U9G1GYNF] .OZH]5'VV\9NPV 5Y\]:9!BNA9XR/A^_(FU&'
M<07L+M1;WL&?DGN@V+=9:C\(-XL--@V(3]YJTQR88TTW!SQE\#D.Y9Q5*FFC
MJM92T>X>(2T8$7HM8$*C(22,[$#\)TY8 C%W/!30.#1L#=1/<FZJ3'J^3PW7
MLC@Q:[B6\;ZE/(.5HS  $YP;G^_T@:]]QF,1TO'/>6HDZW&*'2QWS[.M'O9H
MPF/OP*>/X-2'/IH '#GXT;W31DRT[8!^5W1:#]?67O465QE=H"C%7)A5T$N)
M'-%#0QC[E$&2(,I)$ 1A$II,+C2D;Z2:)IA<>/OK];</O]Y\?O_AV^T_P)</
M=^#3EW<WOWVX)-S9OP@^1VX<NP%,8FGI$D(A=F,$XYB&+"011XG1(=R8BS!)
MH^8F/795U(WA&V;_ ?)-H'KD!0FI$U/9NRL('-G#+X$QDYD7F*+$";DC]F^S
MP54C+LDTN8JWK[(00XX!K(([_2% R[Y\^[N-_AL)KH"28:Q# &WP1CD"Z*?^
MB@< VM"<#__K/^;BH23UQ%!I9W"VD%X'#N0($AKX$+F1V&1BX7?PU/58(O^(
MA\XAZ=*9VV;2?$)5/2NCF4F<*5:'CR8^A;%^H.1"Y":(B&P'C-1,7H&:S5'F
MB1S#P?X(D1TJKS4UY)BH9P:%'+U\F&:X9BQ3.:M2]=21WU]KO?-QG;-JD42Q
M@Z*$0\P"%R(N+%!"A(;P6>Q%4>P+0S0TT1 ]].:F*=[SIZ+*FAA@F^@ J)HI
M+Y2%+)G</09A]0T@E=*8*9"^I=!3)!8!'EFA;#BMK9J:5] P"SZ>!=!8KVC"
M8DF_]%&;5,]HBKZO;W1O&]3J;5.JMFW*W&1<8QSCR',]Z&(60Q21"!),4^C*
MJ>-.2H,PU%(X?83FIVG(2FF9@^FI1NW 3@-[7GW8A&MDO7$:*?/A&N<A,^J2
M9@6ZJ09BK(F*G,F(,&OAY ?3J"DNRTQL<WC5&3\MH_.K!PX(7JJ@<O7 ^<I.
M$PTM&,_V/CM]]Y3]S7IEV.MAUG_],.-NTSCZNJJX.NKJG.<WO<+93?Y-4BVS
M_+X>]UNV_Y2>9V?RJ^M1/^(I@TX<IA!YU('8\RB,(^9[<<R$XD8FIJ!5[N:F
MSK>#+ZY +9_ZQCH2MLW:52_.C9#JJJZ8*K1373#>U^Y+H&>$OMK2CKSUO,JJ
M&MNZHZ!OR3*VR]ND=O0HL.Y;W>,0,;;1MPD2=X4T]SL3DAK;*/%9%#"*(!;W
M0D02#Q(G#2'V_3CP411%CM9NH$-L;LI]R[!T7:6KWYW!IVU\]H/<:[-;A6Z"
M &*#VEVA_/ON@#5SV[T?/FW[W2J,$]GPY^&T8H]KPW+2)N]_PE1VN;8L'=M<
M_Y[!B1EJQ'-9R,'/[.W+[Y4LD?N4/_-*9J1=TU7V7,\^HTE$TC#RH.MZ#**(
M2TV;.)"F!!/"TB@AU# G0Y/TW-(Q9 +&N^O;7\'OMQ_>@T]?Q/_]\>'V[M.7
M7\#UN[M/?WRZ^_3AUO@$6G<=M ^?1T!W@G/G>D)\PS8@+^"-Y!QD^4]@PSS8
M<F_UQ-D0,7N'S;J$ISYG-@3DR!&SZ1.&J;'=-NP?Q=M5SZU:1+())XL=F#*.
M(.(HA9@R!(4F0SQP7/'GP"QEYA2I^>7&?!7F.,V>=(O$>K'44SPV\)DB?-N=
MPB"Y!#6;]O1)'Q"6M,=),I/JBCYA]S5#[_673+WM:5NH*E2$<[NN1S7(%!0?
MAS21!SR)T!&,"H\RP=#SG,AC*$RQ:U1^/X2)N?F76\X K1OT#IF>:[@0>@IF
M;'A'5C[:K5=5XGQ=3;45Q/:8WF$P6AWC:\C"*XSY'0;2\3'  Y]E'#Y[R\N_
MA)=8\E_QZN$[?OF<I;S3^N3Q"><O-^D73DI<_86;:$5$@XB[E$#*I29D7";=
M(!\RFCJ.</+""!'-B-H0^G-3@AL9@!0""RF %&.G,Y 21!YBMJ)H!X\&K1 /
M2) B&D/NA<*>37Q'3C]ED/L.2WU. T0\[2ZV8Z_1-&;N1HIQD>\-A(Z-YLC[
MTN[+?N9=O]F^Z^81TT'0:P=1QUZ"B>*J0Y;"2K3U$OQ.!F '/72JF.PE$G?"
MM!<]9IBK4P=1Y-M8ST7=UL6[L>_A-*60\32 2!8,X4#LYSPA!,=NX+K$,?%G
M3E*:VWZ]9=306SF-I9Y+8@6AD?7[EL>K=A;RG\W_CM(_H!<32T[$:3J3>@J]
MXNZ[ _TW#"ZT>2KY \^K[)G7!3Y?^.HFO<,_%CP*"7>< &)A*\HCG%B.ADL@
MCE$:AF' /.:;'.&<H36W,YO=$MIW-[]]%?_\\.7VTQ\?!A73GH-93VE8 F_\
M(_,ME[M%@5>J0Z-P?03'5P=M K]B.^WH#>"R5YISDM+4Y3E](A\IT>F]Y<+^
MS8==YM_ALGS)\GN5-;1P@Y XC+DPH;)>QY=-1(+0@\S!H4O3T/5<HR1-7<)S
MLT8V ^Q!6I3@OI7"T#31AEU/Z8P!YL@:J&%98'ALW@5HV:Z3(D=HQ:R)E.TV
MS'UD7Z<%LR88)]LOZ]X_L)20"O]\O<0KSCX6)<_N\YH(?;EF_[6NK2V=1J=M
MW,'EL5P@&'@!@2@D,22QCR&F2<*(CWB*C(9IVV5O;OKN3JQPM:SG.0BC(*TE
M!+064;6'T^OB;%BS:'?-]=3HZZWDR,JV(QAH) .M:& KFVY3Z!%F>HP#O:VJ
M2[O,35ND.0JP!S6=XU QVR^J<K7XG*V:G>@=KG@S=81BU^41#$(70Z0<Y0@[
MT$&$H#1(>42U6GL>?_S<]/660YESQXT&AYP \+SRO!R6D96?(2+:JNN\X.=4
MC[BSHW;$O[8JY\1#)U$9YP5J/_F>JX:9>+?T@;/UDM^DM_Q>*HMO_*DH5THS
M")/C4=%Z^]+\<1O()9Z/L<L8C%#J0.1%@>PSPR *,&'$23"F1E[I0#[FI@1N
MUX^/N,S^*;;[AE7P44W[S/ 2="0QL\F&+I*>\34!]",KFE8":2>WL&^$Z,)^
M)1.@VRO^O%/6UBC1^@LQM60^#>5B4COI0JCV#:)+'W=Y1^!WPK+B5)*1/3^%
M$_>-4YX]RY=M$;EIQ'B<0 ]Q81*%001QX,0PB2-*B.\PUZP]ER;=N:E)68;#
M2Z44'\7BW.-[#I:2Y>&M@,^AKJ<'1\!R9+VWVQ1XRW/=%EAP#;9LC],86 .G
M$;H#GZ/Z:BV"-: XUR=8YW;CK,7]'A0?__CRZ3IG_YFM'HJUT(R89<N7]UQV
MXA96BB"U+5;.V:\OI,S8-JN\:D.+=6KY6RY#4H++):ZJ+,VHTJQWQ<XPB;KF
M^5>^E-[I+5[R:U*IQD,+SC AGI?"@/D4HLA',&$AA<P)/)\Z&(>)5C!PUE+.
M3N_J!??_1J_1>=4^:]YGM)$<]%VZ A__@%\^J;% #52@P0ITP0([_3/$Q35B
MG6H@>;34OG4U:E>@Q@WL R>KGG>G"VUZ<DCX9  52 #!GRV$^HF2\WT-]-,Q
MYRO##),^_UZOM)5TT_F_'R>36F?,^E2ILS.&X#!!]V_ K)FQS+@0*E\)H9IS
M]$W8X%9HJG6U2*,0>PZC,)3SA!'B/HS#Q(=1BIT8ASQVL586<!^AN9F,-:^;
M])!M6*UF5V\#[D7WO!EG$[.Q+:F!<&GK>5TLCKC=%:<_WQ?/_R8>47O<XH>M
MH]W[X$D4H:YXK2[2OM[8=U:E@T?R_V2N9JVB[O"/S0C%._XHZ.+RI=:,"^($
M- R(#VG"?*$N6 ))X'G01Q$)N.]R/\2:[NU%C,Q-G?1FM5P!4IM2*_Q#V[J_
M;*UZ?<C)5F!DY517/Y]-06[L6)6"O)WYNA&IZ= [T<)H>T:3+=!$SLOX"V7B
M5UA!]Z3I?]G3I[+.K6#0,:#M/,]X4_M2K'CU?LW%(J#0]?>2]2A&82)V+<@2
M%,EJ: H3U\72T'4\%A$:1%H3ROH(S6U3^I? <<!CMERJ(V+G9\'POP(E 6!K
M#GX3"#\ *8FVWCN/<^^&8PV]D3>4&B/!J$('U,#I)RN:H::]&UA#;R)M7Z/X
MA%]4^(EPK/H)UV!N)I3(%S'+%<YV6K-KH712:Y^_>RJMK"5#1^OJ76^L5:^7
MR^*[+$W^6)3;8[LV(W_A(%F_PP(8I*$'D1L[,$9!"A-.&?(\&C&LU1"IE]+<
M].J&6U6R4V[YO6H,?LW<]'Z(>S6J/>!&5JE;S&1LN,-J&U.P!9FV.K4'W43Z
MM XC2O<2GWD!F^BB'(91M:^C'<VJ!]A)U=IS^U2Z54^*CG+5O&%@GNIWW/:
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MLWX/S8'PZVG6\4 =68F>&G*3Y:#E??O+FGM[FG(8:I:4HB'Q2?7?,&#V5=W
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MKSH-)^^% UV!-TLA/*]^ N(WA_TGK;0V'.&EZ#U@G>]23V*JG6V6>#!ZM8.
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MZHN/??QVY )%+^@(=HJ@^>6%6R1]W5%<AJC5!80Y0,?O&0S&\':=8,[/\-;
MXJV1+HORIM)ECJMUUYU':GZ])Y?#EI<IQCQ*,PS#/*7R+,$H)$Q(/<U%$**
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M37;T*KF3B8]^*/&9!.D5VX.$2+]S7]HA\[L<X'7;U;&[-NWN'4.&2<[S K(
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MJC/N]>J;HB_[>3P<5FH\-I/W@HUG6'ZJ;N.Y5\;I!YT1TNJ;OE)#)BA%49'
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M>)#.T="%*>?V%<7@ ;]!0(./V>RL"\;+:QW^^'#%F%Q(3?>?#V7%P^NDP*E
M!8$BSRE4?79A3EFB&C.%252@($R-&C.=G&5N>WM+*.A(7/0_J/9X''RN#-7W
M:6!/;[K.X)IXSQR-E+&&,T+BB4-/P^EO-ZL?_RK?;\\[\H?=,>?TJ%Y4CQ%C
MO>8P>WB<E^<5K[@HUXUR*$EU4['N1E)U94OS/ QBF"B?.N*J'ALK<DAC$?$@
M8#G*L$VSI:,S62D 'UFLG[]??0"OWGYZ^^[]]V_@ZM,;\/;_^?+VT[>WW^R<
M,,>Q-7.L.$%L8AW0T[@ +94ZW/KMN0 .:R_)62@<>3Z.S^/5FW&6W4,/Q?D7
MQJD'U47^K>[1H%LH='?8-,-Y&J(8AD%20(0C#(L0(4A9'.4,,T'M;MJ>G&5N
M=H$B4O>[6/.V,86=,G@:23-%<#$^$RL!#4U+8-=JPWT\XTD,'*W^I^?PNO)/
MLGFXZD\_/&[%]\E17??7[CLEN$ 9HQF,,HSDBL\*2%@A5 _&(@L*EF9)8;/B
MGYQE;BM^FX[746FWX)\&TFS!7PS/Q O^$)D)UOM)"!RM]Z?G\+K>3[)YN-Y/
M/VP?._BE7K$-77^NO_'Z1TG;2S]6I!%B201)HLK>TYS(S9USR!@-HX"C(,N,
MPI&/33"W5=[1V!9';\FTNG(]"N3II>X"GJE]XO;(6$7KG6+_@HB\)X?U%G5W
MBJEA9-W)Y\;VN6J:USHUZH975%U'EG?-F[*Y*^6A@'W:M$T2HR").4,P"1)Y
MK!=IK)HDJN2#(@DQ94$86P5DF$PZMR7?4J7NY;0/M@&LI]>V%98!X&8[OFL8
M)U8-BEPPH'<!6HK!EN0%:(EVV2;+'")G_;(,IO3<.,L<A,<=M"S>':>"_LS9
MS=X!-R;27(A0 >,HRB#*B@@63(2PH 5%88 R3!,;=7,XP=Q4BZ9OC'_@$7)F
M>N,2/";6$2T44_D#CC'N:.4_&M[K*C_&W.&*/OJ<=8S18<N$@P;0PX;/KW!3
M'@D^/5N8+L0H8$D60!9DL2K'64"2%O*?&*&,AWE,"].Z2'XHGIM^V36(I[I!
MO*-:FY[$?UJGS5*H$RO)+</;^GV/<L-W(E=L \TW,"X2>%EM2T_?A7$TTOR^
M#U]MN.?UG=C$*/F5V=%P)4]D^(I<\HOJ((C)\\3V-=CVZ3F@MCW_;%:;YB]5
MS?%2D:K.15]63:D3&H?T7R<THCDM,ICG:0A1B#)(>$ A"9) %$'$4,X-JX<[
M)&MV 1-JC@/U8UYLRZ&XSIH7SR2$B6V($[U!WVU[@^Z8 SON=- &Z/E;S$&&
MYK72GD>6OLJD^9:I594T]] ?+Y#F<"YOM='<XS,LBS;!Z)?T*/O(U[>K02)4
MTX8Y7R=<4):P$&+&,404<8AY@&%>D)P&41$R9!4E='*VN9W3NYKQ+;5].4-Y
M2O\_J[):@[]*PC?UN#9FQ^ V\Q<Z W'B/6T?OP&EX(^65O"=_Y*''+GB_N:\
MS]D9>)RV.SLVUS-T/3O#]M/-S\Z]-/8J$\LC@LYL>+.ZPZ6T! I&HTQ0B)-0
MFN)YGL."JU)ID6!%$H1%D$9V]Y8',\Q-@R@U#]<KJ$D$?[1$6J:!/X;1]#;R
M G \6+L6N(RX9CS"N[,[Q</Q/5\@'F'O\6WAL0<]'\E5>4"= 15]E$_>[KL8
MKN,@BY(XS6$HB-0+)!8PS^(0LBC,DP@7/!:)ER/Z23+G=F1_EH/>:4%.?'AW
M)IZ_F\.\+JO9IJ-&H&7ZF4[XIP7OZ<3O[ /XN_, 7/(A^',+&,EG(C?!Z;G_
M/MP&1O@Y<R.8S>;84CCBT:"TK5+8_GILHU"4IB1  2Q2=;[("((XY P&*"91
MD*($B73;:<6!.3$A+T;*[* EB[=K@H&:>L/O:T[+KL^#HTB&Y_N"+C1@GON#
MF)%Y<\*9O8-#_VELM\3M9'\'WY4C^V@FW]><K*<Y?&?N#"P/ AYI?DU)V3R,
M,P_8&YMN/F@9FTV^+FNN5O\7N5B_RT%THI1(0RZ2)(8T#2.( F5Z%3B!.4KB
M/,<18<PH*/3T-'/S[^ZH!(I,H.@<5>OS"*IFGM[+L9K88!@#TXCD\E,H.,LN
M?W(2S^GEIQA]G%]^\FGKTUW?</.J8F_*'R7C%6O+&6_O1^5?MC]_X+CA3?O
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MR(:S^KTSMH/BT0VQY>O']-90MA_D3__[?_6_D?]#<,/_]__Z_P!02P,$%
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M42;L9D..CE&.D0?L$[AB$PBAO#'"1XWJ)/7OOO$P]0\XAWF2"(]6/U$>9PT
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MXC,A[EB5#!1A'W$\75S,Z^#/Z@Y](QG61DB):6YY-B"2L:"43A1=U0% *$U
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MB"6?P/."@-+3#URD8'G'-]N353OT;8>AY@<Z&>A$S ,P2.O6<6LFU@WD:F'
M^HO\7Q?KOBN;%.&50VD"ERHFD,D54&1X(<KBP"!R%E7*0;3.1CR=RL, ^*.<
M'#R3M@: QWT=#J\[(&Y84@DMQZ2A<%DON=<B/&4D<6BXL-9*6UK7=Q] UF&(
M^U&."[K21\]U'K?ZSK[&U5R4-Q?3?,]I!\\!>9(()0H)*I-C&5)FD"EV#B&Y
M&(1^=,]\XDL/P]&/DLWO6.@#L%CK5F0?QXN_;];'+C]6<)MBJ.U6LZB]SR30
M4P08KGA*FEDIL;&Y>HRFPPII?[3D?5--# !96UTY=XO31TX3Q?5D*R))1['
M@'S+"/0Q$C-26]\Z>?\ .8?AZ4?+WK>2_P"@=--#<7=-"*%YKLWQG:@CI+F.
MX'(2$',,3B&S&5N7_=]+S&$P^M'2]&UD/P 0O<;Y^!NIX]O=TZQZ6U!SYRG,
MS:;>)380$QE:32PBR2XH5AJCZ'YJ#H/1CY::;R3] >#HNEGB^[*>T3H.D[=3
M$M'%UJV7D9:.4?!:H/:.!>6B!R_1 HNYEI7;XDKKLOV#"#L,73]:\KV]3@8
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MRFPSS\5((1]V/IZ%SG[/(9L#?GBZ'0C0WY=/2#H)2]QTJEY+9_=F8>*.*;2
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MGR\A0A*1":7(HOG6UW"/)+7I1)J#M76S!C$KQID4("S)1VEKP F+D)CR(?"
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MF"HO+S\=P*O27M49(Z"+K04%RD.,]6"U^)AE<-HWKP(YA=Y^M_AGA&N7>AP
M9C]=Q 7^]P7)_-=OM<"%_MEJ][%<DFL3&=C@:\]"J2"49$#:(CUW,@??? SF
M?E+Z;H8Z?&>RA0Z'"<7-8J9H3;.,!;(5=7 <>4$Q"6($L_ ^6*E=\P*+^XCI
MN0ZSA:H?A\\1<A\>@#8&67*CE;4(/G-R(KC-]!5FL,H+3SP1@\T'F^XC9'#
M.4;)#T/G"(D/ #;=F_AWXRFN"IQ'PNMHR::#")[5Z:P:8A8D>R]EL4F(H%5C
M,#XC>WVW@![^5CU4K U@&=[B\F$F:_').&^^&<5LG>:<C(RD;4\YQB *P<%8
M5$4I)9AK/7_U6%K_V8]3CP3?0_%75T@8=#7FIXOS\S"_G)5/],-5:#M=;MI$
MD"16LY;'>'QYYM,>W_!VVO%LM;O;N_.VZ[JTC%HJE@,8C BJ7D&/-F3(SA:C
M9!%"M=Z:[Z?F5&/Z._ZQ]?#Y;$I?IG4AWOOYJ[,P_8)OI]N_,9ZF,>%FO<-)
M9:/+2@#76E TP1SX>AO?2(HR#-K";.N;S"<1W/OMW!:8VK6"SZ?"'C?_Q7PY
MVMPR>3_?W#%9!;0^).4BR^ 89]7)DN XJ[-@%!$O7='^H.8O]((M^-%W-]"[
M[]W]HND9U3YKJ(-A8&C[IM(FO$U&\Z#JI7>F RACZPV-F$@V&2UW,5C1$$AW
M">@'36UT>A<@)PJXWZ*A#V=A?A[2Y57-R&^!/)35TKIB:9/ T&2U;7(<T%>S
M+>NM'H,(*8@00AT:JOW#'M83WM8[0$[5Z:Q; ?>+F1?Y?#P=U^V\MO._8N/]
M='+Y%PR3Y=DKDO(.<\YSX:U(8)GWH$K0X+F)$*3";)R)7#\^M^/I[^WG1*X3
M''4L] $D.VK#E%>K:/8+3JO+^/+R]SJ,L0YIO_[X<F6QN=>T=1L.S%>+73ES
MVB%$I[RR/EA:0XV=\<.IZ_<8^/E]I8[U-SAD;KCZ_\E[T^4V<V1-^(HR!OOR
M4V57]5<3566'[>X3WR]&8K,Y+8L^).4NS]5/@B)EF5K(EP3Y@C[='6U9DHE$
MYH-$;LC<'.=D(]8GW\8F2\<Y(@2&2/M1GLP*EF)L[1>^0,ZX=OJI$/ BT X7
M1P?(>IOGJ[X#=$3_<8MSO%GF344N1[11T,60@W2@LK3@<J8]62,YRNQ3\\D?
MSU/3$ZZ.$/CL)-SO $?WY&_N?L&S$2Q(X**V&B/[D>CG#AAY-E*K2)9EZ]*I
M;1K&O0=/A9FC.#UR1.#57<\ZLA]_+27')>%_.DMORE6:??E>8YN$02832%6[
M^(0ZBUV5!")J(4LNR9J]JIQV! ?VH67<,J=QHD[-9=0YYM9'TG.GC7,%HK4<
ME(IUTJ E_\B+X!ARYN1>^NI(U(T=GVHO_0'0.D 4G8/K*OV?V[M^W&ME'5+(
M*NL""4.J3903>!TS.+H$LG;(XGY-J(]5;EMT]0NX0S Q1)L=(Z"1P?<N+S9E
M ZMCJ0*9%"QGR#P:<FD":?PH"I2$G N=&'VG ;:VEAVWOFB<._(8SO<#FO71
M4DP2'R0#8;,$);0%=#&01<HT_2\;6_:JQ=P?-F-?<D>)[VD8',#+T8'P=;I8
M-0:B0S&;WRG&[R?E_1)O$L[3XI]?4IV'LJTGBW1"H%%@0WU$7!PI9!<%*4N;
MM$E!26&:H.88*KN V"'0F(TBIP[B"(?J\S_NB]QT?:-))QJ"LPH4+PP<2@DL
MJ$A.-\]%MBX9.IKH<<?2C!>Q/Z^T.X#W^^4L_OO3[)H$NOCUOV^GRV_WI91O
M:W--$OAR.9^&V^6JI>7LK]E-K:\D*JY7W8^)$E(L$QFTX.1J@?>9>)X<&:FH
MZ[R42.=9*K2F^?CX)I1?9AG/@7#;?I=Q?MD/1[R_0_Q-_EA'2WQHJ->7WZ=2
M7'W%Z?7=)E_-/G^>W3QD39WN%R<Y%Q65DI#IIJR3*A2$'!.8&$44*M4QKLVU
M^" 2+S/+V@;*IY1F!UKZ5YS?$-,6FP%IKZ?7MW0:)B$94ZQCD$V=@)4Q 0:M
MR5FHEUP2,?C6;=6?(>4R ]-MP-=".@>#[&N>AUFKQS7KA5<5RM^N(MT)B^G=
M XK%\NISO1/N^KK^^O>7?+/($U+Q&&U5_4*1GTK.*;D02!Y%$,H9SA2YKZT?
MU0RD\3*C06V >5)Y=J 6MS*:Q,?Y+5Y?+5_A?/Z-OKD:]3>QFAL40=*F MDG
MNC86,S5[C=9YI=&KF!J#="_"+M/':H/,]I+K%H[$V[MXR22P8(I/"GSAQ#!=
MATJ&E,$D[[T-1H70^K;>0=*X8SY[A.!ATNH7?/AMQ<])*5:H(!",XQZ4LP)<
M"!%XMMD['Z))YU&"&XKV@I[]'P6]0V35]0/5-0,7[W+,TZ_5(R,_[?YYYY,_
M/?BUZA%K-1U+VV3#C=ZQ?E_HP?ADOAJG+2%JFT$5@T!^"@.O \'.IF":QS&>
M(./X]SGY=EG'[?R)-[>%/O!VGN??UYFHS+(E*P%8C(R.4"(;@OE:[:\$HXV6
ML#T\Y?FW.2^N-&[\\%@!/WZ5TXZMX[[(^6M&+OGB=EXK63>SFQYPZ[[][_/;
M?G!,)R[YDI+T(+1RM.\0P#MR[$7B3BMT-FPWCW@"3DU)&C?8UQ!WXPEJ[-[D
MSV]Z8GA(148-?-470]$1P]J<,#)$93 F)^-.O+VTPKCANH;P:<;&#DSXC7UP
M=7,W0OO!5LA0>'4[K[R=2*$]9P7!BDR&9\D.T/L &*7,Q?(8]0D&R.\F;-Q
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MP75K*=.^(;J^SPH*GW5.@,83LP23X-!DL#K0C18D)^/G?"#MP8]J"H']X76
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M1^>(]CNQ,J;DG0./Q"ME% =O@P?I'$8L(BML;:3M)*JGL>!MH-56#L.!Y>^
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M%'58 %]Y>D6#(,W-(HMD#-N=8-I_O;[3M^T0=2()])6I>[")$EB0VD?@= I
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M<: A8NYP6$[;>*]5TODHZQA-3HYYU"01G0I$KDMR$5&<=++.^9,!_J<[#GV
MXW*,IR=^]*,HI.$V:1!1EEI^A;1IXH&64AG&N..\]2B4)H3W7:5PU@1P0PE?
M-*SW/NB1J\@BV7FAJ/J8)&@(FJY$$WC@*@@3[)E?YS38U47DAEM"M=EA.0EN
M+C%;_"QOJAW)HU1>)09>!$,WM7#$!N])KV6;H\&DF[\P;D3Z1>2/3W@RQD#
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M*\.U-L"SK ]/8ZG7BJV=GHHR.1HCMSH@/5$..GS=<8L^3X^YTPNCZU? /V2
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M!<5I&Z]/,Z5QU.O/ \%XXJF,^R#CO QE,\//]K$'ARESAA0^L;I +=K:\97
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M?80L#,\E0#!.D&'5RC0M"NB<C+=!1YU:%[CN0%9_G7C[(&*_6\?]]3!N*/Q
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M!\C>V$ F?$Q22D>NW5ER\L0-2C3@3"P4">@22^LQ00<W^YU'E_Y>J'@QH3]
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M8>F$K@,:*%4K3#KE,>UN/(/2NMO+&OMA;:4?()S?F+[_NL8JLIM:)4K/OJR
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M:?7ZE=31;NH%<L:M4VV&IM:"'W4SW2TSRQUG&T5DBV%:4<C G"566!* *7)
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M'U58&C;G2*2'I#+Q^?6WP46294K<\/*%/+<JY<BR1*"['S2Z&[T )D/T>^/
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MFZU@W/#6@VE^O,Z%1R'DK,Z%QXBK)RP^Z)/'M[,JI9/&TGG%Y)"L:J7 >9;
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MD5M/4-Q%T+87@?&%[&P+SADRC8,FB]O0Z8JR)!ZRB8SGH:#X]+8ZT8ZMH'!
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M\Q->.8MTR"R'0GXP$49,#;7%-9FU+@GO37A<;-IH$LH!FQLW;C0D"(>13P?
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M2O FDK]0"H\:'3%]P)#= !1U$U]IAL&G83XV(%[(\3B"^F*SR6@5Q%RI5]9
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M_E.1*X@V67"69VMXEMJT[ONQ=U/CEH*UQM0PLAA7ZSR(7:Q+I,B!_8"?:B^
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M&,_X_^$Y>/K[MCUW_1G]!5!+ P04    " !*5J5697%NM38V  !;#0$ '@
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MT /X/OS4]PP>?V0#*N7P_YQ*&(E0ZC>V61<F@6>&"=NE-?$4(?:P8,HLV[C
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MZ%,,?>=RYQ-0?9+"V%!HA&B!\0;$+9TT><7.?EP01E2=%)+ 7JQ.BA92JJ_
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M:)2!B4G0L".MUGGPZAX$,T#R6$W52F WT.F*C=38>P!+ G1?R:F"!W3243;
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MZ!UV"N\ PB>);5/!4='4..N4=2\<%K[?4_?[N$'W:*+A'="KEH_3!2I9M"Z
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MO)J3<3ZPR=#81N$7WT.=FH8ZH67((>)V':$]%#"-P6.WI.RNI-T1@;G ] ]
M$$8!;:77HC-%$&%('B>)))X(*RF0E7922:#R)"3P/9WK4"(D@O)QBK20))74
MVUNP)A>EH_ )3P*'>F2B>Y:JD&&FR36EU!UNQOEX2 D^&-]LY.Q=['><O=?[
M%-9_N4\"TE+&6Q1"^"(\[O>'F,M5PN-&@<&C[F!W> P;UA9$[I]V1_W-B'RQ
M0EAC?IFZ0W>/Q)4HEBJX@B;-R)/%TN;9L%%X+P.T820(U9F[MX[EF@26AA4^
MOBCY B&[7"UKU"3K>9<!@D "V@+6@UZW-]@,UC;8D(3X,9E$RE4B7+<4N('&
M1X$GO;7E^9 EQP=Z'<Q"*O.7-O(H-X"E(/M+8QS8#LB1L/IW.9OA/Y&,M2M0
M^1D_<(X #O;N]TNLE13![="GUQ1]GBPC4,4J3B@/MPFOV$E]"\:IRS;A5/\)
MG/H0&K?RAS"82C=A][81+7:/5ZD;LA+X'Q2K/VC41<\=ZH6I\P_MQVLIT(M
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MG8T92=J956L^C5,:G-W=Q]H[5[K,HNOWG5D8+ FBO4!@:)YP[S$8 GZ;@\R
M-7SQ=X[3B3);\PSFXY.9%G$, 7F:WAD?BT==#-OZ !]2WUCB,G]S\9>XUC*'
M'_GP8C55J]3-R2F8T\#W978_17WFH9DCWA?42+DJ)VP]82!K QZ\:P\:&&O8
M12--I*AAIU>*+<5GOA/3M3$D*GDFRK'S6 I;\X+LXA\/2'ILI;K:,3NZ6&M8
M#4$1?Z CKU-C41ZE=2-.K8_-7;Q;&<U(S:L*1LL"WSJYR*(P*X6IK^NU;&^+
MXKZ95!FWL/-<V 'V*^)\>]?4Q&]HYRJ+9R>CY^)*_V8F"T;%G]N'BD63A>V@
MJ+)(%VHQ5PHPS6K2E.ZQFO.E7QY?ETH%'72YE:FI,IO=2 L=YGPIIC;$C$F$
MGI>.GC/I7=;'>9E,-[>G-*$;%QIGA3\KI/_IG)*C%CHEGS"^#WM/:(=68>SQ
MSDC.L#W)>%89\9K[.@+G*DT=>IO&&[S/7X9<8*Z[S=:["; $XKSB0HZ<V)'C
MIU$<)N9Z;T_)>[Y-N5C5RDCG6=Q%=BFTHY;ZQC@J?[T%-WZ6BJ%5]W T< FW
M]!*.*V^G-V-:]W#<L6\5[;98V@2F++F\V!*O0TTUIFWOQLPNL +Y4CZ"SA:9
M:]&S*V"PU)NI+> 'J23($4,S-<W<Q.4[5R<8C6Q*P5?H=*7[!F<4H.Y+JESF
MBB4IAO@0B3M>=3ZSP-Y-8JV^5DRJZUR018?NR*%>W5S<*Q=H (6;A15D<2A,
M9*7L03-%8Y!'EW:D%B0\&AUU'6M-TE*\\]M".TJVI3B3\X/TXOBJF3V1Y6L@
MLF-D,CU4C>-1>QLSS1I(D+F6K=\;[$WV]T[26)2O##SUI*A.TMA,BKZ^?-(4
M04_[YQ]A&B)& R9*(MKO%L&KHWI_V9].DCNIE^1PMLK]Z84:#&;#X]ZT-YNZ
MI\/!Z>1T-!I,CMW^0,KQ>'0Z^N?P15ND/WT23WG5=P.5US?.I^N[FZN/'YU/
M/U_=7KU_VZG(:XM C^$26DAD;B55M' WWAAF;D3DFXJ!GB )]Y$$:!Y$_%._
M3OD#V^D'HZ_"2=FH]K3(6<(Q%&,.^-* >USR5'@:3R8""#_) +OE_EC)!(^
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MV5N0TV650:*WQUN]X:X,7O2&(MR%6T7%<!%P2OTS8K -^ 8XD2\/-I3<,)3
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M%GC06O-0Y=$@MI[=O<W=($_^!E!+ P04    " !*5J56^ ;U/_@#  "L#@
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M'.=.E*=_ 5!+ 0(4 Q0    ( $I6I597.3 6AK0#  9&+P /
M  "  0    !C:2TR,#(S,#,S,2YH=&U02P$"% ,4    " !*5J56N0%]0 DO
M   L4P( #P              @ &SM , 8VDM,C R,S S,S$N>'-D4$L! A0#
M%     @ 2E:E5CJW.%^,2   $2,# !,              ( !Z>,# &-I+3(P
M,C,P,S,Q7V-A;"YX;6Q02P$"% ,4    " !*5J56P<9)X4+9   KY@D $P
M            @ &F+ 0 8VDM,C R,S S,S%?9&5F+GAM;%!+ 0(4 Q0    (
M $I6I5;>#YVGA-\! *%, @ 2              "  1D&!0!C:2TR,#(S,#,S
M,5]G,2YJ<&=02P$"% ,4    " !*5J56%]DD>(@X @#,JQ8 $P
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M86QP8FTN:'1M4$L! A0#%     @ 2E:E5O#J6=. '@  <[<  !X
M     ( !_X$* &5X:&EB:70S,2UT:&5C:6=N86=R;W5P>')E+FAT;5!+ 0(4
M Q0    ( $I6I589UX)5O <  *\D   6              "  ;N@"@!E>&AI
M8FET,S$Q+3(P,C-?<3$N:'1M4$L! A0#%     @ 2E:E5D+X'K:C!P  L2,
M !8              ( !JZ@* &5X:&EB:70S,3(M,C R,U]Q,2YH=&U02P$"
M% ,4    " !*5J56QB/4 ?@#  "<#@  %@              @ &"L H 97AH
M:6)I=#,R,2TR,#(S7W$Q+FAT;5!+ 0(4 Q0    ( $I6I5;X!O4_^ ,  *P.
M   6              "  :ZT"@!E>&AI8FET,S(R+3(P,C-?<3$N:'1M4$L%
3!@     .  X IP,  -JX"@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
